PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Brito, L; Fisk, D; Abreu, A; Pan, JH; Dehgan, A; Kabat, P; Duflo, E				Brito, Lidia; Fisk, David; Abreu, Alice; Pan, Jiahua; Dehgan, Alex; Kabat, Pavel; Duflo, Esther			Science for Sustainable Development	SCIENCE			English	Editorial Material									[Brito, Lidia] UNESCO, Div Sci Policy & Capac Bldg, F-75352 Paris, France; [Fisk, David] Imperial Coll London, Laing ORourke Ctr Syst Engn & Innovat, London SW7 2AZ, England; [Abreu, Alice] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil; [Abreu, Alice] Int Council Sci ICSU, Mexico City, DF, Mexico; [Pan, Jiahua] Chinese Acad Sci, Res Ctr Sustainable Dev, Beijing, Peoples R China; [Dehgan, Alex] US Agcy Int Dev, Washington, DC 20523 USA; [Kabat, Pavel] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Kabat, Pavel] Univ Wageningen & Res Ctr, Earth Syst Sci & Climate Change Grp, NL-6700 AA Wageningen, Netherlands; [Duflo, Esther] Abdul Latif Jameel Poverty Action Lab, Cambridge, MA 02142 USA; [Duflo, Esther] MIT, Cambridge, MA 02139 USA	Imperial College London; Universidade Federal do Rio de Janeiro; Chinese Academy of Sciences; United States Agency for International Development (USAID); International Institute for Applied Systems Analysis (IIASA); Wageningen University & Research; Massachusetts Institute of Technology (MIT)	Brito, L (corresponding author), UNESCO, Div Sci Policy & Capac Bldg, F-75352 Paris, France.		Kabat, Pavel/AAJ-2245-2020	Fisk, David/0000-0003-3335-5695					0	21	21	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1396	1398						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700913				2022-12-28	WOS:000305211700033
J	Etienne, RS; Rosindell, J				Etienne, Rampal S.; Rosindell, James			Comment on "Global Correlations in Tropical Tree Species Richness and Abundance Reject Neutrality"	SCIENCE			English	Editorial Material							NUMBERS ADD; BIODIVERSITY; DIVERSITY; MODEL		[Rosindell, James] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England; [Etienne, Rampal S.] Univ Groningen, Ctr Ecol & Evolutionary Studies, NL-9700 CC Groningen, Netherlands	Imperial College London; University of Groningen	Rosindell, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biol, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	james@rosindell.org	Munoz, Francois/C-4239-2015; Etienne, Rampal S./F-5835-2012; Chen, Anping/H-9960-2014	Munoz, Francois/0000-0001-8776-4705; Etienne, Rampal S./0000-0003-2142-7612; Wang, Shaopeng/0000-0002-9430-8879; Rosindell, James/0000-0002-5060-9346; Chen, Anping/0000-0003-2085-3863	Natural Environment Research Council [NE/I021179/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Etienne RS, 2005, ECOL LETT, V8, P1147, DOI 10.1111/j.1461-0248.2005.00817.x; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; Hubbell Stephen P., 2001, V32, pi; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; Leigh EG, 2007, J EVOLUTION BIOL, V20, P2075, DOI 10.1111/j.1420-9101.2007.01410.x; Nee S, 2005, FUNCT ECOL, V19, P173, DOI 10.1111/j.0269-8463.2005.00922.x; Ostling AM, 2012, J PLANT ECOL, V5, P52, DOI 10.1093/jpe/rtr035; Rickfeld RE, 2003, OIKOS, V100, P185, DOI 10.1034/j.1600-0706.2003.12018.x; Ricklefs RE, 2006, ECOLOGY, V87, P1424, DOI 10.1890/0012-9658(2006)87[1424:TUNTOB]2.0.CO;2; Ricklefs RE, 2012, AM NAT, V179, P423, DOI 10.1086/664622; Ricklefs RE, 2012, SCIENCE, V335, P464, DOI 10.1126/science.1215182; Rosindell J, 2012, TRENDS ECOL EVOL, V27, P203, DOI 10.1016/j.tree.2012.01.004; Wennekes PL, 2012, ACTA BIOTHEOR, V60, P257, DOI 10.1007/s10441-012-9144-6	15	7	7	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089								10.1126/science.1222056	http://dx.doi.org/10.1126/science.1222056			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745404				2022-12-28	WOS:000305794500018
J	Munoz, F; Couteron, P; Hubbell, SP				Munoz, Francois; Couteron, Pierre; Hubbell, Stephen P.			Comment on "Global Correlations in Tropical Tree Species Richness and Abundance Reject Neutrality"	SCIENCE			English	Editorial Material							MODELS; DIVERSITY		[Munoz, Francois; Couteron, Pierre] Univ Montpellier 2, F-34398 Montpellier 5, France; [Munoz, Francois; Couteron, Pierre] Inst Rech Dev, UMR AMAP, F-34398 Montpellier 5, France; [Hubbell, Stephen P.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Hubbell, Stephen P.] Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Miami, FL 34002 USA	Universite de Montpellier; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of California System; University of California Los Angeles; Smithsonian Institution; Smithsonian Tropical Research Institute	Munoz, F (corresponding author), Univ Montpellier 2, TA A-51-PS2, F-34398 Montpellier 5, France.	francois.munoz@cirad.fr	Munoz, Francois/C-4239-2015; Etienne, Rampal S./F-5835-2012; Chen, Anping/H-9960-2014	Munoz, Francois/0000-0001-8776-4705; Etienne, Rampal S./0000-0003-2142-7612; Wang, Shaopeng/0000-0002-9430-8879; Rosindell, James/0000-0002-5060-9346; Chen, Anping/0000-0003-2085-3863	Natural Environment Research Council [NE/I021179/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Chave J, 2006, NATURE, V441, pE1, DOI 10.1038/nature04826; Chisholm RA, 2010, P NATL ACAD SCI USA, V107, P15821, DOI 10.1073/pnas.1009387107; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Hubbell Stephen P., 2001, V32, pi; Munoz F, 2008, AM NAT, V172, P116, DOI 10.1086/587842; Ricklefs RE, 2012, SCIENCE, V335, P464, DOI 10.1126/science.1215182	6	7	7	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089								10.1126/science.1222718	http://dx.doi.org/10.1126/science.1222718			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745404				2022-12-28	WOS:000305794500021
J	Iess, L; Jacobson, RA; Ducci, M; Stevenson, DJ; Lunine, JI; Armstrong, JW; Asmar, SW; Racioppa, P; Rappaport, NJ; Tortora, P				Iess, Luciano; Jacobson, Robert A.; Ducci, Marco; Stevenson, David J.; Lunine, Jonathan I.; Armstrong, John W.; Asmar, Sami W.; Racioppa, Paolo; Rappaport, Nicole J.; Tortora, Paolo			The Tides of Titan	SCIENCE			English	Article							OCEAN; ICE	We have detected in Cassini spacecraft data the signature of the periodic tidal stresses within Titan, driven by the eccentricity (e = 0.028) of its 16-day orbit around Saturn. Precise measurements of the acceleration of Cassini during six close flybys between 2006 and 2011 have revealed that Titan responds to the variable tidal field exerted by Saturn with periodic changes of its quadrupole gravity, at about 4% of the static value. Two independent determinations of the corresponding degree-2 Love number yield k(2) = 0.589 +/- 0.150 and k(2) = 0.637 +/- 0.224 (2 sigma). Such a large response to the tidal field requires that Titan's interior be deformable over time scales of the orbital period, in a way that is consistent with a global ocean at depth.	[Iess, Luciano; Ducci, Marco; Racioppa, Paolo] Univ Roma La Sapienza, Dipartimento Ingn Meccan & Aerosp, I-00184 Rome, Italy; [Jacobson, Robert A.; Armstrong, John W.; Asmar, Sami W.; Rappaport, Nicole J.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Stevenson, David J.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Lunine, Jonathan I.] Cornell Univ, Dept Astron, Ithaca, NY 14850 USA; [Tortora, Paolo] Univ Bologna, DIEM II Fac Ingn, I-47121 Forli, Italy	Sapienza University Rome; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; Cornell University; University of Bologna	Iess, L (corresponding author), Univ Roma La Sapienza, Dipartimento Ingn Meccan & Aerosp, Via Eudossiana 18, I-00184 Rome, Italy.	luciano.iess@uniroma1.it	Tortora, Paolo/J-6191-2012; IESS, Luciano/F-4902-2011	Tortora, Paolo/0000-0001-9259-7673; IESS, Luciano/0000-0002-6230-5825; Ducci, Marco/0000-0003-2586-1037; Lunine, Jonathan/0000-0003-2279-4131	Italian Space Agency; NASA	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); NASA(National Aeronautics & Space Administration (NASA))	L.I., M.D., P.R., and P.T. acknowledge support from the Italian Space Agency. The work of R.A.J., J.W.A., S.W.A., and N.J.R. was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. The Doppler data used in this analysis are archived in NASA's Planetary Data System.	Asmar SW, 2005, RADIO SCI, V40, DOI 10.1029/2004RS003101; Beghin C, 2010, CR GEOSCI, V342, P425, DOI 10.1016/j.crte.2010.03.003; Castillo-Rogez JC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044398; Darwin G.H., 1879, PHIL T R SOC, V170, P1; Fortes AD, 2007, ICARUS, V188, P139, DOI 10.1016/j.icarus.2006.11.002; Goldsby DL, 2001, J GEOPHYS RES-SOL EA, V106, P11017, DOI 10.1029/2000JB900336; Iess L, 2010, SCIENCE, V327, P1367, DOI 10.1126/science.1182583; Paganelli F, 2008, PLANET SPACE SCI, V56, P100, DOI 10.1016/j.pss.2007.03.015; Rappaport N, 1997, ICARUS, V126, P313, DOI 10.1006/icar.1996.5661; Rappaport NJ, 2008, ICARUS, V194, P711, DOI 10.1016/j.icarus.2007.11.024; Sohl F, 2010, SCIENCE, V327, P1338, DOI 10.1126/science.1186255; Tobie G, 2005, ICARUS, V175, P496, DOI 10.1016/j.icarus.2004.12.007	12	171	173	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					457	459		10.1126/science.1219631	http://dx.doi.org/10.1126/science.1219631			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22745254	Green Published			2022-12-28	WOS:000306802300040
J	Grasso, CS; Wu, YM; Robinson, DR; Cao, XH; Dhanasekaran, SM; Khan, AP; Quist, MJ; Jing, X; Lonigro, RJ; Brenner, JC; Asangani, IA; Ateeq, B; Chun, SY; Siddiqui, J; Sam, L; Anstett, M; Mehra, R; Prensner, JR; Palanisamy, N; Ryslik, GA; Vandin, F; Raphael, BJ; Kunju, LP; Rhodes, DR; Pienta, KJ; Chinnaiyan, AM; Tomlins, SA				Grasso, Catherine S.; Wu, Yi-Mi; Robinson, Dan R.; Cao, Xuhong; Dhanasekaran, Saravana M.; Khan, Amjad P.; Quist, Michael J.; Jing, Xiaojun; Lonigro, Robert J.; Brenner, J. Chad; Asangani, Irfan A.; Ateeq, Bushra; Chun, Sang Y.; Siddiqui, Javed; Sam, Lee; Anstett, Matt; Mehra, Rohit; Prensner, John R.; Palanisamy, Nallasivam; Ryslik, Gregory A.; Vandin, Fabio; Raphael, Benjamin J.; Kunju, Lakshmi P.; Rhodes, Daniel R.; Pienta, Kenneth J.; Chinnaiyan, Arul M.; Tomlins, Scott A.			The mutational landscape of lethal castration-resistant prostate cancer	NATURE			English	Article							ANDROGEN RECEPTOR; FOXA1; NETWORK; FUSIONS; BINDING	Characterization of the prostate cancer transcriptome and genome has identified chromosomal rearrangements and copy number gains and losses, including ETS gene family fusions, PTEN loss and androgen receptor (AR) amplification, which drive prostate cancer development and progression to lethal, metastatic castration-resistant prostate cancer (CRPC)(1). However, less is known about the role of mutations(2-4). Here we sequenced the exomes of 50 lethal, heavily pre-treated metastatic CRPCs obtained at rapid autopsy (including three different foci from the same patient) and 11 treatment-naive, high-grade localized prostate cancers. We identified low overall mutation rates even in heavily treated CRPCs (2.00 per megabase) and confirmed the monoclonal origin of lethal CRPC. Integrating exome copy number analysis identified disruptions of CHD1 that define a subtype of ETS gene family fusion-negative prostate cancer. Similarly, we demonstrate that ETS2, which is deleted in approximately one-third of CRPCs (commonly through TMPRSS2:ERG fusions), is also deregulated through mutation. Furthermore, we identified recurrent mutations in multiple chromatin- and histone-modifying genes, including MLL2 (mutated in 8.6% of prostate cancers), and demonstrate interaction of the MLL complex with the AR, which is required for AR-mediated signalling. We also identified novel recurrent mutations in the AR collaborating factor FOXA1, which is mutated in 5 of 147 (3.4%) prostate cancers (both untreated localized prostate cancer and CRPC), and showed that mutated FOXA1 represses androgen signalling and increases tumour growth. Proteins that physically interact with the AR, such as the ERG gene fusion product, FOXA1, MLL2, UTX (also known as KDM6A) and ASXL1 were found to be mutated in CRPC. In summary, we describe the mutational landscape of a heavily treated metastatic cancer, identify novel mechanisms of AR signalling deregulated in prostate cancer, and prioritize candidates for future study.	[Grasso, Catherine S.; Wu, Yi-Mi; Robinson, Dan R.; Cao, Xuhong; Dhanasekaran, Saravana M.; Khan, Amjad P.; Quist, Michael J.; Jing, Xiaojun; Lonigro, Robert J.; Brenner, J. Chad; Asangani, Irfan A.; Ateeq, Bushra; Chun, Sang Y.; Siddiqui, Javed; Sam, Lee; Mehra, Rohit; Prensner, John R.; Palanisamy, Nallasivam; Kunju, Lakshmi P.; Rhodes, Daniel R.; Pienta, Kenneth J.; Chinnaiyan, Arul M.; Tomlins, Scott A.] Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Grasso, Catherine S.; Wu, Yi-Mi; Robinson, Dan R.; Dhanasekaran, Saravana M.; Khan, Amjad P.; Quist, Michael J.; Jing, Xiaojun; Asangani, Irfan A.; Ateeq, Bushra; Siddiqui, Javed; Mehra, Rohit; Prensner, John R.; Palanisamy, Nallasivam; Kunju, Lakshmi P.; Rhodes, Daniel R.; Chinnaiyan, Arul M.; Tomlins, Scott A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Lonigro, Robert J.; Palanisamy, Nallasivam; Pienta, Kenneth J.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA; [Anstett, Matt; Rhodes, Daniel R.] Compendia Biosci, Ann Arbor, MI 48104 USA; [Ryslik, Gregory A.] Yale Sch Publ Hlth, Div Biostat, New Haven, CT 06520 USA; [Vandin, Fabio; Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Vandin, Fabio; Raphael, Benjamin J.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA; [Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Pienta, Kenneth J.; Chinnaiyan, Arul M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University; Brown University; Brown University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pienta, KJ (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	kpienta@med.umich.edu; arul@umich.edu	Ateeq, Bushra/I-3967-2019; Palanisamy, Nallasivam/ABC-8844-2020; Pienta, Kenneth/E-7679-2015	Ateeq, Bushra/0000-0003-4682-9773; Palanisamy, Nallasivam/0000-0002-0633-9772; Prensner, John/0000-0002-7024-636X; Dhanasekaran, saravana mohan/0000-0002-0489-2224; Tomlins, Scott/0000-0001-8661-9821; asangani, irfan/0000-0001-5381-1702; Pienta, Kenneth/0000-0002-4138-2186	National Institutes of Health S.P.O.R.E. [P50 CA69568]; Early Detection Research Network [U01 CA111275, U01 CA113913]; National Functional Genomics Center [W81XWH-09-2-0014]; Prostate Cancer Foundation; American Cancer Society; Doris Duke Foundation; Department of Defense (DOD) [W81XWH-11-1-0339, PC094290]; UM SPORE career development award;  [R01CA132874]; NATIONAL CANCER INSTITUTE [P50CA069568, U01CA111275, R01CA013287, R01CA132874, U01CA113913, T32CA009676, P30CA046592] Funding Source: NIH RePORTER	National Institutes of Health S.P.O.R.E.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network; National Functional Genomics Center; Prostate Cancer Foundation; American Cancer Society(American Cancer Society); Doris Duke Foundation(Doris Duke Charitable Foundation (DDCF)); Department of Defense (DOD)(United States Department of Defense); UM SPORE career development award; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank the patients and families who participated in the rapid autopsy program. The authors thank C. Kumar, J. Shendure, M. Chaisson and A. Mortazavi for assistance with next-generation sequencing data analysis, K. Giles for assistance with manuscript preparation, and S. Varambally, A. Yocum, T. Barrette and M. Iyer for technical assistance. Supported in part by the National Institutes of Health S.P.O.R.E. (P50 CA69568) to K. J. P. and A. M. C., the Early Detection Research Network (U01 CA111275 and U01 CA113913) to A. M. C., R01CA132874 and the National Functional Genomics Center (W81XWH-09-2-0014) to A. M. C. A. M. C. and K. J. P. are supported by the Prostate Cancer Foundation and are American Cancer Society Clinical Research Professors and A. Alfred Taubman Scholars. A. M. C. is supported by the Doris Duke Foundation. D. R. Robinson is supported by a Department of Defense (DOD) Postdoctoral Award (W81XWH-11-1-0339). J. R. P. is supported by a DOD Predoctoral Award (PC094290). N.P. was supported by a UM SPORE career development award. S. A. T. and J. C. B. were supported by Young Investigator Awards from the Prostate Cancer Foundation.	Attard G, 2009, CANCER RES, V69, P4937, DOI 10.1158/0008-5472.CAN-08-4531; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Demichelis F, 2009, GENE CHROMOSOME CANC, V48, P366, DOI 10.1002/gcc.20647; Gao N, 2003, MOL ENDOCRINOL, V17, P1484, DOI 10.1210/me.2003-0020; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lonigro RJ, 2011, NEOPLASIA, V13, P1019, DOI 10.1593/neo.111252; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Werner MH, 1997, J BIOMOL NMR, V10, P317, DOI 10.1023/A:1018399711996; Yoshimoto M, 2006, NEOPLASIA, V8, P465, DOI 10.1593/neo.06283; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yu XP, 2005, ANN NY ACAD SCI, V1061, P77, DOI 10.1196/annals.1336.009; Zhang CP, 2011, CANCER RES, V71, P6738, DOI 10.1158/0008-5472.CAN-11-1882	23	1731	1780	6	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2012	487	7406					239	243		10.1038/nature11125	http://dx.doi.org/10.1038/nature11125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22722839	Green Accepted			2022-12-28	WOS:000306278900041
J	Brogaard, K; Xi, LQ; Wang, JP; Widom, J				Brogaard, Kristin; Xi, Liqun; Wang, Ji-Ping; Widom, Jonathan			A map of nucleosome positions in yeast at base-pair resolution	NATURE			English	Article							CENTROMERIC NUCLEOSOME; DNA INTERACTIONS; CHROMATIN; TRANSCRIPTION; ORGANIZATION; SEQUENCE; HISTONE; FACILITATE; MECHANISM; CLEAVAGE	The exact positions of nucleosomes along genomic DNA can influence many aspects of chromosome function. However, existing methods for mapping nucleosomes do not provide the necessary single-base-pair accuracy to determine these positions. Here we develop and apply a new approach for direct mapping of nucleosome centres on the basis of chemical modification of engineered histones. The resulting map locates nucleosome positions genome-wide in unprecedented detail and accuracy. It shows new aspects of the in vivo nucleosome organization that are linked to transcription factor binding, RNA polymerase pausing and the higher-order structure of the chromatin fibre.	[Xi, Liqun; Wang, Ji-Ping] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA; [Brogaard, Kristin; Widom, Jonathan] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Widom, Jonathan] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Wang, JP (corresponding author), Northwestern Univ, Dept Stat, Evanston, IL 60208 USA.	jzwang@northwestern.edu	Xi, Liqun/I-7689-2014		National Institutes of Health [T32GM00806, R01GM058617, R01GM075313, U54CA143869]; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075313, T32GM008061, R01GM058617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this paper to J.W., who guided this project. We thank R. Holmgren, A. Matouschek, B. Meyer, R. Phillips, E. Segal and O. Uhlenbeck for comments and discussions. We are grateful to Northwestern University's Genomic Core for all sequencing completed for this project. The work was supported by National Institutes of Health grants T32GM00806 (to K. B.), R01GM058617 (to J.W.), R01GM075313 (to J.-P.W.) and U54CA143869 (to J.W.).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; BECKMANN JS, 1991, P NATL ACAD SCI USA, V88, P2380, DOI 10.1073/pnas.88.6.2380; Chung HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015754; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; COCKELL M, 1983, J MOL BIOL, V170, P423, DOI 10.1016/S0022-2836(83)80156-9; Cole HA, 2011, P NATL ACAD SCI USA, V108, P12687, DOI 10.1073/pnas.1104978108; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; DINGWALL C, 1981, NUCLEIC ACIDS RES, V9, P2659, DOI 10.1093/nar/9.12.2659; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Dorn ES, 2011, EPIGENETICS-US, V6, P552, DOI 10.4161/epi.6.5.15082; Engeholm M, 2009, NAT STRUCT MOL BIOL, V16, P151, DOI 10.1038/nsmb.1551; Fan XC, 2010, P NATL ACAD SCI USA, V107, P17945, DOI 10.1073/pnas.1012674107; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Flaus A, 1999, METHOD ENZYMOL, V304, P251; Flaus A, 1996, P NATL ACAD SCI USA, V93, P1370, DOI 10.1073/pnas.93.4.1370; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; Koslover EF, 2010, BIOPHYS J, V99, P3941, DOI 10.1016/j.bpj.2010.10.024; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; LOHR D, 1979, P NATL ACAD SCI USA, V76, P6326, DOI 10.1073/pnas.76.12.6326; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mao CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017521; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Owen-Hughes Thomas, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P403; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Raveh-Sadka T, 2009, GENOME RES, V19, P1480, DOI 10.1101/gr.088260.108; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Teif VB, 2009, NUCLEIC ACIDS RES, V37, P5641, DOI 10.1093/nar/gkp610; Thastrom A, 2004, METHODS, V33, P33, DOI 10.1016/j.ymeth.2003.10.018; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; TRAVERS AA, 1987, PHILOS T ROY SOC B, V317, P537, DOI 10.1098/rstb.1987.0080; Wang JP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000175; Wang JPZ, 2005, NUCLEIC ACIDS RES, V33, P6743, DOI 10.1093/nar/gki977; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; YAGER TD, 1989, BIOCHEMISTRY-US, V28, P2271, DOI 10.1021/bi00431a045; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508	49	304	310	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					496	501		10.1038/nature11142	http://dx.doi.org/10.1038/nature11142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722846	Green Accepted			2022-12-28	WOS:000305760600035
J	Diaz, LA; Williams, RT; Wu, J; Kinde, I; Hecht, JR; Berlin, J; Allen, B; Bozic, I; Reiter, JG; Nowak, MA; Kinzler, KW; Oliner, KS; Vogelstein, B				Diaz, Luis A., Jr.; Williams, Richard T.; Wu, Jian; Kinde, Isaac; Hecht, J. Randolph; Berlin, Jordan; Allen, Benjamin; Bozic, Ivana; Reiter, Johannes G.; Nowak, Martin A.; Kinzler, Kenneth W.; Oliner, Kelly S.; Vogelstein, Bert			The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers	NATURE			English	Article							MET AMPLIFICATION; LUNG-CANCER; MUTATIONS; DNA; CETUXIMAB; CELLS; KRAS	Colorectal tumours that are wild type for KRAS are often sensitive to EGFR blockade, but almost always develop resistance within several months of initiating therapy(1,2). The mechanisms underlying this acquired resistance to anti-EGFR antibodies are largely unknown. This situation is in marked contrast to that of small-molecule targeted agents, such as inhibitors of ABL, EGFR, BRAF and MEK, in which mutations in the genes encoding the protein targets render the tumours resistant to the effects of the drugs(3-6). The simplest hypothesis to account for the development of resistance to EGFR blockade is that rare cells with KRAS mutations preexist at low levels in tumours with ostensibly wild-type KRAS genes. Although this hypothesis would seem readily testable, there is no evidence in pre-clinical models to support it, nor is there data from patients. To test this hypothesis, we determined whether mutant KRAS DNA could be detected in the circulation of 28 patients receiving monotherapy with panitumumab, a therapeutic anti-EGFR antibody. We found that 9 out of 24 (38%) patients whose tumours were initially KRAS wild type developed detectable mutations in KRAS in their sera, three of which developed multiple different KRAS mutations. The appearance of these mutations was very consistent, generally occurring between 5 and 6 months following treatment. Mathematical modelling indicated that the mutations were present in expanded subclones before the initiation of panitumumab treatment. These results suggest that the emergence of KRAS mutations is a mediator of acquired resistance to EGFR blockade and that these mutations can be detected in a non-invasive manner. They explain why solid tumours develop resistance to targeted therapies in a highly reproducible fashion.	[Diaz, Luis A., Jr.; Wu, Jian; Kinde, Isaac; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21287 USA; [Diaz, Luis A., Jr.; Wu, Jian; Kinde, Isaac; Kinzler, Kenneth W.; Vogelstein, Bert] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21287 USA; [Diaz, Luis A., Jr.] Swim Amer Lab Johns Hopkins, Baltimore, MD 21287 USA; [Williams, Richard T.; Oliner, Kelly S.] Amgen Inc, Thousand Oaks, CA 91320 USA; [Wu, Jian] Fourth Mil Med Univ, Cell Engn Res Ctr, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Wu, Jian] Fourth Mil Med Univ, Dept Cell Biol, Xian 710032, Peoples R China; [Hecht, J. Randolph] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Berlin, Jordan] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Allen, Benjamin; Bozic, Ivana; Reiter, Johannes G.; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Reiter, Johannes G.] IST Austria, A-3400 Klosterneuburg, Austria	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Amgen; Air Force Military Medical University; Air Force Military Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vanderbilt University; Harvard University; Institute of Science & Technology - Austria	Diaz, LA (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21287 USA.	ldiaz1@jhmi.edu; koliner@amgen.com	Reiter, Johannes G./Y-4083-2019; Allen, Benjamin I/F-1829-2011; Nowak, Martin A/A-6977-2008; Zheng, Wei/O-3351-2013; Bozic, Ivana/C-5003-2008; ravegnini, gloria/K-1330-2016	Reiter, Johannes G./0000-0002-0170-7353; Allen, Benjamin I/0000-0002-9746-7613; Zheng, Wei/0000-0003-1226-070X; Bozic, Ivana/0000-0003-2761-825X; ravegnini, gloria/0000-0002-7774-402X; Diaz, Luis/0000-0002-7079-8914	Virginia and D. K. Ludwig Fund for Cancer Research; National Colorectal Cancer Research Alliance; NIH [CA129825, CA43460, CA57345, CA62924, CA095103, R01 GM078986]; NCI [N01-CN-43309]; ERC [279307]; FWF NFN [S11407-N23]; John Templeton Foundation; NATIONAL CANCER INSTITUTE [R01CA043309, R01CA043460, R01CA057345, R01CA129825, R37CA057345, R37CA043460, P50CA095103, P50CA062924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058008, R01GM078986] Funding Source: NIH RePORTER	Virginia and D. K. Ludwig Fund for Cancer Research; National Colorectal Cancer Research Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ERC(European Research Council (ERC)European Commission); FWF NFN(Austrian Science Fund (FWF)); John Templeton Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Schaeffer, J. Ptak, N. Silliman and L. Dobbyn for technical assistance and M. Ekdahl for operational assistance. This work was supported by The Virginia and D. K. Ludwig Fund for Cancer Research, the National Colorectal Cancer Research Alliance, NIH grants CA129825, CA43460, CA57345, CA62924, CA095103, and R01 GM078986, NCI contract N01-CN-43309, ERC Start grant (279307: Graph Games), FWF NFN Grant No S11407-N23 (Rise), and the John Templeton Foundation. Simulations were performed on the Orchestra cluster supported by the Harvard Medical School Research Information Technology Group.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Corcoran RB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001148; Dewanji A, 2005, MATH BIOSCI, V197, P140, DOI 10.1016/j.mbs.2005.07.003; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Durrett R, 2010, THEOR POPUL BIOL, V77, P42, DOI 10.1016/j.tpb.2009.10.008; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Hecht JR, 2010, CLIN CANCER RES, V16, P2205, DOI 10.1158/1078-0432.CCR-09-2017; Holdhoff M, 2009, JNCI-J NATL CANCER I, V101, P1284, DOI 10.1093/jnci/djp240; Iwasa Y, 2006, GENETICS, V172, P2557, DOI 10.1534/genetics.105.049791; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Leder K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027682; Lenaerts T, 2010, HAEMATOL-HEMATOL J, V95, P900, DOI 10.3324/haematol.2009.015271; Lu Y, 2007, CANCER RES, V67, P8240, DOI 10.1158/0008-5472.CAN-07-0589; Luria SE, 1943, GENETICS, V28, P491; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Rago C, 2007, CANCER RES, V67, P9364, DOI 10.1158/0008-5472.CAN-07-0605; Tomasetti C, 2010, P NATL ACAD SCI USA, V107, P16766, DOI 10.1073/pnas.1007726107; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442	28	1234	1278	4	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					537	540		10.1038/nature11219	http://dx.doi.org/10.1038/nature11219			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722843	Green Accepted			2022-12-28	WOS:000305760600044
J	Kang, MK; Ha, JW				Kang, Min-Kyung; Ha, Jong-Won			Porcelain Aorta	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kang, Min-Kyung; Ha, Jong-Won] Yonsei Univ, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Kang, MK (corresponding author), Yonsei Univ, Coll Med, Seoul, South Korea.	homes78@naver.com							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					E40	E40		10.1056/NEJMicm1107270	http://dx.doi.org/10.1056/NEJMicm1107270			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965DP	22738115				2022-12-28	WOS:000305747000011
J	Klimov, NN; Jung, S; Zhu, SZ; Li, T; Wright, CA; Solares, SD; Newell, DB; Zhitenev, NB; Stroscio, JA				Klimov, Nikolai N.; Jung, Suyong; Zhu, Shuze; Li, Teng; Wright, C. Alan; Solares, Santiago D.; Newell, David B.; Zhitenev, Nikolai B.; Stroscio, Joseph A.			Electromechanical Properties of Graphene Drumheads	SCIENCE			English	Article							FIELD	We determined the electromechanical properties of a suspended graphene layer by scanning tunneling microscopy (STM) and scanning tunneling spectroscopy (STS) measurements, as well as computational simulations of the graphene-membrane mechanics and morphology. A graphene membrane was continuously deformed by controlling the competing interactions with a STM probe tip and the electric field from a back-gate electrode. The probe tip-induced deformation created a localized strain field in the graphene lattice. STS measurements on the deformed suspended graphene display an electronic spectrum completely different from that of graphene supported by a substrate. The spectrum indicates the formation of a spatially confined quantum dot, in agreement with recent predictions of confinement by strain-induced pseudomagnetic fields.	[Klimov, Nikolai N.; Jung, Suyong; Li, Teng; Solares, Santiago D.] Univ Maryland, Maryland Nanoctr, College Pk, MD 20742 USA; [Klimov, Nikolai N.; Jung, Suyong; Zhitenev, Nikolai B.; Stroscio, Joseph A.] NIST, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA; [Klimov, Nikolai N.; Newell, David B.] NIST, Phys Measurement Lab, Gaithersburg, MD 20899 USA; [Zhu, Shuze; Li, Teng; Wright, C. Alan; Solares, Santiago D.] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park	Li, T (corresponding author), Univ Maryland, Maryland Nanoctr, College Pk, MD 20742 USA.	lit@umd.edu; ssolares@umd.edu; joseph.stroscio@nist.gov	Zhu, Shuze/H-4303-2012; Li, Teng/AGX-2437-2022; Li, Teng/B-1585-2008; Zhitenev, Nikolai/N-1780-2014	Li, Teng/0000-0001-6252-561X; Li, Teng/0000-0001-6252-561X; Zhitenev, Nikolai/0000-0002-7477-6341; Solares, Santiago/0000-0003-0895-8160	U.S. National Science Foundation [CMMI-1069076, CMMI-1129826, CMMI-0841840]; Directorate For Engineering [1129826, 1069076] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We thank M. Stiles and S. Adam for valuable discussions and S. Blankenship and A. Band for technical assistance. The U.S. National Science Foundation is gratefully acknowledged via grants CMMI-1069076 and CMMI-1129826 (T.L. and S.Z.) and grant CMMI-0841840 (C.A.W. and S.D.S.).	Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Fogler MM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.226804; Gibertini M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125437; Guttinger J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.046810; Guinea F, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.205421; Guinea F, 2010, NAT PHYS, V6, P30, DOI 10.1038/NPHYS1420; Guinea F, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.035408; Jung SY, 2011, NAT PHYS, V7, P245, DOI 10.1038/NPHYS1866; Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384; Kim KJ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.081401; Kouwenhoven LP, 2001, REP PROG PHYS, V64, P701, DOI 10.1088/0034-4885/64/6/201; LeRoy BJ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.075413; Levy N, 2010, SCIENCE, V329, P544, DOI 10.1126/science.1191700; Li GH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176804; Luican A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.041405; Miller DL, 2009, SCIENCE, V324, P924, DOI 10.1126/science.1171810; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Rutter GM, 2011, NAT PHYS, V7, P649, DOI [10.1038/NPHYS1988, 10.1038/nphys1988]; Stroscio JA, 2002, NANOSTRUCTURE SCIENCE, METROLOGY AND TECHNOLOGY, P112, DOI 10.1117/12.438493; Wakker GMM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195427; Wehling TO, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/17003	21	233	237	12	364	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1557	1561		10.1126/science.1220335	http://dx.doi.org/10.1126/science.1220335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723417				2022-12-28	WOS:000305507500051
J	Loke, D; Lee, TH; Wang, WJ; Shi, LP; Zhao, R; Yeo, YC; Chong, TC; Elliott, SR				Loke, D.; Lee, T. H.; Wang, W. J.; Shi, L. P.; Zhao, R.; Yeo, Y. C.; Chong, T. C.; Elliott, S. R.			Breaking the Speed Limits of Phase-Change Memory	SCIENCE			English	Article							CRYSTALLIZATION BEHAVIOR; NONVOLATILE; GE2SB2TE5	Phase-change random-access memory (PCRAM) is one of the leading candidates for next-generation data-storage devices, but the trade-off between crystallization (writing) speed and amorphous-phase stability (data retention) presents a key challenge. We control the crystallization kinetics of a phase-change material by applying a constant low voltage via prestructural ordering (incubation) effects. A crystallization speed of 500 picoseconds was achieved, as well as high-speed reversible switching using 500-picosecond pulses. Ab initio molecular dynamics simulations reveal the phase-change kinetics in PCRAM devices and the structural origin of the incubation-assisted increase in crystallization speed. This paves the way for achieving a broadly applicable memory device, capable of nonvolatile operations beyond gigahertz data-transfer rates.	[Loke, D.; Wang, W. J.; Shi, L. P.; Zhao, R.] ASTAR, Data Storage Inst, Singapore 117608, Singapore; [Loke, D.; Lee, T. H.; Elliott, S. R.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Loke, D.] NUS, Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Yeo, Y. C.] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117576, Singapore; [Chong, T. C.] Singapore Univ Technol & Design, Singapore 138682, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Data Storage Institute; University of Cambridge; National University of Singapore; National University of Singapore; Singapore University of Technology & Design	Shi, LP (corresponding author), ASTAR, Data Storage Inst, 5 Engn Dr 1, Singapore 117608, Singapore.	shi_luping@dsi.a-star.edu.sg; sre1@cam.ac.uk	Yeo, Y/GWV-3316-2022; Yeo, Yee-Chia/J-9029-2013; Shi, Lu/AAG-5414-2021; Lee, Tae Hoon/AAB-7490-2021	Loke, Desmond/0000-0001-5799-6441	Advanced Memory Research Program of A*STAR; Data Storage Institute (Singapore); Engineering and Physical Sciences Research Council (UK); NUS Graduate School for Integrative Sciences and Engineering	Advanced Memory Research Program of A*STAR; Data Storage Institute (Singapore); Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NUS Graduate School for Integrative Sciences and Engineering(National University of Singapore)	We acknowledge support by the Advanced Memory Research Program of A*STAR, the Nonvolatile Memory Research Program of Data Storage Institute (Singapore), and the Engineering and Physical Sciences Research Council (UK). The experiments were carried out in the Data Storage Institute, A*STAR, and the AIMD simulations were performed using the Cambridge High-Performance Computing Facility. D. L. thanks the NUS Graduate School for Integrative Sciences and Engineering for scholarship support.	ADLER D, 1978, REV MOD PHYS, V50, P209, DOI 10.1103/RevModPhys.50.209; Bruns G, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3191670; Chong TC, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2181191; Christian J.W, 1975, THEORY TRANSFORMATIO; COOMBS JH, 1995, J APPL PHYS, V78, P4918, DOI 10.1063/1.359780; HA YH, 2003, S VLSI, P175, DOI DOI 10.1016/J.MATLET.2009.11.001; HORII H, 2003, S VLSI TECHN, P177; Jeong TH, 1999, J APPL PHYS, V86, P774, DOI 10.1063/1.370803; Karpov VG, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2715024; Khulbe PK, 2000, J APPL PHYS, V88, P3926, DOI 10.1063/1.1289811; Lai S., 2001, INT EL DEV M, DOI DOI 10.1109/IEDM.2001.979636; Lankhorst MHR, 2005, NAT MATER, V4, P347, DOI 10.1038/nmat1350; Lee BS, 2009, SCIENCE, V326, P980, DOI 10.1126/science.1177483; Lee SH, 2007, NAT NANOTECHNOL, V2, P626, DOI 10.1038/nnano.2007.291; Lee TH, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.145702; Loke D, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/25/254019; Ohshima N, 1996, J APPL PHYS, V79, P8357, DOI 10.1063/1.362548; Orava J, 2012, NAT MATER, V11, P279, DOI [10.1038/NMAT3275, 10.1038/nmat3275]; OVSHINSKY SR, 1968, PHYS REV LETT, V21, P1450, DOI 10.1103/PhysRevLett.21.1450; Pellizzer F, 2004, 2004 SYMPOSIUM ON VLSI TECHNOLOGY, DIGEST OF TECHNICAL PAPERS, P18; Pirovano A., 2003, IEDM, P2961; Raoux S, 2008, J APPL PHYS, V103, DOI 10.1063/1.2938076; TURNBULL D, 1949, J CHEM PHYS, V17, P71, DOI 10.1063/1.1747055; Volmer M, 1926, Z PHYS CHEM-STOCH VE, V119, P277; Wang WJ, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2963196; Wang Y., 2009, P SOC PHOTO-OPT INS; Wong HSP, 2010, P IEEE, V98, P2201, DOI 10.1109/JPROC.2010.2070050; Wuttig M, 2005, NAT MATER, V4, P265, DOI 10.1038/nmat1359; Xiong F, 2011, SCIENCE, V332, P568, DOI 10.1126/science.1201938; YAMADA N, 1991, J APPL PHYS, V69, P2849, DOI 10.1063/1.348620; Yeo EG, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3155200; Zhou GF, 2001, MAT SCI ENG A-STRUCT, V304, P73, DOI 10.1016/S0921-5093(00)01448-9	32	590	602	18	417	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1566	1569		10.1126/science.1221561	http://dx.doi.org/10.1126/science.1221561			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723419				2022-12-28	WOS:000305507500053
J	Sachdev, S				Sachdev, Subir			Entangling Superconductivity and Antiferromagnetism	SCIENCE			English	Editorial Material									Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Sachdev, S (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	sachdev@physics.harvard.edu	Sachdev, Subir/A-8781-2013; Sachdev, Subir/Y-3037-2019	Sachdev, Subir/0000-0002-2432-7070; Sachdev, Subir/0000-0002-2432-7070				Abanov A, 2001, EUROPHYS LETT, V54, P488, DOI 10.1209/epl/i2001-00266-0; Chubukov A, 2012, ANNU REV CONDEN MA P, V3, P57, DOI 10.1146/annurev-conmatphys-020911-125055; Hanaguri T, 2010, SCIENCE, V328, P474, DOI 10.1126/science.1187399; Hashimoto K, 2012, SCIENCE, V336, P1554, DOI 10.1126/science.1219821; Metlitski MA, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.075127; MILLIS AJ, 1992, PHYS REV B, V45, P13047, DOI 10.1103/PhysRevB.45.13047; TSUEI CC, 1994, PHYS REV LETT, V73, P593, DOI 10.1103/PhysRevLett.73.593	7	24	25	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1510	1511		10.1126/science.1223586	http://dx.doi.org/10.1126/science.1223586			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723399	Green Submitted			2022-12-28	WOS:000305507500033
J	Brady, DJ; Gehm, ME; Stack, RA; Marks, DL; Kittle, DS; Golish, DR; Vera, EM; Feller, SD				Brady, D. J.; Gehm, M. E.; Stack, R. A.; Marks, D. L.; Kittle, D. S.; Golish, D. R.; Vera, E. M.; Feller, S. D.			Multiscale gigapixel photography	NATURE			English	Article								Pixel count is the ratio of the solid angle within a camera's field of view to the solid angle covered by a single detector element. Because the size of the smallest resolvable pixel is proportional to aperture diameter and the maximum field of view is scale independent, the diffraction-limited pixel count is proportional to aperture area. At present, digital cameras operate near the fundamental limit of 1-10 megapixels for millimetre-scale apertures, but few approach the corresponding limits of 1-100 gigapixels for centimetre-scale apertures. Barriers to high-pixel-count imaging include scale-dependent geometric aberrations, the cost and complexity of gigapixel sensor arrays, and the computational and communications challenge of gigapixel image management. Here we describe the AWARE-2 camera, which uses a 16-mm entrance aperture to capture snapshot, one-gigapixel images at three frames per minute. AWARE-2 uses a parallel array of microcameras to reduce the problems of gigapixel imaging to those of megapixel imaging, which are more tractable. In cameras of conventional design, lens speed and field of view decrease as lens scale increases(1), but with the experimental system described here we confirm previous theoretical results(2-6) suggesting that lens speed and field of view can be scale independent in microcamera-based imagers resolving up to 50 gigapixels. Ubiquitous gigapixel cameras may transform the central challenge of photography from the question of where to point the camera to that of how to mine the data.	[Brady, D. J.; Marks, D. L.; Kittle, D. S.; Feller, S. D.] Duke Univ, Fitzpatrick Inst Photon, Durham, NC 27708 USA; [Gehm, M. E.; Golish, D. R.; Vera, E. M.] Univ Arizona, ECE Dept, Tucson, AZ 85721 USA; [Stack, R. A.] Distant Focus Corp, Champaign, IL 61826 USA	Duke University; University of Arizona	Brady, DJ (corresponding author), Duke Univ, Fitzpatrick Inst Photon, POB 90291, Durham, NC 27708 USA.	dbrady@duke.edu	Vera, Esteban/H-1345-2013; Vera, Esteban/O-7493-2019	Vera, Esteban/0000-0001-8387-8131; Vera, Esteban/0000-0001-8387-8131; Brady, David Jones/0000-0001-5655-2478; Gehm, Michael/0000-0003-4163-749X	Defense Advanced Research Projects Agency (DARPA) [HR0011-10-C-0073]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The AWARE programme is supported by the Defense Advanced Research Projects Agency (DARPA) contract HR0011-10-C-0073. The project was initiated at DARPA by D. Healy and is managed by N. Dhar. The AWARE-2 microcamera optics design team includes D. Marks, E. Tremblay and J. Ford. Microcamera optics were fabricated by Rochester Photonics Corporation under the management of P. McLaughlin. P. Jansen, J. Hughes and S. Gewalt developed the parallel processing framework, data routing and hardware interface. H. Son and J. Kim developed the optomechanical layout.	Brady DJ, 2009, OPT EXPRESS, V17, P10659, DOI 10.1364/OE.17.010659; Cossairt O., 2011, P IEEE INT C COMP PH; Ford J. E., 2010, IMAGING SYSTEMS 2010; Kahn SM, 2010, PROC SPIE, V7735, DOI 10.1117/12.857920; Kaiser N, 2004, P SOC PHOTO-OPT INS, V5489, P11, DOI 10.1117/12.552472; Leininger B, 2008, PROC SPIE, V6981, DOI 10.1117/12.784724; LOHMANN AW, 1989, APPL OPTICS, V28, P4996, DOI 10.1364/AO.28.004996; Marks D. L., 2010, IMAGING SYSTEMS 2010; Marks DL, 2011, APPL OPTICS, V50, P5824, DOI 10.1364/AO.50.005824; Marks DL, 2011, OPT ENG, V50, DOI 10.1117/1.3554389; Pollock D. B, 2006, US patent application, Patent No. [11/456 745, 11456745]; Reinhard E, 2006, HIGH DYNAMIC RANGE I, P187, DOI 10.1016/B978-012585263-0/50007-5; Son HS, 2011, OPT EXPRESS, V19, P16132, DOI 10.1364/OE.19.016132; Tremblay E. J, APPL OPT IN PRESS	14	211	258	2	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					386	389		10.1038/nature11150	http://dx.doi.org/10.1038/nature11150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722199				2022-12-28	WOS:000305466800040
J	Fischer, D				Fischer, Debra			PLANETARY SCIENCE Early start for rocky planets	NATURE			English	Editorial Material							DISK		Yale Univ, Dept Astron, New Haven, CT 06511 USA	Yale University	Fischer, D (corresponding author), Yale Univ, Dept Astron, New Haven, CT 06511 USA.	debra.fischer@yale.edu	Fischer, Debra/C-1639-2014	Fischer, Debra/0000-0003-2221-0861				Buchhave LA, 2012, NATURE, V486, P375, DOI 10.1038/nature11121; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; LISSAUER JJ, 1987, ICARUS, V69, P249, DOI 10.1016/0019-1035(87)90104-7; Mayor M., 2011, HARPS SEARCH SO EXTR; Mortier A, 2012, ASTRON ASTR IN PRESS; Pascucci I., 2010, PROTOPLANETARY DUST, P263; Raymond SN, 2009, ICARUS, V203, P644, DOI 10.1016/j.icarus.2009.05.016; Raymond SN, 2004, ICARUS, V168, P1, DOI 10.1016/j.icarus.2003.11.019	11	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					331	332		10.1038/nature11199	http://dx.doi.org/10.1038/nature11199			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722189				2022-12-28	WOS:000305466800029
J	Howie, A				Howie, Archie			Akira Tonomura (1942-2012) OBITUARY	NATURE			English	Biographical-Item									Univ Cambridge, Cavendish Lab, Cambridge CB2 1TN, England	University of Cambridge	Howie, A (corresponding author), Univ Cambridge, Cavendish Lab, Cambridge CB2 1TN, England.	ah30@cam.ac.uk							0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					324	324		10.1038/486324a	http://dx.doi.org/10.1038/486324a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722184	Bronze			2022-12-28	WOS:000305466800024
J	Guyatt, GH; Briel, M; Glasziou, P; Bassler, D; Montori, VM				Guyatt, Gordon H.; Briel, Matthias; Glasziou, Paul; Bassler, Dirk; Montori, Victor M.			Problems of stopping trials early	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRACTICE GUIDELINES; NONCARDIAC SURGERY; SEVERE SEPSIS; CARDIAC RISK; MANAGEMENT; BENEFIT; ADULTS		[Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8N 3Z5, Canada; [Guyatt, Gordon H.] McMaster Univ, Dept Biostat & Med, Hamilton, ON L8N 3Z5, Canada; [Briel, Matthias] Univ Basel Hosp, Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Glasziou, Paul] Bond Univ, Ctr Res Evidence Based Practice, Gold Coast, Australia; [Bassler, Dirk] Univ Childrens Hosp Tuebingen, Ctr Pediat Clin Studies, Tubingen, Germany; [Bassler, Dirk] Univ Childrens Hosp Tuebingen, Dept Neonatol, Tubingen, Germany; [Montori, Victor M.] Mayo Clin, Dept Med, Knowledge & Evaluat Res Unit, Ctr Sci Healthcare Delivery, Rochester, MN USA; [Montori, Victor M.] Mayo Clin, Dept & Hlth Sci Res Hlth Care & Policy Re, Ctr Sci Healthcare Delivery, Rochester, MN USA	McMaster University; McMaster University; University of Basel; Bond University; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Mayo Clinic; Mayo Clinic	Guyatt, GH (corresponding author), McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8N 3Z5, Canada.	guyatt@mcmaster.ca	Briel, Matthias/AAT-9284-2021; Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X; Bassler, Dirk/0000-0003-2358-4419; Briel, Matthias/0000-0002-2070-5230; Montori, Victor/0000-0003-0595-2898				Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; [Anonymous], 2009, MEDSCAPE EMERGENCY M; Bangalore S, 2008, LANCET, V372, P1962, DOI 10.1016/S0140-6736(08)61560-3; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Eagle KA, 2002, J AM COLL CARDIOL, V39, P542, DOI 10.1016/S0735-1097(01)01788-0; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Fleisher LA, 2001, NEW ENGL J MED, V345, P1677, DOI 10.1056/NEJMcp002842; Garber Alan J, 2004, Endocr Pract, V10, P77; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; POCOCK SJ, 1989, CONTROL CLIN TRIALS, V10, pS209; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Poldermans D, 2009, EUR HEART J, V30, P2769, DOI 10.1093/eurheartj/ehp337; Shojania K, 2001, HLTH CARE SAFER CRIT; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Stapleton R, 2012, UPTODATE; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300	20	72	72	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2012	344								e3863	10.1136/bmj.e3863	http://dx.doi.org/10.1136/bmj.e3863			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961LC	22705814	Green Published			2022-12-28	WOS:000305464900002
J	Palmer, MA; Febria, CM				Palmer, Margaret A.; Febria, Catherine M.			The Heartbeat of Ecosystems	SCIENCE			English	Editorial Material							BREAKDOWN; METABOLISM		[Palmer, Margaret A.; Febria, Catherine M.] Univ Maryland, Ctr Environm Sci, Chesapeake Biol Lab, Solomons, MD 20688 USA; [Palmer, Margaret A.; Febria, Catherine M.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Palmer, Margaret A.] Natl Socioenvironm Synth Ctr, Annapolis, MD 21401 USA	University System of Maryland; University of Maryland Center for Environmental Science; University System of Maryland; University of Maryland College Park	Palmer, MA (corresponding author), Univ Maryland, Ctr Environm Sci, Chesapeake Biol Lab, Solomons, MD 20688 USA.	mpalmer@sesync.org	Palmer, Margaret A/F-9648-2013	Palmer, Margaret A/0000-0003-1468-7993; Febria, Catherine/0000-0002-3570-3588				Battin TJ, 2008, NAT GEOSCI, V1, P95, DOI 10.1038/ngeo101; Bernot MJ, 2010, FRESHWATER BIOL, V55, P1874, DOI 10.1111/j.1365-2427.2010.02422.x; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Demars BOL, 2011, FRESHWATER BIOL, V56, P1106, DOI 10.1111/j.1365-2427.2010.02554.x; Findlay SEG, 2011, BIOGEOCHEMISTRY, V104, P381, DOI 10.1007/s10533-010-9512-8; Gessner MO, 2002, ECOL APPL, V12, P498, DOI 10.1890/1051-0761(2002)012[0498:ACFULB]2.0.CO;2; Holland RA, 2011, ECOL APPL, V21, P2034, DOI 10.1890/09-2195.1; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Norgaard RB, 2010, ECOL ECON, V69, P1219, DOI 10.1016/j.ecolecon.2009.11.009; Paetzold A, 2010, ECOL COMPLEX, V7, P273, DOI 10.1016/j.ecocom.2009.11.003; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Palmer MA, 2009, SCIENCE, V325, P575, DOI 10.1126/science.1172976; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Reich PB, 2012, SCIENCE, V336, P589, DOI 10.1126/science.1217909; Sellner K. G., 2012, CHESAPEAKE RES CONSO; WEBSTER JR, 1986, ANNU REV ECOL SYST, V17, P567, DOI 10.1146/annurev.es.17.110186.003031; Woodward G, 2012, SCIENCE, V336, P1438, DOI 10.1126/science.1219534; Young RG, 2008, J N AM BENTHOL SOC, V27, P605, DOI 10.1899/07-121.1	20	113	116	1	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1393	1394		10.1126/science.1223250	http://dx.doi.org/10.1126/science.1223250			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700910				2022-12-28	WOS:000305211700031
J	Purvis, JE; Karhohs, KW; Mock, C; Batchelor, E; Loewer, A; Lahav, G				Purvis, Jeremy E.; Karhohs, Kyle W.; Mock, Caroline; Batchelor, Eric; Loewer, Alexander; Lahav, Galit			p53 Dynamics Control Cell Fate	SCIENCE			English	Article							P53-MDM2 FEEDBACK LOOP; GENE-EXPRESSION; TEMPORAL CONTROL; DNA-DAMAGE; OSCILLATIONS; SPECIFICITY; ACTIVATION; MDM2; ANTAGONISTS; DETERMINES	Cells transmit information through molecular signals that often show complex dynamical patterns. The dynamic behavior of the tumor suppressor p53 varies depending on the stimulus; in response to double-strand DNA breaks, it shows a series of repeated pulses. Using a computational model, we identified a sequence of precisely timed drug additions that alter p53 pulses to instead produce a sustained p53 response. This leads to the expression of a different set of downstream genes and also alters cell fate: Cells that experience p53 pulses recover from DNA damage, whereas cells exposed to sustained p53 signaling frequently undergo senescence. Our results show that protein dynamics can be an important part of a signal, directly influencing cellular fate decisions.	[Purvis, Jeremy E.] Harvard Univ, Sch Med, Nikon Imaging Ctr, Cambridge, MA 02138 USA	Harvard University	Purvis, JE (corresponding author), Harvard Univ, Sch Med, Nikon Imaging Ctr, Cambridge, MA 02138 USA.		Loewer, Alexander/AAL-6943-2021	Loewer, Alexander/0000-0002-8819-3040; Mock, Charles/0000-0002-0564-568X; Batchelor, Eric/0000-0003-3870-5615	Novartis Institutes for Biomedical Research; National Institutes of Health [GM083303, F32GM095168]; National Science Foundation; American Cancer Society, California Division; German Research Foundation; Charles A. King Trust; NATIONAL CANCER INSTITUTE [ZIABC011382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM102372, F32GM095168, R01GM083303, R00GM102372] Funding Source: NIH RePORTER	Novartis Institutes for Biomedical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Cancer Society, California Division(American Cancer Society); German Research Foundation(German Research Foundation (DFG)); Charles A. King Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Agami for the MCF7/p53shRNA cell line; B. Fang for the MCF7/Casp3 cell line; A. Raj and Z. Waks for help with mRNA FISH; R. Kishony, R. Ward, W. Forrester, E. O'Shea, T. Mitchison, A. Klein, J. Orth, and U. Alon for comments and discussions; and the Nikon Imaging Center at Harvard Medical School for help with light microscopy. This research was supported by the Novartis Institutes for Biomedical Research, the National Institutes of Health grant GM083303 and fellowship F32GM095168 (J.E.P), a National Science Foundation graduate fellowship (K. W. K), the American Cancer Society, California Division, Pamela and Edward Taft Postdoctoral Fellowship (E.B.), and fellowships from the German Research Foundation and the Charles A. King Trust (A.L.). J.E.P and G.L. conceived the study, designed the experiments, and wrote the paper. J.E.P modeled and designed perturbation experiments and performed gene expression and cell fate assays, live-cell microscopy, single-cell mRNA detection, and image analysis. K.W.K. performed live-cell microscopy, single-cell mRNA detection, and image analysis. C.M. characterized p53 and p53-Venus dynamics under radiation and various drug treatments. E.B. and A.L. performed UV treatment experiments and provided preliminary results and foundational concepts.	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Hamstra DA, 2006, CANCER RES, V66, P7482, DOI 10.1158/0008-5472.CAN-06-1405; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Hu WW, 2007, CANCER RES, V67, P2757, DOI 10.1158/0008-5472.CAN-06-2656; Kelley KD, 2010, CANCER RES, V70, P3566, DOI 10.1158/0008-5472.CAN-09-3219; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Zhao RB, 2000, GENE DEV, V14, P981	35	516	529	10	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1440	1444		10.1126/science.1218351	http://dx.doi.org/10.1126/science.1218351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700930	Green Accepted			2022-12-28	WOS:000305211700046
J	Sugimoto, N; Nagaosa, N				Sugimoto, N.; Nagaosa, N.			Spin-Orbit Echo	SCIENCE			English	Article							ELECTRONS	Preserving and controlling the quantum information content of spins is a central challenge of spintronics. In solids, the relativistic spin-orbit interaction (SOI) leads to a finite spin lifetime. Here, we show that spin information is preserved by the hidden conserved "twisted spin" and survives elastic disorder scatterings. This twisted spin is an adiabatic invariant with respect to a slow change in the SOI. We predict an echo phenomenon, spin-orbit echo, which indicates the recovery of the spin moment when the SOI is tuned off adiabatically, even after spin relaxation has occurred; this is confirmed by numerical simulations. A concrete experiment in two-dimensional semiconductor quantum wells with Rashba-Dresselhaus SOI is proposed to verify our prediction.	[Sugimoto, N.; Nagaosa, N.] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Sugimoto, N.; Nagaosa, N.] RIKEN, Cross Correlated Mat Res Grp, Saitama 3510198, Japan; [Sugimoto, N.; Nagaosa, N.] RIKEN, Correlated Electron Res Grp, Saitama 3510198, Japan	University of Tokyo; RIKEN; RIKEN	Nagaosa, N (corresponding author), Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan.	nagaosa@ap.t.u-tokyo.ac.jp	Sugimoto, Naoyuki/B-3641-2013; Nagaosa, Naoto/G-7057-2012		Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; Funding Program for World-Leading Innovative Research and Development on Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Funding Program for World-Leading Innovative Research and Development on Science and Technology, Japan	We thank K. Richter, V. Krueckl, and S. Onoda for fruitful discussion. This work is supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Strategic International Cooperative Program (Joint Research Type) from Japan Science and Technology Agency; and the Funding Program for World-Leading Innovative Research and Development on Science and Technology, Japan.	Bernevig BA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.236601; Bir G. L., 1976, SOV PHYS JETP, V42, P705; Chen TW, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.235309; Culcer D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.046602; DYAKONOV MI, 1971, SOV PHYS JETP-USSR, V33, P1053; Dzhioev RI, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.245204; ELLIOTT RJ, 1954, PHYS REV, V96, P266, DOI 10.1103/PhysRev.96.266; FROHLICH J, 1993, REV MOD PHYS, V65, P733, DOI 10.1103/RevModPhys.65.733; Jin PQ, 2006, J PHYS A-MATH GEN, V39, P7115, DOI 10.1088/0305-4470/39/22/022; Kikkawa JM, 1998, PHYS REV LETT, V80, P4313, DOI 10.1103/PhysRevLett.80.4313; Koga T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.046801; Leurs BWA, 2008, ANN PHYS-NEW YORK, V323, P907, DOI 10.1016/j.aop.2007.06.012; LIN BJF, 1984, PHYS REV B, V29, P927, DOI 10.1103/PhysRevB.29.927; Meijer FE, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.201307; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Perel V, 1972, SOV PHYS-SOLID STATE, V13, P3023; Shen R, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.125313; Shi JR, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.076604; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Thomas LH, 1926, NATURE, V117, P514, DOI 10.1038/117514a0; Wang Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.066601; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; YAFET Y, 1963, SOLID STATE PHYS, V14, P2; YANG CN, 1954, PHYS REV, V96, P191, DOI 10.1103/PhysRev.96.191	25	3	3	4	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1413	1416		10.1126/science.1217346	http://dx.doi.org/10.1126/science.1217346			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700922				2022-12-28	WOS:000305211700037
J	Woodward, G; Gessner, MO; Giller, PS; Gulis, V; Hladyz, S; Lecerf, A; Malmqvist, B; McKie, BG; Tiegs, SD; Cariss, H; Dobson, M; Elosegi, A; Ferreira, V; Graca, MAS; Fleituch, T; Lacoursiere, JO; Nistorescu, M; Pozo, J; Risnoveanu, G; Schindler, M; Vadineanu, A; Vought, LBM; Chauvet, E				Woodward, Guy; Gessner, Mark O.; Giller, Paul S.; Gulis, Vladislav; Hladyz, Sally; Lecerf, Antoine; Malmqvist, Bjorn; McKie, Brendan G.; Tiegs, Scott D.; Cariss, Helen; Dobson, Mike; Elosegi, Arturo; Ferreira, Veronica; Graca, Manuel A. S.; Fleituch, Tadeusz; Lacoursiere, Jean O.; Nistorescu, Marius; Pozo, Jesus; Risnoveanu, Geta; Schindler, Markus; Vadineanu, Angheluta; Vought, Lena B. -M.; Chauvet, Eric			Continental-Scale Effects of Nutrient Pollution on Stream Ecosystem Functioning	SCIENCE			English	Article							LITTER DECOMPOSITION; LEAF BREAKDOWN; RIVER; DYNAMICS; DETRITUS; INDICATORS; LANDSCAPE	Excessive nutrient loading is a major threat to aquatic ecosystems worldwide that leads to profound changes in aquatic biodiversity and biogeochemical processes. Systematic quantitative assessment of functional ecosystem measures for river networks is, however, lacking, especially at continental scales. Here, we narrow this gap by means of a pan-European field experiment on a fundamental ecosystem process-leaf-litter breakdown-in 100 streams across a greater than 1000-fold nutrient gradient. Dramatically slowed breakdown at both extremes of the gradient indicated strong nutrient limitation in unaffected systems, potential for strong stimulation in moderately altered systems, and inhibition in highly polluted streams. This large-scale response pattern emphasizes the need to complement established structural approaches (such as water chemistry, hydrogeomorphology, and biological diversity metrics) with functional measures (such as litter-breakdown rate, whole-system metabolism, and nutrient spiraling) for assessing ecosystem health.	[Woodward, Guy; Giller, Paul S.; Hladyz, Sally] Natl Univ Ireland Univ Coll Cork, Dept Zool Ecol & Plant Sci, Enterprise Ctr, Distillery Fields, Cork, Ireland; [Woodward, Guy] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Gessner, Mark O.; Tiegs, Scott D.; Schindler, Markus] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, CH-6047 Kastanienbaum, Switzerland; [Gessner, Mark O.; Tiegs, Scott D.; Schindler, Markus] Swiss Fed Inst Technol, Inst Integrat Biol IBZ, CH-8092 Zurich, Switzerland; [Gessner, Mark O.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, D-16775 Stechlin, Germany; [Gessner, Mark O.] Berlin Inst Technol TU Berlin, Dept Ecol, D-10587 Berlin, Germany; [Gulis, Vladislav; Ferreira, Veronica; Graca, Manuel A. S.] Univ Coimbra, Dept Life Sci, P-3001401 Coimbra, Portugal; [Gulis, Vladislav; Ferreira, Veronica; Graca, Manuel A. S.] Univ Coimbra, Inst Marine Res IMAR, P-3001401 Coimbra, Portugal; [Lecerf, Antoine; Chauvet, Eric] Univ Toulouse, INP, UPS, Lab Ecol Fonct & Environm EcoLab, F-31062 Toulouse, France; [Lecerf, Antoine; Chauvet, Eric] CNRS, EcoLab, F-31062 Toulouse, France; [Malmqvist, Bjorn; McKie, Brendan G.] Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden; [Tiegs, Scott D.] Oakland Univ, Dept Biol Sci, Rochester, MI 48309 USA; [Cariss, Helen; Dobson, Mike] Manchester Metropolitan Univ, Dept Environm & Geog Sci, Manchester M15 6BH, Lancs, England; [Elosegi, Arturo; Pozo, Jesus] Univ Basque Country, Fac Sci & Technol, Dept Plant Biol & Ecol, Bilbao 48080, Spain; [Fleituch, Tadeusz] Polish Acad Sci, Inst Nat Conservat, PL-31120 Krakow, Poland; [Lacoursiere, Jean O.; Vought, Lena B. -M.] Kristianstad Univ, Sch Educ & Environm, S-29188 Kristianstad, Sweden; [Nistorescu, Marius; Risnoveanu, Geta; Vadineanu, Angheluta] Univ Bucharest, Dept Syst Ecol & Sustainabil, Bucharest 050095, Romania	University College Cork; University of London; Queen Mary University London; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Technical University of Berlin; Universidade de Coimbra; Universidade de Coimbra; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Umea University; Oakland University; Manchester Metropolitan University; University of Basque Country; Polish Academy of Sciences; Kristianstad University; University of Bucharest	Woodward, G (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Zool Ecol & Plant Sci, Enterprise Ctr, Distillery Fields, Cork, Ireland.	g.woodward@qmul.ac.uk; gessner@igb-berlin.de; eric.chauvet@univ-tlse3.fr	Pozo, Jesús/B-4719-2013; Giller, Paul/AAB-1187-2021; Risnoveanu, Geta/Q-3790-2019; Elosegi, Arturo/B-7796-2009; LECERF, Antoine/ABD-2834-2020; Graca, Manuel A.S./A-5785-2013; Risnoveanu, Geta/B-6666-2012; Ferreira, Verónica/I-6457-2013; LECERF, Antoine/C-5492-2011; Chauvet, Eric/F-7644-2011	Pozo, Jesús/0000-0003-3104-5423; Giller, Paul/0000-0002-0641-7152; Risnoveanu, Geta/0000-0002-5194-5448; Elosegi, Arturo/0000-0001-8809-8484; LECERF, Antoine/0000-0002-7802-9773; Graca, Manuel A.S./0000-0002-7303-9382; Ferreira, Verónica/0000-0001-7688-2626; LECERF, Antoine/0000-0002-7802-9773; Chauvet, Eric/0000-0001-8676-392X; McKie, Brendan/0000-0002-1796-9497; Fleituch, Tadeusz/0000-0001-9362-2703; Graca, Manuel/0000-0002-6470-8919	European Commission; Swiss State Secretariat for Research and Education (European Union) [EVK1-CT-2001-00088]	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss State Secretariat for Research and Education (European Union)	We thank the European Commission and the Swiss State Secretariat for Research and Education for funding the RivFunction research project (European Union contract EVK1-CT-2001-00088), which was supported under the Fifth Framework Programme. The constructive comments by three anonymous reviewers, which substantially improved the paper, are greatly appreciated. All basic data are available in the supplementary materials. This paper is dedicated to the memory of our colleague Bjorn Malmqvist, who sadly passed away in 2010.	Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Boyero L, 2011, ECOL LETT, V14, P289, DOI 10.1111/j.1461-0248.2010.01578.x; Bundschuh M, 2009, ENVIRON TOXICOL CHEM, V28, P197, DOI 10.1897/08-075.1; Cross WF, 2006, ECOLOGY, V87, P1556, DOI 10.1890/0012-9658(2006)87[1556:WNEISP]2.0.CO;2; Feio MJ, 2010, FRESHWATER BIOL, V55, P1050, DOI 10.1111/j.1365-2427.2009.02332.x; Friberg N, 2011, ADV ECOL RES, V44, P1, DOI 10.1016/B978-0-12-374794-5.00001-8; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Gessner MO, 2002, ECOL APPL, V12, P498, DOI 10.1890/1051-0761(2002)012[0498:ACFULB]2.0.CO;2; Gleick PH, 2003, SCIENCE, V302, P1524, DOI 10.1126/science.1089967; Gulis V, 2003, FRESHWATER BIOL, V48, P123, DOI 10.1046/j.1365-2427.2003.00985.x; Helton AM, 2011, FRONT ECOL ENVIRON, V9, P229, DOI 10.1890/080211; Hering D, 2010, SCI TOTAL ENVIRON, V408, P4007, DOI 10.1016/j.scitotenv.2010.05.031; Hieber M, 2002, ECOLOGY, V83, P1026, DOI 10.1890/0012-9658(2002)083[1026:COSDFA]2.0.CO;2; Hilton J, 2006, SCI TOTAL ENVIRON, V365, P66, DOI 10.1016/j.scitotenv.2006.02.055; Hladyz S, 2011, ADV ECOL RES, V44, P211, DOI 10.1016/B978-0-12-374794-5.00004-3; Lecerf A, 2006, ARCH HYDROBIOL, V165, P105, DOI 10.1127/0003-9136/2006/0165-0105; Mason C. F., 2002, BIOL FRESHWATER POLL, V4, P391; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Mulholland PJ, 2010, J N AM BENTHOL SOC, V29, P100, DOI 10.1899/08-035.1; Pascoal C, 2003, FRESHWATER BIOL, V48, P2033, DOI 10.1046/j.1365-2427.2003.01130.x; Perrings C, 2010, SCIENCE, V330, P323, DOI 10.1126/science.1196431; Rosemond AD, 2002, LIMNOL OCEANOGR, V47, P278, DOI 10.4319/lo.2002.47.1.0278; Tank JL, 2010, J N AM BENTHOL SOC, V29, P118, DOI 10.1899/08-170.1; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; WEBSTER JR, 1986, ANNU REV ECOL SYST, V17, P567, DOI 10.1146/annurev.es.17.110186.003031; Young RG, 2009, FRESHWATER BIOL, V54, P2155, DOI 10.1111/j.1365-2427.2009.02239.x	29	443	452	19	507	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2012	336	6087					1438	1440		10.1126/science.1219534	http://dx.doi.org/10.1126/science.1219534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700929	Green Submitted, Green Published			2022-12-28	WOS:000305211700045
J	Jones, SS; Heaton, PS; Rudin, RS; Schneider, EC				Jones, Spencer S.; Heaton, Paul S.; Rudin, Robert S.; Schneider, Eric C.			Unraveling the IT Productivity Paradox - Lessons for Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jones, Spencer S.; Rudin, Robert S.; Schneider, Eric C.] RAND Corp, Boston, MA 02116 USA; [Schneider, Eric C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Med & Primary Care, Boston, MA 02115 USA; [Schneider, Eric C.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	RAND Corporation; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Jones, SS (corresponding author), RAND Corp, Boston, MA 02116 USA.			Jones, Spencer/0000-0003-0358-6273; Schneider, Eric/0000-0002-1132-5084				Brynjolfsson E, 1998, COMMUN ACM, V41, P49, DOI 10.1145/280324.280332; Brynjolfsson E, 2003, REV ECON STAT, V85, P793, DOI 10.1162/003465303772815736; DAVID PA, 1990, AM ECON REV, V80, P355; Kern LM, 2009, JT COMM J QUAL PATIE, V35, P359, DOI 10.1016/S1553-7250(09)35051-5; Landauer T.K., 1995, TROUBLE COMPUTERS US	5	86	86	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2012	366	24					2243	2245						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	957PD	22693996				2022-12-28	WOS:000305174100003
J	Gardner, CP				Gardner, Caleb Pressman			A Moment's Thought How to Tell a True Medical Story	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Gardner, CP (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	cgardn12@jhmi.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2012	307	22					2381	2382		10.1001/jama.2012.5359	http://dx.doi.org/10.1001/jama.2012.5359			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	956UX	22692170				2022-12-28	WOS:000305115900022
J	Gale, EAM				Gale, Edwin A. M.			Post-marketing studies of new insulins: sales or science?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIABETES-MELLITUS; MANAGEMENT; THERAPY; TRIAL		[Gale, Edwin A. M.] Southmead Hosp, Bristol BS10 5NB, Avon, England; [Gale, Edwin A. M.] Univ Bristol, Bristol BS8 1TH, Avon, England	Southmead Hospital; University of Bristol	Gale, EAM (corresponding author), Southmead Hosp, Bristol BS10 5NB, Avon, England.	Edwin.Gale@bristol.ac.uk						[Anonymous], 2005, GUID IND GOOD PHARM; European Medicines Agency, GUID GOOD PHARM PRAC; Gale EAM, 2010, DIABETIC MED, V27, P973, DOI 10.1111/j.1464-5491.2010.03100.x; Health Action International, 2010, LIF SAV INS LARG UN; Hill KP, 2008, ANN INTERN MED, V149, P251, DOI 10.7326/0003-4819-149-4-200808190-00006; Holleman F, 2007, DIABETOLOGIA, V50, P1783, DOI 10.1007/s00125-007-0763-4; Home P, 2011, DIABETES RES CLIN PR, V94, P352, DOI 10.1016/j.diabres.2011.10.021; KESSLER DA, 1994, NEW ENGL J MED, V331, P1350, DOI 10.1056/NEJM199411173312007; Khutsoane D, 2008, DIABETES OBES METAB, V10, P212, DOI 10.1111/j.1463-1326.2007.00826.x; Lilly Diabetes, 2011, OBS STUD DIAB REAL P; Luddeke HJ, 2007, DIABETES OBES METAB, V9, P428, DOI 10.1111/j.1463-1326.2006.00677.x; Mann CJ, 2003, EMERG MED J, V20, P54, DOI 10.1136/emj.20.1.54; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; National Institute for Health and Clinical Excellence, 2009, MAN TYP 2 DIAB NICE; Psaty BM, 2006, JAMA-J AM MED ASSOC, V295, P2787, DOI 10.1001/jama.295.23.2787; Richter B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003816.pub2; Silverman SL, 2009, AM J MED, V122, P114, DOI 10.1016/j.amjmed.2008.09.030; Singh SR, 2009, CAN MED ASSOC J, V180, P385, DOI 10.1503/cmaj.081041; Sox HC, 2008, ANN INTERN MED, V149, P279, DOI 10.7326/0003-4819-149-4-200808190-00012; WHO 18th Expert Committee on the selection and use of essential medicines, 2011, REV EV COMP INS HUM; Yorkshire and Humber Public Health Observatory, 2009, PRESCR DIAB ENGL UPD	21	22	22	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2012	344								e3974	10.1136/bmj.e3974	http://dx.doi.org/10.1136/bmj.e3974			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961KQ	22692652				2022-12-28	WOS:000305463700005
J	Bharat, TAM; Davey, NE; Ulbrich, P; Riches, JD; de Marco, A; Rumlova, M; Sachse, C; Ruml, T; Briggs, JAG				Bharat, Tanmay A. M.; Davey, Norman E.; Ulbrich, Pavel; Riches, James D.; de Marco, Alex; Rumlova, Michaela; Sachse, Carsten; Ruml, Tomas; Briggs, John A. G.			Structure of the immature retroviral capsid at 8 angstrom resolution by cryo-electron microscopy	NATURE			English	Article							PFIZER MONKEY VIRUS; TERMINAL DOMAIN; PARTICLE-PRODUCTION; ASSEMBLY INHIBITOR; HIV-1 VIRIONS; NUCLEIC-ACID; PROTEIN; MATURATION; ORGANIZATION	The assembly of retroviruses such as HIV-1 is driven by oligomerization of their major structural protein, Gag. Gag is a multidomain polyprotein including three conserved folded domains: MA (matrix), CA (capsid) and NC (nucleocapsid)(1). Assembly of an infectious virion proceeds in two stages(2). In the first stage, Gag oligomerization into a hexameric protein lattice leads to the formation of an incomplete, roughly spherical protein shell that buds through the plasma membrane of the infected cell to release an enveloped immature virus particle. In the second stage, cleavage of Gag by the viral protease leads to rearrangement of the particle interior, converting the non-infectious immature virus particle into a mature infectious virion. The immature Gag shell acts as the pivotal intermediate in assembly and is a potential target for anti-retroviral drugs both in inhibiting virus assembly and in disrupting virus maturation(3). However, detailed structural information on the immature Gag shell has not previously been available. For this reason it is unclear what protein conformations and interfaces mediate the interactions between domains and therefore the assembly of retrovirus particles, and what structural transitions are associated with retrovirus maturation. Here we solve the structure of the immature retroviral Gag shell from Mason-Pfizer monkey virus by combining cryo-electron microscopy and tomography. The 8-angstrom resolution structure permits the derivation of a pseudo-atomic model of CA in the immature retrovirus, which defines the protein interfaces mediating retrovirus assembly. We show that transition of an immature retrovirus into its mature infectious form involves marked rotations and translations of CA domains, that the roles of the amino-terminal and carboxy-terminal domains of CA in assembling the immature and mature hexameric lattices are exchanged, and that the CA interactions that stabilize the immature and mature viruses are almost completely distinct.	[Bharat, Tanmay A. M.; Davey, Norman E.; Riches, James D.; de Marco, Alex; Sachse, Carsten; Briggs, John A. G.] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Ulbrich, Pavel; Ruml, Tomas] Inst Chem Technol, Dept Biochem & Microbiol, CR-16628 Prague, Czech Republic; [Rumlova, Michaela] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Vvi, Prague 16610, Czech Republic	European Molecular Biology Laboratory (EMBL); University of Chemistry & Technology, Prague; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Briggs, JAG (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	briggs@embl.de	Sachse, Carsten/AAY-9384-2020; Rumlova, Michaela/G-6140-2014; Rumlova, Michaela/G-9142-2018; Ruml, Tomas/R-2543-2017; Sachse, Carsten/H-2727-2012; Riches, James/M-3873-2013; Briggs, John/J-3096-2012; Ulbrich, Pavel/F-5747-2010; , Alex/AAK-8000-2020; Davey, Norman E/D-5362-2013	Sachse, Carsten/0000-0002-1168-5143; Rumlova, Michaela/0000-0002-5645-8227; Ruml, Tomas/0000-0002-5698-4366; Sachse, Carsten/0000-0002-1168-5143; Riches, James/0000-0001-8494-4743; Ulbrich, Pavel/0000-0002-9076-8210; , Alex/0000-0001-6238-5653; Bharat, Tanmay/0000-0002-0168-0277; Briggs, John/0000-0003-3990-6910; Davey, Norman/0000-0001-6988-4850	Deutsche Forschungsgemeinschaft [SPP1175]; Czech Science foundation [P302/12/1895, 204/09/1388]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Czech Science foundation(Grant Agency of the Czech Republic)	This study was technically supported by the use of the European Molecular Biology Laboratory Information Technology Service unit. This work was partly funded by a grant from the Deutsche Forschungsgemeinschaft within SPP1175 to J.A.G.B. and by grants P302/12/1895 and 204/09/1388 from the Czech Science foundation to T.R. and M.R.	Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Chu HH, 2006, J BIOMED SCI, V13, P645, DOI 10.1007/s11373-006-9094-6; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; de Marco A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001215; de Marco A, 2010, J VIROL, V84, P11729, DOI 10.1128/JVI.01423-10; Egelman EH, 2010, METHOD ENZYMOL, V482, P167, DOI 10.1016/S0076-6879(10)82006-3; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Gottlinger HG, 2001, AIDS, V15, pS13; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Johnson MC, 2002, J VIROL, V76, P11177, DOI 10.1128/JVI.76.22.11177-11185.2002; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Macek P, 2009, J MOL BIOL, V392, P100, DOI 10.1016/j.jmb.2009.06.029; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Ulbrich P, 2006, J VIROL, V80, P7089, DOI 10.1128/JVI.02694-05; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Waheed AA, 2012, AIDS RES HUM RETROV, V28, P54, DOI [10.1089/aid.2011.0230, 10.1089/AID.2011.0230]; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Yeager M, 1998, P NATL ACAD SCI USA, V95, P7299, DOI 10.1073/pnas.95.13.7299; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264	30	129	130	2	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					385	389		10.1038/nature11169	http://dx.doi.org/10.1038/nature11169			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22722831				2022-12-28	WOS:000306506500047
J	McDonough, JE				McDonough, John E.			The Road Ahead for the Affordable Care Act	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	McDonough, JE (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							[Anonymous], 2011, INSIDE NATL HLTH REF; Kenney G., 2012, MAKING MEDICAID EXPA	2	33	33	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2012	367	3					199	201		10.1056/NEJMp1206845	http://dx.doi.org/10.1056/NEJMp1206845			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	975PI	22747178				2022-12-28	WOS:000306522900003
J	Dasmahapatra, KK; Walters, JR; Briscoe, AD; Davey, JW; Whibley, A; Nadeau, NJ; Zimin, AV; Hughes, DST; Ferguson, LC; Martin, SH; Salazar, C; Lewis, JJ; Adler, S; Ahn, SJ; Baker, DA; Baxter, SW; Chamberlain, NL; Chauhan, R; Counterman, BA; Dalmay, T; Gilbert, LE; Gordon, K; Heckel, DG; Hines, HM; Hoff, KJ; Holland, PWH; Jacquin-Joly, E; Jiggins, FM; Jones, RT; Kapan, DD; Kersey, P; Lamas, G; Lawson, D; Mapleson, D; Maroja, LS; Martin, A; Moxon, S; Palmer, WJ; Papa, R; Papanicolaou, A; Pauchet, Y; Ray, DA; Rosser, N; Salzberg, SL; Supple, MA; Surridge, A; Tenger-Trolander, A; Vogel, H; Wilkinson, PA; Wilson, D; Yorke, JA; Yuan, FR; Balmuth, AL; Eland, C; Gharbi, K; Thomson, M; Gibbs, RA; Han, Y; Jayaseelan, JC; Kovar, C; Mathew, T; Muzny, DM; Ongeri, F; Pu, LL; Qu, JX; Thornton, RL; Worley, KC; Wu, YQ; Linares, M; Blaxter, ML; Ffrench-Constant, RH; Joron, M; Kronforst, MR; Mullen, SP; Reed, RD; Scherer, SE; Richards, S; Mallet, J; McMillan, WO; Jiggins, CD				Dasmahapatra, Kanchon K.; Walters, James R.; Briscoe, Adriana D.; Davey, John W.; Whibley, Annabel; Nadeau, Nicola J.; Zimin, Aleksey V.; Hughes, Daniel S. T.; Ferguson, Laura C.; Martin, Simon H.; Salazar, Camilo; Lewis, James J.; Adler, Sebastian; Ahn, Seung-Joon; Baker, Dean A.; Baxter, Simon W.; Chamberlain, Nicola L.; Chauhan, Ritika; Counterman, Brian A.; Dalmay, Tamas; Gilbert, Lawrence E.; Gordon, Karl; Heckel, David G.; Hines, Heather M.; Hoff, Katharina J.; Holland, Peter W. H.; Jacquin-Joly, Emmanuelle; Jiggins, Francis M.; Jones, Robert T.; Kapan, Durrell D.; Kersey, Paul; Lamas, Gerardo; Lawson, Daniel; Mapleson, Daniel; Maroja, Luana S.; Martin, Arnaud; Moxon, Simon; Palmer, William J.; Papa, Riccardo; Papanicolaou, Alexie; Pauchet, Yannick; Ray, David A.; Rosser, Neil; Salzberg, Steven L.; Supple, Megan A.; Surridge, Alison; Tenger-Trolander, Ayse; Vogel, Heiko; Wilkinson, Paul A.; Wilson, Derek; Yorke, James A.; Yuan, Furong; Balmuth, Alexi L.; Eland, Cathlene; Gharbi, Karim; Thomson, Marian; Gibbs, Richard A.; Han, Yi; Jayaseelan, Joy C.; Kovar, Christie; Mathew, Tittu; Muzny, Donna M.; Ongeri, Fiona; Pu, Ling-Ling; Qu, Jiaxin; Thornton, Rebecca L.; Worley, Kim C.; Wu, Yuan-Qing; Linares, Mauricio; Blaxter, Mark L.; Ffrench-Constant, Richard H.; Joron, Mathieu; Kronforst, Marcus R.; Mullen, Sean P.; Reed, Robert D.; Scherer, Steven E.; Richards, Stephen; Mallet, James; McMillan, W. Owen; Jiggins, Chris D.		Heliconius Genome Consortium	Butterfly genome reveals promiscuous exchange of mimicry adaptations among species	NATURE			English	Article							GENE FLOW; HELICONIUS; EVOLUTION; HYBRIDIZATION; SYNTENY; LEPIDOPTERA; SPECIATION; KARYOTYPE; INSIGHTS	The evolutionary importance of hybridization and introgression has long been debated(1). Hybrids are usually rare and unfit, but even infrequent hybridization can aid adaptation by transferring beneficial traits between species. Here we use genomic tools to investigate introgression in Heliconius, a rapidly radiating genus of neotropical butterflies widely used in studies of ecology, behaviour, mimicry and speciation(2-5). We sequenced the genome of Heliconius melpomene and compared it with other taxa to investigate chromosomal evolution in Lepidoptera and gene flow among multiple Heliconius species and races. Among 12,669 predicted genes, biologically important expansions of families of chemosensory and Hox genes are particularly noteworthy. Chromosomal organization has remained broadly conserved since the Cretaceous period, when butterflies split from the Bombyx (silkmoth) lineage. Using genomic resequencing, we show hybrid exchange of genes between three co-mimics, Heliconius melpomene, Heliconius timareta and Heliconius elevatus, especially at two genomic regions that control mimicry pattern. We infer that closely related Heliconius species exchange protective colour-pattern genes promiscuously, implying that hybridization has an important role in adaptive radiation.	[Dasmahapatra, Kanchon K.; Rosser, Neil; Mallet, James] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Walters, James R.; Nadeau, Nicola J.; Martin, Simon H.; Salazar, Camilo; Baxter, Simon W.; Surridge, Alison; Jiggins, Chris D.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Briscoe, Adriana D.; Lewis, James J.; Martin, Arnaud; Yuan, Furong; Reed, Robert D.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Davey, John W.; Blaxter, Mark L.] Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; [Whibley, Annabel; Jones, Robert T.; Joron, Mathieu] Museum Natl Hist Nat, CNRS UMR 7205, F-75005 Paris, France; [Zimin, Aleksey V.; Yorke, James A.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Hughes, Daniel S. T.; Kersey, Paul; Lawson, Daniel; Wilson, Derek] European Bioinformat Inst, Hinxton CB10 1SD, England; [Ferguson, Laura C.; Holland, Peter W. H.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Salazar, Camilo; McMillan, W. Owen; Jiggins, Chris D.] Smithsonian Trop Res Inst, Panama City, Panama; [Adler, Sebastian; Hoff, Katharina J.] Ernst Moritz Arndt Univ Greifswald, Inst Math & Informat, D-17487 Greifswald, Germany; [Ahn, Seung-Joon; Heckel, David G.; Pauchet, Yannick; Vogel, Heiko] Max Planck Inst Chem Biol, D-07745 Jena, Germany; [Baker, Dean A.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Chamberlain, Nicola L.; Tenger-Trolander, Ayse; Kronforst, Marcus R.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Chauhan, Ritika; Ffrench-Constant, Richard H.] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Penryn TR10 9EZ, England; [Counterman, Brian A.] Mississippi State Univ, Dept Biol, Mississippi State, MS 39762 USA; [Dalmay, Tamas] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Gilbert, Lawrence E.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Gilbert, Lawrence E.] Univ Texas Austin, Brackenridge Field Lab, Austin, TX 78712 USA; [Gordon, Karl; Papanicolaou, Alexie] CSIRO Ecosyst Sci, Black Mt Labs, Canberra, ACT 2601, Australia; [Hines, Heather M.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Jacquin-Joly, Emmanuelle] Univ Paris 06, INRA, UMR A 1272, F-78026 Versailles, France; [Jiggins, Francis M.; Palmer, William J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Kapan, Durrell D.] Calif Acad Sci, Dept Entomol, Ctr Comparat Genom, San Francisco, CA 94118 USA; [Kapan, Durrell D.] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Ctr Conservat & Res Training, Honolulu, HI 96822 USA; [Lamas, Gerardo] Univ Nacl Mayor San Marcos, Museo Hist Nat, Lima 14, Peru; [Mapleson, Daniel; Maroja, Luana S.] Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England; [Maroja, Luana S.] Williams Coll, Dept Biol, Williamstown, MA 01267 USA; [Moxon, Simon] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Papa, Riccardo] Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA; [Ray, David A.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Ray, David A.] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39759 USA; [Salzberg, Steven L.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Supple, Megan A.] N Carolina State Univ, Biomath Program, Raleigh, NC 27695 USA; [Wilkinson, Paul A.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Balmuth, Alexi L.; Eland, Cathlene; Gharbi, Karim; Thomson, Marian; Blaxter, Mark L.] Univ Edinburgh, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; [Gibbs, Richard A.; Han, Yi; Jayaseelan, Joy C.; Kovar, Christie; Mathew, Tittu; Muzny, Donna M.; Ongeri, Fiona; Pu, Ling-Ling; Qu, Jiaxin; Thornton, Rebecca L.; Worley, Kim C.; Wu, Yuan-Qing; Scherer, Steven E.; Richards, Stephen] Baylor Coll Med, Human GenomeSequencing Ctr, Houston, TX 77030 USA; [Linares, Mauricio] Univ Nacl Rosario, Fac Ciencias Nat & Matemat, Bogota, Colombia; [Linares, Mauricio] Univ Los Andes, Inst Genet, Bogota, Colombia; [Mullen, Sean P.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Mallet, James] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of London; University College London; University of Cambridge; University of California System; University of California Irvine; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); University System of Maryland; University of Maryland College Park; European Molecular Biology Laboratory (EMBL); University of Oxford; Smithsonian Institution; Smithsonian Tropical Research Institute; Ernst Moritz Arndt Universitat Greifswald; Max Planck Society; Imperial College London; Harvard University; University of Exeter; Mississippi State University; University of East Anglia; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of North Carolina; North Carolina State University; INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Cambridge; California Academy of Sciences; University of Hawaii System; University of Hawaii Manoa; Universidad Nacional Mayor de San Marcos; University of East Anglia; Williams College; Yale University; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; Mississippi State University; Mississippi State University; Johns Hopkins University; University of North Carolina; North Carolina State University; University of Bristol; University of Edinburgh; Baylor College of Medicine; Universidad de los Andes (Colombia); Boston University; Harvard University	Mallet, J (corresponding author), UCL, Dept Genet Evolut & Environm, Gower St, London WC1E 6BT, England.	jmallet@oeb.harvard.edu	Martin, Simon H/H-4400-2019; Jiggins, Chris/T-4296-2019; Pauchet, Yannick/AAU-9751-2021; Salzberg, Steven/Q-6514-2019; Dasmahapatra, Kanchon/AAT-3179-2021; mallet, james L.B./B-5114-2008; Moxon, Simon/A-5385-2010; Briscoe, Adriana/E-8963-2010; Heckel, David G/K-2138-2013; Blaxter, Mark L/B-4113-2010; Whibley, Annabel/P-2509-2017; Davey, John/B-5075-2013; Gordon, Karl H J/A-1976-2008; Papanicolaou, Alexie/A-1618-2011; C, Salazar/A-1647-2010; Tenger-Trolander, Ayse/L-2413-2014; JAYASEELAN, JOY CHRISTINA/F-9824-2015; Linares, Mauricio/I-3509-2016; GenePool, The/D-8812-2012; Salzberg, Steven L/F-6162-2011; Blaxter, Mark/O-2535-2019; Jiggins, Chris D/B-9960-2008; Joron, Mathieu/C-9178-2009; Nadeau, Nicola J./E-1149-2011; Gharbi, Karim/C-5771-2012; Hoff, Katharina/AAX-8809-2021; Dalmay, Tamas/E-1377-2011; Martin, Simon Henry/D-1410-2011	Jiggins, Chris/0000-0002-7809-062X; Pauchet, Yannick/0000-0002-2918-8946; Salzberg, Steven/0000-0002-8859-7432; Briscoe, Adriana/0000-0001-8514-4983; Heckel, David G/0000-0001-8991-2150; Blaxter, Mark L/0000-0003-2861-949X; Whibley, Annabel/0000-0003-1878-7705; Gordon, Karl H J/0000-0002-4371-0454; Papanicolaou, Alexie/0000-0002-3635-6848; C, Salazar/0000-0001-9217-6588; JAYASEELAN, JOY CHRISTINA/0000-0002-7759-0139; Linares, Mauricio/0000-0002-1021-0226; Salzberg, Steven L/0000-0002-8859-7432; Jiggins, Chris D/0000-0002-7809-062X; Joron, Mathieu/0000-0003-1043-4147; Nadeau, Nicola J./0000-0002-9319-921X; Gharbi, Karim/0000-0003-1092-4488; Holland, Peter/0000-0003-1533-9376; Dalmay, Tamas/0000-0003-1492-5429; Ray, David/0000-0002-3340-3987; ffrench-Constant, Richard/0000-0001-5385-9888; Davey, John/0000-0002-1017-9775; Counterman, Brian/0000-0003-2724-071X; Kersey, Paul/0000-0002-7054-800X; Jones, Robert/0000-0001-6421-0881; Lawson, Daniel/0000-0001-7765-983X; Ahn, Seung-Joon/0000-0002-5980-106X; Mallet, James/0000-0002-3370-0367; Martin, Simon Henry/0000-0002-0747-7456; Martin, Arnaud/0000-0002-5980-2249; Rosser, Neil/0000-0001-7796-2548; Jacquin-Joly, Emmanuelle/0000-0002-6904-2036; Jiggins, Francis Michael/0000-0001-7470-8157; Worley, Kim/0000-0002-0282-1000; Tenger-Trolander, Ayse/0000-0001-8319-0273; Lamas, Gerardo/0000-0002-3664-6730; Moxon, Simon/0000-0003-4644-1816; Baxter, Simon/0000-0001-5773-6578; Richards, Stephen/0000-0001-8959-5466; Reed, Robert/0000-0002-6065-6728; Dasmahapatra, Kanchon Kumar/0000-0002-2840-7019	Leverhulme Trust; John Fell Fund; Christ Church College, Oxford; Royal Society; NSF; NIH; CNRS; ERC; Banco de la Republica; COLCIENCAS; BBSRC; BBSRC [BB/G00661X/1, BB/H014268/1, BB/G530425/1, BB/G006903/1, BB/H014357/1, BB/H01439X/1, BB/E006191/1] Funding Source: UKRI; MRC [G0900740] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G00661X/1, BB/G006903/1, BB/H01439X/1, BB/H014268/1, BB/H014357/1, BB/G530425/1, BB/E006191/1] Funding Source: researchfish; Medical Research Council [G0900740] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060555] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, R01HG006677, R01HG006102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER; Direct For Biological Sciences [0959864] Funding Source: National Science Foundation; Div Of Biological Infrastructure [0905698] Funding Source: National Science Foundation	Leverhulme Trust(Leverhulme Trust); John Fell Fund; Christ Church College, Oxford; Royal Society(Royal Society of London); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); ERC(European Research Council (ERC)European Commission); Banco de la Republica; COLCIENCAS; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank the governments of Colombia, Peru and Panama for permission to collect the butterflies. Sequencing was funded by contributions from consortium members. We thank M. Abanto for assistance in raising the inbred line. Individual laboratories were funded by the Leverhulme Trust (C.D.J.), the John Fell Fund and Christ Church College, Oxford (L. C. F.), The Royal Society (M.J., C.D.J.), the NSF (W.O.M., M. R. K., R. D. R., S. M., A. D. B.), the NIH (M. R. K., S. L. S., J.A.Y.), the CNRS (M.J.), the ERC (M.J., P. W. H. H.), the Banco de la Republica and COLCIENCAS (M. L.) and the BBSRC (J.M., C.D.J., M.L.B. and R.H.f.-C.).	Bates H.W., 1862, T LINN SOC LOND, V23, P495; Briscoe AD, 2010, P NATL ACAD SCI USA, V107, P3628, DOI 10.1073/pnas.0910085107; BROWN KS, 1981, ANNU REV ENTOMOL, V26, P427, DOI 10.1146/annurev.en.26.010181.002235; Bull V, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-11; Chai CL, 2008, INSECT BIOCHEM MOLEC, V38, P1111, DOI 10.1016/j.ibmb.2008.06.008; d'Alencon E, 2010, P NATL ACAD SCI USA, V107, P7680, DOI 10.1073/pnas.0910413107; Deng Qiuhong, 2007, Journal of Genetics and Genomics, V34, P196, DOI 10.1016/S1673-8527(07)60021-6; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; Kemkemer C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-84; Kim M, 2008, SCIENCE, V322, P1116, DOI 10.1126/science.1164371; Kronforst MR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-98; Mallet James, 2009, P177; Nadeau NJ, 2012, PHILOS T R SOC B, V367, P343, DOI 10.1098/rstb.2011.0198; Pringle EG, 2007, GENETICS, V177, P417, DOI 10.1534/genetics.107.073122; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; Robinson R., 1971, LEPIDOPTERA GENETICS, P557, DOI [10.1016/B978-0-08-006659-2.50013-4, DOI 10.1016/B978-0-08-006659-2.50013-4]; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Salazar C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000930; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Song Y, 2011, CURR BIOL, V21, P1296, DOI 10.1016/j.cub.2011.06.043; TURNER JRG, 1981, ANNU REV ECOL SYST, V12, P99, DOI 10.1146/annurev.es.12.110181.000531; VANEWRIGHT RI, 1993, PHILOS T R SOC B, V340, P197, DOI 10.1098/rstb.1993.0058; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052	27	787	893	22	579	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					94	98		10.1038/nature11041	http://dx.doi.org/10.1038/nature11041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722851	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-28	WOS:000305982900057
J	Baxter, I; Dilkes, BP				Baxter, Ivan; Dilkes, Brian P.			Elemental Profiles Reflect Plant Adaptations to the Environment	SCIENCE			English	Editorial Material							ARABIDOPSIS-THALIANA; MINERAL CONCENTRATIONS; SERPENTINE SOILS; LEAF IONOME; IDENTIFICATION; TOLERANCE; EFFLUX; BORON; PANEL; QTL	Most mineral elements found in plant tissues come exclusively from the soil, necessitating that plants adapt to highly variable soil compositions to survive and thrive. Profiling element concentrations in genetically diverse plant populations is providing insights into the plant-environment interactions that control elemental accumulation, as well as identifying the underlying genes. The resulting molecular understanding of plant adaptation to the environment both demonstrates how soils can shape genetic diversity and provides solutions to important agricultural challenges.	[Baxter, Ivan] USDA ARS, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Dilkes, Brian P.] Purdue Univ, W Lafayette, IN 47907 USA	Donald Danforth Plant Science Center; United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Baxter, I (corresponding author), USDA ARS, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA.	ivan.baxter@ars.usda.gov; bdilkes@purdue.edu	Baxter, Ivan R/A-1052-2009; Dilkes, Brian/C-9293-2012	Baxter, Ivan R/0000-0001-6680-1722; Dilkes, Brian/0000-0003-2799-954X	Direct For Biological Sciences [1126950] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Baxter I, 2010, BRIEF FUNCT GENOMICS, V9, P149, DOI 10.1093/bfgp/elp055; Baxter I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000492; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Buescher E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011081; Caspary R., 1865, JB WISSENSCHAFTLICHE, V4, P101; Chao DY, 2011, PLANT CELL, V23, P1061, DOI 10.1105/tpc.110.079095; Duan GL, 2012, PLANT CELL PHYSIOL, V53, P154, DOI 10.1093/pcp/pcr161; Ghandilyan A, 2009, J EXP BOT, V60, P1409, DOI 10.1093/jxb/erp084; Gilbert-Diamond D, 2011, P NATL ACAD SCI USA, V108, P20656, DOI 10.1073/pnas.1109127108; Haydon MJ, 2012, PLANT CELL, V24, P724, DOI 10.1105/tpc.111.095042; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Klein MA, 2009, GENOME, V52, P677, DOI [10.1139/G09-039, 10.1139/g09-039]; Mitani-Ueno N, 2011, J EXP BOT, V62, P4391, DOI 10.1093/jxb/err158; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Ryan PR, 2011, J EXP BOT, V62, P9, DOI 10.1093/jxb/erq272; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Sankaran RP, 2009, THEOR APPL GENET, V119, P241, DOI 10.1007/s00122-009-1033-2; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Vance CP, 2001, PLANT PHYSIOL, V127, P390, DOI 10.1104/pp.010331; Wood S., 2000, Pilot analysis of global ecosystems: agroecosystems, P45; Yost JM, 2012, AM J BOT, V99, P890, DOI 10.3732/ajb.1100521; Zhao FJ, 2009, NEW PHYTOL, V181, P777, DOI 10.1111/j.1469-8137.2008.02716.x	28	78	82	2	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1661	1663		10.1126/science.1219992	http://dx.doi.org/10.1126/science.1219992			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745418				2022-12-28	WOS:000305794500037
J	Misale, S; Yaeger, R; Hobor, S; Scala, E; Janakiraman, M; Liska, D; Valtorta, E; Schiavo, R; Buscarino, M; Siravegna, G; Bencardino, K; Cercek, A; Chen, CT; Veronese, S; Zanon, C; Sartore-Bianchi, A; Gambacorta, M; Gallicchio, M; Vakiani, E; Boscaro, V; Medico, E; Weiser, M; Siena, S; Di Nicolantonio, F; Solit, D; Bardelli, A				Misale, Sandra; Yaeger, Rona; Hobor, Sebastijan; Scala, Elisa; Janakiraman, Manickam; Liska, David; Valtorta, Emanuele; Schiavo, Roberta; Buscarino, Michela; Siravegna, Giulia; Bencardino, Katia; Cercek, Andrea; Chen, Chin-Tung; Veronese, Silvio; Zanon, Carlo; Sartore-Bianchi, Andrea; Gambacorta, Marcello; Gallicchio, Margherita; Vakiani, Efsevia; Boscaro, Valentina; Medico, Enzo; Weiser, Martin; Siena, Salvatore; Di Nicolantonio, Federica; Solit, David; Bardelli, Alberto			Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer	NATURE			English	Article							K-RAS MUTATIONS; CETUXIMAB; PANITUMUMAB; MECHANISMS; TUMORS; CELLS	A main limitation of therapies that selectively target kinase signalling pathways is the emergence of secondary drug resistance. Cetuximab, a monoclonal antibody that binds the extracellular domain of epidermal growth factor receptor (EGFR), is effective in a subset of KRAS wild-type metastatic colorectal cancers(1). After an initial response, secondary resistance invariably ensues, thereby limiting the clinical benefit of this drug(2). The molecular bases of secondary resistance to cetuximab in colorectal cancer are poorly understood(3-8). Here we show that molecular alterations (in most instances point mutations) of KRAS are causally associated with the onset of acquired resistance to anti-EGFR treatment in colorectal cancers. Expression of mutant KRAS under the control of its endogenous gene promoter was sufficient to confer cetuximab resistance, but resistant cells remained sensitive to combinatorial inhibition of EGFR and mitogen-activated protein-kinase kinase (MEK). Analysis of metastases from patients who developed resistance to cetuximab or panitumumab showed the emergence of KRAS amplification in one sample and acquisition of secondary KRAS mutations in 60% (6 out of 10) of the cases. KRAS mutant alleles were detectable in the blood of cetuximab-treated patients as early as 10 months before radiographic documentation of disease progression. In summary, the results identify KRAS mutations as frequent drivers of acquired resistance to cetuximab in colorectal cancers, indicate that the emergence of KRAS mutant clones can be detected non-invasively months before radiographic progression and suggest early initiation of a MEK inhibitor as a rational strategy for delaying or reversing drug resistance.	[Yaeger, Rona; Cercek, Andrea; Solit, David] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Misale, Sandra; Hobor, Sebastijan; Scala, Elisa; Buscarino, Michela; Siravegna, Giulia; Zanon, Carlo; Di Nicolantonio, Federica; Bardelli, Alberto] Inst Canc Res & Treatment IRCC, Mol Genet Lab, I-10060 Turin, Italy; [Misale, Sandra; Scala, Elisa; Buscarino, Michela; Medico, Enzo; Bardelli, Alberto] Univ Torino, Sch Med, Dept Oncol Sci, I-10060 Turin, Italy; [Janakiraman, Manickam; Solit, David] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Liska, David; Chen, Chin-Tung; Weiser, Martin] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Valtorta, Emanuele; Veronese, Silvio; Gambacorta, Marcello] Osped Niguarda Ca Granda, Dept Pathol, I-20162 Milan, Italy; [Schiavo, Roberta; Bencardino, Katia; Sartore-Bianchi, Andrea; Siena, Salvatore] Osped Niguarda Ca Granda, Falck Div Med Oncol, I-20162 Milan, Italy; [Gallicchio, Margherita; Boscaro, Valentina] Univ Turin, Dipartimento Sci & Tecnol Farmaco, I-10125 Turin, Italy; [Vakiani, Efsevia] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Medico, Enzo] Inst Canc Res & Treatment IRCC, Lab Funct Genom, I-10060 Turin, Italy; [Di Nicolantonio, Federica; Bardelli, Alberto] FIRC Inst Mol Oncol IFOM, I-20139 Milan, Italy	Memorial Sloan Kettering Cancer Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Turin; Memorial Sloan Kettering Cancer Center; IRCCS Fondazione del Piemonte per l'Oncologia; IFOM - FIRC Institute of Molecular Oncology	Solit, D (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.	solitd@mskcc.org; alberto.bardelli@ircc.it	Sartore-Bianchi, Andrea/AAB-9848-2019; SIENA, SALVATORE/AAC-5806-2019; Medico, Enzo/AAC-3185-2021; Liska, David/L-9180-2019; ravegnini, gloria/K-1330-2016; Solit, David B./AAC-5309-2019; Di Nicolantonio, Federica/A-2503-2011; Siravegna, Giulia/Z-2826-2019; BARDELLI, Alberto/J-9721-2018	Sartore-Bianchi, Andrea/0000-0003-0780-0409; SIENA, SALVATORE/0000-0002-2681-2846; Medico, Enzo/0000-0002-3917-2438; Liska, David/0000-0002-8632-6065; ravegnini, gloria/0000-0002-7774-402X; Di Nicolantonio, Federica/0000-0001-9618-2010; Siravegna, Giulia/0000-0002-7132-6484; Veronese, Silvio Marco/0000-0002-5280-3740; Janakiraman, Manickam/0000-0003-4423-6237; BARDELLI, Alberto/0000-0003-1647-5070; Misale, Sandra/0000-0002-6031-0137; VALTORTA, EMANUELE/0000-0002-5087-6233; Zanon, Carlo/0000-0003-2539-7238	European Union [259015 COLTHERES]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [9970]; Regione Piemonte; Fondazione Piemontese per la Ricerca sul Cancro (FPRC) Intramural Grant, 5xmille 2008, ONLUS; AIRC MFAG [11349]; Oncologia Ca' Granda ONLUS (OCGO); Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Society of MSKCC; National Institutes of Health; Beene Foundation; Regione Lombardia; Ministerio Salute grant 'Gene Mutation Monitoring in mCRC'; NATIONAL CANCER INSTITUTE [R01CA127240, P30CA008748, T32CA009207] Funding Source: NIH RePORTER	European Union(European Commission); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Regione Piemonte(Regione Piemonte); Fondazione Piemontese per la Ricerca sul Cancro (FPRC) Intramural Grant, 5xmille 2008, ONLUS; AIRC MFAG(Fondazione AIRC per la ricerca sul cancro); Oncologia Ca' Granda ONLUS (OCGO); Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Society of MSKCC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beene Foundation; Regione Lombardia(Regione Lombardia); Ministerio Salute grant 'Gene Mutation Monitoring in mCRC'; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are particularly indebted to S. Lamba for generating the KRAS(G12R) knock-in in Lim1215 cells. We thank C. Cancelliere and S. Destefanis for technical assistance. We thank S. Arena, M. Russo and D. Zecchin for critically reading the manuscript. We also thank A. Heguy, A. Viale, N. Socci and M. Pirun for assistance with analysis of next generation sequencing data. This work was supported by European Union Seventh Framework Programme, grant 259015 COLTHERES (A.B. and S. S.); Associazione Italiana per la Ricerca sul Cancro (AIRC) 2010 Special Program Molecular Clinical Oncology 5 x 1000, project 9970 (A. B. and S. S.); Regione Piemonte (A. B. and F.D.N.); Fondazione Piemontese per la Ricerca sul Cancro (FPRC) Intramural Grant, 5xmille 2008, ONLUS (A. B. and F.D.N.); AIRC MFAG 11349 (F.D.N.); Oncologia Ca' Granda ONLUS (OCGO) (S. S.); Mr William H. Goodwin and Mrs Alice Goodwin and the Commonwealth Foundation for Cancer Research; the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center (D. S.); the Society of MSKCC (M. W.); the National Institutes of Health (D. S.); the Beene Foundation (D. S.) and Regione Lombardia and Ministerio Salute grant 'Gene Mutation Monitoring in mCRC' (S.S.).	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Arcila ME, 2011, CLIN CANCER RES, V17, P1169, DOI 10.1158/1078-0432.CCR-10-2277; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Benavente S, 2009, CLIN CANCER RES, V15, P1585, DOI 10.1158/1078-0432.CCR-08-2068; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Hatakeyama H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012702; Janne PA, 2008, LUNG CANCER, V60, pS3, DOI 10.1016/S0169-5002(08)70099-0; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; WHITEHEAD RH, 1985, JNCI-J NATL CANCER I, V74, P759; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442	21	1304	1373	7	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					532	U131		10.1038/nature11156	http://dx.doi.org/10.1038/nature11156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722830	Green Submitted, Green Accepted			2022-12-28	WOS:000305760600043
J	Bendick, C; Mey, S				Bendick, Christoph; Mey, Sithach			Haematomas and gingival bleeding	LANCET			English	Editorial Material									[Bendick, Christoph] Univ Hlth Sci, Fac Med, Dept Dermatol, Phnom Penh, Cambodia; [Mey, Sithach] Preah Kossamak Hosp, Dept Dermatol, Phnom Penh, Cambodia		Bendick, C (corresponding author), Univ Hlth Sci, Fac Med, Dept Dermatol, 73 Preah Monivong Blvd, Phnom Penh, Cambodia.	cambodia.derma@gmail.com						Goebel L, SCURVY; Lewis SJ, 1998, NUTRITION, V14, P231, DOI 10.1016/S0899-9007(97)00435-8; Velandia B, 2008, J GEN INTERN MED, V23, P1281, DOI 10.1007/s11606-008-0577-1; World Health Organization, 1999, SCURV ITS PREV CONTR	4	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 23	2012	379	9834					2400	2400		10.1016/S0140-6736(12)60366-3	http://dx.doi.org/10.1016/S0140-6736(12)60366-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961ZV	22726521				2022-12-28	WOS:000305509600035
J	McCartney, M				McCartney, Margaret			Are schoolchildren unhealthily underhydrated?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2012, ZEENEWS         0504; [Anonymous], 2012, SCOTSMAN        0503; [Anonymous], 2012, DAILY MAIL      0503; [Anonymous], 2012, MSN NZ          0503; [Anonymous], 1996, BMJ, V312, P1337; British Bottled Water Producers, WAT VIT STAT IND DAT; Clayton B., 1980, PAEDIAT CHEM PATHOLO; European Food Safety Authority, SCI OP DIET REF VAL; Higgens D, 2012, INDEPENDENT     0503; Higgens D, 2012, KIDS NOT DRINKING EN; Manz F, 2003, EUR J CLIN NUTR, V57, pS10, DOI 10.1038/sj.ejcn.1601896; Manz F, 2002, J PEDIATR-US, V141, P587, DOI 10.1067/mpd.2002.128031; McCartney M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4280; Nestle Waters, OUR PROD OUR SOL	14	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 19	2012	344								e4196	10.1136/bmj.e4196	http://dx.doi.org/10.1136/bmj.e4196			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965CU	22718965				2022-12-28	WOS:000305744600012
J	McCrimmon, RJ; Ryan, CM; Frier, BM				McCrimmon, Rory J.; Ryan, Christopher M.; Frier, Brian M.			Diabetes and cognitive dysfunction	LANCET			English	Article							SEVERE HYPOGLYCEMIA; FOLLOW-UP; BRAIN COMPLICATIONS; CEREBRAL PERFUSION; TC-99M-HMPAO SPET; TYPE-1; RISK; PERFORMANCE; IMPAIRMENT; MELLITUS	Cognitive dysfunction in type 1 and type 2 diabetes share many similarities, but important differences do exist. A primary distinguishing feature of type 2 diabetes is that people with this disorder often (but not invariably) do poorly on measures of learning and memory, whereas deficits in these domains are rarely seen in people with type 1 diabetes. Chronic hyperglycaemia and microvascular disease contribute to cognitive dysfunction in both type 1 and type 2 diabetes, and both disorders are associated with mental and motor slowing and decrements of similar magnitude on measures of attention and executive functioning. Additionally, both types are characterised by neural slowing, increased cortical atrophy, microstructural abnormalities in white matter tracts, and similar, but not identical, changes in concentrations of brain neurometabolites. Disconcertingly, the rapid rise in obesity and type 2 diabetes in all age groups might result in a substantial increase in prevalence of diabetes-related cognitive dysfunction.	[McCrimmon, Rory J.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland; [Ryan, Christopher M.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Frier, Brian M.] Royal Infirm Edinburgh NHS Trust, Dept Diabet, Edinburgh, Midlothian, Scotland	University of Dundee; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Royal Infirmary of Edinburgh; University of Edinburgh	McCrimmon, RJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland.	r.mccrimmon@dundee.ac.uk	Frier, Brian/ABC-6941-2020; McCrimmon, Rory/I-7593-2019	McCrimmon, Rory/0000-0002-3957-1981; Ryan, Christopher/0000-0003-4278-917X				Ajilore O, 2007, NEUROPSYCHOPHARMACOL, V32, P1224, DOI 10.1038/sj.npp.1301248; [Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; Asvold BO, 2010, DIABETES CARE, V33, P1945, DOI 10.2337/dc10-0621; Auer RN, 2004, METAB BRAIN DIS, V19, P169, DOI 10.1023/B:MEBR.0000043967.78763.5b; Aye T, 2011, DIABETES CARE, V34, P1458, DOI 10.2337/dc10-2164; Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Brands AMA, 2007, DEMENT GERIATR COGN, V23, P343, DOI 10.1159/000100980; Brismar T, 2002, NEUROREPORT, V13, P2469, DOI 10.1097/00001756-200212200-00019; Cardoso S, 2009, J ALZHEIMERS DIS, V18, P483, DOI 10.3233/JAD-2009-1155; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Convit A, 2003, P NATL ACAD SCI USA, V100, P2019, DOI 10.1073/pnas.0336073100; Cramer C, 2008, NEUROLOGY, V71, P344, DOI 10.1212/01.wnl.0000319647.15752.7b; de Bresser J, 2010, DIABETES CARE, V33, P1309, DOI 10.2337/dc09-1923; DEARY IJ, 1993, DIABETES, V42, P341, DOI 10.2337/diabetes.42.2.341; DEJGAARD A, 1991, DIABETIC MED, V8, P162, DOI 10.1111/j.1464-5491.1991.tb01564.x; DEY J, 1995, DIABETOLOGIA, V38, P251; Ding J, 2010, DIABETES, V59, P2883, DOI 10.2337/db10-0752; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Elderkin-Thompson V, 2003, ARCH CLIN NEUROPSYCH, V18, P529, DOI 10.1016/S0887-6177(03)00022-2; European Stroke organization, 2012, GUID STROK MAN; Folsom AR, 1999, DIABETES CARE, V22, P1077, DOI 10.2337/diacare.22.7.1077; Franc DT, 2011, DIABETES, V60, P315, DOI 10.2337/db10-0598; Geissler A, 2003, EXP CLIN ENDOCR DIAB, V111, P421, DOI 10.1055/s-2003-44289; Genuth S, 2007, NEW ENGL J MED, V356, P1842; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GOLD AE, 1993, DIABETIC MED, V10, P503, DOI 10.1111/j.1464-5491.1993.tb00110.x; Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7; Gunstad J, 2010, NEUROEPIDEMIOLOGY, V34, P222, DOI 10.1159/000297742; Haan MN, 2006, NAT CLIN PRACT NEURO, V2, P159, DOI 10.1038/ncpneuro0124; Hallschmid M, 2009, DIABETOLOGIA, V52, P2264, DOI 10.1007/s00125-009-1501-x; Hissa MN, 2002, NEUROENDOCRINOL LETT, V23, P226; Hyllienmark L, 2005, DIABETOLOGIA, V48, P412, DOI 10.1007/s00125-004-1666-2; Jacobson AM, 2011, DIABETOLOGIA, V54, P245, DOI 10.1007/s00125-010-1883-9; Jimenez-Bonilla JF, 2001, EUR J NUCL MED, V28, P1647, DOI 10.1007/s002590100595; Jongen C, 2008, EUR J PHARMACOL, V585, P208, DOI 10.1016/j.ejphar.2007.11.085; Kloppenborg RP, 2008, EUR J PHARMACOL, V585, P97, DOI 10.1016/j.ejphar.2008.02.049; Kodl CT, 2008, DIABETES, V57, P3083, DOI 10.2337/db08-0724; Kumar A, 2008, J MAGN RESON IMAGING, V27, P14, DOI 10.1002/jmri.21224; Kurita A, 1996, DIABETES CARE, V19, P361, DOI 10.2337/diacare.19.4.361; Last D, 2007, DIABETES CARE, V30, P1193, DOI 10.2337/dc06-2052; Launer LJ, 2011, LANCET NEUROL, V10, P969, DOI 10.1016/S1474-4422(11)70188-0; Lyoo IK, 2009, ARCH GEN PSYCHIAT, V66, P878, DOI 10.1001/archgenpsychiatry.2009.86; Makimattila S, 2004, J CEREBR BLOOD F MET, V24, P1393, DOI 10.1097/01.WCB.0000143700.15489.B2; Manschot SM, 2007, DIABETOLOGIA, V50, P2388, DOI 10.1007/s00125-007-0792-z; McCrimmon RJ, 2010, DIABETES, V59, P2333, DOI 10.2337/db10-0103; Musen G, 2006, DIABETES, V55, P326, DOI 10.2337/diabetes.55.02.06.db05-0520; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Northam EA, 2001, DIABETES CARE, V24, P1541, DOI 10.2337/diacare.24.9.1541; Northam EA, 2009, DIABETES CARE, V32, P445, DOI 10.2337/dc08-1657; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Patino-Fernandez AM, 2010, PEDIATR DIABETES, V11, P424, DOI 10.1111/j.1399-5448.2009.00618.x; Petrak F, 2009, CURR OPIN PSYCHIATR, V22, P211, DOI 10.1097/YCO.0b013e3283207b45; POZZESSERE G, 1988, DIABETES CARE, V11, P473, DOI 10.2337/diacare.11.6.473; Quinn TJ, 2011, CARDIOVASC THER, V29, pE31, DOI 10.1111/j.1755-5922.2010.00166.x; Quirce R, 1997, EUR J NUCL MED, V24, P1507, DOI 10.1007/s002590050181; Reijmer YD, 2010, DIABETES-METAB RES, V27, P195; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; RYAN C, 1985, PEDIATRICS, V75, P921; Ryan CM, 2006, DIABETOLOGIA, V49, P2229, DOI 10.1007/s00125-006-0392-3; Ryan CM, 2005, NEUROBIOL AGING, V26, pS21, DOI 10.1016/j.neurobiolaging.2005.09.006; Salem Mona A K, 2002, Pediatr Diabetes, V3, P155, DOI 10.1034/j.1399-5448.2002.30306.x; Selvin E, 2008, ARCH INTERN MED, V168, P2070, DOI 10.1001/archinte.168.19.2070; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Strachan MWJ, 1997, DIABETES CARE, V20, P438, DOI 10.2337/diacare.20.3.438; Tiehuis AM, 2008, DIABETOLOGIA, V51, P1321, DOI 10.1007/s00125-008-1041-9; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van den Berg E, 2010, DIABETOLOGIA, V53, P58, DOI 10.1007/s00125-009-1571-9; van Duinkerken E, 2009, DIABETES, V58, P2335, DOI 10.2337/db09-0425; van Harten B, 2007, AGE AGEING, V36, P164, DOI 10.1093/ageing/afl180; van Harten B, 2006, DIABETES CARE, V29, P2539, DOI 10.2337/dc06-1637; Varkonyi TT, 2002, DIABETES CARE, V25, P1661, DOI 10.2337/diacare.25.9.1661; Waldstein SR, 2003, CURR DIR PSYCHOL SCI, V12, P9, DOI 10.1111/1467-8721.01212; Waters F, 2011, J INT NEUROPSYCH SOC, V17, P571, DOI 10.1017/S1355617711000610; Wessels AM, 2006, DIABETOLOGIA, V49, P2474, DOI 10.1007/s00125-006-0283-7; Wessels AM, 2008, EUR J PHARMACOL, V585, P88, DOI 10.1016/j.ejphar.2007.11.080; Whitmer RA, 2007, CURR NEUROL NEUROSCI, V7, P373, DOI 10.1007/s11910-007-0058-7; Wilcox R, 2007, STROKE, V38, P865, DOI 10.1161/01.STR.0000257974.06317.49; Yau PL, 2010, DIABETOLOGIA, V53, P2298, DOI 10.1007/s00125-010-1857-y; Zammitt NN, 2005, DIABETES CARE, V28, P2948, DOI 10.2337/diacare.28.12.2948	81	554	584	12	141	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2012	379	9833					2291	2299		10.1016/S0140-6736(12)60360-2	http://dx.doi.org/10.1016/S0140-6736(12)60360-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962AM	22683129				2022-12-28	WOS:000305511400036
J	Yuki, N; Hartung, HP				Yuki, Nobuhiro; Hartung, Hans-Peter			Medical Progress Guillain-Barre Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MOTOR AXONAL NEUROPATHY; CAMPYLOBACTER-JEJUNI INFECTION; FISHER-SYNDROME; INTRAVENOUS IMMUNOGLOBULIN; IDIOPATHIC POLYNEURITIS; ANTECEDENT INFECTIONS; CONTINUOUS-SPECTRUM; CLINICAL-FEATURES; NERVE TERMINALS; IGG ANTIBODY		[Yuki, Nobuhiro] Natl Univ Singapore, Dept Med, Ctr Translat Med, Unit 09 01, Singapore 117599, Singapore; [Hartung, Hans-Peter] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany	National University of Singapore; Heinrich Heine University Dusseldorf	Yuki, N (corresponding author), Natl Univ Singapore, Dept Med, Ctr Translat Med, Unit 09 01, 14 Med Dr, Singapore 117599, Singapore.	yuki.research@gmail.com	Yuki, Nobuhiro/H-3187-2012		Biogen Idec; Novartis Pharma; Merck Serono; Bayer HealthCare; Genzyme; Baxter; CSL Behring; Talecris	Biogen Idec(Biogen); Novartis Pharma; Merck Serono(Merck & Company); Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Genzyme(Sanofi-AventisGenzyme Corporation); Baxter; CSL Behring; Talecris	Dr. Hartung reports receiving consulting fees from Biogen Idec, Novartis Pharma, Merck Serono, Bayer HealthCare, and Genzyme and consulting and lecture fees from Baxter, CSL Behring, and Talecris. No other potential conflict of interest relevant to this article was reported.	Annane D, 1997, ANN NEUROL, V41, P298; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001; Burakgazi AZ, 2010, J PERIPHER NERV SYST, V15, P307, DOI 10.1111/j.1529-8027.2010.00293.x; Capasso M, 2003, NEUROLOGY, V61, P617, DOI 10.1212/WNL.61.5.617; Capasso M, 2011, J NEUROL NEUROSUR PS, V82, P664, DOI 10.1136/jnnp.2010.238311; CHIBA A, 1993, NEUROLOGY, V43, P1911, DOI 10.1212/WNL.43.10.1911; Cochen V, 2005, BRAIN, V128, P2535, DOI 10.1093/brain/awh585; DEHAENE I, 1986, NEUROLOGY, V36, P851, DOI 10.1212/WNL.36.6.851; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; Drenthen J, 2011, J NEUROL NEUROSUR PS, V82, P300, DOI 10.1136/jnnp.2010.226639; Eyssen MEB, 2011, NEUROCRIT CARE, V15, P128, DOI 10.1007/s12028-011-9536-5; Farcas P, 1997, LANCET, V350, P1747, DOI 10.1016/S0140-6736(97)24050-X; FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201; Garssen MPJ, 2006, J NEUROL, V253, P1143, DOI 10.1007/s00415-006-0163-6; Goodfellow JA, 2005, J NEUROSCI, V25, P1620, DOI 10.1523/JNEUROSCI.4279-04.2005; Graham RC, 2007, J NEUROL, V254, P228, DOI 10.1007/s00415-006-0335-4; Greenshields KN, 2009, J CLIN INVEST, V119, P595, DOI 10.1172/JCI37338; Griffin JW, 1996, J NEUROCYTOL, V25, P33, DOI 10.1007/BF02284784; Guillain G., 1916, B MEM SOC MED HOP P, V40, P1462; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; Hadden RDM, 2001, NEUROLOGY, V56, P758, DOI 10.1212/WNL.56.6.758; HaferMacko C, 1996, ANN NEUROL, V40, P635, DOI 10.1002/ana.410400414; HaferMacko CE, 1996, ANN NEUROL, V39, P627, DOI 10.1002/ana.410390512; Halstead SK, 2008, BRAIN, V131, P1197, DOI 10.1093/brain/awm316; Hiraga A, 2003, NEUROLOGY, V61, P471, DOI 10.1212/01.WNL.0000081231.08914.A1; HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597; Houliston RS, 2007, BIOCHEMISTRY-US, V46, P8164, DOI 10.1021/bi700685s; Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194; Hughes RAC, 1997, LANCET, V349, P225; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; HUGHES RAC, 1993, LANCET, V341, P586; Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004; Islam Z, 2010, NEUROLOGY, V74, P581, DOI 10.1212/WNL.0b013e3181cff735; Ito M, 2008, J NEUROL, V255, P674, DOI 10.1007/s00415-008-0775-0; Ito M, 2011, J NEUROL NEUROSUR PS, V82, P294, DOI 10.1136/jnnp.2010.222836; Jacobs BC, 2003, BRAIN, V126, P2220, DOI 10.1093/brain/awg235; Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110; Kang JH, 2010, CLIN INFECT DIS, V51, P525, DOI 10.1086/655136; Khan F, 2011, EUR J PHYS REHAB MED, V47, P607; Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C; Koga M, 2002, J NEUROL NEUROSUR PS, V72, P767, DOI 10.1136/jnnp.72.6.767; Kuitwaard K, 2009, J NEUROL NEUROSUR PS, V80, P56, DOI 10.1136/jnnp.2008.156463; Kuitwaard K, 2009, ANN NEUROL, V66, P597, DOI 10.1002/ana.21737; Kusunoki S, 2011, J NEUROCHEM, V116, P828, DOI 10.1111/j.1471-4159.2010.07029.x; Kuwabara S, 2004, NEUROLOGY, V63, P529, DOI 10.1212/01.WNL.0000133205.05169.04; Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7; Liu JX, 2009, INVEST OPHTH VIS SCI, V50, P3226, DOI 10.1167/iovs.08-3333; Lopez PH, 2010, J NEUROSCI, V30, P9533, DOI 10.1523/JNEUROSCI.2281-10.2010; Lyu RK, 1997, J NEUROL NEUROSUR PS, V63, P494, DOI 10.1136/jnnp.63.4.494; MCKHANN, 1985, NEUROLOGY, V35, P1096; MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402; Mori M, 2001, NEUROLOGY, V56, P1104, DOI 10.1212/WNL.56.8.1104; Mori M, 2007, NEUROLOGY, V68, P1144, DOI 10.1212/01.wnl.0000258673.31824.61; Nachamkin I, 2007, NEUROLOGY, V69, P1665, DOI 10.1212/01.wnl.0000265396.87983.bd; Nagashima T, 2007, ARCH NEUROL-CHICAGO, V64, P1519, DOI 10.1001/archneur.64.10.1519; Nishimoto Y, 2004, J NEUROIMMUNOL, V148, P200, DOI 10.1016/j.jneuroim.2003.11.017; Orlikowski D, 2011, CLIN INFECT DIS, V52, P837, DOI 10.1093/cid/cir074; Pineda AAM, 2011, J NEUROL SCI, V306, P115, DOI 10.1016/j.jns.2011.03.031; Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602; ROPPER AH, 1992, NEW ENGL J MED, V326, P1130, DOI 10.1056/NEJM199204233261706; ROPPER AH, 1994, ARCH NEUROL-CHICAGO, V51, P671, DOI 10.1001/archneur.1994.00540190051014; ROPPER AH, 1986, ARCH NEUROL-CHICAGO, V43, P1150, DOI 10.1001/archneur.1986.00520110044012; Ruts L, 2010, NEUROLOGY, V75, P1439, DOI 10.1212/WNL.0b013e3181f88345; Ruts L, 2010, NEUROLOGY, V74, P1680, DOI 10.1212/WNL.0b013e3181e07d14; Ruts L, 2007, J NEUROL, V254, P1318, DOI 10.1007/s00415-006-0515-2; Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Sekiguchi Y, 2012, J NEUROL NEUROSUR PS, V83, P23, DOI 10.1136/jnnp-2011-300309; Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007; Susuki K, 2009, J NEUROL, V256, P1899, DOI 10.1007/s00415-009-5254-8; Uncini A, 2010, J NEUROL NEUROSUR PS, V81, P1157, DOI 10.1136/jnnp.2010.208538; van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1; van Koningsveld R, 2004, LANCET, V363, P192, DOI 10.1016/S0140-6736(03)15324-X; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705; Walgaard C, 2011, NEUROLOGY, V76, P968, DOI 10.1212/WNL.0b013e3182104407; Walgaard C, 2010, ANN NEUROL, V67, P781, DOI 10.1002/ana.21976; Willison HJ, 2011, J PERIPHER NERV SYST, V16, P60, DOI 10.1111/j.1529-8027.2011.00310.x; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771; Yuki N, 2011, J NEUROL        1206; Zhang G, 2004, BRAIN, V127, P1085, DOI 10.1093/brain/awh127; Zhang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027067; Zhang G, 2011, J NEUROSCI, V31, P1664, DOI 10.1523/JNEUROSCI.3829-10.2011	85	670	713	3	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2012	366	24					2294	2304		10.1056/NEJMra1114525	http://dx.doi.org/10.1056/NEJMra1114525			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957PD	22694000				2022-12-28	WOS:000305174100010
J	Fuchs, VR; Schaeffer, LD				Fuchs, Victor R.; Schaeffer, Leonard D.			If Accountable Care Organizations Are the Answer, Who Should Create Them?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE		[Fuchs, Victor R.] Stanford Univ, Stanford Inst Econ Policy Res, Stanford, CA 94305 USA; [Schaeffer, Leonard D.] Univ So Calif, Los Angeles, CA USA	Stanford University; University of Southern California	Fuchs, VR (corresponding author), Stanford Univ, Stanford Inst Econ Policy Res, 366 Galvez, Stanford, CA 94305 USA.	vfuchs@stanford.edu						Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; DOYLE AC, 1890, SIGN 4; Fisher ES, 2011, NEW ENGL J MED, V365, P2445, DOI 10.1056/NEJMp1112442; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; National Association of Children Hospitals and Related Institutions, 2011, HOSP INP PROF CHILDR; Rivlin AM, 2007, PERSPECTIVE LONG RUN; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; Tocknell MD, 2012, HEALTHLEADERS M 0307	8	11	11	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2012	307	21					2261	2262		10.1001/jama.2012.5564	http://dx.doi.org/10.1001/jama.2012.5564			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	952OL	22706830				2022-12-28	WOS:000304801700017
J	Nocon, RS; Sharma, R; Birnberg, JM; Ngo-Metzger, Q; Lee, SM; Chin, MH				Nocon, Robert S.; Sharma, Ravi; Birnberg, Jonathan M.; Ngo-Metzger, Quyen; Lee, Sang Mee; Chin, Marshall H.			Association Between Patient-Centered Medical Home Rating and Operating Cost at Federally Funded Health Centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE; CLINICS	Context Little is known about the cost associated with a health center's rating as a patient-centered medical home (PCMH). Objective To determine whether PCMH rating is associated with operating cost among health centers funded by the US Health Resources and Services Administration. Design, Setting, and Participants Cross-sectional study of PCMH rating and operating cost in 2009. PCMH rating was assessed through surveys of health center administrators conducted by Harris Interactive of all 1009 Health Resources and Services Administration-funded community health centers. The survey provided scores from 0 (worst) to 100 (best) for total PCMH score and 6 subscales: access/communication, care management, external coordination, patient tracking, test/referral tracking, and quality improvement. Costs were obtained from the Uniform Data System reports submitted to the Health Resources and Services Administration. We used generalized linear models to determine the relationship between PCMH rating and operating cost. Main Outcome Measures Operating cost per physician full-time equivalent, operating cost per patient per month, and medical cost per visit. Results Six hundred sixty-nine health centers (66%) were included in the study sample, with 340 excluded because of nonresponse or incomplete data. Mean total PCMH score was 60 (SD, 12; range, 21-90). For the average health center, a 10-point higher total PCMH score was associated with a $2.26 (4.6%) higher operating cost per patient per month (95% CI, $0.86-$4.12). Among PCMH subscales, a 10-point higher score for patient tracking was associated with higher operating cost per physician full-time equivalent ($27 300; 95% CI, $3047-$57 804) and higher operating cost per patient per month ($1.06; 95% CI, $0.29-$1.98). A 10-point higher score for quality improvement was also associated with higher operating cost per physician full-time equivalent ($32 731; 95% CI, $1571-$73 670) and higher operating cost per patient per month ($1.86; 95% CI, $0.54-$3.61). A 10-point higher PCMH subscale score for access/communication was associated with lower operating cost per physician full-time equivalent ($39 809; 95% CI, $1893-$63 169). Conclusions According to a survey of health center administrators, higher scores on a scale that assessed 6 aspects of the PCMH were associated with higher health center operating costs. Two subscales of the medical home were associated with higher cost and 1 with lower cost. JAMA. 2012;308(1):60-66 Published online June 24, 2012. doi: 10.1001/jama.2012.7048 www.jama.com	[Nocon, Robert S.; Chin, Marshall H.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Lee, Sang Mee] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Sharma, Ravi; Ngo-Metzger, Quyen] US Dept Hlth & Human Serv, Hlth Resources & Serv Adm, Rockville, MD USA; [Birnberg, Jonathan M.] Engaged Hlth Solut, Chicago, IL USA	University of Chicago; University of Chicago; United States Health Resources & Service Administration (HRSA)	Nocon, RS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC2007 B232, Chicago, IL 60637 USA.	rnocon@medicine.bsd.uchicago.edu			Robert Wood Johnson Foundation; Merck Company Foundation; Commonwealth Fund [20080366]; US Health Resources and Services Administration; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Hartford Foundation; NIDDK [P30 DK092949, K24 DK071933]; Agency for Healthcare Research and Quality (AHRQ) [5T32 HS00084]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092949, K24DK071933] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Merck Company Foundation; Commonwealth Fund; US Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hartford Foundation; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE form for Disclosure of Potential Conflicts of Interest. Dr Chin and Mr Nocon report receiving funding from the Robert Wood Johnson Foundation, the Merck Company Foundation, and the Commonwealth Fund. Mr Nocon and Drs Lee and Chin report receipt of a grant from the US Health Resources and Services Administration. Dr Chin reports receiving funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Hartford Foundation. Dr Birnberg reports part-time employment with Engaged Health Solutions, a workplace wellness promotion company.; This research was funded by the Commonwealth Fund (grant 20080366), the NIDDK (grants P30 DK092949 and K24 DK071933), and the Agency for Healthcare Research and Quality (AHRQ 5T32 HS00084).	American Medical Association, MED PHYS PAYM SCHED; Birnberg JM, 2011, J GEN INTERN MED, V26, P1418, DOI 10.1007/s11606-011-1767-9; Bitton A, 2010, J GEN INTERN MED, V25, P584, DOI 10.1007/s11606-010-1262-8; Bureau of Primary Health Care, UDS REP INSTR SECT 3; Centers for Medicare & Medicaid Services, EHR INC PROGR; Clarke RMA, 2012, HEALTH AFFAIR, V31, P627, DOI 10.1377/hlthaff.2011.0908; Cosway R, 2011, ANAL COMMUNITY CARE; Doty MM, 2010, ENHANCING CAPACITY C; Flottemesch TJ, 2011, J AMBUL CARE MANAG, V34, P78, DOI 10.1097/JAC.0b013e3181ff6fd2; Fontaine P, 2011, J AMBUL CARE MANAG, V34, P10, DOI 10.1097/JAC.0b013e3181ff7019; Frick Kevin, 2007, Prog Community Health Partnersh, V1, P75, DOI 10.1353/cpr.0.0003; Gilfillan RJ, 2010, AM J MANAG CARE, V16, P607; Health Resources and Services Administration, HLTH CTR DAT; Huang ES, 2008, JT COMM J QUAL PATIE, V34, P138, DOI 10.1016/S1553-7250(08)34016-1; Huang ES, 2007, HEALTH SERV RES, V42, P2174, DOI 10.1111/j.1475-6773.2007.00734.x; Lewis SE, 2012, ARCH INTERN MED, V172, P23, DOI 10.1001/archinternmed.2011.580; Liu CF, 2009, HEALTH SERV RES, V44, P225, DOI 10.1111/j.1475-6773.2008.00911.x; Maeng DD, 2012, AM J MANAG CARE, V18, P149; Marathe S, 2007, J MED SYST, V31, P365, DOI 10.1007/s10916-007-9078-8; Martin Brian C, 2009, J Health Care Finance, V35, P1; Ovretveit J, 2009, REV EVIDENCE WHICH I, P95; Peikes D, 2012, AM J MANAG CARE, V18, P105; Rauh Stephen S, 2011, N Engl J Med, V365, pe48, DOI 10.1056/NEJMp1111662; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Rittenhouse DR, 2009, JAMA-J AM MED ASSOC, V301, P2038, DOI 10.1001/jama.2009.691; Shi Leiyu, 2007, J Public Health Manag Pract, V13, P133; ZUCKERMAN S, 2009, INCREMENTAL COST EST	27	40	40	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2012	308	1					60	66		10.1001/jama.2012.7048	http://dx.doi.org/10.1001/jama.2012.7048			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	971DD	22729481	Bronze, Green Accepted			2022-12-28	WOS:000306183000024
J	Schrijvers, R; Debyser, Z				Schrijvers, Rik; Debyser, Zeger			Quad's in it for antiretroviral therapy?	LANCET			English	Editorial Material							TENOFOVIR DISOPROXIL FUMARATE; CO-FORMULATED ELVITEGRAVIR; INITIAL TREATMENT; HIV-1 INFECTION; DOUBLE-BLIND; PHASE-3; EMTRICITABINE; COBICISTAT; EFAVIRENZ; SAFETY		[Schrijvers, Rik; Debyser, Zeger] Katholieke Univ Leuven, Div Mol Med, B-3000 Louvain, Flanders, Belgium	KU Leuven	Debyser, Z (corresponding author), Katholieke Univ Leuven, Div Mol Med, B-3000 Louvain, Flanders, Belgium.	zeger.debyser@med.kuleuven.be	debyser, zeger/H-1310-2013	debyser, zeger/0000-0002-3982-1565				Airoldi M, 2010, PATIENT PREFER ADHER, V4, P115; Cassetti I, 2007, HIV CLIN TRIALS, V8, P164, DOI 10.1310/hct0803-164; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Eron JJ, 2011, LANCET INFECT DIS, V11, P907, DOI 10.1016/S1473-3099(11)70196-7; Fernandez-Fernandez B, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/354908; German P, 2011, 51 INT C ANT AG CHEM; Gilead Sciences, 2012, ANT DRUGS ADV COMM M; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; Lepist E, 2011, 51 INT C ANT AG CHEM; Mathias AA, 2010, CLIN PHARMACOL THER, V87, P322, DOI 10.1038/clpt.2009.228; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUID US ANT AG HIV 1; Ramanathan S, 2011, CLIN PHARMACOKINET, V50, P229, DOI 10.2165/11584570-000000000-00000; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9	15	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 30	2012	379	9835					2403	2405		10.1016/S0140-6736(12)61029-0	http://dx.doi.org/10.1016/S0140-6736(12)61029-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	967NV	22748575				2022-12-28	WOS:000305915900004
J	Kreysing, M; Pusch, R; Haverkate, D; Landsberger, M; Engelmann, J; Ruiter, J; Mora-Ferrer, C; Ulbricht, E; Grosche, J; Franze, K; Streif, S; Schumacher, S; Makarov, F; Kacza, J; Guck, J; Wolburg, H; Bowmaker, JK; von der Emde, G; Schuster, S; Wagner, HJ; Reichenbach, A; Francke, M				Kreysing, Moritz; Pusch, Roland; Haverkate, Dorothee; Landsberger, Meik; Engelmann, Jacob; Ruiter, Janina; Mora-Ferrer, Carlos; Ulbricht, Elke; Grosche, Jens; Franze, Kristian; Streif, Stefan; Schumacher, Sarah; Makarov, Felix; Kacza, Johannes; Guck, Jochen; Wolburg, Hartwig; Bowmaker, James K.; von der Emde, Gerhard; Schuster, Stefan; Wagner, Hans-Joachim; Reichenbach, Andreas; Francke, Mike			Photonic Crystal Light Collectors in Fish Retina Improve Vision in Turbid Water	SCIENCE			English	Article							SENSITIVITY	Despite their diversity, vertebrate retinae are specialized to maximize either photon catch or visual acuity. Here, we describe a functional type that is optimized for neither purpose. In the retina of the elephantnose fish (Gnathonemus petersii), cone photoreceptors are grouped together within reflecting, photonic crystal-lined cups acting as macroreceptors, but rod photoreceptors are positioned behind these reflectors. This unusual arrangement matches rod and cone sensitivity for detecting color-mixed stimuli, whereas the photoreceptor grouping renders the fish insensitive to spatial noise; together, this enables more reliable flight reactions in the fish's dim and turbid habitat as compared with fish lacking this retinal specialization.	[Ruiter, Janina; Ulbricht, Elke; Grosche, Jens; Franze, Kristian; Reichenbach, Andreas; Francke, Mike] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany; [Kreysing, Moritz; Franze, Kristian; Guck, Jochen; Francke, Mike] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Kreysing, Moritz] Univ Munich, Dept Phys, D-80799 Munich, Germany; [Pusch, Roland; Landsberger, Meik; Engelmann, Jacob; Schumacher, Sarah; von der Emde, Gerhard] Univ Bonn, Inst Zool, D-53115 Bonn, Germany; [Haverkate, Dorothee; Schuster, Stefan] Univ Bayreuth, Dept Anim Physiol, D-95440 Bayreuth, Germany; [Engelmann, Jacob] Univ Bielefeld, Dept Biol, D-33501 Bielefeld, Germany; [Mora-Ferrer, Carlos] Johannes Gutenberg Univ Mainz, Inst Zool Neurobiol, D-55099 Mainz, Germany; [Ulbricht, Elke; Franze, Kristian] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Streif, Stefan] Univ Magdeburg, Inst Automat Engn Syst Theory & Automat Control L, D-39106 Magdeburg, Germany; [Makarov, Felix] IP Pavlov Physiol Inst, St Petersburg 199034, Russia; [Kacza, Johannes] Univ Leipzig, Fac Vet Med, Inst Anat Histol & Embryol, D-04109 Leipzig, Germany; [Guck, Jochen] Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany; [Wolburg, Hartwig] Univ Tubingen, Inst Pathol & Neuropathol, D-72076 Tubingen, Germany; [Bowmaker, James K.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Wagner, Hans-Joachim] Univ Tubingen, Inst Anat, D-72074 Tubingen, Germany; [Francke, Mike] Univ Leipzig, Translat Ctr Regenerat Med, D-04103 Leipzig, Germany	Leipzig University; University of Cambridge; University of Munich; University of Bonn; University of Bayreuth; University of Bielefeld; Johannes Gutenberg University of Mainz; University of Cambridge; Otto von Guericke University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences; Leipzig University; Technische Universitat Dresden; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of London; University College London; Eberhard Karls University of Tubingen; Leipzig University	Reichenbach, A (corresponding author), Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany.	reia@medizin.uni-leipzig.de	Guck, Jochen/AAJ-9283-2021; Reichenbach, Andreas/B-2510-2017; Guck, Jochen/B-4412-2014; Kreysing, Moritz/B-3751-2017; Francke, Mike/A-7505-2017; Pusch, Roland/AAX-1415-2021	Guck, Jochen/0000-0002-1453-6119; Guck, Jochen/0000-0002-1453-6119; Kreysing, Moritz/0000-0001-7432-3871; Schuster, Stefan/0000-0002-0873-8996; Pusch, Roland/0000-0002-6851-4839; Franze, Kristian/0000-0002-8425-7297; Streif, Stefan/0000-0002-3398-1226	Deutsche Forschungsgemeinschaft; German Federal Ministry of Education and Research; Alexander-von-Humboldt Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Alexander-von-Humboldt Foundation(Alexander von Humboldt Foundation)	This work was financially supported by the Deutsche Forschungsgemeinschaft, the German Federal Ministry of Education and Research, and the Alexander-von-Humboldt Foundation. Help with freeze-fracturing by Ria Knittel is gratefully acknowledged. Numerical simulations were run on the Darwin Supercomputer, University of Cambridge. A.R., H.-J.W., S. Schuster, G.v.d.E., J. Guck, M.K., and M.F. developed the idea of the project, supervised the research, and wrote the manuscript; H.-J.W., J.E., F.M., E.U., R.P., J.R., H.W., J.K., and M.F. obtained morphological data; M.K. performed the electrodynamical simulations; J.B. measured the absorption spectra; K.F. measured light reflection of the eye; J. Grosche measured light reflection of the isolated retina and provided the 3D reconstructions of the RPE; M.L., D.H., and S. Schumacher obtained behavioral data; J.E. and R.P. performed tectum measurements; C.M.-F. and D.H. performed the electroretinogram; and S. Schuster designed and S. Streif developed the programs applied in the dynamic noise and color-pooling experiments.	Brauer A., 1908, ERGEBNISSE DTSCH TIE, V15, P1; Ciali S, 1997, J FISH BIOL, V50, P1074, DOI 10.1006/jfbi.1996.0372; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Landsberger M, 2008, J PHYSIOL-PARIS, V102, P291, DOI 10.1016/j.jphysparis.2008.10.015; Large MCJ, 2007, PHYSICA B, V394, P229, DOI 10.1016/j.physb.2006.12.016; LOCKET NA, 1971, PROC R SOC SER B-BIO, V178, P161, DOI 10.1098/rspb.1971.0059; McEWAN MARY RUTH, 1938, ACTA ZOOL [STOCKHOLM], V19, P427; MOLLER P, 1979, BEHAV ECOL SOCIOBIOL, V4, P357, DOI 10.1007/BF00303242; Moller P., 1995, ELECT FISHES HIST BE; MORGAN MJ, 1992, P ROY SOC B-BIOL SCI, V248, P291, DOI 10.1098/rspb.1992.0074; NORMANN RA, 1974, J GEN PHYSIOL, V63, P37, DOI 10.1085/jgp.63.1.37; Oskooi AF, 2010, COMPUT PHYS COMMUN, V181, P687, DOI 10.1016/j.cpc.2009.11.008; Rojas R, 2002, BRAIN BEHAV EVOLUT, V59, P211, DOI 10.1159/000064908; Schaerer S, 1996, VISION RES, V36, P4025, DOI 10.1016/S0042-6989(96)00149-6; Schuster S, 2002, J EXP BIOL, V205, P549; Seeliger Mathias W., 2002, Documenta Ophthalmologica, V104, P57, DOI 10.1023/A:1014454927931; Walls GL, 1963, VERTEBRATE EYE ITS A; WALMSLEY RD, 1980, HYDROBIOLOGIA, V70, P145, DOI 10.1007/BF00015500; WERBLIN FS, 1973, SCI AM, V228, P71; Yokoyama S, 2005, MOL BIOL EVOL, V22, P968, DOI 10.1093/molbev/msi080	21	56	56	1	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1700	1703		10.1126/science.1218072	http://dx.doi.org/10.1126/science.1218072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745429				2022-12-28	WOS:000305794500049
J	Mayer, A; Heidemann, M; Lidschreiber, M; Schreieck, A; Sun, M; Hintermair, C; Kremmer, E; Eick, D; Cramer, P				Mayer, Andreas; Heidemann, Martin; Lidschreiber, Michael; Schreieck, Amelie; Sun, Mai; Hintermair, Corinna; Kremmer, Elisabeth; Eick, Dirk; Cramer, Patrick			CTD Tyrosine Phosphorylation Impairs Termination Factor Recruitment to RNA Polymerase II	SCIENCE			English	Article							ELONGATION-FACTOR SPT6; TANDEM SH2 DOMAIN; TRANSCRIPTION TERMINATION; S. CEREVISIAE; CODE; COMPLEX; PROTEIN; IICTD; ASSOCIATION; SERINE-7	In different phases of the transcription cycle, RNA polymerase (Pol) II recruits various factors via its C-terminal domain (CTD), which consists of conserved heptapeptide repeats with the sequence Tyr(1)-Ser(2)-Pro(3)-Thr(4)-Ser(5)-Pro(6)-Ser(7). We show that the CTD of transcribing yeast Pol II is phosphorylated at Tyr(1), in addition to Ser(2), Thr(4), Ser(5), and Ser(7). Tyr(1) phosphorylation stimulates binding of elongation factor Spt6 and impairs recruitment of termination factors Nrd1, Pcf11, and Rtt103. Tyr(1) phosphorylation levels rise downstream of the transcription start site and decrease before the polyadenylation site, largely excluding termination factors from gene bodies. These results show that CTD modifications trigger and block factor recruitment and lead to an extended CTD code that explains transcription cycle coordination on the basis of differential phosphorylation of Tyr(1), Ser(2), and Ser(5).	[Heidemann, Martin; Hintermair, Corinna; Eick, Dirk] Helmholtz Zentrum Munchen, Dept Mol Epigenet, D-81377 Munich, Germany; [Heidemann, Martin; Hintermair, Corinna; Eick, Dirk] CIPSM, D-81377 Munich, Germany; [Mayer, Andreas; Lidschreiber, Michael; Schreieck, Amelie; Sun, Mai; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Mayer, Andreas; Lidschreiber, Michael; Schreieck, Amelie; Sun, Mai; Cramer, Patrick] Univ Munich, CIPSM, Dept Biochem, D-81377 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Eick, D (corresponding author), Helmholtz Zentrum Munchen, Dept Mol Epigenet, Marchioninistr 25, D-81377 Munich, Germany.	eick@helmholtz-muenchen.de; cramer@genzentrum.LMU.de	Sun, Mai/A-3837-2010; Mayer, Andreas/AAA-5173-2021	Sun, Mai/0000-0003-2824-7964; Mayer, Andreas/0000-0002-4532-9382	Deutsche Forschungsgemeinschaft (DFG) [SFB646, SFB960, TR5, SFB684]; NIM; BioImaging Network; European Research Council (ERC); Jung-Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIM; BioImaging Network; European Research Council (ERC)(European Research Council (ERC)); Jung-Stiftung	We thank S. Etzold and K. Leike for help and S. Hahn for providing yeast strains. P. C. was supported by the Deutsche Forschungsgemeinschaft (DFG), SFB646, SFB960, TR5, NIM, the BioImaging Network, a European Research Council (ERC) Advanced Grant, and the Jung-Stiftung. D. E. was supported by DFG, TR5, and SFB684. Microrray data have been deposited in ArrayExpress under accession code E-MTAB-1060. A. M. carried out ChIP-chip and fluorescence anisotropy experiments. M. H. and C. H. validated antibodies. M. L. analyzed ChIP-chip data. M. S. carried out modeling. A. S. carried out additional ChIP assays. E. K. generated the 3D12 antibody. D. E. and P. C. designed and supervised research. A. M. and P. C. prepared the manuscript, with help from all authors.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Baskaran R, 1999, CELL GROWTH DIFFER, V10, P387; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Close D, 2011, J MOL BIOL, V408, P697, DOI 10.1016/j.jmb.2011.03.002; Corden JL, 2007, SCIENCE, V318, P1735, DOI 10.1126/science.1152624; Creamer TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002329; Dengl S, 2009, J MOL BIOL, V389, P211, DOI 10.1016/j.jmb.2009.04.016; Diebold ML, 2010, J BIOL CHEM, V285, P38389, DOI 10.1074/jbc.M110.146696; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Hsin JP, 2011, SCIENCE, V334, P683, DOI 10.1126/science.1206034; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim KY, 2011, CELL, V144, P745, DOI 10.1016/j.cell.2011.01.034; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Liu JP, 2011, J BIOL CHEM, V286, P29218, DOI 10.1074/jbc.M111.252130; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Stiller JW, 2004, EUKARYOT CELL, V3, P735, DOI 10.1128/EC.3.3.735-740.2004; Sun M, 2010, J BIOL CHEM, V285, P41597, DOI 10.1074/jbc.M110.144568; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; WEST ML, 1995, GENETICS, V140, P1223	30	174	175	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1723	1725		10.1126/science.1219651	http://dx.doi.org/10.1126/science.1219651			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745433	Green Published			2022-12-28	WOS:000305794500055
J	Pecoits, E; Konhauser, KO; Aubet, NR; Heaman, LM; Veroslavsky, G; Stern, RA; Gingras, MK				Pecoits, Ernesto; Konhauser, Kurt O.; Aubet, Natalie R.; Heaman, Larry M.; Veroslavsky, Gerardo; Stern, Richard A.; Gingras, Murray K.			Bilaterian Burrows and Grazing Behavior at > 585 Million Years Ago	SCIENCE			English	Article							EDIACARAN ANIMAL EMBRYOS; MISTAKEN POINT FORMATION; FOSSILIZED NUCLEI; 1ST EVIDENCE; EVOLUTION; OXYGENATION; LOCOMOTION; EMERGENCE; ORIGIN; BIOTA	Based on molecular clocks and biomarker studies, it is possible that bilaterian life emerged early in the Ediacaran, but at present, no fossils or trace fossils from this time have been reported. Here we report the discovery of the oldest bilaterian burrows in shallow-water glaciomarine sediments from the Tacuari Formation, Uruguay. Uranium-lead dating of zircons in cross-cutting granite dykes constrains the age of these burrows to be at least 585 million years old. Their features indicate infaunal grazing activity by early eumetazoans. Active backfill within the burrow, an ability to wander upward and downward to exploit shallowly situated sedimentary laminae, and sinuous meandering suggest advanced behavioral adaptations. These findings unite the paleontological and molecular data pertaining to the evolution of bilaterians, and link bilaterian origins to the environmental changes that took place during the Neoproterozoic glaciations.	[Pecoits, Ernesto; Konhauser, Kurt O.; Aubet, Natalie R.; Heaman, Larry M.; Stern, Richard A.; Gingras, Murray K.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Veroslavsky, Gerardo] Univ Republica, Inst Ciencias Geol, Montevideo 11400, Uruguay	University of Alberta; Universidad de la Republica, Uruguay	Pecoits, E (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada.	epecoits@ualberta.ca		Konhauser, Kurt/0000-0001-7722-7068	Natural Sciences and Engineering Research Council (NSERC) of Canada; Comision Sectorial de Investigacion Cientifica-UdelaR; Agouron Institute; NSERC	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Comision Sectorial de Investigacion Cientifica-UdelaR; Agouron Institute(Pfizer); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grants to K.O.K., M.K.G., and L.M.H.; by a Comision Sectorial de Investigacion Cientifica-UdelaR Grant ("El Ediacarano en Uruguay y su importancia en el contexto del origen de la vida animal") to K.O.K., G.V., M.K.G., E.P., and N.R.A.; and by an Agouron Institute Fellowship Program grant to E. Pecoits. Partial support for the U-Pb analyses was provided by an NSERC Major Resource Support Grant to L.M.H. Laboratory support for the thermal ionization mass spectrometry, LA-MC-ICPMS, and SHRIMP U-Pb analyses was provided by B. Herchuk, J. Schultz, G. Hatchard, A. DuFrane, and A. Simonetti. C. Magee and staff at Geoscience Australia facilitated SHRIMP analysis. We also thank G. Narbonne for many valuable insights. The data presented in this paper are available in the supplementary materials. The trace fossil collection can be found at the Department of Earth and Atmospheric Sciences, with accession nos. TF3 to TF16.	Bengtson S, 2007, PALEOBIOLOGY, V33, P351, DOI 10.1666/04040.1; Brasier MD, 1998, J GEOL SOC LONDON, V155, P5, DOI 10.1144/gsjgs.155.1.0005; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Chen JY, 2004, SCIENCE, V305, P218, DOI 10.1126/science.1099213; Collins AG, 2000, PALEOBIOLOGY, V26, P47, DOI 10.1666/0094-8373(2000)026<0047:MMCTAT>2.0.CO;2; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; Droser ML, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P125; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; Gingras M, 2011, NAT GEOSCI, V4, P372, DOI [10.1038/NGEO1142, 10.1038/ngeo1142]; Hedges SB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-2; Huldtgren T, 2011, SCIENCE, V334, P1696, DOI 10.1126/science.1209537; Jensen S, 2005, PALAEOGEOGR PALAEOCL, V220, P19, DOI 10.1016/j.palaeo.2003.09.035; Jensen S, 2007, GEOL SOC SPEC PUBL, V286, P223, DOI 10.1144/SP286.16; Jensen Soren, 2006, V27, P115; Liu AG, 2010, GEOLOGY, V38, P123, DOI 10.1130/G30368.1; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Maloof AC, 2010, NAT GEOSCI, V3, P653, DOI 10.1038/NGEO934; Martin MW, 2000, SCIENCE, V288, P841, DOI 10.1126/science.288.5467.841; Matz MV, 2008, CURR BIOL, V18, P1849, DOI 10.1016/j.cub.2008.10.028; McFadden KA, 2008, P NATL ACAD SCI USA, V105, P3197, DOI 10.1073/pnas.0708336105; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; NARBONNE GM, 1990, PALAEONTOLOGY, V33, P945; Och LM, 2012, EARTH-SCI REV, V110, P26, DOI 10.1016/j.earscirev.2011.09.004; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Retallack GJ, 2010, GEOLOGY, V38, pE223, DOI 10.1130/G31137C.1; Shen YN, 2008, P NATL ACAD SCI USA, V105, P7376, DOI 10.1073/pnas.0802168105; Veroslavsky G., 2006, REV SOC URU GEOL, V13, P23; Xiao SH, 2012, SCIENCE, V335, DOI 10.1126/science.1218814	29	59	64	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1693	1696		10.1126/science.1216295	http://dx.doi.org/10.1126/science.1216295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745427				2022-12-28	WOS:000305794500047
J	Goldman, YE; Franzini-Armstrong, C; Armstrong, CM				Goldman, Yale E.; Franzini-Armstrong, Clara; Armstrong, Clay M.			Andrew Fielding Huxley (1917-2012) OBITUARY	NATURE			English	Biographical-Item									[Goldman, Yale E.; Franzini-Armstrong, Clara] Univ Penn, Perelman Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Armstrong, Clay M.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Goldman, YE (corresponding author), Univ Penn, Perelman Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA.	goldmany@yahoo.com						HUXLEY AF, PUBLICATION LIST	1	0	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					474	474		10.1038/486474a	http://dx.doi.org/10.1038/486474a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22739307	Bronze			2022-12-28	WOS:000305760600026
J	Moghal, N				Moghal, Nadeem			Mission, vision, and values statements in healthcare: what are they for?	BRITISH MEDICAL JOURNAL			English	Editorial Material												nadeem.moghal@ncl.ac.uk							0	3	3	2	26	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 25	2012	344								e4331	10.1136/bmj.e4331	http://dx.doi.org/10.1136/bmj.e4331			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	968MS	22734077				2022-12-28	WOS:000305986500004
J	Boyce, N				Boyce, Niall			Keith Hawton: chance favours the prepared mind	LANCET			English	Biographical-Item												niall.boyce@lancet.com						HAWTON K, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 23	2012	379	9834					2333	2333		10.1016/S0140-6736(12)61006-X	http://dx.doi.org/10.1016/S0140-6736(12)61006-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961ZV	22726505				2022-12-28	WOS:000305509600014
J	Ryan, RJH; Bernstein, BE				Ryan, Russell J. H.; Bernstein, Bradley E.			Genetic Events That Shape the Cancer Epigenome	SCIENCE			English	Editorial Material							MUTATIONS; DIFFERENTIATION; EZH2		[Ryan, Russell J. H.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Pathol, Boston, MA 02114 USA; [Ryan, Russell J. H.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Ryan, Russell J. H.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ryan, Russell J. H.; Bernstein, Bradley E.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Ryan, RJH (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Pathol, Boston, MA 02114 USA.	bernstein.bradley@mgh.harvard.edu		Ryan, Russell/0000-0001-8174-3962	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Greenberg RA, 2011, FEBS LETT, V585, P2883, DOI 10.1016/j.febslet.2011.05.037; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; McKenna ES, 2008, MOL CELL BIOL, V28, P6223, DOI 10.1128/MCB.00658-08; Misteli T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000794; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Pujadas E, 2012, CELL, V148, P1123, DOI 10.1016/j.cell.2012.02.045; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	20	47	48	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1513	1514		10.1126/science.1223730	http://dx.doi.org/10.1126/science.1223730			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723401				2022-12-28	WOS:000305507500035
J	Wu, QF; Yang, L; Li, S; Wang, Q; Yuan, XB; Gao, X; Bao, L; Zhang, X				Wu, Qing-Feng; Yang, Liu; Li, Shuai; Wang, Qiong; Yuan, Xiao-Bin; Gao, Xiang; Bao, Lan; Zhang, Xu			Fibroblast Growth Factor 13 Is a Microtubule-Stabilizing Protein Regulating Neuronal Polarization and Migration	CELL			English	Article							FACTOR HOMOLOGOUS FACTORS; MULTIPOLAR STAGE; NERVOUS-SYSTEM; DOUBLECORTIN; MICE; OUTGROWTH; MEMORY; MAP1B; NUCLEOKINESIS; TRANSLOCATION	Secretory fibroblast growth factors (FGFs) and their receptors are known for their regulatory function in the early stages of neural development. FGF13, a nonsecretory protein of the FGF family, is expressed in cerebral cortical neurons during development and is a candidate gene for syndromal and nonspecific forms of X-chromosome-linked mental retardation (XLMR). However, its function during development remains unclear. We show that FGF13 acts intracellularly as a microtubule-stabilizing protein required for axon and leading process development and neuronal migration in the cerebral cortex. FGF13 is enriched in axonal growth cones and interacts directly with microtubules. Furthermore, FGF13 polymerizes tubulins and stabilizes microtubules. The loss of FGF13 impairs neuronal polarization and increases the branching of axons and leading processes. Genetic deletion of FGF13 in mice results in neuronal migration defects in both the neocortex and the hippocampus. FGF13-deficient mice also exhibit weakened learning and memory, which is correlated to XLMR patients' intellectual disability.	[Wu, Qing-Feng; Yang, Liu; Li, Shuai; Yuan, Xiao-Bin; Zhang, Xu] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Wu, Qing-Feng; Yang, Liu; Li, Shuai; Yuan, Xiao-Bin; Zhang, Xu] Chinese Acad Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Wang, Qiong; Bao, Lan] Chinese Acad Sci, State Key Lab Cell Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing University	Zhang, X (corresponding author), Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	xu.zhang@ion.ac.cn	Wu, Qing-Feng/AAA-5460-2022	Wu, Qing-Feng/0000-0003-3272-6247	NNSFC [31130066]; MOST [2011CBA00400, 2009CB522005]	NNSFC(National Natural Science Foundation of China (NSFC)); MOST	This work is published in memory of Prof. B. A. Afzelius at the University of Stockholm. We thank Drs. X. Yu, Z.-G. Luo, X.-L. Zhu, and J.-S. Guan for comments. This work was supported by NNSFC (31130066) and MOST (2011CBA00400 and 2009CB522005). Q.-F.W. did major experiments. L.Y. and S. L. worked with in utero electroporation in rats, Q. W. with in situ hybridization, and X. G. with mutant mice. X.-B.Y. contributed to experiment design. X.Z., L. B., and Q.-F.W. designed the project and wrote the manuscript.	Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bouquet C, 2004, J NEUROSCI, V24, P7204, DOI 10.1523/JNEUROSCI.2254-04.2004; Corbo JC, 2002, J NEUROSCI, V22, P7548; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gecz J, 1999, HUM GENET, V104, P56, DOI 10.1007/s004390050910; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Goldfarb M, 2007, NEURON, V55, P449, DOI 10.1016/j.neuron.2007.07.006; Gonzalez-Billault C, 2001, MOL BIOL CELL, V12, P2087, DOI 10.1091/mbc.12.7.2087; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guillemot F, 2011, NEURON, V71, P574, DOI 10.1016/j.neuron.2011.08.002; Hartung H, 1997, MECH DEVELOP, V64, P31, DOI 10.1016/S0925-4773(97)00042-7; He M, 2010, J NEUROSCI, V30, P10885, DOI 10.1523/JNEUROSCI.0240-10.2010; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kerjan G, 2007, TRENDS GENET, V23, P623, DOI 10.1016/j.tig.2007.09.003; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Kornack DR, 2005, CURR OPIN NEUROBIOL, V15, P58, DOI 10.1016/j.conb.2005.01.009; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Lysko DE, 2011, J NEUROSCI, V31, P1739, DOI 10.1523/JNEUROSCI.3118-10.2011; MALMGREN H, 1993, AM J HUM GENET, V52, P1046; Manna T, 2007, BIOCHEMISTRY-US, V46, P3543, DOI 10.1021/bi061819d; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Nishimoto S, 2007, J BIOL CHEM, V282, P24255, DOI 10.1074/jbc.M704277200; Poulain FE, 2010, MOL CELL NEUROSCI, V43, P15, DOI 10.1016/j.mcn.2009.07.012; Qiang L, 2010, MOL BIOL CELL, V21, P334, DOI 10.1091/mbc.E09-09-0834; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Schoorlemmer J, 2001, CURR BIOL, V11, P793, DOI 10.1016/S0960-9822(01)00232-9; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Solomon NM, 2002, GENOMICS, V79, P553, DOI 10.1006/geno.2002.6741; Stiess M, 2011, DEV NEUROBIOL, V71, P430, DOI 10.1002/dneu.20849; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Umeshima H, 2007, P NATL ACAD SCI USA, V104, P16182, DOI 10.1073/pnas.0708047104; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walsh CA, 2010, NEURON, V68, P245, DOI 10.1016/j.neuron.2010.09.042; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Wehner J. M., 2004, CURRENT PROTOCOLS NE; Westerlund N, 2011, NAT NEUROSCI, V14, P305, DOI 10.1038/nn.2755; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004	51	114	125	5	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1549	1564		10.1016/j.cell.2012.04.046	http://dx.doi.org/10.1016/j.cell.2012.04.046			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726441	Bronze			2022-12-28	WOS:000305753800020
J	Burke, D				Burke, David			Donepezil or memantine improved cognitive functioning in moderate-to-severe Alzheimer disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									St Vincents Hlth Network, Sydney, NSW, Australia		Burke, D (corresponding author), St Vincents Hlth Network, Sydney, NSW, Australia.			Howard, Robert/0000-0002-3071-2338				Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Hensel A, 2007, J NEUROL NEUROSUR PS, V78, P1298, DOI 10.1136/jnnp.2006.109074; Mendiondo MS, 2000, STAT MED, V19, P1607, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1607::AID-SIM449>3.0.CO;2-O; National Institute for Health and Clinical Excellence, 2011, NIC TECHN APPR GUID, V217	4	9	9	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12							JC6-10	10.7326/0003-4819-156-12-201206190-02010	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711111				2022-12-28	WOS:000307783200009
J	Levine, M				Levine, Mitchell			Hypnotic drugs were associated with increased risk for mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Ctr Evaluat Med, Hamilton, ON, Canada		Levine, M (corresponding author), Ctr Evaluat Med, Hamilton, ON, Canada.							Belleville G, 2010, CAN J PSYCHIAT, V55, P558, DOI 10.1177/070674371005500904	1	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12							JC6-13	10.7326/0003-4819-156-12-201206190-02013	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711114				2022-12-28	WOS:000307783200012
J	Boyce, N				Boyce, Niall			The Lancet Techology: June, 2012	LANCET			English	Editorial Material												niall.boyce@lancet.com							0	8	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 16	2012	379	9833					2231	2231		10.1016/S0140-6736(12)60965-9	http://dx.doi.org/10.1016/S0140-6736(12)60965-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	962AM	22715507	Bronze			2022-12-28	WOS:000305511400014
J	Naeem, S; Duffy, JE; Zavaleta, E				Naeem, Shahid; Duffy, J. Emmett; Zavaleta, Erika			The Functions of Biological Diversity in an Age of Extinction	SCIENCE			English	Review							PLANT-SPECIES RICHNESS; ECOSYSTEM-FUNCTION; MULTITROPHIC INTERACTIONS; COMMUNITY BIOMASS; BIODIVERSITY; GRASSLAND; PRODUCTIVITY; SERVICES; CONSEQUENCES; CONSERVATION	Ecosystems worldwide are rapidly losing taxonomic, phylogenetic, genetic, and functional diversity as a result of human appropriation of natural resources, modification of habitats and climate, and the spread of pathogenic, exotic, and domestic plants and animals. Twenty years of intense theoretical and empirical research have shown that such biotic impoverishment can markedly alter the biogeochemical and dynamic properties of ecosystems, but frontiers remain in linking this research to the complexity of wild nature, and in applying it to pressing environmental issues such as food, water, energy, and biosecurity. The question before us is whether these advances can take us beyond merely invoking the precautionary principle of conserving biodiversity to a predictive science that informs practical and specific solutions to mitigate and adapt to its loss.	[Naeem, Shahid] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Duffy, J. Emmett] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; [Zavaleta, Erika] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	Columbia University; William & Mary; Virginia Institute of Marine Science; University of California System; University of California Santa Cruz	Naeem, S (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	sn2121@columbia.edu	Duffy, J. Emmett/ABF-9200-2020	Duffy, J. Emmett/0000-0001-8595-6391	NSF [OCE-1031061, DEB-0639161, DEB-0918715]; Division Of Ocean Sciences [1031061] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank two anonymous reviewers for their comments and suggestions. Supported by NSF grants OCE-1031061 (J.E.D.), DEB-0639161 (S.N.), and DEB-0918715 (E.Z.).	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Allan E, 2011, P NATL ACAD SCI USA, V108, P17034, DOI 10.1073/pnas.1104015108; [Anonymous], 2005, EC HUM WELL BEING SY; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Carey MP, 2011, OIKOS, V120, P84, DOI 10.1111/j.1600-0706.2010.18352.x; Connolly J, 2011, ECOLOGY, V92, P1385, DOI 10.1890/10-2270.1; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Dickie IA, 2011, J APPL ECOL, V48, P926, DOI 10.1111/j.1365-2664.2011.01980.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Duffy JE, 2005, ECOL LETT, V8, P301, DOI 10.1111/j.1461-0248.2005.00725.x; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; France KE, 2006, NATURE, V441, P1139, DOI 10.1038/nature04729; Franssen NR, 2011, OIKOS, V120, P582, DOI 10.1111/j.1600-0706.2010.18810.x; Fukami T, 2010, ECOL LETT, V13, P675, DOI 10.1111/j.1461-0248.2010.01465.x; Griffin John n., 2009, P78; Gustafsson C, 2011, OIKOS, V120, P1037, DOI 10.1111/j.1600-0706.2010.19008.x; Haddad NM, 2011, ECOL LETT, V14, P42, DOI 10.1111/j.1461-0248.2010.01548.x; Hargrave CW, 2011, ECOLOGY, V92, P1226, DOI 10.1890/09-1948.1; He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Isbell FI, 2008, OIKOS, V117, P996, DOI 10.1111/j.0030-1299.2008.16692.x; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Latta LC, 2011, EVOL ECOL, V25, P1107, DOI 10.1007/s10682-010-9457-3; Letourneau DK, 2009, ANNU REV ECOL EVOL S, V40, P573, DOI 10.1146/annurev.ecolsys.110308.120320; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; Loureau M., 2010, POPULATIONS ECOSYTEM; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Maggi E, 2011, ECOLOGY, V92, P1399, DOI 10.1890/10-1323.1; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; MEA (Millenium Ecosystem Assessment), 2003, ECOSYSTEMS HUMAN WEL; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Naeem S, 2008, TRENDS ECOL EVOL, V23, P414, DOI 10.1016/j.tree.2008.05.003; Naidoo R, 2011, J APPL ECOL, V48, P310, DOI 10.1111/j.1365-2664.2010.01955.x; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Perrings C, 2011, FRONT ECOL ENVIRON, V9, P512, DOI 10.1890/100212; Rzanny M, 2012, J ANIM ECOL, V81, P614, DOI 10.1111/j.1365-2656.2012.01951.x; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Schmid Bernhard, 2009, P14; Schmitz OJ, 2009, ECOLOGY, V90, P2339, DOI 10.1890/08-1919.1; Selmants PC, 2012, J ECOL, V100, P723, DOI 10.1111/j.1365-2745.2011.01949.x; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Striebel M, 2009, AM NAT, V174, P141, DOI 10.1086/599294; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Weiher E, 2004, OIKOS, V106, P151, DOI 10.1111/j.0030-1299.2004.12545.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zavaleta E, 2009, ANN NY ACAD SCI, V1162, P311, DOI 10.1111/j.1749-6632.2009.04448.x; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	60	505	525	32	744	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1401	1406		10.1126/science.1215855	http://dx.doi.org/10.1126/science.1215855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700920				2022-12-28	WOS:000305211700034
J	Garment, AR				Garment, Ann R.			Goddess Night	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									NYU, Langone Med Ctr, New York, NY 10003 USA	New York University; NYU Langone Medical Center	Garment, AR (corresponding author), NYU, Langone Med Ctr, New York, NY 10003 USA.	ann.garment@nyumc.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2012	307	21					2267	2268		10.1001/jama.2012.4524	http://dx.doi.org/10.1001/jama.2012.4524			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	952OL	22706832				2022-12-28	WOS:000304801700020
J	Polonsky, TS; Bakris, GL				Polonsky, Tamar S.; Bakris, George L.			Chronic kidney disease: a coronary heart disease equivalent?	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; INTERVENTION		[Bakris, George L.] Univ Chicago Med, Sect Endocrinol Diabet & Metab, ASH Comprehens Hypertens Ctr, Chicago, IL 60637 USA; [Polonsky, Tamar S.] Univ Chicago Med, Cardiol Sect, Dept Med, Chicago, IL 60637 USA		Bakris, GL (corresponding author), Univ Chicago Med, Sect Endocrinol Diabet & Metab, ASH Comprehens Hypertens Ctr, Chicago, IL 60637 USA.	gbakris@gmail.com						[Anonymous], 2011 US REN DAT SYST; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Fox CS, 2010, CIRCULATION, V121, P357, DOI 10.1161/CIRCULATIONAHA.109.865352; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Hyre AD, 2007, AM J KIDNEY DIS, V49, P37, DOI 10.1053/j.ajkd.2006.09.017; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; NHS Centre for Clinical Practice at NICE, 2008, NICE CLIN GUID; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Tonelli M, 2012, LANCET, V380, P807, DOI 10.1016/S0140-6736(12)60572-8; Wright RS, 2002, ANN INTERN MED, V137, P563, DOI 10.7326/0003-4819-137-7-200210010-00007	11	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2012	380	9844					783	785		10.1016/S0140-6736(12)60772-7	http://dx.doi.org/10.1016/S0140-6736(12)60772-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000OP	22717316				2022-12-28	WOS:000308396300005
J	Chaudhry, HJ; Talmage, LA; Alguire, PC; Cain, FE; Waters, S; Rhyne, JA				Chaudhry, Humayun J.; Talmage, Lance A.; Alguire, Patrick C.; Cain, Frances E.; Waters, Sandra; Rhyne, Janelle A.			Maintenance of Licensure: Supporting a Physician's Commitment to Lifelong Learning	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chaudhry, Humayun J.] Federat State Med Boards, Euless, TX 76039 USA; SE Area Hlth Educ Ctr, Wilmington, NC USA; Amer Coll Physicians, Philadelphia, PA USA; Univ Toledo, Toledo, OH 43606 USA	American College of Physicians; University of Toledo	Chaudhry, HJ (corresponding author), Federat State Med Boards, 400 Fuller Wiser Rd,Suite 300, Euless, TX 76039 USA.							Ameringer CF, 1999, STATE MED BOARDS POL, P19; [Anonymous], 1967, REPORT NATL ADVISORY; Brier R, 2001, CROSSING QUALITY CHA, P25; Chaudhry HJ, 2012, J MED REGULATION, V97, P8; Chaudhry HJ., 2010, J MED LICENS DISCIP, V96, P13; Finocchio L. J., 1995, REFORMING HLTH CARE; Kohn LT, 2000, ERR IS HUMAN BUILDIN, V2, P116; Leach DC, 2002, JAMA-J AM MED ASSOC, V287, P243, DOI 10.1001/jama.287.2.243; Stevens R., 1998, AM MED PUBLIC INTERE, P59; U.S. Department of Health Education and Welfare, 1971, REP LIC REL HLTH PER	10	17	17	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2012	157	4					287	+		10.7326/0003-4819-157-4-201208210-00478	http://dx.doi.org/10.7326/0003-4819-157-4-201208210-00478			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992XG	22733035				2022-12-28	WOS:000307813200019
J	Wagner, CE; Harmon, LJ; Seehausen, O				Wagner, Catherine E.; Harmon, Luke J.; Seehausen, Ole			Ecological opportunity and sexual selection together predict adaptive radiation	NATURE			English	Article							LOGISTIC-REGRESSION; MIXED MODELS; SPECIATION; EVOLUTION; DIVERSITY; DETERMINISM; GRADIENT; FISHES; SCALE	A fundamental challenge to our understanding of biodiversity is to explain why some groups of species undergo adaptive radiations, diversifying extensively into many and varied species, whereas others do not(1,2). Both extrinsic environmental factors (for example, resource availability, climate) and intrinsic lineage-specific traits (for example, behavioural or morphological traits, genetic architecture) influence diversification, but few studies have addressed how such factors interact. Radiations of cichlid fishes in the African Great Lakes provide some of the most dramatic cases of species diversification. However, most cichlid lineages in African lakes have not undergone adaptive radiations. Here we compile data on cichlid colonization and diversification in 46 African lakes, along with lake environmental features and information about the traits of colonizing cichlid lineages, to investigate why adaptive radiation does and does not occur. We find that extrinsic environmental factors related to ecological opportunity and intrinsic lineage-specific traits related to sexual selection both strongly influence whether cichlids radiate. Cichlids are more likely to radiate in deep lakes, in regions with more incident solar radiation and in lakes where there has been more time for diversification. Weak or negative associations between diversification and lake surface area indicate that cichlid speciation is not constrained by area, in contrast to diversification in many terrestrial taxa(3). Among the suite of intrinsic traits that we investigate, sexual dichromatism, a surrogate for the intensity of sexual selection, is consistently positively associated with diversification. Thus, for cichlids, it is the coincidence between ecological opportunity and sexual selection that best predicts whether adaptive radiation will occur. These findings suggest that adaptive radiation is predictable, but only when species traits and environmental factors are jointly considered.	[Wagner, Catherine E.; Seehausen, Ole] EAWAG Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, CH-6047 Kastanienbaum, Switzerland; [Wagner, Catherine E.; Seehausen, Ole] Univ Bern, Inst Ecol & Evolut, Dept Aquat Ecol, CH-3012 Bern, Switzerland; [Wagner, Catherine E.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Wagner, Catherine E.] Cornell Univ, Ornithol Lab, Fuller Evolutionary Biol Program, Ithaca, NY 14850 USA; [Harmon, Luke J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Bern; Cornell University; Cornell University; Idaho; University of Idaho	Wagner, CE (corresponding author), EAWAG Ctr Ecol Evolut & Biogeochem, Dept Fish Ecol & Evolut, CH-6047 Kastanienbaum, Switzerland.	catherine.wagner@eawag.ch; ole.seehausen@eawag.ch	Seehausen, Ole/C-8272-2011; Wagner, Catherine/F-4692-2012	Seehausen, Ole/0000-0001-6598-1434; Wagner, Catherine/0000-0001-8585-6120; Harmon, Luke/0000-0002-4985-5750	National Center for Research Resources [5P20RR016448-10]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103397-10]; Swiss National Science Foundation [31003A-118293]; US National Science Foundation [DEB 0919499]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103397] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Ives, T. J. Davies and A. Mooers for analytical advice, P. McIntyre and C. Reidy Liermann for access to global energy data, S. Mwaiko, R. B. Stelkens, C. Katongo and U. Schliewen for unpublished DNA sequences, U. Schliewen, J. Jenson and O. Rittner for photographs, and A. McCune, D. Rabosky, R. Harrison, I. Lovette, E. Michel, G. Mittelbach, C. Melian, J. Brodersen, M. Maan, T. Ingram, B. Matthews, B. Dalziel, M. Pennell, J. Eastman, the Harmon laboratory group, the McCune laboratory group and the Seehausen laboratory group for discussions and comments on the manuscript. Bioinformatics facilities were supported by grants from the National Center for Research Resources (5P20RR016448-10) and the National Institute of General Medical Sciences (8 P20 GM103397-10) from the National Institutes of Health. This work was supported by the Swiss National Science Foundation project 31003A-118293 (to O.S.) and US National Science Foundation grant DEB 0919499 (to L.J.H.).	Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; FRYER G, 1959, EVOLUTION, V13, P440, DOI 10.2307/2406127; Greenwood P.H., 1979, Bulletin of the British Museum (Natural History) Zoology, V35, P265; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Ingram T, 2011, P ROY SOC B-BIOL SCI, V278, P613, DOI 10.1098/rspb.2010.1127; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Kisel Y, 2010, AM NAT, V175, P316, DOI 10.1086/650369; Kraaijeveld K., 2010, BIOL REV CAMB PHILOS, V86, P366; Kuwamura T., 1997, FISH COMMUNITIES LAK, P59; Lande R, 1982, EVOLUTION, V36, P1; LIEM KF, 1973, SYST ZOOL, V22, P425, DOI 10.2307/2412950; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Maan ME, 2011, ECOL LETT, V14, P591, DOI 10.1111/j.1461-0248.2011.01606.x; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Menard S, 2000, AM STAT, V54, P17, DOI 10.2307/2685605; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ricklefs RE, 2007, AM NAT, V170, pS56, DOI 10.1086/519402; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 2007, HEREDITY, V99, P361, DOI 10.1038/sj.hdy.6801047; Seehausen O, 1999, ECOL LETT, V2, P262; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sturmbauer C, 2001, MOL BIOL EVOL, V18, P144, DOI 10.1093/oxfordjournals.molbev.a003788; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Vamosi SM, 2003, EVOL ECOL RES, V5, P717; Worthington E. B., 1936, P ZOOL SOC LOND, V1936, P1061	33	337	341	7	369	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					366	U124		10.1038/nature11144	http://dx.doi.org/10.1038/nature11144			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22722840				2022-12-28	WOS:000306506500043
J	Bazari, H; Guimaraes, AR; Kushner, YB				Bazari, Hasan; Guimaraes, Alexander R.; Kushner, Yael B.			Case 20-2012: A 77-Year-Old Man with Leg Edema, Hematuria, and Acute Renal Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHURG-STRAUSS-SYNDROME; GLOMERULAR-BASEMENT-MEMBRANE; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; HEPATITIS-C VIRUS; WEGENERS GRANULOMATOSIS; GOODPASTURE ANTIGEN; MICROSCOPIC POLYARTERITIS; BACTERIAL-ENDOCARDITIS; CLINICAL-SIGNIFICANCE; SYSTEMIC VASCULITIS		[Bazari, Hasan] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Guimaraes, Alexander R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Kushner, Yael B.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bazari, Hasan] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Guimaraes, Alexander R.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Kushner, Yael B.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bazari, H (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							ADU D, 1987, Q J MED, V62, P221; AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; ANDREWS M, 1990, J ROY COLL PHYS LOND, V24, P284; [Anonymous], 2006, NEW ENGL J MED, V354, P2803; Audard V, 2007, AM J KIDNEY DIS, V49, P710, DOI 10.1053/j.ajkd.2007.02.002; BALDWIN DS, 1974, ANN INTERN MED, V80, P342, DOI 10.7326/0003-4819-80-3-342; Berger J, 1968, J Urol Nephrol (Paris), V74, P694; BROUET JC, 1974, AM J MED, V57, P775, DOI 10.1016/0002-9343(74)90852-3; CHURG J, 1951, AM J PATHOL, V27, P277; Coppo R, 2006, AM J KIDNEY DIS, V47, P993, DOI 10.1053/j.ajkd.2006.02.178; Cui Z, 2005, CLIN IMMUNOL, V116, P77, DOI 10.1016/j.clim.2005.02.016; Cunard Robyn, 2003, Journal of Allergy and Clinical Immunology, V111, pS637; DAVENPORT A, 1994, Q J MED, V87, P291; DUNA GF, 1995, RHEUM DIS CLIN N AM, V21, P949; EKNOYAN G, 1985, AM J NEPHROL, V5, P457; FAUCI AS, 1983, ANN INTERN MED, V98, P76, DOI 10.7326/0003-4819-98-1-76; Goodpasture EW, 1918, J MED RES, V38, P213; Guillevin L, 1999, ARTHRITIS RHEUM-US, V42, P421, DOI 10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6; Guillevin L, 1999, MEDICINE, V78, P26, DOI 10.1097/00005792-199901000-00003; HAUSCHILD S, 1993, ADV EXP MED BIOL, V336, P245; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Hoffman GS, 1998, ARTHRITIS RHEUM-US, V41, P1521, DOI 10.1002/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A; JENNETTE JC, 1994, AM J KIDNEY DIS, V24, P130; Jindal KK, 1999, KIDNEY INT, V55, pS33, DOI 10.1046/j.1523-1755.1999.07005.x; LANHAM JG, 1984, MEDICINE, V63, P65, DOI 10.1097/00005792-198403000-00001; LERNER RA, 1967, J EXP MED, V126, P989, DOI 10.1084/jem.126.6.989; Lhote F, 1998, LUPUS, V7, P238, DOI 10.1191/096120398678920055; Majumdar A, 2000, NEPHROL DIAL TRANSPL, V15, P1782, DOI 10.1093/ndt/15.11.1782; Markowitz GS, 2004, AM J KIDNEY DIS, V43, P388, DOI 10.1053/j.ajkd.2003.06.005; Markowitz GS, 2002, HUM PATHOL, V33, P826, DOI 10.1053/hupa.2002.126189; MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806; MCCLUSKEY RT, 1963, AM J MED, V35, P213, DOI 10.1016/0002-9343(63)90213-4; NEUGARTEN J, 1984, AM J KIDNEY DIS, V3, P371, DOI 10.1016/S0272-6386(84)80086-4; PASCUAL M, 1990, J INFECT DIS, V162, P569, DOI 10.1093/infdis/162.2.569; PUSEY CD, 1983, INT J ARTIF ORGANS, V6, P15; Rutgers A, 2010, RHEUM DIS CLIN N AM, V36, P559, DOI 10.1016/j.rdc.2010.05.002; Salama AD, 2002, AM J KIDNEY DIS, V39, P1162, DOI 10.1053/ajkd.2002.33385; Salama AD, 2001, LANCET, V358, P917, DOI 10.1016/S0140-6736(01)06077-9; Sanders JT, 2008, CURR OPIN PEDIATR, V20, P163, DOI 10.1097/MOP.0b013e3282f4308b; SAUS J, 1988, J BIOL CHEM, V263, P13374; SAVAGE COS, 1985, Q J MED, V56, P467; SPAIN DM, 1952, ANN INTERN MED, V36, P1086, DOI 10.7326/0003-4819-36-4-1086; WIESLANDER J, 1985, J BIOL CHEM, V260, P8564; WIESLANDER J, 1984, P NATL ACAD SCI-BIOL, V81, P3838, DOI 10.1073/pnas.81.12.3838; Yamamoto R, 2009, KIDNEY INT, V76, P477, DOI 10.1038/ki.2009.206	45	8	9	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2503	2515		10.1056/NEJMcpc1111577	http://dx.doi.org/10.1056/NEJMcpc1111577			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965DP	22738101				2022-12-28	WOS:000305747000012
J	Illing, PT; Vivian, JP; Dudek, NL; Kostenko, L; Chen, ZJ; Bharadwaj, M; Miles, JJ; Kjer-Nielsen, L; Gras, S; Williamson, NA; Burrows, SR; Purcell, AW; Rossjohn, J; McCluskey, J				Illing, Patricia T.; Vivian, Julian P.; Dudek, Nadine L.; Kostenko, Lyudmila; Chen, Zhenjun; Bharadwaj, Mandvi; Miles, John J.; Kjer-Nielsen, Lars; Gras, Stephanie; Williamson, Nicholas A.; Burrows, Scott R.; Purcell, Anthony W.; Rossjohn, Jamie; McCluskey, James			Immune self-reactivity triggered by drug-modified HLA-peptide repertoire	NATURE			English	Article							STEVENS-JOHNSON-SYNDROME; T-CELL ALLORECOGNITION; GENETIC-VARIATIONS; B REGION; HYPERSENSITIVITY; ABACAVIR; HLA-B-ASTERISK-5701; ASSOCIATION; COMPLEXES; ANTIGENS	Human leukocyte antigens (HLAs) are highly polymorphic proteins that initiate immunity by presenting pathogen-derived peptides to T cells(1). HLA polymorphisms mostly map to the antigen-binding cleft, thereby diversifying the repertoire of self-derived and pathogen-derived peptide antigens selected by different HLA allotypes(2). A growing number of immunologically based drug reactions, including abacavir hypersensitivity syndrome (AHS) and carbamazepine-induced Stevens-Johnson syndrome (SJS), are associated with specific HLA alleles(3-7). However, little is known about the underlying mechanisms of these associations, including AHS, a prototypical HLA-associated drug reaction occurring exclusively in individuals with the common histocompatibility allele HLA-B*57:01, and with a relative risk of more than 1,000 (refs 6, 7). We show that unmodified abacavir binds non-covalently to HLA-B*57:01, lying across the bottom of the antigen-binding cleft and reaching into the F-pocket, where a carboxy-terminal tryptophan typically anchors peptides bound to HLA-B*57:01. Abacavir binds with exquisite specificity to HLA-B*57:01, changing the shape and chemistry of the antigen-binding cleft, thereby altering the repertoire of endogenous peptides that can bind HLA-B*57:01. In this way, abacavir guides the selection of new endogenous peptides, inducing a marked alteration in 'immunological self'. The resultant peptide-centric 'altered self' activates abacavir-specific T-cells, thereby driving polyclonal CD8 T-cell activation and a systemic reaction manifesting as AHS. We also show that carbamazepine, a widely used anti-epileptic drug associated with hypersensitivity reactions in HLA-B*15:02 individuals, binds to this allotype, producing alterations in the repertoire of presented self peptides. Our findings simultaneously highlight the importance of HLA polymorphism in the evolution of pharmacogenomics and provide a general mechanism for some of the growing number of HLA-linked hypersensitivities that involve small-molecule drugs.	[Illing, Patricia T.; Kostenko, Lyudmila; Chen, Zhenjun; Bharadwaj, Mandvi; Kjer-Nielsen, Lars; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Illing, Patricia T.; Dudek, Nadine L.; Williamson, Nicholas A.; Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Illing, Patricia T.; Dudek, Nadine L.; Williamson, Nicholas A.; Purcell, Anthony W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Vivian, Julian P.; Gras, Stephanie; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Miles, John J.; Burrows, Scott R.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Miles, John J.; Burrows, Scott R.] Australian Ctr Vaccine Dev, Brisbane, Qld 4029, Australia; [Miles, John J.; Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [McCluskey, James] Australian Red Cross Blood Serv, Victorian Transplantat & Immunogenet Serv, W Melbourne, Vic 3003, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Monash University; QIMR Berghofer Medical Research Institute; Cardiff University; Australian Red Cross Blood Service	McCluskey, J (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	apurcell@unimelb.edu.au; jamie.rossjohn@monash.edu; jamesm1@unimelb.edu.au	Williamson, Nicholas A/O-9812-2016; Illing, Patricia/AAP-6045-2021; McCluskey, James/A-1291-2007; Purcell, Anthony/AAH-1942-2019; Bharadwaj, Mandvi/C-4446-2014; Burrows, Scott/G-2050-2011; Miles, John J/ABC-1105-2020; gras, stephanie/C-8307-2013; Rossjohn, Jamie/F-9032-2013	Williamson, Nicholas A/0000-0002-2173-3452; Illing, Patricia/0000-0002-3870-0796; McCluskey, James/0000-0002-8597-815X; Purcell, Anthony/0000-0003-0532-8331; Burrows, Scott/0000-0002-1430-0472; Miles, John J/0000-0001-5506-6304; Rossjohn, Jamie/0000-0002-2020-7522; gras, stephanie/0000-0001-7416-038X; Vivian, Julian/0000-0002-9400-4437; Kostenko, Lyudmila/0000-0002-8466-7966	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council (ARC); Monash University; NHMRC	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Monash University(Monash University); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank R. Holdsworth and M. Diviney for support; N. Croft for discussions, and the staff at the MX2 beamline of the Australian synchrotron for assistance with data collection. This research was supported by a Program Grant from the National Health and Medical Research Council of Australia (NHMRC) and the Australian Research Council (ARC). S. G. is supported by a Senior Fellowship from Monash University. A. W. P. is supported by an NHMRC Senior Research Fellowship; J.R. is supported by an NHMRC Australia Fellowship.	Archbold JK, 2008, TRENDS IMMUNOL, V29, P220, DOI 10.1016/j.it.2008.02.005; Barber LD, 1997, J IMMUNOL, V158, P1660; Bharadwaj M, 2012, ANNU REV PHARMACOL, V52, P401, DOI 10.1146/annurev-pharmtox-010611-134701; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; Burrows SR, 2006, TRENDS IMMUNOL, V27, P11, DOI 10.1016/j.it.2005.11.001; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Hughes AR, 2004, PHARMACOGENOMICS, V5, P203, DOI 10.1517/phgs.5.2.203.27481; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Ko TM, 2011, J ALLERGY CLIN IMMUN, V128, P1266, DOI 10.1016/j.jaci.2011.08.013; Macdonald W, 2002, FEBS LETT, V527, P27, DOI 10.1016/S0014-5793(02)03149-6; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Martin AM, 2004, P NATL ACAD SCI USA, V101, P4180, DOI 10.1073/pnas.0307067101; McCluskey J, 1999, Rev Immunogenet, V1, P3; Parham P, 1996, SCIENCE, V272, P67, DOI 10.1126/science.272.5258.67; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; Roder G, 2006, ACTA CRYSTALLOGR D, V62, P1300, DOI 10.1107/S0907444906027636; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941	27	475	492	3	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					554	U158		10.1038/nature11147	http://dx.doi.org/10.1038/nature11147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722860				2022-12-28	WOS:000305760600048
J	Kraemer, JA; Erb, ML; Waddling, CA; Montabana, EA; Zehr, EA; Wang, HN; Nguyen, K; Pham, DSL; Agard, DA; Pogliano, J				Kraemer, James A.; Erb, Marcella L.; Waddling, Christopher A.; Montabana, Elizabeth A.; Zehr, Elena A.; Wang, Hannah; Nguyen, Katrina; Pham, Duy Stephen L.; Agard, David A.; Pogliano, Joe			A Phage Tubulin Assembles Dynamic Filaments by an Atypical Mechanism to Center Viral DNA within the Host Cell	CELL			English	Article							BACTERIAL CYTOSKELETON; STRUCTURAL INSIGHTS; HOMOLOG TUBZ; PROTEIN; PLASMID; FTSZ; PSEUDOMONAS; GENES; POLYMERIZATION; REPLICATION	Tubulins are essential for the reproduction of many eukaryotic viruses, but historically, bacteriophage were assumed not to require a cytoskeleton. Here, we identify a tubulin-like protein, PhuZ, from bacteriophage 201 phi 2-1 and show that it forms filaments in vivo and in vitro. The PhuZ structure has a conserved tubulin fold, with an unusual, extended C terminus that we demonstrate to be critical for polymerization in vitro and in vivo. Longitudinal packing in the crystal lattice mimics packing observed by EM of in-vitro-formed filaments, indicating how interactions between the C terminus and the following monomer drive polymerization. PhuZ forms a filamentous array that is required for positioning phage DNA within the bacterial cell. Correct positioning to the cell center and optimal phage reproduction only occur when the PhuZ filament is dynamic. Thus, we show that PhuZ assembles a spindle-like array that functions analogously to the microtubule-based spindles of eukaryotes.	[Kraemer, James A.; Waddling, Christopher A.; Montabana, Elizabeth A.; Zehr, Elena A.; Pham, Duy Stephen L.; Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Kraemer, James A.; Waddling, Christopher A.; Montabana, Elizabeth A.; Zehr, Elena A.; Pham, Duy Stephen L.; Agard, David A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Erb, Marcella L.; Wang, Hannah; Nguyen, Katrina; Pogliano, Joe] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Diego	Agard, DA (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu; jpogliano@ucsd.edu		Pham, Duy Stephen/0000-0003-0943-2531	HHMI; NIH [GM031627, GM084334, GM073898]; Genentech predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031627, R01GM073898, R01GM084334] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genentech predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Justin Farlow for help with early experiments, Dr. Justin Kollman for EM advice, and Jessica Polka for many helpful discussions. We also thank Drs. Julie Thomas and Steven Hardies of UT Health Sciences San Antonio for the 201 phi 2-1 phage and Dr. Hongwei D Yu of Marshall University for the pHERD30T vector. This work was funded by HHMI and NIH Grant GM031627 (to D. A. A.) and by NIH Grants GM084334 and GM073898 (to J.P.). J.A.K. is supported by a Genentech predoctoral fellowship.	Anand SP, 2008, MOL MICROBIOL, V67, P881, DOI 10.1111/j.1365-2958.2007.06100.x; Aylett CHS, 2010, P NATL ACAD SCI USA, V107, P19766, DOI 10.1073/pnas.1010176107; Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Chen YD, 2008, J BIOL CHEM, V283, P8102, DOI 10.1074/jbc.M709163200; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Downing KH, 1998, CURR OPIN CELL BIOL, V10, P16, DOI 10.1016/S0955-0674(98)80082-3; Drew KRP, 2011, P NATL ACAD SCI USA, V108, P11075, DOI 10.1073/pnas.1018724108; Howard GT, 2007, J APPL MICROBIOL, V103, P2074, DOI 10.1111/j.1365-2672.2007.03447.x; Iwasaki K, 2010, CURR OPIN STRUC BIOL, V20, P632, DOI 10.1016/j.sbi.2010.08.007; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Leopold PL, 2006, TRAFFIC, V7, P516, DOI 10.1111/j.1600-0854.2006.00408.x; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lowe J, 2009, INT J BIOCHEM CELL B, V41, P323, DOI 10.1016/j.biocel.2008.08.010; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Munoz-Espin D, 2009, P NATL ACAD SCI USA, V106, P13347, DOI 10.1073/pnas.0906465106; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Polka JK, 2009, J BACTERIOL, V191, P6219, DOI 10.1128/JB.00676-09; Popp D, 2010, J BIOL CHEM, V285, P10130, DOI 10.1074/jbc.M109.071613; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Rivera CR, 2011, J BIOL CHEM, V286, P14282, DOI 10.1074/jbc.M110.203828; Sakaguchi Y, 2005, P NATL ACAD SCI USA, V102, P17472, DOI 10.1073/pnas.0505503102; Schlieper D, 2005, P NATL ACAD SCI USA, V102, P9170, DOI 10.1073/pnas.0502859102; Serwer P, 2004, VIROLOGY, V329, P412, DOI 10.1016/j.virol.2004.08.021; Sontag CA, 2005, J CELL BIOL, V169, P233, DOI 10.1083/jcb.200410027; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; Thomas JA, 2008, VIROLOGY, V376, P330, DOI 10.1016/j.virol.2008.04.004; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500	39	68	69	2	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1488	1499		10.1016/j.cell.2012.04.034	http://dx.doi.org/10.1016/j.cell.2012.04.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726436	Green Accepted, Bronze			2022-12-28	WOS:000305753800015
J	Kolaja, K				Kolaja, Kyle			DRUG DISCOVERY Computer model predicts side effects	NATURE			English	Editorial Material									Hoffman La Roche, Dept Nonclin Safety, Nutley, NJ 07110 USA	Roche Holding	Kolaja, K (corresponding author), Hoffman La Roche, Dept Nonclin Safety, Nutley, NJ 07110 USA.	kyle.kolaja@roche.com		Kolaja, Kyle/0000-0003-1520-9037				Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Park SC, 2011, WORLD J GASTROENTERO, V17, P4647, DOI 10.3748/wjg.v17.i42.4647; Sasseville VG, 2004, CHEM-BIOL INTERACT, V150, P9, DOI 10.1016/j.cbi.2004.06.009; Schwartz GG, 2012, CURR ATHEROSCLER REP, V14, P41, DOI 10.1007/s11883-011-0217-9	4	6	6	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					326	327		10.1038/nature11198	http://dx.doi.org/10.1038/nature11198			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722185				2022-12-28	WOS:000305466800025
J	Gill, L; Santa, J; Peter, DL; Keehn, J				Gill, Lisa; Santa, John; Peter, Doris L.; Keehn, Joel			Lipitor Goes Generic: Business as Usual or More Big Business?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Gill, Lisa; Santa, John; Peter, Doris L.; Keehn, Joel] Consumer Reports, Yonkers, NY 10703 USA		Santa, J (corresponding author), Consumer Reports, 101 Truman Ave, Yonkers, NY 10703 USA.	HealthImpact@cr.consumer.org						Armstrong D, 2011, BLOOMBERG NEWS  1116; Armstrong D, 2011, BLOOMBERG NEWS  1118; Consulate General Shanghai, 2011, CONSUM REP, P30; Consumer Reports Health Best Buy Drugs, 2010, CONSUM REP, P10; Consumer Reports Health Best Buy Drugs, 2010, CONSUM REP, P21; Consumer Reports National Research Center, 2012, CONSUM REP, P5; Consumer Reports National Research Center, 2011, CONSUM REP, P5; Consumer Reports National Research Center, 2012, CONSUM REP, P6; Consumer Reports National Research Center, 2011, CONSUM REP, P27; Wang M., 2011, PROPUBLICA      1114; Wilson D., 2011, NY TIMES, pB1	11	4	4	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12					892	894		10.7326/0003-4819-156-12-201206190-00420	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-00420			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711082				2022-12-28	WOS:000307783200018
J	Aaby, P; Whittle, H; Benn, CS				Aaby, Peter; Whittle, Hilton; Benn, Christine Stabell			Vaccine programmes must consider their effect on general resistance	BRITISH MEDICAL JOURNAL			English	Editorial Material							DIPHTHERIA-TETANUS-PERTUSSIS; RANDOMIZED CONTROLLED-TRIAL; VITAMIN-A SUPPLEMENTATION; TITER MEASLES-VACCINE; GUINEA-BISSAU; HETEROLOGOUS IMMUNITY; ROUTINE VACCINATIONS; CHILDHOOD MORTALITY; BCG VACCINATION; CHILDREN		[Aaby, Peter; Benn, Christine Stabell] Statens Serum Inst, Bandim Hlth Project, Res Ctr Vitamins & Vaccines CVIVA, DK-2300 Copenhagen S, Denmark; [Aaby, Peter; Benn, Christine Stabell] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Whittle, Hilton] London Sch Hyg & Trop Med, London WC1, England	Statens Serum Institut; University of London; London School of Hygiene & Tropical Medicine	Aaby, P (corresponding author), Statens Serum Inst, Bandim Hlth Project, Res Ctr Vitamins & Vaccines CVIVA, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	P.aaby@bandim.org		Aaby, Peter/0000-0001-8331-1389	European Research Council [243149] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Aaby P, 2006, VACCINE, V24, P2764, DOI 10.1016/j.vaccine.2006.01.004; Aaby P, 2004, INT J EPIDEMIOL, V33, P374, DOI 10.1093/ije/dyh005; Aaby P, 2003, LANCET, V361, P2183, DOI 10.1016/S0140-6736(03)13771-3; AABY P, 1984, J INFECTION, V8, P13, DOI 10.1016/S0163-4453(84)93192-X; Aaby P, 2012, ARCH DIS CHILD  0213; Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Aaby P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6495; Benn CS, 2009, AM J CLIN NUTR, V90, P629, DOI 10.3945/ajcn.2009.27477; Benn CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1101; Biering-Sorensen S, 2012, PEDIATR INFECT DIS J, V31, P306, DOI 10.1097/INF.0b013e3182458289; de Quadros CA, 2004, J INFECT DIS, V189, pS227, DOI 10.1086/377741; DULOU AD, 1995, AM J EPIDEMIOL, V142, P643, DOI 10.1093/oxfordjournals.aje.a117688; Horton R, 2011, LANCET, V378, P296, DOI 10.1016/S0140-6736(11)60765-4; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435; Lucero MG, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004977.PUB2; Mathurin KS, 2009, J VIROL, V83, P3528, DOI 10.1128/JVI.02393-08; Moxon ER, 2011, LANCET, V378, P298, DOI 10.1016/S0140-6736(11)60766-6; ROTH A, 2010, BMJ-BRIT MED J, V340, pC809; Shann F, 2004, PEDIATR INFECT DIS J, V23, P555, DOI 10.1097/01.inf.0000130155.42392.04; Shann F, 2010, ARCH DIS CHILD, V95, P662, DOI 10.1136/adc.2009.157537; Shann F, 2010, PEDIATR INFECT DIS J, V29, P457, DOI 10.1097/INF.0b013e3181c91361; VANBALEN H, 1981, LANCET, V1, P764; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820	23	28	28	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 14	2012	344								e3769	10.1136/bmj.e3769	http://dx.doi.org/10.1136/bmj.e3769			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961LA	22700785				2022-12-28	WOS:000305464700005
J	Lidegaard, O; Lokkegaard, E; Jensen, A; Skovlund, CW; Keiding, N				Lidegaard, Ojvind; Lokkegaard, Ellen; Jensen, Aksel; Skovlund, Charlotte Wessel; Keiding, Niels			Thrombotic Stroke and Myocardial Infarction with Hormonal Contraception	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOSE ORAL-CONTRACEPTIVES; MICA CASE-CONTROL; VENOUS THROMBOEMBOLISM; YOUNG-WOMEN; POOLED ANALYSIS; 2 US; RISK; DROSPIRENONE; MORTALITY; COHORT	BACKGROUND Although several studies have assessed the risk of venous thromboembolism with newer hormonal contraception, few have examined thrombotic stroke and myocardial infarction, and results have been conflicting. METHODS In this 15-year Danish historical cohort study, we followed nonpregnant women, 15 to 49 years old, with no history of cardiovascular disease or cancer. Data on use of hormonal contraception, clinical end points, and potential confounders were obtained from four national registries. RESULTS A total of 1,626,158 women contributed 14,251,063 person-years of observation, during which 3311 thrombotic strokes (21.4 per 100,000 person-years) and 1725 myocardial infarctions (10.1 per 100,000 person-years) occurred. As compared with nonuse, current use of oral contraceptives that included ethinyl estradiol at a dose of 30 to 40 mu g was associated with the following relative risks (and 95% confidence intervals) for thrombotic stroke and myocardial infarction, according to progestin type: norethindrone, 2.2 (1.5 to 3.2) and 2.3 (1.3 to 3.9); levonorgestrel, 1.7 (1.4 to 2.0) and 2.0 (1.6 to 2.5); norgestimate, 1.5 (1.2 to 1.9) and 1.3 (0.9 to 1.9); desogestrel, 2.2 (1.8 to 2.7) and 2.1 (1.5 to 2.8); gestodene, 1.8 (1.6 to 2.0) and 1.9 (1.6 to 2.3); and drospirenone, 1.6 (1.2 to 2.2) and 1.7 (1.0 to 2.6), respectively. With ethinyl estradiol at a dose of 20 mu g, the corresponding relative risks according to progestin type were as follows: desogestrel, 1.5 (1.3 to 1.9) and 1.6 (1.1 to 2.1); gestodene, 1.7 (1.4 to 2.1) and 1.2 (0.8 to 1.9); and drospirenone, 0.9 (0.2 to 3.5) and 0.0. For transdermal patches, the corresponding relative risks were 3.2 (0.8 to 12.6) and 0.0, and for a vaginal ring, 2.5 (1.4 to 4.4) and 2.1 (0.7 to 6.5). CONCLUSIONS Although the absolute risks of thrombotic stroke and myocardial infarction associated with the use of hormonal contraception were low, the risk was increased by a factor of 0.9 to 1.7 with oral contraceptives that included ethinyl estradiol at a dose of 20 mu g and by a factor of 1.3 to 2.3 with those that included ethinyl estradiol at a dose of 30 to 40 mu g, with relatively small differences in risk according to progestin type. (Funded by the Danish Heart Association.)	[Lidegaard, Ojvind; Skovlund, Charlotte Wessel] Univ Copenhagen, Rigshosp, Gynecol Clin 4232, DK-2100 Copenhagen, Denmark; [Lokkegaard, Ellen] Univ Copenhagen, Dept Obstet & Gynecol, Hillerod Hosp, Copenhagen, Denmark; [Jensen, Aksel; Keiding, Niels] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Lidegaard, O (corresponding author), Copenhagen Univ Hosp, Clin Gynecol 4232, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	lidegaard@rh.regionh.dk		Lokkegaard, Ellen/0000-0003-4149-5663	Danish Heart Association [09-10-R75-A2725-22568]; Bayer Pharma; Bayer Denmark; MSD Denmark; Theramex	Danish Heart Association; Bayer Pharma; Bayer Denmark; MSD Denmark; Theramex	Supported by a grant (09-10-R75-A2725-22568) from the Danish Heart Association.; Dr. Lidegaard reports receiving grant support from Bayer Pharma and lecture fees and travel reimbursements from Bayer Denmark, MSD Denmark, and Theramex, and providing testimony in a U.S. legal case on oral contraception and venous thromboembolism; and Dr. Lokkegaard, receiving travel reimbursements from Pfizer. No other potential conflict of interest relevant to this article was reported.	Dunn N, 1999, BRIT MED J, V318, P1579, DOI 10.1136/bmj.318.7198.1579; Dunn NR, 2001, CONTRACEPTION, V63, P65, DOI 10.1016/S0010-7824(01)00172-X; Food and Drug Administration Office of Surveillance and Epidemiology, COM HORM CONTR CHCS; Gronich N, 2011, CAN MED ASSOC J, V183, pE1319, DOI 10.1503/cmaj.110463; HANNAFORD PC, 1994, STROKE, V25, P935, DOI 10.1161/01.STR.25.5.935; Heinemann LAJ, 1998, CONTRACEPTION, V57, P29, DOI 10.1016/S0010-7824(97)00204-7; Horton NJ, 2001, AM STAT, V55, P244, DOI 10.1198/000313001317098266; Jick SS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2151; Lewis MA, 1997, CONTRACEPTION, V56, P129, DOI 10.1016/S0010-7824(97)00118-2; Lidegaard O, 2002, CONTRACEPTION, V65, P197, DOI 10.1016/S0010-7824(01)00306-7; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Lidegaard O, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2890; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Margolis KL, 2007, FERTIL STERIL, V88, P310, DOI 10.1016/j.fertnstert.2006.11.206; METTINGER KL, 1984, STROKE, V15, P795, DOI 10.1161/01.STR.15.5.795; Parkin L, 2000, LANCET, V355, P2133, DOI 10.1016/S0140-6736(00)02382-5; Parkin L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2139; Poulter NR, 1996, LANCET, V348, P505; Poulter NR, 1999, LANCET, V354, P301, DOI 10.1016/S0140-6736(99)01013-2; Poulter NR, 1997, LANCET, V349, P1202, DOI 10.1016/S0140-6736(97)02358-1; Rosenberg L, 2001, ARCH INTERN MED, V161, P1065, DOI 10.1001/archinte.161.8.1065; Schmidt M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e356; Schwartz SM, 1998, STROKE, V29, P2277, DOI 10.1161/01.STR.29.11.2277; Sidney S, 1998, CIRCULATION, V98, P1058, DOI 10.1161/01.CIR.98.11.1058; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P1313, DOI 10.1056/NEJM198811173192004; Tanis BC, 2001, NEW ENGL J MED, V345, P1787, DOI 10.1056/NEJMoa003216; Vlieg AV, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2921; Walker AE, 1981, STROKE S1, V12, pI	28	325	342	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2012	366	24					2257	2266		10.1056/nejmoa1111840	http://dx.doi.org/10.1056/nejmoa1111840			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957PD	22693997	Bronze			2022-12-28	WOS:000305174100006
J	Robinson, G; Parker, M; Kranenburg, TA; Lu, C; Chen, X; Ding, L; Phoenix, TN; Hedlund, E; Wei, L; Zhu, XY; Chalhoub, N; Baker, SJ; Huether, R; Kriwacki, R; Curley, N; Thiruvenkatam, R; Wang, JM; Wu, G; Rusch, M; Hong, X; Becksfort, J; Gupta, P; Ma, J; Easton, J; Vadodaria, B; Onar-Thomas, A; Lin, T; Li, SY; Pounds, S; Paugh, S; Zhao, D; Kawauchi, D; Roussel, MF; Finkelstein, D; Ellison, DW; Lau, CC; Bouffet, E; Hassall, T; Gururangan, S; Cohn, R; Fulton, RS; Fulton, LL; Dooling, DJ; Ochoa, K; Gajjar, A; Mardis, ER; Wilson, RK; Downing, JR; Zhang, JH; Gilbertson, RJ				Robinson, Giles; Parker, Matthew; Kranenburg, Tanya A.; Lu, Charles; Chen, Xiang; Ding, Li; Phoenix, Timothy N.; Hedlund, Erin; Wei, Lei; Zhu, Xiaoyan; Chalhoub, Nader; Baker, Suzanne J.; Huether, Robert; Kriwacki, Richard; Curley, Natasha; Thiruvenkatam, Radhika; Wang, Jianmin; Wu, Gang; Rusch, Michael; Hong, Xin; Becksfort, Jared; Gupta, Pankaj; Ma, Jing; Easton, John; Vadodaria, Bhavin; Onar-Thomas, Arzu; Lin, Tong; Li, Shaoyi; Pounds, Stanley; Paugh, Steven; Zhao, David; Kawauchi, Daisuke; Roussel, Martine F.; Finkelstein, David; Ellison, David W.; Lau, Ching C.; Bouffet, Eric; Hassall, Tim; Gururangan, Sridharan; Cohn, Richard; Fulton, Robert S.; Fulton, Lucinda L.; Dooling, David J.; Ochoa, Kerri; Gajjar, Amar; Mardis, Elaine R.; Wilson, Richard K.; Downing, James R.; Zhang, Jinghui; Gilbertson, Richard J.			Novel mutations target distinct subgroups of medulloblastoma	NATURE			English	Article							BOX RNA HELICASE; E-CADHERIN GENE; BETA-CATENIN; SOMATIC MUTATIONS; BREAST-CANCER; STEM-CELLS; DROSOPHILA; EZH2; TRANSACTIVATION; METHYLATION	Medulloblastoma is a malignant childhood brain tumour comprising four discrete subgroups. Here, to identify mutations that drive medulloblastoma, we sequenced the entire genomes of 37 tumours and matched normal blood. One-hundred and thirty-six genes harbouring somatic mutations in this discovery set were sequenced in an additional 56 medulloblastomas. Recurrent mutations were detected in 41 genes not yet implicated in medulloblastoma; several target distinct components of the epigenetic machinery in different disease subgroups, such as regulators of H3K27 and H3K4 trimethylation in subgroups 3 and 4 (for example, KDM6A and ZMYM3), and CTNNB1-associated chromatin re-modellers in WNT-subgroup tumours (for example, SMARCA4 and CREBBP). Modelling of mutations in mouse lower rhombic lip progenitors that generate WNT-subgroup tumours identified genes that maintain this cell lineage (DDX3X), as well as mutated genes that initiate (CDH1) or cooperate (PIK3CA) in tumorigenesis. These data provide important new insights into the pathogenesis of medulloblastoma subgroups and highlight targets for therapeutic development.	[Robinson, Giles; Parker, Matthew; Kranenburg, Tanya A.; Lu, Charles; Chen, Xiang; Ding, Li; Phoenix, Timothy N.; Hedlund, Erin; Wei, Lei; Zhu, Xiaoyan; Chalhoub, Nader; Baker, Suzanne J.; Huether, Robert; Kriwacki, Richard; Curley, Natasha; Thiruvenkatam, Radhika; Wang, Jianmin; Wu, Gang; Rusch, Michael; Hong, Xin; Becksfort, Jared; Gupta, Pankaj; Ma, Jing; Easton, John; Vadodaria, Bhavin; Onar-Thomas, Arzu; Lin, Tong; Li, Shaoyi; Pounds, Stanley; Paugh, Steven; Zhao, David; Kawauchi, Daisuke; Roussel, Martine F.; Finkelstein, David; Ellison, David W.; Lau, Ching C.; Bouffet, Eric; Hassall, Tim; Gururangan, Sridharan; Cohn, Richard; Fulton, Robert S.; Fulton, Lucinda L.; Dooling, David J.; Ochoa, Kerri; Gajjar, Amar; Mardis, Elaine R.; Wilson, Richard K.; Downing, James R.; Zhang, Jinghui; Gilbertson, Richard J.] Washington Univ, St Jude Childrens Res Hosp, Pediat Canc Genome Project, Memphis, TN 38105 USA; [Robinson, Giles; Kranenburg, Tanya A.; Phoenix, Timothy N.; Zhu, Xiaoyan; Chalhoub, Nader; Baker, Suzanne J.; Curley, Natasha; Thiruvenkatam, Radhika; Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Robinson, Giles; Gajjar, Amar; Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA; [Parker, Matthew; Chen, Xiang; Hedlund, Erin; Wei, Lei; Huether, Robert; Wu, Gang; Rusch, Michael; Easton, John; Vadodaria, Bhavin; Finkelstein, David; Zhang, Jinghui] St Jude Childrens Hosp, Dept Computat Biol & Bioinformat, Memphis, TN 38105 USA; [Lu, Charles; Ding, Li; Hong, Xin; Fulton, Robert S.; Fulton, Lucinda L.; Dooling, David J.; Ochoa, Kerri; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Fulton, Robert S.; Fulton, Lucinda L.; Dooling, David J.; Ochoa, Kerri; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; [Wei, Lei; Ma, Jing; Ellison, David W.; Downing, James R.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Huether, Robert; Kriwacki, Richard] St Jude Childrens Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Wang, Jianmin; Becksfort, Jared; Gupta, Pankaj; Zhao, David] St Jude Childrens Hosp, Dept Informat Sci, Memphis, TN 38105 USA; [Onar-Thomas, Arzu; Lin, Tong; Li, Shaoyi; Pounds, Stanley] St Jude Childrens Hosp, Dept Biostat, Memphis, TN 38105 USA; [Paugh, Steven] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Kawauchi, Daisuke; Roussel, Martine F.] St Jude Childrens Hosp, Dept Tumour Biol & Genet, Memphis, TN 38105 USA; [Lau, Ching C.] Texas Childrens Canc & Hematol Ctr, Houston, TX 77030 USA; [Bouffet, Eric] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Hassall, Tim] Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Gururangan, Sridharan] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Cohn, Richard] Univ New S Wales, Sch Womens & Childrens Hlth, Kensington, NSW 2052, Australia; [Mardis, Elaine R.] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO 63108 USA; [Wilson, Richard K.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63108 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Washington University (WUSTL); Washington University (WUSTL); St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; Texas Children's Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Royal Children's Hospital Melbourne; Duke University; University of New South Wales Sydney; Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Gilbertson, RJ (corresponding author), Washington Univ, St Jude Childrens Res Hosp, Pediat Canc Genome Project, Memphis, TN 38105 USA.	Jinghui.Zhang@stjude.org; Richard.Gilbertson@stjude.org	Zhang, Jing/GWZ-7332-2022; Wu, Gang/M-8012-2014; Wilson, Richard K./AAF-4139-2019; Rusch, Michael/AAG-1998-2019; Robinson, Giles W/N-8095-2018; Lin, Tong/G-4105-2012; Bouffet, Eric/AAB-8999-2020; Baker, Suzanne J/N-8167-2018; Onar-Thomas, Arzu/M-9356-2018; Gilbertson, Richard James/ABE-1346-2021; Downing, James R./N-8102-2018; Ellison, David/N-4806-2018; Huether, Robert/E-9638-2012; Mardis, Elaine/W-2202-2019; wang, jian/GVS-0711-2022; Kriwacki, Richard/N-8154-2018; Gajjar, Amar/N-8059-2018; Kranenburg, Tanya/F-7138-2012; Chen, Xiang/N-2524-2018; Kawauchi, Daisuke/ABE-9133-2021; Paugh, Steven/A-7739-2008; Pounds, Stanley B/N-2480-2018; Roussel, Martine F/F-1469-2016	Wu, Gang/0000-0002-1678-5864; Wilson, Richard K./0000-0002-1992-1358; Rusch, Michael/0000-0002-5363-1848; Robinson, Giles W/0000-0001-7441-9486; Gilbertson, Richard James/0000-0001-7539-9472; Huether, Robert/0000-0001-7077-7470; Kriwacki, Richard/0000-0002-9798-6018; Kranenburg, Tanya/0000-0002-5329-4968; Chen, Xiang/0000-0002-2499-8261; Paugh, Steven/0000-0001-5697-9228; Pounds, Stanley B/0000-0002-9167-2114; Roussel, Martine F/0000-0002-1740-8139; Cohn, Richard/0000-0002-2400-1353; Hassall, Timothy/0000-0002-7883-3710; Parker, Matthew/0000-0003-2999-3870; Easton, John/0000-0003-4503-6608	St Jude Children's Research Hospital, Washington University Pediatric Cancer Genome Project; National Institutes of Health [R01CA129541, P01CA96832, P30CA021765]; Collaborative Ependymoma Research Network (CERN); Musicians against Childhood Cancer (MACC); Noyes Brain Tumour Foundation; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765, P01CA096832, R01CA129541] Funding Source: NIH RePORTER	St Jude Children's Research Hospital, Washington University Pediatric Cancer Genome Project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Ependymoma Research Network (CERN); Musicians against Childhood Cancer (MACC); Noyes Brain Tumour Foundation; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported as part of the St Jude Children's Research Hospital, Washington University Pediatric Cancer Genome Project. This work was supported by grants from the National Institutes of Health (R01CA129541, P01CA96832 and P30CA021765; R.J.G.), the Collaborative Ependymoma Research Network (CERN), Musicians against Childhood Cancer (MACC), The Noyes Brain Tumour Foundation, and by the American Lebanese Syrian Associated Charities (ALSAC). We are grateful to S. Temple for the gift of reagents and the staff of the Hartwell Center for Bioinformatics and Biotechnology and ARC at St Jude Children's Research Hospital for technical assistance.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; BECKER KF, 1994, CANCER RES, V54, P3845; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Castellino RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010849; Central Brain Tumor Registry of the United States, 2006, STAT REP PRIM BRAIN; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Khan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005076; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Lai MC, 2010, MOL CELL BIOL, V30, P5444, DOI 10.1128/MCB.00560-10; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Orsulic S, 1999, J CELL SCI, V112, P1237; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pek JW, 2011, P NATL ACAD SCI USA, V108, P12007, DOI 10.1073/pnas.1106245108; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; RISINGER JI, 1994, NAT GENET, V7, P98, DOI 10.1038/ng0594-98; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Schroder M, 2010, BIOCHEM PHARMACOL, V79, P297, DOI 10.1016/j.bcp.2009.08.032; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Spatz A, 2004, NAT REV CANCER, V4, P617, DOI 10.1038/nrc1413; Taylor MD, 2001, PEDIATR NEUROSURG, V35, P235, DOI 10.1159/000050428; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	50	585	597	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2012	488	7409					43	48		10.1038/nature11213	http://dx.doi.org/10.1038/nature11213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22722829	Green Accepted, hybrid			2022-12-28	WOS:000307010700029
J	[Anonymous]				[Anonymous]			Pre-exposure HIV prophylaxis: the world is waiting	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 30	2012	379	9835					2402	2402		10.1016/S0140-6736(12)61046-0	http://dx.doi.org/10.1016/S0140-6736(12)61046-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	967NV	22748574				2022-12-28	WOS:000305915900002
J	Yang, XM; Minton, TK; Zhang, DH				Yang, Xueming; Minton, Timothy K.; Zhang, Dong Hui			Rethinking Chemical Reactions at Hyperthermal Energies	SCIENCE			English	Editorial Material							DYNAMICS; ATOM		[Yang, Xueming; Minton, Timothy K.; Zhang, Dong Hui] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Peoples R China; [Yang, Xueming] Univ Sci & Technol China, Dept Chem Phys, Hefei 230026, Peoples R China; [Minton, Timothy K.] Montana State Univ, Bozeman, MT 59717 USA	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Montana State University System; Montana State University Bozeman	Yang, XM (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Peoples R China.	xmyang@dicp.ac.cn; tminton@montana.edu; zhangdh@dicp.ac.cn	Yang, Xueming/C-8764-2013	Minton, Timothy/0000-0003-4577-7879				Crim FF, 2008, P NATL ACAD SCI USA, V105, P12654, DOI 10.1073/pnas.0803010105; Jankunas J, 2012, SCIENCE, V336, P1687, DOI 10.1126/science.1221329; Townsend D, 2004, SCIENCE, V306, P1158, DOI 10.1126/science.1104386; Zare RN, 1998, SCIENCE, V279, P1875, DOI 10.1126/science.279.5358.1875; Zhang JM, 2008, J AM CHEM SOC, V130, P8896, DOI 10.1021/ja803080q; Zhang JM, 2011, J PHYS CHEM A, V115, P10894, DOI 10.1021/jp207137t; Zhang WQ, 2010, P NATL ACAD SCI USA, V107, P12782, DOI 10.1073/pnas.1006910107	7	9	10	3	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1650	1651		10.1126/science.1223680	http://dx.doi.org/10.1126/science.1223680			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745412				2022-12-28	WOS:000305794500031
J	Prufer, K; Munch, K; Hellmann, I; Akagi, K; Miller, JR; Walenz, B; Koren, S; Sutton, G; Kodira, C; Winer, R; Knight, JR; Mullikin, JC; Meader, SJ; Ponting, CP; Lunter, G; Higashino, S; Hobolth, A; Dutheil, J; Karakoc, E; Alkan, C; Sajjadian, S; Catacchio, CR; Ventura, M; Marques-Bonet, T; Eichler, EE; Andre, C; Atencia, R; Mugisha, L; Junhold, J; Patterson, N; Siebauer, M; Good, JM; Fischer, A; Ptak, SE; Lachmann, M; Symer, DE; Mailund, T; Schierup, MH; Andres, AM; Kelso, J; Paabo, S				Pruefer, Kay; Munch, Kasper; Hellmann, Ines; Akagi, Keiko; Miller, Jason R.; Walenz, Brian; Koren, Sergey; Sutton, Granger; Kodira, Chinnappa; Winer, Roger; Knight, James R.; Mullikin, James C.; Meader, Stephen J.; Ponting, Chris P.; Lunter, Gerton; Higashino, Saneyuki; Hobolth, Asger; Dutheil, Julien; Karakoc, Emre; Alkan, Can; Sajjadian, Saba; Catacchio, Claudia Rita; Ventura, Mario; Marques-Bonet, Tomas; Eichler, Evan E.; Andre, Claudine; Atencia, Rebeca; Mugisha, Lawrence; Junhold, Joerg; Patterson, Nick; Siebauer, Michael; Good, Jeffrey M.; Fischer, Anne; Ptak, Susan E.; Lachmann, Michael; Symer, David E.; Mailund, Thomas; Schierup, Mikkel H.; Andres, Aida M.; Kelso, Janet; Paeaebo, Svante			The bonobo genome compared with the chimpanzee and human genomes	NATURE			English	Article							LANDSCAPE	Two African apes are the closest living relatives of humans: the chimpanzee (Pan troglodytes) and the bonobo (Pan paniscus). Although they are similar in many respects, bonobos and chimpanzees differ strikingly in key social and sexual behaviours(1-4), and for some of these traits they show more similarity with humans than with each other. Here we report the sequencing and assembly of the bonobo genome to study its evolutionary relationship with the chimpanzee and human genomes. We find that more than three per cent of the human genome is more closely related to either the bonobo or the chimpanzee genome than these are to each other. These regions allow various aspects of the ancestry of the two ape species to be reconstructed. In addition, many of the regions that overlap genes may eventually help us understand the genetic basis of phenotypes that humans share with one of the two apes to the exclusion of the other.	[Pruefer, Kay; Siebauer, Michael; Good, Jeffrey M.; Fischer, Anne; Ptak, Susan E.; Lachmann, Michael; Andres, Aida M.; Kelso, Janet; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Munch, Kasper; Hobolth, Asger; Dutheil, Julien; Mailund, Thomas; Schierup, Mikkel H.] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus C, Denmark; [Hellmann, Ines] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Akagi, Keiko; Symer, David E.] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; [Akagi, Keiko; Symer, David E.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Miller, Jason R.; Walenz, Brian; Sutton, Granger] J Craig Venter Inst, Rockville, MD 20850 USA; [Koren, Sergey] Univ Maryland, College Pk, MD 20742 USA; [Kodira, Chinnappa; Winer, Roger; Knight, James R.] 454 Life Sci, Branford, CT 06405 USA; [Mullikin, James C.] NHGRI, Genome Technol Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; [Meader, Stephen J.; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3QX, England; [Lunter, Gerton] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Higashino, Saneyuki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Kanagawa 2268503, Japan; [Karakoc, Emre; Alkan, Can; Sajjadian, Saba; Ventura, Mario; Marques-Bonet, Tomas; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Karakoc, Emre; Alkan, Can; Sajjadian, Saba; Ventura, Mario; Marques-Bonet, Tomas; Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Catacchio, Claudia Rita; Ventura, Mario] Univ Bari, Dipartimento Anat Patol & Genet, Sez Genet, I-70125 Bari, Italy; [Marques-Bonet, Tomas] UPF CSIC, Inst Biol Evolutiva, ICREA, Barcelona 08003, Catalonia, Spain; [Atencia, Rebeca] Jane Goodall Inst, Pointe Noire, DEM REP CONGO; [Mugisha, Lawrence] CSWCT, Entebbe, Uganda; [Junhold, Joerg] Zoo Leipzig, D-04105 Leipzig, Germany; [Patterson, Nick] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Good, Jeffrey M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Fischer, Anne] Int Ctr Insect Physiol & Ecol, Nairobi 00100, Kenya; [Schierup, Mikkel H.] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark	Max Planck Society; Aarhus University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; J. Craig Venter Institute; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Tokyo Institute of Technology; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Universita degli Studi di Bari Aldo Moro; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); ICREA; Pompeu Fabra University; Harvard University; Harvard Medical School; University of Montana System; University of Montana; International Centre of Insect Physiology & Ecology (ICIPE); Aarhus University	Prufer, K (corresponding author), Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany.	pruefer@eva.mpg.de; paabo@eva.mpg.de	Ventura, Mario/E-6420-2011; Koren, Sergey/AAE-8314-2019; Schierup, Mikkel H/F-1675-2010; Lunter, Gerton/H-4939-2016; Munch, Kasper/A-1434-2010; Schierup, Mikkel Heide/AAM-4997-2020; Andres, Aida/B-4088-2014; Catacchio, Claudia/P-8898-2015; Kelso, Janet/N-1812-2019; Symer, David E./E-4173-2011; Marques-Bonet, Tomas/I-4618-2014; Marques-Bonet, Tomas/ABF-3734-2020; Dutheil, Julien Yann/K-5479-2016; Alkan, Can/D-2982-2009; Ponting, Chris/AAV-2621-2021; Mugisha, Lawrence/N-4916-2017	Ventura, Mario/0000-0001-7762-8777; Schierup, Mikkel H/0000-0002-5028-1790; Munch, Kasper/0000-0003-2880-6252; Schierup, Mikkel Heide/0000-0002-5028-1790; Andres, Aida/0000-0002-8590-9672; Catacchio, Claudia/0000-0002-2166-723X; Kelso, Janet/0000-0002-3618-322X; Marques-Bonet, Tomas/0000-0002-5597-3075; Marques-Bonet, Tomas/0000-0002-5597-3075; Dutheil, Julien Yann/0000-0001-7753-4121; Alkan, Can/0000-0002-5443-0706; Mugisha, Lawrence/0000-0003-4932-3356; Koren, Sergey/0000-0002-1472-8962; Ponting, Chris/0000-0003-0202-7816; Lunter, Gerton/0000-0002-3798-2058; Mailund, Thomas/0000-0001-6206-9239; Hobolth, Asger/0000-0003-4056-1286; Miller, Jason/0000-0002-6912-2925	ERC [233297, StG_20091118]; National Institutes of Health [2R01GM077117-04A1, HG002385]; Ramon y Cajal grant (MICINN-RYC); Ohio State University Comprehensive Cancer Center; Ohio Supercomputer Center [PAS0425]; Ohio Cancer Research Associates [GRT00024299]; Wellcome Trust [090532/Z/09/Z]; US National Science Foundation [OISE-0754461]; Danish Council for Independent Research \ Natural Sciences [09-062535]; Medical Research Council [MC_U137761446] Funding Source: researchfish; MRC [MC_U137761446] Funding Source: UKRI; ICREA Funding Source: Custom; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385, ZIAHG200330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077117] Funding Source: NIH RePORTER	ERC(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ramon y Cajal grant (MICINN-RYC)(German Research Foundation (DFG)); Ohio State University Comprehensive Cancer Center; Ohio Supercomputer Center; Ohio Cancer Research Associates; Wellcome Trust(Wellcome TrustEuropean Commission); US National Science Foundation(National Science Foundation (NSF)); Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ICREA(ICREA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The sequencing effort was made possible by the ERC (grant 233297, TWOPAN) and the Max Planck Society. We thank D. Reich and L. Vigilant for comments; the 454 Sequencing Center, the MPI-EVA sequencing group, M. Kircher, M. Rampp and M. Halbwax for technical support; the staff of Zoo Leipzig (Germany), the Ngamba Island Chimpanzee Sanctuary (Entebbe, Uganda), the Tchimpounga Chimpanzee Rehabilitation Center (Pointe-Noire, Republic of Congo) and the Lola ya Bonobo bonobo sanctuary (Kinshasa, Democratic Republic of Congo) for providing samples; and A. Navarro, E. Gazave and C. Baker for performing the ArrayCGH hybridizations. The ape distribution layers for Fig. 1a were provided by UNEP-WCMC and IUCN.2008 (IUCN Red List of Threatened Species, Version 2011.2, http://www.iucnredlist.org). The National Institutes of Health provided funding for J.R.M., B. W., S. K., G. S. (2R01GM077117-04A1), J.C.M. (Intramural Research Program of the National Human Genome Research Institute) and E. E. E. (HG002385). E. E. E is an Investigator of the Howard Hughes Medical Institute. T.M.-B. was supported by a Ramon y Cajal grant (MICINN-RYC 2010) and an ERC Starting Grant (StG_20091118); D. E. S., K. A. and S. H. were supported by the Ohio State University Comprehensive Cancer Center, the Ohio Supercomputer Center (#PAS0425) and the Ohio Cancer Research Associates (GRT00024299); and G. L. was supported by a Wellcome Trust grant (090532/Z/09/Z). The US National Science Foundation provided an International Postdoctoral Fellowship (OISE-0754461) to J.M.G. The Danish Council for Independent Research vertical bar Natural Sciences (grant no. 09-062535) provided funding for K.M. and M.H.S.	Akagi K, 2008, GENOME RES, V18, P869, DOI 10.1101/gr.075770.107; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Arnold ML, 2006, ZOOLOGY, V109, P261, DOI 10.1016/j.zool.2006.03.006; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Boesch Christophe, 2002, BEHAV DIVERSITY CHIM; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; de Groot NG, 2010, P NATL ACAD SCI USA, V107, P15175, DOI 10.1073/pnas.1009136107; de Waal Frans B. M., 1997, BONOBO FORGOTTEN APE; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; Gottipati S, 2011, NAT GENET, V43, P741, DOI 10.1038/ng.877; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; GYLLENSTEN UB, 1989, P NATL ACAD SCI USA, V86, P9986, DOI 10.1073/pnas.86.24.9986; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Kano T., 1992, LAST APE PYGMY CHIMP; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Wegmann D, 2010, MOL BIOL EVOL, V27, P1425, DOI 10.1093/molbev/msq028; Yohn CT, 2005, PLOS BIOL, V3, P577, DOI 10.1371/journal.pbio.0030110	30	311	322	5	229	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					527	531		10.1038/nature11128	http://dx.doi.org/10.1038/nature11128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722832	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000305760600042
J	Grishin, NV				Grishin, Nick V.			Membrane Protein Structure Predictions for Exploration	CELL			English	Editorial Material									[Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Biophys, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Biochem, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Grishin, NV (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Biophys, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	grishin@chop.swmed.edu			NIGMS NIH HHS [R01 GM094575] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Kloppmann E, 2012, CURR OPIN STRUC BIOL, V22, P326, DOI 10.1016/j.sbi.2012.05.002; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349	10	1	1	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1424	1425		10.1016/j.cell.2012.06.004	http://dx.doi.org/10.1016/j.cell.2012.06.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726429	Bronze, Green Accepted			2022-12-28	WOS:000305753800007
J	Hewak, D; Gholipour, B				Hewak, Dan; Gholipour, Behrad			Primed to Remember	SCIENCE			English	Editorial Material							PHASE-CHANGE MATERIALS		[Hewak, Dan; Gholipour, Behrad] Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England	University of Southampton	Hewak, D (corresponding author), Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England.	dh@orc.soton.ac.uk; bg305@orc.soton.ac.uk	Metamaterials, Nanophotonics and/AAF-3156-2019	Gholipour, Behrad/0000-0002-6196-7130	EPSRC [EP/H02607X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H02607X/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Dantzig JA, 2001, MODELING MAT PROCESS; Kolobov AV, 2011, NAT CHEM, V3, P311, DOI [10.1038/NCHEM.1007, 10.1038/nchem.1007]; Kuzum D, 2012, NANO LETT, V12, P2179, DOI 10.1021/nl201040y; Lencer D, 2011, ADV MATER, V23, P2030, DOI 10.1002/adma.201004255; Loke D, 2012, SCIENCE, V336, P1566, DOI 10.1126/science.1221561; Nam SW, 2012, SCIENCE, V336, P1561, DOI 10.1126/science.1220119; Otten LJ, 2006, NAT NEUROSCI, V9, P489, DOI 10.1038/nn1663; Salinga M, 2011, SCIENCE, V332, P543, DOI 10.1126/science.1204093; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Wright CD, 2011, ADV MATER, V23, P3408, DOI 10.1002/adma.201101060; Xiong F, 2011, SCIENCE, V332, P568, DOI 10.1126/science.1201938	11	6	6	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1515	1516		10.1126/science.1223365	http://dx.doi.org/10.1126/science.1223365			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723402				2022-12-28	WOS:000305507500036
J	Bakalar, N				Bakalar, Nicholas			SENSORY SCIENCE Partners in flavour	NATURE			English	Editorial Material																		Forestell CA, 2007, PEDIATRICS, V120, P1247, DOI 10.1542/peds.2007-0858; Gal D., 2007, SSRN ELIBRARY; Gueguen N, 2004, PERCEPT MOTOR SKILL, V99, P34, DOI 10.2466/PMS.99.5.34-38; Lipchock SV, 2011, CLIN PERINATOL, V38, P627, DOI 10.1016/j.clp.2011.08.008; Ohla K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032434; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; Zampini M, 2010, CHEMOSENS PERCEPT, V3, P57, DOI 10.1007/s12078-010-9064-2	7	10	10	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					S4	S5		10.1038/486S4a	http://dx.doi.org/10.1038/486S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RB	22717401	Bronze			2022-12-28	WOS:000311781000003
J	Banerji, S; Cibulskis, K; Rangel-Escareno, C; Brown, KK; Carter, SL; Frederick, AM; Lawrence, MS; Sivachenko, AY; Sougnez, C; Zou, LH; Cortes, ML; Fernandez-Lopez, JC; Peng, SY; Ardlie, KG; Auclair, D; Bautista-Pina, V; Duke, F; Francis, J; Jung, J; Maffuz-Aziz, A; Onofrio, RC; Parkin, M; Pho, NH; Quintanar-Jurado, V; Ramos, AH; Rebollar-Vega, R; Rodriguez-Cuevas, S; Romero-Cordoba, SL; Schumacher, SE; Stransky, N; Thompson, KM; Uribe-Figueroa, L; Baselga, J; Beroukhim, R; Polyak, K; Sgroi, DC; Richardson, AL; Jimenez-Sanchez, G; Lander, ES; Gabriel, SB; Garraway, LA; Golub, TR; Melendez-Zajgla, J; Toker, A; Getz, G; Hidalgo-Miranda, A; Meyerson, M				Banerji, Shantanu; Cibulskis, Kristian; Rangel-Escareno, Claudia; Brown, Kristin K.; Carter, Scott L.; Frederick, Abbie M.; Lawrence, Michael S.; Sivachenko, Andrey Y.; Sougnez, Carrie; Zou, Lihua; Cortes, Maria L.; Fernandez-Lopez, Juan C.; Peng, Shouyong; Ardlie, Kristin G.; Auclair, Daniel; Bautista-Pina, Veronica; Duke, Fujiko; Francis, Joshua; Jung, Joonil; Maffuz-Aziz, Antonio; Onofrio, Robert C.; Parkin, Melissa; Pho, Nam H.; Quintanar-Jurado, Valeria; Ramos, Alex H.; Rebollar-Vega, Rosa; Rodriguez-Cuevas, Sergio; Romero-Cordoba, Sandra L.; Schumacher, Steven E.; Stransky, Nicolas; Thompson, Kristin M.; Uribe-Figueroa, Laura; Baselga, Jose; Beroukhim, Rameen; Polyak, Kornelia; Sgroi, Dennis C.; Richardson, Andrea L.; Jimenez-Sanchez, Gerardo; Lander, Eric S.; Gabriel, Stacey B.; Garraway, Levi A.; Golub, Todd R.; Melendez-Zajgla, Jorge; Toker, Alex; Getz, Gad; Hidalgo-Miranda, Alfredo; Meyerson, Matthew			Sequence analysis of mutations and translocations across breast cancer subtypes	NATURE			English	Article							HIGH-FREQUENCY; PIK3CA GENE; GENOME; LANDSCAPES; PATTERNS; FUSION; DOMAIN; KINASE	Breast carcinoma is the leading cause of cancer-related mortality in women worldwide, with an estimated 1.38 million new cases and 458,000 deaths in 2008 alone(1). This malignancy represents a heterogeneous group of tumours with characteristic molecular features, prognosis and responses to available therapy(2-4). Recurrent somatic alterations in breast cancer have been described, including mutations and copy number alterations, notably ERBB2 amplifications, the first successful therapy target defined by a genomic aberration(5). Previous DNA sequencing studies of breast cancer genomes have revealed additional candidate mutations and gene rearrangements(6-10). Here we report the whole-exome sequences of DNA from 103 human breast cancers of diverse subtypes from patients in Mexico and Vietnam compared to matched-normal DNA, together with whole-genome sequences of 22 breast cancer/normal pairs. Beyond confirming recurrent somatic mutations in PIK3CA(11), TP53(6), AKT1(12), GATA3(13) and MAP3K1(10), we discovered recurrent mutations in the CBFB transcription factor gene and deletions of its partner RUNX1. Furthermore, we have identified a recurrent MAGI3-AKT3 fusion enriched in triple-negative breast cancer lacking oestrogen and progesterone receptors and ERBB2 expression. The MAGI3-AKT3 fusion leads to constitutive activation of AKT kinase, which is abolished by treatment with an ATP-competitive AKT small-molecule inhibitor.	[Banerji, Shantanu; Cibulskis, Kristian; Carter, Scott L.; Frederick, Abbie M.; Lawrence, Michael S.; Sivachenko, Andrey Y.; Sougnez, Carrie; Zou, Lihua; Cortes, Maria L.; Ardlie, Kristin G.; Auclair, Daniel; Duke, Fujiko; Francis, Joshua; Jung, Joonil; Onofrio, Robert C.; Parkin, Melissa; Pho, Nam H.; Ramos, Alex H.; Schumacher, Steven E.; Stransky, Nicolas; Thompson, Kristin M.; Beroukhim, Rameen; Lander, Eric S.; Gabriel, Stacey B.; Garraway, Levi A.; Golub, Todd R.; Getz, Gad; Meyerson, Matthew] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Banerji, Shantanu; Peng, Shouyong; Schumacher, Steven E.; Beroukhim, Rameen; Polyak, Kornelia; Richardson, Andrea L.; Garraway, Levi A.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Banerji, Shantanu; Baselga, Jose; Beroukhim, Rameen; Polyak, Kornelia; Sgroi, Dennis C.; Richardson, Andrea L.; Lander, Eric S.; Garraway, Levi A.; Golub, Todd R.; Toker, Alex; Meyerson, Matthew] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rangel-Escareno, Claudia; Fernandez-Lopez, Juan C.; Quintanar-Jurado, Valeria; Rebollar-Vega, Rosa; Romero-Cordoba, Sandra L.; Uribe-Figueroa, Laura; Jimenez-Sanchez, Gerardo; Melendez-Zajgla, Jorge; Hidalgo-Miranda, Alfredo] Inst Nacl Med Genom, Mexico City 01900, DF, Mexico; [Brown, Kristin K.; Toker, Alex] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Bautista-Pina, Veronica; Maffuz-Aziz, Antonio; Rodriguez-Cuevas, Sergio] FUCAM, Inst Enfermedades Mama, Mexico City 04980, DF, Mexico; [Baselga, Jose] Massachusetts Gen Hosp, Div Hematol & Oncol, Boston, MA 02114 USA; [Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Polyak, Kornelia] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Sgroi, Dennis C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Cambridge, MA 02139 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Instituto Nacional de Medicina Genomica; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Meyerson, M (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	atoker@bidmc.harvard.edu; gadgetz@broadinstitute.org; ahidalgo@inmegen.gob.mx; matthew_meyerson@dfci.harvard.edu	Hidalgo-Miranda, Alfredo/B-2123-2010; Romero-Cordoba, Sandra/AAY-2625-2020; Fernandez, Juan Carlos/C-4976-2013; Sgroi, Dennis/AAV-2487-2021; Lawrence, Michael/AAC-8202-2020; Romero, Sandra/A-2246-2014; Rangel-Escareno, Claudia/F-4587-2012; Meyerson, Matthew L/E-7123-2012; Melendez-Zajgla, Jorge/A-5708-2008; Schumacher, Steven/E-9821-2013; Cibulskis, Kristian/AAC-7380-2019	Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Fernandez, Juan Carlos/0000-0003-3680-4193; Romero, Sandra/0000-0002-5591-696X; Rangel-Escareno, Claudia/0000-0003-1303-0834; Schumacher, Steven/0000-0002-6819-5647; Cibulskis, Kristian/0000-0003-1343-1582; Meyerson, Matthew/0000-0002-9133-8108; REBOLLAR VEGA, ROSA GLORIA/0000-0002-9293-5959; BROWN, KRISTIN/0000-0002-4991-8870	Carlos Slim Health Institute in Mexico; CancerCare Manitoba; University of Manitoba; John Gavin Post-doctoral Fellowship; Genesis Oncology Trust of New Zealand; Mexican Council of Science and Technology (CONACyT); NIH [CA122099]; Dana-Farber/Harvard SPORE in breast cancer under NCI grant [CA089393]; NATIONAL CANCER INSTITUTE [P50CA089393, R01CA122099] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	Carlos Slim Health Institute in Mexico; CancerCare Manitoba; University of Manitoba; John Gavin Post-doctoral Fellowship; Genesis Oncology Trust of New Zealand; Mexican Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana-Farber/Harvard SPORE in breast cancer under NCI grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank all patients who contributed samples to this study. This study was a collaboration of the Broad Institute in Cambridge, Massachusetts, USA, and the National Institute of Genomic Medicine (INMEGEN) in Mexico City, Mexico. The work was conducted as part of the Slim Initiative for Genomic Medicine, a project funded by the Carlos Slim Health Institute in Mexico. This work is part of a global effort in collaboration with the International Cancer Genome Consortium (ICGC). The authors would also like to acknowledge J. Barretina and H. Greulich for their critical review of the manuscript. In addition, we would like to acknowledge the technical expertise and data generation efforts of The Broad Institute Biological Samples, Genome Sequencing, and Genetic Analysis Platforms. S. B. has received fellowship support co-sponsored by CancerCare Manitoba and the University of Manitoba. K. K. B. is a recipient of the John Gavin Post-doctoral Fellowship, Genesis Oncology Trust of New Zealand. R. R.-V. and S. L. R.-C. received a scholarship from the Mexican Council of Science and Technology (CONACyT). R. B. is a V Foundation Scholar. A. T. is funded by NIH grant CA122099. This work was partially supported by the Dana-Farber/Harvard SPORE in breast cancer under NCI grant reference CA089393.	Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Cameron ER, 2004, ONCOGENE, V23, P4308, DOI 10.1038/sj.onc.1207130; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shigesada K, 2004, ONCOGENE, V23, P4297, DOI 10.1038/sj.onc.1207748; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199	29	877	906	4	170	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					405	409		10.1038/nature11154	http://dx.doi.org/10.1038/nature11154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722202	Green Accepted, hybrid			2022-12-28	WOS:000305466800044
J	Holmes, D				Holmes, David			Frances Ashcroft: the doyenne of diabetes research Profile	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 16	2012	379	9833					2234	2234		10.1016/S0140-6736(12)60968-4	http://dx.doi.org/10.1016/S0140-6736(12)60968-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962AM	22704159				2022-12-28	WOS:000305511400016
J	Loquet, A; Sgourakis, NG; Gupta, R; Giller, K; Riedel, D; Goosmann, C; Griesinger, C; Kolbe, M; Baker, D; Becker, S; Lange, A				Loquet, Antoine; Sgourakis, Nikolaos G.; Gupta, Rashmi; Giller, Karin; Riedel, Dietmar; Goosmann, Christian; Griesinger, Christian; Kolbe, Michael; Baker, David; Becker, Stefan; Lange, Adam			Atomic model of the type III secretion system needle	NATURE			English	Article							SOLID-STATE NMR; SUPRAMOLECULAR STRUCTURE; ELECTRON CRYOMICROSCOPY; CROSS-POLARIZATION; MICROSCOPY; PROTEINS; CRYSTALLOGRAPHY; RESOLUTION; MACHINES; DELIVERY	Pathogenic bacteria using a type III secretion system (T3SS)(1,2) to manipulate host cells cause many different infections including Shigella dysentery, typhoid fever, enterohaemorrhagic colitis and bubonic plague. An essential part of the T3SS is a hollow needle-like protein filament through which effector proteins are injected into eukaryotic host cells(3-6). Currently, the three-dimensional structure of the needle is unknown because it is not amenable to X-ray crystallography and solution NMR, as a result of its inherent non-crystallinity and insolubility. Cryo-electron microscopy combined with crystal or solution NMR subunit structures has recently provided a powerful hybrid approach for studying supramolecular assemblies(7-12), resulting in low-resolution and medium-resolution models(13-17). However, such approaches cannot deliver atomic details, especially of the crucial subunit-subunit interfaces, because of the limited cryo-electron microscopic resolution obtained in these studies. Here we report an alternative approach combining recombinant wild-type needle production, solid-state NMR, electron microscopy and Rosetta modelling to reveal the supramolecular interfaces and ultimately the complete atomic structure of the Salmonella typhimurium T3SS needle. We show that the 80-residue subunits form a right-handed helical assembly with roughly 11 subunits per two turns, similar to that of the flagellar filament of S. typhimurium. In contrast to established models of the needle in which the amino terminus of the protein subunit was assumed to be alpha-helical and positioned inside the needle, our model reveals an extended amino-terminal domain that is positioned on the surface of the needle, while the highly conserved carboxy terminus points towards the lumen.	[Loquet, Antoine; Giller, Karin; Griesinger, Christian; Becker, Stefan; Lange, Adam] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Sgourakis, Nikolaos G.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Gupta, Rashmi; Kolbe, Michael] Max Planck Inst Infect Biol, Dept Cellular Microbiol, D-10117 Berlin, Germany; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Lab Electron Microscopy, D-37077 Gottingen, Germany; [Griesinger, Christian] Max Planck Inst Infect Biol, D-10117 Berlin, Germany	Max Planck Society; University of Washington; University of Washington Seattle; Max Planck Society; Max Planck Society; Max Planck Society	Lange, A (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany.	kolbe@mpiib-berlin.mpg.de; sabe@nmr.mpibpc.mpg.de; adla@nmr.mpibpc.mpg.de	Baker, David/K-8941-2012; Loquet, Antoine/A-1465-2010	Baker, David/0000-0001-7896-6217; Loquet, Antoine/0000-0001-7176-7813; Lange, Adam/0000-0002-7534-5973	Max Planck Society; Deutsche Forschungsgemeinschaft; Fondation Bettencourt Schueller; National Institutes of Health [1 R01 GM092802-01]; EMBO; European Union [261863]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092802] Funding Source: NIH RePORTER	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fondation Bettencourt Schueller; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); European Union(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. C. Marlovits and E. H. Egelman for providing the S. typhimurium T3SS needle cryo-electron microscopy density map; F. DiMaio and J.-P. Demers for discussions; and G. Wolf, B. Angerstein and G. Heim for technical help. This work was supported by the Max Planck Society (to C. Griesinger), the Deutsche Forschungsgemeinschaft (Emmy Noether Fellowship to A. Lange), the Fondation Bettencourt Schueller (to A. Loquet), the National Institutes of Health (1 R01 GM092802-01 to D. B.), EMBO (postdoctoral fellowship to A. Loquet), and the European Union Seventh Framework Program under Grant Agreement 261863 (Bio-NMR).	Baker ML, 2010, NAT PROTOC, V5, P1697, DOI 10.1038/nprot.2010.126; Blocker AJ, 2008, P NATL ACAD SCI USA, V105, P6507, DOI 10.1073/pnas.0708344105; Bockmann A, 2009, J BIOMOL NMR, V45, P319, DOI 10.1007/s10858-009-9374-3; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Galkin VE, 2010, J MOL BIOL, V396, P1392, DOI 10.1016/j.jmb.2010.01.001; Goldbourt A, 2007, J AM CHEM SOC, V129, P2338, DOI 10.1021/ja066928u; Han Y, 2010, J AM CHEM SOC, V132, P1976, DOI 10.1021/ja908687k; Hong M, 1999, J MAGN RESON, V139, P389, DOI 10.1006/jmre.1999.1805; Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lewandowski JR, 2007, J AM CHEM SOC, V129, P728, DOI 10.1021/ja0650394; Loquet A, 2011, J AM CHEM SOC, V133, P4722, DOI 10.1021/ja200066s; Loquet A, 2010, J AM CHEM SOC, V132, P15164, DOI 10.1021/ja107460j; Lundstrom P, 2007, J BIOMOL NMR, V38, P199, DOI 10.1007/s10858-007-9158-6; Nogales E, 2001, J CELL BIOL, V152, pF1, DOI 10.1083/jcb.152.1.F1; Poyraz O, 2010, NAT STRUCT MOL BIOL, V17, P788, DOI 10.1038/nsmb.1822; Rossmann MG, 2005, STRUCTURE, V13, P355, DOI 10.1016/j.str.2005.01.005; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876; Volkmann N, 2003, METHOD ENZYMOL, V374, P204, DOI 10.1016/S0076-6879(03)74010-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	35	277	280	5	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					276	+		10.1038/nature11079	http://dx.doi.org/10.1038/nature11079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699623	Green Accepted, Green Published			2022-12-28	WOS:000305189000039
J	Sarafoglou, K; Banks, K; Kyllo, J; Pittock, S; Thomas, W				Sarafoglou, Kyriakie; Banks, Katie; Kyllo, Jennifer; Pittock, Siobhan; Thomas, William			Cases of Congenital Adrenal Hyperplasia Missed by Newborn Screening in Minnesota	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sarafoglou, Kyriakie] Univ Minnesota, Amplatz Childrens Hosp, Dept Pediat, Minneapolis, MN 55414 USA; [Banks, Katie] Minnesota Dept Hlth, St Paul, MN USA; [Kyllo, Jennifer] Childrens Hosp Minnesota, Dept Pediat, Minneapolis, MN USA; [Pittock, Siobhan] Mayo Clin, Coll Med, Dept Pediat, Rochester, MN USA; [Thomas, William] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Minnesota Department of Health (MHD); Children's Hospitals & Clinics of Minnesota; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Sarafoglou, K (corresponding author), Univ Minnesota, Amplatz Childrens Hosp, Dept Pediat, Minneapolis, MN 55414 USA.	saraf010@umn.edu		Sarafoglou, Kyriakie/0000-0002-5741-3629				Minutolo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015899; Robins T, 2006, MOL ENDOCRINOL, V20, P2946, DOI 10.1210/me.2006-0172; Sarafoglou K, CLIN GENET, DOI [10.1111/j.1399-0004.2011.01694.x, DOI 10.1111/J.1399-0004.2011.01694.X]; Schreiner F, 2008, EUR J PEDIATR, V167, P479, DOI 10.1007/s00431-007-0505-0; Therrell BL, 1998, PEDIATRICS, V101, P583, DOI 10.1542/peds.101.4.583; Varness TS, 2005, J PEDIATR-US, V147, P493, DOI 10.1016/j.jpeds.2005.04.035	6	37	38	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2012	307	22					2371	2374		10.1001/jama.2012.5281	http://dx.doi.org/10.1001/jama.2012.5281			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	956UX	22692165	Bronze			2022-12-28	WOS:000305115900017
J	Margolin, K				Margolin, Kim			BRAF inhibition and beyond in advanced melanoma	LANCET			English	Editorial Material							RAF; MUTATIONS; V600E		Seattle Canc Care Alliance, Seattle, WA 98109 USA	Seattle Cancer Care Alliance	Margolin, K (corresponding author), Seattle Canc Care Alliance, Seattle, WA 98109 USA.	kmargoli@seattlecca.org		Margolin, Kim/0000-0002-5248-4356				Alcala AM, 2012, CLIN CANCER RES, V18, P33, DOI 10.1158/1078-0432.CCR-11-0997; Amanuel B, 2012, PATHOLOGY, V44, P357, DOI 10.1097/PAT.0b013e3283532565; Ascierto PA, 2012, J CLIN ONCOL, V30; Chapman PB, 2012, J CLIN ONCOL, V30; Dummer R, 2011, J CLIN ONCOL, V29; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Hauschild A., 2012, LANCET; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Moreno C, 2012, J CLIN ONCOL, V30; Roche molecular systems, 2011, ROCHE MOL SYSTEMS SU; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Weeraratna AT, 2012, NEW ENGL J MED, V366, P271, DOI 10.1056/NEJMe1111636	15	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2012	380	9839					320	322		10.1016/S0140-6736(12)60993-3	http://dx.doi.org/10.1016/S0140-6736(12)60993-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979TN	22735383				2022-12-28	WOS:000306842800010
J	Bosch, J; Gerstein, HC; Dagenais, GR; Diaz, R; Dyal, L; Jung, H; Maggiono, AP; Probstfield, J; Ramachandran, A; Riddle, MC; Ryden, LE; Yusuf, S				Bosch, Jackie; Gerstein, Hertzel C.; Dagenais, Gilles R.; Diaz, Rafael; Dyal, Leanne; Jung, Hyejung; Maggiono, Aldo P.; Probstfield, Jeffrey; Ramachandran, Ambady; Riddle, Matthew C.; Ryden, Lars E.; Yusuf, Salim			n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; OMEGA-3-FATTY-ACID INTAKE; RISK; PREVENTION; EVENTS; FISH	BACKGROUND The use of n-3 fatty acids may prevent cardiovascular events in patients with recent myocardial infarction or heart failure. Their effects in patients with (or at risk for) type 2 diabetes mellitus are unknown. METHODS In this double-blind study with a 2-by-2 factorial design, we randomly assigned 12,536 patients who were at high risk for cardiovascular events and had impaired fasting glucose, impaired glucose tolerance, or diabetes to receive a 1-g capsule containing at least 900 mg (90% or more) of ethyl esters of n-3 fatty acids or placebo daily and to receive either insulin glargine or standard care. The primary outcome was death from cardiovascular causes. The results of the comparison between n-3 fatty acids and placebo are reported here. RESULTS During a median follow up of 6.2 years, the incidence of the primary outcome was not significantly decreased among patients receiving n-3 fatty acids, as compared with those receiving placebo (574 patients [9.1%] vs. 581 patients [9.3%]; hazard ratio, 0.98; 95% confidence interval [CI], 0.87 to 1.10; P = 0.72). The use of n-3 fatty acids also had no significant effect on the rates of major vascular events (1034 patients [16.5%] vs. 1017 patients [16.3%]; hazard ratio, 1.01; 95% CI, 0.93 to 1.10; P = 0.81), death from any cause (951 [15.1%] vs. 964 [15.4%]; hazard ratio, 0.98; 95% CI, 0.89 to 1.07; P = 0.63), or death from arrhythmia (288 [4.6%] vs. 259 [4.1%]; hazard ratio, 1.10; 95% CI, 0.93 to 1.30; P = 0.26). Triglyceride levels were reduced by 14.5 mg per deciliter (0.16 mmol per liter) more among patients receiving n-3 fatty acids than among those receiving placebo (P<0.001), without a significant effect on other lipids. Adverse effects were similar in the two groups. CONCLUSIONS Daily supplementation with 1 g of n-3 fatty acids did not reduce the rate of cardiovascular events in patients at high risk for cardiovascular events. (Funded by Sanofi; ORIGIN ClinicalTrials.gov number, NCT00069784.)	[Bosch, Jackie; Gerstein, Hertzel C.; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Bosch, Jackie] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Bosch, Jackie; Gerstein, Hertzel C.; Dyal, Leanne; Jung, Hyejung; Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON, Canada; [Gerstein, Hertzel C.; Yusuf, Salim] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Dagenais, Gilles R.] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Diaz, Rafael] Estudios Clin Latino Amer, Rosario, Santa Fe, Argentina; [Maggiono, Aldo P.] ANMCO Res Ctr, Florence, Italy; [Probstfield, Jeffrey] Univ Washington, Seattle, WA 98195 USA; [Ramachandran, Ambady] India Diabet Res Fdn, Madras, Tamil Nadu, India; [Riddle, Matthew C.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Ryden, Lars E.] Karolinska Inst, Stockholm, Sweden	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); University of Washington; University of Washington Seattle; Oregon Health & Science University; Karolinska Institutet	Bosch, J (corresponding author), Hamilton Gen Hosp, DBCVSRI, ORIGIN Project Off, Populat Hlth Res Inst, 237 Barton St E,2nd Fl, Hamilton, ON L8L 2X2, Canada.	origin@phri.ca	Maggioni, Aldo Pietro/AAL-5334-2020; Derosa, Giuseppe/H-8571-2019; Gurevich, Victor/H-2935-2013; cornel, jan hein/Y-7065-2019; Urina-Triana, Miguel A/H-2605-2016; Acevedo, Monica/GSI-9787-2022; Hramiak, Irene/G-3305-2011; Hatipoglu, Esra/I-1793-2013; Zadionchenko, Vladimir/A-7445-2016; Liesivuori, Jyrki/O-2519-2013; Gerstein, Hertzel/ABB-8781-2020; Del Prato, Stefano/K-3405-2016; Draman, Mohd Shazli/H-1261-2013; Colquhoun, David M/F-9078-2013; Derosa, Giuseppe/F-2615-2012; Facanha, Cristina Figueiredo Sampaio/AAW-7586-2021; Berkovic, Maja Cigrovski/AAB-7735-2019; Tütüncü, Neslihan Başçıl/ABG-5027-2020; Clark, Jeanne/AGG-8199-2022; Ramirez, Alfredo/S-5126-2019; Gislason, Gunnar/B-7561-2009; Beniashvili, Allan/J-4649-2017; Cacciatore, Francesco/E-8619-2019; Gerstein, Hertzel C/B-1235-2013; Orlova, Iana/Y-2619-2019; Bosch, Jacqueline/AAP-6910-2021; Adasheva, Tatiana/J-5713-2013; CARMONA-HUERTA, JAIME/E-5849-2019; Taylor, Anne/F-5708-2010; Vasyuk, Yury/G-1772-2013; Bondarenko, Igor/U-5156-2017	Maggioni, Aldo Pietro/0000-0003-2764-6779; Derosa, Giuseppe/0000-0003-3573-4760; Gurevich, Victor/0000-0002-6815-444X; cornel, jan hein/0000-0002-1006-2112; Urina-Triana, Miguel A/0000-0001-6003-4622; Acevedo, Monica/0000-0002-7989-6633; Hatipoglu, Esra/0000-0001-8361-8866; Zadionchenko, Vladimir/0000-0003-2377-5266; Gerstein, Hertzel/0000-0001-8072-2836; Del Prato, Stefano/0000-0002-5388-0270; Draman, Mohd Shazli/0000-0003-0144-8467; Derosa, Giuseppe/0000-0003-3573-4760; Facanha, Cristina Figueiredo Sampaio/0000-0002-9303-4343; Berkovic, Maja Cigrovski/0000-0003-0750-9785; Tütüncü, Neslihan Başçıl/0000-0002-1816-3903; Clark, Jeanne/0000-0003-1194-0092; Ramirez, Alfredo/0000-0003-4991-763X; Gislason, Gunnar/0000-0002-0548-402X; Beniashvili, Allan/0000-0002-5149-3760; Gerstein, Hertzel C/0000-0001-8072-2836; Orlova, Iana/0000-0002-8160-5612; Bosch, Jacqueline/0000-0001-6292-4207; Adasheva, Tatiana/0000-0002-3763-8994; Bohme, Philip/0000-0002-5280-2959; Marin-Neto, Jose Antonio/0000-0002-8651-8833; Ali, Asem/0000-0002-0503-4838; Lanas, Fernando/0000-0003-3595-9759; Aylward, Philip/0000-0002-5358-8552; Hutchinson, Anastasia F/0000-0002-0014-689X; Bulkina, Olga/0000-0003-4773-6966; Vlad, Adrian/0000-0002-1824-2628; forti, adriana/0000-0002-5456-2303; cacciatore, francesco/0000-0003-4720-1427; Bordeleau, Louise/0000-0003-2111-0228; Kashyap, Moti/0000-0002-0052-8302; Richardson, Tristan/0000-0001-7505-7843; Yusuf, Salim/0000-0003-4776-5601; GAZTAMBIDE, SONIA/0000-0003-3569-2265; CARMONA-HUERTA, JAIME/0000-0002-0695-5452; Vonbank, Alexander/0000-0001-5648-5623; kerlan, veronique/0000-0001-8105-6628; Colman, Peter/0000-0001-8718-6175; Lochnan, Heather/0000-0002-3820-7897; Boman, Kurt/0000-0002-0350-2132; Clayton, David/0000-0001-5481-0891; Hancu, Nicolae/0000-0002-4688-5110; Shkolnik, Evgeny/0000-0002-8359-788X; Pirags, Valdis/0000-0002-3650-7394; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Bryan, Laura/0000-0002-9422-2338; Nyomba, B. L. Gregoire/0000-0001-9472-607X; Taylor, Anne/0000-0002-4422-7974; Davies, Melanie/0000-0002-9987-9371; Waldenstrom, Anders/0000-0002-5304-0802; Babenko, Alina/0000-0002-0559-697X; Novials, Anna/0000-0003-0465-2949; Vasyuk, Yury/0000-0003-2913-9797; Lombardo, Flavia Lucia/0000-0001-6183-0735; Ametov, A.S./0000-0002-7936-7619; Fernandez, Angel L./0000-0003-1307-8221; Bondarenko, Igor/0000-0002-7071-2471; Woo, Jeong-Taek/0000-0001-9201-0713; Lejnieks, Aivars/0000-0002-2097-6698; Morillo, Carlos/0000-0002-8739-2099; Psikova, Ol'ga/0000-0001-5832-5009; Joakimsen, Ragnar Martin/0000-0002-2125-8081; AVEZUM, ALVARO/0000-0002-3073-6890	Sanofi	Sanofi	Supported by Sanofi, with study drugs provided by Pronova BioPharma Norge.	[Anonymous], 2007, LANCET, V369, P106; Avanzini F, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-68; Calder PC, 2004, CLIN SCI, V107, P1, DOI 10.1042/CS20040119; Gerstein HC, 2008, AM HEART J, V155, P26, DOI 10.1016/j.ahj.2007.09.009; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Gerstein HC, 2010, LANCET, V375, P2195, DOI 10.1016/S0140-6736(10)60973-7; Holman RR, 2009, DIABETOLOGIA, V52, P50, DOI 10.1007/s00125-008-1179-5; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Hu FB, 2003, CIRCULATION, V107, P1852, DOI 10.1161/01.CIR.0000062644.42133.5F; Hu FB, 2012, ARCH INTERN MED; Kromhout D, 2011, DIABETES CARE, V34, P2515, DOI 10.2337/dc11-0896; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Kwak SM, 2012, ARCH INTERN MED; Leon H., 2008, BMJ-BRIT MED J, V337, P2931; Lichtenstein A, 2006, CIRCULATION, V114, pE629, DOI 10.1161/CIRCULATIONAHA.106.180281; Marik PE, 2009, CLIN CARDIOL, V32, P365, DOI 10.1002/clc.20604; Oikawa S, 2009, ATHEROSCLEROSIS, V206, P535, DOI 10.1016/j.atherosclerosis.2009.03.029; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Zhao YT, 2009, ANN MED, V41, P301, DOI 10.1080/07853890802698834; 2001, LANCET, V357, P642	23	626	668	0	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					309	318		10.1056/NEJMoa1203859	http://dx.doi.org/10.1056/NEJMoa1203859			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	978KD	22686415	Green Accepted			2022-12-28	WOS:000306738300005
J	Trivedi, AN; Grebla, RC; Jiang, L; Yoon, J; Mor, V; Kizer, KW				Trivedi, Amal N.; Grebla, Regina C.; Jiang, Lan; Yoon, Jean; Mor, Vincent; Kizer, Kenneth W.			Duplicate Federal Payments for Dual Enrollees in Medicare Advantage Plans and the Veterans Affairs Health Care System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VA; HMOS; HOSPITALS; DISTANCE; SERVICES; LEVEL	Context Some veterans are eligible to enroll simultaneously in a Medicare Advantage (MA) plan and the Veterans Affairs health care system (VA). This scenario produces the potential for redundant federal spending because MA plans would receive payments to insure veterans who receive care from the VA, another taxpayer-funded health plan. Objective To quantify the prevalence of dual enrollment in VA and MA, the concurrent use of health services in each setting, and the estimated costs of VA care provided to MA enrollees. Design Retrospective analysis of 1 245 657 veterans simultaneously enrolled in the VA and an MA plan between 2004-2009. Main Outcome Measures Use of health services and inflation-adjusted estimated VA health care costs. Results Among individuals who were eligible to enroll in the VA and in an MA plan, the number of persons dually enrolled increased from 485 651 in 2004 to 924 792 in 2009. In 2009, 8.3% of the MA population was enrolled in the VA and 5.0% of MA beneficiaries were VA users. The estimated VA health care costs for MA enrollees to-taled $13.0 billion over 6 years, increasing from $1.3 billion in 2004 to $3.2 billion in 2009. Among dual enrollees, 10% exclusively used the VA for outpatient and acute inpatient services, 35% exclusively used the MA plan, 50% used both the VA and MA, and 4% received no services during the calendar year. The VA financed 44% of all outpatient visits (n=21 353 841), 15% of all acute medical and surgical admissions (n=177 663), and 18% of all acute medical and surgical inpatient days (n=1 106 284) for this dually enrolled population. In 2009, the VA billed private insurers $52.3 million to reimburse care provided to MA enrollees and collected $9.4 million (18% of the billed amount; 0.3% of the total cost of care). Conclusions The federal government spends a substantial and increasing amount of potentially duplicative funds in 2 separate managed care programs for the care of same individuals. JAMA. 2012;308(1):67-72 Published online June 26, 2012. doi: 10.1001/jama.2012.7115 www.jama.com	[Trivedi, Amal N.; Grebla, Regina C.; Jiang, Lan; Mor, Vincent] Providence VA Med Ctr, Providence, RI 02908 USA; [Trivedi, Amal N.; Grebla, Regina C.; Mor, Vincent] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Yoon, Jean] Palo Alto VA Med Ctr, Palo Alto, CA USA; [Kizer, Kenneth W.] Univ Calif Davis, Sacramento, CA 95817 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of California System; University of California Davis	Trivedi, AN (corresponding author), Providence VA Med Ctr, 830 Chalkstone Ave, Providence, RI 02908 USA.	amal_trivedi@brown.edu			US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development Service; NIA [5RC1AG036158]; Kidney Care Partners; Pfizer; NATIONAL INSTITUTE ON AGING [RC1AG036158] Funding Source: NIH RePORTER; Veterans Affairs [I01HX000626] Funding Source: NIH RePORTER	US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development Service; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Kidney Care Partners; Pfizer(Pfizer); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This material is based upon work supported by the US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development Service, and the NIA (5RC1AG036158).; All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Trivedi reports provision of consultancy services to RAND Corporation serving on a CMS technical expert panel to develop quality measures for Medicare Advantage and Special Needs Plans. Dr Mor reports board membership with PointRight, Inc; consultancy services to Navi-Health, Abt Associates Inc, HCRManorCare, Research Triangle Institute Inc; employment with National Institutes of Health, Agency for Healthcare Research and Quality, and the National Institute on Aging (NIA); grants or pending grants from the NIA Program Project and the VA Health Services Research & Development Service Investigator-Initiated Research; lectures or speakers bureau participation for Rutgers University, Harvard Kennedy School, and the University of California San Francisco Division of Geriatrics; stocks or stock options with PointRight; a grant from Kidney Care Partners; and a contract to Brown University from Pfizer to investigate cost of Alzheimer disease and related disorders. Dr Kizer reports board membership with Humana Veterans Healthcare System; consultancy services with the Alaska VA Health System; and lecture or speakers bureau participation with the Department of Veterans Affairs. Dr Grebla and Yoon and Ms Jiang report no disclosures.	BURGESS JF, 1994, SOC SCI MED, V39, P95, DOI 10.1016/0277-9536(94)90169-4; Byrne MM, 2006, MED CARE, V44, P768, DOI 10.1097/01.mlr.0000218786.44722.14; Carey K, 2008, HEALTH SERV RES, V43, P1164, DOI 10.1111/j.1475-6773.2008.00840.x; Centers for Medicare & Medicaid Services Department of Health and Human Services, 2009, ADV NOT METH CHANG C; DeVito CA, 1997, NEW ENGL J MED, V337, P1013, DOI 10.1056/NEJM199710023371418; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; Hester EJ, 2005, NEW ENGL J MED, V353, P1302, DOI 10.1056/NEJMc051890; Hynes DM, 2007, MED CARE, V45, P214, DOI 10.1097/01.mlr.0000244657.90074.b7; McGuire TG, 2011, MILBANK Q, V89, P289, DOI 10.1111/j.1468-0009.2011.00629.x; Medicare Payment Advisory Commission The (MedPac), 2009, REP C IMPR INC MED P; Mooney C, 2000, SOC SCI MED, V50, P1743, DOI 10.1016/S0277-9536(99)00414-1; Panangala SV, VETERANS MED CARE FY; Passman LJ, 1997, J GEN INTERN MED, V12, P247, DOI 10.1007/s11606-006-5048-y; Petersen LA, 2010, HEALTH SERV RES, V45, P762, DOI 10.1111/j.1475-6773.2010.01107.x; Phibbs CS, 2003, MED CARE RES REV, V60, p54S, DOI 10.1177/1077558703256725; Pizer SD, 2011, INQUIRY-J HEALTH CAR, V48, P109, DOI 10.5034/inquiryjrnl_48.02.02; Shen YJ, 2003, MED CARE RES REV, V60, P253, DOI 10.1177/1077558703060002007; US Government Accountability Office, 1997, HEHS984 US GOV ACC; Wagner TH, 2003, MED CARE RES REV, V60, p15S, DOI 10.1177/1077558703256485	19	35	35	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2012	308	1					67	72		10.1001/jama.2012.7115	http://dx.doi.org/10.1001/jama.2012.7115			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	971DD	22735360	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000306183000025
J	Wedemeyer-Bohm, S; Scullion, E; Steiner, O; van der Voort, LR; Rodriguez, JD; Fedun, V; Erdelyi, R				Wedemeyer-Bohm, Sven; Scullion, Eamon; Steiner, Oskar; van der Voort, Luc Rouppe; Rodriguez, Jaime de la Cruz; Fedun, Viktor; Erdelyi, Robert			Magnetic tornadoes as energy channels into the solar corona	NATURE			English	Article							DRIVEN VORTEX FLOWS; ALFVENIC WAVES; QUIET SUN; WIND; SIMULATIONS; GRANULATION; PHOTOSPHERE; CONVECTION; TURBULENCE; POWER	Heating the outer layers of the magnetically quiet solar atmosphere to more than one million kelvin and accelerating the solar wind requires an energy flux of approximately 100 to 300 watts per square metre(1-6), but how this energy is transferred and dissipated there is a puzzle and several alternative solutions have been proposed. Braiding and twisting of magnetic field structures, which is caused by the convective flows at the solar surface, was suggested as an efficient mechanism for atmospheric heating(7). Convectively driven vortex flows that harbour magnetic fields are observed(8-10) to be abundant in the photosphere (the visible surface of the Sun). Recently, corresponding swirling motions have been discovered(11) in the chromosphere, the atmospheric layer sandwiched between the photosphere and the corona. Here we report the imprints of these chromospheric swirls in the transition region and low corona, and identify them as observational signatures of rapidly rotating magnetic structures. These ubiquitous structures, which resemble super-tornadoes under solar conditions, reach from the convection zone into the upper solar atmosphere and provide an alternative mechanism for channelling energy from the lower into the upper solar atmosphere.	[Wedemeyer-Bohm, Sven; Scullion, Eamon; van der Voort, Luc Rouppe] Univ Oslo, Inst Theoret Astrophys, N-0315 Oslo, Norway; [Wedemeyer-Bohm, Sven] Univ Oslo, Ctr Math Applicat, N-0316 Oslo, Norway; [Steiner, Oskar] Kiepenheuer Inst Solar Phys, D-79104 Freiburg, Germany; [Rodriguez, Jaime de la Cruz] Uppsala Univ, Dept Phys & Astron, SE-75120 Uppsala, Sweden; [Fedun, Viktor; Erdelyi, Robert] Univ Sheffield, Sch Math & Stat, Solar Phys & Space Plasma Res Ctr, Sheffield S3 7RH, S Yorkshire, England	University of Oslo; University of Oslo; Kiepenheuer Institut fur Sonnenphysik; Uppsala University; University of Sheffield	Wedemeyer-Bohm, S (corresponding author), Univ Oslo, Inst Theoret Astrophys, POB 1029 Blindern, N-0315 Oslo, Norway.	svenwe@astro.uio.no	Wedemeyer, Sven/F-3957-2010; Fedun, Viktor/M-9244-2013; erdelyi, robertus/AAQ-3262-2020	Wedemeyer, Sven/0000-0002-5006-7540; erdelyi, robertus/0000-0003-3439-4127; Rouppe van der Voort, Luc/0000-0003-2088-028X; de la Cruz Rodriguez, Jaime/0000-0002-4640-5658; Scullion, Eamon/0000-0001-9590-6427	Research Council of Norway; Science and Technology Facilities, UK; STFC [ST/J001430/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J001430/1] Funding Source: researchfish	Research Council of Norway(Research Council of Norway); Science and Technology Facilities, UK; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We acknowledge discussions with R. Hammer, M. Carlsson, V. Hansteen and S. McIntosh. M. Carlsson and B. Gudiksen are thanked for providing BIFROST simulation data and input on its analysis. This work was supported by the Research Council of Norway including computing time through the Programme for Supercomputing (Notur). R. E. acknowledges M. Keray for encouragement and is also grateful to the NSF, Hungary. R. E. and V. F. also acknowledge the support received from the Science and Technology Facilities, UK. The Swedish 1-m Solar Telescope is operated on the island of La Palma by the Institute for Solar Physics of the Royal Swedish Academy of Sciences in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias. We thank the Computational Information Systems Laboratory at the National Center for Atmospheric Research for providing the VAPOR analysis tool.	Attie R, 2009, ASTRON ASTROPHYS, V493, pL13, DOI 10.1051/0004-6361:200811258; Balmaceda L, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/200913584; Bohling L, 2010, J FLUID MECH, V656, P177, DOI 10.1017/S0022112010001473; Bonet JA, 2010, ASTROPHYS J LETT, V723, pL139, DOI 10.1088/2041-8205/723/2/L139; Bonet JA, 2008, ASTROPHYS J LETT, V687, pL131, DOI 10.1086/593329; BRANDT PN, 1988, NATURE, V335, P238, DOI 10.1038/335238a0; Cirtain JW, 2007, SCIENCE, V318, P1580, DOI 10.1126/science.1147050; Clyne J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/301; Cranmer SR, 2007, ASTROPHYS J SUPPL S, V171, P520, DOI 10.1086/518001; De Pontieu B, 2007, SCIENCE, V318, P1574, DOI 10.1126/science.1151747; Fedun V, 2011, ANN GEOPHYS-GERMANY, V29, P1029, DOI 10.5194/angeo-29-1029-2011; Freytag B, 2012, J COMPUT PHYS, V231, P919, DOI 10.1016/j.jcp.2011.09.026; Gudiksen BV, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201116520; Jess DB, 2009, SCIENCE, V323, P1582, DOI 10.1126/science.1168680; Kitiashvili IN, 2011, ASTROPHYS J LETT, V727, DOI 10.1088/2041-8205/727/2/L50; Lemen JR, 2012, SOL PHYS, V275, P17, DOI 10.1007/s11207-011-9776-8; McIntosh SW, 2011, NATURE, V475, P477, DOI 10.1038/nature10235; Moll R, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117441; NORDLUND A, 1985, SOL PHYS, V100, P209, DOI 10.1007/BF00158429; PARKER EN, 1965, SPACE SCI REV, V4, P666; PARKER EN, 1988, ASTROPHYS J, V330, P474, DOI 10.1086/166485; Priest ER, 1998, NATURE, V393, P545, DOI 10.1038/31166; Schrijver CJ, 1998, NATURE, V394, P152, DOI 10.1038/28108; Shelyag S, 2011, ASTRON ASTROPHYS, V526, DOI 10.1051/0004-6361/201015645; Steiner O, 2010, ASTROPHYS J LETT, V723, pL180, DOI 10.1088/2041-8205/723/2/L180; Tu CY, 2005, SCIENCE, V308, P519, DOI 10.1126/science.1109447; van Ballegooijen AA, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/3; Wedemeyer-Bohm S, 2009, ASTRON ASTROPHYS, V507, pL9, DOI 10.1051/0004-6361/200913380; Zhang J, 2011, ASTROPHYS J LETT, V741, DOI 10.1088/2041-8205/741/1/L7	30	232	234	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					505	508		10.1038/nature11202	http://dx.doi.org/10.1038/nature11202			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22739314				2022-12-28	WOS:000305760600037
J	Pilling, S; Baron-Cohen, S; Megnin-Viggars, O; Lee, R; Taylor, C				Pilling, Stephen; Baron-Cohen, Simon; Megnin-Viggars, Odette; Lee, Rachael; Taylor, Clare		Guideline Dev Grp	Recognition, referral, diagnosis, and management of adults with autism: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPECTRUM; PREVALENCE; DISORDERS		[Pilling, Stephen] UCL, Natl Collaborating Ctr Mental Hlth, London WC1E 7HB, England; [Pilling, Stephen] UCL, Ctr Outcomes Res & Effectiveness, London WC1E 7HB, England; [Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge CB2 8AH, England; [Megnin-Viggars, Odette; Lee, Rachael; Taylor, Clare] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England	University of London; University College London; University of London; University College London; University of Cambridge; University of London; University College London	Pilling, S (corresponding author), UCL, Natl Collaborating Ctr Mental Hlth, London WC1E 7HB, England.	s.pilling@ucl.ac.uk	MAVRANEZOULI, IFIGENEIA/C-2430-2008; Howlin, Patricia/A-7622-2011	MAVRANEZOULI, IFIGENEIA/0000-0001-9095-3566; Baron-Cohen, Simon/0000-0001-9217-2544; Megnin-Viggars, Odette/0000-0002-2152-0721	Medical Research Council [G0600977] Funding Source: Medline; MRC [G0600977] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allison C, 2012, J AM ACAD CHILD PSY, V51, P202, DOI 10.1016/j.jaac.2011.11.003; ATTWOOD T, 1997, ASPERGERS SYNDROME; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Barnard J, 2001, IGNORED INELIGIBLE R; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Brugha T., 2012, ESTIMATING PREVALENC; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Esbensen AJ, 2009, J AUTISM DEV DISORD, V39, P1339, DOI 10.1007/s10803-009-0750-3; National Institute for Health and Care Excellence (NICE), 2011, SERV US EXP AD MENT; National Institute for Health and Clinical Excellence,, 2011, AUT REC REF DIAGN CH; National Institute for Health and Clinical Excellence, 2012, AUT REC REF DIAGN MA; Nylander L, 2001, ACTA PSYCHIAT SCAND, V103, P428, DOI 10.1034/j.1600-0447.2001.00175.x; Punshon C, 2009, AUTISM, V13, P265, DOI 10.1177/1362361309103795; Taylor I., 2011, ACCESS SOCIAL CARE A	14	30	30	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2012	344								e4082	10.1136/bmj.e4082	http://dx.doi.org/10.1136/bmj.e4082			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	968MX	22740567				2022-12-28	WOS:000305987100011
J	Spence, D				Spence, Des			What happened to the doctor-patient relationship?	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	3	3	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 25	2012	344								e4349	10.1136/bmj.e4349	http://dx.doi.org/10.1136/bmj.e4349			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	968MS	22734078				2022-12-28	WOS:000305986500002
J	Zarnetske, PL; Skelly, DK; Urban, MC				Zarnetske, Phoebe L.; Skelly, David K.; Urban, Mark C.			Biotic Multipliers of Climate Change	SCIENCE			English	Editorial Material							COMMUNITIES		[Zarnetske, Phoebe L.; Skelly, David K.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Urban, Mark C.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Unit 3043, Storrs, CT 06269 USA	Yale University; University of Connecticut	Zarnetske, PL (corresponding author), Yale Univ, Sch Forestry & Environm Studies, 195 Prospect St, New Haven, CT 06511 USA.	phoebe.zarnetske@yale.edu	Skelly, David/D-3878-2013; Urban, Mark Christopher/Y-2430-2019; Zarnetske, Phoebe/C-5484-2012; Zarnetske, Phoebe/V-3974-2019	Zarnetske, Phoebe/0000-0001-6257-6951; Zarnetske, Phoebe/0000-0001-6257-6951				Araujo MB, 2011, ECOGRAPHY, V34, P897, DOI 10.1111/j.1600-0587.2011.06919.x; Borer ET, 2006, ECOLOGY, V87, P2813, DOI 10.1890/0012-9658(2006)87[2813:AICREO]2.0.CO;2; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Helland IP, 2011, J ANIM ECOL, V80, P539, DOI 10.1111/j.1365-2656.2010.01793.x; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; Kissling W.D., 2012, Journal of Biogeography, V39, P2163; Post E., 2012, ECOLOGY CLIMATE CHAN; Schmitz OJ, 2003, BIOSCIENCE, V53, P1199, DOI 10.1641/0006-3568(2003)053[1199:ERTGCC]2.0.CO;2; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Wilmers CC, 2006, ECOL LETT, V9, P383, DOI 10.1111/j.1461-0248.2006.00890.x	16	186	187	8	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1516	1518		10.1126/science.1222732	http://dx.doi.org/10.1126/science.1222732			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723403				2022-12-28	WOS:000305507500037
J	Allen, NJ; Bennett, ML; Foo, LC; Wang, GX; Chakraborty, C; Smith, SJ; Barres, B				Allen, Nicola J.; Bennett, Mariko L.; Foo, Lynette C.; Wang, Gordon X.; Chakraborty, Chandrani; Smith, Stephen J.; Barres, Ben A.			Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors	NATURE			English	Article							SYNAPTIC PLASTICITY; CNS SYNAPTOGENESIS; SECRETED PROTEINS; NEURONS; BRAIN; STRENGTH; ROLES; LAR	In the developing central nervous system (CNS), the control of synapse number and function is critical to the formation of neural circuits. We previously demonstrated that astrocyte-secreted factors powerfully induce the formation of functional excitatory synapses between CNS neurons(1). Astrocyte-secreted thrombospondins induce the formation of structural synapses, but these synapses are postsynaptically silent(2). Here we use biochemical fractionation of astrocyte-conditioned medium to identify glypican 4 (Gpc4) and glypican 6 (Gpc6) as astrocyte-secreted signals sufficient to induce functional synapses between purified retinal ganglion cell neurons, and show that depletion of these molecules from astrocyte-conditioned medium significantly reduces its ability to induce postsynaptic activity. Application of Gpc4 to purified neurons is sufficient to increase the frequency and amplitude of glutamatergic synaptic events. This is achieved by increasing the surface level and clustering, but not overall cellular protein level, of the GluA1 subunit of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) glutamate receptor (AMPAR). Gpc4 and Gpc6 are expressed by astrocytes in vivo in the developing CNS, with Gpc4 expression enriched in the hippocampus and Gpc6 enriched in the cerebellum. Finally, we demonstrate that Gpc4-deficient mice have defective synapse formation, with decreased amplitude of excitatory synaptic currents in the developing hippocampus and reduced recruitment of AMPARs to synapses. These data identify glypicans as a family of novel astrocyte-derived molecules that are necessary and sufficient to promote glutamate receptor clustering and receptivity and to induce the formation of postsynaptically functioning CNS synapses.	[Allen, Nicola J.; Bennett, Mariko L.; Foo, Lynette C.; Chakraborty, Chandrani; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Wang, Gordon X.; Smith, Stephen J.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Allen, NJ (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	nallen@salk.edu	Ritter, Stefanie L/D-9312-2012	Smith, Stephen/0000-0002-2290-8701; Bennett, Mariko/0000-0002-1642-2887; Wang, Gordon/0000-0002-2707-7118	NIDA [R01DA015043]; Human Frontiers Long Term Fellowship; NIH/NINDS [R01NS0725252, R01NS077601]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077601, R01NS075252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015043] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Human Frontiers Long Term Fellowship; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Winant for mass spectrometry analysis, A. Olson for array tomography assistance, S. Pasca for assistance with quantitative real-time PCR and M. Fabian for technical assistance with cell cultures. This project was funded by a NIDA grant to B. A. B. (R01DA015043). N.J.A. was supported by a Human Frontiers Long Term Fellowship. S.J.S. is supported by grants R01NS0725252 and R01NS077601 from the NIH/NINDS.	Andrasfalvy BK, 2003, J PHYSIOL-LONDON, V552, P35, DOI 10.1113/jphysiol.2003.045575; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Calboli FCF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011504; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; De Cat B, 2001, SEMIN CELL DEV BIOL, V12, P117, DOI 10.1006/scdb.2000.0240; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Song HH, 2002, BBA-GEN SUBJECTS, V1573, P241, DOI 10.1016/S0304-4165(02)00390-2; Steinmetz CC, 2006, J PHYSIOL-LONDON, V577, P249, DOI 10.1113/jphysiol.2006.117358; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; WATANABE K, 1995, J CELL BIOL, V130, P1207, DOI 10.1083/jcb.130.5.1207; Williams EH, 2010, P NATL ACAD SCI USA, V107, P5869, DOI 10.1073/pnas.1001777107; Ybot-Gonzalez P, 2005, DEV DYNAM, V233, P1013, DOI 10.1002/dvdy.20383	32	417	427	5	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					410	+		10.1038/nature11059	http://dx.doi.org/10.1038/nature11059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722203	Green Accepted			2022-12-28	WOS:000305466800045
J	Fong, TG; Jones, RN; Marcantonio, ER; Tommet, D; Gross, AL; Habtemariam, D; Schmitt, E; Yap, L; Inouye, SK				Fong, Tamara G.; Jones, Richard N.; Marcantonio, Edward R.; Tommet, Douglas; Gross, Alden L.; Habtemariam, Daniel; Schmitt, Eva; Yap, Liang; Inouye, Sharon K.			Adverse Outcomes After Hospitalization and Delirium in Persons With Alzheimer Disease	ANNALS OF INTERNAL MEDICINE			English	Article							COGNITIVE IMPAIRMENT; ELDERLY-PATIENTS; DEMENTIA; CARE; DECLINE; ASSOCIATION; FREQUENCY; CONFUSION; COSTS; RISK	Background: Hospitalization, frequently complicated by delirium, can be a life-changing event for patients with Alzheimer disease (AD). Objective: To determine risks for institutionalization, cognitive decline, or death associated with hospitalization and delirium in patients with AD. Design: Prospective cohort enrolled between 1991 and 2006 into the Massachusetts Alzheimer's Disease Research Center (MADRC) patient registry. Setting: Community-based. Participants: 771 persons aged 65 years or older with a clinical diagnosis of AD. Measurements: Hospitalization, delirium, death, and institutionalization were identified through administrative databases. Cognitive decline was defined as a decrease of 4 or more points on the Blessed Information-Memory-Concentration test score. Multivariate analysis was used to calculate adjusted relative risks (RRs). Results: Of 771 participants with AD, 367 (48%) were hospitalized and 194 (25%) developed delirium. Hospitalized patients who did not have delirium had an increased risk for death (adjusted RR, 4.7 95% CI, 1.9 to 11.6]) and institutionalization (adjusted RR, 6.9 [ CI, 4.0 to 11.7]). With delirium, risk for death (adjusted RR, 5.4 [CI, 2.3 to 12.5]) and institutionalization (adjusted RR, 9.3 [CI, 5.5 to 15.7]) increased further. With hospitalization and delirium, the adjusted RR for cognitive decline for patients with AD was 1.6 (CI, 1.2 to 2.3). Among hospitalized patients with AD, 21% of the incidences of cognitive decline, 15% of institutionalization, and 6% of deaths were associated with delirium. Limitations: Cognitive outcome was missing in 291 patients. Sensitivity analysis was performed to test the effect of missing data, and a composite outcome was used to decrease the effect of missing data. Conclusion: Approximately 1 in 8 hospitalized patients with AD who develop delirium will have at least 1 adverse outcome, including death, institutionalization, or cognitive decline, associated with delirium. Delirium prevention may represent an important strategy for reducing adverse outcomes in this population.	[Fong, Tamara G.] Hebrew SeniorLife, Aging Brain Ctr, Inst Aging Res, Boston, MA 02131 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA	Harvard University; Hebrew SeniorLife; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Fong, TG (corresponding author), Hebrew SeniorLife, Aging Brain Ctr, Inst Aging Res, 1200 Ctr St, Boston, MA 02131 USA.	tfong@bidmc.harvard.edu	Jones, Richard Norman/J-3488-2013; Inouye, Sharon/R-7216-2019; Marcantonio, Edward R/U-3929-2017	Jones, Richard Norman/0000-0002-1049-218X; Marcantonio, Edward R/0000-0002-2911-4250	National Institute on Aging; MADRC; Alzheimer's Association [IIRG-08-88737]; National Institute on Aging [P50AG005134, P01AG031720, K24AG035075]; Aging Brain Center, Institute for Aging Research, Hebrew SeniorLife; NATIONAL INSTITUTE ON AGING [P50AG005134, P01AG031720, K24AG035075, K24AG000949] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MADRC; Alzheimer's Association(Alzheimer's Association); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Aging Brain Center, Institute for Aging Research, Hebrew SeniorLife; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging and the MADRC.; Funded in part by grant IIRG-08-88737 to Dr. Inouye from the Alzheimer's Association and grants P50AG005134 to Drs. Inouye and Yap, P01AG031720 to Dr. Inouye, and K24AG035075 to Dr. Marcantonio from the National Institute on Aging, as well as the Aging Brain Center, Institute for Aging Research, Hebrew SeniorLife.	Avidan MS, 2009, ANESTHESIOLOGY, V111, P964, DOI 10.1097/ALN.0b013e3181bc9719; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cordoba G, 2010, BMJ-BRIT MED J, V341, pc3920; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Epstein RS, 1996, ANN INTERN MED, V124, P832, DOI 10.7326/0003-4819-124-9-199605010-00008; Fick DM, 2005, J GERONTOL A-BIOL, V60, P748, DOI 10.1093/gerona/60.6.748; Fillenbaum G, 2000, NEUROLOGY, V54, P740, DOI 10.1212/WNL.54.3.740; Folstein M F, 1991, Int Psychogeriatr, V3, P169, DOI 10.1017/S1041610291000637; Fong TG, 2009, NEUROLOGY, V72, P1570, DOI 10.1212/WNL.0b013e3181a4129a; Gill TM, 2010, JAMA-J AM MED ASSOC, V304, P1919, DOI 10.1001/jama.2010.1568; GREENLAND S, 1988, AM J EPIDEMIOL, V128, P1185, DOI 10.1093/oxfordjournals.aje.a115073; Inouye SK, 2005, J AM GERIATR SOC, V53, P312, DOI 10.1111/j.1532-5415.2005.53120.x; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; KATZMAN R, 1988, ANN NEUROL, V24, P384, DOI 10.1002/ana.410240306; LOCASCIO JJ, 1995, ARCH NEUROL-CHICAGO, V52, P1087, DOI 10.1001/archneur.1995.00540350081020; Maslow K, 2006, IMPROVING HOSP CARE, P740; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nguyen LL, 2010, J VASC SURG, V52, P768, DOI 10.1016/j.jvs.2010.03.027; Pedone C, 2005, J GERONTOL A-BIOL, V60, P1576, DOI 10.1093/gerona/60.12.1576; Powell AE, 2003, QUAL SAF HEALTH CARE, V12, P122, DOI 10.1136/qhc.12.2.122; Rahkonen T, 2001, INT PSYCHOGERIATR, V13, P37, DOI 10.1017/S104161020100744X; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Rudolph JL, 2010, J AM GERIATR SOC, V58, P1542, DOI 10.1111/j.1532-5415.2010.02924.x; SALMON DP, 1990, NEUROLOGY, V40, P1225, DOI 10.1212/WNL.40.8.1225; STERN Y, 1987, NEUROLOGY, V37, P1649, DOI 10.1212/WNL.37.10.1649; WEILER PG, 1991, AM J PUBLIC HEALTH, V81, P1153, DOI 10.2105/AJPH.81.9.1153; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Zhu CW, 2006, NEUROLOGY, V67, P998, DOI 10.1212/01.wnl.0000230160.13272.1b	32	142	145	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12					848	U121		10.7326/0003-4819-156-12-201206190-00005	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	992NF	22711077	Green Published, Green Accepted			2022-12-28	WOS:000307783200014
J	Garber, AJ				Garber, Alan J.			Hypoglycaemia: a therapeutic concern in type 2 diabetes	LANCET			English	Editorial Material							EVENTS; MANAGEMENT; IMPACT		[Garber, Alan J.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Garber, Alan J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Garber, Alan J.] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Garber, Alan J.] Baylor Coll Med, Dept Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Garber, AJ (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	agarber@bcm.edu						Bonds Denise E, 2010, BMJ, V340, pb4909, DOI 10.1136/bmj.b4909; Brod Meryl, 2012, J Med Econ, V15, P77, DOI 10.3111/13696998.2011.624144; Brod M, 2011, VALUE HEALTH, V14, P665, DOI 10.1016/j.jval.2011.02.001; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	10	14	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2012	379	9833					2215	2216		10.1016/S0140-6736(12)60947-7	http://dx.doi.org/10.1016/S0140-6736(12)60947-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962AM	22704156				2022-12-28	WOS:000305511400005
J	Lee, E; Iskow, R; Yang, LX; Gokcumen, O; Haseley, P; Luquette, LJ; Lohr, JG; Harris, CC; Ding, L; Wilson, RK; Wheeler, DA; Gibbs, RA; Kucherlapati, R; Lee, C; Kharchenko, PV; Park, PJ				Lee, Eunjung; Iskow, Rebecca; Yang, Lixing; Gokcumen, Omer; Haseley, Psalm; Luquette, Lovelace J., III; Lohr, Jens G.; Harris, Christopher C.; Ding, Li; Wilson, Richard K.; Wheeler, David A.; Gibbs, Richard A.; Kucherlapati, Raju; Lee, Charles; Kharchenko, Peter V.; Park, Peter J.		Canc Genome Atlas Res Network	Landscape of Somatic Retrotransposition in Human Cancers	SCIENCE			English	Article							HUMAN GENOMES; ELEMENTS; CELLS; DISRUPTION; MECHANISMS; GENE	Transposable elements (TEs) are abundant in the human genome, and some are capable of generating new insertions through RNA intermediates. In cancer, the disruption of cellular mechanisms that normally suppress TE activity may facilitate mutagenic retrotranspositions. We performed single-nucleotide resolution analysis of TE insertions in 43 high-coverage whole-genome sequencing data sets from five cancer types. We identified 194 high-confidence somatic TE insertions, as well as thousands of polymorphic TE insertions in matched normal genomes. Somatic insertions were present in epithelial tumors but not in blood or brain cancers. Somatic L1 insertions tend to occur in genes that are commonly mutated in cancer, disrupt the expression of the target genes, and are biased toward regions of cancer-specific DNA hypomethylation, highlighting their potential impact in tumorigenesis.	[Lee, Eunjung; Yang, Lixing; Haseley, Psalm; Luquette, Lovelace J., III; Kharchenko, Peter V.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Lee, Eunjung; Haseley, Psalm; Kucherlapati, Raju; Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Iskow, Rebecca; Gokcumen, Omer; Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lohr, Jens G.] Eli & Edythe Broad Inst, Cambridge, MA 02412 USA; [Lohr, Jens G.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Harris, Christopher C.; Ding, Li; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Wheeler, David A.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Kharchenko, Peter V.; Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Washington University (WUSTL); Baylor College of Medicine; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Kharchenko, PV (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA.	peter.kharchenko@post.harvard.edu; peter_park@harvard.edu	Wilson, Richard K./AAF-4139-2019; Kucherlapati, Raju/ABC-8807-2021; Yang, Lixing/A-7073-2013; Wheeler, David A/M-9740-2018; Gokcumen, Omer/J-6984-2013	Wilson, Richard K./0000-0002-1992-1358; Wheeler, David A/0000-0002-9056-6299; Gokcumen, Omer/0000-0003-4371-679X; Park, Peter/0000-0001-9378-960X	NIH [R01GM082798, RC1HG005482, K25AG037596, U01HG005209, U01HG005725, F32AG039979, U24CA144025]; NATIONAL CANCER INSTITUTE [T32CA009172, U24CA144025] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005209, U01HG005725, RC1HG005482, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG037596, F32AG039979] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Langdon and U. Samarakoon for technical assistance and T. Golub and the Broad Institute for a myeloma sample obtained under a materials transfer agreement (MTA) from the Multiple Myeloma Research Consortium. This work was supported by NIH grants R01GM082798 and RC1HG005482 (P.J.P.), K25AG037596 (P. V. K.), U01HG005209 and U01HG005725 (C. L.), F32AG039979 (R. I.), and U24CA144025 (R. K.). P.J.P. is a Sloan Research Fellow. R. K. is on the board of directors of AVEO, Metamark, Enlight, and KEW Group. The sequencing data are available at dbGaP (www.ncbi.nlm.nih.gov/gap) with the following accessions: TCGA ovarian cancer, glioblastoma multiforme, and colorectal cancer (phs000178.v5.p5); multiple myeloma (phs000348.v1.p1); and prostate cancer (phs000330.v1.p1). The Tea software is available at http://compbio.med.harvard.edu/Tea.	Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Dickinson RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027792; Ewing AD, 2011, GENOME RES, V21, P985, DOI 10.1101/gr.114777.110; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Izumi H, 2005, HUM MOL GENET, V14, P997, DOI 10.1093/hmg/ddi092; Jin Z, 2007, ONCOGENE, V26, P6332, DOI 10.1038/sj.onc.1210461; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; MIKI Y, 1992, CANCER RES, V52, P643; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Prak ETL, 2000, NAT REV GENET, V1, P134; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Slovak ML, 2011, CLIN CANCER RES, V17, P3443, DOI 10.1158/1078-0432.CCR-10-1071; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Zheng HW, 2010, CANCER CELL, V17, P497, DOI 10.1016/j.ccr.2010.03.020	23	475	489	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2012	337	6097					967	971		10.1126/science.1222077	http://dx.doi.org/10.1126/science.1222077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	992VI	22745252	Green Accepted			2022-12-28	WOS:000307807600046
J	Kono, K; Saeki, Y; Yoshida, S; Tanaka, K; Pellman, D				Kono, Keiko; Saeki, Yasushi; Yoshida, Satoshi; Tanaka, Keiji; Pellman, David			Proteasomal Degradation Resolves Competition between Cell Polarization and Cellular Wound Healing	CELL			English	Article							RSP5 UBIQUITIN LIGASE; PROTEIN-KINASE-C; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; ACTIN CABLES; SECRETORY VESICLES; SINGLE-CELL; YEAST; POLARITY	Cellular wound healing, enabling the repair of membrane damage, is ubiquitous in eukaryotes. One aspect of the wound healing response is the redirection of a polarized cytoskeleton and the secretory machinery to the damage site. Although there has been recent progress in identifying conserved proteins involved in wound healing, the mechanisms linking these components into a coherent response are not defined. Using laser damage in budding yeast, we demonstrate that local cell wall/membrane damage triggers the dispersal of proteins from the site of polarized growth, enabling their accumulation at the wound. We define a protein-kinase-C-dependent mechanism that mediates the destruction of the formin Bni1 and the exocyst component Sec3. This degradation is essential to prevent competition between the site of polarized growth and the wound. Mechanisms to overcome competition from a preexisting polarized cytoskeleton may be a general feature of effective wound healing in polarized cells.	[Kono, Keiko; Yoshida, Satoshi; Pellman, David] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kono, Keiko; Pellman, David] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Yoshida, Satoshi] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Yoshida, Satoshi] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA; [Pellman, David] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Tokyo Metropolitan Institute of Medical Science; Brandeis University; Brandeis University; Howard Hughes Medical Institute	Pellman, D (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 450 Brookline Ave, Boston, MA 02115 USA.	david_pellman@dfci.harvard.edu	Saeki, Yasushi/AAR-8198-2021	Saeki, Yasushi/0000-0002-9202-5453; Kono, Keiko/0000-0003-4057-8790	NIH [RO1 GM061345]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Finley and M. Springer for critical reading of the manuscript; C. Mann, W. Guo, M. Cyert, L. Hicke, and D. Lew for reagents; Z. Shi for pilot experiments; S. Gygi and R. Tomaino for mass spectrometry analysis; L. Cameron for advice on microscopy; members of the Pellman lab, especially S. Buttery and B. Atkins, for helpful discussions; and C. Kuroda for strain construction. This work was supported by NIH grant RO1 GM061345.	Abe M, 2003, J CELL BIOL, V162, P85, DOI 10.1083/jcb.200301022; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Bement WM, 1999, CURR BIOL, V9, P579, DOI 10.1016/S0960-9822(99)80261-9; BEMENT WM, 1990, CELL REGUL, V1, P315, DOI 10.1091/mbc.1.3.315; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Caviston JP, 2002, P NATL ACAD SCI USA, V99, P12185, DOI 10.1073/pnas.182370299; Chan DC, 1996, EMBO J, V15, P1045, DOI 10.1002/j.1460-2075.1996.tb00442.x; de la Fuente N, 2000, BBA-BIOMEMBRANES, V1509, P189, DOI 10.1016/S0005-2736(00)00293-5; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Denis V, 2005, EUKARYOT CELL, V4, P36, DOI 10.1128/EC.4.1.36-45.2005; Djiane A, 2011, J CELL BIOL, V192, P189, DOI 10.1083/jcb.201007023; Edwin F, 2010, J BIOL CHEM, V285, P255, DOI 10.1074/jbc.M109.030882; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Evangelista Marie, 2002, Nature Cell Biology, V4, P260; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gorelik R, 2011, MOL BIOL CELL, V22, P189, DOI 10.1091/mbc.E10-03-0256; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; Gwizdek C, 2005, J BIOL CHEM, V280, P13401, DOI 10.1074/jbc.C500040200; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoshikawa C, 2003, P NATL ACAD SCI USA, V100, P11505, DOI 10.1073/pnas.1933153100; Howell AS, 2009, CELL, V139, P731, DOI 10.1016/j.cell.2009.10.024; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Kaminska J, 2011, EUR J CELL BIOL, V90, P1016, DOI 10.1016/j.ejcb.2011.08.002; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Ory S, 2011, SEMIN CELL DEV BIOL, V22, P27, DOI 10.1016/j.semcdb.2010.12.002; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Schmitz HP, 2002, MOL MICROBIOL, V44, P829, DOI 10.1046/j.1365-2958.2002.02925.x; Shcherbik N, 2004, J BIOL CHEM, V279, P53892, DOI 10.1074/jbc.M410325200; Shcherbik N, 2003, CURR BIOL, V13, P1227, DOI 10.1016/S0960-9822(03)00457-3; Slaughter BD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003384; Sonnemann KJ, 2011, ANNU REV CELL DEV BI, V27, P237, DOI 10.1146/annurev-cellbio-092910-154251; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Yoshida S, 2009, GENE DEV, V23, P810, DOI 10.1101/gad.1785209; Yoshiuchi S, 2006, GENETICS, V173, P527, DOI 10.1534/genetics.105.055210; Zhang XY, 2008, J CELL BIOL, V180, P145, DOI 10.1083/jcb.200704128	52	68	67	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 6	2012	150	1					151	164		10.1016/j.cell.2012.05.030	http://dx.doi.org/10.1016/j.cell.2012.05.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22727045	Bronze			2022-12-28	WOS:000306115000014
J	Pierce, SE; Clack, JA; Hutchinson, JR				Pierce, Stephanie E.; Clack, Jennifer A.; Hutchinson, John R.			Three-dimensional limb joint mobility in the early tetrapod Ichthyostega	NATURE			English	Article							DEVONIAN TETRAPOD; PECTORAL FIN; HINDLIMB KINEMATICS; TERRESTRIAL; LOCOMOTION; EVOLUTION; WALKING; TRACKWAYS; ANATOMY; ORIGIN	The origin of tetrapods and the transition from swimming to walking was a pivotal step in the evolution and diversification of terrestrial vertebrates. During this time, modifications of the limbs-particularly the specialization of joints and the structures that guide their motions-fundamentally changed the ways in which early tetrapods could move(1-4). Nonetheless, little is known about the functional consequences of limb anatomy in early tetrapods and how that anatomy influenced locomotion capabilities at this very critical stage in vertebrate evolution. Here we present a three-dimensional reconstruction of the iconic Devonian tetrapod Ichthyostega and a quantitative and comparative analysis of limb mobility in this early tetrapod. We show that Ichthyostega could not have employed typical tetrapod locomotory behaviours, such as lateral sequence walking. In particular, it lacked the necessary rotary motions in its limbs to push the body off the ground and move the limbs in an alternating sequence. Given that long-axis rotation was present in the fins of tetrapodomorph fishes(5-7), it seems that either early tetrapods evolved through an initial stage of restricted shoulder(8,9) and hip joint mobility or that Ichthyostega was unique in this respect. We conclude that early tetrapods with the skeletal morphology and limb mobility of Ichthyostega were unlikely to have made some of the recently described Middle Devonian trackways(10).	[Pierce, Stephanie E.; Hutchinson, John R.] Royal Vet Coll, Dept Vet Basic Sci & Struct & Motion Lab, Hatfield AL9 7TA, Herts, England; [Pierce, Stephanie E.; Clack, Jennifer A.] Univ Cambridge, Dept Zool, Univ Museum Zool, Cambridge CB2 3EJ, England	University of London; University of London Royal Veterinary College; University of Cambridge	Pierce, SE (corresponding author), Royal Vet Coll, Dept Vet Basic Sci & Struct & Motion Lab, Hawkshead Lane, Hatfield AL9 7TA, Herts, England.	spierce@rvc.ac.uk	Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038	National Science Foundation [IIS-9874781, IIS-0208675]; Natural Environment Research Council [NE/G005877/1, NE/G00711X/1]; NERC [NE/G005877/1, NE/G00711X/1] Funding Source: UKRI	National Science Foundation(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. Molnar for assistance with segmentation, model construction, and movie generation; L. Witmer for access to platypus scan data; Digimorph for access to salamander scan data (National Science Foundation grant IIS-9874781 and IIS-0208675 to T. Rowe); M. Lowe for collections support at the University Museum of Zoology, Cambridge; G. Cuny for access to collections housed in the Geological Museum at the University of Copenhagen; J. Rankin for musculoskeletal modelling support; and P. Ahlberg for commenting on an earlier draft of this manuscript. For access to mu CT scanning equipment in their care, we also acknowledge R. Abel, C. Martin and A. Heaver. This research was supported by Natural Environment Research Council grants NE/G005877/1 and NE/G00711X/1.	Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; Ahlberg PE, 2011, SPEC PAP PALAEONTOL, P17, DOI 10.1111/j.1475-4983.2011.01077.x; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Ashley-Ross MA, 2009, J EXP ZOOL PART A, V311A, P240, DOI 10.1002/jez.522; ASHLEYROSS MA, 1994, J EXP BIOL, V193, P255; Barnett CH, 1961, SYNOVIAL JOINTS THEI; Boisvert CA, 2008, NATURE, V456, P636, DOI 10.1038/nature07339; Clack JA, 1997, PALAEOGEOGR PALAEOCL, V130, P227, DOI 10.1016/S0031-0182(96)00142-3; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; COATES MI, 1990, NATURE, V347, P66, DOI 10.1038/347066a0; Cole NJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001168; DAESCHLER EB, 1994, SCIENCE, V265, P639, DOI 10.1126/science.265.5172.639; DELP SL, 1995, COMPUT BIOL MED, V25, P21, DOI 10.1016/0010-4825(95)98882-E; Eastman C. R., 1905, MAJOR PATTERNS VERTE, V13, P1; GREGORY WILLIAM K., 1941, ANN NEW YORK ACAD SCI, V42, P273, DOI 10.1111/j.1749-6632.1941.tb55396.x; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; Jarvik Erik, 1996, Fossils and Strata, V40, P1; Jayne BC, 1999, J EXP BIOL, V202, P143; JENKINS FA, 1983, J MORPHOL, V175, P195, DOI 10.1002/jmor.1051750207; King HM, 2011, P NATL ACAD SCI USA, V108, P21146, DOI 10.1073/pnas.1118669109; Markey MJ, 2007, P NATL ACAD SCI USA, V104, P7134, DOI 10.1073/pnas.0701706104; Neyt C, 2000, NATURE, V408, P82, DOI 10.1038/35040549; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; O'Gorman F, 1962, P ZOOL SOC LOND, V141, P837; Pace CM, 2009, J EXP BIOL, V212, P2279, DOI 10.1242/jeb.029041; PRIDMORE PA, 1994, ZOOL-ANAL COMPLEX SY, V98, P278; Reilly SM, 1998, J EXP BIOL, V201, P2559; REWCASTLE SC, 1981, S ZOOL SOC LONDON, V48, P239; Shubin NH, 2004, SCIENCE, V304, P90, DOI 10.1126/science.1094295; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637	30	146	147	3	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					523	U123		10.1038/nature11124	http://dx.doi.org/10.1038/nature11124			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722854				2022-12-28	WOS:000305760600041
J	Cassel, CK; Jain, SH				Cassel, Christine K.; Jain, Sachin H.			Assessing Individual Physician Performance Does Measurement Suppress Motivation?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRIMARY-CARE		[Cassel, Christine K.] Amer Board Internal Med, Philadelphia, PA 19106 USA; [Jain, Sachin H.] Harvard Univ, Sch Business, Brigham & Womens Hosp, Harvard Med Sch,Inst Strategy & Competitiveness, Boston, MA 02163 USA	American Board of Internal Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cassel, CK (corresponding author), Amer Board Internal Med, 510 Walnut St,Ste 1700, Philadelphia, PA 19106 USA.	ccassel@abim.org						Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Doran T, 2010, HEALTH AFFAIR, V29, P1023, DOI 10.1377/hlthaff.2010.0069; Jain SH, 2010, JAMA-J AM MED ASSOC, V304, P1009, DOI 10.1001/jama.2010.1250; Perednia D, MOTIVATION HEALTHC 2; Pink DH, 2011, DRIVE SURPRISING TRU; Sandel M.J, 2012, WHAT MONEY CANT BUY; Trisolini M, 2011, PAY PERFORMANCE HLTH, P85; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694	8	39	40	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2012	307	24					2595	2596		10.1001/jama.2012.6382	http://dx.doi.org/10.1001/jama.2012.6382			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	964KF	22735427				2022-12-28	WOS:000305692600026
J	Lorenz, A; Osman, F; Sun, WL; Nandi, S; Steinacher, R; Whitby, MC				Lorenz, Alexander; Osman, Fekret; Sun, Weili; Nandi, Saikat; Steinacher, Roland; Whitby, Matthew C.			The Fission Yeast FANCM Ortholog Directs Non-Crossover Recombination During Meiosis	SCIENCE			English	Article							HOLLIDAY JUNCTION RESOLVASE; MEIOTIC RECOMBINATION; SCHIZOSACCHAROMYCES-POMBE; CROSSING-OVER; D-LOOPS; COMPLEX; MUS81-EME1; MUTANT	The formation of healthy gametes depends on programmed DNA double-strand breaks (DSBs), which are each repaired as a crossover (CO) or non-crossover (NCO) from a homologous template. Although most of these DSBs are repaired without giving COs, little is known about the genetic requirements of NCO-specific recombination. We show that Fml1, the Fanconi anemia complementation group M (FANCM)-ortholog of Schizosaccharomyces pombe, directs the formation of NCOs during meiosis in competition with the Mus81-dependent pro-CO pathway. We also define the Rad51/Dmc1-mediator Swi5-Sfr1 as a major determinant in biasing the recombination process in favor of Mus81, to ensure the appropriate amount of COs to guide meiotic chromosome segregation. The conservation of these proteins from yeast to humans suggests that this interplay may be a general feature of meiotic recombination.	[Lorenz, Alexander; Osman, Fekret; Sun, Weili; Nandi, Saikat; Steinacher, Roland; Whitby, Matthew C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Whitby, MC (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	matthew.whitby@bioch.ox.ac.uk	Nandi, Saikat/AAS-2466-2020; Lorenz, Alexander/B-4735-2008	Nandi, Saikat/0000-0002-5693-6129; Lorenz, Alexander/0000-0003-1925-3713; Whitby, Matthew/0000-0003-0951-3374	Wellcome Trust [090767/Z/09/Z]; Austrian Science Fund (FWF) [J 2489-B03]	Wellcome Trust(Wellcome TrustEuropean Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank R. Mercier for discussions and sharing data before publication. We are grateful to A. Decottignies, J. Kohli, R. J. McFarlane, P. Russell, G. R. Smith, and W. W. Steiner for providing strains/reagents and to C. Bryer and J. Witzki for technical assistance. This work was supported by Wellcome Trust Programme grant 090767/Z/09/Z. A. L. was funded in part by an Erwin Schrodinger Fellowship (J 2489-B03) from the Austrian Science Fund (FWF).	Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Bugreev DV, 2011, NAT STRUCT MOL BIOL, V18, P56, DOI 10.1038/nsmb.1946; Cromie GA, 2008, GENETICS, V179, P1157, DOI 10.1534/genetics.108.088955; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; Ellermeier C, 2004, GENETICS, V168, P1891, DOI 10.1534/genetics.104.034280; Gaskell LJ, 2007, EMBO J, V26, P1891, DOI 10.1038/sj.emboj.7601645; Haruta N, 2006, NAT STRUCT MOL BIOL, V13, P823, DOI 10.1038/nsmb1136; Lorenz A, 2010, NUCLEIC ACIDS RES, V38, P1866, DOI 10.1093/nar/gkp1179; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; McMahill MS, 2007, PLOS BIOL, V5, P2589, DOI 10.1371/journal.pbio.0050299; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Rosu S, 2011, SCIENCE, V334, P1286, DOI 10.1126/science.1212424; SCHUCHERT P, 1988, GENETICS, V119, P507; Singh TR, 2010, MOL CELL, V37, P879, DOI 10.1016/j.molcel.2010.01.036; Steiner WW, 2005, GENETICS, V169, P1973, DOI 10.1534/genetics.104.039230; Sun W, 2008, MOL CELL, V32, P118, DOI 10.1016/j.molcel.2008.08.024; Sun W, 2011, NUCLEIC ACIDS RES, V39, P1718, DOI 10.1093/nar/gkq977; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112	20	81	85	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1585	1588		10.1126/science.1220111	http://dx.doi.org/10.1126/science.1220111			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723423	Green Accepted, Green Submitted			2022-12-28	WOS:000305507500059
J	Zarin, DJ				Zarin, Daniel J.			Carbon from Tropical Deforestation	SCIENCE			English	Editorial Material							EMISSIONS; STOCKS; MAP		Climate & Land Use Alliance, San Francisco, CA 94104 USA		Zarin, DJ (corresponding author), Climate & Land Use Alliance, 235 Montgomery St,13th Floor, San Francisco, CA 94104 USA.	daniel.zarin@climateandlandusealliance.org						[Anonymous], 2010, GLOBAL FOREST RESOUR; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; FAO, 2011, GLOB FOR LAND US CHA; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Indonesia National Development Planning Agency, 2009, RED CARB EM IND PEAT; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; United Nations Environment Programme, 2011, BRIDG EM GAP; United Nations Framework Convention on Climate Change, 2011, 17 C PART DEC 12	13	28	30	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1518	1519		10.1126/science.1223251	http://dx.doi.org/10.1126/science.1223251			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723404				2022-12-28	WOS:000305507500038
J	Smith, B				Smith, Barry			Complexities of flavour	NATURE			English	Editorial Material									Univ London, Sch Adv Study, Inst Philosophy, London WC1E 7HU, England	University of London; University of London School of Advanced Study	Smith, B (corresponding author), Univ London, Sch Adv Study, Inst Philosophy, London WC1E 7HU, England.	barry.smith@sas.ac.uk			AHRC [AH/K503393/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/K503393/1] Funding Source: researchfish	AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))			0	25	26	3	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					S6	S6		10.1038/486S6a	http://dx.doi.org/10.1038/486S6a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	046RB	22717402	Bronze			2022-12-28	WOS:000311781000004
J	Taguchi, T; Terada, Y				Taguchi, Takafumi; Terada, Yoshio			Pencil-Core Granuloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Taguchi, Takafumi; Terada, Yoshio] Kochi Med Sch, Kochi, Japan	Kochi University	Taguchi, T (corresponding author), Kochi Med Sch, Kochi, Japan.								0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					2408	2408		10.1056/NEJMicm1101530	http://dx.doi.org/10.1056/NEJMicm1101530			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961GH	22716979				2022-12-28	WOS:000305451700011
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS DNA; RANDOMIZED CONTROLLED-TRIAL; LIQUID-BASED CYTOLOGY; INTRAEPITHELIAL NEOPLASIA; ARTISTIC TRIAL; CONVENTIONAL CYTOLOGY; HPV INFECTION; WOMEN; RISK; OUTCOMES	Methods: The USPSTF reviewed new evidence on the comparative test performance of liquid-based cytology and the benefits and harms of human papillomavirus (HPV) testing as a stand-alone test or in combination with cytology. In addition to the systematic evidence review, the USPSTF commissioned a decision analysis to help clarify the age at which to begin and end screening, the optimal interval for screening, and the relative benefits and harms of different strategies for screening (such as cytology and co-testing). Recommendations: This recommendation statement applies to women who have a cervix, regardless of sexual history. This recommendation statement does not apply to women who have received a diagnosis of a high-grade precancerous cervical lesion or cervical cancer, women with in utero exposure to diethylstilbestrol, or women who are immunocompromised (such as those who are HIV positive). The USPSTF recommends screening for cervical cancer in women aged 21 to 65 years with cytology (Papanicolaou smear) every 3 years or, for women aged 30 to 65 years who want to lengthen the screening interval, screening with a combination of cytology and HPV testing every 5 years. See the Clinical Considerations for discussion of cytology method, HPV testing, and screening interval (A recommendation). The USPSTF recommends against screening for cervical cancer in women younger than age 21 years (D recommendation). The USPSTF recommends against screening for cervical cancer in women older than age 65 years who have had adequate prior screening and are not otherwise at high risk for cervical cancer. See the Clinical Considerations for discussion of adequacy of prior screening and risk factors (D recommendation). The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and who do not have a history of a high-grade precancerous lesion (cervical intraepithelial neoplasia grade 2 or 3) or cervical cancer (D recommendation). The USPSTF recommends against screening for cervical cancer with HPV testing, alone or in combination with cytology, in women younger than age 30 years (D recommendation).	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.				Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.	American Academy of Family Physicians, 2003, CLIN PREV SERV CERV; [Anonymous], 1986, BMJ-BRIT MED J, V293, P659; [Anonymous], 2009, Obstet Gynecol, V114, P1409, DOI 10.1097/AOG.0b013e3181c6f8a4; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Bigras G, 2005, BRIT J CANCER, V93, P575, DOI 10.1038/sj.bjc.6602728; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Cardenas-Turanzas M, 2008, CANCER EPIDEM BIOMAR, V17, P2865, DOI 10.1158/1055-9965.EPI-08-0137; Castle PE, 2009, OBSTET GYNECOL, V113, P595, DOI 10.1097/AOG.0b013e3181996ffa; Centers for Disease Control and Prevention National Breast and Cervical Cancer Early Detection Program, 2011, SCREEN PROGR SUMM NA; Coste J, 2003, BMJ-BRIT MED J, V326, P733, DOI 10.1136/bmj.326.7392.733; Datta SD, 2008, ANN INTERN MED, V148, P493, DOI 10.7326/0003-4819-148-7-200804010-00004; Elfgren K, 2005, AM J OBSTET GYNECOL, V193, P650, DOI 10.1016/j.ajog.2005.01.056; FAHS MC, 1992, ANN INTERN MED, V117, P520, DOI 10.7326/0003-4819-117-6-520; Fox J, 1999, AM J OBSTET GYNECOL, V180, P1104, DOI 10.1016/S0002-9378(99)70601-0; Howlader N, 2011, SEER CANC STAT REV 1; Insinga RP, 2004, AM J OBSTET GYNECOL, V191, P105, DOI 10.1016/j.ajog.2004.01.043; JANERICH DT, 1995, AM J PUBLIC HEALTH, V85, P791, DOI 10.2105/AJPH.85.6.791; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Kitchener HC, 2008, INT J GYNECOL CANCER, V18, P743, DOI 10.1111/j.1525-1438.2007.01113.x; Kitchener HC, 2006, BRIT J CANCER, V95, P56, DOI 10.1038/sj.bjc.6603210; Kitchener HC, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13510; KITCHENER HC, 2009, HEALTH TECHNOL ASSES, V13, pR3; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Kulasingam SL, 2011, AHRQ PUBLICATION; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Naucler P, 2009, JNCI-J NATL CANCER I, V101, P88, DOI 10.1093/jnci/djn444; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Pearce KF, 1996, NEW ENGL J MED, V335, P1559, DOI 10.1056/NEJM199611213352103; Peto J, 2004, BRIT J CANCER, V91, P942, DOI 10.1038/sj.bjc.6602049; Petry KU, 2003, BRIT J CANCER, V88, P1570, DOI 10.1038/sj.bjc.6600918; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2007, BRIT MED J, V335, P28, DOI 10.1136/bmj.39196.740995.BE; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Sargent A, 2008, BRIT J CANCER, V98, P1704, DOI 10.1038/sj.bjc.6604324; Sargent A, 2010, J CLIN MICROBIOL, V48, P554, DOI 10.1128/JCM.00896-09; Sasieni P., 2006, CURR DIAGN PATHOL, V12, P114, DOI [10.1016/j.cdip.2005.12.006, DOI 10.1016/J.CDIP.2005.12.006]; Saslow D, 2012, CA CANC J CLIN; Sharp L, 2009, BJOG-INT J OBSTET GY, V116, P1506, DOI 10.1111/j.1471-0528.2009.02263.x; Siebers AG, 2009, JAMA-J AM MED ASSOC, V302, P1757, DOI 10.1001/jama.2009.1569; US Preventive Services Task Force. Screening for Cervical Cancer: Recommendations and Rationale. Agency for Healthcare Research and Quality, 2003, SCREEN CERV CANC REC; Vesco KK, 2011, ANN INTERN MED, V155, P698, DOI 10.7326/0003-4819-155-10-201111150-00377; Whitlock EP, 2012, ANN INTERN MED; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376	46	694	709	4	48	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12					880	U91		10.7326/0003-4819-156-12-201206190-00424	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-00424			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711081				2022-12-28	WOS:000307783200017
J	Van Dyck, D; Chen, FR				Van Dyck, Dirk; Chen, Fu-Rong			'Big Bang' tomography as a new route to atomic-resolution electron tomography	NATURE			English	Article							RECONSTRUCTION; HOLOGRAPHY; NEBULAE	Until now it has not been possible to image at atomic resolution using classical electron tomographic methods(1), except when the target is a perfectly crystalline nano-object imaged along a few zone axes(2). The main reasons are that mechanical tilting in an electron microscope with sub-angstrom precision over a very large angular range is difficult, that many real-life objects such as dielectric layers in microelectronic devices impose geometrical constraints and that many radiation-sensitive objects such as proteins limit the total electron dose. Hence, there is a need for a new tomographic scheme that is able to deduce three-dimensional information from only one or a few projections. Here we present an electron tomographic method that can be used to determine, from only one viewing direction and with sub-angstrom precision, both the position of individual atoms in the plane of observation and their vertical position. The concept is based on the fact that an experimentally reconstructed exit wave(3,4) consists of the superposition of the spherical waves that have been scattered by the individual atoms of the object. Furthermore, the phase of a Fourier component of a spherical wave increases with the distance of propagation at a known 'phase speed'. If we assume that an atom is a point-like object, the relationship between the phase and the phase speed of each Fourier component is linear, and the distance between the atom and the plane of observation can therefore be determined by linear fitting. This picture has similarities with Big Bang cosmology, in which the Universe expands from a point-like origin such that the distance of any galaxy from the origin is linearly proportional to the speed at which it moves away from the origin (Hubble expansion). The proof of concept of the method has been demonstrated experimentally for graphene with a two-layer structure and it will work optimally for similar layered materials, such as boron nitride and molybdenum disulphide.	[Van Dyck, Dirk] Univ Antwerp, B-2020 Antwerp, Belgium; [Chen, Fu-Rong] Natl Tsing Hua Univ, Hsinchu 300, Taiwan	University of Antwerp; National Tsing Hua University	Van Dyck, D (corresponding author), Univ Antwerp, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.	dirk.vandyck@ua.ac.be; frchen@ess.nthu.edu.tw	Jinschek, Joerg/AAS-3344-2020	Jinschek, Joerg/0000-0003-1574-0899; CHEN, Fu-Rong/0000-0003-4707-6590	Research foundation - Flanders (FWO) [G.0220.05, G.0188.08];  [NSC-100-2120-M-007-005];  [NSC-99-2120-M-007-008]	Research foundation - Flanders (FWO)(FWO); ; 	We acknowledge discussions with A. Wang, S. Van Aert and I. Lobato. D. V. D. acknowledges financial support from the "Research foundation - Flanders (FWO)" under project nos G.0220.05 and G.0188.08. F.-R.C. would like to acknowledge the support from NSC-100-2120-M-007-005 and NSC-99-2120-M-007-008	Bals S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.096106; Coene WMJ, 1996, ULTRAMICROSCOPY, V64, P109, DOI 10.1016/0304-3991(96)00010-1; Hsieh WK, 2004, ULTRAMICROSCOPY, V98, P99, DOI 10.1016/j.ultramic.2003.08.004; Hubble E, 1929, P NATL ACAD SCI USA, V15, P168, DOI 10.1073/pnas.15.3.168; Hubble E, 1936, ASTROPHYS J, V84, P517, DOI 10.1086/143782; Jinschek JR, 2011, CARBON, V49, P556, DOI 10.1016/j.carbon.2010.09.058; Lehmann M, 2002, MICROSC MICROANAL, V8, P447, DOI 10.1017/S1431927602020147; Midgley PA, 2009, NAT MATER, V8, P271, DOI 10.1038/nmat2406; Reich S, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.035412; SPENCE JCH, 2003, HIGH RESOLUTION ELEC, P61; Van Aert S, 2011, NATURE, V470, P374, DOI 10.1038/nature09741; Van Dyck D, 2010, ULTRAMICROSCOPY, V110, P571, DOI 10.1016/j.ultramic.2009.12.016	12	86	86	4	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					243	246		10.1038/nature11074	http://dx.doi.org/10.1038/nature11074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699616				2022-12-28	WOS:000305189000032
J	Brunkhorst, FM; Oppert, M; Marx, G; Bloos, F; Ludewig, K; Putensen, C; Nierhaus, A; Jaschinski, U; Meier-Hellmann, A; Weyland, A; Grundling, M; Moerer, O; Riessen, R; Seibel, A; Ragaller, M; Buchler, MW; John, S; Bach, F; Spies, C; Reill, L; Fritz, H; Kiehntopf, M; Kuhnt, E; Bogatsch, H; Engel, C; Loeffler, M; Kollef, MH; Reinhart, K; Welte, T				Brunkhorst, Frank M.; Oppert, Michael; Marx, Gernot; Bloos, Frank; Ludewig, Katrin; Putensen, Christian; Nierhaus, Axel; Jaschinski, Ulrich; Meier-Hellmann, Andreas; Weyland, Andreas; Gruendling, Matthias; Moerer, Onnen; Riessen, Reimer; Seibel, Armin; Ragaller, Maximilian; Buechler, Markus W.; John, Stefan; Bach, Friedhelm; Spies, Claudia; Reill, Lorenz; Fritz, Harald; Kiehntopf, Michael; Kuhnt, Evelyn; Bogatsch, Holger; Engel, Christoph; Loeffler, Markus; Kollef, Marin H.; Reinhart, Konrad; Welte, Tobias		German Study Grp Competence Networ	Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe Sepsis A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMBINATION ANTIBIOTIC-THERAPY; GRAM-NEGATIVE BACTEREMIA; INTENSIVE-CARE; SEPTIC SHOCK; ANTIMICROBIAL THERAPY; MONOTHERAPY; SURVIVAL; GUIDELINES; RESISTANCE; MORTALITY	Context Early appropriate antimicrobial therapy leads to lower mortality rates associated with severe sepsis. The role of empirical combination therapy comprising at least 2 antibiotics of different mechanisms remains controversial. Objective To compare the effect of moxifloxacin and meropenem with the effect of meropenem alone on sepsis-related organ dysfunction. Design, Setting, and Patients A randomized, open-label, parallel-group trial of 600 patients who fulfilled criteria for severe sepsis or septic shock (n=298 for monotherapy and n=302 for combination therapy). The trial was performed at 44 intensive care units in Germany from October 16, 2007, to March 23, 2010. The number of evaluable patients was 273 in the monotherapy group and 278 in the combination therapy group. Interventions Intravenous meropenem (1 g every 8 hours) and moxifloxacin (400 mg every 24 hours) or meropenem alone. The intervention was recommended for 7 days and up to a maximum of 14 days after randomization or until discharge from the intensive care unit or death, whichever occurred first. Main Outcome Measure Degree of organ failure (mean of daily total Sequential Organ Failure Assessment [SOFA] scores over 14 days; score range: 0-24 points with higher scores indicating worse organ failure); secondary outcome: 28-day and 90-day all-cause mortality. Survivors were followed up for 90 days. Results Among 551 evaluable patients, there was no statistically significant difference in mean SOFA score between the meropenem and moxifloxacin group (8.3 points; 95% CI, 7.8-8.8 points) and the meropenem alone group (7.9 points; 95% CI, 7.5-8.4 points) (P=.36). The rates for 28-day and 90-day mortality also were not statistically significantly different. By day 28, there were 66 deaths (23.9%; 95% CI, 19.0%-29.4%) in the combination therapy group compared with 59 deaths (21.9%; 95% CI, 17.1%-27.4%) in the monotherapy group (P=.58). By day 90, there were 96 deaths (35.3%; 95% CI, 29.6%-41.3%) in the combination therapy group compared with 84 deaths (32.1%; 95% CI, 26.5%-38.1%) in the monotherapy group (P=.43). Conclusion Among adult patients with severe sepsis, treatment with combined meropenem and moxifloxacin compared with meropenem alone did not result in less organ failure.	[Welte, Tobias] Hannover Med Sch, Klin Pneumol, Dept Pneumol, D-30625 Hannover, Germany; [Brunkhorst, Frank M.; Bloos, Frank; Ludewig, Katrin; Reinhart, Konrad] Univ Jena, Dept Anesthesiol & Intens Care Med, Jena, Germany; [Kiehntopf, Michael] Univ Jena, Inst Clin Chem & Lab Med, Jena, Germany; [Oppert, Michael] Univ Med Ctr, Campus Virchow Klinikum, Charite, Dept Nephrol & Med Intens Care, Berlin, Germany; [Marx, Gernot] Univ Aachen, Dept Anesthesiol & Intens Care Med, Aachen, Germany; [Putensen, Christian] Univ Bonn, Dept Anesthesiol & Intens Care Med, Bonn, Germany; [Nierhaus, Axel] Univ Med Ctr Hamburg Eppendorf, Dept Crit Care, Hamburg, Germany; [Jaschinski, Ulrich] Klinikum Augsburg, Dept Anesthesiol & Crit Care Med, Augsburg, Germany; [Meier-Hellmann, Andreas] HELIOS Klin, Dept Anesthesiol & Intens Care Med, Erfurt, Germany; [Weyland, Andreas] Klinikum Oldenburg, Dept Anesthesiol & Intens Care Med, Oldenburg, Germany; [Gruendling, Matthias] Ernst Moritz Arndt Univ Greifswald, Dept Anesthesiol & Intens Care Med, Greifswald, Germany; [Moerer, Onnen] Univ Gottingen, Dept Anesthesiol & Intens Care Med, Gottingen, Germany; [Riessen, Reimer] Univ Tubingen, Dept Internal Med, D-7400 Tubingen, Germany; [Seibel, Armin] Jung Stilling Krankenhaus, Dept Anesthesiol & Intens Care Med, Siegen, Germany; [Ragaller, Maximilian] Tech Univ Dresden, Univ Hosp, Dept Anesthesiol & Intens Care Med, D-01062 Dresden, Germany; [Buechler, Markus W.] Heidelberg Univ, Dept Surg, D-6900 Heidelberg, Germany; [John, Stefan] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Erlangen, Germany; [John, Stefan] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Nurnberg, Germany; [Bach, Friedhelm] Evangel Krankenhaus Bielefeld, Dept Anesthesiol & Intens Care Med, Bielefeld, Germany; [Spies, Claudia] Univ Med Ctr, Charite, Dept Anesthesiol & Intens Care Med, Berlin, Germany; Vivantes Klinikum Neukolln, Dept Cardiol & Intens Care Med, Berlin, Germany; [Fritz, Harald] Krankenhaus Martha Maria Halle, Dept Anesthesiol & Intens Care Med, Halle, Germany; [Kuhnt, Evelyn; Bogatsch, Holger] Univ Leipzig, Clin Trial Ctr Leipzig, Leipzig, Germany; [Engel, Christoph; Loeffler, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Kollef, Marin H.] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO USA	Hannover Medical School; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH Aachen University; University of Bonn; University of Hamburg; University Medical Center Hamburg-Eppendorf; Klinikum Augsburg; Helios Kliniken; Klinikum Oldenburg; Ernst Moritz Arndt Universitat Greifswald; University of Gottingen; Eberhard Karls University of Tubingen; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Evangelical Hospital Bethel (EvKB) - House Gilead I; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; VIivantes Klinikum Neukolln; Leipzig University; Leipzig University; Washington University (WUSTL)	Welte, T (corresponding author), Hannover Med Sch, Klin Pneumol, Dept Pneumol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	welte.tobias@mh-hannover.de	Spies, Claudia/AAJ-5412-2020; Bloos, Frank/AAY-8265-2020; Riessen, Reimer/AFR-0686-2022; Seifert, Harald/F-8411-2012; Moerer, Onnen/K-6349-2019	Spies, Claudia/0000-0002-1062-0495; Bloos, Frank/0000-0002-0767-7941; Brunkhorst, Frank Martin/0000-0002-8132-8651; Grundling, Matthias/0000-0001-8043-7293; Trips, Evelyn/0000-0002-6530-5855; Seibel, Armin/0000-0003-1617-7225; Engel, Christoph/0000-0002-7247-282X	Bayer HealthCare AG; AstraZeneca GmbH; Thermo Fisher Scientific; Pfizer Deutschland GmbH; Becton Dickinson and Company; bioMerieux Deutschland GmbH; SIRS-Lab GmbH; Biosyn GmbH; Roche Diagnostics; Drager Medical GmbH; Sysmex Europe; Biotest Pharma; Merck Sharpe and Dohme; Pulsion Medical Systems; Edwards Life Sciences; Becton Dickinson Management GmbHCo KG; Maquet Critical Care and Carefusion; Johnson Johnson; UpToDate GmbH; sanofi-aventis GmbH; Bayer HeathCare AG; Fresenius Kabi; Baxter Germany; CLS Behring; GlaxoSmithKline; Abbott; Aspect; Baxter; Care Fusion; Deltex; Fresenius; Grunenthal; Hutchinson; Kohler Chemie; Medizinische Congressorganisation Nurnberg AG; Novartis; Pajunk; Pulsion; Roche; Sysmex; Essex Pharma; German Federal Ministry of Education and Research [01 KI 0106, 01 EO 1002]; Cubist; Hospira; Brahms GmbH; Bayer HealthCare; AstraZeneca; Astellas; Pfizer; Paul-Martini Clinical Sepsis Research Group; Thuringian Ministry of Education, Science and Culture [PE 108-2]; Thuringian Foundation for Technology, Innovation and Research; Jena Center of Sepsis Control and Care	Bayer HealthCare AG(Bayer AGBayer Healthcare Pharmaceuticals); AstraZeneca GmbH(AstraZeneca); Thermo Fisher Scientific; Pfizer Deutschland GmbH; Becton Dickinson and Company; bioMerieux Deutschland GmbH; SIRS-Lab GmbH; Biosyn GmbH; Roche Diagnostics; Drager Medical GmbH; Sysmex Europe; Biotest Pharma; Merck Sharpe and Dohme(Merck & Company); Pulsion Medical Systems; Edwards Life Sciences; Becton Dickinson Management GmbHCo KG; Maquet Critical Care and Carefusion; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); UpToDate GmbH; sanofi-aventis GmbH(Sanofi-Aventis); Bayer HeathCare AG; Fresenius Kabi; Baxter Germany; CLS Behring; GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); Aspect; Baxter; Care Fusion; Deltex; Fresenius; Grunenthal(HAL Allergy Group); Hutchinson; Kohler Chemie; Medizinische Congressorganisation Nurnberg AG; Novartis(Novartis); Pajunk; Pulsion; Roche(Roche Holding); Sysmex; Essex Pharma; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Cubist; Hospira; Brahms GmbH; Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); AstraZeneca(AstraZeneca); Astellas(Astellas Pharmaceuticals); Pfizer(Pfizer); Paul-Martini Clinical Sepsis Research Group; Thuringian Ministry of Education, Science and Culture; Thuringian Foundation for Technology, Innovation and Research; Jena Center of Sepsis Control and Care	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Brunkhorst reported receiving payment for lectures from Bayer HealthCare AG, AstraZeneca GmbH, Thermo Fisher Scientific, Pfizer Deutschland GmbH, Becton Dickinson and Company, and bioMerieux Deutschland GmbH. Dr Oppert reported receiving payments for lectures Bayer HealthCare AG. Dr Marx reported receiving grants from SIRS-Lab GmbH; and payments for lectures from Thermo Fisher Scientific. Dr Bloos reported receiving grants from Pfizer Deutschland GmbH; payments for lectures from Biosyn GmbH and Roche Diagnostics; and travel expenses from SIRS-Lab GmbH, Roche Diagnostics, and Bayer HealthCare AG. Dr Putensen reported serving as a consultant to Pulsion AG; and receiving payments for lectures from Drager Medical GmbH. Dr Nierhaus reported receiving grants from Sysmex Europe; and receiving payments for lectures from Thermo Fisher Scientific, Biotest Pharma, and Merck Sharpe and Dohme. Dr Meier-Hellmann reported owning stock options in Fresenius. Dr Weyland reported receiving grants and payments for lectures from Pulsion Medical Systems and Edwards Life Sciences. Dr Grundling reported receiving grants from Pfizer Deutschland GmbH; and payment for lectures from Becton Dickinson Management GmbH&Co KG. Dr Moerer reported receiving payments for lectures from Maquet Critical Care and Carefusion. Dr Ragaller reported receiving grants from Johnson & Johnson. Dr John reported receiving payment for lectures from UpToDate GmbH. Dr Bach reported receiving payments for development of educational presentations from AstraZeneca GmbH, sanofi-aventis GmbH, Roche Diagnostics, Thermo Fisher Scientific, Bayer HeathCare AG, Fresenius Kabi, Baxter Germany, CLS Behring, and GlaxoSmithKline. Dr Spies reported receiving grants from Abbott, Aspect, Baxter, Care Fusion, Deltex, Fresenius, Grunenthal, Hutchinson, Kohler Chemie, Merck Sharpe and Dohme, Medizinische Congressorganisation Nurnberg AG, Novartis, Pajunk, Pulsion, Roche, and Sysmex; payments for lectures from Abbott, Essex Pharma, and GlaxoSmithKline; and travel expenses from Abbott and Aspect. Dr Reill reported receiving payment for lectures from Merck Sharpe and Dohme; and travel expenses from Merck Sharpe and Dohme and Pfizer. Dr Fritz reported receiving payment for employment in the HYPRESS study (NCT00670254). Dr Kiehntopf reported board membership with and payment for lectures from Telematik; and grants from the German Federal Ministry of Education and Research. Dr Kollef reported receiving payments for lectures from Cubist and Hospira. Dr Reinhart reported receiving payments from Brahms GmbH for serving as a consult and for giving lectures. Dr Welte reported board memberships at AstraZeneca, Bayer HealthCare, Novartis, Pfizer Pharma, and Astellas; receiving grants from Novartis and Bayer HealthCare; and receiving payments for lectures from AstraZeneca, Astellas, Bayer HealthCare, GlaxoSmithKline, Novartis, Pfizer, and Merck Sharpe and Dohme. Drs Ludewig, Jaschinski, Riessen, Seibel, Buchler, Bogatsch, Engel, and Loeffler and Ms Kuhnt did not report any disclosures.; This study was supported by the German Federal Ministry of Education and Research grant 01 KI 0106; the Paul-Martini Clinical Sepsis Research Group, which is funded by the Thuringian Ministry of Education, Science and Culture grant PE 108-2; the publicy funded Thuringian Foundation for Technology, Innovation and Research; and the Jena Center of Sepsis Control and Care, which is funded by the German Ministry of Education and Research grant 01 EO 1002. AstraZeneca and Bayer HealthCare provided the drugs for this study.	ANDERSON ET, 1978, CHEMOTHERAPY, V24, P45, DOI 10.1159/000237759; Baddour LM, 2004, AM J RESP CRIT CARE, V170, P440, DOI 10.1164/rccm.200311-1578OC; Bochud PY, 2001, INTENS CARE MED, V27, pS33, DOI 10.1007/PL00003796; Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Bouza E, 2000, MED CLIN N AM, V84, P1357, DOI 10.1016/S0025-7125(05)70293-5; CALANDRA T, 1987, NEW ENGL J MED, V317, P1692; CALANDRA T, 1986, AM J MED, V80, P45; DarrasJoly C, 1996, ANTIMICROB AGENTS CH, V40, P2147, DOI 10.1128/AAC.40.9.2147; DEJONGH CA, 1986, AM J MED, V80, P96; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Garnacho-Montero J, 2003, CRIT CARE MED, V31, P2742, DOI 10.1097/01.CCM.0000098031.24329.10; GIAMARELLOU H, 1986, AM J MED, V80, P126, DOI 10.1016/0002-9343(86)90490-0; GRIBBLE MJ, 1983, ANTIMICROB AGENTS CH, V24, P388, DOI 10.1128/AAC.24.3.388; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; KLASTERSKY J, 1982, REV INFECT DIS, V4, P294; Kumar A, 2004, ICAAC P, V26, pA; Kumar A, 2010, CRIT CARE MED, V38, P1773, DOI 10.1097/CCM.0b013e3181eb3ccd; Kumar A, 2010, CRIT CARE MED, V38, P1651, DOI 10.1097/CCM.0b013e3181e96b91; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Labro MT, 2000, CLIN MICROBIOL REV, V13, P615, DOI 10.1128/CMR.13.4.615-650.2000; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lister PD, 2005, CLIN INFECT DIS, V40, pS105, DOI 10.1086/426190; MILATOVIC D, 1987, EUR J CLIN MICROBIOL, V6, P234, DOI 10.1007/BF02017607; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pasquale TR, 2005, CLIN INFECT DIS, V40, P127, DOI 10.1086/426545; Paul M, 2004, BMJ-BRIT MED J, V328, P668, DOI 10.1136/bmj.38028.520995.63; Pocock SJ., 2013, CLIN TRIALS PRACTICA; Reinhart K, 2010, ANAESTHESIST, V59, P347, DOI 10.1007/s00101-010-1719-5; Safdar N, 2004, LANCET INFECT DIS, V4, P519, DOI 10.1016/S1473-3099(04)01108-9	31	155	162	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2012	307	22					2390	2399		10.1001/jama.2012.5833	http://dx.doi.org/10.1001/jama.2012.5833			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	956UX	22692171	Bronze			2022-12-28	WOS:000305115900024
J	Francia, S; Michelini, F; Saxena, A; Tang, D; de Hoon, M; Anelli, V; Mione, M; Carninci, P; di Fagagna, FD				Francia, Sofia; Michelini, Flavia; Saxena, Alka; Tang, Dave; de Hoon, Michiel; Anelli, Viviana; Mione, Marina; Carninci, Piero; di Fagagna, Fabrizio d'Adda			Site-specific DICER and DROSHA RNA products control the DNA-damage response	NATURE			English	Article							DOUBLE-STRAND BREAKS; NONCODING RNAS; CELLULAR SENESCENCE; CHROMATIN; PROTEINS; HETEROCHROMATIN; BIOGENESIS; REVEALS; DISEASE; COMPLEX	Non-coding RNAs (ncRNAs) are involved in an increasingly recognized number of cellular events(1). Some ncRNAs are processed by DICER and DROSHA RNases to give rise to small double-stranded RNAs involved in RNA interference (RNAi)(2). The DNA-damage response (DDR) is a signalling pathway that originates from a DNA lesion and arrests cell proliferation(3). So far, DICER and DROSHA RNA products have not been reported to control DDR activation. Here we show, in human, mouse and zebrafish, that DICER and DROSHA, but not downstream elements of the RNAi pathway, are necessary to activate the DDR upon exogenous DNA damage and oncogene-induced genotoxic stress, as studied by DDR foci formation and by checkpoint assays. DDR foci are sensitive to RNase A treatment, and DICER-and DROSHA-dependent RNA products are required to restore DDR foci in RNase-A-treated cells. Through RNA deep sequencing and the study of DDR activation at a single inducible DNA double-strand break, we demonstrate that DDR foci formation requires site-specific DICER- and DROSHA-dependent small RNAs, named DDRNAs, which act in a MRE11-RAD50-NBS1-complex-dependent manner (MRE11 also known as MRE11A; NBS1 also known as NBN). DDRNAs, either chemically synthesized or in vitro generated by DICER cleavage, are sufficient to restore the DDR in RNase-A-treated cells, also in the absence of other cellular RNAs. Our results describe an unanticipated direct role of a novel class of ncRNAs in the control of DDR activation at sites of DNA damage.	[Francia, Sofia; Michelini, Flavia; Anelli, Viviana; Mione, Marina; di Fagagna, Fabrizio d'Adda] IFOM Fdn FIRC Inst Mol Oncol Fdn, I-20139 Milan, Italy; [Francia, Sofia] Ist Italiano Tecnol, IIT SEMM, Center Genom Sci, I-20139 Milan, Italy; [Saxena, Alka; Tang, Dave; de Hoon, Michiel; Carninci, Piero] RIKEN Yokohama Inst, Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [di Fagagna, Fabrizio d'Adda] CNR, Ist Genet Mol, I-27100 Pavia, Italy	IFOM - FIRC Institute of Molecular Oncology; Istituto Italiano di Tecnologia - IIT; RIKEN; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	di Fagagna, FD (corresponding author), IFOM Fdn FIRC Inst Mol Oncol Fdn, Via Adamello 16, I-20139 Milan, Italy.	fabrizio.dadda@ifom-ieo-campus.it	de Hoon, Michiel/A-6443-2013; Hoon, Dave SB/C-7146-2018; Mione, Maria Caterina/I-3073-2013; Carninci, Piero/K-1568-2014; Mione, Maria Caterina/ABG-9926-2021; Tang, Dave/G-9670-2014; d'Adda di Fagagna, Fabrizio/AAC-4683-2022	Hoon, Dave SB/0000-0003-1915-3683; Carninci, Piero/0000-0001-7202-7243; Tang, Dave/0000-0002-4790-9014; d'Adda di Fagagna, Fabrizio/0000-0002-9603-5966; de Hoon, Michiel/0000-0003-0489-2352; DADDADIFAGAGNA, FABRIZIO/0000-0002-1976-3185; Michelini, Flavia/0000-0002-3727-4887; ANELLI, Viviana Vittoria/0000-0003-1964-3252; Mione, Maria Caterina/0000-0002-9040-3705; Francia, Sofia/0000-0002-4578-9442	Fondazione Italiana Ricerca Sul Cancro (FIRC); Associazione Italiana Ricerca sul Cancro (AIRC) European Community's 7th Framework Programme [202230]; Telethon [GGP08183]; 7th Framework of the European Union commission, Funding Program for the Next Generation World-Leading Researchers (NEXT Program) [20241047]; MEXT; Center for Genomic Science of IIT@SEMM (Scuola Europea di Medicina Molecolare); AIRC; Cariplo [2007-5500]; JSPS [P09745]; European Union 7th Framework Programme [FP7-People-ITN-2008-238055]	Fondazione Italiana Ricerca Sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana Ricerca sul Cancro (AIRC) European Community's 7th Framework Programme(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); 7th Framework of the European Union commission, Funding Program for the Next Generation World-Leading Researchers (NEXT Program); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center for Genomic Science of IIT@SEMM (Scuola Europea di Medicina Molecolare); AIRC(Fondazione AIRC per la ricerca sul cancro); Cariplo(Fondazione Cariplo); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Union 7th Framework Programme	We thank E. Soutoglou, W. C. Hahn, M. Kastan, V. Orlando, R. Shiekhattar, J. Amatruda, T. Halazonetis, E. Dejana, P. Ng and F. Nicassio for sharing reagents, M. Fumagalli and F. Rossiello for reading the manuscript, M. Dobreva, V. Matti and F. Pezzimenti for technical support, G. D'Ario for help with statistical analyses, B. Amati, M. Foiani, V. Costanzo and F.d.A.d.F. group members for help and discussions. The F.d.A.d.F. laboratory was supported by Fondazione Italiana Ricerca Sul Cancro (FIRC), Associazione Italiana Ricerca sul Cancro (AIRC) European Community's 7th Framework Programme (FP7/2007-2013) under grant agreement no. 202230, acronym "GENINCA", HFSP, AICR, the EMBO Young Investigator Program. The initial part of this project was supported by Telethon grant no. GGP08183. P. C. was supported by 7th Framework of the European Union commission to the Dopaminet consortium, a Grant-in-Aids for Scientific Research (A) no. 20241047, Funding Program for the Next Generation World-Leading Researchers (NEXT Program) to P. C. and a Research Grant to RIKEN Omics Science Center from MEXT. S. F. is supported by Center for Genomic Science of IIT@SEMM (Scuola Europea di Medicina Molecolare) and AIRC. M. M. was supported by Cariplo (grant no. 2007-5500) and AIRC. A. S. is supported by a JSPS fellowship P09745 and grant in aid by JSPS, and D. T. is supported by the European Union 7th Framework Programme under grant agreement FP7-People-ITN-2008-238055 ("BrainTrain" project) to P.C.	Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kawano M, 2010, BIOTECHNIQUES, V49, P751, DOI 10.2144/000113516; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Pryde F, 2005, J CELL SCI, V118, P2043, DOI 10.1242/jcs.02336; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Tritschler F, 2010, NAT REV MOL CELL BIO, V11, P379, DOI 10.1038/nrm2885; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; White SA, 2008, CURR TOP MICROBIOL, V320, P157; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	30	370	379	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2012	488	7410					231	+		10.1038/nature11179	http://dx.doi.org/10.1038/nature11179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22722852	Green Accepted			2022-12-28	WOS:000307267000038
J	Berryman, KR; Cochran, UA; Clark, KJ; Biasi, GP; Langridge, RM; Villamor, P				Berryman, Kelvin R.; Cochran, Ursula A.; Clark, Kate J.; Biasi, Glenn P.; Langridge, Robert M.; Villamor, Pilar			Major Earthquakes Occur Regularly on an Isolated Plate Boundary Fault	SCIENCE			English	Article							ALPINE FAULT; SOUTH WESTLAND; SLIP RATE; RECURRENCE; PALEOSEISMICITY; DISPLACEMENT; KINEMATICS; FJORDLAND; RECORD; ISLAND	The scarcity of long geological records of major earthquakes, on different types of faults, makes testing hypotheses of regular versus random or clustered earthquake recurrence behavior difficult. We provide a fault-proximal major earthquake record spanning 8000 years on the strike-slip Alpine Fault in New Zealand. Cyclic stratigraphy at Hokuri Creek suggests that the fault ruptured to the surface 24 times, and event ages yield a 0.33 coefficient of variation in recurrence interval. We associate this near-regular earthquake recurrence with a geometrically simple strike-slip fault, with high slip rate, accommodating a high proportion of plate boundary motion that works in isolation from other faults. We propose that it is valid to apply time-dependent earthquake recurrence models for seismic hazard estimation to similar faults worldwide.	[Berryman, Kelvin R.; Cochran, Ursula A.; Clark, Kate J.; Langridge, Robert M.; Villamor, Pilar] GNS Sci, Lower Hutt 5040, New Zealand; [Biasi, Glenn P.] Univ Nevada Reno, Seismol Lab, Reno, NV 89557 USA	GNS Science - New Zealand; Nevada System of Higher Education (NSHE); University of Nevada Reno	Berryman, KR (corresponding author), GNS Sci, POB 30-368, Lower Hutt 5040, New Zealand.	k.berryman@gns.cri.nz		Cochran, Ursula/0000-0001-8002-4958	Royal Society of New Zealand	Royal Society of New Zealand(Royal Society of New Zealand)	This research was funded by the Marsden Fund of the Royal Society of New Zealand. The Department of Conservation provided permits for us to work in the field area. D. Barker, T. Bartholomew, M. Hemphill-Haley, N. Litchfield, S. Marco, N. Palmer, D. Pantosti, and R. Van Dissen contributed to the field work. T. Bartholomew, T. Dutton, L. Ingham, G. Turner, and J. West carried out laboratory work. C. Prior and her team produced all the radiocarbon analyses. N. Litchfield, A. Nicol, R. Sibson, M. Stirling, R. Sutherland, J. Townend, and L. Wallace made comments that improved the manuscript. Data reported in this paper are provided in the supporting online material. K.R.B. initiated the research, led the fieldwork, and contributed to all aspects of the project, especially interpretation. U.A.C. contributed to preliminary fieldwork, produced the diatom-based paleoenvironmental interpretations, contributed to figures, and led the writing of the manuscript. K.J.C. was involved in all fieldwork, led development of the stratigraphic model, organized laboratory analyses, and contributed to figures and writing. G.P.B. contributed to fieldwork, interpretation, figures, and writing and produced the event sequence using Oxcal. R.M.L. and P.V. contributed to a large proportion of the fieldwork and to interpretations presented in the manuscript.	ADAMS J, 1980, GEOLOGY, V8, P72, DOI 10.1130/0091-7613(1980)8<72:POTAFS>2.0.CO;2; Barnes PM, 2009, GEOLOGY, V37, P3, DOI 10.1130/G24764A.1; Barnes PM, 2005, GEOL SOC AM BULL, V117, P411, DOI 10.1130/B25458.1; Berryman K.R., 1992, ANN TECTONICAE, V6, P126; Berryman K, 2012, B SEISMOL SOC AM, V102, P620, DOI 10.1785/0120110177; COOPER AF, 1990, NEW ZEAL J GEOL GEOP, V33, P303, DOI 10.1080/00288306.1990.10425688; Cullen LE, 2003, J ROY SOC NEW ZEAL, V33, P693, DOI 10.1080/03014223.2003.9517753; Dolan JF, 2007, GEOLOGY, V35, P855, DOI 10.1130/G23789A.1; Ferry M, 2011, B SEISMOL SOC AM, V101, P39, DOI 10.1785/0120100097; KAGAN YY, 1991, GEOPHYS J INT, V104, P117, DOI 10.1111/j.1365-246X.1991.tb02498.x; Kagan YY, 1999, B SEISMOL SOC AM, V89, P1147; Knudson KP, 2011, QUATERNARY SCI REV, V30, P3124, DOI 10.1016/j.quascirev.2011.07.017; Langridge RM, 2010, LITHOSPHERE-US, V2, P139, DOI 10.1130/L88.1; Lorrey A, 2008, QUATERN INT, V187, P52, DOI 10.1016/j.quaint.2007.09.039; Marco S, 1996, J GEOPHYS RES-SOL EA, V101, P6179, DOI 10.1029/95JB01587; McCalpin JP, 2009, INT GEOPHYS SER, V95, P1, DOI 10.1016/S0074-6142(09)95001-X; Norris RJ, 2001, J STRUCT GEOL, V23, P507, DOI 10.1016/S0191-8141(00)00122-X; Parsons T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035887; Reid HF., 1910, CALIF EARTHQ, V18, P192; Scharer KM, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008099; Scharer KM, 2010, GEOLOGY, V38, P555, DOI 10.1130/G30746.1; SHIMAZAKI K, 1980, GEOPHYS RES LETT, V7, P279, DOI 10.1029/GL007i004p00279; Sutherland R, 2007, GEOPHYS MONOGR SER, V175, P235, DOI 10.1029/175GM12; Sutherland R, 2006, GEOL SOC AM BULL, V118, P464, DOI 10.1130/B25627.1; Sutherland R, 1995, NEW ZEAL J GEOL GEOP, V38, P419, DOI 10.1080/00288306.1995.9514669; THATCHER W, 1984, J GEOPHYS RES, V89, P5674, DOI 10.1029/JB089iB07p05674; Wallace LM, 2007, GEOPHYS J INT, V168, P332, DOI 10.1111/j.1365-246X.2006.03183.x; Wells A, 1999, GEOLOGY, V27, P995, DOI 10.1130/0091-7613(1999)027<0995:PDOTMR>2.3.CO;2; Wells A, 2006, HOLOCENE, V16, P543, DOI 10.1191/0959683606hl949rp	29	168	175	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1690	1693		10.1126/science.1218959	http://dx.doi.org/10.1126/science.1218959			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745426				2022-12-28	WOS:000305794500046
J	Loh, ND; Hampton, CY; Martin, AV; Starodub, D; Sierra, RG; Barty, A; Aquila, A; Schulz, J; Lomb, L; Steinbrener, J; Shoeman, RL; Kassemeyer, S; Bostedt, C; Bozek, J; Epp, SW; Erk, B; Hartmann, R; Rolles, D; Rudenko, A; Rudek, B; Foucar, L; Kimmel, N; Weidenspointner, G; Hauser, G; Holl, P; Pedersoli, E; Liang, M; Hunter, MM; Gumprecht, L; Coppola, N; Wunderer, C; Graafsma, H; Maia, FRNC; Ekeberg, T; Hantke, M; Fleckenstein, H; Hirsemann, H; Nass, K; White, TA; Tobias, HJ; Farquar, GR; Benner, WH; Hau-Riege, SP; Reich, C; Hartmann, A; Soltau, H; Marchesini, S; Bajt, S; Barthelmess, M; Bucksbaum, P; Hodgson, KO; Struder, L; Ullrich, J; Frank, M; Schlichting, I; Chapman, HN; Bogan, MJ				Loh, N. D.; Hampton, C. Y.; Martin, A. V.; Starodub, D.; Sierra, R. G.; Barty, A.; Aquila, A.; Schulz, J.; Lomb, L.; Steinbrener, J.; Shoeman, R. L.; Kassemeyer, S.; Bostedt, C.; Bozek, J.; Epp, S. W.; Erk, B.; Hartmann, R.; Rolles, D.; Rudenko, A.; Rudek, B.; Foucar, L.; Kimmel, N.; Weidenspointner, G.; Hauser, G.; Holl, P.; Pedersoli, E.; Liang, M.; Hunter, M. M.; Gumprecht, L.; Coppola, N.; Wunderer, C.; Graafsma, H.; Maia, F. R. N. C.; Ekeberg, T.; Hantke, M.; Fleckenstein, H.; Hirsemann, H.; Nass, K.; White, T. A.; Tobias, H. J.; Farquar, G. R.; Benner, W. H.; Hau-Riege, S. P.; Reich, C.; Hartmann, A.; Soltau, H.; Marchesini, S.; Bajt, S.; Barthelmess, M.; Bucksbaum, P.; Hodgson, K. O.; Strueder, L.; Ullrich, J.; Frank, M.; Schlichting, I.; Chapman, H. N.; Bogan, M. J.			Fractal morphology, imaging and mass spectrometry of single aerosol particles in flight	NATURE			English	Article							FREE-ELECTRON LASER; OPTICAL-PROPERTIES; SOOT AEROSOLS; BLACK CARBON; MIXING STATE; SCATTERING; CLIMATE; FLAME	The morphology of micrometre-size particulate matter is of critical importance in fields ranging from toxicology(1) to climate science(2), yet these properties are surprisingly difficult to measure in the particles' native environment. Electron microscopy requires collection of particles on a substrate(3); visible light scattering provides insufficient resolution(4); and X-ray synchrotron studies have been limited to ensembles of particles(5). Here we demonstrate an in situ method for imaging individual sub-micrometre particles to nanometre resolution in their native environment, using intense, coherent X-ray pulses from the Linac Coherent Light Source(6) free-electron laser. We introduced individual aerosol particles into the pulsed X-ray beam, which is sufficiently intense that diffraction from individual particles can be measured for morphological analysis. At the same time, ion fragments ejected from the beam were analysed using mass spectrometry, to determine the composition of single aerosol particles. Our results show the extent of internal dilation symmetry of individual soot particles subject to non-equilibrium aggregation, and the surprisingly large variability in their fractal dimensions. More broadly, our methods can be extended to resolve both static and dynamic morphology of general ensembles of disordered particles. Such general morphology has implications in topics such as solvent accessibilities in proteins(7), vibrational energy transfer by the hydrodynamic interaction of amino acids(8), and large-scale production of nanoscale structures by flame synthesis(9).	[Loh, N. D.; Hampton, C. Y.; Starodub, D.; Sierra, R. G.; Bucksbaum, P.; Hodgson, K. O.; Bogan, M. J.] PULSE Inst, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Martin, A. V.; Barty, A.; Aquila, A.; Schulz, J.; Liang, M.; Gumprecht, L.; Fleckenstein, H.; Nass, K.; White, T. A.; Chapman, H. N.] DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Aquila, A.; Schulz, J.; Coppola, N.] European XFEL GmbH, D-22761 Hamburg, Germany; [Lomb, L.; Steinbrener, J.; Shoeman, R. L.; Kassemeyer, S.; Rolles, D.; Foucar, L.; Schlichting, I.] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Bostedt, C.; Bozek, J.] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Epp, S. W.; Erk, B.; Rolles, D.; Rudenko, A.; Rudek, B.; Foucar, L.; Schlichting, I.] Ctr Free Electron Laser Sci CFEL, Max Planck Adv Study Grp, D-22607 Hamburg, Germany; [Epp, S. W.; Erk, B.; Rudenko, A.; Rudek, B.; Ullrich, J.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Hartmann, R.; Holl, P.; Reich, C.; Hartmann, A.; Soltau, H.] PNSensor GmbH, D-81739 Munich, Germany; [Kimmel, N.; Weidenspointner, G.; Hauser, G.; Strueder, L.] Max Planck Inst Halbleiterlab, D-81739 Munich, Germany; [Kimmel, N.; Weidenspointner, G.; Hauser, G.; Strueder, L.] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Pedersoli, E.] Sincrotrone Trieste, Microscopy Sect, I-34149 Trieste, Italy; [Hunter, M. M.; Farquar, G. R.; Benner, W. H.; Hau-Riege, S. P.; Frank, M.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Wunderer, C.; Graafsma, H.; Hirsemann, H.; Bajt, S.; Barthelmess, M.] DESY, Photon Sci, D-22607 Hamburg, Germany; [Maia, F. R. N. C.] Natl Energy Res Sci Comp Ctr NERSC, Berkeley, CA 94720 USA; [Ekeberg, T.; Hantke, M.] Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden; [Nass, K.; Chapman, H. N.] Univ Hamburg, D-22761 Hamburg, Germany; [Tobias, H. J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Marchesini, S.] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); European XFEL; Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Max Planck Society; Max Planck Society; PNSensor GmbH; Max Planck Society; Max Planck Society; Elettra Sincrotrone Trieste; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Uppsala University; University of Hamburg; Cornell University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Loh, ND (corresponding author), PULSE Inst, SLAC Natl Accelerator Lab, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	duaneloh@slac.stanford.edu; mbogan@slac.stanford.edu	Bozek, John D/E-9260-2010; Frank, Matthias/O-9055-2014; Rudenko, Artem/C-7412-2009; Marchesini, Stefano/A-6795-2009; Nass, Karol/K-1970-2012; Rudek, Benedikt/AAX-1278-2021; Bajt, Sasa/G-2228-2010; Barty, Anton/K-5137-2014; Marchesini, Stefano/GYR-1409-2022; Schlichting, Ilme/I-1339-2013; Bajt, Sasa/O-4695-2019; FRS, Henry N Chapman/G-2153-2010; Maia, Filipe R.N.C./C-3146-2014; Loh, Duane/I-7371-2013; Rudek, Benedikt/A-5100-2017	Bozek, John D/0000-0001-7486-7238; Rudenko, Artem/0000-0002-9154-8463; Marchesini, Stefano/0000-0002-6798-2913; Nass, Karol/0000-0001-8843-1566; Rudek, Benedikt/0000-0002-6404-4294; Barty, Anton/0000-0003-4751-2727; Bajt, Sasa/0000-0002-7163-7602; FRS, Henry N Chapman/0000-0002-4655-1743; Maia, Filipe R.N.C./0000-0002-2141-438X; Loh, Duane/0000-0002-8886-510X; Bucksbaum, Philip/0000-0003-1258-5571; Frank, Matthias/0000-0002-5244-0791; Epp, Sascha/0000-0001-6366-9113; MARTIN, ANDREW/0000-0003-3704-1829; graafsma, heinz/0000-0003-2304-667X; Bogan, Michael J./0000-0001-9318-3333; Wunderer, Cornelia/0000-0001-8211-3604; Tobias, Herbert/0000-0002-2835-8739; Erk, Benjamin/0000-0001-8413-3588; White, Thomas/0000-0002-8407-0270; Aquila, Andrew/0000-0003-0358-2774; Pedersoli, Emanuele/0000-0003-0572-6735	AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy; SLAC Laboratory Directed Research and Development Program; Max Planck Society; Hamburg Ministry of Science and Research; Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research (LEXI); Hamburg School for Structure and Dynamics in Infection, CBST at UC [PHY 0120999]; US Department of Energy, National Nuclear Security Administration [DE-AC52-07NA27344]; University of California [09-LR-05-118036-BARA]; Swedish Research Council; European Research Council; Knut och Alice Wallenbergs Stiftelse; DFG Cluster of Excellence at the Munich Centre for Advanced Photonics	AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy(United States Department of Energy (DOE)); SLAC Laboratory Directed Research and Development Program; Max Planck Society(Max Planck SocietyFoundation CELLEX); Hamburg Ministry of Science and Research; Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research (LEXI); Hamburg School for Structure and Dynamics in Infection, CBST at UC; US Department of Energy, National Nuclear Security Administration(National Nuclear Security AdministrationUnited States Department of Energy (DOE)); University of California(University of California System); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); DFG Cluster of Excellence at the Munich Centre for Advanced Photonics(German Research Foundation (DFG))	Experiments were carried out at the Linac Coherent Light Source, a national user facility operated by Stanford University on behalf of the US Department of Energy (DOE), Office of Basic Energy Sciences. N.D.L., C.Y.H., R. G. S., P. B. and M.J.B. were supported by the AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy. M.J.B. acknowledges support by the SLAC Laboratory Directed Research and Development Program. We acknowledge support from the Max Planck Society for funding the development and operation of the CAMP instrument within the ASG at CFEL, the Hamburg Ministry of Science and Research and Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research (LEXI) and the Hamburg School for Structure and Dynamics in Infection, CBST at UC under Cooperative Agreement number PHY 0120999. Lawrence Livermore National Laboratory (LLNL) is operated by Lawrence Livermore National Security, LLC, for the US Department of Energy, National Nuclear Security Administration under Contract DE-AC52-07NA27344. Work by LLNL has been supported, in part, by University of California Laboratory Fee grant 09-LR-05-118036-BARA. We also acknowledge support from the Swedish Research Council, the European Research Council, Knut och Alice Wallenbergs Stiftelse, and the DFG Cluster of Excellence at the Munich Centre for Advanced Photonics. We acknowledge the staff of the LCLS for their support in carrying out these experiments. The Max Planck Advanced Study Group at CFEL acknowledges technical support by R. Andritschke, K. Gartner, O. Halker, S. Herrmann, A. Homke, Ch. Kaiser, K.-U. Kuhnel, W. Leitenberger, D. Miessner, D. Pietschner, M. Porro, R. Richter, G. Schaller, C. Schmidt, F. Schopper, C.-D. Schroter, Ch. Thamm, A. Walenta, A. Ziegler and H. Gorke. N.D.L. thanks M. J. Berg, G. Simpson, G. Williams and J. Hajdu for their critique, and G. M. Stewart for rendering the experiment's schematic.	BALAFAS JS, 1995, PHYS REV E, V52, P880, DOI 10.1103/PhysRevE.52.880; Beaucage G, 2004, NAT MATER, V3, P370, DOI 10.1038/nmat1135; Berg MJ, 2010, OPT EXPRESS, V18, P23343, DOI 10.1364/OE.18.023343; Bogan MJ, 2010, PHYS REV SPEC TOP-AC, V13, DOI 10.1103/PhysRevSTAB.13.094701; Bogan MJ, 2008, NANO LETT, V8, P310, DOI 10.1021/nl072728k; Bogan MJ, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/19/194013; Bogan MJ, 2010, AEROSOL SCI TECH, V44, pI, DOI 10.1080/02786820903485800; Bozek JD, 2009, EUR PHYS J-SPEC TOP, V169, P129, DOI 10.1140/epjst/e2009-00982-y; Braun A, 2005, CARBON, V43, P2588, DOI 10.1016/j.carbon.2005.05.017; Cho YS, 2007, LANGMUIR, V23, P12079, DOI 10.1021/la7018346; Dhaubhadel R, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011404; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; FIENUP JR, 1982, J OPT SOC AM, V72, P610, DOI 10.1364/JOSA.72.000610; Granek R, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.020902; Jacobson MZ, 2006, J PHYS CHEM A, V110, P6860, DOI 10.1021/jp056391r; Jacobson MZ, 2001, NATURE, V409, P695, DOI 10.1038/35055518; Luke DR, 2005, INVERSE PROBL, V21, P37, DOI 10.1088/0266-5611/21/1/004; Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101; MARTIN JE, 1987, J APPL CRYSTALLOGR, V20, P61, DOI 10.1107/S0021889887087107; MEAKIN P, 1988, ADV COLLOID INTERFAC, V28, P249, DOI 10.1016/0001-8686(87)80016-7; Moffet RC, 2009, P NATL ACAD SCI USA, V106, P11872, DOI 10.1073/pnas.0900040106; NELSON J, 1989, J MOD OPTIC, V36, P1031, DOI 10.1080/09500348914551081; NELSON J, 1989, NATURE, V339, P611, DOI 10.1038/339611a0; PURI R, 1993, COMBUST FLAME, V92, P320, DOI 10.1016/0010-2180(93)90043-3; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Seibert MM, 2011, NATURE, V470, P78, DOI 10.1038/nature09748; Sorensen CM, 2001, AEROSOL SCI TECH, V35, P648, DOI 10.1080/027868201316900007; Struder L, 2010, NUCL INSTRUM METH A, V614, P483, DOI 10.1016/j.nima.2009.12.053; Wentzel M, 2003, J AEROSOL SCI, V34, P1347, DOI 10.1016/S0021-8502(03)00360-4; Zereini F, 2010, ENVIRON SCI ENG, P1; Zhang RY, 2008, P NATL ACAD SCI USA, V105, P10291, DOI 10.1073/pnas.0804860105	31	144	144	3	268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					513	517		10.1038/nature11222	http://dx.doi.org/10.1038/nature11222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22739316				2022-12-28	WOS:000305760600039
J	Yip, PSF; Caine, E; Yousuf, S; Chang, SS; Wu, KCC; Chen, YY				Yip, Paul S. F.; Caine, Eric; Yousuf, Saman; Chang, Shu-Sen; Wu, Kevin Chien-Chang; Chen, Ying-Yeh			Means restriction for suicide prevention	LANCET			English	Article							STATE FIREARM REGULATIONS; CHARCOAL-BURNING SUICIDE; SAFE STORAGE; GUN-CONTROL; BILL C-17; RATES; IMPACT; LEGISLATION; DEATHS; ACCESS	Limitation of access to lethal methods used for suicide-so-called means restriction-is an important population strategy for suicide prevention. Many empirical studies have shown that such means restriction is effective. Although some individuals might seek other methods, many do not; when they do, the means chosen are less lethal and are associated with fewer deaths than when more dangerous ones are available. We examine how the spread of information about suicide methods through formal and informal media potentially affects the choices that people make when attempting to kill themselves. We also discuss the challenges associated with implementation of means restriction and whether numbers of deaths by suicide are reduced.	[Yip, Paul S. F.; Yousuf, Saman] Univ Hong Kong, Dept Social Work, Hong Kong, Hong Kong, Peoples R China; [Yip, Paul S. F.; Yousuf, Saman] Univ Hong Kong, Social Adm, Hong Kong, Hong Kong, Peoples R China; [Yip, Paul S. F.; Chang, Shu-Sen] Univ Hong Kong, Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China; [Caine, Eric] Univ Rochester, Ctr Study & Prevent Suicide, Dept Psychiat, Rochester, NY USA; [Caine, Eric] VA Ctr Excellence Suicide Prevent, Canandaigua, NY USA; [Wu, Kevin Chien-Chang] Natl Taiwan Univ, Coll Med, Dept Social Med, Taipei 10764, Taiwan; [Wu, Kevin Chien-Chang] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Ying-Yeh] Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chen, Ying-Yeh] Natl Yang Ming Univ, Dept Publ Hlth, Taipei 112, Taiwan	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Rochester; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, YY (corresponding author), 309 Songde Rd, Taipei 110, Taiwan.	ychen@tpech.gov.tw	Chang, Shu-Sen/B-3518-2012; Chang, Shu-Sen/AAH-6733-2021; Chen, Ying-Yeh/AAY-1478-2021	Chang, Shu-Sen/0000-0001-5012-1132; Chang, Shu-Sen/0000-0001-5012-1132; Chen, Ying-Yeh/0000-0001-5543-5704; WU, KEVIN CHIEN-CHANG/0000-0003-3685-1731	University of Hong Kong [HKU 784210M]; National Institutes of Health [D43TW009101]; National Science Council, Taiwan [99-2314-B-532-004-]; National Health Research Institute, Taiwan [NHRI-EX100-10024PC]; FOGARTY INTERNATIONAL CENTER [D43TW009101] Funding Source: NIH RePORTER	University of Hong Kong(University of Hong Kong); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	PSFY was supported by a GRF grant of the University of Hong Kong (HKU 784210M). EC was partly supported by the National Institutes of Health (grant number D43TW009101). Y-YC was supported by the National Science Council, Taiwan (grant number 99-2314-B-532-004-) and the National Health Research Institute, Taiwan (grant number NHRI-EX100-10024PC). We thank the research team of the Centre for Suicide Research and Prevention (University of Hong Kong, Hong Kong SAR, China) for their diligent efforts to implement suicide prevention programmes in Hong Kong.	Ajdacic-Gross V, 2008, B WORLD HEALTH ORGAN, V86, P726, DOI 10.2471/BLT.07.043489; Amos T, 2001, PSYCHOL MED, V31, P935, DOI 10.1017/S0033291701003920; Andres AR, 2011, HEALTH POLICY, V101, P95, DOI 10.1016/j.healthpol.2010.10.005; Bateman DN, 2009, CLIN TOXICOL, V47, P536, DOI 10.1080/15563650903093192; Beautrais AL, 2006, AUST NZ J PSYCHIAT, V40, P253, DOI 10.1111/j.1440-1614.2006.01782.x; Beautrais AL, 2001, AUST NZ J PSYCHIAT, V35, P557, DOI 10.1080/0004867010060501; Beautrais AL, 2009, AUST NZ J PSYCHIAT, V43, P495, DOI 10.1080/00048670902873714; Bennewith O, 2007, BRIT J PSYCHIAT, V190, P266, DOI 10.1192/bjp.bp.106.027136; Bridges FS, 2004, PSYCHOL REP, V94, P819; Cantor CH, 1998, AUST NZ J PSYCHIAT, V32, P8, DOI 10.3109/00048679809062700; Caron J, 2008, SUICIDE LIFE-THREAT, V38, P195, DOI 10.1521/suli.2008.38.2.195; Caron Jean, 2004, Arch Suicide Res, V8, P361, DOI 10.1080/13811110490476752; Chan KPM, 2005, BRIT J PSYCHIAT, V186, P67, DOI 10.1192/bjp.186.1.67; Chapman S, 2006, INJURY PREV, V12, P365, DOI 10.1136/ip.2006.013714; Chen VCH, 2009, SOC PSYCH PSYCH EPID, V44, P1005, DOI 10.1007/s00127-009-0021-9; Chen YY, 2009, INJURY PREV, V15, P41, DOI 10.1136/ip.2008.019794; Chen YY, 2012, EPIDEMIOL REV, V34, P129, DOI 10.1093/epirev/mxr025; Chen YY, 2011, J EPIDEMIOL COMMUN H, V65, P934, DOI 10.1136/jech.2010.117903; Chen YY, 2011, INTERNATIONAL HANDBOOK OF SUICIDE PREVENTION: RESEARCH, POLICY AND PRACTICE, P545; Chen YY, 2012, SOC PSYCH PSYCH EPID, V47, P215, DOI 10.1007/s00127-010-0331-y; Chen YY, 2009, OXFORD TXB SUICIDOLO, P569; Cheung AH, 2005, CAN J PUBLIC HEALTH, V96, P131, DOI 10.1007/BF03403676; Clarke R. V., 1989, SUICIDE CLOSING EXIT; Conner KR, 2003, AM J PREV MED, V25, P320, DOI 10.1016/S0749-3797(03)00212-5; Daigle MS, 2005, ACCIDENT ANAL PREV, V37, P625, DOI 10.1016/j.aap.2005.03.004; De Leo D, 2003, SUICIDE LIFE-THREAT, V33, P151, DOI 10.1521/suli.33.2.151.22775; de Silva VA, 2012, B WORLD HEALTH ORGAN, V90, P40, DOI 10.2471/BLT.11.091785; Elnour AA, 2008, INJURY PREV, V14, P39, DOI 10.1136/ip.2007.016246; Felson M, 1997, BUSINESS AND CRIME PREVENTION, P1; Gagne M, 2010, INJURY PREV, V16, P247, DOI 10.1136/ip.2009.022491; Glasgow G, 2011, SOC SCI MED, V72, P884, DOI 10.1016/j.socscimed.2011.01.001; Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164; Gunnell D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3054; Gunnell D, 2003, INT J EPIDEMIOL, V32, P902, DOI 10.1093/ije/dyg307; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; Hadlaczky G, 2011, INTERNATIONAL HANDBOOK OF SUICIDE PREVENTION: RESEARCH, POLICY AND PRACTICE, P475; Hawton K, 2004, BMJ-BRIT MED J, V329, P1076, DOI 10.1136/bmj.38253.572581.7C; Hawton K, 2001, BMJ-BRIT MED J, V322, P1203, DOI 10.1136/bmj.322.7296.1203; Hawton K, 2007, CRISIS, V28, P4, DOI 10.1027/0227-5910.28.S1.4; JOHNSON STEVEN, 2006, GHOST MAP STORY LOND; Kapusta ND, 2007, BRIT J PSYCHIAT, V191, P253, DOI 10.1192/bjp.bp.106.032862; Klieve H, 2009, SOC PSYCH PSYCH EPID, V44, P285, DOI 10.1007/s00127-008-0435-9; Knox KL, 2004, AM J PUBLIC HEALTH, V94, P37, DOI 10.2105/AJPH.94.1.37; Konradsen F, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-13; KREITMAN N, 1976, BRIT J PREV SOC MED, V30, P86; Law CK, 2009, J AFFECT DISORDERS, V114, P254, DOI 10.1016/j.jad.2008.07.021; Law CK, 2011, CRISIS, V32, P152, DOI 10.1027/0227-5910/a000070; Lee WS, 2010, CONTEMP ECON POLICY, V28, P65, DOI 10.1111/j.1465-7287.2009.00165.x; Lubin G, 2010, SUICIDE LIFE-THREAT, V40, P421, DOI 10.1521/suli.2010.40.5.421; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; de Souza MDM, 2007, HEALTH AFFAIR, V26, P575, DOI 10.1377/hlthaff.26.2.575; Mott JA, 2002, JAMA-J AM MED ASSOC, V288, P988, DOI 10.1001/jama.288.8.988; Niederkrotenthaler T, 2010, BRIT J PSYCHIAT, V197, P234, DOI 10.1192/bjp.bp.109.074633; Nordentoft M, 2007, SUICIDE LIFE-THREAT, V37, P688, DOI 10.1521/suli.2007.37.6.688; Oquendo MA, 2006, ACTA PSYCHIAT SCAND, V114, P151, DOI 10.1111/j.1600-0447.2006.00829.x; Ozanne-Smith J, 2004, INJURY PREV, V10, P280, DOI 10.1136/ip.2003.004150; Pelletier AR, 2007, INJURY PREV, V13, P57, DOI 10.1136/ip.2006.013748; Pirkis J, 2011, INTERNATIONAL HANDBOOK OF SUICIDE PREVENTION: RESEARCH, POLICY AND PRACTICE, P531; Reisch T, 2005, SUICIDE LIFE-THREAT, V35, P460, DOI 10.1521/suli.2005.35.4.460; Roberts DM, 2003, B WORLD HEALTH ORGAN, V81, P789; Rosengart M, 2005, INJURY PREV, V11, P77, DOI 10.1136/ip.2004.007062; Shah A, 2007, INT PSYCHOGERIATR, V19, P1141, DOI 10.1017/S1041610207005285; Sinyor M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c2884; Skegg K, 2009, AUST NZ J PSYCHIAT, V43, P498, DOI 10.1080/00048670902873698; Skilling GD, 2008, SCOT MED J, V53, P3; Spicer RS, 2000, AM J PUBLIC HEALTH, V90, P1885, DOI 10.2105/AJPH.90.12.1885; Studdert DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000210; The Age Company, 2005, UK REC 1 ONL SUIC PA; Thomas K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-314; Tsai CW, 2011, J AFFECT DISORDERS, V131, P402, DOI 10.1016/j.jad.2010.12.013; Vijayakumar L, 2009, INT J SOC PSYCHIATR, V55, P401, DOI 10.1177/0020764008095340; Webster DW, 2004, JAMA-J AM MED ASSOC, V292, P594, DOI 10.1001/jama.292.5.594; Wong PWC, 2009, SUICIDE LIFE-THREAT, V39, P82, DOI 10.1521/suli.2009.39.1.82; World Health Organization, 2011, SUIC PREV SUPRE; Yip PSF, 2012, INJURY PREV, V18, P187, DOI 10.1136/injuryprev-2011-040177; Yip PSF, 2010, BRIT J PSYCHIAT, V196, P241, DOI 10.1192/bjp.bp.109.065185	76	313	314	7	69	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2012	379	9834					2393	2399		10.1016/S0140-6736(12)60521-2	http://dx.doi.org/10.1016/S0140-6736(12)60521-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961ZV	22726520	Green Accepted			2022-12-28	WOS:000305509600034
J	Kalyana-Sundaram, S; Kumar-Sinha, C; Shankar, S; Robinson, DR; Wu, YM; Cao, XH; Asangani, IA; Kothari, V; Prensner, JR; Lonigro, RJ; Iyer, MK; Barrette, T; Shanmugam, A; Dhanasekaran, SM; Palanisamy, N; Chinnaiyan, AM				Kalyana-Sundaram, Shanker; Kumar-Sinha, Chandan; Shankar, Sunita; Robinson, Dan R.; Wu, Yi-Mi; Cao, Xuhong; Asangani, Irfan A.; Kothari, Vishal; Prensner, John R.; Lonigro, Robert J.; Iyer, Matthew K.; Barrette, Terrence; Shanmugam, Achiraman; Dhanasekaran, Saravana M.; Palanisamy, Nallasivam; Chinnaiyan, Arul M.			Expressed Pseudogenes in the Transcriptional Landscape of Human Cancers	CELL			English	Article							PROSTATE-CANCER; TRANSCRIBED PSEUDOGENE; CONNEXIN43 PSEUDOGENE; GENE-EXPRESSION; GASTRIC-CANCER; IDENTIFICATION; RNA; CELLS; PROTEIN; GENOME	Pseudogene transcripts can provide a novel tier of gene regulation through generation of endogenous siRNAs or miRNA-binding sites. Characterization of pseudogene expression, however, has remained confined to anecdotal observations due to analytical challenges posed by the extremely close sequence similarity with their counterpart coding genes. Here, we describe a systematic analysis of pseudogene "transcription" from an RNA-Seq resource of 293 samples, representing 13 cancer and normal tissue types, and observe a surprisingly prevalent, genome-wide expression of pseudogenes that could be categorized as ubiquitously expressed or lineage and/or cancer specific. Further, we explore disease subtype specificity and functions of selected expressed pseudogenes. Taken together, we provide evidence that transcribed pseudogenes are a significant contributor to the transcriptional landscape of cells and are positioned to play significant roles in cellular differentiation and cancer progression, especially in light of the recently described ceRNA networks. Our work provides a transcriptome resource that enables high-throughput analyses of pseudogene expression.	[Kalyana-Sundaram, Shanker; Kumar-Sinha, Chandan; Shankar, Sunita; Robinson, Dan R.; Wu, Yi-Mi; Cao, Xuhong; Asangani, Irfan A.; Kothari, Vishal; Prensner, John R.; Lonigro, Robert J.; Iyer, Matthew K.; Barrette, Terrence; Dhanasekaran, Saravana M.; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Kalyana-Sundaram, Shanker; Kumar-Sinha, Chandan; Shankar, Sunita; Robinson, Dan R.; Wu, Yi-Mi; Asangani, Irfan A.; Prensner, John R.; Lonigro, Robert J.; Barrette, Terrence; Dhanasekaran, Saravana M.; Palanisamy, Nallasivam; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Cao, Xuhong; Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Kalyana-Sundaram, Shanker; Shanmugam, Achiraman] Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli 620024, India	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Bharathidasan University	Chinnaiyan, AM (corresponding author), Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Kalyana-Sundaram, Shanker/F-6860-2012; Palanisamy, Nallasivam/ABC-8844-2020	Palanisamy, Nallasivam/0000-0002-0633-9772; Prensner, John/0000-0002-7024-636X; Dhanasekaran, saravana mohan/0000-0002-0489-2224; Kothari, Vishal/0000-0001-7453-1435; Kumar, Chandan/0000-0002-8696-3400; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; asangani, irfan/0000-0001-5381-1702	National Institutes of Health [R01CA132874]; Early Detection Research Network grant [UO1 CA111275]; Prostate SPORE grant [P50CA69568]; Department of Defense Era of Hope grant [BC075023]; Doris Duke Charitable Foundation Clinical Scientist Award; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [U01CA111275, T32CA009676, P50CA069568, R01CA132874] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Early Detection Research Network grant; Prostate SPORE grant; Department of Defense Era of Hope grant(United States Department of Defense); Doris Duke Charitable Foundation Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Ram-Shankar Mani, Kalpana Ramnarayanan, Joseph Mierwaza, and Sooryanarayana Varambally for technical help and Javed Siddiqui for providing samples. This work was supported, in part, by the National Institutes of Health (R01CA132874), Early Detection Research Network grant UO1 CA111275, Prostate SPORE grant P50CA69568, and the Department of Defense Era of Hope grant BC075023 (A. M. C.). A. M. C. is supported by the Doris Duke Charitable Foundation Clinical Scientist Award and the Prostate Cancer Foundation. A. M. C. is an American Cancer Society Research Professor and A. Alfred Taubman Scholar.	Bier A, 2009, MOL CANCER THER, V8, P786, DOI 10.1158/1535-7163.MCT-08-0930; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Dormeyer W, 2008, J PROTEOME RES, V7, P2936, DOI 10.1021/pr800056j; Han H, 2011, CELL, V146, P1044, DOI 10.1016/j.cell.2011.09.002; Han YJ, 2011, FASEB J, V25, P2305, DOI 10.1096/fj.10-177808; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Kandouz M, 2004, ONCOGENE, V23, P4763, DOI 10.1038/sj.onc.1207506; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Karro JE, 2007, NUCLEIC ACIDS RES, V35, pD55, DOI 10.1093/nar/gkl851; Kastler S, 2010, PROSTATE, V70, P666, DOI 10.1002/pros.21100; Katoh M, 2003, INT J ONCOL, V23, P525; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khachane AN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010316; Khoo C, 1997, PROTEIN EXPRES PURIF, V9, P379, DOI 10.1006/prep.1996.0709; Lai J, 2010, RNA, V16, P1156, DOI 10.1261/rna.2019810; Lam HYK, 2009, NUCLEIC ACIDS RES, V37, pD738, DOI 10.1093/nar/gkn758; Li G, 2011, MOL BIOL EVOL, V28, P911, DOI 10.1093/molbev/msq281; Lu W, 2006, PROSTATE, V66, P936, DOI 10.1002/pros.20382; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pong RC, 2003, CANCER RES, V63, P8680; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rieger MA, 2004, CANCER RES, V64, P2357, DOI 10.1158/0008-5472.CAN-03-0849; Ruan YJ, 2007, GENOME RES, V17, P828, DOI 10.1101/gr.6018607; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Yao A, 2006, NUCLEIC ACIDS RES, V34, P4477, DOI 10.1093/nar/gkl591; Zhang ZL, 2006, BIOINFORMATICS, V22, P1437, DOI 10.1093/bioinformatics/btl116; Zhang ZD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r26; Zhang ZL, 2004, CURR OPIN GENET DEV, V14, P328, DOI 10.1016/j.gde.2004.06.003; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zheng D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s13; ZHOU BS, 1992, CANCER RES, V52, P4280; Zou MJ, 2009, NEOPLASIA, V11, P57, DOI 10.1593/neo.81044	44	197	211	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1622	1634		10.1016/j.cell.2012.04.041	http://dx.doi.org/10.1016/j.cell.2012.04.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726445	Green Accepted, Bronze			2022-12-28	WOS:000305753800025
J	Kasahara, S; Shi, HJ; Hashimoto, K; Tonegawa, S; Mizukami, Y; Shibauchi, T; Sugimoto, K; Fukuda, T; Terashima, T; Nevidomskyy, AH; Matsuda, Y				Kasahara, S.; Shi, H. J.; Hashimoto, K.; Tonegawa, S.; Mizukami, Y.; Shibauchi, T.; Sugimoto, K.; Fukuda, T.; Terashima, T.; Nevidomskyy, Andriy H.; Matsuda, Y.			Electronic nematicity above the structural and superconducting transition in BaFe2(As1-xPx)(2)	NATURE			English	Article							ROTATIONAL SYMMETRY; ANISOTROPY; BREAKING; STATE; PHASE	Electronic nematicity, a unidirectional self-organized state that breaks the rotational symmetry of the underlying lattice(1,2), has been observed in the iron pnictide(3-7) and copper oxide(8-11) high-temperature superconductors. Whether nematicity plays an equally important role in these two systems is highly controversial. In iron pnictides, the nematicity has usually been associated with the tetragonal-to-orthorhombic structural transition at temperature T-s. Although recent experiments(3-7) have provided hints of nematicity, they were performed either in the low-temperature orthorhombic phase(3,5) or in the tetragonal phase under uniaxial strain(4,6,7), both of which break the 90 degrees rotational C-4 symmetry. Therefore, the question remains open whether the nematicity can exist above T-s without an external driving force. Here we report magnetic torque measurements of the isovalent-doping system BaFe2(As1-xPx)(2), showing that the nematicity develops well above T-s and, moreover, persists to the non-magnetic superconducting regime, resulting in a phase diagram similar to the pseudogap phase diagram of the copper oxides(8,12). By combining these results with synchrotron X-ray measurements, we identify two distinct temperatures-one at T*, signifying a true nematic transition, and the other at T-s (<T*), which we show not to be a true phase transition, but rather what we refer to as a 'meta-nematic transition', in analogy to the well-known meta-magnetic transition in the theory of magnetism.	[Kasahara, S.; Shi, H. J.; Hashimoto, K.; Tonegawa, S.; Mizukami, Y.; Shibauchi, T.; Matsuda, Y.] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Kasahara, S.; Terashima, T.] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Kyoto 6068501, Japan; [Sugimoto, K.] JASRI SPring 8, Res & Utilizat Div, Sayo, Hyogo 6795198, Japan; [Sugimoto, K.] RIKEN SPring 8, Struct Mat Sci Lab, Sayo, Hyogo 6795148, Japan; [Fukuda, T.] JAEA SPring 8, Quantum Beam Sci Directorate, Sayo, Hyogo 6795148, Japan; [Fukuda, T.] RIKEN SPring 8, Mat Dynam Lab, Sayo, Hyogo 6795148, Japan; [Fukuda, T.] Transformat Res Project Iron Pnictides TRIP, JST, Chiyoda Ku, Tokyo 1020075, Japan; [Nevidomskyy, Andriy H.] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA	Kyoto University; Kyoto University; Japan Synchrotron Radiation Research Institute; RIKEN; Japan Atomic Energy Agency; RIKEN; Japan Science & Technology Agency (JST); Rice University	Matsuda, Y (corresponding author), Kyoto Univ, Dept Phys, Kyoto 6068502, Japan.	shibauchi@scphys.kyoto-u.ac.jp; matsuda@scphys.kyoto-u.ac.jp	Shibauchi, Takasada/B-9349-2008; Sugimoto, Kunihisa/R-2799-2019; Mizukami, Yuta/AAG-9991-2019; Kasahara, Shigeru/H-3064-2014; Hashimoto, Kenichiro/C-4925-2012; Matsuda, Yuji/ABH-7166-2020	Shibauchi, Takasada/0000-0001-5831-4924; Mizukami, Yuta/0000-0002-3881-331X; Kasahara, Shigeru/0000-0002-6007-9617; Hashimoto, Kenichiro/0000-0003-4651-4077; Matsuda, Yuji/0000-0001-9947-9418; Sugimoto, Kunihisa/0000-0002-0103-8153; Nevidomskyy, Andriy/0000-0002-8684-7979	Global COE programme 'The Next Generation of Physics, Spun from Universality and Emergence' from MEXT of Japan; KAKENHI programme from JSPS; Grants-in-Aid for Scientific Research [23654118] Funding Source: KAKEN	Global COE programme 'The Next Generation of Physics, Spun from Universality and Emergence' from MEXT of Japan; KAKENHI programme from JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J. G. Analytis, A. Q. R. Baron, E. Bascones, A. Carrington, A. V. Chubukov, R. M. Fernandes, I. Fischer, H. Ikeda, H. Kontani, R. Okazaki and J. Schmalian for discussions. This research was supported by a Grant-in-Aid for the Global COE programme 'The Next Generation of Physics, Spun from Universality and Emergence' from MEXT of Japan, and by the KAKENHI programme from JSPS. A.H.N. and Y.M. acknowledge the hospitality of the Aspen Center for Physics. The synchrotron radiation experiments were performed at the BL02B1 of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI).	Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Bohmer A. E., 2012, THERMODYNAMIC PHASE; Chen CC, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.100504; Chu JH, 2010, SCIENCE, V329, P824, DOI 10.1126/science.1190482; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Fang C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.224509; Fernandes RM, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.024534; Fernandes RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.157003; Fradkin E, 2010, ANNU REV CONDEN MA P, V1, P153, DOI 10.1146/annurev-conmatphys-070909-103925; Hashimoto K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.220501; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Inoue Y., 2011, IMPURITY INDUCED ELE; Kasahara S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.184519; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Lang G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.097001; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; Lee CC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.267001; Lv WC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.224506; Martinelli A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.227001; Nakai Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.107003; Nevidomskyy A. H, 2011, INTERPLAY ORBITAL SP; Okazaki R, 2011, SCIENCE, V331, P439, DOI 10.1126/science.1197358; Shishido H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.057008; Singh R. R. P, 2009, EXCHANGE CONSTANTS N; Tanatar MA, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.184508; Xu C, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020501; Yi M, 2011, P NATL ACAD SCI USA, V108, P6878, DOI 10.1073/pnas.1015572108; Zhao J, 2009, NAT PHYS, V5, P555, DOI 10.1038/NPHYS1336	30	363	365	5	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					382	385		10.1038/nature11178	http://dx.doi.org/10.1038/nature11178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722198	Green Submitted			2022-12-28	WOS:000305466800039
J	Diamant, M				Diamant, Michaela			Choosing a blood-glucose-lowering agent after metformin	LANCET			English	Editorial Material							TYPE-2; INITIATION; THERAPY; TRIAL		Vrije Univ Amsterdam, Med Ctr, Ctr Diabet, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Diamant, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, Ctr Diabet, NL-1081 HV Amsterdam, Netherlands.	m.diamant@vumc.nl						Aschner P, 2012, LANCET, V379, P2262, DOI 10.1016/S0140-6736(12)60439-5; Esposito K, 2011, ARCH INTERN MED, V171, P365, DOI 10.1001/archinternmed.2011.4; Fineman MS, 2012, DIABETES OBES METAB, V14, P675, DOI 10.1111/j.1463-1326.2012.01560.x; Gerstein HC, 2008, AM HEART J, V155, P26, DOI 10.1016/j.ahj.2007.09.009; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kunt T, 2009, INT J CLIN PRACT, V63, P6, DOI 10.1111/j.1742-1241.2009.02176.x; Liu SC, 2012, DIABETES OBES METAB, V14, P810, DOI 10.1111/j.1463-1326.2012.01606.x; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; van Genugten RE, 2012, DIABETES OBES METAB, V14, P101, DOI 10.1111/j.1463-1326.2011.01473.x; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Zinman B, 2012, DIABETES OBES METAB, V14, P77, DOI 10.1111/j.1463-1326.2011.01493.x	14	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2012	379	9833					2220	2221		10.1016/S0140-6736(12)60780-6	http://dx.doi.org/10.1016/S0140-6736(12)60780-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962AM	22683135				2022-12-28	WOS:000305511400008
J	Dixon, JB; le Roux, CW; Rubino, F; Zimmet, P				Dixon, John B.; le Roux, Carel W.; Rubino, Francesco; Zimmet, Paul			Bariatric surgery for type 2 diabetes	LANCET			English	Article							Y GASTRIC BYPASS; VERTICAL BANDED GASTROPLASTY; CARDIOVASCULAR RISK-FACTORS; GLUCAGON-LIKE PEPTIDE-1; FACILITATE WEIGHT-LOSS; LONG-TERM PERSISTENCE; BETA-CELL FUNCTION; SLEEVE GASTRECTOMY; INSULIN SENSITIVITY; MORBID-OBESITY	Bariatric surgery provides substantial, sustained weight loss and major improvements in glycaemic control in severely obese individuals with type 2 diabetes. However, uptake of surgery in eligible patients is poor, and the barriers are difficult to surmount. We examine the indications for and efficacy and safety of conventional bariatric surgical procedures and their effect on glycaemic control in type 2 diabetes. How surgical gastrointestinal interventions achieve these changes is of great research interest, and is evolving rapidly. Old classifications about restriction and malabsorption are inadequate, and we explore understanding of putative mechanisms. Some bariatric procedures improve glycaemic control in people with diabetes beyond that expected for weight loss, and understanding this additional effect could provide insights into the pathogenesis of type 2 diabetes and assist in the development of new procedures, devices, and drugs both for obese and non-obese patients.	[Dixon, John B.; Zimmet, Paul] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [le Roux, Carel W.] Univ London Imperial Coll Sci Technol & Med, Imperial Weight Ctr, London, England; [Rubino, Francesco] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA	Baker Heart and Diabetes Institute; Imperial College London; Cornell University	Dixon, JB (corresponding author), Baker IDI Heart & Diabet Inst, 75 Commercial Rd, Melbourne, Vic 3004, Australia.	john.dixon@bakeridi.edu.au	Zimmet, Paul/O-8486-2019; Dixon, John B/A-5318-2011; Zimmet, Paul/H-7635-2013	Zimmet, Paul/0000-0003-0627-0776; Dixon, John B/0000-0001-5391-4082; Le Roux, Carel/0000-0001-5521-5445	Allergan; Scientific Intake; Metagenics; Covidien; Roche; Metacure; Novo Nordisk; GlaxoSmithKline; Abbott; Eli Lilly; ResMed; Novartis; National Health and Medical Research Council of Australia; National Institute for Health Research [DHCS/05/05] Funding Source: researchfish	Allergan(AbbVieAllergan); Scientific Intake; Metagenics; Covidien; Roche(Roche Holding); Metacure; Novo Nordisk(Novo Nordisk); GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); Eli Lilly(Eli Lilly); ResMed; Novartis(Novartis); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research(National Institute for Health Research (NIHR))	JBD has received research funding and support from Allergan and Scientific Intake. He is on the Medical Advisory Board for Nestle Australia and has received consultancy fees from Allergan and Metagenics. FR has received research grants from Covidien and Roche. He is a member of the scientific advisory board of NGM Biopharmaceuticals. PZ has received a consultancy fee from Covidien in the past. He has received speakers' fees from Metacure, Novo Nordisk, GlaxoSmithKline, Abbott, Eli Lilly, ResMed, and Novartis. CWlR declares that he has no conflicts of interest.; JBD receives a research fellowship from the National Health and Medical Research Council of Australia. We thank Toni McGee for her assistance with the collation, review, and submission of the article.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Adams TD, 2010, OBESITY, V18, P121, DOI 10.1038/oby.2009.178; Adams TD, 2009, WORLD J SURG, V33, P2028, DOI 10.1007/s00268-009-0169-1; Afonso BB, 2010, SURG OBES RELAT DIS, V6, P16, DOI 10.1016/j.soard.2009.07.006; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; [Anonymous], 1995, Diabetes, V44, P1249; [Anonymous], 1980, JAMA, V243, P519; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; Bjorklund P, 2010, OBES SURG, V20, P1408, DOI 10.1007/s11695-010-0192-1; Borg CM, 2006, BRIT J SURG, V93, P210, DOI 10.1002/bjs.5227; Brethauer SA, 2009, SURG OBES RELAT DIS, V5, P469, DOI 10.1016/j.soard.2009.05.011; Buchwald H, 2004, OBES SURG, V14, P1157, DOI 10.1381/0960892042387057; Buchwald H., 2004, JAMA (Journal of the American Medical Association), V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H, 2007, SURGERY, V142, P621, DOI 10.1016/j.surg.2007.07.018; Buchwald H, 2009, OBES SURG, V19, P1, DOI [10.1007/s11695-008-9788-0, 10.1007/s11695-009-0014-5]; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Bueter M, 2011, PHYSIOL BEHAV, V104, P709, DOI 10.1016/j.physbeh.2011.07.025; Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; Burton PR, 2009, OBES SURG, V19, P905, DOI 10.1007/s11695-009-9845-3; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Camastra S, 2011, DIABETOLOGIA, V54, P2093, DOI 10.1007/s00125-011-2193-6; Centers for Medicare and Medicaid Services, BAR SURG CMS NAT COV; Chapman AE, 2004, SURGERY, V135, P326, DOI 10.1016/S0039-6060(03)00392-1; Chikunguwo SM, 2010, SURG OBES RELAT DIS, V6, P254, DOI 10.1016/j.soard.2009.11.003; Cigaina V, 2004, OBES SURG, V14, pS14, DOI 10.1007/BF03342133; Colles SL, 2008, OBES SURG, V18, P833, DOI 10.1007/s11695-007-9409-3; Colquitt J., 2009, COCHRANE DB SYST REV, V15, P1, DOI DOI 10.1002/14651858.CD003641.PUB3; Cummings DE, 2009, INT J OBESITY, V33, pS33, DOI 10.1038/ijo.2009.15; Deitel M, 2010, HDB OBESITY SURG; DeMaria EJ, 2010, SURG OBES RELAT DIS, V6, P347, DOI 10.1016/j.soard.2009.11.015; DePaula AL, 2011, OBES SURG, V21, P668, DOI 10.1007/s11695-010-0232-x; DePaula AL, 2011, WORLD J SURG, V35, P102, DOI 10.1007/s00268-010-0799-3; DiGiorgi M, 2010, SURG OBES RELAT DIS, V6, P249, DOI 10.1016/j.soard.2009.09.019; Dixon AFR, 2005, J CLIN ENDOCR METAB, V90, P813, DOI 10.1210/jc.2004-1546; Dixon JB, 2012, OBES REV, V13, P57, DOI 10.1111/j.1467-789X.2011.00928.x; Dixon JB, 2011, DIABETIC MED, V28, P628, DOI 10.1111/j.1464-5491.2011.03306.x; Dixon JB, 2003, ARCH INTERN MED, V163, P2058, DOI 10.1001/archinte.163.17.2058; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Dumonceau JM, 2008, OBES SURG, V18, P1611, DOI 10.1007/s11695-008-9593-9; Favretti F, 2002, AM J SURG, V184, p38S, DOI 10.1016/S0002-9610(02)01178-9; Favretti F, 2007, OBES SURG, V17, P168, DOI 10.1007/s11695-007-9043-0; Fenske WK, 2012, INT J OBESITY, V36, P379, DOI 10.1038/ijo.2011.126; Ferzli GS, 2009, WORLD J SURG, V33, P972, DOI 10.1007/s00268-009-9968-7; Finkelstein EA, 2011, SURG OBES RELAT DIS, V7, P295, DOI 10.1016/j.soard.2010.10.011; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Fried M, 2007, INT J OBESITY, V31, P569, DOI 10.1038/sj.ijo.0803560; FRIEDMAN MN, 1955, SURG GYNECOL OBSTET, V100, P201; Gill RS, 2010, SURG OBES RELAT DIS, V6, P707, DOI 10.1016/j.soard.2010.07.011; Gluckman PD, 2008, INT J OBESITY, V32, pS62, DOI 10.1038/ijo.2008.240; Gregg EW, 2007, PREV MED, V45, P348, DOI 10.1016/j.ypmed.2007.07.020; Hayden MJ, 2008, AUST J PRIM HEALTH, V14, P9, DOI 10.1071/PY08031; Hofso D, 2010, EUR J ENDOCRINOL, V163, P735, DOI 10.1530/EJE-10-0514; Hudson SM, 2002, OBES SURG, V12, P789, DOI 10.1381/096089202320995565; Iaconelli A, 2011, DIABETES CARE, V34, P561, DOI 10.2337/dc10-1761; Isbell JM, 2010, DIABETES CARE, V33, P1438, DOI 10.2337/dc09-2107; Kasama K, 2008, OBES SURG, V18, P1473, DOI 10.1007/s11695-008-9492-0; Korner J, 2009, INT J OBESITY, V33, P786, DOI 10.1038/ijo.2009.79; Korner J, 2007, SURG OBES RELAT DIS, V3, P597, DOI 10.1016/j.soard.2007.08.004; Kramer H, 2010, J DIABETES COMPLICAT, V24, P368, DOI 10.1016/j.jdiacomp.2009.10.001; Laferrere B, 2008, J CLIN ENDOCR METAB, V93, P2479, DOI 10.1210/jc.2007-2851; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Laferrere B, 2010, J CLIN ENDOCR METAB, V95, P4072, DOI 10.1210/jc.2009-2767; Laurenius A, 2012, INT J OBESITY, V36, P348, DOI 10.1038/ijo.2011.217; le Roux CW, 2007, ANN SURG, V246, P780, DOI 10.1097/SLA.0b013e3180caa3e3; le Roux CW, 2011, AM J PHYSIOL-REG I, V301, pR1057, DOI 10.1152/ajpregu.00139.2011; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Lee HC, 2010, OBES SURG, V20, P1530, DOI 10.1007/s11695-010-0248-2; Lee WJ, 2011, ARCH SURG-CHICAGO, V146, P143, DOI 10.1001/archsurg.2010.326; Leslie DB, 2012, OBES SURG, V22, P367, DOI 10.1007/s11695-011-0494-y; Li JV, 2011, GUT, V60, P1214, DOI 10.1136/gut.2010.234708; Liebl A, 2002, DIABETOLOGIA, V45, pS23, DOI 10.1007/s00125-002-0863-0; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Logue J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c154; MacDonald K G Jr, 1997, J Gastrointest Surg, V1, P213, DOI 10.1016/S1091-255X(97)80112-6; Mari A, 2006, DIABETOLOGIA, V49, P2136, DOI 10.1007/s00125-006-0337-x; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; Mechanick JI, 2008, SURG OBES RELAT DIS, V4, pS109, DOI 10.1016/j.soard.2008.08.009; Mingrone G, 2009, DIABETES OBES METAB, V11, P130, DOI 10.1111/j.1463-1326.2009.01120.x; Nannipieri M, 2011, J CLIN ENDOCR METAB, V96, pE1372, DOI 10.1210/jc.2011-0446; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; National Institutes of Health (USA), 1992, American Journal of Clinical Nutrition, V55, p615S; NICE, 2006, OB GUID PREV ID ASS; O'Brien PE, 2006, OBES SURG, V16, P1032, DOI 10.1381/096089206778026316; O'Brien PE, 2010, J GASTROEN HEPATOL, V25, P1358, DOI 10.1111/j.1440-1746.2010.06391.x; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; Padwal RS, 2011, J OBES, V2011, DOI 10.1155/2011/686521; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Peeters A, 2007, ANN SURG, V246, P1028, DOI 10.1097/SLA.0b013e31814a6929; Picot J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13410; Pinheiro JS, 2008, SURG OBES RELAT DIS, V4, P521, DOI 10.1016/j.soard.2007.12.016; Pinkney JH, 2001, LANCET, V357, P1357, DOI 10.1016/S0140-6736(00)04524-4; Pontiroli AE, 2005, DIABETES CARE, V28, P2703, DOI 10.2337/diacare.28.11.2703; Pories WJ, 2010, OBESITY, V18, P865, DOI 10.1038/oby.2010.8; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Pournaras DJ, 2012, BRIT J SURG, V99, P100, DOI 10.1002/bjs.7704; Pournaras DJ, 2010, ANN SURG, V252, P966, DOI 10.1097/SLA.0b013e3181efc49a; Reis CE, 2011, DIABETES TECHNOL THE, V14, P41; Ritz P, 2011, DIABETES METAB, V37, P274, DOI 10.1016/j.diabet.2011.04.003; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Rosenbaum M, 2010, BRAIN RES, V1350, P95, DOI 10.1016/j.brainres.2010.05.062; Rubino FA, 2004, ANN SURG, V239, P1, DOI 10.1097/01.sla.0000102989.54824.fc; Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b; Rubino F, 2010, ANN SURG, V251, P399, DOI 10.1097/SLA.0b013e3181be34e7; Scopinaro N, 2011, ANN SURG, V253, P699, DOI 10.1097/SLA.0b013e318203ae44; Serrot FJ, 2011, SURGERY, V150, P684, DOI 10.1016/j.surg.2011.07.069; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shikora SA, 2009, SURG OBES RELAT DIS, V5, P31, DOI 10.1016/j.soard.2008.09.012; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Spector AC, 2000, NEUROSCI BIOBEHAV R, V24, P391, DOI 10.1016/S0149-7634(00)00013-0; Stylopoulos N, 2009, OBESITY, V17, P1839, DOI 10.1038/oby.2009.207; SUGERMAN HJ, 1987, ANN SURG, V205, P613, DOI 10.1097/00000658-198706000-00002; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Thomas DE, 2010, BRIT J NUTR, V104, P797, DOI 10.1017/S0007114510001534; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; UN News Centre, UN LAUNCH GLOB CAMP; Unwin N, 2010, DIABETES RES CLIN PR, V87, P2, DOI 10.1016/j.diabres.2009.11.006; Van der Schueren BJ, 2012, DIABETES CARE, V35, P42, DOI 10.2337/dc11-1472; Vetter ML, 2009, ANN INTERN MED, V150, P94, DOI 10.7326/0003-4819-150-2-200901200-00007; Vidal J, 2008, OBES SURG, V18, P1077, DOI 10.1007/s11695-008-9547-2; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Welbourn R, 2011, 1 REGISTRY REPORT MA; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Zimmet P, 2011, LANCET, V378, P108, DOI 10.1016/S0140-6736(11)61027-1	128	200	218	1	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2012	379	9833					2300	2311		10.1016/S0140-6736(12)60401-2	http://dx.doi.org/10.1016/S0140-6736(12)60401-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962AM	22683132				2022-12-28	WOS:000305511400037
J	Funnell, MM; Piatt, GA				Funnell, Martha M.; Piatt, Gretchen A.			Diabetes quality improvement: beyond glucose control	LANCET			English	Editorial Material							CHRONIC CARE MODEL		[Funnell, Martha M.] Univ Michigan, Sch Med, Dept Med Educ, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Michigan Diabet Res & Training Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Funnell, MM (corresponding author), Univ Michigan, Sch Med, Dept Med Educ, Ann Arbor, MI 48109 USA.	mfunnell@umich.edu		Piatt, Gretchen/0000-0001-6641-6330				Anderson Robert M, 2009, Ther Patient Educ, V1, P3; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; CDC, 2009, NAT DIAB FACT SHEET; Cheung BMY, 2009, AM J MED, V122, P443, DOI 10.1016/j.amjmed.2008.09.047; Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Davidson MB, 2003, DIABETES CARE, V26, P2281, DOI 10.2337/diacare.26.8.2281; Haire-Joshu D, 1999, DIABETES CARE, V22, P1887, DOI 10.2337/diacare.22.11.1887; Piatt GA, 2006, DIABETES CARE, V29, P811, DOI 10.2337/diacare.29.04.06.dc05-1785; Piatt GA, 2010, DIABETES EDUCATOR, V36, P301, DOI 10.1177/0145721710361388; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Snow V, 2003, ANN INTERN MED, V138, P587, DOI 10.7326/0003-4819-138-7-200304010-00017; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2	12	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 16	2012	379	9833					2218	2219		10.1016/S0140-6736(12)60637-0	http://dx.doi.org/10.1016/S0140-6736(12)60637-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	962AM	22683133				2022-12-28	WOS:000305511400007
J	Shay, JW; Reddel, RR; Wright, WE				Shay, Jerry W.; Reddel, Roger R.; Wright, Woodring E.			Cancer and Telomeres-An ALTernative to Telomerase	SCIENCE			English	Editorial Material							HUMAN-CELLS; SENESCENCE; MUTATIONS; MECHANISM; TUMORS		[Shay, Jerry W.; Wright, Woodring E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Shay, Jerry W.; Wright, Woodring E.] KAU, CEGMR, Jeddah, Saudi Arabia; [Reddel, Roger R.] Childrens Med Res Inst, Canc Res Unit, Westmead, NSW 2145, Australia; [Reddel, Roger R.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Texas System; University of Texas Southwestern Medical Center Dallas; King Abdulaziz University; Children's Medical Research Institute - Australia; University of Sydney	Shay, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	jerry.shay@utsouthwestern.edu	Reddel, Roger R/A-6635-2014	Reddel, Roger R/0000-0002-6302-6107	NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR030414] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA070907] Funding Source: Medline; NCRR NIH HHS [C06 RR030414] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bechter OE, 2004, CANCER RES, V64, P3444, DOI 10.1158/0008-5472.CAN-04-0323; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Henson JD, 2010, FEBS LETT, V584, P3800, DOI 10.1016/j.febslet.2010.06.009; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; Ouellette MM, 2011, J CELL MOL MED, V15, P1433, DOI 10.1111/j.1582-4934.2011.01279.x; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2	16	99	103	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1388	1390		10.1126/science.1222394	http://dx.doi.org/10.1126/science.1222394			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700908				2022-12-28	WOS:000305211700028
J	O'Leary, B; Eminowicz, G; Powell, ME; Pacey, S				O'Leary, B.; Eminowicz, G.; Powell, M. E.; Pacey, S.			PICTURE QUIZ Another patient with low back pain	BRITISH MEDICAL JOURNAL			English	Editorial Material							SPINAL-CORD COMPRESSION		[O'Leary, B.; Eminowicz, G.; Powell, M. E.; Pacey, S.] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Pacey, S (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Box 193 R4, Cambridge CB2 0QQ, England.	simonpacey@medschl.cam.ac.uk		Pacey, Simon Christopher/0000-0002-3303-7577; O'Leary, Ben/0000-0002-1092-9169				Levack P, 2002, CLIN ONCOL-UK, V14, P472, DOI 10.1053/clon.2002.0098; Levack P, 2001, PROSPECTIVE AUDIT DI; Loblaw DA, 2003, CLIN ONCOL-UK, V15, P211, DOI 10.1016/S0936-6555(02)00400-4; *NAT I HLTH CLIN E, 2008, MET SPIN CORD COMPR; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1; Shirado O, 2004, LUMBAR SPINE, P824; World Health Organization, 2010, WHOS PAIN LADD	7	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 14	2012	344								e3510	10.1136/bmj.e3510	http://dx.doi.org/10.1136/bmj.e3510			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961LA	22700783				2022-12-28	WOS:000305464700003
J	Egdell, R; Egdell, D; Solomon, T				Egdell, Raymond; Egdell, Darren; Solomon, Tom			Herpes simplex virus encephalitis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool L9 7LJ, Merseyside, England; [Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England	Walton Centre; University of Liverpool	Solomon, T (corresponding author), Walton Ctr NHS Fdn Trust, Liverpool L9 7LJ, Merseyside, England.	tsolomon@liverpool.ac.uk		Solomon, Tom/0000-0001-7266-6547	Medical Research Council [G116/194] Funding Source: Medline; Department of Health [RP-PG-0108-10048] Funding Source: Medline; MRC [G116/194] Funding Source: UKRI; National Institute for Health Research [RP-PG-0108-10048] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))			0	3	3	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 13	2012	344								e3630	10.1136/bmj.e3630	http://dx.doi.org/10.1136/bmj.e3630			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961KT	22695900				2022-12-28	WOS:000305464000004
J	Hammond, GRV; Fischer, MJ; Anderson, KE; Holdich, J; Koteci, A; Balla, T; Irvine, RF				Hammond, Gerald R. V.; Fischer, Michael J.; Anderson, Karen E.; Holdich, Jon; Koteci, Ardita; Balla, Tamas; Irvine, Robin F.			PI4P and PI(4,5)P-2 Are Essential But Independent Lipid Determinants of Membrane Identity	SCIENCE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; LIVING CELLS; K+ CHANNEL; PHOSPHOINOSITIDES; DOMAINS; POOLS; ACTIVATION; PROTEINS; MULTIPLE	The quantitatively minor phospholipid phosphatidylinositol (4,5)-bisphosphate [PI(4,5)P-2] fulfills many cellular functions in the plasma membrane (PM), whereas its synthetic precursor, phosphatidylinositol 4-phosphate (PI4P), has no assigned PM roles apart from PI(4,5)P-2 synthesis. We used a combination of pharmacological and chemical genetic approaches to probe the function of PM PI4P, most of which was not required for the synthesis or functions of PI(4,5)P-2. However, depletion of both lipids was required to prevent PM targeting of proteins that interact with acidic lipids or activation of the transient receptor potential vanilloid 1 cation channel. Therefore, PI4P contributes to the pool of polyanionic lipids that define plasma membrane identity and to some functions previously attributed specifically to PI(4,5)P-2, which may be fulfilled by a more general polyanionic lipid requirement.	[Hammond, Gerald R. V.; Fischer, Michael J.; Holdich, Jon; Koteci, Ardita; Irvine, Robin F.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Anderson, Karen E.] Babraham Inst, Inositide Lab, Cambridge CB22 3AT, England; [Hammond, Gerald R. V.; Balla, Tamas] NICHHD, Sect Mol Signal Transduct, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA	University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hammond, GRV (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	gerald.hammond@nih.gov; rfi20@cam.ac.uk	Hammond, Gerald R/A-5759-2016; Fischer, Michael J.M./P-8715-2014	Hammond, Gerald R/0000-0002-6660-3272; Fischer, Michael J.M./0000-0002-3811-7066; Koteci, Ardita/0000-0002-6074-7099; Anderson, Karen/0000-0002-7394-6660; Balla, Tamas/0000-0002-9077-3335	Wellcome Trust; Isaac Newton Trust; Alexander von Humboldt Foundation; UK Biotechnology and Biological Sciences Research Council; Dame Rosemary Murray Scholarship; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0415] Funding Source: researchfish; BBSRC [BBS/E/B/000C0415] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Isaac Newton Trust; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dame Rosemary Murray Scholarship; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. Lemmon, K. Moravcevic, D. Oliver, D. D. Saur, and L. Stephens for helpful discussions and constructs. G. R. V. H. and R. F. I. were supported by the Wellcome Trust and the Isaac Newton Trust, M.J.F. by the Alexander von Humboldt Foundation and the Isaac Newton Trust, K. E. A. by the UK Biotechnology and Biological Sciences Research Council, A. K. by a Dame Rosemary Murray Scholarship, and T. B. by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH. We thank V. Schram of the NICHD Microscopy and Imaging Core for technical assistance with fluorescence recovery after photobleaching experiments. Constructs used in this work are available from www.addgene.com.	Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; D'Avanzo N, 2010, J BIOL CHEM, V285, P37129, DOI 10.1074/jbc.C110.186692; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Sarkes D, 2010, BIOCHEM J, V428, P375, DOI 10.1042/BJ20100129; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	29	297	303	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2012	337	6095					727	730		10.1126/science.1222483	http://dx.doi.org/10.1126/science.1222483			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22722250	Green Accepted			2022-12-28	WOS:000307354500053
J	Bagijn, MP; Goldstein, LD; Sapetschnig, A; Weick, EM; Bouasker, S; Lehrbach, NJ; Simard, MJ; Miska, EA				Bagijn, Marloes P.; Goldstein, Leonard D.; Sapetschnig, Alexandra; Weick, Eva-Maria; Bouasker, Samir; Lehrbach, Nicolas J.; Simard, Martin J.; Miska, Eric A.			Function, Targets, and Evolution of Caenorhabditis elegans piRNAs	SCIENCE			English	Article							C-ELEGANS; DNA METHYLATION; PIWI; RNA; DROSOPHILA; 21U-RNAS; PATHWAY; AMPLIFICATION; ARGONAUTE; REVEALS	Piwi-interacting RNAs (piRNAs) are small RNAs required to maintain germline integrity and fertility, but their mechanism of action is poorly understood. Here we demonstrate that Caenorhabditis elegans piRNAs silence transcripts in trans through imperfectly complementary sites. Target silencing is independent of Piwi endonuclease activity or "slicing." Instead, piRNAs initiate a localized secondary endogenous small interfering RNA (endo-siRNA) response. Endogenous protein-coding gene and transposon transcripts exhibit Piwi-dependent endo-siRNAs at sites complementary to piRNAs and are derepressed in Piwi mutants. Genomic loci of piRNA biogenesis are depleted of protein-coding genes and tend to overlap the start and end of transposons in sense and antisense, respectively. Our data suggest that nematode piRNA clusters are evolving to generate piRNAs against active mobile elements. Thus, piRNAs provide heritable, sequence-specific triggers for RNA interference in C. elegans.	[Bagijn, Marloes P.; Goldstein, Leonard D.; Sapetschnig, Alexandra; Weick, Eva-Maria; Lehrbach, Nicolas J.; Miska, Eric A.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Bagijn, Marloes P.; Goldstein, Leonard D.; Sapetschnig, Alexandra; Weick, Eva-Maria; Lehrbach, Nicolas J.; Miska, Eric A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Bouasker, Samir; Simard, Martin J.] Univ Laval, Canc Res Ctr, Hotel Dieu Quebec CHUQ, Quebec City, PQ G1R 2J6, Canada	University of Cambridge; University of Cambridge; Laval University	Miska, EA (corresponding author), Univ Cambridge, Gurdon Inst, Henry Wellcome Bldg Canc & Dev Biol,Tennis Court, Cambridge CB2 1QN, England.	e.miska@gurdon.cam.ac.uk		Weick, Eva-Maria/0000-0002-3504-2572; Miska, Eric/0000-0002-4450-576X; Simard, Martin/0000-0002-3189-9309; Lehrbach, Nicolas/0000-0001-7342-4136	Human Frontier Science Program; Herchel-Smith Fund; Wellcome Trust (UK); Ph.D. studentship from the Herchel-Smith Fund; Canadian Institutes of Health Research (CIHR); Cancer Research UK; Wellcome Trust; Cancer Research UK [11832] Funding Source: researchfish	Human Frontier Science Program(Human Frontier Science Program); Herchel-Smith Fund; Wellcome Trust (UK)(Wellcome Trust); Ph.D. studentship from the Herchel-Smith Fund; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	We are grateful to J. Ahringer and E. Jorgensen for providing reagents. A. S. was supported by the Human Frontier Science Program and the Herchel-Smith Fund. N.J.L. was supported by a Ph.D. studentship from the Wellcome Trust (UK). E.-M. W. was supported by a Ph.D. studentship from the Herchel-Smith Fund. S. B. and M. J. S. were funded by the Canadian Institutes of Health Research (CIHR). M. J. S. is a New Investigator from CIHR. This work was supported by Cancer Research UK and the Wellcome Trust. Small RNA sequence data and Affymetrix gene expression data were submitted to the Gene Expression Omnibus under accession no. GSE37433. Detailed methods can be found in the supplementary materials.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	19	234	238	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					574	578		10.1126/science.1220952	http://dx.doi.org/10.1126/science.1220952			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22700655	Green Accepted			2022-12-28	WOS:000307058700043
J	Gerstein, HC; Bosch, J; Dagenais, GR; Diaz, R; Jung, HJ; Maggioni, AP; Pogue, J; Probstfield, J; Ramachandran, A; Riddle, MC; Ryden, LE; Yusuf, S				Gerstein, Hertzel C.; Bosch, Jackie; Dagenais, Gilles R.; Diaz, Rafael; Jung, Hyejung; Maggioni, Aldo P.; Pogue, Janice; Probstfield, Jeffrey; Ramachandran, Ambady; Riddle, Matthew C.; Ryden, Lars E.; Yusuf, Salim		ORIGIN Trial Investigators	Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-CELL FUNCTION; ENDOTHELIAL FUNCTION; DIABETES-MELLITUS; GLYCEMIC CONTROL; GLUCOSE CONTROL; RISK; THERAPY; PEOPLE; GLARGINE; DISEASE	BACKGROUND The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested. METHODS We randomly assigned 12,537 people (mean age, 63.5 years) with cardiovascular risk factors plus impaired fasting glucose, impaired glucose tolerance, or type 2 diabetes to receive insulin glargine (with a target fasting blood glucose level of <= 95 mg per deciliter [5.3 mmol per liter]) or standard care and to receive n-3 fatty acids or placebo with the use of a 2-by-2 factorial design. The results of the comparison between insulin glargine and standard care are reported here. The coprimary outcomes were nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes and these events plus revascularization or hospitalization for heart failure. Microvascular outcomes, incident diabetes, hypoglycemia, weight, and cancers were also compared between groups. RESULTS The median follow-up was 6.2 years (interquartile range, 5.8 to 6.7). Rates of incident cardiovascular outcomes were similar in the insulin-glargine and standard-care groups: 2.94 and 2.85 per 100 person-years, respectively, for the first coprimary outcome (hazard ratio, 1.02; 95% confidence interval [CI], 0.94 to 1.11; P = 0.63) and 5.52 and 5.28 per 100 person-years, respectively, for the second coprimary outcome (hazard ratio, 1.04; 95% CI, 0.97 to 1.11; P = 0.27). New diabetes was diagnosed approximately 3 months after therapy was stopped among 30% versus 35% of 1456 participants without baseline diabetes (odds ratio, 0.80; 95% CI, 0.64 to 1.00; P = 0.05). Rates of severe hypoglycemia were 1.00 versus 0.31 per 100 person-years. Median weight increased by 1.6 kg in the insulin-glargine group and fell by 0.5 kg in the standard-care group. There was no significant difference in cancers (hazard ratio, 1.00; 95% CI, 0.88 to 1.13; P = 0.97). CONCLUSIONS When used to target normal fasting plasma glucose levels for more than 6 years, insulin glargine had a neutral effect on cardiovascular outcomes and cancers. Although it reduced new-onset diabetes, insulin glargine also increased hypoglycemia and modestly increased weight. (Funded by Sanofi; ORIGIN ClinicalTrials.gov number, NCT00069784.)	[Gerstein, Hertzel C.; Yusuf, Salim] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Gerstein, Hertzel C.; Bosch, Jackie; Pogue, Janice; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Gerstein, Hertzel C.; Bosch, Jackie; Jung, Hyejung; Pogue, Janice; Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON, Canada; [Bosch, Jackie] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Dagenais, Gilles R.] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Diaz, Rafael] Estudios Clin Latino Amer, Rosario, Argentina; [Maggioni, Aldo P.] Assoc Nazl Med Cardiol Osped ANMCO Res Ctr, Florence, Italy; [Probstfield, Jeffrey] Univ Washington, Seattle, WA 98195 USA; [Ramachandran, Ambady] India Diabet Res Fdn, Madras, Tamil Nadu, India; [Riddle, Matthew C.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Ryden, Lars E.] Karolinska Inst, Dept Med, Stockholm, Sweden	McMaster University; McMaster University; Population Health Research Institute; McMaster University; McMaster University; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); University of Washington; University of Washington Seattle; Oregon Health & Science University; Karolinska Institutet	Gerstein, HC (corresponding author), Hamilton Gen Hosp, ORIGIN Project Off, Populat Hlth Res Inst, DBCVSRI, 237 Barton St E,2nd Fl, Hamilton, ON L8L 2X2, Canada.	origin@phri.ca	Hatipoglu, Esra/I-1793-2013; Gerstein, Hertzel/ABB-8781-2020; Urina-Triana, Miguel A/H-2605-2016; Gerstein, Hertzel C/B-1235-2013; Maggioni, Aldo Pietro/AAL-5334-2020; Adasheva, Tatiana/J-5713-2013; Facanha, Cristina Figueiredo Sampaio/AAW-7586-2021; Liesivuori, Jyrki/O-2519-2013; Carta, Karina Gonzalez/F-2649-2019; Acevedo, Monica/GSI-9787-2022; Ramirez, Alfredo/S-5126-2019; cornel, jan hein/Y-7065-2019; Colquhoun, David M/F-9078-2013; Derosa, Giuseppe/H-8571-2019; Bosch, Jacqueline/AAP-6910-2021; Freitas, Ismael/D-1723-2012; Cacciatore, Francesco/E-8619-2019; Zadionchenko, Vladimir/A-7445-2016; Gurevich, Victor/H-2935-2013; Del Prato, Stefano/K-3405-2016; Tütüncü, Neslihan Başçıl/ABG-5027-2020; Beniashvili, Allan/J-4649-2017; Hramiak, Irene/G-3305-2011; Berkovic, Maja Cigrovski/AAB-7735-2019; Gislason, Gunnar/B-7561-2009; Derosa, Giuseppe/F-2615-2012; Draman, Mohd Shazli/H-1261-2013; Taylor, Anne/F-5708-2010; Bondarenko, Igor/U-5156-2017; Vasyuk, Yury/G-1772-2013; CARMONA-HUERTA, JAIME/E-5849-2019	Hatipoglu, Esra/0000-0001-8361-8866; Gerstein, Hertzel/0000-0001-8072-2836; Urina-Triana, Miguel A/0000-0001-6003-4622; Gerstein, Hertzel C/0000-0001-8072-2836; Maggioni, Aldo Pietro/0000-0003-2764-6779; Adasheva, Tatiana/0000-0002-3763-8994; Facanha, Cristina Figueiredo Sampaio/0000-0002-9303-4343; Carta, Karina Gonzalez/0000-0003-2383-3868; Acevedo, Monica/0000-0002-7989-6633; Ramirez, Alfredo/0000-0003-4991-763X; cornel, jan hein/0000-0002-1006-2112; Derosa, Giuseppe/0000-0003-3573-4760; Bosch, Jacqueline/0000-0001-6292-4207; Freitas, Ismael/0000-0002-5071-0428; Zadionchenko, Vladimir/0000-0003-2377-5266; Gurevich, Victor/0000-0002-6815-444X; Del Prato, Stefano/0000-0002-5388-0270; Tütüncü, Neslihan Başçıl/0000-0002-1816-3903; Beniashvili, Allan/0000-0002-5149-3760; Berkovic, Maja Cigrovski/0000-0003-0750-9785; Gislason, Gunnar/0000-0002-0548-402X; Derosa, Giuseppe/0000-0003-3573-4760; Draman, Mohd Shazli/0000-0003-0144-8467; Vlad, Adrian/0000-0002-1824-2628; Lejnieks, Aivars/0000-0002-2097-6698; Ametov, A.S./0000-0002-7936-7619; Woo, Jeong-Taek/0000-0001-9201-0713; Kashyap, Moti/0000-0002-0052-8302; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Ali, Asem/0000-0002-0503-4838; Morillo, Carlos/0000-0002-8739-2099; Taylor, Anne/0000-0002-4422-7974; Pirags, Valdis/0000-0002-3650-7394; Waldenstrom, Anders/0000-0002-5304-0802; Aylward, Philip/0000-0002-5358-8552; kerlan, veronique/0000-0001-8105-6628; Richardson, Tristan/0000-0001-7505-7843; Marin-Neto, Jose Antonio/0000-0002-8651-8833; Bondarenko, Igor/0000-0002-7071-2471; Hancu, Nicolae/0000-0002-4688-5110; Novials, Anna/0000-0003-0465-2949; Vasyuk, Yury/0000-0003-2913-9797; Joakimsen, Ragnar Martin/0000-0002-2125-8081; AVEZUM, ALVARO/0000-0002-3073-6890; Davies, Melanie/0000-0002-9987-9371; Vonbank, Alexander/0000-0001-5648-5623; cacciatore, francesco/0000-0003-4720-1427; Lanas, Fernando/0000-0003-3595-9759; Nyomba, B. L. Gregoire/0000-0001-9472-607X; Bohme, Philip/0000-0002-5280-2959; Colman, Peter/0000-0001-8718-6175; Clayton, David/0000-0001-5481-0891; Lochnan, Heather/0000-0002-3820-7897; Fernandez, Angel L./0000-0003-1307-8221; Babenko, Alina/0000-0002-0559-697X; Psikova, Ol'ga/0000-0001-5832-5009; Bryan, Laura/0000-0002-9422-2338; Bulkina, Olga/0000-0003-4773-6966; Yusuf, Salim/0000-0003-4776-5601; Lombardo, Flavia Lucia/0000-0001-6183-0735; forti, adriana/0000-0002-5456-2303; Boman, Kurt/0000-0002-0350-2132; CARMONA-HUERTA, JAIME/0000-0002-0695-5452; Shkolnik, Evgeny/0000-0002-8359-788X; Hutchinson, Anastasia F/0000-0002-0014-689X; GAZTAMBIDE, SONIA/0000-0003-3569-2265; Bordeleau, Louise/0000-0003-2111-0228	Sanofi; Sanofi-Aventis; Bayer; Merck; Novo Nordisk; GlaxoSmithKline; Roche; Novartis; Janssen; Abbott; AstraZeneca; Eli Lilly; Boehringer Ingelheim; Merck Sharp Dohme; Bristol-Myers Squibb; AFA Insurance; Swedish Heart-Lung Foundation	Sanofi; Sanofi-Aventis(Sanofi-Aventis); Bayer(Bayer AG); Merck(Merck & Company); Novo Nordisk(Novo Nordisk); GlaxoSmithKline(GlaxoSmithKline); Roche(Roche Holding); Novartis(Novartis); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Abbott(Abbott Laboratories); AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly); Boehringer Ingelheim(Boehringer Ingelheim); Merck Sharp Dohme(Merck & Company); Bristol-Myers Squibb(Bristol-Myers Squibb); AFA Insurance; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	Supported by Sanofi.; Dr. Dagenais reports receiving payment for serving on a data and safety monitoring board from Sanofi-Aventis and payment for serving on a steering committee from Eli Lilly; Dr. Gerstein, consulting and lecture fees from Sanofi-Aventis and other funds through his institution from Sanofi-Aventis, consulting and lecture fees from Bayer, consulting fees from Merck and other funds through his institution from Merck, consulting fees and other funds through his institution from Novo Nordisk, consulting fees from GlaxoSmithKline, Roche, Novartis, Janssen, Abbott, and AstraZeneca, grant support and other funds through his institution from Eli Lilly, and other funds through his institution from Boehringer Ingelheim; Dr. Maggioni, payment for serving on advisory boards from Oxford University, Sanofi-Aventis, Novartis, and Amgen; Dr. Probstfield, consulting fees from Amylin and Boehringer Ingelheim; Dr. Ramachandran, grant support through this institution from Merck Sharp & Dohme; Dr. Riddle, consulting and lecture fees from Sanofi-Aventis and grant support through his institution from Sanofi-Aventis; Dr. Ryden, consulting fees from Bristol-Myers Squibb and AstraZeneca, grant support from AFA Insurance and the Swedish Heart-Lung Foundation, and lecture fees from Roche and Sanofi-Aventis; and Dr. Yusuf, consulting and lecture fees and grant support from Sanofi-Aventis. No other potential conflict of interest relevant to this article was reported.	Anand SS, 2011, EUR J CARDIOVASC PRE; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Currie CJ, 2012, DIABETES OBES METAB, V14, P1, DOI 10.1111/j.1463-1326.2011.01469.x; Dandona P, 2007, AM J CARDIOL, V99, p15B, DOI 10.1016/j.amjcard.2006.11.003; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Franklin VL, 2008, DIABETOLOGIA, V51, P353, DOI 10.1007/s00125-007-0870-2; Gerstein HC, 2010, DIABETOLOGIA, V53, P2509, DOI 10.1007/s00125-010-1871-0; Gerstein HC, 2008, AM HEART J, V155, P26, DOI 10.1016/j.ahj.2007.09.009; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hu Y, 2011, DIABETES CARE, V34, P1848, DOI 10.2337/dc10-2105; Lepore M, 2000, DIABETES, V49, P2142, DOI 10.2337/diabetes.49.12.2142; Li YB, 2004, DIABETES CARE, V27, P2597, DOI 10.2337/diacare.27.11.2597; Mellbin LG, 2011, DIABETOLOGIA, V54, P1308, DOI 10.1007/s00125-011-2084-x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Sturnvoll M, 2007, ENDOCR RES, V32, P19, DOI 10.1080/07435800701743810; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; TURNER RC, 1976, LANCET, V1, P1272; Vehkavaara S, 2004, ARTERIOSCL THROM VAS, V24, P325, DOI 10.1161/01.ATV.0000113817.48983.c5; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Yakubovich N, 2011, CIRCULATION, V123, P342, DOI 10.1161/CIRCULATIONAHA.110.948489	29	1132	1167	3	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2012	367	4					319	328		10.1056/NEJMoa1203858	http://dx.doi.org/10.1056/NEJMoa1203858			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	978KD	22686416	Bronze, Green Accepted			2022-12-28	WOS:000306738300006
J	Devkota, S; Wang, YW; Musch, MW; Leone, V; Fehlner-Peach, H; Nadimpalli, A; Antonopoulos, DA; Jabri, B; Chang, EB				Devkota, Suzanne; Wang, Yunwei; Musch, Mark W.; Leone, Vanessa; Fehlner-Peach, Hannah; Nadimpalli, Anuradha; Antonopoulos, Dionysios A.; Jabri, Bana; Chang, Eugene B.			Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10(-/-) mice	NATURE			English	Article							SULFATE-REDUCING BACTERIA; CONJUGATED BILE-ACIDS; BILOPHILA-WADSWORTHIA; HYDROGEN-SULFIDE; HEALTHY; MICROBIOTA; SPECIMENS; DISEASES; CULTURE; LIVER	The composite human microbiome of Western populations has probably changed over the past century, brought on by new environmental triggers that often have a negative impact on human health(1). Here we show that consumption of a diet high in saturated (milk-derived) fat, but not polyunsaturated (safflower oil) fat, changes the conditions for microbial assemblage and promotes the expansion of a low-abundance, sulphite-reducing pathobiont, Bilophila wadsworthia(2). This was associated with a pro-inflammatory T helper type 1 (T(H)1) immune response and increased incidence of colitis in genetically susceptible Il10(-/-), but not wild-type mice. These effects are mediated by milk-derived-fat-promoted taurine conjugation of hepatic bile acids, which increases the availability of organic sulphur used by sulphite-reducing microorganisms like B. wadsworthia. When mice were fed a low-fat diet supplemented with taurocholic acid, but not with glycocholic acid, for example, a bloom of B. wadsworthia and development of colitis were observed in Il10(-/-) mice. Together these data show that dietary fats, by promoting changes in host bile acid composition, can markedly alter conditions for gut microbial assemblage, resulting in dysbiosis that can perturb immune homeostasis. The data provide a plausible mechanistic basis by which Western-type diets high in certain saturated fats might increase the prevalence of complex immune-mediated diseases like inflammatory bowel disease in genetically susceptible hosts.	[Devkota, Suzanne; Wang, Yunwei; Musch, Mark W.; Leone, Vanessa; Fehlner-Peach, Hannah; Nadimpalli, Anuradha; Jabri, Bana; Chang, Eugene B.] Univ Chicago, Dept Med, Knapp Ctr Biomed Discovery, Gastroenterol Sect, Chicago, IL 60637 USA; [Antonopoulos, Dionysios A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Chang, EB (corresponding author), Univ Chicago, Dept Med, Knapp Ctr Biomed Discovery, Gastroenterol Sect, 900 E 57th St, Chicago, IL 60637 USA.	echang@medicine.bsd.uchicago.edu	Devkota, Suzanne/AAG-1958-2021; Antonopoulos, Dionysios/ABE-6212-2020	Devkota, Suzanne/0000-0001-5575-9362; Antonopoulos, Dionysios/0000-0002-2238-5031	National Center for Research Resources; NIDDK of the National Institutes of Health; NIGMS of the National Institutes of Health; NCCAM of the National Institutes of Health [DK-42086, DK47722, UH3DK083993, F31AT006073]; Gastrointestinal Research Foundation; Crohns and Colitis Foundation of America; Peter and Carol Goldman Family Research Fund; Harry and Leona Helmsley Trust Foundation (SHARE); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [F31AT006073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086, UH3DK083993, R01DK097268, R01DK047722, R37DK047722, T32DK007074] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCCAM of the National Institutes of Health; Gastrointestinal Research Foundation; Crohns and Colitis Foundation of America; Peter and Carol Goldman Family Research Fund; Harry and Leona Helmsley Trust Foundation (SHARE); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Center for Research Resources and the NIDDK, NIGMS and NCCAM of the National Institutes of Health through grant number DK-42086 (E. B. C.), DK47722 (E. B. C.), UH3DK083993 (E. B. C.), F31AT006073 (S. D.). Also, the Gastrointestinal Research Foundation, Crohns and Colitis Foundation of America (Y.W.), the Peter and Carol Goldman Family Research Fund, and the Harry and Leona Helmsley Trust Foundation (SHARE). We are also indebted to S. Finegold for his suggestions on successful culture of B. wadsworthia and Alistipes, J. Tiedje and M. Vital for dsrA primer sequences, L. Hagey for mass spectrometry, E. Huang, B. Theriault and J. Stencel for assistance with experiments, and R. Bouziat for T-cell purification.	Ananieva O, 2002, CLIN DIAGN LAB IMMUN, V9, P1160, DOI 10.1128/CDLI.9.6.1160-1164.2002; Arzese A, 1997, ANAEROBE, V3, P219, DOI 10.1006/anae.1997.0076; Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126; Baron EJ, 1997, ANAEROBE, V3, P83, DOI 10.1006/anae.1997.0075; BARON EJ, 1989, J GEN MICROBIOL, V135, P3405; BARON EJ, 1992, J CLIN MICROBIOL, V30, P1882, DOI 10.1128/JCM.30.7.1882-1884.1992; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Dussurget O, 2002, MOL MICROBIOL, V45, P1095, DOI 10.1046/j.1365-2958.2002.03080.x; GIBSON GR, 1991, FEMS MICROBIOL ECOL, V86, P103, DOI 10.1111/j.1574-6968.1991.tb04799.x; GRAHAM TO, 1979, AM J PHYSIOL, V237, pE177, DOI 10.1152/ajpendo.1979.237.2.E177; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Laue H, 1997, APPL ENVIRON MICROB, V63, P2016, DOI 10.1128/AEM.63.5.2016-2021.1997; LINDSTEDT S, 1965, J CLIN INVEST, V44, P1754, DOI 10.1172/JCI105283; Loubinoux J, 2002, FEMS MICROBIOL ECOL, V40, P107, DOI 10.1111/j.1574-6941.2002.tb00942.x; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; NHANES, 2004, TRENDS INT EN MACR U; ROSSI SS, 1987, J LIPID RES, V28, P589; Rowan FE, 2009, BRIT J SURG, V96, P151, DOI 10.1002/bjs.6454; Rueda A, 1996, ARCH PHYSIOL BIOCHEM, V104, P246, DOI 10.1076/apab.104.2.246.12884; Scanlan PD, 2009, FEMS MICROBIOL ECOL, V69, P213, DOI 10.1111/j.1574-6941.2009.00709.x; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wang YY, 2010, RES J BIOTECHNOL, V5, P5; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Zinkevich V, 2000, FEMS MICROBIOL ECOL, V34, P147, DOI 10.1111/j.1574-6941.2000.tb00764.x	26	1137	1183	16	290	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					104	+		10.1038/nature11225	http://dx.doi.org/10.1038/nature11225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722865	Green Submitted, Green Accepted			2022-12-28	WOS:000305982900059
J	Chen, AP; Wang, SP; Pacala, SW				Chen, Anping; Wang, Shaopeng; Pacala, Stephen W.			Comment on "Global Correlations in Tropical Tree Species Richness and Abundance Reject Neutrality"	SCIENCE			English	Editorial Material							NUMBERS ADD; BIODIVERSITY; DIVERSITY; MODEL		[Chen, Anping; Pacala, Stephen W.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Wang, Shaopeng] Peking Univ, Dept Ecol, Beijing 100871, Peoples R China	Princeton University; Peking University	Chen, AP (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	anpingc@princeton.edu	Chen, Anping/H-9960-2014; Wang, Shaopeng/J-7091-2012	Chen, Anping/0000-0003-2085-3863; 	Engineering and Physical Sciences Research Council [EP/F043112/1] Funding Source: researchfish; Natural Environment Research Council [NE/I021179/1] Funding Source: researchfish; EPSRC [EP/F043112/1] Funding Source: UKRI; NERC [NE/I021179/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Hubbell Stephen P., 2001, V32, pi; LEIGH EG, 1981, J THEOR BIOL, V90, P213; LEIGH EG, 1993, EVOL ECOL, V7, P76, DOI 10.1007/BF01237735; LEVIN DA, 1988, AM NAT, V132, P643, DOI 10.1086/284879; Mayr E, 1942, SYSTEMATICS ORIGIN S; Nee S, 2005, FUNCT ECOL, V19, P173, DOI 10.1111/j.0269-8463.2005.00922.x; Rickfeld RE, 2003, OIKOS, V100, P185, DOI 10.1034/j.1600-0706.2003.12018.x; Ricklefs RE, 2006, ECOLOGY, V87, P1424, DOI 10.1890/0012-9658(2006)87[1424:TUNTOB]2.0.CO;2; Ricklefs RE, 2012, SCIENCE, V335, P464, DOI 10.1126/science.1215182; Wing SL, 2009, P NATL ACAD SCI USA, V106, P18627, DOI 10.1073/pnas.0905130106; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913	12	4	4	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089								10.1126/science.1222534	http://dx.doi.org/10.1126/science.1222534			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745403				2022-12-28	WOS:000305794500020
J	Gutierrez, RA				Gutierrez, Rodrigo A.			Systems Biology for Enhanced Plant Nitrogen Nutrition	SCIENCE			English	Review							NITRATE; ARABIDOPSIS; RESPONSES; NETWORK; NUTRIENT; GENE; ARCHITECTURE; CLOCK; TIME	Nitrogen (N)-based fertilizers increase agricultural productivity but have detrimental effects on the environment and human health. Research is generating improved understanding of the signaling components plants use to sense N and regulate metabolism, physiology, and growth and development. However, we still need to integrate these regulatory factors into signal transduction pathways and connect them to downstream response pathways. Systems biology approaches facilitate identification of new components and N-regulatory networks linked to other plant processes. A holistic view of plant N nutrition should open avenues to translate this knowledge into effective strategies to improve N-use efficiency and enhance crop production systems for more sustainable agricultural practices.	Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Millennium Nucleus Ctr Plant Funct Genom, FONDAP Ctr Genome Regulat, Santiago, Chile	Pontificia Universidad Catolica de Chile	Gutierrez, RA (corresponding author), Pontificia Univ Catolica Chile, Dept Mol Genet & Microbiol, Millennium Nucleus Ctr Plant Funct Genom, FONDAP Ctr Genome Regulat, Ave Libertador Bernardo OHiggins 340, Santiago, Chile.	rgutierrez@bio.puc.cl	Gutiérrez, Rodrigo A/C-2611-2008; Gutierrez, Rodrigo/ABA-9285-2020	Gutiérrez, Rodrigo A/0000-0002-5961-5005; Gutierrez, Rodrigo/0000-0002-5961-5005	Howard Hughes Medical Institute; Fondo de Desarrollo de Areas Prioritarias (FONDAP) Center for Genome Regulation [15090007]; Millennium Nucleus Center for Plant Functional Genomics [P10-062-F]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1100698]; Comision Nacional de Investigacion Cientifica y Tecnologica-ANR [ANR-007]; Corporacion de Fomento de la Produccion Genome Program [CORFO07Genoma01]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Fondo de Desarrollo de Areas Prioritarias (FONDAP) Center for Genome Regulation(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Millennium Nucleus Center for Plant Functional Genomics; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Comision Nacional de Investigacion Cientifica y Tecnologica-ANR(French National Research Agency (ANR)); Corporacion de Fomento de la Produccion Genome Program	Thanks to N. Crawford and Y.-F. Tsay for critical comments on the manuscript. Thanks also to J. M. Alvarez, E. Vidal, and O. Contreras for figures and constructive discussions. Research in our group is funded by International Early Career Scientist program from Howard Hughes Medical Institute, Fondo de Desarrollo de Areas Prioritarias (FONDAP) Center for Genome Regulation (15090007), Millennium Nucleus Center for Plant Functional Genomics (P10-062-F), Fondo Nacional de Desarrollo Cientifico y Tecnologico (1100698), Comision Nacional de Investigacion Cientifica y Tecnologica-ANR program (ANR-007), and Corporacion de Fomento de la Produccion Genome Program (CORFO07Genoma01).	Alvarez JM, 2012, CURR OPIN PLANT BIOL, V15, P185, DOI 10.1016/j.pbi.2012.03.009; [Anonymous], 2005, MINERAL NUTR PLANTS; [Anonymous], 2012, REGISTRY STANDARD BI; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Castaings L, 2009, PLANT J, V57, P426, DOI 10.1111/j.1365-313X.2008.03695.x; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; COMLY HH, 1945, JAMA-J AM MED ASSOC, V129, P112, DOI 10.1001/jama.1945.02860360014004; Dechorgnat J, 2011, J EXP BOT, V62, P1349, DOI 10.1093/jxb/erq409; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Gojon A, 2011, J EXP BOT, V62, P2299, DOI 10.1093/jxb/erq419; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Gutierrez RA, 2005, PLANT PHYSIOL, V138, P550, DOI 10.1104/pp.104.900150; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Hirel B, 2011, SUSTAINABILITY-BASEL, V3, P1452, DOI 10.3390/su3091452; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Jonassen EM, 2009, J PLANT PHYSIOL, V166, P2071, DOI 10.1016/j.jplph.2009.05.010; Kant S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002021; Krouk G, 2011, TRENDS PLANT SCI, V16, P178, DOI 10.1016/j.tplants.2011.02.004; Krouk G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r123; Lima JE, 2010, PLANT CELL, V22, P3621, DOI 10.1105/tpc.110.076216; LIN JK, 1990, CLIN BIOCHEM, V23, P67, DOI 10.1016/0009-9120(90)90489-H; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; McClung CR, 2010, CURR OPIN GENET DEV, V20, P588, DOI 10.1016/j.gde.2010.08.010; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Peng MS, 2007, PLANT J, V50, P320, DOI 10.1111/j.1365-313X.2007.03050.x; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Rollie S, 2012, CHEM ENG SCI, V69, P1, DOI 10.1016/j.ces.2011.10.068; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; UN, 2010, WORLD POP PROSP 2010; Vidal EA, 2008, CURR OPIN PLANT BIOL, V11, P521, DOI 10.1016/j.pbi.2008.07.003; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Wang RC, 2009, PLANT PHYSIOL, V151, P472, DOI 10.1104/pp.109.140434; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407	39	130	149	15	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1673	1675		10.1126/science.1217620	http://dx.doi.org/10.1126/science.1217620			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745422				2022-12-28	WOS:000305794500041
J	Richards, T				Richards, Tessa			The crusade for health equity	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com						BMJ Group Blogs, 2011, FRAN BAUM ALT RIO DE; Rada AG, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3196; Kentikelenis A, 2011, LANCET, V378, P1457, DOI 10.1016/S0140-6736(11)61556-0; Moszynski P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6822; Sen A, 2011, LANCET, V377, P200, DOI 10.1016/S0140-6736(11)60035-4; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ; World Health Organization, 1978, DECL ALM AT INT C PR	7	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 27	2012	344								e4414	10.1136/bmj.e4414	http://dx.doi.org/10.1136/bmj.e4414			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	968MX	22740576				2022-12-28	WOS:000305987100022
J	Hawton, K; Saunders, KEA; O'Connor, RC				Hawton, Keith; Saunders, Kate E. A.; O'Connor, Rory C.			Self-harm and suicide in adolescents	LANCET			English	Article							SEROTONIN REUPTAKE INHIBITORS; YOUNG-PEOPLE; RISK-FACTORS; RANDOMIZED-TRIAL; GROUP-THERAPY; BEHAVIOR-THERAPY; COMMUNITY SAMPLE; HELP-SEEKING; AGED 15-24; YOUTHS	Self-harm and suicide are major public health problems in adolescents, with rates of self-harm being high in the teenage years and suicide being the second most common cause of death in young people worldwide. Important contributors to self-harm and suicide include genetic vulnerability and psychiatric, psychological, familial, social, and cultural factors. The effects of media and contagion are also important, with the internet having an important contemporary role. Prevention of self-harm and suicide needs both universal measures aimed at young people in general and targeted initiatives focused on high-risk groups. There is little evidence of effectiveness of either psychosocial or pharmacological treatment, with particular controversy surrounding the usefulness of antidepressants. Restriction of access to means for suicide is important. Major challenges include the development of greater understanding of the factors that contribute to self-harm and suicide in young people, especially mechanisms underlying contagion and the effect of new media. The identification of successful prevention initiatives aimed at young people and those at especially high risk, and the establishment of effective treatments for those who self-harm, are paramount needs.	[Hawton, Keith; Saunders, Kate E. A.] Warneford Hosp, Univ Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England; [O'Connor, Rory C.] Univ Stirling, Sch Nat Sci, Suicidal Behav Res Grp, Stirling FK9 4LA, Scotland	University of Oxford; University of Stirling	Hawton, K (corresponding author), Warneford Hosp, Univ Dept Psychiat, Ctr Suicide Res, Oxford OX3 7JX, England.	keith.hawton@psych.ox.ac.uk		Saunders, kate/0000-0003-3448-9927				Al Ansari AM, 2001, SUICIDE LIFE-THREAT, V31, P197, DOI 10.1521/suli.31.2.197.21517; Aseltine RH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-161; Aseltine RH, 2009, J AM ACAD CHILD PSY, V48, P262, DOI 10.1097/CHI.0b013e318195bce8; Beautrais AL, 1996, J AM ACAD CHILD PSY, V35, P1174, DOI 10.1097/00004583-199609000-00015; Bertolote Jose Manoel, 2002, World Psychiatry, V1, P181; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Boeninger DK, 2010, SUICIDE LIFE-THREAT, V40, P451, DOI 10.1521/suli.2010.40.5.451; Boergers J, 1998, J AM ACAD CHILD PSY, V37, P1287, DOI 10.1097/00004583-199812000-00012; Braquehais MD, 2010, COMPR PSYCHIAT, V51, P121, DOI 10.1016/j.comppsych.2009.05.003; Brent DA, 2003, AM BEHAV SCI, V46, P1192, DOI 10.1177/0002764202250662; Brent DA, 1996, ARCH GEN PSYCHIAT, V53, P1145; Brent DA, 1999, J AM ACAD CHILD PSY, V38, P1497, DOI 10.1097/00004583-199912000-00010; Brent DA, 2006, NEW ENGL J MED, V355, P2719, DOI 10.1056/NEJMp068195; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Bronisch T, 2008, J AFFECT DISORDERS, V108, P135, DOI 10.1016/j.jad.2007.10.010; Burrows S, 2010, INT J INJ CONTROL SA, V17, P23, DOI 10.1080/17457300903309231; Cauce AM, 2002, J CONSULT CLIN PSYCH, V70, P44, DOI 10.1037//0022-006X.70.1.44; Cho HS, 2005, J ABNORM CHILD PSYCH, V33, P363, DOI 10.1007/s10802-005-3574-4; Collings S. C., 2011, MEDIA INFLUENCES SUI; COTGROVE A, 1995, J ADOLESCENCE, V18, P569, DOI 10.1006/jado.1995.1039; De Leo D, 2004, MED J AUSTRALIA, V181, P140, DOI 10.5694/j.1326-5377.2004.tb06204.x; Donaldson D, 2005, J AM ACAD CHILD PSY, V44, P113, DOI 10.1097/00004583-200502000-00003; Eaton Danice K., 2010, Morbidity and Mortality Weekly Report, V59, P1; Eisenberg ME, 2006, J ADOLESCENT HEALTH, V39, P662, DOI 10.1016/j.jadohealth.2006.04.024; Evans E, 2004, CLIN PSYCHOL REV, V24, P957, DOI 10.1016/j.cpr.2004.04.005; Fergusson DM, 2005, PSYCHOL MED, V35, P983, DOI 10.1017/S0033291704004167; Fergusson DM, 1999, ARCH GEN PSYCHIAT, V56, P876, DOI 10.1001/archpsyc.56.10.876; FERGUSSON DM, 1995, J AM ACAD CHILD PSY, V34, P612, DOI 10.1097/00004583-199505000-00013; Fergusson DM, 2000, PSYCHOL MED, V30, P23, DOI 10.1017/S003329179900135X; Fortune S, 2007, J AFFECT DISORDERS, V100, P199, DOI 10.1016/j.jad.2006.10.022; Fortune S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-369; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/appi.ajp.2007.07030454; Goodyer I, 2007, BMJ-BRIT MED J, V335, P142, DOI 10.1136/bmj.39224.494340.55; Gosney H, 2007, PSYCHIATR BULL, V31, P203, DOI 10.1192/pb.bp.105.007773; Gould MS, 2009, J AM ACAD CHILD PSY, V48, P1193, DOI 10.1097/CHI.0b013e3181bef6d5; Gould MS, 2005, JAMA-J AM MED ASSOC, V293, P1635, DOI 10.1001/jama.293.13.1635; Green JM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d682; Hargus E, 2009, SUICIDE LIFE-THREAT, V39, P518, DOI 10.1521/suli.2009.39.5.518; Harrington R, 1998, J AM ACAD CHILD PSY, V37, P512, DOI 10.1016/S0890-8567(14)60001-0; Hawton K, 2002, BMJ-BRIT MED J, V325, P1207, DOI 10.1136/bmj.325.7374.1207; Hawton K, 2004, BMJ-BRIT MED J, V329, P1076, DOI 10.1136/bmj.38253.572581.7C; Hawton K, 2003, J CHILD PSYCHOL PSYC, V44, P1191, DOI 10.1111/1469-7610.00200; HAWTON K, 1982, BRIT J PSYCHIAT, V141, P286, DOI 10.1192/bjp.141.3.286; Hawton K, J CHILD PSY IN PRESS; Hawton K, 1982, PERSONAL MEANINGS; Hawton K, 2008, J CHILD PSYCHOL PSYC, V49, P441, DOI 10.1111/j.1469-7610.2007.01852.x; Hawton K, 2007, J CLIN PSYCHIAT, V68, P1574, DOI 10.4088/JCP.v68n1017; Hawton K, 2010, EUR CHILD ADOLES PSY, V19, P513, DOI 10.1007/s00787-009-0065-0; Hazell PL, 2009, J AM ACAD CHILD PSY, V48, P662, DOI [10.1097/CHI.0b013e3181aOacec, 10.1097/CHI.0b013e3181a0acec]; Houston K, 2001, J AFFECT DISORDERS, V63, P159, DOI 10.1016/S0165-0327(00)00175-0; Huey SJ, 2004, J AM ACAD CHILD PSY, V43, P183, DOI 10.1097/00004583-200402000-00014; James A, 2004, ACTA PSYCHIAT SCAND, V110, P408, DOI 10.1111/j.1600-0447.2004.00384.x; James AC, 2008, CHILD ADOL MENT H-UK, V13, P148, DOI 10.1111/j.1475-3588.2007.00470.x; Johnson JG, 2002, ARCH GEN PSYCHIAT, V59, P741, DOI 10.1001/archpsyc.59.8.741; Joiner TE, 2003, J ADOLESCENCE, V26, P495, DOI 10.1016/S0140-1971(02)00133-1; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Klonsky ED, 2007, CLIN PSYCHOL REV, V27, P226, DOI 10.1016/j.cpr.2006.08.002; Lake AM, 2011, INTERNATIONAL HANDBOOK OF SUICIDE PREVENTION: RESEARCH, POLICY AND PRACTICE, P507; Li XY, 2008, PSYCHOL MED, V38, P397, DOI 10.1017/S0033291707001407; Madge N, 2008, J CHILD PSYCHOL PSYC, V49, P667, DOI 10.1111/j.1469-7610.2008.01879.x; Madge N, 2011, EUR CHILD ADOLES PSY, V20, P499, DOI 10.1007/s00787-011-0210-4; Makikyro TH, 2004, J ADOLESCENT HEALTH, V34, P250, DOI 10.1016/S1054-139X(03)00284-2; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Manor I, 2010, EUR PSYCHIAT, V25, P146, DOI 10.1016/j.eurpsy.2009.06.001; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; MARTTUNEN MJ, 1994, J AM ACAD CHILD PSY, V33, P490, DOI 10.1097/00004583-199405000-00007; Melvin GA, 2006, J AM ACAD CHILD PSY, V45, P1151, DOI 10.1097/01.chi.0000233157.21925.71; Moran P, 2012, LANCET, V379, P236, DOI 10.1016/S0140-6736(11)61141-0; National Collaborating Centre for Mental Health, 2011, NICE CLIN GUID 133, P133; Nock MK, 2006, PSYCHIAT RES, V144, P65, DOI 10.1016/j.psychres.2006.05.010; O'Connor RC, 2007, SUICIDE LIFE-THREAT, V37, P698, DOI 10.1521/suli.2007.37.6.698; O'Connor RC, 2012, BRIT J PSYCHIAT, V200, P330, DOI 10.1192/bjp.bp.111.097808; O'Connor RC, 2010, BEHAV RES THER, V48, P52, DOI 10.1016/j.brat.2009.09.008; O'Connor RC, 2009, SUICIDE LIFE-THREAT, V39, P364, DOI 10.1521/suli.2009.39.4.364; O'Connor RC, 2009, BRIT J PSYCHIAT, V194, P68, DOI 10.1192/bjp.bp.107.047704; OConnor RC, 2011, INTERNATIONAL HANDBOOK OF SUICIDE PREVENTION: RESEARCH, POLICY AND PRACTICE, P1, DOI 10.1002/9781119998556; Olfson M, 2005, ARCH GEN PSYCHIAT, V62, P1122, DOI 10.1001/archpsyc.62.10.1122; Patton GC, 2007, J AM ACAD CHILD PSY, V46, P508, DOI 10.1097/chi.0b013e31803065c7; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Pearson M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-879; Pirkis J, 2011, INTERNATIONAL HANDBOOK OF SUICIDE PREVENTION: RESEARCH, POLICY AND PRACTICE, P531; Platt S, 2006, EVALUATION 1 PHASE C; Rodham K, 2004, J AM ACAD CHILD PSY, V43, P80, DOI 10.1097/00004583-200401000-00017; ROY A, 1995, AM J PSYCHIAT, V152, P1075; Scott MA, 2009, AM J PUBLIC HEALTH, V99, P334, DOI 10.2105/AJPH.2007.127928; Sebastian C, 2010, BRAIN COGNITION, V72, P134, DOI 10.1016/j.bandc.2009.06.008; Simon GE, 2006, AM J PSYCHIAT, V163, P41, DOI 10.1176/appi.ajp.163.1.41; Sourander A, 2009, ARCH GEN PSYCHIAT, V66, P398, DOI 10.1001/archgenpsychiatry.2009.21; Speckens AEM, 2005, SUICIDE LIFE-THREAT, V35, P365, DOI 10.1521/suli.2005.35.4.365; Spirito Anthony, 2002, Evid Based Ment Health, V5, P55; Thompson EA, 2001, AM J PUBLIC HEALTH, V91, P742, DOI 10.2105/AJPH.91.5.742; Varnik A, 2009, J AFFECT DISORDERS, V113, P216, DOI 10.1016/j.jad.2008.06.004; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Wasserman Danuta, 2005, World Psychiatry, V4, P114; Wheeler BW, 2008, BMJ-BRIT MED J, V336, P542, DOI 10.1136/bmj.39462.375613.BE; Wilkinson P, 2011, AM J PSYCHIAT, V168, P495, DOI 10.1176/appi.ajp.2010.10050718; Wood A, 2001, J AM ACAD CHILD PSY, V40, P1246, DOI 10.1097/00004583-200111000-00003	97	1053	1092	22	403	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2012	379	9834					2373	2382		10.1016/S0140-6736(12)60322-5	http://dx.doi.org/10.1016/S0140-6736(12)60322-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961ZV	22726518				2022-12-28	WOS:000305509600032
J	Behie, SW; Zelisko, PM; Bidochka, MJ				Behie, S. W.; Zelisko, P. M.; Bidochka, M. J.			Endophytic Insect-Parasitic Fungi Translocate Nitrogen Directly from Insects to Plants	SCIENCE			English	Article							COLONIZATION	Most plants obtain nitrogen through nitrogen-fixing bacteria and microbial decomposition of plant and animal material. Many vascular plants are able to form close symbiotic associations with endophytic fungi. Metarhizium is a common plant endophyte found in a large number of ecosystems. This abundant soil fungus is also a pathogen to a large number of insects, which are a source of nitrogen. It is possible that the endophytic capability and insect pathogenicity of Metarhizium are coupled to provide an active method of nitrogen transfer to plant hosts via fungal mycelia. We used soil microcosms to test the ability of M. robertsii to translocate insect-derived nitrogen to plants. Insects were injected with N-15-labeled nitrogen, and we tracked the incorporation of N-15 into amino acids in two plant species, haricot bean (Phaseolus vulgaris) and switchgrass (Panicum virgatum), in the presence of M. robertsii. These findings are evidence that active nitrogen acquisition by plants in this tripartite interaction may play a larger role in soil nitrogen cycling than previously thought.	[Behie, S. W.; Bidochka, M. J.] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Zelisko, P. M.] Brock Univ, Dept Chem, St Catharines, ON L2S 3A1, Canada	Brock University; Brock University	Bidochka, MJ (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada.	mbidochka@brocku.ca	Zelisko, Paul/K-2101-2016	Zelisko, Paul/0000-0002-3770-2562; Bidochka, Michael/0000-0002-2544-9977	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant (M.J.B.). We thank M. K. Bidochka for Fig. 2.	BUSCHENA CA, 1992, CAN J FOREST RES, V22, P1883, DOI 10.1139/x92-246; Cocking EC, 2003, PLANT SOIL, V252, P169, DOI 10.1023/A:1024106605806; Fang WG, 2010, PLANT PHYSIOL, V154, P1549, DOI 10.1104/pp.110.163014; Galloway JN, 1998, ENVIRON POLLUT, V102, P15, DOI 10.1016/S0269-7491(98)80010-9; Klironomos JN, 2001, NATURE, V410, P651, DOI 10.1038/35070643; Milner R.J., 1991, BIOL CONTROL LOCUSTS, P200; RICHTER DL, 1993, SOIL BIOL BIOCHEM, V25, P355, DOI 10.1016/0038-0717(93)90135-X; Roberts D. W., 1992, Frontiers in industrial mycology, P144; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Sasan RK, 2012, AM J BOT, V99, P101, DOI 10.3732/ajb.1100136; Schulze W, 2001, J EXP BOT, V52, P1041, DOI 10.1093/jexbot/52.358.1041; Scully LR, 2005, CAN J MICROBIOL, V51, P185, DOI 10.1139/W04-124; St Leger Raymond, 1993, P211; Wyrebek M, 2011, MICROBIOL-SGM, V157, P2904, DOI 10.1099/mic.0.051102-0	14	234	247	23	538	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1576	1577		10.1126/science.1222289	http://dx.doi.org/10.1126/science.1222289			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723421				2022-12-28	WOS:000305507500056
J	Russell, CA; Fonville, JM; Brown, AEX; Burke, DF; Smith, DL; James, SL; Herfst, S; van Boheemen, S; Linster, M; Schrauwen, EJ; Katzelnick, L; Mosterin, A; Kuiken, T; Maher, E; Neumann, G; Osterhaus, ADME; Kawaoka, Y; Fouchier, RAM; Smith, DJ				Russell, Colin A.; Fonville, Judith M.; Brown, Andre E. X.; Burke, David F.; Smith, David L.; James, Sarah L.; Herfst, Sander; van Boheemen, Sander; Linster, Martin; Schrauwen, Eefje J.; Katzelnick, Leah; Mosterin, Ana; Kuiken, Thijs; Maher, Eileen; Neumann, Gabriele; Osterhaus, Albert D. M. E.; Kawaoka, Yoshihiro; Fouchier, Ron A. M.; Smith, Derek J.			The Potential for Respiratory Droplet-Transmissible A/H5N1 Influenza Virus to Evolve in a Mammalian Host	SCIENCE			English	Article							A VIRUSES; H5N1; MODEL; REPLICATION; DYNAMICS	Avian A/H5N1 influenza viruses pose a pandemic threat. As few as five amino acid substitutions, or four with reassortment, might be sufficient for mammal-to-mammal transmission through respiratory droplets. From surveillance data, we found that two of these substitutions are common in A/H5N1 viruses, and thus, some viruses might require only three additional substitutions to become transmissible via respiratory droplets between mammals. We used a mathematical model of within-host virus evolution to study factors that could increase and decrease the probability of the remaining substitutions evolving after the virus has infected a mammalian host. These factors, combined with the presence of some of these substitutions in circulating strains, make a virus evolving in nature a potentially serious threat. These results highlight critical areas in which more data are needed for assessing, and potentially averting, this threat.	[Russell, Colin A.; Fonville, Judith M.; Burke, David F.; James, Sarah L.; Katzelnick, Leah; Mosterin, Ana; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Russell, Colin A.; Fonville, Judith M.; Burke, David F.; James, Sarah L.; Katzelnick, Leah; Mosterin, Ana; Smith, Derek J.] World Hlth Org WHO Collaborating Ctr Modeling Evo, Cambridge CB2 3EJ, England; [Russell, Colin A.; Smith, David L.; Smith, Derek J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Brown, Andre E. X.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Smith, David L.] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Baltimore, MD 21205 USA; [Herfst, Sander; van Boheemen, Sander; Linster, Martin; Schrauwen, Eefje J.; Kuiken, Thijs; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.; Smith, Derek J.] Erasmus MC, Dept Virol, NL-3015 CE Rotterdam, Netherlands; [Mosterin, Ana] Univ Pompeu Fabra, Ctr Res Hlth & Econ, Barcelona 08005, Spain; [Maher, Eileen; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens,Minato Ku, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, Tokyo 1088639, Japan; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO Infect Induced, Saitama 1020076, Japan	University of Cambridge; World Health Organization; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); MRC Laboratory Molecular Biology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Erasmus University Rotterdam; Erasmus MC; Pompeu Fabra University; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Smith, DJ (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	dsmith@zoo.cam.ac.uk	Linster, Martin/AAY-9088-2020; Burke, David F/C-2091-2013; Smith, Derek/Z-3075-2019; Russell, Colin/ABE-7106-2020; Smith, David L/L-8850-2013; Fouchier, Ron A/A-1911-2014	Burke, David F/0000-0001-8830-3951; Smith, Derek/0000-0002-2393-1890; Smith, David L/0000-0003-4367-3849; Fouchier, Ron A/0000-0001-8095-2869; James, Sarah/0000-0002-6969-1167; Kuiken, Thijs/0000-0001-5501-9049; Brown, Andre/0000-0002-1324-8764; Osterhaus, Albert/0000-0002-6074-1172; Linster, Martin/0000-0003-2636-2512; Russell, Colin/0000-0002-2113-162X; Herfst, Sander/0000-0001-9866-8903	University Research Fellowship from the Royal Society; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) VICI grant; European Union (EU) FP7 program EMPERIE [223498]; European Union (EU) FP7 program ANTIGONE [278976]; Human Frontier Science Program (HFSP) program [P0050/2008]; Wellcome [087982AIA]; Bill and Melinda Gates Foundation [OPPGH5383]; NIH Director's Pioneer Award [DP1-OD000490-01]; National Institute of Allergy and Infectious Diseases (NIAID)-NIH [HHSN266200700010C.]; NIAID-NIH [R01 AI 069274]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; ERATO; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI069274, R01AI069274] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER	University Research Fellowship from the Royal Society(Royal Society of London); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) VICI grant(Netherlands Organization for Scientific Research (NWO)); European Union (EU) FP7 program EMPERIE; European Union (EU) FP7 program ANTIGONE; Human Frontier Science Program (HFSP) program; Wellcome; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ERATO(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	C.A.R. was supported by a University Research Fellowship from the Royal Society. The authors acknowledge an Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) VICI grant, European Union (EU) FP7 programs EMPERIE (223498) and ANTIGONE (278976), Human Frontier Science Program (HFSP) program grant P0050/2008, Wellcome 087982AIA, the Bill and Melinda Gates Foundation (OPPGH5383), and NIH Director's Pioneer Award DP1-OD000490-01. R. A. M. F was supported by National Institute of Allergy and Infectious Diseases (NIAID)-NIH contract HHSN266200700010C. A. E. X. B. was supported by a long-term fellowship from the HFSP. E. M., G.N., and Y.K. are supported by the Bill and Melinda Gates Foundation (OPPGH5383) and NIAID-NIH grant R01 AI 069274; in addition, Y.K. was supported by a Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by ERATO. Y.K. and G.N. have a financial interest as founders of FluGen and hold a patent on influenza virus reverse genetics. Y.K and G.N. have a paid consulting relationship with Theraclone; Y.K. also has a paid consulting relationship with Crucell. Y.K. has received speaker's honoraria from Chugai Pharmaceuticals, Novartis, Daiichi-Sankyo Pharmaceutical, Toyama Chemical, Wyeth, GlaxoSmithKline, and Astellas and grant support from Chugai Pharmaceuticals, Daiichi Sankyo Pharmaceutical, Toyama Chemical, Otsuka Pharmaceutical Company A.D.M.E.O. (on behalf of Viroclinics Biosciences BV) has advisory affiliations with GlaxoSmithKline, Novartis, and Roche. A.D.M.E.O. is Chief Scientific Officer of Viroclinics Biosciences BV. We thank S. Cornell, E. Ghedin, R. Johnstone, L. Reperant, and D. M. Smith for helpful discussions and the reviewers for their detailed and thoughtful comments.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Aditama TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029971; Anton A, 2010, DIAGN MICR INFEC DIS, V68, P214, DOI 10.1016/j.diagmicrobio.2010.08.003; Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; Bahl J., 2012, INFLUENZA OTHER RESP, V6, P1; Bonhoeffer S, 1997, P ROY SOC B-BIOL SCI, V264, P631; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Lednicky JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-231; Luria SE, 1943, GENETICS, V28, P491; Mode CJ, 2011, J PROBAB STAT, V2011, DOI 10.1155/2011/867493; Mohler L, 2005, BIOTECHNOL BIOENG, V90, P46, DOI 10.1002/bit.20363; Murcia PR, 2010, J VIROL, V84, P6943, DOI 10.1128/JVI.00112-10; Nidom CA, 2010, EMERG INFECT DIS, V16, P1515, DOI 10.3201/eid1610.100508; Ord T, 2010, J RISK RES, V13, P191, DOI 10.1080/13669870903126267; Perelson AS, 2012, J INFECT DIS, V205, P1642, DOI 10.1093/infdis/jis265; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qi X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004682; Reperant LA, 2009, REV SCI TECH OIE, V28, P137, DOI 10.20506/rst.28.1.1876; Sidorenko Y, 2004, BIOTECHNOL BIOENG, V88, P1, DOI 10.1002/bit.20096; Spiegelhalter DJ, 2011, PHILOS T R SOC A, V369, P4730, DOI 10.1098/rsta.2011.0163; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; WAINHOBSON S, 1993, CURR OPIN GENET DEV, V3, P878, DOI 10.1016/0959-437X(93)90008-D; WEIBEL ER, 1979, B EUR PHYSIOPATH RES, V15, P999; Yang Y, 2007, EMERG INFECT DIS, V13, P1348, DOI 10.3201/eid1309.070111; Zwickl D.J., 2006, THESIS	37	232	248	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1541	1547		10.1126/science.1222526	http://dx.doi.org/10.1126/science.1222526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723414	Green Accepted			2022-12-28	WOS:000305507500048
J	Zullo, JM; Demarco, IA; Pique-Regi, R; Gaffney, DJ; Epstein, CB; Spooner, CJ; Luperchio, TR; Bernstein, BE; Pritchard, JK; Reddy, KL; Singh, H				Zullo, Joseph M.; Demarco, Ignacio A.; Pique-Regi, Roger; Gaffney, Daniel J.; Epstein, Charles B.; Spooner, Chauncey J.; Luperchio, Teresa R.; Bernstein, Bradley E.; Pritchard, Jonathan K.; Reddy, Karen L.; Singh, Harinder			DNA Sequence-Dependent Compartmentalization and Silencing of Chromatin at the Nuclear Lamina	CELL			English	Article							TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; GENE-EXPRESSION; GAGA FACTOR; PERIPHERY; PROTEIN; ORGANIZATION; LOCUS; DEACETYLATION; MAINTENANCE	A large fraction of the mammalian genome is organized into inactive chromosomal domains along the nuclear lamina. The mechanism by which these lamina associated domains (LADs) are established remains to be elucidated. Using genomic repositioning assays, we show that LADs, spanning the developmentally regulated IgH and Cyp3a loci contain discrete DNA regions that associate chromatin with the nuclear lamina and repress gene activity in fibroblasts. Lamina interaction is established during mitosis and likely involves the localized recruitment of Lamin B during late anaphase. Fine-scale mapping of LADs reveals numerous lamina-associating sequences (LASs), which are enriched for a GAGA motif. This repeated motif directs lamina association and is bound by the transcriptional repressor cKrox, in a complex with HDAC3 and Lap2 beta. Knockdown of cKrox or HDAC3 results in dissociation of LASs/LADs from the nuclear lamina. These results reveal a mechanism that couples nuclear compartmentalization of chromatin domains with the control of gene activity.	[Zullo, Joseph M.; Singh, Harinder] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Pique-Regi, Roger; Gaffney, Daniel J.; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Demarco, Ignacio A.; Spooner, Chauncey J.; Singh, Harinder] Genentech Inc, Dept Discovery Immunol, San Francisco, CA 94080 USA; [Pique-Regi, Roger; Gaffney, Daniel J.; Pritchard, Jonathan K.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Epstein, Charles B.; Bernstein, Bradley E.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Epstein, Charles B.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Epstein, Charles B.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Luperchio, Teresa R.; Reddy, Karen L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Ctr Epigenet, Baltimore, MD 21205 USA	University of Chicago; University of Chicago; Roche Holding; Genentech; Howard Hughes Medical Institute; University of Chicago; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University	Singh, H (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.	harindsi@gene.com	Pique-Regi, Roger/A-4110-2009	Pique-Regi, Roger/0000-0002-1262-2275; Luperchio, Teresa/0000-0001-8586-3101; Epstein, Charles B./0000-0001-8358-8345; Reddy, Karen/0000-0003-4548-5999; Gaffney, Daniel/0000-0002-1529-1862	NIH [GM086213]; Cancer Research Institute; Howard Hughes Medical Institute; Chicago Biomedical Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183, R01GM086213] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Chicago Biomedical Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from the University of Chicago Functional Genomics Facility for genome-wide expression and DamID analyses. We thank Lazlo Komuves and Allison Bruce at Genentech for assistance with confocal imaging and graphics art, respectively. We are grateful to members of the Singh laboratory for critical input. J.M.Z. was supported by an NIH training grant. I. A. D. acknowledges support by the Cancer Research Institute. H. S. acknowledges support by the Howard Hughes Medical Institute and the Chicago Biomedical Consortium and from NIH GM086213. H. S. and C.J.S. are employees of Genentech Inc.	Adkins NL, 2006, BIOCHEM CELL BIOL, V84, P559, DOI 10.1139/O06-062; Ahmed S, 2010, NAT CELL BIOL, V12, P111, DOI 10.1038/ncb2011; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Bhat KM, 1996, DEVELOPMENT, V122, P1113; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Brown CR, 2007, CURR OPIN GENET DEV, V17, P100, DOI 10.1016/j.gde.2007.02.005; de Nooijer S, 2009, NUCLEIC ACIDS RES, V37, P3558, DOI 10.1093/nar/gkp219; Feng YQ, 1999, J MOL BIOL, V292, P779, DOI 10.1006/jmbi.1999.3113; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; GALERA P, 1994, P NATL ACAD SCI USA, V91, P9372, DOI 10.1073/pnas.91.20.9372; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; He X., 2008, ANNU REV IMMUNOL, V28, P295; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Li Y, 2009, MOL PHARMACOL, V75, P1171, DOI 10.1124/mol.108.052993; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Matharu NK, 2010, J MOL BIOL, V400, P434, DOI 10.1016/j.jmb.2010.05.010; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; RAFF JW, 1994, EMBO J, V13, P5977, DOI 10.1002/j.1460-2075.1994.tb06943.x; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Schirmer EC, 2007, EXP CELL RES, V313, P2167, DOI 10.1016/j.yexcr.2007.03.012; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Taddei A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000612; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Yang QX, 2005, MOL CELL BIOL, V25, P6021, DOI 10.1128/MCB.25.14.6021-6030.2005; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; Yu JJ, 2003, EMBO J, V22, P3403, DOI 10.1093/emboj/cdg326; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107	43	310	319	1	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1474	1487		10.1016/j.cell.2012.04.035	http://dx.doi.org/10.1016/j.cell.2012.04.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726435	Bronze			2022-12-28	WOS:000305753800014
J	Nakamura, T; Liu, YJ; Nakashima, H; Umehara, H; Inoue, K; Matoba, S; Tachibana, M; Ogura, A; Shinkai, Y; Nakano, T				Nakamura, Toshinobu; Liu, Yu-Jung; Nakashima, Hiroyuki; Umehara, Hiroki; Inoue, Kimiko; Matoba, Shogo; Tachibana, Makoto; Ogura, Atsuo; Shinkai, Yoichi; Nakano, Toru			PGC7 binds histone H3K9me2 to protect against conversion of 5mC to 5hmC in early embryos	NATURE			English	Article							DNA METHYLTRANSFERASES; 5-HYDROXYMETHYLCYTOSINE; METHYLATION; CHROMATIN; 5-METHYLCYTOSINE; TRANSCRIPTION; EXCISION; GENOME; CELLS; TET1	The modification of DNA by 5-methylcytosine (5mC) has essential roles in cell differentiation and development through epigenetic gene regulation(1). 5mC can be converted to another modified base, 5-hydroxymethylcytosine (5hmC), by the tet methylcytosine dioxygenase (Tet) family of enzymes(2,3). Notably, the balance between 5hmC and 5mC in the genome is linked with cell-differentiation processes such as pluripotency and lineage commitment(4-7). We have previously reported that the maternal factor PGC7 (also known as Dppa3, Stella) is required for the maintenance of DNA methylation in early embryogenesis, and protects 5mC from conversion to 5hmC in the maternal genome(8,9). Here we show that PGC7 protects 5mC from Tet3-mediated conversion to 5hmC by binding to maternal chromatin containing dimethylated histone H3 lysine 9 (H3K9me2) in mice. In addition, imprinted loci that are marked with H3K9me2 in mature sperm are protected by PGC7 binding in early embryogenesis. This type of regulatory mechanism could be involved in DNA modifications in somatic cells as well as in early embryos.	[Liu, Yu-Jung; Nakashima, Hiroyuki; Umehara, Hiroki] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Nakamura, Toshinobu; Nakano, Toru] Osaka Univ, Dept Pathol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Inoue, Kimiko; Matoba, Shogo; Ogura, Atsuo] RIKEN BioResouce Ctr, Tsukuba, Ibaraki 3050074, Japan; [Tachibana, Makoto; Shinkai, Yoichi] Kyoto Univ, Expt Res Ctr Infect Dis, Inst Virus Res, Kyoto 6068507, Japan	Osaka University; Osaka University; RIKEN; Kyoto University	Nakamura, T (corresponding author), Nagahama Inst Biosci & Technol, Shiga 5260829, Japan.	tnakamura@nagahama-i-bio.ac.jp; tnakano@patho.med.osaka-u.ac.jp	Shinkai, Yoichi/N-3909-2014; MATOBA, Shogo/D-9995-2016; Ogura, Atsuo/J-3916-2014; Nakamura, Toshinobu/ABD-5906-2020	Shinkai, Yoichi/0000-0002-6051-2484; MATOBA, Shogo/0000-0003-0474-232X; Ogura, Atsuo/0000-0003-0447-1988; Nakamura, Toshinobu/0000-0003-3881-3368	Ministry of Education, Science, Sports, Culture and Technology of Japan; Grants-in-Aid for Scientific Research [20062005, 19061001] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Okano, H. Niwa and H. Kimura for providing Dnmt1<SUP>-/-</SUP> Dnmt3a<SUP>-/-</SUP> Dnmt3b<SUP>-/-</SUP> ES cells, plasmids and antibody. We also thank N. Asada for assistance, and A. Mizokami and M. Imaizumi for secretarial assistance. This work was supported in part by grants from the Ministry of Education, Science, Sports, Culture and Technology of Japan.	Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275; Pogribny I, 1999, BIOCHEM BIOPH RES CO, V262, P624, DOI 10.1006/bbrc.1999.1187; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	25	332	345	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					415	+		10.1038/nature11093	http://dx.doi.org/10.1038/nature11093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722204				2022-12-28	WOS:000305466800046
J	Tricco, AC; Ivers, NM; Grimshaw, JM; Moher, D; Turner, L; Galipeau, J; Halperin, I; Vachon, B; Ramsay, T; Manns, B; Tonelli, M; Shojania, K				Tricco, Andrea C.; Ivers, Noah M.; Grimshaw, Jeremy M.; Moher, David; Turner, Lucy; Galipeau, James; Halperin, Ilana; Vachon, Brigitte; Ramsay, Tim; Manns, Braden; Tonelli, Marcello; Shojania, Kaveh			Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis	LANCET			English	Article							CARDIOVASCULAR RISK-FACTORS	Background The effectiveness of quality improvement (QI) strategies on diabetes care remains unclear. We aimed to assess the effects of QI strategies on glycated haemoglobin (HbA(1c)), vascular risk management, microvascular complication monitoring, and smoking cessation in patients with diabetes. Methods We identified studies through Medline, the Cochrane Effective Practice and Organisation of Care database (from inception to July 2010), and references of included randomised clinical trials. We included trials assessing 11 predefined QI strategies or financial incentives targeting health systems, health-care professionals, or patients to improve management of adult outpatients with diabetes. Two reviewers independently abstracted data and appraised risk of bias. Findings We reviewed 48 cluster randomised controlled trials, including 2538 clusters and 84 865 patients, and 94 patient randomised controlled trials, including 38 664 patients. In random effects meta-analysis, the QI strategies reduced HbA(1c) by a mean difference of 0.37% (95% CI 0.28-0.45; 120 trials), LDL cholesterol by 0.10 mmol/L (0.05-0.14; 47 trials), systolic blood pressure by 3.13 mm Hg (2.19-4.06, 65 trials), and diastolic blood pressure by 1.55 mm Hg (0.95-2.15, 61 trials) versus usual care. We noted larger effects when baseline concentrations were greater than 8.0% for HbA(1c), 2.59 mmol/L for LDL cholesterol, and 80 mm Hg for diastolic and 140 mm Hg for systolic blood pressure. The effectiveness of QI strategies varied depending on baseline HbA(1c) control. QI strategies increased the likelihood that patients received aspirin (11 trials; relative risk [RR] 1.33, 95% CI 1.21-1.45), antihypertensive drugs (ten trials; RR 1.17, 1.01-1.37), and screening for retinopathy (23 trials; RR 1.22, 1.13-1.32), renal function (14 trials; RR 128, 1.13-1.44), and foot abnormalities (22 trials; RR 1.27, 1.16-1.39). However, statin use (ten trials; RR 1.12, 0.99-1.28), hypertension control (18 trials; RR 1.01, 0.96-1.07), and smoking cessation (13 trials; RR 1.13, 0.99-1.29) were not significantly increased. Interpretation Many trials of QI strategies showed improvements in diabetes care. Interventions targeting the system of chronic disease management along with patient-mediated QI strategies should be an important component of interventions aimed at improving diabetes management. Interventions solely targeting health-care professionals seem to be beneficial only if baseline HbA(1c) control is poor.	[Tricco, Andrea C.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Ivers, Noah M.] Univ Toronto, Womens Coll Hosp, Toronto, ON M5S 1A1, Canada; [Ivers, Noah M.] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Halperin, Ilana] Univ Toronto, Dept Med, Div Endocrinol, Toronto, ON M5S 1A1, Canada; [Grimshaw, Jeremy M.; Moher, David; Turner, Lucy; Galipeau, James; Vachon, Brigitte; Ramsay, Tim] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Grimshaw, Jeremy M.] Univ Ottawa, Fac Med, Dept Med, Ottawa, ON, Canada; [Moher, David; Ramsay, Tim] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Vachon, Brigitte] Univ Montreal, Sch Rehabil, Occupat Therapy Program, Montreal, PQ, Canada; [Manns, Braden] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Manns, Braden; Tonelli, Marcello] Univ Calgary, Dept Med, Calgary, AB, Canada; [Manns, Braden; Tonelli, Marcello] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada; [Shojania, Kaveh] Univ Toronto, Ctr Patient Safety, Toronto, ON M5B 1W8, Canada; [Shojania, Kaveh] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON M5B 1W8, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Universite de Montreal; University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Tricco, AC (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	triccoa@smh.ca	Moher, David/I-3408-2019; Tonelli, Marcello/B-3028-2009; Ivers, Noah/O-7643-2018; Tricco, Andrea/B-9920-2011; Grimshaw, Jeremy/D-8726-2013; Manns, Braden J/I-8942-2012; Greiver, Michelle/N-8764-2015	Moher, David/0000-0003-2434-4206; Tonelli, Marcello/0000-0002-0846-3187; Tricco, Andrea/0000-0002-4114-8971; Greiver, Michelle/0000-0001-8957-0285; Ramsay, Tim/0000-0001-8478-8170; Grimshaw, Jeremy/0000-0001-8015-8243	Ontario Ministry of Health and Long-term Care; Alberta Innovates-Health Solutions; Canadian Institutes for Health Research (CIHR); Canada Research Chairs; University of Ottawa Research Chair; Alberta Heritage Foundation for Medical Research Population Health	Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario); Alberta Innovates-Health Solutions; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs(Canada Research ChairsCGIAR); University of Ottawa Research Chair; Alberta Heritage Foundation for Medical Research Population Health(Alberta Heritage Foundation for Medical Research)	Ontario Ministry of Health and Long-term Care and the Alberta Heritage Foundation for Medical Research (now Alberta Innovates-Health Solutions).; We acknowledge the generous funding from the Ontario Ministry of Health and Long-term Care and the Alberta Heritage Foundation for Medical Research Interdisciplinary Team Grants program (now Alberta Innovates-Health Solutions). NI is supported by a Canadian Institutes for Health Research (CIHR) Fellowship Award; JMG and MT are supported by Canada Research Chairs. DM is supported by a University of Ottawa Research Chair. BM and MT are also supported by the Alberta Heritage Foundation for Medical Research Population Health Scholar awards. We thank the Advisory Board, Joan Canavan, Michael Hillmer, Erin Keely, and Baiju Shah for their guidance on the systematic review protocol. We thank Michelle Fiander for undertaking the searches of published work, Raymond Daniel for obtaining the articles, Steve Doucette for his statistical analysis expertise, and Alain Mayhew for guiding the review conceptualisation. We thank Natasha Wiebe, Natasha Krahn, Avtar Lal, and Mohammad Karkhaneh for their assistance with abstracting some of the included studies and appraising their study quality.	Allemann S, 2009, CURR MED RES OPIN, V25, P2903, DOI 10.1185/03007990903364665; American Diabetes Association, 2010, Diabetes Care, V33 Suppl 1, pS11, DOI 10.2337/dc10-S011; Armstrong R., 2011, COCHRANE HDB SYSTEMA; Braga MFB, 2010, CAN J CARDIOL, V26, P297, DOI 10.1016/S0828-282X(10)70393-7; Campbell M, 2000, J Health Serv Res Policy, V5, P12; Cochrane Eff ective Practice and Organisation of Care Group, RISK BIAS EPOC SPEC; Cook C, 2009, CHILD YOUTH SERV REV, V31, P495, DOI 10.1016/j.childyouth.2008.09.010; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Donner A, 2002, STAT MED, V21, P2971, DOI 10.1002/sim.1301; Duke S, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD005268.PUB2; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kerry SM, 1998, BRIT MED J, V316, P1455, DOI 10.1136/bmj.316.7142.1455; Kogan Allan Jay, 2009, Am J Manag Care, V15, pS255; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; McFarlane SI, 2002, DIABETES CARE, V25, P718, DOI 10.2337/diacare.25.4.718; Michie S, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-40; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Narayan V, 2004, ANN INTERN MED, V140, P958, DOI 10.7326/0003-4819-140-11-200406010-00037; RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Shojania KG, 2004, CLOSING QUALITY GAP, V2; Simpson SH, 2003, CAN MED ASSOC J, V168, P1661; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; van Bokhoven MA, 2003, QUAL SAF HEALTH CARE, V12, P215, DOI 10.1136/qhc.12.3.215	27	452	458	2	67	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2012	379	9833					2252	2261		10.1016/S0140-6736(12)60480-2	http://dx.doi.org/10.1016/S0140-6736(12)60480-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962AM	22683130				2022-12-28	WOS:000305511400032
J	Schmeisser, MJ; Ey, E; Wegener, S; Bockmann, J; Stempel, AV; Kuebler, A; Janssen, AL; Udvardi, PT; Shiban, E; Spilker, C; Balschun, D; Skryabin, BV; Dieck, ST; Smalla, KH; Montag, D; Leblond, CS; Faure, P; Torquet, N; Le Sourd, AM; Toro, R; Grabrucker, AM; Shoichet, SA; Schmitz, D; Kreutz, MR; Bourgeron, T; Gundelfinger, ED; Boeckers, TM				Schmeisser, Michael J.; Ey, Elodie; Wegener, Stephanie; Bockmann, Juergen; Stempel, A. Vanessa; Kuebler, Angelika; Janssen, Anna-Lena; Udvardi, Patrick T.; Shiban, Ehab; Spilker, Christina; Balschun, Detlef; Skryabin, Boris V.; Dieck, Susanne Tom; Smalla, Karl-Heinz; Montag, Dirk; Leblond, Claire S.; Faure, Philippe; Torquet, Nicolas; Le Sourd, Anne-Marie; Toro, Roberto; Grabrucker, Andreas M.; Shoichet, Sarah A.; Schmitz, Dietmar; Kreutz, Michael R.; Bourgeron, Thomas; Gundelfinger, Eckart D.; Boeckers, Tobias M.			Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2	NATURE			English	Article							SPECTRUM DISORDER; SYNAPTIC-TRANSMISSION; POSTSYNAPTIC DENSITY; MUTATIONS; SHANK3; GENE	Autism spectrum disorders comprise a range of neurodevelopmental disorders characterized by deficits in social interaction and communication, and by repetitive behaviour(1). Mutations in synaptic proteins such as neuroligins(2,3), neurexins(4), GKAPs/SAPAPs(5) and ProSAPs/Shanks(6-10) were identified in patients with autism spectrum disorder, but the causative mechanisms remain largely unknown. ProSAPs/Shanks build large homo-and heteromeric protein complexes at excitatory synapses and organize the complex protein machinery of the postsynaptic density in a laminar fashion(11,12). Here we demonstrate that genetic deletion of ProSAP1/Shank2 results in an early, brain-region-specific upregulation of ionotropic glutamate receptors at the synapse and increased levels of ProSAP2/Shank3. Moreover, ProSAP1/Shank2(-/-) mutants exhibit fewer dendritic spines and show reduced basal synaptic transmission, a reduced frequency of miniature excitatory postsynaptic currents and enhanced N-methyl-D-aspartate receptor-mediated excitatory currents at the physiological level. Mutants are extremely hyperactive and display profound autistic-like behavioural alterations including repetitive grooming as well as abnormalities in vocal and social behaviours. By comparing the data on ProSAP1/Shank2(-/-) mutants with ProSAP2/Shank3 alpha beta(-/-) mice, we show that different abnormalities in synaptic glutamate receptor expression can cause alterations in social interactions and communication. Accordingly, we propose that appropriate therapies for autism spectrum disorders are to be carefully matched to the underlying synaptopathic phenotype.	[Schmeisser, Michael J.; Bockmann, Juergen; Kuebler, Angelika; Janssen, Anna-Lena; Udvardi, Patrick T.; Shiban, Ehab; Grabrucker, Andreas M.; Boeckers, Tobias M.] Univ Ulm, Inst Anat & Cell Biol, D-89081 Ulm, Germany; [Ey, Elodie; Leblond, Claire S.; Torquet, Nicolas; Le Sourd, Anne-Marie; Toro, Roberto; Bourgeron, Thomas] Inst Pasteur, CNRS, URA Genes Synapses & Cognit 2182, F-75724 Paris 15, France; [Ey, Elodie; Leblond, Claire S.; Torquet, Nicolas; Le Sourd, Anne-Marie; Toro, Roberto; Bourgeron, Thomas] Univ Paris Diderot, Sorbonne Paris Cite, F-75013 Paris, France; [Wegener, Stephanie; Stempel, A. Vanessa; Shoichet, Sarah A.; Schmitz, Dietmar] Charite, Neurosci Res Ctr, D-10117 Berlin, Germany; [Spilker, Christina; Kreutz, Michael R.] Leibniz Inst Neurobiol, PG Neuroplast, D-39118 Magdeburg, Germany; [Balschun, Detlef] Catholic Univ Louvain, Lab Biol Psychol, Dept Psychol, B-3000 Louvain, Belgium; [Skryabin, Boris V.] Univ Munster, Inst Expt Pathol ZMBE, D-48149 Munster, Germany; [Skryabin, Boris V.] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48149 Munster, Germany; [Dieck, Susanne Tom] Max Planck Inst Brain Res, Dept Synapt Plast, D-60528 Frankfurt, Germany; [Smalla, Karl-Heinz; Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Dept Neurochem, D-39118 Magdeburg, Germany; [Montag, Dirk] Leibniz Inst Neurobiol, Neurogenet Special Lab, D-39118 Magdeburg, Germany; [Faure, Philippe] Univ Paris 06, CNRS, UMR 7102, F-75005 Paris, France	Ulm University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Institut fur Neurobiologie (LIN); Universite Catholique Louvain; University of Munster; University of Munster; Max Planck Society; Leibniz Institut fur Neurobiologie (LIN); Leibniz Institut fur Neurobiologie (LIN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Boeckers, TM (corresponding author), Univ Ulm, Inst Anat & Cell Biol, D-89081 Ulm, Germany.	tobias.boeckers@uni-ulm.de	Meyer, Bernhard/AAH-3329-2019; Torquet, Nicolas/ABF-9755-2020; Schmeisser, Michael/S-6347-2019; Smalla, Dr. Karl-Heinz/C-3950-2012; Skryabin, Boris/AAL-3100-2020; Montag, Dirk/D-3925-2014	Meyer, Bernhard/0000-0001-6486-7955; Torquet, Nicolas/0000-0001-9032-193X; Smalla, Dr. Karl-Heinz/0000-0002-0269-0311; Skryabin, Boris/0000-0002-4392-185X; Montag, Dirk/0000-0002-4964-1330; Toro, Roberto/0000-0002-6671-858X; Spilker, Christina/0000-0002-7996-7673; Wegener, Stephanie/0000-0002-5809-2222; Butscher, Anna-Lena/0000-0001-5556-4610; Bourgeron, Thomas/0000-0001-8164-9220; Stempel, Vanessa/0000-0003-0420-7765; Grabrucker, Andreas/0000-0003-0005-4810; Ey, Elodie/0000-0002-8202-3163; Schmitz, Dietmar/0000-0003-2741-5241; Faure, Philippe/0000-0003-3573-4971; Shiban, Ehab/0000-0001-7427-3034	Baustein 3.2 [L.SBN.0081, L.SBN.0083]; Fondation de France; Agence Nationale de la Recherche (ANR) FLEXNEURIM [ANR09BLAN034003]; Deutsche Forschungsgemeinschaft (DFG) [GRK 1123, EXC 257, SFB 618, SFB 665, SFB 779, Bo 1718/3-1, 1718/4-1, SFB 497/B8]; Bundesministerium fur Bildung und Forschung (BMBF) (BCCN, BFNL); Einstein Foundation; ANR [ANR-08-MNPS-037-01 - SynGen]; Neuron-ERANET [EUHF-AUTISM]; Fondation Orange; Fondation FondaMentale; Bettencourt-Schueller Fondation; CNRS Neuroinformatic; BMBF (EraNET Neuron)	Baustein 3.2; Fondation de France(Fondation de France); Agence Nationale de la Recherche (ANR) FLEXNEURIM(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF) (BCCN, BFNL); Einstein Foundation; ANR(French National Research Agency (ANR)); Neuron-ERANET; Fondation Orange; Fondation FondaMentale; Bettencourt-Schueller Fondation; CNRS Neuroinformatic; BMBF (EraNET Neuron)(Federal Ministry of Education & Research (BMBF))	We thank M. Manz, R. Zienecker, S. Gerlach-Arbeiter, N. Damm, H. Riederer, C. Jean, S. Rieckmann, S. Hochmuth and K. Sowa for technical assistance. M.J.S., A.-L.J. and P. T. U. are members of the International Graduate School in Molecular Medicine at Ulm University. M.J.S. is further supported by Baustein 3.2 (L.SBN.0081), E. E. by the Fondation de France and the Agence Nationale de la Recherche (ANR) FLEXNEURIM (ANR09BLAN034003), S. W. and A. V. S. by the Deutsche Forschungsgemeinschaft (DFG) (GRK 1123), A. M. G. by Baustein 3.2 (L.SBN.0083), S. A. S by the DFG (EXC 257), D. S. by the DFG (SFB 618, SFB 665, EXC 257), the Bundesministerium fur Bildung und Forschung (BMBF) (BCCN, BFNL) and the Einstein Foundation, M. R. K. by the DFG (SFB 779), C. S. L., R. T., N. T., A.LS. and T. B. by the ANR (ANR-08-MNPS-037-01 - SynGen), Neuron-ERANET (EUHF-AUTISM), Fondation Orange and the Fondation FondaMentale, P. F. by the Bettencourt-Schueller Fondation, R. T., T. B., P. F. by the CNRS Neuroinformatic, E. D. G. by the DFG (SFB779) and the BMBF (EraNET Neuron), and T. M. B. by the DFG (Bo 1718/3-1 and 1718/4-1; SFB 497/B8).	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Bangash MA, 2011, CELL, V145, P758, DOI 10.1016/j.cell.2011.03.052; Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Berkel S, 2012, HUM MOL GENET, V21, P344, DOI 10.1093/hmg/ddr470; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Bourgeron T, 2006, CONTEMPORARY CLIN NE, P151; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Etherton MR, 2011, EMBO J, V30, P2908, DOI 10.1038/emboj.2011.182; Ey E, 2011, AUTISM RES, V4, P5, DOI 10.1002/aur.175; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Grabrucker AM, 2011, TRENDS CELL BIOL, V21, P594, DOI 10.1016/j.tcb.2011.07.003; Grabrucker AM, 2011, EMBO J, V30, P569, DOI 10.1038/emboj.2010.336; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Pearson BL, 2011, GENES BRAIN BEHAV, V10, P228, DOI 10.1111/j.1601-183X.2010.00659.x; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P1, DOI 10.1111/j.1601-183X.2010.00653.x; Schmeisser MJ, 2009, J BIOL CHEM, V284, P29146, DOI 10.1074/jbc.M109.020628; Schmitz D, 2003, NAT NEUROSCI, V6, P1058, DOI 10.1038/nn1116; Silverman JL, 2011, BRAIN RES, V1380, P120, DOI 10.1016/j.brainres.2010.09.026; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Whishaw IQ, 1999, MODERN TECHNIQUES NE, P1243, DOI 10.1007/978-3-642-58552-4_44; Wohr M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020631; Zitzer H, 1999, J BIOL CHEM, V274, P32997, DOI 10.1074/jbc.274.46.32997	38	419	437	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					256	+		10.1038/nature11015	http://dx.doi.org/10.1038/nature11015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699619				2022-12-28	WOS:000305189000035
J	Susarla, SM; Peacock, ZS				Susarla, Srinivas M.; Peacock, Zachary S.			Obstructive Parotitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Susarla, Srinivas M.; Peacock, Zachary S.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Susarla, SM (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.		Peacock, Zachary/AAF-9942-2019; Susarla, Srinivas/P-1051-2019	Susarla, Srinivas/0000-0003-0155-8260					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2012	366	24					2305	2305						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	957PD	22694001				2022-12-28	WOS:000305174100011
J	van der Graaf, R; Roes, KCB; van Delden, JJM				van der Graaf, Rieke; Roes, Kit C. B.; van Delden, Johannes J. M.			Adaptive Trials in Clinical Research Scientific and Ethical Issues to Consider	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DESIGNS		[van der Graaf, Rieke; Roes, Kit C. B.; van Delden, Johannes J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	van der Graaf, R (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Huispost STR 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.	r.vandergraaf@umcutrecht.nl	Roes, Kit/AAC-4093-2019; Van der Graaf, Rieke/AAF-6142-2019	Roes, Kit/0000-0002-6775-1963; Van der Graaf, Rieke/0000-0003-4907-7044				Berry DA, 2011, J CLIN ONCOL, V29, P606, DOI 10.1200/JCO.2010.32.2685; CLAYTON DG, 1982, BRIT J CLIN PHARMACO, V13, P469; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Korn EL, 2011, J CLIN ONCOL, V29, P771, DOI 10.1200/JCO.2010.31.1423; Krams M, 2003, STROKE, V34, P2543, DOI 10.1161/01.STR.0000092527.33910.89; Palmer CR, 2002, STAT METHODS MED RES, V11, P381, DOI 10.1191/0962280202sm298ra; ROSENBERGER WF, 1993, CONTROL CLIN TRIALS, V14, P471, DOI 10.1016/0197-2456(93)90028-C	7	26	26	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2012	307	22					2379	2380		10.1001/jama.2012.6380	http://dx.doi.org/10.1001/jama.2012.6380			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	956UX	22692169				2022-12-28	WOS:000305115900021
J	Hankey, GJ				Hankey, Graeme J.			How effective is citicoline for acute ischaemic stroke?	LANCET			English	Editorial Material							RANDOMIZED EFFICACY TRIAL		[Hankey, Graeme J.] Royal Perth Hosp, Dept Neurol, Perth, WA 6000, Australia; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia	Hankey, GJ (corresponding author), Royal Perth Hosp, Dept Neurol, Perth, WA 6000, Australia.	graeme.hankey@uwa.edu.au	Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Cappelleri JC, 1996, JAMA-J AM MED ASSOC, V276, P1332, DOI 10.1001/jama.276.16.1332; Clark WM, 1999, STROKE, V30, P2592, DOI 10.1161/01.STR.30.12.2592; Clark WM, 1997, NEUROLOGY, V49, P671, DOI 10.1212/WNL.49.3.671; Clark WM, 2001, NEUROLOGY, V57, P1595, DOI 10.1212/WNL.57.9.1595; Davalos A, 2002, STROKE, V33, P2850, DOI 10.1161/01.STR.0000038691.03334.71; Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7; Davalos A, 2011, STROKE, V42, pS36, DOI 10.1161/STROKEAHA.110.605568; del Zoppo GJ, 2006, NEW ENGL J MED, V354, P553, DOI 10.1056/NEJMp058312; Diederich K, 2012, STROKE, V43, P1931, DOI 10.1161/STROKEAHA.112.654806; Fletcher J, 2007, BMJ-BRIT MED J, V334, P94, DOI 10.1136/bmj.39057.406644.68; MUIR KW, 2003, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001244; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Saver Jeffrey L, 2008, Rev Neurol Dis, V5, P167; TAZAKI Y, 1988, STROKE, V19, P211, DOI 10.1161/01.STR.19.2.211; Warach S, 2000, ANN NEUROL, V48, P713, DOI 10.1002/1531-8249(200011)48:5<713::AID-ANA4>3.3.CO;2-R; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2	16	3	7	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2012	380	9839					318	320		10.1016/S0140-6736(12)60912-X	http://dx.doi.org/10.1016/S0140-6736(12)60912-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979TN	22691568				2022-12-28	WOS:000306842800009
J	Yvon-Durocher, G; Caffrey, JM; Cescatti, A; Dossena, M; del Giorgio, P; Gasol, JM; Montoya, JM; Pumpanen, J; Staehr, PA; Trimmer, M; Woodward, G; Allen, AP				Yvon-Durocher, Gabriel; Caffrey, Jane M.; Cescatti, Alessandro; Dossena, Matteo; del Giorgio, Paul; Gasol, Josep M.; Montoya, Jose M.; Pumpanen, Jukka; Staehr, Peter A.; Trimmer, Mark; Woodward, Guy; Allen, Andrew P.			Reconciling the temperature dependence of respiration across timescales and ecosystem types	NATURE			English	Article							BIOMASS DISTRIBUTION; METABOLIC BALANCE; CARBON EXCHANGE; COMMUNITIES; PATTERNS; EMISSIONS; CLIMATE; LINKING; SOILS; CYCLE	Ecosystem respiration is the biotic conversion of organic carbon to carbon dioxide by all of the organisms in an ecosystem, including both consumers and primary producers. Respiration exhibits an exponential temperature dependence at the subcellular and individual levels(1), but at the ecosystem level respiration can be modified by many variables(2-4) including community abundance and biomass(5), which vary substantially among ecosystems(6). Despite its importance for predicting the responses of the biosphere to climate change, it is as yet unknown whether the temperature dependence of ecosystem respiration varies systematically between aquatic and terrestrial environments. Here we use the largest database of respiratory measurements yet compiled to show that the sensitivity of ecosystem respiration to seasonal changes in temperature is remarkably similar for diverse environments encompassing lakes, rivers, estuaries, the open ocean and forested and non-forested terrestrial ecosystems, with an average activation energy similar to that of the respiratory complex(3) (approximately 0.65 electronvolts (eV)). By contrast, annual ecosystem respiration shows a substantially greater temperature dependence across aquatic (approximately 0.65 eV) versus terrestrial ecosystems (approximately 0.32 eV) that span broad geographic gradients in temperature. Using a model(5) derived from metabolic theory(7), these findings can be reconciled by similarities in the biochemical kinetics of metabolism at the subcellular level, and fundamental differences in the importance of other variables besides temperature-such as primary productivity and allochthonous carbon inputs-on the structure of aquatic and terrestrial biota at the community level.	[Yvon-Durocher, Gabriel; Dossena, Matteo; Trimmer, Mark; Woodward, Guy] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Yvon-Durocher, Gabriel] Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9EZ, Cornwall, England; [Caffrey, Jane M.] Univ W Florida, Ctr Environm Diagnost & Bioremediat, Pensacola, FL 32514 USA; [Cescatti, Alessandro] European Commiss, Joint Res Ctr, Inst Environm & Sustainabil, I-21027 Ispra, Italy; [del Giorgio, Paul] Univ Quebec Montreal, Dept Sci Biol, Montreal, PQ H2X 3X8, Canada; [Gasol, Josep M.; Montoya, Jose M.] Inst Marine Sci ICM CSIC, E-08003 Barcelona, Spain; [Pumpanen, Jukka] Univ Helsinki, Dept Forest Sci, FI-00014 Helsinki, Finland; [Staehr, Peter A.] Aarhus Univ, Inst Biosci, DK-4000 Roskilde, Denmark; [Allen, Andrew P.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	University of London; Queen Mary University London; University of Exeter; State University System of Florida; University of West Florida; European Commission Joint Research Centre; EC JRC ISPRA Site; University of Quebec; University of Quebec Montreal; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Helsinki; Aarhus University; Macquarie University	Yvon-Durocher, G (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	g.yvon-durocher@exeter.ac.uk	del Giorgio, Paul/AAD-1315-2019; Montoya, Jose/AAH-2369-2019; Trimmer, Mark/HGT-8823-2022; Gasol, Josep M M/B-1709-2008; Yvon-Durocher, Gabriel/M-4600-2014; Trimmer, Mark/ABB-2336-2021; Staehr, Peter/S-6110-2018; Pumpanen, Jukka/B-1254-2012; Allen, Andrew/B-8045-2011; Cescatti, Alessandro/ABE-6319-2020; Staehr, Peter/J-3693-2013	del Giorgio, Paul/0000-0003-1866-8159; Gasol, Josep M M/0000-0001-5238-2387; Yvon-Durocher, Gabriel/0000-0002-1749-3417; Trimmer, Mark/0000-0002-9859-5537; Staehr, Peter/0000-0002-1580-4875; Pumpanen, Jukka/0000-0003-4879-3663; Allen, Andrew/0000-0003-0304-7544; Staehr, Peter/0000-0002-1580-4875; Montoya, Jose M./0000-0002-6676-7592	Natural Environment Research Council, UK [NE/F004753/1]; Danish Council for Independent Research, Natural Sciences [10-085238]; Danish Centre for Lake Restoration(CLEAR); Academy of Finland Centre of Excellence program [218094]; Ramon y Cajal Fellowship [RYC-892 2008-03664]; Ministry of Economy [CGL2010-20091]; Generalitat de Catalunya [2009SGR142]; NERC [NE/H022511/1] Funding Source: UKRI; Natural Environment Research Council [NE/H022511/1] Funding Source: researchfish	Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Danish Centre for Lake Restoration(CLEAR); Academy of Finland Centre of Excellence program(Academy of Finland); Ramon y Cajal Fellowship(Spanish Government); Ministry of Economy; Generalitat de Catalunya(Generalitat de Catalunya); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We wish to thank J. Cole, M. Pace, M. Reichstein and D. Baldocchi for helpful comments that greatly improved the manuscript. M. Mahecha, C. S. Hopkinson, E. Smith, C. Gudasz, C. Solomon, E. Gaiser, E. de Eyto, C.-Y. Chiu, D. Hamilton, S. Hendricks, R. Adrian, K. Rose, D. Bruesewitz, D. Richardson, M. Van de Bogert, FLUXNET and GLEON are gratefully acknowledged for supplying raw data. G.Y.-D., M. T. and G. W. acknowledge the support of the Natural Environment Research Council, UK (grant NE/F004753/1) for financial support. P. A. S. was funded by the Danish Council for Independent Research, Natural Sciences grant 10-085238 and the Danish Centre for Lake Restoration(CLEAR). J. P. acknowledges the Academy of Finland Centre of Excellence program (project number 218094) for funding. J. M. M. was supported by a Ramon y Cajal Fellowship (RYC-892 2008-03664), a Ministry of Economy grant (CGL2010-20091) and Generalitat de Catalunya grant (2009SGR142).	Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cebrian J, 1999, AM NAT, V154, P449, DOI 10.1086/303244; Chapin III S.F., 2002, PRINCIPLES TERRESTRI; Del Giorgio P., 2005, RESP AQUATIC ECOSYST, P57; Del Giorgio PA, 1999, ECOLOGY, V80, P1422, DOI 10.1890/0012-9658(1999)080[1422:LPBAMT]2.0.CO;2; DELGIORGIO PA, 1995, AM NAT, V146, P135, DOI 10.1086/285790; Dewar RC, 1999, GLOBAL CHANGE BIOL, V5, P615, DOI 10.1046/j.1365-2486.1999.00253.x; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; Enquist BJ, 2003, NATURE, V423, P639, DOI 10.1038/nature01671; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gu LH, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003164; Kesselmeier J, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001813; Lopez-Urrutia A, 2006, P NATL ACAD SCI USA, V103, P8739, DOI 10.1073/pnas.0601137103; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Pereira JS, 2007, BIOGEOSCIENCES, V4, P791, DOI 10.5194/bg-4-791-2007; Pinheiro J, 2001, MIXED EFFECTS MODELS; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Regaudie-De-Gioux A, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003907; Savage VM, 2004, J THEOR BIOL, V227, P525, DOI 10.1016/j.jtbi.2003.11.030; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Vargas R, 2010, ECOL APPL, V20, P1569, DOI 10.1890/09-0693.1; Yvon-Durocher G, 2010, PHILOS T R SOC B, V365, P2117, DOI 10.1098/rstb.2010.0038	28	289	298	17	458	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2012	487	7408					472	476		10.1038/nature11205	http://dx.doi.org/10.1038/nature11205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979KD	22722862				2022-12-28	WOS:000306815300036
J	Rising, JP; Reynolds, IS; Sedrakyan, A				Rising, Joshua P.; Reynolds, Ian S.; Sedrakyan, Art			Delays and Difficulties in Assessing Metal-on-Metal Hip Implants	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rising, Joshua P.; Reynolds, Ian S.] Pew Charitable Trusts, Pew Hlth Grp, Med Device Initiat, Washington, DC USA; [Sedrakyan, Art] Weill Cornell Med Coll, Patient Centered Comparat Effectiveness Program, New York, NY USA; [Sedrakyan, Art] New York Presbyterian Hosp, New York, NY USA	Cornell University; NewYork-Presbyterian Hospital	Rising, JP (corresponding author), Pew Charitable Trusts, Pew Hlth Grp, Med Device Initiat, Washington, DC USA.		Reynolds, Ian/S-1485-2019					British Orthopaedic Association British Hip Society, 2011, LARG DIAM MET MET BE; Graves Stephen E, 2011, J Bone Joint Surg Am, V93 Suppl 3, P43, DOI 10.2106/JBJS.K.01220; U.S. Food and Drug Administration, POSTM SURV STUD LETT	3	24	24	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 5	2012	367	1								10.1056/NEJMp1206794	http://dx.doi.org/10.1056/NEJMp1206794			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	968KJ	22716934				2022-12-28	WOS:000305979400018
J	Chong, LY; Fenu, E; Stansby, G; Hodgkinson, S				Chong, Lee-Yee; Fenu, Elisabetta; Stansby, Gerard; Hodgkinson, Sarah		Guideline Dev Grp	Management of venous thromboembolic diseases and the role of thrombophilia testing: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							D-DIMER; ANTICOAGULANT-THERAPY; RISK; METAANALYSIS; RECURRENCE		[Stansby, Gerard] Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Chong, Lee-Yee; Fenu, Elisabetta; Hodgkinson, Sarah] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	Newcastle Freeman Hospital; Newcastle University - UK; Royal College of Physicians	Stansby, G (corresponding author), Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.	Gerard.Stansby@nuth.nhs.uk	Langford, Nigel/P-3308-2019	Stansby, Gerard/0000-0001-5539-3049; Keeling, David/0000-0001-6779-6566				Douketis J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d813; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; National Institute for Health and Clinical Excellence, GUID MAN 2009; National Institute for Health and Clinical Excellence Guidance, 2012, VEN THROMB DIS MAN V; Palareti G, 2003, CIRCULATION, V108, P313, DOI 10.1161/01.CIR.0000079162.69615.0F; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Stain M, 2005, J THROMB HAEMOST, V3, P2671, DOI 10.1111/j.1538-7836.2005.01648.x; Verhovsek M, 2008, ANN INTERN MED, V149, P481, DOI 10.7326/0003-4819-149-7-200810070-00008; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	10	53	53	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 27	2012	344								e3979	10.1136/bmj.e3979	http://dx.doi.org/10.1136/bmj.e3979			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	968MX	22740565				2022-12-28	WOS:000305987100009
J	Jakicic, JM; Tate, DF; Lang, W; Davis, KK; Polzien, K; Rickman, AD; Erickson, K; Neiberg, RH; Finkelstein, EA				Jakicic, John M.; Tate, Deborah F.; Lang, Wei; Davis, Kelli K.; Polzien, Kristen; Rickman, Amy D.; Erickson, Karen; Neiberg, Rebecca H.; Finkelstein, Eric A.			Effect of a Stepped-Care Intervention Approach on Weight Loss in Adults A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIFE-STYLE INTERVENTION; PHYSICAL-ACTIVITY; OVERWEIGHT; EXERCISE; DISORDER	Context Given the obesity epidemic, effective but resource-efficient weight loss treatments are needed. Stepped-treatment approaches customize interventions based on milestone completion and can be more effective while costing less to administer than conventional treatment approaches. Objective To determine whether a stepped-care weight loss intervention (STEP) compared with a standard behavioral weight loss intervention (SBWI) would result in greater weight loss. Design, Setting, and Participants A randomized clinical trial of 363 overweight and obese adults (body mass index: 25-<40; age: 18-55 years, 33% nonwhite, and 83% female) who were randomized to SBWI (n = 165) or STEP (n = 198) at 2 universities affiliated with academic medical centers in the United States (Step-Up Study). Participants were enrolled between May 2008 and February 2010 and data collection was completed by September 2011. Interventions All participants were placed on a low-calorie diet, prescribed increases in physical activity, and attended group counseling sessions ranging from weekly to monthly during an 18-month period. The SBWI group was assigned to a fixed program. Counseling frequency, type, and weight loss strategies could be modified every 3 months for the STEP group in response to observed weight loss as it related to weight loss goals. Main Outcome Measure Mean change in weight over 18 months. Additional outcomes included resting heart rate and blood pressure, waist circumference, body composition, fitness, physical activity, dietary intake, and cost of the program. Results Of the 363 participants randomized, 260 (71.6%) provided a measure of mean change in weight over 18 months. The 18-month intervention resulted in weight decreasing from 93.1 kg (95% CI, 91.0 to 95.2 kg) to 85.6 kg (95% CI, 83.4 to 87.7 kg) (P < .001) in the SBWI group and from 92.7 kg (95% CI, 90.8 to 94.6 kg) to 86.4 kg (95% CI, 84.5 to 88.4 kg) in the STEP group (P < .001). The percentage change in weight from baseline to 18 months was -8.1% (95% CI, -9.4% to -6.9%) in the SBWI group (P < .001) compared with -6.9% (95% CI, -8.0% to -5.8%) in the STEP group (P < .001). Although the between-group difference in 18-month weight loss was not statistically different (-1.3 kg [95% CI, -2.8 to 0.2 kg]; P = .09), there was a significant group x time interaction effect (P = .03). The cost per participant was $1357 (95% CI, $1272 to $1442) for the SBWI group vs $785 (95% CI, $739 to $830) for the STEP group (P < .001). Both groups had significant and comparable improvements in resting heart rate, blood pressure level, and fitness. Conclusions Among overweight and obese adults, the use of SBWI resulted in a greater mean weight loss than STEP over 18 months. Compared with SBWI, STEP resulted in clinically meaningful weight loss that cost less to implement.	[Jakicic, John M.; Davis, Kelli K.; Rickman, Amy D.] Univ Pittsburgh, Phys Act & Weight Management Res Ctr, Dept Hlth & Phys Act, Pittsburgh, PA 15261 USA; [Tate, Deborah F.] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Tate, Deborah F.] Univ N Carolina, Dept Hlth Behav & Educ, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Tate, Deborah F.; Polzien, Kristen; Erickson, Karen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lang, Wei; Neiberg, Rebecca H.] Wake Forest Univ, Dept Biostat Sci, Div Publ Hlth Sci, Winston Salem, NC 27109 USA; [Finkelstein, Eric A.] Duke NUS Grad Med Sch, Hlth Serv & Syst Res Program, Singapore, Singapore	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University; National University of Singapore	Jakicic, JM (corresponding author), Univ Pittsburgh, Phys Act & Weight Management Res Ctr, Dept Hlth & Phys Act, 140 Trees Hall, Pittsburgh, PA 15261 USA.	jjakicic@pitt.edu	Biguzzi, Felipe A/E-4724-2015		Beverage Institute for Health and Wellness; BodyMedia Inc; National Institutes of Health [HL084400]; National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084400] Funding Source: NIH RePORTER	Beverage Institute for Health and Wellness; BodyMedia Inc; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Jakicic reported serving on the scientific advisory board for Alere Wellbeing; receiving honoraria for a scientific presentation from Jenny Craig and from the Nestle Nutrition Institute; and serving as the principal investigator on research grants from the Beverage Institute for Health and Wellness and BodyMedia Inc awarded to the University of Pittsburgh. Dr Finkelstein reported serving as a consultant to Allergan Inc to conduct data analyses not related to the data presented in this article.; This study was supported by grant HL084400 from the National Institutes of Health and the National Heart, Lung, and Blood Institute.	American College of Sports Medicine, 2009, ACSMS GUID EX TEST P, VV; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Brooner RK, 2004, J SUBST ABUSE TREAT, V27, P223, DOI 10.1016/j.jsat.2004.07.005; BROWNELL KD, 1986, ANNU REV PUBL HEALTH, V7, P521, DOI 10.1146/annurev.pu.07.050186.002513; Carels RA, 2005, J PSYCHOSOM RES, V59, P375, DOI 10.1016/j.jpsychores.2005.06.060; Carels RA, 2008, OBESITY, V16, P1460, DOI 10.1038/oby.2008.49; Carels RA, 2009, J BEHAV MED, V32, P503, DOI 10.1007/s10865-009-9221-8; Davison GC, 2000, J CONSULT CLIN PSYCH, V68, P580, DOI 10.1037/0022-006X.68.4.580; Espeland M, 2007, DIABETES CARE, V30, P1374; Jakicic JM, 2003, JAMA-J AM MED ASSOC, V290, P1323, DOI 10.1001/jama.290.10.1323; Jakicic JM, 2008, ARCH INTERN MED, V168, P1550, DOI 10.1001/archinte.168.14.1550; Jeffery RW, 2003, AM J CLIN NUTR, V78, P684, DOI 10.1093/ajcn/78.4.684; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Newman MG, 2000, J CONSULT CLIN PSYCH, V68, P549, DOI 10.1037//0022-006X.68.4.549; Otto MW, 2000, J CONSULT CLIN PSYCH, V68, P556, DOI 10.1037//0022-006X.68.4.556; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; SEGAL KR, 1985, J APPL PHYSIOL, V58, P1565, DOI 10.1152/jappl.1985.58.5.1565; Sobell MB, 2000, J CONSULT CLIN PSYCH, V68, P573, DOI 10.1037//0022-006X.68.4.573; Stevens J, 2006, INT J OBESITY, V30, P391, DOI 10.1038/sj.ijo.0803175; Unick JL, 2010, MED SCI SPORT EXER, V42, P745, DOI 10.1249/MSS.0b013e3181bd1a57; Wilson GT, 2000, J CONSULT CLIN PSYCH, V68, P564, DOI 10.1037/0022-006X.68.4.564; Wing R. R., 2002, Handbook of obesity treatment, P301; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; 1998, OBES RES, V6, P464	26	118	118	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2012	307	24					2617	2626		10.1001/jama.2012.6866	http://dx.doi.org/10.1001/jama.2012.6866			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	964KF	22735431	Green Accepted			2022-12-28	WOS:000305692600030
J	Page, SP; Archbold, A; Abrams, DJ				Page, Stephen P.; Archbold, Andrew; Abrams, Dominic J.			Chest pain and ST elevation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BRUGADA-SYNDROME		[Page, Stephen P.; Abrams, Dominic J.] St Bartholomews Hosp, Inherited Arrhythmia Serv, London EC1A 7BE, England; [Archbold, Andrew] London Chest Hosp, Dept Cardiol, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Page, SP (corresponding author), St Bartholomews Hosp, Inherited Arrhythmia Serv, London EC1A 7BE, England.	stephen.page@bartsandthelondon.nhs.uk	Abrams, Dominic/AAD-8306-2021	Archbold, Richard/0000-0002-9847-070X; Abrams, Dominic/0000-0001-5266-2805				Brugada P, 2005, CIRCULATION, V112, P279, DOI 10.1161/CIRCULATIONAHA.104.485326; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Probst V, 2007, CIRCULATION, V115, P2042, DOI 10.1161/CIRCULATIONAHA.106.664219; Skinner JR, 2007, PEDIATRICS, V119, pE1206, DOI 10.1542/peds.2006-2628; Wang K, 2003, NEW ENGL J MED, V349, P2128, DOI 10.1056/NEJMra022580; Wilde AAM, 2002, CIRCULATION, V106, P2514, DOI 10.1161/01.CIR.0000034169.45752.4A	7	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2012	344								e4323	10.1136/bmj.e4323	http://dx.doi.org/10.1136/bmj.e4323			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	968MX	22740569				2022-12-28	WOS:000305987100015
J	Carel, H; Macnaughton, J				Carel, Havi; Macnaughton, Jane			"How do you feel?": oscillating perspectives in the clinic	LANCET			English	Editorial Material									[Macnaughton, Jane] Univ Durham, Ctr Med Humanities, Durham DH1 3LN, England; [Carel, Havi] Univ W England, Dept Arts, Fac Arts Creat Ind & Educ, Bristol BS16 1QY, Avon, England	Durham University; University of West England	Macnaughton, J (corresponding author), Univ Durham, Ctr Med Humanities, Durham DH1 3LN, England.	jane.macnaughton@durham.ac.uk		Carel, Havi/0000-0002-1260-2362	Wellcome Trust [086049] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Carel H., 2008, ILLNESS CRY FLESH; Edwards S D, 1998, Med Health Care Philos, V1, P47, DOI 10.1023/A:1009985821964; Husserl E, 1952, IDEAS PERTAINING PUR; Macnaughton J, 2009, LANCET, V373, P1940, DOI 10.1016/S0140-6736(09)61055-2; Ratcliffe Matthew., 2008, FEELINGS BEING PHENO, DOI [10.1093/med/, DOI 10.1093/MED/9780199206469.001.0001]; TOOMBS SK, 1987, J MED PHILOS, V12, P219, DOI 10.1093/jmp/12.3.219	6	24	24	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2012	379	9834					2334	2335		10.1016/S0140-6736(12)61007-1	http://dx.doi.org/10.1016/S0140-6736(12)61007-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961ZV	22734145	Green Accepted, Green Submitted			2022-12-28	WOS:000305509600015
J	Frankel, MS				Frankel, Mark S.			Regulating the Boundaries of Dual-Use Research	SCIENCE			English	Editorial Material							INFLUENZA	A new U.S. policy for dual-use life science research defines what is permissible by scientists and the government. However, further negotiations will be needed as governments realize the consequences of such boundaries for research and society.	Amer Assoc Advancement Sci, Program Sci Responsibil Human Rights & Law, Washington, DC 20005 USA		Frankel, MS (corresponding author), Amer Assoc Advancement Sci, Program Sci Responsibil Human Rights & Law, 1200 New York Ave NW, Washington, DC 20005 USA.	mfrankel@aaas.org						[Anonymous], 2012, US GOVT POLICY OVERS; Arkin, 2019, SCIENCE, DOI [10.1126/science.364.6438.320, 10.1126/science.abe9728]; Cohen J, 2012, SCIENCE, V335, P512, DOI 10.1126/science.335.6068.512; Edsall J.T., 1975, SCI FREEDOM RESPONSI; Enserink M., SCIENCEINSIDER; Enserink M, 2012, SCIENCE, V336, P529, DOI 10.1126/science.336.6081.529; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Malakoff D., SCIENCEINSIDER	9	8	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1523	1525		10.1126/science.1221285	http://dx.doi.org/10.1126/science.1221285			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	961ZE	22723408				2022-12-28	WOS:000305507500042
J	Hoffmeyer, K; Raggioli, A; Rudloff, S; Anton, R; Hierholzer, A; Del Valle, I; Hein, K; Vogt, R; Kemler, R				Hoffmeyer, Katrin; Raggioli, Angelo; Rudloff, Stefan; Anton, Roman; Hierholzer, Andreas; Del Valle, Ignacio; Hein, Kerstin; Vogt, Riana; Kemler, Rolf			Wnt/beta-Catenin Signaling Regulates Telomerase in Stem Cells and Cancer Cells	SCIENCE			English	Article							BETA-CATENIN; TARGET; GENE; ACTIVATION; CHROMATIN	Telomerase activity controls telomere length and plays a pivotal role in stem cells, aging, and cancer. Here, we report a molecular link between Wnt/beta-catenin signaling and the expression of the telomerase subunit Tert. beta-Catenin-deficient mouse embryonic stem (ES) cells have short telomeres; conversely, ES cell expressing an activated form of beta-catenin (beta-cat(Delta Ex3/+)) have long telomeres. We show that beta-catenin regulates Tert expression through the interaction with Klf4, a core component of the pluripotency transcriptional network. beta-Catenin binds to the Tert promoter in a mouse intestinal tumor model and in human carcinoma cells. We uncover a previously unknown link between the stem cell and oncogenic potential whereby beta-catenin regulates Tert expression, and thereby telomere length, which could be critical in human regenerative therapy and cancer.	[Hoffmeyer, Katrin; Raggioli, Angelo; Rudloff, Stefan; Anton, Roman; Hierholzer, Andreas; Del Valle, Ignacio; Hein, Kerstin; Vogt, Riana; Kemler, Rolf] Max Planck Inst Immunobiol & Epigenet, Dept Mol Embryol, D-79108 Freiburg, Germany	Max Planck Society	Kemler, R (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Mol Embryol, Stuebeweg 51, D-79108 Freiburg, Germany.	kemler@immunbio.mpg.de		del Valle, Ignacio/0000-0003-2595-3652; Raggioli, Angelo/0000-0002-6748-0307; Anton, Roman/0000-0002-9036-0012	Max Planck Society	Max Planck Society(Max Planck Society)	We thank H. H. Ng (Singapore) for the antibody against Klf4, I. Horikawa (NIH) for the 300-bp promoter construct, and J.-H. Lee (Indiana University) for Ash2l and Setd1a expression vectors. We thank E. M. Varela and M. Blasco (Madrid) for advice and reagents for the Q-fish analysis and for antibodies against Tert. We are grateful to M. M. Taketo (Kyoto) and to S. Robine (Paris) for providing mutant mice. We thank S. Lugert for advice on neurosphere cultures, J. Volkind for technical assistance, V. Taylor and D. Junghans for discussion and critical reading, and R. Schneider for typing of the manuscript. K. H. and A. R. are members of the International Max Planck Research School for Molecular and Cellular Biology (IMPRS-MCB). This work was supported by the Max Planck Society. The authors declare no financial interests.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Miura T, 2004, AGING CELL, V3, P333, DOI 10.1111/j.1474-9728.2004.00134.x; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Wong CW, 2010, STEM CELLS, V28, P1510, DOI 10.1002/stem.477; Wyatt HDM, 2010, NUCLEIC ACIDS RES, V38, P5609, DOI 10.1093/nar/gkq370	16	375	398	4	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1549	1554		10.1126/science.1218370	http://dx.doi.org/10.1126/science.1218370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723415				2022-12-28	WOS:000305507500049
J	Schneier, B				Schneier, Bruce			Securing Medical Research: A Cybersecurity Point of View	SCIENCE			English	Editorial Material								The problem of securing biological research data is a difficult and complicated one. Our ability to secure data on computers is not robust enough to ensure the security of existing data sets. Lessons from cryptography illustrate that neither secrecy measures, such as deleting technical details, nor national solutions, such as export controls, will work.				schneier@schneier.com						[Anonymous], 2012, M H5N1 RES BIOS BIOS; Daly MK, 2009, 23 LARG INST SYST AD; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kerckhoffs A, 1883, J SCI MILITAIRES, V9, P5; KERCKHOFFS A, 1883, J SCI MILITAIRES, V9, P161; Levy S., 2001, CRYPTO CODE REBELS B; National Institute of Standards and Technology, 2007, FED REG         1107, V72, P62212; Schneier B., 2000, CRYPTOGRAM      0215; Schneier B., 1994, APPL CRYPTOGRAPHY PR; Schneier B., 2001, CRYPTOGRAM      1115; Schneier B, 2000, CRYPTOGRAM 0915	12	8	8	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1527	1529		10.1126/science.1224321	http://dx.doi.org/10.1126/science.1224321			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	961ZE	22723410				2022-12-28	WOS:000305507500044
J	Van Kerkhove, MD; Riley, S; Lipsitch, M; Guan, Y; Monto, AS; Webster, RG; Zambon, M; Nicoll, A; Peiris, JSM; Ferguson, NM				Van Kerkhove, Maria D.; Riley, Steven; Lipsitch, Marc; Guan, Yi; Monto, Arnold S.; Webster, Robert G.; Zambon, Maria; Nicoll, Angus; Peiris, J. S. Malik; Ferguson, Neil M.			Comment on "Seroevidence for H5N1 Influenza Infections in Humans: Meta-Analysis"	SCIENCE			English	Editorial Material							HEALTH-CARE WORKERS; A H5N1; RISK		[Van Kerkhove, Maria D.; Riley, Steven; Ferguson, Neil M.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Outbreak Anal & Modelling, London W2 1PG, England; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Guan, Yi; Peiris, J. S. Malik] Univ Hong Kong, Ctr Influenza Res, Hong Kong, Hong Kong, Peoples R China; [Guan, Yi; Peiris, J. S. Malik] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Monto, Arnold S.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; [Zambon, Maria] Hlth Protect Agcy, London NW9 5HT, England; [Nicoll, Angus] European Ctr Dis Prevent & Control, Stockholm, Sweden; [Peiris, J. S. Malik] Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China	Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Hong Kong; University of Hong Kong; University of Michigan System; University of Michigan; St Jude Children's Research Hospital; Health Protection Agency; European Centre for Disease Prevention & Control; University of Hong Kong	Van Kerkhove, MD (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Outbreak Anal & Modelling, London W2 1PG, England.	m.vankerkhove@imperial.ac.uk	Ferguson, Neil/B-8578-2008; Peiris, Joseph Sriyal Malik/C-4380-2009	Ferguson, Neil/0000-0002-1154-8093; Lipsitch, Marc/0000-0003-1504-9213; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Riley, Steven/0000-0001-7904-4804; Guan, Yi/0000-0001-6057-9243	Medical Research Council [G0600719B] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [R01TW008246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER; FIC NIH HHS [R01 TW008246-01] Funding Source: Medline; Medical Research Council Funding Source: Medline; NIGMS NIH HHS [1U54GM088558] Funding Source: Medline; PHS HHS [HHSN266200700005C] Funding Source: Medline; Wellcome Trust [093488/Z/10/Z] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome Trust)		[Anonymous], 2011, Wkly Epidemiol Rec, V86, P161; Apisarnthanarak A, 2005, CLIN INFECT DIS, V40, pE16, DOI 10.1086/427034; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Cavailler P, 2010, J CLIN VIROL, V48, P123, DOI 10.1016/j.jcv.2010.02.021; Egger M., 2008, SYSTEMATIC REV HLTH, V2nd, DOI DOI 10.1002/9780470693926.CH12; Garcia JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007918; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Van Kerkhove MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014582; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888; WHO, 2010, WKLY EPIDEMIOL REC, V85, P229; WHO, 2012, CUM NUMB CONF HUM CA; Zhang RQ, 2011, SCAND J INFECT DIS, V43, P216, DOI 10.3109/00365548.2010.539258	15	28	28	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088								10.1126/science.1221434	http://dx.doi.org/10.1126/science.1221434			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723396				2022-12-28	WOS:000305507500028
J	Vaseva, AV; Marchenko, ND; Ji, K; Tsirka, SE; Holzmann, S; Moll, UM				Vaseva, Angelina V.; Marchenko, Natalie D.; Ji, Kyungmin; Tsirka, Stella E.; Holzmann, Sonja; Moll, Ute M.			p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis	CELL			English	Article							FOCAL CEREBRAL-ISCHEMIA; CYCLOPHILIN-D; CELL-DEATH; MEMBRANE PERMEABILIZATION; OXIDATIVE STRESS; TUMOR-SUPPRESSOR; NECROTIC DEATH; DNA-DAMAGE; APOPTOSIS; TRANSLOCATION	Ischemia-associated oxidative damage leading to necrosis is a major cause of catastrophic tissue loss, and elucidating its signaling mechanism is therefore of paramount importance. p53 is a central stress sensor responding to multiple insults, including oxidative stress to orchestrate apoptotic and autophagic cell death. Whether p53 can also activate oxidative stress-induced necrosis is, however, unknown. Here, we uncover a role for p53 in activating necrosis. In response to oxidative stress, p53 accumulates in the mitochondrial matrix and triggers mitochondrial permeability transition pore (PTP) opening and necrosis by physical interaction with the PTP regulator cyclophilin D (CypD). Intriguingly, a robust p53-CypD complex forms during brain ischemia/reperfusion injury. In contrast, reduction of p53 levels or cyclosporine A pretreatment of mice prevents this complex and is associated with effective stroke protection. Our study identifies the mitochondrial p53-CypD axis as an important contributor to oxidative stress-induced necrosis and implicates this axis in stroke pathology.	[Vaseva, Angelina V.; Marchenko, Natalie D.; Moll, Ute M.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Ji, Kyungmin; Tsirka, Stella E.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Holzmann, Sonja; Moll, Ute M.] Univ Gottingen, Dept Mol Oncol, D-37077 Gottingen, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Gottingen	Moll, UM (corresponding author), SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA.	ute.moll@sbumed.org	Tsirka, Stella/AAD-4018-2019		National Cancer Institute [CA060664]; NATIONAL CANCER INSTITUTE [R29CA060664, R01CA060664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042168] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Susan Vanhorn and Ioana Russ for technical assistance and Franz X. Schmid and Philipp Schmidpeter for discussion. This work was funded by a grant from the National Cancer Institute (CA060664) to U.M.M.	Baines CP, 2010, ANNU REV PHYSIOL, V72, P61, DOI 10.1146/annurev-physiol-021909-135929; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493; Bianchi ME, 2004, BBA-GENE STRUCT EXPR, V1677, P181, DOI 10.1016/j.bbaexp.2003.10.017; Bonini P, 2004, J NEUROSCI RES, V75, P83, DOI 10.1002/jnr.10822; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; CRUMRINE RC, 1994, J CEREBR BLOOD F MET, V14, P887, DOI 10.1038/jcbfm.1994.119; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Eliseev RA, 2009, J BIOL CHEM, V284, P9692, DOI 10.1074/jbc.M808750200; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gudkov AV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001180; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Heyne K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-54; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Javadov S, 2007, CELL PHYSIOL BIOCHEM, V20, P1, DOI 10.1159/000103747; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Khaspekov L, 1999, EUR J NEUROSCI, V11, P3194, DOI 10.1046/j.1460-9568.1999.00743.x; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Korde AS, 2007, J NEUROTRAUM, V24, P895, DOI 10.1089/neu.2006.0122; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Li YM, 2004, BIOCHEM J, V383, P101, DOI 10.1042/BJ20040669; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Palacios G, 2008, CELL CYCLE, V7, P2584, DOI 10.4161/cc.7.16.6070; Petronilli V, 1998, BIOFACTORS, V8, P263, DOI 10.1002/biof.5520080314; Pietsch EC, 2007, CANCER BIOL THER, V6, P1576, DOI 10.4161/cbt.6.10.4719; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sansome C, 2001, FEBS LETT, V488, P110, DOI 10.1016/S0014-5793(00)02368-1; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Tu HC, 2009, P NATL ACAD SCI USA, V106, P1093, DOI 10.1073/pnas.0808173106; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	42	526	545	4	100	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1536	1548		10.1016/j.cell.2012.05.014	http://dx.doi.org/10.1016/j.cell.2012.05.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726440	Bronze, Green Accepted			2022-12-28	WOS:000305753800019
J	Ott, SM				Ott, Susan M.			Review: Vitamin D with calcium reduces fractures in adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COHORT; RISK		Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Ott, SM (corresponding author), Univ Washington, Seattle, WA 98195 USA.							Cauley JA, 2011, J BONE MINER RES, V26, P2378, DOI 10.1002/jbmr.449; Chung Mei, 2009, Evid Rep Technol Assess (Full Rep), P1; Helzlsouer KJ, 2010, AM J EPIDEMIOL, V172, P4, DOI 10.1093/aje/kwq119; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Smith H, 2007, RHEUMATOLOGY, V46, P1852, DOI 10.1093/rheumatology/kem240; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7	6	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12							JC6-7	10.7326/0003-4819-156-12-201206190-02007	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711108				2022-12-28	WOS:000307783200006
J	Rembold, CM				Rembold, Christopher M.			Review: Aspirin does not reduce CHD or cancer mortality but increases bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRIALS		Univ Virginia, Charlottesville, VA 22903 USA	University of Virginia	Rembold, CM (corresponding author), Univ Virginia, Charlottesville, VA 22903 USA.		Rembold, Christopher/K-8359-2013	Rembold, Christopher/0000-0003-0819-7488				Bartolucci AA, 2011, AM J CARDIOL, V107, P1796, DOI 10.1016/j.amjcard.2011.02.325; Rembold CM, 2007, ATHEROSCLEROSIS, V195, P1, DOI 10.1016/j.atherosclerosis.2006.09.009; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0	3	5	5	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12							JC6-3	10.7326/0003-4819-156-12-201206190-02003	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711104				2022-12-28	WOS:000307783200002
J	McMichael, CH; Piperno, DR; Bush, MB; Silman, MR; Zimmerman, AR; Raczka, MF; Lobato, LC				McMichael, C. H.; Piperno, D. R.; Bush, M. B.; Silman, M. R.; Zimmerman, A. R.; Raczka, M. F.; Lobato, L. C.			Sparse Pre-Columbian Human Habitation in Western Amazonia	SCIENCE			English	Article							CLIMATE-CHANGE; FIRE; LANDSCAPE	Locally extensive pre-Columbian human occupation and modification occurred in the forests of the central and eastern Amazon Basin, but whether comparable impacts extend westward and into the vast terra firme (interfluvial) zones, remains unclear. We analyzed soils from 55 sites across central and western Amazonia to assess the history of human occupation. Sparse occurrences of charcoal and the lack of phytoliths from agricultural and disturbance species in the soils during pre-Columbian times indicated that human impacts on interfluvial forests were small, infrequent, and highly localized. No human artifacts or modified soils were found at any site surveyed. Riverine bluff areas also appeared less heavily occupied and disturbed than similar settings elsewhere. Our data indicate that human impacts on Amazonian forests were heterogeneous across this vast landscape.	[McMichael, C. H.; Bush, M. B.; Raczka, M. F.] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; [Piperno, D. R.] Smithsonian Natl Museum Nat Hist, Dept Anthropol, Program Human Ecol & Archaeobiol, Washington, DC 20560 USA; [Piperno, D. R.] Smithsonian Trop Res Inst, Balboa, Panama; [Silman, M. R.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27106 USA; [Silman, M. R.] Ctr Energy Environm & Sustainabil, Winston Salem, NC 27106 USA; [Zimmerman, A. R.] Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA; [Lobato, L. C.] Univ Fed Rondonia, Lab Geog Humana & Planejamento Ambiental, Porto Velho, Rondonia, Brazil	Florida Institute of Technology; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian Tropical Research Institute; Wake Forest University; State University System of Florida; University of Florida; Universidade Federal de Rondonia	McMichael, CH (corresponding author), Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA.	cmcmicha@my.fit.edu		Raczka, Marco/0000-0002-6602-8087; Bush, Mark/0000-0001-6894-8613; McMichael, Crystal/0000-0002-1064-1499; Zimmerman, Andrew/0000-0001-5137-4916	NSF [DEB 0742301, DEB 0743666]; Florida Institute of Technology; Smithsonian National Museum of Natural History; Smithsonian Tropical Research Institute	NSF(National Science Foundation (NSF)); Florida Institute of Technology; Smithsonian National Museum of Natural History(Smithsonian InstitutionSmithsonian National Museum of Natural History); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute)	Field work and <SUP>14</SUP>C dating of charcoal fragments were funded by the NSF Ecology Program (awards DEB 0742301 and DEB 0743666). Other funding was provided by the Florida Institute of Technology; the Smithsonian National Museum of Natural History, including a Restricted Endowment and Small Grant Award; and the Smithsonian Tropical Research Institute. All data will be deposited in the Neotoma Database (www.neotomadb.org/). We thank B. McMichael, A. Correa-Metrio, J. Hernandez, T. Harrison, and B. Rado for field assistance.	Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Balee W. L., 2006, TIME COMPLEXITY HIST; Bush MB, 2008, PHILOS T R SOC B, V363, P1795, DOI 10.1098/rstb.2007.0014; Clement CR, 2006, HIST ECOL SER, P165; Denevan WM, 1996, ANN ASSOC AM GEOGR, V86, P654, DOI 10.1111/j.1467-8306.1996.tb01771.x; Dull RA, 2010, ANN ASSOC AM GEOGR, V100, P755, DOI 10.1080/00045608.2010.502432; ERICKSON CL, 2010, DIVERSITY-BASEL, V2, P618, DOI DOI 10.3390/d2040619; Erickson CL, 2006, HIST ECOL SER, P235; Erickson CL, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P157, DOI 10.1007/978-0-387-74907-5_11; Fraser JA, 2011, HUM ECOL, V39, P395, DOI 10.1007/s10745-011-9405-z; Glaser B., 2004, AMAZONIAN DARK EARTH; Heckenberger M, 2009, ANNU REV ANTHROPOL, V38, P251, DOI 10.1146/annurev-anthro-091908-164310; Heckenberger MJ, 2007, PHILOS T R SOC B, V362, P197, DOI 10.1098/rstb.2006.1979; Heckenberger MJ, 2003, SCIENCE, V301, P1710, DOI 10.1126/science.1086112; LEHMANN J, 2003, AMAZONIAN DARK EARTH; Leigh EG, 2004, BIOTROPICA, V36, P447, DOI 10.1111/j.1744-7429.2004.tb00342.x; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Mann C., 2005, 1491 NEW REVELATIONS; McMichael CH, 2012, HOLOCENE, V22, P131, DOI 10.1177/0959683611414932; Meggers B. J., 2004, REV ARCHAEOLOGY, V25, P31; Meggers B. J., 1957, ARCHEOLOGICAL INVEST; Meggers B. J, 1971, AMAZONIA MAN CULTURE; Nepstad D, 2004, GLOBAL CHANGE BIOL, V10, P704, DOI 10.1111/j.1529-8817.2003.00772.x; Neves EG, 2006, HIST ECOL SER, P279; Nevle RJ, 2011, HOLOCENE, V21, P853, DOI 10.1177/0959683611404578; Piperno DR, 2011, S-P B ENVIRON SCI, P185; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Piperno DR, 1996, QUATERNARY RES, V45, P202, DOI 10.1006/qres.1996.0020; ROOSEVELT AC, 1991, SCIENCE, V254, P1621, DOI 10.1126/science.254.5038.1621; Roosevelt Anna, 1991, MOUNDBUILDERS AMAZON; WinklerPrins AMGA, 2010, J LAT AM GEOGR, V9, P33, DOI 10.1353/lag.2010.0029	31	132	135	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2012	336	6087					1429	1431		10.1126/science.1219982	http://dx.doi.org/10.1126/science.1219982			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700926				2022-12-28	WOS:000305211700042
J	Koser, CU; Holden, MTG; Ellington, MJ; Cartwright, EJP; Brown, NM; Ogilvy-Stuart, AL; Hsu, LY; Chewapreecha, C; Croucher, NJ; Harris, SR; Sanders, M; Enright, MC; Dougan, G; Bentley, SD; Parkhill, J; Fraser, LJ; Betley, JR; Schulz-Trieglaff, OB; Smith, GP; Peacock, SJ				Koeser, Claudio U.; Holden, Matthew T. G.; Ellington, Matthew J.; Cartwright, Edward J. P.; Brown, Nicholas M.; Ogilvy-Stuart, Amanda L.; Hsu, Li Yang; Chewapreecha, Claire; Croucher, Nicholas J.; Harris, Simon R.; Sanders, Mandy; Enright, Mark C.; Dougan, Gordon; Bentley, Stephen D.; Parkhill, Julian; Fraser, Louise J.; Betley, Jason R.; Schulz-Trieglaff, Ole B.; Smith, Geoffrey P.; Peacock, Sharon J.			Rapid Whole-Genome Sequencing for Investigation of a Neonatal MRSA Outbreak	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; MUTATIONS; EVOLUTION	BACKGROUND Isolates of methicillin-resistant Staphylococcus aureus (MRSA) belonging to a single lineage are often indistinguishable by means of current typing techniques. Whole-genome sequencing may provide improved resolution to define transmission pathways and characterize outbreaks. METHODS We investigated a putative MRSA outbreak in a neonatal intensive care unit. By using rapid high-throughput sequencing technology with a clinically relevant turnaround time, we retrospectively sequenced the DNA from seven isolates associated with the outbreak and another seven MRSA isolates associated with carriage of MRSA or bacteremia in the same hospital. RESULTS We constructed a phylogenetic tree by comparing single-nucleotide polymorphisms (SNPs) in the core genome to a reference genome (an epidemic MRSA clone, EMRSA-15 [sequence type 22]). This revealed a distinct cluster of outbreak isolates and clear separation between these and the nonoutbreak isolates. A previously missed transmission event was detected between two patients with bacteremia who were not part of the outbreak. We created an artificial "resistome" of antibiotic-resistance genes and demonstrated concordance between it and the results of phenotypic susceptibility testing; we also created a "toxome" consisting of toxin genes. One outbreak isolate had a hypermutator phenotype with a higher number of SNPs than the other outbreak isolates, highlighting the difficulty of imposing a simple threshold for the number of SNPs between isolates to decide whether they are part of a recent transmission chain. CONCLUSIONS Whole-genome sequencing can provide clinically relevant data within a time frame that can influence patient care. The need for automated data interpretation and the provision of clinically meaningful reports represent hurdles to clinical implementation. (Funded by the U.K. Clinical Research Collaboration Translational Infection Research Initiative and others.)	[Koeser, Claudio U.; Cartwright, Edward J. P.; Peacock, Sharon J.] Univ Cambridge, Cambridge CB2 0QQ, England; [Koeser, Claudio U.; Ellington, Matthew J.; Cartwright, Edward J. P.; Brown, Nicholas M.; Peacock, Sharon J.] Hlth Protect Agcy, Cambridge, England; [Holden, Matthew T. G.; Chewapreecha, Claire; Croucher, Nicholas J.; Harris, Simon R.; Sanders, Mandy; Dougan, Gordon; Bentley, Stephen D.; Parkhill, Julian; Peacock, Sharon J.] Wellcome Trust Sanger Inst, Hinxton, England; [Brown, Nicholas M.; Ogilvy-Stuart, Amanda L.; Peacock, Sharon J.] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Cambridge, England; [Fraser, Louise J.; Betley, Jason R.; Schulz-Trieglaff, Ole B.; Smith, Geoffrey P.] Illumina Cambridge, Saffron Walden, England; [Enright, Mark C.] AmpliPhi Biosci, Sharnbrook, Beds, England; [Hsu, Li Yang] Natl Univ Hlth Syst, Singapore, Singapore	University of Cambridge; Health Protection Agency; Wellcome Trust Sanger Institute; Illumina; National University of Singapore	Peacock, SJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Level 5,Box 157, Cambridge CB2 0QQ, England.	sjp97@medschl.cam.ac.uk	Peacock, Sharon J/ABE-6331-2020; Weinstock, George M/C-6314-2013; Köser, Claudio/I-3740-2013; Parkhill, Julian/G-4703-2011; Harris, Simon R/K-1318-2013; Holden, Matthew TG/K-6449-2014; Ellington, Matthew/ABH-7978-2020; Chewapreecha, Claire/D-6446-2016	Weinstock, George M/0000-0002-2997-4592; Köser, Claudio/0000-0002-0232-846X; Parkhill, Julian/0000-0002-7069-5958; Harris, Simon R/0000-0003-1512-6194; Holden, Matthew TG/0000-0002-4958-2166; Chewapreecha, Claire/0000-0002-1313-4011; Peacock, Sharon/0000-0002-1718-2782; Cartwright, Edward/0000-0001-5666-5990; Croucher, Nicholas/0000-0001-6303-8768; Brown, Nicholas/0000-0002-6657-300X; Hsu, Li Yang/0000-0002-0396-066X; Enright, Mark/0000-0001-5273-8750	U.K. Clinical Research Collaboration Translational Infection Research Initiative; Medical Research Council [G1000803]; Biotechnology and Biological Sciences Research Council; National Institute for Health Research (NIHR) on behalf of the U.K. Department of Health; Chief Scientist Office of the Scottish Government Health Directorate; Health Protection Agency; NIHR Cambridge Biomedical Research Centre; Wellcome Trust; U.K. Department of Health; MRC [G1000803] Funding Source: UKRI	U.K. Clinical Research Collaboration Translational Infection Research Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research (NIHR) on behalf of the U.K. Department of Health(National Institute for Health Research (NIHR)); Chief Scientist Office of the Scottish Government Health Directorate; Health Protection Agency; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); U.K. Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the U.K. Clinical Research Collaboration Translational Infection Research Initiative; the Medical Research Council (G1000803), with contributions from the Biotechnology and Biological Sciences Research Council, the National Institute for Health Research (NIHR) on behalf of the U.K. Department of Health, and the Chief Scientist Office of the Scottish Government Health Directorate (to Dr. Peacock); the Health Protection Agency (to Dr. Peacock); the NIHR Cambridge Biomedical Research Centre (to Drs. Cartwright and Peacock); the U.K. Department of Health (to Dr. Enright); and the Wellcome Trust (to Ms. Chewapreecha, Mr. Croucher, Drs. Harris, Holden, Hsu, Parkhill, and Peacock, and Ms. Sanders).	Alcoceba E, 2007, CLIN MICROBIOL INFEC, V13, P599, DOI 10.1111/j.1469-0691.2007.01703.x; Andersen BM, 2010, J INFECTION, V60, P293, DOI 10.1016/j.jinf.2010.01.008; Baldry S, 2010, NAT REV MICROBIOL, V8, P390, DOI 10.1038/nrmicro2369; British Society for Antimicrobial Chemotherapy, 2009, BSAC METH ANT SUSC T; Cartwright EJP, 2011, NATURE, V471, P578, DOI 10.1038/471578d; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Cooke FJ, 2010, CLIN MICROBIOL INFEC, V16, P921, DOI 10.1111/j.1469-0691.2009.02969.x; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Dolgin E, 2010, NAT MED, V16, P1054, DOI 10.1038/nm1010-1054a; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P446, DOI 10.1093/jac/dkp448; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gardy JL, 2011, NEW ENGL J MED, V364, P2174; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Niedringhaus TP, 2011, ANAL CHEM, V83, P4327, DOI 10.1021/ac2010857; Otto TD, 2011, NAT REV MICROBIOL, V9, P633, DOI 10.1038/nrmicro2638; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Schaaff F, 2003, INT J MED MICROBIOL, V293, P427, DOI 10.1078/1438-4221-00282; Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004; Tanaka M, 2000, J Infect Chemother, V6, P131, DOI 10.1007/s101560070010; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997; Wichelhaus TA, 2001, J ANTIMICROB CHEMOTH, V47, P153, DOI 10.1093/jac/47.2.153	26	467	483	3	97	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2012	366	24					2267	2275						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957PD	22693998	Green Accepted, Bronze			2022-12-28	WOS:000305174100007
J	Tallis, R				Tallis, Raymond			END OF LIFE CARE Our professional bodies should stop opposing assisted dying	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOCTORS; LEGALISATION		[Tallis, Raymond] Univ Manchester, Manchester M13 9PL, Lancs, England; [Tallis, Raymond] Healthcare Profess Assisted Dying, New York, NY USA	University of Manchester	Tallis, R (corresponding author), Univ Manchester, Manchester M13 9PL, Lancs, England.	raymond@rtallis.wanadoo.co.uk						BMA, 2010, RESP PAT REQ REL ASS; Clery E., 2007, BRIT SOCIAL ATTITUDE, P35; Jansen-van der Weide M, 2009, DEATH STUD, V33, P199, DOI 10.1080/07481180802672272; Kmietovicz Z, 2002, BRIT MED J, V324, P11, DOI 10.1136/bmj.324.7328.11; Lee W, 2009, BMC MED ETHICS, V10, DOI 10.1186/1472-6939-10-2; McAndrew Siobhan, 2010, BRIT SOCIAL ATTITUDE, P87; Seale C, 2009, PALLIATIVE MED, V23, P205, DOI 10.1177/0269216308102041; Tallis R, UNBEARABLE SUFFERING; van der Heide A, 2007, NEW ENGL J MED, V356, P1957, DOI 10.1056/NEJMsa071143	9	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2012	344								e4115	10.1136/bmj.e4115	http://dx.doi.org/10.1136/bmj.e4115			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961LA	22695307				2022-12-28	WOS:000305464700012
J	Valleix, S; Gillmore, JD; Bridoux, F; Mangione, PP; Dogan, A; Nedelec, B; Boimard, M; Touchard, G; Goujon, JM; Lacombe, C; Lozeron, P; Adams, D; Lacroix, C; Maisonobe, T; Plante-Bordeneuve, V; Vrana, JA; Theis, JD; Giorgetti, S; Porcari, R; Ricagno, S; Bolognesi, M; Stoppini, M; Delpech, M; Pepys, MB; Hawkins, PN; Bellotti, V				Valleix, Sophie; Gillmore, Julian D.; Bridoux, Frank; Mangione, Palma P.; Dogan, Ahmet; Nedelec, Brigitte; Boimard, Mathieu; Touchard, Guy; Goujon, Jean-Michel; Lacombe, Corinne; Lozeron, Pierre; Adams, David; Lacroix, Catherine; Maisonobe, Thierry; Plante-Bordeneuve, Violaine; Vrana, Julie A.; Theis, Jason D.; Giorgetti, Sofia; Porcari, Riccardo; Ricagno, Stefano; Bolognesi, Martino; Stoppini, Monica; Delpech, Marc; Pepys, Mark B.; Hawkins, Philip N.; Bellotti, Vittorio			Hereditary Systemic Amyloidosis Due to Asp76Asn Variant beta(2)-Microglobulin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-2-MICROGLOBULIN; FIBRILS; HEMODIALYSIS; TRANSTHYRETIN; AGGREGATION	We describe a kindred with slowly progressive gastrointestinal symptoms and autonomic neuropathy caused by autosomal dominant, hereditary systemic amyloidosis. The amyloid consists of Asp76Asn variant beta(2)-microglobulin. Unlike patients with dialysis-related amyloidosis caused by sustained high plasma concentrations of wild-type beta(2)-microglobulin, the affected members of this kindred had normal renal function and normal circulating beta 2-microglobulin values. The Asp76Asn beta(2)-microglobulin variant was thermodynamically unstable and remarkably fibrillogenic in vitro under physiological conditions. Previous studies of beta(2)-microglobulin aggregation have not shown such amyloidogenicity for single-residue substitutions. Comprehensive biophysical characterization of the beta(2)-microglobulin variant, including its 1.40-angstrom, three-dimensional structure, should allow further elucidation of fibrillogenesis and protein misfolding.	[Valleix, Sophie; Boimard, Mathieu; Delpech, Marc] Univ Paris 05, AP HP, Fac Med Paris, Lab Biochim & Genet Mol, Paris, France; [Valleix, Sophie; Nedelec, Brigitte; Plante-Bordeneuve, Violaine; Delpech, Marc] INSERM, Inst Cochin U1016, Paris, France; [Bridoux, Frank; Touchard, Guy; Lacombe, Corinne] CHU Poitiers, Ctr Reference Amylose & Autres Malad Depots Immun, Serv Nephrol, Poitiers, France; [Goujon, Jean-Michel] CHU Poitiers, Ctr Reference Amylose & Autres Malad Depots Immun, Serv Anat Pathol, Poitiers, France; [Lozeron, Pierre; Adams, David] CHU Bicetre, Ctr Reference Neuropathies Amyloides Familiales &, Hop Paris Sud, AP HP,Serv Neurol Adulte, Le Kremlin Bicetre, France; [Lacroix, Catherine] CHU Bicetre, Ctr Reference Neuropathies Amyloides Familiales &, Hop Paris Sud, AP HP,Lab Neuropathol, Le Kremlin Bicetre, France; [Maisonobe, Thierry] Grp Hosp Pitie Salpetriere, Dept Clin Neurophysiol, F-75634 Paris, France; [Plante-Bordeneuve, Violaine] CHU Henri Mondor, Hop Paris Sud, AP HP, Serv Neurol, F-94010 Creteil, France; [Gillmore, Julian D.; Mangione, Palma P.; Pepys, Mark B.; Hawkins, Philip N.; Bellotti, Vittorio] UCL, Ctr Amyloidosis & Acute Phase Proteins, Natl Amyloidosis Ctr, London NW3 2PF, England; [Dogan, Ahmet; Vrana, Julie A.; Theis, Jason D.] Mayo Clin, Div Anat Pathol, Rochester, MN USA; [Mangione, Palma P.; Giorgetti, Sofia; Porcari, Riccardo; Stoppini, Monica; Bellotti, Vittorio] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Ricagno, Stefano; Bolognesi, Martino] Univ Milan, Dept Biomol Sci & Biotechnol, CNR IBF, Milan, Italy; [Ricagno, Stefano; Bolognesi, Martino] Univ Milan, CIMAINA, Milan, Italy	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; University of London; University College London; Mayo Clinic; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Milan	Valleix, S (corresponding author), Hop Cochin, Lab Biochim & Genet Mol, 123 Bd Port Royal, F-75014 Paris, France.	sophie.valleix@cch.aphp.fr; v.bellotti@ucl.ac.uk	nedelec, brigitte/H-3002-2017; VALLEIX, Sophie/H-5048-2017; Bellotti, Vittorio/A-6201-2014; Giorgetti, Sofia/AAD-4341-2019; Bolognesi, Martino/B-7924-2017; Ricagno, Stefano/G-1456-2015	nedelec, brigitte/0000-0002-4487-9438; VALLEIX, Sophie/0000-0002-4812-7102; Bellotti, Vittorio/0000-0001-8678-662X; Giorgetti, Sofia/0000-0001-9438-6511; Bolognesi, Martino/0000-0002-9253-5170; Lozeron, Pierre/0000-0003-0816-6526; Ricagno, Stefano/0000-0001-6678-5873; Bridoux, Frank/0000-0002-2005-8424; Mangione, Palma/0000-0003-0260-1400	U.K. National Health Service; University College London; U.K. Medical Research Council [G7900510, MR/K000187/1]; Wolfson Foundation; Cariplo Foundation [2009-2543]; Italian Ministry of University and Research [FIRB RBFR109EOS, PRIN 20083ERXWS]; MRC [G7900510, MR/K000187/1] Funding Source: UKRI; Medical Research Council [MR/K000187/1, G7900510] Funding Source: researchfish	U.K. National Health Service; University College London(General Electric); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wolfson Foundation; Cariplo Foundation(Fondazione Cariplo); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the U.K. National Health Service Research and Development Programme, the University College London Amyloidosis Research Fund, the U.K. Medical Research Council (G7900510 and MR/K000187/1), the Wolfson Foundation, the Cariplo Foundation (2009-2543), and the Italian Ministry of University and Research (FIRB RBFR109EOS and PRIN 20083ERXWS).	Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bridoux F, 2005, AM J KIDNEY DIS, V45, P749, DOI 10.1053/j.ajkd.2004.12.020; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Eichner T, 2011, FEBS J, V278, P3868, DOI 10.1111/j.1742-4658.2011.08186.x; Esposito G, 2008, J MOL BIOL, V378, P887, DOI 10.1016/j.jmb.2008.03.002; FLOEGE J, 1991, J LAB CLIN MED, V118, P153; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Giorgetti S, 2005, PROTEIN SCI, V14, P696, DOI 10.1110/ps.041194005; Giorgetti S, 2007, PROTEIN SCI, V16, P343, DOI 10.1110/ps.062563507; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; GUSSOW D, 1987, J IMMUNOL, V139, P3132; HAMILTON JA, 1993, J BIOL CHEM, V268, P2416; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; Hoernke M, 2011, LANGMUIR, V27, P14218, DOI 10.1021/la203016z; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Mangione P, 2001, PROTEIN SCI, V10, P187, DOI 10.1110/ps.29201; MUNOZGOMEZ J, 1985, ANN RHEUM DIS, V44, P729, DOI 10.1136/ard.44.11.729; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Pepys MB, 2009, J PATHOL, V217, P1, DOI 10.1002/path.2467; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Tennent GA, 1999, AMYLOID AND AMYLOIDOSIS 1998, P160; Tennent GA, 1999, METHOD ENZYMOL, V309, P26; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7	25	131	133	1	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2012	366	24					2276	2283		10.1056/nejmoa1201356	http://dx.doi.org/10.1056/nejmoa1201356			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957PD	22693999	Bronze			2022-12-28	WOS:000305174100008
J	Walter, F; Decarli, R; Carilli, C; Bertoldi, F; Cox, P; Da Cunha, E; Daddi, E; Dickinson, M; Downes, D; Elbaz, D; Ellis, R; Hodge, J; Neri, R; Riechers, DA; Weiss, A; Bell, E; Dannerbauer, H; Krips, M; Krumholz, M; Lentati, L; Maiolino, R; Menten, K; Rix, HW; Robertson, B; Spinrad, H; Stark, DP; Stern, D				Walter, Fabian; Decarli, Roberto; Carilli, Chris; Bertoldi, Frank; Cox, Pierre; Da Cunha, Elisabete; Daddi, Emanuele; Dickinson, Mark; Downes, Dennis; Elbaz, David; Ellis, Richard; Hodge, Jacqueline; Neri, Roberto; Riechers, Dominik A.; Weiss, Axel; Bell, Eric; Dannerbauer, Helmut; Krips, Melanie; Krumholz, Mark; Lentati, Lindley; Maiolino, Roberto; Menten, Karl; Rix, Hans-Walter; Robertson, Brant; Spinrad, Hyron; Stark, Dan P.; Stern, Daniel			The intense starburst HDF 850.1 in a galaxy overdensity at z approximate to 5.2 in the Hubble Deep Field	NATURE			English	Article							BRIGHTEST SUBMILLIMETER SOURCE; MOLECULAR GAS; HIGH-REDSHIFT; STAR-FORMATION; BIG-BANG; NORTH; IDENTIFICATION; CONSTRAINTS; INDICATOR; OBJECT	The Hubble Deep Field provides one of the deepest multiwave-length views of the distant Universe and has led to the detection of thousands of galaxies seen throughout cosmic time(1). An early map of the Hubble Deep Field at a wavelength of 850 micrometres, which is sensitive to dust emission powered by star formation, revealed the brightest source in the field, dubbed HDF 850.1 (ref. 2). For more than a decade, and despite significant efforts, no counterpart was found at shorter wavelengths, and it was not possible to determine its redshift, size or mass(3-7). Here we report a redshift of z = 5.183 for HDF 850.1, from a millimetre-wave molecular line scan. This places HDF 850.1 in a galaxy overdensity at z approximate to 5.2, corresponding to a cosmic age of only 1.1 billion years after the Big Bang. This redshift is significantly higher than earlier estimates(3,4,6,8) and higher than those of most of the hundreds of submillimetre-bright galaxies identified so far. The source has a star-formation rate of 850 solar masses per year and is spatially resolved on scales of 5 kiloparsecs, with an implied dynamical mass of about 1.3 x 10(11) solar masses, a significant fraction of which is present in the form of molecular gas. Despite our accurate determination of redshift and position, a counterpart emitting starlight remains elusive.	[Walter, Fabian; Decarli, Roberto; Da Cunha, Elisabete; Hodge, Jacqueline; Rix, Hans-Walter] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Walter, Fabian; Carilli, Chris] Natl Radio Astron Observ, Pete V Domenici Array Sci Ctr, Socorro, NM 87801 USA; [Carilli, Chris; Lentati, Lindley; Maiolino, Roberto] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Bertoldi, Frank] Univ Bonn, Argelander Inst Astron, D-53121 Bonn, Germany; [Cox, Pierre; Downes, Dennis; Neri, Roberto; Krips, Melanie] IRAM, F-38406 St Martin Dheres, France; [Da Cunha, Elisabete; Elbaz, David] Univ Paris Diderot, Lab AIM, CEA, DSM,CNRS,Irfu Serv Astrophys,CEA Saclay, F-91191 Gif Sur Yvette, France; [Dickinson, Mark] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Ellis, Richard; Riechers, Dominik A.] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Weiss, Axel; Menten, Karl] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Bell, Eric] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Dannerbauer, Helmut] Univ Vienna, Inst Astron, A-1080 Vienna, Austria; [Krumholz, Mark] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Maiolino, Roberto] INAF Osservatorio Astron Roma, I-00040 Monte Porzio Catone, Italy; [Robertson, Brant; Stark, Dan P.] Univ Arizona, Dept Astron, Tucson, AZ 85721 USA; [Spinrad, Hyron] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Stern, Daniel] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Max Planck Society; National Radio Astronomy Observatory (NRAO); University of Cambridge; University of Bonn; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; National Optical Astronomy Observatory; California Institute of Technology; Max Planck Society; University of Michigan System; University of Michigan; University of Vienna; University of California System; University of California Santa Cruz; Istituto Nazionale Astrofisica (INAF); University of Arizona; University of California System; University of California Berkeley; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Walter, F (corresponding author), Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany.	walter@mpia.de	Daddi, Emanuele/D-1649-2012; Robertson, Brant/AAA-6124-2022; Elbaz, David/AAB-4141-2020; da Cunha, Elisabete/AAY-2027-2021	Daddi, Emanuele/0000-0002-3331-9590; Robertson, Brant/0000-0002-4271-0364; Elbaz, David/0000-0002-7631-647X; da Cunha, Elisabete/0000-0001-9759-4797; Maiolino, Roberto/0000-0002-4985-3819; Walter, Fabian/0000-0003-4793-7880; Hodge, Jacqueline/0000-0001-6586-8845; Stern, Daniel/0000-0003-2686-9241; Krumholz, Mark/0000-0003-3893-854X	MPG (Germany); INSU/CNRS (France); IGN (Spain); NASA; DLR [FKZ 50OR1004]	MPG (Germany)(Max Planck Society); INSU/CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); IGN (Spain); NASA(National Aeronautics & Space Administration (NASA)); DLR(Helmholtz AssociationGerman Aerospace Centre (DLR))	This work is based on observations carried out with the IRAM Plateau de Bure Interferometer. IRAM is supported by MPG (Germany), INSU/CNRS (France) and IGN (Spain). The Jansky Very Large Array of NRAO is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. D. A. R. acknowledges support from NASA through a Spitzer Space Telescope grant. R. D. acknowledges funding through DLR project FKZ 50OR1004.	Alexander DM, 2003, ASTRON J, V126, P539, DOI 10.1086/376473; Barger AJ, 2008, ASTROPHYS J, V689, P687, DOI 10.1086/592735; Barger AJ, 2002, ASTRON J, V124, P1839, DOI 10.1086/342448; Capak PL, 2011, NATURE, V470, P233, DOI 10.1038/nature09681; Carilli CL, 1999, ASTROPHYS J, V513, pL13, DOI 10.1086/311909; Combes F, 2012, ASTRON ASTROPHYS, V538, DOI 10.1051/0004-6361/201118750; Cowie LL, 2009, ASTROPHYS J LETT, V697, pL122, DOI 10.1088/0004-637X/697/2/L122; Cox P, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/63; Daddi E, 2010, ASTROPHYS J, V713, P686, DOI 10.1088/0004-637X/713/1/686; Daddi E, 2009, ASTROPHYS J, V694, P1517, DOI 10.1088/0004-637X/694/2/1517; Dickinson M, 2000, ASTROPHYS J, V531, P624, DOI 10.1086/308508; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; Downes D, 1999, ASTRON ASTROPHYS, V347, P809; Dunlop JS, 2004, MON NOT R ASTRON SOC, V350, P769, DOI 10.1111/j.1365-2966.2004.07700.x; Hogg DW, 1996, ASTROPHYS J, V467, pL73, DOI 10.1086/310213; Hughes DH, 1998, NATURE, V394, P241, DOI 10.1038/28328; Ivison RJ, 2011, MON NOT R ASTRON SOC, V412, P1913, DOI 10.1111/j.1365-2966.2010.18028.x; Ivison RJ, 2005, MON NOT R ASTRON SOC, V364, P1025, DOI 10.1111/j.1365-2966.2005.09639.x; Krumholz MR, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/69; Loenen AF, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201015114; Richards EA, 1999, ASTROPHYS J, V513, pL9, DOI 10.1086/311905; Riechers DA, 2010, ASTROPHYS J LETT, V720, pL131, DOI 10.1088/2041-8205/720/2/L131; Schinnerer E, 2008, ASTROPHYS J LETT, V689, pL5, DOI 10.1086/595680; Solomon PM, 2005, ANNU REV ASTRON ASTR, V43, P677, DOI 10.1146/annurev.astro.43.051804.102221; Stacey GJ, 2010, ASTROPHYS J, V724, P957, DOI 10.1088/0004-637X/724/2/957; Tacconi LJ, 2008, ASTROPHYS J, V680, P246, DOI 10.1086/587168; Wagg J, 2007, MON NOT R ASTRON SOC, V375, P745, DOI 10.1111/j.1365-2966.2006.11352.x; Walter F, 2009, NATURE, V457, P699, DOI 10.1038/nature07681; Wiklind T, 2008, ASTROPHYS J, V676, P781, DOI 10.1086/524919; Williams RE, 1996, ASTRON J, V112, P1335, DOI 10.1086/118105	30	203	203	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					233	236		10.1038/nature11073	http://dx.doi.org/10.1038/nature11073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699613	Green Submitted			2022-12-28	WOS:000305189000029
J	Genders, TSS; Steyerberg, EW; Hunink, MGM; Nieman, K; Galema, TW; Mollet, NR; de Feyter, PJ; Krestin, GP; Alkadhi, H; Leschka, S; Desbiolles, L; Meijs, MFL; Cramer, MJ; Knuuti, J; Kajander, S; Bogaert, J; Goetschalckx, K; Cademartiri, F; Maffei, E; Martini, C; Seitun, S; Aldrovandi, A; Wildermuth, S; Stinn, B; Fornaro, J; Feuchtner, G; De Zordo, T; Auer, T; Plank, F; Friedrich, G; Pugliese, F; Petersen, SE; Davies, LC; Schoepf, UJ; Rowe, GW; van Mieghem, CAG; van Driessche, L; Sinitsyn, V; Gopalan, D; Nikolaou, K; Bamberg, F; Cury, RC; Battle, J; Maurovich-Horvat, P; Bartykowszki, A; Merkely, B; Becker, D; Hadamitzky, M; Hausleiter, J; Dewey, M; Zimmermann, E; Laule, M				Genders, Tessa S. S.; Steyerberg, Ewout W.; Hunink, M. G. Myriam; Nieman, Koen; Galema, Tjebbe W.; Mollet, Nico R.; de Feyter, Pim J.; Krestin, Gabriel P.; Alkadhi, Hatem; Leschka, Sebastian; Desbiolles, Lotus; Meijs, Matthijs F. L.; Cramer, Maarten J.; Knuuti, Juhani; Kajander, Sami; Bogaert, Jan; Goetschalckx, Kaatje; Cademartiri, Filippo; Maffei, Erica; Martini, Chiara; Seitun, Sara; Aldrovandi, Annachiara; Wildermuth, Simon; Stinn, Bjoern; Fornaro, Juergen; Feuchtner, Gudrun; De Zordo, Tobias; Auer, Thomas; Plank, Fabian; Friedrich, Guy; Pugliese, Francesca; Petersen, Steffen E.; Davies, L. Ceri; Schoepf, U. Joseph; Rowe, Garrett W.; van Mieghem, Carlos A. G.; van Driessche, Luc; Sinitsyn, Valentin; Gopalan, Deepa; Nikolaou, Konstantin; Bamberg, Fabian; Cury, Ricardo C.; Battle, Juan; Maurovich-Horvat, Pal; Bartykowszki, Andrea; Merkely, Bela; Becker, David; Hadamitzky, Martin; Hausleiter, Joerg; Dewey, Marc; Zimmermann, Elke; Laule, Michael			Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; STABLE ANGINA-PECTORIS; MULTIPLE IMPUTATION; COST-EFFECTIVENESS; PROGNOSTIC VALUE; RISK; METAANALYSIS; VALIDATION; GUIDELINES; DIAGNOSIS	Objectives To develop prediction models that better estimate the pretest probability of coronary artery disease in low prevalence populations. Design Retrospective pooled analysis of individual patient data. Setting 18 hospitals in Europe and the United States. Participants Patients with stable chest pain without evidence for previous coronary artery disease, if they were referred for computed tomography (CT) based coronary angiography or catheter based coronary angiography (indicated as low and high prevalence settings, respectively). Main outcome measures Obstructive coronary artery disease (>= 50% diameter stenosis in at least one vessel found on catheter based coronary angiography). Multiple imputation accounted for missing predictors and outcomes, exploiting strong correlation between the two angiography procedures. Predictive models included a basic model (age, sex, symptoms, and setting), clinical model (basic model factors and diabetes, hypertension, dyslipidaemia, and smoking), and extended model (clinical model factors and use of the CT based coronary calcium score). We assessed discrimination (c statistic), calibration, and continuous net reclassification improvement by cross validation for the four largest low prevalence datasets separately and the smaller remaining low prevalence datasets combined. Results We included 5677 patients (3283 men, 2394 women), of whom 1634 had obstructive coronary artery disease found on catheter based coronary angiography. All potential predictors were significantly associated with the presence of disease in univariable and multivariable analyses. The clinical model improved the prediction, compared with the basic model (cross validated c statistic improvement from 0.77 to 0.79, net reclassification improvement 35%); the coronary calcium score in the extended model was a major predictor (0.79 to 0.88, 102%). Calibration for low prevalence datasets was satisfactory. Conclusions Updated prediction models including age, sex, symptoms, and cardiovascular risk factors allow for accurate estimation of the pretest probability of coronary artery disease in low prevalence populations. Addition of coronary calcium scores to the prediction models improves the estimates.	[Genders, Tessa S. S.; Hunink, M. G. Myriam] Erasmus Univ, Med Ctr, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Nieman, Koen] Erasmus Univ, Med Ctr, Dept Radiol, ICCU, NL-3000 CA Rotterdam, Netherlands; [Steyerberg, Ewout W.] Erasmus Univ, Med Ctr, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Nieman, Koen] Erasmus Univ, Med Ctr, Dept Cardiol, ICCU, NL-3000 CA Rotterdam, Netherlands; [Alkadhi, Hatem; Leschka, Sebastian; Desbiolles, Lotus] Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland; [Meijs, Matthijs F. L.; Cramer, Maarten J.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Meijs, Matthijs F. L.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Knuuti, Juhani; Kajander, Sami] Turku Univ Hosp, Turku PET Ctr, FIN-20520 Turku, Finland; [Bogaert, Jan] Univ Hosp Leuven, Dept Cardiovasc Dis, Dept Radiol, Louvain, Belgium; [Cademartiri, Filippo] Azienda Osped Univ, Dept Radiol & Cardiol, Cardiovasc Imaging Unit, Parma, Italy; [Cademartiri, Filippo] Giovanni XXIII Clin, Dept Radiol, Cardiovasc Imaging Unit, Treviso, Italy; [Wildermuth, Simon; Stinn, Bjoern; Fornaro, Juergen] Kantonsspital St Gallen, Inst Radiol, St Gallen, Switzerland; [Feuchtner, Gudrun; De Zordo, Tobias; Auer, Thomas; Plank, Fabian] Innsbruck Med Univ, Dept Radiol, Innsbruck, Austria; [Friedrich, Guy] Innsbruck Med Univ, Dept Cardiol, Innsbruck, Austria; [Pugliese, Francesca; Petersen, Steffen E.; Davies, L. Ceri] Barts & London NHS Trust, Barts & London Sch Med & Dent, Barts & London NIHR Cardiovasc Biomed Res Unit, Ctr Adv Cardiovasc Imaging, London, England; [Schoepf, U. Joseph; Rowe, Garrett W.] Med Univ S Carolina, Dept Radiol, Charleston, SC 29425 USA; [van Mieghem, Carlos A. G.] Onze Lieve Vrouwziekenhuis Hosp Aalst, Dept Cardiol, Aalst, Belgium; [Sinitsyn, Valentin] Fed Ctr Med & Rehabil, Dept Radiol, Moscow, Russia; [Gopalan, Deepa] Papworth Hosp NHS Trust, Dept Radiol, Cambridge, England; [Nikolaou, Konstantin; Bamberg, Fabian] Univ Hosp Munich, Dept Clin Radiol, Munich, Germany; [Cury, Ricardo C.; Battle, Juan] Baptist Hosp Miami, Dept Radiol, Miami, FL USA; [Cury, Ricardo C.; Battle, Juan] Baptist Cardiac & Vasc Inst, Miami, FL USA; [Maurovich-Horvat, Pal] Semmelweis Univ, Ctr Heart, Dept Radiol, Budapest, Hungary; [Hadamitzky, Martin; Hausleiter, Joerg] German Heart Ctr, Dept Cardiol, D-8000 Munich, Germany; [Dewey, Marc; Zimmermann, Elke] Humboldt Univ, Sch Med, Charite, Dept Radiol, D-10099 Berlin, Germany; [Hunink, M. G. Myriam] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Cardiac Catheterisat Lab, Boston, MA 02115 USA; [Cademartiri, Filippo] Erasmus Univ, Med Ctr, Dept Radiol, Cardiovasc Imaging Unit, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Zurich; University Zurich Hospital; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Turku; KU Leuven; University Hospital Leuven; University of Parma; University Hospital of Parma; Kantonsspital St. Gallen; Medical University of Innsbruck; Medical University of Innsbruck; Barts Health NHS Trust; University of London; Queen Mary University London; Medical University of South Carolina; Papworth Hospital; University of Munich; Baptist Hospital Miami; Baptist Cardiac & Vascular Institute; Semmelweis University; German Heart Centre Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC	Hunink, MGM (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.hunink@erasmusmc.nl	Petersen, Steffen E/A-8389-2011; Hausleiter, Jörg/V-4206-2019; Martini, Chiara/M-3546-2016; Seitun, Sara/F-1773-2016; Sinitsyn, Valentin/A-5417-2016; Laule, Michael E/A-6548-2013; bogaert, jan g/E-6181-2012; Martini, Chiara/AAU-5825-2021; Maffei, Erica/J-2370-2016; Knuuti, Juhani/AAA-7472-2019; Sinitsyn, Valentin/AAD-4301-2019; Cademartiri, Filippo/H-7336-2015; Maurovich-Horvat, Pal/J-8003-2017; Steyerberg, Ewout/C-1509-2018	Petersen, Steffen E/0000-0003-4622-5160; Martini, Chiara/0000-0002-0877-4954; Sinitsyn, Valentin/0000-0002-5649-2193; Martini, Chiara/0000-0002-0877-4954; Maffei, Erica/0000-0002-0388-4433; Knuuti, Juhani/0000-0003-3156-9593; Sinitsyn, Valentin/0000-0002-5649-2193; Cademartiri, Filippo/0000-0002-0579-3279; Maurovich-Horvat, Pal/0000-0003-0885-736X; Davies, Ceri/0000-0001-7239-2996; Plank, Fabian/0000-0002-1861-9480; De Zordo, Tobias/0000-0002-1994-5907; Nikolaou, Konstantin/0000-0003-2668-7325; Seitun, Sara/0000-0003-1642-4521; Dewey, Marc/0000-0002-4402-2733; Goetschalckx, Kaatje/0000-0002-5419-7684; Laule, Michael/0000-0002-7579-295X; Steyerberg, Ewout/0000-0002-7787-0122	Erasmus University Medical Centre; National Institute for Health Research; Bayer; Bracco; General Electric; Siemens; European Regional Development Fund; German Heart Foundation/German Foundation of Heart Research; GE Healthcare (Amersham); Guerbet; Toshiba Medical Systems; Bayer-Schering	Erasmus University Medical Centre; National Institute for Health Research(National Institute for Health Research (NIHR)); Bayer(Bayer AG); Bracco; General Electric(General Electric); Siemens(Siemens AG); European Regional Development Fund(European Commission); German Heart Foundation/German Foundation of Heart Research; GE Healthcare (Amersham)(General ElectricGE Healthcare); Guerbet; Toshiba Medical Systems; Bayer-Schering(Bayer AG)	This research was supported by a healthcare efficiency grant from the Erasmus University Medical Centre. The authors' work was independent of the funding sources. The funding organisations had no involvement in design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review, or approval of the manuscript; and in the decision to publish the manuscript.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the Erasmus University Medical Centre; FP, SEP, and LCD's work contributes to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute for Health Research; UJS is a consultant for Bayer and Siemens and provides research support to Bayer, Bracco, General Electric, and Siemens; MD holds research grants (European Regional Development Fund, German Heart Foundation/German Foundation of Heart Research, GE Healthcare (Amersham), Bracco, Guerbet, and Toshiba Medical Systems), receives speaker fees (Toshiba Medical Systems, Guerbet, and Bayer-Schering), runs cardiac CT workshops at Charite (www.ct-kurs.de), has written the book Coronary CT Angiography (Springer, 2008), and is involved in institutional research collaborations (Siemens Medical Solutions, Philips Medical Systems, and Toshiba Medical Systems); FC is a consultant for Servier, received speaker fees (Bracco Imaging), and holds a research grant with HE Healthcare; EM is a consultant for Servier and holds a research grants with HE Healthcare; FB has received speakers fees from Siemens Healthcare; all other authors have no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years and no other relationships or activities that could appear to have influenced the submitted work.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; American Heart Association, 2010, HEART DIS STROK STAT; BEGG CB, 1983, BIOMETRICS, V39, P207, DOI 10.2307/2530820; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Budoff MJ, 2002, CIRCULATION, V105, P1791, DOI 10.1161/01.CIR.0000014483.43921.8C; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cooper A, 2010, CHEST PAIN RECENT ON; de Groot JAH, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4770; Dedic A, 2011, RADIOLOGY, V261, P428, DOI 10.1148/radiol.11110744; DeFrances Carol J, 2008, Natl Health Stat Report, P1; Diamond G A, 1983, J Am Coll Cardiol, V1, P574; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Elias-Smale SE, 2010, J AM COLL CARDIOL, V56, P1407, DOI 10.1016/j.jacc.2010.06.029; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Fraker TD, 2007, J AM COLL CARDIOL, V50, P2264, DOI [10.1016/j.jacc.2007.08.002, 10.1161/CIRCULATIONAHA.107.187930]; Gavin JR, 1999, DIABETES CARE, V22, pS5; Genders TSS, 2011, EUR HEART J, V32, P1316, DOI 10.1093/eurheartj/ehr014; Genders TSS, 2009, RADIOLOGY, V253, P734, DOI 10.1148/radiol.2533090507; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Glasziou PP, 2001, DECISION MAKING HLTH; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Haberl R, 2001, J AM COLL CARDIOL, V37, P451, DOI 10.1016/S0735-1097(00)01119-0; Hadamitzky M, 2011, CIRC-CARDIOVASC IMAG, V4, P16, DOI 10.1161/CIRCIMAGING.110.955351; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Knez A, 2004, AM J CARDIOL, V93, P1150, DOI 10.1016/j.amjcard.2004.01.044; Kwok Y, 1999, AM J CARDIOL, V83, P660, DOI 10.1016/S0002-9149(98)00963-1; Ladapo JA, 2009, J AM COLL CARDIOL, V54, P2409, DOI 10.1016/j.jacc.2009.10.012; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; Min JK, 2010, RADIOLOGY, V254, P801, DOI 10.1148/radiol.09090349; Mowatt G, 2008, HEART, V94, P1386, DOI 10.1136/hrt.2008.145292; Patel Manesh R, 2010, N Engl J Med, V362, P886, DOI 10.1056/NEJMoa0907272; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; PRYOR DB, 1983, AM J MED, V75, P771, DOI 10.1016/0002-9343(83)90406-0; PRYOR DB, 1993, ANN INTERN MED, V118, P81, DOI 10.7326/0003-4819-118-2-199301150-00001; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Schuetz GM, 2010, ANN INTERN MED, V152, P167, DOI 10.7326/0003-4819-152-3-201002020-00008; Steyerberg E.W., 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, DOI 10.1007/978-3-030-16399-0]; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; von Ballmoos MW, 2011, ANN INTERN MED, V154, P413, DOI 10.7326/0003-4819-154-6-201103150-00007; Yamada H, 1997, PROG CARDIOVASC DIS, V39, P457, DOI 10.1016/S0033-0620(97)80040-0	42	183	188	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2012	344								e3485	10.1136/bmj.e3485	http://dx.doi.org/10.1136/bmj.e3485			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961KQ	22692650	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-28	WOS:000305463700002
J	Trivedi, NS; Ship, AN				Trivedi, Neha S.; Ship, Amy N.			A 42-Year-Old Man Considering Whether to Drink Alcohol for His Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material														Trivedi, Neha/0000-0003-1006-1408				Mukamal KJ, 2010, JAMA-J AM MED ASSOC, V303, P2065, DOI 10.1001/jama.2010.550	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2012	307	21					2315	2315		10.1001/jama.2012.5865	http://dx.doi.org/10.1001/jama.2012.5865			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	952OL	22706837				2022-12-28	WOS:000304801700026
J	Tsai, HH; Li, HL; Fuentealba, LC; Molofsky, AV; Taveira-Marques, R; Zhuang, HL; Tenney, A; Murnen, AT; Fancy, SPJ; Merkle, F; Kessaris, N; Alvarez-Buylla, A; Richardson, WD; Rowitch, DH				Tsai, Hui-Hsin; Li, Huiliang; Fuentealba, Luis C.; Molofsky, Anna V.; Taveira-Marques, Raquel; Zhuang, Helin; Tenney, April; Murnen, Alice T.; Fancy, Stephen P. J.; Merkle, Florian; Kessaris, Nicoletta; Alvarez-Buylla, Arturo; Richardson, William D.; Rowitch, David H.			Regional Astrocyte Allocation Regulates CNS Synaptogenesis and Repair	SCIENCE			English	Article							SPINAL-CORD; CRUCIAL ROLE; NEURAL-TUBE; GLIAL-CELLS; OLIGODENDROCYTES; SPECIFICATION; NEURONS; TRANSFORMATION; PROGENITORS; GENERATION	Astrocytes, the most abundant cell population in the central nervous system (CNS), are essential for normal neurological function. We show that astrocytes are allocated to spatial domains in mouse spinal cord and brain in accordance with their embryonic sites of origin in the ventricular zone. These domains remain stable throughout life without evidence of secondary tangential migration, even after acute CNS injury. Domain-specific depletion of astrocytes in ventral spinal cord resulted in abnormal motor neuron synaptogenesis, which was not rescued by immigration of astrocytes from adjoining regions. Our findings demonstrate that region-restricted astrocyte allocation is a general CNS phenomenon and reveal intrinsic limitations of the astroglial response to injury.	[Fuentealba, Luis C.; Merkle, Florian; Alvarez-Buylla, Arturo; Rowitch, David H.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Tsai, Hui-Hsin; Molofsky, Anna V.; Tenney, April; Murnen, Alice T.; Fancy, Stephen P. J.; Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Tsai, Hui-Hsin; Tenney, April; Murnen, Alice T.; Fancy, Stephen P. J.; Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Molofsky, Anna V.] Univ Calif San Francisco, Langley Porter Inst, Dept Psychiat, San Francisco, CA 94143 USA; [Tsai, Hui-Hsin; Fuentealba, Luis C.; Molofsky, Anna V.; Murnen, Alice T.; Fancy, Stephen P. J.; Alvarez-Buylla, Arturo; Rowitch, David H.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Li, Huiliang; Taveira-Marques, Raquel; Zhuang, Helin; Kessaris, Nicoletta; Richardson, William D.] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Li, Huiliang; Taveira-Marques, Raquel; Zhuang, Helin; Kessaris, Nicoletta; Richardson, William D.] UCL, Res Dept Cell & Dev Biol, London WC1E 6BT, England	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of London; University College London; University of London; University College London	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu; w.richardson@ucl.ac.uk; rowitchd@peds.ucsf.edu	Ritter, Stefanie L/D-9312-2012; Kessaris, Nicoletta/AAD-6774-2019; Molofsky, Anna Victoria/P-2506-2018; Richardson FMedSci FRS, William D/C-1762-2008	Kessaris, Nicoletta/0000-0003-1191-6009; Molofsky, Anna Victoria/0000-0002-4709-2411; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Rowitch, David/0000-0002-0079-0060; Richardson FMedSci FRS, William D/0000-0001-7261-2485; Merkle, Florian/0000-0002-8513-2998	Portuguese Fundacao para a Ciencia e a Tecnologia; NIH; UK Medical Research Council; Wellcome Trust; European Research Council; Medical Research Council [G0501173, G0800575] Funding Source: researchfish; MRC [G0501173, G0800575] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028478] Funding Source: NIH RePORTER	Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Wong, S. Kaing, U. Dennehy, M. Grist, and S. Chang for technical help and E. Huillard, V. Heine, and C. Stiles for helpful comments. We thank A. Leiter (University of Massachusetts, Worcester) for Ngn3-cre mice. L. C. F. is a Howard Hughes Medical Institute (HHMI) Fellow of the Helen Hay Whitney Foundation. R.T.-M. was funded by the Portuguese Fundacao para a Ciencia e a Tecnologia. This work was supported by grants from the NIH, UK Medical Research Council, Wellcome Trust, and European Research Council. A.A.-B. holds the Heather and Melanie Muss Chair of Neurological Surgery. D. H. R. is a HHMI Investigator.	Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cai J, 2007, DEVELOPMENT, V134, P1887, DOI 10.1242/dev.02847; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Houades V, 2008, J NEUROSCI, V28, P5207, DOI 10.1523/JNEUROSCI.5100-07.2008; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kettenmann H, 2005, NEUROGLIA, DOI Oxford University Press; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Magavi S, 2012, J NEUROSCI, V32, P4762, DOI 10.1523/JNEUROSCI.3560-11.2012; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Shannon C, 2007, J ANAT, V210, P684, DOI 10.1111/j.1469-7580.2007.00731.x; Tsai HH, 2006, J NEUROSCI, V26, P1913, DOI 10.1523/JNEUROSCI.3571-05.2006; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015	30	337	342	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					358	362		10.1126/science.1222381	http://dx.doi.org/10.1126/science.1222381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22745251	Green Accepted			2022-12-28	WOS:000306542600056
J	DellaPenna, D; O'Connor, SE				DellaPenna, Dean; O'Connor, Sarah E.			Plant Gene Clusters and Opiates	SCIENCE			English	Editorial Material							SECONDARY METABOLISM; IDENTIFICATION; EVOLUTION; RICE		[DellaPenna, Dean] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [O'Connor, Sarah E.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [O'Connor, Sarah E.] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England	Michigan State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	DellaPenna, D (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	dellapen@msu.edu	O'Connor, Sarah Ellen/X-2893-2019; O'Connor, Sarah/O-5850-2016	O'Connor, Sarah/0000-0003-0356-6213				Chu HY, 2011, PLANT J, V66, P66, DOI 10.1111/j.1365-313X.2011.04503.x; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Field B, 2011, P NATL ACAD SCI USA, V108, P16116, DOI 10.1073/pnas.1109273108; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Liscombe DK, 2011, PHYTOCHEMISTRY, V72, P1969, DOI 10.1016/j.phytochem.2011.07.001; Mahmoudian M., 2009, ANTICANCER DRUG DISC, V4, P92, DOI [10.2174/15748920978700252419149691, DOI 10.2174/15748920978700252419149691]; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; Takos AM, 2011, PLANT J, V68, P273, DOI 10.1111/j.1365-313X.2011.04685.x; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757	12	16	17	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1648	1649		10.1126/science.1225473	http://dx.doi.org/10.1126/science.1225473			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745410				2022-12-28	WOS:000305794500029
J	Dissemond, J				Dissemond, Joachim			Necrobiosis Lipoidica Diabeticorum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Essen Gesamthsch, Essen, Germany	University of Duisburg Essen	Dissemond, J (corresponding author), Univ Essen Gesamthsch, Essen, Germany.		Dissemond, Joachim/AFG-0691-2022						0	7	8	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2502	2502		10.1056/NEJMicm1109700	http://dx.doi.org/10.1056/NEJMicm1109700			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965DP	22738100				2022-12-28	WOS:000305747000010
J	Erler, J; Birge, N; Kortelainen, M; Nazarewicz, W; Olsen, E; Perhac, AM; Stoitsov, M				Erler, Jochen; Birge, Noah; Kortelainen, Markus; Nazarewicz, Witold; Olsen, Erik; Perhac, Alexander M.; Stoitsov, Mario			The limits of the nuclear landscape	NATURE			English	Article							GROUND-STATE PROPERTIES	In 2011, 100 new nuclides were discovered(1). They joined the approximately 3,000 stable and radioactive nuclides that either occur naturally on Earth or are synthesized in the laboratory(2,3). Every atomic nucleus, characterized by a specific number of protons and neutrons, occupies a spot on the chart of nuclides, which is bounded by 'drip lines' indicating the values of neutron and proton number at which nuclear binding ends. The placement of the neutron drip line for the heavier elements is based on theoretical predictions using extreme extrapolations, and so is uncertain. However, it is not known how uncertain it is or how many protons and neutrons can be bound in a nucleus. Here we estimate these limits of the nuclear 'landscape' and provide statistical and systematic uncertainties for our predictions. We use nuclear density functional theory, several Skyrme interactions and high-performance computing, and find that the number of bound nuclides with between 2 and 120 protons is around 7,000. We find that extrapolations for drip-line positions and selected nuclear properties, including neutron separation energies relevant to astrophysical processes, are very consistent between the models used.	[Erler, Jochen; Birge, Noah; Kortelainen, Markus; Nazarewicz, Witold; Olsen, Erik; Perhac, Alexander M.; Stoitsov, Mario] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Erler, Jochen; Kortelainen, Markus; Nazarewicz, Witold; Olsen, Erik; Stoitsov, Mario] Oak Ridge Natl Lab, Div Phys, Oak Ridge, TN 37831 USA; [Kortelainen, Markus] Univ Jyvaskyla, Dept Phys, FI-40014 Jyvaskyla, Finland; [Nazarewicz, Witold] Univ Warsaw, Inst Theoret Phys, PL-00681 Warsaw, Poland	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Jyvaskyla; University of Warsaw	Nazarewicz, W (corresponding author), Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA.	witek@utk.edu	Kortelainen, Markus/C-9215-2018; Nazarewicz, Witold/C-2056-2012	Kortelainen, Markus/0000-0001-6244-764X; Nazarewicz, Witold/0000-0002-8084-7425; Olsen, Erik/0000-0002-3298-5647	Office of Nuclear Physics, US Department of Energy; Academy of Finland	Office of Nuclear Physics, US Department of Energy(United States Department of Energy (DOE)); Academy of Finland(Academy of Finland)	This work was supported by the Office of Nuclear Physics, US Department of Energy, and by the Academy of Finland.	[Anonymous], EV NUCL STRUCT DAT F; BARTEL J, 1982, NUCL PHYS A, V386, P79, DOI 10.1016/0375-9474(82)90403-1; Baumann T, 2007, NATURE, V449, P1022, DOI 10.1038/nature06213; BEINER M, 1975, NUCL PHYS A, V249, P1, DOI 10.1016/0375-9474(75)90089-5; Bender M, 2003, REV MOD PHYS, V75, P121, DOI 10.1103/RevModPhys.75.121; Brink D., 2005, CAMBRIDGE MONOGRAPHS; Chabanat E, 1998, NUCL PHYS A, V643, P441; Delaroche JP, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.014303; Dobaczewski J, 2007, PROG PART NUCL PHYS, V59, P432, DOI 10.1016/j.ppnp.2007.01.022; Dobaczewski J, 2002, EUR PHYS J A, V15, P21, DOI 10.1140/epja/i2001-10218-8; DOBACZEWSKI J, 1984, NUCL PHYS A, V422, P103, DOI 10.1016/0375-9474(84)90433-0; Goriely S, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.035804; Goriely S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.242501; Klupfel P, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.034310; Kortelainen M, 2012, PHYS REV C, V85, DOI 10.1103/PhysRevC.85.024304; Kortelainen M, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.024313; Langanke K, 2001, REP PROG PHYS, V64, P1657, DOI 10.1088/0034-4885/64/12/202; Matsuo M, 2010, J PHYS G NUCL PARTIC, V37, DOI 10.1088/0954-3899/37/6/064017; Moller P, 2008, ATOM DATA NUCL DATA, V94, P758, DOI 10.1016/j.adt.2008.05.002; MOLLER P, 1995, ATOM DATA NUCL DATA, V59, P185, DOI 10.1006/adnd.1995.1002; Nazarewicz W, 2002, NUCL PHYS A, V701, p165C, DOI 10.1016/S0375-9474(01)01567-6; Oganessian YT, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.044602; Otsuka T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.032501; *RAR IS SCI ASS CO, 2007, SCI OPP RAR IS FAC U; Reinhard PG, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.051303; Stoitsov M, 2009, INT J MOD PHYS E, V18, P816, DOI 10.1142/S0218301309012914; Stoitsov MV, 2005, COMPUT PHYS COMMUN, V167, P43, DOI 10.1016/j.cpc.2005.01.001; Stoitsov MV, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.054312; Thoennessen M, 2004, REP PROG PHYS, V67, P1187, DOI 10.1088/0034-4885/67/7/R04; Thoennessen M, 2011, NATURE, V473, P25, DOI 10.1038/473025a	30	304	316	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					509	512		10.1038/nature11188	http://dx.doi.org/10.1038/nature11188			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22739315				2022-12-28	WOS:000305760600038
J	Stern, RS				Stern, Robert S.			Exanthematous Drug Eruptions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON-SYNDROME; CUTANEOUS REACTIONS; RISK-FACTORS; HYPERSENSITIVITY REACTIONS; ALLERGIC REACTIONS; SKIN REACTIONS; MANAGEMENT; PHOTOSENSITIVITY; CARBAMAZEPINE	A 50-year-old woman with bipolar depression presents with a widespread pruritic rash of 1 day's duration. She is afebrile and otherwise well. She has a history of childhood eczema and is allergic to sulfonamide antibiotics. Her medications include thyroxine daily, naproxen intermittently, and lamotrigine, which she began taking 3 weeks earlier. How should this case be evaluated and treated?	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Dermatol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Stern, RS (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Dermatol, 330 Brookline Ave,Gryzmish 522A, Boston, MA 02215 USA.	rstern@bidmc.harvard.edu			Vertex; InterMune; Johnson Johnson; Boehringer Ingelheim; Takeda and its Millennium Division	Vertex(Vertex Pharmaceuticals); InterMune; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Boehringer Ingelheim(Boehringer Ingelheim); Takeda and its Millennium Division	Dr. Stern reports receiving consulting fees for the assessment of skin reactions associated with drugs under development from Vertex, InterMune, Johnson & Johnson, Boehringer Ingelheim, and Takeda and its Millennium Division, and for serving on a drug-safety panel for Takeda and as an expert witness in product liability litigation relating to skin reactions for Johnson & Johnson and Mutual, as a consultant to Audet Partners in litigation unrelated to cutaneous drug reactions, and as an expert in patent litigation for Nycomed. No other potential conflict of interest relevant to this article was reported.	Agbabiaka TB, 2008, DRUG SAFETY, V31, P21, DOI 10.2165/00002018-200831010-00003; Ball P, 2004, INT J ANTIMICROB AG, V23, P421, DOI 10.1016/j.ijantimicag.2004.02.014; BIGBY M, 1986, JAMA-J AM MED ASSOC, V256, P3358; Bigby M, 2001, ARCH DERMATOL, V137, P765; Brahimi N, 2010, EUR J DERMATOL, V20, P461, DOI 10.1684/ejd.2010.0980; Bronnimann M, 2005, CURR OPIN ALLERGY CL, V5, P317; Byrd JB, 2010, ALLERGY, V65, P1381, DOI 10.1111/j.1398-9995.2010.02398.x; Cacoub P, 2012, J HEPATOL, V56, P455, DOI 10.1016/j.jhep.2011.08.006; CHAN HL, 1990, ARCH DERMATOL, V126, P43, DOI 10.1001/archderm.126.1.43; Chen KR, 2008, AM J CLIN DERMATOL, V9, P71, DOI 10.2165/00128071-200809020-00001; Chen YC, 2010, ARCH DERMATOL, V146, P1373, DOI 10.1001/archdermatol.2010.198; COOPMAN SA, 1993, NEW ENGL J MED, V328, P1670, DOI 10.1056/NEJM199306103282304; Dona I, 2011, CLIN EXP ALLERGY, V41, P86, DOI 10.1111/j.1365-2222.2010.03651.x; Drake LA, 1996, J AM ACAD DERMATOL, V35, P458; Drucker AM, 2011, DRUG SAFETY, V34, P821, DOI 10.2165/11592780-000000000-00000; Eliaszewicz M, 2002, J AM ACAD DERMATOL, V47, P40, DOI 10.1067/mjd.2002.120468; Ferguson J, 2002, PHOTODERMATOL PHOTO, V18, P262, DOI 10.1034/j.1600-0781.2002.02778.x; Garcia-Doval I, 2000, ARCH DERMATOL, V136, P323, DOI 10.1001/archderm.136.3.323; Hirsch LJ, 2008, NEUROLOGY, V71, P1527, DOI 10.1212/01.wnl.0000334295.50403.4c; Hunziker T, 1997, ALLERGY, V52, P388, DOI 10.1111/j.1398-9995.1997.tb01017.x; Ibia EO, 2000, ARCH DERMATOL, V136, P849, DOI 10.1001/archderm.136.7.849; Kaiser statehealthfacts.org, US HLTH COSTS BUDG; Lee A Y, 2000, Am J Clin Dermatol, V1, P277; Lynch TJ, 2007, ONCOLOGIST, V12, P610, DOI 10.1634/theoncologist.12-5-610; Mayorga C, 2010, J INVEST ALLERG CLIN, V20, P103; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Merkel PA, 2001, RHEUM DIS CLIN N AM, V27, P849, DOI 10.1016/S0889-857X(05)70239-8; Mirakian R, 2009, CLIN EXP ALLERGY, V39, P43, DOI 10.1111/j.1365-2222.2008.03155.x; Mockenhaupt M, 2008, J INVEST DERMATOL, V128, P35, DOI 10.1038/sj.jid.5701033; Pichichero ME, 2005, PEDIATRICS, V115, P1048, DOI 10.1542/peds.2004-1276; Pichler WJ, 2011, J ALLERGY CLIN IMMUN, V127, pS74, DOI 10.1016/j.jaci.2010.11.048; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Roujeau Jean-Claude, 2006, Allergol Int, V55, P27, DOI 10.2332/allergolint.55.27; Rozieres A, 2009, CURR OPIN ALLERGY CL, V9, P305, DOI 10.1097/ACI.0b013e32832d565c; Sassolas B, 2010, CLIN PHARMACOL THER, V88, P60, DOI 10.1038/clpt.2009.252; Schlapbach C, 2011, ALLERGY, V66, P1469, DOI 10.1111/j.1398-9995.2011.02677.x; Scott Lycia A, 2003, Dermatol Online J, V9, P4; Sekula P, 2010, PHARMACOEPIDEM DR S, V19, P10, DOI 10.1002/pds.1863; Shehab N, 2008, CLIN INFECT DIS, V47, P735, DOI 10.1086/591126; Sidoroff A, 2007, BRIT J DERMATOL, V157, P989, DOI 10.1111/j.1365-2133.2007.08156.x; Solensky R, 2010, ANN ALLERG ASTHMA IM, V105, P259, DOI 10.1016/j.anai.2010.08.002; Stern RS, 2005, PHARMACOEPIDEM DR S, V14, P677, DOI 10.1002/pds.1065; Strom BL, 2003, NEW ENGL J MED, V349, P1628, DOI 10.1056/NEJMoa022963; Tennis P, 1997, NEUROLOGY, V49, P542, DOI 10.1212/WNL.49.2.542; Thong BYH, 2011, BRIT J CLIN PHARMACO, V71, P684, DOI 10.1111/j.1365-2125.2010.03774.x; Torres MJ, 2009, J INVEST ALLERG CLIN, V19, P80; Valeyrie-Allanore L, 2010, BRIT J DERMATOL, V163, P847, DOI 10.1111/j.1365-2133.2010.09863.x; VanDerKlauw MM, 1996, CLIN EXP ALLERGY, V26, P1355, DOI 10.1046/j.1365-2222.1996.d01-300.x; Wei CY, 2012, DRUG METAB PHARMACOK, V27, P132, DOI 10.2133/dmpk.DMPK-11-RV-116; WILSON JT, 1978, BRIT MED J, V1, P1583, DOI 10.1136/bmj.1.6127.1583	50	76	77	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2492	2501		10.1056/NEJMcp1104080	http://dx.doi.org/10.1056/NEJMcp1104080			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965DP	22738099				2022-12-28	WOS:000305747000009
J	Yu, EW; Finkelstein, JS				Yu, Elaine W.; Finkelstein, Joel S.			Bone Density Screening Intervals for Osteoporosis One Size Does Not Fit All	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FRACTURE RISK; FEMORAL-NECK; WOMEN		[Yu, Elaine W.; Finkelstein, Joel S.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Yu, EW (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, 50 Blossom St,Thier 1051, Boston, MA 02114 USA.		Finkelstein, Joel/M-6463-2019					[Anonymous], 2011, AM FAM PHYSICIAN, V83, P1197; Gourlay ML, 2012, NEW ENGL J MED, V366, P225, DOI 10.1056/NEJMoa1107142; Hillier TA, 2007, ARCH INTERN MED, V167, P155, DOI 10.1001/archinte.167.2.155; King AB, 2011, HEALTH AFFAIR, V30, P2362, DOI 10.1377/hlthaff.2011.0233; National Osteoporosis Foundation, NOF CLIN GUID PREV T; Nguyen TV, 2005, J BONE MINER RES, V20, P1195, DOI 10.1359/JBMR.050215; Quandt SA, 2005, MAYO CLIN PROC, V80, P343, DOI 10.4065/80.3.343; Siris ES, 2008, OSTEOPOROSIS INT, V19, P681, DOI 10.1007/s00198-007-0493-y; Wainwright SA, 2005, J CLIN ENDOCR METAB, V90, P2787, DOI 10.1210/jc.2004-1568; World Health Organization Collaborating Centre for Metabolic Bone Diseases, WHO FRACT RISK ASS T	10	18	18	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2012	307	24					2591	2592		10.1001/jama.2012.6977	http://dx.doi.org/10.1001/jama.2012.6977			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	964KF	22735425				2022-12-28	WOS:000305692600024
J	Oakeshott, P; Aghaizu, A; Reid, F; Howell-Jones, R; Hay, PE; Sadiq, ST; Lacey, CJ; Beddows, S; Soldan, K				Oakeshott, Pippa; Aghaizu, Adamma; Reid, Fiona; Howell-Jones, Rebecca; Hay, Phillip E.; Sadiq, S. Tariq; Lacey, Charles J.; Beddows, Simon; Soldan, Kate			Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							YOUNG-WOMEN; NATURAL-HISTORY; CERVICAL-CANCER; HPV INFECTION; VACCINES; CYTOLOGY; TRIAL; AGE; PREVENTION; CHLAMYDIA	Objective To investigate frequency and risk factors for prevalent, incident, and persistent carcinogenic human papillomavirus (HPV) in young women before the introduction of immunisation against HPV types 16 and 18 for schoolgirls. Design Cohort study Setting 20 London universities and further education colleges. Participants 2185 sexually active female students, mean age 21 years (range 16-27), 38% from ethnic minorities, who took part in the POPI (prevention of pelvic infection) chlamydia screening trial in 2004-08 and who provided duplicate, self taken vaginal swabs and completed questionnaires at baseline. At follow-up, a median of 16 months later, 821 women (38%) returned repeat vaginal swabs by post. In 2009-10, stored samples were tested for HPV. Results Samples from 404/2185 (18.5% (95% CI 16.9% to 20.2%)) of the cohort were positive for carcinogenic HPV at baseline, including 15.0% (327) positive for non-vaccine carcinogenic genotypes. Reporting two or more sexual partners in the previous year and concurrent Chlamydia trachomatis or bacterial vaginosis were independent risk factors for prevalent vaginal HPV infection. Infection with one or more new HPV types was found in 17.7% (145/821) of follow-up samples, giving an estimated annual incidence of carcinogenic HPV infection of 12.9% (95% CI 11.0% to 15.0%). Incident infection was more common in women reporting two or more partners in the previous year, aged<20, of black ethnicity, or with C trachomatis vaginosis at baseline. Multiple partners was the only independent risk factor for incident infection (adjusted relative risk 1.99 (95% CI 1.46 to 2.72)). Of 143 women with baseline carcinogenic HPV infection, 20 (14% (8.3% to 19.7%) had infection with the same carcinogenic HPV type(s) detected after 12-28 months. Of these women, 13 (65%) had redetected infection with HPV 16 or 18, and nine (45%) with non-vaccine carcinogenic HPV genotypes. Conclusion In the first UK cohort study of carcinogenic HPV in young women in the community, multiple sexual partners was an independent predictor of both prevalent and incident infection. Infection with non-vaccine carcinogenic genotypes was common. Although current HPV vaccines offer partial cross protection against some non-vaccine carcinogenic HPV types, immunised women will still need cervical screening.	[Oakeshott, Pippa; Aghaizu, Adamma; Reid, Fiona] Univ London, Div Populat Hlth Sci, London SW17 0RE, England; [Howell-Jones, Rebecca; Soldan, Kate] Hlth Protect Agcy, HIV & STI Dept, London NW9 5EQ, England; [Hay, Phillip E.; Sadiq, S. Tariq] Dept Genitourinary Med, London, England; [Lacey, Charles J.] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Beddows, Simon] Hlth Protect Agcy, Virus Reference Dept, London, England	University of London; Health Protection Agency; University of Hull; University of York - UK; Health Protection Agency	Oakeshott, P (corresponding author), Univ London, Div Populat Hlth Sci, London SW17 0RE, England.	p.oakeshott@sgul.ac.uk		Reid, Fiona/0000-0002-0762-8111; Beddows, Simon/0000-0002-6879-6215; Soldan, Kate/0000-0002-0361-3174; Oakeshott, Pippa/0000-0003-2568-8211; Sadiq, S Tariq/0000-0002-0608-3818	BUPA foundation [TBF-08-025]; Medical Research Council [80280]; GlaxoSmithKline [EPI-HPV-109903]; Policy Research Programme in the Department of Health, UK [039/030]; UK Clinical Research Collaboration; Medical Research Council [G0901608, G0601669] Funding Source: researchfish; MRC [G0901608, G0601669] Funding Source: UKRI	BUPA foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSmithKline(GlaxoSmithKline); Policy Research Programme in the Department of Health, UK; UK Clinical Research Collaboration; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	BUPA foundation grant TBF-08-025 and Medical Research Council grant 80280. Gen-Probe provided the Aptima test kits. The HPV testing was supported by a grant from GlaxoSmithKline (study No EPI-HPV-109903). RHJ was funded by the Policy Research Programme in the Department of Health, UK (grant reference No 039/030). PO, STS, and PEH are members of the eSTI2 consortium funded by the UK Clinical Research Collaboration. The views expressed in the publication are those of the authors and not necessarily those of the Department of Health or other funders.	Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brabin L, 2008, BRIT MED J, V336, P1056, DOI 10.1136/bmj.39541.534109.BE; Castle PE, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2569; Garnett GP, 2006, VACCINE, V24, P178, DOI 10.1016/j.vaccine.2006.05.116; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Howell-Jones R, 2010, BRIT J CANCER, V103, P209, DOI 10.1038/sj.bjc.6605747; Howell-Jones R, 2012, VACCINE IN PRESS; Kim S, 2011, SEX TRANSM DIS, V38, P587, DOI 10.1097/OLQ.0b013e31820a9324; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Maucort-Boulch D, 2010, INT J CANCER, V126, P684, DOI 10.1002/ijc.24752; Moser K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2025; Oakeshott P., 2010, BRIT MED J, V340, pc1642, DOI [10.1136/bmj.c1642, DOI 10.1136/BMJ.C1642]; Oakeshott P, 2010, CLIN INFECT DIS, V51, P1160, DOI 10.1086/656739; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Romanowski B, 2011, HUM VACCINES, V7, P161, DOI 10.4161/hv.7.2.13690; Ronco G, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3005; Sargent A, 2008, BRIT J CANCER, V98, P1704, DOI 10.1038/sj.bjc.6604324; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Sinka K, 2011, SEX TRANSM INFECT, V87, P548, DOI 10.1136/sextrans-2011-050211; Steben M, 2007, GYNECOL ONCOL, V107, pS2, DOI 10.1016/j.ygyno.2007.07.067; Verheijen RHM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5720; Winer RL, 2007, SEX TRANSM DIS, V34, P371, DOI 10.1097/01.olq.0000240315.19652.59; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; Winer RL, 2011, CANCER EPIDEM BIOMAR, V20, P699, DOI 10.1158/1055-9965.EPI-10-1108; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4	28	35	39	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2012	344								e4168	10.1136/bmj.e4168	http://dx.doi.org/10.1136/bmj.e4168			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965CL	22730542	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000305743600001
J	Humphries, C				Humphries, Courtney			COOKING Delicious science	NATURE			English	Editorial Material																		Ahn YY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00196; Barham P, 2010, CHEM REV, V110, P2313, DOI 10.1021/cr900105w; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Snitkjaer P, 2010, FOOD CHEM, V122, P645, DOI 10.1016/j.foodchem.2010.03.025	4	4	4	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					S10	S11		10.1038/486S10a	http://dx.doi.org/10.1038/486S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	046RB	22717395	Bronze			2022-12-28	WOS:000311781000006
J	Wilcken, NRC; Stockler, MR				Wilcken, Nicholas R. C.; Stockler, Martin R.			Individual patient meta-analysis: Taxane plus anthracycline reduces mortality from early breast cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Wilcken, Nicholas R. C.] Univ Sydney, Westmead Hosp, Sydney Canc Ctr, Sydney, NSW 2006, Australia; [Stockler, Martin R.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Wilcken, NRC (corresponding author), Univ Sydney, Westmead Hosp, Sydney Canc Ctr, Sydney, NSW 2006, Australia.		Stockler, Martin R/N-3859-2016	Stockler, Martin R/0000-0003-3793-8724				Coates AS, 2012, J CLIN ONCOL, V30, P1260, DOI 10.1200/JCO.2011.37.7879	1	0	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12							JC6-4	10.7326/0003-4819-156-12-201206190-02004	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711105				2022-12-28	WOS:000307783200003
J	Gomez-Outes, A; Terleira-Fernandez, AI; Suarez-Gea, ML; Vargas-Castrillon, E				Gomez-Outes, Antonio; Isabel Terleira-Fernandez, Ana; Luisa Suarez-Gea, M.; Vargas-Castrillon, Emilio			Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FACTOR-XA INHIBITOR; SYMPTOMATIC VENOUS THROMBOEMBOLISM; DIRECT THROMBIN INHIBITOR; DOUBLE-BLIND; ORTHOPEDIC-SURGERY; PREVENTION; ETEXILATE; BAY-59-7939; EVENTS; ARTHROPLASTY	Objective To analyse clinical outcomes with new oral anticoagulants for prophylaxis against venous thromboembolism after total hip or knee replacement. Design Systematic review, meta-analysis, and indirect treatment comparisons. Data sources Medline and CENTRAL (up to April 2011), clinical trials registers, conference proceedings, and websites of regulatory agencies. Study selection Randomised controlled trials of rivaroxaban, dabigatran, or apixaban compared with enoxaparin for prophylaxis against venous thromboembolism after total hip or knee replacement. Two investigators independently extracted data. Relative risks of symptomatic venous thromboembolism, clinically relevant bleeding, deaths, and a net clinical endpoint (composite of symptomatic venous thromboembolism, major bleeding, and death) were estimated using a random effect meta-analysis. RevMan and ITC software were used for direct and indirect comparisons, respectively. Results 16 trials in 38 747 patients were included. Compared with enoxaparin, the risk of symptomatic venous thromboembolism was lower with rivaroxaban (relative risk 0.48, 95% confidence interval 0.31 to 0.75) and similar with dabigatran (0.71, 0.23 to 2.12) and apixaban (0.82, 0.41 to 1.64). Compared with enoxaparin, the relative risk of clinically relevant bleeding was higher with rivaroxaban (1.25, 1.05 to 1.49), similar with dabigatran (1.12, 0.94 to 1.35), and lower with apixaban (0.82, 0.69 to 0.98). The treatments did not differ on the net clinical endpoint in direct or indirect comparisons. Conclusions A higher efficacy of new anticoagulants was generally associated with a higher bleeding tendency. The new anticoagulants did not differ significantly for efficacy and safety.	[Gomez-Outes, Antonio; Luisa Suarez-Gea, M.] Spanish Agcy Med & Med Devices, Med Human Use, Div Pharmacol & Clin Evaluat, Madrid 28022, Spain; [Isabel Terleira-Fernandez, Ana; Vargas-Castrillon, Emilio] Hosp Clin San Carlos, Dept Clin Pharmacol, Madrid, Spain	Hospital Clinico San Carlos	Gomez-Outes, A (corresponding author), Spanish Agcy Med & Med Devices, Med Human Use, Div Pharmacol & Clin Evaluat, Parque Empresarial Las Mercedes,Edificio 8,C Camp, Madrid 28022, Spain.	agomezo@aemps.es	Vargas-Castrillón, Emilio/AAZ-7621-2021	Vargas-Castrillón, Emilio/0000-0003-4828-6004; Gomez-Outes, Antonio/0000-0002-8393-9691				[Anonymous], 2011, REV MAN REVMAN COMP; Bjornara BT, 2006, J BONE JOINT SURG BR, V88B, P386, DOI 10.1302/0301-620X.88B3.17207; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Dahl OE, 2010, J THROMB HAEMOST, V8, P1966, DOI 10.1111/j.1538-7836.2010.03965.x; Dahl OE, 2012, INT ORTHOP, V36, P741, DOI 10.1007/s00264-011-1393-5; Deitelzweig SB, 2011, CLIN APPL THROMB-HEM, V17, P640, DOI 10.1177/1076029611404215; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eriksson BI, 2007, J THROMB HAEMOST, V5, P2178, DOI 10.1111/j.1538-7836.2007.02748.x; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Eriksson BI, 2007, THROMB RES, V120, P685, DOI 10.1016/j.thromres.2006.12.025; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Eriksson BI, 2006, CIRCULATION, V114, P2374, DOI 10.1161/CIRCULATIONAHA.106.642074; Eriksson BI, 2011, THROMB HAEMOSTASIS, V105, P721, DOI 10.1160/TH10-10-0679; Eriksson BI, 2006, J THROMB HAEMOST, V4, P121, DOI 10.1111/j.1538-7836.2005.01657.x; Eriksson BI, 2005, J THROMB HAEMOST, V3, P103, DOI 10.1111/j.1538-7836.2004.01100.x; Eriksson BI, 2004, J THROMB HAEMOST, V2, P1573, DOI 10.1111/j.1538-7836.2004.00890.x; European Medicines Agency, 2011, XAR SUMM PROD CHAR; European Medicines Agency, 2011, PRAD SUMM PROD CHAR; European Medicines Agency, 2011, EL SUMM PROD CHAR; Fuji T, 2010, J ARTHROPLASTY, V25, P1267, DOI 10.1016/j.arth.2009.08.010; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Ginsberg JS, 2009, J ARTHROPLASTY, V24, P1, DOI 10.1016/j.arth.2008.01.132; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Gomez-Outes A, 2009, LANCET, V374, P682, DOI 10.1016/S0140-6736(09)61552-X; Gomez-Outes A, 2009, CURR VASC PHARMACOL, V7, P309, DOI 10.2174/157016109788340785; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jensen CD, 2011, J BONE JOINT SURG BR, V93B, P91, DOI 10.1302/0301-620X.93B1.24987; Kakkar AK, 2008, LANCET, V372, P31, DOI 10.1016/S0140-6736(08)60880-6; Kearon C, 2003, CIRCULATION, V107, pI22, DOI 10.1161/01.CIR.0000078464.82671.78; Lassen MR, 2007, J THROMB HAEMOST, V5, P2368, DOI 10.1111/j.1538-7836.2007.02764.x; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Lassen MR, 2010, NEW ENGL J MED, V363, P2487, DOI 10.1056/NEJMoa1006885; Lassen MR, 2010, LANCET, V375, P807, DOI 10.1016/S0140-6736(09)62125-5; Lassen MR, 2009, NEW ENGL J MED, V361, P594, DOI 10.1056/NEJMoa0810773; Legrand M, 2011, ARCH INTERN MED, V171, P1285, DOI 10.1001/archinternmed.2011.314; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Loke YK, 2011, J CLIN PHARM THER, V36, P111, DOI 10.1111/j.1365-2710.2010.01162.x; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; MANTEL N, 1959, J NATL CANCER I, V22, P719; Maratea D, 2011, J THROMB HAEMOST, V9, P1868, DOI 10.1111/j.1538-7836.2011.04421.x; Quinlan DJ, 2007, J THROMB HAEMOST, V5, P1438, DOI 10.1111/j.1538-7836.2007.02571.x; Trkulja V, 2010, CROAT MED J, V51, P113, DOI 10.3325/cmj.2010.51.113; Turpie AGG, 2005, J THROMB HAEMOST, V3, P2479, DOI 10.1111/j.1538-7836.2005.01602.x; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; Waddell James, 2010, Am J Orthop (Belle Mead NJ), V39, P5; Wells GA, 2009, INDIRECT TREATMENT C; White RH, 2003, THROMB HAEMOSTASIS, V90, P446, DOI 10.1160/TH03-03-0152	49	148	159	0	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2012	344								e3675	10.1136/bmj.e3675	http://dx.doi.org/10.1136/bmj.e3675			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961LA	22700784	Green Published, hybrid			2022-12-28	WOS:000305464700004
J	Sax, PE; DeJesus, E; Mills, A; Zolopa, A; Cohen, C; Wohl, D; Gallant, JE; Liu, HC; Zhong, LJ; Yale, K; White, K; Kearney, BP; Szwarcberg, J; Quirk, E; Cheng, AK				Sax, Paul E.; DeJesus, Edwin; Mills, Anthony; Zolopa, Andrew; Cohen, Calvin; Wohl, David; Gallant, Joel E.; Liu, Hui C.; Zhong, Lijie; Yale, Kitty; White, Kirsten; Kearney, Brian P.; Szwarcberg, Javier; Quirk, Erin; Cheng, Andrew K.		GS-US-236-0102 Study Team	Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks	LANCET			English	Article							TREATMENT-NAIVE PATIENTS; TREATMENT-EXPERIENCED PATIENTS; SINGLE-TABLET REGIMEN; ANTIRETROVIRAL THERAPY; DISOPROXIL FUMARATE; NON-INFERIORITY; LAMIVUDINE; ADULTS; RALTEGRAVIR; RILPIVIRINE	Background The integrase inhibitor elvitegravir (EVG) has been co-formulated with the CYP3A4 inhibitor cobicistat (COBI), emtricitabine (FTC), and tenofovir disoproxil fumarate (TDF) in a single tablet given once daily. We compared the efficacy and safety of EVG/COBI/FTC/TDF with standard of care-co-formulated efavirenz (EFV)/FTC/TDF-as initial treatment for HIV infection. Methods In this phase 3 trial, treatment-naive patients from outpatient clinics in North America were randomly assigned by computer-generated allocation sequence with a block size of four in a 1: 1 ratio to receive EVG/COBI/FTC/TDF or EFV/FTC/TDF, once daily, plus matching placebo. Patients and study staff involved in giving study treatment, assessing outcomes, and collecting and analysing data were masked to treatment allocation. Eligibility criteria included screening HIV RNA concentration of 5000 copies per mL or more, and susceptibility to efavirenz, emtricitabine, and tenofovir. The primary endpoint was HIV RNA concentration of fewer than 50 copies per mL at week 48. The study is registered with ClinicalTrials.gov, number NCT01095796. Findings 700 patients were randomly assigned and treated (348 with EVG/COBI/FTC/TDF, 352 with EFV/FTC/TDF). EVG/COBI/FTC/TDF was non-inferior to EFV/FTC/TDF; 305/348 (87.6%) versus 296/352 (84.1%) of patients had HIV RNA concentrations of fewer than 50 copies per mL at week 48 (difference 3.6%, 95% CI -1.6% to 8.8%). Proportions of patients discontinuing drugs for adverse events did not differ substantially (13/348 in the EVG/COBI/FTC/TDF group vs 18/352 in the EFV/FTC/TDF group). Nausea was more common with EVG/COBI/FTC/TDF than with EFV/FTC/TDF (72/348 vs 48/352) and dizziness (23/348 vs 86/352), abnormal dreams (53/348 vs 95/352), insomnia (30/348 vs 49/352), and rash (22/348 vs 43/352) were less common. Serum creatinine concentration increased more by week 48 in the EVG/COBI/FTC/TDF group than in the EFV/FTC/TDF group (median 13 mu mol/L, IQR 5 to 20 vs 1 mu mol/L, -6 to 8; p < 0.001). Interpretation If regulatory approval is given, EVG/COBI/FTC/TDF would be the only single-tablet, once-daily, integrase-inhibitor-based regimen for initial treatment of HIV infection.	[Sax, Paul E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [DeJesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Mills, Anthony] Anthony Mills MD, Los Angeles, CA USA; [Zolopa, Andrew] Stanford Univ, Palo Alto, CA 94304 USA; [Cohen, Calvin] Community Res Initiat New England, Boston, MA USA; [Wohl, David; Gallant, Joel E.] Univ N Carolina, Chapel Hill, NC USA; [Liu, Hui C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Zhong, Lijie; Yale, Kitty; White, Kirsten; Kearney, Brian P.; Szwarcberg, Javier; Quirk, Erin; Cheng, Andrew K.] Gilead Sci, Foster City, CA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Orlando Immunology Center; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Gilead Sciences	Sax, PE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA.	psax@partners.org		Mills, Anthony/0000-0002-6997-5581	Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Merck Laboratories; Tibotec; Abbott Laboratories; Aeliron Scientific; Janssen Therapeutics; Achillion Pharmaceuticals; Avexa; Boehringer Ingelheim; Hoffmann LaRoche; Idenix; Janssen; Merck; Pfizer; Sangamo; Taimed; Tobira; Vertex; Kowa; ViiV; Merck Co; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Merck Laboratories(Merck & Company); Tibotec; Abbott Laboratories(Abbott Laboratories); Aeliron Scientific; Janssen Therapeutics; Achillion Pharmaceuticals; Avexa; Boehringer Ingelheim(Boehringer Ingelheim); Hoffmann LaRoche(Hoffmann-La Roche); Idenix; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Pfizer(Pfizer); Sangamo; Taimed; Tobira; Vertex(Vertex Pharmaceuticals); Kowa; ViiV; Merck Co(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	PES has received research support from Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Laboratories, and Tibotec; consulting fees from Abbott Laboratories, Aeliron Scientific, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Laboratories, and Janssen Therapeutics. EDJ has received research grant support from Abbott Laboratories, Achillion Pharmaceuticals, Avexa, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Hoffmann LaRoche, Idenix, Janssen, Merck, Pfizer, Sangamo, Taimed, Tobira, and Vertex; and consulting fees as a member of advisory boards for Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and Vertex. AM has received research support from Boehringer Ingelheim, Gilead Sciences, GlaxoSmithKline, Janssen Therapeutics, Kowa, Merck, Pfizer, Tobira, and ViiV, and consulting fees for speakers bureaux and advisory boards from Bristol-Myers Squibb, Gilead Sciences, Janssen Therapeutics, and Merck. AZ has received research grant support from Gilead Sciences, consulting fees as an advisory board member for Bristol-Myers Squibb, Gilead Sciences, and Janssen Therapeutics. C C has received research grant support from Gilead Sciences, Bristol-Myers Squibb, Merck, Janssen, and Viiv, and receives consulting fees from Gilead Sciences, Bristol-Myers Squibb, Merck, Janssen, Viiv, and Tobira. DW has received research grant support from Merck and GlaxoSmithKline, and receives consulting fees from Janssen Therapeutics and Gilead Sciences. JEG has received research support from Gilead Sciences and consulting fees from Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck, and Janssen Therapeutics. DW has received grant support from Merck & Co, and GlaxoSmithKline, and has been on advisory boards for Janssen Therapeutics and Gilead Sciences. HCL, LZ, KY, KW, BPK, JS, EQ, and AKC are employed by Gilead Sciences.	Airoldi M, 2010, PATIENT PREFER ADHER, V4, P115; [Anonymous], EV 200 MG 25MG 245MG; [Anonymous], 2011, ATRIPLA EF EMTR TEN; [Anonymous], 2011, COMPLERA EMTR RILP T; Arribas JR, 2008, JAIDS-J ACQ IMM DEF, V47, P74, DOI 10.1097/QAI.0b013e31815acab8; Bangsberg DR, 2010, AIDS, V24, P2835, DOI 10.1097/QAD.0b013e328340a209; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cohen C, 2011, AIDS, V25, pF7, DOI 10.1097/QAD.0b013e328345766f; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; Cohen CJ, 2011, 51 INT C ANT AG CHEM; DAAR E, 2010, 17 C RETR OPP INF SA; DeJesus E, 2006, JAIDS-J ACQ IMM DEF, V43, P1, DOI 10.1097/01.qai.0000233308.82860.2f; DeJesus E, 2012, LANCET, V379, P2429, DOI 10.1016/S0140-6736(12)60918-0; Elion R, 2011, AIDS, V25, P1881, DOI 10.1097/QAD.0b013e32834b4d48; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; German P, 2011, 51 INT C ANT AG CHEM; Haubrich RH, 2011, AIDS, V25, P2269, DOI 10.1097/QAD.0b013e32834d0c20; Hodder SL, 2010, AIDS PATIENT CARE ST, V24, P87, DOI 10.1089/apc.2009.0259; KIM D, 2010, 17 C RETR OPP INF SA; Koch GG, 1989, STAT METHODOLOGY PHA, P414; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Lennox JL, 2011, J ACQ IMMUN DEF SYND, V55, P39; Llibre JM, 2011, AIDS, V25, P1683, DOI 10.1097/QAD.0b013e3283499cd9; McKinnell JA, 2010, AIDS PATIENT CARE ST, V24, P79, DOI 10.1089/apc.2009.0220; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Ocfemia CB, 2012, 19 C RETR OPP INF SE; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; US Department of Health and Human Services, 2011, GUID US ANT AG HIV 1; US Department of Health and Human Services Food and Drug Administration, 2002, GUID IND ANT DRUGS U; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7	35	361	365	0	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 30	2012	379	9835					2439	2448		10.1016/S0140-6736(12)60917-9	http://dx.doi.org/10.1016/S0140-6736(12)60917-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967NV	22748591				2022-12-28	WOS:000305915900028
J	Lazar, MA; Birnbaum, MJ				Lazar, Mitchell A.; Birnbaum, Morris J.			De-Meaning of Metabolism	SCIENCE			English	Editorial Material									[Lazar, Mitchell A.] Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lazar, MA (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu; birnbaum@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019	Birnbaum, Morris/0000-0001-9972-8680	NATIONAL CANCER INSTITUTE [P01CA093615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, R01DK056886] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA093615] Funding Source: Medline; NIDDK NIH HHS [P01 DK49210, R01 DK056886] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2010, OXFORD DICT ENGLISH; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; RODBELL M, 1980, NATURE, V284, P17, DOI 10.1038/284017a0; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92	8	27	27	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1651	1652		10.1126/science.1221834	http://dx.doi.org/10.1126/science.1221834			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745413				2022-12-28	WOS:000305794500032
J	Gabbie, S				Gabbie, Susie			Lessons as a paediatrician-parent	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Free Hosp, London NW3 2QG, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Gabbie, S (corresponding author), Royal Free Hosp, Pond St, London NW3 2QG, England.	susie.gabbie@nhs.net							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 27	2012	344								e4392	10.1136/bmj.e4392	http://dx.doi.org/10.1136/bmj.e4392			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	968MX	22740573				2022-12-28	WOS:000305987100013
J	Chung, HC; Pamp, SJ; Hill, JA; Surana, NK; Edelman, SM; Troy, EB; Reading, NC; Villablanca, EJ; Wang, S; Mora, JR; Umesaki, Y; Mathis, D; Benoist, C; Relman, DA; Kasper, DL				Chung, Hachung; Pamp, Suenje J.; Hill, Jonathan A.; Surana, Neeraj K.; Edelman, Sanna M.; Troy, Erin B.; Reading, Nicola C.; Villablanca, Eduardo J.; Wang, Sen; Mora, Jorge R.; Umesaki, Yoshinori; Mathis, Diane; Benoist, Christophe; Relman, David A.; Kasper, Dennis L.			Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota	CELL			English	Article							SEGMENTED FILAMENTOUS BACTERIA; ROR-GAMMA-T; CELLS; DIFFERENTIATION; RECEPTORS; TOLERANCE; SEQUENCES; EVOLUTION; RESPONSES; INDUCER	Gut microbial induction of host immune maturation exemplifies host-microbe mutualism. We colonized germ-free (GF) mice with mouse microbiota (MMb) or human microbiota (HMb) to determine whether small intestinal immune maturation depends on a coevolved host-specific microbiota. Gut bacterial numbers and phylum abundance were similar in MMb and HMb mice, but bacterial species differed, especially the Firmicutes. HMb mouse intestines had low levels of CD4(+) and CD8(+) T cells, few proliferating T cells, few dendritic cells, and low antimicrobial peptide expression-all characteristics of GF mice. Rat microbiota also failed to fully expand intestinal T cell numbers in mice. Colonizing GF or HMb mice with mouse-segmented filamentous bacteria (SFB) partially restored T cell numbers, suggesting that SFB and other MMb organisms are required for full immune maturation in mice. Importantly, MMb conferred better protection against Salmonella infection than HMb. A host-specific microbiota appears to be critical for a healthy immune system.	[Chung, Hachung; Surana, Neeraj K.; Edelman, Sanna M.; Troy, Erin B.; Reading, Nicola C.; Kasper, Dennis L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA; [Chung, Hachung; Hill, Jonathan A.; Surana, Neeraj K.; Edelman, Sanna M.; Troy, Erin B.; Reading, Nicola C.; Mathis, Diane; Benoist, Christophe; Kasper, Dennis L.] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Pamp, Suenje J.; Relman, David A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Pamp, Suenje J.; Relman, David A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Villablanca, Eduardo J.; Wang, Sen; Mora, Jorge R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Med,Gastrointestinal Unit, Boston, MA 02114 USA; [Umesaki, Yoshinori] Yakult Cent Inst Microbiol Res, Kunitachi, Tokyo 1868650, Japan; [Pamp, Suenje J.; Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Surana, Neeraj K.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Stanford University; Stanford University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Yakult Honsha Company, Limited; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Harvard University; Boston Children's Hospital	Kasper, DL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Lab, Boston, MA 02115 USA.	dennis_kasper@hms.harvard.edu	Pamp, Sünje Johanna/AAP-5178-2020; Pamp, Sünje/H-8787-2012; Villablanca, Eduardo/E-1380-2016	Pamp, Sünje Johanna/0000-0002-6236-1763; Pamp, Sünje/0000-0002-6236-1763; Villablanca, Eduardo/0000-0001-9522-9729; Relman, David A./0000-0001-8331-1354; Chung, Hachung/0000-0003-3426-0225	Crohn's & Colitis Foundation of America; Juvenile Diabetes Research Foundation; Danish Council for Independent Research Natural Sciences; National Institutes of Health [F32 AI091104]; Director's Pioneer Award [DP1OD000964]; Thomas C. and Joan M. Merigan Endowment at Stanford University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061, R21AI090102, F32AI091104] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000964] Funding Source: NIH RePORTER	Crohn's & Colitis Foundation of America; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Danish Council for Independent Research Natural Sciences(Det Frie Forskningsrad (DFF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Director's Pioneer Award; Thomas C. and Joan M. Merigan Endowment at Stanford University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Shakir Edwards for gnotobiotic animal care, Julie B. McCoy for editing, Tom DiCesare for image design, Dr. Rod Bronson for pathology scoring, Jennifer Dinalo for ten human fecal samples, and Les Dethlefsen and Robert Edgar for helpful advice. This work was supported by a Senior Research Award from the Crohn's & Colitis Foundation of America (to D. L. K.), by the Juvenile Diabetes Research Foundation (to H. C.), by the Danish Council for Independent Research Natural Sciences (to S.J.P.), by National Institutes of Health Grant F32 AI091104 (to N.K.S.), and by Director's Pioneer Award DP1OD000964 (to D. A. R.). D. A. R. is supported by the Thomas C. and Joan M. Merigan Endowment at Stanford University.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; BANDEIRA A, 1990, J EXP MED, V172, P239, DOI 10.1084/jem.172.1.239; Chassin C, 2010, CELL HOST MICROBE, V8, P358, DOI 10.1016/j.chom.2010.09.005; Chung HC, 2010, CURR OPIN IMMUNOL, V22, P455, DOI 10.1016/j.coi.2010.06.008; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Duan JY, 2010, CELL HOST MICROBE, V7, P140, DOI 10.1016/j.chom.2010.01.005; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2010, CURR OPIN IMMUNOL, V22, P448, DOI 10.1016/j.coi.2010.06.002; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ferreira RBR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020338; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hand T, 2010, CURR OPIN IMMUNOL, V22, P63, DOI 10.1016/j.coi.2010.01.008; Heczko U, 2000, J INFECT DIS, V181, P1027, DOI 10.1086/315348; Imaoka A, 2004, J APPL MICROBIOL, V96, P656, DOI 10.1111/j.1365-2672.2004.02189.x; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansson MEV, 2011, SCIENCE, V334, P182, DOI 10.1126/science.1213909; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; KLAASEN HLBM, 1993, LAB ANIM-UK, V27, P141, DOI 10.1258/002367793780810441; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pais R, 2008, APPL ENVIRON MICROB, V74, P5965, DOI 10.1128/AEM.00741-08; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Prakash T, 2011, CELL HOST MICROBE, V10, P273, DOI 10.1016/j.chom.2011.08.007; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; SNEL J, 1995, INT J SYST BACTERIOL, V45, P780, DOI 10.1099/00207713-45-4-780; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	58	768	805	8	207	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1578	1593		10.1016/j.cell.2012.04.037	http://dx.doi.org/10.1016/j.cell.2012.04.037			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726443	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000305753800022
J	Lin, CC; Melo, FA; Ghosh, R; Suen, KM; Stagg, LJ; Kirkpatrick, J; Arold, ST; Ahmed, Z; Ladbury, JE				Lin, Chi-Chuan; Melo, Fernando A.; Ghosh, Ragini; Suen, Kin M.; Stagg, Loren J.; Kirkpatrick, John; Arold, Stefan T.; Ahmed, Zamal; Ladbury, John E.			Inhibition of Basal FGF Receptor Signaling by Dimeric Grb2	CELL			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; TRANSFORMING ACTIVITY; SH3 DOMAIN; CANCER; MUTATIONS; BINDING; ADAPTER; KINASE; AUTOPHOSPHORYLATION	Receptor tyrosine kinase activity is known to occur in the absence of extracellular stimuli. Importantly, this "background" level of receptor phosphorylation is insufficient to effect a downstream response, suggesting that strict controls are present and prohibit full activation. Here a mechanism is described in which control of FGFR2 activation is provided by the adaptor protein Grb2. Dimeric Grb2 binds to the C termini of two FGFR2 molecules. This heterotetramer is capable of a low-level receptor transphosphorylation, but C-terminal phosphorylation and recruitment of signaling proteins are sterically hindered. Upon stimulation, FGFR2 phosphorylates tyrosine residues on Grb2, promoting dissociation from the receptor and allowing full activation of downstream signaling. These observations establish a role for Grb2 as an active regulator of RTK signaling.	[Lin, Chi-Chuan; Melo, Fernando A.; Suen, Kin M.; Stagg, Loren J.; Arold, Stefan T.; Ahmed, Zamal; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Lin, Chi-Chuan; Melo, Fernando A.; Suen, Kin M.; Stagg, Loren J.; Arold, Stefan T.; Ahmed, Zamal; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Ctr Biomol Struct & Funct, Houston, TX 77030 USA; [Lin, Chi-Chuan; Ghosh, Ragini; Kirkpatrick, John] UCL, Inst Struct Mol Biol, London WC1E 6BT, England	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of London; Birkbeck University London; University College London	Ladbury, JE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Unit 1000,1515 Holcombe Blvd, Houston, TX 77030 USA.	jeladbury@mdanderson.org	Arold, Stefan/T-2612-2019; Melo, Fernando A/A-6242-2013	Melo, Fernando A/0000-0002-8676-3150; Arold, Stefan T/0000-0001-5278-0668; Ladbury, John/0000-0002-6328-7200; suen, kin man/0000-0001-9452-2528	G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the G. Harold and Leila Y. Mathers Charitable Foundation.	Ahmed Z, 2010, CELL SIGNAL, V22, P23, DOI 10.1016/j.cellsig.2009.08.011; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant MR, 2009, GLIA, V57, P935, DOI 10.1002/glia.20818; Cha JY, 2008, MOL CANCER RES, V6, P435, DOI 10.1158/1541-7786.MCR-07-0187; Cha JYY, 2009, J BIOL CHEM, V284, P6227, DOI 10.1074/jbc.M803998200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Gartside MG, 2009, MOL CANCER RES, V7, P41, DOI 10.1158/1541-7786.MCR-08-0021; Haines E, 2009, MOL CELL BIOL, V29, P2505, DOI 10.1128/MCB.00034-09; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Hu JJ, 2003, MOL CELL, V12, P1379, DOI 10.1016/S1097-2765(03)00487-8; ISHII H, 1995, MOL CELL BIOL, V15, P3664; ITOH H, 1994, CANCER RES, V54, P3237; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; KOHDA D, 1994, STRUCTURE, V2, P1029, DOI 10.1016/S0969-2126(94)00106-5; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Li SG, 2001, EMBO J, V20, P6793, DOI 10.1093/emboj/20.23.6793; MAIGNAN S, 1995, SCIENCE, V268, P291, DOI 10.1126/science.7716522; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; McDonald CB, 2008, ARCH BIOCHEM BIOPHYS, V475, P25, DOI 10.1016/j.abb.2008.04.008; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Robertson SC, 2000, TRENDS GENET, V16, P265, DOI 10.1016/S0168-9525(00)02021-7; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Takeda M, 2007, CLIN CANCER RES, V13, P3051, DOI 10.1158/1078-0432.CCR-06-2743; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wesche J, 2011, BIOCHEM J, V437, P199, DOI 10.1042/BJ20101603; Yuzawa S, 2001, J MOL BIOL, V306, P527, DOI 10.1006/jmbi.2000.4396; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhao WM, 2010, CLIN CANCER RES, V16, P5750, DOI 10.1158/1078-0432.CCR-10-0531	36	111	113	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1514	1524		10.1016/j.cell.2012.04.033	http://dx.doi.org/10.1016/j.cell.2012.04.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726438	Bronze			2022-12-28	WOS:000305753800017
J	Davidson, K; Humphreys, RM				Davidson, Kris; Humphreys, Roberta M.			The Great Eruption of eta Carinae	NATURE			English	Letter									[Davidson, Kris; Humphreys, Roberta M.] Univ Minnesota, Minnesota Inst Astrophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Davidson, K (corresponding author), Univ Minnesota, Minnesota Inst Astrophys, Minneapolis, MN 55455 USA.	kd@umn.edu			Division Of Astronomical Sciences [1109394] Funding Source: National Science Foundation	Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Cenarro AJ, 2001, MON NOT R ASTRON SOC, V326, P981, DOI 10.1046/j.1365-8711.2001.04689.x; DAVIDSON K, 1987, ASTROPHYS J, V317, P760, DOI 10.1086/165324; Davidson K., 2012, ETA CARINAE SUPERNOV, V384; FLOWER PJ, 1977, ASTRON ASTROPHYS, V54, P31; HUMPHREYS RM, 1984, ASTROPHYS J, V284, P565, DOI 10.1086/162439; Kovtyukh VV, 2010, MON NOT R ASTRON SOC, V408, P1568, DOI 10.1111/j.1365-2966.2010.17217.x; Krone-Martins A, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/200913881; Rest A, 2012, NATURE, V482, P375, DOI 10.1038/nature10775	8	18	18	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					E1	E1		10.1038/nature11166	http://dx.doi.org/10.1038/nature11166			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722207	Bronze, Green Submitted			2022-12-28	WOS:000305466800001
J	Savage, N				Savage, Neil			TECHNOLOGY The taste of things to come	NATURE			English	Editorial Material																			0	18	18	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					S18	S19		10.1038/486S18a	http://dx.doi.org/10.1038/486S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	046RB	22717399	Bronze			2022-12-28	WOS:000311781000010
J	Chalasani, N; Vuppalanchi, R; Navarro, V; Fontana, R; Bonkovsky, H; Barnhart, H; Kleiner, DE; Hoofnagle, JH				Chalasani, Naga; Vuppalanchi, Raj; Navarro, Victor; Fontana, Robert; Bonkovsky, Herbert; Barnhart, Huiman; Kleiner, David E.; Hoofnagle, Jay H.		Drug-Induced Liver Injury Network	Acute Liver Injury due to Flavocoxid (Limbrel), a Medical Food for Osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Article							MULTICENTER; BAICALIN; SAFETY; KNEE	Background: Flavocoxid is a prescription medical food that is used to treat osteoarthritis. It is a proprietary blend of 2 flavonoids, baicalin and catechins, which are derived from the botanicals Scutellaria baicalensis and Acacia catechu, respectively. Objective: To describe characteristics of patients with acute liver injury suspected of being caused by flavocoxid. Design: Case series. Setting: Drug-Induced Liver Injury Network Prospective Study ongoing at multiple academic medical centers since 2004. Patients: Four adults with liver injury. Measurements: Clinical characteristics, liver biochemistry values, and outcomes. Results: Among 877 patients enrolled in the prospective study, 4 had liver injury suspected to have been caused by flavocoxid. All were women; ages ranged from 57 to 68 years. All developed symptoms and signs of liver injury within 1 to 3 months after initiating flavocoxid. Liver injury was characterized by marked elevations in levels of alanine aminotransferase (mean peak, 1268 U/L; range, 741 to 1540 U/L), alkaline phosphatase (mean peak, 510 U/L; range, 286 to 770 U/L), and serum bilirubin (mean peak, 160.7 mu mol/L [9.4 mg/dL]; range, 34.2 to 356 mu mol/L [2.0 to 20.8 mg/dL]). Liver biochemistry values decreased to the normal range within 3 to 12 weeks after flavocoxid was stopped, and all patients recovered without experiencing acute liver failure or chronic liver injury. Causality was adjudicated as highly likely in 3 patients and as possible in 1 patient. Limitation: The frequency and mechanism of liver injury could not be assessed. Conclusion: Flavocoxid can cause clinically significant liver injury, which seems to resolve within weeks after cessation.	[Chalasani, Naga] Indiana Univ Sch Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA; Temple Univ, Sch Med, Philadelphia, PA 19122 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Carolinas Med Ctr, Charlotte, NC 28203 USA; Duke Clin Res Inst, Durham, NC USA; NCI, Bethesda, MD 20892 USA; NIDDK, Bethesda, MD USA	Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Michigan System; University of Michigan; Carolinas Medical Center; Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Chalasani, N (corresponding author), Indiana Univ Sch Med, Div Gastroenterol & Hepatol, 1050 Wishard Blvd,RG 4100, Indianapolis, IN 46202 USA.	nchalasa@iupui.edu	Vuppalanchi, Raj/AAI-2482-2021; Vuppalanchi, Raj/AAI-2481-2021; Kleiner, David E/N-2770-2013; Bonkovsky, Herbert L./AAH-1892-2021	Vuppalanchi, Raj/0000-0003-0637-1577; Vuppalanchi, Raj/0000-0003-0637-1577; Kleiner, David E/0000-0003-3442-4453; Bonkovsky, Herbert L./0000-0001-7387-3230	National Institute of Diabetes and Digestive and Kidney Diseases; Intramural Research Program of the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZICBC010687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK065184, U01DK065176, U01DK083023, U01DK065201, U01DK065238, U01DK083020, U01DK065211, U01DK083027, U01DK082992] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases.; The DILIN is supported by the National Institute of Diabetes and Digestive and Kidney Diseases (https://dilin.dcri.duke.edu/). This research was supported in part by the Intramural Research Program of the National Cancer Institute, National Institutes of Health.	Bonkovsky HL, 2006, ANN INTERN MED, V144, P68, DOI 10.7326/0003-4819-144-1-200601030-00020; Davern TJ, 2011, GASTROENTEROLOGY, V141, P1665, DOI 10.1053/j.gastro.2011.07.051; Fontana RJ, 2009, DRUG SAFETY, V32, P55, DOI 10.2165/00002018-200932010-00005; Guo HX, 2009, ACTA PHARMACOL SIN, V30, P1505, DOI 10.1038/aps.2009.150; Levy RM, 2011, CHEST, V140, P827, DOI 10.1378/chest.11-0632; Levy RM, 2010, ADV THER, V27, P731, DOI 10.1007/s12325-010-0064-z; Mazzanti G, 2009, EUR J CLIN PHARMACOL, V65, P331, DOI 10.1007/s00228-008-0610-7; Morgan SL, 2009, J MED FOOD, V12, P1143, DOI 10.1089/jmf.2008.0244; Pillai L, 2010, CURR MED RES OPIN, V26, P1055, DOI 10.1185/03007991003694522; Primus Pharmaceuticals, 2011, LIMBR PROD INF; Qiao HX, 2011, PHARM BIOL, V49, P38, DOI 10.3109/13880209.2010.493179; Rockey DC, 2010, HEPATOLOGY, V51, P2117, DOI 10.1002/hep.23577; Schmidt M, 2005, FOOD CHEM TOXICOL, V43, P307, DOI 10.1016/j.fct.2004.11.001; U.S. Food and Drug Administration, 2009, MED FOODS; US Food and Drug Administration, 2007, GUID IND FREQ ASK QU	15	38	39	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12					857	U129		10.7326/0003-4819-156-12-201206190-00006	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711078	Green Accepted			2022-12-28	WOS:000307783200015
J	Perreault, L; Pan, Q; Mather, KJ; Watson, KE; Hamman, RF; Kahn, SE				Perreault, Leigh; Pan, Qing; Mather, Kieren J.; Watson, Karol E.; Hamman, Richard F.; Kahn, Steven E.		Diabet Prevention Program Res Grp	Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study	LANCET			English	Article							LIFE-STYLE MODIFICATION; IMPAIRED FASTING GLUCOSE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; NATURAL-HISTORY; TOLERANCE; METFORMIN; INTERVENTION; PREVALENCE; MELLITUS	Background Our objective was to quantify and predict diabetes risk reduction during the Diabetes Prevention Program Outcomes Study (DPPOS) in participants who returned to normal glucose regulation at least once during the Diabetes Prevention Program (DPP) compared with those who consistently met criteria for prediabetes. Methods DPPOS is an ongoing observational study of participants from the DPP randomised trial. For this analysis, diabetes cumulative incidence in DPPOS was calculated for participants with normal glucose regulation or prediabetes status during DPP with and without stratification by previous randomised treatment group. Cox proportional hazards modelling and generalised linear mixed models were used to quantify the effect of previous (DPP) glycaemic status on risk of later (DPPOS) diabetes and normal glucose regulation status, respectively, per SD in change. Included in this analysis were 1990 participants of DPPOS who had been randomly assigned to treatment groups during DPP (736 intensive lifestyle intervention, 647 metformin, 607 placebo). These studies are registered at ClinicalTrials.gov, NCT00004992 (DPP) and NCT00038727 (DPPOS). Findings Diabetes risk during DPPOS was 56% lower for participants who had returned to normal glucose regulation versus those who consistently had prediabetes (hazard ratio [HR] 0.44, 95% CI 0.37-0.55, p < 0.0001) and was unaffected by previous group assignment (interaction test for normal glucose regulation and lifestyle intervention, p = 0.1722; normal glucose regulation and metformin, p = 0.3304). Many, but not all, of the variables that increased diabetes risk were inversely associated with the chance of a participant reaching normal glucose regulation status in DPPOS. Specifically, previous achievement of normal glucose regulation (odds ratio [OR] 3.18, 95% CI 2.71-3.72, p < 0.0001), increased beta-cell function (OR 1.28; 95% CI 1.18-1.39, p < 0.0001), and insulin sensitivity (OR 1.16, 95% CI 1.08-1.25, p < 0.0001) were associated with normal glucose regulation in DPPOS, whereas the opposite was true for prediction of diabetes, with increased beta-cell function (HR 0.80, 95% CI 0.71-0.89, p < 0.0001) and insulin sensitivity (HR 0.83, 95% CI 0.74-0.94, p = 0.0001) having a protective effect. Among participants who did not return to normal glucose regulation in DPP, those assigned to the intensive lifestyle intervention had a higher diabetes risk (HR 1.31, 95% CI 1.03-1.68, p = 0.0304) and lower chance of normal glucose regulation (OR 0.59, 95% CI 0.42-0.82, p = 0.0014) than did the placebo group in DPPOS. Interpretation We conclude that prediabetes is a high-risk state for diabetes, especially in patients who remain with prediabetes despite intensive lifestyle intervention. Reversion to normal glucose regulation, even if transient, is associated with a significantly reduced risk of future diabetes independent of previous treatment group.	[Pan, Qing; Diabet Prevention Program Res Grp] George Washington Univ, Diabet Prevent Program Coordinating Ctr, Biostat Ctr, Rockville, MD 20852 USA; [Perreault, Leigh] Univ Colorado, Aurora, CO USA; [Mather, Kieren J.] Indiana Univ, Sch Med, Indianapolis, IN 46204 USA; [Watson, Karol E.] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; [Hamman, Richard F.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Kahn, Steven E.] Univ Washington, Seattle, WA 98195 USA; [Kahn, Steven E.] VA Puget Sound Hlth Care Syst1, Seattle, WA USA	George Washington University; University of Colorado System; University of Colorado Anschutz Medical Campus; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Colorado School of Public Health; University of Washington; University of Washington Seattle	Perreault, L (corresponding author), George Washington Univ, Diabet Prevent Program Coordinating Ctr, Biostat Ctr, Rockville, MD 20852 USA.		Soliman, Elsayed Z/AAD-7135-2020; Mather, Kieren/ABE-4117-2020; Uwaifo, Gabriel I/M-2361-2016; Watson, Karol/ABD-7425-2021	Soliman, Elsayed Z/0000-0001-5632-8150; Uwaifo, Gabriel I/0000-0002-6962-9304; Kahn, Steven/0000-0001-7307-9002; Christophi, Christopher/0000-0002-1349-0884	US National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the US National Institutes of Health [5U01-DK048375-12]; NIDDK; Indian Health Service; National Institute of Child Health and Human Development; National Institute on Aging; National Eye Institute; National Heart Lung and Blood Institute; Office of Research on Women's Health; National Center for Minority Health and Human Disease; Centers for Disease Control and Prevention; American Diabetes Association; Bristol-Myers Squibb; Parke-Davis; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, ZIADK075078, U01DK048375, U01DK048489, P30DK079637, U01DK048406] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the US National Institutes of Health; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Indian Health Service(United States Department of Health & Human Services); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); National Center for Minority Health and Human Disease; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Diabetes Association(American Diabetes Association); Bristol-Myers Squibb(Bristol-Myers Squibb); Parke-Davis; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	US National Institutes of Health.; The research group thanks the participants of DPP and DPPOS for their commitment and dedication. During DPPOS, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the US National Institutes of Health (grant 5U01-DK048375-12) provided funding to the clinical centres and the coordinating centre for the design and conduct of the study and collection, management, analysis, and interpretation of the data. The Southwestern American Indian Centers were supported directly by the NIDDK, including its Intramural Research Program, and the Indian Health Service. The General Clinical Research Center Program, National Center for Research Resources, and the Department of Veterans Affairs supported data collection at many of the clinical centres. Funding was also provided by the National Institute of Child Health and Human Development, the National Institute on Aging, the National Eye Institute, the National Heart Lung and Blood Institute, the Office of Research on Women's Health, the National Center for Minority Health and Human Disease, the Centers for Disease Control and Prevention, and the American Diabetes Association. Bristol-Myers Squibb and Parke-Davis provided additional funding and material support during DPP, Lipha (Merck-Sante) provided drugs, and LifeScan Inc donated materials during DPP and DPPOS. The opinions expressed are those of the investigators and do not necessarily reflect the views of the funding agencies. A complete list of centres, investigators, and staff is shown in the appendix pp 1-3. This Article is dedicated to Christopher D Saudek, our friend and collaborator, who passed away on Oct 6, 2010.	[Anonymous], 2000, Diabetes Care, V23, P1619; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bray GA, 1999, DIABETES CARE, V22, P623; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Cheng YJ, 2009, DIABETES CARE, V32, P2027, DOI 10.2337/dc09-0440; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Crandall J, 2006, J GERONTOL A-BIOL, V61, P1075; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Edelstein SL, 2005, DIABETES CARE, V28, P138, DOI 10.2337/diacare.28.1.138; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Herman WH, 2005, ANN INTERN MED, V142, P323, DOI 10.7326/0003-4819-142-5-200503010-00007; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Mather KJ, 2008, DIABETES, V57, P980, DOI 10.2337/db07-1419; Meigs JB, 2003, DIABETES, V52, P1475, DOI 10.2337/diabetes.52.6.1475; Nathan DM, 2007, DIABETIC MED, V24, P137; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Perreault L, 2008, DIABETES CARE, V31, P1416, DOI 10.2337/dc07-2390; Perreault L, 2009, DIABETES CARE, V32, P1583, DOI 10.2337/dc09-0523; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; SAAD MF, 1988, BRIT MED J, V297, P1438, DOI 10.1136/bmj.297.6661.1438; Saito T, 2011, ARCH INTERN MED, V171, P1352, DOI 10.1001/archinternmed.2011.275; Tataranni PA, 2005, DIABETES, V54, P917, DOI 10.2337/diabetes.54.4.917; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; US Centers for Disease Control and Prevention, 2011, DIAB FACT SHEET; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Venditti EM, 2008, INT J OBESITY, V32, P1537, DOI 10.1038/ijo.2008.134; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Ziegler D, 2008, DIABETES CARE, V31, P464, DOI 10.2337/dc07-1796	38	306	314	4	73	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2012	379	9833					2243	2251		10.1016/S0140-6736(12)60525-X	http://dx.doi.org/10.1016/S0140-6736(12)60525-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962AM	22683134	Green Accepted			2022-12-28	WOS:000305511400031
J	Hobson, J; Weatherall, MW				Hobson, Joyce; Weatherall, Mark W.			A PATIENT'S JOURNEY Lyme neuroborreliosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Weatherall, Mark W.] Ealing Hosp NHS Trust, Southall UB1 3HW, Middx, England; [Hobson, Joyce] Denham Garden Village, Denham, Bucks, England		Weatherall, MW (corresponding author), Ealing Hosp NHS Trust, Southall UB1 3HW, Middx, England.	mark.weatherall@doctors.org.uk							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 14	2012	344								e3250	10.1136/bmj.e3250	http://dx.doi.org/10.1136/bmj.e3250			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961LA	22700781	Bronze			2022-12-28	WOS:000305464700001
J	Methe, BA; Nelson, KE; Pop, M; Creasy, HH; Giglio, MG; Huttenhower, C; Gevers, D; Petrosino, JF; Abubucker, S; Badger, JH; Chinwalla, AT; Earl, AM; FitzGerald, MG; Fulton, RS; Hallsworth-Pepin, K; Lobos, EA; Madupu, R; Magrini, V; Martin, JC; Mitreva, M; Muzny, DM; Sodergren, EJ; Versalovic, J; Wollam, AM; Worley, KC; Wortman, JR; Young, SK; Zeng, Q; Aagaard, KM; Abolude, OO; Allen-Vercoe, E; Alm, EJ; Alvarado, L; Andersen, GL; Anderson, S; Appelbaum, E; Arachchi, HM; Armitage, G; Arze, CA; Ayvaz, T; Baker, CC; Begg, L; Belachew, T; Bhonagiri, V; Bihan, M; Blaser, MJ; Bloom, T; Bonazzi, VR; Brooks, P; Buck, G; Buhay, CJ; Busam, DA; Campbell, JL; Canon, SR; Cantarel, BL; Chain, PS; Chen, IMA; Chen, L; Chhibba, S; Chu, K; Ciulla, DM; Clemente, JC; Clifton, SW; Conlan, S; Crabtree, J; Cutting, MA; Davidovics, NJ; Davis, CC; DeSantis, TZ; Deal, C; Delehaunty, KD; Dewhisrst, FE; Deych, E; Ding, Y; Dooling, DJ; Dugan, SP; Dunne, WM; Durkin, AS; Edgar, RC; Erlich, RL; Farmer, CN; Farrell, RM; Faust, K; Feldgarden, M; Felix, VM; Fisher, S; Fodor, AA; Forney, L; Foster, L; Di Francesco, V; Friedman, J; Friedrich, DC; Fronick, CC; Fulton, LL; Gao, H; Garcia, N; Giannoukos, G; Giblin, C; Giovanni, MY; Goldberg, JM; Goll, J; Gonzalez, A; Griggs, A; Gujja, S; Haas, BJ; Hamilton, HA; Harris, EL; Hepburn, TA; Herter, B; Hoffmann, DE; Holder, ME; Howarth, C; Huang, KH; Huse, SM; Izard, J; Jansson, JK; Jiang, HY; Jordan, C; Joshi, V; Katancik, J; Keitel, W; Kelley, ST; Kells, C; Kinder-Haake, S; King, NB; Knight, R; Knights, D; Kong, HH; Koren, O; Koren, S; Kota, KC; Kovar, CL; Kyrpides, NC; La Rosa, PS; Lee, SL; Lemon, KP; Lennon, N; Lewis, CM; Lewis, L; Ley, RE; Li, K; Liolios, K; Liu, B; Liu, Y; Lo, CC; Lozupone, CA; Lunsford, RD; Madden, T; Mahurkar, AA; Mannon, PJ; Mardis, ER; Markowitz, VM; Mavrommatis, K; McCorrison, JM; McDonald, D; McEwen, J; McGuire, AL; McInnes, P; Mehta, T; Mihindukulasuriya, KA; Miller, JR; Minx, PJ; Newsham, I; Nusbaum, C; O'Laughlin, M; Orvis, J; Pagani, I; Palaniappan, K; Patel, SM; Pearson, M; Peterson, J; Podar, M; Pohl, C; Pollard, KS; Priest, ME; Proctor, LM; Qin, X; Raes, J; Ravel, J; Reid, JG; Rho, M; Rhodes, R; Riehle, KP; Rivera, MC; Rodriguez-Mueller, B; Rogers, YH; Ross, MC; Russ, C; Sanka, RK; Sankar, P; Sathirapongsasuti, JF; Schloss, JA; Schloss, PD; Schmidt, TM; Scholz, M; Schriml, L; Schubert, AM; Segata, N; Segre, JA; Shannon, WD; Sharp, RR; Sharpton, TJ; Shenoy, N; Sheth, NU; Simone, GA; Singh, I; Smillie, CS; Sobel, JD; Sommer, DD; Spicer, P; Sutton, GG; Sykes, SM; Tabbaa, DG; Thiagarajan, M; Tomlinson, CM; Torralba, M; Treangen, TJ; Truty, RM; Vishnivetskaya, TA; Walker, J; Wang, L; Wang, Z; Ward, DV; Warren, W; Watson, MA; Wellington, C; Wetterstrand, KA; White, JR; Wilczek-Boney, K; Wu, YQ; Wylie, KM; Wylie, T; Yandava, C; Ye, L; Ye, Y; Yooseph, S; Youmans, BP; Zhang, L; Zhou, YJ; Zhu, YM; Zoloth, L; Zucker, JD; Birren, BW; Gibbs, RA; Highlander, SK; Weinstock, GM; Wilson, RK; White, O				Methe, Barbara A.; Nelson, Karen E.; Pop, Mihai; Creasy, Heather H.; Giglio, Michelle G.; Huttenhower, Curtis; Gevers, Dirk; Petrosino, Joseph F.; Abubucker, Sahar; Badger, Jonathan H.; Chinwalla, Asif T.; Earl, Ashlee M.; FitzGerald, Michael G.; Fulton, Robert S.; Hallsworth-Pepin, Kymberlie; Lobos, Elizabeth A.; Madupu, Ramana; Magrini, Vincent; Martin, John C.; Mitreva, Makedonka; Muzny, Donna M.; Sodergren, Erica J.; Versalovic, James; Wollam, Aye M.; Worley, Kim C.; Wortman, Jennifer R.; Young, Sarah K.; Zeng, Qiandong; Aagaard, Kjersti M.; Abolude, Olukemi O.; Allen-Vercoe, Emma; Alm, Eric J.; Alvarado, Lucia; Andersen, Gary L.; Anderson, Scott; Appelbaum, Elizabeth; Arachchi, Harindra M.; Armitage, Gary; Arze, Cesar A.; Ayvaz, Tulin; Baker, Carl C.; Begg, Lisa; Belachew, Tsegahiwot; Bhonagiri, Veena; Bihan, Monika; Blaser, Martin J.; Bloom, Toby; Bonazzi, Vivien R.; Brooks, Paul; Buck, GregoryA.; Buhay, Christian J.; Busam, Dana A.; Campbell, Joseph L.; Canon, Shane R.; Cantarel, Brandi L.; Chain, Patrick S.; Chen, I-Min A.; Chen, Lei; Chhibba, Shaila; Chu, Ken; Ciulla, Dawn M.; Clemente, Jose C.; Clifton, Sandra W.; Conlan, Sean; Crabtree, Jonathan; Cutting, Mary A.; Davidovics, Noam J.; Davis, Catherine C.; DeSantis, Todd Z.; Deal, Carolyn; Delehaunty, Kimberley D.; Dewhisrst, Floyd E.; Deych, Elena; Ding, Yan; Dooling, David J.; Dugan, Shannon P.; Dunne, W. Michael, Jr.; Durkin, A. Scott; Edgar, Robert C.; Erlich, Rachel L.; Farmer, Candace N.; Farrell, Ruth M.; Faust, Karoline; Feldgarden, Michael; Felix, Victor M.; Fisher, Sheila; Fodor, Anthony A.; Forney, Larry; Foster, Leslie; Di Francesco, Valentina; Friedman, Jonathan; Friedrich, Dennis C.; Fronick, Catrina C.; Fulton, Lucinda L.; Gao, Hongyu; Garcia, Nathalia; Giannoukos, Georgia; Giblin, Christina; Giovanni, Maria Y.; Goldberg, Jonathan M.; Goll, Johannes; Gonzalez, Antonio; Griggs, Allison; Gujja, Sharvari; Haas, Brian J.; Hamilton, Holli A.; Harris, Emily L.; Hepburn, Theresa A.; Herter, Brandi; Hoffmann, Diane E.; Holder, Michael E.; Howarth, Clinton; Huang, Katherine H.; Huse, Susan M.; Izard, Jacques; Jansson, Janet K.; Jiang, Huaiyang; Jordan, Catherine; Joshi, Vandita; Katancik, JamesA.; Keitel, WendyA.; Kelley, Scott T.; Kells, Cristyn; Kinder-Haake, Susan; King, Nicholas B.; Knight, Rob; Knights, Dan; Kong, Heidi H.; Koren, Omry; Koren, Sergey; Kota, Karthik C.; Kovar, Christie L.; Kyrpides, Nikos C.; La Rosa, Patricio S.; Lee, Sandra L.; Lemon, Katherine P.; Lennon, Niall; Lewis, Cecil M.; Lewis, Lora; Ley, Ruth E.; Li, Kelvin; Liolios, Konstantinos; Liu, Bo; Liu, Yue; Lo, Chien-Chi; Lozupone, Catherine A.; Lunsford, R. Dwayne; Madden, Tessa; Mahurkar, Anup A.; Mannon, Peter J.; Mardis, Elaine R.; Markowitz, Victor M.; Mavrommatis, Konstantinos; McCorrison, Jamison M.; McDonald, Daniel; McEwen, Jean; McGuire, Amy L.; McInnes, Pamela; Mehta, Teena; Mihindukulasuriya, Kathie A.; Miller, Jason R.; Minx, Patrick J.; Newsham, Irene; Nusbaum, Chad; O'Laughlin, Michelle; Orvis, Joshua; Pagani, Ioanna; Palaniappan, Krishna; Patel, Shital M.; Pearson, Matthew; Peterson, Jane; Podar, Mircea; Pohl, Craig; Pollard, Katherine S.; Priest, Margaret E.; Proctor, Lita M.; Qin, Xiang; Raes, Jeroen; Ravel, Jacques; Reid, Jeffrey G.; Rho, Mina; Rhodes, Rosamond; Riehle, Kevin P.; Rivera, Maria C.; Rodriguez-Mueller, Beltran; Rogers, Yu-Hui; Ross, Matthew C.; Russ, Carsten; Sanka, Ravi K.; Sankar, Pamela; Sathirapongsasuti, J. Fah; Schloss, Jeffery A.; Schloss, Patrick D.; Schmidt, Thomas M.; Scholz, Matthew; Schriml, Lynn; Schubert, Alyxandria M.; Segata, Nicola; Segre, Julia A.; Shannon, William D.; Sharp, Richard R.; Sharpton, Thomas J.; Shenoy, Narmada; Sheth, Nihar U.; Simone, Gina A.; Singh, Indresh; Smillie, Chris S.; Sobel, Jack D.; Sommer, Daniel D.; Spicer, Paul; Sutton, Granger G.; Sykes, Sean M.; Tabbaa, Diana G.; Thiagarajan, Mathangi; Tomlinson, Chad M.; Torralba, Manolito; Treangen, Todd J.; Truty, Rebecca M.; Vishnivetskaya, Tatiana A.; Walker, Jason; Wang, Lu; Wang, Zhengyuan; Ward, Doyle V.; Warren, Wesley; Watson, Mark A.; Wellington, Christopher; Wetterstrand, Kris A.; White, James R.; Wilczek-Boney, Katarzyna; Wu, Yuan Qing; Wylie, Kristine M.; Wylie, Todd; Yandava, Chandri; Ye, Liang; Ye, Yuzhen; Yooseph, Shibu; Youmans, Bonnie P.; Zhang, Lan; Zhou, Yanjiao; Zhu, Yiming; Zoloth, Laurie; Zucker, Jeremy D.; Birren, Bruce W.; Gibbs, Richard A.; Highlander, Sarah K.; Weinstock, George M.; Wilson, Richard K.; White, Owen		Human Microbiome Project Consortiu	A framework for human microbiome research	NATURE			English	Article							CATALOG	A variety of microbial communities and their genes (the microbiome) exist throughout the human body, with fundamental roles in human health and disease. The National Institutes of Health (NIH)-funded Human Microbiome Project Consortium has established a population-scale framework to develop metagenomic protocols, resulting in a broad range of quality-controlled resources and data including standardized methods for creating, processing and interpreting distinct types of high-throughput metagenomic data available to the scientific community. Here we present resources from a population of 242 healthy adults sampled at 15 or 18 body sites up to three times, which have generated 5,177 microbial taxonomic profiles from 16S ribosomal RNA genes and over 3.5 terabases of metagenomic sequence so far. In parallel, approximately 800 reference strains isolated from the human body have been sequenced. Collectively, these data represent the largest resource describing the abundance and variety of the human microbiome, while providing a framework for current and future studies.	[Methe, Barbara A.; Nelson, Karen E.; Madupu, Ramana; Bihan, Monika; Busam, Dana A.; Durkin, A. Scott; Foster, Leslie; Goll, Johannes; Li, Kelvin; McCorrison, Jamison M.; Miller, Jason R.; Orvis, Joshua; Rogers, Yu-Hui; Sanka, Ravi K.; Singh, Indresh; Sutton, Granger G.; Thiagarajan, Mathangi; Torralba, Manolito] J Craig Venter Inst, Rockville, MD 20850 USA; [Pop, Mihai; Koren, Sergey; Liu, Bo; Sommer, Daniel D.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Pop, Mihai; Koren, Sergey; Liu, Bo; Sommer, Daniel D.] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Creasy, Heather H.; Giglio, Michelle G.; Abolude, Olukemi O.; Arze, Cesar A.; Cantarel, Brandi L.; Crabtree, Jonathan; Davidovics, Noam J.; Felix, Victor M.; Jordan, Catherine; Mahurkar, Anup A.; Ravel, Jacques; Schriml, Lynn; White, James R.; White, Owen] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Huttenhower, Curtis; Sathirapongsasuti, J. Fah; Segata, Nicola] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Huttenhower, Curtis; Gevers, Dirk; Earl, Ashlee M.; FitzGerald, Michael G.; Wortman, Jennifer R.; Young, Sarah K.; Zeng, Qiandong; Alm, Eric J.; Alvarado, Lucia; Anderson, Scott; Arachchi, Harindra M.; Bloom, Toby; Ciulla, Dawn M.; Erlich, Rachel L.; Feldgarden, Michael; Fisher, Sheila; Friedrich, Dennis C.; Giannoukos, Georgia; Goldberg, Jonathan M.; Griggs, Allison; Gujja, Sharvari; Haas, Brian J.; Hepburn, Theresa A.; Howarth, Clinton; Huang, Katherine H.; Jiang, Huaiyang; Kells, Cristyn; McDonald, Daniel; Mehta, Teena; Nusbaum, Chad; Pearson, Matthew; Priest, Margaret E.; Russ, Carsten; Shenoy, Narmada; Sykes, Sean M.; Tabbaa, Diana G.; Wang, Zhengyuan; Ward, Doyle V.; Wilczek-Boney, Katarzyna; Yandava, Chandri; Zucker, Jeremy D.; Birren, Bruce W.] Broad Inst & Harvard, Cambridge, MA 02142 USA; [Petrosino, Joseph F.; Muzny, Donna M.; Worley, Kim C.; Buhay, Christian J.; Ding, Yan; Dugan, Shannon P.; Holder, Michael E.; Joshi, Vandita; Kovar, Christie L.; Lee, Sandra L.; Lennon, Niall; Lewis, Lora; Liu, Yue; Newsham, Irene; Qin, Xiang; Reid, Jeffrey G.; Wu, Yuan Qing; Zhang, Lan; Zhu, Yiming; Gibbs, Richard A.; Highlander, Sarah K.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Abubucker, Sahar; Chinwalla, Asif T.; Fulton, Robert S.; Hallsworth-Pepin, Kymberlie; Lobos, Elizabeth A.; Magrini, Vincent; Martin, John C.; Mitreva, Makedonka; Sodergren, Erica J.; Wollam, Aye M.; Appelbaum, Elizabeth; Bhonagiri, Veena; Chen, Lei; Clifton, Sandra W.; Delehaunty, Kimberley D.; Deych, Elena; Dooling, David J.; Farmer, Candace N.; Fronick, Catrina C.; Fulton, Lucinda L.; Herter, Brandi; Kota, Karthik C.; Mardis, Elaine R.; Mihindukulasuriya, Kathie A.; Minx, Patrick J.; O'Laughlin, Michelle; Pagani, Ioanna; Pohl, Craig; Tomlinson, Chad M.; Walker, Jason; Warren, Wesley; Wylie, Kristine M.; Wylie, Todd; Ye, Liang; Zhou, Yanjiao; Weinstock, George M.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Versalovic, James; Gao, Hongyu] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Versalovic, James] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; [Aagaard, Kjersti M.] Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA; [Allen-Vercoe, Emma] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Alm, Eric J.] MIT, Dept Civil & Environm Engn, Parsons Lab, Cambridge, MA 02139 USA; [Andersen, Gary L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Ctr Environm Biotechnol, Berkeley, CA 94720 USA; [Armitage, Gary] Univ Calif San Francisco, Sch Dent, San Francisco, CA 94143 USA; [Baker, Carl C.; Deal, Carolyn] Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, NIH, Bethesda, MD 20892 USA; [Begg, Lisa] NIH, Off Res Womens Hlth, Bethesda, MD 20892 USA; [Belachew, Tsegahiwot; Campbell, Joseph L.; Di Francesco, Valentina; Giblin, Christina; Giovanni, Maria Y.] NIAID, NIH, Bethesda, MD 20892 USA; [Blaser, Martin J.] NYU, Langone Med Ctr, Dept Med, New York, NY 10016 USA; [Bonazzi, Vivien R.; Campbell, Joseph L.; Chhibba, Shaila; McEwen, Jean; Peterson, Jane; Proctor, Lita M.; Schloss, Jeffery A.; Wang, Lu; Wellington, Christopher; Wetterstrand, Kris A.] NHGRI, NIH, Bethesda, MD 20892 USA; [Brooks, Paul] Virginia Commonwealth Univ, Dept Stat Sci & Operat Res, Richmond, VA 23284 USA; [Brooks, Paul; Buck, GregoryA.; Rivera, Maria C.; Sheth, Nihar U.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA; [Buck, GregoryA.; Rivera, Maria C.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Canon, Shane R.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Technol Integrat Grp, Natl Energy Res Sci Comp, Berkeley, CA 94720 USA; [Chain, Patrick S.; Lo, Chien-Chi; Scholz, Matthew] Los Alamos Natl Lab, Genome Sci Grp, Biosci Div, HRL, Los Alamos, NM 87545 USA; [Chain, Patrick S.; Kyrpides, Nikos C.; Liolios, Konstantinos; Markowitz, Victor M.; Mavrommatis, Konstantinos] Joint Genome Inst, Walnut Creek, CA 94598 USA; [Chen, I-Min A.; Chu, Ken; Markowitz, Victor M.; Palaniappan, Krishna] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Data Management & Technol Ctr, Computat Res Div, Berkeley, CA 94720 USA; [Clemente, Jose C.; Knight, Rob; Lozupone, Catherine A.; McDonald, Daniel] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Cutting, Mary A.; Hamilton, Holli A.; Harris, Emily L.; Lunsford, R. Dwayne; McInnes, Pamela] NIDCR, NIH, Bethesda, MD 20892 USA; [Davis, Catherine C.] Procter & Gamble Co, FemCare Prod Safety & Regulatory Affairs, Cincinnati, OH 45224 USA; [DeSantis, Todd Z.] Second Genome Inc, San Bruno, CA 94066 USA; [Dewhisrst, Floyd E.; Izard, Jacques; Lemon, Katherine P.] Forsyth Inst, Dept Mol Genet, Cambridge, MA 02142 USA; [Dewhisrst, Floyd E.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Dunne, W. Michael, Jr.; Watson, Mark A.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Dunne, W. Michael, Jr.] bioMerieux Inc, Durham, NC 27712 USA; [Edgar, Robert C.] Drive5 Com, Tiburon, CA 94920 USA; [Farrell, Ruth M.; Sharp, Richard R.] Cleveland Clin, Ctr Bioeth Human & Spiritual Care, Cleveland, OH 44195 USA; [Faust, Karoline; Raes, Jeroen] VIB, Dept Biol Struct, B-1050 Brussels, Belgium; [Faust, Karoline; Raes, Jeroen] Vrije Univ Brussel, Dept Appl Biol Sci DBIT, B-1050 Brussels, Belgium; [Fodor, Anthony A.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA; [Forney, Larry] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA; [Friedman, Jonathan; Smillie, Chris S.] MIT, Parsons Lab, Cambridge, MA 02139 USA; [Garcia, Nathalia] St Louis Univ, Ctr Adv Dent Educ, St Louis, MO 63104 USA; [Gonzalez, Antonio; Knights, Dan] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Hoffmann, Diane E.] Univ Maryland, Francis King Carey Sch Law, Baltimore, MD 21201 USA; [Huse, Susan M.] Josephine Bay Paul Ctr, Marine Biol Lab, Woods Hole, MA 02543 USA; [Jansson, Janet K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Ecol, Div Earth Sci, Berkeley, CA 94720 USA; [Katancik, JamesA.] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Periodont, Houston, TX 77030 USA; [Kelley, Scott T.; Rodriguez-Mueller, Beltran] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Kinder-Haake, Susan] Univ Calif Los Angeles, Sch Dent, Div Associated Clin Specialties, Los Angeles, CA 90095 USA; [Kinder-Haake, Susan] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90095 USA; [King, Nicholas B.] McGill Univ, Fac Med, Montreal, PQ H3A 1X1, Canada; [Knight, Rob] Howard Hughes Med Inst, Boulder, CO 80309 USA; [Kong, Heidi H.] NCI, NIH, Bethesda, MD 20892 USA; [Koren, Omry; Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY USA; [La Rosa, Patricio S.; Shannon, William D.] Washington Univ, Sch Med, Dept Med, Div Gen Med Sci, St Louis, MO 63110 USA; [Lemon, Katherine P.; Ravel, Jacques] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Infect Dis, Boston, MA 02115 USA; [Lewis, Cecil M.; Rho, Mina; Spicer, Paul] Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; [Madden, Tessa] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Mannon, Peter J.] Univ Alabama Birmingham, Div Gastroenterol & Hepatol, Birmingham, AL 35294 USA; [Podar, Mircea; Vishnivetskaya, Tatiana A.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Pollard, Katherine S.; Sharpton, Thomas J.; Truty, Rebecca M.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Ye, Yuzhen] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Rhodes, Rosamond] Mt Sinai Sch Med, New York, NY 10029 USA; [Riehle, Kevin P.] Baylor Coll Med Mol & Human Genet, Houston, TX 77030 USA; [Sankar, Pamela] Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; [Sankar, Pamela] Univ Penn, Dept Med Eth, Philadelphia, PA 19104 USA; [Schloss, Patrick D.; Schubert, Alyxandria M.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Schmidt, Thomas M.] Michigan State Univ, Dept Microbiol, E Lansing, MI 48824 USA; [Simone, Gina A.] EMMES Corp, Rockville, MD 20850 USA; [Sobel, Jack D.] Wayne State Univ, Sch Med, Harper Univ Hosp, Detroit, MI 48201 USA; [Treangen, Todd J.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Badger, Jonathan H.; Yooseph, Shibu] J Craig Venter Inst, San Diego, CA 92121 USA; [Zoloth, Laurie] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Conlan, Sean; Segre, Julia A.] NHGRI, NIH, Genet & Mol Biol Branch, Bethesda, MD 20892 USA	J. Craig Venter Institute; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Baylor College of Medicine; Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Guelph; Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); New York University; NYU Langone Medical Center; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; HRL Laboratories; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Colorado System; University of Colorado Boulder; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Procter & Gamble; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; Washington University (WUSTL); bioMerieux; Cleveland Clinic Foundation; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of North Carolina; University of North Carolina Charlotte; Idaho; University of Idaho; Massachusetts Institute of Technology (MIT); Saint Louis University; University of Colorado System; University of Colorado Boulder; University System of Maryland; University of Maryland Baltimore; Marine Biological Laboratory - Woods Hole; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Texas System; University of Texas Health Science Center Houston; California State University System; San Diego State University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; McGill University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University; Washington University (WUSTL); Harvard University; Boston Children's Hospital; Harvard Medical School; University of Oklahoma System; University of Oklahoma - Norman; Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System of Maryland; University of Maryland Baltimore; Indiana University System; Indiana University Bloomington; Icahn School of Medicine at Mount Sinai; Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Michigan System; University of Michigan; Michigan State University; Emmes Corporation; Wayne State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; J. Craig Venter Institute; Northwestern University; Feinberg School of Medicine; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Methe, BA (corresponding author), J Craig Venter Inst, 9704 Med Ctr Dr, Rockville, MD 20850 USA.		Bihan, Monika/C-7469-2014; Gevers, Dirk/C-1451-2009; Weinstock, George M/C-6314-2013; Friedman, Jonathan/I-6930-2019; Walker, Jason/A-9702-2013; raes, jeroen/D-7835-2018; Lemon, Katherine P/AGS-8572-2022; Cantarel, Brandi/ABF-5756-2020; Ravel, Jacques/D-2530-2009; Schriml, Lynn/AFO-9472-2022; Kong, Heidi H/L-4856-2018; Wilson, Richard K./AAF-4139-2019; Magrini, Vincent/AAT-5830-2020; Koren, Omry/A-5222-2016; Knight, Rob/D-1299-2010; Petrosino, Joseph F./AAF-1621-2019; Rivera, Maria/GYU-2150-2022; Conlan, Sean/B-4401-2008; Lozupone, Catherine/AAD-9317-2020; Zeng, Qiandong/AAF-3305-2019; Chain, Patrick/O-4140-2019; Pagani, Ioanna/E-7390-2012; Faust, Karoline/P-7578-2017; Pop, Mihai/A-7987-2013; Jansson, Janet/H-5478-2018; wang, zhengyuan/HGA-0435-2022; Zucker, Jeremy/M-3643-2016; Segata, Nicola/AAB-2980-2019; Podar, Mircea/B-7299-2012; Gonzalez, Antonio/A-6421-2018; Mardis, Elaine/W-2202-2019; Ley, Ruth E/M-8542-2014; Kyrpides, Nikos C./A-6305-2014; Koren, Sergey/AAE-8314-2019; Andersen, Gary/G-2792-2015; Wang, Zhengyuan/GWV-6069-2022; chain, patrick/B-9777-2013; Vishnivetskaya, Tatiana/A-4488-2008; Segata, Nicola/K-7240-2016	Weinstock, George M/0000-0002-2997-4592; Friedman, Jonathan/0000-0001-8476-8030; Walker, Jason/0000-0001-7547-5789; raes, jeroen/0000-0002-1337-041X; Cantarel, Brandi/0000-0003-4126-4478; Kong, Heidi H/0000-0003-4424-064X; Wilson, Richard K./0000-0002-1992-1358; Magrini, Vincent/0000-0002-2019-4872; Koren, Omry/0000-0002-7738-1337; Conlan, Sean/0000-0001-6848-3465; Chain, Patrick/0000-0003-3949-3634; Faust, Karoline/0000-0001-7129-2803; Pop, Mihai/0000-0001-9617-5304; Jansson, Janet/0000-0002-5487-4315; wang, zhengyuan/0000-0002-8447-9674; Zucker, Jeremy/0000-0002-7276-9009; Podar, Mircea/0000-0003-2776-0205; Ley, Ruth E/0000-0002-9087-1672; Kyrpides, Nikos C./0000-0002-6131-0462; Andersen, Gary/0000-0002-1618-9827; Vishnivetskaya, Tatiana/0000-0002-0660-023X; Schriml, Lynn/0000-0001-8910-9851; Schloss, Jeffery/0000-0003-4646-3652; Sharpton, Thomas/0000-0002-5996-7764; Schmidt, Thomas/0000-0002-8209-6055; Smillie, Chris/0000-0002-7606-3433; Dewhirst, Floyd E./0000-0003-4427-7928; Yooseph, Shibu/0000-0001-5581-5002; Koren, Sergey/0000-0002-1472-8962; Schloss, Patrick/0000-0002-6935-4275; ross, matthew/0000-0002-7621-8829; King, Nicholas/0000-0002-2093-3380; Madden, Tessa/0000-0001-9455-1943; Mihindukulasuriya, Kathie/0000-0001-9372-3758; Huttenhower, Curtis/0000-0002-1110-0096; Knight, Rob/0000-0002-0975-9019; Wortman, Jennifer/0000-0002-8713-1227; Earl, Ashlee/0000-0001-7857-9145; Segata, Nicola/0000-0002-1583-5794; Izard, Jacques/0000-0002-5904-5436; Miller, Jason/0000-0002-6912-2925; Ravel, Jacques/0000-0002-0851-2233; Bonazzi, Vivien/0000-0002-7359-9072; Chinwalla, Asif/0000-0001-7831-3996; Garcia, M. Nathalia/0000-0003-3685-027X; Palaniappan, Krishnaveni/0000-0003-4484-7505; Arze, Cesar/0000-0002-3606-4183; Mitreva, Makedonka/0000-0001-9572-3436; Sathirapongsasuti, Fah/0000-0002-8157-3665; Worley, Kim/0000-0002-0282-1000; Riehle, Kevin/0000-0003-4888-2404; Mavrommatis, Konstantinos/0000-0003-4549-385X; Sykes, Sean/0000-0001-8344-5176	NIH [U54HG004969, U54HG003273, U54HG004973, U54HG003067, U54AI084844, N01AI30071, U54HG004968, U01HG004866, U54HG003079, R01HG005969, R01HG004872, R01HG004885, R01HG005975, R01HG004908, R01HG004900, R01HG005171, R01HG004853, R01HG004856, R01HG004877, R01HG005172, R01HG004857, R01HG004906, R21HG005811, UH2AI083263, UH3AI083263, UH2AR057506, UH3DK083993, UH2DK083990, UH2AR057504, UH3AR057504, DP2OD001500, N01HG62088, U01DE016937, RC1DE020298, R01DE021574, R21CA139193, P30DE020751, T32AI007528]; Army Research Office [W911NF-11-1-0473]; National Science Foundation [NSF DBI-1053486, NSF IIS-0812111]; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; LANL Laboratory [20100034DR]; US Defense Threat Reduction Agency [B104153I, B084531I]; Research Foundation - Flanders (FWO); Gordon & Betty Moore Foundation from the J. David Gladstone Institutes; Rackham Graduate School; Crohn's and Colitis Foundation of Canada; IBM; NATIONAL CANCER INSTITUTE [ZIABC010938, R21CA139193] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, R01HG005171, U54HG003273, U54HG003079, R01HG004853, U01HG004866, R01HG005975, R01HG004872, R01HG004900, R01HG004906, R01HG005172, R01HG004856, U54HG004969, U54HG004973, R01HG004908, U54HG004968, R01HG005969, R01HG004877, R01HG000485, R01HG004885, R01HG004857, R21HG005811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UH2AI083263, UH3AI083263, U54AI084844, T32AI007528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR057506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021574, R37DE016937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE016937, P30DE020751, RC1DE020298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH3DK083993, UH2DK083990] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001500] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1053486] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; National Science Foundation(National Science Foundation (NSF)); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); LANL Laboratory; US Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Research Foundation - Flanders (FWO)(FWO); Gordon & Betty Moore Foundation from the J. David Gladstone Institutes; Rackham Graduate School; Crohn's and Colitis Foundation of Canada; IBM(International Business Machines (IBM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The consortium would like to thank our external scientific advisory board: R. Blumberg, J. Davies, R. Holt, P. Ossorio, F. Ouellette, G. Schoolnik and A. Williamson. We would also like to thank our collaborators throughout the International Human Microbiome Consortium, particularly the investigators of the MetaHIT project, for advancing human microbiome research. Data repository management was provided by the NCBI and the Intramural Research Program of the NIH National Library of Medicine. We especially appreciate the generous participation of the individuals from the St Louis, Missouri, and Houston, Texas areas who made this study possible. This research was supported in part by NIH grants U54HG004969 to B. W. B.; U54HG003273 to R. A. G.; U54HG004973 to R. A. G., S. K. H. and J. F. P.; U54HG003067 to E. S. Lander.; U54AI084844 to K.E.N.; N01AI30071 to R. L. Strausberg; U54HG004968 to G. M. W.; U01HG004866 to O.W.; U54HG003079 to R. K. W.; R01HG005969 to C. H.; R01HG004872 to R. K.; R01HG004885 to M. P.; R01HG005975 to P. D. S.; R01HG004908 to Y.Y.; R01HG004900 to M. K. Cho and P. Sankar; R01HG005171 to D. E. H.; R01HG004853 to A. L. M.; R01HG004856 to R. R.; R01HG004877 to R. R. S. and R. M. F.; R01HG005172 to P. Spicer; R01HG004857 to M. P.; R01HG004906 to T. M. S.; R21HG005811 to E.A.-V.; G. A. B. was supported by UH2AI083263 and UH3AI083263 (G. A. B., C. N. Cornelissen, L. K. Eaves and J. F. Strauss); M. J. B. was supported by UH2AR057506, S. M. H. was supported by UH3DK083993 (V. B. Young, E. B. Chang, F. Meyer, T. M. S., M. L. Sogin, J. M. Tiedje); K. P. R. was supported by UH2DK083990 (J. V.); J. A. S. and H. H. K. were supported by UH2AR057504 and UH3AR057504 (J. A. S.); DP2OD001500 to K. M. A.; N01HG62088 to the Coriell Institute for Medical Research; U01DE016937 to F. E. D.; S.K.-H. was supported by RC1DE020298and R01DE021574 (S.K.-H. and H. Li); J. I. was supported by R21CA139193 (J. I. and D. S. Michaud); K. P. L. was supported by P30DE020751 (D. J. Smith); Army Research Office grant W911NF-11-1-0473 to C. H.; National Science Foundation grants NSF DBI-1053486 to C. H. and NSF IIS-0812111 to M. P.; The Office of Science of the US Department of Energy under contract no. DE-AC02-05CH11231 for P. S. C.; LANL Laboratory-Directed Research and Development grant 20100034DR and the US Defense Threat Reduction Agency grants B104153I and B084531I to P. S. C.; Research Foundation - Flanders (FWO) grant to K. F. and J. Raes; R. K. is a Howard Hughes Medical Institute (HHMI) Early Career Scientist; Gordon & Betty Moore Foundation funding and institutional funding from the J. David Gladstone Institutes to K. S. P.; A. M. S. was supported by fellowships provided by the Rackham Graduate School and the NIH Molecular Mechanisms in Microbial Pathogenesis Training Grant T32AI007528; a Crohn's and Colitis Foundation of Canada Grant in Aid of Research to E.A.-V.; 2010 IBM Faculty Award to K. C. W. Analysis of the HMP data was performed using National Energy Research Scientific Computing resources; the BluBioU Computational Resource at Rice University.	Abubucker S., 2012, PLOS COMPUT BIOL; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Goll J., 2012, PLOS ONE; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jumpstart Consortium Human Microbiome Project Data Generation Working Group, 2012, PLOS ONE; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Martin J. S., 2012, PLOS ONE; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09	16	1546	1611	11	419	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					215	221		10.1038/nature11209	http://dx.doi.org/10.1038/nature11209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699610	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000305189000026
J	Kumar, N; Yadav, S; Reddy, V; Robert, F				Kumar, Nilay; Yadav, Swetha; Reddy, Vishnu; Robert, Francisco			Leukaemia cutis	LANCET			English	Editorial Material									[Kumar, Nilay] Univ Alabama Birmingham, Dept Internal Med, Birmingham, AL 35294 USA; [Reddy, Vishnu] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Yadav, Swetha; Robert, Francisco] Univ Alabama Birmingham, Dept Haematol Oncol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kumar, N (corresponding author), Univ Alabama Birmingham, Dept Internal Med, Birmingham, AL 35294 USA.	nkumar@uab.edu		Reddy, Vishnu/0000-0001-5474-3289					0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2012	380	9848					1179	1179		10.1016/S0140-6736(12)60352-3	http://dx.doi.org/10.1016/S0140-6736(12)60352-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	012SD	22704804				2022-12-28	WOS:000309255900035
J	Sandberg, T; Skoog, G; Hermansson, AB; Kahlmeter, G; Kuylenstierna, N; Lannergard, A; Otto, G; Settergren, B; Ekman, GS				Sandberg, Torsten; Skoog, Gunilla; Hermansson, Anna Bornefalk; Kahlmeter, Gunnar; Kuylenstierna, Nils; Lannergard, Anders; Otto, Gisela; Settergren, Bo; Ekman, Gunilla Stridh			Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial	LANCET			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE; RESISTANCE; PIVAMPICILLIN; NORFLOXACIN; COMBINATION	Background Acute pyelonephritis is a common infection in adult women, but there is a paucity of controlled trials of its treatment and the optimum duration of antibiotic treatment has not been properly defined. We compared the efficacy of ciprofloxacin for 7 days and 14 days in women with community-acquired acute pyelonephritis. Methods In a prospective, non-inferiority trial undertaken at 21 centres of infectious diseases in Sweden, women (aged >= 18 years) who were not pregnant and had a presumptive diagnosis of acute pyelonephritis were randomly assigned to oral treatment with ciprofloxacin 500 mg twice daily for 7 days or 14 days. The first week was open label. A computer-generated randomisation list in block sizes of two was used for treatment allocation in a 1: 1 ratio. The study was double-blind and placebo-controlled during the second week of treatment, which was either continuation of ciprofloxacin 500 mg or placebo tablets twice daily according to the randomisation code. Patients, carers, site investigators, and trial coordinating centre staff were masked to group assignment. The primary endpoint was the clinical and bacteriological outcome 10-14 days after completion of treatment with active drug. Analysis was by per protocol. This trial is registered with EudraCT, number 2005-004992-39, and ClinicalTrials.gov, number ISRCTN73338924. Findings 126 of 248 patients were randomly assigned to 7 days and 122 to 14 days of ciprofloxacin. 73 and 83 patients, respectively, were analysed. Short-term clinical cure occurred in 71 (97%) patients treated with ciprofloxacin for 7 days and 80 (96%) treated for 14 days (difference -0.9%; 90% CI -6.5 to 4.8; p=0.004; non-inferiority test). Cumulative efficacy at long-term follow-up was 93% in each group (68 of 73 vs 78 of 84; -0.3%; -7.4 to 7.2; p=0.015). Both regimens were well tolerated. Two patients discontinued ciprofloxacin because of myalgia with 7 days of treatment and itching exanthema with 14 days. Four (5%) of 86 patients assigned to 7 days of treatment who complied with study criteria and six (6%) of 93 assigned to 14 days reported an adverse event after the first week of treatment that was possibly or probably related to the study drug. In those assigned to 7 days, no patient had mucosal candida infection after the first week versus five treated for 14 days (p=0.036). Interpretation Our results show that acute pyelonephritis in women, including older women and those with a more severe infection, can be treated successfully and safely with oral ciprofloxacin for 7 days. Short courses of antibiotics should be favoured in an era of increasing resistance.	[Sandberg, Torsten] Sahlgrens Univ Hosp, Dept Infect Dis, SE-41685 Gothenburg, Sweden; [Skoog, Gunilla; Ekman, Gunilla Stridh] Swedish Inst Infect Dis Control, Solna, Sweden; [Hermansson, Anna Bornefalk] Univ Uppsala Hosp, Uppsala Clin Res Ctr, Uppsala, Sweden; [Kahlmeter, Gunnar] Cent Hosp Vaxjo, Dept Clin Microbiol, Vaxjo, Sweden; [Kuylenstierna, Nils] Cent Hosp Falun, Dept Infect Dis, Falun, Sweden; [Lannergard, Anders] Uppsala Univ, Dept Infect Dis, Uppsala, Sweden; [Otto, Gisela] Skane Univ Hosp, Dept Infect Dis, Lund, Sweden; [Settergren, Bo] Cent Hosp Kristianstad, Dept Infect Dis, Kristianstad, Sweden	Sahlgrenska University Hospital; Swedish Institute for Infectious Disease Control; Uppsala University; Uppsala University Hospital; Falun Hospital; Uppsala University; Lund University; Skane University Hospital	Sandberg, T (corresponding author), Sahlgrens Univ Hosp, Dept Infect Dis, SE-41685 Gothenburg, Sweden.	torsten.sandberg@infect.gu.se		Skoog Stahlgren, Gunilla/0000-0002-0248-3048; Bornefalk-Hermansson, Anna/0000-0001-9934-8485	Swedish Strategic Programme against Antibiotic Resistance (Strama); Strama, Swedish Institute for Infectious Disease Control, Solna, Sweden	Swedish Strategic Programme against Antibiotic Resistance (Strama); Strama, Swedish Institute for Infectious Disease Control, Solna, Sweden	Swedish Strategic Programme against Antibiotic Resistance (Strama).; This trial was supported by a grant from the Strama, Swedish Institute for Infectious Disease Control, Solna, Sweden. We thank Carina Alvfors and Eva Svensson at Uppsala Clinical Research Center for help with monitoring and data management, and Bayer AB, Solna, Sweden for providing study drugs. Presented in part at the 20th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, April 10-13, 2010.	Cronberg S, 2001, SCAND J INFECT DIS, V33, P339, DOI 10.1080/003655401750173922; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; EDLUND C, 1988, INFECTION, V16, P8, DOI 10.1007/BF01646921; ERIKSSON S, 1986, SCAND J INFECT DIS, V18, P431, DOI 10.3109/00365548609032360; Guidos RJ, 2011, CLIN INFECT DIS, V52, pS397, DOI 10.1093/cid/cir153; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; JERNELIUS H, 1988, ACTA MED SCAND, V223, P469; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Livermore DM, 2009, J ANTIMICROB CHEMOTH, V64, P29, DOI 10.1093/jac/dkp255; Rice LB, 2008, CLIN INFECT DIS, V46, P491, DOI 10.1086/526535; Sandberg T, 1997, SCAND J INFECT DIS, V29, P175, DOI 10.3109/00365549709035880; SANDBERG T, 1990, EUR J CLIN MICROBIOL, V9, P317, DOI 10.1007/BF01973737; STAMM WE, 1987, ANN INTERN MED, V106, P341, DOI 10.7326/0003-4819-106-3-341; SWEDRES, 2010, REP SWED ANT UT RES; Talan DA, 2000, JAMA-J AM MED ASSOC, V283, P1583, DOI 10.1001/jama.283.12.1583; TARTAGLIONE TA, 1988, ANTIMICROB AGENTS CH, V32, P1640, DOI 10.1128/AAC.32.11.1640; van Nieuwkoop C, 2010, J INFECTION, V60, P114, DOI 10.1016/j.jinf.2009.11.008; WINBERG J, 1993, PEDIATR NEPHROL, V7, P509, DOI 10.1007/BF00852528	18	107	109	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2012	380	9840					484	490		10.1016/S0140-6736(12)60608-4	http://dx.doi.org/10.1016/S0140-6736(12)60608-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	983GY	22726802				2022-12-28	WOS:000307109000029
J	Davalos, A; Alvarez-Sabin, J; Castillo, J; Diez-Tejedor, E; Ferro, J; Martinez-Vila, E; Serena, J; Segura, T; Cruz, VT; Masjuan, J; Cobo, E; Secades, JJ				Davalos, Antoni; Alvarez-Sabin, Jose; Castillo, Jose; Diez-Tejedor, Exuperio; Ferro, Jose; Martinez-Vila, Eduardo; Serena, Joaquin; Segura, Tomas; Cruz, Vitor T.; Masjuan, Jaime; Cobo, Erik; Secades, Julio J.		Int Citicoline Trial AcUte Stroke	Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)	LANCET			English	Article							CLINICAL-TRIALS; INTRAVENOUS ALTEPLASE; EFFICACY TRIAL; EPIDEMIOLOGY; PLASTICITY; ECASS	Background Citicoline is approved in some countries for the treatment of acute ischaemic stroke. The drug has shown some evidence of efficacy in a pooled analysis. We sought to confirm the efficacy of citicoline in a larger trial. Methods We undertook a randomised, placebo-controlled, sequential trial in patients with moderate-to-severe acute ischaemic stroke admitted at university hospitals in Germany, Portugal, and Spain. Using a centralised minimisation process, patients were randomly assigned in a 1: 1 ratio to receive citicoline or placebo within 24 h after the onset of symptoms (1000 mg every 12 h intravenously during the first 3 days and orally thereafter for a total of 6 weeks [2x500 mg oral tablets given every 12 h]). All study participants were masked. The primary outcome was recovery at 90 days measured by a global test combining three measures of success: National Institutes of Health Stroke Scale <= 1, modified Rankin score <= 1, and Barthel Index >= 95. Safety endpoints included symptomatic intracranial haemorrhage in patients treated with recombinant tissue plasminogen activator, neurological deterioration, and mortality. This trial is registered, NCT00331890. Results 2298 patients were enrolled into the study from Nov 26, 2006, to Oct 27, 2011. 37 centres in Spain, 11 in Portugal, and 11 in Germany recruited patients. Of the 2298 patients who gave informed consent and underwent randomisation, 1148 were assigned to citicoline and 1150 to placebo. The trial was stopped for futility at the third interim analysis on the basis of complete data from 2078 patients. The final randomised analysis was based on data for 2298 patients: 1148 in citicoline group and 1150 in placebo group. Global recovery was similar in both groups (odds ratio 1.03, 95% CI 0.86-1.25; p=0.364). No significant differences were reported in the safety variables nor in the rate of adverse events. Interpretation Under the circumstances of the ICTUS trial, citicoline is not efficacious in the treatment of moderate-to-severe acute ischaemic stroke.	[Davalos, Antoni] Hosp Badalona Germans Trias & Pujol, Badalona, Spain; [Alvarez-Sabin, Jose] Hosp Univ Vall dHebron, Barcelona, Spain; [Castillo, Jose] Hosp Clin Univ Santiago, Santiago De Compostela, Spain; [Diez-Tejedor, Exuperio] Hosp Univ La Paz, idiPAZ, Madrid, Spain; [Ferro, Jose] Hosp Santa Maria, Lisbon, Portugal; [Martinez-Vila, Eduardo] Univ Navarra Clin, Pamplona, Spain; [Serena, Joaquin] Hosp Univ Girona Dr Josep Trueta, Girona, Spain; [Segura, Tomas] Hosp Gen Albacete, Albacete, Spain; [Cruz, Vitor T.] Hosp Sao Sebastiao, Santa Maria Feira, Portugal; [Masjuan, Jaime] Hosp Univ Ramon Y Cajal, Madrid, Spain; [Cobo, Erik] Univ Politecn Cataluna, Barcelona, Spain; [Secades, Julio J.] Ferrer Grp, Barcelona, Spain	Hospital Germans Trias i Pujol; Hospital Universitari Vall d'Hebron; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitario La Paz; Universidade de Lisboa; Hospital Santa Maria; University of Navarra; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Hospital Universitario Ramon y Cajal; Universitat Politecnica de Catalunya	Davalos, A (corresponding author), Hosp Badalona Germans Trias & Pujol, Dept Neurosci, Crta Canyet S-N, Barcelona 08916, Spain.	adavalos.germanstrias@gencat.cat	Segura, Tomas/K-5701-2019; Trejo, Jose/L-7505-2014; Arboix, Adrià/E-2067-2018; masjuan, Jaime/DIW-6614-2022; Cobo, Erik/H-6230-2011; Azevedo, Elsa I/C-1060-2014; Ferro, José/ABA-1779-2021; Fuentes, Blanca/I-2114-2019; Perona-Moratalla, Ana-Belén/AAB-6141-2019; Cruz, Vítor Tedim/AAM-3014-2020; Egido, Jose A/E-3837-2015; Montaner, Joan/D-3063-2015; Ayo-Martin, Oscar/Q-8541-2017	Segura, Tomas/0000-0003-3625-0987; Trejo, Jose/0000-0001-9591-8452; Arboix, Adrià/0000-0002-8512-7881; masjuan, Jaime/0000-0003-1329-0943; Cobo, Erik/0000-0002-3534-5602; Azevedo, Elsa I/0000-0003-3731-4508; Fuentes, Blanca/0000-0002-0363-862X; Perona-Moratalla, Ana-Belén/0000-0002-6804-331X; Cruz, Vítor Tedim/0000-0002-5333-4771; Egido, Jose A/0000-0003-1698-9127; Montaner, Joan/0000-0003-4845-2279; Ferro, Jose/0000-0002-2343-9097; Serrano-Heras, Gemma/0000-0001-9368-4832; Diez Tejedor, Exuperio/0000-0003-2295-1707; Alvarez-Sabin, Jose/0000-0002-8054-9209; Martinez-Vila, Eduardo/0000-0003-3422-4726; Ayo-Martin, Oscar/0000-0002-3632-1696; Castellanos, Maria del Mar/0000-0003-3116-1352; Ringleb, Peter/0000-0002-5473-8671; Marti-Fabregas, Joan/0000-0001-9229-8649; Castillo, Jose/0000-0002-6685-3001; Perez de la Ossa, Natalia/0000-0002-6063-211X; Rodriguez Campello, Ana/0000-0001-8621-1420; Ximenez-Carrillo Rico, Alvaro/0000-0002-4195-7752	Ferrer Grupo; trial steering committee	Ferrer Grupo; trial steering committee	Ferrer Grupo.; AD and EC have received consultant fees and honoraria as chairman and statistician, respectively, of the trial steering committee; and honoraria for giving lectures for Grupo Ferrer. JAS, JC, ED-T, JF, and EM-V have received consultant fees and honoraria from Ferrer Grupo as members of the trial steering committee. JAS, ED-T, EM-V, JS, TS, and JM have received honoraria for giving lectures for Ferrer Grupo. VTC has received honoraria and travel grants from Ferrer Grupo for undertaking the ICTUS trial. JJS is a full-time employee of Ferrer Grupo. The authors did not receive any payment for writing or contributing to the report.	Bolland K, 2009, PHARM STAT, V8, P136, DOI 10.1002/pst.344; Clark WM, 1999, STROKE, V30, P2592, DOI 10.1161/01.STR.30.12.2592; Clark WM, 1997, NEUROLOGY, V49, P671, DOI 10.1212/WNL.49.3.671; Clark WM, 2001, NEUROLOGY, V57, P1595, DOI 10.1212/WNL.57.9.1595; Cobo E, 2010, STROKE, V41, pE143, DOI 10.1161/STROKEAHA.109.567404; Davalos A, 2002, STROKE, V33, P2850, DOI 10.1161/01.STR.0000038691.03334.71; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Gutierrez-Fernandez M, 2012, NEUROCHEM INT, V60, P310, DOI 10.1016/j.neuint.2011.12.015; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Labiche Lise A, 2004, NeuroRx, V1, P46, DOI 10.1007/BF03206567; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; Rother J, 2008, STROKE, V39, P523, DOI 10.1161/STROKEAHA.107.494799; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; Saver Jeffrey L, 2010, Rev Neurol Dis, V7 Suppl 1, pS14; Saver Jeffrey L, 2008, Rev Neurol Dis, V5, P167; Secades JJ, 2011, REV NEUROLOGIA, V52, pS1, DOI 10.33588/rn.52S02.2010787; Stroke Study Group National Institute of Neurological Disorders, 1995, NEW ENGL J MED, V333, P1581, DOI [10.1056/NEJM199512143332401, DOI 10.1056/NEJM199512143332401]; TAZAKI Y, 1988, STROKE, V19, P211, DOI 10.1161/01.STR.19.2.211; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Warach S, 2000, ANN NEUROL, V48, P713, DOI 10.1002/1531-8249(200011)48:5<713::AID-ANA4>3.3.CO;2-R; Whitehead J, 2011, STAT METHODS MED RES, V20, P635, DOI 10.1177/0962280210379036; Whitehead J, 2010, STAT MED, V29, P521, DOI 10.1002/sim.3822	24	152	176	0	53	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 28	2012	380	9839					349	357		10.1016/S0140-6736(12)60813-7	http://dx.doi.org/10.1016/S0140-6736(12)60813-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979TN	22691567	Green Submitted			2022-12-28	WOS:000306842800032
J	Foldes, P; Cuzin, B; Andro, A				Foldes, Pierre; Cuzin, Beatrice; Andro, Armelle			Reconstructive surgery after female genital mutilation: a prospective cohort study	LANCET			English	Article							6 AFRICAN COUNTRIES; SURGICAL INNOVATION; SEXUAL FUNCTION; DEFIBULATION; CLITORIS	Background Women who have undergone female genital mutilation rarely have access to the reconstructive surgery that is now available. Our objective was to assess the immediate and long-term outcomes of this surgery. Methods Between 1998 and 2009, we included consecutive patients with female genital mutilation aged 18 years or older who had consulted a urologist at Poissy-St Germain Hospital, France. We used the WHO classification to prospectively include patients with type II or type III mutilation. The skin covering the stump was resected to reveal the clitoris. The suspensory ligament was then sectioned to mobilise the stump, the scar tissue was removed from the exposed portion and the glans was brought into a normal position. All patients answered a questionnaire at entry about their characteristics, expectations, and preoperative clitoris pleasure and pain, measured on a 5-point scale. Those patients who returned at 1 year for follow-up were questioned about clitoris pain and functionality. We compared data from the 1-year group with the total group of patients who had surgery. Findings We operated on 2938 women with a mean age of 29.2 (SD 7.77 years; age at excision 6.1, SD 3.5 years). Mali, Senegal, and Ivory Coast were the main countries of origin, but 564 patients had undergone female genital mutilation in France. The 1-year follow-up visit was attended by 866 patients (29%). Expectations before surgery were identity recovery for 2933 patients (99%), improved sex life for 2378 patients (81%), and pain reduction for 847 patients (29%). At 1-year follow-up, 363 women (42%) had a hoodless glans, 239 (28%) had a normal clitoris, 210 (24%) had a visible projection, 51 (6%) had a palpable projection, and three (0.4%) had no change. Most patients reported an improvement, or at least no worsening, in pain (821 of 840 patients) and clitoral pleasure (815 of 834 patients). At 1 year, 430 (51%) of 841 women experienced orgasms. Immediate complications after surgery (haematoma, suture failure, moderate fever) were noted in 155 (5%) of the 2938 patients, and 108 (4%) were briefly re-admitted to hospital. Interpretation Reconstructive surgery after female genital mutilation seems to be associated with reduced pain and restored pleasure. It needs to be made more readily available in developed countries by training surgeons.	[Foldes, Pierre] St Germain Poissy Hosp, St Germain En Laye, France; [Cuzin, Beatrice] Edouard Herriot Univ Hosp, Dept Urol, Lyon, France; [Andro, Armelle] Univ Paris 01, Demog Inst, F-75231 Paris 05, France	CHU Lyon	Cuzin, B (corresponding author), Hop Edouard Herriot, Serv Urol & Transplantat, F-69437 Lyon, France.	beatrice.cuzin@chu-lyon.fr		Andro, Armelle/0000-0002-4620-627X	French Urological Association (AFU); French Urological Association	French Urological Association (AFU); French Urological Association	French Urological Association.; This study was funded by the French Urological Association (AFU). We thank Pierre-Jean Cousteix (French National Health Insurance Fund for Salaried Workers, CNAMTS) for advice on the reimbursement procedure, Herve Maisonneuve and Elizabeth Portier for editing and translating the paper into English, and Christine Louis Sylvestre for the initial analysis of results.	Adam T, 2010, B WORLD HEALTH ORGAN, V88, P281, DOI 10.2471/BLT.09.064808; Almroth L, 2005, LANCET, V366, P385, DOI 10.1016/S0140-6736(05)67023-7; Andro A, 2009, HANDICAP EXCISION; [Anonymous], 2010, LANCET, V376, P1800, DOI 10.1016/S0140-6736(10)62149-6; Banks E, 2006, LANCET, V367, P1835, DOI 10.1016/S0140-6736(06)68805-3; Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Behrendt A, 2005, AM J PSYCHIAT, V162, P1000, DOI 10.1176/appi.ajp.162.5.1000; Catania L, 2007, J SEX MED, V4, P1666, DOI 10.1111/j.1743-6109.2007.00620.x; Dorkenoo Efua, 1996, World Health Statistics Quarterly, V49, P142; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; Foldes P, 2006, Gynecol Obstet Fertil, V34, P1137, DOI 10.1016/j.gyobfe.2006.09.026; Foldes P, 2004, PROG UROL, V14, P47; Foundation for Women's Health Research and Development, 2002, RES DEV REP FEM GEN; Fox EF, 1997, INT J STD AIDS, V8, P599, DOI 10.1258/0956462971918779; Gruenbaum E, 2005, CULT HEALTH SEX, V7, P429, DOI 10.1080/13691050500262953; Johnsdotter S, 2004, INT NETW AN COMM TRA; Johnson C, 2007, J SEX MED, V4, P1544, DOI 10.1111/j.1743-6109.2007.00616.x; Krause E, 2011, J SEX MED, V8, P1420, DOI 10.1111/j.1743-6109.2011.02225.x; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Nour NM, 2006, OBSTET GYNECOL, V108, P55, DOI 10.1097/01.AOG.0000224613.72892.77; O'Connell HE, 2005, J UROLOGY, V174, P1189, DOI 10.1097/01.ju.0000173639.38898.cd; Osifo David Osarumwese, 2009, Afr J Reprod Health, V13, P17; WHO, 2008, EL FEM GEN MUT INT S, P48; WHO Technical Working Group, 1996, FEM GEN MUT; World Health Organisation, 2012, FEM GEN MUT; Yoder PS, 2004, FEMALE GENITAL CUTTI	26	107	107	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 14	2012	380	9837					134	141		10.1016/S0140-6736(12)60400-0	http://dx.doi.org/10.1016/S0140-6736(12)60400-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	973KN	22695031				2022-12-28	WOS:000306359100040
J	Lee, HC; Gu, WF; Shirayama, M; Youngman, E; Conte, D; Mello, CC				Lee, Heng-Chi; Gu, Weifeng; Shirayama, Masaki; Youngman, Elaine; Conte, Darryl, Jr.; Mello, Craig C.			C. elegans piRNAs Mediate the Genome-wide Surveillance of Germline Transcripts	CELL			English	Article							SMALL RNAS; EPIGENETIC MEMORY; ARGONAUTE FAMILY; PIWI; SIRNA; RECOGNITION; BIOGENESIS; MICRORNAS; 21U-RNAS; REVEALS	Piwi Argonautes and Piwi-interacting RNAs (piRNAs) mediate genome defense by targeting transposons. However, many piRNA species lack obvious sequence complementarity to transposons or other loci; only one C. elegans transposon is a known piRNA target. Here, we show that, in mutants lacking the Piwi Argonaute PRG-1 (and consequently its associated piRNAs/21U-RNAs), many silent loci in the germline exhibit increased levels of mRNA expression with a concomitant depletion of RNA-dependent RNA polymerase (RdRP)-derived secondary small RNAs termed 22G-RNAs. Sequences depleted of 22G-RNAs are proximal to potential target sites that base pair imperfectly but extensively to 21U-RNAs. We show that PRG-1 is required to initiate, but not to maintain, silencing of transgenes engineered to contain complementarity to endogenous 21U-RNAs. Our findings support a model in which C. elegans piRNAs utilize their enormous repertoire of targeting capacity to scan the germline transcriptome for foreign sequences, while endogenous germline-expressed genes are actively protected from piRNA-induced silencing.	[Lee, Heng-Chi; Gu, Weifeng; Shirayama, Masaki; Youngman, Elaine; Conte, Darryl, Jr.; Mello, Craig C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Shirayama, Masaki; Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	craig.mello@umassmed.edu	Youngman, Elaine/O-7449-2019	Lee, Heng-Chi/0000-0001-8154-906X	Ruth L. Kirschstein National Research Service Award [GM099372]; NIH [GM058800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058800, R01GM058800, F32GM099372] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Miska for sharing unpublished results and G. Seydoux for providing the multisite gateway system. H.-C.L. is supported by a Ruth L. Kirschstein National Research Service Award (GM099372). C.C.M. is a Howard Hughes Medical Institute Investigator. This work is supported by NIH grant GM058800 to C.C.M.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BRENNER S, 1974, GENETICS, V77, P71; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Conine CC, 2010, P NATL ACAD SCI USA, V107, P3588, DOI 10.1073/pnas.0911685107; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Han T, 2009, P NATL ACAD SCI USA, V106, P18674, DOI 10.1073/pnas.0906378106; Klobutcher LA, 1991, CURR OPIN GENET DEV, V1, P397, DOI 10.1016/S0959-437X(05)80306-5; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Maniar JM, 2011, CURR BIOL, V21, P449, DOI 10.1016/j.cub.2011.02.019; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Smith JJ, 2009, P NATL ACAD SCI USA, V106, P11212, DOI 10.1073/pnas.0902358106; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Steiner FA, 2009, NAT STRUCT MOL BIOL, V16, P207, DOI 10.1038/nsmb.1541; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Vasale JJ, 2010, P NATL ACAD SCI USA, V107, P3582, DOI 10.1073/pnas.0911908107; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	36	255	265	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 6	2012	150	1					78	87		10.1016/j.cell.2012.06.016	http://dx.doi.org/10.1016/j.cell.2012.06.016			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22738724	Green Accepted, Bronze			2022-12-28	WOS:000306115000008
J	Mora, C				Mora, Camilo			Comment on "Global Correlations in Tropical Tree Species Richness and Abundance Reject Neutrality"	SCIENCE			English	Editorial Material									Univ Hawaii, Dept Geog, Honolulu, HI 96822 USA	University of Hawaii System	Mora, C (corresponding author), Univ Hawaii, Dept Geog, Honolulu, HI 96822 USA.	cmora@hawaii.edu						Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Ricklefs RE, 2012, SCIENCE, V335, P464, DOI 10.1126/science.1215182	3	1	1	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089								10.1126/science.1220980	http://dx.doi.org/10.1126/science.1220980			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745402				2022-12-28	WOS:000305794500019
J	Patel, K				Patel, Kinesh			We're too weak to strike	BRITISH MEDICAL JOURNAL			English	Editorial Material												kinesh_patel@yahoo.co.uk						2012, BRIT MED J, V344; 2012, BRIT MED J, V344	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 27	2012	344								e4387	10.1136/bmj.e4387	http://dx.doi.org/10.1136/bmj.e4387			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	968MX	22740572				2022-12-28	WOS:000305987100012
J	Wen, LM; Baur, LA; Simpson, JM; Rissel, C; Wardle, K; Flood, VM				Wen, Li Ming; Baur, Louise A.; Simpson, Judy M.; Rissel, Chris; Wardle, Karen; Flood, Victoria M.			Effectiveness of home based early intervention on children's BMI at age 2: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTHY BEGINNINGS TRIAL; BODY-MASS INDEX; CHILDHOOD OBESITY; RISK-FACTORS; WEIGHT-GAIN; FOLLOW-UP; PRESCHOOL-CHILDREN; RAPID GROWTH; OVERWEIGHT; LIFE	Objective To assess the effectiveness of a home based early intervention on children's body mass index (BMI) at age 2. Design Randomised controlled trial. Setting The Healthy Beginnings Trial was conducted in socially and economically disadvantaged areas of Sydney, Australia, during 2007-10. Participants 667 first time mothers and their infants. Intervention Eight home visits from specially trained community nurses delivering a staged home based intervention, one in the antenatal period, and seven at 1, 3, 5, 9, 12, 18 and 24 months after birth. Timing of the visits was designed to coincide with early childhood developmental milestones. Main outcome measures The primary outcome was children's BMI (the healthy BMI ranges for children aged 2 are 14.12-18.41 for boys and 13.90-18.02 for girls). Secondary outcomes included infant feeding practices and TV viewing time when children were aged 2, according to a modified research protocol. The data collectors and data entry staff were blinded to treatment allocation, but the participating mothers were not blinded. Results 497 mothers and their children (75%) completed the trial. An intention to treat analysis in all 667 participants recruited, and multiple imputation of BMI for the 170 lost to follow-up and the 14 missing, showed that mean BMI was significantly lower in the intervention group (16.53) than in the control group (16.82), with a difference of 0.29 (95% confidence interval -0.55 to -0.02; P=0.04). Conclusions The home based early intervention delivered by trained community nurses was effective in reducing mean BMI for children at age 2.	[Wen, Li Ming; Wardle, Karen] S Western Sydney & Sydney Local Hlth Dist, Hlth Promot Serv, Camperdown, NSW 2050, Australia; [Wen, Li Ming; Baur, Louise A.; Simpson, Judy M.; Rissel, Chris] Univ Sydney, Sydney Med Sch, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Baur, Louise A.] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Sydney, NSW 2145, Australia; [Flood, Victoria M.] Univ Wollongong, Fac Hlth & Behav Sci, Sch Hlth Sci, Wollongong, NSW 2522, Australia	University of Sydney; University of Sydney; University of Wollongong	Wen, LM (corresponding author), S Western Sydney & Sydney Local Hlth Dist, Hlth Promot Serv, Level 9,King George V Bldg, Camperdown, NSW 2050, Australia.	lmwen@email.cs.nsw.gov.au	Rissel, Chris/ABA-5881-2020; Wen, Li Ming/ABG-9005-2021; Flood, Victoria/H-2279-2011; Rissel, Chris/AAH-2423-2019; Baur, Louise/AAE-3413-2021; Flood, Victoria M/A-8732-2016	Rissel, Chris/0000-0002-2156-8581; Wen, Li Ming/0000-0003-1381-4022; Flood, Victoria M/0000-0001-5310-7221; Simpson, Judy M/0000-0001-5172-3004; Wardle, Karen/0000-0002-6075-7123; Baur, Louise/0000-0002-4521-9482	Australian National Health and Medical Research Council [393112]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the Australian National Health and Medical Research Council (ID No 393112).	[Anonymous], 2007, 2007 AUSTR NATL CHIL; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Armstrong J, 2002, LANCET, V359, P2003, DOI 10.1016/S0140-6736(02)08837-2; Armstrong KL, 2000, J PAEDIATR CHILD H, V36, P555, DOI 10.1046/j.1440-1754.2000.00591.x; Australian Department of Health and Ageing, NAT PHYS ACT GUID AD; Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41; Chinese Nutrition Society, 2022, DIET GUID SCH AG CHI; Ciampa PJ, 2010, ARCH PEDIAT ADOL MED, V164, P1098, DOI 10.1001/archpediatrics.2010.232; Cole TJ, 2005, EUR J CLIN NUTR, V59, P807, DOI 10.1038/sj.ejcn.1602155; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dennison BA, 2002, PEDIATRICS, V109, P1028, DOI 10.1542/peds.109.6.1028; Flood V., 2010, OBESITY RES CLIN PRA, V4, pS61, DOI [10.1016/j.orcp.2010.09.119, DOI 10.1016/J.ORCP.2010.09.119]; Gardner DSL, 2009, PEDIATRICS, V123, pE67, DOI 10.1542/peds.2008-1292; Gauntlett E, 2001, METAANALYSIS IMPACT; Griffiths LJ, 2009, ARCH DIS CHILD, V94, P577, DOI 10.1136/adc.2008.137554; Hesketh KD, 2010, OBESITY, V18, pS27, DOI 10.1038/oby.2009.429; Kramer MS, 2010, AM J CLIN NUTR, V91, P500, DOI 10.3945/ajcn.2010.29199; Laitinen J, 2001, AM J CLIN NUTR, V74, P287; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; New South Wales Ombudsman`, 2007, REP REV DEATHS 2006; Olds DL, 2007, PEDIATRICS, V120, pE832, DOI 10.1542/peds.2006-2111; Olds DL, 1997, JAMA-J AM MED ASSOC, V278, P637, DOI 10.1001/jama.278.8.637; Ong KK, 2006, PEDIATRICS, V117, pE503, DOI 10.1542/peds.2005-1668; Salmon J, 2006, MED J AUSTRALIA, V184, P64, DOI 10.5694/j.1326-5377.2006.tb00117.x; Stettler N, 2010, CURR OPIN CLIN NUTR, V13, P294, DOI 10.1097/MCO.0b013e328337d7b9; Stocks T, 2011, OBES REV, V12, P637, DOI 10.1111/j.1467-789X.2011.00869.x; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Taveras EM, 2010, PEDIATRICS, V125, P686, DOI 10.1542/peds.2009-2100; Tsukada Hisae, 2003, Nihon Koshu Eisei Zasshi, V50, P1125; Wake M, 2007, INT J OBESITY, V31, P1044, DOI 10.1038/sj.ijo.0803503; Wen LM, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-13; Wen LM, 2012, CONTEMP CLIN TRIALS, V33, P396, DOI 10.1016/j.cct.2011.11.008; Wen LM, 2011, ARCH PEDIAT ADOL MED, V165, P701, DOI 10.1001/archpediatrics.2011.115; Wen LM, 2010, PEDIATR EXERC SCI, V22, P408, DOI 10.1123/pes.22.3.408; Wen LM, 2009, J PAEDIATR CHILD H, V45, P577, DOI 10.1111/j.1440-1754.2009.01568.x; Wen LM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-76; World Health Organiaation, 2011, CHILDH OV OB	39	192	195	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2012	344								e3732	10.1136/bmj.e3732	http://dx.doi.org/10.1136/bmj.e3732			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	968MU	22735103	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000305986700001
J	Nam, SW; Chung, HS; Lo, YC; Qi, L; Li, J; Lu, Y; Johnson, ATC; Jung, YW; Nukala, P; Agarwal, R				Nam, Sung-Wook; Chung, Hee-Suk; Lo, Yu Chieh; Qi, Liang; Li, Ju; Lu, Ye; Johnson, A. T. Charlie; Jung, Yeonwoong; Nukala, Pavan; Agarwal, Ritesh			Electrical Wind Force-Driven and Dislocation-Templated Amorphization in Phase-Change Nanowires	SCIENCE			English	Article							IN-SITU OBSERVATION; DEFORMATION	Phase-change materials undergo rapid and reversible crystalline-to-amorphous structural transformation and are being used for nonvolatile memory devices. However, the transformation mechanism remains poorly understood. We have studied the effect of electrical pulses on the crystalline-to-amorphous phase change in a single-crystalline Ge2Sb2Te5 (GST) nanowire memory device by in situ transmission electron microscopy. We show that electrical pulses produce dislocations in crystalline GST, which become mobile and glide in the direction of hole-carrier motion. The continuous increase in the density of dislocations moving unidirectionally in the material leads to dislocation jamming, which eventually induces the crystalline-to-amorphous phase change with a sharp interface spanning the entire nanowire cross section. The dislocation-templated amorphization explains the large on/off resistance ratio of the device.	[Nam, Sung-Wook; Chung, Hee-Suk; Lo, Yu Chieh; Qi, Liang; Li, Ju; Johnson, A. T. Charlie; Jung, Yeonwoong; Nukala, Pavan; Agarwal, Ritesh] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Lo, Yu Chieh; Qi, Liang; Li, Ju] MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA; [Lo, Yu Chieh; Qi, Liang; Li, Ju] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Lu, Ye; Johnson, A. T. Charlie] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Pennsylvania; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Pennsylvania	Agarwal, R (corresponding author), Univ Penn, Dept Mat Sci & Engn, 3231 Walnut St, Philadelphia, PA 19104 USA.	riteshag@seas.upenn.edu	Jung, Yeonwoong/A-1716-2011; Qi, Liang/A-3851-2010; Nam, Sung-Wook/V-5519-2019; Li, Ju/A-2993-2008; Nukala, Pavan/O-3562-2017	Qi, Liang/0000-0002-0201-9333; Nam, Sung-Wook/0000-0002-2306-6032; Li, Ju/0000-0002-7841-8058; Nukala, Pavan/0000-0002-3988-4224; Agarwal, Ritesh/0000-0002-1289-4334	Office of Naval Research [N000140910116]; Materials Structures and Devices Center at the Massachusetts Institute of Technology, NSF [DMR-0706381, DMR-1002164]; Penn-Materials Research Science and Engineering Center [DMR05-20020, DMR11-20901]; NSF [DMR-1008104, DMR-1120901]; Air Force Office of Scientific Research [FA9550-08-1-0325]; Nano/Bio Interface Center through NSF Nanoscale Science and Engineering Center [DMR08-32802]	Office of Naval Research(Office of Naval Research); Materials Structures and Devices Center at the Massachusetts Institute of Technology, NSF; Penn-Materials Research Science and Engineering Center(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Nano/Bio Interface Center through NSF Nanoscale Science and Engineering Center	This work was supported by the Office of Naval Research (grant N000140910116), Materials Structures and Devices Center at the Massachusetts Institute of Technology, NSF (DMR-0706381 and DMR-1002164), and Penn-Materials Research Science and Engineering Center (DMR05-20020 and DMR11-20901). Y.C.L., L. Q., and J.L. acknowledge the support of NSF DMR-1008104 and DMR-1120901, and Air Force Office of Scientific Research FA9550-08-1-0325. Y.L. and A.T.C.J. acknowledge the support of the Nano/Bio Interface Center through NSF Nanoscale Science and Engineering Center DMR08-32802. Electron microscopy experiments were performed at the Penn Regional Nanotechnology Facility at the University of Pennsylvania. S.-W.N. thanks D. Strachan for useful discussions on in situ TEM experiments. The data described in the paper are archived by the Agarwal group at the University of Pennsylvania.	Fons P, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.041203; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Huang JY, 2010, SCIENCE, V330, P1515, DOI 10.1126/science.1195628; Huang JY, 1999, PHIL MAG LETT, V79, P305, DOI 10.1080/095008399177147; Huang JY, 2004, PHIL MAG LETT, V84, P183, DOI 10.1080/09500830310001657353; Hull D., 2001, INTRO DISLOCATIONS; Jung YW, 2011, NANO LETT, V11, P1364, DOI 10.1021/nl104537c; KAXIRAS E, 1993, PHYS REV LETT, V70, P3752, DOI 10.1103/PhysRevLett.70.3752; KIMURA H, 1959, ACTA METALL MATER, V7, P145, DOI 10.1016/0001-6160(59)90067-7; Kolobov AV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.035701; Kolobov AV, 2011, NAT CHEM, V3, P311, DOI [10.1038/NCHEM.1007, 10.1038/nchem.1007]; Kolobov AV, 2004, NAT MATER, V3, P703, DOI 10.1038/nmat1215; Kooi BJ, 2004, J APPL PHYS, V95, P924, DOI 10.1063/1.1636259; Lee MH, 2010, INT EL DEVICES MEET; Lee SH, 2007, NAT NANOTECHNOL, V2, P626, DOI 10.1038/nnano.2007.291; Mishin Y, 2010, ACTA MATER, V58, P1117, DOI 10.1016/j.actamat.2009.10.049; Mitra M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3447941; Nagel K, 1996, PHYS REV E, V53, P4655, DOI 10.1103/PhysRevE.53.4655; Nam SW, 2009, ELECTROCHEM SOLID ST, V12, pH155, DOI 10.1149/1.3079480; Ogata S, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.224102; Oh SH, 2009, NAT MATER, V8, P95, DOI [10.1038/NMAT2370, 10.1038/nmat2370]; Raoux S, 2009, ANNU REV MATER RES, V39, P25, DOI [10.1146/annurev-matsci-082908-145405, 10.1146/annurev.matsci.082908-145405]; SCHOECK G, 1960, PHILOS MAG, V5, P43, DOI 10.1080/14786436008241199; Shan ZW, 2008, NAT MATER, V7, P115, DOI 10.1038/nmat2085; Strachan DR, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.056805; Sun ZM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.055507; Telling RH, 2003, PHIL MAG LETT, V83, P411, DOI 10.1080/0950083031000137839; WOLF D, 1990, J MATER RES, V5, P286, DOI 10.1557/JMR.1990.0286; Wuttig M, 2007, NAT MATER, V6, P824, DOI 10.1038/nmat2009; Yang TY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3184584; Yu Q, 2010, NATURE, V463, P335, DOI 10.1038/nature08692; Zheng H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1149; Zhu T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.025502	33	136	137	5	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1561	1566		10.1126/science.1220119	http://dx.doi.org/10.1126/science.1220119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723418				2022-12-28	WOS:000305507500052
J	Saito, D; Takase, Y; Murai, H; Takahashi, Y				Saito, Daisuke; Takase, Yuta; Murai, Hidetaka; Takahashi, Yoshiko			The Dorsal Aorta Initiates a Molecular Cascade That Instructs Sympatho-Adrenal Specification	SCIENCE			English	Article							NEURAL CREST; SYMPATHETIC NEURONS; CHROMAFFIN CELLS; IN-VIVO; DIFFERENTIATION; GLUCOCORTICOIDS; RECEPTORS; PERSPECTIVES; GENERATION; MIGRATION	The autonomic nervous system, which includes the sympathetic neurons and adrenal medulla, originates from the neural crest. Combining avian blood vessel-specific gene manipulation and mouse genetics, we addressed a long-standing question of how neural crest cells (NCCs) generate sympathetic and medullary lineages during embryogenesis. We found that the dorsal aorta acts as a morphogenetic signaling center that coordinates NCC migration and cell lineage segregation. Bone morphogenetic proteins (BMPs) produced by the dorsal aorta are critical for the production of the chemokine stromal cell-derived factor-1 (SDF 1) and Neuregulin 1 in the para-aortic region, which act as chemoattractants for early migration. Later, BMP signaling is directly involved in the sympatho-medullary segregation. This study provides insights into the complex developmental signaling cascade that instructs one of the earliest events of neurovascular interactions guiding embryonic development.	[Saito, Daisuke; Takase, Yuta; Murai, Hidetaka; Takahashi, Yoshiko] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan; [Saito, Daisuke; Takahashi, Yoshiko] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan; [Takase, Yuta; Murai, Hidetaka; Takahashi, Yoshiko] Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan	Nara Institute of Science & Technology; Japan Science & Technology Agency (JST); Kyoto University	Takahashi, Y (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Ikoma, Nara 6300192, Japan.	yotayota@develop.zool.kyoto-u.ac.jp	Saito, Daisuke/AAL-8492-2021	Saito, Daisuke/0000-0002-5999-2505	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Global Centers of Excellence (GCOE) program (Frontier Biosciences, Nara Institute of Science and Technology) from MEXT, Japan; CREST (JST); Mitsubishi Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Centers of Excellence (GCOE) program (Frontier Biosciences, Nara Institute of Science and Technology) from MEXT, Japan; CREST (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Mitsubishi Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank S. F. Gilbert, L. Niswander, G. Corfas, S. O. Yoon, and Y. Wakamatsu for experimental materials and discussions and K. Morohashi for providing us with Sf1 KO mice. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, and Grant-in-Aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); the Global Centers of Excellence (GCOE) program (Frontier Biosciences, Nara Institute of Science and Technology) from MEXT, Japan; CREST (JST); The Mitsubishi Foundation; and Takeda Science Foundation. Y. Takase is a fellow of the Japan Society for the Promotion of Science.	ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; ANDERSON DJ, 1993, ANNU REV NEUROSCI, V16, P129, DOI 10.1146/annurev.ne.16.030193.001021; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; DOUPE AJ, 1985, J NEUROSCI, V5, P2119; Gut P, 2005, DEVELOPMENT, V132, P4611, DOI 10.1242/dev.02052; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Howard MJ, 2005, DEV BIOL, V277, P271, DOI 10.1016/j.ydbio.2004.09.034; Huber K, 2006, DEV BIOL, V298, P335, DOI 10.1016/j.ydbio.2006.07.010; Huber K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-28; Kasemeier-Kulesa JC, 2010, J NEUROSCI, V30, P13078, DOI 10.1523/JNEUROSCI.0892-10.2010; Kim JY, 2003, J NEUROSCI, V23, P5561; Langley K, 1999, CELL TISSUE RES, V298, P185, DOI 10.1007/PL00008810; Le Douarin NM, 1999, NEURAL CREST, V2; LEDOUARIN N, 1971, CR ACAD SCI D NAT, V272, P481; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Moberg G.P., 2000, BIOL ANIMAL STRESS B, V1st; Morikawa Y, 2009, DEVELOPMENT, V136, P3575, DOI 10.1242/dev.038133; Ohata E, 2009, DEV BIOL, V335, P33, DOI 10.1016/j.ydbio.2009.08.010; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SHINODA K, 1995, DEV DYNAM, V204, P22, DOI 10.1002/aja.1002040104; TEILLET MA, 1974, ARCH ANAT MICROSC MO, V63, P51; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; Watanabe T, 2007, DEV BIOL, V305, P625, DOI 10.1016/j.ydbio.2007.01.042; Yokota Y, 2011, DEV BIOL, V353, P382, DOI 10.1016/j.ydbio.2011.02.001; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	30	97	98	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1578	1581		10.1126/science.1222369	http://dx.doi.org/10.1126/science.1222369			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723422				2022-12-28	WOS:000305507500057
J	Catlin, EA; Warren, HS; Shailam, R; Lahoud-Rahme, M; Lew, M				Catlin, Elizabeth A.; Warren, H. Shaw; Shailam, Randheer; Lahoud-Rahme, Manuella; Lew, Madelyn			Case 19-2012: A Premature Newborn Boy with Respiratory Distress	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HERPES-SIMPLEX-VIRUS; INFECTION		[Catlin, Elizabeth A.; Warren, H. Shaw] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Warren, H. Shaw; Lahoud-Rahme, Manuella] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Shailam, Randheer] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Lew, Madelyn] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Catlin, Elizabeth A.; Warren, H. Shaw] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Warren, H. Shaw; Lahoud-Rahme, Manuella] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Shailam, Randheer] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Lew, Madelyn] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Catlin, EA (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.							BALDWIN S, 1989, TERATOLOGY, V39, P1, DOI 10.1002/tera.1420390102; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; BROWN ZA, 1991, NEW ENGL J MED, V324, P1247, DOI 10.1056/NEJM199105023241804; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Cadge W, 2006, J RELIG HLTH, V45, P1; Catlin E A, 2001, J Perinatol, V21, P426, DOI 10.1038/sj.jp.7210600; Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Gardella C, 2007, CLEV CLIN J MED, V74, P217, DOI 10.3949/ccjm.74.3.217; Kimberlin DW, 2004, CLIN MICROBIOL REV, V17, P1, DOI 10.1128/CMR.17.1.1-13.2004; Levy PA, 2010, J DEV BEHAV PEDIATR, V31, P622, DOI 10.1097/DBP.0b013e3181eedf01; Levy PA, 2009, PEDIATR REV, V30, P131, DOI 10.1542/pir.30-4-131; Morrow RA, 2005, AM J OBSTET GYNECOL, V193, P361, DOI 10.1016/j.ajog.2005.01.025; Page J, 2003, SEX TRANSM INFECT, V79, P276, DOI 10.1136/sti.79.4.276; Payan I, 2005, INTENSIVE CARE FETUS, P1205; Perrin JM, 2010, GENET MED, V12, P131, DOI 10.1097/GIM.0b013e3181d28eb1; Reilly-Smorawski B, 2002, DEATH STUD, V26, P21, DOI 10.1080/07481180210145; Roberts CM, 2003, SEX TRANSM DIS, V30, P797, DOI 10.1097/01.OLQ.0000092387.58746.C7; Shani L, 2008, ACTA PAEDIATR, V97, P12, DOI 10.1111/j.1651-2227.2007.00571.x; Stern TA, 1998, NEW HORIZ-SCI PRACT, V6, P398; Xin B, 2007, AM J MED GENET A, V143A, P2662, DOI 10.1002/ajmg.a.31981; Xu F., 2007, AM J OBSTET GYNECOL, V196	22	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					2409	2419		10.1056/NEJMcpc1109276	http://dx.doi.org/10.1056/NEJMcpc1109276			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961GH	22716980				2022-12-28	WOS:000305451700013
J	Aschner, P; Chan, J; Owens, DR; Picard, S; Wang, E; Dain, MP; Pilorget, V; Echtay, A; Fonseca, V				Aschner, Pablo; Chan, Juliana; Owens, David R.; Picard, Sylvie; Wang, Edward; Dain, Marie-Paule; Pilorget, Valerie; Echtay, Akram; Fonseca, Vivian		EASIE Investigators	Insulin glargine versus sitagliptin in insulin-naive patients with type 2 diabetes mellitus uncontrolled on metformin (EASIE): a multicentre, randomised open-label trial	LANCET			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; BETA-CELL FUNCTION; GLYCEMIC CONTROL; THERAPY; METAANALYSIS; GLUCOSE; HYPERGLYCEMIA; SULFONYLUREA; MANAGEMENT; EFFICACY	Background In people with type 2 diabetes, a dipeptidyl peptidase-4 (DPP-4) inhibitor is one choice as second-line treatment after metformin, with basal insulin recommended as an alternative. We aimed to compare the efficacy, tolerability, and safety of insulin glargine and sitagliptin, a DPP-4 inhibitor, in patients whose disease was uncontrolled with metformin. Methods In this comparative, parallel, randomised, open-label trial, metformin-treated people aged 35-70 years with glycated haemoglobin A(1c) (HbA(1c)) of 7-11%, diagnosis of type 2 diabetes for at least 6 months, and body-mass index of 25-45 kg/m(2) were recruited from 17 countries. Participants were randomly assigned (1:1) to 24-week treatment with insulin glargine (titrated from an initial subcutaneous dose of 0.2 units per kg bodyweight to attain fasting plasma glucose of 4.0-5.5 mmol/L) or sitagliptin (oral dose of 100 mg daily). Randomisation (via a central interactive voice response system) was by random sequence generation and was stratified by centre. Patients and investigators were not masked to treatment assignment. The primary outcome was change in HbA(1c) from baseline to study end. Efficacy analysis included all randomly assigned participants who had received at least one dose of study drug and had at least one on-treatment assessment of any primary or secondary efficacy variable. This trial is registered at ClinicalTrials.gov, NCT00751114. Findings 732 people were screened and 515 were randomly assigned to insulin glargine (n=250) or sitagliptin (n=265). At study end, adjusted mean reduction in HbA(1c) was greater for patients on insulin glargine (n=227; -1.72%, SE 0.06) than for those on sitagliptin (n=253; -1.13%, SE 0.06) with a mean difference of -0.59% (95% CI -0.77 to -0.42, p<0.0001). The estimated rate of all symptomatic hypoglycaemic episodes was greater with insulin glargine than with sitagliptin (4.21 [SE 0.54] vs 0.50 [SE 0.09] events per patient-year; p<0.0001). Severe hypoglycaemia occurred in only three (1%) patients on insulin glargine and one (<1%) on sitagliptin. 15 (6%) of patients on insulin glargine versus eight (3%) on sitagliptin had at least one serious treatment-emergent adverse event. Interpretation Our results support the option of addition of basal insulin in patients with type 2 diabetes inadequately controlled by metformin. Long-term benefits might be expected from the achievement of optimum glycaemic control early in the course of the disease.	[Aschner, Pablo] Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia; [Chan, Juliana] Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Owens, David R.] Cardiff Univ, Ctr Endocrine & Diabet Sci, Cardiff, S Glam, Wales; [Picard, Sylvie] Point Medical Rond Point Nation, Dijon, France; [Wang, Edward] Sanofi, Bridgewater, NJ USA; [Dain, Marie-Paule; Pilorget, Valerie] Sanofi, Paris, France; [Echtay, Akram] Rafic Hariri Univ Hosp, Beirut, Lebanon; [Fonseca, Vivian] Tulane Univ, Med Ctr, New Orleans, LA 70118 USA	Hospital Universitario San Ignacio; Pontificia Universidad Javeriana; Chinese University of Hong Kong; Prince of Wales Hospital; Cardiff University; Sanofi-Aventis; Sanofi-Aventis; Sanofi France; Tulane University	Aschner, P (corresponding author), Pontificia Univ Javeriana, Hosp Univ San Ignacio, Bogota, Colombia.	paschner@cable.net.co	Chan, Juliana/B-7918-2016; PICARD, Sylvie/AAI-6569-2020; Gönen, Mustafa Sait/AAH-5654-2019; Bellido Guerrero, Diego/C-9446-2017	Chan, Juliana/0000-0003-1325-1194; PICARD, Sylvie/0000-0003-0463-8063; Gönen, Mustafa Sait/0000-0002-1089-623X; Bellido Guerrero, Diego/0000-0003-0631-2710; Tinahones, Francisco J/0000-0001-6871-4403	Sanofi; Amylin; AstraZeneca; Bayer Healthcare; Eli Lilly Co; Eli Lilly AMP; Co, GlaxoSmithKline; Merck-Serono; Merck; Sharpe Dohme; Takeda; Boehringer Ingelheim; Roche	Sanofi; Amylin; AstraZeneca(AstraZeneca); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Eli Lilly Co(Eli Lilly); Eli Lilly AMP; Co, GlaxoSmithKline; Merck-Serono(Merck & Company); Merck(Merck & Company); Sharpe Dohme; Takeda(Takeda Pharmaceutical Company Ltd); Boehringer Ingelheim(Boehringer Ingelheim); Roche(Roche Holding)	Sanofi.r PA has served on advisory boards for AstraZeneca, Eli Lilly & Co, GlaxoSmithKline, Janssen, Merck, Sharpe & Dohme, Novartis, and Sanofi and on speakers' bureaus for AstraZeneca, Eli Lilly & Co, Merck, Sharpe & Dohme, Novartis, and Sanofi. JC has served on advisory boards for Amylin, AstraZeneca, Bayer Healthcare, Eli Lilly & Co, GlaxoSmithKline, Merck-Serono, Merck, Sharpe & Dohme, Pfizer, and Sanofi and on speakers' bureaus for AstraZeneca, Bayer Healthcare, Eli Lilly & Co, GlaxoSmithKline, Merck-Serono, Merck, Sharpe & Dohme, Pfizer, Sanofi, and Takeda; she has received research support from Amylin, AstraZeneca, Bayer Healthcare, Eli Lilly & Co, GlaxoSmithKline, Merck-Serono, Merck, Sharpe & Dohme, Sanofi, and Takeda. DRO has served on advisory boards and speakers' bureaus for Roche and Sanofi and has received research support from Boehringer Ingelheim, Roche, and Sanofi. SP has served on advisory boards, as a board member, and as a consultant for Medtronics, Novo Nordisk, and Sanofi and on speakers' bureaus for Eli Lilly & Co, Lifescan, Medtronic, Merck-Serono, Novartis, Pierre Fabre, Novo Nordisk, Sanofi, and Solvay. EW, M-PD, and VP are employees of Sanofi. AE has served on an advisory board for Merck, Sharpe & Dohme and on speakers' bureaus for AstraZeneca, Eli Lilly & Co, Merck & Co, Merck, Sharpe & Dohme, Novartis, Novo Nordisk, and Sanofi. VF has served as a consultant and on speakers' bureaus for AstraZeneca, Daiichi Sankyo, Eli Lilly & Co, GlaxoSmithKline, Novo Nordisk, Pamlabs, Sanofi, Takeda, and Xoma.r The study was funded by Sanofi. Editorial support was provided by Tom Claus of PPSI (a PAREXEL Company; Hackensack, NJ, USA) and funded by Sanofi.	Ahren B, 2010, DIABETES METAB SYNDR, V3, P31, DOI 10.2147/DMSO.S7327; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Charbonnel B, 2006, DIABETES CARE, V29, P2638, DOI 10.2337/dc06-0706; Chen HS, 2008, DIABETES CARE, V31, P1927, DOI 10.2337/dc08-0075; Desouza CV, 2010, DIABETES CARE, V33, P1389, DOI 10.2337/dc09-2082; Fonseca V, 2011, DIABETES OBES METAB, V13, P814, DOI 10.1111/j.1463-1326.2011.01412.x; Gerstein HC, 2008, AM HEART J, V155, P26, DOI 10.1016/j.ahj.2007.09.009; Hemmingsen B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6898; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; *IDF CLIN GUID TAS, 2007, GUID MAN POSTM GLUC; Mannucci E, 2009, NUTR METAB CARDIOVAS, V19, P604, DOI 10.1016/j.numecd.2009.03.021; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; Noh YH, 2008, DIABETES-METAB RES, V24, P384, DOI 10.1002/dmrr.849; Pozzilli P, 2010, DIABETES-METAB RES, V26, P239, DOI 10.1002/dmrr.1092; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Rodbard Helena W, 2007, Endocr Pract, V13 Suppl 1, P1; Rosenstock J, 2008, DIABETOLOGIA, V51, P408, DOI 10.1007/s00125-007-0911-x; Triplitt C, 2006, DIABETES CARE, V29, P2371, DOI 10.2337/dc06-0564; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wainstein J, 2012, DIABETES OBES METAB, V14, P409, DOI 10.1111/j.1463-1326.2011.01530.x; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X	25	83	88	0	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2012	379	9833					2262	2269		10.1016/S0140-6736(12)60439-5	http://dx.doi.org/10.1016/S0140-6736(12)60439-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962AM	22683131				2022-12-28	WOS:000305511400033
J	Caplan, LR; Gonzalez, G; Buonanno, FS				Caplan, Louis R.; Gonzalez, R. Gilberto; Buonanno, Ferdinando S.			Case 18-2012: A 35-Year-Old Man with Neck Pain, Hoarseness, and Dysphagia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CERVICAL ARTERY DISSECTION; TERM-FOLLOW-UP; OSTEOGENESIS-IMPERFECTA; HYPOPERFUSION; HEMORRHAGE; PATIENT; STROKE		[Caplan, Louis R.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Buonanno, Ferdinando S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Caplan, Louis R.; Buonanno, Ferdinando S.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Caplan, LR (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.							Arauz A, 2006, CEREBROVASC DIS, V22, P150, DOI 10.1159/000093244; Baumgartner RW, 2005, HDB CEREBRAL ARTERY; Beletsky V, 2003, STROKE, V34, P2856, DOI 10.1161/01.STR.0000098649.39767.BC; Bogousslavsky J, 2001, UNCOMMON CAUSES STRO, P211; Brandt T, 1998, ANN NEUROL, V44, P281, DOI 10.1002/ana.410440224; Caplan LR, 2008, NAT CLIN PRACT NEURO, V4, P34, DOI 10.1038/ncpneuro0683; Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475; Caplan LR, 2006, CEREBROVASC DIS, V21, P145, DOI 10.1159/000090791; Caplan LR., CAPLANS STROKE, P63; Debette S, 2009, STROKE, V40, pE459, DOI 10.1161/STROKEAHA.108.534669; Georgiadis D, 2005, NEUROLOGY, V64, P1612, DOI 10.1212/01.WNL.0000159548.45013.C1; Goddeau RP, 2010, ARCH NEUROL-CHICAGO, V67, P236, DOI 10.1001/archneurol.2009.319; Guillon B, 1999, NEUROLOGY, V53, P117, DOI 10.1212/WNL.53.1.117; Lee VH, 2006, NEUROLOGY, V67, P1809, DOI 10.1212/01.wnl.0000244486.30455.71; Martin JJ, 2006, STROKE, V37, P2924, DOI 10.1161/01.STR.0000248916.52976.49; Metso TM, 2009, EUR J NEUROL, V16, P656, DOI 10.1111/j.1468-1331.2009.02535.x; Molina CA, 2000, NEUROLOGY, V55, P1738, DOI 10.1212/WNL.55.11.1738; Narvaez J, 1996, BRIT J RHEUMATOL, V35, P1332; Pepin M, 2001, NEW ENGL J MED, V344, P392; Pham MH, 2011, NEUROSURGERY, V68, P856, DOI 10.1227/NEU.0b013e318209ce03; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; SCHIEVINK WI, 1994, STROKE, V25, P889, DOI 10.1161/01.STR.25.4.889; Schwartz NE, 2009, J STROKE CEREBROVASC, V18, P416, DOI 10.1016/j.jstrokecerebrovasdis.2008.11.016; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Touze E, 2001, STROKE, V32, P418, DOI 10.1161/01.STR.32.2.418	26	3	3	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2012	366	24					2306	2314		10.1056/NEJMcpc1110050	http://dx.doi.org/10.1056/NEJMcpc1110050			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	957PD	22694002				2022-12-28	WOS:000305174100013
J	Fu, ZQ; Yan, SP; Saleh, A; Wang, W; Ruble, J; Oka, N; Mohan, R; Spoel, SH; Tada, Y; Zheng, N; Dong, XN				Fu, Zheng Qing; Yan, Shunping; Saleh, Abdelaty; Wang, Wei; Ruble, James; Oka, Nodoka; Mohan, Rajinikanth; Spoel, Steven H.; Tada, Yasuomi; Zheng, Ning; Dong, Xinnian			NPR3 and NPR4 are receptors for the immune signal salicylic acid in plants	NATURE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; CELL-DEATH; PSEUDOMONAS-SYRINGAE; DEFENSE GENES; ARABIDOPSIS; TOBACCO; INDUCTION; PERCEPTION; INTERACTS; REVEALS	Salicylic acid (SA) is a plant immune signal produced after pathogen challenge to induce systemic acquired resistance. It is the only major plant hormone for which the receptor has not been firmly identified. Systemic acquired resistance in Arabidopsis requires the transcription cofactor nonexpresser of PR genes 1 (NPR1), the degradation of which acts as a molecular switch. Here we show that the NPR1 paralogues NPR3 and NPR4 are SA receptors that bind SA with different affinities. NPR3 and NPR4 function as adaptors of the Cullin 3 ubiquitin E3 ligase to mediate NPR1 degradation in an SA-regulated manner. Accordingly, the Arabidopsis npr3 npr4 double mutant accumulates higher levels of NPR1, and is insensitive to induction of systemic acquired resistance. Moreover, this mutant is defective in pathogen effector-triggered programmed cell death and immunity. Our study reveals the mechanism of SA perception in determining cell death and survival in response to pathogen challenge.	[Fu, Zheng Qing; Yan, Shunping; Saleh, Abdelaty; Wang, Wei; Mohan, Rajinikanth; Dong, Xinnian] Duke Univ, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Dept Biol, Durham, NC 27708 USA; [Ruble, James; Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; [Oka, Nodoka] Kagawa Univ, Fac Agr, Miki, Kagawa 7610795, Japan; [Spoel, Steven H.] Univ Edinburgh, Inst Mol Plant Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Tada, Yasuomi] Kagawa Univ, Life Sci Res Ctr, Inst Res Promot, Miki, Kagawa 7610795, Japan	Duke University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Kagawa University; University of Edinburgh; Kagawa University	Dong, XN (corresponding author), Duke Univ, Howard Hughes Med Inst, Gordon & Betty Moore Fdn, Dept Biol, POB 90338, Durham, NC 27708 USA.	xdong@duke.edu	Wang, Wei/F-7425-2013; Yan, Shunping/D-7597-2011; Tada, Yasuomi/M-5041-2014; Yan, Shunping/AAD-8336-2021; Wang, Wei/I-5230-2015	Yan, Shunping/0000-0002-3665-1310; Yan, Shunping/0000-0002-3665-1310; Wang, Wei/0000-0002-3780-5158; Tada, Yasuomi/0000-0001-9900-069X; Spoel, Steven/0000-0003-4340-7591	Hargitt Fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan [23120520]; Royal Society [Uf090321];  [GM069594-05];  [CA107134];  [T32GM008268-23]; NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069594, T32GM008268] Funding Source: NIH RePORTER	Hargitt Fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Royal Society(Royal Society of London); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Zhang for sharing the npr3, npr4, npr3 npr4 and npr1 npr3 npr4 mutants; J. Song for providing the NPR3 and NPR4 Y2H constructs; Z. Mou for providing the data on the NPR1-GFP protein levels in the nahG transgenic plants, P. Zhou for discussion of the work and for critiquing the manuscript. This work was supported by the Hargitt Fellowship (to Z. Q. F.), grants GM069594-05 (to X. D.), CA107134 (to N.Z.), T32GM008268-23 (to J. R.), Grants-in-Aid for Scientific Research (no. 23120520) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y. T). and the Royal Society Uf090321 (to S. H. S.). N.Z. is a Howard Hughes Medical Institute investigator and X. D. is a Howard Hughes Medical Institute-Gordon and Betty Moore Foundation investigator.	Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Dieterle M, 2005, PLANT J, V41, P386, DOI 10.1111/j.1365-313X.2004.02302.x; Dorey S, 1997, MOL PLANT MICROBE IN, V10, P646, DOI 10.1094/MPMI.1997.10.5.646; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; ENYEDI AJ, 1992, P NATL ACAD SCI USA, V89, P2480, DOI 10.1073/pnas.89.6.2480; Fan WH, 2002, PLANT CELL, V14, P1377, DOI 10.1105/tpc.001628; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Lu H, 2009, PLANT J, V58, P401, DOI 10.1111/j.1365-313X.2009.03791.x; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Metraux J. P., 1991, Advances in molecular genetics of plant-microbe interactions. Vol. 1. Proceedings of the 5th international symposium on the molecular genetics of plant-microbe interactions, Interlaken, Switzerland, September 9-14, 1990., P432; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Rate DN, 2001, PLANT J, V27, P203, DOI 10.1046/j.0960-7412.2001.1075umedoc.x; Rossignol P, 2007, J CELL SCI, V120, P3678, DOI 10.1242/jcs.004119; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Spoel SH, 2009, CELL, V137, P860, DOI 10.1016/j.cell.2009.03.038; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Zhang YL, 2006, PLANT J, V48, P647, DOI 10.1111/j.1365-313X.2006.02903.x	30	572	609	21	392	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					228	+		10.1038/nature11162	http://dx.doi.org/10.1038/nature11162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699612	Green Accepted			2022-12-28	WOS:000305189000028
J	Harper, S; Rushani, D; Kaufman, JS				Harper, Sam; Rushani, Dinela; Kaufman, Jay S.			Trends in the Black-White Life Expectancy Gap, 2003-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Harper, Sam; Rushani, Dinela; Kaufman, Jay S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	McGill University	Harper, S (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	sam.harper@mcgill.ca	Harper, Sam/A-3406-2008	Harper, Sam/0000-0002-2767-1053; Kaufman, Jay/0000-0003-1606-401X				Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; ARRIAGA EE, 1984, DEMOGRAPHY, V21, P83, DOI 10.2307/2061029; Centers for Disease Control and Prevention, COMPR MORT FIL; Harper S, 2007, JAMA-J AM MED ASSOC, V297, P1224, DOI 10.1001/jama.297.11.1224; National Center for Health Statistics, TABL 37 HLTH US 2010; Warner M, DRUG POISONING DEATH	6	58	60	2	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2012	307	21					2257	2259		10.1001/jama.2012.5059	http://dx.doi.org/10.1001/jama.2012.5059			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	952OL	22706828				2022-12-28	WOS:000304801700015
J	Kirchhof, P; Andresen, D; Bosch, R; Borggrefe, M; Meinertz, T; Parade, U; Ravens, U; Samol, A; Steinbeck, G; Treszl, A; Wegscheider, K; Breithardt, G				Kirchhof, Paulus; Andresen, Dietrich; Bosch, Ralph; Borggrefe, Martin; Meinertz, Thomas; Parade, Ulli; Ravens, Ursula; Samol, Alexander; Steinbeck, Gerhard; Treszl, Andras; Wegscheider, Karl; Breithardt, Guenter			Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial	LANCET			English	Article							MAINTAIN SINUS RHYTHM; AMIODARONE; MANAGEMENT; THERAPY; EQUIVALENCE; MAINTENANCE; FLECAINIDE; SOTALOL; IMPACT; RISK	Background Antiarrhythmic drugs prolong the atrial action potential and refractory period, and thereby prevent recurrent atrial fibrillation after cardioversion. The atrial action potential normalises after 2-4 weeks of sinus rhythm, suggesting that antiarrhythmic drugs might not be needed beyond that period. Therefore, we investigated whether short-term antiarrhythmic drug treatment after cardioversion is non-inferior to long-term treatment. Methods We enrolled patients in a prospective, randomised, open-label, blinded endpoint assessment trial between May 4, 2007, and March 12, 2010, at 44 centres in Germany. Eligible patients were adults with persistent atrial fibrillation undergoing planned cardioversion. After successful cardioversion, patients were randomly assigned in permuted blocks of six per centre to: no antiarrhythmic drug treatment (control); treatment with flecainide (200-300 mg per day) for 4 weeks (short-term treatment); or flecainide for 6 months (long-term treatment). The primary endpoint was time to persistent atrial fibrillation or death. Patients and clinicians were unmasked to group assignment and treatment. The primary outcome was assessed in a core laboratory, members of which were masked to treatment group. Patients were monitored for 6 months by daily telemetric electrocardiograph (ECG) and centrally adjudicated Holter ECG recordings whenever atrial fibrillation was noted in two consecutive ECGs. Analyses were per protocol. This trial is registered, number ISRCTN62728742. Findings After assay sensitivity was established with 4-week follow-up data from 242 patients showing that flecainide was superior to no treatment (Kaplan-Meier survival 70.2% vs 52.5%; p=0.0160), the trial continued to compare short-term versus long-term treatment. The primary outcome occurred in 120 (46%) of 261 patients receiving short-term treatment and in 103 (39%) of 263 patients receiving long-term treatment (event-free survival 48.4% [95% CI 41.9-55.0] vs 56.4% [49.1-63.6]; Kaplan-Meier estimate of difference 7.9% [-1.9 to 17.7]; p=0.2081 for non-inferiority; margin prespecified at 12%). In a post-hoc landmark analysis of patients who had not reached the primary endpoint in the first month, long-term treatment was superior to short-term treatment (Kaplan-Meier estimate of difference 14.3% [5.1-23.6]; hazard ratio 0.31 [0.18-0.56]; p=0.0001). Interpretation Short-term antiarrhythmic drug treatment after cardioversion is less effective than is long-term treatment, but can prevent most recurrences of atrial fibrillation.	[Kirchhof, Paulus] Univ Birmingham, Ctr Cardiovasc Sci, Sch Clin & Expt Med, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England; [Andresen, Dietrich] Vivantes Urban Hosp, Dept Cardiol, Berlin, Germany; [Bosch, Ralph] Cardiol Off Ludwigsburg, Ludwigsburg, Germany; [Borggrefe, Martin] Univ Mannheim, Dept Cardiol, D-6800 Mannheim 1, Germany; [Meinertz, Thomas] Univ Hamburg, Univ Heart Ctr, Hamburg, Germany; [Treszl, Andras; Wegscheider, Karl] Univ Hamburg, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Parade, Ulli] Robert Bosch Krankenhaus, Stuttgart, Germany; [Ravens, Ursula] Tech Univ, Dept Pharmacol, Dresden, Germany; [Steinbeck, Gerhard] Univ Munich, Dept Cardiol, Munich, Germany; [Kirchhof, Paulus; Samol, Alexander; Breithardt, Guenter] Hosp Univ Munster, Dept Cardiol & Angiol, Munster, Germany	University of Birmingham; University of Mannheim; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; Bosch; Robert Bosch Krankenhaus; Technische Universitat Dresden; University of Munich; University of Munster	Kirchhof, P (corresponding author), Univ Birmingham, Ctr Cardiovasc Sci, Sch Clin & Expt Med, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England.	p.kirchhof@bham.ac.uk	Kirchhof, Paulus/AAT-7074-2021; Samol, Alexander/AAB-9187-2020	Kirchhof, Paulus/0000-0002-1881-0197; 	German Federal Ministry of Education and Research; Deutsche Forschungsgemeinschaft; 3M Medica; MEDA Pharmaceuticals; German Federal Ministry of Education and Research (BMBF) within AFNET [01Gi0204]; BMBF	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 3M Medica(3M); MEDA Pharmaceuticals; German Federal Ministry of Education and Research (BMBF) within AFNET(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF))	The German Federal Ministry of Education and Research, Deutsche Forschungsgemeinschaft, 3M Medica, and MEDA Pharmaceuticals.; Flec-SL was funded by the German Federal Ministry of Education and Research (BMBF) within AFNET (project B11, grant 01Gi0204). Following the rules of industry engagement of BMBF, 3M Medica and MEDA Pharmaceuticals agreed to co-fund the Flec-SL trial. Deutsche Forschungsgemeinschaft provided funds for the central analysis of the primary endpoint.	Ahmed S, 2008, JAMA-J AM MED ASSOC, V300, P1784, DOI 10.1001/jama.300.15.1784; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Buyse M, 1996, STAT MED, V15, P2797, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2797::AID-SIM290>3.0.CO;2-V; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Channer KS, 2004, EUR HEART J, V25, P144, DOI 10.1016/j.ehj.2003.10.020; COMNOUGUE C, 1993, STAT MED, V12, P1353, DOI 10.1002/sim.4780121407; COPLEN SE, 1990, CIRCULATION, V82, P1106, DOI 10.1161/01.CIR.82.4.1106; Fetsch T, 2004, EUR HEART J, V25, P1385, DOI 10.1016/j.ehj.2004.04.015; Hobbs WJC, 2000, CIRCULATION, V101, P1145, DOI 10.1161/01.CIR.101.10.1145; Kirchhof P, 2002, LANCET, V360, P1275, DOI 10.1016/S0140-6736(02)11315-8; Kirchhof P, 2005, BASIC RES CARDIOL, V100, P112, DOI 10.1007/s00395-005-0513-4; Kirchhof P, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.07.020; Kirchhof P, 2007, EUR HEART J, V28, P2803, DOI 10.1093/eurheartj/ehm358; Kirchhof P, 2007, HEART RHYTHM, V4, P790, DOI 10.1016/j.hrthm.2007.01.023; Kirchhof P, 2011, THROMB HAEMOSTASIS, V105, P1010, DOI 10.1160/TH11-02-0070; Kirchhof P, 2009, EUR HEART J, V30, P2969, DOI 10.1093/eurheartj/ehp235; Lafuente-Lafuente C, 2006, ARCH INTERN MED, V166, P719, DOI 10.1001/archinte.166.7.719; Madrid AH, 2002, CIRCULATION, V106, P331, DOI 10.1161/01.CIR.0000022665.18619.83; Manios EG, 2000, CARDIOVASC RES, V47, P244, DOI 10.1016/S0008-6363(00)00100-0; Perneger TV, 2005, J CLIN EPIDEMIOL, V58, P142, DOI 10.1016/j.jclinepi.2004.06.005; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Singh BN, 2005, NEW ENGL J MED, V352, P1861, DOI 10.1056/NEJMoa041705; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954	28	99	103	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2012	380	9838					238	246		10.1016/S0140-6736(12)60570-4	http://dx.doi.org/10.1016/S0140-6736(12)60570-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	976TV	22713626				2022-12-28	WOS:000306609200033
J	Kinoshita, M; Matsui, R; Kato, S; Hasegawa, T; Kasahara, H; Isa, K; Watakabe, A; Yamamori, T; Nishimura, Y; Alstermark, B; Watanabe, D; Kobayashi, K; Isa, T				Kinoshita, Masaharu; Matsui, Ryosuke; Kato, Shigeki; Hasegawa, Taku; Kasahara, Hironori; Isa, Kaoru; Watakabe, Akiya; Yamamori, Tetsuo; Nishimura, Yukio; Alstermark, Bror; Watanabe, Dai; Kobayashi, Kazuto; Isa, Tadashi			Genetic dissection of the circuit for hand dexterity in primates	NATURE			English	Article							DISYNAPTIC PYRAMIDAL EXCITATION; SPINAL-CORD-INJURY; PROPRIOSPINAL NEURONS; FORELIMB MOTONEURONS; MACAQUE MONKEY; MOTOR SYSTEM; EXPRESSION; PATHWAYS; INTEGRATION; CAT	It is generally accepted that the direct connection from the motor cortex to spinal motor neurons is responsible for dexterous hand movements in primates(1-3). However, the role of the 'phylogenetically older' indirect pathways from the motor cortex to motor neurons, mediated by spinal interneurons, remains elusive. Here we used a novel double-infection technique to interrupt the transmission through the propriospinal neurons (PNs)(4-6), which act as a relay of the indirect pathway in macaque monkeys (Macaca fuscata and Macaca mulatta). The PNs were double infected by injection of a highly efficient retrograde gene-transfer vector into their target area and subsequent injection of adeno-associated viral vector at the location of cell somata. This method enabled reversible expression of green fluorescent protein (GFP)-tagged tetanus neurotoxin, thereby permitting the selective and temporal blockade of the motor cortex-PN-motor neuron pathway. This treatment impaired reach and grasp movements, revealing a critical role for the PN-mediated pathway in the control of hand dexterity. Anti-GFP immunohistochemistry visualized the cell bodies and axonal trajectories of the blocked PNs, which confirmed their anatomical connection to motor neurons. This pathway-selective and reversible technique for blocking neural transmission does not depend on cell-specific promoters or transgenic techniques, and is a new and powerful tool for functional dissection in system-level neuroscience studies.	[Kinoshita, Masaharu; Isa, Kaoru; Nishimura, Yukio; Isa, Tadashi] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan; [Matsui, Ryosuke; Hasegawa, Taku; Kasahara, Hironori; Watanabe, Dai] Kyoto Univ, Grad Sch Biostudies, Dept Mol & Syst Biol, Sakyo Ku, Kyoto 6068501, Japan; [Kato, Shigeki; Kobayashi, Kazuto] Fukushima Med Univ Sch Med, Inst Biomed Sci, Dept Mol Genet, Fukushima 9601295, Japan; [Watakabe, Akiya; Yamamori, Tetsuo] Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 4448585, Japan; [Watakabe, Akiya; Yamamori, Tetsuo; Nishimura, Yukio; Isa, Tadashi] Grad Univ Adv Studies Sokendai, Kanagawa 2400193, Japan; [Nishimura, Yukio] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Tokyo 1020076, Japan; [Alstermark, Bror] Umea Univ, Physiol Sect, Dept Integrat Med Biol, S-90187 Umea, Sweden	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kyoto University; Fukushima Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Umea University	Isa, T (corresponding author), Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 4448585, Japan.	tisa@nips.ac.jp	Kinoshita, Masaharu/N-8450-2019; Yamamori, Tetsuo/N-6536-2015; Kato, Shigeki/S-8016-2018; Kinoshita, Masaharu/A-5464-2019	Kinoshita, Masaharu/0000-0001-8588-843X; Yamamori, Tetsuo/0000-0001-5016-0078; Kato, Shigeki/0000-0002-8792-7591; Kinoshita, Masaharu/0000-0001-8588-843X; Kobayashi, Kazuto/0000-0002-7617-2939; Hasegawa, Taku/0000-0003-4837-0855	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Swedish Research Council	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank S. Nakanishi, H. Jingami and C. Akazawa for continuous encouragement. We thank P. Redgrave for comments on the earlier version of the manuscript. This study was supported by the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. B. A. was supported by the Swedish Research Council. We thank T. Oishi for providing macaque brain sample tissue. We thank P. Phongphanphanee, M. Togawa, Y. Yamanishi, T. Katoh, K. Shimizu, N. Takahashi and K. Takada for technical support.	ALSTERMARK B, 1981, EXP BRAIN RES, V42, P282, DOI 10.1007/BF00237495; Alstermark B, 1999, J NEUROPHYSIOL, V82, P3580, DOI 10.1152/jn.1999.82.6.3580; ALSTERMARK B, 1990, EXP BRAIN RES, V80, P1; Alstermark B, 2011, J NEUROPHYSIOL, V106, P122, DOI 10.1152/jn.00089.2011; ALSTERMARK B, 1992, IBRO SER, P327; BOCKER R, 1983, J CHROMATOGR, V274, P255, DOI 10.1016/S0378-4347(00)84428-X; Croyle MA, 2001, GENE THER, V8, P1281, DOI 10.1038/sj.gt.3301527; Diester I, 2011, NAT NEUROSCI, V14, P387, DOI 10.1038/nn.2749; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Hioki H, 2009, NEUROSCI RES, V63, P149, DOI 10.1016/j.neures.2008.10.010; ILLERT M, 1977, EXP BRAIN RES, V29, P323; Isa T, 2006, J NEUROPHYSIOL, V95, P3674, DOI 10.1152/jn.00103.2005; Kaneda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018452; Kato S, 2007, HUM GENE THER, V18, P1141, DOI 10.1089/hum.2007.082; Kato S, 2011, J NEUROSCI, V31, P17169, DOI 10.1523/JNEUROSCI.4005-11.2011; Kato S, 2011, HUM GENE THER, V22, P197, DOI 10.1089/hum.2009.179; Komatsu Y, 2005, CEREB CORTEX, V15, P96, DOI 10.1093/cercor/bhh112; KUYPERS HGJM, 1982, PROG BRAIN RES, V57, P381, DOI 10.1016/S0079-6123(08)64138-2; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nishimura Y, 2007, SCIENCE, V318, P1150, DOI 10.1126/science.1147243; Nishimura Y, 2009, BRAIN, V132, P709, DOI 10.1093/brain/awn338; Sasaki S, 2004, J NEUROPHYSIOL, V92, P3142, DOI 10.1152/jn.00342.2004; Watakabe A, 2007, CEREB CORTEX, V17, P1918, DOI 10.1093/cercor/bhl102; Watakabe A, 2010, METHODS, V52, P367, DOI 10.1016/j.ymeth.2010.07.003; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780	32	172	173	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2012	487	7406					235	U1510		10.1038/nature11206	http://dx.doi.org/10.1038/nature11206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22722837				2022-12-28	WOS:000306278900040
J	Perner, A; Haase, N; Guttormsen, AB; Tenhunen, J; Klemenzson, G; Aneman, A; Madsen, KR; Moller, MH; Elkjaer, JM; Poulsen, LM; Bendtsen, A; Winding, R; Steensen, M; Berezowicz, P; Soe-Jensen, P; Bestle, M; Strand, K; Wiis, J; White, JO; Thornberg, KJ; Quist, L; Nielsen, J; Andersen, LH; Holst, LB; Thormar, K; Kjaeldgaard, AL; Fabritius, ML; Mondrup, F; Pott, FC; Moller, TP; Winkel, P; Wetterslev, J				Perner, Anders; Haase, Nicolai; Guttormsen, Anne B.; Tenhunen, Jyrki; Klemenzson, Gudmundur; Aneman, Anders; Madsen, Kristian R.; Moller, Morten H.; Elkjaer, Jeanie M.; Poulsen, Lone M.; Bendtsen, Asger; Winding, Robert; Steensen, Morten; Berezowicz, Pawel; Soe-Jensen, Peter; Bestle, Morten; Strand, Kristian; Wiis, Jorgen; White, Jonathan O.; Thornberg, Klaus J.; Quist, Lars; Nielsen, Jonas; Andersen, Lasse H.; Holst, Lars B.; Thormar, Katrin; Kjaeldgaard, Anne-Lene; Fabritius, Maria L.; Mondrup, Frederik; Pott, Frank C.; Moller, Thea P.; Winkel, Per; Wetterslev, Jorn		6S Trial Grp; Scandinavian Critical Care Trials	Hydroxyethyl Starch 130/0.4 versus Ringer's Acetate in Severe Sepsis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE-RENAL-FAILURE; SEPTIC SHOCK; RESUSCITATION; THERAPY; MULTICENTER; MORTALITY; IMPACT; SAFETY; TRIAL; SCORE	BACKGROUND Hydroxyethyl starch (HES) 130/0.4 is widely used for fluid resuscitation in intensive care units (ICUs), but its safety and efficacy have not been established in patients with severe sepsis. METHODS In this multicenter, parallel-group, blinded trial, we randomly assigned patients with severe sepsis to fluid resuscitation in the ICU with either 6% HES 130/0.4 or Ringer's acetate at a dose of up to 33 ml per kilogram of ideal body weight per day. The primary outcome measure was either death or end-stage kidney failure (dependence on dialysis) at 90 days after randomization. RESULTS Of the 804 patients who underwent randomization, 798 were included in the modified intention-to-treat population. The two intervention groups had similar baseline characteristics. At 90 days after randomization, 201 of 398 patients (51%) assigned to HES 130/0.4 had died, as compared with 172 of 400 patients (43%) assigned to Ringer's acetate (relative risk, 1.17; 95% confidence interval [CI], 1.01 to 1.36; P=0.03); 1 patient in each group had end-stage kidney failure. In the 90-day period, 87 patients (22%) assigned to HES 130/0.4 were treated with renal-replacement therapy versus 65 patients (16%) assigned to Ringer's acetate (relative risk, 1.35; 95% CI, 1.01 to 1.80; P=0.04), and 38 patients (10%) and 25 patients (6%), respectively, had severe bleeding (relative risk, 1.52; 95% CI, 0.94 to 2.48; P=0.09). The results were supported by multivariate analyses, with adjustment for known risk factors for death or acute kidney injury at baseline. CONCLUSIONS Patients with severe sepsis assigned to fluid resuscitation with HES 130/0.4 had an increased risk of death at day 90 and were more likely to require renal-replacement therapy, as compared with those receiving Ringer's acetate. (Funded by the Danish Research Council and others; 6S ClinicalTrials.gov number, NCT00962156.)	[Perner, Anders; Haase, Nicolai; Wiis, Jorgen; White, Jonathan O.; Thornberg, Klaus J.; Quist, Lars; Nielsen, Jonas; Andersen, Lasse H.; Holst, Lars B.; Thormar, Katrin] Rigshosp, Copenhagen Univ Hosp, Dept Intens Care, DK-2100 Copenhagen, Denmark; [Winkel, Per; Wetterslev, Jorn] Rigshosp, Copenhagen Univ Hosp, Copenhagen Trial Unit, Ctr Clin Intervent Res, DK-2100 Copenhagen, Denmark; [Madsen, Kristian R.; Kjaeldgaard, Anne-Lene; Fabritius, Maria L.; Mondrup, Frederik] Naestved Hosp, Naestved, Denmark; [Elkjaer, Jeanie M.; Moller, Thea P.] Holbaek Cent Hosp, Holbaek, Denmark; [Poulsen, Lone M.] Koge Hosp, Koge, Denmark; [Bendtsen, Asger] Copenhagen Univ Hosp, Glostrup, Denmark; [Winding, Robert] Herning Hosp, Herning, Denmark; [Steensen, Morten] Copenhagen Univ Hosp, Hvidovre, Denmark; [Berezowicz, Pawel] Vejle Hosp, Vejle, Denmark; [Soe-Jensen, Peter] Copenhagen Univ Hosp, Herlev, Denmark; [Bestle, Morten] Copenhagen Univ Hosp, Hillerod, Denmark; [Guttormsen, Anne B.] Haukeland Hosp, N-5021 Bergen, Norway; [Guttormsen, Anne B.] Univ Bergen, Bergen, Norway; [Strand, Kristian] Stavanger Univ Hosp, Stavanger, Norway; [Tenhunen, Jyrki] Tampere Univ Hosp, Tampere, Finland; [Tenhunen, Jyrki] Uppsala Univ, Uppsala, Sweden; [Klemenzson, Gudmundur] Landspitali, Reykjavik, Iceland; [Aneman, Anders] Liverpool Hosp, Sydney, NSW, Australia	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Holbaek Hospital; University of Copenhagen; Aarhus University; University of Copenhagen; University of Southern Denmark; Lillebaelt Hospital; University of Copenhagen; University of Copenhagen; University of Bergen; Stavanger University Hospital; Tampere University; Tampere University Hospital; Uppsala University; Liverpool Hospital	Perner, A (corresponding author), Rigshosp, Dept Intens Care 4131, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	anders.perner@rh.regionh.dk	Wetterslev, Jørn/ABF-1251-2020; Møller, Morten Hylander/AAQ-6891-2020; Epelde, Francisco/AAT-7213-2021; Moller, Kirsten/A-4751-2009	Wetterslev, Jørn/0000-0001-7778-1771; Møller, Morten Hylander/0000-0002-6378-9673; Epelde, Francisco/0000-0001-5547-4025; Moller, Thea Palsgaard/0000-0001-7658-2447; Brunkhorst, Frank Martin/0000-0002-8132-8651; Vested, Matias/0000-0002-5165-2725; Poulsen, Lone Musaeus/0000-0002-7030-3395; Perner, Anders/0000-0002-4668-0123; Berthelsen, Rasmus Ehrenfreid/0000-0003-1945-0944; Moller, Thea Palsgaard/0000-0002-8436-6194; Aneman, Anders/0000-0003-2096-5304; Fabritius, Maria Louise/0000-0002-6497-2963; Moller, Kirsten/0000-0003-3058-1072; Rasmussen, Lars/0000-0002-7480-3004; Bestle, Morten/0000-0001-6585-2659	Danish Research Council [271-08-0691, 09-066938]; Rigshospitalet Research Council; Scandinavian Society of Anesthesiology and Intensive Care Medicine; ACTA Foundation; Fresenius Kabi	Danish Research Council(Det Frie Forskningsrad (DFF)); Rigshospitalet Research Council; Scandinavian Society of Anesthesiology and Intensive Care Medicine; ACTA Foundation; Fresenius Kabi	Supported by grants from the Danish Research Council (271-08-0691 and 09-066938), the Rigshospitalet Research Council, and the Scandinavian Society of Anesthesiology and Intensive Care Medicine (funded by the ACTA Foundation).; Dr. Perner reports receiving grant support from Fresenius Kabi. No other potential conflict of interest relevant to this article was reported.	Afshari A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005370.pub2; Bagshaw SM, 2006, INT J ARTIF ORGANS, V29, P1023, DOI 10.1177/039139880602901102; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Bellmann R, 2012, CLIN PHARMACOKINET, V51, P225, DOI 10.2165/11594700-000000000-00000; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Carlsen S, 2011, ACTA ANAESTH SCAND, V55, P394, DOI 10.1111/j.1399-6576.2011.02399.x; Christidis C, 2001, J HEPATOL, V35, P726, DOI 10.1016/S0168-8278(01)00200-8; Clermont G, 2002, KIDNEY INT, V62, P986, DOI 10.1046/j.1523-1755.2002.00509.x; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Expert Working Group International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 2009, ICH HARMONIZATION TR, V51; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6; Fluids Study Investigators, 2008, ACTA ANAESTH SCAND, V52, P750, DOI 10.1111/j.1399-6576.2008.01690.x; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; Hartog CS, 2011, ANESTH ANALG, V112, P635, DOI 10.1213/ANE.0b013e31820ad607; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; LEGALL JR, 1994, JAMA-J AM MED ASSOC, V271, P1321; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Perel P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub4; Perner A, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-24; Pillebout E, 2005, AM J TRANSPLANT, V5, P1120, DOI 10.1111/j.1600-6143.2005.00852.x; Reinhart K, 2012, INTENS CARE MED, V38, P368, DOI 10.1007/s00134-012-2472-9; Reinikainen M, 2010, INTENS CARE MED, V36, P673, DOI 10.1007/s00134-009-1688-9; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Sakr Y, 2007, BRIT J ANAESTH, V98, P216, DOI 10.1093/bja/ael333; Schmidt-Hieber M, 2006, EUR J HAEMATOL, V77, P83, DOI 10.1111/j.1600-0609.2006.00657.x; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Warren BL, 2002, JAMA-J AM MED ASSOC, V287, P192	33	1190	1270	2	89	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2012	367	2					124	134		10.1056/NEJMoa1204242	http://dx.doi.org/10.1056/NEJMoa1204242			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	972IO	22738085				2022-12-28	WOS:000306270800009
J	Asch, DA; Muller, RW; Volpp, KG				Asch, David A.; Muller, Ralph W.; Volpp, Kevin G.			Automated Hovering in Health Care - Watching Over the 5000 Hours	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FINANCIAL INCENTIVES		[Asch, David A.; Volpp, Kevin G.] Univ Penn, Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA 19104 USA; [Asch, David A.; Muller, Ralph W.; Volpp, Kevin G.] Univ Penn, Hlth Syst Ctr Innovat Hlth Care Financing, Philadelphia, PA 19104 USA; [Asch, David A.; Volpp, Kevin G.] Univ Penn, Penn CMU Roybal Ctr Behav Econ & Hlth P30, Philadelphia, PA 19104 USA; [Asch, David A.; Muller, Ralph W.; Volpp, Kevin G.] Univ Penn, Ctr Hlth Incent & Behav Econ, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Asch, David A.; Volpp, Kevin G.] Univ Penn, Perelman Sch, Philadelphia, PA 19104 USA; [Asch, David A.; Volpp, Kevin G.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Carnegie Mellon University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Asch, DA (corresponding author), Univ Penn, Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA 19104 USA.			Asch, David/0000-0002-7970-286X; Volpp, Kevin/0000-0003-1423-4599				Gawande Atul, 2011, NEW YORKER      0124; Long JA, 2012, ANN INTERN MED, V156, P416, DOI 10.7326/0003-4819-156-6-201203200-00004; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Volpp KG, 2011, NEW ENGL J MED, V365, P388, DOI 10.1056/NEJMp1105966; Volpp KG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-272	5	119	119	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 5	2012	367	1					1	3		10.1056/NEJMp1203869	http://dx.doi.org/10.1056/NEJMp1203869			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	968KJ	22716935	Green Published			2022-12-28	WOS:000305979400014
J	Chen, JN; Badioli, M; Alonso-Gonzalez, P; Thongrattanasiri, S; Huth, F; Osmond, J; Spasenovic, M; Centeno, A; Pesquera, A; Godignon, P; Elorza, AZ; Camara, N; de Abajo, FJG; Hillenbrand, R; Koppens, FHL				Chen, Jianing; Badioli, Michela; Alonso-Gonzalez, Pablo; Thongrattanasiri, Sukosin; Huth, Florian; Osmond, Johann; Spasenovic, Marko; Centeno, Alba; Pesquera, Amaia; Godignon, Philippe; Zurutuza Elorza, Amaia; Camara, Nicolas; Javier Garcia de Abajo, F.; Hillenbrand, Rainer; Koppens, Frank H. L.			Optical nano-imaging of gate-tunable graphene plasmons	NATURE			English	Article							SCATTERING; DYNAMICS; SCALE	The ability to manipulate optical fields and the energy flow of light is central to modern information and communication technologies, as well as quantum information processing schemes. However, because photons do not possess charge, a way of controlling them efficiently by electrical means has so far proved elusive. A promising way to achieve electric control of light could be through plasmon polaritons-coupled excitations of photons and charge carriers-in graphene(1-5). In this two-dimensional sheet of carbon atoms(6), it is expected that plasmon polaritons and their associated optical fields can readily be tuned electrically by varying the graphene carrier density. Although evidence of optical graphene plasmon resonances has recently been obtained spectroscopically(7,8), no experiments so far have directly resolved propagating plasmons in real space. Here we launch and detect propagating optical plasmons in tapered graphene nanostructures using near-field scattering microscopy with infrared excitation light(9-11). We provide real-space images of plasmon fields, and find that the extracted plasmon wavelength is very short-more than 40 times smaller than the wavelength of illumination. We exploit this strong optical field confinement to turn a graphene nanostructure into a tunable resonant plasmonic cavity with extremely small mode volume. The cavity resonance is controlled in situ by gating the graphene, and in particular, complete switching on and off of the plasmon modes is demonstrated, thus paving the way towards graphene-based optical transistors. This successful alliance between nanoelectronics and nano-optics enables the development of active subwavelength-scale optics and a plethora of nano-optoelectronic devices and functionalities, such as tunable metamaterials(12), nanoscale optical processing, and strongly enhanced light-matter interactions for quantum devices(13) and biosensing applications.	[Thongrattanasiri, Sukosin; Javier Garcia de Abajo, F.] CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain; [Chen, Jianing; Alonso-Gonzalez, Pablo; Huth, Florian; Hillenbrand, Rainer] CIC nanoGUNE Consolider, Donostia San Sebastian 20018, Spain; [Chen, Jianing] Ctr Fis Mat CSIC UPV EHU, Donostia San Sebastian 20018, Spain; [Chen, Jianing] DIPC, Donostia San Sebastian 20018, Spain; [Badioli, Michela; Osmond, Johann; Spasenovic, Marko; Koppens, Frank H. L.] ICFO Inst Ciencies Foton, Barcelona 08860, Spain; [Huth, Florian] Neaspec GmbH, D-82152 Munich, Germany; [Centeno, Alba; Pesquera, Amaia; Zurutuza Elorza, Amaia] Graphenea SA, Donostia San Sebastian 20018, Spain; [Godignon, Philippe] CSIC, IMB, CNM, Barcelona 08193, Spain; [Camara, Nicolas] Univ Tours, CNRS, UMR 7347, GREMAN, F-37071 Tours 2, France; [Hillenbrand, Rainer] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Basque Country; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Microelectronica (CNM); CSIC - Instituto de Microelectronica de Barcelona (IMB-CNM); Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Basque Foundation for Science	de Abajo, FJG (corresponding author), CSIC, Inst Quim Fis Rocasolano, Serrano 119, E-28006 Madrid, Spain.	J.G.deAbajo@csic.es; r.hillenbrand@nanogune.eu; frank.koppens@icfo.es	Koppens, Frank/X-4422-2018; Spasenović, Marko/ABC-4552-2021; Badioli, Michela/J-1984-2014; Huth, Florian/E-9725-2012; García de Abajo, Javier/A-6095-2009; Osmond, Johann/B-4995-2008; Chen, Jianing/G-2140-2012; Camara, Nicolas/ABE-6368-2020; Alonso-González, Pablo/B-8101-2013; Hillenbrand, Rainer/N-3428-2016	Koppens, Frank/0000-0001-9764-6120; Spasenović, Marko/0000-0002-2173-0972; García de Abajo, Javier/0000-0002-4970-4565; Chen, Jianing/0000-0002-7525-1424; Camara, Nicolas/0000-0002-8714-284X; Alonso-González, Pablo/0000-0002-4597-9326; Hillenbrand, Rainer/0000-0002-1904-4551; nanoGUNE, CIC/0000-0001-7874-5254; Godignon, Philippe/0000-0002-9273-9819	Fundacicio Cellex Barcelona; Spanish MICINN [MAT2010-14885, Consolider NanoLight.es]; European FP7 projects [FP7-HEALTH-F5-2009-241818-NANOANTENNA, FP7-ICT-2009-4-248909-LIMA, FP7-ICT-2009-4-248855-N4E]; ERC [258461]	Fundacicio Cellex Barcelona; Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European FP7 projects; ERC(European Research Council (ERC)European Commission)	We thank L. Novotny, N. van Hulst, R. Quidant and P. Jarillo-Herrero for discussions. This work was supported in part by the Fundacicio Cellex Barcelona, the Spanish MICINN (MAT2010-14885 and Consolider NanoLight.es), the European FP7 projects FP7-HEALTH-F5-2009-241818-NANOANTENNA, FP7-ICT-2009-4-248909-LIMA and FP7-ICT-2009-4-248855-N4E, the ERC Starting grant no. 258461 (TERATOMO), and the ERC Career integration grant GRANOP.	Atwater HA, 2007, SCI AM, V296, P56, DOI 10.1038/scientificamerican0407-56; Bostwick A, 2007, NAT PHYS, V3, P36, DOI 10.1038/nphys477; Camara N, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/37/374011; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Christensen J, 2012, ACS NANO, V6, P431, DOI 10.1021/nn2037626; Crassee I, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.035103; Eberlein T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.233406; Fei Z, 2011, NANO LETT, V11, P4701, DOI 10.1021/nl202362d; Hecht B, 1996, PHYS REV LETT, V77, P1889, DOI 10.1103/PhysRevLett.77.1889; Hill A, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/27005; Hillenbrand R, 2002, NATURE, V418, P159, DOI 10.1038/nature00899; HOFMANN M, 1994, PHYS REV B, V50, P13401, DOI 10.1103/PhysRevB.50.13401; Huber A, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2032595; Hwang EH, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205418; Jablan M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245435; Ju L, 2011, NAT NANOTECHNOL, V6, P630, DOI [10.1038/nnano.2011.146, 10.1038/NNANO.2011.146]; Keilmann F, 2004, PHILOS T R SOC A, V362, P787, DOI 10.1098/rsta.2003.1347; Koppens FHL, 2011, NANO LETT, V11, P3370, DOI 10.1021/nl201771h; Liu Y, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.201403; Nikitin AY, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.161407; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Novotny L., 2012, PRINCIPLES NANOOPTIC; Ocelic N, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2348781; Polini M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.081411; Thongrattanasiri S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.047401; Vakil A, 2011, SCIENCE, V332, P1291, DOI 10.1126/science.1202691; Wunsch B, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/12/318; Zhou W, 2012, NAT NANOTECHNOL, V7, P161, DOI [10.1038/nnano.2011.252, 10.1038/NNANO.2011.252]; Zia R, 2006, MATER TODAY, V9, P20, DOI 10.1016/S1369-7021(06)71572-3	29	1521	1554	51	1453	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					77	81		10.1038/nature11254	http://dx.doi.org/10.1038/nature11254			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722861	Green Submitted			2022-12-28	WOS:000305982900053
J	Yen, KY; Vinayachandran, V; Batta, K; Koerber, RT; Pugh, BF				Yen, Kuangyu; Vinayachandran, Vinesh; Batta, Kiran; Koerber, R. Thomas; Pugh, B. Franklin			Genome-wide Nucleosome Specificity and Directionality of Chromatin Remodelers	CELL			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; EXTRANUCLEOSOMAL DNA; IN-VIVO; PROMOTER NUCLEOSOMES; ISW2-NUCLEOSOME COMPLEX; SWI/SNF COMPLEX; YEAST; TRANSCRIPTION; ISWI	How chromatin remodelers cooperate to organize nucleosomes around the start and end of genes is not known. We determined the genome-wide binding of remodeler complexes SWI/SNF, RSC, ISW1a, ISW1b, ISW2, and INO80 to individual nucleosomes in Saccharomyces, and determined their functional contributions to nucleosome positioning through deletion analysis. We applied ultra-high-resolution ChIP-exo mapping to Isw2 to determine its subnucleosomal orientation and organization on a genomic scale. Remodelers interacted with selected nucleosome positions relative to the start and end of genes and produced net directionality in moving nucleosomes either away or toward nucleosome-free regions at the 5' and 3' ends of genes. Isw2 possessed a subnucleosomal organization in accord with biochemical and crystallographic-based models that place its linker binding region within promoters and abutted against Reb1-bound locations. Together, these findings reveal a coordinated position-specific approach taken by remodelers to organize genic nucleosomes into arrays.	[Yen, Kuangyu; Vinayachandran, Vinesh; Batta, Kiran; Koerber, R. Thomas; Pugh, B. Franklin] Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Yen, Kuangyu; Vinayachandran, Vinesh; Batta, Kiran; Koerber, R. Thomas; Pugh, B. Franklin] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	bfp2@psu.edu	Vinayachandran, Vinesh/ABD-6386-2020	Vinayachandran, Vinesh/0000-0002-2045-6086	National Institutes of Health [5R01HG4160]; Pennsylvania Department of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Charles V. Meade, David Goffman, Anna Chan, Kasthuri Kannan, and Yunfei Li for assistance in nucleosome preparation, DNA sequencing, and data analysis. This work was funded by National Institutes of Health Grant 5R01HG4160 and The Pennsylvania Department of Health using Tobacco Settlement Funds.	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5; Angermayr M, 2003, J BIOL CHEM, V278, P17918, DOI 10.1074/jbc.M301806200; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Celona B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001086; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FEDOR MJ, 1988, J MOL BIOL, V204, P109, DOI 10.1016/0022-2836(88)90603-1; Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015; Gangaraju VK, 2007, MOL CELL BIOL, V27, P3217, DOI 10.1128/MCB.01731-06; Gkikopoulos T, 2011, SCIENCE, V333, P1758, DOI 10.1126/science.1206097; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Hota SK, 2011, BBA-GENE REGUL MECH, V1809, P476, DOI 10.1016/j.bbagrm.2011.05.007; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Langst G, 2001, MOL CELL, V8, P1085, DOI 10.1016/S1097-2765(01)00397-5; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Matangkasombut O, 2000, GENE DEV, V14, P951; McKnight JN, 2011, MOL CELL BIOL, V31, P4746, DOI 10.1128/MCB.05735-11; Mellor J, 2004, BBA-GENE STRUCT EXPR, V1677, P100, DOI 10.1016/j.bbaexp.2003.10.014; Montel F, 2011, NUCLEIC ACIDS RES, V39, P2571, DOI 10.1093/nar/gkq1254; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Narlikar GJ, 2010, CURR OPIN CHEM BIOL, V14, P660, DOI 10.1016/j.cbpa.2010.08.001; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; SCHMID A, 1992, CELL, V71, P853, DOI 10.1016/0092-8674(92)90560-Y; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Singh SK, 2010, CELL, V142, P868, DOI 10.1016/j.cell.2010.08.013; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Tirosh I, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r49; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Udugama M, 2011, MOL CELL BIOL, V31, P662, DOI 10.1128/MCB.01035-10; Vary JC, 2003, MOL CELL BIOL, V23, P80, DOI 10.1128/MCB.23.1.80-91.2003; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Whitehouse I, 2006, NAT STRUCT MOL BIOL, V13, P633, DOI 10.1038/nsmb1111; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071; Zofall M, 2004, MOL CELL BIOL, V24, P10047, DOI 10.1128/MCB.24.22.10047-10057.2004	67	209	209	1	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1461	1473		10.1016/j.cell.2012.04.036	http://dx.doi.org/10.1016/j.cell.2012.04.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726434	Bronze, Green Accepted			2022-12-28	WOS:000305753800013
J	Dunne, J; Evershed, RP; Salque, M; Cramp, L; Bruni, S; Ryan, K; Biagetti, S; di Lernia, S				Dunne, Julie; Evershed, Richard P.; Salque, Melanie; Cramp, Lucy; Bruni, Silvia; Ryan, Kathleen; Biagetti, Stefano; di Lernia, Savino			First dairying in green Saharan Africa in the fifth millennium BC	NATURE			English	Article							LACTASE-PERSISTENCE PHENOTYPE; ORGANIC RESIDUE ANALYSIS; ARCHAEOLOGICAL POTTERY; CATTLE; LIBYA; MILK; DATE	In the prehistoric green Sahara of Holocene North Africa-in contrast to the Neolithic of Europe and Eurasia-a reliance on cattle, sheep and goats emerged as a stable and widespread way of life, long before the first evidence for domesticated plants or settled village farming communities(1-3). The remarkable rock art found widely across the region depicts cattle herding among early Saharan pastoral groups, and includes rare scenes of milking; however, these images can rarely be reliably dated(4). Although the faunal evidence provides further confirmation of the importance of cattle and other domesticates(5), the scarcity of cattle bones makes it impossible to ascertain herd structures via kill-off patterns, thereby precluding interpretations of whether dairying was practiced. Because pottery production begins early in northern Africa(6) the potential exists to investigate diet and subsistence practices using molecular and isotopic analyses of absorbed food residues(7). This approach has been successful in determining the chronology of dairying beginning in the 'Fertile Crescent' of the Near East and its spread across Europe(8-11). Here we report the first unequivocal chemical evidence, based on the delta C-13 and Delta C-13 values of the major alkanoic acids of milk fat, for the adoption of dairying practices by prehistoric Saharan African people in the fifth millennium BC. Interpretations are supported by a new database of modern ruminant animal fats collected from Africa. These findings confirm the importance of 'lifetime products', such as milk, in early Saharan pastoralism, and provide an evolutionary context for the emergence of lactase persistence in Africa.	[Dunne, Julie; Evershed, Richard P.; Salque, Melanie; Cramp, Lucy] Univ Bristol, Sch Chem, Organ Geochem Unit, Bristol BS8 1TS, Avon, England; [Bruni, Silvia] Univ Milan, Dipartimento Chim Inorgan Metallorgan & Analit La, I-20133 Milan, Italy; [Ryan, Kathleen] Univ Penn, African Sect, Museum Archaeol & Anthropol, Philadelphia, PA 19104 USA; [Biagetti, Stefano; di Lernia, Savino] Univ Roma La Sapienza, Dipartimento Sci Antichita, I-00185 Rome, Italy; [di Lernia, Savino] Univ Witwatersrand, Sch Geog Archaeology& Environm Sci, ZA-2050 Wits, South Africa	University of Bristol; University of Milan; University of Pennsylvania; Sapienza University Rome; University of Witwatersrand	Evershed, RP (corresponding author), Univ Bristol, Sch Chem, Organ Geochem Unit, Cantocks Close, Bristol BS8 1TS, Avon, England.	r.p.evershed@bristol.ac.uk; Savino.Dilernia@uniroma1.it	di Lernia, Savino/AAI-4535-2020; biagetti, stefano/M-4875-2015; Bruni, Silvia/R-4100-2016; Cramp, Lucy/AAL-6905-2021	biagetti, stefano/0000-0003-0936-3070; Bruni, Silvia/0000-0002-5077-0391; Roffet-Salque, Melanie/0000-0001-9508-788X	UK Natural Environment Research Council; Sapienza, University of Rome (Grandi Scavi di Ateneo); Minister of Foreign Affairs (DGSP); USA National Science Foundation; Royal Society	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Sapienza, University of Rome (Grandi Scavi di Ateneo); Minister of Foreign Affairs (DGSP); USA National Science Foundation(National Science Foundation (NSF)); Royal Society(Royal Society of London)	We thank the UK Natural Environment Research Council for a PhD studentship to J. D. and the Life Science Mass Spectrometry Facility. Sapienza, University of Rome (Grandi Scavi di Ateneo) and The Minister of Foreign Affairs (DGSP) are thanked for funding for the Italian Archaeological Mission in the Sahara. Our Libyan colleagues in the Departments of Archaeology in Tripoli and Ghat, in particular S. Agab, are also thanked. The USA National Science Foundation and The Royal Society are further thanked for funding.	Biagetti S., 2007, BRIT ARCHAEOLOGICA S, VS1655, P125; Biagetti S., 2004, J AFR ARCHAEOL, V2, P3; Caneva I., 1987, BRIT ARCHAEOLOGICAL, VS368, p[1978, 231]; CHARTERS S, 1993, ARCHAEOMETRY, V35, P211, DOI 10.1111/j.1475-4754.1993.tb01036.x; Christie W. W., 1981, LIPID METABOLISM RUM; Copley MS, 2003, P NATL ACAD SCI USA, V100, P1524, DOI 10.1073/pnas.0335955100; Copley MS, 2001, P ROY SOC B-BIOL SCI, V268, P593, DOI 10.1098/rspb.2000.1394; Craig OE, 2005, ANTIQUITY, V79, P882, DOI 10.1017/S0003598X00115017; Cremaschi M, 2010, PALAEOGEOGR PALAEOCL, V287, P81, DOI 10.1016/j.palaeo.2010.01.019; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; di Lernia S, 2002, DROUGHTS FOOD CULTUR, P225; di Lernia S, 2010, ANTIQUITY, V84, P954, DOI 10.1017/S0003598X00067016; Dudd SN, 1998, SCIENCE, V282, P1478, DOI 10.1126/science.282.5393.1478; Evershed RP, 2008, ARCHAEOMETRY, V50, P895, DOI 10.1111/j.1475-4754.2008.00446.x; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Gallinaro M., 2008, MEMORIA ARTE PITTURE, P73; Gautier A., 2002, DROUGHTS FOOD CULTUR, P195, DOI [10.1007/0-306-47547-2_12, DOI 10.1007/0-306-47547-2_12]; Gifford-Gonzalez D, 2011, J WORLD PREHIST, V24, P1, DOI DOI 10.1007/s10963-010-9042-2; Gregg MW, 2009, J ARCHAEOL SCI, V36, P937, DOI 10.1016/j.jas.2008.09.009; Huysecom E, 2009, ANTIQUITY, V83, P905, DOI 10.1017/S0003598X00099245; Itan Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-36; Lutz R., 1995, SECRET DESERT ROCK A; Marshall F, 2002, J WORLD PREHIST, V16, P99, DOI 10.1023/A:1019954903395; Mills, 1987, ORGANIC CHEM MUSEUM; Mulcare CA, 2004, AM J HUM GENET, V74, P1102, DOI 10.1086/421050; Outram AK, 2009, SCIENCE, V323, P1332, DOI 10.1126/science.1168594; SHERRATT A, 1983, WORLD ARCHAEOL, V15, P90, DOI 10.1080/00438243.1983.9979887; Spangenberg JE, 2006, J ARCHAEOL SCI, V33, P1, DOI 10.1016/j.jas.2005.05.013; Tulloch A. P., 1976, CHEM BIOCH NATURAL W, P235; West JB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P1, DOI 10.1007/978-90-481-3354-3	30	224	228	10	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					390	394		10.1038/nature11186	http://dx.doi.org/10.1038/nature11186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	961LV	22722200				2022-12-28	WOS:000305466800041
J	Gray, J; Druker, B				Gray, Joe; Druker, Brian			GENOMICS The breast cancer landscape	NATURE			English	Editorial Material							TUMORS		[Gray, Joe; Druker, Brian] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA	Oregon Health & Science University	Gray, J (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA.	grayjo@ohsu.edu; drukerb@ohsu.edu	Gray, Joe/AAX-9549-2020	Druker, Brian/0000-0001-8331-8206	NATIONAL CANCER INSTITUTE [U54CA112970] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA112970] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Corless CL, 2011, SCIENCE, V334, P1217, DOI 10.1126/science.1216427; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kristensen VN, 2012, P NATL ACAD SCI USA, V109, P2802, DOI 10.1073/pnas.1108781108; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sims D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r104; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a	19	31	33	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					328	329		10.1038/486328a	http://dx.doi.org/10.1038/486328a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722187				2022-12-28	WOS:000305466800027
J	Nakanishi, K; Weinberg, DE; Bartel, DP; Patel, DJ				Nakanishi, Kotaro; Weinberg, David E.; Bartel, David P.; Patel, Dinshaw J.			Structure of yeast Argonaute with guide RNA	NATURE			English	Article							CRYSTAL-STRUCTURE; RECOGNITION; SIRNA; DROSOPHILA; RISC; DNA; MECHANISMS; MICRORNAS; CLEAVAGE; SYSTEM	The RNA-induced silencing complex, comprising Argonaute and guide RNA, mediates RNA interference. Here we report the 3.2 angstrom crystal structure of Kluyveromyces polysporus Argonaute (KpAGO) fortuitously complexed with guide RNA originating from small-RNA duplexes autonomously loaded and processed by recombinant KpAGO. Despite their diverse sequences, guide-RNA nucleotides 1-8 are positioned similarly, with sequence-independent contacts to bases, phosphates and 2'-hydroxyl groups pre-organizing the backbone of nucleotides 2-8 in a near-A-form conformation. Compared with prokaryotic Argonautes, KpAGO has numerous surface-exposed insertion segments, with a cluster of conserved insertions repositioning the N domain to enable full propagation of guide-target pairing. Compared with Argonautes in inactive conformations, KpAGO has a hydrogen-bond network that stabilizes an expanded and repositioned loop, which inserts an invariant glutamate into the catalytic pocket. Mutation analyses and analogies to ribonuclease H indicate that insertion of this glutamate finger completes a universally conserved catalytic tetrad, thereby activating Argonaute for RNA cleavage.	[Nakanishi, Kotaro; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Weinberg, David E.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Weinberg, David E.; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Weinberg, David E.; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA	Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	dbartel@wi.mit.edu; pateld@mskcc.org		Nakanishi, Kotaro/0000-0002-9857-6010	National Institutes of Health [AI068776, GM61835]; Human Frontier Science Program Long-term Fellowship; Japan Society for the Promotion of Science; National Science Foundation graduate research fellowship; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061835, R37GM061835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Long-term Fellowship(Human Frontier Science Program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Science Foundation graduate research fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Rajashankar for data processing and phasing, V. Auyeung and D. Shechner for discussions, the Whitehead Genome Technology Core for high-throughput sequencing, and the NE-CAT beamline at the Advanced Photon Source. This work was supported by National Institutes of Health grants AI068776 (D.J.P.) and GM61835 (D. P. B.), a Human Frontier Science Program Long-term Fellowship (K.N.), a fellowship from the Japan Society for the Promotion of Science for Research Abroad (K.N.), and a National Science Foundation graduate research fellowship (D. E. W.). D. P. B. is an Investigator of the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Boland A, 2010, EMBO REP, V11, P522, DOI 10.1038/embor.2010.81; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hall TMT, 2005, STRUCTURE, V13, P1403, DOI 10.1016/j.str.2005.08.005; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan YP, 2003, NUCLEIC ACIDS RES, V31, P7131, DOI 10.1093/nar/gkg941; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Parker James S, 2010, Silence, V1, P3, DOI 10.1186/1758-907X-1-3; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Schirle N. T., 2012, SCIENCE         0426; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; SIKORSKI RS, 1989, GENETICS, V122, P19; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Weinberg DE, 2011, CELL, V146, P262, DOI 10.1016/j.cell.2011.06.021; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	64	220	227	4	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					368	+		10.1038/nature11211	http://dx.doi.org/10.1038/nature11211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722195	Green Accepted, Green Submitted			2022-12-28	WOS:000305466800036
J	King, WC; Chen, JY; Mitchell, JE; Kalarchian, MA; Steffen, KJ; Engel, SG; Courcoulas, AP; Pories, WJ; Yanovski, SZ				King, Wendy C.; Chen, Jia-Yuh; Mitchell, James E.; Kalarchian, Melissa A.; Steffen, Kristine J.; Engel, Scott G.; Courcoulas, Anita P.; Pories, Walter J.; Yanovski, Susan Z.			Prevalence of Alcohol Use Disorders Before and After Bariatric Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GASTRIC BYPASS-SURGERY; WEIGHT-LOSS; LONGITUDINAL ASSESSMENT; PSYCHIATRIC-DISORDERS; OBESITY; CANDIDATES; DEPENDENCE; DRINKING; COMORBIDITY; METABOLISM	Context Anecdotal reports suggest bariatric surgery may increase the risk of alcohol use disorder (AUD), but prospective data are lacking. Objective To determine the prevalence of preoperative and postoperative AUD, and independent predictors of postoperative AUD. Design, Setting, and Participants A prospective cohort study (Longitudinal Assessment of Bariatric Surgery-2) of adults who underwent bariatric surgery at 10 US hospitals. Of 2458 participants, 1945 (78.8% female; 87.0% white; median age, 47 years; median body mass index, 45.8) completed preoperative and postoperative (at 1 year and/or 2 years) assessments between 2006 and 2011. Main Outcome Measure Past year AUD symptoms determined with the Alcohol Use Disorders Identification Test (indication of alcohol-related harm, alcohol dependence symptoms, or score >8). Results The prevalence of AUD symptoms did not significantly differ from 1 year before to 1 year after bariatric surgery (7.6% vs 7.3%; P=.98), but was significantly higher in the second postoperative year (9.6%; P=.01). The following preoperative variables were independently related to an increased odds of AUD after bariatric surgery: male sex (adjusted odds ratio [AOR], 2.14 [95% CI, 1.51-3.01]; P < .001), younger age (age per 10 years younger with preoperative AUD: AOR, 1.31 [95% CI, 1.03-1.68], P=.03; age per 10 years younger without preoperative AUD: AOR, 1.95 [95% CI, 1.65-2.30], P < .001), smoking (AOR, 2.58 [95% CI, 1.19-5.58]; P=.02), regular alcohol consumption (>= 2 drinks/week: AOR, 6.37 [95% CI, 4.17-9.72]; P < .001), AUD (eg, at age 45, AOR, 11.14 [95% CI, 7.71-16.10]; P < .001), recreational drug use (AOR, 2.38 [95% CI, 1.37-4.14]; P=.01), lower sense of belonging (12-item Interpersonal Support Evaluation List score per 1 point lower: AOR, 1.09 [95% CI, 1.04-1.15]; P=.01), and undergoing a Roux-en-Y gastric bypass procedure (AOR, 2.07 [95% CI, 1.40-3.08]; P < .001; reference category: laparoscopic adjustable gastric band procedure). Conclusion In this cohort, the prevalence of AUD was greater in the second postoperative year than the year prior to surgery or in the first postoperative year and was associated with male sex and younger age, numerous preoperative variables (smoking, regular alcohol consumption, AUD, recreational drug use, and lower interpersonal support) and undergoing a Roux-en-Y gastric bypass procedure. JAMA. 2012; 307(23):2516-2525 Published online June 18, 2012. doi:10.1001/jama.2012.6147 www.jama.com	[King, Wendy C.] Univ Pittsburgh, Dept Epidemiol, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Chen, Jia-Yuh] Univ Pittsburgh, Dept Biostat, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Kalarchian, Melissa A.] Univ Pittsburgh, Dept Psychiat, Sch Med, Pittsburgh, PA 15261 USA; [Mitchell, James E.; Steffen, Kristine J.; Engel, Scott G.] Neuropsychiat Res Inst, Fargo, ND USA; [Courcoulas, Anita P.] Univ Pittsburgh, Dept Surg, Med Ctr, Pittsburgh, PA 15261 USA; [Pories, Walter J.] E Carolina Univ, Dept Surg, Brody Sch Med, Greenville, NC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Neuropsychiatric Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; East Carolina University	King, WC (corresponding author), Univ Pittsburgh, Dept Epidemiol, Grad Sch Publ Hlth, 130 DeSoto St,Off 517, Pittsburgh, PA 15261 USA.	kingw@edc.pitt.edu	King, Wendy C/AAC-5122-2022	King, Wendy C/0000-0002-0740-0029; Kalarchian, Melissa/0000-0003-2099-9299	Allergan; Pfizer; Covidien; EndoGastric Solutions; Johnson & Johnson's Ethicon Endo-Surgery Inc; GlaxoSmithKline; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01 DK066557, U01-DK66667, UL1-RR024996, U01-DK66568, M01RR-00037, U01-DK66471, U01-DK66526, U01-DK66585, UL1-RR024153, U01-DK66555]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996, UL1RR024153, M01RR000037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066471, U01DK066667, U01DK066526, U01DK066557, U01DK066568, U01DK066585, U01DK066555] Funding Source: NIH RePORTER	Allergan(AbbVieAllergan); Pfizer(Pfizer); Covidien; EndoGastric Solutions; Johnson & Johnson's Ethicon Endo-Surgery Inc; GlaxoSmithKline(GlaxoSmithKline); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Courcoulas reported receiving research grants from Allergan, Pfizer, Covidien, and EndoGastric Solutions; and is both a consultant for and serves on the scientific advisory board of Johnson & Johnson's Ethicon Healthcare System. Dr Pories reported serving as a consultant to Johnson & Johnson's Ethicon Endo-Surgery Inc; and receiving research grants from Johnson & Johnson's Ethicon Endo-Surgery Inc and GlaxoSmithKline.; The Longitudinal Assessment of Bariatric Surgery-2 was funded by a cooperative agreement by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants U01 DK066557 (data coordinating center); U01-DK66667 and UL1-RR024996 (wColumbia-Presbyterian in collaboration with Cornell University Medical Center Clinical and Translational Research Center [CTRC]); U01-DK66568 and M01RR-00037 (University of Washington in collaboration with Cornell University Medical Center CTRC); U01-DK66471 (Neuropsychiatric Research Institute); U01-DK66526 (East Carolina University); U01-DK66585 and UL1-RR024153 (University of Pittsburgh Medical Center in collaboration with Cornell University Medical Center CTRC); and U01-DK66555 (Oregon Health & Science University).	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Barbor T., 2001, AUDIT ALCOHOL USE DI; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belle SH, 2007, SURG OBES RELAT DIS, V3, P116, DOI 10.1016/j.soard.2007.01.006; Black DW, 2003, OBES SURG, V13, P746, DOI 10.1381/096089203322509327; BROOKINGS JB, 1988, AM J COMMUN PSYCHOL, V16, P137, DOI 10.1007/BF00906076; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Buffington C.K., 2007, BARIATRIC TIMES, V4, P1; Buffington CK, 2007, BARIATRIC TIMES, V4, P21; Clark MM, 2003, OBES SURG, V13, P739, DOI 10.1381/096089203322509318; Dawson DA, 2005, DRUG ALCOHOL DEPEN, V77, P139, DOI 10.1016/j.drugalcdep.2004.07.012; Dixon JB, 2001, OBES SURG, V11, P200, DOI 10.1381/096089201321577884; Ertelt TW, 2008, SURG OBES RELAT DIS, V4, P647, DOI 10.1016/j.soard.2008.01.004; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Hagedorn JC, 2007, SURG OBES RELAT DIS, V3, P543, DOI 10.1016/j.soard.2007.07.003; Hasin DS, 2007, ARCH GEN PSYCHIAT, V64, P830, DOI 10.1001/archpsyc.64.7.830; Heinberg LJ, 2010, SURG OBES RELAT DIS, V6, P417, DOI 10.1016/j.soard.2010.04.001; Holt PR, 2011, LANCET, V378, P767, DOI 10.1016/S0140-6736(11)61372-X; Kalarchian MA, 2007, AM J PSYCHIAT, V164, P328, DOI 10.1176/appi.ajp.164.2.328; Kalarchian MA, 2008, SURG OBES RELAT DIS, V4, P544, DOI 10.1016/j.soard.2008.03.003; King WC, 2012, SURG OBES RELAT DIS, V8, P48, DOI 10.1016/j.soard.2011.07.003; Kleiner KD, 2004, J ADDICT DIS, V23, P105, DOI 10.1300/J069v23n03_08; Klockhoff H, 2002, BRIT J CLIN PHARMACO, V54, P587, DOI 10.1046/j.1365-2125.2002.01698.x; Lieber Charles S, 2005, Clin Liver Dis, V9, P1, DOI 10.1016/j.cld.2004.10.005; Livingston EH, 2010, AM J SURG, V200, P378, DOI 10.1016/j.amjsurg.2009.11.007; Maluenda F, 2010, OBES SURG, V20, P744, DOI 10.1007/s11695-010-0136-9; Mechanick JI, 2010, OBESITY, V18, P649; Mechanick JI, 2009, OBESITY, V17, pS1, DOI 10.1038/oby.2009.28; Mechanick JI, 2009, OBESITY SILVER SP S1, V17, pv; Mitchell JE, 2001, OBES SURG, V11, P464, DOI 10.1381/096089201321209341; Molenberghs G, 2007, MISSING DATA CLIN ST, P27; Muhlhans Barbara, 2009, Gen Hosp Psychiatry, V31, P414, DOI 10.1016/j.genhosppsych.2009.05.004; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; National Institutes of Health, NAT I HLTH CONS DEV; Odom J, 2010, OBES SURG, V20, P349, DOI 10.1007/s11695-009-9895-6; Peltzer K, 2011, AFR J PSYCHIATRY, V14, P30; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Rosenberger PH, 2006, J CLIN PSYCHIAT, V67, P1080, DOI 10.4088/JCP.v67n0710; Sarwer DB, 2004, OBES SURG, V14, P1148, DOI 10.1381/0960892042386922; Schuckit MA, 2000, J STUD ALCOHOL, V61, P827, DOI 10.15288/jsa.2000.61.827; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sogg S, 2007, SURG OBES RELAT DIS, V3, P366, DOI 10.1016/j.soard.2007.03.004; Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality, RES 2010 NAT SURV DR; Suzuki J, 2012, OBES SURG, V22, P201, DOI 10.1007/s11695-010-0346-1; Thavorncharoensap M, 2009, SUBST ABUSE TREAT PR, V4, DOI 10.1186/1747-597X-4-20; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Woodard GA, 2011, J AM COLL SURGEONS, V212, P209, DOI 10.1016/j.jamcollsurg.2010.09.020	49	277	282	2	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2012	307	23					2516	2525		10.1001/jama.2012.6147	http://dx.doi.org/10.1001/jama.2012.6147			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	960MB	22710289	Bronze, Green Accepted			2022-12-28	WOS:000305391400028
J	Ahmed, H; Naik, G; Willoughby, H; Edwards, AGK				Ahmed, Haroon; Naik, Gurudutt; Willoughby, Hannah; Edwards, Adrian G. K.			Communicating risk	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DECISION AID; HEALTH-RISK; UNCERTAINTY; INFORMATION; ART		[Naik, Gurudutt; Edwards, Adrian G. K.] Cardiff Univ, Sch Med, Cochrane Inst Primary Care & Publ Hlth, Cardiff CF14 4YS, S Glam, Wales; [Ahmed, Haroon] Foundry Town Clin, Aberdare, Scotland; [Ahmed, Haroon; Willoughby, Hannah] Cardiff Univ, Sch Med, Dept Postgrad Gen Practice Educ, Cardiff CF14 4YS, S Glam, Wales	Cardiff University; Cardiff University	Edwards, AGK (corresponding author), Cardiff Univ, Sch Med, Cochrane Inst Primary Care & Publ Hlth, Cardiff CF14 4YS, S Glam, Wales.	edwardsag@cf.ac.uk	Crichton, Jonathan/F-4588-2013	Crichton, Jonathan/0000-0002-8054-4272				Ahl A S, 1993, Rev Sci Tech, V12, P1045; Akl EA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006777.pub2; Akl EA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006776.pub2; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; BREWER NT, 2011, COMMUNICATING RISKS, P3; Edwards A, 2001, QUAL HEALTH CARE, V10, pI9; Edwards A, 2001, J HEALTH COMMUN, V6, P61, DOI 10.1080/10810730150501413; Edwards A., 2009, SHARED DECISION MAKI, V2nd, P135; Edwards AGK, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001865.pub2; Fagerlin A, 2011, JNCI-J NATL CANCER I, V103, P1436, DOI 10.1093/jnci/djr318; GIGERENZER G, 2002, RECKONING RISK LEARN, P201; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gigerenzer G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e245; Gigerenzer G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6386; Gotzsche P, 2012, SCREENING BREAST CAN, P2012; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Legare F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006732.pub2; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Lipkus IM, 2007, MED DECIS MAKING, V27, P696, DOI 10.1177/0272989x07307271; Moyer VA, 2012, ANN INTERN MED, V156, P392, DOI 10.7326/0003-4819-156-5-201203060-00015; Nagle C, 2008, BJOG-INT J OBSTET GY, V115, P339, DOI 10.1111/j.1471-0528.2007.01576.x; Neuner-Jehle S, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-15; Politi MC, 2007, MED DECIS MAKING, V27, P681, DOI 10.1177/0272989x07307270; Politi MC, 2011, HEALTH EXPECT, V14, P84, DOI 10.1111/j.1369-7625.2010.00626.x; Portnoy DB, 2011, HLTH EXPECT; Schwartz LM, 2011, ARCH INTERN MED, V171, P1463, DOI 10.1001/archinternmed.2011.396; Smith SK, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5370; Stacey D, 2011, COCHRANE DB SYST REV, V1; Steckelberg A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3193; Waldron CA, 2011, PATIENT EDUC COUNS, V82, P169, DOI 10.1016/j.pec.2010.04.014; Wegwarth O, 2011, PATIENT EDUC COUNS, V84, P251, DOI 10.1016/j.pec.2010.07.025; WEINSTEIN ND, 1995, HEALTH PSYCHOL, V14, P132, DOI 10.1037/0278-6133.14.2.132; BMJ CLIN EVIDENCE	33	88	88	2	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2012	344								e3996	10.1136/bmj.e3996	http://dx.doi.org/10.1136/bmj.e3996			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965BT	22709962	Green Accepted			2022-12-28	WOS:000305741800009
J	Gallwitz, B; Guzman, J; Dotta, F; Guerci, B; Simo, R; Basson, BR; Festa, A; Kiljanski, J; Sapin, H; Trautmann, M; Schernthaner, G				Gallwitz, Baptist; Guzman, Juan; Dotta, Francesco; Guerci, Bruno; Simo, Rafael; Basson, Bruce R.; Festa, Andreas; Kiljanski, Jacek; Sapin, Helene; Trautmann, Michael; Schernthaner, Guntram			Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial	LANCET			English	Article							BETA-CELL FUNCTION; INSULIN SENSITIVITY; VS. GLIMEPIRIDE; PARALLEL-GROUP; EFFICACY; LIRAGLUTIDE; SAFETY; ROSIGLITAZONE; MANAGEMENT; MELLITUS	Background Glycaemic control deteriorates progressively over time in patients with type 2 diabetes. Options for treatment escalation remain controversial after failure of first-line treatment with metformin. We compared add-on exenatide with glimepiride for durability of glycaemic control in patients with type 2 diabetes inadequately controlled by metformin alone. Methods We did an open-label, randomised controlled trial at 128 centres in 14 countries between Sept 5, 2006, and March 29, 2011. Patients aged 18-85 years with type 2 diabetes inadequately treated by metformin were randomly assigned via a computer-generated randomisation sequence to receive exenatide twice daily or glimepiride once daily as add-on to metformin. Randomisation was stratified by predetermined categories of glycated haemoglobin (HbA(1C)) concentration. The primary outcome was time to inadequate glycaemic control and need for alternative treatment, defined as an HbA(1c) concentration of more than 9% after the first 3 months of treatment, or more than 7% at two consecutive visits after the first 6 months. Analysis was by intention to treat. This trial is registered with EudraCT, number 2005-005448-21, and ClinicalTrials.gov, number NCT00359762. Findings We randomly assigned 515 patients to the exenatide group and 514 to the glimepiride group, of whom 490 versus 487 were the intention-to-treat population. 203 (41%) patients had treatment failure in the exenatide group compared with 262 (54%) in the glimepiride group (risk difference 12.4 [95% CI 6.2-18.6], hazard ratio 0.748 [0.623-0.899]; p=0.002). 218 (44%) of 490 patients in the exenatide group, and 150 (31%) of 487 in the glimepiride group achieved an HbA(1c) concentration of less than 7% (p<0.0001), and 140 (29%) versus 87 (18%) achieved concentrations of 6.5% and less (p=0.0001). We noted a significantly greater decrease in bodyweight in patients given exenatide than in those given glimepiride (p<0.0001). Five patients in each treatment group died from causes unrelated to treatment. Significantly fewer patients in the exenatide group than in the glimepiride group reported documented symptomatic (p<0.0001), nocturnal (p=0.007), and non-nocturnal (p<0.0001) hypoglycaemia. Discontinuation because of adverse events (mainly gastrointestinal) was significantly higher (p=0.0005) in the exenatide group than in the glimepiride group in the first 6 months of treatment, but not thereafter. Interpretation These findings provide evidence for the benefits of exenatide versus glimepiride for control of glycaemic deterioration in patients with type-2 diabetes inadequately controlled by metformin alone.	[Gallwitz, Baptist] Univ Tubingen, Dept Med 4, Tubingen, Germany; [Guzman, Juan] Celaya Ctr Specialist Med, Guanajuato, Mexico; [Dotta, Francesco] Policlin Scotte, Dept Internal Med Endocrine & Metab Sci, Siena, Italy; [Guerci, Bruno] Hosp Brabois, Vandoeuvre Les Nancy, France; [Guerci, Bruno] CHU Nancy, Ctr Invest Clin, INSERM, Vandoeuvre Les Nancy, France; [Simo, Rafael] Vall dHebron Res Inst, Barcelona, Spain; [Simo, Rafael] Carlos III Hlth Inst, Ctr Invest Biomed Diabet & Enfermedades Metab, Barcelona, Spain; [Basson, Bruce R.] Eli Lilly & Co, St Cyr Au Mont Dor, France; [Festa, Andreas] Eli Lilly & Co, Vienna, Austria; [Kiljanski, Jacek] Eli Lilly Polska, Warsaw, Poland; [Sapin, Helene] Eli Lilly & Co, Suresnes, France; [Trautmann, Michael] Lilly Deutschland, Hamburg, Germany; [Schernthaner, Guntram] Rudolfstiftung Hosp, Dept Med 1, Vienna, Austria	Eberhard Karls University of Tubingen; University of Siena; CHU de Nancy; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly; Lilly Deutschland GmbH; Rudolfstiftung Hospital	Gallwitz, B (corresponding author), Univ Klinikum Tubingen, Med Klin 4, D-72076 Tubingen, Germany.	baptist.gaiiwitz@med.uni-tuebingen.de	Gallwitz, Baptist/AAQ-2051-2020; Dotta, Francesco/AAF-1123-2019; Dotta, Francesco/H-3788-2012	Gallwitz, Baptist/0000-0002-8880-6409; Dotta, Francesco/0000-0003-4947-7478; Simo Canonge, Rafael/0000-0003-0475-3096	Eli Lilly and Company; Amylin Pharmaceuticals	Eli Lilly and Company(Eli Lilly); Amylin Pharmaceuticals(Bristol-Myers Squibb)	Eli Lilly and Company; Amylin Pharmaceuticals.	Aguilar RB, 2011, CLIN THER, V33, P408, DOI 10.1016/j.clinthera.2011.04.008; Bergenstal RM, 2010, LANCET, V376, P431, DOI 10.1016/S0140-6736(10)60590-9; Bergenstal RM, 2010, AM J MED, V123, P374; Bunck MC, 2011, DIABETES CARE, V34, P2041, DOI 10.2337/dc11-0291; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Childs BP, 2005, DIABETES CARE, V28, P1245; DeFronzo RA, 2011, J CLIN ENDOCR METAB, V96, P2354, DOI 10.1210/jc.2011-0246; DeFronzo RA, 2010, DIABETES CARE, V33, P951, DOI [10.2337/dc09-1521, 10.2337/dc10-0646]; DeFronzo RA, 2009, DIABETES CARE, V32, P1649, DOI 10.2337/dc08-1984; Derosa G, 2010, DIABETES TECHNOL THE, V12, P233, DOI 10.1089/dia.2009.0141; Derosa G, 2009, DIABETES OBES METAB, V11, P1091, DOI 10.1111/j.1463-1326.2009.01087.x; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Drucker DJ, 2010, DIABETES CARE, V33, P428, DOI 10.2337/dc09-1499; Ferrannini E, 2009, DIABETES OBES METAB, V11, P157, DOI 10.1111/j.1463-1326.2008.00994.x; Gallwitz B, 2011, DRUGS, V71, P1675, DOI 10.2165/11592810-000000000-00000; Garber A, 2011, DIABETES OBES METAB, V13, P348, DOI 10.1111/j.1463-1326.2010.01356.x; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; International Diabetes Federation, 2005, GLOB GUID TYP 2 DIAB; International Diabetes Federation, 2011, TREATM ALG PEOPL TYP; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kahn SE, 2011, DIABETES, V60, P1552, DOI 10.2337/db10-1392; Kazda C, 2009, DIABETES OBES METAB, V11, P1131, DOI 10.1111/j.1463-1326.2009.01091.x; Malone JK, 2004, CLIN THER, V26, P2034, DOI 10.1016/j.clinthera.2004.12.015; Matthews DR, 2010, DIABETES OBES METAB, V12, P780, DOI 10.1111/j.1463-1326.2010.01233.x; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Schernthaner G, 2004, EUR J CLIN INVEST, V34, P535, DOI 10.1111/j.1365-2362.2004.01381.x; Seino Y, 2010, CURR MED RES OPIN, V26, P1013, DOI 10.1185/03007991003672551; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; The European Agency for the Evaluation of Medicinal Products, 2000, POINTS CONS SWITCH S; Vilsboll T, 2009, DIABETES OBES METAB, V11, P11, DOI 10.1111/j.1463-1326.2009.01073.x	32	116	126	2	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2012	379	9833					2270	2278		10.1016/S0140-6736(12)60479-6	http://dx.doi.org/10.1016/S0140-6736(12)60479-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962AM	22683137				2022-12-28	WOS:000305511400034
J	Blackstock, J				Blackstock, Jason			Researchers can't regulate climate engineering alone	NATURE			English	Editorial Material									Univ Oxford, Inst Sci Innovat & Soc, Oxford OX1 2JD, England	University of Oxford	Blackstock, J (corresponding author), Univ Oxford, Inst Sci Innovat & Soc, Oxford OX1 2JD, England.	jason.blackstock@insis.ox.ac.uk						Nature, 2012, NATURE, V485, P415	1	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					159	159		10.1038/486159a	http://dx.doi.org/10.1038/486159a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699573	Bronze			2022-12-28	WOS:000305189000002
J	Hughes, J				Hughes, John			PERSONAL VIEW The primary-secondary care divide fails older patients	BRITISH MEDICAL JOURNAL			English	Editorial Material									Sue Ryder, London WC1H 0AF, England		Hughes, J (corresponding author), Sue Ryder, London WC1H 0AF, England.	john.hughes@sueryder.org						Cornwell J, 2012, TELEGRAPH       0327	1	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 14	2012	344								e4009	10.1136/bmj.e4009	http://dx.doi.org/10.1136/bmj.e4009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961LA	22700789				2022-12-28	WOS:000305464700010
J	Jagsi, R; Griffith, KA; Stewart, A; Sambuco, D; DeCastro, R; Ubel, PA				Jagsi, Reshma; Griffith, Kent A.; Stewart, Abigail; Sambuco, Dana; DeCastro, Rochelle; Ubel, Peter A.			Gender Differences in the Salaries of Physician Researchers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACADEMIC MEDICINE; WOMEN PHYSICIANS; SEX-DIFFERENCES; MEN; COMPENSATION; ADVANCEMENT; DISCRIMINATION; EARNINGS; INCOMES; GAP	Context It is unclear whether male and female physician researchers who perform similar work are currently paid equally. Objectives To determine whether salaries differ by gender in a relatively homogeneous cohort of physician researchers and, if so, to determine if these differences are explained by differences in specialization, productivity, or other factors. Design and Setting A US nationwide postal survey was sent in 2009-2010 to assess the salary and other characteristics of a relatively homogeneous population of physicians. From all 1853 recipients of National Institutes of Health (NIH) K08 and K23 awards in 2000-2003, we contacted the 1729 who were alive and for whom we could identify a mailing address. Participants The survey achieved a 71% response rate. Eligibility for the present analysis was limited to the 800 physicians who continued to practice at US academic institutions and reported their current annual salary. Main Outcome Measures A linear regression model of self-reported current annual salary was constructed considering the following characteristics: gender, age, race, marital status, parental status, additional graduate degree, academic rank, leadership position, specialty, institution type, region, institution NIH funding rank, change of institution since K award, K award type, K award funding institute, years since K award, grant funding, publications, work hours, and time spent in research. Results The mean salary within our cohort was $167 669 (95% CI, $158 417-$176 922) for women and $200 433 (95% CI, $194 249-$206 617) for men. Male gender was associated with higher salary (+$ 13 399; P=.001) even after adjustment in the final model for specialty, academic rank, leadership positions, publications, and research time. Peters-Belson analysis (use of coefficients derived from regression model for men applied to women) indicated that the expected mean salary for women, if they retained their other measured characteristics but their gender was male, would be $12 194 higher than observed. Conclusion Gender differences in salary exist in this select, homogeneous cohort of mid-career academic physicians, even after adjustment for differences in specialty, institutional characteristics, academic productivity, academic rank, work hours, and other factors. JAMA. 2012;307(22):2410-2417 www.jama.com	[Jagsi, Reshma; Sambuco, Dana; DeCastro, Rochelle] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Stewart, Abigail] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Stewart, Abigail] Univ Michigan, Dept Womens Studies, Ann Arbor, MI 48109 USA; [Jagsi, Reshma; Sambuco, Dana; DeCastro, Rochelle] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; [Griffith, Kent A.] Univ Michigan, Ctr Comprehens Canc, Biostat Unit, Ann Arbor, MI 48109 USA; [Ubel, Peter A.] Duke Univ, Fuqua Sch Business, Sanford Sch Publ Policy, Durham, NC 27706 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Duke University	Jagsi, R (corresponding author), Univ Michigan, Dept Radiat Oncol, UHB2C490,SPC 5010,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	rjagsi@med.umich.edu		Jagsi, Reshma/0000-0001-6562-1228; Jones, Rochelle/0000-0001-7757-5396	Robert Wood Johnson Foundation; University of Michigan Office of the Vice President; NIH	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); University of Michigan Office of the Vice President; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Robert Wood Johnson Foundation Physician Faculty Scholars Program and the University of Michigan Office of the Vice President for Research provided financial support for this work through grants to Dr Jagsi. Dr Ubel was also supported by grants from the NIH and by a Robert Wood Johnson Foundation Investigator Award in Health Policy Research.	Ash AS, 2004, ANN INTERN MED, V141, P205, DOI 10.7326/0003-4819-141-3-200408030-00009; Babcock L, 2003, WOMEN DONT ASK: NEGOTIATION AND THE GENDER DIVIDE, P1; Baker LC, 1996, NEW ENGL J MED, V334, P960, DOI 10.1056/NEJM199604113341506; BELSON WA, 1956, ROY STAT SOC C-APP, V5, P195; Benard S, 2010, GENDER SOC, V24, P616, DOI 10.1177/0891243210383142; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; COLLINS KA, 1989, B MED LIBR ASSOC, V77, P8; Correll SJ, 2007, AM J SOCIOL, V112, P1297, DOI 10.1086/511799; DesRoches CM, 2010, ACAD MED, V85, P631, DOI 10.1097/ACM.0b013e3181d2b095; Goldin C., 2015, HOURS FLEXIBILITY GE; Heilman ME, 2008, IND ORGAN PSYCHOL-US, V1, P393, DOI 10.1111/j.1754-9434.2008.00072.x; Jagsi R, 2009, ANN INTERN MED, V151, P804, DOI 10.7326/0003-4819-151-11-200912010-00009; Kaplan SH, 1996, NEW ENGL J MED, V335, P1282, DOI 10.1056/NEJM199610243351706; KEHRER BH, 1976, J HUM RESOUR, V11, P526, DOI 10.2307/145430; LANGWELL KM, 1982, J HUM RESOUR, V17, P261, DOI 10.2307/145472; Lo Sasso AT, 2011, HEALTH AFFAIR, V30, P193, DOI 10.1377/hlthaff.2010.0597; National Academy of Sciences; National Academy of Engineering; Institute of Medicine Committee on Maximizing the Potential of Women in Academic Science and Engineering, 2006, BIAS BARR FULF POT W; National Institutes of Health, RES PORTF ONL REP TO; Ness RB, 2000, ANN INTERN MED, V133, P104, DOI 10.7326/0003-4819-133-2-200007180-00009; Nonnemaker L, 2000, NEW ENGL J MED, V342, P399, DOI 10.1056/NEJM200002103420606; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; OHSFELDT RL, 1986, J HEALTH ECON, V5, P335, DOI 10.1016/0167-6296(86)90008-1; Peters CC, 1941, J EDUC RES, V34, P606, DOI 10.1080/00220671.1941.10881036; Phelan JE, 2008, PSYCHOL WOMEN QUART, V32, P406, DOI 10.1111/j.1471-6402.2008.00454.x; Rao RS, 2004, MED CARE, V42, P789, DOI 10.1097/01.mlr.0000132838.29236.7e; Steinpreis RE, 1999, SEX ROLES, V41, P509, DOI 10.1023/A:1018839203698; Waldfogel J, 1998, J ECON PERSPECT, V12, P137, DOI 10.1257/jep.12.1.137; Watson R., 2004, IND RELATIONS J, V35, P19, DOI DOI 10.1111/J.1468-2338.2004.00298.X; Webb S, 1891, ECON J, V1, P635; Weeks WB, 2009, HEALTH AFFAIR, V28, P557, DOI 10.1377/hlthaff.28.2.557; Willis G.B, 2004, COGNITIVE INTERVIEWI; Wright AL, 2003, ACAD MED, V78, P500, DOI 10.1097/00001888-200305000-00015; Wright AL, 2007, J GEN INTERN MED, V22, P1398, DOI 10.1007/s11606-007-0329-7; Xie Y., 2003, WOMEN SCI CAREER PRO	34	273	274	4	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2012	307	22					2410	2417		10.1001/jama.2012.6183	http://dx.doi.org/10.1001/jama.2012.6183			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	956UX	22692173				2022-12-28	WOS:000305115900026
J	King, DM; Tuna, F; McInnes, EJL; McMaster, J; Lewis, W; Blake, AJ; Liddle, ST				King, David M.; Tuna, Floriana; McInnes, Eric J. L.; McMaster, Jonathan; Lewis, William; Blake, Alexander J.; Liddle, Stephen T.			Synthesis and Structure of a Terminal Uranium Nitride Complex	SCIENCE			English	Article							INFRARED-SPECTRA; AZIDE; ACTIVATION; MOLECULES; ANALOGS; NUO+	The terminal uranium nitride linkage is a fundamental target in the study of f-orbital participation in metal-ligand multiple bonding but has previously eluded characterization in an isolable molecule. Here, we report the preparation of the terminal uranium(V) nitride complex [UN(Tren(TIPS))][Na(12-crown-4)(2)] {in which Tren(TIPS) = [N(CH2CH2NSiPr3i)(3)](3-)and Pr-i = CH(CH3)(2)} by reaction of the uranium(III) complex [U(Tren(TIPS))] with sodium azide followed by abstraction and encapsulation of the sodium cation by the polydentate crown ether 12-crown-4. Single-crystal x-ray diffraction reveals a uranium-terminal nitride bond length of 1.825(15) angstroms (where 15 is the standard uncertainty). The structural assignment is supported by means of N-15-isotopic labeling, electronic absorption spectroscopy, magnetometry, electronic structure calculations, elemental analyses, and liberation of ammonia after treatment with water.	[King, David M.; McMaster, Jonathan; Lewis, William; Blake, Alexander J.; Liddle, Stephen T.] Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England; [Tuna, Floriana; McInnes, Eric J. L.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England; [Tuna, Floriana; McInnes, Eric J. L.] Univ Manchester, Photon Sci Inst, Manchester M13 9PL, Lancs, England	University of Nottingham; University of Manchester; University of Manchester	Liddle, ST (corresponding author), Univ Nottingham, Sch Chem, Univ Pk, Nottingham NG7 2RD, England.	stephen.liddle@nottingham.ac.uk	Tuna, Floriana/K-5198-2016; McMaster, Jonathan/P-2978-2015; Lewis, William/O-6571-2014	Tuna, Floriana/0000-0002-5541-1750; McMaster, Jonathan/0000-0003-0917-7454; Lewis, William/0000-0001-7103-6981	European Research Council; UK Engineering and Physical Sciences Research Council; National UK EPR Facility at Manchester; University of Nottingham; UK National Nuclear Laboratory; Royal Society; COST Action [CM1006]; Engineering and Physical Sciences Research Council [EP/G051763/1, EP/F030517/1] Funding Source: researchfish; EPSRC [EP/F030517/1, EP/G051763/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National UK EPR Facility at Manchester; University of Nottingham; UK National Nuclear Laboratory; Royal Society(Royal Society of London); COST Action(European Cooperation in Science and Technology (COST)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are grateful to the European Research Council, the UK Engineering and Physical Sciences Research Council, including the National UK EPR Facility at Manchester, the University of Nottingham, and the UK National Nuclear Laboratory for generous funding and support, the Royal Society for the award of a University Research Fellowship (S. T. L.), COST Action CM1006 for support, and F. Moro (University of Nottingham) for assistance with magnetometric measurements. Metrical parameters for the structures of compounds 1 to 4 are available free of charge from the Cambridge Crystallographic Data Centre under reference nos. CCDC 876421 to 876424, respectively.	Andrews L, 2008, ANGEW CHEM INT EDIT, V47, P5366, DOI 10.1002/anie.200801120; Bart SC, 2008, J AM CHEM SOC, V130, P12536, DOI 10.1021/ja804263w; Cooper OJ, 2011, ANGEW CHEM INT EDIT, V50, P2383, DOI 10.1002/anie.201007675; Ephritikhine M, 2006, DALTON T, P2501, DOI 10.1039/b603463b; Evans WJ, 2007, INORG CHEM, V46, P8008, DOI 10.1021/ic7006099; Evans WJ, 2005, SCIENCE, V309, P1835, DOI 10.1126/science.1116452; Fortier S, 2011, J AM CHEM SOC, V133, P6894, DOI 10.1021/ja2001133; Fortier S, 2010, J AM CHEM SOC, V132, P6888, DOI 10.1021/ja101567h; Fox AR, 2008, NATURE, V455, P341, DOI 10.1038/nature07372; Fox AR, 2010, J AM CHEM SOC, V132, P3250, DOI 10.1021/ja910364u; Fox AR, 2009, J AM CHEM SOC, V131, P5716, DOI 10.1021/ja8095812; Graves CR, 2009, CHEM COMMUN, P3831, DOI 10.1039/b902969a; GREEN DW, 1976, J CHEM PHYS, V65, P2921, DOI 10.1063/1.433406; Hayton TW, 2010, DALTON T, V39, P1145, DOI 10.1039/b909238b; Hayton TW, 2005, SCIENCE, V310, P1941, DOI 10.1126/science.1120069; HEINEMANN C, 1995, CHEM-EUR J, V1, P7, DOI 10.1002/chem.19950010105; HUNT RD, 1993, J CHEM PHYS, V98, P6070, DOI 10.1063/1.464845; Kaltsoyannis N, 2000, INORG CHEM, V39, P6009, DOI 10.1021/ic000891b; KAUFMAN V, 1976, J OPT SOC AM, V66, P599, DOI 10.1364/JOSA.66.000599; KEMPTER CP, 1959, ANAL CHEM, V31, P156, DOI 10.1021/ac60145a601; Korobkov I, 2002, ANGEW CHEM INT EDIT, V41, P3433, DOI 10.1002/1521-3773(20020916)41:18<3433::AID-ANIE3433>3.0.CO;2-V; Nocton G, 2008, ANGEW CHEM INT EDIT, V47, P3040, DOI 10.1002/anie.200705742; PEPPER M, 1991, CHEM REV, V91, P719, DOI 10.1021/cr00005a005; Scepaniak JJ, 2011, SCIENCE, V331, P1049, DOI 10.1126/science.1198315; Silva GWC, 2009, INORG CHEM, V48, P10635, DOI 10.1021/ic901165j; Thomson RK, 2010, NAT CHEM, V2, P723, DOI [10.1038/nchem.705, 10.1038/NCHEM.705]; Tourneux JC, 2011, J AM CHEM SOC, V133, P6162, DOI 10.1021/ja201276h; Zhou MF, 1999, J CHEM PHYS, V111, P11044, DOI 10.1063/1.480463	28	231	233	4	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2012	337	6095					717	720		10.1126/science.1223488	http://dx.doi.org/10.1126/science.1223488			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986PE	22745250				2022-12-28	WOS:000307354500050
J	Manske, M; Miotto, O; Campino, S; Auburn, S; Almagro-Garcia, J; Maslen, G; O'Brien, J; Djimde, A; Doumbo, O; Zongo, I; Ouedraogo, JB; Michon, P; Mueller, I; Siba, P; Nzila, A; Borrmann, S; Kiara, SM; Marsh, K; Jiang, H; Su, XZ; Amaratunga, C; Fairhurst, R; Socheat, D; Nosten, F; Imwong, M; White, NJ; Sanders, M; Anastasi, E; Alcock, D; Drury, E; Oyola, S; Quail, MA; Turner, DJ; Ruano-Rubio, V; Jyothi, D; Amenga-Etego, L; Hubbart, C; Jeffreys, A; Rowlands, K; Sutherland, C; Roper, C; Mangano, V; Modiano, D; Tan, JC; Ferdig, MT; Amambua-Ngwa, A; Conway, DJ; Takala-Harrison, S; Plowe, CV; Rayner, JC; Rockett, KA; Clark, TG; Newbold, CI; Berriman, M; MacInnis, B; Kwiatkowski, DP				Manske, Magnus; Miotto, Olivo; Campino, Susana; Auburn, Sarah; Almagro-Garcia, Jacob; Maslen, Gareth; O'Brien, Jack; Djimde, Abdoulaye; Doumbo, Ogobara; Zongo, Issaka; Ouedraogo, Jean-Bosco; Michon, Pascal; Mueller, Ivo; Siba, Peter; Nzila, Alexis; Borrmann, Steffen; Kiara, Steven M.; Marsh, Kevin; Jiang, Hongying; Su, Xin-Zhuan; Amaratunga, Chanaki; Fairhurst, Rick; Socheat, Duong; Nosten, Francois; Imwong, Mallika; White, Nicholas J.; Sanders, Mandy; Anastasi, Elisa; Alcock, Dan; Drury, Eleanor; Oyola, Samuel; Quail, Michael A.; Turner, Daniel J.; Ruano-Rubio, Valentin; Jyothi, Dushyanth; Amenga-Etego, Lucas; Hubbart, Christina; Jeffreys, Anna; Rowlands, Kate; Sutherland, Colin; Roper, Cally; Mangano, Valentina; Modiano, David; Tan, John C.; Ferdig, Michael T.; Amambua-Ngwa, Alfred; Conway, David J.; Takala-Harrison, Shannon; Plowe, Christopher V.; Rayner, Julian C.; Rockett, Kirk A.; Clark, Taane G.; Newbold, Chris I.; Berriman, Matthew; MacInnis, Bronwyn; Kwiatkowski, Dominic P.			Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing	NATURE			English	Article							PAPUA-NEW-GUINEA; MALARIA PARASITE; LIBRARY PREPARATION; GENOME; RESISTANCE; TRANSMISSION; POLYMORPHISM; EVOLUTION; SELECTION; PATTERNS	Malaria elimination strategies require surveillance of the parasite population for genetic changes that demand a public health response, such as new forms of drug resistance(1,2). Here we describe methods for the large-scale analysis of genetic variation in Plasmodium falciparum by deep sequencing of parasite DNA obtained from the blood of patients with malaria, either directly or after short-term culture. Analysis of 86,158 exonic single nucleotide polymorphisms that passed genotyping quality control in 227 samples from Africa, Asia and Oceania provides genome-wide estimates of allele frequency distribution, population structure and linkage disequilibrium. By comparing the genetic diversity of individual infections with that of the local parasite population, we derive a metric of within-host diversity that is related to the level of inbreeding in the population. An open-access web application has been established for the exploration of regional differences in allele frequency and of highly differentiated loci in the P. falciparum genome.	[Manske, Magnus; Campino, Susana; Auburn, Sarah; Almagro-Garcia, Jacob; Maslen, Gareth; Sanders, Mandy; Anastasi, Elisa; Alcock, Dan; Drury, Eleanor; Oyola, Samuel; Quail, Michael A.; Turner, Daniel J.; Ruano-Rubio, Valentin; Jyothi, Dushyanth; Rayner, Julian C.; Rockett, Kirk A.; Clark, Taane G.; Newbold, Chris I.; Berriman, Matthew; MacInnis, Bronwyn; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Manske, Magnus; Miotto, Olivo; Campino, Susana; Auburn, Sarah; Almagro-Garcia, Jacob; Maslen, Gareth; O'Brien, Jack; Ruano-Rubio, Valentin; Jyothi, Dushyanth; Amenga-Etego, Lucas; Rockett, Kirk A.; Clark, Taane G.; Newbold, Chris I.; MacInnis, Bronwyn; Kwiatkowski, Dominic P.] Univ Oxford, MRC Ctr Genom & Global Hlth, Oxford OX3 7BN, England; [Miotto, Olivo; Nosten, Francois; White, Nicholas J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand; [Auburn, Sarah] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0811, Australia; [Almagro-Garcia, Jacob; O'Brien, Jack; Ruano-Rubio, Valentin; Amenga-Etego, Lucas; Hubbart, Christina; Jeffreys, Anna; Rowlands, Kate; Rockett, Kirk A.; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Djimde, Abdoulaye; Doumbo, Ogobara] Univ Bamako, Fac Med, Malaria Res & Training Ctr, Bamako, Mali; [Zongo, Issaka; Ouedraogo, Jean-Bosco] Inst Rech Sci Sante, Direct Reg Ouest, Bobo Dioulasso, Burkina Faso; [Michon, Pascal; Mueller, Ivo; Siba, Peter] Papua New Guinea Inst Med Res, Madang 511, Papua N Guinea; [Nzila, Alexis; Borrmann, Steffen; Kiara, Steven M.; Marsh, Kevin] KEMRI Wellcome Trust Res Program, Kilifi, Kenya; [Jiang, Hongying; Su, Xin-Zhuan; Amaratunga, Chanaki; Fairhurst, Rick] Nat Inst Allergy & Infect Dis, NIH, Rockville, MD 20892 USA; [Socheat, Duong] Cambodia Natl Malaria Ctr, Phnom Penh, Cambodia; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot 63110, Tak, Thailand; [Nosten, Francois; White, Nicholas J.] Univ Oxford, Ctr Trop Med, Oxford OX3 7LJ, England; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok 10400, Thailand; [Amenga-Etego, Lucas] Navrongo Hlth Ctr, Navrongo, Ghana; [Sutherland, Colin; Roper, Cally; Conway, David J.; Clark, Taane G.] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Mangano, Valentina; Modiano, David] Univ Roma La Sapienza, Dept Publ Hlth Sci, I-00185 Rome, Italy; [Tan, John C.; Ferdig, Michael T.] Univ Notre Dame, Eck Inst Global Hlth, Dept Biol Sci, Notre Dame, IN 46556 USA; [Amambua-Ngwa, Alfred; Conway, David J.] MRC Labs, Fajara, Gambia; [Takala-Harrison, Shannon; Plowe, Christopher V.] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Newbold, Chris I.] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England	Wellcome Trust Sanger Institute; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Charles Darwin University; Menzies School of Health Research; University of Oxford; Wellcome Centre for Human Genetics; University of Bamako; PNG Institute Of Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mahidol University; University of Oxford; Mahidol University; University of London; London School of Hygiene & Tropical Medicine; Sapienza University Rome; University of Notre Dame; MRC Laboratory Molecular Biology; University System of Maryland; University of Maryland Baltimore; University of Oxford	Kwiatkowski, DP (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	dominic@sanger.ac.uk	Sutherland, Colin/AAN-3939-2020; Amambua-Ngwa, Alfred/AHD-7882-2022; Imwong, Mallika/ABE-6493-2020; White, Nicholas J/I-4629-2012; Campino, Susana/AAM-2577-2020; Quail, michael/ABE-6131-2020; Amambua-Ngwa, Alfred/HGU-8062-2022; Amambua-Ngwa, Alfred/ABA-7305-2020; Clark, Taane G./AAM-2570-2020; Berriman, Matthew/A-7618-2011; mangano, valentina/I-2456-2012; Borrmann, Steffen/G-1838-2013; Nosten, Francois/AAC-5509-2019; Jyothi, Dushyanth/H-9517-2014; White, Nick/AAC-6527-2019; Roper, Cally/K-2989-2013; Ferdig, Michael/C-6627-2016; Mueller, Ivo/C-7251-2013; Miotto, Olivo/AAE-7124-2019; Auburn, Sarah/N-2266-2013	Sutherland, Colin/0000-0003-1592-6407; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Campino, Susana/0000-0003-1403-6138; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Clark, Taane G./0000-0001-8985-9265; Berriman, Matthew/0000-0002-9581-0377; Borrmann, Steffen/0000-0001-9189-4393; Nosten, Francois/0000-0002-7951-0745; Jyothi, Dushyanth/0000-0002-0448-5303; White, Nick/0000-0002-1897-1978; Roper, Cally/0000-0002-6545-309X; Mueller, Ivo/0000-0001-6554-6889; Miotto, Olivo/0000-0001-8060-6771; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Auburn, Sarah/0000-0002-4638-536X; Conway, David/0000-0002-8711-3037; Maslen, Gareth/0000-0001-7318-3678; Oyola, Samuel O./0000-0002-6425-7345; Mangano, Valentina D/0000-0002-2021-6162; Kwiatkowski, Dominic/0000-0002-5023-0176; Manske, Magnus/0000-0001-5916-0947; Takala-Harrison, Shannon/0000-0003-4674-8500; Rayner, Julian/0000-0002-9835-1014; Newbold, Chris/0000-0002-9274-3789; Su, Xinzhuan/0000-0003-3246-3248	Wellcome Trust through Sanger Institute [077012/Z/05/Z, 098051, 090770/Z/09/Z]; Medical Research Council (MRC) through the MRC Centre for Genomics and Global Health [G0600718]; MRC [G19/9]; Wellcome Trust [075491/Z/04, 090532/Z/09/Z]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Howard Hughes Medical Institute [55005502]; MRC [G0600718] Funding Source: UKRI; Medical Research Council [G19/9, G0600718] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001000, ZIAAI001066] Funding Source: NIH RePORTER	Wellcome Trust through Sanger Institute; Medical Research Council (MRC) through the MRC Centre for Genomics and Global Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank G. Dougan and N. Day for support, and T. Anderson and M. Mackinnon for comments. The sequencing and analysis components of this study were supported by the Wellcome Trust through Sanger Institute core funding (077012/Z/05/Z; 098051) and a Strategic Award (090770/Z/09/Z); the Medical Research Council (MRC) through the MRC Centre for Genomics and Global Health (G0600718) and an MRC Professorship to D.P.K. (G19/9). Other parts of this study were partly supported by the Wellcome Trust including core support to the Wellcome Trust Centre for Human Genetics (075491/Z/04; 090532/Z/09/Z); the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; and a Howard Hughes Medical Institute International Scholarship (55005502) to A.D.	Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anthony TG, 2007, MOL BIOCHEM PARASIT, V156, P117, DOI 10.1016/j.molbiopara.2007.07.008; Auburn S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032891; Auburn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022213; Boisson B, 2011, MOL MICROBIOL, V81, P1343, DOI 10.1111/j.1365-2958.2011.07767.x; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dye C, 1997, P ROY SOC B-BIOL SCI, V264, P61, DOI 10.1098/rspb.1997.0009; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; HILL WG, 1995, GENET RES, V65, P53, DOI 10.1017/S0016672300033000; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Mehlotra RK, 2001, P NATL ACAD SCI USA, V98, P12689, DOI 10.1073/pnas.221440898; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Mu JB, 2010, NAT GENET, V42, P268, DOI 10.1038/ng.528; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Neafsey DE, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r171; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; PAUL REL, 1995, SCIENCE, V269, P1709, DOI 10.1126/science.7569897; Paul REL, 1999, T ROY SOC TROP MED H, V93, P587, DOI 10.1016/S0035-9203(99)90057-3; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; Smith DL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1107; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	30	329	331	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					375	379		10.1038/nature11174	http://dx.doi.org/10.1038/nature11174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22722859	Green Accepted			2022-12-28	WOS:000306506500045
J	Macfarlan, TS; Gifford, WD; Driscoll, S; Lettieri, K; Rowe, HM; Bonanomi, D; Firth, A; Singer, O; Trono, D; Pfaff, SL				Macfarlan, Todd S.; Gifford, Wesley D.; Driscoll, Shawn; Lettieri, Karen; Rowe, Helen M.; Bonanomi, Dario; Firth, Amy; Singer, Oded; Trono, Didier; Pfaff, Samuel L.			Embryonic stem cell potency fluctuates with endogenous retrovirus activity	NATURE			English	Article							GENE-EXPRESSION; MUERV-L; TRANSPOSABLE ELEMENTS; MOUSE; EVOLUTION; DIFFERENTIATION; TROPHECTODERM; ESTABLISHMENT; REPRESSION; GENERATION	Embryonic stem (ES) cells are derived from blastocyst-stage embryos and are thought to be functionally equivalent to the inner cell mass, which lacks the ability to produce all extraembryonic tissues. Here we identify a rare transient cell population within mouse ES and induced pluripotent stem (iPS) cell cultures that expresses high levels of transcripts found in two-cell (2C) embryos in which the blastomeres are totipotent. We genetically tagged these 2C-like ES cells and show that they lack the inner cell mass pluripotency proteins Oct4 (also known as Pou5f1), Sox2 and Nanog, and have acquired the ability to contribute to both embryonic and extraembryonic tissues. We show that nearly all ES cells cycle in and out of this privileged state, which is partially controlled by histone-modifying enzymes. Transcriptome sequencing and bioinformatic analyses showed that many 2C transcripts are initiated from long terminal repeats derived from endogenous retroviruses, suggesting this foreign sequence has helped to drive cell-fate regulation in placental mammals.	[Macfarlan, Todd S.; Gifford, Wesley D.; Driscoll, Shawn; Lettieri, Karen; Bonanomi, Dario; Pfaff, Samuel L.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; [Rowe, Helen M.; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Firth, Amy; Singer, Oded] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Salk Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, 10010 N Torrey Pines, La Jolla, CA 92037 USA.	pfaff@salk.edu	Bonanomi, Dario/K-3450-2016; Firth, Amy/H-9535-2012; Rowe, Helen/AAQ-7138-2021; Firth, Amy/M-2302-2016; Macfarlan, Todd/S-3750-2017; Ryan, Amy L/AFO-2326-2022	Bonanomi, Dario/0000-0003-4517-1244; Firth, Amy/0000-0003-1363-905X; Rowe, Helen/0000-0001-5881-0290; Firth, Amy/0000-0003-1363-905X; Macfarlan, Todd/0000-0003-2495-9809; Ryan, Amy L/0000-0003-1363-905X	National Institute of Neurological Disorders and Stroke [R37NS037116]; Marshall Heritage Foundation; California Institute for Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS037116] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Marshall Heritage Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank members of the Pfaff laboratory for discussion; S. Andrews, D. Chambers, Y. Dayn, T.-C. Sung, J. Fitzpatrick, M. Joens, Y. Sigal, D. Gibbs and L. Ouyang for technical assistance, Y. Shinkai and D. Gilbert for the G9a mutant ES cells, and T. Heidmann for MuERV-L-Gag antibodies. This research was supported by the National Institute of Neurological Disorders and Stroke (R37NS037116) and the Marshall Heritage Foundation. T.S.M. and W.D.G. were supported by the California Institute for Regenerative Medicine and S.L.P. is an investigator of the Howard Hughes Medical Institute and Benjamin H. Lewis Chair in Neurobiology.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Benit L, 1999, J VIROL, V73, P3301; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Choo KB, 2001, MOL REPROD DEV, V59, P249, DOI 10.1002/mrd.1029; Cockburn K, 2010, J CLIN INVEST, V120, P995, DOI 10.1172/JCI41229; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Evsikov AV, 2004, CYTOGENET GENOME RES, V105, P240, DOI 10.1159/000078195; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hirata T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00208; Huang CJ, 2004, GENE, V324, P117, DOI 10.1016/j.gene.2003.09.022; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanka J, 2003, THERIOGENOLOGY, V59, P3, DOI 10.1016/S0093-691X(02)01267-0; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Li WL, 2009, STEM CELLS, V27, P2992, DOI 10.1002/stem.240; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Ma J, 2001, BIOL REPROD, V64, P1713, DOI 10.1095/biolreprod64.6.1713; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; PAPAIOANNOU VE, 1989, DEVELOPMENT, V106, P817; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Ribet D, 2008, J VIROL, V82, P1622, DOI 10.1128/JVI.02097-07; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323; Shao GB, 2009, THERIOGENOLOGY, V71, P1245, DOI 10.1016/j.theriogenology.2009.01.004; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Suzuki T, 2006, CLONING STEM CELLS, V8, P295, DOI 10.1089/clo.2006.8.295; Svoboda P, 2004, DEV BIOL, V269, P276, DOI 10.1016/j.ydbio.2004.01.028; TARKOWSKI AK, 1959, NATURE, V184, P1286, DOI 10.1038/1841286a0; Wiekowski M, 1997, J CELL SCI, V110, P1147; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zhang W, 2006, NUCLEIC ACIDS RES, V34, P4780, DOI 10.1093/nar/gkl631	42	644	661	9	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					57	+		10.1038/nature11244	http://dx.doi.org/10.1038/nature11244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722858	Green Accepted, Green Submitted			2022-12-28	WOS:000305982900049
J	Floudas, D; Binder, M; Riley, R; Barry, K; Blanchette, RA; Henrissat, B; Martinez, AT; Otillar, R; Spatafora, JW; Yadav, JS; Aerts, A; Benoit, I; Boyd, A; Carlson, A; Copeland, A; Coutinho, PM; de Vries, RP; Ferreira, P; Findley, K; Foster, B; Gaskell, J; Glotzer, D; Gorecki, P; Heitman, J; Hesse, C; Hori, C; Igarashi, K; Jurgens, JA; Kallen, N; Kersten, P; Kohler, A; Kues, U; Kumar, TKA; Kuo, A; LaButti, K; Larrondo, LF; Lindquist, E; Ling, A; Lombard, V; Lucas, S; Lundell, T; Martin, R; McLaughlin, DJ; Morgenstern, I; Morin, E; Murat, C; Nagy, LG; Nolan, M; Ohm, RA; Patyshakuliyeva, A; Rokas, A; Ruiz-Duenas, FJ; Sabat, G; Salamov, A; Samejima, M; Schmutz, J; Slot, JC; John, FS; Stenlid, J; Sun, H; Sun, S; Syed, K; Tsang, A; Wiebenga, A; Young, D; Pisabarro, A; Eastwood, DC; Martin, F; Cullen, D; Grigoriev, IV; Hibbett, DS				Floudas, Dimitrios; Binder, Manfred; Riley, Robert; Barry, Kerrie; Blanchette, Robert A.; Henrissat, Bernard; Martinez, Angel T.; Otillar, Robert; Spatafora, Joseph W.; Yadav, Jagjit S.; Aerts, Andrea; Benoit, Isabelle; Boyd, Alex; Carlson, Alexis; Copeland, Alex; Coutinho, Pedro M.; de Vries, Ronald P.; Ferreira, Patricia; Findley, Keisha; Foster, Brian; Gaskell, Jill; Glotzer, Dylan; Gorecki, Pawel; Heitman, Joseph; Hesse, Cedar; Hori, Chiaki; Igarashi, Kiyohiko; Jurgens, Joel A.; Kallen, Nathan; Kersten, Phil; Kohler, Annegret; Kuees, Ursula; Kumar, T. K. Arun; Kuo, Alan; LaButti, Kurt; Larrondo, Luis F.; Lindquist, Erika; Ling, Albee; Lombard, Vincent; Lucas, Susan; Lundell, Taina; Martin, Rachael; McLaughlin, David J.; Morgenstern, Ingo; Morin, Emanuelle; Murat, Claude; Nagy, Laszlo G.; Nolan, Matt; Ohm, Robin A.; Patyshakuliyeva, Aleksandrina; Rokas, Antonis; Ruiz-Duenas, Francisco J.; Sabat, Grzegorz; Salamov, Asaf; Samejima, Masahiro; Schmutz, Jeremy; Slot, Jason C.; John, Franz St.; Stenlid, Jan; Sun, Hui; Sun, Sheng; Syed, Khajamohiddin; Tsang, Adrian; Wiebenga, Ad; Young, Darcy; Pisabarro, Antonio; Eastwood, Daniel C.; Martin, Francis; Cullen, Dan; Grigoriev, Igor V.; Hibbett, David S.			The Paleozoic Origin of Enzymatic Lignin Decomposition Reconstructed from 31 Fungal Genomes	SCIENCE			English	Article							WOOD DECAY; GENE; EVOLUTION; DEGRADATION; PEROXIDASE; CELLULOSE; SEQUENCE; MODELS; FAMILY	Wood is a major pool of organic carbon that is highly resistant to decay, owing largely to the presence of lignin. The only organisms capable of substantial lignin decay are white rot fungi in the Agaricomycetes, which also contains non-lignin-degrading brown rot and ectomycorrhizal species. Comparative analyses of 31 fungal genomes (12 generated for this study) suggest that lignin-degrading peroxidases expanded in the lineage leading to the ancestor of the Agaricomycetes, which is reconstructed as a white rot species, and then contracted in parallel lineages leading to brown rot and mycorrhizal species. Molecular clock analyses suggest that the origin of lignin degradation might have coincided with the sharp decrease in the rate of organic carbon burial around the end of the Carboniferous period.	[Riley, Robert; Barry, Kerrie; Otillar, Robert; Aerts, Andrea; Copeland, Alex; Foster, Brian; Kuo, Alan; LaButti, Kurt; Lindquist, Erika; Lucas, Susan; Nolan, Matt; Ohm, Robin A.; Salamov, Asaf; Sun, Hui; Grigoriev, Igor V.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Floudas, Dimitrios; Binder, Manfred; Carlson, Alexis; Glotzer, Dylan; Kallen, Nathan; Ling, Albee; Martin, Rachael; Nagy, Laszlo G.; Young, Darcy; Hibbett, David S.] Clark Univ, Dept Biol, Worcester, MA 01610 USA; [Blanchette, Robert A.; Jurgens, Joel A.; Kumar, T. K. Arun; McLaughlin, David J.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Henrissat, Bernard; Coutinho, Pedro M.; Lombard, Vincent] Aix Marseille Univ, CNRS, UMR 6098, F-13288 Marseille 9, France; [Martinez, Angel T.; Ruiz-Duenas, Francisco J.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Spatafora, Joseph W.; Boyd, Alex; Hesse, Cedar] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Yadav, Jagjit S.; Syed, Khajamohiddin] Univ Cincinnati, Coll Med, Dept Environm Hlth, Environm Genet & Mol Toxicol Div, Cincinnati, OH 45267 USA; [Benoit, Isabelle; de Vries, Ronald P.] Univ Utrecht, Microbiol & Kluyver Ctr Genom Ind Fermentat, NL-3584 CH Utrecht, Netherlands; [Benoit, Isabelle; de Vries, Ronald P.; Patyshakuliyeva, Aleksandrina; Wiebenga, Ad] CBS KNAW Fungal Biodivers Ctr, NL-3584 CT Utrecht, Netherlands; [Ferreira, Patricia] Univ Zaragoza, Dept Biochem & Mol & Cellular Biol, E-50009 Zaragoza, Spain; [Ferreira, Patricia] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, E-50009 Zaragoza, Spain; [Findley, Keisha; Heitman, Joseph; Sun, Sheng] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Gaskell, Jill; Kersten, Phil; John, Franz St.; Cullen, Dan] USDA, Forest Prod Lab, Madison, WI 53726 USA; [Gorecki, Pawel] Warsaw Univ, Inst Informat, PL-02097 Warsaw, Poland; [Hori, Chiaki; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Kohler, Annegret; Morin, Emanuelle; Murat, Claude; Martin, Francis] Nancy Univ, INRA, UMR 1136, F-54280 Champenoux, France; [Kuees, Ursula] Univ Gottingen, Busgen Inst, D-37077 Gottingen, Germany; [Larrondo, Luis F.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Santiago 8331010, Chile; [Lundell, Taina] Univ Helsinki, Viikki Bioctr, Dept Appl Chem & Microbiol, FIN-00014 Helsinki, Finland; [Morgenstern, Ingo; Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ H4B 1R6, Canada; [Rokas, Antonis; Slot, Jason C.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Sabat, Grzegorz] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53726 USA; [Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Stenlid, Jan] Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, S-75007 Uppsala, Sweden; [Pisabarro, Antonio] Univ Publ Navarra, Genet & Microbiol Res Grp, Pamplona 31006, Spain; [Eastwood, Daniel C.] Univ Swansea, Coll Sci, Swansea SA2 8PP, W Glam, Wales	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Clark University; University of Minnesota System; University of Minnesota Twin Cities; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Oregon State University; University System of Ohio; University of Cincinnati; Utrecht University; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); University of Zaragoza; University of Zaragoza; Duke University; United States Department of Agriculture (USDA); United States Forest Service; University of Warsaw; University of Tokyo; INRAE; Universite de Lorraine; University of Gottingen; Pontificia Universidad Catolica de Chile; University of Helsinki; Concordia University - Canada; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; HudsonAlpha Institute for Biotechnology; Swedish University of Agricultural Sciences; Universidad Publica de Navarra; Swansea University	Grigoriev, IV (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA.	ivgrigoriev@lbl.gov; dhibbett@clarku.edu	Riley, Robert/AAA-4531-2020; Schmutz, Jeremy/N-3173-2013; Slot, Jason/L-5500-2018; Lundell, Taina/P-6623-2016; Cullen, Daniel/AAN-5484-2020; Hori, Chiaki/AAO-9734-2021; Henrissat, Bernard/J-2475-2012; Ruiz-Dueñas, Francisco J/L-9837-2015; Kumar, TK Arun/S-2310-2019; Binder, Manfred/C-8571-2013; Heitman, Joseph/ABC-6006-2021; Murat, Claude/AAA-5226-2020; morin, emmanuelle/AAA-1246-2019; Barry, Kerrie Whitelaw/AAA-5500-2020; Igarashi, Kiyohiko/E-6799-2016; St John, Franz/J-8970-2016; Martínez, Angel T/G-7284-2017; Ohm, Robin A/I-6689-2016; Lundell, Taina/ABA-8393-2021; Kües, Ursula/B-8280-2008; Slot, Jason/E-4802-2011; Neila, Patricia Ferreira/Y-4803-2019; Rokas, Antonis/A-9775-2008; Yadav, Jagjit S./AAN-8805-2020; Stenlid, Jan/K-5909-2019; Pisabarro, Antonio G./K-3622-2014; de Vries, Ronald P./F-8125-2011; Kohler, Annegret/AAD-1876-2019; Gorecki, Pawel/D-3160-2013; Syed, Khajamohiddin/L-8774-2013; Larrondo, Luis/J-1086-2016	Riley, Robert/0000-0003-0224-0975; Schmutz, Jeremy/0000-0001-8062-9172; Lundell, Taina/0000-0003-3899-1658; Hori, Chiaki/0000-0002-5740-153X; Henrissat, Bernard/0000-0002-3434-8588; Ruiz-Dueñas, Francisco J/0000-0002-9837-5665; Murat, Claude/0000-0003-0685-7307; morin, emmanuelle/0000-0002-7268-972X; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Igarashi, Kiyohiko/0000-0001-5152-7177; St John, Franz/0000-0003-3458-5628; Martínez, Angel T/0000-0002-1584-2863; Lundell, Taina/0000-0003-3899-1658; Kües, Ursula/0000-0001-9180-4079; Rokas, Antonis/0000-0002-7248-6551; Yadav, Jagjit S./0000-0001-5036-3609; Pisabarro, Antonio G./0000-0001-6987-5794; de Vries, Ronald P./0000-0002-4363-1123; Gorecki, Pawel/0000-0002-2045-5892; Syed, Khajamohiddin/0000-0002-1497-3570; Ohm, Robin A./0000-0003-2548-0074; Stenlid, Jan/0000-0002-5344-2094; Blanchette, Robert A./0000-0003-2819-6511; Larrondo, Luis/0000-0002-8832-7109; Ferreira Neila, Patricia/0000-0003-4076-6118; Lombard, Vincent/0000-0002-9684-7067; Eastwood, Daniel/0000-0002-7015-0739; Hesse, Cedar/0000-0002-1006-0491; Sabat, Grzegorz/0000-0001-7668-7767; Grigoriev, Igor/0000-0002-3136-8903	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Assembling the Fungal Tree of Life (AFTOL) project under NSF [DEB-0732968, DEB-0732993, DEB-0732550]	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Assembling the Fungal Tree of Life (AFTOL) project under NSF	The work conducted by the U.S. Department of Energy Joint Genome Institute was supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH11231. Also supported by the Assembling the Fungal Tree of Life (AFTOL) project under NSF awards DEB-0732968 (D. S. H.), DEB-0732993 (J.W.S.), and DEB-0732550 (D.J.M.). We thank R. H. Petersen for the strain of A. delicata. The organisms A. delicata and Dacryopinax sp. were obtained in Costa Rica and can only be used for research purposes. Assemblies and annotations of the 12 genomes reported here are available from the JGI fungal portal MycoCosm (http://jgi.doe.gov/fungi) and from DDBJ/EMBL/GenBank under the following accessions: AFVO00000000, AEIT00000000, AEUS00000000, AEID00000000, AEJJ00000000, AEHC00000000, AFVP00000000, AEGM00000000, AEGX00000000, AEJI00000000, AFVY00000000, and AEHD00000000. Aligned sequence data for organismal and gene family phylogenies and molecular clock analyses, and secretome results are available at DRYAD (http://dx.doi.org/10.5061/dryad.5k3t47p0).	Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Barker D, 2007, BIOINFORMATICS, V23, P14, DOI 10.1093/bioinformatics/btl558; Berner R.A., 2004, PHANEROZOIC CARBON C; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; FitzJohn RG, 2009, SYST BIOL, V58, P595, DOI 10.1093/sysbio/syp067; Gorecki P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S15; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Krings M, 2011, MYCOSCIENCE, V52, P18, DOI 10.1007/s10267-010-0065-4; Larrondo LF, 2005, BIOPHYS CHEM, V116, P167, DOI 10.1016/j.bpc.2005.03.006; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; ROBINSON JM, 1990, GEOLOGY, V18, P607, DOI 10.1130/0091-7613(1990)015<0607:LLPAFB>2.3.CO;2; Ruiz-Duenas FJ, 2011, CR BIOL, V334, P795, DOI 10.1016/j.crvi.2011.06.004; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; SCHMIDT O, 1980, HOLZFORSCHUNG, V34, P67, DOI 10.1515/hfsg.1980.34.2.67; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STUBBLEFIELD SP, 1986, BOT GAZ, V147, P116, DOI 10.1086/337577; Vanden Wymelenberg A, 2006, APPL ENVIRON MICROB, V72, P4871, DOI 10.1128/AEM.00375-06	25	1048	1108	26	792	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1715	1719		10.1126/science.1221748	http://dx.doi.org/10.1126/science.1221748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745431	Green Submitted			2022-12-28	WOS:000305794500053
J	Marini, JC; Forlino, A				Marini, Joan C.; Forlino, Antonella			Replenishing Cartilage from Endogenous Stem Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Marini, Joan C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD USA; [Forlino, Antonella] Univ Pavia, Dept Mol Med, Biochem Sect, I-27100 Pavia, Italy	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Pavia	Marini, JC (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD USA.		Forlino, Antonella/H-5385-2015	Forlino, Antonella/0000-0002-6385-1182	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000408] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HD000408-25] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Hunter DJ, 2011, NAT REV RHEUMATOL, V7, P13, DOI 10.1038/nrrheum.2010.178; Johnson DJ, 2012, SCIENCE, V338, DOI 10.1126/science.1225996; Panaroni C, 2009, BLOOD, V114, P459, DOI 10.1182/blood-2008-12-195859; Wurdak H, 2010, P NATL ACAD SCI USA, V107, P16542, DOI 10.1073/pnas.1010300107; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005	5	21	23	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2522	2524		10.1056/NEJMcibr1204283	http://dx.doi.org/10.1056/NEJMcibr1204283			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965DP	22738103	Green Accepted			2022-12-28	WOS:000305747000015
J	Pawar, S; Dell, AI; Savage, V				Pawar, Samraat; Dell, Anthony I.; Savage, Van M.			Dimensionality of consumer search space drives trophic interaction strengths	NATURE			English	Article							BODY-SIZE RELATIONSHIPS; TERRESTRIAL FOOD WEBS; POPULATION-DENSITY; REAL DIFFERENCES; DYNAMICS; STABILITY; ABUNDANCE; MARINE; PHYTOPLANKTON; CONSTRAINTS	Trophic interactions govern biomass fluxes in ecosystems, and stability in food webs. Knowledge of how trophic interaction strengths are affected by differences among habitats is crucial for understanding variation in ecological systems. Here we show how substantial variation in consumption-rate data, and hence trophic interaction strengths, arises because consumers tend to encounter resources more frequently in three dimensions (3D) (for example, arboreal and pelagic zones) than two dimensions (2D) (for example, terrestrial and benthic zones). By combining new theory with extensive data (376 species, with body masses ranging from 5.24 x 10(-14) kg to 800 kg), we find that consumption rates scale sublinearly with consumer body mass (exponent of approximately 0.85) for 2D interactions, but superlinearly (exponent of approximately 1.06) for 3D interactions. These results contradict the currently widespread assumption of a single exponent (of approximately 0.75) in consumer-resource and food-web research. Further analysis of 2,929 consumer-resource interactions shows that dimensionality of consumer search space is probably a major driver of species coexistence, and the stability and abundance of populations.	[Pawar, Samraat; Dell, Anthony I.; Savage, Van M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; [Dell, Anthony I.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Savage, Van M.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Savage, Van M.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; James Cook University; University of California System; University of California Los Angeles; The Santa Fe Institute	Pawar, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.	samraat@ucla.edu	Pawar, Samraat/E-7388-2012	Pawar, Samraat/0000-0001-8375-5684	University of California, Los Angeles; US National Science Foundation Division of Environmental Biology [1021010]	University of California, Los Angeles(University of California System); US National Science Foundation Division of Environmental Biology(National Science Foundation (NSF))	We thank the authors who contributed data (Supplementary Tables 5-8), and P. Amarasekare, J. H. Brown, E. Economo, A. Mikheyev, C. Estrada, C. Johnson, M. Johnson and K. Lafferty for helpful discussions and comments. S. P., A. I. D. and V. M. S. were supported by University of California, Los Angeles Biomathematics start-up funds and by the US National Science Foundation Division of Environmental Biology award 1021010. The data reported in this paper are available in the Supplementary Information online.	Alexander RM., 2003, PRINCIPLES ANIMAL LO; Belgrano A, 2002, ECOL LETT, V5, P611, DOI 10.1046/j.1461-0248.2002.00364.x; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; BRIAND F, 1987, SCIENCE, V238, P956, DOI 10.1126/science.3672136; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Brose U, 2010, FUNCT ECOL, V24, P28, DOI 10.1111/j.1365-2435.2009.01618.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cermeno P, 2006, ECOL LETT, V9, P1210, DOI 10.1111/j.1461-0248.2006.00973.x; Chase JM, 2000, TRENDS ECOL EVOL, V15, P408, DOI 10.1016/S0169-5347(00)01942-X; COHEN JE, 1994, PHILOS T R SOC B, V343, P57, DOI 10.1098/rstb.1994.0008; Cyr H, 1997, OIKOS, V80, P139, DOI 10.2307/3546525; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; FARLOW JO, 1976, ECOLOGY, V57, P841, DOI 10.2307/1941052; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Jeschke JM, 2004, BIOL REV, V79, P337, DOI 10.1017/S1464793103006286; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Laska MS, 1998, ECOLOGY, V79, P461, DOI 10.2307/176946; Leaper R, 1999, ECOL LETT, V2, P191; Lewis HM, 2008, J ANIM ECOL, V77, P1056, DOI 10.1111/j.1365-2656.2008.01405.x; McGill BJ, 2006, EVOL ECOL RES, V8, P691; MILNE BT, 1992, THEOR POPUL BIOL, V41, P337, DOI 10.1016/0040-5809(92)90033-P; Otto SB, 2007, NATURE, V450, P1226, DOI 10.1038/nature06359; Pawar S, 2009, J THEOR BIOL, V259, P601, DOI 10.1016/j.jtbi.2009.04.006; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Reuman DC, 2009, ADV ECOL RES, V41, P1, DOI 10.1016/S0065-2504(09)00401-2; Rip JMK, 2011, ECOL LETT, V14, P733, DOI 10.1111/j.1461-0248.2011.01636.x; Ritchie M. E, 2009, HETEROGENEITY STRUCT, V112; Savage VM, 2007, J THEOR BIOL, V247, P213, DOI 10.1016/j.jtbi.2007.03.007; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Shurin JB, 2006, P ROY SOC B-BIOL SCI, V273, P1, DOI 10.1098/rspb.2005.3377; Vucic-Pestic O, 2010, J ANIM ECOL, V79, P249, DOI 10.1111/j.1365-2656.2009.01622.x; Weibel ER, 2004, RESP PHYSIOL NEUROBI, V140, P115, DOI 10.1016/j.resp.2004.01.006; Weitz JS, 2006, ECOL LETT, V9, P548, DOI 10.1111/j.1461-0248.2006.00900.x; WHITEHEAD H, 1992, THEOR POPUL BIOL, V42, P1, DOI 10.1016/0040-5809(92)90002-B; WITTING L, 1995, J THEOR BIOL, V177, P129, DOI 10.1006/jtbi.1995.0231; YODZIS P, 1992, AM NAT, V139, P1151, DOI 10.1086/285380	40	182	183	2	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					485	489		10.1038/nature11131	http://dx.doi.org/10.1038/nature11131			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722834				2022-12-28	WOS:000305760600033
J	Clark, D; Field, S; Layard, R				Clark, David; Field, Steve; Layard, Richard			Mental health loses out in the National Health Service	LANCET			English	Editorial Material									[Layard, Richard] London Sch Econ, Wellbeing Programme, Ctr Econ Performance, London WC2A 2AE, England; [Clark, David] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Field, Steve] Bellevue Med Ctr, Birmingham, W Midlands, England	University of London; London School Economics & Political Science; University of Oxford	Layard, R (corresponding author), London Sch Econ, Wellbeing Programme, Ctr Econ Performance, London WC2A 2AE, England.	r.layard@lse.ac.uk		Clark, David/0000-0002-8173-6022	Economic and Social Research Council [ES/H02123X/1] Funding Source: researchfish; ESRC [ES/H02123X/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		[Anonymous], 2011, HAPPINESS LESSONS NE; Brugha T, 2009, ADULT PSYCHIAT MORBI; Chiles JA, 1999, CLIN PSYCHOL-SCI PR, V6, P204, DOI 10.1093/clipsy/6.2.204; Clark D, 2007, EFFECTIVENESS PSYCHO; Clark DM, 2011, INT REV PSYCHIATR, V23, P318, DOI 10.3109/09540261.2011.606803; Department of Health, 2011, NHS OUTC FRAM 2012 1; Gyani A, 2011, ENHANCING RECOVERY R; Layard R, 2007, NATL INST ECON REV, V202, P90, DOI 10.1177/0027950107086171; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Naylor C, 2012, LONG TERM CONDITIONS; Nimnuan C, 2001, J PSYCHOSOM RES, V51, P361, DOI 10.1016/S0022-3999(01)00223-9; The Centre for Economic Performance and Mental Health Policy Group, 2012, MENT ILLN LOS OUT NH; WHO, 2022, GLOB BURD DIS 2004 U; Young Minds, 2012, BRIEF CUTS CHILDR YO	14	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2012	379	9834					2315	2316		10.1016/S0140-6736(12)60985-4	http://dx.doi.org/10.1016/S0140-6736(12)60985-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961ZV	22726501				2022-12-28	WOS:000305509600004
J	Hopewell, S; Ravaud, P; Baron, G; Boutron, I				Hopewell, Sally; Ravaud, Philippe; Baron, Gabriel; Boutron, Isabelle			Effect of editors' implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED-TRIALS; EXPLANATION; QUALITY	Objective To investigate the effect of the CONSORT for Abstracts guidelines, and different editorial policies used by five leading general medical journals to implement the guidelines, on the reporting quality of abstracts of randomised trials. Design Interrupted time series analysis. Sample We randomly selected up to 60 primary reports of randomised trials per journal per year from five high impact, general medical journals in 2006-09, if indexed in PubMed with an electronic abstract. We excluded reports that did not include an electronic abstract, and any secondary trial publications or economic analyses. We classified journals in three categories: those not mentioning the guidelines in their instructions to authors (JAMA and New England Journal of Medicine), those referring to the guidelines in their instructions to authors but with no specific policy to implement them (BMJ), and those referring to the guidelines in their instructions to authors with an active policy to implement them (Annals of Internal Medicine and Lancet). Two authors extracted data independently using the CONSORT for Abstracts checklist. Main outcome Mean number of CONSORT items reported in selected abstracts, among nine items reported in fewer than 50% of the abstracts published across the five journals in 2006. Results We assessed 955 reports of abstracts of randomised trials. Journals with an active policy to enforce the guidelines showed an immediate increase in the level of mean number of items reported (increase of 1.50 items; P=0.0037). At 23 months after publication of the guidelines, the mean number of items reported per abstract for the primary outcome was 5.41 of nine items, a 53% increase compared with the expected level estimated on the basis of pre-intervention trends. The change in level or trend did not increase in journals with no policy to enforce the guidelines (BMJ, JAMA, and New England Journal of Medicine). Conclusion Active implementation of the CONSORT for Abstracts guidelines by journals can lead to improvements in the reporting of abstracts of randomised trials.	[Hopewell, Sally] Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England; [Hopewell, Sally; Ravaud, Philippe; Baron, Gabriel; Boutron, Isabelle] INSERM, U738, Paris, France; [Ravaud, Philippe; Baron, Gabriel; Boutron, Isabelle] Hop Hotel Dieu, Assistance Publ Hop Paris, Ctr Clin Epidemiol, Paris, France; [Ravaud, Philippe; Baron, Gabriel; Boutron, Isabelle] Univ Paris 05, Fac Med, Paris, France; [Ravaud, Philippe; Boutron, Isabelle] French Cochrane Ctr, Paris, France	University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Hopewell, S (corresponding author), Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England.	sally.hopewell@csm.ox.ac.uk	ravaud, philippe/C-1694-2009	Hopewell, Sally/0000-0002-6881-6984; Ravaud, Philippe/0000-0001-8264-9206; Boutron, Isabelle/0000-0002-5263-6241	MRC [MR/J004871/1] Funding Source: UKRI; Medical Research Council [MR/J004871/1] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		[Anonymous], 2006, PLOS MED, V3, P563, DOI 10.1371/journal.pmed.0030252; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Berwanger O, 2009, J CLIN EPIDEMIOL, V62, P387, DOI 10.1016/j.jclinepi.2008.05.013; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Can OS, 2011, EUR J ANAESTH, V28, P485, DOI 10.1097/EJA.0b013e32833fb96f; Chen YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011926; Cook TD, 1979, QUASIEXPERIMENTS INT; FROOM P, 1993, J CLIN EPIDEMIOL, V46, P591, DOI 10.1016/0895-4356(93)90029-Z; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Hopewell S, 2008, J INF SCI, V34, P162, DOI 10.1177/0165551507080415; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Mills E, 2005, J CLIN EPIDEMIOL, V58, P662, DOI 10.1016/j.jclinepi.2005.01.004; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Pitkin RM, 1999, JAMA-J AM MED ASSOC, V281, P1110, DOI 10.1001/jama.281.12.1110; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WOOLF SH, 1993, ARCH INTERN MED, V153, P2646, DOI 10.1001/archinte.153.23.2646; Yoon U, 2012, BRIT J SPORT MED, V46, P202, DOI 10.1136/bjsm.2008.053876	19	138	142	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2012	344								e4178	10.1136/bmj.e4178	http://dx.doi.org/10.1136/bmj.e4178			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965CL	22730543	Green Published, hybrid			2022-12-28	WOS:000305743600002
J	Prusiner, SB				Prusiner, Stanley B.			A Unifying Role for Prions in Neurodegenerative Diseases	SCIENCE			English	Editorial Material							CHRONIC TRAUMATIC ENCEPHALOPATHY; PARKINSONS-DISEASE; LONG-TERM; PROPAGATION; CELLS; TRANSMISSION; TAUOPATHY; DISORDER; NEURONS; BRAIN		[Prusiner, Stanley B.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Prusiner, Stanley B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Prusiner, SB (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA.	stanley@ind.ucsf.edu			NIA NIH HHS [P01 AG021601, P01 AG010770, P01 AG002132] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG010770, P01AG002132, P01AG021601] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Colby DW, 2011, NAT REV MICROBIOL, V9, P771, DOI 10.1038/nrmicro2650; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Olanow CW, 2009, P NATL ACAD SCI USA, V106, P12571, DOI 10.1073/pnas.0906759106; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ridley RM, 2006, J NEURAL TRANSM, V113, P1243, DOI 10.1007/s00702-005-0385-2; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Stohr J., P NATL ACAD SCI USA, DOI [10.1073/pnas.1206555109, DOI 10.1073/PNAS.1206555109]	23	377	388	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1511	1513		10.1126/science.1222951	http://dx.doi.org/10.1126/science.1222951			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723400	Green Accepted			2022-12-28	WOS:000305507500034
J	Crow, JM				Crow, James Mitchell			OBESITY Insensitive issue	NATURE			English	Editorial Material							ORAL-SENSITIVITY; FAT; PERCEPTION; SWEET; ACID											Bartoshuk LM, 2006, PHILOS T R SOC B, V361, P1137, DOI 10.1098/rstb.2006.1853; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; Sartor F, 2011, APPETITE, V57, P237, DOI 10.1016/j.appet.2011.05.107; Stewart J. E., 2011, J INT J OBESITY, DOI [10.1038/ijo.2011.155, DOI 10.1038/IJO.2011.155]; Stewart JE, 2011, CLIN NUTR, V30, P838, DOI 10.1016/j.clnu.2011.06.007; Tucker RM, 2012, J FOOD SCI, V77, pS148, DOI 10.1111/j.1750-3841.2011.02518.x	6	120	130	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					S12	S13						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	046RB	22717396	Bronze			2022-12-28	WOS:000311781000007
J	Frenking, G; Holzmann, N				Frenking, Gernot; Holzmann, Nicole			A Boron-Boron Triple Bond	SCIENCE			English	Editorial Material							HETEROCYCLIC CARBENE; MOLECULE		[Frenking, Gernot; Holzmann, Nicole] Univ Marburg, Fachbereich Chem, D-35039 Marburg, Germany	Philipps University Marburg	Frenking, G (corresponding author), Univ Marburg, Fachbereich Chem, Hans Meerwein Str, D-35039 Marburg, Germany.	frenking@chemie.uni-marburg.de	Holzmann, Nicole/I-1752-2014	Holzmann, Nicole/0000-0001-5717-1984				Abraham MY, 2010, CHEM-EUR J, V16, P432, DOI 10.1002/chem.200902840; Braunschweig H, 2012, SCIENCE, V336, P1420, DOI 10.1126/science.1221138; Ducati LC, 2009, J PHYS CHEM A, V113, P11693, DOI 10.1021/jp902780t; Holzmann N, 2011, CHEM-EUR J, V17, P13517, DOI 10.1002/chem.201101915; Huber K.P., 1979, MOL SPECTRA MOL STRU; Kinjo R, 2011, SCIENCE, V333, P610, DOI 10.1126/science.1207573; Lein M, 2005, J AM CHEM SOC, V127, P6290, DOI 10.1021/ja042295c; Li SD, 2008, J AM CHEM SOC, V130, P2573, DOI 10.1021/ja0771080; Power PP, 1999, CHEM REV, V99, P3463, DOI 10.1021/cr9408989; Sidiropoulos A, 2009, ANGEW CHEM INT EDIT, V48, P9701, DOI 10.1002/anie.200905495; Wang YZ, 2008, SCIENCE, V321, P1069, DOI 10.1126/science.1160768; Wang YZ, 2008, J AM CHEM SOC, V130, P3298, DOI 10.1021/ja800257j; Zhou MF, 2002, J AM CHEM SOC, V124, P12936, DOI 10.1021/ja026257+	13	64	64	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1394	1395		10.1126/science.1224003	http://dx.doi.org/10.1126/science.1224003			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700911				2022-12-28	WOS:000305211700032
J	Hawlena, D; Strickland, MS; Bradford, MA; Schmitz, OJ				Hawlena, Dror; Strickland, Michael S.; Bradford, Mark A.; Schmitz, Oswald J.			Fear of Predation Slows Plant-Litter Decomposition	SCIENCE			English	Article							ECOSYSTEM; STRESS; CARBON; SOIL; BIODIVERSITY; RISK	Aboveground consumers are believed to affect ecosystem functioning by regulating the quantity and quality of plant litter entering the soil. We uncovered a pathway whereby terrestrial predators regulate ecosystem processes via indirect control over soil community function. Grasshopper herbivores stressed by spider predators have a higher body carbon-to-nitrogen ratio than do grasshoppers raised without spiders. This change in elemental content does not slow grasshopper decomposition but perturbs belowground community function, decelerating the subsequent decomposition of plant litter. This legacy effect of predation on soil community function appears to be regulated by the amount of herbivore protein entering the soil.	[Hawlena, Dror; Strickland, Michael S.; Bradford, Mark A.; Schmitz, Oswald J.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Hawlena, Dror] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Ecol Evolut & Behav, IL-91904 Jerusalem, Israel; [Strickland, Michael S.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	Yale University; Hebrew University of Jerusalem; Virginia Polytechnic Institute & State University	Hawlena, D (corresponding author), Yale Univ, Sch Forestry & Environm Studies, 370 Prospect St, New Haven, CT 06511 USA.	dror.hawlena@mail.huji.ac.il	Strickland, Michael/B-7137-2016; Bradford, Mark A/G-3850-2012	Strickland, Michael/0000-0001-5349-0363; Bradford, Mark A/0000-0002-2022-8331	Yale Climate and Energy Institute; NSF [DEB-0816504]	Yale Climate and Energy Institute; NSF(National Science Foundation (NSF))	We thank P. Raymond, A. Genin, G. Bloch, and three anonymous reviewers for their comments and suggestions on earlier versions of this manuscript and K. Hughes and K. McLean for field assistance. This research was supported by a grant from the Yale Climate and Energy Institute to O.J.S. and M.A.B. and by NSF grant DEB-0816504 to O.J.S. Data used in this study are available at http://dx.doi.org/10.5061/dryad.2cm3h1q7.	Allison SD, 2009, SOIL BIOL BIOCHEM, V41, P293, DOI 10.1016/j.soilbio.2008.10.032; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Cebrian J, 2004, ECOL LETT, V7, P232, DOI 10.1111/j.1461-0248.2004.00574.x; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; DuRant SE, 2007, COMP BIOCHEM PHYS C, V145, P442, DOI 10.1016/j.cbpc.2007.01.014; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hawlena D, 2011, FUNCT ECOL, V25, P1223, DOI 10.1111/j.1365-2435.2011.01891.x; Hawlena D, 2010, AM NAT, V176, P537, DOI 10.1086/656495; Hawlena D, 2010, P NATL ACAD SCI USA, V107, P15503, DOI 10.1073/pnas.1009300107; Pauwels K, 2005, J EVOLUTION BIOL, V18, P867, DOI 10.1111/j.1420-9101.2005.00890.x; Rovero F, 2000, J ANIM ECOL, V69, P683, DOI 10.1046/j.1365-2656.2000.00426.x; Schimel J, 2007, ECOLOGY, V88, P1386, DOI 10.1890/06-0219; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Steiner UK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006160; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Sterner RW, 1997, FRESHWATER BIOL, V38, P473, DOI 10.1046/j.1365-2427.1997.00234.x; Stoks R, 2005, ECOL LETT, V8, P1307, DOI 10.1111/j.1461-0248.2005.00840.x; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875	25	160	164	5	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2012	336	6087					1434	1438		10.1126/science.1220097	http://dx.doi.org/10.1126/science.1220097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700928				2022-12-28	WOS:000305211700044
J	Spence, D				Spence, Des			Why doctors should support welfare reform	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Beatty C, INCAPACITY BENEFITS; Office for National Statistics, 2011, OFF NAT STAT STAT B	2	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 13	2012	344								e4054	10.1136/bmj.e4054	http://dx.doi.org/10.1136/bmj.e4054			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961KT	22695908				2022-12-28	WOS:000305464000019
J	Chu, HT; Pazgier, M; Jung, G; Nuccio, SP; Castillo, PA; de Jong, MF; Winter, MG; Winter, SE; Wehkamp, J; Shen, B; Salzman, NH; Underwood, MA; Tsolis, RM; Young, GM; Lu, WY; Lehrer, RI; Baumler, AJ; Bevins, CL				Chu, Hiutung; Pazgier, Marzena; Jung, Grace; Nuccio, Sean-Paul; Castillo, Patricia A.; de Jong, Maarten F.; Winter, Maria G.; Winter, Sebastian E.; Wehkamp, Jan; Shen, Bo; Salzman, Nita H.; Underwood, Mark A.; Tsolis, Renee M.; Young, Glenn M.; Lu, Wuyuan; Lehrer, Robert I.; Baeumler, Andreas J.; Bevins, Charles L.			Human alpha-Defensin 6 Promotes Mucosal Innate Immunity Through Self-Assembled Peptide Nanonets	SCIENCE			English	Article							PANETH CELLS; MICE; HD5	Defensins are antimicrobial peptides that contribute broadly to innate immunity, including protection of mucosal tissues. Human alpha-defensin (HD) 6 is highly expressed by secretory Paneth cells of the small intestine. However, in contrast to the other defensins, it lacks appreciable bactericidal activity. Nevertheless, we report here that HD6 affords protection against invasion by enteric bacterial pathogens in vitro and in vivo. After stochastic binding to bacterial surface proteins, HD6 undergoes ordered self-assembly to form fibrils and nanonets that surround and entangle bacteria. This self-assembly mechanism occurs in vivo, requires histidine-27, and is consistent with x-ray crystallography data. These findings support a key role for HD6 in protecting the small intestine against invasion by diverse enteric pathogens and may explain the conservation of HD6 throughout Hominidae evolution.	[Chu, Hiutung; Nuccio, Sean-Paul; Castillo, Patricia A.; de Jong, Maarten F.; Winter, Maria G.; Winter, Sebastian E.; Wehkamp, Jan; Tsolis, Renee M.; Baeumler, Andreas J.; Bevins, Charles L.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Pazgier, Marzena; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem Mol Biol, Baltimore, MD 21201 USA; [Jung, Grace; Lehrer, Robert I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Shen, Bo] Cleveland Clin Fdn, Dept Gastroenterol & Hepatol, Cleveland, OH 44195 USA; [Salzman, Nita H.] Med Coll Wisconsin, Dept Pediat, Div Gastroenterol, Milwaukee, WI 53226 USA; [Underwood, Mark A.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Young, Glenn M.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cleveland Clinic Foundation; Medical College of Wisconsin; University of California System; University of California Davis; University of California System; University of California Davis	Bevins, CL (corresponding author), Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA.	clbevins@ucdavis.edu	Wehkamp, Jan/B-7319-2011; Winter, Sebastian E/A-4118-2009; Baumler, Andreas J/H-2301-2011; Lu, Wuyuan/B-2268-2010; Bevins, Charles L/P-4438-2015; Lu, Wuyuan/J-8452-2017	Winter, Sebastian E/0000-0003-1532-9178; Baumler, Andreas J/0000-0001-9152-7809; Bevins, Charles L/0000-0003-2725-2622; Lu, Wuyuan/0000-0003-1318-9968; Chu, Hiutung/0000-0001-7489-0446; Nuccio, Sean-Paul/0000-0002-9683-9278; Salzman, Nita/0000-0003-0939-6139; de jong, maarten/0000-0003-2278-286X; Tsolis, Renee/0000-0001-9131-6657; Wehkamp, Jan/0000-0001-6788-841X	National Institutes of Health [AI032738, AI050843, HD059127, AI076246, AI040124, AI044170, AI073120, AI088122, AI072732, AI070726, AI082320, AI057757, T32AI060555]; Robert Bosch Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060555, R21AI057757, R29AI040124, R21AI088122, R01AI032738, R01AI040124, R21AI082320, R01AI072732, R37AI032738, R01AI044170, R01AI076246, R21AI073120, R01AI057757, R01AI050843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Bosch Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank W. Yuan for expert assistance in synthesizing the defensin peptides and R. W. Feathers and H. K. Rho for technical help related to transgenic mice. We thank G. Adamson, P. E. Kysar, and E. Lee from Electron Microscopy Laboratory, Department of Pathology and Laboratory Medicine, School of Medicine, University of California at Davis. We gratefully acknowledge A. J. Ouellette for help with HD6 antibody production. We are indebted to A. C. Gelli and S. C. Dawson for expert guidance in exploring possible biological activities of HD6 and to S. J. Howell for initial investigations of this peptide. Finally, we appreciate the many suggestions from colleagues and members of our laboratories that helped us unravel the properties of HD6 described here. This work was supported by grants from the National Institutes of Health: AI032738 (C.L.B.), AI050843 (C.L.B.), HD059127 (M.A.U. and C.L.B.), AI076246 (A.J.B. and C.L.B.), AI040124 (A.J.B.), AI044170 (A.J.B.), AI073120 (A.J.B.), AI088122 (A.J.B.), AI072732 (W.L.), AI070726 (R.I.L.), AI082320 (R.M.T.), AI057757 (N.H.S.), and T32AI060555 (H.C. and S.P.N.) and a fellowship from the Robert Bosch Foundation (J.W.). The authors declare no competing interests. The data described in this manuscript are tabulated in the main paper and in the supplementary materials. The structure factor files and coordinates for H27W-HD6 are deposited in the Protein Data Bank under accession code 3QTE.	Andrews-Polymenis HL, 2010, INFECT IMMUN, V78, P2356, DOI 10.1128/IAI.00096-10; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Baumler AJ, 1997, INFECT IMMUN, V65, P2254; Bevins C.L., 2004, MUCOSAL IMMUNOL, V1, P95; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Ouellette AJ, 2010, CURR OPIN GASTROEN, V26, P547, DOI 10.1097/MOG.0b013e32833dccde; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Shanahan MT, 2011, INFECT IMMUN, V79, P459, DOI 10.1128/IAI.00996-10; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2010, J CROHNS COLITIS, V4, P523, DOI 10.1016/j.crohns.2010.05.010; Wei G, 2010, J BIOL CHEM, V285, P16275, DOI 10.1074/jbc.M110.102749; Wei G, 2009, J BIOL CHEM, V284, P29180, DOI 10.1074/jbc.M109.018085	20	246	260	9	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					477	481		10.1126/science.1218831	http://dx.doi.org/10.1126/science.1218831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22722251	Green Accepted			2022-12-28	WOS:000306802300046
J	Baranova, E; Fronzes, R; Garcia-Pino, A; Van Gerven, N; Papapostolou, D; Pehau-Arnaudet, G; Pardon, E; Steyaert, J; Howorka, S; Remaut, H				Baranova, Ekaterina; Fronzes, Remi; Garcia-Pino, Abel; Van Gerven, Nani; Papapostolou, David; Pehau-Arnaudet, Gerard; Pardon, Els; Steyaert, Jan; Howorka, Stefan; Remaut, Han			SbsB structure and lattice reconstruction unveil Ca2+ triggered S-layer assembly	NATURE			English	Article							PROTEIN SBSB; DOMAINS; BINDING; SYSTEM; ORGANIZATION; SCATTERING; ANTHRACIS; RESIDUES; ADHESION; MODEL	S-layers are regular two-dimensional semipermeable protein layers that constitute a major cell-wall component in archaea and many bacteria(1-3). The nanoscale repeat structure of the S-layer lattices and their self-assembly from S-layer proteins (SLPs) have sparked interest in their use as patterning and display scaffolds for a range of nano-biotechnological applications(4-7). Despite their biological abundance and the technological interest in them, structural information about SLPs is limited to truncated and assembly-negative proteins(8-10). Here we report the X-ray structure of the SbsB SLP of Geobacillus stearothermophilus PV72/p2 by the use of nanobody-aided crystallization. SbsB consists of a seven-domain protein, formed by an amino-terminal cell-wall attachment domain and six consecutive immunoglobulin-like domains, that organize into a phi-shaped disk-like monomeric crystallization unit stabilized by interdomain Ca2+ ion coordination. A Ca2+-dependent switch to the condensed SbsB quaternary structure pre-positions intermolecular contact zones and renders the protein competent for S-layer assembly. On the basis of crystal packing, chemical crosslinking data and cryo-electron microscopy projections, we present a model for the molecular organization of this SLP into a porous protein sheet inside the S-layer. The SbsB lattice represents a previously undescribed structural model for protein assemblies and may advance our understanding of SLP physiology and self-assembly, as well as the rational design of engineered higher-order structures for biotechnology(4-7).	[Baranova, Ekaterina; Van Gerven, Nani; Remaut, Han] VIB, VIB Dept Struct Biol, B-1050 Brussels, Belgium; [Baranova, Ekaterina; Garcia-Pino, Abel; Van Gerven, Nani; Pardon, Els; Steyaert, Jan; Remaut, Han] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Fronzes, Remi] Inst Pasteur, Unite G5, F-75015 Paris, France; [Fronzes, Remi; Pehau-Arnaudet, Gerard] Inst Pasteur, CNRS, Unite Rech Mixte 3538, F-75015 Paris, France; [Papapostolou, David; Howorka, Stefan] UCL, Inst Struct & Mol Biol, Dept Chem, London WC1H 0AJ, England	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; Birkbeck University London; University College London	Remaut, H (corresponding author), VIB, VIB Dept Struct Biol, Pl Laan 2, B-1050 Brussels, Belgium.	han.remaut@vib-vub.be	Fronzes, Rémi/GLS-0406-2022; steyaert, jan/GQP-7811-2022; Steyaert, Jan/H-4662-2011; Fronzes, Remi/T-2578-2019	Steyaert, Jan/0000-0002-3825-874X; Fronzes, Remi/0000-0003-3031-9824; Remaut, Han/0000-0002-9775-4102; Pardon, Els/0000-0002-2466-0172; Howorka, Stefan/0000-0002-6527-2846; Van Gerven, Nani/0000-0002-4269-3904; Baranova, Ekaterina/0000-0003-3211-7134; Garcia-Pino, Abel/0000-0002-0634-0300	VIB (Vlaams Institute voor Biotechnologie) [PRJ9]; Fonds Wetenschappelijk Onderzoek-Vlaanderen through an Odysseus grant; Centre National de la Recherche Scientifique (CNRS); Institut Pasteur; Interuniversity Attraction Poles grant [P6/19]; Biotechnology and Biological Sciences Research Council [BB/E010466/1]; University College London;  [FWO551]; BBSRC [BB/E010466/1] Funding Source: UKRI	VIB (Vlaams Institute voor Biotechnologie); Fonds Wetenschappelijk Onderzoek-Vlaanderen through an Odysseus grant; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); Interuniversity Attraction Poles grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University College London(General Electric); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank staff at beamlines Proxima-1 and SWING (Soleil), beamline BM30A (European Synchrotron Radiation Facility) and beamline X33 (Deutsches Elektronen-Synchrotron) for technical assistance during data collection. We thank G. Waksman for suggestions on the manuscript, and D. Levy for advice on cryo-EM grid preparation and data collection. This work was supported by VIB (Vlaams Institute voor Biotechnologie) grant PRJ9 to H. R., the Fonds Wetenschappelijk Onderzoek-Vlaanderen through an Odysseus grant to H. R., a postdoctoral fellowship to A. P. G. and research grant FWO551 to J.S. R. F. is supported by the Centre National de la Recherche Scientifique (CNRS) and the Institut Pasteur. G. P. A. is supported by the CNRS. E. P. received support from Interuniversity Attraction Poles grant P6/19. D. P. was funded by Biotechnology and Biological Sciences Research Council grant BB/E010466/1, and S. H. is grateful for support from University College London. We acknowledge Professor Emeritus U. Sleytr for his lifelong devotion to S-layer protein research and G. stearothermophilus SbsB in particular.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; De Genst E, 2004, J BIOL CHEM, V279, P53593, DOI 10.1074/jbc.M407843200; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelhardt H, 1998, J STRUCT BIOL, V124, P276, DOI 10.1006/jsbi.1998.4070; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Gipson B, 2007, J STRUCT BIOL, V160, P375, DOI 10.1016/j.jsb.2007.09.011; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; GLAUERT AM, 1962, BRIT MED BULL, V18, P245, DOI 10.1093/oxfordjournals.bmb.a069988; Howorka S, 2000, J BIOL CHEM, V275, P37876, DOI 10.1074/jbc.M003838200; Howorka S, 2011, CURR OPIN BIOTECH, V22, P485, DOI 10.1016/j.copbio.2011.05.003; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kern J, 2011, J BIOL CHEM, V286, P26042, DOI 10.1074/jbc.M111.248070; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; Kinns H, 2008, J MOL BIOL, V377, P589, DOI 10.1016/j.jmb.2008.01.019; Kinns H, 2010, J MOL BIOL, V395, P742, DOI 10.1016/j.jmb.2009.10.012; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546; Mader C, 1999, BBA-BIOMEMBRANES, V1418, P106, DOI 10.1016/S0005-2736(99)00030-9; Mark SS, 2006, LANGMUIR, V22, P3763, DOI 10.1021/la053115v; Messner P, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P53, DOI 10.1007/978-3-642-05062-6_2; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moll D, 2002, P NATL ACAD SCI USA, V99, P14646, DOI 10.1073/pnas.232299399; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nam YS, 2010, NAT NANOTECHNOL, V5, P340, DOI [10.1038/NNANO.2010.57, 10.1038/nnano.2010.57]; Pavkov T, 2008, STRUCTURE, V16, P1226, DOI 10.1016/j.str.2008.05.012; Pavkov-Keller T, 2011, PROG MOL BIOL TRANSL, V103, P73, DOI 10.1016/B978-0-12-415906-8.00004-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Runzler D, 2004, J BIOL CHEM, V279, P5207, DOI 10.1074/jbc.M308819200; Sara M, 1996, J BACTERIOL, V178, P2108, DOI 10.1128/jb.178.7.2108-2117.1996; Sara M, 1998, J BACTERIOL, V180, P6780; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Sleytr UB, 2011, PROG MOL BIOL TRANSL, V103, P277, DOI 10.1016/B978-0-12-415906-8.00003-0; Sotomayor M, 2008, BIOPHYS J, V94, P4621, DOI 10.1529/biophysj.107.125591; Steyaert J, 2011, CURR OPIN STRUC BIOL, V21, P567, DOI 10.1016/j.sbi.2011.06.011; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006	47	99	99	1	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					119	+		10.1038/nature11155	http://dx.doi.org/10.1038/nature11155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722836	Green Published			2022-12-28	WOS:000305982900062
J	von Caemmerer, S; Quick, WP; Furbank, RT				von Caemmerer, Susanne; Quick, W. Paul; Furbank, Robert T.			The Development of C-4 Rice: Current Progress and Future Challenges	SCIENCE			English	Editorial Material							PHOTOSYNTHETIC PATHWAY; CARBOXYLASE; RUBISCO	Another "green revolution" is needed for crop yields to meet demands for food. The international C-4 Rice Consortium is working toward introducing a higher-capacity photosynthetic mechanism-the C-4 pathway-into rice to increase yield. The goal is to identify the genes necessary to install C-4 photosynthesis in rice through different approaches, including genomic and transcriptional sequence comparisons and mutant screening.	[von Caemmerer, Susanne] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Quick, W. Paul] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England; [Quick, W. Paul] Int Rice Res Inst, Los Banos, Philippines; [Furbank, Robert T.] CSIRO Plant Ind, High Resolut Plant Phen Ctr, Canberra, ACT 2601, Australia	Australian National University; University of Sheffield; CGIAR; International Rice Research Institute (IRRI); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	von Caemmerer, S (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	susanne.caemmerer@anu.edu.au	von Caemmerer, Susanne/C-9317-2009; Furbank, Robert T/A-1884-2010	Furbank, Robert T/0000-0001-8700-6613				Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Borlaug N, 2007, SCIENCE, V318, P359, DOI 10.1126/science.1151062; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Cousins AB, 2010, PLANT CELL ENVIRON, V33, P444, DOI 10.1111/j.1365-3040.2009.02095.x; Furumoto T, 2007, PLANT PHYSIOL, V144, P1936, DOI 10.1104/pp.107.102541; Hibberd JM, 2008, CURR OPIN PLANT BIOL, V11, P228, DOI 10.1016/j.pbi.2007.11.002; Kajala K, 2011, J EXP BOT, V62, P3001, DOI 10.1093/jxb/err022; Langdale JA, 2011, PLANT CELL, V23, P3879, DOI 10.1105/tpc.111.092098; Miyao M, 2011, J EXP BOT, V62, P3021, DOI 10.1093/jxb/err023; Pengelly JJL, 2011, PLANT PHYSIOL, V156, P503, DOI 10.1104/pp.111.176495; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; von Caemmerer S., 2000, BIOCH MODELS LEAF PH, V2	12	230	233	6	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1671	1672		10.1126/science.1220177	http://dx.doi.org/10.1126/science.1220177			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745421				2022-12-28	WOS:000305794500040
J	Luke, B; Brown, MB; Wantman, E; Lederman, A; Gibbons, W; Schattman, GL; Lobo, RA; Leach, RE; Stern, JE				Luke, Barbara; Brown, Morton B.; Wantman, Ethan; Lederman, Avi; Gibbons, William; Schattman, Glenn L.; Lobo, Rogerio A.; Leach, Richard E.; Stern, Judy E.			Cumulative Birth Rates with Linked Assisted Reproductive Technology Cycles	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; LIVE-BIRTH; COUPLES DISCONTINUE; PREGNANCY; SPERM; PROGRAM; DROPOUT	BACKGROUND Live-birth rates after treatment with assisted reproductive technology have traditionally been reported on a per-cycle basis. For women receiving continued treatment, cumulative success rates are a more important measure. METHODS We linked data from cycles of assisted reproductive technology in the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for the period from 2004 through 2009 to individual women in order to estimate cumulative live-birth rates. Conservative estimates assumed that women who did not return for treatment would not have a live birth; optimal estimates assumed that these women would have live-birth rates similar to those for women continuing treatment. RESULTS The data were from 246,740 women, with 471,208 cycles and 140,859 live births. Live-birth rates declined with increasing maternal age and increasing cycle number with autologous, but not donor, oocytes. By the third cycle, the conservative and optimal estimates of live-birth rates with autologous oocytes had declined from 63.3% and 74.6%, respectively, for women younger than 31 years of age to 18.6% and 27.8% for those 41 or 42 years of age and to 6.6% and 11.3% for those 43 years of age or older. When donor oocytes were used, the rates were higher than 60% and 80%, respectively, for all ages. Rates were higher with blastocyst embryos (day of transfer, 5 or 6) than with cleavage embryos (day of transfer, 2 or 3). At the third cycle, the conservative and optimal estimates of cumulative live-birth rates were, respectively, 42.7% and 65.3% for transfer of cleavage embryos and 52.4% and 80.7% for transfer of blastocyst embryos when fresh autologous oocytes were used. CONCLUSIONS Our results indicate that live-birth rates approaching natural fecundity can be achieved by means of assisted reproductive technology when there are favorable patient and embryo characteristics. Live-birth rates among older women are lower than those among younger women when autologous oocytes are used but are similar to the rates among young women when donor oocytes are used. (Funded by the National Institutes of Health and the Society for Assisted Reproductive Technology.)	[Luke, Barbara; Leach, Richard E.] Michigan State Univ, Dept Obstet, E Lansing, MI 48824 USA; [Luke, Barbara; Leach, Richard E.] Michigan State Univ, Dept Gynecol, E Lansing, MI 48824 USA; [Luke, Barbara; Leach, Richard E.] Michigan State Univ, Dept Reprod Biol, E Lansing, MI 48824 USA; [Brown, Morton B.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Leach, Richard E.] Spectrum Hlth Med Grp, Dept Obstet Gynecol & Womens Hlth, Grand Rapids, MI USA; [Wantman, Ethan; Lederman, Avi] Redshift Technol, New York, NY USA; [Schattman, Glenn L.] Cornell Med Ctr, Dept Obstet & Gynecol, New York, NY USA; [Lobo, Rogerio A.] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY USA; [Gibbons, William] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Stern, Judy E.] Geisel Sch Med Dartmouth, Dartmouth Hitchcock Med Ctr, Dept Obstet & Gynecol, Lebanon, NH USA	Michigan State University; Michigan State University; Michigan State University; University of Michigan System; University of Michigan; Spectrum Health Medical Group; Cornell University; Columbia University; Baylor College of Medicine; Dartmouth College	Luke, B (corresponding author), Michigan State Univ, Dept Obstet, E Lansing, MI 48824 USA.			Stern, Judy/0000-0002-7672-3913	National Cancer Institute, National Institutes of Health [R01 CA151973]; Society for Assisted Reproductive Technology (SART); National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA151973] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Society for Assisted Reproductive Technology (SART); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Institutes of Health and the Society for Assisted Reproductive Technology.; Supported by the National Cancer Institute, National Institutes of Health (grant R01 CA151973), and the Society for Assisted Reproductive Technology (SART).	Adamson GD, 2006, FERTIL STERIL, V85, P1586, DOI 10.1016/j.fertnstert.2006.01.011; Brandes M, 2009, HUM REPROD, V24, P3127, DOI 10.1093/humrep/dep340; [Centers for Disease Control and Prevention Assisted Reproductive Technology (ART)], 2008, 2008 ASS REPR TECHN; Cobo A, 2010, HUM REPROD, V25, P2239, DOI 10.1093/humrep/deq146; Domar AD, 2004, FERTIL STERIL, V81, P271, DOI 10.1016/j.fertnstert.2003.08.013; Donckers J, 2011, FERTIL STERIL, V96, P160, DOI 10.1016/j.fertnstert.2011.04.019; Gibbons WE, 2011, FERTIL STERIL, V95, P1645, DOI 10.1016/j.fertnstert.2010.11.029; Greenwood M., 1926, REPORTS PUBLIC HLTH, V33, P1; Land JA, 1997, FERTIL STERIL, V68, P278, DOI 10.1016/S0015-0282(97)81515-4; Lande Y, 2011, FERTIL STERIL, V95, P568, DOI 10.1016/j.fertnstert.2010.06.005; Luke B, 2011, FERTIL STERIL, V95, P1661, DOI 10.1016/j.fertnstert.2010.12.035; Luke B, 2011, HUM REPROD, V26, P245, DOI 10.1093/humrep/deq306; Luke B, 2010, FERTIL STERIL, V93, P490, DOI 10.1016/j.fertnstert.2009.02.077; Malizia BA, 2009, NEW ENGL J MED, V360, P236, DOI 10.1056/NEJMoa0803072; Nygren KG, 2011, FERTIL STERIL, V95, P2209, DOI 10.1016/j.fertnstert.2011.03.058; Olivius C, 2004, FERTIL STERIL, V81, P258, DOI 10.1016/j.fertnstert.2003.06.029; Olivius K, 2002, FERTIL STERIL, V77, P505, DOI 10.1016/S0015-0282(01)03217-4; Sharma V, 2002, FERTIL STERIL, V78, P40, DOI 10.1016/S0015-0282(02)03160-6; Stern JE, 2012, FERTIL STERIL, V97, P890, DOI 10.1016/j.fertnstert.2011.12.050; Stern JE, 2011, FERTIL STERIL, V95, P600, DOI 10.1016/j.fertnstert.2010.06.009; Stern JE, 2010, FERTIL STERIL, V94, P1334, DOI 10.1016/j.fertnstert.2009.05.052; Witsenburg C, 2005, FERTIL STERIL, V84, P99, DOI 10.1016/j.fertnstert.2005.02.013	22	148	156	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2483	2491		10.1056/NEJMoa1110238	http://dx.doi.org/10.1056/NEJMoa1110238			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965DP	22738098	Green Accepted, Bronze			2022-12-28	WOS:000305747000008
J	Yilmaz, OH; Katajisto, P; Lamming, DW; Gultekin, Y; Bauer-Rowe, KE; Sengupta, S; Birsoy, K; Dursun, A; Yilmaz, VO; Selig, M; Nielsen, GP; Mino-Kenudson, M; Zukerberg, LR; Bhan, AK; Deshpande, V; Sabatini, DM				Yilmaz, Oemer H.; Katajisto, Pekka; Lamming, Dudley W.; Gueltekin, Yetis; Bauer-Rowe, Khristian E.; Sengupta, Shomit; Birsoy, Kivanc; Dursun, Abdulmetin; Yilmaz, V. Onur; Selig, Martin; Nielsen, G. Petur; Mino-Kenudson, Mari; Zukerberg, Lawrence R.; Bhan, Atul K.; Deshpande, Vikram; Sabatini, David M.			mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake	NATURE			English	Article							DIETARY RESTRICTION; MICE; HOMEOSTASIS; PTEN; LGR5; RENEWAL; C57BL/6; IMPACT; GROWTH; SIZE	How adult tissue stem and niche cells respond to the nutritional state of an organism is not well understood. Here we find that Paneth cells, a key constituent of the mammalian intestinal stem-cell (ISC) niche, augment stem-cell function in response to calorie restriction. Calorie restriction acts by reducing mechanistic target of rapamycin complex 1 (mTORC1) signalling in Paneth cells, and the ISC-enhancing effects of calorie restriction can be mimicked by rapamycin. Calorie intake regulates mTORC1 in Paneth cells, but not ISCs, and forced activation of mTORC1 in Paneth cells during calorie restriction abolishes the ISC-augmenting effects of the niche. Finally, increased expression of bone stromal antigen 1 (Bst1) in Paneth cells-an ectoenzyme that produces the paracrine factor cyclic ADP ribose-mediates the effects of calorie restriction and rapamycin on ISC function. Our findings establish that mTORC1 non-cell-autonomously regulates stem-cell self-renewal, and highlight a significant role of the mammalian intestinal niche in coupling stem-cell function to organismal physiology.	[Yilmaz, Oemer H.; Katajisto, Pekka; Lamming, Dudley W.; Gueltekin, Yetis; Bauer-Rowe, Khristian E.; Sengupta, Shomit; Birsoy, Kivanc; Yilmaz, V. Onur; Sabatini, David M.] Whitehead Inst Biomed Res, Boston, MA 02142 USA; [Yilmaz, Oemer H.; Gueltekin, Yetis; Dursun, Abdulmetin; Selig, Martin; Nielsen, G. Petur; Mino-Kenudson, Mari; Zukerberg, Lawrence R.; Bhan, Atul K.; Deshpande, Vikram] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Yilmaz, Oemer H.; Gueltekin, Yetis; Dursun, Abdulmetin; Selig, Martin; Nielsen, G. Petur; Mino-Kenudson, Mari; Zukerberg, Lawrence R.; Bhan, Atul K.; Deshpande, Vikram] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Yilmaz, Oemer H.; Katajisto, Pekka; Lamming, Dudley W.; Gueltekin, Yetis; Bauer-Rowe, Khristian E.; Sengupta, Shomit; Birsoy, Kivanc; Yilmaz, V. Onur; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Yilmaz, Oemer H.; Katajisto, Pekka; Lamming, Dudley W.; Gueltekin, Yetis; Bauer-Rowe, Khristian E.; Sengupta, Shomit; Birsoy, Kivanc; Yilmaz, V. Onur; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Yilmaz, Oemer H.; Katajisto, Pekka; Lamming, Dudley W.; Gueltekin, Yetis; Bauer-Rowe, Khristian E.; Sengupta, Shomit; Birsoy, Kivanc; Yilmaz, V. Onur; Sabatini, David M.] Broad Inst Harvard & MIT, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Yilmaz, Oemer H.; Katajisto, Pekka; Lamming, Dudley W.; Gueltekin, Yetis; Bauer-Rowe, Khristian E.; Sengupta, Shomit; Birsoy, Kivanc; Yilmaz, V. Onur; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, Boston, MA 02142 USA.	sabatini@wi.mit.edu; sabatini@wi.mit.edu	Gultekin, Yetis/H-4194-2013; Parry, Lee/A-9623-2011; Lamming, Dudley/O-7191-2015	Parry, Lee/0000-0002-4467-9196; Lamming, Dudley/0000-0002-0079-4467; Gultekin, Yetis/0000-0003-0103-351X; /0000-0002-1446-7256; Katajisto, Pekka/0000-0002-3033-4189	National Institutes of Health [CA103866, CA129105, 1F32AG032833-01A1]; Koch Institute; Ellison Medical Foundation; Warshaw Institute from the Massachusetts General Hospital; Center for the study of Inflammatory Bowel Disease from the Massachusetts General Hospital; NCI [T32CA09216]; Academy of Finland; Foundations' Post Doc Pool; Jane Coffin Childs Medical Fund; NATIONAL CANCER INSTITUTE [R01CA129105, R01CA103866, T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Koch Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); Warshaw Institute from the Massachusetts General Hospital; Center for the study of Inflammatory Bowel Disease from the Massachusetts General Hospital; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Academy of Finland(Academy of Finland); Foundations' Post Doc Pool; Jane Coffin Childs Medical Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (CA103866 and CA129105 to D. M. S.), the Koch Institute (Initiator award to D. M. S.), Ellison Medical Foundation (D. M. S.), the Warshaw Institute from the Massachusetts General Hospital (O.H.Y.), and the Center for the study of Inflammatory Bowel Disease from the Massachusetts General Hospital (O.H.Y. and D. M. S.), and fellowship support from the NCI (T32CA09216 to the Department of Pathology at the MGH to O.H.Y.), the Academy of Finland and the Foundations' Post Doc Pool (P. K.), the NIH (1F32AG032833-01A1 to D. W. L.) and Jane Coffin Childs Medical Fund (K. B.). We thank P. Wisniewski and C. Araneo of the Whitehead flow cytometry core facility, the Whitehead Genome Technology Core and Bioinformatics and Research Computing, S. Holder for histology and help with special stains, K. Ottina for laboratory management, and A. Hutchins for animal husbandry and genotyping. D. M. S. is an investigator of the Howard Hughes Medical Institute.	ALTMANN GG, 1972, AM J ANAT, V133, P391, DOI 10.1002/aja.1001330403; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bondolfi L, 2004, NEUROBIOL AGING, V25, P333, DOI 10.1016/S0197-4580(03)00083-6; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Chen JC, 2003, EXP HEMATOL, V31, P1097, DOI 10.1016/S0301-472X(03)00238-8; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Dunel-Erb S, 2001, COMP BIOCHEM PHYS A, V129, P933, DOI 10.1016/S1095-6433(01)00360-9; Ertl RP, 2008, BLOOD, V111, P1709, DOI 10.1182/blood-2007-01-069807; Gregorieff A., 2010, CURR PROTOC STEM CEL, V2; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Hempenstall S, 2010, MECH AGEING DEV, V131, P111, DOI 10.1016/j.mad.2009.12.008; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; MCCAY CM, 1975, NUTR REV, V33, P241; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Podesta M, 2005, J BIOL CHEM, V280, P5343, DOI 10.1074/jbc.M408085200; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Spindler SR, 2005, MECH AGEING DEV, V126, P960, DOI 10.1016/j.mad.2005.03.016; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	31	469	488	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					490	U87		10.1038/nature11163	http://dx.doi.org/10.1038/nature11163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722868	Green Submitted, Green Accepted			2022-12-28	WOS:000305760600034
J	Cheung, ACM; Cramer, P				Cheung, Alan C. M.; Cramer, Patrick			A Movie of RNA Polymerase II Transcription	CELL			English	Review							3.3 ANGSTROM RESOLUTION; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; PREINITIATION COMPLEX; ELONGATION COMPLEX; ABORTIVE INITIATION; ALPHA-AMANITIN; TRIGGER LOOP; ACTIVE-SITE; DNA HYBRID		[Cheung, Alan C. M.; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Cheung, Alan C. M.; Cramer, Patrick] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci Munich CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@lmb.uni-muenchen.de		Cheung, Alan/0000-0001-6430-5127				Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Andrecka J, 2009, NUCLEIC ACIDS RES, V37, P5803, DOI 10.1093/nar/gkp601; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Brueckner F, 2009, CURR OPIN STRUC BIOL, V19, P294, DOI 10.1016/j.sbi.2009.04.005; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; BUROVA E, 1995, J BACTERIOL, V177, P1388, DOI 10.1128/jb.177.5.1388-1392.1995; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheung ACM, 2011, EMBO J, V30, P4755, DOI 10.1038/emboj.2011.396; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Damsma GE, 2007, NAT STRUCT MOL BIOL, V14, P1127, DOI 10.1038/nsmb1314; Damsma GE, 2009, J BIOL CHEM, V284, P31658, DOI 10.1074/jbc.M109.022764; Dvir A, 2001, CURR OPIN GENET DEV, V11, P209, DOI 10.1016/S0959-437X(00)00181-7; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feig M, 2010, BIOPHYS J, V99, P2577, DOI 10.1016/j.bpj.2010.08.010; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Guo M, 2008, STRUCTURE, V16, P1649, DOI 10.1016/j.str.2008.08.013; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hieb AR, 2006, EMBO J, V25, P3100, DOI 10.1038/sj.emboj.7601197; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Jasiak AJ, 2008, J BIOL CHEM, V283, P26423, DOI 10.1074/jbc.M803237200; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Knutson BA, 2011, SCIENCE, V333, P1637, DOI 10.1126/science.1207699; Korkhin Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000102; Kosa PF, 1997, P NATL ACAD SCI USA, V94, P6042, DOI 10.1073/pnas.94.12.6042; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Lane WJ, 2010, J MOL BIOL, V395, P686, DOI 10.1016/j.jmb.2009.10.063; Littlefield O, 1999, P NATL ACAD SCI USA, V96, P13668, DOI 10.1073/pnas.96.24.13668; Liu X, 2011, SCIENCE, V333, P633, DOI 10.1126/science.1206629; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; LUSE DS, 1987, J BIOL CHEM, V262, P14990; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qureshi SA, 1997, EMBO J, V16, P2927, DOI 10.1093/emboj/16.10.2927; REINES D, 1989, J BIOL CHEM, V264, P10799; Reines D, 1996, TRENDS BIOCHEM SCI, V21, P351, DOI 10.1016/0968-0004(96)10045-1; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Svejstrup JQ, 2004, BBA-GENE STRUCT EXPR, V1677, P64, DOI 10.1016/j.bbaexp.2003.10.012; Sydow JF, 2009, CURR OPIN STRUC BIOL, V19, P732, DOI 10.1016/j.sbi.2009.10.009; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; Treutlein B, 2012, MOL CELL, V46, P136, DOI 10.1016/j.molcel.2012.02.008; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; VANDYKE MW, 1988, SCIENCE, V241, P1335, DOI 10.1126/science.3413495; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Werner F, 2012, J MOL BIOL, V417, P13, DOI 10.1016/j.jmb.2012.01.031; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	87	80	81	0	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1431	1437		10.1016/j.cell.2012.06.006	http://dx.doi.org/10.1016/j.cell.2012.06.006			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726432	Bronze			2022-12-28	WOS:000305753800010
J	Crismani, W; Girard, C; Froger, N; Pradillo, M; Santos, JL; Chelysheva, L; Copenhaver, GP; Horlow, C; Mercier, R				Crismani, Wayne; Girard, Chloe; Froger, Nicole; Pradillo, Monica; Luis Santos, Juan; Chelysheva, Liudmila; Copenhaver, Gregory P.; Horlow, Christine; Mercier, Raphael			FANCM Limits Meiotic Crossovers	SCIENCE			English	Article							CROSSING-OVER; RECOMBINATION; INTERFERENCE; ORTHOLOG; MEIOSIS; REPAIR; SGS1	The number of meiotic crossovers (COs) is tightly regulated within a narrow range, despite a large excess of molecular precursors. The factors that limit COs remain largely unknown. Here, using a genetic screen in Arabidopsis thaliana, we identified the highly conserved FANCM helicase, which is required for genome stability in humans and yeasts, as a major factor limiting meiotic CO formation. The fancm mutant has a threefold-increased CO frequency as compared to the wild type. These extra COs arise not from the pathway that accounts for most of the COs in wild type, but from an alternate, normally minor pathway. Thus, FANCM is a key factor imposing an upper limit on the number of meiotic COs, and its manipulation holds much promise for plant breeding.	[Crismani, Wayne; Girard, Chloe; Froger, Nicole; Chelysheva, Liudmila; Horlow, Christine; Mercier, Raphael] INRA, Inst Jean Pierre Bourgin, UMR1318, F-78000 Versailles, France; [Crismani, Wayne; Girard, Chloe; Froger, Nicole; Chelysheva, Liudmila; Horlow, Christine; Mercier, Raphael] AgroParisTech, Inst Jean Pierre Bourgin, F-78000 Versailles, France; [Pradillo, Monica; Luis Santos, Juan] Univ Complutense Madrid, Fac Biol, Dept Genet, E-28040 Madrid, Spain; [Copenhaver, Gregory P.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Copenhaver, Gregory P.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Copenhaver, Gregory P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Complutense University of Madrid; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Mercier, R (corresponding author), INRA, Inst Jean Pierre Bourgin, UMR1318, RD10, F-78000 Versailles, France.	raphael.mercier@versailles.inra.fr	Copenhaver, Gregory P/A-7549-2014; Girard, Chloé/AAA-3414-2022; Pradillo, Mónica/G-2432-2017; Santos, Juan/R-1410-2017; Copenhaver, Gregory/AFL-9831-2022; Copenhaver, Gregory/AAH-2031-2022; mercier, Raphael/L-1497-2016	Copenhaver, Gregory P/0000-0002-7962-3862; Pradillo, Mónica/0000-0001-6625-6015; Santos, Juan/0000-0003-4475-9628; Copenhaver, Gregory/0000-0002-7962-3862; Copenhaver, Gregory/0000-0002-7962-3862; mercier, Raphael/0000-0001-6508-6608; Crismani, Associate Professor Wayne/0000-0003-0143-8293; Chelysheva, Liudmila/0000-0002-7538-2184; Girard, Chloe/0000-0002-1459-6226	EU-FP7 program [Meiosys-KBBE-2009-222883]; NSF [MCB-1121563]; Direct For Biological Sciences [1121563] Funding Source: National Science Foundation	EU-FP7 program(European Commission); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	R.M. and J.L.S. thank the EU-FP7 program (Meiosys-KBBE-2009-222883), and G. P. C. thanks the NSF (MCB-1121563) for financial support. We thank V. Borde, M. Grelon, C. Mezard, F. Nogue, A. Demuyt, and O. Loudet for critical reading of the manuscript and helpful discussions. A provisional patent application based on the work has been filed by INRA.	Berchowitz LE, 2008, NAT PROTOC, V3, P41, DOI 10.1038/nprot.2007.491; Berchowitz LE, 2007, PLOS GENET, V3, P1355, DOI 10.1371/journal.pgen.0030132; Berchowitz LE, 2010, CURR GENOMICS, V11, P91, DOI 10.2174/138920210790886835; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Chelysheva L, 2010, CYTOGENET GENOME RES, V129, P143, DOI 10.1159/000314096; Chelysheva L, 2007, PLOS GENET, V3, P802, DOI 10.1371/journal.pgen.0030083; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; Hadany L, 2008, ANN NY ACAD SCI, V1133, P26, DOI 10.1196/annals.1438.011; Higgins JD, 2008, PLANT J, V54, P152, DOI 10.1111/j.1365-313X.2008.03403.x; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; PERKINS DD, 1949, GENETICS, V34, P607; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Stahl FW, 2008, GENETICS, V179, P701, DOI 10.1534/genetics.108.086918; Sun W, 2008, MOL CELL, V32, P118, DOI 10.1016/j.molcel.2008.08.024; Whitby MC, 2010, DNA REPAIR, V9, P224, DOI 10.1016/j.dnarep.2009.12.012; Wijnker E, 2008, TRENDS PLANT SCI, V13, P640, DOI 10.1016/j.tplants.2008.09.004; Youds JL, 2011, J CELL SCI, V124, P501, DOI 10.1242/jcs.074427; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112	20	180	185	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1588	1590		10.1126/science.1220381	http://dx.doi.org/10.1126/science.1220381			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723424				2022-12-28	WOS:000305507500060
J	Liu, D; Amagai, S; Bricken, J				Liu, Dennis; Amagai, Satoshi; Bricken, Jennifer			Engaging Teachers, Scientists, and Multimedia to Promote Learning	SCIENCE			English	Editorial Material									[Liu, Dennis; Amagai, Satoshi; Bricken, Jennifer] Howard Hughes Med Inst, Dept Sci Educ, Chevy Chase, MD 20815 USA	Howard Hughes Medical Institute	Liu, D (corresponding author), Howard Hughes Med Inst, Dept Sci Educ, Chevy Chase, MD 20815 USA.	dliu@hhmi.org			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Falk J.H., 2018, LEARNING MUSEUMS; Guy R., 2011, AUSTRAL PHYSL SOC, V42, P41; Jenkinson J, 2012, CBE-LIFE SCI EDUC, V11, P103, DOI 10.1187/cbe.11-08-0071; Liu D., 2005, CURATOR, V48, P125; Liu Dennis, 2007, CBE Life Sci Educ, V6, P21, DOI 10.1187/cbe.06-12-0210; O'Day Danton H, 2006, CBE Life Sci Educ, V5, P255, DOI 10.1187/cbe.05-11-0122	6	0	0	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1509	1509		10.1126/science.1220252	http://dx.doi.org/10.1126/science.1220252			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	961ZE	22723398				2022-12-28	WOS:000305507500032
J	Nudler, E				Nudler, Evgeny			RNA Polymerase Backtracking in Gene Regulation and Genome Instability	CELL			English	Review							INTRINSIC TRANSCRIPTION TERMINATION; II ELONGATION COMPLEX; CLEAVAGE FACTORS GREA; ESCHERICHIA-COLI; STRUCTURAL BASIS; TRIGGER LOOP; DNA HYBRID; NASCENT TRANSCRIPT; SIGMA(70) SUBUNIT; ALPHA-AMANITIN		NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	New York University	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	evgeny.nudler@nyumc.org		Nudler, Evgeny/0000-0002-8811-3071	NIGMS NIH HHS [R01 GM058750, R01 GM58750] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Alff-Steinberger C, 2000, J THEOR BIOL, V206, P307, DOI 10.1006/jtbi.2000.2126; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Brodolin K, 2004, NAT STRUCT MOL BIOL, V11, P551, DOI 10.1038/nsmb768; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Chamberlin M.J., 1994, HARVEY LECT, V88, P1; Cheung ACM, 2012, CELL, V149, P1431, DOI 10.1016/j.cell.2012.06.006; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Chiba K, 2010, EXP CELL RES, V316, P2723, DOI 10.1016/j.yexcr.2010.05.036; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Gusarov I, 2001, CELL, V107, P437, DOI 10.1016/S0092-8674(01)00582-7; Hatoum A, 2008, MOL MICROBIOL, V68, P17, DOI 10.1111/j.1365-2958.2008.06138.x; Hawryluk PJ, 2004, NUCLEIC ACIDS RES, V32, P1904, DOI 10.1093/nar/gkh505; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Jin J, 2010, NAT STRUCT MOL BIOL, V17, P745, DOI 10.1038/nsmb.1798; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Kireeva ML, 2008, MOL CELL, V30, P557, DOI 10.1016/j.molcel.2008.04.017; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Koyama H, 2003, GENES CELLS, V8, P779, DOI 10.1046/j.1365-2443.2003.00677.x; Koyama H, 2007, GENES CELLS, V12, P547, DOI 10.1111/j.1365-2443.2007.01072.x; KRUMMEL B, 1992, J MOL BIOL, V225, P239, DOI 10.1016/0022-2836(92)90918-A; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; Lewis DEA, 2008, J MOL BIOL, V382, P843, DOI 10.1016/j.jmb.2008.07.060; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Nagaike T, 2011, MOL CELL, V41, P409, DOI 10.1016/j.molcel.2011.01.022; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nesser NK, 2006, P NATL ACAD SCI USA, V103, P3268, DOI 10.1073/pnas.0511330103; Nickels BE, 2004, NAT STRUCT MOL BIOL, V11, P544, DOI 10.1038/nsmb757; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; NUDLER E, 1994, SCIENCE, V265, P793, DOI 10.1126/science.8047884; Oesterreich FC, 2011, TRENDS CELL BIOL, V21, P328, DOI 10.1016/j.tcb.2011.03.002; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; Pomerantz RT, 2010, CELL CYCLE, V9, P2537, DOI 10.4161/cc.9.13.12122; Poteete AR, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-12; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; REINBERG D, 1987, J BIOL CHEM, V262, P3331; REINES D, 1993, P NATL ACAD SCI USA, V90, P1917, DOI 10.1073/pnas.90.5.1917; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Roghanian M, 2011, NUCLEIC ACIDS RES, V39, P4352, DOI 10.1093/nar/gkq1359; Saeki H, 2009, MOL CELL, V35, P191, DOI 10.1016/j.molcel.2009.06.009; Santangelo TJ, 2006, J MOL BIOL, V355, P196, DOI 10.1016/j.jmb.2005.10.062; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shankar S, 2007, MOL CELL, V27, P914, DOI 10.1016/j.molcel.2007.07.025; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Stepanova E, 2009, J BIOL CHEM, V284, P35702, DOI 10.1074/jbc.M109.053983; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Walter W, 2003, J BIOL CHEM, V278, P36148, DOI 10.1074/jbc.M305647200; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Washburn RS, 2011, P NATL ACAD SCI USA, V108, P792, DOI 10.1073/pnas.1009564108; Werner M, 2009, CURR OPIN STRUC BIOL, V19, P740, DOI 10.1016/j.sbi.2009.10.005; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	86	171	173	2	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1438	1445		10.1016/j.cell.2012.06.003	http://dx.doi.org/10.1016/j.cell.2012.06.003			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726433	Green Accepted, Bronze			2022-12-28	WOS:000305753800011
J	Bazin, D				Bazin, Daniel			NUCLEAR PHYSICS Symmetrical tin	NATURE			English	Editorial Material									Michigan State Univ, Natl Superconducting Cyclotron Lab, E Lansing, MI 48824 USA	Michigan State University	Bazin, D (corresponding author), Michigan State Univ, Natl Superconducting Cyclotron Lab, E Lansing, MI 48824 USA.	bazin@nscl.msu.edu	Bazin, Daniel/N-1226-2019	Bazin, Daniel/0000-0002-5663-9693				Mayer M. G., 1955, ELEMENTARY THEORY NU; MAYER MG, 1948, PHYS REV, V74, P235, DOI 10.1103/PhysRev.74.235; Morrissey DJ, 1998, PHILOS T R SOC A, V356, P1985, DOI 10.1098/rsta.1998.0260; Seweryniak D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.022504; Sorlin O, 2008, PROG PART NUCL PHYS, V61, P602, DOI 10.1016/j.ppnp.2008.05.001	6	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					330	331		10.1038/486330a	http://dx.doi.org/10.1038/486330a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722188				2022-12-28	WOS:000305466800028
J	Collins, GS; Altman, DG				Collins, Gary S.; Altman, Douglas G.			Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2	BRITISH MEDICAL JOURNAL			English	Article							PROSPECTIVE OPEN COHORT; DECISION CURVE ANALYSIS; MODELS; SCORE; PERFORMANCE; DERIVATION; IMPACT; TESTS	Objective To evaluate the performance of the QRISK2-2011 score for predicting the 10 year risk of cardiovascular disease in an independent UK cohort of patients from general practice and to compare it with earlier versions of the model and a National Institute for Health and Clinical Excellence version of the Framingham equation. Design Prospective cohort study to validate a cardiovascular risk score with routinely collected data between June 1994 and June 2008. Setting 364 practices from the United Kingdom contributing to The Health Improvement Network (THIN) database. Participants Two million patients aged 30 to 84 years (11.8 million person years) with 93 564 cardiovascular events. Main outcome measure First diagnosis of cardiovascular disease (myocardial infarction, angina, coronary heart disease, stroke, and transient ischaemic attack) recorded in general practice records. Results Results from this independent and external validation of QRISK2-2011 indicate good performance data when compared with the NICE version of the Framingham equation. QRISK2-2011 had better ability to identify those at high risk of developing cardiovascular disease than did the NICE Framingham equation. QRISK2-2011 is well calibrated, with reasonable agreement between observed and predicted outcomes, whereas the NICE Framingham equation seems to consistently over-predict risk in men by about 5% and shows poor calibration in women. Conclusions QRISK2-2011 seems to be a useful model, with good discriminative and calibration properties when compared with the NICE version of the Framingham equation. Furthermore, based on current high risk thresholds, concerns exist on the clinical usefulness of the NICE version of the Framingham equation for identifying women at high risk of developing cardiovascular disease. At current thresholds the NICE version of the Framingham equation has no clinical benefit in either men or women.	[Collins, Gary S.; Altman, Douglas G.] Univ Oxford, Wolfson Coll Annexe, Ctr Stat Med, Oxford OX2 6UD, England	University of Oxford	Collins, GS (corresponding author), Univ Oxford, Wolfson Coll Annexe, Ctr Stat Med, Oxford OX2 6UD, England.	gary.collins@csm.ox.ac.uk	Collins, Gary Stephen/A-2258-2014	Collins, Gary Stephen/0000-0002-2772-2316				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], 2012, R LANGUAGE ENV STAT; Burton A, 2004, BRIT J CANCER, V91, P4, DOI 10.1038/sj.bjc.6601907; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Collins GS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2584; Department of Health, 2008, PUTT PREV 1 VASC CHE; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hippisley-Cox J, 2011, HEART, V97, P515, DOI 10.1136/hrt.2010.221085; Mayor S, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1774; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; National Institute for Health and Clinical Excellence, 2008, LIP MOD CARD RISK AS; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; StataCorp, 2021, STATA STAT SOFTWARE; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Vergouwe Y, 2010, J CLIN EPIDEMIOL, V63, P205, DOI 10.1016/j.jclinepi.2009.03.017; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; World Health Organization, 2011, 317 WHO	26	109	112	1	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 21	2012	344								e4181	10.1136/bmj.e4181	http://dx.doi.org/10.1136/bmj.e4181			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965CH	22723603	Green Published, hybrid			2022-12-28	WOS:000305743200002
J	Siegel, JS				Siegel, Jay S.			MATERIALS CHEMISTRY Carbon origami	NATURE			English	Editorial Material							CHEMICAL-SYNTHESIS; CYCLODEHYDROGENATION; FULLERENES		Univ Zurich, Inst Organ Chem, CH-8057 Zurich, Switzerland	University of Zurich	Siegel, JS (corresponding author), Univ Zurich, Inst Organ Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jss@oci.uzh.ch	Siegel, Jay/E-6415-2011	Siegel, Jay/0000-0002-3226-3521				Allemann O, 2011, SCIENCE, V332, P574, DOI 10.1126/science.1202432; Amsharov KY, 2012, ANGEW CHEM INT EDIT, V51, P4594, DOI 10.1002/anie.201200516; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Brown R. F. C., 1980, PYROLYTIC METHODS OR; Butterfield AM, 2012, ORG PROCESS RES DEV, V16, P664, DOI 10.1021/op200387s; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Douvris C, 2008, SCIENCE, V321, P1188, DOI 10.1126/science.1159979; Ebbesen TW, 1996, PHYS TODAY, V49, P26, DOI 10.1063/1.881603; Hassan J, 2002, CHEM REV, V102, P1359, DOI 10.1021/cr000664r; Jasti R, 2008, J AM CHEM SOC, V130, P17646, DOI 10.1021/ja807126u; Omachi H., 2012, ACC CHEM RES; Otero G, 2008, NATURE, V454, P865, DOI 10.1038/nature07193; Scott LT, 2012, J AM CHEM SOC, V134, P107, DOI 10.1021/ja209461g; Scott LT, 2009, ANGEW CHEM INT EDIT, V48, P436, DOI 10.1002/anie.200804532; Scott LT, 2002, SCIENCE, V295, P1500, DOI 10.1126/science.1068427; Simpson CD, 2004, J AM CHEM SOC, V126, P3139, DOI 10.1021/ja036732j	16	4	4	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					327	328		10.1038/486327a	http://dx.doi.org/10.1038/486327a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722186				2022-12-28	WOS:000305466800026
J	Trivedi, BP				Trivedi, Bijal P.			NEUROSCIENCE Hardwired for taste	NATURE			English	Editorial Material							RECEPTORS; SECRETION; GUSTDUCIN											Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Finger Thomas E, 2011, F1000 Biol Rep, V3, P20, DOI 10.3410/B3-20; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Kaji I, 2009, AM J PHYSIOL-GASTR L, V296, pG971, DOI 10.1152/ajpgi.90514.2008; Li F, 2012, MOL HUM REPROD, V18, P289, DOI 10.1093/molehr/gas005; Meyer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032354; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107	9	37	38	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					S7	S9		10.1038/486S7a	http://dx.doi.org/10.1038/486S7a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RB	22717403	Bronze			2022-12-28	WOS:000311781000005
J	Violari, A; Lindsey, JC; Hughes, MD; Mujuru, HA; Barlow-Mosha, L; Kamthunzi, P; Chi, BH; Cotton, MF; Moultrie, H; Khadse, S; Schimana, W; Bobat, R; Purdue, L; Eshleman, SH; Abrams, EJ; Millar, L; Petzold, E; Mofenson, LM; Jean-Philippe, P; Palumbo, P				Violari, Avy; Lindsey, Jane C.; Hughes, Michael D.; Mujuru, Hilda A.; Barlow-Mosha, Linda; Kamthunzi, Portia; Chi, Benjamin H.; Cotton, Mark F.; Moultrie, Harry; Khadse, Sandhya; Schimana, Werner; Bobat, Raziya; Purdue, Lynette; Eshleman, Susan H.; Abrams, Elaine J.; Millar, Linda; Petzold, Elizabeth; Mofenson, Lynne M.; Jean-Philippe, Patrick; Palumbo, Paul			Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SINGLE-DOSE NEVIRAPINE; RANDOMIZED CONTROLLED-TRIAL; ANTIRETROVIRAL THERAPY; PROTEASE INHIBITOR; DRUG-RESISTANCE; GROWTH; INITIATION; DYNAMICS; EXPOSURE; FAILURE	BACKGROUND Nevirapine-based antiretroviral therapy is the predominant (and often the only) regimen available for children in resource-limited settings. Nevirapine resistance after exposure to the drug for prevention of maternal-to-child human immunodeficiency virus (HIV) transmission is common, a problem that has led to the recommendation of ritonavir-boosted lopinavir in such settings. Regardless of whether there has been prior exposure to nevirapine, the performance of nevirapine versus ritonavir-boosted lopinavir in young children has not been rigorously established. METHODS In a randomized trial conducted in six African countries and India, we compared the initiation of HIV treatment with zidovudine, lamivudine, and either nevirapine or ritonavir-boosted lopinavir in HIV-infected children 2 to 36 months of age who had no prior exposure to nevirapine. The primary end point was virologic failure or discontinuation of treatment by study week 24. RESULTS A total of 288 children were enrolled; the median percentage of CD4+ T cells was 15%, and the median plasma HIV type 1 (HIV-1) RNA level was 5.7 log(10) copies per milliliter. The percentage of children who reached the primary end point was significantly higher in the nevirapine group than in the ritonavir-boosted lopinavir group (40.8% vs. 19.3%; P < 0.001). Among the nevirapine-treated children with virologic failure for whom data on resistance were available, more than half (19 of 32) had resistance at the time of virologic failure. In addition, the time to a protocol-defined toxicity end point was shorter in the nevirapine group (P=0.04), as was the time to death (P=0.06). CONCLUSIONS Outcomes were superior with ritonavir-boosted lopinavir among young children with no prior exposure to nevirapine. Factors that may have contributed to the suboptimal results with nevirapine include elevated viral load at baseline, selection for nevirapine resistance, background regimen of nucleoside reverse-transcriptase inhibitors, and the standard ramp-up dosing strategy. The results of this trial present policymakers with difficult choices. (Funded by the National Institute of Allergy and Infectious Diseases and others; P1060 ClinicalTrials.gov number, NCT00307151.)	[Violari, Avy] Univ Witwatersrand, Perinatal HIV Res Unit, ZA-2050 Johannesburg, South Africa; [Mujuru, Hilda A.] Univ Witwatersrand, Reprod Hlth & HIV Inst, Fac Hlth Sci, Johannesburg, South Africa; [Cotton, Mark F.] Univ Stellenbosch, Tygerberg Childrens Hosp, ZA-7505 Tygerberg, South Africa; [Bobat, Raziya] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Durban, South Africa; [Lindsey, Jane C.; Hughes, Michael D.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Mujuru, Hilda A.] Univ Zimbabwe, Coll Hlth Sci, Dept Paediat & Child Hlth, Harare, Zimbabwe; [Barlow-Mosha, Linda] Johns Hopkins Univ, Res Collaborat, Makerere Univ, Kampala, Uganda; [Kamthunzi, Portia] Univ N Carolina Project, Lilongwe, Malawi; [Chi, Benjamin H.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Khadse, Sandhya] BJ Med Coll & Sassoon Gen Hosp, Dept Pediat, Pune, Maharashtra, India; [Schimana, Werner] Duke Univ, Kilimanjaro Christian Med Ctr Collaborat, Moshi, Tanzania; [Purdue, Lynette] NIAID, NIH, Div Aids, Pharmaceut Affairs Branch, Bethesda, MD 20892 USA; [Jean-Philippe, Patrick] NIAID, NIH, Div Aids, Henry Jackson Fdn, Bethesda, MD 20892 USA; [Petzold, Elizabeth] Social & Sci Syst, Silver Spring, MD USA; [Mofenson, Lynne M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pediat Adolescent & Maternal AIDS Branch, NIH, Rockville, MD USA; [Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Abrams, Elaine J.] Columbia Univ, Sch Publ Hlth, Int Ctr AIDS Care Program, New York, NY USA; [Abrams, Elaine J.] Columbia Univ, Sch Publ Hlth, Treatment Program, New York, NY USA; [Abrams, Elaine J.] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Millar, Linda] Frontier Sci & Technol Res Fdn Inc, Amherst, NY USA; [Palumbo, Paul] Dartmouth Med Sch, Lebanon, NH USA	University of Witwatersrand; University of Witwatersrand; Stellenbosch University; University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; University of Zimbabwe; Makerere University; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Duke University; Kilimanjaro Christian Medical Centre; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Social & Scientific Systems; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Columbia University; Columbia University; Columbia University; Frontier Science Foundation; Dartmouth College	Palumbo, P (corresponding author), Dartmouth Hitchcock Med Ctr, Int Pediat HIV Program, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	paul.e.palumbo@dartmouth.edu	Cotton, Mark/AAQ-9936-2020; Moultrie, Harry/H-1842-2014; Mujuru, Hilda Angela/AAF-2511-2020; Moultrie, Harry/AFV-0903-2022; Mofenson, Lynne/P-9631-2019	Cotton, Mark/0000-0003-2559-6034; Moultrie, Harry/0000-0001-9722-0699; Mujuru, Hilda Angela/0000-0003-1615-3856; Moultrie, Harry/0000-0001-9722-0699; Mofenson, Lynne/0000-0002-2818-9808; Barlow-Mosha, Linda/0000-0003-3241-2141	National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI068632]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Mental Health [U01 AI068632, 5 U01 AI41110, 1 U01 AI068616]; NIAID [HHSN272200800014C]; Abbott; Tibotec; Boehringer Ingelheim; Pfizer; Medicines Development; GlaxoSmithKline; ViiV Healthcare; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068616, UM1AI068632, U01AI068632, U01AI041110, UM1AI106716, R21AI141110, U01AI068616] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Abbott(Abbott Laboratories); Tibotec; Boehringer Ingelheim(Boehringer Ingelheim); Pfizer(Pfizer); Medicines Development; GlaxoSmithKline(GlaxoSmithKline); ViiV Healthcare; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by a grant [U01 AI068632] from the National Institute of Allergy and Infectious Diseases (NIAID), the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health to the Pediatric AIDS Clinical Trials Group (PACTG) and the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group; the Statistical and Data Analysis Center at Harvard School of Public Health under NIAID cooperative agreements (5 U01 AI41110 with the PACTG and 1 U01 AI068616 and U01 AI068632 with the IMPAACT Group); and by a contract from the NIAID (HHSN272200800014C).; Dr. Avy Violari reports receiving lecture fees from Abbott, consulting fees from Tibotec, and trial drugs from GlaxoSmithKline; Dr. Hughes, consulting fees from Boehringer Ingelheim, Pfizer, Medicines Development, and Tibotec and support for a scientific workshop from Merck; Dr. Cotton, lecture fees from Abbott; and Dr. Moultrie, grants from GlaxoSmithKline, ViiV Healthcare, and Tibotec. No other potential conflict of interest relevant to this article was reported.	Aldrovandi GM, 2009, AIDS, V23, P661, DOI 10.1097/QAD.0b013e3283269dfb; [Anonymous], 2010, ANT THER HIV INF INF; Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Boltz VF, 2011, P NATL ACAD SCI USA, V108, P9202, DOI 10.1073/pnas.1105688108; Buchacz K, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e72; Coovadia A, 2010, JAMA-J AM MED ASSOC, V304, P1082, DOI 10.1001/jama.2010.1278; Dreimane D, 2001, PEDIATR INFECT DIS J, V20, P315, DOI 10.1097/00006454-200103000-00020; Hunt GM, 2011, AIDS, V25, P1461, DOI 10.1097/QAD.0b013e3283492180; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lockman S, 2010, NEW ENGL J MED, V363, P1499, DOI 10.1056/NEJMoa0906626; Luzuriaga K, 1999, J VIROL, V73, P362, DOI 10.1128/JVI.73.1.362-367.1999; Mulenga V, 2010, CLIN INFECT DIS, V51, P1081, DOI 10.1086/656628; Nachman SA, 2002, ARCH PEDIAT ADOL MED, V156, P497, DOI 10.1001/archpedi.156.5.497; Palumbo P, 2007, J INFECT DIS, V196, P23, DOI 10.1086/518508; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971	16	153	155	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					2380	2389		10.1056/NEJMoa1113249	http://dx.doi.org/10.1056/NEJMoa1113249			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961GH	22716976	Green Accepted, Green Published			2022-12-28	WOS:000305451700007
J	Mandl, KD; Kohane, IS				Mandl, Kenneth D.; Kohane, Isaac S.			Escaping the EHR Trap - The Future of Health IT	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[Mandl, Kenneth D.] Childrens Hosp Informat Program, Boston, MA 02115 USA; Harvard MIT Div Hlth Sci & Technol, Boston, MA USA; Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard Medical School	Mandl, KD (corresponding author), Childrens Hosp Informat Program, Boston, MA 02115 USA.		Kohane, Isaac Kohane/K-3716-2012	Kohane, Isaac Kohane/0000-0003-2192-5160				BARNETT GO, 1968, NEW ENGL J MED, V279, P1321, DOI 10.1056/NEJM196812122792407; Hwang J, 2008, HEALTH AFFAIR, V27, P1329, DOI 10.1377/hlthaff.27.5.1329; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Mandl KD, 2009, NEW ENGL J MED, V360, P1278, DOI 10.1056/NEJMp0900411; Weber GM, 2009, J AM MED INFORM ASSN, V16, P624, DOI 10.1197/jamia.M3191	5	110	114	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2012	366	24					2240	2242						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	957PD	22693995				2022-12-28	WOS:000305174100002
J	Lane, R				Lane, Richard			Bill Foege: gentle giant of global health Profile	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 30	2012	379	9835					2419	2419		10.1016/S0140-6736(12)61054-X	http://dx.doi.org/10.1016/S0140-6736(12)61054-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967NV	22748578				2022-12-28	WOS:000305915900013
J	Droser, ML; Gehling, JG				Droser, Mary L.; Gehling, James G.			Old and Groovy	SCIENCE			English	Editorial Material							FOSSILS; RECORD; LIFE; SEA		[Droser, Mary L.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Gehling, James G.] S Australian Museum, Adelaide, SA 5000, Australia	University of California System; University of California Riverside	Droser, ML (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	mary.droser@ucr.edu; jim.gehling@samuseum.sa.gov.au						Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Collins AG, 2000, PALEOBIOLOGY, V26, P47, DOI 10.1666/0094-8373(2000)026<0047:MMCTAT>2.0.CO;2; Droser ML, 2006, PALAEOGEOGR PALAEOCL, V232, P131, DOI 10.1016/j.palaeo.2005.12.015; Gehling JG, 2009, EARTH-SCI REV, V96, P196, DOI 10.1016/j.earscirev.2009.03.002; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Martin MW, 2000, SCIENCE, V288, P841, DOI 10.1126/science.288.5467.841; Matz MV, 2008, CURR BIOL, V18, P1849, DOI 10.1016/j.cub.2008.10.028; Narbonne GM, 2003, GEOLOGY, V31, P27, DOI 10.1130/0091-7613(2003)031<0027:LASTOC>2.0.CO;2; Noffke N, 2010, GEOBIOLOGY: MICROBIAL MATS IN SANDY DEPOSITS FROM THE ARCHEAN ERA TO TODAY, P1, DOI 10.1007/978-3-642-12772-4; Pecoits E, 2012, SCIENCE, V336, P1693, DOI 10.1126/science.1216295; Rogov V, 2012, GEOLOGY, V40, P395, DOI 10.1130/G32807.1; Seilacher A, 1999, PALAIOS, V14, P86, DOI 10.2307/3515363	12	3	3	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1646	1647		10.1126/science.1223848	http://dx.doi.org/10.1126/science.1223848			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	965VD	22745409				2022-12-28	WOS:000305794500028
J	Jankunas, J; Zare, RN; Bouakline, F; Althorpe, SC; Herraez-Aguilar, D; Aoiz, FJ				Jankunas, Justin; Zare, Richard N.; Bouakline, Foudhil; Althorpe, Stuart C.; Herraez-Aguilar, Diego; Aoiz, F. Javier			Seemingly Anomalous Angular Distributions in H+D-2 Reactive Scattering	SCIENCE			English	Article							DIFFERENTIAL CROSS-SECTIONS; CLASSICAL TRAJECTORY METHOD; HYDROGEN-EXCHANGE REACTION; EV COLLISION ENERGY; DYNAMICS	When a hydrogen (H) atom approaches a deuterium (D-2) molecule, the minimum-energy path is for the three nuclei to line up. Consequently, nearly collinear collisions cause HD reaction products to be backscattered with low rotational excitation, whereas more glancing collisions yield sideways-scattered HD products with higher rotational excitation. Here we report that measured cross sections for the H + D-2 -> HD(v' = 4, j') + D reaction at a collision energy of 1.97 electron volts contradict this behavior. The anomalous angular distributions match closely fully quantum mechanical calculations, and for the most part quasiclassical trajectory calculations. As the energy available in product recoil is reduced, a rotational barrier to reaction cuts off contributions from glancing collisions, causing high-j' HD products to become backward scattered.	[Jankunas, Justin; Zare, Richard N.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Bouakline, Foudhil] Univ Potsdam, Inst Chem, D-14476 Potsdam Golm, Germany; [Althorpe, Stuart C.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Herraez-Aguilar, Diego; Aoiz, F. Javier] Univ Complutense, Dept Quim Fis, Fac Quim, E-28040 Madrid, Spain	Stanford University; University of Potsdam; University of Cambridge; Complutense University of Madrid	Zare, RN (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	zare@stanford.edu	/G-8240-2015	/0000-0001-5718-5905; Zare, Richard/0000-0001-5266-4253; Herraez, Diego/0000-0002-9764-4210	U.S. National Science Foundation [NSF CHE-1025960]; Alexander von Humboldt Foundation; UK Engineering and Physical Sciences Research Council; Spanish Ministry of Science and Innovation (MCINN) [CTQ2008-02578, CSD2009-00038]; FPU [AP2009-0038]; Direct For Mathematical & Physical Scien [1025960] Funding Source: National Science Foundation; Engineering and Physical Sciences Research Council [EP/I002499/1] Funding Source: researchfish; EPSRC [EP/I002499/1] Funding Source: UKRI	U.S. National Science Foundation(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Spanish Ministry of Science and Innovation (MCINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FPU(Spanish Government); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We gratefully acknowledge funding support from the U.S. National Science Foundation (grant NSF CHE-1025960 to J.J. and R.N.Z.), the Alexander von Humboldt Foundation (F.B.), the UK Engineering and Physical Sciences Research Council (S.C.A.), and the Spanish Ministry of Science and Innovation (MCINN) (grants CTQ2008-02578 and CSD2009-00038 to F.J.A. and D.H.). D.H. acknowledges the FPU fellowship AP2009-0038.	Althorpe SC, 2002, NATURE, V416, P67, DOI 10.1038/416067a; Althorpe SC, 2001, J CHEM PHYS, V114, P1601, DOI 10.1063/1.1334866; Aoiz FJ, 2005, INT REV PHYS CHEM, V24, P119, DOI 10.1080/01442350500195659; Banares L, 2003, J CHEM PHYS, V118, P565, DOI 10.1063/1.1527014; Bartlett NCM, 2011, PHYS CHEM CHEM PHYS, V13, P8175, DOI 10.1039/c0cp02460k; Bean BD, 2002, J CHEM PHYS, V116, P6634, DOI 10.1063/1.1462576; Bonnet L, 2004, CHEM PHYS LETT, V397, P106, DOI 10.1016/j.cplett.2004.08.068; Bonnet L, 1997, CHEM PHYS LETT, V277, P183, DOI 10.1016/S0009-2614(97)00881-6; Boothroyd AI, 1996, J CHEM PHYS, V104, P7139, DOI 10.1063/1.471430; Casavecchia P., 2010, TUTORIALS MOL REACTI, P175; Dobbyn AJ, 1999, PHYS CHEM CHEM PHYS, V1, P1115, DOI 10.1039/a809498e; Fernandez-Alonso F, 2001, J CHEM PHYS, V115, P4534, DOI 10.1063/1.1390505; Harich SA, 2002, NATURE, V419, P281, DOI 10.1038/nature01068; Koszinowski K, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2771157; Koszinowski K, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2217742; Levine RD, 2005, MOL REACTION DYNAMIC, DOI 10.1017/CBO9780511614125; Skouteris D, 2000, COMPUT PHYS COMMUN, V133, P128, DOI 10.1016/S0010-4655(00)00167-3; Wrede E, 1999, J CHEM PHYS, V110, P9971, DOI 10.1063/1.478870	18	39	39	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1687	1690		10.1126/science.1221329	http://dx.doi.org/10.1126/science.1221329			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745425				2022-12-28	WOS:000305794500045
J	Powell, ALT; Nguyen, CV; Hill, T; Cheng, KL; Figueroa-Balderas, R; Aktas, H; Ashrafi, H; Pons, C; Fernandez-Munoz, R; Vicente, A; Lopez-Baltazar, J; Barry, CS; Liu, YS; Chetelat, R; Granell, A; Van Deynze, A; Giovannoni, JJ; Bennett, AB				Powell, Ann L. T.; Nguyen, Cuong V.; Hill, Theresa; Cheng, Kalai Lam; Figueroa-Balderas, Rosa; Aktas, Hakan; Ashrafi, Hamid; Pons, Clara; Fernandez-Munoz, Rafael; Vicente, Ariel; Lopez-Baltazar, Javier; Barry, Cornelius S.; Liu, Yongsheng; Chetelat, Roger; Granell, Antonio; Van Deynze, Allen; Giovannoni, James J.; Bennett, Alan B.			Uniform ripening Encodes a Golden 2-like Transcription Factor Regulating Tomato Fruit Chloroplast Development	SCIENCE			English	Article							SOLUBLE SOLIDS CONTENT; EXPRESSION; SPECIALIZATION; NUCLEAR	Modern tomato (Solanum lycopersicum) varieties are bred for uniform ripening (u) light green fruit phenotypes to facilitate harvests of evenly ripened fruit. U encodes a Golden 2-like (GLK) transcription factor, SlGLK2, which determines chlorophyll accumulation and distribution in developing fruit. In tomato, two GLKs-SlGLK1 and SlGLK2-are expressed in leaves, but only SlGLK2 is expressed in fruit. Expressing GLKs increased the chlorophyll content of fruit, whereas SlGLK2 suppression recapitulated the u mutant phenotype. GLK overexpression enhanced fruit photosynthesis gene expression and chloroplast development, leading to elevated carbohydrates and carotenoids in ripe fruit. SlGLK2 influences photosynthesis in developing fruit, contributing to mature fruit characteristics and suggesting that selection of u inadvertently compromised ripe fruit quality in exchange for desirable production traits.	[Powell, Ann L. T.; Hill, Theresa; Cheng, Kalai Lam; Figueroa-Balderas, Rosa; Aktas, Hakan; Ashrafi, Hamid; Vicente, Ariel; Lopez-Baltazar, Javier; Chetelat, Roger; Van Deynze, Allen; Bennett, Alan B.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Nguyen, Cuong V.; Giovannoni, James J.] Cornell Univ, Dept Plant Breeding, Ithaca, NY 14853 USA; [Nguyen, Cuong V.; Giovannoni, James J.] Cornell Univ, Dept Genet & Plant Biol, Ithaca, NY 14853 USA; [Pons, Clara; Granell, Antonio] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, Consejo Super Invest Cient, E-46022 Valencia, Spain; [Fernandez-Munoz, Rafael] Univ Malaga, Inst Hort Subtrop & Mediterranea Mayora, Consejo Super Invest Cient, E-29750 Malaga, Spain; [Vicente, Ariel] UNLP, Ctr Invest & Desarrollo Criotecnol Alimentos, Consejo Nacl Invest Cient & Tecn, RA-1900 La Plata, Argentina; [Vicente, Ariel] Univ Nacl La Plata, Fac Ciencias Agr & Forestales, RA-1900 La Plata, Argentina; [Barry, Cornelius S.] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Liu, Yongsheng; Giovannoni, James J.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Liu, Yongsheng; Giovannoni, James J.] Cornell Univ, USDA ARS, Robert W Holley Ctr, Ithaca, NY 14853 USA	University of California System; University of California Davis; Cornell University; Cornell University; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata; Michigan State University; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; United States Department of Agriculture (USDA)	Powell, ALT (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	alpowell@ucdavis.edu; jjg33@cornell.edu	Bennett, Alan B/D-8980-2011; Pons, Clara/AAA-6233-2020; Fernandez-Munoz, Rafael/F-3714-2010; Lopez, Javier/G-6946-2019; AKTAS, Hakan/E-9174-2013; Barry, Cornelius/D-7759-2012; Vicente, Ariel/AAH-1908-2020; Figueroa, Rosa/B-3172-2013; Granell, Antonio/G-3664-2010	Bennett, Alan B/0000-0002-3684-4307; Pons, Clara/0000-0002-8296-2937; Fernandez-Munoz, Rafael/0000-0002-4054-8949; Vicente, Ariel/0000-0003-1289-9554; Barry, Cornelius/0000-0003-4685-0273; Figueroa-Balderas, Rosa/0000-0003-3321-1376; Ashrafi, Hamid/0000-0002-2094-2367	University of California; Vietnam Education Foundation; USDA-Agricultural Research Service; USDA-National Research Initiative [2007-02773]; NSF [IOS-0923312]	University of California(University of California System); Vietnam Education Foundation; USDA-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-National Research Initiative(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF))	Minimum Information About a Microarray Experiment (MIAME)-compliant microarray data are available at http://ted.bti.cornell.edu. and at http://www.ebi.ac.uk/arrayexpress/(accession E-MEXP-3652). F. Carrari and A. Fernie provided S. pennellii SlGLK2, and J. Maloof provided S. habrochaites SlGLK2 sequences. The U. S. Department of Agriculture (USDA)/National Institute of Food and Agriculture Solanaceae Coordinated Agricultural Project provided potato data. We are grateful to the Tomato Genome Consortium and the SOL Genomics Network for prepublication access to the tomato genome sequence. The S. pennellii introgression lines were provided by the C. M. Rick Tomato Genetics Resource Center; the S. pimpinellifolium populations were provided by the Instituto de Hortofruticultura Subtropical y Mediterranea "La Mayora," Consejo Superior de Investigaciones Cientificas; and both populations are available by request from the sources. The AtGLK-expressing lines were provided by Mendel Biotechnology and Seminis/Monsanto Vegetable Seeds. SlGLK2, the corresponding lines, and the F2 10-1 IL x M82 population lines and seeds are available from J. J. G. without restriction. Seminis/Monsanto will make available, upon request, and under a material transfer agreement indicating they are to be used for noncommercial purposes, the following lines: LexA:AtGLK1:p35S:LexA-Gal4; LexA:AtGLK1:pLTP:LexA-Gal4; LexA:AtGLK1:pRbcS:LexA-Gal4; LexA:AtGLK1:pPDS:LexA-Gal4; LexA:AtGLK2:p35S:LexA-Gal4; LexA:AtGLK2:pLTP:LexA-Gal4; LexA:AtGLK2:pRbcS:LexA-Gal4; LexA:AtGLK2:pPDS:LexA-Gal4; plus the T63 control line. Other biological materials are available by request from A. L. T. P. or J.J.G. A. L. T. P., T. H., K.L.-C., R.F.-B., and A. B. B. have filed a provisional U. S. patent application UC #2011-841, "Introduction of wild species GLK genes for improved ripe tomato fruit quality," through the University of California. A. L. T. P. and A. B. B. have filed the U. S. patent application #2010/0154078, " Transcription factors that enhance traits in plant organs," through Mendel Biotechnology. Assistance from B. Blanco-Ulate, S. Phothiset, S. Reyes, A. Abraham, L. Gilani, and G. Arellano is gratefully acknowledged. J. Langdale provided helpful advice regarding GLK phylogeny and nomenclature. G. Adamson and P. Kysar, Electron Microscopy (EM) Laboratory, University of California Davis Medical Center did the EM work. University of California Discovery and partners funded the pepper analysis and the initial investigations of the Arabidopsis GLKs. The Vietnam Education Foundation supported C.N. Fundacion Genoma Espana ESPSOL Project provided partial funding to A.G. USDA-Agricultural Research Service, USDA-National Research Initiative (2007-02773), and NSF (Plant Genome Program IOS-0923312) provided support to J.J.G.	BLANKE MM, 1989, PLANT CELL ENVIRON, V12, P31, DOI 10.1111/j.1365-3040.1989.tb01914.x; Bravo-Garcia A, 2009, NEW PHYTOL, V183, P133, DOI 10.1111/j.1469-8137.2009.02829.x; BUTLER L, 1952, J HERED, V43, P25, DOI 10.1093/oxfordjournals.jhered.a106252; Carrara S, 2001, PHOTOSYNTHETICA, V39, P75, DOI 10.1023/A:1012495903093; ESHED Y, 1995, GENETICS, V141, P1147; Fitter DW, 2002, PLANT J, V31, P713, DOI 10.1046/j.1365-313X.2002.01390.x; Hetherington SE, 1998, J EXP BOT, V49, P1173, DOI 10.1093/jexbot/49.324.1173; KEMP G. A., 1960, CANADIAN JOUR PLANT SCI, V40, P306; KINZER SM, 1990, THEOR APPL GENET, V79, P489, DOI 10.1007/BF00226158; Langdale JA, 2011, PLANT CELL, V23, P3879, DOI 10.1105/tpc.111.092098; MANZARA T, 1993, PLANT MOL BIOL, V21, P69, DOI 10.1007/BF00039619; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Nakamura H, 2009, PLANT CELL PHYSIOL, V50, P1933, DOI 10.1093/pcp/pcp138; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PIECHULLA B, 1987, PLANT PHYSIOL, V84, P911, DOI 10.1104/pp.84.3.911; PIECHULLA B, 1987, EMBO J, V6, P3593, DOI 10.1002/j.1460-2075.1987.tb02690.x; RICK CM, 1956, ADV GENET, V8, P267, DOI 10.1016/S0065-2660(08)60504-0; RICK CM, 1974, HILGARDIA, V42, P493, DOI 10.3733/hilg.v42n15p493; Rohrmann J, 2011, PLANT J, V68, P999, DOI 10.1111/j.1365-313X.2011.04750.x; SUGITA M, 1987, P NATL ACAD SCI USA, V84, P7104, DOI 10.1073/pnas.84.20.7104; Tanksley S. D., 1987, GENETIC MAPS 1987 CO, P655; TANKSLEY SD, 1988, THEOR APPL GENET, V75, P811, DOI 10.1007/BF00265610; WANNER LA, 1991, PLANT CELL, V3, P1289, DOI 10.1105/tpc.3.12.1289; Waters MT, 2008, PLANT J, V56, P432, DOI 10.1111/j.1365-313X.2008.03616.x; Waters MT, 2009, EMBO J, V28, P2861, DOI 10.1038/emboj.2009.264; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Yasumura Y, 2005, PLANT CELL, V17, P1894, DOI 10.1105/tpc.105.033191; YEAGER A. F., 1935, PROC AMER SOC HORT SCI, V33, P512	28	260	286	28	377	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1711	1715		10.1126/science.1222218	http://dx.doi.org/10.1126/science.1222218			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745430				2022-12-28	WOS:000305794500052
J	Tomasik, T				Tomasik, Tomasz			We don't know if health system changes in eastern Europe have improved quality	BRITISH MEDICAL JOURNAL			English	Editorial Material									Jagiellonian Univ, Coll Med, Dept Family Med, Chair Internal Med & Gerontol, PL-31061 Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University	Tomasik, T (corresponding author), Jagiellonian Univ, Coll Med, Dept Family Med, Chair Internal Med & Gerontol, PL-31061 Krakow, Poland.	mmtomasi@cyf-kr.edu.pl		Tomasik, Tomasz/0000-0002-9109-4174				Bala M, 2011, ANAL SUCCESSFULLY IM; European Commission, INGPINQI EX CAS STUD; European Commission Leonardo da Vinci programme, INN LIF LEARN EUR GE; Legido-Quigley H, 2008, OBSERVATORY STUDIES, V12; Pajak A, 2010, KARDIOL POL, V68, P1332	5	1	1	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 25	2012	344								e3923	10.1136/bmj.e3923	http://dx.doi.org/10.1136/bmj.e3923			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	968MS	22734076				2022-12-28	WOS:000305986500003
J	Patel, V; Ramasundarahettige, C; Vijayakumar, L; Thakur, JS; Gajalakshmi, V; Gururaj, G; Suraweera, W; Jha, P				Patel, Vikram; Ramasundarahettige, Chinthanie; Vijayakumar, Lakshmi; Thakur, J. S.; Gajalakshmi, Vendhan; Gururaj, Gopalkrishna; Suraweera, Wilson; Jha, Prabhat		Million Death Study Collaborators	Suicide mortality in India: a nationally representative survey	LANCET			English	Article							RISK-FACTORS; VERBAL AUTOPSY; RURAL INDIA; TAMIL-NADU; DEATHS; RATES; WORLD; CHINA; NEED	Background WHO estimates that about 170 000 deaths by suicide occur in India every year, but few epidemiological studies of suicide have been done in the country. We aimed to quantify suicide mortality in India in 2010. Methods The Registrar General of India implemented a nationally representative mortality survey to determine the cause of deaths occurring between 2001 and 2003 in 1.1 million homes in 6671 small areas chosen randomly from all parts of India. As part of this survey, fieldworkers obtained information about cause of death and risk factors for suicide from close associates or relatives of the deceased individual. Two of 140 trained physicians were randomly allocated (stratified only by their ability to read the local language in which each survey was done) to independently and anonymously assign a cause to each death on the basis of electronic field reports. We then applied the age-specific and sex-specific proportion of suicide deaths in this survey to the 2010 UN estimates of absolute numbers of deaths in India to estimate the number of suicide deaths in India in 2010. Findings About 3% of the surveyed deaths (2684 of 95 335) in individuals aged 15 years or older were due to suicide, corresponding to about 187 000 suicide deaths in India in 2010 at these ages (115 000 men and 72 000 women; age-standardised rates per 100 000 people aged 15 years or older of 26.3 for men and 17.5 for women). For suicide deaths at ages 15 years or older, 40% of suicide deaths in men (45 100 of 114 800) and 56% of suicide deaths in women (40 500 of 72 100) occurred at ages 15-29 years. A 15-year-old individual in India had a cumulative risk of about 1.3% of dying before the age of 80 years by suicide; men had a higher risk (1.7%) than did women (1.0%), with especially high risks in south India (3.5% in men and 1.8% in women). About half of suicide deaths were due to poisoning (mainly ingestions of pesticides). Interpretation Suicide death rates in India are among the highest in the world. A large proportion of adult suicide deaths occur between the ages of 15 years and 29 years, especially in women. Public health interventions such as restrictions in access to pesticides might prevent many suicide deaths in India.	[Ramasundarahettige, Chinthanie; Suraweera, Wilson; Jha, Prabhat] St Michaels Hosp, Ctr Global Hlth Res, Dalla Lana Sch Publ Hlth, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Patel, Vikram] London Sch Hyg & Trop Med, London, England; [Patel, Vikram] London Sch Hyg & Trop Med, Sangath, India; [Gajalakshmi, Vendhan] Epidemiol Res Ctr, Madras, Tamil Nadu, India; [Thakur, J. S.] Sch Publ Hlth, Postgrad Inst Med Educ & Res, Chandigarh, India; [Vijayakumar, Lakshmi] Soc Natal Effect Hlth Adults, Madras, Tamil Nadu, India; [Gururaj, Gopalkrishna] Natl Inst Mental Hlth & Neurosci, Bangalore 560029, Karnataka, India	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of London; London School of Hygiene & Tropical Medicine; Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; National Institute of Mental Health & Neurosciences - India	Jha, P (corresponding author), St Michaels Hosp, Ctr Global Hlth Res, Dalla Lana Sch Publ Hlth, 30 Bond St, Toronto, ON M5B 1W8, Canada.	prabhat.jha@utoronto.ca	Suraweera, Wilson MG/O-8962-2014	Pednekar, Mangesh/0000-0001-6266-5356; Suraweera, Wilson/0000-0001-9673-5746; Bhala, Neeraj/0000-0003-2502-1177; Patel, Vikram/0000-0003-1066-8584	US National Institutes of Health; John E Fogarty International Center of the National Institutes of Health [R01-TW05991-01, TW07939-01]; Canada Research chair programme; University of Toronto; Wellcome Trust [091834/Z/10/Z]; FOGARTY INTERNATIONAL CENTER [R01TW005991, R01TW007939] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John E Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Canada Research chair programme(Canada Research Chairs); University of Toronto(University of Toronto); Wellcome Trust(Wellcome TrustEuropean Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	US National Institutes of Health.r A list of all Million Death Study Collaborators is given in the appendix. The study was supported by grants from the John E Fogarty International Center of the National Institutes of Health (R01-TW05991-01 and TW07939-01); the Canada Research chair programme and University of Toronto (to PJ); and the Wellcome Trust (Grant 091834/Z/10/Z to VP). The opinions expressed in this Article are those of the authors and do not necessarily represent those of the Government of India or the Office of the Registrar General. We thank the Office of the Registrar General for the productive collaboration on the Million Death Study; David Gunnell and Arthur S Slutsky for their helpful comments and Colin Mathers for providing WHO mortality estimates.	Aaron R, 2004, LANCET, V363, P1117, DOI 10.1016/S0140-6736(04)15896-0; Abraham VJ, 2005, INT J GERIATR PSYCH, V20, P953, DOI 10.1002/gps.1385; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; Borges G, 2010, J CLIN PSYCHIAT, V71, P1617, DOI 10.4088/JCP.08m04967blu; Cantor C., 2000, INT HDB SUICIDE ATTE, P9; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Gajalakshmi V, 2007, INT J EPIDEMIOL, V36, P203, DOI 10.1093/ije/dyl308; Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164; Gunnell D, 2003, INT J EPIDEMIOL, V32, P902, DOI 10.1093/ije/dyg307; Jacob KS, 2008, CRISIS, V29, P102, DOI 10.1027/0227-5910.29.2.102; Jagnoor J, 2009, LANCET, V374, P117, DOI 10.1016/S0140-6736(09)61287-3; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P., 2009, CHOOSING HLTH ENTITL; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c621; Joseph A, 2003, BRIT MED J, V326, P1121, DOI 10.1136/bmj.326.7399.1121; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; Kumar R, 2006, Indian J Public Health, V50, P90; Lester D, 1999, ARCH SUICIDE RES, V5, P91, DOI 10.1080/13811119908258320; Manoranjitham S, 2007, NATL MED J INDIA, V20, P176; Manoranjitham SD, 2010, BRIT J PSYCHIAT, V196, P26, DOI 10.1192/bjp.bp.108.063347; Maselko J, 2008, J EPIDEMIOL COMMUN H, V62, P817, DOI 10.1136/jech.2007.069351; Mayer P, 2003, PSYCHOL REP, V92, P1022, DOI 10.2466/PR0.92.3.1022-1028; Mayer P., 2002, CRISIS, V23, P98; National Crime Records Bureau, 2008, ACC DEATHS SUIC IND; National Crime Records Bureau, 2011, ACC DEATHS SUIC IND; Patel V, 2007, INT J EPIDEMIOL, V36, P1242, DOI 10.1093/ije/dym197; Patel V, 2011, BRIT J PSYCHIAT, V199, P459, DOI 10.1192/bjp.bp.111.092155; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Registrar General of India, 2007, MED CERT CAUS DEATH; Registrar General of India, SPEC B MAT MORT IND; Registrar General of India and Center for Global Health Research, 2009, CAUS DEATH IND 2001; Rehkopf DH, 2006, PSYCHOL MED, V36, P145, DOI 10.1017/S003329170500588X; SIVANANDAN V, 2004, ASSESSMENT COMPLETEN; Srijit Mishra, 2006, Economic and Political Weekly, V41, P1538; Vijayakumar L, 1999, ACTA PSYCHIAT SCAND, V99, P407, DOI 10.1111/j.1600-0447.1999.tb00985.x; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; World Health Organization, SUIC RAT PER 100000; World Health Organization, 2008, GLOB BURD DIS 2004 U; [No title captured]	45	296	300	3	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2012	379	9834					2343	2351		10.1016/S0140-6736(12)60606-0	http://dx.doi.org/10.1016/S0140-6736(12)60606-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961ZV	22726517	Green Accepted			2022-12-28	WOS:000305509600029
J	Zhang, XJ; Abreu, JG; Yokota, C; MacDonald, BT; Singh, S; Coburn, KLA; Cheong, SM; Zhang, MZM; Ye, QZ; Hang, HC; Steen, H; He, X				Zhang, Xinjun; Abreu, Jose Garcia; Yokota, Chika; MacDonald, Bryan T.; Singh, Sasha; Almeida Coburn, Karla Loureiro; Cheong, Seong-Moon; Zhang, Mingzi M.; Ye, Qi-Zhuang; Hang, Howard C.; Steen, Hanno; He, Xi			Tiki1 Is Required for Head Formation via Wnt Cleavage-Oxidation and Inactivation	CELL			English	Article							PROTEINS; WINGLESS; PALMITOYLATION; GLYCOSYLATION; RECEPTORS; INDUCTION; SECRETION; ORGANIZER; MEMBRANE; PATHWAY	Secreted Wnt morphogens are signaling molecules essential for embryogenesis, pathogenesis, and regeneration and require distinct modifications for secretion, gradient formation, and activity. Whether Wnt proteins can be posttranslationally inactivated during development and homeostasis is unknown. Here we identify, through functional cDNA screening, a transmembrane protein Tiki1 that is expressed specifically in the dorsal Spemann-Mangold Organizer and is required for anterior development during Xenopus embryogenesis. Tiki1 antagonizes Wnt function in embryos and human cells via a TIKI homology domain that is conserved from bacteria to mammals and acts likely as a protease to cleave eight amino-terminal residues of a Wnt protein, resulting in oxidized Wnt oligomers that exhibit normal secretion but minimized receptor-binding capability. Our findings identify a Wnt-specific protease that controls head formation, reveal a mechanism for morphogen inactivation through proteolysis-induced oxidation-oligomerization, and suggest a role of the Wnt amino terminus in evasion of oxidizing inactivation. TIKI proteins may represent potential therapeutic targets.	[Zhang, Xinjun; Abreu, Jose Garcia; Yokota, Chika; MacDonald, Bryan T.; Almeida Coburn, Karla Loureiro; Cheong, Seong-Moon; He, Xi] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA; [Abreu, Jose Garcia; Almeida Coburn, Karla Loureiro] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941902 Rio De Janeiro, RJ, Brazil; [Singh, Sasha; Steen, Hanno] Harvard Univ, Sch Med, Dept Pathol, Prote Ctr,Boston Childrens Hosp, Boston, MA 02115 USA; [Zhang, Mingzi M.; Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10065 USA; [Ye, Qi-Zhuang] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Universidade Federal do Rio de Janeiro; Harvard University; Boston Children's Hospital; Harvard Medical School; Rockefeller University; Indiana University System; Indiana University Bloomington	He, X (corresponding author), Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Boston Childrens Hosp, Boston, MA 02115 USA.	xi.he@childrens.harvard.edu	Abreu, Jose G/ABB-1199-2021; Zhang, Xinjun/H-8034-2012; Neurociencia, Inct/I-1011-2013; Singh, Sasha/H-3612-2012; Abreu, Jose G/G-6159-2010	Abreu, Jose G/0000-0002-1363-1755; Singh, Sasha/0000-0003-0929-3164; Abreu, Jose G/0000-0002-9875-7786; Zhang, Mingzi/0000-0002-1213-3340; Steen, Hanno/0000-0003-0179-6648	William Randolph Hearst Fund of Harvard Medical School; NRSA/NIH postdoctoral fellowship; CNPq (Brazil); CAPES (Brazil); A*STAR, Singapore; Ellison Medical Foundation; NIH [R01 GM087544-01, R01-GM094844-01, RO1 GM057603, GM057603S1]; Boston Children's Hospital's Intellectual and Developmental Disabilities Research Center [P30 HD-18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087544, R01GM094844, R01GM057603] Funding Source: NIH RePORTER	William Randolph Hearst Fund of Harvard Medical School; NRSA/NIH postdoctoral fellowship; CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Children's Hospital's Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We dedicate this study to the 30th anniversary of the discovery of Wnt1 by R. Nusse and H. E. Varmus. We thank S. An (StemRD) for recombinant WNT3A, J. Brown, D. Kimelman, R. Nusse, S. Takada, M. Taira, and R. Weinberg (via Addgene) for reagents, M. Resh for <SUP>125</SUP>I-palmitate, A. Najafov, D. Winter, and W. Yang for help, K. Willert, R. Segal, Y.-J. Shi for discussion, J. Dubrulle and A. Schier for help on experimentation of zebrafish Tiki1/2, and Tufts Medical Proteomics Facility for peptide sequencing. X.Z. is supported by a grant from the William Randolph Hearst Fund of Harvard Medical School. B. T. M. was supported by a NRSA/NIH postdoctoral fellowship. J. G. A. was funded partially by CNPq (Brazil) as a visiting scientist, and K. L. A. C. by CAPES (Brazil) as a visiting student, both to the X. H. laboratory. M. M.Z. is supported by A*STAR, Singapore. H. C. H. acknowledges support from Ellison Medical Foundation and NIH (R01 GM087544-01). H. S. acknowledges support from NIH (R01-GM094844-01). This work was supported by NIH (RO1 GM057603 and GM057603S1) to X. H. and by Boston Children's Hospital's Intellectual and Developmental Disabilities Research Center (P30 HD-18655). X. H. was a Leukemia and Lymphoma Society Scholar.	Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barrett A. J., 1998, HDB PROTEOLYTIC ENZY; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Franch-Marro X, 2008, J CELL SCI, V121, P1587, DOI 10.1242/jcs.015958; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Kurayoshi M, 2007, BIOCHEM J, V402, P515, DOI 10.1042/BJ20061476; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Singh S, 2009, J PROTEOME RES, V8, P2201, DOI 10.1021/pr800654s; Singh SA, 2012, NAT METHODS, V9, P504, DOI [10.1038/NMETH.1970, 10.1038/nmeth.1970]; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Voigt J, 2005, MECH DEVELOP, V122, P289, DOI 10.1016/j.mod.2004.11.002; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	38	102	120	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1565	1577		10.1016/j.cell.2012.04.039	http://dx.doi.org/10.1016/j.cell.2012.04.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726442	Green Accepted, Bronze			2022-12-28	WOS:000305753800021
J	Imai, M; Watanabe, T; Hatta, M; Das, SC; Ozawa, M; Shinya, K; Zhong, GX; Hanson, A; Katsura, H; Watanabe, S; Li, CJ; Kawakami, E; Yamada, S; Kiso, M; Suzuki, Y; Maher, EA; Neumann, G; Kawaoka, Y				Imai, Masaki; Watanabe, Tokiko; Hatta, Masato; Das, Subash C.; Ozawa, Makoto; Shinya, Kyoko; Zhong, Gongxun; Hanson, Anthony; Katsura, Hiroaki; Watanabe, Shinji; Li, Chengjun; Kawakami, Eiryo; Yamada, Shinya; Kiso, Maki; Suzuki, Yasuo; Maher, Eileen A.; Neumann, Gabriele; Kawaoka, Yoshihiro			Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets	NATURE			English	Article							RECEPTOR-BINDING SPECIFICITY; SWINE-ORIGIN H1N1; SINGLE AMINO-ACID; SIALIC-ACID; AVIAN H5N1; A VIRUSES; MEMBRANE-FUSION; MOLECULAR-BASIS; IN-VITRO; HEMAGGLUTININ	Highly pathogenic avian H5N1 influenza A viruses occasionally infect humans, but currently do not transmit efficiently among humans. The viral haemagglutinin (HA) protein is a known host-range determinant as it mediates virus binding to host-specific cellular receptors(1-3). Here we assess the molecular changes in HA that would allow a virus possessing subtype H5 HA to be transmissible among mammals. We identified a reassortant H5 HA/H1N1 virus-comprising H5 HA (from an H5N1 virus) with four mutations and the remaining seven gene segments from a 2009 pandemic H1N1 virus-that was capable of droplet transmission in a ferret model. The transmissible H5 reassortant virus preferentially recognized human-type receptors, replicated efficiently in ferrets, caused lung lesions and weight loss, but was not highly pathogenic and did not cause mortality. These results indicate that H5 HA can convert to an HA that supports efficient viral transmission in mammals; however, we do not know whether the four mutations in the H5 HA identified here would render a wholly avian H5N1 virus transmissible. The genetic origin of the remaining seven viral gene segments may also critically contribute to transmissibility in mammals. Nevertheless, as H5N1 viruses continue to evolve and infect humans, receptor-binding variants of H5N1 viruses with pandemic potential, including avian-human reassortant viruses as tested here, may emerge. Our findings emphasize the need to prepare for potential pandemics caused by influenza viruses possessing H5 HA, and will help individuals conducting surveillance in regions with circulating H5N1 viruses to recognize key residues that predict the pandemic potential of isolates, which will inform the development, production and distribution of effective countermeasures.	[Imai, Masaki; Watanabe, Tokiko; Hatta, Masato; Das, Subash C.; Ozawa, Makoto; Zhong, Gongxun; Hanson, Anthony; Watanabe, Shinji; Li, Chengjun; Maher, Eileen A.; Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53711 USA; [Watanabe, Tokiko; Watanabe, Shinji; Kawakami, Eiryo; Kawaoka, Yoshihiro] ERATO Infect Induced Host Responses Project, Kawaguchi, Saitama 3320012, Japan; [Ozawa, Makoto; Kawaoka, Yoshihiro] Univ Tokyo, Dept Special Pathogens, Int Res Ctr Infect Dis, Inst Med Sci, Tokyo 1088639, Japan; [Shinya, Kyoko] Kobe Univ, Dept Microbiol & Infect Dis, Kobe, Hyogo 6500017, Japan; [Katsura, Hiroaki; Yamada, Shinya; Kiso, Maki; Kawaoka, Yoshihiro] Univ Tokyo, Div Virol, Dept Microbiol & Immunol, Inst Med Sci, Tokyo 1088639, Japan; [Suzuki, Yasuo] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan	University of Wisconsin System; University of Wisconsin Madison; Japan Science & Technology Agency (JST); University of Tokyo; Kobe University; University of Tokyo; Chubu University	Kawaoka, Y (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53711 USA.	kawaokay@svm.vetmed.wisc.edu	Ozawa, Makoto/AFM-4137-2022; Li, Chengjun/GWM-7661-2022	Ozawa, Makoto/0000-0002-7731-5321; Zhong, Gongxun/0000-0002-0748-9641; Yasuo, Suzuki/0000-0003-3518-5642	Bill & Melinda Gates Foundation [48339, OPPGH5383]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; ERATO (Japan Science and Technology Agency); National Institute of Allergy and Infectious Diseases Public Health Service Research grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078985, R01AI069274] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ERATO (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)); National Institute of Allergy and Infectious Diseases Public Health Service Research grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to acknowledge D. Holtzman for his contributions to the initial concept for this project and thoughtful scientific discussions. We thank M. McGregor, R. Moritz, L. Burley, K. Moore, A. Luka, J. Bettridge, N. Fujimoto and M. Ito for technical support, S. Watson for editing the manuscript, and the National Institute of Hygiene and Epidemiology, Hanoi, Vietnam for the A/Vietnam/1203/2004 (H5N1) virus, which was obtained from the CDC. This work was supported by the Bill & Melinda Gates Foundation (Grants 48339 and OPPGH5383), by a Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by ERATO (Japan Science and Technology Agency), and by the National Institute of Allergy and Infectious Diseases Public Health Service Research grants. The following reagents were obtained from the NIH Biodefense and Emerging Infections Research Resources Repository, NIAID, NIH: polyclonal anti-monovalent influenza subvirion vaccine rgA/Vietnam/1203/2004 (H5N1), (antiserum, Human), high tire pool, NR-4109 and low titre pool, NR-4110.	Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Cline TD, 2011, J VIROL, V85, P12262, DOI 10.1128/JVI.05582-11; England RJA, 1999, CLIN OTOLARYNGOL, V24, P67, DOI 10.1046/j.1365-2273.1999.00223.x; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HAYWOOD AM, 1986, J GEN VIROL, V67, P2813, DOI 10.1099/0022-1317-67-12-2813; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Krenn BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018577; [李海燕 Li Haiyan], 2004, [中国预防兽医学报, Chinase Journal of Preventive Veterinary Medicine], V26, P1; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nidom CA, 2010, EMERG INFECT DIS, V16, P1515, DOI 10.3201/eid1610.100508; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Octaviani CP, 2010, J VIROL, V84, P10918, DOI 10.1128/JVI.01140-10; Pasma T, 2010, EMERG INFECT DIS, V16, P706, DOI 10.3201/eid1604.091636; Pereda A, 2010, EMERG INFECT DIS, V16, P304, DOI 10.3201/eid1602.091230; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Welsh MD, 2010, VET REC, V166, P642, DOI 10.1136/vr.4851; Xu Q, 2010, J VIROL, V84, P4936, DOI 10.1128/JVI.02489-09; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yamada S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001034; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	46	1050	1104	10	295	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					420	+		10.1038/nature10831	http://dx.doi.org/10.1038/nature10831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722205	Green Accepted, hybrid			2022-12-28	WOS:000305466800047
J	Miyawaki, Y; Suzuki, A; Fujita, J; Maki, A; Okuyama, E; Murata, M; Takagi, A; Murate, T; Kunishima, S; Sakai, M; Okamoto, K; Matsushita, T; Naoe, T; Saito, H; Kojima, T				Miyawaki, Yuhri; Suzuki, Atsuo; Fujita, Junko; Maki, Asuka; Okuyama, Eriko; Murata, Moe; Takagi, Akira; Murate, Takashi; Kunishima, Shinji; Sakai, Michio; Okamoto, Kohji; Matsushita, Tadashi; Naoe, Tomoki; Saito, Hidehiko; Kojima, Tetsuhito			Thrombosis from a Prothrombin Mutation Conveying Antithrombin Resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENE; IDENTIFICATION	We identified a novel mechanism of hereditary thrombosis associated with antithrombin resistance, with a substitution of arginine for leucine at position 596 (p.Arg596Leu) in the gene encoding prothrombin (called prothrombin Yukuhashi). The mutant prothrombin had moderately lower activity than wild-type prothrombin in clotting assays, but the formation of thrombin-antithrombin complex was substantially impaired. A thrombin-generation assay revealed that the peak activity of the mutant prothrombin was fairly low, but its inactivation was extremely slow in reconstituted plasma. The Leu596 substitution caused a gain-of-function mutation in the prothrombin gene, resulting in resistance to antithrombin and susceptibility to thrombosis.	[Kojima, Tetsuhito] Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Higashi Ku, Nagoya, Aichi 4618673, Japan; [Miyawaki, Yuhri; Suzuki, Atsuo; Fujita, Junko; Maki, Asuka; Okuyama, Eriko; Murata, Moe; Takagi, Akira; Murate, Takashi; Kojima, Tetsuhito] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi 4618673, Japan; [Naoe, Tomoki] Nagoya Univ, Grad Sch Med, Dept Hematol Oncol, Nagoya, Aichi 4618673, Japan; [Kunishima, Shinji] Clin Res Ctr, Dept Adv Diag, Nagoya, Aichi, Japan; [Kunishima, Shinji; Saito, Hidehiko] Nagoya Med Ctr, Nagoya, Aichi, Japan; [Matsushita, Tadashi] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi, Japan; [Sakai, Michio] Univ Occupat & Environm Hlth, Dept Pediat, Kitakyushu, Fukuoka 807, Japan; [Okamoto, Kohji] Univ Occupat & Environm Hlth, Dept Surg 1, Kitakyushu, Fukuoka 807, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya Medical Center; Nagoya University; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Kojima, T (corresponding author), Nagoya Univ, Sch Hlth Sci, Dept Med Technol, Higashi Ku, 1-1-20 Daiko Minami, Nagoya, Aichi 4618673, Japan.	kojima@met.nagoya-u.ac.jp	Matsushita, Tadadshi/I-7349-2014; Naoe, Tomoki/I-1888-2012; Kojima, Tetsuhito/I-6271-2014; Okamoto, Kohji/AAF-5980-2020	Kojima, Tetsuhito/0000-0002-1905-1065; Okamoto, Kohji/0000-0002-9170-717X	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Ministry of Health, Labor and Welfare; Senshin Medical Research Foundation; Grants-in-Aid for Scientific Research [22659114] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported in part by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; the Japanese Ministry of Health, Labor and Welfare; and the Senshin Medical Research Foundation.	Akhavan S, 2000, THROMB HAEMOSTASIS, V84, P989; BODE W, 1992, PROTEIN SCI, V1, P426; DANG QD, 1995, P NATL ACAD SCI USA, V92, P5977, DOI 10.1073/pnas.92.13.5977; Dang QD, 1997, NAT BIOTECHNOL, V15, P146, DOI 10.1038/nbt0297-146; den Dunnen JT, 2002, HUM MUTAT, V20, P403; DeStefano V, 1996, BLOOD, V87, P3531, DOI 10.1182/blood.V87.9.3531.bloodjournal8793531; Khan S, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-15; KOJIMA T, 1987, BLOOD, V69, P349; Lefkowitz JB, 2003, J THROMB HAEMOST, V1, P2381, DOI 10.1046/j.1538-7836.2003.00420.x; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Lundblad R L, 1976, Methods Enzymol, V45, P156; Okada H, 2004, BRIT J HAEMATOL, V126, P219, DOI 10.1111/j.1365-2141.2004.05026.x; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Sakai Michio, 2001, Journal of UOEH, V23, P297; Suzuki A, 2012, THROMB RES, V129, pE200, DOI 10.1016/j.thromres.2011.12.030; Suzuki A, 2010, J BIOL CHEM, V285, P13444, DOI 10.1074/jbc.M109.062430; ten Kate M, 2009, 22 C INT SOC THROMB	19	65	66	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					2390	2396		10.1056/NEJMoa1201994	http://dx.doi.org/10.1056/NEJMoa1201994			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961GH	22716977				2022-12-28	WOS:000305451700008
J	Hull, RD				Hull, Russell D.			Semuloparin reduced venous thromboembolism in patients receiving chemotherapy for cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calgary, Calgary, AB, Canada	University of Calgary	Hull, RD (corresponding author), Univ Calgary, Calgary, AB, Canada.							Akl EA, 2012, NEW ENGL J MED, V366, P661, DOI 10.1056/NEJMe1113672	1	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12							JC6-5	10.7326/0003-4819-156-12-201206190-02005	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711106				2022-12-28	WOS:000307783200004
J	Cantor, JD				Cantor, Julie D.			Court-Ordered Care - A Complication of Pregnancy to Avoid	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									UCLA Sch Law, Los Angeles, CA USA		Cantor, JD (corresponding author), UCLA Sch Law, Los Angeles, CA USA.							ACOG Committee on Ethics, 2005, Obstet Gynecol, V106, P1127; Adams SF, 2003, CLIN PERINATOL, V30, P127, DOI 10.1016/S0095-5108(02)00082-9; Roth Rachel, 2000, MAKING WOMEN PAY HID; Samuels TA, 2007, WOMEN HEALTH ISS, V17, P107, DOI 10.1016/j.whi.2006.12.001	4	16	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2012	366	24					2237	2240						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	957PD	22693994				2022-12-28	WOS:000305174100001
J	Yatsunenko, T; Rey, FE; Manary, MJ; Trehan, I; Dominguez-Bello, MG; Contreras, M; Magris, M; Hidalgo, G; Baldassano, RN; Anokhin, AP; Heath, AC; Warner, B; Reeder, J; Kuczynski, J; Caporaso, JG; Lozupone, CA; Lauber, C; Clemente, JC; Knights, D; Knight, R; Gordon, JI				Yatsunenko, Tanya; Rey, Federico E.; Manary, Mark J.; Trehan, Indi; Dominguez-Bello, Maria Gloria; Contreras, Monica; Magris, Magda; Hidalgo, Glida; Baldassano, Robert N.; Anokhin, Andrey P.; Heath, Andrew C.; Warner, Barbara; Reeder, Jens; Kuczynski, Justin; Caporaso, J. Gregory; Lozupone, Catherine A.; Lauber, Christian; Clemente, Jose Carlos; Knights, Dan; Knight, Rob; Gordon, Jeffrey I.			Human gut microbiome viewed across age and geography	NATURE			English	Article							FREE AMINO-ACIDS; INTESTINAL MICROBIOTA; BACTERIAL COMMUNITIES; HUMAN INFANT; NORMAL MEN; UREA; NITROGEN; CLUSTER; VALIDATION; PROTEIN	Gut microbial communities represent one source of human genetic and metabolic diversity. To examine how gut microbiomes differ among human populations, here we characterize bacterial species in fecal samples from 531 individuals, plus the gene content of 110 of them. The cohort encompassed healthy children and adults from the Amazonas of Venezuela, rural Malawi and US metropolitan areas and included mono-and dizygotic twins. Shared features of the functional maturation of the gut microbiome were identified during the first three years of life in all three populations, including age-associated changes in the genes involved in vitamin biosynthesis and metabolism. Pronounced differences in bacterial assemblages and functional gene repertoires were noted between US residents and those in the other two countries. These distinctive features are evident in early infancy as well as adulthood. Our findings underscore the need to consider the microbiome when evaluating human development, nutritional needs, physiological variations and the impact of westernization.	[Yatsunenko, Tanya; Rey, Federico E.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Manary, Mark J.; Trehan, Indi; Warner, Barbara] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Manary, Mark J.] Univ Malawi, Dept Community Hlth, Coll Med, Blantyre, Malawi; [Trehan, Indi] Univ Malawi, Dept Paediat & Child Hlth, Coll Med, Blantyre, Malawi; [Dominguez-Bello, Maria Gloria] Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA; [Contreras, Monica] Venezuelan Inst Sci Res IVIC, Altos De Pipe, Venezuela; [Magris, Magda; Hidalgo, Glida] Amazon Ctr Res & Control Trop Dis CAICET, Amazonas, Venezuela; [Baldassano, Robert N.] Childrens Hosp Philadelphia, Div Gastroenterol & Nutr, Philadelphia, PA 19104 USA; [Anokhin, Andrey P.; Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Reeder, Jens; Kuczynski, Justin; Lozupone, Catherine A.; Lauber, Christian; Clemente, Jose Carlos; Knights, Dan; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Caporaso, J. Gregory] No Arizona Univ, Dept Comp Sci, Flagstaff, AZ 86001 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Washington University (WUSTL); Washington University (WUSTL); University of Malawi; University of Malawi; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; Venezuelan Institute Science Research; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Washington University (WUSTL); University of Colorado System; University of Colorado Boulder; Northern Arizona University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu	Lozupone, Catherine/AAD-9317-2020; Knight, Rob/D-1299-2010; Trehan, Indi/K-7912-2013	Trehan, Indi/0000-0002-3364-6858; Contreras Valero, Monica/0000-0003-4729-9559; Manary, Mark/0000-0003-2733-9568; Anokhin, Andrey/0000-0001-8158-6346; Caporaso, Greg/0000-0002-8865-1670; Knight, Rob/0000-0002-0975-9019	National Institutes of Health [DK078669, T32-HD049338]; St. Louis Children's Discovery Institute [MD112009-201]; Howard Hughes Medical Institute; Crohn's and Colitis Foundation of America; Bill and Melinda Gates Foundation; National Science Foundation [CNS-0821794]; University of Colorado, Boulder; University of Colorado, Denver; National Center for Atmospheric Research; Direct For Biological Sciences [0959864] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, K01DK090285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Louis Children's Discovery Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Crohn's and Colitis Foundation of America; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Science Foundation(National Science Foundation (NSF)); University of Colorado, Boulder; University of Colorado, Denver; National Center for Atmospheric Research; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Wagoner and J. Manchester for superb technical assistance, plus B. Muegge, A. Grimm, A. Hsiao, N. Griffin and P. Tarr for suggestions, and M. Ndao, T. Tinnin and R. Mkakosya for patient recruitment and/or technical assistance. This work was supported in part by grants from the National Institutes of Health (DK078669, T32-HD049338), St. Louis Children's Discovery Institute (MD112009-201), the Howard Hughes Medical Institute, the Crohn's and Colitis Foundation of America, and the Bill and Melinda Gates Foundation. Parts of this work used the Janus supercomputer, which is supported by National Science Foundation grant CNS-0821794, the University of Colorado, Boulder, the University of Colorado, Denver, and the National Center for Atmospheric Research.	[Anonymous], 2010, R LANG ENV STAT COMP; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; HARZER G, 1984, AM J CLIN NUTR, V40, P303, DOI 10.1093/ajcn/40.2.303; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Kaufman L., 1990, FINDING GROUPS DATA, P68, DOI [10.1002/9780470316801.ch2, DOI 10.1002/9780470316801.CH2]; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Krautler B, 2005, BIOCHEM SOC T, V33, P806; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; LANGRAN M, 1992, CLIN SCI, V82, P191, DOI 10.1042/cs0820191; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Meakins TS, 1996, CLIN SCI, V90, P215, DOI 10.1042/cs0900215; Metges CC, 1999, AM J CLIN NUTR, V70, P1046; Millward DJ, 2000, BRIT J NUTR, V83, P505; Monsen AUB, 2003, CLIN CHEM, V49, P2067, DOI 10.1373/clinchem.2003.019869; Mora D, 2004, J APPL MICROBIOL, V96, P209, DOI 10.1046/j.1365-2672.2003.02148.x; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; PEACH S, 1974, J MED MICROBIOL, V7, P213, DOI 10.1099/00222615-7-2-213; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Tannock GW, 2007, SEMIN IMMUNOL, V19, P94, DOI 10.1016/j.smim.2006.09.001; Teal T. K., 2010, COLD SPRING HARB PRO, V2010; Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	39	4432	4661	73	1631	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					222	+		10.1038/nature11053	http://dx.doi.org/10.1038/nature11053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699611	Green Accepted, Green Submitted			2022-12-28	WOS:000305189000027
J	Chappell, LC; Gurung, V; Seed, PT; Chambers, J; Williamson, C; Thornton, JG				Chappell, Lucy C.; Gurung, Vinita; Seed, Paul T.; Chambers, Jenny; Williamson, Catherine; Thornton, James G.		PITCH Study Consortium	Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OBSTETRIC CHOLESTASIS; GROWTH RESTRICTION; IN-VITRO; DEXAMETHASONE; TAUROCHOLATE; ARRHYTHMIA; INDUCTION; MODEL	Objectives To test whether ursodeoxycholic acid reduces pruritus in women with intrahepatic cholestasis of pregnancy, whether early term delivery does not increase the incidence of caesarean section, and the feasibility of recruiting women with intrahepatic cholestasis of pregnancy to trials of these interventions. Design First phase of a semifactorial randomised controlled trial. Setting Nine consultant led maternity units, United Kingdom. Participants 125 women with intrahepatic cholestasis of pregnancy (pruritus and raised levels of serum bile acids) or pruritus and raised alanine transaminase levels (>100 IU/L) recruited after 24 weeks' gestation and followed until delivery. 56 women were randomised to ursodeoxycholic acid, 55 to placebo, 30 to early term delivery, and 32 to expectant management. Interventions Ursodeoxycholic acid 500 mg twice daily or placebo increased as necessary for symptomatic or biochemical improvement until delivery; early term delivery (induction or delivery started between 37+0 and 37+6) or expectant management (spontaneous labour awaited until 40 weeks' gestation or caesarean section undertaken by normal obstetric guidelines, usually after 39 weeks' gestation). Main outcome measures The primary outcome for ursodeoxycholic acid was maternal itch (arithmetic mean of measures (100 mm visual analogue scale) of worst itch in past 24 hours) and for the timing of delivery was caesarean section. Secondary outcomes were other maternal and perinatal outcomes and recruitment rates. Results Ursodeoxycholic acid reduced itching by -16 mm (95% confidence interval -27 mm to -6 mm), less than the 30 mm difference prespecified by clinicians and women as clinically meaningful. 32% (14/44) of women randomised to ursodeoxycholic acid experienced a reduction in worst itching by at least 30 mm compared with 16% (6/37) randomised to placebo. The difference of 16% (95% confidence interval -3 to 34); this would represent a number needed to treat of 6, but it failed to reach significance. Early term delivery did not increase caesarean sections (7/30 (23%) in the early term delivery group versus 11/32 (33%) in the expectant management group (relative risk 0.70, 95% confidence interval 0.31 to 1.57). No serious harms were noted in either trial. 22% (73/325) of eligible women participated in the drug trial and 19% (39/209) in the timing of delivery trial; both groups had a similar spectrum of disease severity to non-participants. Conclusions Ursodeoxycholic acid significantly reduces pruritus, but the size of the benefit may be too small for most doctors to recommend it, or for most women to want to take it. Women are, however, likely to differ in whether they consider the benefit to be worthwhile. Planned early term delivery seems not to increase incidence of caesarean section, although a small increase cannot be excluded. A trial to test whether ursodeoxycholic acid reduces adverse perinatal outcomes would have to be large, but is feasible. A trial to test the effect of early term delivery on adverse fetal outcomes would have to be significantly larger and may not be feasible.	[Thornton, James G.] Nottingham Hlth Sci Partners, Queens Med Ctr, Nottingham Clin Trials Unit, Nottingham NG7 2UH, England; [Chappell, Lucy C.; Seed, Paul T.] Kings Hlth Partners, Womens Hlth Acad Ctr, London, England; [Gurung, Vinita] Birmingham City Hosp, Birmingham, W Midlands, England; [Chambers, Jenny; Williamson, Catherine] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London SW7 2AZ, England	University of Nottingham; University of London; King's College London; Imperial College London	Thornton, JG (corresponding author), Nottingham Hlth Sci Partners, Queens Med Ctr, Nottingham Clin Trials Unit, Nottingham NG7 2UH, England.	jim.thornton@nottingham.ac.uk	Thornton, Jim/B-8336-2008; Seed, Paul T/C-4435-2008	Thornton, Jim/0000-0001-9764-6876; Seed, Paul T/0000-0001-7904-7933; Williamson, Catherine/0000-0002-6226-7611	research for patient benefit programme of the National Institute for Health Research (NIHR); Department of Health-NHS clinical senior lecturer award; Nottingham University Hospitals NHS Trust; Tommy's Charity; Biomedical Research Centre at Imperial College Healthcare NHS Trust; University of Nottingham; National Institute for Health Research [PB-PG-0107-12037] Funding Source: researchfish	research for patient benefit programme of the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Department of Health-NHS clinical senior lecturer award; Nottingham University Hospitals NHS Trust; Tommy's Charity; Biomedical Research Centre at Imperial College Healthcare NHS Trust; University of Nottingham; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the research for patient benefit programme of the National Institute for Health Research (NIHR). LCC is funded by a Department of Health-NHS clinical senior lecturer award. VG was funded by Nottingham University Hospitals NHS Trust and the NIHR research for patient benefit programme. PTS is funded by Tommy's Charity. CW is funded by the Biomedical Research Centre at Imperial College Healthcare NHS Trust. The sponsor was the University of Nottingham. The sponsor played no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Abedin P, 1999, Ethn Health, V4, P35; Al Inizi S, 2006, INT J GYNECOL OBSTET, V93, P53, DOI 10.1016/j.ijgo.2005.12.030; Boers KE, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c7087; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Brites D, 1998, EUR J OBSTET GYN R B, V76, P165, DOI 10.1016/S0301-2115(97)00185-1; Buchanan SL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004735.pub3; Burrows RF., 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000493; Campos G A, 1988, Rev Chil Obstet Ginecol, V53, P229; CAMPOS GA, 1986, ACTA OBSTET GYN SCAN, V65, P23, DOI 10.3109/00016348609158224; Clark SL, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.068; COSTOYA AL, 1980, PLACENTA, V1, P361, DOI 10.1016/S0143-4004(80)80038-5; Dare MR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005302.pub2; Diaferia A, 1996, INT J GYNECOL OBSTET, V52, P133, DOI 10.1016/0020-7292(95)02528-6; FISK NM, 1988, AUST NZ J OBSTET GYN, V28, P172, DOI 10.1111/j.1479-828X.1988.tb01657.x; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; Geenes V, 2011, PLACENTA        1018; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; Glantz A, 2005, HEPATOLOGY, V42, P1399, DOI 10.1002/hep.20952; Gorelik J, 2003, BJOG-INT J OBSTET GY, V110, P467, DOI 10.1016/S1470-032(03)02973; Gurung V, 2011, COCHRANE DATAB UNPUB; Gurung V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-19; Kadir SHSA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009689; Kadir SHSA, 2009, J CELL MOL MED, V13, P3730, DOI 10.1111/j.1582-4934.2009.00741.x; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; LAATIKAINEN T, 1977, OBSTET GYNECOL, V50, P313; Liebhart M, 1970, Pol Med J, V9, P1589; Liu Yuling, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P350; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Miragoli M, 2011, HEPATOLOGY, V54, P1282, DOI 10.1002/hep.24492; Nicastri PL, 1998, BRIT J OBSTET GYNAEC, V105, P1205, DOI 10.1111/j.1471-0528.1998.tb09976.x; Palma J, 1997, J HEPATOL, V27, P1022, DOI 10.1016/S0168-8278(97)80146-8; Perez MJ, 2006, PLACENTA, V27, P34, DOI 10.1016/j.placenta.2004.10.020; REID R, 1976, BRIT MED J, V1, P870, DOI 10.1136/bmj.1.6014.870; Rogers WH, 1993, STATA TECHN B, V13, P19; Roncaglia N, 2002, EUR J OBSTET GYN R B, V100, P167, DOI 10.1016/S0301-2115(01)00463-8; Royal College of Obstetricians and Gynaecologists, 2006, OBST CHOL; Saleh MM, 2007, BJOG-INT J OBSTET GY, V114, P99, DOI 10.1111/j.1471-0528.2006.01102.x; Saleh MM, 2007, J WOMENS HEALTH, V16, P833, DOI 10.1089/jwh.2007.0158; Thornton JG, 2004, LANCET, V364, P513, DOI 10.1016/S0140-6736(04)16809-8; Webster JR, 2011, OBSTET MED, V4, P66, DOI 10.1258/om.2011.110080; Williamson C, 2004, BJOG-INT J OBSTET GY, V111, P676, DOI 10.1111/j.1471-0528.2004.00167.x; Williamson C, 2001, CLIN SCI, V100, P363, DOI 10.1042/CS20000164; Zapata R, 2005, LIVER INT, V25, P548, DOI 10.1111/j.1478-3231.2004.0996.x; Zecca E, 2006, PEDIATRICS, V117, P1669, DOI 10.1542/peds.2005-1801; Zecca E, 2004, PEDIATRICS, V114, P269, DOI 10.1542/peds.114.1.269	46	93	95	2	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2012	344								e3799	10.1136/bmj.e3799	http://dx.doi.org/10.1136/bmj.e3799			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961KT	22695903	Green Published, hybrid			2022-12-28	WOS:000305464000013
J	Yudkin, JS				Yudkin, John S.			Post-marketing observational trials and catastrophic health expenditure	BRITISH MEDICAL JOURNAL			English	Editorial Material							A(1)CHIEVE; COUNTRIES; PEOPLE		UCL, Dept Med, London WC1E 6BT, England	University of London; University College London	Yudkin, JS (corresponding author), UCL, Dept Med, Mortimer St, London WC1E 6BT, England.	j.yudkin@ucl.ac.uk	Yudkin, John S/C-1988-2008					Access To Medicine Index, IND 2008; Access To Medicine Index, IND 2010; [Anonymous], 2010, Drug Ther Bull, V48, P85, DOI 10.1136/dtb.2010.08.0040; [Anonymous], OBS STUD EV SAF LEV; [Anonymous], 2011, INS DET TRIAL ID NN3; Brabant M, 2010, BBC NEWS        0529; Consulate General of India New York, 2010, CMIE SURV IND HOUS T; Gale EAM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3974; Gill GV, 2011, DIABETOLOGIA, V54, P19, DOI 10.1007/s00125-010-1897-3; Home P, 2011, DIABETES RES CLIN PR, V94, P352, DOI 10.1016/j.diabres.2011.10.021; National Institute for Health and Clinical Excellence, 2009, TYP 2 DIAB NEW AG SH; Novo Nordisk, 2001, NOV NORD LEAD IN LEA; Ramachandran A, 2007, DIABETES CARE, V30, P252, DOI 10.2337/dc06-0144; Shah S, 2011, DIABETES RES CLIN PR, V94, P364, DOI 10.1016/j.diabres.2011.10.020; Shah SN, 2010, DIABETES RES CLIN PR, V88, pS11, DOI 10.1016/S0168-8227(10)70003-6; Smith-Spangler CM, 2012, DIABETES CARE, V35, P319, DOI 10.2337/dc11-1770; Tapscott D, 2006, NOVO NORDISK TRANSPA; World Bank, 2012, WORLD DATABANK WORLD; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	19	4	4	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 12	2012	344								e3987	10.1136/bmj.e3987	http://dx.doi.org/10.1136/bmj.e3987			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961KQ	22692653				2022-12-28	WOS:000305463700006
J	Sheth, SA; Mian, MK; Patel, SR; Asaad, WF; Williams, ZM; Dougherty, DD; Bush, G; Eskandar, EN				Sheth, Sameer A.; Mian, Matthew K.; Patel, Shaun R.; Asaad, Wael F.; Williams, Ziv M.; Dougherty, Darin D.; Bush, George; Eskandar, Emad N.			Human dorsal anterior cingulate cortex neurons mediate ongoing behavioural adaptation	NATURE			English	Article							MULTISOURCE INTERFERENCE TASK; PREFRONTAL CORTEX; COGNITIVE CONTROL; ERROR-LIKELIHOOD; FRONTAL-CORTEX; CONFLICT; PERFORMANCE; INFORMATION; ACTIVATION; ADJUSTMENT	The ability to optimize behavioural performance when confronted with continuously evolving environmental demands is a key element of human cognition. The dorsal anterior cingulate cortex (dACC), which lies on the medial surface of the frontal lobes, is important in regulating cognitive control. Hypotheses about its function include guiding reward-based decision making(1), monitoring for conflict between competing responses(2) and predicting task difficulty(3). Precise mechanisms of dACC function remain unknown, however, because of the limited number of human neurophysiological studies. Here we use functional imaging and human single-neuron recordings to show that the firing of individual dACC neurons encodes current and recent cognitive load. We demonstrate that the modulation of current dACC activity by previous activity produces a behavioural adaptation that accelerates reactions to cues of similar difficulty to previous ones, and retards reactions to cues of different difficulty. Furthermore, this conflict adaptation, or Gratton effect(2,4), is abolished after surgically targeted ablation of the dACC. Our results demonstrate that the dACC provides a continuously updated prediction of expected cognitive demand to optimize future behavioural responses. In situations with stable cognitive demands, this signal promotes efficiency by hastening responses, but in situations with changing demands it engenders accuracy by delaying responses.	[Sheth, Sameer A.; Mian, Matthew K.; Patel, Shaun R.; Williams, Ziv M.; Eskandar, Emad N.] Massachusetts Gen Hosp, Dept Neurosurg, Nayef Al Rodhan Labs, Boston, MA 02114 USA; [Patel, Shaun R.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Asaad, Wael F.] Brown Univ, Alpert Med Sch, Dept Neurosurg, Providence, RI 02912 USA; [Asaad, Wael F.] Rhode Isl Hosp, Providence, RI 02912 USA; [Dougherty, Darin D.; Bush, George] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Boston University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Massachusetts General Hospital	Eskandar, EN (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, Nayef Al Rodhan Labs, Boston, MA 02114 USA.	eeskandar@partners.org	Dougherty, Darin D./G-9896-2012; Asaad, Wael/I-8485-2012	Asaad, Wael/0000-0003-4406-9096	National Science Foundation [IOB 0645886]; National Institutes of Health [NEI 1R01EY017658-01A1, NIDA 1R01NS063249, MH086400, R25 NS065743]; Klingenstein Foundation; Howard Hughes Medical Institute; Sackler Scholar Programme in Psychobiology; Centers for Disease Control [5 R01 DP000339]; Benson-Henry Institute at Massachusetts General Hospital for Mind-Body Medicine; David Judah Fund; McIngvale Fund; Center for Functional Neuroimaging Technologies [P41RR14075]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [R01DP000339] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS065743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026297] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein Foundation(Klingenstein Philanthropies); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sackler Scholar Programme in Psychobiology; Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Benson-Henry Institute at Massachusetts General Hospital for Mind-Body Medicine; David Judah Fund; McIngvale Fund; Center for Functional Neuroimaging Technologies; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Science Foundation (IOB 0645886), the National Institutes of Health (NEI 1R01EY017658-01A1, NIDA 1R01NS063249, NIMH Conte Award MH086400 and R25 NS065743), the Klingenstein Foundation, the Howard Hughes Medical Institute, the Sackler Scholar Programme in Psychobiology, the Centers for Disease Control (5 R01 DP000339), the Benson-Henry Institute at Massachusetts General Hospital for Mind-Body Medicine, the David Judah Fund, the McIngvale Fund, and the Center for Functional Neuroimaging Technologies (P41RR14075).	Asaad WF, 2008, J NEUROSCI METH, V174, P245, DOI 10.1016/j.jneumeth.2008.07.014; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Bush G, 2008, ARCH GEN PSYCHIAT, V65, P102, DOI 10.1001/archgenpsychiatry.2007.16; Bush G, 2006, NAT PROTOC, V1, P308, DOI 10.1038/nprot.2006.48; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cole MW, 2009, TRENDS NEUROSCI, V32, P566, DOI 10.1016/j.tins.2009.07.001; Davis KD, 2000, J NEUROPHYSIOL, V83, P3575, DOI 10.1152/jn.2000.83.6.3575; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; di Pellegrino G, 2007, J COGNITIVE NEUROSCI, V19, P275, DOI 10.1162/jocn.2007.19.2.275; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hayden BY, 2010, J NEUROSCI, V30, P3339, DOI 10.1523/JNEUROSCI.4874-09.2010; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; Narayanan NS, 2008, J NEUROPHYSIOL, V100, P520, DOI 10.1152/jn.00035.2008; Nieuwenhuis S, 2007, CEREB CORTEX, V17, P1570, DOI 10.1093/cercor/bhl068; Rauch SL, 2000, J NEUROSURG, V93, P1019, DOI 10.3171/jns.2000.93.6.1019; Ridderinkhof KR, 2002, PSYCHOL RES-PSYCH FO, V66, P312, DOI 10.1007/s00426-002-0104-7; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354	29	279	282	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2012	488	7410					218	+		10.1038/nature11239	http://dx.doi.org/10.1038/nature11239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	985LE	22722841	Green Accepted			2022-12-28	WOS:000307267000035
J	Storch, D; Keil, P; Jetz, W				Storch, David; Keil, Petr; Jetz, Walter			Universal species-area and endemics-area relationships at continental scales	NATURE			English	Article							SPATIAL TURNOVER; GLOBAL PATTERNS; RANGE; DISTRIBUTIONS; RICHNESS; GEOMETRY; MODEL; EVOLUTIONARY; BIODIVERSITY; BIOGEOGRAPHY	Despite the broad conceptual and applied relevance of how the number of species or endemics changes with area (the species-area and endemics-area relationships (SAR and EAR)), our understanding of universality and pervasiveness of these patterns across taxa and regions has remained limited. The SAR has traditionally been approximated by a power law(1), but recent theories predict a triphasic SAR in logarithmic space, characterized by steeper increases in species richness at both small and large spatial scales(2-6). Here we uncover such universally upward accelerating SARs for amphibians, birds and mammals across the world's major landmasses. Although apparently taxon-specific and continent-specific, all curves collapse into one universal function after the area is rescaled by using the mean range sizes of taxa within continents. In addition, all EARs approximately follow a power law with a slope close to 1, indicating that for most spatial scales there is roughly proportional species extinction with area loss. These patterns can be predicted by a simulation model based on the random placement of contiguous ranges within a domain. The universality of SARs and EARs after rescaling implies that both total and endemic species richness within an area, and also their rate of change with area, can be estimated by using only the knowledge of mean geographic range size in the region and mean species richness at one spatial scale.	[Storch, David] Charles Univ Prague, Ctr Theoret Study, Prague 11000 1, Czech Republic; [Storch, David] Acad Sci Czech Republ, Prague 11000 1, Czech Republic; [Storch, David] Charles Univ Prague, Fac Sci, Dept Ecol, CR-12844 Prague 2, Czech Republic; [Keil, Petr; Jetz, Walter] Yale Univ, Dept Ecol & Evolut Biol, New Haven, CT 06520 USA	Charles University Prague; Czech Academy of Sciences; Charles University Prague; Yale University	Storch, D (corresponding author), Charles Univ Prague, Ctr Theoret Study, Jilska 1, Prague 11000 1, Czech Republic.	storch@cts.cuni.cz	Keil, Petr/A-9875-2014; Storch, David/C-3339-2017; Jetz, Walter/ABF-1517-2020	Storch, David/0000-0001-5967-1544; Jetz, Walter/0000-0002-1971-7277	Grant Agency of the Czech Republic [P505/11/2387]; Czech Ministry of Education [MSM0021620845]; EU FP7 SCALES project [26852]; National Science Foundation [DBI 0960550, DEB 1026764]; NASA Biodiversity Program [NNX11AP72G]; Direct For Biological Sciences [1026764] Funding Source: National Science Foundation	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); EU FP7 SCALES project; National Science Foundation(National Science Foundation (NSF)); NASA Biodiversity Program(National Aeronautics & Space Administration (NASA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Belmaker, K. Mertes-Schwartz, C. Sheard and D. Rosauer for useful comments. The study was supported by the Grant Agency of the Czech Republic (P505/11/2387), the Czech Ministry of Education (MSM0021620845) and the EU FP7 SCALES project ('Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal and Ecological Scales'; project No. 26852). W. J. acknowledges support from National Science Foundation grants DBI 0960550 and DEB 1026764, and NASA Biodiversity Program grant number NNX11AP72G.	Allen AP, 2003, EVOL ECOL RES, V5, P493; Arita HT, 2002, ECOGRAPHY, V25, P541, DOI 10.1034/j.1600-0587.2002.250504.x; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Drakare S, 2006, ECOL LETT, V9, P215, DOI 10.1111/j.1461-0248.2005.00848.x; Green JL, 2003, ECOLOGY, V84, P3090, DOI 10.1890/02-3096; Harte J, 1997, OIKOS, V80, P417, DOI 10.2307/3546614; Harte J, 2009, ECOL LETT, V12, P789, DOI 10.1111/j.1461-0248.2009.01328.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Hubbell Stephen P., 2001, V32, pi; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Kinzig AP, 2000, ECOLOGY, V81, P3305, DOI 10.1890/0012-9658(2000)081[3305:IOEARF]2.0.CO;2; Kunin WE, 1997, BIOL CONSERV, V82, P369, DOI 10.1016/S0006-3207(97)00042-6; Lawton J. H., 1995, EXTINCTION RATES; Leitner WA, 1997, OIKOS, V79, P503, DOI 10.2307/3546894; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; McGill B, 2003, EVOL ECOL RES, V5, P469; McGill BJ, 2010, ECOL LETT, V13, P627, DOI 10.1111/j.1461-0248.2010.01449.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; O'Dwyer JP, 2010, ECOL LETT, V13, P87, DOI 10.1111/j.1461-0248.2009.01404.x; Pereira HM, 2012, NATURE, V482, pE3, DOI 10.1038/nature10857; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosindell J, 2007, ECOL LETT, V10, P586, DOI 10.1111/j.1461-0248.2007.01050.x; Scheiner SM, 2003, GLOBAL ECOL BIOGEOGR, V12, P441, DOI 10.1046/j.1466-822X.2003.00061.x; Sizling AL, 2004, ECOL LETT, V7, P60, DOI 10.1046/j.1461-0248.2003.00549.x; Sizling AL, 2011, AM NAT, V178, P602, DOI 10.1086/662176; Smith AB, 2010, BIOL CONSERV, V143, P555, DOI 10.1016/j.biocon.2009.11.003; Storch D, 2008, ECOL LETT, V11, P771, DOI 10.1111/j.1461-0248.2008.01206.x; Storch D, 2006, ECOL LETT, V9, P1308, DOI 10.1111/j.1461-0248.2006.00984.x	34	118	119	3	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2012	488	7409					78	+		10.1038/nature11226	http://dx.doi.org/10.1038/nature11226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ZE	22722856				2022-12-28	WOS:000307010700036
J	Lu, YH; Wu, KM; Jiang, YY; Guo, YY; Desneux, N				Lu, Yanhui; Wu, Kongming; Jiang, Yuying; Guo, Yuyuan; Desneux, Nicolas			Widespread adoption of Bt cotton and insecticide decrease promotes biocontrol services	NATURE			English	Article							NATURAL PEST-CONTROL; BIOLOGICAL-CONTROL; AGRICULTURAL LANDSCAPES; BENEFICIAL ARTHROPODS; POPULATION-DYNAMICS; MULTIPLE CROPS; NORTHERN CHINA; BIODIVERSITY; SUPPRESSION; MANAGEMENT	Over the past 16 years, vast plantings of transgenic crops producing insecticidal proteins from the bacterium Bacillus thuringiensis (Bt) have helped to control several major insect pests(1-5) and reduce the need for insecticide sprays(1,5,6). Because broad-spectrum insecticides kill arthropod natural enemies that provide biological control of pests, the decrease in use of insecticide sprays associated with Bt crops could enhance biocontrol services(7-12). However, this hypothesis has not been tested in terms of long-term landscape-level impacts(10). On the basis of data from 1990 to 2010 at 36 sites in six provinces of northern China, we show here a marked increase in abundance of three types of generalist arthropod predators (ladybirds, lacewings and spiders) and a decreased abundance of aphid pests associated with widespread adoption of Bt cotton and reduced insecticide sprays in this crop. We also found evidence that the predators might provide additional biocontrol services spilling over from Bt cotton fields onto neighbouring crops (maize, peanut and soybean). Our work extends results from general studies evaluating ecological effects of Bt crops(1-4,6,12,13) by demonstrating that such crops can promote biocontrol services in agricultural landscapes.	[Lu, Yanhui; Wu, Kongming; Guo, Yuyuan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Jiang, Yuying] Natl Agrotech Extens & Serv Ctr, Beijing 100026, Peoples R China; [Desneux, Nicolas] French Natl Inst Agr Res INRA, UMR1355, ISA, F-06903 Sophia Antipolis, France	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Wu, KM (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn	Desneux, Nicolas/J-6262-2013	Lu, Yanhui/0000-0002-6552-0248	Key Project for Breeding Genetically Modified Organisms [2011ZX08012-004]; International Science and Technology Cooperation Project [2010DFA32200]	Key Project for Breeding Genetically Modified Organisms; International Science and Technology Cooperation Project	We thank the agricultural technicians of the 36 surveyed locations for providing data sets from cotton fields; W. Li and L. Wang for providing the predator exclusion cage data sets; Y. Zhang and C. Li for assistance in making the survey map; H. Yuan for help in preparing the list of insecticides in cotton; and R. Senoussi for advice on data analyses. This work was funded by the Key Project for Breeding Genetically Modified Organisms (grant no. 2011ZX08012-004) and the International Science and Technology Cooperation Project (grant no. 2010DFA32200).	Bale JS, 2008, PHILOS T R SOC B, V363, P761, DOI 10.1098/rstb.2007.2182; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Crowder DW, 2010, NATURE, V466, P109, DOI 10.1038/nature09183; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Ding Y. Q., 2010, J PEANUT SCI, V39, P45; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; Gatehouse AMR, 2011, PHILOS T R SOC B, V366, P1438, DOI 10.1098/rstb.2010.0330; HARDIN MR, 1995, CROP PROT, V14, P3, DOI 10.1016/0261-2194(95)91106-P; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Institute of Plant Protection Chinese Academy of Agricultural Sciences, 1995, CROP DIS PESTS CHIN; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Lu Y. H., 2010, INTEGRATED MANAGEMEN; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Miao J, 2007, ENVIRON ENTOMOL, V36, P840, DOI 10.1603/0046-225X(2007)36[840:PDOAGH]2.0.CO;2; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1193, DOI 10.1603/0046-225X(2005)034[1193:LAOTEO]2.0.CO;2; Qu X.F., 1992, COTTON PEST FORECAST; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Rao C. N., 2007, ENCY PEST MANAGEMENT, V2, P597; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J., 2008, INTEGRATION INSECT R; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006; Winqvist C, 2011, J APPL ECOL, V48, P570, DOI 10.1111/j.1365-2664.2010.01950.x; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Wu K., 1992, ACTA ECOL SIN, V12, P341; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2003, ENVIRON ENTOMOL, V32, P312, DOI 10.1603/0046-225X-32.2.312; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xu Hongfu, 2000, Acta Phytophylacica Sinica, V27, P199; Yang Qin-min, 2004, Journal of Shandong Agricultural University, V35, P217	37	571	629	16	535	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					362	365		10.1038/nature11153	http://dx.doi.org/10.1038/nature11153			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22722864				2022-12-28	WOS:000306506500042
J	Scuoppo, C; Miething, C; Lindqvist, L; Reyes, J; Ruse, C; Appelmann, I; Yoon, S; Krasnitz, A; Teruya-Feldstein, J; Pappin, D; Pelletier, J; Lowe, SW				Scuoppo, Claudio; Miething, Cornelius; Lindqvist, Lisa; Reyes, Jose; Ruse, Cristian; Appelmann, Iris; Yoon, Seungtai; Krasnitz, Alexander; Teruya-Feldstein, Julie; Pappin, Darryl; Pelletier, Jerry; Lowe, Scott W.			A tumour suppressor network relying on the polyamine-hypusine axis	NATURE			English	Article							INITIATION-FACTOR 5A; COMMONLY DELETED SEGMENT; AMINO-ACID; CANCER; GENES; EXPRESSION; EIF5A; IDENTIFICATION; DECARBOXYLASE; ACTIVATION	Tumour suppressor genes encode a broad class of molecules whose mutational attenuation contributes to malignant progression. In the canonical situation, the tumour suppressor is completely inactivated through a two-hit process involving a point mutation in one allele and chromosomal deletion of the other(1). Here, to identify tumour suppressor genes in lymphoma, we screen a short hairpin RNA library targeting genes deleted in human lymphomas. We functionally identify those genes whose suppression promotes tumorigenesis in a mouse lymphoma model. Of the nine tumour suppressors we identified, eight correspond to genes occurring in three physically linked 'clusters', suggesting that the common occurrence of large chromosomal deletions in human tumours reflects selective pressure to attenuate multiple genes. Among the new tumour suppressors are adenosylmethionine decarboxylase 1 (AMD1) and eukaryotic translation initiation factor 5A (eIF5A), two genes associated with hypusine, a unique amino acid produced as a product of polyamine metabolism through a highly conserved pathway(2). Through a secondary screen surveying the impact of all polyamine enzymes on tumorigenesis, we establish the polyamine-hypusine axis as a new tumour suppressor network regulating apoptosis. Unexpectedly, heterozygous deletions encompassing AMD1 and eIF5A often occur together in human lymphomas and co-suppression of both genes promotes lymphomagenesis in mice. Thus, some tumour suppressor functions can be disabled through a two-step process targeting different genes acting in the same pathway.	[Scuoppo, Claudio; Lowe, Scott W.] Watson Sch Biol Sci, Cold Spring Harbor Lab, New York, NY 11724 USA; [Miething, Cornelius; Reyes, Jose; Ruse, Cristian; Appelmann, Iris; Krasnitz, Alexander; Pappin, Darryl; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Miething, Cornelius; Appelmann, Iris; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10065 USA; [Lindqvist, Lisa; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Yoon, Seungtai] Mt Sinai Sch Med, New York, NY 10029 USA; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pelletier, Jerry] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center; McGill University; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center; McGill University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Lowe, SW (corresponding author), Watson Sch Biol Sci, Cold Spring Harbor Lab, New York, NY 11724 USA.	lowes@mskcc.org	Miething, Cornelius/F-9498-2014; Ruse, Cristian/A-4609-2011	Miething, Cornelius/0000-0003-4699-3805; Ruse, Cristian/0000-0001-8237-6308; Pappin, Darryl/0000-0002-8981-8401	Don Monti Memorial Research Foundation; National Cancer Institute [CA087497]; National Institutes of Health/American Recovery and Reinvestment Act [CA148532]; Canadian Institutes of Health Research [MOP-106530]; Angel Foundation; Curt Engelhorn fellowship; American Association for Cancer Research-Astellas fellowship; NATIONAL CANCER INSTITUTE [P01CA013106, RC2CA148532, P01CA087497] Funding Source: NIH RePORTER	Don Monti Memorial Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/American Recovery and Reinvestment Act(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Angel Foundation; Curt Engelhorn fellowship; American Association for Cancer Research-Astellas fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Simon, M. Taylor, D. Grace and S. Peacock for technical assistance, S. Muller for help in tumour sequencing and members of the Lowe laboratory for discussions. We thank G. Hannon and S. Powers for advice. We thank J. Maragulia, C. Gonzalez, A. Zelenetz, L. Lopez, E. Iskidarova, M. Asher and I. Linkov for help on the tissue microarray staining and data management. This work was supported by the Don Monti Memorial Research Foundation and grants from the National Cancer Institute (CA087497) and National Institutes of Health/American Recovery and Reinvestment Act (CA148532) to S. W. L. and by a Canadian Institutes of Health Research grant (MOP-106530) to J. P. C. S. was supported by the Angel Foundation with a Curt Engelhorn fellowship and C. M. was supported by an American Association for Cancer Research-Astellas fellowship. S. W. L. is a Howard Hughes Medical Institute Investigator.	Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Berger AH, 2011, J PATHOL, V223, P137, DOI 10.1002/path.2800; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bric A, 2009, CANCER CELL, V16, P324, DOI 10.1016/j.ccr.2009.08.015; Cano VSP, 2008, FEBS J, V275, P44, DOI 10.1111/j.1742-4658.2007.06172.x; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Chen WY, 2006, BLOOD, V107, P2477, DOI 10.1182/blood-2005-07-2950; COOPER HL, 1982, CELL, V29, P791, DOI 10.1016/0092-8674(82)90441-X; Curtiss NP, 2005, GENOMICS, V85, P600, DOI 10.1016/j.ygeno.2005.01.013; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Eischen CM, 2001, MOL CELL BIOL, V21, P7653, DOI 10.1128/MCB.21.22.7653-7662.2001; Hanahan D, 2007, GENE DEV, V21, P2258, DOI 10.1101/gad.1583307; Hedvat CV, 2002, HUM PATHOL, V33, P968, DOI 10.1053/hupa.2002.127438; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; Henderson A, 2011, P NATL ACAD SCI USA, V108, P6415, DOI 10.1073/pnas.1008150108; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jenkins ZA, 2001, GENOMICS, V71, P101, DOI 10.1006/geno.2000.6418; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knudson AG, 2002, AM J MED GENET, V111, P96, DOI 10.1002/ajmg.10320; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kratz CP, 2001, GENOMICS, V77, P171, DOI 10.1006/geno.2001.6636; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; McCurrach ME, 2001, METHOD CELL BIOL, V66, P197; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; Parreiras-e-Silva LT, 2010, J CELL PHYSIOL, V225, P500, DOI 10.1002/jcp.22229; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rubio-Moscardo F, 2005, BLOOD, V105, P4445, DOI 10.1182/blood-2004-10-3907; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Salaverria I, 2007, J CLIN ONCOL, V25, P1216, DOI 10.1200/JCO.2006.08.4251; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Sun Z, 2010, J CELL PHYSIOL, V223, P798, DOI 10.1002/jcp.22100; Taylor P, 2009, J PROTEOME RES, V8, P1610, DOI 10.1021/pr800986c; Washburn Michael P., 2004, Briefings in Functional Genomics & Proteomics, V3, P280, DOI 10.1093/bfgp/3.3.280; Xue W, 2012, P NATL ACAD SCI USA, V109, P8212, DOI 10.1073/pnas.1206062109; Young KH, 2007, BLOOD, V110, P4396, DOI 10.1182/blood-2007-02-072082; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	42	102	103	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2012	487	7406					244	U131		10.1038/nature11126	http://dx.doi.org/10.1038/nature11126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22722845	Green Accepted			2022-12-28	WOS:000306278900042
J	Radley, DC; Schoen, C				Radley, David C.; Schoen, Cathy			Geographic Variation in Access to Care - The Relationship with Quality	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Radley, David C.] Inst Healthcare Improvement, Cambridge, MA USA; [Schoen, Cathy] Commonwealth Fund, New York, NY USA	Institute for Healthcare Improvement; Commonwealth Fund	Radley, DC (corresponding author), Inst Healthcare Improvement, Cambridge, MA USA.							Pauly MV, 2007, HEALTH AFFAIR, V26, P1304, DOI 10.1377/hlthaff.26.5.1304; Radley D, 2012, RISING CHALLENGE RES; Schoen C, 2011, HEALTH AFFAIR, V30, P1762, DOI 10.1377/hlthaff.2011.0335; Shih A, 2012, MEDSCAPE NEWS; Wennberg JE, 1999, DARTMOUTH ATLAS HLTH, P80	5	55	55	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 5	2012	367	1					3	6		10.1056/NEJMp1204516	http://dx.doi.org/10.1056/NEJMp1204516			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	968KJ	22693955				2022-12-28	WOS:000305979400015
J	Hittinger, CT				Hittinger, Chris Todd			Endless Rots Most Beautiful	SCIENCE			English	Editorial Material							LIGNIN BIOSYNTHESIS; TRANSPORTER GENES; EVOLUTION; RECRUITMENT; PEROXIDASE		Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Wisconsin Bioenergy Initiat, Genet Lab, Madison, WI 53706 USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Hittinger, CT (corresponding author), Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Wisconsin Bioenergy Initiat, Genet Lab, Madison, WI 53706 USA.	cthittinger@wisc.edu						Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Doyle WA, 1998, BIOCHEMISTRY-US, V37, P15097, DOI 10.1021/bi981633h; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Larrondo LF, 2005, BIOPHYS CHEM, V116, P167, DOI 10.1016/j.bpc.2005.03.006; Lin ZG, 2011, MOL BIOL EVOL, V28, P131, DOI 10.1093/molbev/msq184; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; Tien M, 1987, NATURE, V326, P520, DOI 10.1038/326520a0; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1	15	3	3	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1649	1650		10.1126/science.1224682	http://dx.doi.org/10.1126/science.1224682			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745411				2022-12-28	WOS:000305794500030
J	Shelach, G				Shelach, Gideon			On the Invention of Pottery	SCIENCE			English	Editorial Material							CAVE		Hebrew Univ Jerusalem, Dept E Asian Studies, IL-91905 Jerusalem, Israel	Hebrew University of Jerusalem	Shelach, G (corresponding author), Hebrew Univ Jerusalem, Dept E Asian Studies, IL-91905 Jerusalem, Israel.	msshe@huji.ac.il						Bar-Yosef O, 2011, CURR ANTHROPOL, V52, pS175, DOI 10.1086/659784; Boaretto E, 2009, P NATL ACAD SCI USA, V106, P9595, DOI 10.1073/pnas.0900539106; Elston RG, 2011, QUATERN INT, V242, P401, DOI 10.1016/j.quaint.2011.02.045; Hebeisheng, 2010, ACTA ARCHAEOL SIN, V3, P361; Kuzmin YV, 2006, ANTIQUITY, V80, P362, DOI 10.1017/S0003598X00093686; Liu L, 2010, J ARCHAEOL SCI, V37, P2630, DOI 10.1016/j.jas.2010.05.023; Madsen B. D., 2007, LATE QUATERNARY CLIM, P69; Stiner MC, 2001, P NATL ACAD SCI USA, V98, P6993, DOI 10.1073/pnas.121176198; Tang C., 2000, J E ASIAN ARCHAEOLOG, V2, P37, DOI [10.1163/156852300509781, DOI 10.1163/156852300509781]; Wu XH, 2012, SCIENCE, V336, P1696, DOI 10.1126/science.1218643; Zhang JF, 2011, J ARCHAEOL SCI, V38, P1537, DOI 10.1016/j.jas.2011.02.019	11	25	26	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1644	1645		10.1126/science.1224119	http://dx.doi.org/10.1126/science.1224119			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	965VD	22745407				2022-12-28	WOS:000305794500026
J	Handel, AE; Patel, SV; Pakpoor, J; Ebers, GC; Goldacre, B; Ramagopalan, SV				Handel, Adam E.; Patel, Sunil V.; Pakpoor, Julia; Ebers, George C.; Goldacre, Ben; Ramagopalan, Sreeram V.			High reprint orders in medical journals and pharmaceutical industry funding: case-control study	BRITISH MEDICAL JOURNAL			English	Article							COMPANIES	Objectives To assess the extent to which funding and study design are associated with high reprint orders. Design Case-control study. Setting Top articles by size of reprint orders in seven journals, 2002-09. Participants Lancet, Lancet Neurology, Lancet Oncology (Lancet Group), BMJ, Gut, Heart, and Journal of Neurology, Neurosurgery & Psychiatry (BMJ Group) matched to contemporaneous articles not in the list of high reprint orders. Main outcome measures Funding and design of randomised controlled trials or other study designs. Results Median reprint orders for the seven journals ranged from 3000 to 126 350. Papers with high reprint orders were more likely to be funded by the pharmaceutical industry than were control papers (industry funding versus other or none: odds ratio 8.64, 95% confidence interval 5.09 to 14.68, and mixed funding versus other or none: 3.72, 2.43 to 5.70). Conclusions Funding by the pharmaceutical industry is associated with high numbers of reprint orders.	[Patel, Sunil V.; Goldacre, Ben; Ramagopalan, Sreeram V.] London Sch Hyg & Trop Med, Dept Epidemiol, London WC1, England; [Handel, Adam E.; Pakpoor, Julia; Ebers, George C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Handel, Adam E.; Pakpoor, Julia; Ebers, George C.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci Clin Neurol, Oxford OX3 9DU, England; [Patel, Sunil V.] London Hlth Sci Ctr, Dept Surg, London, ON, Canada; [Ramagopalan, Sreeram V.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Ramagopalan, Sreeram V.] Univ Oxford, MRC, Funct Genom Unit, Oxford, England; [Ramagopalan, Sreeram V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; London Health Sciences Centre; University of Oxford; University of Oxford; University of London; Queen Mary University London	Ramagopalan, SV (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol, London WC1, England.	s.ramagopalan@qmul.ac.uk	Patel, Sunil/X-8559-2018	Goldacre, Ben/0000-0002-5127-4728; Handel, Adam/0000-0001-8385-6346; Ebers, George/0000-0003-4771-4177	National Institute for Health Research [ACF-2011-18-008] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Hopewell S, 2003, INT J TECHNOL ASSESS, V19, P711, DOI 10.1017/S0266462303000680; Jefferson T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b354; Smith R, 2005, PLOS MED, V2, P364, DOI 10.1371/journal.pmed.0020138.g001; Stryer D, 1996, J GEN INTERN MED, V11, P575, DOI 10.1007/BF02599024; Vinson D C, 1990, Fam Med, V22, P404	5	29	29	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 28	2012	344								e4212	10.1136/bmj.e4212	http://dx.doi.org/10.1136/bmj.e4212			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	968MY	22745328	hybrid, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000305987300001
J	Morita, A; Kirino, T; Hashi, K; Aoki, N; Fukuhara, S; Hashimoto, N; Nakayama, T; Sakai, M; Teramoto, A; Tominari, S; Yoshimoto, T				Morita, Akio; Kirino, Takaaki; Hashi, Kazuo; Aoki, Noriaki; Fukuhara, Shunichi; Hashimoto, Nobuo; Nakayama, Takeo; Sakai, Michi; Teramoto, Akira; Tominari, Shinjiro; Yoshimoto, Takashi		UCAS Japan Investigators	The Natural Course of Unruptured Cerebral Aneurysms in a Japanese Cohort	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRACRANIAL ANEURYSMS; RUPTURE; MANAGEMENT; SHAPE; RISK	BACKGROUND The natural history of unruptured cerebral aneurysms has not been clearly defined. METHODS From January 2001 through April 2004, we enrolled patients with newly identified, unruptured cerebral aneurysms in Japan. Information on the rupture of aneurysms, deaths, and the results of periodic follow-up examinations were recorded. We included 5720 patients 20 years of age or older (mean age, 62.5 years; 68% women) who had saccular aneurysms that were 3 mm or more in the largest dimension and who initially presented with no more than a slight disability. RESULTS Of the 6697 aneurysms studied, 91% were discovered incidentally. Most aneurysms were in the middle cerebral arteries (36%) and the internal carotid arteries (34%). The mean (+/- SD) size of the aneurysms was 5.7 +/- 3.6 mm. During a follow-up period that included 11,660 aneurysm-years, ruptures were documented in 111 patients, with an annual rate of rupture of 0.95% (95% confidence interval [CI], 0.79 to 1.15). The risk of rupture increased with increasing size of the aneurysm. With aneurysms that were 3 to 4 mm in size as the reference, the hazard ratios for size categories were as follows: 5 to 6 mm, 1.13 (95% CI, 0.58 to 2.22); 7 to 9 mm, 3.35 (95% CI, 1.87 to 6.00); 10 to 24 mm, 9.09 (95% CI, 5.25 to 15.74); and 25 mm or larger, 76.26 (95% CI, 32.76 to 177.54). As compared with aneurysms in the middle cerebral arteries, those in the posterior and anterior communicating arteries were more likely to rupture (hazard ratio, 1.90 [95% CI, 1.12 to 3.21] and 2.02 [95% CI, 1.13 to 3.58], respectively). Aneurysms with a daughter sac (an irregular protrusion of the wall of the aneurysm) were also more likely to rupture (hazard ratio, 1.63; 95% CI, 1.08 to 2.48). CONCLUSIONS This study showed that the natural course of unruptured cerebral aneurysms varies according to the size, location, and shape of the aneurysm. (Funded by the Ministry of Health, Labor, and Welfare in Japan and others; UCAS Japan UMIN-CTR number, C000000418.)	[Morita, Akio] Univ Tokyo, Fac Med, UCAS Japan Coordinating Off, Dept Neurosurg,Bunkyo Ku, Tokyo 1138655, Japan; [Morita, Akio] NTT Med Ctr Tokyo, Dept Neurosurg, Tokyo, Japan; [Kirino, Takaaki] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Hashi, Kazuo] Pacific Neurosurg Consulting, Sapporo, Hokkaido, Japan; [Aoki, Noriaki] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA; [Aoki, Noriaki] Outcomes Res & Dev Japan CHORD J, Ctr Hlth Serv, Tokyo, Japan; [Fukuhara, Shunichi] Kyoto Univ, Sch Med & Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan; [Hashimoto, Nobuo] Natl Cerebral & Cardiovasc Ctr, Osaka, Japan; [Nakayama, Takeo; Tominari, Shinjiro] Kyoto Univ, Sch Publ Hlth, Dept Hlth Informat, Kyoto, Japan; [Sakai, Michi] CHORD J, Tokyo, Japan; [Teramoto, Akira] Nippon Med Sch, Dept Neurosurg, Tokyo 113, Japan; [Teramoto, Akira] Japan Neurosurg Soc, Tokyo, Japan; [Yoshimoto, Takashi] Natl Ctr Univ Entrance Examinat, Tokyo, Japan	University of Tokyo; Kanto Medical Center NTT EC; National Center for Global Health & Medicine - Japan; University of Texas System; University of Texas Health Science Center Houston; Kyoto University; National Cerebral & Cardiovascular Center - Japan; Kyoto University; Nippon Medical School	Morita, A (corresponding author), Univ Tokyo, Fac Med, UCAS Japan Coordinating Off, Dept Neurosurg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ucasj-head@umin.ac.jp	Nakahara, Ichiro/G-3259-2010; Fujioka, Hiroyuki/E-7041-2013; NAKAYAMA, Takeo/HCH-0537-2022	Nakahara, Ichiro/0000-0001-8909-2949; Fujioka, Hiroyuki/0000-0001-8653-3761; Nakayama, Takeo/0000-0002-7918-6252; Morita, Akio/0000-0002-2497-5772	Ministry of Health, Labor and Welfare in Japan; National Cerebral and Cardiovascular Center in Japan; Japan Brain Foundation; UCAS Japan UMIN-CTR [C000000418]	Ministry of Health, Labor and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); National Cerebral and Cardiovascular Center in Japan; Japan Brain Foundation; UCAS Japan UMIN-CTR	Funded by the Ministry of Health, Labor, and Welfare in Japan and others; UCAS Japan UMIN-CTR number, C000000418.); Supported by grants from the Ministry of Health, Labor and Welfare in Japan, the National Cerebral and Cardiovascular Center in Japan, and the Japan Brain Foundation.	Bederson JB, 2000, STROKE, V31, P2742, DOI 10.1161/01.STR.31.11.2742; Huang MC, 2011, STROKE, V42, P1730, DOI 10.1161/STROKEAHA.110.603803; Ishibashi T, 2009, STROKE, V40, P313, DOI 10.1161/STROKEAHA.108.521674; Juvela S, 2008, J NEUROSURG, V108, P1052, DOI 10.3171/JNS/2008/108/5/1052; Morita A, 2005, J NEUROSURG, V102, P601, DOI 10.3171/jns.2005.102.4.0601; NAKAGAWA T, 1994, J NEUROSURG, V80, P217, DOI 10.3171/jns.1994.80.2.0217; Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355; Sonobe M, 2010, STROKE, V41, P1969, DOI 10.1161/STROKEAHA.110.585059; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Weir B, 2002, J NEUROSURG, V96, P3, DOI 10.3171/jns.2002.96.1.0003; Wermer MJH, 2007, STROKE, V38, P1404, DOI 10.1161/01.STR.0000260955.51401.cd; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Wiebers D, 1999, NEW ENGL J MED, V340, P744; Wiebers D, 1998, NEW ENGL J MED, V339, P1725, DOI 10.1056/nejm199812103392401; Yasui N, 1997, NEUROSURGERY, V40, P1155, DOI 10.1097/00006123-199706000-00007	17	846	904	4	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2474	2482		10.1056/nejmoa1113260	http://dx.doi.org/10.1056/nejmoa1113260			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965DP	22738097				2022-12-28	WOS:000305747000007
J	Zisoulis, DG; Kai, ZS; Chang, RK; Pasquinelli, AE				Zisoulis, Dimitrios G.; Kai, Zoya S.; Chang, Roger K.; Pasquinelli, Amy E.			Autoregulation of microRNA biogenesis by let-7 and Argonaute	NATURE			English	Article							CAENORHABDITIS-ELEGANS; C. ELEGANS; SMALL RNAS; LIN-28; EXPRESSION; MATURATION; SITES; BINDS; LIN28; DECAY	MicroRNAs (miRNAs) comprise a large family of small RNA molecules that post-transcriptionally regulate gene expression in many biological pathways(1). Most miRNAs are derived from long primary transcripts that undergo processing by Drosha to produce similar to 65-nucleotide precursors that are then cleaved by Dicer, resulting in the mature 22-nucleotide forms(2,3). Serving as guides in Argonaute protein complexes, mature miRNAs use imperfect base pairing to recognize sequences in messenger RNA transcripts, leading to translational repression and destabilization of the target messenger RNAs4,5. Here we show that the miRNA complex also targets and regulates non-coding RNAs that serve as substrates for the miRNA-processing pathway. We found that the Argonaute protein in Caenorhabditis elegans, ALG-1, binds to a specific site at the 3' end of let-7 miRNA primary transcripts and promotes downstream processing events. This interaction is mediated by mature let-7 miRNA through a conserved complementary site in its own primary transcript, thus creating a positive-feedback loop. We further show that ALG-1 associates with let-7 primary transcripts in nuclear fractions. Argonaute also binds let-7 primary transcripts in human cells, demonstrating that the miRNA pathway targets non-coding RNAs in addition to protein-coding messenger RNAs across species. Moreover, our studies in C. elegans reveal a novel role for Argonaute in promoting biogenesis of a targeted transcript, expanding the functions of the miRNA pathway in gene regulation. This discovery of autoregulation of let-7 biogenesis establishes a new mechanism for controlling miRNA expression.	[Zisoulis, Dimitrios G.; Kai, Zoya S.; Chang, Roger K.; Pasquinelli, Amy E.] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; [Chang, Roger K.] Stockholm Univ, Dept Biol Educ, S-10691 Stockholm, Sweden	University of California System; University of California San Diego; Stockholm University	Pasquinelli, AE (corresponding author), Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA.	apasquinelli@ucsd.edu		Chang, Roger/0000-0001-8085-9285	Leukemia & Lymphoma Society [3611-11]; US National Institutes of Health (NIH) CMG; NIH/NCI [T32 CA009523]; Swedish Board of Study Support; NIH [GM071654]; Keck Foundation; Peter Gruber Foundation; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071654] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); US National Institutes of Health (NIH) CMG; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Board of Study Support; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Foundation(W.M. Keck Foundation); Peter Gruber Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Lykke-Andersen and members of the Pasquinelli lab for reading the manuscript, and we thank D. Hogan for discussions. We thank F. Slack for originally pointing out the let-7 complementary site in pri-let-7; the M. David lab for sharing their real-time PCR machine; P. Van Wynsberghe for the Delta alg-1 primary let-7 plasmid; C. Mello for the worm fractionation protocol; E. Moss for LIN-28 antibodies; and A. Gorin, H. Jenq and S. Verma for technical assistance. Funding was provided by a Leukemia & Lymphoma Society Special Fellow Award 3611-11 (D.G.Z.); US National Institutes of Health (NIH) CMG and NIH/NCI T32 CA009523 Training Grants (Z.S.K.); the Swedish Board of Study Support (R. K. C.); and NIH grant GM071654, the Keck Foundation and the Peter Gruber Foundation (A.E.P.).	Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Bussing I, 2010, EMBO J, V29, P1830, DOI 10.1038/emboj.2010.82; Castanotto D, 2009, P NATL ACAD SCI USA, V106, P21655, DOI 10.1073/pnas.0912384106; Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Suh N, 2011, DEVELOPMENT, V138, P1653, DOI 10.1242/dev.056234; Tan GS, 2009, NUCLEIC ACIDS RES, V37, P7533, DOI 10.1093/nar/gkp812; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Van Wynsberghe PM, 2011, NAT STRUCT MOL BIOL, V18, P302, DOI 10.1038/nsmb.1986; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	29	164	173	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					541	U140		10.1038/nature11134	http://dx.doi.org/10.1038/nature11134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722835	Green Accepted			2022-12-28	WOS:000305760600045
J	Reed, RV; Fazel, M; Goldring, L				Reed, Ruth V.; Fazel, Mina; Goldring, Lorna			Post-traumatic stress disorder	BRITISH MEDICAL JOURNAL			English	Editorial Material							NATIONAL COMORBIDITY SURVEY; MENTAL-HEALTH; PREVALENCE		[Reed, Ruth V.] Oxford Hlth NHS Fdn Trust, Warneford Hosp, Oxford OX3 7JX, England; [Fazel, Mina] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [Goldring, Lorna] Portobello Surg, Edinburgh EH15 2AW, Midlothian, Scotland	University of Oxford	Reed, RV (corresponding author), Oxford Hlth NHS Fdn Trust, Warneford Hosp, Oxford OX3 7JX, England.	ruth.reed@psych.ox.ac.uk		Fazel, Mina/0000-0001-9342-2365				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Brewin CR, 2008, J TRAUMA STRESS, V21, P3, DOI 10.1002/jts.20310; Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158, DOI 10.1192/bjp.181.2.158; Brugha T, 2009, ADULT PSYCHIAT MORBI; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; Ehlers A, 2009, LOND J PRIMARY CARE, P36; Fazel M, 2005, LANCET, V365, P1309, DOI 10.1016/S0140-6736(05)61027-6; Forbes D, 2010, J TRAUMA STRESS, V23, P537, DOI 10.1002/jts.20565; Ford T, 2003, J AM ACAD CHILD PSY, V42, P1203, DOI 10.1097/00004583-200310000-00011; Gradus JL, 2010, AM J EPIDEMIOL, V171, P721, DOI 10.1093/aje/kwp456; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2010, CURR TOP BEHAV NEURO, V2, P21, DOI 10.1007/7854_2009_9; Leen-Feldner EW, 2011, J ANXIETY DISORD, V25, P169, DOI 10.1016/j.janxdis.2010.08.017; National Institute for Health and Clinical Excellence, 2005, MAN PTSD AD CHILDR P; Scheeringa MS, 2011, DEPRESS ANXIETY, V28, P770, DOI 10.1002/da.20736; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Wittchen HU, 1998, PSYCHOL MED, V28, P109, DOI 10.1017/S0033291797005928; World Health Organization, 1992, ICD 10 INT STAT CLAS	18	4	4	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 25	2012	344								e3790	10.1136/bmj.e3790	http://dx.doi.org/10.1136/bmj.e3790			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	968MS	22734075				2022-12-28	WOS:000305986500001
J	Wolinetz, CD				Wolinetz, Carrie D.			Implementing the New US Dual-Use Policy	SCIENCE			English	Editorial Material							SCIENCE	After a decade of intensive policy discussions on the topic of dual-use research of concern (DURC) in the life sciences, there has been a lack of consensus on how to practically define DURC; whether it is feasible to identify and regulate DURC experiments; how to address the risks associated with DURC; and how to balance this risk with the necessity of fostering life sciences research for public health and biodefense. The publication of two avian influenza studies has brought the DURC issue back into sharp focus and has resulted in a new set of federal guidelines. However, the new DURC policy raises questions regarding whether this is the best policy solution to a complicated biosecurity concern.	Assoc Amer Univ, Washington, DC 20005 USA	American University	Wolinetz, CD (corresponding author), Assoc Amer Univ, 1200 New York Ave NW, Washington, DC 20005 USA.	carrie_wolinetz@aau.edu						[Anonymous], 2011, FED REG FR, V76FR, P61206; [Anonymous], 2012, SCIENTIST       0401; Bouvier NM, 2012, J INFECT DIS, V205, P1632, DOI 10.1093/infdis/jis256; Center for Arms Control and Non-Proliferation, 2009, ENS COMPL BIOL WEAP; Cohen J., 2012, NSABB MEMBERS REACT; Cohen J, 2012, SCIENCE, V335, P899, DOI 10.1126/science.335.6071.899; Committee on a New Government-University Partnership for Science and Security National Research Council, 2007, SCI SEC POST 9 11 WO; Committee on Assessing Fundamental Attitudes of Life Scientists as a Basis for Biosecurity Education National Research Council, 2007, SURV ATT ACT DUAL US; Epstein GL, 2012, BIOSECUR BIOTERROR, V10, P17, DOI 10.1089/bsp.2011.0091; Federal Experts Security Advisory Panel, 2010, REC SEL AG PROGR; Federation of American Scientists, CAS STUD DUAL US BIO; *NAT SCI ADV BOARD, 2012, FIND REC; NSABB, 2012, DURC ED MOD; NSABB (National Science Advisory Board for Biosecurity), 2007, RESP COMM LIF SCI RE; Shea Dana, 2007, OVERSIGHT DUAL USE B; Smith TL, 2011, ISSUES SCI TECHNOL, V27, P57; United States Government Policy for Oversight of Life Sciences Dual Use Research of Concern, 2012, UNITED STATES GOVT P	17	15	15	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1525	1527		10.1126/science.1223995	http://dx.doi.org/10.1126/science.1223995			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	961ZE	22723409				2022-12-28	WOS:000305507500043
J	Campbell, D				Campbell, Denis			Will London's Olympic public health legacy turn to dust?	BRITISH MEDICAL JOURNAL			English	Editorial Material												denis.campbell@guardian.co.uk						Centre for Sport Physical Education and Activity Research, 2009, SYST REV EV BAS DEV; Coalter F, 2004, GOLDRUSH SUSTAINABLE; Department for Culture Media and Sport, 2008, MAK MOST LOND 2012 G; Department for Education, PE SPORT SURV 2009 1; House of Commons Select Committee on Culture Media and Sport, 2007, LOND 2012 OL GAM PAR; London East Research Institute at the University of East London, 2007, LAST LEG LOND ASS LE; Pappous A., 2011, SUSTAINABILITY SPORT; Vasagar J, 2012, GUARDIAN        0208; Women's Sport and Fitness Foundation, 2012, CHANG GAM GIRLS	9	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 21	2012	344								e4207	10.1136/bmj.e4207	http://dx.doi.org/10.1136/bmj.e4207			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965CH	22723606				2022-12-28	WOS:000305743200019
J	Watts, G				Watts, Geoff			David Nathan: putting diabetes on trial Profile	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 16	2012	379	9833					2233	2233		10.1016/S0140-6736(12)60967-2	http://dx.doi.org/10.1016/S0140-6736(12)60967-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962AM	22704158				2022-12-28	WOS:000305511400015
J	Pike, AWG; Hoffmann, DL; Garcia-Diez, M; Pettitt, PB; Alcolea, J; De Balbin, R; Gonzalez-Sainz, C; de las Heras, C; Lasheras, JA; Montes, R; Zilhao, J				Pike, A. W. G.; Hoffmann, D. L.; Garcia-Diez, M.; Pettitt, P. B.; Alcolea, J.; De Balbin, R.; Gonzalez-Sainz, C.; de las Heras, C.; Lasheras, J. A.; Montes, R.; Zilhao, J.			U-Series Dating of Paleolithic Art in 11 Caves in Spain	SCIENCE			English	Article							ISOTOPE MEASUREMENTS; MODERNITY; EMERGENCE; AGE	Paleolithic cave art is an exceptional archive of early human symbolic behavior, but because obtaining reliable dates has been difficult, its chronology is still poorly understood after more than a century of study. We present uranium-series disequilibrium dates of calcite deposits overlying or underlying art found in 11 caves, including the United Nations Educational, Scientific, and Cultural Organization (UNESCO) World Heritage sites of Altamira, El Castillo, and Tito Bustillo, Spain. The results demonstrate that the tradition of decorating caves extends back at least to the Early Aurignacian period, with minimum ages of 40.8 thousand years for a red disk, 37.3 thousand years for a hand stencil, and 35.6 thousand years for a claviform-like symbol. These minimum ages reveal either that cave art was a part of the cultural repertoire of the first anatomically modern humans in Europe or that perhaps Neandertals also engaged in painting caves.	[Pike, A. W. G.] Univ Bristol, Dept Archaeol & Anthropol, Bristol BS8 1UU, Avon, England; [Hoffmann, D. L.] Univ Bristol, Bristol Isotope Grp, Sch Geograph Sci, Bristol BS8 1SS, Avon, England; [Hoffmann, D. L.] Ctr Nacl Invest Evoluc Humana CENIEH, Burgos 09002, Spain; [Garcia-Diez, M.] Univ Basque Country UPV EHU, Dept Geog Prehist & Archaeol, Vitoria 01006, Spain; [Pettitt, P. B.] Univ Sheffield, Dept Archaeol, Sheffield S1 4ET, S Yorkshire, England; [Alcolea, J.; De Balbin, R.] Univ Alcala de Henares, Prehist Sect, Madrid 28801, Spain; [Gonzalez-Sainz, C.] Univ Cantabria, Dept Hist Sci, E-39005 Santander, Spain; [de las Heras, C.; Lasheras, J. A.; Montes, R.] Museo Nacl & Ctr Invest Altamira, Santillana Del Mar 39330, Cantabria, Spain; [Zilhao, J.] Univ Barcelona, ICREA, Dept Prehist Hist Antiga & Arqueol SERP, Barcelona 08001, Spain	University of Bristol; University of Bristol; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of Basque Country; University of Sheffield; Universidad de Alcala; Universidad de Cantabria; ICREA; University of Barcelona	Pike, AWG (corresponding author), Univ Bristol, Dept Archaeol & Anthropol, 43 Woodland Rd, Bristol BS8 1UU, Avon, England.	pike@bristol.ac.uk	Pettitt, Paul/R-3539-2019; Diez, Marcos García/L-4494-2014; Zilhão, João/L-5670-2014; Sainz, César González/AAB-2136-2019; Alcolea, Javier/N-4275-2015	Zilhão, João/0000-0001-5937-3061; Garcia-Diez, Marcos/0000-0001-7923-5280; Hoffmann, Dirk/0000-0002-9245-2041; Alcolea, Javier/0000-0003-1968-0117; Garcia Diez, Marcos/0000-0002-4135-5145; Pike, Alistair/0000-0002-5610-8948	Natural Environmental Research Council [NE/F000510/1]; ICREA Funding Source: Custom; NERC [NE/F000510/1] Funding Source: UKRI; Natural Environment Research Council [NE/F000510/1] Funding Source: researchfish	Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ICREA(ICREA); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by a grant to A.W.G.P. from the Natural Environmental Research Council (NE/F000510/1). C. Taylor performed the sample preparation and assisted in collecting samples in the field along with C. Hinds, S. White, and S. Paine. We thank the governments of Asturias and Cantabria for granting permission to sample the cave art and B. Hanson for editorial guidance. The data described are presented in the supplementary materials.	Bahn P., 2009, ENQUIRING MIND STUDI, P239; Beltran A., 1999, CAVE ALTAMITA; Breuil H., 1952, QUATRE CENTS SIECLES; Breuil H., 1935, CAVE ALTAMIRA SANTIL; Broglio A., 2006, INT NEWSLETTER ROCK, V44, P1; CLOTTES J, 2003, RETURN CHAUVET CAVE; Clottes J., 2006, CAVE BENEATH SEA PAL; Conard NJ, 2010, P NATL ACAD SCI USA, V107, P7621, DOI 10.1073/pnas.1001458107; de Balbin R., 2003, ARTE PREHISTORICO IN; de Quiros F. Bernaldo, 1991, P PREHIST SOC, V57, P81; Delluc B., 1991, ART PARIETAL ARCHA S; Djindjian F., 2004, ART MOBILIER PALEOLI, P249; Fairchild IJ, 2007, GEOCHEMICAL SEDIMENT, P200, DOI [10.1002/9780470712917, DOI 10.1002/9780470712917]; Fortea F.J., 2002, B SOC PREHISTORIQUE, VLVII, P7; Fortea J., 2005, PITTURE PALEOLITICHE, P89; Gonzalez-Sainz C., 2003, ARTE PALEOLITICO REG; Hoffmann DL, 2008, INT J MASS SPECTROM, V275, P75, DOI 10.1016/j.ijms.2008.05.033; Hoffmann DL, 2007, INT J MASS SPECTROM, V264, P97, DOI 10.1016/j.ijms.2007.03.020; Leroi-Gourhan A., 1995, PREHISTOIRE ART OCCI, V1; Lorblanchet M., 1995, GROTTES ORNEES PREHI; Maroto J, 2012, QUATERN INT, V247, P15, DOI 10.1016/j.quaint.2011.07.007; Martin C. Heras, 2008, CUADERNOS ARTE RUPES, V4, P117; Mujika J., 2011, INT NEWSL ROCK ART, V60, P13; Pettitt P, 2007, J ARCHAEOL METHOD TH, V14, P27, DOI 10.1007/s10816-007-9026-4; Pike AWG, 2005, J ARCHAEOL SCI, V32, P1649, DOI 10.1016/j.jas.2005.05.002; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Renard C, 2011, WORLD ARCHAEOL, V43, P726, DOI 10.1080/00438243.2011.624789; Sinclair A, 2003, NATURE, V426, P774, DOI 10.1038/426774a; Straus LG, 2005, EVOL ANTHROPOL, V14, P145, DOI 10.1002/evan.20067; Zilhao J., 2006, PYRENAE, V37, P7, DOI DOI 10.1039/C4CC09587A; Zilhao J., 1999, FACI S LEPTOLITHIQUE, P165; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1; Zilhao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008880	33	261	265	9	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2012	336	6087					1409	1413		10.1126/science.1219957	http://dx.doi.org/10.1126/science.1219957			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	958BT	22700921				2022-12-28	WOS:000305211700036
J	McPherson, T				McPherson, Tess			PERSONAL VIEW My mum wanted assisted dying but we watched her die slowly and in pain	BRITISH MEDICAL JOURNAL			English	Editorial Material									Churchill Hosp, Oxford OX3 7LJ, England	University of Oxford	McPherson, T (corresponding author), Churchill Hosp, Oxford OX3 7LJ, England.	tess.mcpherson@msd.ox.ac.uk						McPherson A, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2827; Warlow C, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3424	2	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 14	2012	344								e4007	10.1136/bmj.e4007	http://dx.doi.org/10.1136/bmj.e4007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961LA	22695305				2022-12-28	WOS:000305464700009
J	Hadas, R				Hadas, Rachel			The art of medicine Nothing's mortal enemy	LANCET			English	Editorial Material												rhadas@andromeda.rutgers.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 9	2012	379	9832					2142	2143		10.1016/S0140-6736(12)60933-7	http://dx.doi.org/10.1016/S0140-6736(12)60933-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	955BA	22690396	Bronze			2022-12-28	WOS:000304990900018
J	Sokol, DK				Sokol, Daniel K.			How to be a cool headed clinician	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel K.] Univ London Imperial Coll Sci Technol & Med, London, England; [Sokol, Daniel K.] Inner Temple, London, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	daniel.sokol@talk21.com						Clark T, 2011, NERVE, P121; Clark T, 2011, NERVE, P112; Smajdor A, 2011, J MED ETHICS, V37, P380, DOI 10.1136/jme.2010.039628; Sokol D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6073	4	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 8	2012	344								e3980	10.1136/bmj.e3980	http://dx.doi.org/10.1136/bmj.e3980			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	957TI	22685176				2022-12-28	WOS:000305185400004
J	Emanuel, EJ				Emanuel, Ezekiel J.			Why Accountable Care Organizations Are Not 1990s Managed Care Redux	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIGH-DOSE CHEMOTHERAPY; BREAST-CANCER		[Emanuel, Ezekiel J.] Univ Penn, Off Provost, Perelman Sch Med, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Off Provost, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Emanuel, EJ (corresponding author), Univ Penn, Off Provost, Perelman Sch Med, 1 Coll Hall,Room 122, Philadelphia, PA 19104 USA.	vp-global@upenn.edu						Blendon RJ, 1998, HEALTH AFFAIR, V17, P80, DOI 10.1377/hlthaff.17.4.80; Blue Shield of California, ACC CAR ORG FACT SHE; Centers for Medicaid and Medicare Services, NAT HLTH EXP TABL 1; Centers for Medicare & Medicaid Services, 2011, FED REG, V76, P67819; Chandra A, 2010, AM ECON REV, V100, P193, DOI 10.1257/aer.100.1.193; Mello MM, 2001, HEALTH AFFAIR, V20, P101, DOI 10.1377/hlthaff.20.5.101; Milstein A, 2009, HEALTH AFFAIR, V28, P1317, DOI 10.1377/hlthaff.28.5.1317; Robinson JC, 1996, JAMA-J AM MED ASSOC, V276, P1060, DOI 10.1001/jama.276.13.1060; Stadtmauer EA, 2000, NEW ENGL J MED, V342, P1069, DOI 10.1056/NEJM200004133421501	9	24	25	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2012	307	21					2263	2264		10.1001/jama.2012.4313	http://dx.doi.org/10.1001/jama.2012.4313			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	952OL	22706831				2022-12-28	WOS:000304801700018
J	Mohr, DC; Ho, J; Duffecy, J; Reifler, D; Sokol, L; Burns, MN; Jin, L; Siddique, J				Mohr, David C.; Ho, Joyce; Duffecy, Jenna; Reifler, Douglas; Sokol, Leslie; Burns, Michelle Nicole; Jin, Ling; Siddique, Juned			Effect of Telephone-Administered vs Face-to-face Cognitive Behavioral Therapy on Adherence to Therapy and Depression Outcomes Among Primary Care Patients A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NON-INFERIORITY TRIAL; PSYCHOLOGICAL TREATMENTS; DOUBLE-BLIND; PSYCHOTHERAPY; DISORDER; METAANALYSIS; DULOXETINE; INTERVIEW; SYMPTOMS; BARRIERS	Context Primary care is the most common site for the treatment of depression. Most depressed patients prefer psychotherapy over antidepressant medications, but access barriers are believed to prevent engagement in and completion of treatment. The telephone has been investigated as a treatment delivery medium to overcome access barriers, but little is known about its efficacy compared with face-to-face treatment delivery. Objective To examine whether telephone-administered cognitive behavioral therapy (T-CBT) reduces attrition and is not inferior to face-to-face CBT in treating depression among primary care patients. Design, Setting, and Participants A randomized controlled trial of 325 Chicago-area primary care patients with major depressive disorder, recruited from November 2007 to December 2010. Interventions Eighteen sessions of T-CBT or face-to-face CBT. Main Outcome Measures The primary outcome was attrition (completion vs non-completion) at posttreatment (week 18). Secondary outcomes included masked interviewer-rated depression with the Hamilton Depression Rating Scale (Ham-D) and self-reported depression with the Patient Health Questionnaire-9 (PHQ-9). Results Significantly fewer participants discontinued T-CBT (n=34; 20.9%) compared with face-to-face CBT (n=53; 32.7%; P=.02). Patients showed significant improvement in depression across both treatments (P<.001). There were no significant treatment differences at posttreatment between T-CBT and face-to-face CBT on the Ham-D (P=.22) or the PHQ-9(P=.89). The intention-to-treat posttreatment effect size on the Ham-D was d=0.14 (90% CI,-0.05 to 0.33), and for the PHQ-9 it was d=-0.02 (90% CI, -0.20 to 0.17). Both results were within the inferiority margin of d=0.41, indicating that T-CBT was not inferior to face-to-face CBT. Although participants remained significantly less depressed at 6-month follow-up relative to baseline (P<.001), participants receiving face-to-face CBT were significantly less depressed than those receiving T-CBT on the Ham-D(difference, 2.91; 95% CI, 1.20-4.63; P<.001) and the PHQ-9(difference, 2.12;95% CI, 0.68-3.56; P=.004). Conclusions Among primary care patients with depression, providing CBT over the telephone compared with face-to-face resulted in lower attrition and close to equivalent improvement in depression at posttreatment. At 6-month follow-up, patients remained less depressed relative to baseline; however, those receiving face-to-face CBT were less depressed than those receiving T-CBT. These results indicate that T-CBT improves adherence compared with face-to-face delivery, but at the cost of some increased risk of poorer maintenance of gains after treatment cessation.	[Mohr, David C.; Ho, Joyce; Duffecy, Jenna; Burns, Michelle Nicole; Jin, Ling; Siddique, Juned] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Reifler, Douglas] Northwestern Univ, Dept Med, Div Gen Internal Med, Evanston, IL 60208 USA; [Sokol, Leslie] Beck Inst Cognit Therapy, Bala Cynwyd, PA USA	Northwestern University; Feinberg School of Medicine; Northwestern University	Mohr, DC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lakeshore Dr,Ste 1400, Chicago, IL 60611 USA.	d-mohr@northwestern.edu	Duffecy, Jennifer/GLQ-8985-2022; Ho, Joyce/F-8664-2019	Ho, Joyce/0000-0003-4191-0054; Mohr, David/0000-0002-5443-7596; Burns, Michelle/0000-0002-4002-7836	 [NIMH R01-MH059708]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059708] Funding Source: NIH RePORTER	; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by research grant NIMH R01-MH059708 to Dr Mohr.	[Anonymous], 2006, ACSMS GUID EX TEST P, P4; Beck J.S., 2011, COGNITIVE BEHAV THER, V(2nd); Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330; Cuijpers P, 2010, PSYCHOL MED, V40, P211, DOI 10.1017/S0033291709006114; Cuijpers P, 2010, BRIT J PSYCHIAT, V196, P173, DOI 10.1192/bjp.bp.109.066001; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; DESMOND DW, 1994, INT J GERIATR PSYCH, V9, P803, DOI 10.1002/gps.930091006; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Dwight-Johnson M, 2000, J GEN INTERN MED, V15, P527, DOI 10.1046/j.1525-1497.2000.08035.x; Foundation M., 2021, MACARTHUR IN DEPR PR; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hardin JW, 2012, GEN ESTIMATING EQUAT; Herrman H, 2002, PSYCHOL MED, V32, P889, DOI 10.1017/S003329170200586X; Himelhoch S, 2011, PSYCHOL HEALTH MED, V16, P156, DOI 10.1080/13548506.2010.534641; Jaycox Lisa H, 2003, Ment Health Serv Res, V5, P109, DOI 10.1023/A:1023233612022; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee P, 2007, PSYCHIAT CLIN NEUROS, V61, P295, DOI 10.1111/j.1440-1819.2007.01666.x; Mohr DC, 2008, CLIN PSYCHOL-SCI PR, V15, P243, DOI 10.1111/j.1468-2850.2008.00134.x; Mohr DC, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1602; Mohr DC, 2010, ANN BEHAV MED, V40, P89, DOI 10.1007/s12160-010-9203-7; Mohr DC, 2010, J CLIN PSYCHOL, V66, P394, DOI 10.1002/jclp.20659; Mohr DC, 2006, ANN BEHAV MED, V32, P254, DOI 10.1207/s15324796abm3203_12; Mohr DC, 2005, ARCH GEN PSYCHIAT, V62, P1007, DOI 10.1001/archpsyc.62.9.1007; Mohr DC, 2000, J CONSULT CLIN PSYCH, V68, P356, DOI 10.1037//0022-006X.68.2.356; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; Nutt D, 2008, J PSYCHOPHARMACOL, V22, P409, DOI 10.1177/0269881108091068; Perahia DGS, 2006, INT CLIN PSYCHOPHARM, V21, P285, DOI 10.1097/00004850-200609000-00007; *R FDN STAT COMP, 2009, R LANG ENV STAT COMP; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Szegedi A, 2005, BMJ-BRIT MED J, V330, P503, DOI 10.1136/bmj.38356.655266.82; VALLIS TM, 1986, J CONSULT CLIN PSYCH, V54, P381, DOI 10.1037/0022-006X.54.3.381; van Buuren S, 2011, J STAT SOFTW, V45, P1; Walther J.B., 2002, HDB INTERPERSONAL CO, V3, P529; WIERZBICKI M, 1993, PROF PSYCHOL-RES PR, V24, P190, DOI 10.1037/0735-7028.24.2.190	40	216	219	1	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2012	307	21					2278	2285		10.1001/jama.2012.5588	http://dx.doi.org/10.1001/jama.2012.5588			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	952OL	22706833	Green Accepted			2022-12-28	WOS:000304801700022
J	Carvunis, AR; Rolland, T; Wapinski, I; Calderwood, MA; Yildirim, MA; Simonis, N; Charloteaux, B; Hidalgo, CA; Barbette, J; Santhanam, B; Brar, GA; Weissman, JS; Regev, A; Thierry-Mieg, N; Cusick, ME; Vidal, M				Carvunis, Anne-Ruxandra; Rolland, Thomas; Wapinski, Ilan; Calderwood, Michael A.; Yildirim, Muhammed A.; Simonis, Nicolas; Charloteaux, Benoit; Hidalgo, Cesar A.; Barbette, Justin; Santhanam, Balaji; Brar, Gloria A.; Weissman, Jonathan S.; Regev, Aviv; Thierry-Mieg, Nicolas; Cusick, Michael E.; Vidal, Marc			Proto-genes and de novo gene birth	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST GENOME; EVOLUTION; ADAPTATION; SELECTION; PROTEINS; SEQUENCE; ORIGIN; DNA	Novel protein-coding genes can arise either through re-organization of pre-existing genes or de novo(1,2). Processes involving re-organization of pre-existing genes, notably after gene duplication, have been extensively described(1,2). In contrast, de novo gene birth remains poorly understood, mainly because translation of sequences devoid of genes, or 'non-genic' sequences, is expected to produce insignificant polypeptides rather than proteins with specific biological functions(1,3-6). Here we formalize an evolutionary model according to which functional genes evolve de novo through transitory proto-genes(4) generated by widespread translational activity in non-genic sequences. Testing this model at the genome scale in Saccharomyces cerevisiae, we detect translation of hundreds of short species-specific open reading frames (ORFs) located in non-genic sequences. These translation events seem to provide adaptive potential(7), as suggested by their differential regulation upon stress and by signatures of retention by natural selection. In line with our model, we establish that S. cerevisiae ORFs can be placed within an evolutionary continuum ranging from non-genic sequences to genes. We identify similar to 1,900 candidate proto-genes among S. cerevisiae ORFs and find that de novo gene birth from such a reservoir may be more prevalent than sporadic gene duplication. Our work illustrates that evolution exploits seemingly dispensable sequences to generate adaptive functional innovation.	[Carvunis, Anne-Ruxandra; Rolland, Thomas; Calderwood, Michael A.; Simonis, Nicolas; Charloteaux, Benoit; Barbette, Justin; Santhanam, Balaji; Cusick, Michael E.; Vidal, Marc] Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA; [Carvunis, Anne-Ruxandra; Rolland, Thomas; Calderwood, Michael A.; Simonis, Nicolas; Charloteaux, Benoit; Barbette, Justin; Santhanam, Balaji; Cusick, Michael E.; Vidal, Marc] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Carvunis, Anne-Ruxandra; Rolland, Thomas; Calderwood, Michael A.; Simonis, Nicolas; Charloteaux, Benoit; Barbette, Justin; Santhanam, Balaji; Cusick, Michael E.; Vidal, Marc] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Carvunis, Anne-Ruxandra; Thierry-Mieg, Nicolas] UJF Grenoble 1, CNRS, TIMC IMAG, UMR 5525,Computat & Math Biol Grp, F-38031 Grenoble, France; [Wapinski, Ilan] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Yildirim, Muhammed A.] Harvard Univ, Cambridge, MA 02138 USA; [Yildirim, Muhammed A.] Ctr Int Dev, Cambridge, MA 02138 USA; [Charloteaux, Benoit] Univ Liege, GIGA R, Unit Anim Genom, B-4000 Liege, Wallonia Brusse, Belgium; [Hidalgo, Cesar A.] MIT, MIT Media Lab, Cambridge, MA 02142 USA; [Brar, Gloria A.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cell & Mol Pharmacol, San Francisco, CA 94158 USA; [Brar, Gloria A.; Weissman, Jonathan S.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Charloteaux, Benoit] Univ Liege, Fac Vet Med, B-4000 Liege, Belgium	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Harvard University; Harvard Medical School; Harvard University; University of Liege; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Liege	Vidal, M (corresponding author), Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA.	marc_vidal@dfci.harvard.edu	Yildirim, Muhammed/J-3695-2014; Calderwood, Mike/B-2475-2014; Thierry-Mieg, Nicolas/M-6007-2014; Hidalgo, Cesar A./B-5155-2009	Yildirim, Muhammed/0000-0003-2826-1766; Calderwood, Mike/0000-0001-6475-1418; Thierry-Mieg, Nicolas/0000-0002-7667-2853; Hidalgo, Cesar A./0000-0002-6977-9492; Carvunis, Anne-Ruxandra/0000-0002-6474-6413; /0000-0002-6031-5982; Rolland, Thomas/0000-0001-6468-8391; Weissman, Jonathan/0000-0003-2445-670X	National Institute of Health; Scientific Interface from the Burroughs Wellcome Fund; Howard Hughes Medical Institute (HHMI); American Cancer Society [117945-PF-09-136-01-RMC]; National Human Genome Research Institute [R01-HG006061]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006061] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scientific Interface from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); American Cancer Society(American Cancer Society); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank L. Duret, E. Levy, J. Vandenhaute, Q. Li, H. Yu, P. Braun, M. Dreze, C. Foo, M. Mann, N. Kulak, J. Cox, C. Maire and S. Jhavery-Schneider as well as members of the Center for Cancer Systems Biology (CCSB), in particular A. Dricot-Ziter, A. MacWilliams, F. Roth, Y. Jacob and D. Hill for discussions and proofreading. A.R. was supported by a National Institute of Health Pioneer Award, a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and the Howard Hughes Medical Institute (HHMI). I.W. is a HHMI fellow of the Damon Runyon Cancer Research Institute. G.A.B. was supported by American Cancer Society Postdoctoral fellowship 117945-PF-09-136-01-RMC. M.V. is a Chercheur Qualifie Honoraire from the Fonds de la Recherche Scientifique (FRS-FNRS, Wallonia-Brussels Federation, Belgium). This work was supported by the grant R01-HG006061 from the National Human Genome Research Institute awarded to M.V.	Boyer J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r72; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Cai JJ, 2010, GENOME BIOL EVOL, V2, P393, DOI 10.1093/gbe/evq019; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Ekman D, 2010, J MOL BIOL, V396, P396, DOI 10.1016/j.jmb.2009.11.053; Fisk DG, 2006, YEAST, V23, P857, DOI 10.1002/yea.1400; Gao LZ, 2004, SCIENCE, V306, P1367, DOI 10.1126/science.1102033; Giacomelli MG, 2007, MOL BIOL EVOL, V24, P457, DOI 10.1093/molbev/msl172; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jansen R, 2000, NUCLEIC ACIDS RES, V28, P1481, DOI 10.1093/nar/28.6.1481; Jarosz DF, 2010, ANNU REV GENET, V44, P189, DOI 10.1146/annurev.genet.40.110405.090412; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Li QR, 2008, GENOME RES, V18, P1294, DOI 10.1101/gr.076661.108; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; Pal C, 2001, GENETICS, V158, P927; Prat Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-285; Siepel A, 2009, GENOME RES, V19, P1693, DOI 10.1101/gr.098376.109; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Vishnoi A, 2010, GENOME RES, V20, P1574, DOI 10.1101/gr.109595.110; Wilson BA, 2011, GENOME BIOL EVOL, V3, P1245, DOI 10.1093/gbe/evr099; Wolf YI, 2009, P NATL ACAD SCI USA, V106, P7273, DOI 10.1073/pnas.0901808106; Wu DD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002379; Yomtovian I, 2010, BIOINFORMATICS, V26, P996, DOI 10.1093/bioinformatics/btq093; Zheng DY, 2007, TRENDS GENET, V23, P219, DOI 10.1016/j.tig.2007.03.003	30	340	348	2	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					370	374		10.1038/nature11184	http://dx.doi.org/10.1038/nature11184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22722833	Green Submitted, Green Accepted			2022-12-28	WOS:000306506500044
J	Fei, Z; Rodin, AS; Andreev, GO; Bao, W; McLeod, AS; Wagner, M; Zhang, LM; Zhao, Z; Thiemens, M; Dominguez, G; Fogler, MM; Castro Neto, AH; Lau, CN; Keilmann, F; Basov, DN				Fei, Z.; Rodin, A. S.; Andreev, G. O.; Bao, W.; McLeod, A. S.; Wagner, M.; Zhang, L. M.; Zhao, Z.; Thiemens, M.; Dominguez, G.; Fogler, M. M.; Castro Neto, A. H.; Lau, C. N.; Keilmann, F.; Basov, D. N.			Gate-tuning of graphene plasmons revealed by infrared nano-imaging	NATURE			English	Article							METAMATERIALS; SPECTROSCOPY; OPTICS	Surface plasmons are collective oscillations of electrons in metals or semiconductors that enable confinement and control of electromagnetic energy at subwavelength scales(1-5). Rapid progress in plasmonics has largely relied on advances in device nano-fabrication(5-7), whereas less attention has been paid to the tunable properties of plasmonic media. One such medium-graphene-is amenable to convenient tuning of its electronic and optical properties by varying the applied voltage(8-11). Here, using infrared nano-imaging, we show that common graphene/SiO2/Si back-gated structures support propagating surface plasmons. The wavelength of graphene plasmons is of the order of 200 nanometres at technologically relevant infrared frequencies, and they can propagate several times this distance. We have succeeded in altering both the amplitude and the wavelength of these plasmons by varying the gate voltage. Using plasmon interferometry, we investigated losses in graphene by exploring real-space profiles of plasmon standing waves formed between the tip of our nano-probe and the edges of the samples. Plasmon dissipation quantified through this analysis is linked to the exotic electrodynamics of graphene(10). Standard plasmonic figures of merit of our tunable graphene devices surpass those of common metal-based structures.	[Fei, Z.; Rodin, A. S.; Andreev, G. O.; McLeod, A. S.; Wagner, M.; Fogler, M. M.; Basov, D. N.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Bao, W.; Zhao, Z.; Lau, C. N.] Univ Calif Riverside, Dept Phys & Astron, Riverside, CA 92521 USA; [Bao, W.] Univ Maryland, Mat Res Sci & Engn Ctr, College Pk, MD 20742 USA; [Zhang, L. M.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Thiemens, M.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dominguez, G.] Calif State Univ, Dept Phys, San Marcos, CA 92096 USA; [Castro Neto, A. H.] Natl Univ Singapore, Graphene Res Ctr, Singapore 117542, Singapore; [Castro Neto, A. H.] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Keilmann, F.] Max Planck Inst Quantum Opt, D-85714 Garching, Germany; [Keilmann, F.] Ctr Nanosci, D-85714 Garching, Germany	University of California System; University of California San Diego; University of California System; University of California Riverside; University System of Maryland; University of Maryland College Park; Boston University; University of California System; University of California San Diego; California State University System; California State University San Marcos; National University of Singapore; National University of Singapore; Max Planck Society	Basov, DN (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	dbasov@physics.ucsd.edu	Bao, Wenzhong/B-2453-2012; Castro Neto, Antonio/C-8363-2014; Fei, Zhe/E-6475-2015; Fogler, Michael M/O-4610-2017	Bao, Wenzhong/0000-0002-3871-467X; Castro Neto, Antonio/0000-0003-0613-4010; Fei, Zhe/0000-0002-7940-5566; Fogler, Michael M/0000-0001-8239-7221; Andreev, Gregory/0000-0001-9908-2162; Lau, Chun Ning/0000-0003-2159-6723; Rodin, Aleksandr/0000-0001-5321-7690	AFOSR; ONR [N00014-09-1-0724]; DARPA; DOE-BES [DE-FG02-00ER45799]; NSF [DMR/1106358, PHY11-25915]; ONR/DMEA [H94003-10-2-1003]; FENA Focus Center; NASA; UCOP; NRF-CRP [R-144-000-295-281]; DOE [DE-FG02-08ER46512]; Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft through the Cluster of Excellence Munich Centre for Advanced Photonics; Direct For Mathematical & Physical Scien [1106358] Funding Source: National Science Foundation	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ONR(Office of Naval Research); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); DOE-BES(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); ONR/DMEA(Office of Naval Research); FENA Focus Center; NASA(National Aeronautics & Space Administration (NASA)); UCOP; NRF-CRP(National Research Foundation, Singapore); DOE(United States Department of Energy (DOE)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft through the Cluster of Excellence Munich Centre for Advanced Photonics; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge support from AFOSR, ONR and DARPA. The analysis of plasmonic losses and many-body effects was supported by DOE-BES grant DE-FG02-00ER45799. W. B., Z.Z. and C.N.L. were supported by NSF DMR/1106358, ONR N00014-09-1-0724, ONR/DMEA H94003-10-2-1003 and FENA Focus Center. G. D. and M. T. were supported by NASA. M. M. F. was supported by UCOP and NSF PHY11-25915. A.H.C.N. acknowledges NRF-CRP grant R-144-000-295-281. L.M.Z was supported by DOE grant no. DE-FG02-08ER46512. M. W. thanks the Alexander von Humboldt Foundation for financial support. F. K. was supported by Deutsche Forschungsgemeinschaft through the Cluster of Excellence Munich Centre for Advanced Photonics.	Ando T, 2002, J PHYS SOC JPN, V71, P1318, DOI 10.1143/JPSJ.71.1318; Atwater HA, 2007, SCI AM, V296, P56, DOI 10.1038/scientificamerican0407-56; Caridad JM, 2010, J APPL PHYS, V108, DOI 10.1063/1.3500295; Casiraghi C, 2009, NANO LETT, V9, P1433, DOI 10.1021/nl8032697; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Dallapiccola R, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3152291; Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67; Fei Z, 2011, NANO LETT, V11, P4701, DOI 10.1021/nl202362d; Grushin AG, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155417; Gusynin VP, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245411; Huber A, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2032595; Hwang EH, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205418; Hwang J, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/24/245601; Jablan M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245435; Ju L, 2011, NAT NANOTECHNOL, V6, P630, DOI [10.1038/nnano.2011.146, 10.1038/NNANO.2011.146]; Lal S, 2007, NAT PHOTONICS, V1, P641, DOI 10.1038/nphoton.2007.223; Li ZQ, 2008, NAT PHYS, V4, P532, DOI 10.1038/nphys989; Maier S. A., 2007, PLASMONICS FUNDAMENT; Nagpal P, 2009, SCIENCE, V325, P594, DOI 10.1126/science.1174655; Novotny L., 2012, PRINCIPLES NANOOPTIC; Peres NMR, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.055501; Peres NMR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125411; Rana F, 2008, IEEE T NANOTECHNOL, V7, P91, DOI 10.1109/TNANO.2007.910334; Rodin A. S., 2012, THESIS UCSD; Schuller JA, 2010, NAT MATER, V9, P193, DOI [10.1038/NMAT2630, 10.1038/nmat2630]; Stockman MI, 2011, PHYS TODAY, V64, P39, DOI 10.1063/1.3554315; Vakil A, 2011, SCIENCE, V332, P1291, DOI 10.1126/science.1202691; Wang F, 2008, SCIENCE, V320, P206, DOI 10.1126/science.1152793; West PR, 2010, LASER PHOTONICS REV, V4, P795, DOI 10.1002/lpor.200900055	29	1547	1579	35	974	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					82	85		10.1038/nature11253	http://dx.doi.org/10.1038/nature11253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722866	Green Submitted			2022-12-28	WOS:000305982900054
J	DeJesus, E; Rockstroh, JK; Henry, K; Molina, JM; Gathe, J; Ramanathan, S; Wei, XL; Yale, K; Szwarcberg, J; White, K; Cheng, AK; Kearney, BP				DeJesus, Edwin; Rockstroh, Juergen K.; Henry, Keith; Molina, Jean-Michel; Gathe, Joseph; Ramanathan, Srinivasan; Wei, Xuelian; Yale, Kitty; Szwarcberg, Javier; White, Kirsten; Cheng, Andrew K.; Kearney, Brian P.		GS-236-0103 Study Team	Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial	LANCET			English	Article							PATIENTS 96-WEEK EFFICACY; SINGLE-TABLET REGIMEN; TREATMENT-NAIVE; EFAVIRENZ; SAFETY; COMBINATION; ADULTS; PHARMACOKINETICS; RALTEGRAVIR; ADHERENCE	Background The HIV integrase strand transfer inhibitor elvitegravir (EVG) has been co-formulated with the CYP3A4 inhibitor cobicistat (COBI), emtricitabine (FTC), and tenofovir disoproxil fumarate (TDF) into a once-daily, single tablet. We compared EVG/COBI/FTC/TDF with a ritonavir-boosted (RTV) protease inhibitor regimen of atazanavir (ATV)/RTV+FTC/TDF as initial therapy for HIV-1 infection. Methods This phase 3, non-inferiority study enrolled treatment-naive patients with an HIV-1 RNA concentration of 5000 copies per mL or more and susceptibility to atazanavir, emtricitabine, and tenofovir. Patients were randomly assigned (1: 1) to receive EVG/COBI/FTC/TDF or ATV/RTV+FTC/TDF plus matching placebos, administered once daily. Randomisation was by a computer-generated random sequence, accessed via an interactive telephone and web response system. Patients, and investigators and study staff who gave treatments, assessed outcomes, or analysed data were masked to the assignment. The primary endpoint was HIV RNA concentration of 50 copies per mL or less after 48 weeks (according to the US FDA snapshot algorithm), with a 12% non-inferiority margin. This trial is registered with ClinicalTrials.gov, number NCT01106586. Findings 1017 patients were screened, 715 were enrolled, and 708 were treated (353 with EVG/COBI/FTC/TDF and 355 with ATV/RTV+FTC/TDF). EVG/COBI/FTC/TDF was non-inferior to ATV/RTV+FTC/TDF for the primary outcome (316 patients [89.5%] vs 308 patients [86.8%], adjusted difference 3.0%, 95% CI -1.9% to 7.8%). Both regimens had favourable safety and tolerability; 13 (3.7%) versus 18 (5.1%) patients discontinued treatment because of adverse events. Fewer patients receiving EVG/COBI/FTC/TDF had abnormal results in liver function tests than did those receiving ATV/RTV+FTC/TDF and had smaller median increases in fasting triglyceride concentration (90 mu mol/L vs 260 mu mol/L, p=0.006). Small median increases in serum creatinine concentration with accompanying decreases in estimated glomerular filtration rate occurred in both study groups by week 2; they generally stabilised by week 8 and did not change up to week 48 (median change 11 mu mol/L vs 7 mu mol/L). Interpretation If regulatory approval is given, EVG/COBI/FTC/TDF would be the first integrase-inhibitor-based regimen given once daily and the only one formulated as a single tablet for initial HIV treatment.	[Ramanathan, Srinivasan; Wei, Xuelian; Yale, Kitty; Szwarcberg, Javier; White, Kirsten; Cheng, Andrew K.; Kearney, Brian P.] Gilead Sci, Foster City, CA 94110 USA; [DeJesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Rockstroh, Juergen K.] Univ Bonn, Dept Med, Bonn, Germany; [Henry, Keith] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Molina, Jean-Michel] Hop St Louis, AP HP, Paris Sorbonne Cite, France; [Molina, Jean-Michel] Univ Paris Diderot, Paris Sorbonne Cite, France; [Gathe, Joseph] Therapeut Concepts, Houston, TX USA	Gilead Sciences; Orlando Immunology Center; University of Bonn; Hennepin County Medical Center; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite	Kearney, BP (corresponding author), Gilead Sci, Foster City, CA 94110 USA.	bkearney@gilead.com	Stephan, Christoph/D-1305-2014; Vandekerckhove, Linos/J-6420-2013	Stephan, Christoph/0000-0003-3777-9006; Vandekerckhove, Linos/0000-0002-8600-1631	Abbott Laboratories; Achillion Pharmaceuticals; Avexa; Boehringer Ingelheim; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Hoffmann LaRoche; Idenix; Janssen; Merck; Pfizer; Sangamo; Taimed; Tobira; Vertex; Bionor; Novartis; Roche; Tibotec; Viiv Healthcare; US Centers for Disease Control; US National Institutes of Health; Abbott	Abbott Laboratories(Abbott Laboratories); Achillion Pharmaceuticals; Avexa; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Hoffmann LaRoche(Hoffmann-La Roche); Idenix; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Pfizer(Pfizer); Sangamo; Taimed; Tobira; Vertex(Vertex Pharmaceuticals); Bionor; Novartis(Novartis); Roche(Roche Holding); Tibotec; Viiv Healthcare; US Centers for Disease Control; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott(Abbott Laboratories)	EDJ has received research grant support from Abbott Laboratories, Achillion Pharmaceuticals, Avexa, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Hoffmann LaRoche, Idenix, Janssen, Merck, Pfizer, Sangamo, Taimed, Tobira, and Vertex; and consulting fees as a member of advisory boards for Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and Vertex. JR has received lecture fees and advisory board honoraria from Abbot Laboratories, Bionor, Gilead Sciences, Boehringer Ingelheim, Bristol-Myers Squibb, Merck, Novartis, Pfizer, Roche, Tibotec, and Viiv Healthcare. KH has received research grant support from Gilead Sciences, GlaxoSmithKline, US Centers for Disease Control, and the US National Institutes of Health; consulting fees as an advisory board member for Gilead Sciences. J-MM has acted as a consultant, participated in advisory boards, has received speaker fees, and has been an investigator for clinical trials for Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Merck, Tibotec, and ViiV Healthcare. JG has received research grant support from Abbott Laboratories, Boehringer Ingelheim, Gilead Sciences, GlaxoSmithKline, Janssen, and receives consulting fees from Abbott Laboratories and Boehringer Ingelheim. SR, XW, KY, JS, KW, AC, and BPK are employees of Gilead Sciences.	Airoldi M, 2010, PATIENT PREFER ADHER, V4, P115; [Anonymous], 2011, GUID US ANT AG HIV 1, P1; Bangsberg DR, 2010, AIDS, V24, P2835, DOI 10.1097/QAD.0b013e328340a209; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Cassetti I, 2007, HIV CLIN TRIALS, V8, P164, DOI 10.1310/hct0803-164; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Cohen C, 2011, AIDS, V25, pF7, DOI 10.1097/QAD.0b013e328345766f; Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5; Cohen CJ, 2011, 51 INT C ANT AG CHEM; Daar E, 2010, 17 C RETR OPP INF CR; DeJesus E, 2006, JAIDS-J ACQ IMM DEF, V43, P1, DOI 10.1097/01.qai.0000233308.82860.2f; Elion R, 2011, AIDS, V25, P1881, DOI 10.1097/QAD.0b013e32834b4d48; European AIDS Clinical Society (EACS), 2011, EUR AIDS CLIN SOC EA, P1; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; German P, 2011, 51 INT C ANT AG CHEM; German P, 2010, JAIDS-J ACQ IMM DEF, V55, P323, DOI 10.1097/QAI.0b013e3181eb376b; Hodder SL, 2010, AIDS PATIENT CARE ST, V24, P87, DOI 10.1089/apc.2009.0259; Lennox JL, 2010, JAIDS-J ACQ IMM DEF, V55, P39, DOI 10.1097/QAI.0b013e3181da1287; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Lepist E, 2011, 51 INT C ANT AG CHEM; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Llibre JM, 2011, AIDS, V25, P1683, DOI 10.1097/QAD.0b013e3283499cd9; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7; Molina JM, 2010, JAIDS-J ACQ IMM DEF, V53, P323, DOI 10.1097/QAI.0b013e3181c990bf; Ramanathan S, 2007, JAIDS-J ACQ IMM DEF, V45, P274; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Sax PE, 2010, 10 INT C DRUG THER H; Smith F, 2011, DRUG INF J, V45, P291, DOI 10.1177/009286151104500309; Smith Kimberly Y, 2008, AIDS Res Ther, V5, P5, DOI 10.1186/1742-6405-5-5; Soriano V, 2011, ANTIVIR THER, V16, P339, DOI 10.3851/IMP1745; STONE VE, 2002, 40 ANN M INF DIS SOC; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Tong L, 2007, ANTIMICROB AGENTS CH, V51, P3498, DOI 10.1128/AAC.00671-07; US Department of Health and Human Services Food and Drug Administration, 2002, GUID IND ANT DRUGS U; VIREAD&REG;(tenofovir disoproxil fumarate) tablets, 2010, VIREAD TEN DIS FUM T; Walmsley S, 2009, JAIDS-J ACQ IMM DEF, V50, P367, DOI 10.1097/QAI.0b013e318198a815	38	291	296	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 30	2012	379	9835					2429	2438		10.1016/S0140-6736(12)60918-0	http://dx.doi.org/10.1016/S0140-6736(12)60918-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967NV	22748590				2022-12-28	WOS:000305915900027
J	Cipolletta, D; Feuerer, M; Li, A; Kamei, N; Lee, J; Shoelson, SE; Benoist, C; Mathis, D				Cipolletta, Daniela; Feuerer, Markus; Li, Amy; Kamei, Nozomu; Lee, Jongsoon; Shoelson, Steven E.; Benoist, Christophe; Mathis, Diane			PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue T-reg cells	NATURE			English	Article							INSULIN-RESISTANCE; SYSTEM; MICE; THIAZOLIDINEDIONES; DIFFERENTIATION; RETROVIRUSES; INFLAMMATION; SENSITIVITY; ACTIVATION; EXPRESSION	Obesity and type-2 diabetes have increased markedly over the past few decades, in parallel. One of the major links between these two disorders is chronic, low-grade inflammation(1). Prolonged nutrient excess promotes the accumulation and activation of leukocytes in visceral adipose tissue (VAT) and ultimately other tissues, leading to metabolic abnormalities such as insulin resistance, type-2 diabetes and fatty-liver disease. Although invasion of VAT by pro-inflammatory macrophages is considered to be a key event driving adipose-tissue inflammation and insulin resistance, little is known about the roles of other immune system cell types in these processes. A unique population of VAT-resident regulatory T (T-reg) cells was recently implicated in control of the inflammatory state of adipose tissue and, thereby, insulin sensitivity(2). Here we identify peroxisome proliferator-activated receptor (PPAR)-gamma, the 'master regulator' of adipocyte differentiation, as a crucial molecular orchestrator of VAT T-reg cell accumulation, phenotype and function. Unexpectedly, PPAR-gamma expression by VAT T-reg cells was necessary for complete restoration of insulin sensitivity in obese mice by the thiazolidinedione drug pioglitazone. These findings suggest a previously unknown cellular mechanism for this important class of thiazolidinedione drugs, and provide proof-of-principle that discrete populations of T-reg cells with unique functions can be precisely targeted to therapeutic ends.	[Cipolletta, Daniela; Feuerer, Markus; Li, Amy; Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Dept Microbiol & Immunol, Div Immunol, Boston, MA 02115 USA; [Kamei, Nozomu; Lee, Jongsoon; Shoelson, Steven E.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [Kamei, Nozomu; Lee, Jongsoon; Shoelson, Steven E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Mathis, D (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunol, Div Immunol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu	Lee, Jongsoon/AAG-1674-2020	Lee, Jongsoon/0000-0002-0891-5059; Kamei, Nozomu/0000-0002-7686-437X	National Institutes of Health (NIH) [DK092541, DK51729]; Ellison Foundation (Boston); Dana Foundation; American Diabetes Association [RA 110BS97]; Joslin Diabetes Center [P30DK36836]; King Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092541, R01DK051729, P30DK036836, R37DK051729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation (Boston)(Lawrence Ellison Foundation); Dana Foundation; American Diabetes Association(American Diabetes Association); Joslin Diabetes Center; King Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Rudensky, F. Gonzalez, R. Kahn, B. Spiegelman and D. Vignali for providing materials; K. Hattori, M. Davenport, J. LaVecchio, G. Buruzala, J. Ericson, K. Leatherbee and S. Davis for technical assistance; A. Ergun, A. Morton and J. Shu for experimental help; and M. Wilson and J. Hill for discussions. Supported by grants from the National Institutes of Health (NIH; DK092541) and Ellison Foundation (Boston) to D. M. and C. B., Dana Foundation to D. M. and S. E. S.; the American Diabetes Association (RA 110BS97) to J. L., and the NIH (DK51729) to S. E. S.; as well as by core facilities of the Joslin Diabetes Center (P30DK36836). M. F. received a postdoctoral fellowship from the King Trust.	Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Ilan Y, 2010, P NATL ACAD SCI USA, V107, P9765, DOI 10.1073/pnas.0908771107; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Miyazaki Y, 2004, J CLIN ENDOCR METAB, V89, P4312, DOI 10.1210/jc.2004-0190; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Olefsky J.M., 2010, NAT MED, V16, P972; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001	23	773	801	4	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					549	U151		10.1038/nature11132	http://dx.doi.org/10.1038/nature11132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722857	Green Accepted, Green Submitted			2022-12-28	WOS:000305760600047
J	Lipsitch, M; Plotkin, JB; Simonsen, L; Bloom, B				Lipsitch, Marc; Plotkin, Joshua B.; Simonsen, Lone; Bloom, Barry			Evolution, Safety, and Highly Pathogenic Influenza Viruses	SCIENCE			English	Editorial Material							A H3N2 VIRUSES; ADAMANTANE RESISTANCE; TRANSMISSION; OSELTAMIVIR; VIRULENCE; FERRETS	Experience with influenza has shown that predictions of virus phenotype or fitness from nucleotide sequence are imperfect and that predicting the timing and course of evolution is extremely difficult. Such uncertainty means that the risk of experiments with mammalian-transmissible, possibly highly virulent influenza viruses remains high even if some aspects of their laboratory biology are reassuring; it also implies limitations on the ability of laboratory observations to guide interpretation of surveillance of strains in the field. Thus, we propose that future experiments with virulent pathogens whose accidental or deliberate release could lead to extensive spread in human populations should be limited by explicit risk-benefit considerations.	[Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lipsitch, Marc; Bloom, Barry] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Simonsen, Lone] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Global Hlth, Washington, DC 20037 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania; George Washington University	Lipsitch, M (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, 665 Huntington Ave, Boston, MA 02115 USA.	mlipsitc@hsph.harvard.edu	Simonsen, Lone/K-4531-2014; Plotkin, Joshua B/E-6947-2013	Simonsen, Lone/0000-0003-1535-8526; Lipsitch, Marc/0000-0003-1504-9213	NIGMS NIH HHS [U54GM088558, U54 GM088558] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2003, EURO SURVEILL, V7, P2347; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Bouvier N. M., 2012, J VIROL; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Cohen J, 2012, SCIENCE, V335, P1155, DOI 10.1126/science.335.6073.1155; HAYDEN FG, 1989, NEW ENGL J MED, V321, P1696, DOI 10.1056/NEJM198912213212502; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Herfst S, 2010, J VIROL, V84, P3752, DOI 10.1128/JVI.02634-09; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Hottes A. K., 2012, BIOSECURITY CHALLENG; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kramarz P, 2009, EUROSURVEILLANCE, V14; Kryazhimskiy S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001301; National Science Advisory Board for Biosecurity, 2012, NAT SCI ADV BOARD BI; Pennington H, 2003, B WORLD HEALTH ORGAN, V81, P762; Plotkin JB, 2003, P NATL ACAD SCI USA, V100, P7152, DOI 10.1073/pnas.1132114100; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; SWEET C, 1991, J INFECT DIS, V164, P969, DOI 10.1093/infdis/164.5.969; U. S. Department of Health and Human Services Public Health Service Centers for Disease Control and Prevention National Institutes of Health, 2009, HHS PUBL; U.S. Department of Homeland Security, 2007, NAT BIO AGR FAC FIN; U.S. Government Accountability Office, 2009, GAO09574 US GOV ACC; UK Health and Safety Executive, 2007, FIN REP POT BREACH B; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, REP TECHN CONS H5N1	27	26	26	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1529	1531		10.1126/science.1223204	http://dx.doi.org/10.1126/science.1223204			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	961ZE	22723411	Green Submitted, Green Accepted			2022-12-28	WOS:000305507500045
J	Macilwain, C				Macilwain, Colin			Scientific Misconduct: More Cops, More Robbers?	CELL			English	Editorial Material																		Cyranoski D, 2004, NATURE, V429, P3, DOI 10.1038/429003a; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Kennedy Donald, 2006, Science, V311, P335	3	7	7	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1417	1419		10.1016/j.cell.2012.06.001	http://dx.doi.org/10.1016/j.cell.2012.06.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726427	Bronze			2022-12-28	WOS:000305753800005
J	Riccomagno, MM; Hurtado, A; Wang, HB; Macopson, JGJ; Griner, EM; Betz, A; Brose, N; Kazanietz, MG; Kolodkin, AL				Riccomagno, Martin M.; Hurtado, Andres; Wang, HongBin; Macopson, Joshua G. J.; Griner, Erin M.; Betz, Andrea; Brose, Nils; Kazanietz, Marcelo G.; Kolodkin, Alex L.			The RacGAP beta 2-Chimaerin Selectively Mediates Axonal Pruning in the Hippocampus	CELL			English	Article							MOSSY FIBERS; IN-VIVO; RETRACTION; ALPHA-2-CHIMAERIN; SCHIZOPHRENIA; DEGENERATION; GUIDANCE; NEURONS; PROTEIN; RATS	Axon pruning and synapse elimination promote neural connectivity and synaptic plasticity. Stereotyped pruning of axons that originate in the hippocampal dentate gyrus (DG) and extend along the infrapyramidal tract (IPT) occurs during postnatal murine development by neurite retraction and resembles axon repulsion. The chemorepellent Sema3F is required for IPT axon pruning, dendritic spine remodeling, and repulsion of DG axons. The signaling events that regulate IPT axon pruning are not known. We find that inhibition of the small G protein Rac1 by the Rac GTPase-activating protein (GAP) beta 2-Chimaerin (beta 2Chn) mediates Sema3F-dependent pruning. The Sema3F receptor neuropilin-2 selectively binds beta 2Chn, and ligand engagement activates this GAP to ultimately restrain Rac1-dependent effects on cytoskeletal reorganization. beta 2Chn is necessary for axon pruning both in vitro and in vivo, but it is dispensable for axon repulsion and spine remodeling. Therefore, a Npn2/beta 2Chn/Rac1 signaling axis distinguishes DG axon pruning from the effects of Sema3F on repulsion and dendritic spine remodeling.	[Riccomagno, Martin M.; Macopson, Joshua G. J.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Hurtado, Andres] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Riccomagno, Martin M.; Macopson, Joshua G. J.; Kolodkin, Alex L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Wang, HongBin; Griner, Erin M.; Kazanietz, Marcelo G.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Betz, Andrea; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Betz, Andrea; Brose, Nils] Max Planck Inst Expt Med, DFG Ctr Mol Physiol Brain, D-37075 Gottingen, Germany; [Hurtado, Andres] Hugo W Moser Res Inst Kennedy Krieger, Int Ctr Spinal Cord Injury, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine; Max Planck Society; German Research Foundation (DFG); Max Planck Society	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu		Riccomagno, Martin/0000-0002-1867-4439	National Ataxia Foundation; NIH [R01 CA74197, RO1 MH59199]; NATIONAL CANCER INSTITUTE [R01CA074197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050274] Funding Source: NIH RePORTER	National Ataxia Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Silvio Gutkind for the RacQL construct, Barbara Smith and the JHU School of Medicine Microscope Facility for assistance with the TEM, and Dr. Michael Greenberg for the pLLX and pLEMPRA vectors. We also thank Drs. Cynthia Duggan, Roman Giger, David Ginty, Randal Hand, Kang Shen, and Marc Tessier-Lavigne for helpful comments on the manuscript and discussions, and we thank members of Kolodkin laboratory for assistance. This work was supported by a postdoctoral fellowship from the National Ataxia Foundation to M. M. R, NIH R01 CA74197 to M. G. K, and NIH RO1 MH59199 to A. L. K. A. L. K. is an investigator of the Howard Hughes Medical Institute.	Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Buttery P, 2006, P NATL ACAD SCI USA, V103, P1924, DOI 10.1073/pnas.0510655103; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; CRUSIO WE, 1987, BRAIN RES, V425, P182, DOI 10.1016/0006-8993(87)90498-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Grosse G, 1998, J NEUROSCI RES, V51, P602, DOI 10.1002/(SICI)1097-4547(19980301)51:5<602::AID-JNR7>3.0.CO;2-J; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Harrington AW, 2011, CELL, V146, P421, DOI 10.1016/j.cell.2011.07.008; Hashimoto R, 2005, SCHIZOPHR RES, V73, P383, DOI 10.1016/j.schres.2004.01.017; Holmes GL, 1999, J COMP NEUROL, V404, P537, DOI 10.1002/(SICI)1096-9861(19990222)404:4<537::AID-CNE9>3.0.CO;2-#; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Ip JPK, 2012, NAT NEUROSCI, V15, P39, DOI 10.1038/nn.2972; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Johnston MV, 2004, BRAIN DEV-JPN, V26, P73, DOI 10.1016/S0387-7604(03)00102-5; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LAUDER JM, 1977, NATURE, V268, P335, DOI 10.1038/268335a0; Lee T, 1999, DEVELOPMENT, V126, P4065; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; LIPP HP, 1988, J NEUROSCI, V8, P1905; Liu XB, 2005, J NEUROSCI, V25, P9124, DOI 10.1523/JNEUROSCI.2648-05.2005; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Low LK, 2008, P NATL ACAD SCI USA, V105, P8136, DOI 10.1073/pnas.0803849105; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Rapoport JL, 1999, ARCH GEN PSYCHIAT, V56, P649, DOI 10.1001/archpsyc.56.7.649; Sahay A, 2003, J NEUROSCI, V23, P6671; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Siliceo M, 2006, J CELL SCI, V119, P141, DOI 10.1242/jcs.02722; STANFIELD BB, 1982, NATURE, V298, P371, DOI 10.1038/298371a0; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Vanderhaeghen P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001859; Wang HB, 2006, EMBO J, V25, P2062, DOI 10.1038/sj.emboj.7601098; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; WEST JR, 1981, SCIENCE, V211, P957; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Yang CF, 2007, BIOCHEM J, V403, P1, DOI 10.1042/bj20061750; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	48	54	55	2	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1594	1606		10.1016/j.cell.2012.05.018	http://dx.doi.org/10.1016/j.cell.2012.05.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726444	Green Accepted, Bronze			2022-12-28	WOS:000305753800023
J	Cannon, CP; Cannon, PJ				Cannon, Christopher P.; Cannon, Paul J.			COX-2 Inhibitors and Cardiovascular Risk	SCIENCE			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROSTACYCLIN; ROFECOXIB; CELECOXIB; TRIAL		[Cannon, Christopher P.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc,Thrombolysis Myocardial Infarct St, Boston, MA 02115 USA; [Cannon, Paul J.] Columbia Presbyterian Med Ctr, Div Cardiol, New York, NY 10032 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Columbia University; NewYork-Presbyterian Hospital	Cannon, CP (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc,Thrombolysis Myocardial Infarct St, 75 Francis St, Boston, MA 02115 USA.	cpcannon@partners.org						Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Rodriguez LAG, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-17; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Solomon SD, 2008, CIRCULATION, V117, P2104, DOI 10.1161/CIRCULATIONAHA.108.764530; Yu Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003787	13	97	109	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1386	1387		10.1126/science.1224398	http://dx.doi.org/10.1126/science.1224398			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700906				2022-12-28	WOS:000305211700026
J	van der Heide, T; Govers, LL; de Fouw, J; Olff, H; van der Geest, M; van Katwijk, MM; Piersma, T; van de Koppel, J; Silliman, BR; Smolders, AJP; van Gils, JA				van der Heide, Tjisse; Govers, Laura L.; de Fouw, Jimmy; Olff, Han; van der Geest, Matthijs; van Katwijk, Marieke M.; Piersma, Theunis; van de Koppel, Johan; Silliman, Brian R.; Smolders, Alfons J. P.; van Gils, Jan A.			A Three-Stage Symbiosis Forms the Foundation of Seagrass Ecosystems	SCIENCE			English	Article							MUTUALISTIC NETWORKS; ZOSTERA-MARINA; BIODIVERSITY; BIVALVES; SULFIDE; ARCHITECTURE; DIVERSITY; SEDIMENTS; BACTERIA; MOLLUSCA	Seagrasses evolved from terrestrial plants into marine foundation species around 100 million years ago. Their ecological success, however, remains a mystery because natural organic matter accumulation within the beds should result in toxic sediment sulfide levels. Using a meta-analysis, a field study, and a laboratory experiment, we reveal how an ancient three-stage symbiosis between seagrass, lucinid bivalves, and their sulfide-oxidizing gill bacteria reduces sulfide stress for seagrasses. We found that the bivalve-sulfide-oxidizer symbiosis reduced sulfide levels and enhanced seagrass production as measured in biomass. In turn, the bivalves and their endosymbionts profit from organic matter accumulation and radial oxygen release from the seagrass roots. These findings elucidate the long-term success of seagrasses in warm waters and offer new prospects for seagrass ecosystem conservation.	[van der Heide, Tjisse; Olff, Han] Univ Groningen, CEES, Community & Conservat Ecol Grp, NL-9700 CC Groningen, Netherlands; [Govers, Laura L.; van Katwijk, Marieke M.] Radboud Univ Nijmegen, Dept Environm Sci, Inst Water & Wetland Res, Fac Sci, NL-6525 AJ Nijmegen, Netherlands; [de Fouw, Jimmy; van der Geest, Matthijs; Piersma, Theunis; van Gils, Jan A.] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Ecol, NL-1790 AB Den Burg, Texel, Netherlands; [Piersma, Theunis] Univ Groningen, CEES, Anim Ecol Grp, NL-9700 CC Groningen, Netherlands; [van de Koppel, Johan] NIOZ Royal Netherlands Inst Sea Res, Ctr Estuarine & Marine Ecol, NL-4400 AC Yerseke, Netherlands; [Silliman, Brian R.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Smolders, Alfons J. P.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Aquat Ecol & Environm Biol, Fac Sci, NL-6525 AJ Nijmegen, Netherlands	University of Groningen; Radboud University Nijmegen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Groningen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); State University System of Florida; University of Florida; Radboud University Nijmegen	van der Heide, T (corresponding author), Univ Groningen, CEES, Community & Conservat Ecol Grp, POB 11103, NL-9700 CC Groningen, Netherlands.	t.van.der.heide@rug.nl	Van de Koppel, Johan/E-7266-2010; van der Heide, Tjisse/M-3000-2013; van der Geest, Matthijs/A-4744-2013; Piersma, Theunis/D-1871-2012; Smolders, Alfons J.P./H-2583-2012; Govers, Laura/B-8838-2011; van Katwijk, Marieke M/B-1709-2012; Olff, Han/A-8516-2008; van Gils, Jan/B-5544-2008	van der Geest, Matthijs/0000-0002-9837-3803; van Katwijk, Marieke M/0000-0002-4482-5835; Olff, Han/0000-0003-2154-3576; van Gils, Jan/0000-0002-4132-8243; Silliman, Brian/0000-0001-6360-650X; Piersma, Theunis/0000-0001-9668-466X	"Waddenfonds" program; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)-WOTRO [W.01.65.221.00]; NWO-VIDI [864.09.002]; NSF; Andrew Mellon Foundation; Royal Netherlands Academy	"Waddenfonds" program; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)-WOTRO; NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); NSF(National Science Foundation (NSF)); Andrew Mellon Foundation; Royal Netherlands Academy	We thank G. Quaintenne and H. Blanchet for their help with the collection of Loripes; J. Eygensteyn and E. Pierson for technical assistance; and G. J. Vermeij, H. de Kroon, T. J. Bouma, E. J. Weerman, and C. Smit for their comments on the manuscript. T.v.d.H. was financially supported by the "Waddenfonds" program; M.v.d.G. and T.P. by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)-WOTRO Integrated Programme grant W.01.65.221.00 awarded to T.P.; and J.d.F. and J.v.G. by the NWO-VIDI grant 864.09.002 awarded to J.v.G. B.S. was supported by an NSF CAREER award, the Andrew Mellon Foundation, and the Royal Netherlands Academy Visiting Professorship. The authors declare no conflicts of interest. A detailed description of all materials and methods, sources, as well as supplementary information are available as supplementary materials. The data are deposited in DRYAD at http://dx.doi.org/10.5061/dryad.210mp.	ANDERSON AE, 1995, AM ZOOL, V35, P121; [Anonymous], 2006, SEAGRASSES BIOL ECOL, DOI DOI 10.1007/978-1-4020-2983-7; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; CAFFREY JM, 1991, AQUAT BOT, V40, P109, DOI 10.1016/0304-3770(91)90090-R; Calleja ML, 2007, ESTUAR COAST SHELF S, V73, P583, DOI 10.1016/j.ecss.2007.02.016; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; CAVANAUGH CM, 1983, NATURE, V302, P58, DOI 10.1038/302058a0; Childress JJ, 2011, J EXP BIOL, V214, P312, DOI 10.1242/jeb.049023; Distel DL, 1998, BIOSCIENCE, V48, P277, DOI 10.2307/1313354; Fonseca MS, 2002, HANDBOOK OF ECOLOGICAL RESTORATION, VOL 2, P149; JOHNSON M, 1994, SYMBIOSIS, V17, P1; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Koch MS, 2007, J EXP MAR BIOL ECOL, V341, P91, DOI 10.1016/j.jembe.2006.10.004; LILJEDAHL L, 1991, PALAEONTOLOGY, V34, P219; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P1; Reynolds LK, 2007, ESTUAR COAST, V30, P482, DOI 10.1007/BF02819394; Sand-Jensen K, 2005, ANN BOT-LONDON, V96, P613, DOI 10.1093/aob/mci214; Stanley S.M., 1977, DEV PALAEONTOLOGY ST, V5, P209, DOI DOI 10.1016/S0920-5446(08)70327-3; Taylor JD, 2000, GEOL SOC SPEC PUBL, V177, P207, DOI 10.1144/GSL.SP.2000.177.01.12; Taylor JD, 2011, ZOOL J LINN SOC-LOND, V163, P15, DOI 10.1111/j.1096-3642.2011.00700.x; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; van der Heide T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016504; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vermeij GJ, 2011, P ROY SOC B-BIOL SCI, V278, P2362, DOI 10.1098/rspb.2010.2362; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106	27	157	160	10	295	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1432	1434		10.1126/science.1219973	http://dx.doi.org/10.1126/science.1219973			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700927	Green Submitted, Green Published			2022-12-28	WOS:000305211700043
J	Veitch, L; Dulvy, NK; Koldewey, H; Lieberman, S; Pauly, D; Roberts, CM; Rogers, AD; Baillie, JEM				Veitch, Liane; Dulvy, Nicholas K.; Koldewey, Heather; Lieberman, Susan; Pauly, Daniel; Roberts, Callum M.; Rogers, Alex D.; Baillie, Jonathan E. M.			Avoiding Empty Ocean Commitments at Rio+20	SCIENCE			English	Editorial Material							ECOSYSTEM APPROACH; FISHERIES; CONSERVATION; IMPLEMENTATION; MANAGEMENT; NETWORK; SCIENCE; EUROPE; STATE		[Veitch, Liane; Koldewey, Heather; Baillie, Jonathan E. M.] Zool Soc London, London NW1 4RY, England; [Dulvy, Nicholas K.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Lieberman, Susan] Pew Environm Grp, Washington, DC 20004 USA; [Pauly, Daniel] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada; [Roberts, Callum M.] Univ York, York YO10 5DD, N Yorkshire, England; [Rogers, Alex D.] Univ Oxford, Oxford OX1 3PS, England	Zoological Society of London; Simon Fraser University; University of British Columbia; University of York - UK; University of Oxford	Veitch, L (corresponding author), Zool Soc London, London NW1 4RY, England.	liane.veitch@zsl.org	Dulvy, Nicholas/I-2895-2012; Pauly, Daniel Marc/AAY-2316-2021	Dulvy, Nicholas/0000-0002-4295-9725; Pauly, Daniel/0000-0003-3756-4793				Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Anticamara JA, 2011, FISH RES, V107, P131, DOI 10.1016/j.fishres.2010.10.016; Bull LS, 2009, FISH FISH, V10, P408, DOI 10.1111/j.1467-2979.2009.00327.x; Burke L., 2011, REEFS RISK REVISITED; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; CICINSAIN B, 2011, OCEANS RIO 20 WELL A; Croxall JP, 2008, BIRD CONSERV INT, V18, pS13, DOI 10.1017/S0959270908000300; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Drammeh O. K. L., 2000, ILLEGAL UNREPORTED U, P135; Edgar GJ, 2011, AQUAT CONSERV, V21, P313, DOI 10.1002/aqc.1187; Ellis SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018997; Fabra A., 2011, CLOSING GAP COMP TUN; FAO Fisheries Department, 2010, STAT WORLD FISH AQ 2; FAO-UN Environment Programme (UNEP), 2010, FAO UNEP EXP M IMP D; Flothmann S, 2010, SCIENCE, V328, P1235, DOI 10.1126/science.1190245; Fox HE, 2012, CONSERV LETT, V5, P1, DOI 10.1111/j.1755-263X.2011.00207.x; Froese R, 2010, FISH FISH, V11, P194, DOI 10.1111/j.1467-2979.2009.00349.x; Garcia SM, 2005, ICES J MAR SCI, V62, P311, DOI 10.1016/j.icesjms.2004.12.003; Hilborn R, 2007, ECOSYSTEMS, V10, P1362, DOI 10.1007/s10021-007-9100-5; Human Development Report Office UN Development Programme (UNDP), 2005, SUBS AFR HUM COSTS 2; IOC/UNESCO, 2011, BLUEPR OC COAST SUST; IUCN, GLOB MAR SPEC ASS PR; IUCN, 2011, RED LIST VERS 2011 2; IUCN and UNEP-WCMC, 2011, WORLD DAT PROT AR; Jennings S, 2011, FISH FISH, V12, P125, DOI 10.1111/j.1467-2979.2011.00409.x; Mace GM, 2010, CURR OPIN ENV SUST, V2, P3, DOI 10.1016/j.cosust.2010.03.003; McClenachan L, 2012, CONSERV LETT, V5, P73, DOI 10.1111/j.1755-263X.2011.00206.x; MRAG-Fisheries Ecosystem Restoration Research (FERR), 2008, GLOB EXT ILL FISH; O'Leary BC, 2012, MAR POLICY, V36, P598, DOI 10.1016/j.marpol.2011.11.003; Pauly D, 2012, MAR POLICY, V36, P746, DOI 10.1016/j.marpol.2011.10.021; Rice JC, 2005, MAR ECOL PROG SER, V300, P265; Roberts C., 2012, OCEAN LIFE OUR SEAS; Rogers A. D., 2011, INT EARTH SYSTEM EXP; Ruckelshaus M, 2008, BIOSCIENCE, V58, P53, DOI 10.1641/B580110; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Sumaila U. Rashid, 2010, Journal of Bioeconomics, V12, P201, DOI 10.1007/s10818-010-9091-8; Sumaila U. R., 2011, GREEN EC REPORT; Sumaila UR, 2012, NATURE, V481, P265, DOI 10.1038/481265c; Tallis H, 2010, MAR POLICY, V34, P340, DOI 10.1016/j.marpol.2009.08.003; Techera EJ, 2011, MAR POLICY, V35, P73, DOI 10.1016/j.marpol.2010.08.003; Thurstan RH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1013; Toropova C., 2010, GLOBAL OCEAN PROTECT; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Ye Y., 2011, REV STATE MARINE FIS, P3; Ye Y., 2012, FISH FISH, DOI [10.0000/ j.1467- 2979.2012.00460.x, DOI 10.0000/J.1467-2979.2012.00460.X]; [No title captured]	48	30	30	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2012	336	6087					1383	1385		10.1126/science.1223009	http://dx.doi.org/10.1126/science.1223009			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700905				2022-12-28	WOS:000305211700025
J	Narain, S				Narain, Sunita			Sanitation for all	NATURE			English	Editorial Material									Ctr Sci & Environm, New Delhi, India		Narain, S (corresponding author), Ctr Sci & Environm, New Delhi, India.	sunita@cseindia.org						CPCB, 2009, STAT WAT SUPPL WAST; Kamyotra J. S, 2011, WATER QUALITY WASTE; Office of the Registrar General and Census Commissioner, 2012, CENS IND 2011; WHO UNICEF, 2012, PROGR DRINK WAT SAN	4	18	18	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2012	486	7402					185	185		10.1038/486185a	http://dx.doi.org/10.1038/486185a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699595	Bronze			2022-12-28	WOS:000305189000013
J	Perez-Mancera, PA; Rust, AG; van der Weyden, L; Kristiansen, G; Li, A; Sarver, AL; Silverstein, KAT; Grutzmann, R; Aust, D; Rummele, P; Knosel, T; Herd, C; Stemple, DL; Kettleborough, R; Brosnan, JA; Li, A; Morgan, R; Knight, S; Yu, J; Stegeman, S; Collier, LS; ten Hoeve, JJ; de Ridder, J; Klein, AP; Goggins, M; Hruban, RH; Chang, DK; Biankin, AV; Grimmond, SM; Wessels, LFA; Wood, SA; Iacobuzio-Donahue, CA; Pilarsky, C; Largaespada, DA; Adams, DJ; Tuveson, DA				Perez-Mancera, Pedro A.; Rust, Alistair G.; van der Weyden, Louise; Kristiansen, Glen; Li, Allen; Sarver, Aaron L.; Silverstein, Kevin A. T.; Gruetzmann, Robert; Aust, Daniela; Ruemmele, Petra; Knoesel, Thomas; Herd, Colin; Stemple, Derek L.; Kettleborough, Ross; Brosnan, Jacqueline A.; Li, Ang; Morgan, Richard; Knight, Spencer; Yu, Jun; Stegeman, Shane; Collier, Lara S.; ten Hoeve, Jelle J.; de Ridder, Jeroen; Klein, Alison P.; Goggins, Michael; Hruban, Ralph H.; Chang, David K.; Biankin, Andrew V.; Grimmond, Sean M.; Wessels, Lodewyk F. A.; Wood, Stephen A.; Iacobuzio-Donahue, Christine A.; Pilarsky, Christian; Largaespada, David A.; Adams, David J.; Tuveson, David A.		Australian Pancreatic Canc Genome	The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma	NATURE			English	Article							SOMATIC MUTATIONS; INSERTION SITES; K-RAS; GENE; CANCER; MOUSE; MUTAGENESIS; CARCINOMA; EXPRESSION; STABILIZATION	Pancreatic ductal adenocarcinoma (PDA) remains a lethal malignancy despite much progress concerning its molecular characterization. PDA tumours harbour four signature somatic mutations(1-4) in addition to numerous lower frequency genetic events of uncertain significance(5). Here we use Sleeping Beauty (SB) transposon-mediated insertional mutagenesis(6,7) in a mouse model of pancreatic ductal preneoplasia(8) to identify genes that cooperate with oncogenic Kras(G12D) to accelerate tumorigenesis and promote progression. Our screen revealed new candidate genes for PDA and confirmed the importance of many genes and pathways previously implicated in human PDA. The most commonly mutated gene was the X-linked deubiquitinase Usp9x, which was inactivated in over 50% of the tumours. Although previous work had attributed a pro-survival role to USP9X in human neoplasia(9), we found instead that loss of Usp9x enhances transformation and protects pancreatic cancer cells from anoikis. Clinically, low USP9X protein and messenger RNA expression in PDA correlates with poor survival after surgery, and USP9X levels are inversely associated with metastatic burden in advanced disease. Furthermore, chromatin modulation with trichostatin A or 5-aza-2'-deoxycytidine elevates USP9X expression in human PDA cell lines, indicating a clinical approach for certain patients. The conditional deletion of Usp9x cooperated with Kras(G12D) to accelerate pancreatic tumorigenesis in mice, validating their genetic interaction. We propose that USP9X is a major tumour suppressor gene with prognostic and therapeutic relevance in PDA.	[Rust, Alistair G.; van der Weyden, Louise; Herd, Colin; Stemple, Derek L.; Kettleborough, Ross; Adams, David J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Perez-Mancera, Pedro A.; Tuveson, David A.] Canc Res UK, Li Ka Shing Ctr, Cambridge Res Inst, Cambridge CB2 0RE, England; [Perez-Mancera, Pedro A.; Tuveson, David A.] Dept Oncol, Cambridge CB2 0RE, England; [Kristiansen, Glen] Univ Hosp Bonn, Inst Pathol, D-53127 Bonn, Germany; [Li, Allen; Brosnan, Jacqueline A.; Li, Ang; Morgan, Richard; Knight, Spencer; Yu, Jun; Klein, Alison P.; Goggins, Michael; Hruban, Ralph H.; Iacobuzio-Donahue, Christine A.] Johns Hopkins Med Inst, Dept Oncol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21231 USA; [Li, Allen; Brosnan, Jacqueline A.; Li, Ang; Morgan, Richard; Knight, Spencer; Yu, Jun; Klein, Alison P.; Goggins, Michael; Hruban, Ralph H.; Iacobuzio-Donahue, Christine A.] Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21231 USA; [Sarver, Aaron L.; Silverstein, Kevin A. T.; Largaespada, David A.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Gruetzmann, Robert; Pilarsky, Christian] Univ Hosp Dresden, Dept Surg, D-01307 Dresden, Germany; [Aust, Daniela] Univ Hosp Dresden, Inst Pathol, D-01307 Dresden, Germany; [Ruemmele, Petra] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany; [Knoesel, Thomas] Univ Hosp Jena, Inst Pathol, D-07743 Jena, Germany; [Knoesel, Thomas] Univ Munich, Inst Pathol, D-80337 Munich, Germany; [Stegeman, Shane; Wood, Stephen A.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Collier, Lara S.] Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA; [ten Hoeve, Jelle J.; de Ridder, Jeroen; Wessels, Lodewyk F. A.] Delft Univ Technol, Delft Bioinformat Lab, Fac EEMCS, NL-2628 CD Delft, Netherlands; [ten Hoeve, Jelle J.; Wessels, Lodewyk F. A.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Chang, David K.; Biankin, Andrew V.] Garvan Inst Med Res, Kinghorn Canc Ctr, Canc Res Program, Sydney, NSW 2010, Australia; [Chang, David K.; Biankin, Andrew V.] Bankstown Hosp, Dept Surg, Sydney, NSW 2200, Australia; [Chang, David K.; Biankin, Andrew V.] Univ NSW, S Western Sydney Clin Sch, Fac Med, Liverpool, NSW 2170, Australia; [Grimmond, Sean M.] Univ Queensland, Queensland Ctr Med Genom, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Wellcome Trust Sanger Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Bonn; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Minnesota System; University of Minnesota Twin Cities; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Regensburg; Friedrich Schiller University of Jena; University of Munich; Griffith University; University of Wisconsin System; University of Wisconsin Madison; Delft University of Technology; Netherlands Cancer Institute; Garvan Institute of Medical Research; University of Queensland	Adams, DJ (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	da1@sanger.ac.uk; david.tuveson@cancer.org.uk	Cowley, Mark/D-4504-2012; Wood, Stephen A/E-8357-2011; Zeps, Nikolajs/C-4180-2013; Gill, Anthony/D-4215-2015; Corbo, Vincenzo/J-7754-2016; Largaespada, David/C-9832-2014; Iacobuzio-Donahue, Christine/ABF-1295-2020; Waddell, Nicola/H-4929-2015; Fink, Lynn/C-2031-2008; scarpa, aldo/K-6832-2016; Grimmond, Sean M/J-5304-2016; Grimmond, Sean/K-3246-2019; Merrett, Neil/H-8033-2019; Cloonan, Nicole/B-5272-2008; van der Weyden, Louise/AAV-5711-2021; Cowley, Mark/K-8731-2019; Clouston, Andrew/E-7199-2011	Wood, Stephen A/0000-0002-2576-7457; Zeps, Nikolajs/0000-0002-6404-6839; Gill, Anthony/0000-0002-9447-1967; Corbo, Vincenzo/0000-0002-6340-8009; Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Waddell, Nicola/0000-0002-3950-2476; Fink, Lynn/0000-0003-2912-6048; scarpa, aldo/0000-0003-1678-739X; Grimmond, Sean M/0000-0002-8102-7998; Grimmond, Sean/0000-0002-8102-7998; Merrett, Neil/0000-0002-8370-0293; Cloonan, Nicole/0000-0001-7802-6647; van der Weyden, Louise/0000-0002-0645-1879; Cowley, Mark/0000-0002-9519-5714; Adams, David/0000-0001-9490-0306; Brancato, Mary-Anne/0000-0002-5439-4549; Daly, Roger/0000-0002-5739-8027; Spry, Nigel/0000-0001-8659-5065; Chang, David/0000-0002-4821-3078; SALVIA, Roberto/0000-0002-3514-8473; Nones, Katia/0000-0003-1925-5196; Rust, Alistair/0000-0001-7287-192X; Chin, Venessa/0000-0002-4630-4451; Li, Allen/0000-0001-7482-8204; Kench, James Geoffrey/0000-0001-8687-4988; Christophi, Christopher/0000-0002-1349-0884; Pilarsky, Christian/0000-0002-7968-3283; Biankin, Andrew/0000-0002-0362-5597; Nikfarjam, Mehrdad/0000-0003-4866-276X; Clouston, Andrew/0000-0002-9601-7952; Jones, Marc/0000-0002-3078-8359; Chou, Angela/0000-0001-9212-6927; Pinese, Mark/0000-0001-5078-6687; Chantrill, Lorraine/0000-0002-5790-0208; Barbour, Andrew/0000-0002-0991-7662; Pajic, Marina/0000-0002-3871-3829; lawlor, Rita/0000-0003-3160-0634	University of Cambridge; Cancer Research UK; Li Ka Shing Foundation; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre; NIH [2P50CA101955, CA62924, CA128920, CA106610, P50CA62924, CA122183]; Wellcome Trust; Kay Kendall Leukemia Fund; Wilhelm Sander Stiftung [2009.039.1]; Deutsche Forschungsgemeinschaft [PI 341/5-1]; National Health and Medical research Council of Australia (NHMRC); Queensland Government; Cancer Council NSW; Australian Cancer Research Foundation; Cancer Institute NSW; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Cancer Research UK [13031] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K01CA122183, P50CA101955, P50CA062924, K08CA106610, R01CA128920] Funding Source: NIH RePORTER	University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); Li Ka Shing Foundation; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); Kay Kendall Leukemia Fund; Wilhelm Sander Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Health and Medical research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government; Cancer Council NSW(Cancer Council New South Wales); Australian Cancer Research Foundation; Cancer Institute NSW; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Labosky for assistance in generating the Rosa26-LSL-SB13 mouse; B. Bhagavan for pathology consultation; M. Tsao for providing the HPDE cell line; and N. Copeland and K. Mann for sharing pre-published information. We thank A. Gopinathan, H. Tiriac, D. Engle, D. Chan, F. Connor, S. Derkits and other members of the Tuveson laboratory for assistance and advice, and the animal care staff and histology core at CRI, and The University of Minnesota's Mouse Genetics Laboratory. This research was supported by the University of Cambridge and Cancer Research UK, The Li Ka Shing Foundation and Hutchison Whampoa Limited, the NIHR Cambridge Biomedical Research Centre, and the NIH (2P50CA101955 SPORE grant to D. A. T., D. A. L. and C.A.I.-D.; grants CA62924, CA128920 and CA106610 to C.A.I.-D.; P50CA62924 SPORE grant to R. H. H. and C.A.I.-D.; and CA122183 to L. S. C.). D.J.A. is supported by Cancer Research UK and the Wellcome Trust. L.v.d.W. is supported by the Kay Kendall Leukemia Fund. C. P. is supported by Wilhelm Sander Stiftung (2009.039.1) and Deutsche Forschungsgemeinschaft (PI 341/5-1). A. V. B., D. K. C., S. M. G. and the APGI investigators are funded by the National Health and Medical research Council of Australia (NHMRC); Queensland Government; Cancer Council NSW; Australian Cancer Research Foundation; Cancer Institute NSW; The Avner Nahmani Pancreatic Cancer Research Foundation; and the R.T. Hall Trust. Additional support was obtained from Fundacion Ibercaja (P.A.P.-M.).	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Furukawa T, 1996, AM J PATHOL, V148, P1763; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; March HN, 2011, NAT GENET, V43, P1202, DOI 10.1038/ng.990; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Nagai H, 2009, MOL CELL, V36, P805, DOI 10.1016/j.molcel.2009.10.016; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Oberdoerffer P, 2005, MOL CELL BIOL, V25, P3896, DOI 10.1128/MCB.25.10.3896-3905.2005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pilarsky C, 2008, J CELL MOL MED, V12, P2823, DOI 10.1111/j.1582-4934.2008.00289.x; REDSTON MS, 1994, CANCER RES, V54, P3025; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Su GH, 2001, P NATL ACAD SCI USA, V98, P3254, DOI 10.1073/pnas.051484398; Sun HS, 2011, BLOOD, V117, P3151, DOI 10.1182/blood-2010-03-276477; Tompers DM, 2004, STEM CELLS, V22, P243, DOI 10.1634/stemcells.22-3-243; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang X, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r79; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109	38	245	248	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					266	+		10.1038/nature11114	http://dx.doi.org/10.1038/nature11114			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699621	Green Accepted			2022-12-28	WOS:000305189000037
J	Olausson, M; Patil, PB; Kuna, VK; Chougule, P; Hernandez, N; Methe, K; Kullberg-Lindh, C; Borg, H; Ejnell, H; Sumitran-Holgersson, S				Olausson, Michael; Patil, Pradeep B.; Kuna, Vijay Kumar; Chougule, Priti; Hernandez, Nidia; Methe, Ketaki; Kullberg-Lindh, Carola; Borg, Helena; Ejnell, Hasse; Sumitran-Holgersson, Suchitra			Transplantation of an allogeneic vein bioengineered with autologous stem cells: a proof-of-concept study	LANCET			English	Article							LIVER-TRANSPLANTATION; CHILDREN	Background Extrahepatic portal vein obstruction can have severe health consequences. Variceal bleeding associated with this disorder causes upper gastrointestinal bleeding, leading to substantial morbidity and mortality. We report the clinical transplantation of a deceased donor iliac vein graft repopulated with recipient autologous stem cells in a patient with extrahepatic portal vein obstruction. Methods A 10 year old girl with extrahepatic portal vein obstruction was admitted to the Sahlgrenska University Hospital in Gothenburg, Sweden, for a bypass procedure between the superior mesenteric vein and the intrahepatic left portal vein (meso Rex bypass). A 9 cm segment of allogeneic donor iliac vein was decellularised and subsequently recellularised with endothelial and smooth muscle cells differentiated from stem cells obtained from the bone marrow of the recipient. This graft was used because the patient's umbilical vein was not suitable and other strategies (eg, liver transplantation) require lifelong immunosuppression. Findings The graft immediately provided the recipient with a functional blood supply (25-30 cm/s in the portal vein and 40 mL/s in the artery was measured intraoperatively and confirmed with ultrasound). The patient had normal laboratory values for 9 months. However, at 1 year the blood flow was low and, on exploration, the shunt was patent but too narrow due to mechanical obstruction of tissue in the mesocolon. Once the tissue causing the compression was removed the graft dilated. We therefore used a second stem-cell populated vein graft to lengthen the previous graft. After this second operation, the portal pressure was reduced from 20 mm Hg to 13 mm Hg and blood flow was 25-40 cm/s in the portal vein. With restored portal circulation the patient has substantially improved physical and mental function and growth. The patient has no anti-endothelial cell antibodies and is receiving no immunosuppressive drugs. Interpretation An acellularised deceased donor vein graft recellularised with autologous stem cells can be considered for patients in need of vascular vein shunts without the need for immunosuppression.	[Olausson, Michael; Patil, Pradeep B.; Kuna, Vijay Kumar; Chougule, Priti; Hernandez, Nidia; Methe, Ketaki; Sumitran-Holgersson, Suchitra] Univ Gothenburg, Sahlgrens Univ Hosp, Dept Surg, Gothenburg, Sweden; [Kullberg-Lindh, Carola; Borg, Helena] Univ Gothenburg, Sahlgrens Univ Hosp, Dept Pediat, Gothenburg, Sweden; [Ejnell, Hasse] Univ Gothenburg, Sahlgrens Univ Hosp, Dept Head & Neck Surg, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg	Sumitran-Holgersson, S (corresponding author), Sahlgrenska Sci Pk, Lab Transplantat & Regenerat Med, Med Regatan 8A, S-41346 Gothenburg, Sweden.	suchitra.holgersson@gu.se	kuna, Vijay Kumar/Z-2407-2019; Olausson, Michael/E-5822-2012	kuna, Vijay Kumar/0000-0003-1578-2861; Olausson, Michael/0000-0002-3949-9430	Absorber AB (Stockholm, Sweden); Swedish Government LUA ALF; Swedish Government	Absorber AB (Stockholm, Sweden); Swedish Government LUA ALF; Swedish Government	SS-H receives royalties from Absorber AB (Stockholm, Sweden), a company that has developed the XM-ONE kit.; This study was financed by the Swedish Government LUA ALF grants to MO and SS-H.; Swedish Government.	ALVAREZ F, 1983, J PEDIATR-US, V103, P696, DOI 10.1016/S0022-3476(83)80460-0; Dijkman PE, 2012, BIOMATERIALS, V33, P4545, DOI 10.1016/j.biomaterials.2012.03.015; Facciuto ME, 2009, SURGERY, V145, P406, DOI 10.1016/j.surg.2008.12.004; IAFFALDANO RA, 1995, CHEST, V108, P725, DOI 10.1378/chest.108.3.725; Krebs-Schmitt D, 2009, PEDIATR TRANSPLANT, V13, P540, DOI 10.1111/j.1399-3046.2008.01109.x; Kuang AA, 1996, TRANSPLANTATION, V62, P742, DOI 10.1097/00007890-199609270-00007; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mack CL, 2006, PEDIATRICS, V117, pE405, DOI 10.1542/peds.2005-1177; Pate M, 2010, ADV CLIN CHEM, V52, P109, DOI 10.1016/S0065-2423(10)52004-3; Selvaggi G, 2007, AM J TRANSPLANT, V7, P454, DOI 10.1111/j.1600-6143.2006.01649.x; Superina R, 2006, PEDIATR TRANSPLANT, V10, P908, DOI 10.1111/j.1399-3046.2006.00598.x; Teebken OE, 2003, EUR J VASC ENDOVASC, V25, P305, DOI 10.1053/ejvs.2002.1873; Vianna R, 2005, TRANSPLANTATION, V80, P534, DOI 10.1097/01.tp.0000168344.16547.da	13	118	128	0	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2012	380	9838					230	237		10.1016/S0140-6736(12)60633-3	http://dx.doi.org/10.1016/S0140-6736(12)60633-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	976TV	22704550				2022-12-28	WOS:000306609200032
J	Abdulcadir, J; Boulvain, M; Petignat, P				Abdulcadir, Jasmine; Boulvain, Michel; Petignat, Patrick			Reconstructive surgery for female genital mutilation	LANCET			English	Editorial Material							6 AFRICAN COUNTRIES; HEALTH		[Abdulcadir, Jasmine; Boulvain, Michel; Petignat, Patrick] Univ Hosp Geneva, Dept Obstet & Gynecol, CH-1211 Geneva, Switzerland	University of Geneva	Abdulcadir, J (corresponding author), Univ Hosp Geneva, Dept Obstet & Gynecol, CH-1211 Geneva, Switzerland.	jasmine.abdulcadir@hcuge.ch		Petignat, Patrick/0000-0002-6835-533X				Adam T, 2010, B WORLD HEALTH ORGAN, V88, P281, DOI 10.2471/BLT.09.064808; Banks E, 2006, LANCET, V367, P1835, DOI 10.1016/S0140-6736(06)68805-3; Catania L, 2007, J SEX MED, V4, P1666, DOI 10.1111/j.1743-6109.2007.00620.x; Foldes P, 2012, LANCET; Johnsdotter S, 2011, 20 WORLD C SEX HLTH; Leye E, 2007, CRIME LAW SOCIAL CH, V47, P1, DOI 10.1007/s10611-007-9055-7; Ministere de la Sante et des Sports, 2010, PRACT FAC MUT GEN FE; Nour NM, 2006, OBSTET GYNECOL, V108, P55, DOI 10.1097/01.AOG.0000224613.72892.77; Obermeyer CM, 2005, CULT HEALTH SEX, V7, P443, DOI 10.1080/14789940500181495; Population Reference Bureau, 2008, FEM GEN MUT CUTT DAT; Puppo V, 2011, EUR J OBSTET GYN R B, V154, P3, DOI 10.1016/j.ejogrb.2010.08.009; Simpson J, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1361; World Health Organization, 2008, EL FEM GEN MUT INT S	13	18	18	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 14	2012	380	9837					90	92		10.1016/S0140-6736(12)60636-9	http://dx.doi.org/10.1016/S0140-6736(12)60636-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	973KN	22695030				2022-12-28	WOS:000306359100013
J	Barber, MF; Michishita-Kioi, E; Xi, YX; Tasselli, L; Kioi, M; Moqtaderi, Z; Tennen, RI; Paredes, S; Young, NL; Chen, KF; Struhl, K; Garcia, BA; Gozani, O; Li, W; Chua, KF				Barber, Matthew F.; Michishita-Kioi, Eriko; Xi, Yuanxin; Tasselli, Luisa; Kioi, Mitomu; Moqtaderi, Zarmik; Tennen, Ruth I.; Paredes, Silvana; Young, Nicolas L.; Chen, Kaifu; Struhl, Kevin; Garcia, Benjamin A.; Gozani, Or; Li, Wei; Chua, Katrin F.			SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation	NATURE			English	Article							LIFE-SPAN; HISTONE MODIFICATION; PREDICT PROGNOSIS; BINDING PROFILES; TRANSCRIPTION; GENE; CHROMATIN; EXPRESSION; PATTERNS; CANCER	Sirtuin proteins regulate diverse cellular pathways that influence genomic stability, metabolism and ageing(1,2). SIRT7 is a mammalian sirtuin whose biochemical activity, molecular targets and physiological functions have been unclear. Here we show that SIRT7 is an NAD(+)-dependent H3K18Ac (acetylated lysine 18 of histone H3) deacetylase that stabilizes the transformed state of cancer cells. Genome-wide binding studies reveal that SIRT7 binds to promoters of a specific set of gene targets, where it deacetylates H3K18Ac and promotes transcriptional repression. The spectrum of SIRT7 target genes is defined in part by its interaction with the cancer-associated E26 transformed specific (ETS) transcription factor ELK4, and comprises numerous genes with links to tumour suppression. Notably, selective hypoacetylation of H3K18Ac has been linked to oncogenic transformation, and in patients is associated with aggressive tumour phenotypes and poor prognosis(3-6). We find that deacetylation of H3K18Ac by SIRT7 is necessary for maintaining essential features of human cancer cells, including anchorage-independent growth and escape from contact inhibition. Moreover, SIRT7 is necessary for a global hypoacetylation of H3K18Ac associated with cellular transformation by the viral oncoprotein E1A. Finally, SIRT7 depletion markedly reduces the tumorigenicity of human cancer cell xenografts in mice. Together, our work establishes SIRT7 as a highly selective H3K18Ac deacetylase and demonstrates a pivotal role for SIRT7 in chromatin regulation, cellular transformation programs and tumour formation in vivo.	[Barber, Matthew F.; Michishita-Kioi, Eriko; Tasselli, Luisa; Tennen, Ruth I.; Paredes, Silvana; Chua, Katrin F.] Stanford Univ, Dept Med, Div Endocrinol Gerontol & Metab, Stanford, CA 94305 USA; [Barber, Matthew F.; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Michishita-Kioi, Eriko; Tasselli, Luisa; Paredes, Silvana; Chua, Katrin F.] VA Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA 94304 USA; [Xi, Yuanxin; Chen, Kaifu; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Kioi, Mitomu] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Moqtaderi, Zarmik; Struhl, Kevin] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Tennen, Ruth I.; Chua, Katrin F.] Stanford Univ, Canc Biol Program, Stanford, CA 94305 USA; [Young, Nicolas L.; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Stanford University; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Baylor College of Medicine; Stanford University; Harvard University; Harvard Medical School; Stanford University; Princeton University	Chua, KF (corresponding author), Stanford Univ, Dept Med, Div Endocrinol Gerontol & Metab, Stanford, CA 94305 USA.	WL1@bcm.edu; kfchua@stanford.edu	Young, Nicolas/AAI-5242-2020; Gozani, Or P/I-6157-2013; Tasselli, Luisa/AAM-6781-2020	Young, Nicolas/0000-0002-3323-2815; Tasselli, Luisa/0000-0003-3349-1371; Barber, Matthew/0000-0003-2008-2165; Li, Wei/0000-0001-9931-5990; Gozani, Or/0000-0002-1365-4463; Kioi, Mitomu/0000-0002-7981-3340	National Institutes of Health (NIH) [K08 AG028961, R01 AG028867, U01DA025956, R01 GM079641, GM 30186, HG 4558, DP2OD007447, 1018438-142 PABCA, 3T32DK007217-36S1]; National Science Foundation [CBET-0941143]; Department of Defense [PC094421]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110471-C3]; Department of Veterans Affairs; ARCS Scholarship; American Italian Cancer Foundation Post-doctoral Research Fellowship; Duncan Scholar Award; Mason Case Graduate Fellowship; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030186, R01GM079641, R01GM030186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028867, K08AG028961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA025956] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007447] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); Cancer Prevention and Research Institute of Texas (CPRIT); Department of Veterans Affairs(US Department of Veterans Affairs); ARCS Scholarship; American Italian Cancer Foundation Post-doctoral Research Fellowship; Duncan Scholar Award; Mason Case Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Snyder and colleagues for high-throughput sequencing (conducted as part of the ENCODE consortium), and members of the Chua and Gozani laboratories for discussions and comments on the manuscript. This work was supported by grants from the National Institutes of Health (NIH) to K. F. C. (K08 AG028961, R01 AG028867), W. L. (U01DA025956), O.G. (R01 GM079641), K. S. (GM 30186, HG 4558) and B. A. G. (DP2OD007447); from the National Science Foundation to B. A. G. (CAREER Award, CBET-0941143); from the Department of Defense to W. L. (PC094421); from the Cancer Prevention and Research Institute of Texas (CPRIT) to W. L. (RP110471-C3); from the Department of Veterans Affairs to K. F. C. (Merit Award); and by fellowship awards to M. F. B. (ARCS Scholarship and Mason Case Graduate Fellowship), R. I. T. (NIH training grant 1018438-142 PABCA), L. T. (American Italian Cancer Foundation Post-doctoral Research Fellowship), S. P. (NIH training grant 3T32DK007217-36S1) and N.L.Y. (NIH F32 NRSA). W. L. is a recipient of a Duncan Scholar Award. K. F. C. is a Paul Beeson Scholar and an Ellison Medical Foundation New Scholar in Aging.	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Ashraf N, 2006, BRIT J CANCER, V95, P1056, DOI 10.1038/sj.bjc.6603384; BRAITHWAITE AW, 1983, J VIROL, V45, P192, DOI 10.1128/JVI.45.1.192-199.1983; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; de Nigris F, 2002, BRIT J CANCER, V86, P917, DOI 10.1038/sj.bjc.6600156; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Frye R, 2002, BRIT J CANCER, V87, P1479, DOI 10.1038/sj.bjc.6600635; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Kaikkonen S, 2010, BBA-GENE REGUL MECH, V1799, P555, DOI 10.1016/j.bbagrm.2010.07.001; Leal JFM, 2008, ONCOGENE, V27, P1961, DOI 10.1038/sj.onc.1210846; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Makkonen H, 2008, ONCOGENE, V27, P4865, DOI 10.1038/onc.2008.125; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Moqtaderi Z, 2010, NAT STRUCT MOL BIOL, V17, P635, DOI 10.1038/nsmb.1794; O'Geen H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-689; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	42	406	417	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					114	+		10.1038/nature11043	http://dx.doi.org/10.1038/nature11043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722849	Green Submitted, Green Accepted			2022-12-28	WOS:000305982900061
J	Milo, R; Last, RL				Milo, Ron; Last, Robert L.			Achieving Diversity in the Face of Constraints: Lessons from Metabolism	SCIENCE			English	Review							AMINO-ACID; PATHWAY; EVOLUTIONARY; OPTIMALITY; BIOSYNTHESIS; EXPRESSION; INDUCTION; SYNTHASE; TOMATO; ENZYME	Metabolic engineering of plants can reduce the cost and environmental impact of agriculture while providing for the needs of a growing population. Although our understanding of plant metabolism continues to increase at a rapid pace, relatively few plant metabolic engineering projects with commercial potential have emerged, in part because of a lack of principles for the rational manipulation of plant phenotype. One underexplored approach to identifying such design principles derives from analysis of the dominant constraints on plant fitness, and the evolutionary innovations in response to those constraints, that gave rise to the enormous diversity of natural plant metabolic pathways.	[Last, Robert L.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Last, Robert L.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Milo, Ron] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Michigan State University; Michigan State University; Weizmann Institute of Science	Last, RL (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	lastr@msu.edu	Milo, Hilla/C-8767-2016	Last, Robert/0000-0001-6974-9587; Milo, Ron/0000-0003-1641-2299	NSF [DBI-1025636, MCB-1119778]; European Research Council [260392]; Israel Science Foundation [750/09]	NSF(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation)	We thank A. Bar Even, A. Flamholz, A. D. Jones, E. Noor, A. Schilmiller, and T. Skaipe for input on the manuscript. Research in R.L.L.'s group is funded by NSF grants DBI-1025636 and MCB-1119778. Research in R.M.'s lab is funded by the European Research Council (grant 260392) and by the Israel Science Foundation (grant 750/09). R.M. is the incumbent of the Anna and Maurice Boukstein career development chair.	Arrivault S, 2009, PLANT J, V59, P824, DOI 10.1111/j.1365-313X.2009.03902.x; Bar-Even A, 2012, NAT CHEM BIOL, V8, P509, DOI [10.1038/NCHEMBIO.971, 10.1038/nchembio.971]; Bar-Even A, 2012, J EXP BOT, V63, P2325, DOI 10.1093/jxb/err417; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; de Kraker JW, 2011, PLANT CELL, V23, P38, DOI 10.1105/tpc.110.079269; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Eames M, 2012, SCIENCE, V336, P911, DOI 10.1126/science.1219083; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; LANDRY LG, 1995, PLANT PHYSIOL, V109, P1159, DOI 10.1104/pp.109.4.1159; Long SR, 2001, PLANT PHYSIOL, V125, P69, DOI 10.1104/pp.125.1.69; MELENDEZHEVIA E, 1985, J THEOR BIOL, V117, P251, DOI 10.1016/S0022-5193(85)80220-4; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; PARKER GA, 1990, NATURE, V348, P27, DOI 10.1038/348027a0; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Pitera DJ, 2007, METAB ENG, V9, P193, DOI 10.1016/j.ymben.2006.11.002; RADWANSKI ER, 1995, MOL GEN GENET, V248, P657, DOI 10.1007/BF02191705; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Sage RF, 2011, J EXP BOT, V62, P2989, DOI 10.1093/jxb/err179; Sallaud C, 2009, PLANT CELL, V21, P301, DOI 10.1105/tpc.107.057885; Savir Y, 2010, P NATL ACAD SCI USA, V107, P3475, DOI 10.1073/pnas.0911663107; Schilmiller AL, 2009, P NATL ACAD SCI USA, V106, P10865, DOI 10.1073/pnas.0904113106; Smolke CD, 2011, CELL, V144, P855, DOI 10.1016/j.cell.2011.02.020; STITT M, 1980, BIOCHIM BIOPHYS ACTA, V593, P85, DOI 10.1016/0005-2728(80)90010-9; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177; Weinhold A, 2011, P NATL ACAD SCI USA, V108, P7855, DOI 10.1073/pnas.1101306108; Weissmann S, 2012, CURR OPIN BIOTECH, V23, P298, DOI 10.1016/j.copbio.2011.12.018; Weng JK, 2012, SCIENCE, V336, P1667, DOI 10.1126/science.1217411; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814; Zhao JM, 1998, PLANT CELL, V10, P359, DOI 10.1105/tpc.10.3.359	35	46	46	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1663	1667		10.1126/science.1217665	http://dx.doi.org/10.1126/science.1217665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745419				2022-12-28	WOS:000305794500038
J	Aarestrup, F				Aarestrup, Frank			Get pigs off antibiotics	NATURE			English	Editorial Material							PRODUCTIVITY; RESISTANCE; FARMS		[Aarestrup, Frank] Tech Univ Denmark, EU Reference Lab Antimicrobial Resistance, DK-2800 Lyngby, Denmark; [Aarestrup, Frank] Tech Univ Denmark, WHO Collaborating Ctr Antimicrobial Resistance Fo, Natl Food Inst, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Aarestrup, F (corresponding author), Tech Univ Denmark, EU Reference Lab Antimicrobial Resistance, DK-2800 Lyngby, Denmark.	fmaa@food.dtu.dk		Aarestrup, Frank/0000-0002-7116-2723				Aarestrup FM, 1995, MICROB DRUG RESIST, V1, P255, DOI 10.1089/mdr.1995.1.255; Aarestrup FM, 2000, APMIS, V108, P5; Aarestrup FM, 2008, EXPERT REV ANTI-INFE, V6, P733, DOI 10.1586/14787210.6.5.733; Aarestrup FM, 2010, AM J VET RES, V71, P726, DOI 10.2460/ajvr.71.7.726; Emborg HD, 2001, PREV VET MED, V50, P53, DOI 10.1016/S0167-5877(01)00218-5; FAOSTAT, 2010, FOOD AGR COMM PROD; Food and Drug Administration, 2012, JUD US MED IMP ANT D; Food and Drug Administration, 2011, 2010 SUMM REP ANT SO; Swann M.M., 1969, REPORT JOINT COMMITT; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1	10	132	138	0	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					465	466		10.1038/486465a	http://dx.doi.org/10.1038/486465a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	965IJ	22739296				2022-12-28	WOS:000305760600017
J	Bitton, A; Flier, LA; Jha, AK				Bitton, Asaf; Flier, Lydia A.; Jha, Ashish K.			Health Information Technology in the Era of Care Delivery Reform To What End?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SYSTEM		[Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Bitton, Asaf; Flier, Lydia A.; Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Bitton, Asaf] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu						Adler-Milstein J, 2012, J AM MED INFORM ASSN, V19, P537, DOI 10.1136/amiajnl-2011-000759; Adler-Milstein J, 2012, JAMA-J AM MED ASSOC, V307, P1695, DOI 10.1001/jama.2012.525; Bates DW, 2010, HEALTH AFFAIR, V29, P614, DOI 10.1377/hlthaff.2010.0007; DesRoches CM, 2012, HEALTH AFFAIR, V31, P1092, DOI 10.1377/hlthaff.2012.0153; Devers K, CAN ACCOUNTABLE CARE; Goldzweig CL, 2009, HEALTH AFFAIR, V28, pW282, DOI 10.1377/hlthaff.28.2.w282; Grumbach K, 2009, JAMA-J AM MED ASSOC, V302, P2363, DOI 10.1001/jama.2009.1772; McCormick D, 2012, HEALTH AFFAIR, V31, P488, DOI 10.1377/hlthaff.2011.0876; Wolf L, 2012, HEALTH AFFAIR, V31, P505, DOI 10.1377/hlthaff.2011.0351	9	40	40	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2012	307	24					2593	2594		10.1001/jama.2012.6663	http://dx.doi.org/10.1001/jama.2012.6663			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	964KF	22735426				2022-12-28	WOS:000305692600025
J	Ebbeling, CB; Swain, JF; Feldman, HA; Wong, WW; Hachey, DL; Garcia-Lago, E; Ludwig, DS				Ebbeling, Cara B.; Swain, Janis F.; Feldman, Henry A.; Wong, William W.; Hachey, David L.; Garcia-Lago, Erica; Ludwig, David S.			Effects of Dietary Composition on Energy Expenditure During Weight-Loss Maintenance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MUSCLE WORK EFFICIENCY; LOW-GLYCEMIC LOAD; LOW-FAT DIET; SKELETAL-MUSCLE; INSULIN SENSITIVITY; RANDOMIZED-TRIAL; LOW-CARBOHYDRATE; OBESE ADULTS; RISK-FACTORS; BODY-WEIGHT	Context Reduced energy expenditure following weight loss is thought to contribute to weight gain. However, the effect of dietary composition on energy expenditure during weight-loss maintenance has not been studied. Objective To examine the effects of 3 diets differing widely in macronutrient composition and glycemic load on energy expenditure following weight loss. Design, Setting, and Participants A controlled 3-way crossover design involving 21 overweight and obese young adults conducted at Children's Hospital Boston and Brigham and Women's Hospital, Boston, Massachusetts, between June 16, 2006, and June 21, 2010, with recruitment by newspaper advertisements and postings. Intervention After achieving 10% to 15% weight loss while consuming a run-in diet, participants consumed an isocaloric low-fat diet (60% of energy from carbohydrate, 20% from fat, 20% from protein; high glycemic load), low-glycemic index diet (40% from carbohydrate, 40% from fat, and 20% from protein; moderate glycemic load), and very low-carbohydrate diet (10% from carbohydrate, 60% from fat, and 30% from protein; low glycemic load) in random order, each for 4 weeks. Main Outcome Measures Primary outcome was resting energy expenditure (REE), with secondary outcomes of total energy expenditure (TEE), hormone levels, and metabolic syndrome components. Results Compared with the pre-weight-loss baseline, the decrease in REE was greatest with the low-fat diet (mean [95% CI], -205 [-265 to -144] kcal/d), intermediate with the low-glycemic index diet (-166 [-227 to -106] kcal/d), and least with the very low-carbohydrate diet (-138 [-198 to -77] kcal/d; overall P = .03; P for trend by glycemic load = .009). The decrease in TEE showed a similar pattern (mean [95% CI], -423 [-606 to -239] kcal/d; -297 [-479 to -115] kcal/d; and -97 [-281 to 86] kcal/d, respectively; overall P = .003; P for trend by glycemic load < .001). Hormone levels and metabolic syndrome components also varied during weight maintenance by diet (leptin, P < .001; 24-hour urinary cortisol, P = .005; indexes of peripheral [P = .02] and hepatic [P = .03] insulin sensitivity; high-density lipoprotein [HDL] cholesterol, P < .001; non-HDL cholesterol, P < .001; triglycerides, P < .001; plasminogen activator inhibitor 1, P for trend = .04; and C-reactive protein, P for trend = .05), but no consistent favorable pattern emerged. Conclusion Among overweight and obese young adults compared with pre-weight-loss energy expenditure, isocaloric feeding following 10% to 15% weight loss resulted in decreases in REE and TEE that were greatest with the low-fat diet, intermediate with the low-glycemic index diet, and least with the very low-carbohydrate diet.	[Ebbeling, Cara B.; Garcia-Lago, Erica; Ludwig, David S.] Childrens Hosp Boston, New Balance Fdn, Obes Prevent Ctr, Boston, MA 02115 USA; [Feldman, Henry A.] Childrens Hosp Boston, Clin Res Ctr, Boston, MA 02115 USA; [Swain, Janis F.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Wong, William W.] ARS, Baylor Coll Med, USDA, Childrens Nutr Res Ctr, Houston, TX USA; [Hachey, David L.] Vanderbilt Univ, Nashville, TN USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Baylor College of Medicine; United States Department of Agriculture (USDA); Vanderbilt University	Ludwig, DS (corresponding author), Childrens Hosp Boston, New Balance Fdn, Obes Prevent Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu	Feldman, Henry/M-2302-2013	Wong, William/0000-0002-7147-5850; Ludwig, David/0000-0003-3307-8544	National Institutes of Health; foundations for obesity-related research; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland [R01DK072428, K24DK082730]; National Center for Research Resources, National Institutes of Health [M01RR02172, M0102635, UL1RR02575801]; New Balance Foundation; foundations for obesity-related research, mentoring, and patient care; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, M01RR002172, M01RR002635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730, R01DK072428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); foundations for obesity-related research; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); New Balance Foundation; foundations for obesity-related research, mentoring, and patient care; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Ebbeling reported receiving grants from the National Institutes of Health and foundations for obesity-related research. Dr Ludwig reported receiving grants from the National Institutes of Health and foundations for obesity-related research, mentoring, and patient care; and royalties from a book about childhood obesity. No other authors reported any conflicts of interest.; This study was supported by grants R01DK072428 and K24DK082730 from the National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland; grant M01RR02172 from the National Center for Research Resources, National Institutes of Health, to the Children's Hospital Boston General Clinical Research Center; grant M0102635 from the National Center for Research Resources, National Institutes of Health, to the Brigham and Women's Hospital General Clinical Research Center; grant UL1RR02575801 from the National Center for Research Resources, National Institutes of Health, to the Harvard Catalyst Clinical and Translational Science Center; and a grant from the New Balance Foundation.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Adam TC, 2010, J CLIN ENDOCR METAB, V95, P4729, DOI 10.1210/jc.2010-0322; Agus MSD, 2000, AM J CLIN NUTR, V71, P901; Atkins RC, 2004, ATKINS LIFE; Baldwin KM, 2011, AM J PHYSIOL-REG I, V301, pR1259, DOI 10.1152/ajpregu.00397.2011; Brand-Miller Jennie, 2007, Curr Atheroscler Rep, V9, P479, DOI 10.1007/s11883-007-0064-x; Chaput JP, 2008, AM J CLIN NUTR, V87, P303, DOI 10.1093/ajcn/87.2.303; Crujeiras AB, 2010, J CLIN ENDOCR METAB, V95, P5037, DOI 10.1210/jc.2009-2566; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Ebbeling CB, 2007, JAMA-J AM MED ASSOC, V297, P2092, DOI 10.1001/jama.297.19.2092; Erez G, 2011, INT J OBESITY, V35, P785, DOI 10.1038/ijo.2010.217; Feinman RD, 2003, METAB SYNDR RELAT D, V1, P209, DOI 10.1089/154041903322716688; Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005; Gadbury G L, 2003, Obes Rev, V4, P175, DOI 10.1046/j.1467-789X.2003.00109.x; Gogebakan O, 2011, CIRCULATION, V124, P2829, DOI 10.1161/CIRCULATIONAHA.111.033274; Goldsmith R, 2010, AM J PHYSIOL-REG I, V298, pR79, DOI 10.1152/ajpregu.00053.2009; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Holt HB, 2007, DIABETOLOGIA, V50, P1024, DOI 10.1007/s00125-007-0629-9; IMAN RL, 1979, TECHNOMETRICS, V21, P499, DOI 10.2307/1268289; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Kelly KR, 2011, J NUTR, V141, P1089, DOI 10.3945/jn.111.139964; Klein S, 2004, AM J CLIN NUTR, V80, P257, DOI 10.1093/ajcn/80.2.257; Kraschnewski JL, 2010, INT J OBESITY, V34, P1644, DOI 10.1038/ijo.2010.94; Labayen I, 1999, EUR J NUTR, V38, P158, DOI 10.1007/s003940050057; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Ludwig DS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e26; Lustig RH, 2004, INT J OBESITY, V28, P1344, DOI 10.1038/sj.ijo.0802753; Mavri A, 2001, DIABETES OBES METAB, V3, P293, DOI 10.1046/j.1463-1326.2001.00134.x; Pereira MA, 2004, JAMA-J AM MED ASSOC, V292, P2482, DOI 10.1001/jama.292.20.2482; Purnell JQ, 2009, AM J PHYSIOL-ENDOC M, V296, pE351, DOI 10.1152/ajpendo.90769.2008; Rankin JW, 2007, J AM COLL NUTR, V26, P163, DOI 10.1080/07315724.2007.10719598; Rosenbaum M, 2003, AM J PHYSIOL-REG I, V285, pR183, DOI 10.1152/ajpregu.00474.2002; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Rousseeuw P. J., 1987, ROBUST REGRESSION OU; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Senn S, 2002, CROSS OVER TRIALS CL; SIMS EAH, 1976, CLIN ENDOCRINOL META, V5, P377, DOI 10.1016/S0300-595X(76)80027-8; Stimson RH, 2007, J CLIN ENDOCR METAB, V92, P4480, DOI 10.1210/jc.2007-0692; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Tentolouris N, 2011, NUTRITION, V27, P310, DOI 10.1016/j.nut.2010.02.007; Vogelzangs N, 2010, J CLIN ENDOCR METAB, V95, P4959, DOI 10.1210/jc.2010-0192	44	255	257	5	83	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2012	307	24					2627	2634		10.1001/jama.2012.6607	http://dx.doi.org/10.1001/jama.2012.6607			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	964KF	22735432	Green Accepted			2022-12-28	WOS:000305692600031
J	Xian, Y; Liang, L; Smith, EE; Schwamm, LH; Reeves, MJ; Olson, DM; Hernandez, AF; Fonarow, GC; Peterson, ED				Xian, Ying; Liang, Li; Smith, Eric E.; Schwamm, Lee H.; Reeves, Mathew J.; Olson, DaiWai M.; Hernandez, Adrian F.; Fonarow, Gregg C.; Peterson, Eric D.			Risks of Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Receiving Warfarin and Treated With Intravenous Tissue Plasminogen Activator	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SYMPTOMATIC INTRACEREBRAL HEMORRHAGE; GUIDELINES-STROKE; CLINICAL-PRACTICE; THROMBOLYSIS; ALTEPLASE; MORTALITY; THERAPY; ASSOCIATION; OUTCOMES; DISEASE	Context Intravenous tissue plasminogen activator (tPA) is known to improve outcomes in ischemic stroke; however, patients receiving long-term chronic warfarin therapy may face an increased risk for intracranial hemorrhage when treated with tPA. Although current guidelines endorse administering intravenous tPA to warfarin-treated patients if their international normalized ratio (INR) is 1.7 or lower, there are few data on safety of intravenous tPA in warfarin-treated patients in clinical practice. Objectives To determine the risk of symptomatic intracranial hemorrhage (sICH) among patients with ischemic stroke treated with intravenous tPA who were receiving warfarin vs those who were not and to determine this risk as a function of INR. Design, Setting, and Patients Observational study, using data from the American Heart Association Get With The Guidelines-Stroke Registry, of 23 437 patients with ischemic stroke and with INR of 1.7 or lower, treated with intravenous tPA in 1203 registry hospitals from April 2009 through June 2011. Main Outcome Measure Symptomatic intracranial hemorrhage. Secondary end points include life-threatening/serious systemic hemorrhage, any tPA complications, and in-hospital mortality. Results Overall, 1802 (7.7%) patients with stroke treated with tPA were receiving warfarin (median INR, 1.20; interquartile range [IQR], 1.07-1.40). Warfarin-treated patients were older, had more comorbid conditions, and had more severe strokes. The unadjusted sICH rate in warfarin-treated patients was higher than in non-warfarin-treated patients (5.7% vs 4.6%, P < .001), but these differences were not significantly different after adjustment for baseline clinical factors (adjusted odds ratio [OR], 1.01 [95% CI, 0.82-1.25]). Similarly, there were no significant differences between warfarin-treated and non-warfarin-treated patients for serious systemic hemorrhage (0.9% vs 0.9%; adjusted OR, 0.78 [95% CI, 0.49-1.24]), any tPA complications (10.6% vs 8.4%; adjusted OR, 1.09 [95% CI, 0.93-1.29]), or in-hospital mortality (11.4% vs 7.9%; adjusted OR, 0.94 [95% CI, 0.79-1.13]). Among warfarin-treated patients with INRs of 1.7 or lower, the degree of anticoagulation was not statistically significantly associated with sICH risk (adjusted OR, 1.10 per 0.1-unit increase in INR [95% CI, 1.00-1.20]; P = .06). Conclusion Among patients with ischemic stroke, the use of intravenous tPA among warfarin-treated patients (INR <= 1.7) was not associated with increased sICH risk compared with non-warfarin-treated patients.	[Xian, Ying; Liang, Li; Olson, DaiWai M.; Hernandez, Adrian F.; Peterson, Eric D.] Duke Clin Res Inst, Durham, NC 27715 USA; [Smith, Eric E.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Schwamm, Lee H.] Massachusetts Gen Hosp, Div Neurol, Boston, MA 02114 USA; [Reeves, Mathew J.] Michigan State Univ, Dept Epidemiol, E Lansing, MI 48824 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA USA	Duke University; University of Calgary; Harvard University; Massachusetts General Hospital; Michigan State University; University of California System; University of California Los Angeles	Peterson, ED (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	peter016@mc.duke.edu	Xian, Ying/O-1956-2019; Peterson, Eric David/ABF-5033-2021; Olson, DaiWai/I-5932-2019; Smith, Eric E/C-5443-2012; Hernandez, Adrian F/A-7818-2016; Fonarow, Gregg C/D-5988-2014	Olson, DaiWai/0000-0002-9280-078X; Smith, Eric E/0000-0003-3956-1668; Hernandez, Adrian F/0000-0003-3387-9616; Fonarow, Gregg C/0000-0002-3192-8093; Schwamm, Lee/0000-0003-0592-9145; Xian, Ying/0000-0002-1237-1162	American Heart Association; Johnson Johnson; Amylin; Portola; Preventis; National Institutes of Health; Eli Lilly; Janssen Pharmaceuticals; American Heart Association-Pharmaceutical Roundtable; David and Stevie Spina; Janssen Pharmaceutical Companies of Johnson Johnson; Boehringer Ingelheim; Merck; Bristol-Myers Squibb/Sanofi Pharmaceutical Partnership; AHA Pharmaceutical Roundtable	American Heart Association(American Heart Association); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Amylin; Portola; Preventis; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly(Eli Lilly); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); American Heart Association-Pharmaceutical Roundtable(American Heart Association); David and Stevie Spina; Janssen Pharmaceutical Companies of Johnson Johnson; Boehringer Ingelheim(Boehringer Ingelheim); Merck(Merck & Company); Bristol-Myers Squibb/Sanofi Pharmaceutical Partnership(Bristol-Myers Squibb); AHA Pharmaceutical Roundtable(American Heart Association)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Smith reported serving as a volunteer for the American Heart Association (AHA) Get With The Guidelines (GWTG) Steering Committee and serving on the advisory board for Genentech. Dr Schwamm reported serving as the chair of the AHA GWTG Steering Committee; serving as a consultant to the Massachusetts Department of Public Health; providing expert review of medical records for malpractice claims against neurologists regarding care of acute stroke; and serving as principal investigator of a phase 2 multicenter study of extended-window intravenous thrombolysis (alteplase provided at no cost to Massachusetts General Hospital). Dr Olson reported receiving a grant from the American Heart Association (Duke Clinical Research Institute serves as the statistical coordinating center for AHA GWTG). Dr Hernandez reported serving as a consultant for Johnson & Johnson, AstraZeneca, sanofi, and Corthera; receiving research grants or grants pending from Johnson & Johnson, Amylin, Portola, and Preventis; and serving as a consultant to Corthera. Dr Fonarow reported serving as a consultant to Pfizer, Merck, Schering-Plough, Bristol-Myers Squibb, and sanofi-aventis; receiving research grants or grants pending from the National Institutes of Health; receiving speakers honoraria from Pfizer, Merck, Schering-Plough, Bristol-Myers Squibb, and sanofi-aventis; and that he is an employee of the University of California, which holds a patent on retriever devices for stroke. Dr Peterson reported receiving research grants from Johnson & Johnson, Eli Lilly, and Janssen Pharmaceuticals and serving as a consultant to Boehringer Ingelheim, Johnson & Johnson, Medscape, Merck, Novartis, Ortho-McNeil-Janssen, Pfizer, Westat, the Cardiovascular Research Foundation, WebMD, and United Healthcare. No other authors reported disclosures.; This study received an award from the American Heart Association-Pharmaceutical Roundtable and from David and Stevie Spina. The Get With The Guidelines-Stroke (GWTG-Stroke) program is provided by the American Heart Association/American Stroke Association. The GWTG-Stroke Program is currently supported in part by a charitable contribution from Janssen Pharmaceutical Companies of Johnson & Johnson. GWTG-Stroke has been funded in the past through support from Boehringer Ingelheim, Merck, Bristol-Myers Squibb/Sanofi Pharmaceutical Partnership, and the AHA Pharmaceutical Roundtable.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Bambauer KZ, 2006, ARCH NEUROL-CHICAGO, V63, P661, DOI 10.1001/archneur.63.5.661; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Matute MC, 2011, THROMB HAEMOSTASIS, V106, P178, DOI 10.1160/TH11-01-0042; De Marchis GM, 2011, STROKE, V42, P3061, DOI 10.1161/STROKEAHA.111.615476; De Smedt A, 2010, CEREBROVASC DIS, V30, P533, DOI 10.1159/000319886; del Zoppo GJ, 2009, STROKE, V40, P2945, DOI 10.1161/STROKEAHA.109.192535; Fonarow GC, 2012, J AM HEART ASSOC, V1, P42, DOI 10.1161/JAHA.111.000034; Fonarow GC, 2010, CIRC-CARDIOVASC QUAL, V3, P291, DOI 10.1161/CIRCOUTCOMES.109.921858; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Graham GD, 2003, STROKE, V34, P2847, DOI 10.1161/01.STR.0000101752.23813.C3; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Kim YD, 2010, J NEUROL SCI, V298, P101, DOI 10.1016/j.jns.2010.07.025; LaBresh KA, 2008, ARCH INTERN MED, V168, P411, DOI 10.1001/archinternmed.2007.101; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Menon BK, 2012, STROKE, V43, pA68; Meretoja A, 2010, STROKE, V41, P1450, DOI 10.1161/STROKEAHA.109.576140; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Prabhakaran S, 2010, ARCH NEUROL-CHICAGO, V67, P559, DOI 10.1001/archneurol.2010.25; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Seet RCS, 2011, STROKE, V42, P2333, DOI 10.1161/STROKEAHA.111.614214; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; Tanne D, 2002, CIRCULATION, V105, P1679, DOI 10.1161/01.CIR.0000012747.53592.6A; Vergouwen MDI, 2011, STROKE, V42, P1041, DOI 10.1161/STROKEAHA.110.599183; Wahlgren N, 2008, LANCET, V372, P1303, DOI 10.1016/S0140-6736(08)61339-2; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wann LS, 2011, CIRCULATION, V123, P1144, DOI 10.1161/CIR.0b013e31820f14c0; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Xian Y, 2012, AM HEART J, V163, P392, DOI 10.1016/j.ahj.2011.12.012	34	115	125	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2012	307	24					2600	2608		10.1001/jama.2012.6756	http://dx.doi.org/10.1001/jama.2012.6756			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	964KF	22735429				2022-12-28	WOS:000305692600028
J	Furst, T; Sayasone, S; Odermatt, P; Keiser, J; Utzinger, J				Fuerst, Thomas; Sayasone, Somphou; Odermatt, Peter; Keiser, Jennifer; Utzinger, Juerg			Manifestation, diagnosis, and management of foodborne trematodiasis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BORNE; CLONORCHIASIS; CHEMOTHERAPY; FASCIOLIASIS; INFECTION; LIVER; PART		[Utzinger, Juerg] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Ecosyst Hlth Sci Unit, CH-4002 Basel, Switzerland; [Utzinger, Juerg] Univ Basel, Ecosyst Hlth Sci Unit, Basel, Switzerland; [Odermatt, Peter] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Res Grp, CH-4002 Basel, Switzerland; [Odermatt, Peter] Univ Basel, Res Grp, Basel, Switzerland; [Keiser, Jennifer] Univ Basel, Helminth Drug Dev Unit, Basel, Switzerland; [Sayasone, Somphou] Minist Hlth, Natl Inst Publ Hlth, Viangchan, Laos; [Keiser, Jennifer] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Helminth Drug Dev Unit, CH-4002 Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Basel; University of Basel; Swiss Tropical & Public Health Institute	Utzinger, J (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Ecosyst Hlth Sci Unit, CH-4002 Basel, Switzerland.	juerg.utzinger@unibas.ch	Odermatt, Peter/K-7727-2015; Odermatt, Peter/AAF-4996-2020	Odermatt, Peter/0000-0002-0296-2508; Sayasone, Somphou/0000-0001-8219-9567	Pro*Doc Research Module from the Swiss National Science Foundation (SNSF) [PDFMP3-123185]; SNSF [PPOOA3-114941, PPOOP3_135170]	Pro*Doc Research Module from the Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF))	TF is associated to the National Centre of Competence in Research (NCCR) North-South and received financial support through a Pro*Doc Research Module from the Swiss National Science Foundation (SNSF; project number PDFMP3-123185). JK acknowledges a personal career development grant from SNSF (projects no PPOOA3-114941 and PPOOP3_135170). The donors had no influence on study design, data collection, analysis, interpretation, writing, or submission.	[Anonymous], 1995, World Health Organ Tech Rep Ser, V849, P1; [Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P121; Bergquist R, 2010, ADV PARASIT, V73, P297, DOI 10.1016/S0065-308X(10)73010-4; Blair David, 2007, V11, P117; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Chai Jong-Yil, 2007, V11, P53; Chai JY, 2009, KOREAN J PARASITOL, V47, pS69, DOI 10.3347/kjp.2009.47.S.S69; Devi KR, 2007, T ROY SOC TROP MED H, V101, P786, DOI 10.1016/j.trstmh.2007.02.028; ELKINS DB, 1991, PARASITOLOGY, V102, P283, DOI 10.1017/S0031182000062600; Furst T, 2012, INFECT DIS CLIN N AM, V26, P399, DOI 10.1016/j.idc.2012.03.008; Furst T, 2012, LANCET INFECT DIS, V12, P210, DOI 10.1016/S1473-3099(11)70294-8; Graczyk TK, 2007, ADV PARASIT, V64, P111, DOI 10.1016/S0065-308X(06)64002-5; Keiser J, 2004, EXPERT OPIN PHARMACO, V5, P1711, DOI 10.1517/14656566.5.8.1711; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6; Keiser J, 2009, CLIN MICROBIOL REV, V22, P466, DOI 10.1128/CMR.00012-09; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Mansour-Ghanaei Fariborz, 2003, Med Sci Monit, V9, pPI127; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; Mas-Coma S, 1999, FASCIOLOSIS, P411; Mas-Coma Santiago, 2007, V11, P293; Ming-gang Chen, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P760; Montresor A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000278; Rim HJ, 2005, J HELMINTHOL, V79, P269, DOI 10.1079/JOH2005300; Sato M, 2009, KOREAN J PARASITOL, V47, P315, DOI 10.3347/kjp.2009.47.3.315; Sayasone S, 2009, T ROY SOC TROP MED H, V103, P247, DOI 10.1016/j.trstmh.2008.10.011; Sithithaworn P, 2009, MANSONS TROPICAL DIS, P1461; Sithithaworn Paiboon, 2007, V11, P3; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Sripa B, 2010, ADV PARASIT, V72, P305, DOI 10.1016/S0065-308X(10)72011-X; Tinga N, 1999, TROP MED INT HEALTH, V4, P814, DOI 10.1046/j.1365-3156.1999.00499.x; Valero MA, 2006, PARASITOLOGY, V133, P453, DOI 10.1017/S003118200600059X; Yang JS, 2000, CHIN J PARASITOL PAR, V18, P1; Yu SH, 1994, REPORT WORLD HLTH OR, P1	34	35	35	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2012	344								e4093	10.1136/bmj.e4093	http://dx.doi.org/10.1136/bmj.e4093			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	968MU	22736467				2022-12-28	WOS:000305986700014
J	Buchhave, LA; Latham, DW; Johansen, A; Bizzarro, M; Torres, G; Rowe, JF; Batalha, NM; Borucki, WJ; Brugamyer, E; Caldwell, C; Bryson, ST; Ciardi, DR; Cochran, WD; Endl, M; Esquerdo, GA; Ford, EB; Geary, JC; Gilliland, RL; Hansen, T; Isaacson, H; Laird, JB; Lucas, PW; Marcy, GW; Morse, JA; Robertson, P; Shporer, A; Stefanik, RP; Still, M; Quinn, SN				Buchhave, Lars A.; Latham, David W.; Johansen, Anders; Bizzarro, Martin; Torres, Guillermo; Rowe, Jason F.; Batalha, Natalie M.; Borucki, William J.; Brugamyer, Erik; Caldwell, Caroline; Bryson, Stephen T.; Ciardi, David R.; Cochran, William D.; Endl, Michael; Esquerdo, Gilbert A.; Ford, Eric B.; Geary, John C.; Gilliland, Ronald L.; Hansen, Terese; Isaacson, Howard; Laird, John B.; Lucas, Philip W.; Marcy, Geoffrey W.; Morse, Jon A.; Robertson, Paul; Shporer, Avi; Stefanik, Robert P.; Still, Martin; Quinn, Samuel N.			An abundance of small exoplanets around stars with a wide range of metallicities	NATURE			English	Article							PLANETESIMAL FORMATION; GIANT PLANETS; HOST STARS; MASS; PHOTOEVAPORATION; CANDIDATES; PARAMETERS; LIFETIMES; SEARCH; SYSTEM	The abundance of heavy elements (metallicity) in the photospheres of stars similar to the Sun provides a 'fossil' record of the chemical composition of the initial protoplanetary disk. Metal-rich stars are much more likely to harbour gas giant planets(1-4), supporting the model that planets form by accumulation of dust and ice particles(5). Recent ground-based surveys suggest that this correlation is weakened for Neptunian-sized planets(4,6-9). However, how the relationship between size and metallicity extends into the regime of terrestrial-sized exoplanets is unknown. Here we report spectroscopic metallicities of the host stars of 226 small exoplanet candidates discovered by NASA's Kepler mission(10), including objects that are comparable in size to the terrestrial planets in the Solar System. We find that planets with radii less than four Earth radii form around host stars with a wide range of metallicities (but on average a metallicity close to that of the Sun), whereas large planets preferentially form around stars with higher metallicities. This observation suggests that terrestrial planets may be widespread in the disk of the Galaxy, with no special requirement of enhanced metallicity for their formation.	[Buchhave, Lars A.; Hansen, Terese] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Buchhave, Lars A.; Bizzarro, Martin] Univ Copenhagen, Ctr Star & Planet Format, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Latham, David W.; Torres, Guillermo; Esquerdo, Gilbert A.; Geary, John C.; Stefanik, Robert P.; Quinn, Samuel N.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Johansen, Anders] Lund Univ, Lund Observ, S-22100 Lund, Sweden; [Rowe, Jason F.] NASA, SETI Inst, Ames Res Ctr, Moffett Field, CA 94035 USA; [Batalha, Natalie M.] San Jose State Univ, San Jose, CA 95192 USA; [Brugamyer, Erik; Caldwell, Caroline; Cochran, William D.; Endl, Michael; Robertson, Paul] Univ Texas Austin, Austin, TX 78712 USA; [Ciardi, David R.] CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91109 USA; [Ford, Eric B.] Univ Florida, Bryant Space Sci Ctr 211, Gainesville, FL 32611 USA; [Gilliland, Ronald L.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Isaacson, Howard; Marcy, Geoffrey W.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Laird, John B.] Bowling Green State Univ, Bowling Green, OH 43403 USA; [Lucas, Philip W.] Univ Hertfordshire, Ctr Astrophys, Hatfield AL10 9AB, Herts, England; [Morse, Jon A.] Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY 12180 USA; [Shporer, Avi] Las Cumbres Observ, Global Telescope Network, Goleta, CA 93117 USA; [Shporer, Avi] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Still, Martin] NASA, Bay Area Environm Res Inst, Ames Res Ctr, Moffett Field, CA 94035 USA	University of Copenhagen; Niels Bohr Institute; University of Copenhagen; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Lund University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California State University System; San Jose State University; University of Texas System; University of Texas Austin; California Institute of Technology; National Aeronautics & Space Administration (NASA); State University System of Florida; University of Florida; Space Telescope Science Institute; University of California System; University of California Berkeley; University System of Ohio; Bowling Green State University; University of Hertfordshire; Rensselaer Polytechnic Institute; University of California System; University of California Santa Barbara; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Buchhave, LA (corresponding author), Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	buchhave@astro.ku.dk	Robertson, Paul/AEV-0522-2022; Buchhave, Lars A./ABF-2000-2020; Cochran, William D/M-4421-2014; Bizzarro, Martin/M-7474-2019; Shporer, Avi/Y-2777-2019; Ford, Eric B./AAB-5479-2019; Marcy, Geoff/AAC-6050-2019; Bizzarro, Martin/I-8701-2012	Robertson, Paul/0000-0003-0149-9678; Buchhave, Lars A./0000-0003-1605-5666; Cochran, William D/0000-0001-9662-3496; Bizzarro, Martin/0000-0001-9966-2124; Shporer, Avi/0000-0002-1836-3120; Ford, Eric B./0000-0001-6545-639X; Bizzarro, Martin/0000-0001-9966-2124; Rowe, Jason/0000-0002-5904-1865; Ciardi, David/0000-0002-5741-3047; Batalha, Natalie/0000-0002-7030-9519; Johansen, Anders/0000-0002-5893-6165; Latham, David/0000-0001-9911-7388; Lucas, Philip/0000-0002-8872-4462	NASA's Science Mission Directorate; Danish National Research Foundation; Carlsberg Foundation; European Research Council under ERC Starting Grant agreement [278675-PEBBLE2PLANET]	NASA's Science Mission Directorate; Danish National Research Foundation(Danmarks Grundforskningsfond); Carlsberg Foundation(Carlsberg Foundation); European Research Council under ERC Starting Grant agreement	The Kepler mission was competitively selected as the tenth NASA Discovery mission. Funding for this mission is provided by NASA's Science Mission Directorate. The Centre for Star and Planet Formation is funded by the Danish National Research Foundation. L. A. B. was funded by the Carlsberg Foundation. A.J. was partially funded by the European Research Council under ERC Starting Grant agreement 278675-PEBBLE2PLANET.	Borucki WJ, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/19; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Ghezzi L, 2010, ASTROPHYS J, V720, P1290, DOI 10.1088/0004-637X/720/2/1290; Gonzalez G, 2001, ICARUS, V152, P185, DOI 10.1006/icar.2001.6617; Gorti U, 2009, ASTROPHYS J, V690, P1539, DOI 10.1088/0004-637X/690/2/1539; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; Hester JJ, 2004, SCIENCE, V304, P1116, DOI 10.1126/science.1096808; Howard A. W., 2011, PLANET OCCURRENCE 0; Ida S, 2004, ASTROPHYS J, V616, P567, DOI 10.1086/424830; Johansen A, 2009, ASTROPHYS J LETT, V704, pL75, DOI 10.1088/0004-637X/704/2/L75; Johnson JA, 2010, PUBL ASTRON SOC PAC, V122, P905, DOI 10.1086/655775; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; Lissauer JJ, 2011, NATURE, V470, P53, DOI 10.1038/nature09760; Mayor M., 2011, HARPS SEARCH SO EXTR; Morton TD, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/170; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Schiller M, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/1/L22; Schlaufman KC, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/177; Sousa SG, 2008, ASTRON ASTROPHYS, V487, P373, DOI 10.1051/0004-6361:200809698; Throop HB, 2005, ASTROPHYS J, V623, pL149, DOI 10.1086/430272; Udry S, 2006, ASTRON ASTROPHYS, V447, P361, DOI 10.1051/0004-6361:20054084; Yi S, 2001, ASTROPHYS J SUPPL S, V136, P417, DOI 10.1086/321795	27	440	443	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					375	377		10.1038/nature11121	http://dx.doi.org/10.1038/nature11121			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722196				2022-12-28	WOS:000305466800037
J	Gravitz, L				Gravitz, Lauren			FOOD SCIENCE Taste bud hackers	NATURE			English	Editorial Material																		Tieman D, 2012, CURR BIOL, V22, P1035, DOI 10.1016/j.cub.2012.04.016	1	6	6	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					S14	S15		10.1038/486S14a	http://dx.doi.org/10.1038/486S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RB	22717397				2022-12-28	WOS:000311781000008
J	Joing, S; Strote, S; Caroon, L; Wall, C; Hess, J; Roline, C; Oh, L; Dolan, B; Poutre, R; Carney, K; Plummer, D; Reardon, R				Joing, Scott; Strote, Seth; Caroon, Liberty; Wall, Christopher; Hess, Jamie; Roline, Chad; Oh, Laura; Dolan, Ben; Poutre, Robb; Carney, Kathleen; Plummer, David; Reardon, Robert			Ultrasound-Guided Peripheral IV Placement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DIFFICULT INTRAVENOUS ACCESS		[Joing, Scott; Strote, Seth; Caroon, Liberty; Wall, Christopher; Hess, Jamie; Roline, Chad; Poutre, Robb; Plummer, David; Reardon, Robert] Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA; [Oh, Laura] W Suburban Med Ctr, Dept Emergency Med, Oak Pk, IL USA; [Dolan, Ben] Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA; [Carney, Kathleen] Women & Childrens Hosp Buffalo, Dept Emergency Med, Buffalo, NY USA	Hennepin County Medical Center; Michigan State University; Michigan State University College of Human Medicine; Women & Children's Hospital of Buffalo	Joing, S (corresponding author), Hennepin Cty Med Ctr, Dept Emergency Med, 701 Pk Ave,MC R2, Minneapolis, MN 55415 USA.	scott.joing@hcmed.org		Hess, Jamie/0000-0002-3411-2751				Blaivas M, 2003, ACAD EMERG MED, V10, P1307, DOI 10.1197/S1069-6563(03)00534-7; Costantino TG, 2005, ANN EMERG MED, V46, P456, DOI 10.1016/j.annemergmed.2004.12.026; Keyes LE, 1999, ANN EMERG MED, V34, P711, DOI 10.1016/S0196-0644(99)70095-8; STEIN JC, 2004, ACAD EMERG MED, V11, P581; Stone MB, 2010, AM J EMERG MED, V28, P343, DOI 10.1016/j.ajem.2008.11.022	5	22	23	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					E38	E38		10.1056/NEJMvcm1005951	http://dx.doi.org/10.1056/NEJMvcm1005951			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961GH	22716992				2022-12-28	WOS:000305451700010
J	Shamliyan, T; Wyman, JF; Ramakrishnan, R; Sainfort, F; Kane, RL				Shamliyan, Tatyana; Wyman, Jean F.; Ramakrishnan, Rema; Sainfort, Francois; Kane, Robert L.			Benefits and Harms of Pharmacologic Treatment for Urinary Incontinence in Women A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							QUALITY-OF-LIFE; OVERACTIVE BLADDER SYNDROME; EXTENDED-RELEASE TOLTERODINE; SELECTIVE RECEPTOR ANTAGONIST; ANTIMUSCARINIC AGENT SOLIFENACIN; RANDOMIZED CONTROLLED-TRIAL; PATIENT-REPORTED OUTCOMES; DAILY TROSPIUM CHLORIDE; PLACEBO-CONTROLLED TRIAL; ONCE-DAILY FORMULATION	Background: Urinary incontinence (UI) in women adversely affects quality of life. Purpose: To conduct a systematic literature review of drugs for urgency UI in women. Data Sources: MEDLINE, the Cochrane Central Register of Controlled Trials, SCIRUS, and Google Scholar were searched for articles published from 1966 to November 2011. Study Selection: Randomized, controlled trials (RCTs) reported in English. Data Extraction: Rates of outcomes and risk of bias were extracted by using a standardized form to pool absolute risk differences and calculate the number of attributable events per 1000 patients treated, with 95% CIs. Data Synthesis: 94 RCTs were eligible. Pooled analyses showed that among drugs for urgency UI, per 1000 treated women, continence was restored in 130 with fesoterodine (CI, 58 to 202), 85 with tolterodine (CI, 40 to 129), 114 with oxybutynin (CI, 64 to 163), 107 with solifenacin (CI, 58 to 156), and 114 with trospium (CI, 83 to 144). Rates of treatment discontinuation due to adverse effects were 31 per 1000 treated with fesoterodine (CI, 10 to 56), 63 with oxybutynin (CI, 12 to 127), 18 with trospium (CI, 4 to 33), and 13 with solifenacin (CI, 1 to 26). The studies' inconsistent definitions of reduction in UI and quality of life hampered synthesis of evidence. Limitation: Evidence for quality-of-life improvements and comparative effectiveness with drugs was limited, and evidence for the effects of race, baseline severity of UI, and comorbid conditions on treatment success was insufficient. Conclusion: Overall, drugs for urgency UI showed similar small benefit. Therapeutic choices should consider the harms profile. Evidence for long-term adherence and safety of treatments is lacking. Primary Funding Source: Agency for Healthcare Research and Quality.	[Shamliyan, Tatyana] Univ Minnesota, Sch Publ Hlth, Minnesota Evidence Based Practice Ctr, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Nursing, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Shamliyan, T (corresponding author), Univ Minnesota, Sch Publ Hlth, Minnesota Evidence Based Practice Ctr, D330-5 Mayo MMC 729,420 Delaware St, Minneapolis, MN 55455 USA.	shaml005@umn.edu	Ramakrishnan, Rema/AAE-1742-2022; Ramakrishnan, Rema/AAM-7811-2020; Shamliyan, Tatyana/AAU-8323-2020	Ramakrishnan, Rema/0000-0002-6784-8319; Shamliyan, Tatyana/0000-0003-3584-2008	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Abdel-Fattah M, 2007, EUR J OBSTET GYN R B, V133, P86, DOI 10.1016/j.ejogrb.2006.04.034; Abrams P, 1998, BRIT J UROL, V81, P801; Abrams P, 2017, INCONTINENCE 6 INT C; Abrams P, 2009, INCONTINENCE, P1027; Abrams P, 2009, INCONTINENCE, P46; Abrams P, 2008, BJU INT, V102, P208, DOI 10.1111/j.1464-410X.2008.07523.x; Abrams P, 2007, BJU INT, V100, P987, DOI 10.1111/j.1464-410X.2007.07205.x; Agency for Healthcare Research and Quality, 2010, HHS AW 473 MILL PAT; Agency for Healthcare Research and Quality, 2007, METH GUID COMP EFF R, V2009; Altan-Yaycioglu R, 2005, BRIT J CLIN PHARMACO, V59, P588, DOI 10.1111/j.1365-2125.2005.02356.x; Amarenco G, 2003, EUR UROL, V43, P391, DOI 10.1016/S0302-2838(03)00054-X; Anderson RU, 2006, INT UROGYNECOL J, V17, P502, DOI 10.1007/s00192-005-0057-7; Anderson RU, 1999, J UROLOGY, V161, P1809, DOI 10.1016/S0022-5347(05)68810-6; Andersson KE, 2000, BEST PRACT RES CL OB, V14, P291, DOI 10.1053/beog.1999.0075; [Anonymous], 2005, P 20 C EUR ASS UR IS; Appell RA, 2001, MAYO CLIN PROC, V76, P358; Arends LR, 2000, STAT MED, V19, P3497, DOI 10.1002/1097-0258(20001230)19:24<3497::AID-SIM830>3.0.CO;2-H; Armstrong RB, 2007, INT UROL NEPHROL, V39, P1069, DOI 10.1007/s11255-006-9157-7; Armstrong Robert B., 2005, International Urology and Nephrology, V37, P247, DOI 10.1007/s11255-004-4703-7; Aschengrau A., 2020, ESSENTIALS EPIDEMIOL; Avery K, 2004, NEUROUROL URODYNAM, V23, P322, DOI 10.1002/nau.20041; Barkin J, 2004, CLIN THER, V26, P1026, DOI 10.1016/S0149-2918(04)90174-9; Basra R, 2010, NEUROUROL URODYNAM, V29, P943; Birns J, 2000, BJU INT, V85, P793, DOI 10.1046/j.1464-410x.2000.00623.x; Bodeker RH, 2010, BMC UROL, V10, DOI 10.1186/1471-2490-10-15; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Bradway Christine, 2003, J Gerontol Nurs, V29, P13; Burgio KL, 2008, ANN INTERN MED, V149, P161, DOI 10.7326/0003-4819-149-3-200808050-00005; Burgio KL, 2006, NEUROUROL URODYNAM, V25, P411, DOI 10.1002/nau.20243; Burgio KL, 2010, J UROLOGY, V184, P598, DOI 10.1016/j.juro.2010.03.141; Burgio KL, 2000, J AM GERIATR SOC, V48, P370, DOI 10.1111/j.1532-5415.2000.tb04692.x; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; Burgio KL, 2001, J GERONTOL B-PSYCHOL, V56, pP46, DOI 10.1093/geronb/56.1.P46; But I, 2010, NEUROUROL URODYNAM, V29, P1217; Cardozo L, 2004, J UROLOGY, V172, P1919, DOI 10.1097/01.ju.0000140729.07840.16; Cardozo L, 2008, BJU INT, V102, P1120, DOI 10.1111/j.1464-410X.2008.07939.x; Cardozo L, 2006, INT UROGYNECOL J, V17, P512, DOI 10.1007/s00192-005-0058-6; Cardozo L, 2010, BJU INT, V106, P816, DOI 10.1111/j.1464-410X.2010.09202.x; Cardozo L, 2010, BJU INT, V106, P506, DOI 10.1111/j.1464-410X.2009.09160.x; Cartwright R, 2011, BJU INT, V107, P70, DOI 10.1111/j.1464-410X.2010.09508.x; Chancellor MB, 2008, INT J CLIN PRACT, V62, P606, DOI 10.1111/j.1742-1241.2008.01714.x; Chancellor MB, 2001, CLIN THER, V23, P753, DOI 10.1016/S0149-2918(01)80024-2; Chancellor MB, 2010, NEUROUROL URODYNAM, V29, P551, DOI 10.1002/nau.20787; Chapple C, 2007, CURR MED RES OPIN, V23, P2347, DOI 10.1185/03007X226294; Chapple C, 2005, BJU INT, V95, P993, DOI 10.1111/j.1464-410X.2005.05454.x; Chapple C, 2004, 2004 C INT CONT SOC; Chapple CR, 2006, INT J CLIN PRACT, V60, P959, DOI 10.1111/j.1742-1241.2006.01067.x; Chapple C, 2007, EUR UROL, V52, P1204, DOI 10.1016/j.eururo.2007.07.009; Chapple CR, 2008, BJU INT, V102, P1128, DOI 10.1111/j.1464-410X.2008.07907.x; Chapple CR, 2007, EUR UROL, V52, P1195, DOI 10.1016/j.eururo.2007.05.027; Chapple CR, 2005, EUR UROL, V48, P102, DOI 10.1016/j.eururo.2005.04.018; Chapple CR, 2004, EXPERT OPIN INV DRUG, V13, P1493, DOI 10.1517/13543784.13.11.1493; Chapple CR, 2005, EUR UROL, V48, P464, DOI 10.1016/j.eururo.2005.05.015; Chapple CR, 2004, BJU INT, V93, P303, DOI 10.1111/j.1464-410X.2004.04606.x; Chapple CR, 2004, BJU INT, V93, P71, DOI 10.1111/j.1464-410X.2004.04561.x; Chapple CR, 2000, UROLOGY, V55, P33, DOI 10.1016/S0090-4295(99)00492-6; Choo MS, 2008, INT J CLIN PRACT, V62, P1675, DOI 10.1111/j.1742-1241.2008.01898.x; Chou R, 2010, J CLIN EPIDEMIOL, V63, P502, DOI 10.1016/j.jclinepi.2008.06.007; Chu FM, 2005, AM J OBSTET GYNECOL, V192, P1849, DOI 10.1016/j.ajog.2005.03.036; Corcos J, 2006, BJU INT, V97, P520, DOI 10.1111/j.1464-410X.2005.06031.x; Coyne KS, 2011, BJU INT, V108, P1459, DOI 10.1111/j.1464-410X.2010.10013.x; Coyne KS, 2003, BJU INT, V92, P731, DOI 10.1046/j.1464-410X.2003.04463.x; Davila GW, 2001, J UROLOGY, V166, P140, DOI 10.1016/S0022-5347(05)66095-8; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diokno AC, 2003, MAYO CLIN PROC, V78, P687, DOI 10.4065/78.6.687; Dmochowski R, 2007, BJU INT, V100, P107, DOI 10.1111/j.1464-410X.2007.06926.x; Dmochowski RR, 2008, UROLOGY, V71, P449, DOI 10.1016/j.urology.2007.11.008; Dmochowski RR, 2010, VALUE HEALTH, V13, P251, DOI 10.1111/j.1524-4733.2009.00652.x; Dmochowski RR, 2010, UROLOGY, V75, P62, DOI 10.1016/j.urology.2009.09.018; Dmochowski RR, 2003, UROLOGY, V62, P237, DOI 10.1016/S0090-4295(03)00356-X; Dmochowski RR, 2005, WORLD J UROL, V23, P263, DOI 10.1007/s00345-005-0012-8; Dmochowski RR, 2002, J UROLOGY, V168, P580, DOI 10.1016/S0022-5347(05)64684-8; Drutz H P, 1999, Int Urogynecol J Pelvic Floor Dysfunct, V10, P283, DOI 10.1007/s001929970003; DuBeau CE, 2005, NEUROUROL URODYNAM, V24, P13, DOI 10.1002/nau.20083; Ebrahim S, 2001, EVAL HEALTH PROF, V24, P152, DOI 10.1177/01632780122034858; Egger M., 2001, SYSTEMATIC REV HLTH; ENZELSBERGER H, 1995, BRIT J OBSTET GYNAEC, V102, P929, DOI 10.1111/j.1471-0528.1995.tb10885.x; Epstein LB, 2005, INT J FERTIL WOMEN M, V50, P30; Fe RW, 2011, J CLIN EPIDEMIOL, V64, P1187, DOI 10.1016/j.jclinepi.2010.08.010; FitzGerald MP, 2008, INT UROGYNECOL J, V19, P1545, DOI 10.1007/s00192-008-0687-7; Foote J, 2005, EUR UROL, V48, P471, DOI 10.1016/j.eururo.2005.05.009; Franzen K, 2010, INT UROGYNECOL J, V21, P1517, DOI 10.1007/s00192-010-1213-2; Freeman R, 2003, OBSTET GYNECOL, V102, P605, DOI 10.1016/S0029-7844(03)00623-9; Garely AD, 2007, ANN PHARMACOTHER, V41, P391, DOI 10.1345/aph.1H581; Ghoniem G, 2008, INT UROGYNECOL J, V19, P5, DOI 10.1007/s00192-007-0495-5; Gleason DM, 1999, UROLOGY, V54, P420, DOI 10.1016/S0090-4295(99)00259-9; Goode PS, 2004, UROLOGY, V63, P58, DOI 10.1016/j.urology.2003.10.032; Goode PS, 2002, J AM GERIATR SOC, V50, P808, DOI 10.1046/j.1532-5415.2002.50204.x; Gupta SK, 1999, J CLIN PHARMACOL, V39, P289; Gupta SK, 1999, CLIN PHARMACOL THER, V65, P672, DOI 10.1016/S0009-9236(99)90089-9; Haab F, 2005, EUR UROL, V47, P376, DOI 10.1016/j.eururo.2004.11.004; Haab F, 2004, EUR UROL, V45, P420, DOI 10.1016/j.eururo.2004.01.008; Haab F, 2006, BJU INT, V98, P1025, DOI 10.1111/j.1464-410X.2006.06439.x; Halaska M., 2003, World Journal of Urology, V20, P392; Hartmann Katherine E, 2009, Evid Rep Technol Assess (Full Rep), P1; Hartmann KE, 2009, EVID REP TECHNOL ASS, pv; Haylen BT, 2011, NEUROUROL URODYNAM, V30, P2, DOI 10.1002/nau.21036; Haylen BT, 2010, INT UROGYNECOL J, V21, P5, DOI [10.1007/s00192-009-0976-9, 10.1590/S1677-55382010000100032]; Herbison P, 2006, J CLIN EPIDEMIOL, V59, P1249, DOI 10.1016/j.jclinepi.2006.03.008; Herschorn S, 2007, 32 ANN IUGA M CANC M; Herschorn Sender, 2004, Can J Urol, V11, P2430; Herschorn S, 2010, J UROLOGY, V183, P1892, DOI 10.1016/j.juro.2010.01.012; Herschorn S, 2010, BJU INT, V105, P58, DOI 10.1111/j.1464-410X.2009.09086.x; Herschorn S, 2008, CURR MED RES OPIN, V24, P3513, DOI 10.1185/03007990802537122 ; Higgins J, 2011, COCHR HDB SYSTEMATIC; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill S, 2006, INT UROGYNECOL J, V17, P239, DOI 10.1007/s00192-005-1340-3; Ho CH, 2010, J FORMOS MED ASSOC, V109, P702, DOI 10.1016/S0929-6646(10)60114-3; Homma Y, 2006, NEUROUROL URODYNAM, V25, P228, DOI 10.1002/nau.20195; Homma Y, 2004, WORLD J UROL, V22, P251, DOI 10.1007/s00345-004-0455-3; Homma Y, 2003, BJU INT, V92, P741, DOI 10.1046/j.1464-410X.2003.04468.x; Hughes DA, 2004, PHARMACOECONOMICS, V22, P1047, DOI 10.2165/00019053-200422160-00002; Jacquetin B, 2001, EUR J OBSTET GYN R B, V98, P97, DOI 10.1016/S0301-2115(00)00561-3; Johnson TM, 2005, J AM GERIATR SOC, V53, P846, DOI 10.1111/j.1532-5415.2005.53260.x; Jonas U, 1997, WORLD J UROL, V15, P144, DOI 10.1007/BF02201987; Junemann KP, 2000, NEUROUROL URODYNAM, V19, P488; Kaplan SA, 2011, BJU INT, V107, P1432, DOI 10.1111/j.1464-410X.2010.09640.x; Karram MM, 2009, UROLOGY, V73, P14, DOI 10.1016/j.urology.2008.08.485; Kelleher CJ, 2002, AM J MANAG CARE, V8, pS608; Kelleher C, 2006, INT UROGYNECOL J, V17, P382, DOI 10.1007/s00192-005-0023-4; Kelleher CJ, 2008, BJU INT, V102, P56, DOI 10.1111/j.1464-410X.2008.07710.x; Khullar V, 2004, UROLOGY, V64, P269, DOI 10.1016/j.urology.2004.02.029; Khullar V, 2008, UROLOGY, V71, P839, DOI 10.1016/j.urology.2007.12.017; Knapp G, 2006, BIOMETRICAL J, V48, P271, DOI 10.1002/bimj.200510175; Ko Y, 2006, PHARMACOTHERAPY, V26, P1694, DOI 10.1592/phco.26.12.1694; Kreder KJ, 2003, BJU INT, V92, P418, DOI 10.1046/j.1464-410X.2003.04363.x; Lackner TE, 2008, J AM GERIATR SOC, V56, P862, DOI 10.1111/j.1532-5415.2008.01680.x; Landis JR, 2004, J UROLOGY, V171, P752, DOI 10.1097/01.ju.0000103540.71683.e5; Layton D, 2001, DRUG SAFETY, V24, P703, DOI 10.2165/00002018-200124090-00005; Lee JG, 2002, INT J UROL, V9, P247, DOI 10.1046/j.1442-2042.2002.00460.x; Lehtoranta K, 2002, SCAND J UROL NEPHROL, V36, P18, DOI 10.1080/003655902317259319; Leung HY, 2002, BJU INT, V90, P375, DOI 10.1046/j.1464-410X.2002.02905.x; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lipton RB, 2005, J UROLOGY, V173, P493, DOI 10.1097/01.ju.0000148963.21096.5d; MacDiarmid SA, 2005, J UROLOGY, V174, P1301, DOI 10.1097/01.ju.0000173076.93737.d5; MacDiarmid SA, 2010, J UROLOGY, V183, P234, DOI 10.1016/j.juro.2009.08.160; Madersbacher H, 1999, BJU INT, V84, P646; Malhotra B, 2010, INT J CLIN PHARM TH, V48, P309; Malone-Lee J, 2003, BJU INT, V92, P415, DOI 10.1046/j.1464-410X.2003.04351.x; Malone-Lee JG, 2009, BJU INT, V103, P931, DOI 10.1111/j.1464-410X.2009.08361.x; Malone-Lee JG, 2001, J AM GERIATR SOC, V49, P700, DOI 10.1046/j.1532-5415.2001.49144.x; Martin JL, 2006, NEUROUROL URODYNAM, V25, P674, DOI 10.1002/nau.20340; Millard R, 1999, J UROLOGY, V161, P1551, DOI 10.1016/S0022-5347(05)68951-3; MOORE KH, 1990, BRIT J UROL, V66, P479, DOI 10.1111/j.1464-410X.1990.tb14992.x; Nitti VW, 2007, J UROLOGY, V178, P2488, DOI 10.1016/j.juro.2007.08.033; Nitti VW, 2010, BJU INT, V105, P1268, DOI 10.1111/j.1464-410X.2009.09037.x; Norris S., 2010, METHODS GUIDE COMP E; O'Brien BJ, 2001, CLIN THER, V23, P2038, DOI 10.1016/S0149-2918(01)80156-9; Oh MS, 2008, NEUROLOGY, V70, P405, DOI 10.1212/01.wnl.0000298726.31304.be; Oh SJ, 2005, NEUROUROL URODYNAM, V24, P341, DOI 10.1002/nau.20130; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Ozdedeli S, 2010, CLIN REHABIL, V24, P342, DOI 10.1177/0269215509346092; Perfetto EM, 2005, AM J MANAG CARE, V11, pS150; Peters KM, 2009, J UROLOGY, V182, P1055, DOI 10.1016/j.juro.2009.05.045; Pontari MA, 2010, J UROLOGY, V183, P1899, DOI 10.1016/j.juro.2010.01.009; Preik M, 2004, BJU INT, V94, P821, DOI 10.1111/j.1464-410X.2004.05040.x; Rentzhog L, 1998, BRIT J UROL, V81, P42; Robinson D, 2007, BJU INT, V100, P840, DOI 10.1111/j.1464-410X.2007.07162.x; Rogers R, 2008, INT UROGYNECOL J, V19, P1551, DOI 10.1007/s00192-008-0688-6; Rogers RG, 2009, CURR MED RES OPIN, V25, P2159, DOI 10.1185/03007990903103279; Rogers RG, 2009, INT UROGYNECOL J, V20, P381, DOI 10.1007/s00192-008-0782-9; Rudy D, 2006, BJU INT, V97, P540, DOI 10.1111/j.1464-410X.2006.06035.x; Rudy D, 2006, UROLOGY, V67, P275, DOI 10.1016/j.urology.2005.08.017; Rucker G, 2009, STAT MED, V28, P721, DOI 10.1002/sim.3511; Salvatore S, 2005, EUR J OBSTET GYN R B, V119, P237, DOI 10.1016/j.ejogrb.2004.07.042; Sand P, 2007, BJU INT, V99, P835, DOI 10.1111/j.1464-410X.2006.06658.x; Sand PK, 2006, AM J OBSTET GYNECOL, V195, P1730, DOI 10.1016/j.ajog.2006.08.013; Sand PK, 2011, BJU INT, V107, P612, DOI 10.1111/j.1464-410X.2010.09519.x; Sand PK, 2011, DRUG AGING, V28, P151, DOI 10.2165/11586740-000000000-00000; Sand PK, 2009, INT UROGYNECOL J, V20, P1431, DOI 10.1007/s00192-009-0969-8; Sand PK, 2009, INT UROGYNECOL J, V20, P827, DOI 10.1007/s00192-009-0857-2; Sand PK, 2004, INT UROGYNECOL J, V15, P243, DOI 10.1007/s00192-004-1161-9; Staskin DR, 2009, INT J CLIN PRACT, V63, P1715, DOI 10.1111/j.1742-1241.2009.02189.x; Staskin DR, 2009, INT J CLIN PRACT, V63, P973, DOI 10.1111/j.1742-1241.2009.02065.x; Staskin D, 2007, J UROLOGY, V178, P978, DOI 10.1016/j.juro.2007.05.058; Staskin DR, 2006, BJU INT, V97, P1256, DOI 10.1111/j.1464-410X.2006.06150.x; Staskin David R, 2004, Curr Urol Rep, V5, P423, DOI 10.1007/s11934-004-0064-0; Staskin DR, 2009, J UROLOGY, V181, P1764, DOI 10.1016/j.juro.2008.11.125; Steers W, 2005, BJU INT, V95, P580, DOI 10.1111/j.1464-410X.2005.05343.x; Stijnen T, 2010, STAT MED, V29, P3046, DOI 10.1002/sim.4040; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Swift S, 2003, INT UROGYNECOL J, V14, P50, DOI 10.1007/s00192-002-1009-0; SZONYI G, 1995, AGE AGEING, V24, P287, DOI 10.1093/ageing/24.4.287; Takei M, 2005, INT J UROL, V12, P456, DOI 10.1111/j.1442-2042.2005.01066.x; TAPP AJS, 1990, BRIT J OBSTET GYNAEC, V97, P521, DOI 10.1111/j.1471-0528.1990.tb02523.x; Tennstedt SL, 2007, INT UROGYNECOL J, V18, P543, DOI 10.1007/s00192-006-0188-5; THUROFF JW, 1991, J UROLOGY, V145, P813, DOI 10.1016/S0022-5347(17)38459-8; Tincello DG, 2000, BJU INT, V85, P416, DOI 10.1046/j.1464-410x.2000.00520.x; Toglia MR, 2010, INT UROGYNECOL J, V21, P847, DOI 10.1007/s00192-010-1120-6; Toglia MR, 2009, POSTGRAD MED, V121, P151, DOI 10.3810/pgm.2009.09.2062; U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Urology and Lithotripsy Devices Branch Division of Reproductive Abdominal and Radiological Devices Office of Device Evaluation, 2008, CLIN INV DE IN PRESS, V2009; U.S. Food and Drug Administration Center for Drug Evaluation and Research, 2004, STAT REV EN DAR HYDR, V2010; U.S. Food and Drug Administration Center for Drug Evaluation and Research, 1998, MED REV DITR XL OX C, V2010; U.S. Food and Drug Administration Center for Drug Evaluation and Research, 2004, MED REV EN CLAR EXT, V2010; U.S. Food and Drug Administration Center for Drug Evaluation and Research, 2004, STAT REV SANCT TROSP, V2010; U.S. Food and Drug Administration Center for Drug Evaluation and Research, 2007, STAT REV SANCT XR TR, V2010; U.S. Food and Drug Administration Center for Drug Evaluation and Research, 2004, SOL TREATM UR SYMPT, V2010; U.S. Food and Drug Administration Center for Drug Evaluation and Research, 2007, MED REV SANCT XR TRO, V2010; U.S. Food and Drug Administration Center for Drug Evaluation and Research, 2004, MED REV SANCT TROSP, V2010; Van Kerrebroeck P, 2001, UROLOGY, V57, P414, DOI 10.1016/S0090-4295(00)01113-4; Van Kerrebroeck PEV, 2010, INT J CLIN PRACT, V64, P584, DOI 10.1111/j.1742-1241.2010.02361.x; Varadharajan S, 2005, AM J MANAG CARE, V11, pS140; Vardy MD, 2009, INT J CLIN PRACT, V63, P1702, DOI 10.1111/j.1742-1241.2009.02209.x; Versi E, 2000, OBSTET GYNECOL, V95, P718, DOI 10.1016/S0029-7844(99)00661-4; Viechtbauer W, 2007, STAT MED, V26, P37, DOI 10.1002/sim.2514; Wagg Adrian, 2006, Am J Geriatr Pharmacother, V4, P14, DOI 10.1016/j.amjopharm.2006.03.004; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Wang AC, 2006, UROLOGY, V68, P999, DOI 10.1016/j.urology.2006.05.038; Wang AC, 2009, INT UROGYNECOL J, V20, P819, DOI 10.1007/s00192-009-0860-7; Wang PS, 2002, J AM GERIATR SOC, V50, P117, DOI 10.1046/j.1532-5415.2002.50017.x; Wein AJ, 2007, BJU INT, V99, P360, DOI 10.1111/j.1464-410X.2006.06621.x; Whitehead A., 2002, METAANALYSIS CONTROL; Wieseler B, 2010, BMJ-BRIT MED J, V341, pc4942; Yamaguchi O, 2007, BJU INT, V100, P579, DOI 10.1111/j.1464-410X.2007.07031.x; Yu YF, 2005, VALUE HEALTH, V8, P495, DOI 10.1111/j.1524-4733.2005.00041.x; Zellner M, 2009, CLIN THER, V31, P2519, DOI 10.1016/j.clinthera.2009.11.005; Zimmern P, 2010, BJU INT, V105, P1680, DOI 10.1111/j.1464-410X.2009.09055.x; Zinner N, 2008, INT J CLIN PRACT, V62, P1664, DOI 10.1111/j.1742-1241.2008.01893.x; Zinner N, 2006, INT J CLIN PRACT, V60, P119, DOI 10.1111/j.1368-5031.2005.00770.x; Zinner N, 2005, J UROLOGY, V173, P1639, DOI 10.1097/01.ju.0000154692.73129.d8; Zinner N, 2004, J UROLOGY, V171, P2311, DOI 10.1097/01.ju.0000127742.73136.0c; Zinner N, 2005, WORLD J UROL, V23, P248, DOI 10.1007/s00345-005-0507-3; Zinner NR, 2002, J AM GERIATR SOC, V50, P799, DOI 10.1046/j.1532-5415.2002.50203.x	224	54	54	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12					861	U153		10.7326/0003-4819-156-12-201206190-00436	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-00436			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711079				2022-12-28	WOS:000307783200016
J	Griffith, CA; Lora, JM; Turner, J; Penteado, PF; Brown, RH; Tomasko, MG; Doose, L; See, C				Griffith, Caitlin A.; Lora, Juan M.; Turner, Jake; Penteado, Paulo F.; Brown, Robert H.; Tomasko, Martin G.; Doose, Lyn; See, Charles			Possible tropical lakes on Titan from observations of dark terrain	NATURE			English	Article							HUYGENS PROBE; CASSINI RADAR; ATMOSPHERE; MODEL; CLOUDS; DUNES	Titan has clouds, rain and lakes-like Earth-but composed of methane rather than water. Unlike Earth, most of the condensable methane (the equivalent of 5 m depth globally averaged(1)) lies in the atmosphere. Liquid detected on the surface (about 2 m deep) has been found by radar images only poleward of 50 degrees latitude(2,3), while dune fields pervade the tropics(4). General circulation models explain this dichotomy, predicting that methane efficiently migrates to the poles from these lower latitudes(5-7). Here we report an analysis of near-infrared spectral images(8) of the region between 20 degrees N and 20 degrees S latitude. The data reveal that the lowest fluxes in seven wavelength bands that probe Titan's surface occur in an oval region of about 60 x 40 km(2), which has been observed repeatedly since 2004. Radiative transfer analyses demonstrate that the resulting spectrum is consistent with a black surface, indicative of liquid methane on the surface. Enduring low-latitude lakes are best explained as supplied by subterranean sources (within the last 10,000 years), which may be responsible for Titan's methane, the continual photochemical depletion of which furnishes Titan's organic chemistry(9).	[Griffith, Caitlin A.; Lora, Juan M.; Turner, Jake; Brown, Robert H.; Tomasko, Martin G.; Doose, Lyn; See, Charles] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Penteado, Paulo F.] Univ Sao Paulo, IAG, BR-05508090 Sao Paulo, Brazil	University of Arizona; Universidade de Sao Paulo	Griffith, CA (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	griffith@lpl.arizona.edu	Penteado, Paulo/F-9081-2012	Penteado, Paulo/0000-0001-6759-2037; Lora, Juan/0000-0001-9925-1050	NASA	NASA(National Aeronautics & Space Administration (NASA))	Research by C. A. G., J.T., L. D., C. S. and M. G. T. are funded by NASA's Planetary Astronomy and Cassini Data Analysis programmes. J.T. was also funded by a NASA Space Grant.	Barnes JW, 2008, ICARUS, V195, P400, DOI 10.1016/j.icarus.2007.12.006; Brown RH, 2008, NATURE, V454, P607, DOI 10.1038/nature07100; Brown RH, 2004, SPACE SCI REV, V115, P111, DOI 10.1007/s11214-004-1453-x; de Bergh C, 2012, PLANET SPACE SCI, V61, P85, DOI 10.1016/j.pss.2011.05.003; GRIFFITH CA, 1993, NATURE, V364, P511, DOI 10.1038/364511a0; Griffith CA, 2012, ICARUS, V218, P975, DOI 10.1016/j.icarus.2011.11.034; Griffith CA, 2009, ASTROPHYS J LETT, V702, pL105, DOI 10.1088/0004-637X/702/2/L105; Griffith CA, 2009, PHILOS T R SOC A, V367, P713, DOI 10.1098/rsta.2008.0245; Grundy WM, 2002, ICARUS, V155, P486, DOI 10.1006/icar.2001.6726; Hayes AG, 2011, ICARUS, V211, P655, DOI 10.1016/j.icarus.2010.08.017; Karkoschka E, 2010, ICARUS, V205, P674, DOI 10.1016/j.icarus.2009.07.044; LEMMON MT, 1993, ICARUS, V103, P329, DOI 10.1006/icar.1993.1074; Lorenz RD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032118; Lorenz RD, 2006, SCIENCE, V312, P724, DOI 10.1126/science.1123257; Mitchell JL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003017; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; Penteado PF, 2010, ICARUS, V206, P352, DOI 10.1016/j.icarus.2009.11.003; Radebaugh J, 2008, ICARUS, V194, P690, DOI 10.1016/j.icarus.2007.10.015; Rannou P, 2006, SCIENCE, V311, P201, DOI 10.1126/science.1118424; Rothman LS, 2009, J QUANT SPECTROSC RA, V110, P533, DOI 10.1016/j.jqsrt.2009.02.013; Schaller EL, 2009, NATURE, V460, P873, DOI 10.1038/nature08193; Schneider T, 2012, NATURE, V481, P58, DOI 10.1038/nature10666; Soderblom LA, 2007, PLANET SPACE SCI, V55, P2025, DOI 10.1016/j.pss.2007.04.014; Stofan ER, 2007, NATURE, V445, P61, DOI 10.1038/nature05438; Tobie G, 2005, ICARUS, V175, P496, DOI 10.1016/j.icarus.2004.12.007; Tokano T, 2009, ICARUS, V204, P619, DOI 10.1016/j.icarus.2009.07.032; Tomasko MG, 2008, PLANET SPACE SCI, V56, P669, DOI 10.1016/j.pss.2007.11.019; Tomasko MG, 2008, PLANET SPACE SCI, V56, P624, DOI 10.1016/j.pss.2007.10.009; Turtle EP, 2011, SCIENCE, V331, P1414, DOI 10.1126/science.1201063; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963	30	41	43	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2012	486	7402					237	239		10.1038/nature11165	http://dx.doi.org/10.1038/nature11165			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699614				2022-12-28	WOS:000305189000030
J	Laviano, A; Rossi Fanelli, F				Laviano, Alessandro; Rossi Fanelli, Filippo			Toxicity in Chemotherapy - When Less Is More	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CANCER; HUMANS		[Laviano, Alessandro; Rossi Fanelli, Filippo] Univ Roma La Sapienza, Dept Clin Med, Rome, Italy	Sapienza University Rome	Laviano, A (corresponding author), Univ Roma La Sapienza, Dept Clin Med, Rome, Italy.		Fanelli, Filippo Rossi/E-9587-2011	Fanelli, Filippo Rossi/0000-0002-8674-1672				Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Laviano A, 2011, EUR J PHARMACOL, V668, pS87, DOI 10.1016/j.ejphar.2011.06.060; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Safdie FM, 2009, AGING-US, V1, P988, DOI 10.18632/aging.100114; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	5	23	27	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2012	366	24					2319	2320						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	957PD	22694004				2022-12-28	WOS:000305174100016
J	McMinn, DJW; Snell, KIE; Daniel, J; Treacy, RBC; Pynsent, PB; Riley, RD				McMinn, D. J. W.; Snell, K. I. E.; Daniel, J.; Treacy, R. B. C.; Pynsent, P. B.; Riley, R. D.			Mortality and implant revision rates of hip arthroplasty in patients with osteoarthritis: registry based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							METAL-ON-METAL; NATIONAL JOINT REGISTRY; FOLLOW-UP; REPORTED OUTCOMES; REPLACEMENT; MODELS; POPULATION; CEMENT; PREVALENCE; PROGNOSIS	Objectives To examine mortality and revision rates among patients with osteoarthritis undergoing hip arthroplasty and to compare these rates between patients undergoing cemented or uncemented procedures and to compare outcomes between men undergoing stemmed total hip replacements and Birmingham hip resurfacing. Design Cohort study. Setting National Joint Registry. Population About 275 000 patient records. Main outcome measures Hip arthroplasty procedures were linked to the time to any subsequent mortality or revision (implant failure). Flexible parametric survival analysis methods were used to analyse time to mortality and also time to revision. Comparisons between procedure groups were adjusted for age, sex, American Society of Anesthesiologists (ASA) grade, and complexity. Results As there were large baseline differences in the characteristics of patients receiving cemented, uncemented, or resurfacing procedures, unadjusted comparisons are inappropriate. Multivariable survival analyses identified a higher mortality rate for patients undergoing cemented compared with uncemented total hip replacement (adjusted hazard ratio 1.11, 95% confidence interval 1.07 to 1.16); conversely, there was a lower revision rate with cemented procedures (0.53, 0.50 to 0.57). These translate to small predicted differences in population averaged absolute survival probability at all time points. For example, compared with the uncemented group, at eight years after surgery the predicted probability of death in the cemented group was 0.013 higher (0.007 to 0.019) and the predicted probability of revision was 0.015 lower (0.012 to 0.017). In multivariable analyses restricted to men, there was a higher mortality rate in the cemented group and the uncemented group compared with the Birmingham hip resurfacing group. In terms of revision, the Birmingham hip resurfacings had a similar revision rate to uncemented total hip replacements. Both uncemented total hip replacements and Birmingham hip resurfacings had a higher revision rate than cemented total hip replacements. Conclusions There is a small but significant increased risk of revision with uncemented rather than cemented total hip replacement, and a small but significant increased risk of death with cemented procedures. It is not known whether these are causal relations or caused by residual confounding. Compared with uncemented and cemented total hip replacements, Birmingham hip resurfacing has a significantly lower risk of death in men of all ages. Previously, only adjusted analyses of hip implant revision rates have been used to recommend and justify use of cheaper cemented total hip implants. Our investigations additionally consider mortality rates and suggest a potentially higher mortality rate with cemented total hip replacements, which merits further investigation.	[Snell, K. I. E.; Riley, R. D.] Univ Birmingham, Sch Hlth & Populat Sci, MRC Midlands Hub Trials Methodol Res, Birmingham B15 2TT, W Midlands, England; [McMinn, D. J. W.; Daniel, J.] McMinn Ctr, Birmingham B15 3DP, W Midlands, England; [Pynsent, P. B.] Royal Orthopaed Hosp, Res & Teaching Ctr, Birmingham B31 2AP, W Midlands, England	University of Birmingham; Royal Orthopaedic Hospital	Riley, RD (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, MRC Midlands Hub Trials Methodol Res, Birmingham B15 2TT, W Midlands, England.	r.d.riley@bham.ac.uk	Snell, Kym/L-1918-2015; Riley, Richard David/ABE-5877-2020; Riley, Richard/G-2406-2011	Snell, Kym/0000-0001-9373-6591; Riley, Richard David/0000-0001-8699-0735; 	MRC Midlands Hub for Trials Methodology Research at the University of Birmingham (Medical Research Council) [G0800808]; Medical Research Council [G0800808, 1587806] Funding Source: researchfish; MRC [G0800808] Funding Source: UKRI	MRC Midlands Hub for Trials Methodology Research at the University of Birmingham (Medical Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	KIES is funded by the MRC Midlands Hub for Trials Methodology Research at the University of Birmingham (Medical Research Council Grant ID G0800808). RDR is also supported by funding from this Hub.	Aynardi M, 2009, CLIN ORTHOP RELAT R, V467, P213, DOI 10.1007/s11999-008-0528-5; Baker RP, 2011, J BONE JOINT SURG BR, V93B, P158, DOI 10.1302/0301-620X.93B2.25625; Boyer R, 2011, OSTEOARTHR CARTILAGE, V19, P858, DOI 10.1016/j.joca.2011.02.006; Byrick RJ, 1997, CAN J ANAESTH, V44, P107, DOI 10.1007/BF03012996; CHARNLEY J, 1960, BRIT MED J, V1, P821, DOI 10.1136/bmj.1.5176.821; Charnley J., 1979, LOW FRICTION ARTHROP; Corbett KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013520; COX DR, 1972, J R STAT SOC B, V34, P187; Daniel J, 2004, J BONE JOINT SURG BR, V86B, P177, DOI 10.1302/0301-620X.86B2.14600; Donaldson AJ, 2009, BRIT J ANAESTH, V102, P12, DOI 10.1093/bja/aen328; Edmonds CR, 2000, ANESTHESIOLOGY, V93, P315, DOI 10.1097/00000542-200008000-00006; Eskelinen A, 2005, ACTA ORTHOP, V76, P28, DOI 10.1080/00016470510030292; Freeman JW, 2009, MODERN HIP RESURFACING, P167, DOI 10.1007/978-1-84800-088-9_15; Garellick G, SWEDISH HIP ARTHROPL; Gillam MH, 2011, ACTA ORTHOP, V82, P513, DOI 10.3109/17453674.2011.618918; Goodfellow JW, 2010, J BONE JOINT SURG BR, V92B, P1628, DOI 10.1302/0301-620X.92B12.25193; Gorenoi V, 2009, GMS HLTH TECHNOL ASS, V5; Hailer NP, 2010, ACTA ORTHOP, V81, P34, DOI 10.3109/17453671003685400; Halaszynski TM, 2004, CRIT CARE MED, V32, pS76, DOI 10.1097/01.CCM.0000122046.30687.5C; Hilmarsson S, 2006, J BONE JOINT SURG BR, V88, P47; Issack Paul S, 2009, Am J Orthop (Belle Mead NJ), V38, P72; Kolling C, 2007, J BONE JOINT SURG BR, V89B, P1567, DOI 10.1302/0301-620X.89B12.19409; Labek G, 2009, Z ORTHOP UNFALLCHIR, V147, P151, DOI 10.1055/s-0029-1185532; Lambert PC, 2009, STATA J, V9, P265, DOI 10.1177/1536867X0900900206; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; Lie SA, 2000, ACTA ORTHOP SCAND, V71, P19, DOI 10.1080/00016470052943838; Lie SA, 2010, J BONE JOINT SURG AM, V92A, P58, DOI 10.2106/JBJS.H.01882; Lingard EA, 2009, J BONE JOINT SURG BR, V91B, P1550, DOI 10.1302/0301-620X.91B12.22326; LYNCH JJ, 1984, AM J CARDIOL, V53, P1478, DOI 10.1016/S0002-9149(84)91617-5; Mahomed NN, 2003, J BONE JOINT SURG AM, V85A, P27, DOI 10.2106/00004623-200301000-00005; Makela KT, 2011, ACTA ORTHOP, V82, P521, DOI 10.3109/17453674.2011.618908; Malchau H, 2002, J BONE JOINT SURG AM, V84A, P2, DOI 10.2106/00004623-200200002-00002; Malchau P, 2000, P 67 ANN M AM AC ORT; McBryde CW, 2010, J BONE JOINT SURG AM, V92A, P105, DOI 10.2106/JBJS.I.00197; McMinn D, 1996, Clin Orthop Relat Res, pS89, DOI 10.1097/00003086-199608001-00009; McMinn D, 2011, COMB BRIT ORTH ASS I; McMinn DJW, 2011, INT ORTHOP, V35, P231, DOI 10.1007/s00264-010-1148-8; National Institute for Health and Clinical Excellence, 2003, GUID SEL PROSTH PRIM; National Joint Registry for England and Wales, 2010, 7 NAT JOINT REG ENGL; National joint registry for England and Wales, 2011, 8 NAT JOINT REG ENGL; Nedungayil SK, 2006, ANN ROY COLL SURG, V88, P127, DOI 10.1308/003588406X94931; ORSINI EC, 1987, J BONE JOINT SURG AM, V69A, P822, DOI 10.2106/00004623-198769060-00005; Parvizi J, 1999, CLIN ORTHOP RELAT R, P39; PATTERSON BM, 1991, J BONE JOINT SURG AM, V73A, P271, DOI 10.2106/00004623-199173020-00015; Pedersen AB, 2011, J BONE JOINT SURG BR, V93B, P172, DOI 10.1302/0301-620X.93B2.25629; PEEBLES DJ, 1972, BMJ-BRIT MED J, V1, P349, DOI 10.1136/bmj.1.5796.349; Pitto RP, 1998, CLIN ORTHOP RELAT R, P23; Pradhan C, 2009, MODERN HIP RESURFACING, P371, DOI 10.1007/978-1-84800-088-9_28; Pynsent PB, 2005, J BONE JOINT SURG BR, V87B, P241, DOI 10.1302/0301-620X.87B2.15095; Rothwell A G, 1999, Bull Hosp Jt Dis, V58, P148; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Royston P, 2011, FLEXIBLE PARAMETRIC; Saklad M., 1941, ANESTHESIOLOGY, V2, P281, DOI DOI 10.1097/00000542-194105000-00004; Salem DN, 2008, CHEST, V133, p593S, DOI 10.1378/chest.08-0724; Santaguida PL, 2008, CAN J SURG, V51, P428; Sedgwick P, 2009, BMJ-BRIT MED J, V339, pb3401; Smith AJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2383; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Smith T, DATA FILE; Treacy RBC, 2011, J BONE JOINT SURG BR, V93B, P27, DOI 10.1302/0301-620X.93B1.24134; Treacy RBC, 2006, ANN ROY COLL SURG, V88, P349; Verhaar J A N, 2007, Ned Tijdschr Geneeskd, V151, P1915; VISURI T, 1994, ACTA ORTHOP SCAND, V65, P9, DOI 10.3109/17453679408993708; Visuri T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-78; Winkelmayer WC, 2004, NEPHROL DIAL TRANSPL, V19, P1671, DOI 10.1093/ndt/gfh104; Wroblewski BM, 2007, J BONE JOINT SURG BR, V89B, P1015, DOI 10.1302/0301-620X.89B8; Wylde V, 2011, J BONE JOINT SURG BR, V93B, P569, DOI 10.1302/0301-620X.93B5.26687; Wylde V, 2009, J ARTHROPLASTY, V24, P210, DOI 10.1016/j.arth.2007.12.001	68	92	94	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2012	344								e3319	10.1136/bmj.e3319	http://dx.doi.org/10.1136/bmj.e3319			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961LA	22700782	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000305464700002
J	Smith-Bindman, R; Miglioretti, DL; Johnson, E; Lee, C; Feigelson, HS; Flynn, M; Greenlee, RT; Kruger, RL; Hornbrook, MC; Roblin, D; Solberg, LI; Vanneman, N; Weinmann, S; Williams, AE				Smith-Bindman, Rebecca; Miglioretti, Diana L.; Johnson, Eric; Lee, Choonsik; Feigelson, Heather Spencer; Flynn, Michael; Greenlee, Robert T.; Kruger, Randell L.; Hornbrook, Mark C.; Roblin, Douglas; Solberg, Leif I.; Vanneman, Nicholas; Weinmann, Sheila; Williams, Andrew E.			Use of Diagnostic Imaging Studies and Associated Radiation Exposure for Patients Enrolled in Large Integrated Health Care Systems, 1996-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPUTED-TOMOGRAPHY; BENEFITS	Context Use of diagnostic imaging has increased significantly within fee-for-service models of care. Little is known about patterns of imaging among members of integrated health care systems. Objective To estimate trends in imaging utilization and associated radiation exposure among members of integrated health care systems. Design, Setting, and Participants Retrospective analysis of electronic records of members of 6 large integrated health systems from different regions of the United States. Review of medical records allowed direct estimation of radiation exposure from selected tests. Between 1 million and 2 million member-patients were included each year from 1996 to 2010. Main Outcome Measure Advanced diagnostic imaging rates and cumulative annual radiation exposure from medical imaging. Results During the 15-year study period, enrollees underwent a total of 30.9 million imaging examinations (25.8 million person-years), reflecting 1.18 tests (95% CI, 1.17-1.19) per person per year, of which 35% were for advanced diagnostic imaging (computed tomography [CT], magnetic resonance imaging [MRI], nuclear medicine, and ultrasound). Use of advanced diagnostic imaging increased from 1996 to 2010; CT examinations increased from 52 per 1000 enrollees in 1996 to 149 per 1000 in 2010, 7.8% annual increase (95% CI, 5.8%-9.8%); MRI use increased from 17 to 65 per 1000 enrollees, 10% annual growth (95% CI, 3.3%-16.5%); and ultrasound rates increased from 134 to 230 per 1000 enrollees, 3.9% annual growth (95% CI, 3.0%-4.9%). Although nuclear medicine use decreased from 32 to 21 per 1000 enrollees, 3% annual decline (95% CI, 7.7% decline to 1.3% increase), PET imaging rates increased after 2004 from 0.24 to 3.6 per 1000 enrollees, 57% annual growth. Although imaging use increased within all health systems, the adoption of different modalities for anatomic area assessment varied. Increased use of CT between 1996 and 2010 resulted in increased radiation exposure for enrollees, with a doubling in the mean per capita effective dose (1.2 mSv vs 2.3 mSv) and the proportion of enrollees who received high (>20-50 mSv) exposure (1.2% vs 2.5%) and very high (>50 mSv) annual radiation exposure (0.6% vs 1.4%). By 2010, 6.8% of enrollees who underwent imaging received high annual radiation exposure (>20-50 mSv) and 3.9% received very high annual exposure (>50 mSv). Conclusion Within integrated health care systems, there was a large increase in the rate of advanced diagnostic imaging and associated radiation exposure between 1996 and 2010. JAMA. 2012;307(22):2400-2409 www.jama.com	[Smith-Bindman, Rebecca] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, Dept Epidemiol & Biostat, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Miglioretti, Diana L.; Johnson, Eric; Vanneman, Nicholas] Univ Washington, Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA 98195 USA; [Miglioretti, Diana L.; Johnson, Eric; Vanneman, Nicholas] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Lee, Choonsik] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD USA; [Feigelson, Heather Spencer] Kaiser Permanente, Inst Hlth Res, Denver, CO USA; [Flynn, Michael] Henry Ford Hlth Syst, Ctr Hlth Serv Res, Dept Radiol, Detroit, MI USA; [Greenlee, Robert T.; Kruger, Randell L.] Marshfield Clin Res Fdn, Epidemiol Res Ctr, Marshfield, WI USA; [Hornbrook, Mark C.; Weinmann, Sheila] Kaiser Permanente NW, Ctr Hlth Res, Portland, OR USA; [Roblin, Douglas] Kaiser Permanente SE, Ctr Hlth Res, Atlanta, GA USA; [Solberg, Leif I.] HealthPartners Res Fdn, Minneapolis, MN USA; [Williams, Andrew E.] Kaiser Permanente Hawaii, Ctr Hlth Res, Honolulu, HI USA	University of California System; University of California San Francisco; Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kaiser Permanente; Henry Ford Health System; Henry Ford Hospital; Kaiser Permanente; Kaiser Permanente; HealthPartners Institute for Education & Research; Kaiser Permanente	Smith-Bindman, R (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, Dept Epidemiol & Biostat, Dept Obstet Gynecol & Reprod Sci, 350 Parnassus Ave,Ste 307, San Francisco, CA 94143 USA.	rebecca.smith-bindman@ucsf.edu	Lee, Choonsik/C-9023-2015	Lee, Choonsik/0000-0003-4289-9870	National Cancer Institute [U19CA79689]; National Institutes of Health [NIH R21CA131698, NIH K24 CA125036]; NATIONAL CANCER INSTITUTE [U19CA079689, ZIACP010222, K24CA125036, R21CA131698] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute-funded Cancer Research Network Across Health Care Systems (U19CA79689) and grants from the National Institutes of Health (NIH R21CA131698 and NIH K24 CA125036).	[Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; [Anonymous], ENS QUAL APPR US DIA; [Anonymous], GAO08452; [Anonymous], INT BAS SAF STAND PR; [Anonymous], 2008, GAO081102R; [Anonymous], 2010, JUN 2010 DAT BOOK HE; Bhargavan M, 2005, RADIOLOGY, V234, P824, DOI 10.1148/radiol.2343031536; Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies Committee on the Biological Effects of Ionizing Radiation, 1990, HLTH EFF EXP LOW LEV; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Charles M, 2001, J Radiol Prot, V21, P83, DOI 10.1088/0952-4746/21/1/609; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Douglas PS, 2006, J AM COLL CARDIOL, V48, P2152, DOI 10.1016/j.jacc.2006.04.107; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Glabman M, MANAGED CARE MAGAZIN; Graham S, 2005, BALTIMORE BUSIN 0228; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Hackbarth G, 2008, NEW ENGL J MED, V359, P3, DOI 10.1056/NEJMp0803749; Hendrick RE, 2010, AM J ROENTGENOL, V194, P362, DOI 10.2214/AJR.08.2114; Hornbrook MC, 2005, J NATL CANC I MONOGR, V35, P12, DOI DOI 10.1093/JNCIMONOGRAPHS/LGI033; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; International Committee on Radiological Protection, 1991, ICRP PUBL; Lee C, 2011, MED PHYS, V38, P1196, DOI 10.1118/1.3544658; Lee C, 2010, PHYS MED BIOL, V55, P339, DOI 10.1088/0031-9155/55/2/002; Levin DC, 2011, AM J ROENTGENOL, V196, pW25, DOI 10.2214/AJR.10.4835; Levin DC, 2010, J AM COLL RADIOL, V7, P33, DOI 10.1016/j.jacr.2009.09.012; Levin DC, 2010, HEALTH AFFAIR, V29, P189, DOI 10.1377/hlthaff.2009.0528; Lieu TA, 2011, CLIN MED RES, V9, P137, DOI 10.3121/cmr.2011.1025; Murray IPC, 1998, NUCL MED CLIN DIAGNO; National Council on Radiation Protection and Measurements, 160 NCRP; Parker L, 2010, AM J ROENTGENOL, V194, P1034, DOI 10.2214/AJR.09.3528; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Redberg RF, 2008, NEW ENGL J MED, V359, P2309, DOI 10.1056/NEJMp0805920; Shortell SM, 2010, STUD HEALTH TECHNOL, V153, P369, DOI 10.3233/978-1-60750-533-4-369; Shuryak I, 2010, JNCI-J NATL CANCER I, V102, P1628, DOI 10.1093/jnci/djq346; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Smith-Bindman R, 2011, RADIOLOGY, V261, P999, DOI 10.1148/radiol.11111055; Statement of Glenn M. Hackbarth Chairman Medicare Payment Advisory Commission, COMMUNICATION; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Winter A, 2008, MED PAYM ADV COMM SE	40	558	564	2	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2012	307	22					2400	2409		10.1001/jama.2012.5960	http://dx.doi.org/10.1001/jama.2012.5960			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	956UX	22692172	Green Accepted, Bronze			2022-12-28	WOS:000305115900025
J	Vernooij, JWP; Kaasjager, HAH; van der Graaf, Y; Wierdsma, J; Grandjean, HMH; Hovens, MMC; de Wit, GA; Visseren, FLJ				Vernooij, J. W. P.; Kaasjager, H. A. H.; van der Graaf, Y.; Wierdsma, J.; Grandjean, H. M. H.; Hovens, M. M. C.; de Wit, G. A.; Visseren, F. L. J.		SMART Study Grp	Internet based vascular risk factor management for patients with clinically manifest vascular disease: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANSIENT ISCHEMIC ATTACK; CORONARY-HEART-DISEASE; INTEROBSERVER AGREEMENT; PREVENTION; STROKE; PREDICTION; INTERVENTIONS; GUIDELINES; HANDICAP; PROGRAM	Objective To investigate whether an internet based, nurse led vascular risk factor management programme promoting self management on top of usual care is more effective than usual care alone in reducing vascular risk factors in patients with clinically manifest vascular disease. Design Prospective randomised controlled trial. Setting Multicentre trial in secondary and tertiary healthcare setting. Participants 330 patients with a recent clinical manifestation of atherosclerosis in the coronary, cerebral, or peripheral arteries and with at least two treatable risk factors not at goal. Intervention Personalised website with an overview and actual status of patients' risk factors and mail communication via the website with a nurse practitioner for 12 months; the intervention combined self management support, monitoring of disease control, and drug treatment. Main outcome measures The primary endpoint was the relative change in Framingham heart risk score after 1 year. Secondary endpoints were absolute changes in the levels of risk factors and the differences between groups in the change in proportion of patients reaching treatment goals for each risk factor. Results Participants' mean age was 59.9 (SD 8.4) years, and most patients (n=246; 75%) were male. After 1 year, the relative change in Framingham heart risk score of the intervention group compared with the usual care group was -14% (95% confidence interval -25% to -2%). At baseline, the Framingham heart risk score was higher in the intervention group than in the usual care group (16.1 (SD 10.6) v 14.0 (10.5)), so the outcome was adjusted for the separate variables of the Framingham heart risk score and for the baseline Framingham heart risk score. This produced a relative change of -12% (-22% to -3%) in Framingham heart risk score for the intervention group compared with the usual care group adjusted for the separate variables of the score and -8% (-18% to 2%) adjusted for the baseline score. Of the individual risk factors, a difference between groups was observed in low density lipoprotein cholesterol (-0.3, -0.5 to -0.1, mmol/L) and smoking (-7.7%, -14.9% to -0.4%). Some other risk factors tended to improve (body mass index, triglycerides, systolic blood pressure, renal function) or tended to worsen (glucose concentration, albuminuria). Conclusion An internet based, nurse led treatment programme on top of usual care for vascular risk factors had a small effect on lowering vascular risk and on lowering of some vascular risk factors in patients with vascular disease.	[Vernooij, J. W. P.; Wierdsma, J.; Visseren, F. L. J.] Univ Med Ctr Utrecht, Dept Vasc Med, NL-3508 GA Utrecht, Netherlands; [Kaasjager, H. A. H.; Grandjean, H. M. H.; Hovens, M. M. C.] Rijnstate Hosp, Dept Internal Med, Arnhem, Netherlands; [van der Graaf, Y.; de Wit, G. A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Rijnstate Hospital; Utrecht University; Utrecht University Medical Center	Visseren, FLJ (corresponding author), Univ Med Ctr Utrecht, Dept Vasc Med, POB 85500, NL-3508 GA Utrecht, Netherlands.	F.L.J.Visseren@umcutrecht.nl	Visseren, Frank LJ/I-4855-2013; Grobbee, Diederick/C-7651-2014; Mali, Willem PThM/I-1123-2014	Grobbee, Diederick/0000-0003-4472-4468; Mali, Willem PThM/0000-0003-4391-0904; de Wit, G. Ardine/0000-0002-1375-7657; Visseren, Frank/0000-0003-3951-5223	ZonMw; Netherlands Organization for Health Research and Development [80-00702-98-084]; Merck; Catharijne Foundation Utrecht; AstraZeneca	ZonMw(Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Merck(Merck & Company); Catharijne Foundation Utrecht; AstraZeneca(AstraZeneca)	This study was financially supported by ZonMw, the Netherlands Organization for Health Research and Development, grant No 80-00702-98-084. The sponsor of this research participated in the design of the study but had no influence over the conduct of the study, the analyses of study data, or the content of this paper.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf. The department of FLJV has received grant support from Merck, the Netherlands Organisation for Health Research and Development, and the Catharijne Foundation Utrecht; and speakers' fees from Merck and AstraZeneca. HAHK has received fees for cardiovascular risk management education programmes from non-profit organisations. JWPV, YG, JW, HMHG, MMCH, and GAW declare: no financial relationships with any companies that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.	Adams RJ, 2003, CIRCULATION, V108, P1278, DOI 10.1161/01.CIR.0000090444.87006.CF; Andersson G, 2011, J MENT HEALTH; [Anonymous], CLIN PSYCHOL PSYCHOT; Avdal EU, 2011, CIN-COMPUT INFORM NU, V29, P101, DOI [10.1097/NCN.0b013e3181fcbdc6, 10.1097/NCN.0b013e3182155318]; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BAMFORD JM, 1989, STROKE, V20, P828, DOI 10.1161/01.STR.20.6.828; Brouwer BG, 2010, J INTERN MED, V268, P83, DOI 10.1111/j.1365-2796.2010.02229.x; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; Dekkers JC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-49; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; European Commission, 2011, INT US ONL CONT; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Glasgow RE, 2012, PATIENT EDUC COUNS, V87, P81, DOI 10.1016/j.pec.2011.07.024; Goessens BMB, 2008, PATIENT EDUC COUNS, V73, P67, DOI 10.1016/j.pec.2008.06.004; Goessens BMB, 2006, EUR J CARDIOV PREV R, V13, P996, DOI 10.1097/01.hjr.0000216549.92184.40; Hurkmans EJ, 2010, RHEUMATOLOGY, V49, P167, DOI 10.1093/rheumatology/kep285; Kannel WB, 1998, CLIN THER, V20, pB2, DOI 10.1016/S0149-2918(98)80027-1; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; Murchie P, 2003, BRIT MED J, V326, P84, DOI 10.1136/bmj.326.7380.84; Padilla R, 2008, HLTH PROMOT PRACT, V11, P140; Polisena J, 2010, J TELEMED TELECARE, V16, P68, DOI 10.1258/jtt.2009.090406; Quinn CC, 2011, DIABETES CARE, V34, P1934, DOI 10.2337/dc11-0366; Southard Barbara H, 2003, J Cardiopulm Rehabil, V23, P341, DOI 10.1097/00008483-200309000-00003; Stalman WAB, 2006, DUTCH GUIDELINE CARD; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wagner E H, 1999, Manag Care Q, V7, P56; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wijnhoud AD, 2010, STROKE, V41, P2178, DOI 10.1161/STROKEAHA.110.580985; Williams DA, 2010, PAIN, V151, P694, DOI 10.1016/j.pain.2010.08.034; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zutz A, 2007, TELEMED J E-HEALTH, V13, P323, DOI 10.1089/tmj.2006.0051	36	45	47	4	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 12	2012	344								e3750	10.1136/bmj.e3750	http://dx.doi.org/10.1136/bmj.e3750			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961KQ	22692651	hybrid, Green Published			2022-12-28	WOS:000305463700003
J	Fish, DR				Fish, David R.			Academic health sciences networks in England	LANCET			English	Editorial Material							INTEGRATION		UCLPartners, London W1T 7HA, England	University of London; University College London	Fish, DR (corresponding author), UCLPartners, London W1T 7HA, England.	david.fish@uclpartners.com						Daniels RJ, 2011, JAMA-J AM MED ASSOC, V306, P1912, DOI 10.1001/jama.2011.1606; Department of Health, 2012, EXPR INT CREAT AC HL; Dzau VJ, 2010, LANCET, V375, P949, DOI 10.1016/S0140-6736(09)61082-5; Green LW, 2009, ANNU REV PUBL HEALTH, V30, P151, DOI 10.1146/annurev.publhealth.031308.100049; Mountford J, 2010, JAMA-J AM MED ASSOC, V304, P2407, DOI 10.1001/jama.2010.1751; NHS, INN HLTH WEALTH ACC; Porter ME, 1998, HARVARD BUS REV, V76, P77; Selby Rita, 2009, Hematology Am Soc Hematol Educ Program, P286, DOI 10.1182/asheducation-2009.1.286; The North East London, REV SUCC EN FACT	9	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 8	2013	381	9882					E18	E19		10.1016/S0140-6736(12)60866-6	http://dx.doi.org/10.1016/S0140-6736(12)60866-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171JY	22743543				2022-12-28	WOS:000320924400001
J	Bhullar, BAS; Marugan-Lobon, J; Racimo, F; Bever, GS; Rowe, TB; Norell, MA; Abzhanov, A				Bhullar, Bhart-Anjan S.; Marugan-Lobon, Jesus; Racimo, Fernando; Bever, Gabe S.; Rowe, Timothy B.; Norell, Mark A.; Abzhanov, Arhat			Birds have paedomorphic dinosaur skulls	NATURE			English	Article							EVOLUTION; SIZE; ONTOGENY; GROWTH; BRAIN; EAR	The interplay of evolution and development has been at the heart of evolutionary theory for more than a century(1). Heterochrony-change in the timing or rate of developmental events-has been implicated in the evolution of major vertebrate lineages such as mammals(2), including humans(1). Birds are the most speciose land vertebrates, with more than 10,000 living species(3) representing a bewildering array of ecologies. Their anatomy is radically different from that of other vertebrates. The unique bird skull houses two highly specialized systems: the sophisticated visual and neuromuscular coordination system(4,5) allows flight coordination and exploitation of diverse visual landscapes, and the astonishing variations of the beak enable a wide range of avian lifestyles. Here we use a geometric morphometric approach integrating developmental, neontological and palaeontological data to show that the heterochronic process of paedomorphosis, by which descendants resemble the juveniles of their ancestors, is responsible for several major evolutionary transitions in the origin of birds. We analysed the variability of a series of landmarks on all known theropod dinosaur skull ontogenies as well as outgroups and birds. The first dimension of variability captured ontogeny, indicating a conserved ontogenetic trajectory. The second dimension accounted for phylogenetic change towards more bird-like dinosaurs. Basally branching eumaniraptorans and avialans clustered with embryos of other archosaurs, indicating paedomorphosis. Our results reveal at least four paedomorphic episodes in the history of birds combined with localized peramorphosis (development beyond the adult state of ancestors) in the beak. Paedomorphic enlargement of the eyes and associated brain regions parallels the enlargement of the nasal cavity and olfactory brain in mammals(6). This study can be a model for investigations of heterochrony in evolutionary transitions, illuminating the origin of adaptive features and inspiring studies of developmental mechanisms.	[Bhullar, Bhart-Anjan S.; Racimo, Fernando; Abzhanov, Arhat] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Marugan-Lobon, Jesus] Univ Autonoma Madrid, Dept Biol, Unidad Paleontol, E-28049 Madrid, Spain; [Bever, Gabe S.] New York Inst Technol, New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; [Rowe, Timothy B.] Univ Texas Austin, Jackson Sch Geosci, Dept Geol Sci, Austin, TX 78712 USA; [Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Harvard University; Autonomous University of Madrid; New York Institute Technology; University of Texas System; University of Texas Austin; American Museum of Natural History (AMNH)	Bhullar, BAS (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	bhartanjan.bhullar@gmail.com; abzhanov@fas.harvard.edu	Marugán-Lobón, Jesús/AAA-7614-2019	Racimo, Fernando/0000-0002-5025-2607	National Science Foundation [1110564];  [BFU2008-00642]; Direct For Biological Sciences [1110564] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. M. Elsey and colleagues at the Rockefeller Wildlife Refuge, Louisiana Department of Wildlife and Fisheries for assistance in obtaining alligator embryos, S. Majadla for imaging assistance, C. Sanchez for constructing the Supplementary Movie, I. Sarris for assistance with the R script packages, and J. B. Losos, H. E. Hoekstra, F. A. Jenkins Jr and B. Zweig for comments that improved the manuscript. B.-A. S. B. was partly funded by National Science Foundation dissertation improvement grant 1110564. J. M.-L. was supported by project BFU2008-00642.	ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Brusatte SL, 2012, J EVOLUTION BIOL, V25, P365, DOI 10.1111/j.1420-9101.2011.02427.x; Butler A. B., 1996, COMP VERTEBRATE NEUR, DOI DOI 10.1002/0471733849.CH19; Clarke JA, 2008, SYST BIOL, V57, P185, DOI 10.1080/10635150802022231; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; FINK WL, 1982, PALEOBIOLOGY, V8, P254, DOI 10.1017/S0094837300006977; GILL F.B., 2006, ORNITHOLOGY; Gould S. J., 1977, ONTOGENY PHYLOGENY; HOPSON JA, 1977, ANNU REV ECOL SYST, V8, P429, DOI 10.1146/annurev.es.08.110177.002241; Hu D, 2009, DEVELOPMENT, V136, P107, DOI 10.1242/dev.026583; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Jerison HJ., 1973, EVOLUTION BRAIN INTE; JOLLIE MALCOLM T., 1957, J MORPH, V100, P389, DOI 10.1002/jmor.1051000302; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Norell MA, 2009, AM MUS NOVIT, P1; Northcutt RG, 2011, SCIENCE, V332, P926, DOI 10.1126/science.1206915; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; PEARSON R, 1972, AVIAN BRAIN; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Smith KK, 2003, INT J DEV BIOL, V47, P613; Thulborn RA, 2006, NEUES JAHRB GEOL P-A, V242, P205, DOI 10.1127/njgpa/242/2006/205; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Wellnhofer P., 2009, ARCHAEOPTERYX ICON E	29	146	148	3	252	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2012	487	7406					223	226		10.1038/nature11146	http://dx.doi.org/10.1038/nature11146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22722850				2022-12-28	WOS:000306278900037
J	James, A; Pitchford, JW; Plank, MJ				James, Alex; Pitchford, Jonathan W.; Plank, Michael J.			Disentangling nestedness from models of ecological complexity	NATURE			English	Article							MUTUALISTIC NETWORKS; ARCHITECTURE; BIODIVERSITY; ECOSYSTEMS; STABILITY	Complex networks of interactions are ubiquitous(1) and are particularly important in ecological communities, in which large numbers of species exhibit negative (for example, competition or predation) and positive (for example, mutualism) interactions with one another. Nestedness in mutualistic ecological networks is the tendency for ecological specialists to interact with a subset of species that also interact with more generalist species(2). Recent mathematical and computational analysis has suggested that such nestedness increases species richness(3,4). By examining previous results and applying computational approaches to 59 empirical data sets representing mutualistic plant-pollinator networks, we show that this statement is incorrect. A simpler metric-the number of mutualistic partners a species has-is a much better predictor of individual species survival and hence, community persistence. Nestedness is, at best, a secondary covariate rather than a causative factor for biodiversity in mutualistic communities. Analysis of complex networks should be accompanied by analysis of simpler, underpinning mechanisms that drive multiple higher-order network properties.	[James, Alex; Plank, Michael J.] Univ Canterbury, Biomath Res Ctr, Christchurch 8040, New Zealand; [Pitchford, Jonathan W.] Univ York, York Ctr Complex Syst Anal, York YO10 5DD, N Yorkshire, England; [Pitchford, Jonathan W.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Pitchford, Jonathan W.] Univ York, Dept Math, York YO10 5DD, N Yorkshire, England	University of Canterbury; University of York - UK; University of York - UK; University of York - UK	James, A (corresponding author), Univ Canterbury, Biomath Res Ctr, Private Bag 4800, Christchurch 8040, New Zealand.	alex.james@canterbury.ac.nz	Plank, Michael John/H-8030-2019	Plank, Michael John/0000-0002-7539-3465; James, Alex/0000-0002-1543-7139	Royal Society of New Zealand [08-UOC-034]; University of Canterbury	Royal Society of New Zealand(Royal Society of New Zealand); University of Canterbury	We thank D. Franks, D. Kelly, R. Law, D. Stouffer, C. Thomas and J. Tylianakis for discussions and constructive criticisms, and J. Williams for independent verification of numerical results. M. J. P., A. J. and J. W. P. were supported by the Royal Society of New Zealand Marsden Fund, grant number 08-UOC-034. J. W. P. acknowledges the support of the University of Canterbury Erskine Programme.	Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bastolla U, 2005, J THEOR BIOL, V235, P521, DOI 10.1016/j.jtbi.2005.02.005; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Flores CO, 2011, P NATL ACAD SCI USA, V108, pE288, DOI 10.1073/pnas.1101595108; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kondoh M, 2010, ECOLOGY, V91, P3123, DOI 10.1890/09-2219.1; Long JS, 1997, REGRESSION MODELS CA; May R.M., 1973, STABILITY COMPLEXITY; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Vermaat JE, 2009, ECOLOGY, V90, P278, DOI 10.1890/07-0978.1; Wiggins S., 2003, INTRO APPL NONLINEAR, DOI 10.1007/b97481; Williams RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017645; Williams RJ, 2010, THEOR ECOL-NETH, V3, P45, DOI 10.1007/s12080-009-0052-6; Zar JH., 1999, BIOSTAT ANAL, V663rd; Zhang F, 2011, ECOL LETT, V14, P797, DOI 10.1111/j.1461-0248.2011.01647.x	21	129	136	5	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2012	487	7406					227	230		10.1038/nature11214	http://dx.doi.org/10.1038/nature11214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22722863				2022-12-28	WOS:000306278900038
J	Ashe, A; Sapetschnig, A; Weick, EM; Mitchell, J; Bagijn, MP; Cording, AC; Doebley, AL; Goldstein, LD; Lehrbach, NJ; Le Pen, J; Pintacuda, G; Sakaguchi, A; Sarkies, P; Ahmed, S; Miska, EA				Ashe, Alyson; Sapetschnig, Alexandra; Weick, Eva-Maria; Mitchell, Jacinth; Bagijn, Marloes P.; Cording, Amy C.; Doebley, Anna-Lisa; Goldstein, Leonard D.; Lehrbach, Nicolas J.; Le Pen, Jeremie; Pintacuda, Greta; Sakaguchi, Aisa; Sarkies, Peter; Ahmed, Shawn; Miska, Eric A.			piRNAs Can Trigger a Multigenerational Epigenetic Memory in the Germline of C. elegans	CELL			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; ARGONAUTE FAMILY; INHERITANCE; SIRNA; EXPRESSION; 21U-RNAS; REQUIREMENTS; REVEALS	Transgenerational effects have wide-ranging implications for human health, biological adaptation, and evolution; however, their mechanisms and biology remain poorly understood. Here, we demonstrate that a germline nuclear small RNA/chromatin pathway can maintain stable inheritance for many generations when triggered by a piRNA-dependent foreign RNA response in C. elegans. Using forward genetic screens and candidate approaches, we find that a core set of nuclear RNAi and chromatin factors is required for multigenerational inheritance of environmental RNAi and piRNA silencing. These include a germline-specific nuclear Argonaute HRDE1/WAGO-9, a HP1 ortholog HPL-2, and two putative histone methyltransferases, SET-25 and SET-32. piRNAs can trigger highly stable long-term silencing lasting at least 20 generations. Once established, this long-term memory becomes independent of the piRNA trigger but remains dependent on the nuclear RNAi/chromatin pathway. Our data present a multigenerational epigenetic inheritance mechanism induced by piRNAs.	[Mitchell, Jacinth; Sakaguchi, Aisa; Ahmed, Shawn] Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA; [Ashe, Alyson; Sapetschnig, Alexandra; Weick, Eva-Maria; Bagijn, Marloes P.; Cording, Amy C.; Goldstein, Leonard D.; Lehrbach, Nicolas J.; Le Pen, Jeremie; Pintacuda, Greta; Sarkies, Peter; Miska, Eric A.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Ashe, Alyson; Sapetschnig, Alexandra; Weick, Eva-Maria; Bagijn, Marloes P.; Cording, Amy C.; Goldstein, Leonard D.; Lehrbach, Nicolas J.; Le Pen, Jeremie; Sarkies, Peter; Miska, Eric A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Mitchell, Jacinth; Doebley, Anna-Lisa; Ahmed, Shawn] Univ N Carolina, Dept Biol, Chapel Hill, NC 27514 USA; [Mitchell, Jacinth; Ahmed, Shawn] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27514 USA; [Pintacuda, Greta] Scuola Normale Super Pisa, I-56126 Pisa, Italy	University of North Carolina; University of North Carolina Chapel Hill; University of Cambridge; University of Cambridge; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Scuola Normale Superiore di Pisa	Ahmed, S (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA.	shawn@med.unc.edu; eric.miska@gurdon.cam.ac.uk		Pintacuda, Greta/0000-0001-5126-2279; Lehrbach, Nicolas/0000-0001-7342-4136; Le Pen, Jeremie/0000-0001-7025-9526; Doebley, Anna-Lisa/0000-0002-3371-3352; Miska, Eric/0000-0002-4450-576X; Sarkies, Peter/0000-0003-0279-6199; Weick, Eva-Maria/0000-0002-3504-2572	Cancer Research UK; Wellcome Trust; ERC; NIH [GM083048]; Cancer Research UK [11832] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083048, T32GM007092] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); ERC(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Sylviane Moss for excellent laboratory management and help with genetic crosses and high-throughput sequencing. We thank Craig Mello and Scott Kennedy for sharing unpublished information. We thank Andrew Bannister and Anne Ferguson-Smith for helpful comments on the manuscript. This work was supported by Cancer Research UK, the Wellcome Trust, and an ERC Starting Grant to E.A.M. and by NIH grant GM083048 to S.A.	Alcazar RM, 2008, GENETICS, V180, P1275, DOI 10.1534/genetics.108.089433; Alder MN, 2003, RNA, V9, P25, DOI 10.1261/rna.2650903; Bagijn M.P., 2012, SCIENCE; Bateson W, 1919, NATURE, V103, P344, DOI 10.1038/103344b0; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bean CJ, 2004, NAT GENET, V36, P100, DOI 10.1038/ng1283; Bender LB, 2006, DEVELOPMENT, V133, P3907, DOI 10.1242/dev.02584; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BRENNER S, 1974, GENETICS, V77, P71; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chandler VL, 2010, SCIENCE, V330, P628, DOI 10.1126/science.1191044; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haig D, 2007, BIOL PHILOS, V22, P415, DOI 10.1007/s10539-006-9033-y; Han W, 2008, GENETICS, V178, P1875, DOI 10.1534/genetics.107.085472; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Hynes MJ, 2003, BIOESSAYS, V25, P99, DOI 10.1002/bies.10241; Johnson CL, 2011, SCIENCE, V333, P1311, DOI 10.1126/science.1208178; Jose AM, 2011, NAT STRUCT MOL BIOL, V18, P1183, DOI 10.1038/nsmb.2134; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Kelly WG, 1997, GENETICS, V146, P227; Kelly WG, 2002, DEVELOPMENT, V129, P479; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee JT, 2005, CURR BIOL, V15, pR249, DOI 10.1016/j.cub.2005.03.024; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mello C, 1995, METHOD CELL BIOL, V48, P451; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Stam M, 2005, TRENDS PLANT SCI, V10, P283, DOI 10.1016/j.tplants.2005.04.009; Suter CM, 2010, TRENDS GENET, V26, P9, DOI 10.1016/j.tig.2009.11.003; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tijsterman M, 2004, CURR BIOL, V14, P111, DOI 10.1016/j.cub.2003.12.029; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Varmuza S, 2003, GENOME, V46, P963, DOI 10.1139/G03-115; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Vastenhouw NL, 2004, TRENDS GENET, V20, P314, DOI 10.1016/j.tig.2004.04.011; Wang G, 2008, CURR BIOL, V18, P861, DOI 10.1016/j.cub.2008.05.009; WEISMANN A, 1891, ESSAYS HEREDITY; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang C, 2012, CURR BIOL, V22, P881, DOI 10.1016/j.cub.2012.04.011	61	471	484	4	105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 6	2012	150	1					88	99		10.1016/j.cell.2012.06.018	http://dx.doi.org/10.1016/j.cell.2012.06.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22738725	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000306115000009
J	Visbal, E; Barkana, R; Fialkov, A; Tseliakhovich, D; Hirata, CM				Visbal, Eli; Barkana, Rennan; Fialkov, Anastasia; Tseliakhovich, Dmitriy; Hirata, Christopher M.			The signature of the first stars in atomic hydrogen at redshift 20	NATURE			English	Article							COSMOLOGICAL REIONIZATION; POWER SPECTRUM; EARLY GALAXIES; DARK-MATTER; UNIVERSE; FLUCTUATIONS; POPULATION; RADIATION; EPOCH	Dark and baryonic matter moved at different velocities in the early Universe, which strongly suppressed star formation in some regions(1). This was estimated(2) to imprint a large-scale fluctuation signal of about two millikelvin in the 21-centimetre spectral line of atomic hydrogen associated with stars at a redshift of 20, although this estimate ignored the critical contribution of gas heating due to X-rays(3,4) and major enhancements of the suppression. A large velocity difference reduces the abundance of haloes(1,5,6) and requires the first stars to form in haloes of about a million solar masses(7,8), substantially greater than previously expected(9,10). Here we report a simulation of the distribution of the first stars at redshift 20 (cosmic age of around 180 million years), incorporating all these ingredients within a 400-megaparsec box. We find that the 21-centimetre hydrogen signature of these stars is an enhanced (ten millikelvin) fluctuation signal on the hundred-megaparsec scale, characterized(2) by a flat power spectrum with prominent baryon acoustic oscillations. The required sensitivity to see this signal is achievable with an integration time of a thousand hours with an instrument like the Murchison Wide-field Array(11) or the Low Frequency Array(12) but designed to operate in the range of 50-100 megahertz.	[Visbal, Eli] Harvard Univ, Jefferson Lab Phys, Cambridge, MA 02138 USA; [Visbal, Eli] Harvard Univ, Inst Theory & Computat, Cambridge, MA 02138 USA; [Barkana, Rennan; Fialkov, Anastasia] Tel Aviv Univ, Raymond & Beverly Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Tseliakhovich, Dmitriy; Hirata, Christopher M.] CALTECH, Pasadena, CA 91125 USA	Harvard University; Harvard University; Tel Aviv University; California Institute of Technology	Visbal, E (corresponding author), Harvard Univ, Jefferson Lab Phys, Cambridge, MA 02138 USA.	evisbal@fas.harvard.edu; barkana@wise.tau.ac.il	Fialkov, Anastasia/AAI-6731-2021		Israel Science Foundation; European Research Council; US Department of Energy; National Science Foundation; David & Lucile Packard Foundation	Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); US Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); David & Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was supported by the Israel Science Foundation (for R. B., and E.V.'s stay at Tel Aviv University) and by the European Research Council (for A. F.). D. T. and C. M. H. were supported by the US Department of Energy and the National Science Foundation. C. M. H. is also supported by the David & Lucile Packard Foundation.	Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Aihara H, 2011, ASTROPHYS J SUPPL S, V195, DOI 10.1088/0067-0049/195/2/26; Aihara H, 2011, ASTROPHYS J SUPPL S, V193, DOI 10.1088/0067-0049/193/2/29; Anderson L, 2012, CLUSTERING GALAXIES; Barkana R, 2005, ASTROPHYS J, V626, P1, DOI 10.1086/429954; Barkana R, 2004, ASTROPHYS J, V609, P474, DOI 10.1086/421079; Barkana R, 2001, ASTROPHYS J, V558, P482, DOI 10.1086/322393; Bouwens RJ, 2011, NATURE, V469, P504, DOI 10.1038/nature09717; Bowman JD, 2009, ASTROPHYS J, V695, P183, DOI 10.1088/0004-637X/695/1/183; Bromm V, 1999, ASTROPHYS J, V527, pL5, DOI 10.1086/312385; Colless M, 2001, MON NOT R ASTRON SOC, V328, P1039, DOI 10.1046/j.1365-8711.2001.04902.x; Fialkov A., MON NOT R ASTR UNPUB; Furlanetto SR, 2006, PHYS REP, V433, P181, DOI 10.1016/j.physrep.2006.08.002; Greif TH, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/147; Haiman Z, 1997, ASTROPHYS J, V484, P985, DOI 10.1086/304386; Harker G, 2010, MON NOT R ASTRON SOC, V405, P2492, DOI 10.1111/j.1365-2966.2010.16628.x; Holzbauer LN, 2012, MON NOT R ASTRON SOC, V419, P718, DOI 10.1111/j.1365-2966.2011.19752.x; Liu A, 2012, MON NOT R ASTRON SOC, V419, P3491, DOI 10.1111/j.1365-2966.2011.19989.x; Madau P, 1997, ASTROPHYS J, V475, P429, DOI 10.1086/303549; Maio U, 2011, MON NOT R ASTRON SOC, V412, pL40, DOI 10.1111/j.1745-3933.2010.01001.x; McQuinn M, 2006, ASTROPHYS J, V653, P815, DOI 10.1086/505167; Mesinger A, 2011, MON NOT R ASTRON SOC, V411, P955, DOI 10.1111/j.1365-2966.2010.17731.x; Naoz S, 2006, MON NOT R ASTRON SOC, V373, pL98, DOI 10.1111/j.1745-3933.2006.00251.x; Naoz S, 2008, MON NOT R ASTRON SOC, V385, pL63, DOI 10.1111/j.1745-3933.2008.00434.x; Naoz S, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/128; Pritchard JR, 2007, MON NOT R ASTRON SOC, V376, P1680, DOI 10.1111/j.1365-2966.2007.11519.x; Springel V, 2006, NATURE, V440, P1137, DOI 10.1038/nature04805; Stacy A, 2011, ASTROPHYS J LETT, V730, DOI 10.1088/2041-8205/730/1/L1; Tseliakhovich D, 2011, MON NOT R ASTRON SOC, V418, P906, DOI 10.1111/j.1365-2966.2011.19541.x	32	95	95	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2012	487	7405					70	73		10.1038/nature11177	http://dx.doi.org/10.1038/nature11177			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722853	Green Accepted			2022-12-28	WOS:000305982900051
J	Boyce, N; Palmer, J; Pini, P; Yaqub, F				Boyce, Niall; Palmer, Joanna; Pini, Pia; Yaqub, Farhat			The Wakley Prize, 2012: "This is my truth, now tell me yours"	LANCET			English	Editorial Material									[Boyce, Niall; Palmer, Joanna; Pini, Pia; Yaqub, Farhat] Lancet, London NW1 7BY, England		Boyce, N (corresponding author), Lancet, London NW1 7BY, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 30	2012	379	9835					2411	2411		10.1016/S0140-6736(12)60860-5	http://dx.doi.org/10.1016/S0140-6736(12)60860-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967NV	22748576				2022-12-28	WOS:000305915900036
J	Zhang, XY; Liu, DX; Xu, DD; Asahina, S; Cychosz, KA; Agrawal, KV; Al Wahedi, Y; Bhan, A; Al Hashimi, S; Terasaki, O; Thommes, M; Tsapatsis, M				Zhang, Xueyi; Liu, Dongxia; Xu, Dandan; Asahina, Shunsuke; Cychosz, Katie A.; Agrawal, Kumar Varoon; Al Wahedi, Yasser; Bhan, Aditya; Al Hashimi, Saleh; Terasaki, Osamu; Thommes, Matthias; Tsapatsis, Michael			Synthesis of Self-Pillared Zeolite Nanosheets by Repetitive Branching	SCIENCE			English	Article							HETEROEPITAXIAL GROWTH; INTERGROWTH; MEMBRANES; NANOCRYSTALS; PRECURSOR; MEL	Hierarchical zeolites are a class of microporous catalysts and adsorbents that also contain mesopores, which allow for fast transport of bulky molecules and thereby enable improved performance in petrochemical and biomass processing. We used repetitive branching during one-step hydrothermal crystal growth to synthesize a new hierarchical zeolite made of orthogonally connected microporous nanosheets. The nanosheets are 2 nanometers thick and contain a network of 0.5-nanometer micropores. The house-of-cards arrangement of the nanosheets creates a permanent network of 2- to 7-nanometer mesopores, which, along with the high external surface area and reduced micropore diffusion length, account for higher reaction rates for bulky molecules relative to those of other mesoporous and conventional MFI zeolites.	[Zhang, Xueyi; Liu, Dongxia; Xu, Dandan; Agrawal, Kumar Varoon; Al Wahedi, Yasser; Bhan, Aditya; Tsapatsis, Michael] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Asahina, Shunsuke] JEOL Ltd, SM Applicat Grp, Akishima, Tokyo 1968558, Japan; [Cychosz, Katie A.; Thommes, Matthias] Quantachrome Instruments, Boynton Beach, FL 33426 USA; [Al Hashimi, Saleh] Petr Inst, Chem Engn Program, Abu Dhabi, U Arab Emirates; [Terasaki, Osamu] Korea Adv Inst Sci & Technol, World Class Univ Program, Grad Sch Energy Environm Water & Sustainabil EEWS, Taejon 305701, South Korea; [Terasaki, Osamu] Stockholm Univ, Bezelii Ctr EXSELENT Porous Mat, S-10691 Stockholm, Sweden; [Terasaki, Osamu] Stockholm Univ, Dept Mat & Environm Chem, S-10691 Stockholm, Sweden	University of Minnesota System; University of Minnesota Twin Cities; Jeol Ltd; JEOL Japan; Khalifa University of Science & Technology; Korea Advanced Institute of Science & Technology (KAIST); Stockholm University; Stockholm University	Tsapatsis, M (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	tsapatsis@umn.edu	Wahedi, Yasser Al/R-6807-2019; Terasaki, Osamu/Y-1137-2018; Tsapatsis, Michael/AAA-2527-2019	Terasaki, Osamu/0000-0001-5803-0817; Al Wahedi, Yasser/0000-0003-3599-9515; Struckhoff, Katie/0000-0002-2032-7030; Agrawal, Kumar Varoon/0000-0002-5170-6412; Zhang, Xueyi/0000-0002-3790-5116	Catalysis Center for Energy Innovation, an Energy Frontier Research Center [DESC00001004]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences; ADMIRE (Abu Dhabi-Minnesota Institute for Research Excellence); NSF Emerging Frontiers in Research and Innovation [0937706]; Initiative for Renewable Energy and the Environment of the University of Minnesota's Institute on the Environment; NSF through the NNIN; University of Minnesota Graduate School; ADGAS; GASCO; Argilex; Directorate For Engineering [0937706] Funding Source: National Science Foundation	Catalysis Center for Energy Innovation, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); ADMIRE (Abu Dhabi-Minnesota Institute for Research Excellence); NSF Emerging Frontiers in Research and Innovation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Initiative for Renewable Energy and the Environment of the University of Minnesota's Institute on the Environment; NSF through the NNIN(National Science Foundation (NSF)); University of Minnesota Graduate School(University of Minnesota System); ADGAS; GASCO; Argilex; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	We acknowledge support, for all aspects of SPP zeolite, from the Catalysis Center for Energy Innovation (award DESC00001004), an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences. Partial support for synthesizing conventional, 3DOm-i, and pillared zeolites and their catalytic testing was provided by ADMIRE (Abu Dhabi-Minnesota Institute for Research Excellence), NSF Emerging Frontiers in Research and Innovation grant 0937706, and the Initiative for Renewable Energy and the Environment, a program of the University of Minnesota's Institute on the Environment. Portions of this work were conducted at the University of Minnesota Characterization Facility, which receives partial support from NSF through the NNIN program. Computing resources were provided by the Minnesota Supercomputing Institute. Supported by a University of Minnesota Graduate School doctoral dissertation fellowship (X.Z.) and by ADGAS and GASCO (Y.A.W.). We thank T. Ohsuna for helpful suggestions and S. Hwang for obtaining solid-state NMR spectra. M.T. has an equity interest in, and serves as the Chief Scientific Officer for, Argilex, a company that may commercially benefit from the results of this research. M.T., X.Z., and the University of Minnesota have financial interests arising from a right to receive royalty income under the terms of a license agreement with Argilex. These relationships have been reviewed and managed by the University of Minnesota in accordance with its conflict of interest policies. A U.S. patent application by M.T. and X.Z. was filed on 3 November 2011 (Application No. 13/288,595).	Aris R., 1989, ELEMENTARY CHEM REAC; Casanova O, 2010, J CATAL, V275, P236, DOI 10.1016/j.jcat.2010.08.002; Cheung P, 2006, ANGEW CHEM INT EDIT, V45, P1617, DOI 10.1002/anie.200503898; Corma A, 1998, NATURE, V396, P353, DOI 10.1038/24592; HOU LY, 1983, P 6 INT ZEOL C BUTT, P887; Jeong HK, 2002, J AM CHEM SOC, V124, P12966, DOI 10.1021/ja020947w; Jun YW, 2011, J MATER CHEM, V21, P10283, DOI 10.1039/c1jm11405k; Karwacki L, 2009, NAT MATER, V8, P959, DOI [10.1038/NMAT2530, 10.1038/nmat2530]; Li ZJ, 2005, J PHYS CHEM B, V109, P8652, DOI 10.1021/jp0441893; Liu DX, 2011, ACS CATAL, V1, P7, DOI 10.1021/cs100042r; Maheshwari S, 2008, J AM CHEM SOC, V130, P1507, DOI 10.1021/ja077711i; Manna L, 2003, NAT MATER, V2, P382, DOI 10.1038/nmat902; MILLWARD GR, 1985, P ROY SOC LOND A MAT, V399, P57, DOI 10.1098/rspa.1985.0047; Moller K, 2011, SCIENCE, V333, P297, DOI 10.1126/science.1208528; Na K, 2011, SCIENCE, V333, P328, DOI 10.1126/science.1204452; Na K, 2010, J AM CHEM SOC, V132, P4169, DOI 10.1021/ja908382n; Ohsuna T, 1997, J PHYS CHEM B, V101, P9881, DOI 10.1021/jp971448y; Okubo T, 2001, ANGEW CHEM INT EDIT, V40, P1069, DOI 10.1002/1521-3773(20010316)40:6<1069::AID-ANIE10690>3.0.CO;2-W; Perez-Ramirez J, 2008, CHEM SOC REV, V37, P2530, DOI 10.1039/b809030k; Ravikovitch PI, 2001, COLLOID SURFACE A, V187, P11, DOI 10.1016/S0927-7757(01)00614-8; Roth WJ, 2011, MICROPOR MESOPOR MAT, V142, P32, DOI 10.1016/j.micromeso.2010.11.007; Serrano DP, 2011, CATAL TODAY, V168, P86, DOI 10.1016/j.cattod.2010.12.040; Snyder MA, 2007, ANGEW CHEM INT EDIT, V46, P7560, DOI 10.1002/anie.200604910; Treacy MMJ, 1996, P ROY SOC A-MATH PHY, V452, P813, DOI 10.1098/rspa.1996.0041; Tsapatsis M, 2011, SCIENCE, V334, P767, DOI 10.1126/science.1205957; TUEL A, 1994, MICROPOROUS MATER, V2, P501, DOI 10.1016/0927-6513(93)E0065-O; Varoon K, 2011, SCIENCE, V334, P72, DOI 10.1126/science.1208891; Wang J, 2009, MICROPOR MESOPOR MAT, V120, P19, DOI 10.1016/j.micromeso.2008.08.060; Wang YX, 2005, CHEM MATER, V17, P43, DOI 10.1021/cm048677z	29	554	568	36	1126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1684	1687		10.1126/science.1221111	http://dx.doi.org/10.1126/science.1221111			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745424				2022-12-28	WOS:000305794500044
J	Bradshaw, D; Nwokolo, N				Bradshaw, Daniel; Nwokolo, Nneka			Dizziness and rash in an HIV positive man	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GUIDELINES		[Bradshaw, Daniel; Nwokolo, Nneka] Chelsea & Westminster Hosp, London SW10 9NH, England	Imperial College London	Bradshaw, D (corresponding author), Chelsea & Westminster Hosp, London SW10 9NH, England.	dan.bradshaw@doctors.org.uk		Bradshaw, Daniel/0000-0001-7186-2482				BORDON J, 1995, EUR J CLIN MICROBIOL, V14, P864, DOI 10.1007/BF01691492; Chanem KG, 2008, AIDS, V22, P1145, DOI 10.1097/QAD.0b013e32830184df; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Gjestland T, 1955, Acta Derm Venereol Suppl (Stockh), V35, P3; Health Protection Agency, 2012, STI DAT UK; Kingston M, 2008, INT J STD AIDS, V19, P729, DOI 10.1258/ijsa.2008.008279; Lee Ma, 2007, Morbidity and Mortality Weekly Report, V56, P625	7	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2012	344								e4167	10.1136/bmj.e4167	http://dx.doi.org/10.1136/bmj.e4167			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	968MY	22745326				2022-12-28	WOS:000305987300007
J	Ferreira, C; Veldhoen, M				Ferreira, Cristina; Veldhoen, Marc			Host and Microbes Date Exclusively	CELL			English	Editorial Material							MUTUALISM		[Ferreira, Cristina; Veldhoen, Marc] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Veldhoen, M (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England.	marc.veldhoen@babraham.ac.uk	Veldhoen, Marc/AAM-5357-2021	Ferreira, Cristina/0000-0001-6746-932X; Veldhoen, Marc/0000-0002-1478-9562	Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C242, BBS/E/B/000C0407] Funding Source: Medline; BBSRC [BBS/E/B/0000C242, BBS/E/B/0000S042] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000S042] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Reinhardt C, 2012, NATURE, V483, P627, DOI 10.1038/nature10893; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002	10	7	7	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1428	1430		10.1016/j.cell.2012.06.005	http://dx.doi.org/10.1016/j.cell.2012.06.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726431	Bronze			2022-12-28	WOS:000305753800009
J	Vincent, JP; Magee, T				Vincent, Jean-Paul; Magee, Tony			Tiki Casts a Spell on Wnt	CELL			English	Editorial Material							GLYCOSYLATION		[Vincent, Jean-Paul] Natl Inst Med Res, MRC, London NW7 1AA, England; [Magee, Tony] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England	MRC National Institute for Medical Research; Imperial College London	Vincent, JP (corresponding author), Natl Inst Med Res, MRC, London NW7 1AA, England.	jvincen@nimr.mrc.ac.uk	Magee, Anthony/V-8345-2019		MRC [MC_U117584268] Funding Source: UKRI; Medical Research Council [MC_U117584268] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Kiecker C., 2003, WNT SIGNALLING DEV; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tang XF, 2012, DEV BIOL, V364, P32, DOI 10.1016/j.ydbio.2012.01.009; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039	10	2	2	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1426	1427		10.1016/j.cell.2012.06.007	http://dx.doi.org/10.1016/j.cell.2012.06.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726430	Bronze			2022-12-28	WOS:000305753800008
J	Morens, DM; Subbarao, K; Taubenberger, JK				Morens, David M.; Subbarao, Kanta; Taubenberger, Jeffery K.			Engineering H5N1 avian influenza viruses to study human adaptation	NATURE			English	Article							A VIRUSES; RECEPTOR SPECIFICITY; MOUSE MODEL; VIRULENCE DETERMINANTS; SWINE INFLUENZA; CLEAVAGE SITE; TRANSMISSION; HEMAGGLUTININ; FERRETS; REPLICATION	Two studies of H5N1 avian influenza viruses that had been genetically engineered to render them transmissible between ferrets have proved highly controversial. Divergent opinions exist about the importance of these studies of influenza transmission and about potential 'dual use' research implications. No consensus has developed yet about how to balance these concerns. After not recommending immediate full publication of earlier, less complete versions of the studies, the United States National Science Advisory Board for Biosecurity subsequently recommended full publication of more complete manuscripts; however, controversy about this and similar research remains.	[Morens, David M.; Subbarao, Kanta; Taubenberger, Jeffery K.] NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Morens, DM (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	dm270q@nih.gov	Taubenberger, Jeffery/AAQ-1407-2021	Subbarao, Kanta/0000-0003-1713-3056	National Institutes of Health; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000933, ZIAAI000986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health and the National Institute of Allergy and Infectious Diseases. The authors declare no competing financial interests. We thank L. Qi for translation and discussion of a Chinese language publication.	Aditama TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029971; Aditama TY, 2011, CLIN INFECT DIS, V53, P1237, DOI 10.1093/cid/cir740; BEARE AS, 1991, ARCH VIROL, V119, P37, DOI 10.1007/BF01314321; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Bogs J, 2011, J VIROL, V85, P10691, DOI 10.1128/JVI.00786-11; Bogs J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011826; Brady RC, 2009, VACCINE, V27, P5091, DOI 10.1016/j.vaccine.2009.06.057; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Bray M, 2001, J COMP PATHOL, V125, P243, DOI 10.1053/jcpa.2001.0503; Brown T., 2012, H5N1 RES DISCUSSED S; Chen GL, 2010, J VIROL, V84, P7695, DOI 10.1128/JVI.00511-10; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Chen YX, 2009, ARCH VIROL, V154, P227, DOI 10.1007/s00705-008-0277-5; Chosewood L. C., 2009, BIOSAFETY MICROBIOLO; Doherty PC, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-10; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fouchier R, 2012, NATURE, V481, P257, DOI 10.1038/481257a; Fouchier RAM, 2012, SCIENCE, V335, P400, DOI [10.1126/science.1219412, 10.1126/science.335.6067.400]; FRANCIS T, 1953, ANN INTERN MED, V39, P203, DOI 10.7326/0003-4819-39-2-203; Gohrbandt S, 2011, J GEN VIROL, V92, P51, DOI 10.1099/vir.0.023887-0; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S., 2012, SCIENCE         0622; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Hillman MR, 2002, VACCINE, V20, P3068, DOI 10.1016/S0264-410X(02)00254-2; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Horby P, 2010, EPIDEMIOL INFECT, V138, P1550, DOI 10.1017/S0950268810000518; Ilyushina NA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000043; Joseph T, 2007, J VIROL, V81, P10558, DOI 10.1128/JVI.00970-07; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Kawaoka Y., 2012, ROYAL SOC M H5N1 RES; Kawaoka Y, 2012, NATURE, V482, P155, DOI 10.1038/nature10884; Killingley B, 2011, LANCET INFECT DIS, V11, P879, DOI 10.1016/S1473-3099(11)70142-6; Kimble JB, 2011, P NATL ACAD SCI USA, V108, P12084, DOI 10.1073/pnas.1108058108; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Koster F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033118; Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443; MacKenzie D, 2011, NEW SCI; Mackenzie D, 2012, NEW SCI; Manz B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1804; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; MASSUNG RF, 1993, NATURE, V366, P748, DOI 10.1038/366748a0; MASUREL N, 1973, AM J EPIDEMIOL, V97, P44, DOI 10.1093/oxfordjournals.aje.a121483; Memoli MJ, 2011, J INFECT DIS, V203, P348, DOI 10.1093/infdis/jiq067; Mernoli MJ, 2009, VIROLOGY, V393, P338, DOI 10.1016/j.virol.2009.08.021; Morens DM, 2011, REV MED VIROL, V21, P262, DOI 10.1002/rmv.689; Morens DM, 2010, MBIO, V1, DOI 10.1128/mBio.00211-10; Morens DM, 2010, INFLUENZA OTHER RESP, V4, P327, DOI 10.1111/j.1750-2659.2010.00148.x; Morens DM, 2010, CRIT CARE MED, V38, pE10, DOI 10.1097/CCM.0b013e3181ceb25b; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; National Research Council, 2007, SCI SEC POST 9 11 WO, P57; NSABB, 2012, NAT SCI ADV BOARD BI; Osterholm M. T., 2012, DISCUSSION NSABBS PU; Osterholm MT, 2012, MBIO, V3, DOI 10.1128/mBio.00045-12; Palese P, 2012, P NATL ACAD SCI USA, V109, P2211, DOI 10.1073/pnas.1121297109; Palese P, 2012, NATURE, V481, P115, DOI 10.1038/481115a; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Qi L, 2011, VIROLOGY, V412, P426, DOI 10.1016/j.virol.2011.01.029; Roos R., 2012, NO SIGN MISSED H5N1; Rudneva IA, 2010, VIRAL IMMUNOL, V23, P181, DOI 10.1089/vim.2009.0086; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Song HC, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-126; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Spesock A, 2011, J VIROL, V85, P7048, DOI 10.1128/JVI.00417-11; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Suguitan AL, 2012, J VIROL, V86, P2706, DOI 10.1128/JVI.05546-11; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Taubenberger JK, 2011, VIRUS RES, V162, P2, DOI 10.1016/j.virusres.2011.09.003; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Trammell RA, 2008, EXPERT REV MOL DIAGN, V8, P515, DOI 10.1586/14737159.8.4.515; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888; Wang WJ, 2010, J VIROL, V84, P6570, DOI 10.1128/JVI.00221-10; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P588, DOI 10.1073/pnas.0806959106; Webster RG, 2012, MBIO, V3, DOI 10.1128/mBio.00005-12; WHO, 2012, REP TECHN CONS H5N1; *WHO, 2006, WHO CAS DEF HUM INF; WHO, 2012, CUM NUMB CONF HUM CA; WHO, 2012, PUBL HLTH INFL EXP A; WILSON HE, 1947, J EXP MED, V85, P199, DOI 10.1084/jem.85.2.199; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yamanaka T, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-25; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07; Yen HL, 2009, P NATL ACAD SCI USA, V106, P286, DOI 10.1073/pnas.0811052106; Zhang L, 2009, INFECT GENET EVOL, V9, P1148, DOI 10.1016/j.meegid.2009.07.006; Zhou JY, 2009, J VIROL, V83, P8957, DOI 10.1128/JVI.00793-09; Zielecki F, 2010, J VIROL, V84, P10708, DOI 10.1128/JVI.00610-10	101	43	45	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					335	340		10.1038/nature11170	http://dx.doi.org/10.1038/nature11170			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722191	Green Published, Green Accepted			2022-12-28	WOS:000305466800031
J	Rutledge, RK; Keen, EC				Rutledge, Renee K.; Keen, Erica C.			Whooping Cough in an Adult	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rutledge, Renee K.; Keen, Erica C.] Newton Wellesley Hosp, Newton, MA USA	Newton Wellesley Hospital	Rutledge, RK (corresponding author), Newton Wellesley Hosp, Newton, MA USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH094612] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))			0	7	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					E39	E39		10.1056/NEJMicm1111819	http://dx.doi.org/10.1056/NEJMicm1111819			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961GH	22716993				2022-12-28	WOS:000305451700012
J	Shennan, A; Bewley, S				Shennan, Andrew; Bewley, Susan			What has happened to the UK Confidential Enquiry into Maternal Deaths?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shennan, Andrew] Kings Coll London, Womens Acad Hlth Ctr, London SE1 7EH, England; St Thomas Hosp, Kings Hlth Partners, London SE1 7EH, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Shennan, A (corresponding author), Kings Coll London, Womens Acad Hlth Ctr, London SE1 7EH, England.	andrew.shennan@kcl.ac.uk		Shennan, Andrew/0000-0001-5273-3132; bewley, susan/0000-0001-8064-652X				Angelow A, 2011, BMJ QUAL SAF, V20, P38, DOI 10.1136/bmjqs.2010.040477; Bewley S, 2012, LANCET, V379, P1198, DOI 10.1016/S0140-6736(12)60511-X; Bewley S, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d436; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Lewis G., 2007, 7 CONFIDENTIAL ENQUI; Lewis G, 2012, SEMIN PERINATOL, V36, P19, DOI 10.1053/j.semperi.2011.09.005; McFarlane A, 2004, WHY MOTHERS 2000 200, P296; National Patient Safety Agency, 2011, EXP PAN MAT NEWB CLI; Schutte JM, 2007, ACTA OBSTET GYN SCAN, V86, P240, DOI 10.1080/00016340601104054; Shennan AH, 2012, LANCET, V379, P1686, DOI 10.1016/S0140-6736(11)60785-X; Vasireddy A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3575; WELLS J, 1993, BRIT MED J, V307, P1426, DOI 10.1136/bmj.307.6916.1426-d	12	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 21	2012	344								e4147	10.1136/bmj.e4147	http://dx.doi.org/10.1136/bmj.e4147			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965CH	22723602				2022-12-28	WOS:000305743200009
J	Ferner, R				Ferner, Robin			Summertime	BRITISH MEDICAL JOURNAL			English	Editorial Material							THALLIUM ACETATE		Birmingham City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				[Anonymous], 1847, PLIN NAT HIST 37 BOO; Greenbaum SS, 1931, J AMER MED ASSOC, V96, P1868, DOI 10.1001/jama.1931.27220480003010a; Ingram JT, 1932, BMJ-BRIT MED J, V1932, P8, DOI 10.1136/bmj.1.3704.8; National Institute for Health and Clinical Excellence, ANG MYOC INF MYOC PE; Robb-Smith AHT, 1987, LANCET, V329, P872	5	0	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 19	2012	344								e4245	10.1136/bmj.e4245	http://dx.doi.org/10.1136/bmj.e4245			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965CU	22718967				2022-12-28	WOS:000305744600016
J	Willett, LR				Willett, Laura Rees			Meta-analysis: Self-monitoring in non-insulin-treated type 2 diabetes improved HbA(1c) by 0.25%	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Willett, LR (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA.							Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Karagiannis T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1369	3	13	14	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12							JC6-12	10.7326/0003-4819-156-12-201206190-02012	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711113				2022-12-28	WOS:000307783200011
J	Kraemer, C; Nikseresht, N; Piatek, JO; Tsyrulin, N; Dalla Piazza, B; Kiefer, K; Klemke, B; Rosenbaum, TF; Aeppli, G; Gannarelli, C; Prokes, K; Podlesnyak, A; Strassle, T; Keller, L; Zaharko, O; Kramer, KW; Ronnow, HM				Kraemer, Conradin; Nikseresht, Neda; Piatek, Julian O.; Tsyrulin, Nikolay; Dalla Piazza, Bastien; Kiefer, Klaus; Klemke, Bastian; Rosenbaum, Thomas F.; Aeppli, Gabriel; Gannarelli, Che; Prokes, Karel; Podlesnyak, Andrey; Straessle, Thierry; Keller, Lukas; Zaharko, Oksana; Kraemer, Karl W.; Ronnow, Henrik M.			Dipolar Antiferromagnetism and Quantum Criticality in LiErF4	SCIENCE			English	Article							FERROMAGNET LITBF4; PHASE-TRANSITION; SPIN BATH; LIHOF4; FLUCTUATIONS; TEMPERATURE; MAGNETS; LATTICE; ORDER; FIELD	Magnetism has been predicted to occur in systems in which dipolar interactions dominate exchange. We present neutron scattering, specific heat, and magnetic susceptibility data for LiErF4, establishing it as a model dipolar-coupled antiferromagnet with planar spin-anisotropy and a quantum phase transition in applied field H-c parallel to = 4.0 +/- 0.1 kilo-oersteds. We discovered non-mean-field critical scaling for the classical phase transition at the antiferromagnetic transition temperature that is consistent with the two-dimensional XY/h(4) universality class; in accord with this, the quantum phase transition at H-c exhibits three-dimensional classical behavior. The effective dimensional reduction may be a consequence of the intrinsic frustrated nature of the dipolar interaction, which strengthens the role of fluctuations.	[Kraemer, Conradin; Nikseresht, Neda; Piatek, Julian O.; Tsyrulin, Nikolay; Dalla Piazza, Bastien; Ronnow, Henrik M.] Ecole Polytech Fed Lausanne, Lab Quantum Magnetism, CH-1015 Lausanne, Switzerland; [Kraemer, Conradin; Straessle, Thierry; Keller, Lukas; Zaharko, Oksana] Paul Scherrer Inst, Neutron Scattering Lab, CH-5232 Villigen, Switzerland; [Kiefer, Klaus; Klemke, Bastian; Prokes, Karel] Helmholtz Zentrum Berlin, D-14109 Berlin, Germany; [Rosenbaum, Thomas F.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Rosenbaum, Thomas F.] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Aeppli, Gabriel; Gannarelli, Che] UCL, London Ctr Nanotechnol, London WC1E 6BT, England; [Aeppli, Gabriel; Gannarelli, Che] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Podlesnyak, Andrey] Oak Ridge Natl Lab, Spallat Neutron Source, Oak Ridge, TN 37831 USA; [Kraemer, Karl W.] Univ Bern, Dept Chem & Biochem, CH-3000 Bern 9, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of Chicago; University of Chicago; University of London; University College London; University of London; University College London; United States Department of Energy (DOE); Oak Ridge National Laboratory; Spallation Neutron Source; University of Bern	Ronnow, HM (corresponding author), Ecole Polytech Fed Lausanne, Lab Quantum Magnetism, CH-1015 Lausanne, Switzerland.	henrik.ronnow@epfl.ch	Dalla Piazza, Bastien/M-6954-2014; Klemke, Bastian/J-4746-2013; Prokes, Karel/J-5438-2013; Krämer, Karl W/J-5021-2013; Ronnow, Henrik M/A-4953-2009; Kiefer, Klaus/J-3544-2013; Podlesnyak, Andrey/A-5593-2013	Dalla Piazza, Bastien/0000-0003-4997-7165; Klemke, Bastian/0000-0003-4560-6025; Prokes, Karel/0000-0002-7034-1738; Krämer, Karl W/0000-0001-5524-7703; Ronnow, Henrik M/0000-0002-8832-8865; Kiefer, Klaus/0000-0002-5178-0495; Podlesnyak, Andrey/0000-0001-9366-6319; Keller, Lukas/0000-0002-8492-4117	Swiss National Science Foundation; U.S. Department of Energy Basic Energy Sciences; NSF Materials Research Science and Engineering Center; London Centre for Nanotechnology by the UK Engineering and Physical Sciences Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. Department of Energy Basic Energy Sciences(United States Department of Energy (DOE)); NSF Materials Research Science and Engineering Center(National Science Foundation (NSF)); London Centre for Nanotechnology by the UK Engineering and Physical Sciences Research Council	We gratefully acknowledge fruitful discussions with J. Mesot, J. Jensen, A. J. Fisher, S. T. Bramwell, and S. Sachdev; support from Swiss National Science Foundation and Materials with Novel Electronic Properties; and neutron beam access at the Berlin Neutron Scattering Center, Helmholz-Zentrum Berlin, and the Swiss Spallation Neutron Source, Paul Scherrer Institut. Work at the University of Chicago was supported by the U.S. Department of Energy Basic Energy Sciences, the NSF Materials Research Science and Engineering Center, and the London Centre for Nanotechnology by the UK Engineering and Physical Sciences Research Council.	AHLERS G, 1975, PHYS REV LETT, V34, P1227, DOI 10.1103/PhysRevLett.34.1227; ALSNIELSEN J, 1976, PHYS REV LETT, V37, P1161, DOI 10.1103/PhysRevLett.37.1161; BEAUVILLAIN P, 1977, J PHYS C SOLID STATE, V10, pL709, DOI 10.1088/0022-3719/10/24/007; Bitko D, 1996, PHYS REV LETT, V77, P940, DOI 10.1103/PhysRevLett.77.940; BROWN MR, 1969, J PHYS PART C SOLID, V2, P593, DOI 10.1088/0022-3719/2/4/304; CHRISTENSEN HP, 1979, PHYS REV B, V19, P6564, DOI 10.1103/PhysRevB.19.6564; Giraud R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.057203; HANSEN PE, 1975, PHYS REV B, V12, P5315, DOI 10.1103/PhysRevB.12.5315; HENLEY CL, 1994, PHYS REV LETT, V73, P2788, DOI 10.1103/PhysRevLett.73.2788; Hertz A. J., 1976, PHYS REV B, V14, P1165; Jonsson PE, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.256403; Lubarda MV, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3532839; LUTTINGER JM, 1946, PHYS REV, V70, P954, DOI 10.1103/PhysRev.70.954; MAGARINO J, 1980, PHYS REV B, V21, P18, DOI 10.1103/PhysRevB.21.18; Martin JI, 2003, J MAGN MAGN MATER, V256, P449, DOI 10.1016/S0304-8853(02)00898-3; MENNENGA G, 1984, J MAGN MAGN MATER, V44, P48, DOI 10.1016/0304-8853(84)90046-5; Misra K. S., 1977, PHYS REV B, V15, P4309; Mol LAS, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.054404; Nikkel J, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevLett.87.214420; Prokof'ev NV, 2000, REP PROG PHYS, V63, P669, DOI 10.1088/0034-4885/63/4/204; Quilliam JA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.187204; REICH DH, 1990, PHYS REV B, V42, P4631, DOI 10.1103/PhysRevB.42.4631; Ronnow HM, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.054426; Ronnow HM, 2005, SCIENCE, V308, P389, DOI 10.1126/science.1108317; SATTLER JP, 1971, PHYS REV B-SOLID ST, V4, P1, DOI 10.1103/PhysRevB.4.1; Schechter M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.137204; Schroder A, 1998, PHYS REV LETT, V80, P5623, DOI 10.1103/PhysRevLett.80.5623; Silevitch DM, 2007, NATURE, V448, P567, DOI 10.1038/nature06050; Tabei SMA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.237203; Taroni A, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/27/275233; VILLAIN J, 1980, J PHYS-PARIS, V41, P1263, DOI 10.1051/jphys:0198000410110126300; Wang RF, 2006, NATURE, V439, P303, DOI 10.1038/nature04447; WU WH, 1991, PHYS REV LETT, V67, P2076, DOI 10.1103/PhysRevLett.67.2076	34	35	35	4	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1416	1419		10.1126/science.1221878	http://dx.doi.org/10.1126/science.1221878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700923	Green Submitted			2022-12-28	WOS:000305211700038
J	Love, C; Morice, AH				Love, Caroline; Morice, Alyn H.			After repair of tracheo-oesophageal atresia	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Love, Caroline] York Dist Gen Hosp, York YO32 9FT, N Yorkshire, England; [Morice, Alyn H.] Castle Hill Hosp, Cottingham HU16 5JQ, E Riding Yorksh, England	University of Hull	Love, C (corresponding author), York Dist Gen Hosp, York YO32 9FT, N Yorkshire, England.	caroline.love@york.nhs.uk							0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 15	2012	344								e3517	10.1136/bmj.e3517	http://dx.doi.org/10.1136/bmj.e3517			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961LC	22705813	Bronze			2022-12-28	WOS:000305464900001
J	Grande, D				Grande, David			The Cost of Drug Coupons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Grande, David] Univ Penn, Perelman Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Grande, David] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Grande, D (corresponding author), 3641 Locust Walk,Colonial Penn Ctr 407, Philadelphia, PA 19104 USA.	dgrande@wharton.upenn.edu	Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735				Heisler M, 2004, MED CARE, V42, P626, DOI 10.1097/01.mlr.0000129352.36733.cc; Heisler M, 2010, MED CARE, V48, P87, DOI 10.1097/MLR.0b013e3181c12e53; Jackevicius CA, 2012, NEW ENGL J MED, V366, P201, DOI 10.1056/NEJMp1113112; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Madden JM, 2008, JAMA-J AM MED ASSOC, V299, P1922, DOI 10.1001/jama.299.16.1922; Pharmaceutical Care Management Association, 2011, COP COUP COULD RAIS; Thomas JM, 2012, HIS NAME WAS RICO HE	7	19	20	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2012	307	22					2375	2376		10.1001/jama.2012.5603	http://dx.doi.org/10.1001/jama.2012.5603			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	956UX	22692167				2022-12-28	WOS:000305115900019
J	Jardine, MJ; Kang, A; Zoungas, S; Navaneethan, SD; Ninomiya, T; Nigwekar, SU; Gallagher, MP; Cass, A; Strippoli, G; Perkovic, V				Jardine, Meg J.; Kang, Amy; Zoungas, Sophia; Navaneethan, Sankar D.; Ninomiya, Toshiharu; Nigwekar, Sagar U.; Gallagher, Martin P.; Cass, Alan; Strippoli, Giovanni; Perkovic, Vlado			The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLASMA TOTAL HOMOCYSTEINE; STAGE RENAL-DISEASE; B-VITAMINS; TRANSPLANT RECIPIENTS; RISK-FACTOR; ELEVATED HOMOCYSTEINE; MYOCARDIAL-INFARCTION; REVERSE EPIDEMIOLOGY; STROKE PREVENTION; MORTALITY	Objective To systematically review the effect of folic acid based homocysteine lowering on cardiovascular outcomes in people with kidney disease. Design Systematic review and meta-analysis. Data sources Medline, Embase, the Cochrane Library, and ClinicalTrials.gov to June 2011. Study selection Randomised trials in people with non-dialysis dependent chronic kidney disease or end stage kidney disease or with a functioning kidney transplant reporting at least 100 patient years of follow-up and assessing the effect of folic acid based homocysteine lowering therapy. No language restrictions were applied. Data extraction Two reviewers independently extracted data on study setting, design, and outcomes using a standardised form. The primary endpoint was cardiovascular events (myocardial infarction, stroke, and cardiovascular mortality, or as defined by study author). Secondary endpoints included the individual composite components, all cause mortality, access thrombosis, requirement for renal replacement therapy, and reported adverse events, including haematological and neurological events. The effect of folic acid based homocysteine lowering on outcomes was assessed with meta-analysis using random effects models. Results 11 trials were identified that reported on 4389 people with chronic kidney disease, 2452 with end stage kidney disease, and 4110 with functioning kidney transplants (10 951 participants in total). Folic acid based homocysteine therapy did not prevent cardiovascular events (relative risk 0.97, 95% confidence interval 0.92 to 1.03, P=0.326) or any of the secondary outcomes. There was no evidence of heterogeneity in subgroup analyses, including those of kidney disease category, background fortification, rates of pre-existing disease, or baseline homocysteine level. The definitions of chronic kidney disease varied widely between the studies. Non-cardiovascular events could not be analysed as few studies reported these outcomes. Conclusions Folic acid based homocysteine lowering does not reduce cardiovascular events in people with kidney disease. Folic acid based regimens should not be used for the prevention of cardiovascular events in people with kidney disease.	[Jardine, Meg J.; Kang, Amy; Zoungas, Sophia; Ninomiya, Toshiharu; Gallagher, Martin P.; Cass, Alan; Perkovic, Vlado] George Inst Global Hlth, Camperdown, NSW 2050, Australia; [Jardine, Meg J.; Gallagher, Martin P.] Concord Repatriat Gen Hosp, Sydney, NSW, Australia; [Kang, Amy] Royal N Shore Hosp, Sydney, NSW, Australia; [Zoungas, Sophia] Monash Univ, Sch Publ Hlth, Melbourne, Vic 3004, Australia; [Navaneethan, Sankar D.] Cleveland Clin, Dept Hypertens & Nephrol, Cleveland, OH 44106 USA; [Ninomiya, Toshiharu] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Nigwekar, Sagar U.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Strippoli, Giovanni] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Strippoli, Giovanni] Mario Negri Sud Consortium, Santa Maria Imbaro, Italy	George Institute for Global Health; University of Sydney; Concord Repatriation General Hospital; Royal North Shore Hospital; University of Sydney; Monash University; Cleveland Clinic Foundation; Kyushu University; Harvard University; Massachusetts General Hospital; University of Sydney; Consorzio Mario Negri Sud	Jardine, MJ (corresponding author), George Inst Global Hlth, POB M201, Camperdown, NSW 2050, Australia.	mjardine@georgeinstitute.org.au	Jardine, Meg/AFR-1699-2022; Perkovic, Vlado/AAY-1933-2021; Jardine, Meg/AAS-1864-2020	Jardine, Meg/0000-0002-0160-2375; Jardine, Meg/0000-0002-0160-2375; Zoungas, Sophia/0000-0003-2672-0949; Gallagher, Martin/0000-0001-9187-6187; Cass, Alan/0000-0002-3923-3173; Perkovic, Vlado/0000-0002-4257-7620; Strippoli, Giovanni/0000-0002-6936-0616	Royal Australasian College of Physicians Jacquot Research Establishment; Banyu Life Science Foundation International fellowship programme (Japan); Foundation of High Blood Pressure Research ISH visiting postdoctoral award (Australia); National Heart Foundation of Australia Career Development Award; NSW Cardiovascular Research Network Heart Foundation of Australia fellowship; MSD; Novo Nordisk; Astra Zeneca/BMS; Novartis; Sanofi Aventis; Servier International; KL2 grant from the National Institutes of Health; unrestricted grant from CSL; educational grant from Shire; Roche	Royal Australasian College of Physicians Jacquot Research Establishment; Banyu Life Science Foundation International fellowship programme (Japan); Foundation of High Blood Pressure Research ISH visiting postdoctoral award (Australia); National Heart Foundation of Australia Career Development Award(National Heart Foundation of Australia); NSW Cardiovascular Research Network Heart Foundation of Australia fellowship; MSD; Novo Nordisk(Novo Nordisk); Astra Zeneca/BMS(AstraZeneca); Novartis(Novartis); Sanofi Aventis(Sanofi-Aventis); Servier International(Servier); KL2 grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); unrestricted grant from CSL; educational grant from Shire; Roche(Roche Holding)	We thank SZ and K Polkinghorne for additional data from the ASFAST study; Gail Higgins, trials search coordinator of the Cochrane Renal Group, for assistance with the search strategy and implementation; MJJ and MPG were supported by grants from the Royal Australasian College of Physicians Jacquot Research Establishment; TN was supported by a Banyu Life Science Foundation International fellowship programme (Japan) and by a Foundation of High Blood Pressure Research ISH visiting postdoctoral award (Australia). SZ was supported by a National Heart Foundation of Australia Career Development Award. VP was supported by a NSW Cardiovascular Research Network Heart Foundation of Australia fellowship. The authors were independently responsible for the study design, analysis, interpretation, preparation of the manuscript, and the decision to submit for publication.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that : no support from any organisation for the submitted work; SZ is a member of the advisory boards for MSD, Novo Nordisk, and Boehringer Ingelheim, and has received consultancies from Novo Nordisk and Johnson and Johnson, speakers fees from MSD, Novo Nordisk, Astra Zeneca/BMS, Novartis, Sanofi Aventis, and Servier International, and payment for the development of educational presentations from Medi Mark; MG has received payment for lectures from Roche Pharmaceuticals; SDN has received a KL2 grant from the National Institutes of Health; AC has received payment for lectures from Roche, Servier, AMGEN, and MSD; MJ has received an unrestricted grant from CSL; Concord Hospital has received an educational grant from Shire; VP is a member of the Abbot advisory board, has grants or grants pending from Roche, Johnson and Johnson, Baxter, and Servier and has received payment for lectures from Roche, Servier, and Astra Zeneca; MJ, AK, SZ, TN, MG, AC, and VP are affiliated with the George Institute, which receives funding from various pharmaceutical companies to support parts of its research activities, which companies might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.	Andreucci VE, 2004, AM J KIDNEY DIS, V44, pS61, DOI 10.1053/j.ajkd.2004.08.013; [Anonymous], KDOQI CLIN PRACTICE; Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840; Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Bostom AG, 2011, CIRCULATION, V123, P1763, DOI 10.1161/CIRCULATIONAHA.110.000588; Cianciolo G, 2008, AM J NEPHROL, V28, P941, DOI 10.1159/000142363; Clarke R, 2005, AM J CLIN NUTR, V82, P806, DOI 10.1093/ajcn/82.4.806; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Clarke R, 2010, ARCH INTERN MED, V170, P1622, DOI 10.1001/archinternmed.2010.348; Connolly GM, 2010, NEPHRON CLIN PRACT, V114, pC5, DOI 10.1159/000242443; Ducloux D, 2000, J AM SOC NEPHROL, V11, P134, DOI 10.1681/ASN.V111134; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ganji V, 2006, AM J CLIN NUTR, V84, P989, DOI 10.1093/ajcn/84.5.989; Hankey GJ, 2010, LANCET NEUROL, V9, P855, DOI 10.1016/S1474-4422(10)70187-3; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Heinz J, 2010, CIRCULATION, V121, P1432, DOI 10.1161/CIRCULATIONAHA.109.904672; Heinz J, 2009, AM J KIDNEY DIS, V54, P478, DOI 10.1053/j.ajkd.2009.01.266; Holt S, 2010, CARDIOVASCULAR DIS C; House AA, 2010, JAMA-J AM MED ASSOC, V303, P1603, DOI 10.1001/jama.2010.490; Jamison RL, 2007, JAMA-J AM MED ASSOC, V298, P1163, DOI 10.1001/jama.298.10.1163; Kalantar-Zadeh K, 2004, J AM SOC NEPHROL, V15, P442, DOI 10.1097/01.ASN.0000107564.60018.51; Kopple JD, 2005, AM J CLIN NUTR, V81, P1257; Levey AS, 1999, NEPHROL DIAL TRANSPL, V14, P828, DOI 10.1093/ndt/14.4.828; Lin YH, 2007, CLIN BIOCHEM, V40, P230, DOI 10.1016/j.clinbiochem.2006.11.010; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mann JFE, 2008, NEPHROL DIAL TRANSPL, V23, P645, DOI 10.1093/ndt/gfm485; MASSY ZA, 1994, NEPHROL DIAL TRANSPL, V9, P1103, DOI 10.1093/ndt/9.8.1103; Mei W, 2010, INT J CLIN PRACT, V64, P208, DOI 10.1111/j.1742-1241.2009.02207.x; Menon V, 2006, CIRCULATION, V113, P1572, DOI 10.1161/CIRCULATIONAHA.105.570127; Menon V, 2005, KIDNEY INT, V67, P1539, DOI 10.1111/j.1523-1755.2005.00234.x; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Nair AP, 2005, MT SINAI J MED, V72, P365; National Kidney Foundation, 2005, Am J Kidney Dis, V45, pS1; Nerbass FB, 2006, J AM DIET ASSOC, V106, P267, DOI 10.1016/j.jada.2005.10.035; Potter K, 2008, ARTERIOSCL THROM VAS, V28, P1158, DOI 10.1161/ATVBAHA.108.162743; Qin XH, 2011, CLIN J AM SOC NEPHRO, V6, P482, DOI 10.2215/CJN.05310610; Righetti M, 2006, BLOOD PURIFICAT, V24, P379, DOI 10.1159/000093680; Robinson K, 1996, CIRCULATION, V94, P2743, DOI 10.1161/01.CIR.94.11.2743; de Almeida CCS, 2011, J RENAL NUTR, V21, P394, DOI 10.1053/j.jrn.2010.12.005; Suliman M, 2007, NEPHROL DIAL TRANSPL, V22, P209, DOI 10.1093/ndt/gfl510; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Vianna Areuza C A, 2007, Hemodial Int, V11, P210, DOI 10.1111/j.1542-4758.2007.00171.x; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Winkelmayer WC, 2005, J AM SOC NEPHROL, V16, P255, DOI 10.1681/ASN.2004070576; Woodward M., 2013, EPIDEMIOLOGY STUDY D; Wrone EM, 2004, J AM SOC NEPHROL, V15, P420, DOI 10.1097/01.ASN.0000110181.64655.6C; Yap S, 2003, J INHERIT METAB DIS, V26, P259, DOI 10.1023/A:1024497419821; Zoungas S, 2006, J AM COLL CARDIOL, V47, P1108, DOI 10.1016/j.jacc.2005.10.064	51	64	70	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 13	2012	344								e3533	10.1136/bmj.e3533	http://dx.doi.org/10.1136/bmj.e3533			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961KT	22695899	Green Published, hybrid			2022-12-28	WOS:000305464000003
J	Devereaux, PJ; Chan, MTV; Alonso-Coello, P; Walsh, M; Berwanger, O; Villar, JC; Wang, CY; Garutti, RI; Jacka, MJ; Sigamani, A; Srinathan, S; Biccard, BM; Chow, CK; Abraham, V; Tiboni, M; Pettit, S; Szczeklik, W; Buse, GL; Botto, F; Guyatt, G; Heels-Ansdell, D; Sessler, DI; Thorlund, K; Garg, AX; Mrkobrada, M; Thomas, S; Rodseth, RN; Pearse, RM; Thabane, L; McQueen, MJ; VanHelder, T; Bhandari, M; Bosch, J; Kurz, A; Polanczyk, C; Malaga, G; Nagele, P; Le Manach, Y; Leuwer, M; Yusuf, S				Devereaux, P. J.; Chan, Matthew T. V.; Alonso-Coello, Pablo; Walsh, Michael; Berwanger, Otavio; Villar, Juan Carlos; Wang, C. Y.; Garutti, R. Ignacio; Jacka, Michael J.; Sigamani, Alben; Srinathan, Sadeesh; Biccard, Bruce M.; Chow, Clara K.; Abraham, Valsa; Tiboni, Maria; Pettit, Shirley; Szczeklik, Wojciech; Buse, Giovanna Lurati; Botto, Fernando; Guyatt, Gordon; Heels-Ansdell, Diane; Sessler, Daniel I.; Thorlund, Kristian; Garg, Amit X.; Mrkobrada, Marko; Thomas, Sabu; Rodseth, Reitze N.; Pearse, Rupert M.; Thabane, Lehana; McQueen, Matthew J.; VanHelder, Tomas; Bhandari, Mohit; Bosch, Jackie; Kurz, Andrea; Polanczyk, Carisi; Malaga, German; Nagele, Peter; Le Manach, Yannick; Leuwer, Martin; Yusuf, Salim		Vasc Events Noncardiac Surg Patien	Association Between Postoperative Troponin Levels and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; RISK; COMPLICATIONS; DEFINITION; PREDICTION; STRATEGY	Context Of the 200 million adults worldwide who undergo noncardiac surgery each year, more than 1 million will die within 30 days. Objective To determine the relationship between the peak fourth-generation troponin T (TnT) measurement in the first 3 days after noncardiac surgery and 30-day mortality. Design, Setting, and Participants A prospective, international cohort study that enrolled patients from August 6, 2007, to January 11, 2011. Eligible patients were aged 45 years and older and required at least an overnight hospital admission after having noncardiac surgery. Main Outcome Measures Patients' TnT levels were measured 6 to 12 hours after surgery and on days 1, 2, and 3 after surgery. We undertook Cox regression analysis in which the dependent variable was mortality until 30 days after surgery, and the independent variables included 24 preoperative variables. We repeated this analysis, adding the peak TnT measurement during the first 3 postoperative days as an independent variable and used a minimum P value approach to determine if there were TnT thresholds that independently altered patients' risk of death. Results A total of 15 133 patients were included in this study. The 30-day mortality rate was 1.9% (95% CI, 1.7%-2.1%). Multivariable analysis demonstrated that peak TnT values of at least 0.02 ng/mL, occurring in 11.6% of patients, were associated with higher 30-day mortality compared with the reference group (peak TnT <= 0.01 ng/mL): peak TnT of 0.02 ng/mL (adjusted hazard ratio [aHR], 2.41; 95% CI, 1.33-3.77); 0.03 to 0.29 ng/mL (aHR, 5.00; 95% CI, 3.72-6.76); and 0.30 ng/mL or greater (aHR, 10.48; 95% CI, 6.25-16.62). Patients with a peak TnT value of 0.01 ng/mL or less, 0.02, 0.03-0.29, and 0.30 or greater had 30-day mortality rates of 1.0%, 4.0%, 9.3%, and 16.9%, respectively. Peak TnT measurement added incremental prognostic value to discriminate those likely to die within 30 days for the model with peak TnT measurement vs without (C index=0.85 vs 0.81; difference, 0.4; 95% CI, 0.2-0.5; P<.001 for difference between C index values). The net reclassification improvement with TnT was 25.0% (P<.001). Conclusion Among patients undergoing noncardiac surgery, the peak postoperative TnT measurement during the first 3 days after surgery was significantly associated with 30-day mortality. JAMA. 2012;307(21):2295-2304 www.jama.com	[Devereaux, P. J.; Walsh, Michael; Tiboni, Maria; Guyatt, Gordon; Heels-Ansdell, Diane; Thorlund, Kristian; Thabane, Lehana; Bhandari, Mohit; Bosch, Jackie] McMaster Univ, Hamilton, ON, Canada; [Chan, Matthew T. V.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Alonso-Coello, Pablo] Biomed Res Inst St Pau IIB St Pau, Barcelona, Spain; [Berwanger, Otavio] Hosp Coracao, Res Inst Hcor, Sao Paulo, Brazil; [Villar, Juan Carlos] Univ Autonoma Bucaramanga, Bucaramanga, Colombia; [Wang, C. Y.] Univ Malaya, Kuala Lumpur, Malaysia; [Garutti, R. Ignacio] Hosp Gen Univ Gregorio Maranon, Madrid, Spain; [Jacka, Michael J.] Univ Alberta Hosp, Edmonton, AB, Canada; [Sigamani, Alben] St Johns Med Coll & Res Inst, Bangalore, Karnataka, India; [Srinathan, Sadeesh] Univ Manitoba, Winnipeg, MB, Canada; [Biccard, Bruce M.; Rodseth, Reitze N.] Univ Kwazulu Natal, Durban, South Africa; [Chow, Clara K.] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia; [Abraham, Valsa] Christian Med Coll & Hosp, Ludhiana, Punjab, India; [Pettit, Shirley; McQueen, Matthew J.; VanHelder, Tomas] Hamilton Hlth Sci Ctr, Hamilton, ON, Canada; [Szczeklik, Wojciech] Jagiellonian Univ, Coll Med, Krakow, Poland; [Buse, Giovanna Lurati; Botto, Fernando; Yusuf, Salim] Populat Hlth Res Inst, Hamilton, ON, Canada; [Sessler, Daniel I.; Kurz, Andrea] Cleveland Clin, Cleveland, OH USA; [Garg, Amit X.; Mrkobrada, Marko] London Hlth Sci Ctr, London, ON, Canada; [Thomas, Sabu] Univ Rochester, Sch Med, Rochester, NY USA; [Pearse, Rupert M.] Barts & London Queen Marys Sch Med & Dent, London, England; [Polanczyk, Carisi] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Malaga, German] Univ Peruana Cayetano Heredia, Lima, Peru; [Nagele, Peter] Washington Univ, Sch Med, St Louis, MO USA; [Le Manach, Yannick] Hop La Pitie Salpetriere, Paris, France; [Leuwer, Martin] Royal Liverpool Broadgreen Univ Hosp Trust, Liverpool, Merseyside, England	McMaster University; Chinese University of Hong Kong; Hospital do Coracao - HCor; Universiti Malaya; General University Gregorio Maranon Hospital; University of Alberta; St. John's National Academy of Health Sciences; St. John's Medical College; University of Manitoba; University of Kwazulu Natal; George Institute for Global Health; University of Sydney; McMaster University; Jagiellonian University; Collegium Medicum Jagiellonian University; Population Health Research Institute; Cleveland Clinic Foundation; London Health Sciences Centre; University of Rochester; University of London; Queen Mary University London; Universidade Federal do Rio Grande do Sul; Universidad Peruana Cayetano Heredia; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Royal Liverpool & Broadgreen University Hospitals NHS Trust; University of Liverpool	Devereaux, PJ (corresponding author), McMaster Univ, David Braley Cardiac Vasc & Stroke Res Inst, Populat Hlth Res Inst, Dept Clin Epidemiol & Biostat & Med, 237 Barton St E, Hamilton, ON L8L 2X4, Canada.	philipj@mcmaster.ca	SHARIFFUDDIN, INA ISMIARTI/B-8658-2010; Gerstein, Hertzel/ABB-8781-2020; GIN, Tony/J-2521-2013; Nagele, Peter/AAW-1651-2020; O'Donnell, Martin/ABE-7459-2020; Pearse, Rupert/H-5426-2011; Polanczyk, Carisi CAP/D-6208-2013; Wang, Chew Yin/F-7573-2010; Le Manach, Yannick/AAE-5700-2019; Garutti, Ignacio/AAB-4699-2019; Rodseth, Reitze Nils/N-5008-2013; Garutti, Ignacio/H-9035-2017; Szczeklik, Wojciech/N-8096-2014; McAlister, Finlay/C-4151-2013; Walsh, Michael/ABE-1278-2021; Bosch, Jacqueline/AAP-6910-2021; Lai, Hou Yee/Q-6189-2016; Winemaker, Mitchell/AAQ-5131-2021; Garg, Amit X/G-3295-2011; MD HASHIM, NOORJAHAN HANEEM/B-9289-2010; Mrkobrada, Marko/G-3336-2011; WANG, CHEW YIN/B-7534-2010; Lee, Vincent/H-6468-2019; Nagele, Peter/ABA-5189-2020; Villar Centeno, Juan Carlos/AAX-5401-2021; Nagele, Peter/A-2922-2008; Devereaux, PJ/AAY-1757-2021; Bhandari, Mohit/AAQ-1675-2021; Lai, Hou Yee/AAN-5531-2020; Rodseth, Reitze/B-2471-2010; Sessler, Daniel/D-3504-2011; Sigamani, Alben/GQH-0406-2022; Razack, Azad HA/B-8152-2009; Gerstein, Hertzel C/B-1235-2013; Chan, Matthew/J-2884-2013; Buse, Giovanna Lurati/ABE-6008-2020; Devereaux, PJ/AAF-2862-2019; Adili, Anthony/AAR-7196-2021; Suzumura, Erica A/C-4197-2013	SHARIFFUDDIN, INA ISMIARTI/0000-0002-7528-9027; Gerstein, Hertzel/0000-0001-8072-2836; GIN, Tony/0000-0001-7283-6761; Nagele, Peter/0000-0001-8369-3858; O'Donnell, Martin/0000-0002-7347-7761; Pearse, Rupert/0000-0002-4373-5934; Le Manach, Yannick/0000-0003-0474-8545; Garutti, Ignacio/0000-0001-8284-2903; Garutti, Ignacio/0000-0001-8284-2903; Szczeklik, Wojciech/0000-0002-1349-1123; McAlister, Finlay/0000-0001-7435-3341; Walsh, Michael/0000-0001-8292-2014; Bosch, Jacqueline/0000-0001-6292-4207; MD HASHIM, NOORJAHAN HANEEM/0000-0002-2500-7589; Lee, Vincent/0000-0002-9400-3696; Nagele, Peter/0000-0001-8369-3858; Rodseth, Reitze/0000-0002-3779-7805; Sessler, Daniel/0000-0001-9932-3077; Razack, Azad HA/0000-0002-4237-6511; Gerstein, Hertzel C/0000-0001-8072-2836; Chan, Matthew/0000-0002-3574-7855; Buse, Giovanna Lurati/0000-0002-8076-5737; Suzumura, Erica A/0000-0003-1752-6095; SIGAMANI, ALBEN/0000-0002-6927-1947; Popova, Ekaterine/0000-0002-8781-9873; Salehian, Omid/0000-0002-3373-2967; Kurz, Andrea/0000-0001-5887-3099; Zacharias, James/0000-0002-4887-5338; Polanczyk, Carisi/0000-0002-2447-2577; Yusuf, Salim/0000-0003-4776-5601; Villar, Juan Carlos/0000-0002-7047-7299; Malaga, German/0000-0002-7828-300X; Botto, Fernando/0000-0002-0572-8493; Iwaszczuk, Pawel/0000-0002-7827-7734; Alonso-Coello, Pablo/0000-0002-8001-8504; Devereaux, PJ/0000-0003-2935-637X; Archbold, Richard/0000-0002-9847-070X; Wragg, Andrew/0000-0002-8934-5712; Cortes, Olga L/0000-0002-9023-7479	Roche Diagnostics Global Office; Public Policy Research Fund; Research Grant Council; Hong Kong SAR; Australian College of Anesthesiologists; New Zealand College of Anesthesiologists; Instituto de Salud Carlos III; Fundacio La Marato de TV3; Canadian Institutes of Health Research; Pfizer Canada; Spanish Health Ministry; Manitoba Medical Services Foundation; Manitoba Health Research Council; Univerity of Manitoba Department of Surgery; Health Sciences Research Foundation; Abbott; AstraZeneca; National Health and Medical Research Council (Australia); Christian Medical College, Ludhiana; McMaster University; National Institute for Health Research (UK); Circassia Holdings plc; LiDCo Ltd; Covidien Inc; Pulsion Medical Systems, Edwards Lifesciences; Sanofi; GlaxoSmithKline; Roche; Beckman; Smith Nephew; DePuy; American Heart Association; Heart and Stroke Foundation of Ontario; Academic Health Science Centres; Population Health Research Institute; Clarity Research Group; Department of Surgery; Surgical Associates Research Grant; Hamilton Health Science New Investigator Fund Grant; Hamilton Health Sciences Grant; Ontario Ministry of Resource and Innovation; Stryker Canada; McMaster University, Department of Anesthesiology; Saint Joseph's Healthcare-Department of Medicine; Father Sean O'Sullivan Research Centre; McMaster University-Department of Medicine; Hamilton Health Sciences Summer Studentships; McMaster University-Department of Clinical Epidemiology and Biostatistics; McMaster University-Division of Cardiology; Canadian Network Centre for Trials	Roche Diagnostics Global Office; Public Policy Research Fund; Research Grant Council(Hong Kong Research Grants Council); Hong Kong SAR; Australian College of Anesthesiologists; New Zealand College of Anesthesiologists; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacio La Marato de TV3; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer Canada(Pfizer); Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); Manitoba Medical Services Foundation; Manitoba Health Research Council; Univerity of Manitoba Department of Surgery; Health Sciences Research Foundation; Abbott(Abbott Laboratories); AstraZeneca(AstraZeneca); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Christian Medical College, Ludhiana; McMaster University; National Institute for Health Research (UK)(National Institute for Health Research (NIHR)); Circassia Holdings plc; LiDCo Ltd; Covidien Inc; Pulsion Medical Systems, Edwards Lifesciences; Sanofi; GlaxoSmithKline(GlaxoSmithKline); Roche(Roche Holding); Beckman; Smith Nephew; DePuy; American Heart Association(American Heart Association); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Academic Health Science Centres; Population Health Research Institute; Clarity Research Group; Department of Surgery; Surgical Associates Research Grant; Hamilton Health Science New Investigator Fund Grant; Hamilton Health Sciences Grant; Ontario Ministry of Resource and Innovation; Stryker Canada; McMaster University, Department of Anesthesiology; Saint Joseph's Healthcare-Department of Medicine; Father Sean O'Sullivan Research Centre; McMaster University-Department of Medicine; Hamilton Health Sciences Summer Studentships; McMaster University-Department of Clinical Epidemiology and Biostatistics; McMaster University-Division of Cardiology; Canadian Network Centre for Trials	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Chan, Walsh, Carlos Villar, Garutti, Jacka, Srinathan, Biccard, Tiboni, Szczeklik, McQueen, VanHelder, Bhandari, Kurz, Malaga, Nagele, Leuwer, and Devereaux; and Ms Bosch report receipt of a grant(s) to their institution from Roche Diagnostics Global Office (Troponin T assays and some financial support for the VISION Study). Dr Chan reports receipt of institutional grants from the Public Policy Research Fund, Research Grant Council, Hong Kong SAR, and a project grant from the Australian and New Zealand College of Anesthesiologists; Drs Alonzo-Coello and Garutti report receipt of institutional grants from Instituto de Salud Carlos III, and Fundacio La Marato de TV3; Dr Walsh reports receipt of institutional grants from the Canadian Institutes of Health Research, and Pfizer Canada; Dr Garutti reports receipt of an institutional grant from the Spanish Health Ministry; Dr Srinathan reports receipt of institutional grants from Manitoba Medical Services Foundation, Manitoba Health Research Council, Univerity of Manitoba Department of Surgery, Health Sciences Research Foundation, and employment with the Winnipeg Regional Health Authority; Dr Chow reports receipt of an institutional grant from Abbott, fees for development of educational presentations from AstraZeneca, and that her salary is partially supported by the National Health and Medical Research Council Program Grant (Australia); Dr Abraham reports receipt of an institutional grant from Christian Medical College, Ludhiana; Dr Szczeklik reports having served on the speakers bureau for Jagiellonian University; Drs Guyatt and Devereaux report receipt of an institutional grant from McMaster University (no department specified); Dr Pearse reports receipt of institutional grants from National Institute for Health Research (UK), Circassia Holdings plc, and LiDCo Ltd; consultancy fees from Covidien Inc; and having served on speakers bureaus for Pulsion Medical Systems, Edwards Lifesciences, and B. Braun. Dr McQueen reports receipt of an institutional grant from the Canadian Institutes of Health Research, Sanofi, GlaxoSmithKline, AstraZeneca, Roche, and Beckman; and having served on speakers bureaus for Merck, Roche, and Merck-Frosst. Dr Bhandari reports receipt of institutional grants from Smith & Nephew and DePuy; and provision of consultancy services to Stryker, Smith & Nephew, and Amgen. Dr Malaga reports employment with Universidad Peruana Cayetano Heredia; and Dr Nagele reports receipt of an institutional grant from the American Heart Association, and provision of consultancy services to the Gerson-Lehrman Group. The remainining authors report no disclosures.; Funding for this study comes from more than 50 grants for VISION and its substudies. Dr Devereaux reports receipt of institutional grants for VISION from: Canadian Institutes of Health Research (6 grants), Heart and Stroke Foundation of Ontario (2 grants), Academic Health Science Centres Alternative Funding Plan Innovation Fund Grant, Population Health Research Institute Grant, Clarity Research Group Grant, McMaster University, Department of Surgery, Surgical Associates Research Grant, Hamilton Health Science New Investigator Fund Grant, Hamilton Health Sciences Grant, Ontario Ministry of Resource and Innovation Grant, Stryker Canada, McMaster University, Department of Anesthesiology (2 grants), Saint Joseph's Healthcare-Department of Medicine (2 grants), Father Sean O'Sullivan Research Centre (2 grants), McMaster University-Department of Medicine (2 grants), Hamilton Health Sciences Summer Studentships (6 grants), McMaster University-Department of Clinical Epidemiology and Biostatistics Grant, McMaster University-Division of Cardiology Grant, and Canadian Network and Centre for Trials International Grant. Other grants provided but not indicated as received by a specific author/ institution: Winnipeg Health Sciences Foundation Operating Grant; Diagnostic Services of Manitoba Research Grant; University of Manitoba, Faculty of Dentistry Operational Fund; Projeto Hospitais de Excelencia a Servico do SUS grant from the Brazilian Ministry of Health in Partnership with Hcor (Cardiac Hospital Sao Paulo-SP); School of Nursing, Universidad Industrial de Santander; Grupo de Cardiologia Preventiva, Universidad Autonoma de Bucaramanga; Fundacion Cardioinfantil-Instituto de Cardiologia; Alianza Diagnostica SA; University of Malaya Research Grant; and University of Malaya, Penyelidikan Jangka Pendek Grant.	Aviles RJ, 2002, NEW ENGL J MED, V346, P2047, DOI 10.1056/NEJMoa013456; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; DERKSEN S, 1992, BRIT J MATH STAT PSY, V45, P265, DOI 10.1111/j.2044-8317.1992.tb00992.x; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003; Devereaux PJ, 2009, EVIDENCE BASED CARDI, P47; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Ford MK, 2010, ANN INTERN MED, V152, P26, DOI 10.7326/0003-4819-152-1-201001050-00007; Gordon HS, 2005, MED CARE, V43, P159, DOI 10.1097/00005650-200502000-00009; Hougaard P, 2000, SHARED FRAILTY MODEL, P215; Jaffe AS, 2000, CIRCULATION, V102, P1216, DOI 10.1161/01.CIR.102.11.1216; Kim LJ, 2002, CIRCULATION, V106, P2366, DOI 10.1161/01.CIR.0000036016.52396.BB; Kline R, 1998, PRINCIPLES PRACTICE, P67; Kremers WK, 2007, MAYO CLIN TECHNICAL; Le Manach Y, 2005, ANESTHESIOLOGY, V102, P885, DOI 10.1097/00000542-200505000-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levy M, 2011, ANESTHESIOLOGY, V114, P796, DOI 10.1097/ALN.0b013e31820ad503; May S, 1998, LIFETIME DATA ANAL, V4, P109, DOI 10.1023/A:1009612305785; Mazumdar M, 2003, STAT MED, V22, P559, DOI 10.1002/sim.1333; Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039; Panteghini M, 2004, CLIN CHEM, V50, P327, DOI 10.1373/clinchem.2003.026815; Parzen M, 1999, BIOMETRICS, V55, P580, DOI 10.1111/j.0006-341X.1999.00580.x; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Qaseem A, 2006, ANN INTERN MED, V144, P575, DOI 10.7326/0003-4819-144-8-200604180-00008; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	29	662	685	2	81	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2012	307	21					2295	2304		10.1001/jama.2012.5502	http://dx.doi.org/10.1001/jama.2012.5502			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	952OL	22706835				2022-12-28	WOS:000304801700024
J	Nicolle, LE				Nicolle, Lindsay E.			Minimum antimicrobial treatment for acute pyelonephritis	LANCET			English	Editorial Material							URINARY-TRACT-INFECTIONS		Univ Manitoba, Dept Internal Med & Med Microbiol, Winnipeg, MB R3A 1R9, Canada	University of Manitoba	Nicolle, LE (corresponding author), Univ Manitoba, Dept Internal Med & Med Microbiol, Winnipeg, MB R3A 1R9, Canada.	lnicolle@hsc.mb.ca						Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Kahlmeter G, 2012, INT J ANTIMICROB AG, V39, P45, DOI 10.1016/j.ijantimicag.2011.09.013; Levy-Hara G, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00230; Nicolle LE, 2008, UROL CLIN N AM, V35, P1, DOI 10.1016/j.ucl.2007.09.004; Peterson J, 2008, UROLOGY, V71, P17, DOI 10.1016/j.urology.2007.09.002; Sandberg T, 2012, LANCET; Talan DA, 2000, JAMA-J AM MED ASSOC, V283, P1583, DOI 10.1001/jama.283.12.1583	7	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2012	380	9840					452	453		10.1016/S0140-6736(12)60770-3	http://dx.doi.org/10.1016/S0140-6736(12)60770-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	983GY	22726803				2022-12-28	WOS:000307109000006
J	Auslander, S; Auslander, D; Muller, M; Wieland, M; Fussenegger, M				Auslaender, Simon; Auslaender, David; Mueller, Marius; Wieland, Markus; Fussenegger, Martin			Programmable single-cell mammalian biocomputers	NATURE			English	Article							CANCER-CELLS; MICE; NETWORKS; CIRCUIT; COMMUNICATION; HOMEOSTASIS; SWITCHES	Synthetic biology has advanced the design of standardized control devices that program cellular functions and metabolic activities in living organisms(1). Rational interconnection of these synthetic switches resulted in increasingly complex designer networks that execute input-triggered genetic instructions with precision, robustness and computational logic reminiscent of electronic circuits(2,3). Using trigger-controlled transcription factors, which independently control gene expression(4,5), and RNA-binding proteins that inhibit the translation of transcripts harbouring specific RNA target motifs(6,7), we have designed a set of synthetic transcription-translation control devices that could be rewired in a plug-and-play manner. Here we show that these combinatorial circuits integrated a two-molecule input and performed digital computations with NOT, AND, NAND and N-IMPLY expression logic in single mammalian cells. Functional interconnection of two N-IMPLY variants resulted in bitwise intracellular XOR operations, and a combinatorial arrangement of three logic gates enabled independent cells to perform programmable half-subtractor and half-adder calculations. Individual mammalian cells capable of executing basic molecular arithmetic functions isolated or coordinated to metabolic activities in a predictable, precise and robust manner may provide new treatment strategies and bio-electronic interfaces in future gene-based and cell-based therapies.	[Auslaender, Simon; Auslaender, David; Mueller, Marius; Wieland, Markus; Fussenegger, Martin] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Fussenegger, Martin] Univ Basel, Fac Sci, CH-4058 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Fussenegger, M (corresponding author), ETH, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.	fussenegger@bsse.ethz.ch			Swiss National Science Foundation [31003A-126022]; EC Framework 7 (Persist)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EC Framework 7 (Persist)(European Commission)	We thank R. Singer for providing pMS2dIFG, M. Tigges for generous advice, E. Gutzwiller for experimental support, and M. Dessing and V. Jaggin for assistance with flow cytometry. This work was supported by the Swiss National Science Foundation (grant no. 31003A-126022) and in part by EC Framework 7 (Persist).	Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gitzinger M, 2009, P NATL ACAD SCI USA, V106, P10638, DOI 10.1073/pnas.0901501106; Greber D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq671; Kemmer C, 2011, J CONTROL RELEASE, V150, P23, DOI 10.1016/j.jconrel.2010.11.016; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kramer BP, 2004, BIOTECHNOL BIOENG, V87, P478, DOI 10.1002/bit.20142; Leisner M, 2010, NAT NANOTECHNOL, V5, P666, DOI [10.1038/NNANO.2010.135, 10.1038/nnano.2010.135]; Nissim L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.99; Paraskeva E, 1998, P NATL ACAD SCI USA, V95, P951, DOI 10.1073/pnas.95.3.951; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Saito H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1157; Saito H, 2010, NAT CHEM BIOL, V6, P71, DOI [10.1038/NCHEMBIO.273, 10.1038/nchembio.273]; Stojanovic MN, 2003, J AM CHEM SOC, V125, P6673, DOI 10.1021/ja0296632; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Weber W, 2002, NAT BIOTECHNOL, V20, P901, DOI 10.1038/nbt731; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104; Weber W, 2007, P NATL ACAD SCI USA, V104, P2643, DOI 10.1073/pnas.0606398104; Weber W, 2011, CURR OPIN CHEM BIOL, V15, P414, DOI 10.1016/j.cbpa.2011.03.003; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	30	260	275	9	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2012	487	7405					123	+		10.1038/nature11149	http://dx.doi.org/10.1038/nature11149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722847				2022-12-28	WOS:000305982900063
J	Dever, TE				Dever, Thomas E.			A New Start for Protein Synthesis	SCIENCE			English	Editorial Material							TRANSLATION INITIATION; MAMMALIAN-CELLS; AUG; RIBOSOME; SITE		Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dever, TE (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA.	tdever@nih.gov	Dever, Thomas/GSE-0966-2022	Dever, Thomas/0000-0001-7120-9678	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CIGAN AM, 1988, SCIENCE, V242, P93, DOI 10.1126/science.3051379; Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z; Drabkin HJ, 1998, MOL CELL BIOL, V18, P5140, DOI 10.1128/MCB.18.9.5140; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Malarkannan S, 1999, IMMUNITY, V10, P681, DOI 10.1016/S1074-7613(00)80067-9; Nemeth AL, 2007, FEBS J, V274, P1610, DOI 10.1111/j.1742-4658.2007.05708.x; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Schwab SR, 2003, SCIENCE, V301, P1367, DOI 10.1126/science.1085650; Starck SR, 2012, SCIENCE, V336, P1719, DOI 10.1126/science.1220270; Starck SR, 2011, CELL MOL LIFE SCI, V68, P1471, DOI 10.1007/s00018-011-0655-0	13	7	7	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1645	1646		10.1126/science.1224439	http://dx.doi.org/10.1126/science.1224439			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745408	Green Published			2022-12-28	WOS:000305794500027
J	Germain, RN; Robey, EA; Cahalan, MD				Germain, Ronald N.; Robey, Ellen A.; Cahalan, Michael D.			A Decade of Imaging Cellular Motility and Interaction Dynamics in the Immune System	SCIENCE			English	Review							SUBCAPSULAR SINUS MACROPHAGES; BEARING DENDRITIC CELLS; CD8(+) T-CELLS; NODE B-CELLS; IN-VIVO; LYMPH-NODES; 2-PHOTON MICROSCOPY; STOP SIGNAL; MYCOBACTERIAL GRANULOMAS; PATHOGEN INTERACTIONS	To mount an immune response, lymphocytes must recirculate between the blood and lymph nodes, recognize antigens upon contact with specialized presenting cells, proliferate to expand a small number of clonally relevant lymphocytes, differentiate to antibody-producing plasma cells or effector T cells, exit from lymph nodes, migrate to tissues, and engage in host-protective activities. All of these processes involve motility and cellular interactions-events that were hidden from view until recently. Introduced to immunology by three papers in this journal in 2002, in vivo live-cell imaging studies are revealing the behavior of cells mediating adaptive and innate immunity in diverse tissue environments, providing quantitative measurement of cellular motility, interactions, and response dynamics. Here, we review themes emerging from such studies and speculate on the future of immunoimaging.	[Germain, Ronald N.] NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Robey, Ellen A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Cahalan, Michael D.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Berkeley; University of California System; University of California Irvine	Germain, RN (corresponding author), NIAID, Lab Syst Biol, NIH, Bethesda, MD 20892 USA.	rgermain@nih.gov; erobey@berkeley.edu; mcahalan@uci.edu	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020		National Institute of Allergy and Infectious Diseases, NIH; NIH [GM-41514];  [AI-065537];  [AI-064227]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545, R01AI064227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041514] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank members of our laboratory groups for their contributions to the research described here and for comments on the manuscript. We apologize to the many authors who contributed importantly to the field of imaging the immune response but whose work could not be included in the references for lack of space. This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH (R.N.G.); AI-065537 and AI-064227 (E.A.R.); and NIH RO1 grant GM-41514 (M.D.C.).	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Azar GA, 2010, P NATL ACAD SCI USA, V107, P3675, DOI 10.1073/pnas.0905901107; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Cahalan SM, 2011, NAT CHEM BIOL, V7, P254, DOI 10.1038/nchembio.547; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cavanagh LL, 2005, NAT IMMUNOL, V6, P1029, DOI 10.1038/ni1249; Celli S, 2011, NAT MED, V17, P744, DOI 10.1038/nm.2376; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Chtanova T, 2008, IMMUNITY, V29, P487, DOI 10.1016/j.immuni.2008.07.012; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Coombes JL, 2010, NAT REV IMMUNOL, V10, P353, DOI 10.1038/nri2746; Coppieters K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015732; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; DONNADIEU E, 1994, CURR BIOL, V4, P584, DOI 10.1016/S0960-9822(00)00130-5; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; Ehrlich LIR, 2009, IMMUNITY, V31, P986, DOI 10.1016/j.immuni.2009.09.020; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Filipe-Santos O, 2009, CELL HOST MICROBE, V6, P23, DOI 10.1016/j.chom.2009.04.014; Friedman RS, 2010, J EXP MED, V207, P2733, DOI 10.1084/jem.20091201; Garrod KR, 2007, P NATL ACAD SCI USA, V104, P12081, DOI 10.1073/pnas.0702867104; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Gowans J L, 1966, Int Rev Exp Pathol, V5, P1; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; John B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000505; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Katzman SD, 2010, P NATL ACAD SCI USA, V107, P18085, DOI 10.1073/pnas.1010560107; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Khairy K, 2011, GENESIS, V49, P488, DOI 10.1002/dvg.20698; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Klauschen F, 2009, NAT PROTOC, V4, P1305, DOI 10.1038/nprot.2009.129; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Melichar HJ, 2011, IMMUNOL CELL BIOL, V89, P549, DOI 10.1038/icb.2010.122; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Schaeffer M, 2009, J IMMUNOL, V182, P6379, DOI 10.4049/jimmunol.0804307; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Sen D, 2010, P NATL ACAD SCI USA, V107, P8334, DOI 10.1073/pnas.0912817107; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Wei SH, 2007, J IMMUNOL, V179, P1586, DOI 10.4049/jimmunol.179.3.1586; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706	91	266	270	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1676	1681		10.1126/science.1221063	http://dx.doi.org/10.1126/science.1221063			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745423	Green Accepted			2022-12-28	WOS:000305794500042
J	Kang, DH; Kim, YJ; Kim, SH; Sun, BJ; Kim, DH; Yun, SC; Song, JM; Choo, SJ; Chung, CH; Song, JK; Lee, JW; Sohn, DW				Kang, Duk-Hyun; Kim, Yong-Jin; Kim, Sung-Han; Sun, Byung Joo; Kim, Dae-Hee; Yun, Sung-Cheol; Song, Jong-Min; Choo, Suk Jung; Chung, Cheol-Hyun; Song, Jae-Kwan; Lee, Jae-Won; Sohn, Dae-Won			Early Surgery versus Conventional Treatment for Infective Endocarditis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATIVE VALVE ENDOCARDITIS; 6-MONTH MORTALITY; PROGNOSTIC VALUE; EMBOLIC EVENTS; IMPACT; MANAGEMENT; DIAGNOSIS; ADULTS; RISK; GUIDELINES	BACKGROUND The timing and indications for surgical intervention to prevent systemic embolism in infective endocarditis remain controversial. We conducted a trial to compare clinical outcomes of early surgery and conventional treatment in patients with infective endocarditis. METHODS We randomly assigned patients with left-sided infective endocarditis, severe valve disease, and large vegetations to early surgery (37 patients) or conventional treatment (39). The primary end point was a composite of in-hospital death and embolic events that occurred within 6 weeks after randomization. RESULTS All the patients assigned to the early-surgery group underwent valve surgery within 48 hours after randomization, whereas 30 patients (77%) in the conventional-treatment group underwent surgery during the initial hospitalization (27 patients) or during follow-up (3). The primary end point occurred in 1 patient (3%) in the early-surgery group as compared with 9 (23%) in the conventional-treatment group (hazard ratio, 0.10; 95% confidence interval [CI], 0.01 to 0.82; P = 0.03). There was no significant difference in all-cause mortality at 6 months in the early-surgery and conventional-treatment groups (3% and 5%, respectively; hazard ratio, 0.51; 95% CI, 0.05 to 5.66; P = 0.59). The rate of the composite end point of death from any cause, embolic events, or recurrence of infective endocarditis at 6 months was 3% in the early-surgery group and 28% in the conventional-treatment group (hazard ratio, 0.08; 95% CI, 0.01 to 0.65; P = 0.02). CONCLUSIONS As compared with conventional treatment, early surgery in patients with infective endocarditis and large vegetations significantly reduced the composite end point of death from any cause and embolic events by effectively decreasing the risk of systemic embolism. (EASE ClinicalTrials.gov number, NCT00750373.)	[Kang, Duk-Hyun] Univ Ulsan, Asan Med Ctr, Div Cardiol, Coll Med, Seoul, South Korea; [Choo, Suk Jung; Chung, Cheol-Hyun; Lee, Jae-Won] Univ Ulsan, Asan Med Ctr, Div Cardiac Surg, Seoul, South Korea; [Kim, Sung-Han] Univ Ulsan, Asan Med Ctr, Div Infect Dis, Seoul, South Korea; [Yun, Sung-Cheol] Univ Ulsan, Asan Med Ctr, Div Biostat, Seoul, South Korea; [Kim, Yong-Jin; Sohn, Dae-Won] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Seoul National University (SNU); Seoul National University Hospital	Kang, DH (corresponding author), Univ Ulsan, Asan Med Ctr, Div Cardiol, Coll Med, 388-1 Poongnap Dong, Seoul, South Korea.	dhkang@amc.seoul.kr	Sohn, Dae Won/J-5516-2012	Kim, Dae-Hee/0000-0002-8275-4871; Sun, Byung Joo/0000-0001-6019-4343				Baddour, 2005, CIRCULATION, V112, P2373, DOI 10.1161/CIRCULATIONHA.105.167942; Baddour LM, 2008, CIRCULATION, V118, pE497, DOI 10.1161/CIRCULATIONAHA.108.190868; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Bonow RO, 2010, CIRCULATION, V121, pE443, DOI 10.1161/CIR.0b013e3181e3e359; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Chan KL, 2003, J AM COLL CARDIOL, V42, P775, DOI 10.1016/S0735-1097(03)00829-5; Delahaye F, 2011, ARCH CARDIOVASC DIS, V104, P35, DOI 10.1016/j.acvd.2010.11.003; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Habib G, 2006, HEART, V92, P124, DOI 10.1136/hrt.2005.063719; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Hasbun R, 2003, JAMA-J AM MED ASSOC, V289, P1933, DOI 10.1001/jama.289.15.1933; Kim DH, 2010, CIRCULATION, V122, pS17, DOI 10.1161/CIRCULATIONAHA.109.927665; Lalani T, 2010, CIRCULATION, V121, P1005, DOI 10.1161/CIRCULATIONAHA.109.864488; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Miro JM, 2005, CLIN INFECT DIS, V41, P1075; Miro JM, 2005, CLIN INFECT DIS, V41, P507, DOI 10.1086/431979; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Prendergast BD, 2010, CIRCULATION, V121, P1141, DOI 10.1161/CIRCULATIONAHA.108.773598; STECKELBERG JM, 1991, ANN INTERN MED, V114, P635, DOI 10.7326/0003-4819-114-8-635; Thuny F, 2005, CIRCULATION, V112, P69, DOI 10.1161/CIRCULATIONAHA.104.493155; Thuny F, 2011, EUR HEART J, V32, P2027, DOI 10.1093/eurheartj/ehp089; Tleyjeh IM, 2008, HEART, V94, P1496, DOI 10.1136/hrt.2007.118968corr1; Tleyjeh IM, 2008, HEART, V94, P892, DOI 10.1136/hrt.2007.118968; Tleyjeh IM, 2007, CIRCULATION, V115, P1721, DOI 10.1161/CIRCULATIONAHA.106.658831; Tornos P, 2005, HEART, V91, P571, DOI 10.1136/hrt.2003.032128; Vikram HR, 2003, JAMA-J AM MED ASSOC, V290, P3207, DOI 10.1001/jama.290.24.3207	27	492	529	3	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2466	2473		10.1056/NEJMoa1112843	http://dx.doi.org/10.1056/NEJMoa1112843			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965DP	22738096				2022-12-28	WOS:000305747000006
J	Santos, SDM; Wollman, R; Meyer, T; Ferrell, JE				Santos, Silvia D. M.; Wollman, Roy; Meyer, Tobias; Ferrell, James E., Jr.			Spatial Positive Feedback at the Onset of Mitosis	CELL			English	Article							CELL-CYCLE REGULATION; PROTEIN-KINASE; NUCLEAR EXPORT; NEGATIVE REGULATION; NETWORK MOTIFS; XENOPUS-OOCYTE; LOCALIZATION; B1; PHOSPHORYLATION; ACTIVATION	Mitosis is triggered by the activation of Cdk1-cyclin B1 and its translocation from the cytoplasm to the nucleus. Positive feedback loops regulate the activation of Cdk1-cyclin B1 and help make the process irreversible and all-or-none in character. Here we examine whether an analogous process, spatial positive feedback, regulates Cdk1-cyclin B1 redistribution. We used chemical biology approaches and live-cell microscopy to show that nuclear Cdk1-cyclin B1 promotes the translocation of Cdk1-cyclin B1 to the nucleus. Mechanistic studies suggest that cyclin B1 phosphorylation promotes nuclear translocation and, conversely, nuclear translocation promotes cyclin B1 phosphorylation, accounting for the feedback. Interfering with the abruptness of Cdk1-cyclin B1 translocation affects the timing and synchronicity of subsequent mitotic events, underscoring the functional importance of this feedback. We propose that spatial positive feedback ensures a rapid, complete, robust, and irreversible transition from interphase to mitosis and suggest that bistable spatiotemporal switches may be widespread in biological regulation.	[Santos, Silvia D. M.; Wollman, Roy; Meyer, Tobias; Ferrell, James E., Jr.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Santos, SDM (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, CCSR Bldg,269 Campus Dr, Stanford, CA 94305 USA.	sdsantos@stanford.edu; james.ferrell@stanford.edu		Meyer, Tobias/0000-0003-4339-3804	National Institutes of Health [GM061276]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030179, R01GM061276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Pearlman and P. Beltrao for help with analysis scripts; M. Teruel, S. Bandara, and T. Wandless for iRap; O. Rocks and S. Spenser for reagents; J. Wu from the Stanford High-Throughput Bioscience Center for technical assistance; M. Covert for generous use of his microscope; and J. Skotheim, P. Beltrao, S. Collins, A. Hayer, A. Salmeen S. Carrasco, J. Chang, and the Meyer and Ferrell labs for helpful discussions and comments on the manuscript. This work was supported by a grant from the National Institutes of Health (GM061276). S. D. M. S. is a Human Frontier Science Program Fellow (HFSP) and an EMBO fellow.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; ATHERTONFESSLER S, 1994, MOL BIOL CELL, V5, P989, DOI 10.1091/mbc.5.9.989; Borgne A, 1999, J BIOL CHEM, V274, P11977, DOI 10.1074/jbc.274.17.11977; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Deibler RW, 2010, MOL CELL, V37, P753, DOI 10.1016/j.molcel.2010.02.023; Eser U, 2011, MOL CELL, V43, P515, DOI 10.1016/j.molcel.2011.06.024; Ferrell JE, 2008, CURR BIOL, V18, pR244, DOI 10.1016/j.cub.2008.02.035; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; Ferrell JE, 1998, TRENDS BIOCHEM SCI, V23, P461, DOI 10.1016/S0968-0004(98)01316-4; Gavet O, 2010, J CELL BIOL, V189, P247, DOI 10.1083/jcb.200909144; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Guignet EG, 2008, NAT METHODS, V5, P393, DOI 10.1038/NMETH.1201; Hagting A, 1999, CURR BIOL, V9, P680, DOI 10.1016/S0960-9822(99)80308-X; Hagting A, 1998, EMBO J, V17, P4127, DOI 10.1093/emboj/17.14.4127; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Jones JT, 2004, NAT BIOTECHNOL, V22, P306, DOI 10.1038/nbt941; Kallstrom H, 2005, EXP CELL RES, V303, P89, DOI 10.1016/j.yexcr.2004.09.012; Komatsu T, 2010, NAT METHODS, V7, P206, DOI [10.1038/nmeth.1428, 10.1038/NMETH.1428]; KORNBLUTH S, 1994, MOL BIOL CELL, V5, P273, DOI 10.1091/mbc.5.3.273; Kumagai A, 1999, GENE DEV, V13, P1067, DOI 10.1101/gad.13.9.1067; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Li J, 1997, P NATL ACAD SCI USA, V94, P502, DOI 10.1073/pnas.94.2.502; LI JK, 1995, MOL BIOL CELL, V6, P1111, DOI 10.1091/mbc.6.9.1111; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Sun TT, 2010, J BIOL CHEM, V285, P38730, DOI 10.1074/jbc.M110.177642; TANG ZH, 1993, EMBO J, V12, P3427, DOI 10.1002/j.1460-2075.1993.tb06017.x; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; Walsh S, 2003, MOL CANCER RES, V1, P280; Yang J, 1999, EMBO J, V18, P2174, DOI 10.1093/emboj/18.8.2174; Yang J, 2001, J BIOL CHEM, V276, P3604, DOI 10.1074/jbc.M008151200	58	92	92	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1500	1513		10.1016/j.cell.2012.05.028	http://dx.doi.org/10.1016/j.cell.2012.05.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726437	Green Accepted, Bronze			2022-12-28	WOS:000305753800016
J	Wei, JT; Nygaard, I; Richter, HE; Nager, CW; Barber, MD; Kenton, K; Amundsen, CL; Schaffer, J; Meikle, SF; Spino, C				Wei, John T.; Nygaard, Ingrid; Richter, Holly E.; Nager, Charles W.; Barber, Matthew D.; Kenton, Kim; Amundsen, Cindy L.; Schaffer, Joseph; Meikle, Susan F.; Spino, Cathie		Pelvic Floor Disorders Network	A Midurethral Sling to Reduce Incontinence after Vaginal Prolapse Repair	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PELVIC ORGAN PROLAPSE; URINARY-INCONTINENCE; STRESS-INCONTINENCE; WOMEN; OUTCOMES; SURGERY; RISK; TAPE	BACKGROUND Women without stress urinary incontinence undergoing vaginal surgery for pelvicorgan prolapse are at risk for postoperative urinary incontinence. A midurethral sling may be placed at the time of prolapse repair to reduce this risk. METHODS We performed a multicenter trial involving women without symptoms of stress incontinence and with anterior prolapse (of stage 2 or higher on a Pelvic Organ Prolapse Quantification system examination) who were planning to undergo vaginal prolapse surgery. Women were randomly assigned to receive either a midurethral sling or sham incisions during surgery. One primary end point was urinary incontinence or treatment for this condition at 3 months. The second primary end point was the presence of incontinence at 12 months, allowing for subsequent treatment for incontinence. RESULTS Of the 337 women who underwent randomization, 327 (97%) completed follow-up at 1 year. At 3 months, the rate of urinary incontinence (or treatment) was 23.6% in the sling group and 49.4% in the sham group (P < 0.001). At 12 months, urinary incontinence (allowing for subsequent treatment of incontinence) was present in 27.3% and 43.0% of patients in the sling and sham groups, respectively (P = 0.002). The number needed to treat with a sling to prevent one case of urinary incontinence at 12 months was 6.3. The rate of bladder perforation was higher in the sling group than in the sham group (6.7% vs. 0%), as were rates of urinary tract infection (31.0% vs. 18.3%), major bleeding complications (3.1% vs. 0%), and incomplete bladder emptying 6 weeks after surgery (3.7% vs. 0%) (P <= 0.05 for all comparisons). CONCLUSIONS A prophylactic midurethral sling inserted during vaginal prolapse surgery resulted in a lower rate of urinary incontinence at 3 and 12 months but higher rates of adverse events. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institutes of Health Office of Research on Women's Health; OPUS ClinicalTrials.gov number, NCT00460434.)	[Wei, John T.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Nygaard, Ingrid] Univ Utah, Salt Lake City, UT USA; [Richter, Holly E.] Univ Alabama Birmingham, Birmingham, AL USA; [Nager, Charles W.] Univ Calif San Diego, San Diego, CA 92103 USA; [Barber, Matthew D.] Cleveland Clin, Cleveland, OH USA; [Kenton, Kim] Loyola Univ, Chicago, IL 60611 USA; [Amundsen, Cindy L.] Duke Univ, Durham, NC USA; [Schaffer, Joseph] Univ Texas SW, Dallas, TX USA; [Meikle, Susan F.] Natl Inst Child Hlth & Human Dev, Bethesda, MD USA	University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego; Cleveland Clinic Foundation; Loyola University Chicago; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Wei, JT (corresponding author), Univ Michigan, Dept Urol, 2800 Plymouth Rd,Bldg 520,Rm 3192, Ann Arbor, MI 48109 USA.	jtwei@umich.edu	Wei, John T/E-8967-2012	Richter, Holly E/0000-0001-7741-5771	Eunice Kennedy Shriver National Institute of Child Health and Human Development [2U01 HD41249, 2U10 HD41250, 2U10 HD41261, 2U10 HD41267, 1U10 HD54136, 1U10 HD54214, 1U10 HD54215, 1U10 HD54241]; National Institutes of Health Office of Research on Women's Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD054214, U10HD041267, U10HD054136, U10HD054215, U10HD041261, U10HD041250, U10HD054241] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD041249] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Office of Research on Women's Health (ORWH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (2U01 HD41249, 2U10 HD41250, 2U10 HD41261, 2U10 HD41267, 1U10 HD54136, 1U10 HD54214, 1U10 HD54215, and 1U10 HD54241) and the National Institutes of Health Office of Research on Women's Health.	Al-Mandeel H, 2011, NEUROUROL URODYNAM, V30, P390, DOI 10.1002/nau.20947; Barber MD, 2001, AM J OBSTET GYNECOL, V185, P1388, DOI 10.1067/mob.2001.118659; Brubaker L, 2006, NEW ENGL J MED, V354, P1557, DOI 10.1056/NEJMoa054208; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Fatton B, 2009, INT UROGYNECOL J, V20, P235, DOI 10.1007/s00192-008-0734-4; Hartanto Victor H, 2003, Can J Urol, V10, P1759; Koops SES, 2007, INT UROGYNECOL J, V18, P437, DOI 10.1007/s00192-006-0170-2; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Meschia M, 2004, AM J OBSTET GYNECOL, V190, P609, DOI 10.1016/j.ajog.2003.09.027; Richter HE, 2010, NEW ENGL J MED, V362, P2066, DOI 10.1056/NEJMoa0912658; Rogers RG, 2001, AM J OBSTET GYNECOL, V184, P552, DOI 10.1067/mob.2001.111100; SANDVIK H, 1993, J EPIDEMIOL COMMUN H, V47, P497, DOI 10.1136/jech.47.6.497; Selvin S., 1996, STAT ANAL EPIDEMIOLO; Smith FJ, 2010, OBSTET GYNECOL, V116, P1096, DOI 10.1097/AOG.0b013e3181f73729; Wei J, 2009, CLIN TRIALS, V6, P162, DOI 10.1177/1740774509102605; ZIEBLAND S, 1995, J EPIDEMIOL COMMUN H, V49, P102, DOI 10.1136/jech.49.1.102	16	227	237	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					2358	2367		10.1056/NEJMoa1111967	http://dx.doi.org/10.1056/NEJMoa1111967			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961GH	22716974	Green Accepted			2022-12-28	WOS:000305451700005
J	Zuber, MT; Head, JW; Smith, DE; Neumann, GA; Mazarico, E; Torrence, MH; Aharonson, O; Tye, AR; Fassett, CI; Rosenburg, MA; Melosh, HJ				Zuber, Maria T.; Head, James W.; Smith, David E.; Neumann, Gregory A.; Mazarico, Erwan; Torrence, Mark H.; Aharonson, Oded; Tye, Alexander R.; Fassett, Caleb I.; Rosenburg, Margaret A.; Melosh, H. Jay			Constraints on the volatile distribution within Shackleton crater at the lunar south pole	NATURE			English	Article							RECONNAISSANCE ORBITER; ICE; DEPOSITS; SURFACE	Shackleton crater is nearly coincident with the Moon's south pole. Its interior receives almost no direct sunlight and is a perennial cold trap(1,2), making Shackleton a promising candidate location in which to seek sequestered volatiles(3). However, previous orbital and Earth-based radar mapping(4-8) and orbital optical imaging(9) have yielded conflicting interpretations about the existence of volatiles. Here we present observations from the Lunar Orbiter Laser Altimeter on board the Lunar Reconnaissance Orbiter, revealing Shackleton to be an ancient, unusually well-preserved simple crater whose interior walls are fresher than its floor and rim. Shackleton floor deposits are nearly the same age as the rim, suggesting that little floor deposition has occurred since the crater formed more than three billion years ago. At a wavelength of 1,064 nanometres, the floor of Shackleton is brighter than the surrounding terrain and the interiors of nearby craters, but not as bright as the interior walls. The combined observations are explicable primarily by downslope movement of regolith on the walls exposing fresher underlying material. The relatively brighter crater floor is most simply explained by decreased space weathering due to shadowing, but a one-micrometre-thick layer containing about 20 per cent surficial ice is an alternative possibility.	[Zuber, Maria T.; Smith, David E.; Mazarico, Erwan] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Head, James W.; Tye, Alexander R.; Fassett, Caleb I.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Neumann, Gregory A.] NASA, Solar Syst Explorat Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Torrence, Mark H.] Stinger Ghaffarian Technol, Greenbelt, MD 20770 USA; [Aharonson, Oded; Rosenburg, Margaret A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Melosh, H. Jay] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA	Massachusetts Institute of Technology (MIT); Brown University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Stinger Ghaffarian Technologies, Inc. (SGT); California Institute of Technology; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zuber, MT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	zuber@mit.edu	Mazarico, Erwan/N-6034-2014; Tye, Alexander/HIA-0880-2022; Neumann, Gregory A/I-5591-2013	Mazarico, Erwan/0000-0003-3456-427X; Neumann, Gregory A/0000-0003-0644-9944; Fassett, Caleb/0000-0001-9155-3804; Aharonson, Oded/0000-0001-9930-2495	Lunar Reconnaissance Orbiter Mission under NASA's Exploration Systems Mission Directorate; Lunar Reconnaissance Orbiter Mission under NASA's Science Mission Directorate	Lunar Reconnaissance Orbiter Mission under NASA's Exploration Systems Mission Directorate; Lunar Reconnaissance Orbiter Mission under NASA's Science Mission Directorate	The LOLA investigation is supported by the Lunar Reconnaissance Orbiter Mission under the auspices of NASA's Exploration Systems Mission Directorate and Science Mission Directorate. We thank T. Perron for discussions.	ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Campbell DB, 2006, NATURE, V443, P835, DOI 10.1038/nature05167; Folkner W.M., 2008, PLANETARY LUNAR EPHE; Gladstone GR, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003913; Hapke B, 2001, J GEOPHYS RES-PLANET, V106, P10039, DOI 10.1029/2000JE001338; Haruyama J, 2008, SCIENCE, V322, P938, DOI 10.1126/science.1164020; Howard K.A., 1974, LUNAR PLANETARY SCI, P61; Kwok R, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003175; Mazarico E, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003472; Mazarico E, 2012, J GEODESY, V86, P193, DOI 10.1007/s00190-011-0509-4; Neumann GA, 2001, J GEOPHYS RES-PLANET, V106, P23753, DOI 10.1029/2000JE001381; Nozette S, 1996, SCIENCE, V274, P1495, DOI 10.1126/science.274.5292.1495; Nozette S, 2001, J GEOPHYS RES-PLANET, V106, P23253, DOI 10.1029/2000JE001417; PAVLIS DE, 2009, GEODYN OPERATIONS MA; Pieters CM, 2009, SCIENCE, V326, P568, DOI 10.1126/science.1178658; Pike R. J., 1974, Geophysical Research Letters, V1, P291, DOI 10.1029/GL001i007p00291; Pike RJ., 1977, IMPACT EXPLOSION CRA, P489; Simpson RA, 1999, J GEOPHYS RES-PLANET, V104, P3845, DOI 10.1029/1998JE900038; Smith D., 2011, LUNAR PLANET SCI C, V42, P2350; Smith DE, 2010, SPACE SCI REV, V150, P209, DOI 10.1007/s11214-009-9512-y; Spudis PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034468; Squyres SW, 2009, SCIENCE, V324, P1058, DOI 10.1126/science.1170355; Stacy NJS, 1997, SCIENCE, V276, P1527, DOI 10.1126/science.276.5318.1527; Sun X., 2009, LASER RANGING SUBSYS; Thomson B.J., 2011, LUNAR PLANETARY SCI, V42, P1626; WARD WR, 1975, SCIENCE, V189, P377, DOI 10.1126/science.189.4200.377; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033; Wilhelms D.E., 1979, GEOLOGIC MAP S SIDE; Williams JG, 2008, LUNAR ORBIT PHYS LIB; Zimmerman MI, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048880; Zuber MT, 2010, SPACE SCI REV, V150, P63, DOI 10.1007/s11214-009-9511-z	31	82	84	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					378	+		10.1038/nature11216	http://dx.doi.org/10.1038/nature11216			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722197	Green Submitted			2022-12-28	WOS:000305466800038
J	[Anonymous]				[Anonymous]			Prediabetes and the potential to prevent diabetes	LANCET			English	Editorial Material																			0	13	14	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2012	379	9833					2213	2213						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	962AM	22704153	Bronze			2022-12-28	WOS:000305511400002
J	Seo, M; Hillmyer, MA				Seo, Myungeun; Hillmyer, Marc A.			Reticulated Nanoporous Polymers by Controlled Polymerization-Induced Microphase Separation	SCIENCE			English	Article							LIVING RADICAL POLYMERIZATION; ANGLE NEUTRON-SCATTERING; SPINODAL DECOMPOSITION; BLOCK-COPOLYMERS; POLYSTYRENE; ADSORPTION; KINETICS	Materials with percolating mesopores are attractive for applications such as catalysis, nanotemplating, and separations. Polymeric frameworks are particularly appealing because the chemical composition and the surface chemistry are readily tunable. We report on the preparation of robust nanoporous polymers with percolating pores in the 4- to 8-nanometer range from a microphase-separated bicontinuous precursor. We combined polymerization-induced phase separation with in situ block polymer formation from a mixture of multifunctional monomers and a chemically etchable polymer containing a terminal chain transfer agent. This marriage results in microphase separation of the mixture into continuous domains of the etchable polymer and the emergent cross-linked polymer. Precise control over pore size distribution and mechanical integrity renders these materials particularly suited for various advanced applications.	[Seo, Myungeun; Hillmyer, Marc A.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hillmyer, MA (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	hillmyer@umn.edu	Seo, Myungeun/F-1031-2011	Seo, Myungeun/0000-0002-5218-3502; Hillmyer, Marc/0000-0001-8255-3853	Dow Chemical Company; National Science Foundation [DMR-1006370]; E. I. DuPont de Nemours Co.; Northwestern University; U.S. DOE [DE-AC02-06CH11357]; Direct For Mathematical & Physical Scien [1006370] Funding Source: National Science Foundation	Dow Chemical Company; National Science Foundation(National Science Foundation (NSF)); E. I. DuPont de Nemours Co.; Northwestern University; U.S. DOE(United States Department of Energy (DOE)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank Dow Chemical Company for financial support. Partial support for this work was also provided by the National Science Foundation (DMR-1006370). We acknowledge E. L. Cussler, J. Rzayev, and M. Schulze for helpful input, M. Soma for tensile testing, and C. Frethem and F. Zhou for SEM imaging of the cross-linked precursor. Parts of this work were carried out in the College of Science and Engineering Characterization Facility, University of Minnesota, a member of the NSF-funded Materials Research Facilities Network. Synchrotron SAXS data were acquired at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) located at Sector 5 of the Advanced Photon Source (APS). DND-CAT is supported by E. I. DuPont de Nemours & Co., The Dow Chemical Company, and Northwestern University. Use of the APS, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under contract DE-AC02-06CH11357. The authors are declared to be inventors on a patent filed by the University of Minnesota and the Dow Chemical Company related to the work presented here.	Arai T., 2003, U.S. Patent, Patent No. [6,559,234, 6559234]; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; BATES FS, 1989, J CHEM PHYS, V91, P3258, DOI 10.1063/1.456901; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Chen HY, 2009, SCRIPTA MATER, V61, P52, DOI 10.1016/j.scriptamat.2009.03.006; Chen L, 2007, J AM CHEM SOC, V129, P13786, DOI 10.1021/ja0753041; CONNELL JG, 1991, POLYMER, V32, P2033, DOI 10.1016/0032-3861(91)90169-J; Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529; HASHIMOTO T, 1987, MACROMOLECULES, V20, P465, DOI 10.1021/ma00168a053; Hawker CJ, 2005, SCIENCE, V309, P1200, DOI 10.1126/science.1109778; Jackson EA, 2010, ACS NANO, V4, P3548, DOI 10.1021/nn1014006; Kanamori K, 2006, ADV MATER, V18, P2407, DOI 10.1002/adma.200601026; KOGA T, 1993, PHYSICA A, V198, P473, DOI 10.1016/0378-4371(93)90235-V; Koh ML, 2011, MACROMOLECULES, V44, P2715, DOI 10.1021/ma102537h; LEVITZ P, 1991, J CHEM PHYS, V95, P6151, DOI 10.1063/1.461583; Li L, 2011, ACS NANO, V5, P7754, DOI 10.1021/nn200610r; Lu G.Q, 2004, NANOPOROUS MAT SCI E; Moad G, 2008, ACCOUNTS CHEM RES, V41, P1133, DOI 10.1021/ar800075n; Motokawa R, 2007, POLYM J, V39, P1312, DOI 10.1295/polymj.PJ2007099; Muralidharan V, 2004, MACROMOL RAPID COMM, V25, P1487, DOI 10.1002/marc.200400190; Okay O, 2000, PROG POLYM SCI, V25, P711, DOI 10.1016/S0079-6700(00)00015-0; Olson DA, 2008, CHEM MATER, V20, P869, DOI 10.1021/cm702239k; Pitet LM, 2010, J AM CHEM SOC, V132, P8230, DOI 10.1021/ja100985d; Rzayev J, 2005, J AM CHEM SOC, V127, P13373, DOI 10.1021/ja053731d; Stanford MJ, 2009, MACROMOLECULES, V42, P141, DOI 10.1021/ma801977e; Uehara H, 2006, MACROMOLECULES, V39, P3971, DOI 10.1021/ma0601316; Weber J, 2009, MACROMOLECULES, V42, P8234, DOI 10.1021/ma901322t; Yamamoto K, 2009, MACROMOLECULES, V42, P9561, DOI 10.1021/ma9009774; Zalusky AS, 2002, J AM CHEM SOC, V124, P12761, DOI 10.1021/ja0278584; Zhou N, 2006, NANO LETT, V6, P2354, DOI 10.1021/nl061765t	30	205	220	17	328	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1422	1425		10.1126/science.1221383	http://dx.doi.org/10.1126/science.1221383			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700925				2022-12-28	WOS:000305211700040
J	Aynajian, P; Neto, EHD; Gyenis, A; Baumbach, RE; Thompson, JD; Fisk, Z; Bauer, ED; Yazdani, A				Aynajian, Pegor; da Silva Neto, Eduardo H.; Gyenis, Andras; Baumbach, Ryan E.; Thompson, J. D.; Fisk, Zachary; Bauer, Eric D.; Yazdani, Ali			Visualizing heavy fermions emerging in a quantum critical Kondo lattice	NATURE			English	Article							HIDDEN ORDER; TRANSITIONS; CERHIN5; CECOIN5	In solids containing elements with f orbitals, the interaction between f-electron spins and those of itinerant electrons leads to the development of low-energy fermionic excitations with a heavy effective mass. These excitations are fundamental to the appearance of unconventional superconductivity and non-Fermi-liquid behaviour observed in actinide- and lanthanide-based compounds. Here we use spectroscopic mapping with the scanning tunnelling microscope to detect the emergence of heavy excitations with lowering of temperature in a prototypical family of cerium-based heavy-fermion compounds. Wedemonstrate the sensitivity of the tunnelling process to the compositenature of these heavy quasiparticles, which arises from quantum entanglement of itinerant conduction and f electrons. Scattering and interference of the composite quasiparticles is used to resolve their energy-momentum structure and to extract their mass enhancement, which develops with decreasing temperature. The lifetime of the emergent heavy quasiparticles reveals signatures of enhanced scattering and their spectral lineshape shows evidence of energy-temperature scaling. These findings demonstrate that proximity to a quantum critical point results in critical damping of the emergent heavy excitation of our Kondo lattice system.	[Aynajian, Pegor; da Silva Neto, Eduardo H.; Gyenis, Andras; Yazdani, Ali] Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA; [Aynajian, Pegor; da Silva Neto, Eduardo H.; Gyenis, Andras; Yazdani, Ali] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Baumbach, Ryan E.; Thompson, J. D.; Bauer, Eric D.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Fisk, Zachary] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA	Princeton University; Princeton University; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Irvine	Yazdani, A (corresponding author), Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA.	yazdani@princeton.edu		Bauer, Eric/0000-0003-0017-1937; Aynajian, Pegor/0000-0002-0123-527X; da Silva Neto, Eduardo/0000-0001-6902-6100; Yazdani, Ali/0000-0003-4996-8904	DOE Office of Basic Energy Sciences [DE-FG02-07ER46419]; Princeton Center for Complex Materials [NSF-DMR1104612, NSF-MRSEC, DMR-0819860]; W.M. Keck foundation; Eric and Linda Schmidt Transformative fund at Princeton; Princeton Center for Complex Materials; NSF-MRSEC; US Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering;  [NSF-DMR-0801253]; Direct For Mathematical & Physical Scien [0801253] Funding Source: National Science Foundation	DOE Office of Basic Energy Sciences(United States Department of Energy (DOE)); Princeton Center for Complex Materials; W.M. Keck foundation(W.M. Keck Foundation); Eric and Linda Schmidt Transformative fund at Princeton; Princeton Center for Complex Materials; NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); US Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering(United States Department of Energy (DOE)); ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge discussions with P. W. Anderson, E. Abrahams, P. Coleman, N. Curro, D. Pines, D. Morr, T. Senthil, S. Sachdev, M. Vojta, C. Varma and C. V. Parker. Work at Princeton University was primarily supported by a grant from the DOE Office of Basic Energy Sciences (DE-FG02-07ER46419). The instrumentation and infrastructure at the Princeton Nanoscale Microscopy Laboratory are also supported by grants from the NSF-DMR1104612 and NSF-MRSEC programmes through the Princeton Center for Complex Materials (DMR-0819860), and the W.M. Keck foundation as well as the Eric and Linda Schmidt Transformative fund at Princeton. P. A. acknowledges postdoctoral fellowship support through the Princeton Center for Complex Materials funded by the NSF-MRSEC programme. Work at Los Alamos National Laboratory was performed under the auspices of the US Department of Energy, Office of Basic Energy Sciences, Division of Materials Science and Engineering. Z.F. acknowledges support from NSF-DMR-0801253.	Anderson PW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.176403; ANDERSON PW, 1961, PHYS REV, V124, P41, DOI 10.1103/PhysRev.124.41; ARONSON MC, 1995, PHYS REV LETT, V75, P725, DOI 10.1103/PhysRevLett.75.725; Aynajian P, 2010, P NATL ACAD SCI USA, V107, P10383, DOI 10.1073/pnas.1005892107; Benlagra A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.195141; Booth CH, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.144519; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; Coleman P., 2007, HDB MAGNETISM ADV MA, V1, P45; Ehm D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045117; Ernst S, 2011, NATURE, V474, P362, DOI 10.1038/nature10148; Figgins J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.187202; FISK Z, 1995, P NATL ACAD SCI USA, V92, P6663, DOI 10.1073/pnas.92.15.6663; Fujimori S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.224517; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Grenzebach C, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195119; Hall D, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.212508; Hegger H, 2000, PHYS REV LETT, V84, P4986, DOI 10.1103/PhysRevLett.84.4986; Jacob D, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195115; Koitzsch A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155128; Maltseva M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.206402; Martin LC, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.245105; Moshopoulou EG, 2002, APPL PHYS A-MATER, V74, pS895, DOI 10.1007/s003390201673; Oppeneer PM, 2007, J MAGN MAGN MATER, V310, P1684, DOI 10.1016/j.jmmm.2006.10.763; Paglione J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.246405; Paglione J, 2007, NAT PHYS, V3, P703, DOI 10.1038/nphys711; PALSTRA TTM, 1985, PHYS REV LETT, V55, P2727, DOI 10.1103/PhysRevLett.55.2727; Park T, 2006, NATURE, V440, P65, DOI 10.1038/nature04571; Park WK, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.177001; Petrovic C, 2001, J PHYS-CONDENS MAT, V13, pL337, DOI 10.1088/0953-8984/13/17/103; Pfleiderer C, 2009, REV MOD PHYS, V81, P1551, DOI 10.1103/RevModPhys.81.1551; SACHDEV S, 1992, PHYS REV LETT, V69, P2411, DOI 10.1103/PhysRevLett.69.2411; Sachdev S., 1999, QUANTUM PHASE TRANSI; Schmidt AR, 2010, NATURE, V465, P570, DOI 10.1038/nature09073; Schroder A, 1998, PHYS REV LETT, V80, P5623, DOI 10.1103/PhysRevLett.80.5623; Schroder A, 2000, NATURE, V407, P351, DOI 10.1038/35030039; Senthil T, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.216403; Senthil T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035103; Shiba H, 2005, J PHYS SOC JPN, V74; Shim JH, 2007, SCIENCE, V318, P1615, DOI 10.1126/science.1149064; Shishido H, 2004, J MAGN MAGN MATER, V272, P225, DOI 10.1016/j.jmmm.2003.11.087; Si QM, 2010, SCIENCE, V329, P1161, DOI 10.1126/science.1191195; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; Sidorov VA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.157004; STEGLICH F, 1995, J LOW TEMP PHYS, V99, P267, DOI 10.1007/BF00752293; STEWART GR, 1984, REV MOD PHYS, V56, P755, DOI 10.1103/RevModPhys.56.755; Urbano RR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.146402; VARMA CM, 1976, REV MOD PHYS, V48, P219, DOI 10.1103/RevModPhys.48.219; Wolfle P, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.246401; Yang YF, 2008, NATURE, V454, P611, DOI 10.1038/nature07157; Yang YF, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.241107	50	154	159	3	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					201	206		10.1038/nature11204	http://dx.doi.org/10.1038/nature11204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699608	Green Submitted, Green Published			2022-12-28	WOS:000305189000024
J	Maslin, M; Austin, P				Maslin, Mark; Austin, Patrick			Climate models at their limit?	NATURE			English	Editorial Material									[Maslin, Mark; Austin, Patrick] UCL, Inst Environm, London WC1E 6BT, England; [Maslin, Mark; Austin, Patrick] UCL, Dept Geog, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Maslin, M (corresponding author), UCL, Inst Environm, Pearson Bldg,Gower St, London WC1E 6BT, England.	m.maslin@ucl.ac.uk		Maslin, Mark/0000-0001-9957-3463				Joshi M, 2011, NAT CLIM CHANGE, V1, P407, DOI 10.1038/NCLIMATE1261; Kingston DG, 2011, HYDROL EARTH SYST SC, V15, P1459, DOI 10.5194/hess-15-1459-2011; Lenton TM, 2011, NAT CLIM CHANGE, V1, P201, DOI [10.1038/NCLIMATE1143, 10.1038/NCLIMATE143]; ORESKES N, 1994, SCIENCE, V263, P641, DOI 10.1126/science.263.5147.641; Rowlands DJ, 2012, NAT GEOSCI, V5, P256, DOI [10.1038/NGEO1430, 10.1038/ngeo1430]; Schmittner A, 2011, SCIENCE, V334, P1385, DOI 10.1126/science.1203513; Stern N. H., 2007, EC CLIMATE CHANGE ST, P692; Valdes P, 2011, NAT GEOSCI, V4, P414, DOI 10.1038/ngeo1200	8	104	108	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2012	486	7402					183	184		10.1038/486183a	http://dx.doi.org/10.1038/486183a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699594				2022-12-28	WOS:000305189000012
J	Dworzynski, K; Pollit, V; Kelsey, A; Higgins, B; Palmer, K				Dworzynski, Katharina; Pollit, Vicki; Kelsey, Amy; Higgins, Bernard; Palmer, Kelvin		Guideline Dev Grp	Management of acute upper gastrointestinal bleeding: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEMORRHAGE		[Dworzynski, Katharina; Pollit, Vicki; Kelsey, Amy; Higgins, Bernard] Royal Coll Phys London, Natl Clin Guideline Ctr, London NW1 4LE, England; [Palmer, Kelvin] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Dworzynski, K (corresponding author), Royal Coll Phys London, Natl Clin Guideline Ctr, London NW1 4LE, England.	Katharina.Dworzynski@rcplondon.co.uk		Wonderling, David/0000-0003-0315-6273				Blatchford O, 2000, LANCET, V356, P1318, DOI 10.1016/S0140-6736(00)02816-6; Hearnshaw SA, 2011, GUT, V60, P1327, DOI 10.1136/gut.2010.228437; National Institute for Health and Clinical Excellence, 2012, MAN AC UPP GASTR BLE; Rockall TA, 1996, GUT, V38, P316, DOI 10.1136/gut.38.3.316	4	58	66	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 13	2012	344								e3412	10.1136/bmj.e3412	http://dx.doi.org/10.1136/bmj.e3412			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961KT	22695897				2022-12-28	WOS:000305464000001
J	Yepes, JF; White, D				Yepes, Juan F.; White, Dean			A Young Patient With Persistent Gingival Bleeding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PEMPHIGUS-VULGARIS		[Yepes, Juan F.] Univ Kentucky, Coll Dent, Dept Pediat Dent, Div Pediat Dent, Lexington, KY 40536 USA; [White, Dean] Univ Kentucky, Coll Dent, Div Oral Pathol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Yepes, JF (corresponding author), Univ Kentucky, Coll Dent, Dept Pediat Dent, Div Pediat Dent, 740 S Limestone,A-219, Lexington, KY 40536 USA.	jfyepe2@email.uky.edu						Amagai M, 2000, J CLIN INVEST, V105, P625, DOI 10.1172/JCI8748; Bystryn JC, 2005, LANCET, V366, P61, DOI 10.1016/S0140-6736(05)66829-8; Ettlin Dominik A, 2005, Dent Clin North Am, V49, P107, DOI 10.1016/j.cden.2004.08.002; Fellner MJ, 2001, MT SINAI J MED, V68, P268; Koturoglu G, 2008, Minerva Pediatr, V60, P347; Mignogna MD, 2001, J CLIN PERIODONTOL, V28, P489, DOI 10.1034/j.1600-051x.2001.028005489.x; NEVILLE BW, 1999, COLOR ATLAS CLIN ORA; Ramirez-Amador VA, 2000, INT J DERMATOL, V39, P501, DOI 10.1046/j.1365-4362.2000.00955.x; Shamim T, 2007, Indian J Pathol Microbiol, V50, P498; Shamim T, 2008, MED ORAL PATOL ORAL, V13, pE622	10	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2012	307	22					2430	2431		10.1001/jama.2012.4307	http://dx.doi.org/10.1001/jama.2012.4307			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	956UX	22692174				2022-12-28	WOS:000305115900028
J	Alexander, EK; Kennedy, GC; Baloch, ZW; Cibas, ES; Chudova, D; Diggans, J; Friedman, L; Kloos, RT; LiVolsi, VA; Mandel, SJ; Raab, SS; Rosai, J; Steward, DL; Walsh, PS; Wilde, JI; Zeiger, MA; Lanman, RB; Haugen, BR				Alexander, Erik K.; Kennedy, Giulia C.; Baloch, Zubair W.; Cibas, Edmund S.; Chudova, Darya; Diggans, James; Friedman, Lyssa; Kloos, Richard T.; LiVolsi, Virginia A.; Mandel, Susan J.; Raab, Stephen S.; Rosai, Juan; Steward, David L.; Walsh, P. Sean; Wilde, Jonathan I.; Zeiger, Martha A.; Lanman, Richard B.; Haugen, Bryan R.			Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEEDLE-ASPIRATION BIOPSY; FNA SAMPLES; CANCER; MANAGEMENT; MUTATIONS; CARCINOMA; ACCURACY; IMMUNOHISTOCHEMISTRY; SURGERY; TUMORS	BACKGROUND Approximately 15 to 30% of thyroid nodules evaluated by means of fine-needle aspiration are not clearly benign or malignant. Patients with cytologically indeterminate nodules are often referred for diagnostic surgery, though most of these nodules prove to be benign. A novel diagnostic test that measures the expression of 167 genes has shown promise in improving preoperative risk assessment. METHODS We performed a 19-month, prospective, multicenter validation study involving 49 clinical sites, 3789 patients, and 4812 fine-needle aspirates from thyroid nodules 1 cm or larger that required evaluation. We obtained 577 cytologically indeterminate aspirates, 413 of which had corresponding histopathological specimens from excised lesions. Results of a central, blinded histopathological review served as the reference standard. After inclusion criteria were met, a gene-expression classifier was used to test 265 indeterminate nodules in this analysis, and its performance was assessed. RESULTS Of the 265 indeterminate nodules, 85 were malignant. The gene-expression classifier correctly identified 78 of the 85 nodules as suspicious (92% sensitivity; 95% confidence interval [CI], 84 to 97), with a specificity of 52% (95% CI, 44 to 59). The negative predictive values for "atypia (or follicular lesion) of undetermined clinical significance," "follicular neoplasm or lesion suspicious for follicular neoplasm," or "suspicious cytologicfindings" were 95%, 94%, and 85%, respectively. Analysis of 7 aspirates with false negative results revealed that 6 had a paucity of thyroid follicular cells, suggesting insufficient sampling of the nodule. CONCLUSIONS These data suggest consideration of a more conservative approach for most patients with thyroid nodules that are cytologically indeterminate on fine-needle aspiration and benign according to gene-expression classifier results. (Funded by Veracyte.)	[Alexander, Erik K.] Brigham & Womens Hosp, Div Endocrinol Metab & Diabet, Thyroid Unit, Dept Med, Boston, MA 02115 USA; [Cibas, Edmund S.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Kennedy, Giulia C.; Chudova, Darya; Diggans, James; Friedman, Lyssa; Walsh, P. Sean; Wilde, Jonathan I.; Lanman, Richard B.] Veracyte Inc, San Francisco, CA 94080 USA; [Baloch, Zubair W.; LiVolsi, Virginia A.] Univ Penn, Perelman Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Mandel, Susan J.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Kloos, Richard T.] Ohio State Univ, Coll Med, Dept Med, Columbus, OH 43210 USA; [Raab, Stephen S.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Rosai, Juan] Ctr Diagnost Italiano, Milan, Italy; [Steward, David L.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45267 USA; [Zeiger, Martha A.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Haugen, Bryan R.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University System of Ohio; Ohio State University; University of Washington; University of Washington Seattle; University System of Ohio; University of Cincinnati; Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus	Alexander, EK (corresponding author), Brigham & Womens Hosp, Div Endocrinol Metab & Diabet, Thyroid Unit, Dept Med, 75 Francis St,Rm PBB-B4, Boston, MA 02115 USA.	ekalexander@partners.org; giulia@veracyte.com	Lanman, Richard B/D-8290-2016; Kloos, Richard/Q-9963-2019	Lanman, Richard B/0000-0001-8122-4329; 	Veracyte	Veracyte	Supported by research grants to the individual study institutions from Veracyte.	ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Baloch ZW, 2008, CYTOJOURNAL, V5, DOI 10.1186/1742-6413-5-6; Banks ND, 2008, THYROID, V18, P933, DOI 10.1089/thy.2008.0108; Bergenfelz A, 2008, LANGENBECK ARCH SURG, V393, P667, DOI 10.1007/s00423-008-0366-7; Bilimoria KY, 2007, ANN SURG, V246, P375, DOI 10.1097/SLA.0b013e31814697d9; Bossuyt PM, 2003, AM J CLIN PATHOL, V119, P18, DOI 10.1309/8EXCCM6YR1THUBAF; Bryson PC, 2008, ARCH OTOLARYNGOL, V134, P581, DOI 10.1001/archotol.134.6.581; Chudova D, 2010, J CLIN ENDOCR METAB, V95, P5296, DOI 10.1210/jc.2010-1087; Cibas ES, 2009, AM J CLIN PATHOL, V132, P658, DOI 10.1309/AJCPPHLWMI3JV4LA; Cooper DS, 2010, THYROID, V20, P674, DOI 10.1089/thy.2009.0110.cxn; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Esnaola NF, 2001, SURGERY, V130, P921, DOI 10.1067/msy.2001.118370; Eszlinger M, 2010, MOL CELL ENDOCRINOL, V322, P29, DOI 10.1016/j.mce.2010.01.010; Ferraz C, 2011, J CLIN ENDOCR METAB, V96, P2016, DOI 10.1210/jc.2010-2567; Fischer S, 2008, ARCH PATHOL LAB MED, V132, P359, DOI 10.1043/1543-2165(2008)132[359:AOITTN]2.0.CO;2; Fusco A, 2002, AM J PATHOL, V160, P2157, DOI 10.1016/S0002-9440(10)61164-9; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P51; Hu SY, 2006, J CLIN ENDOCR METAB, V91, P98, DOI 10.1210/jc.2005-1810; Hundahl SA, 2000, CANCER-AM CANCER SOC, V89, P202, DOI 10.1002/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A; Kim ES, 2004, CLIN ENDOCRINOL, V61, P145, DOI 10.1111/j.1365-2265.2004.02065.x; Lewis CM, 2009, THYROID, V19, P717, DOI 10.1089/thy.2008.0425; Li H, 2011, J CLIN ENDOCR METAB, V96, pE1719, DOI 10.1210/jc.2011-0459; Milas M, 2010, ANN SURG, V252, P643, DOI 10.1097/SLA.0b013e3181f5ba51; Moses W, 2010, WORLD J SURG, V34, P2589, DOI 10.1007/s00268-010-0720-0; Nikiforov YE, 2011, J CLIN ENDOCR METAB, V96, P3390, DOI 10.1210/jc.2011-1469; Nikiforov YE, 2009, J CLIN ENDOCR METAB, V94, P2092, DOI 10.1210/jc.2009-0247; Prasad ML, 2005, MODERN PATHOL, V18, P48, DOI 10.1038/modpathol.3800235; Prasad NB, 2008, CLIN CANCER RES, V14, P3327, DOI 10.1158/1078-0432.CCR-07-4495; Shrime MG, 2007, ARCH OTOLARYNGOL, V133, P1245, DOI 10.1001/archotol.133.12.1245; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sosa JA, 1998, ANN SURG, V228, P320, DOI 10.1097/00000658-199809000-00005; Wang CCC, 2011, THYROID, V21, P243, DOI 10.1089/thy.2010.0243; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yassa L, 2007, CANCER CYTOPATHOL, V111, P508, DOI 10.1002/cncr.23116	34	744	775	6	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2012	367	8					705	715		10.1056/NEJMoa1203208	http://dx.doi.org/10.1056/NEJMoa1203208			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992CX	22731672				2022-12-28	WOS:000307754200005
J	Camm, AJ; Savelieva, I				Camm, A. John; Savelieva, Irene			The long and short of antiarrhythmic drug treatment	LANCET			English	Editorial Material							ATRIAL-FIBRILLATION; FLECAINIDE; CARDIOVERSION; DRONEDARONE; MANAGEMENT		[Camm, A. John; Savelieva, Irene] St Georges Univ London, Dept Cardiol Sci, London SW17 0RE, England	St Georges University London	Camm, AJ (corresponding author), St Georges Univ London, Dept Cardiol Sci, London SW17 0RE, England.	jcamm@sgul.ac.uk						Aliot E, 2011, EUROPACE, V13, P161, DOI 10.1093/europace/euq382; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Connolly SJ, 2011, NEW ENGL J MED, V365, P2268, DOI 10.1056/NEJMoa1109867; Darbar D, 2007, J CARDIOVASC ELECTR, V18, P636, DOI 10.1111/j.1540-8167.2007.00817.x; Ehrlich JR, 2009, CURR OPIN CARDIOL, V24, P50, DOI 10.1097/HCO.0b013e32831bc336; Freemantle N, 2011, EUROPACE, V13, P329, DOI 10.1093/europace/euq450; Gallagher MM, 1998, PACE, V21, P776, DOI 10.1111/j.1540-8159.1998.tb00140.x; Kirchhof P, 2012, LANCET, V380, P238, DOI 10.1016/S0140-6736(12)60570-4; Lafuente-Lafuente C, 2006, ARCH INTERN MED, V166, P719, DOI 10.1001/archinte.166.7.719; Tieleman RG, 2005, HEART RHYTHM, V2, P223, DOI 10.1016/j.hrthm.2004.11.014; Timmermans C, 2000, J AM COLL CARDIOL, V35, P1428, DOI 10.1016/S0735-1097(00)00579-9; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954	13	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2012	380	9838					198	200		10.1016/S0140-6736(12)60950-7	http://dx.doi.org/10.1016/S0140-6736(12)60950-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	976TV	22713625				2022-12-28	WOS:000306609200010
J	Micheletti, R; Rosenbach, M				Micheletti, Robert; Rosenbach, Misha			A Violaceous Plaque in an Immunosuppressed Patient	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ZYGOMYCOSIS; THERAPY		Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Micheletti, R (corresponding author), Hosp Univ Penn, 2 Maloney Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	robert.micheletti@uphs.upenn.edu		Micheletti, Robert/0000-0003-2517-7008				Chamilos G, 2008, CLIN INFECT DIS, V47, P503, DOI 10.1086/590004; Kontoyiannis DP, 2005, J INFECT DIS, V191, P1350, DOI 10.1086/428780; Rubin AI, 2004, J AM ACAD DERMATOL, V51, P996, DOI 10.1016/j.jaad.2004.07.027; Tragiannidis A, 2009, CLIN MICROBIOL INFEC, V15, P82, DOI 10.1111/j.1469-0691.2009.02986.x; Trifilio SM, 2007, BONE MARROW TRANSPL, V39, P425, DOI [10.1038/sj.bmt.1705614, 10.1038/SJ.BMT.1705614]	5	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2012	307	24					2635	2636		10.1001/jama.2012.4302	http://dx.doi.org/10.1001/jama.2012.4302			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	964KF	22735433				2022-12-28	WOS:000305692600032
J	Sun, XR; Giovannucci, A; Sgro, AE; Wang, SSH				Sun, X. Richard; Giovannucci, Andrea; Sgro, Allyson E.; Wang, Samuel S-H			SnapShot: Optical Control and Imaging of Brain Activity	CELL			English	Editorial Material							LIGHT		[Sun, X. Richard] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Sun, XR (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.		Giovannucci, Andrea/AAH-8084-2021	Giovannucci, Andrea/0000-0002-7850-444X; Sgro, Allyson/0000-0003-2155-3918				Card J.P., 2001, CURR PROTOC NEUROSCI, P151; Dombeck D, 2011, IMAGING NEUROSCIENCE, P827; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Looger LL, 2012, CURR OPIN NEUROBIOL, V22, P18, DOI 10.1016/j.conb.2011.10.024; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Thompson SM, 2005, J NEUROSCI, V25, P10358, DOI 10.1523/JNEUROSCI.3515-05.2005; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	10	2	2	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1650	+		10.1016/j.cell.2012.06.009	http://dx.doi.org/10.1016/j.cell.2012.06.009			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726446	Bronze			2022-12-28	WOS:000305753800028
J	Stephens, PJ; Tarpey, PS; Davies, H; Van Loo, P; Greenman, C; Wedge, DC; Nik-Zainal, S; Martin, S; Varela, I; Bignell, GR; Yates, LR; Papaemmanuil, E; Beare, D; Butler, A; Cheverton, A; Gamble, J; Hinton, J; Jia, MM; Jayakumar, A; Jones, D; Latimer, C; Lau, KW; McLaren, S; McBride, DJ; Menzies, A; Mudie, L; Raine, K; Rad, R; Chapman, MS; Teague, J; Easton, D; Langerod, A; Lee, MTM; Shen, CY; Tee, BTK; Huimin, BW; Broeks, A; Vargas, AC; Turashvili, G; Martens, J; Fatima, A; Miron, P; Chin, SF; Thomas, G; Boyault, S; Mariani, O; Lakhani, SR; van de Vijver, M; Van 'Tveer, L; Foekens, J; Desmedt, C; Sotiriou, C; Tutt, A; Caldas, C; Reis, JS; Aparicio, SAJR; Salomon, AV; Borresen-Dale, AL; Richardson, AL; Campbell, PJ; Futreal, PA; Stratton, MR				Stephens, Philip J.; Tarpey, Patrick S.; Davies, Helen; Van Loo, Peter; Greenman, Chris; Wedge, David C.; Nik-Zainal, Serena; Martin, Sancha; Varela, Ignacio; Bignell, Graham R.; Yates, Lucy R.; Papaemmanuil, Elli; Beare, David; Butler, Adam; Cheverton, Angela; Gamble, John; Hinton, Jonathan; Jia, Mingming; Jayakumar, Alagu; Jones, David; Latimer, Calli; Lau, King Wai; McLaren, Stuart; McBride, David J.; Menzies, Andrew; Mudie, Laura; Raine, Keiran; Rad, Roland; Chapman, Michael Spencer; Teague, Jon; Easton, Douglas; Langerod, Anita; Lee, Ming Ta Michael; Shen, Chen-Yang; Tee, Benita Tan Kiat; Huimin, Bernice Wong; Broeks, Annegien; Vargas, Ana Cristina; Turashvili, Gulisa; Martens, John; Fatima, Aquila; Miron, Penelope; Chin, Suet-Feung; Thomas, Gilles; Boyault, Sandrine; Mariani, Odette; Lakhani, Sunil R.; van de Vijver, Marc; Van 'tVeer, Laura; Foekens, John; Desmedt, Christine; Sotiriou, Christos; Tutt, Andrew; Caldas, Carlos; Reis-Filho, Jorge S.; Aparicio, Samuel A. J. R.; Salomon, Anne Vincent; Borresen-Dale, Anne-Lise; Richardson, Andrea L.; Campbell, Peter J.; Futreal, P. Andrew; Stratton, Michael R.		OSBREAC	The landscape of cancer genes and mutational processes in breast cancer	NATURE			English	Article							NUCLEOTIDE EXCISION-REPAIR; GENOME-WIDE ASSOCIATION; SWI/SNF COMPLEX; SUSCEPTIBILITY; MECHANISMS; ARID1A; CELLS	All cancers carry somatic mutations in their genomes. A subset, known as driver mutations, confer clonal selective advantage on cancer cells and are causally implicated in oncogenesis(1), and the remainder are passenger mutations. The driver mutations and mutational processes operative in breast cancer have not yet been comprehensively explored. Here we examine the genomes of 100 tumours for somatic copy number changes and mutations in the coding exons of protein-coding genes. The number of somatic mutations varied markedly between individual tumours. We found strong correlations between mutation number, age at which cancer was diagnosed and cancer histological grade, and observed multiple mutational signatures, including one present in about ten per cent of tumours characterized by numerous mutations of cytosine at TpC dinucleotides. Driver mutations were identified in several new cancer genes including AKT2, ARID1B, CASP8, CDKN1B, MAP3K1, MAP3K13, NCOR1, SMARCD1 and TBX3. Among the 100 tumours, we found driver mutations in at least 40 cancer genes and 73 different combinations of mutated cancer genes. The results highlight the substantial genetic diversity underlying this common disease.	[Stephens, Philip J.; Tarpey, Patrick S.; Davies, Helen; Van Loo, Peter; Greenman, Chris; Wedge, David C.; Nik-Zainal, Serena; Martin, Sancha; Varela, Ignacio; Bignell, Graham R.; Yates, Lucy R.; Papaemmanuil, Elli; Beare, David; Butler, Adam; Cheverton, Angela; Gamble, John; Hinton, Jonathan; Jia, Mingming; Jayakumar, Alagu; Jones, David; Latimer, Calli; Lau, King Wai; McLaren, Stuart; McBride, David J.; Menzies, Andrew; Mudie, Laura; Raine, Keiran; Rad, Roland; Chapman, Michael Spencer; Teague, Jon; Campbell, Peter J.; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Van Loo, Peter] VIB, Human Genome Lab, Dept Human Genet, B-3000 Louvain, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, B-3000 Louvain, Belgium; [Greenman, Chris] Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England; [Greenman, Chris] Genome Anal Ctr, Norwich NR4 7TJ, Norfolk, England; [Yates, Lucy R.; Tutt, Andrew] Kings Coll London, Breakthrough Breast Canc Res Unit, Sch Med, London SE1 9RT, England; [Yates, Lucy R.] Guys & St Thomas NHS Trust, Dept Clin Oncol, London SE1 7EH, England; [Easton, Douglas] Ctr Canc Genet Epidemiol, Dept Oncol, Strangeways Res Lab, Cambridge CB1 8RN, England; [Easton, Douglas] Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England; [Langerod, Anita; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Dept Genet, Inst Canc Res, Norwegian Radium Hosp, N-0310 Oslo, Norway; [Lee, Ming Ta Michael; Shen, Chen-Yang] Acad Sinica, Natl Genotyping Ctr, Inst Biomed Sci, Taipei 115, Taiwan; [Tee, Benita Tan Kiat] Singapore Gen Hosp, Dept Gen Surg, Singapore 169608, Singapore; [Huimin, Bernice Wong] Natl Canc Ctr Singapore, NCCS VARI Translat Res Lab, Singapore 169610, Singapore; [Broeks, Annegien; Van 'tVeer, Laura] Netherlands Canc Inst, Dept Expt Therapy, NL-1066 CX Amsterdam, Netherlands; [Vargas, Ana Cristina; Lakhani, Sunil R.] Univ Queensland, Clin Res Ctr, Royal Brisbane & Womens Hosp, Brisbane, Qld 4029, Australia; [Turashvili, Gulisa; Aparicio, Samuel A. J. R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Turashvili, Gulisa; Aparicio, Samuel A. J. R.] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Martens, John; Foekens, John] Erasmus Univ, Dept Med Oncol, Med Ctr, Daniel den Hoed Canc Ctr, NL-3000 CA Rotterdam, Netherlands; [Martens, John; Foekens, John] Canc Genom Ctr, NL-3000 CA Rotterdam, Netherlands; [Fatima, Aquila; Miron, Penelope; Richardson, Andrea L.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Chin, Suet-Feung; Caldas, Carlos] Univ Cambridge, Dept Oncol, Cambridge CB2 0RE, England; [Chin, Suet-Feung; Caldas, Carlos] Canc Res UK, Cambridge Res Inst, Li Ka Shin Ctr, Cambridge CB2 0RE, England; [Thomas, Gilles; Boyault, Sandrine] Univ Lyon 1, INCa Synergie, Ctr Leon Berard, F-69365 Lyon 08, France; [Mariani, Odette; Salomon, Anne Vincent] Inst Curie, Dept Tumor Biol, F-75248 Paris 05, France; [Lakhani, Sunil R.] Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia; [Lakhani, Sunil R.] Royal Brisbane & Womens Hosp, Brisbane, Qld 4029, Australia; [van de Vijver, Marc] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Desmedt, Christine; Sotiriou, Christos] Univ Libre Bruxelles, Breast Canc Translat Lab, Inst Jules Bordet, B-1000 Brussels, Belgium; [Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, NIHR Cambridge Biomed Res Ctr, Cambridge CB2 2QQ, England; [Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Expt Canc Med Ctr, Cambridge CB2 2QQ, England; [Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Salomon, Anne Vincent] INSERM, U830, Inst Curie, F-75248 Paris 05, France; [Borresen-Dale, Anne-Lise] Univ Oslo, KG Jebsen Ctr Breast Canc Res, Inst Clin Med, Fac Med, N-0318 Oslo, Norway; [Richardson, Andrea L.] Harvard Univ, Dept Pathol, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Campbell, Peter J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England	Wellcome Trust Sanger Institute; Flanders Institute for Biotechnology (VIB); KU Leuven; University of East Anglia; The Genome Analysis Centre (TGAC); University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Oslo; Academia Sinica - Taiwan; Singapore General Hospital; National Cancer Centre Singapore (NCCS); Netherlands Cancer Institute; Royal Brisbane & Women's Hospital; University of Queensland; University of British Columbia; British Columbia Cancer Agency; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Institut National du Cancer (INCA) France; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Queensland; Royal Brisbane & Women's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Institut Jules Bordet; Universite Libre de Bruxelles; University of Cambridge; University of Cambridge; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; University of Oslo; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England.	mrs@sanger.ac.uk	Van Loo, Peter/A-3287-2012; Lee, Ming Ta Michael/N-5396-2015; Vargas, Ana/GSE-1963-2022; Varela, Ignacio/AAA-7680-2021; Desmedt, Christine/P-7438-2017; Nik-Zainal, Serena/ABD-4437-2020; Caldas, Carlos/U-7250-2019; Lakhani, Sunil R/I-1970-2018; Wedge, David/AAC-4977-2021; Varela, Ignacio/G-1699-2016; Shen, CY/F-6271-2010; Caldas, Carlos/A-7543-2008	Lee, Ming Ta Michael/0000-0003-2510-8977; Varela, Ignacio/0000-0002-0969-506X; Desmedt, Christine/0000-0002-5223-5579; Caldas, Carlos/0000-0003-3547-1489; Lakhani, Sunil R/0000-0003-4067-2760; Varela, Ignacio/0000-0002-0969-506X; Nik-Zainal, Serena/0000-0001-5054-1727; Yates, Lucy/0000-0003-4519-7794; van de Vijver, Marc/0000-0002-0385-4787; Raine, Keiran/0000-0002-5634-1539; Wong, Bernice/0000-0001-8981-1376; Spencer Chapman, Michael/0000-0002-5320-8193; Wedge, David/0000-0002-7572-3196; Tutt, Andrew/0000-0001-8715-2901; chin, suet-feung/0000-0001-5697-1082; Aparicio, Samuel/0000-0002-0487-9599; Martin, Sancha/0000-0001-6213-5259; Van Loo, Peter/0000-0003-0292-1949; Turashvili, Gulisa/0000-0001-6125-5865	Wellcome Trust [077012/Z/05/Z]; Breakthrough Breast Cancer; Wellcome Trust Senior Clinical Research Fellowship [WT088340MA]; Research Foundation - Flanders (FWO); travel grant from the FWO; International Human Frontier Science Program Organization; Norwegian Research Council; Norwegian Cancer Society; Radium Hospital Foundation; Health Region SO; 'Interface INSERM' grant; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award; St Thomas' NHS Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust; Cancer Research UK; National Institute for Health Research; Welsh Assembly Government; HSC R&D Office for Northern Ireland and the Chief Scientist Office, Scotland; MEDIC foundation; Fonds National de Recherche Scientifique; Netherlands Genomics Initiative/Netherlands Organization for Scientific Research; Institut National du Cancer; Fondation Synergie-Lyon-Cancer; Canceropole Lyon Auverge Rhone Alpes; Centre Leon Berard; Ludwig Institute for Cancer Research; Dutch Genomics Initiative-Cancer Genomics Center; NATIONAL CANCER INSTITUTE [P50CA089393, P30CA016672] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish; Cancer Research UK [10118, 11022] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Breakthrough Breast Cancer; Wellcome Trust Senior Clinical Research Fellowship(Wellcome Trust); Research Foundation - Flanders (FWO)(FWO); travel grant from the FWO(FWO); International Human Frontier Science Program Organization(Human Frontier Science Program); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Radium Hospital Foundation; Health Region SO; 'Interface INSERM' grant; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award; St Thomas' NHS Foundation Trust; King's College London; King's College Hospital NHS Foundation Trust; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Welsh Assembly Government; HSC R&D Office for Northern Ireland and the Chief Scientist Office, Scotland; MEDIC foundation; Fonds National de Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation Synergie-Lyon-Cancer; Canceropole Lyon Auverge Rhone Alpes; Centre Leon Berard; Ludwig Institute for Cancer Research; Dutch Genomics Initiative-Cancer Genomics Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust (grant reference 077012/Z/05/Z) and Breakthrough Breast Cancer. P.J.C. is personally funded through a Wellcome Trust Senior Clinical Research Fellowship (grant reference WT088340MA). P. V. L. is a postdoctoral researcher at the Research Foundation - Flanders (FWO) and is a visiting scientist at the Wellcome Trust Sanger Institute, supported by a travel grant from the FWO. I. V. is supported by a fellowship from The International Human Frontier Science Program Organization. A.-L.B.-D. and A. L. are funded by the Norwegian Research Council, The Norwegian Cancer Society, The Radium Hospital Foundation and Health Region SO. A. V. S. was supported by an 'Interface INSERM' grant. J.S.R.-F. is funded in part by Breakthrough Breast Cancer and is a recipient of the 2010 CRUK Future Leaders Prize. D. E. is a Principal Research Fellow of Cancer Research UK. A. T. receives financial support from the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London, and from King's College Hospital NHS Foundation Trust in conjunction with The Experimental Cancer Medicine Centre Initiative jointly funded by Cancer Research UK, the National Institute for Health Research, the Welsh Assembly Government, the HSC R&D Office for Northern Ireland and the Chief Scientist Office, Scotland. C. D. and C. S. received partial funding from the MEDIC foundation and the Fonds National de Recherche Scientifique. J.M. and J.F. are funded in part by a research grant from the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The INCa-Synergie facility received support from the Institut National du Cancer, the Fondation Synergie-Lyon-Cancer, the Canceropole Lyon Auverge Rhone Alpes and the Centre Leon Berard. A. C. V. is funded by The Ludwig Institute for Cancer Research. L.v.'t.V. and A. Broeks receive funding from the Dutch Genomics Initiative-Cancer Genomics Center. We also acknowledge support for sample collection, banking and processing from the Biological Resource Center of Institut Curie; the Breakthrough Breast Cancer Unit; P. Watson and the BCCA Tumour Tissue Repository; the Centre for Translational Genomics; A. Lane and P. T. Simpson; the Australian Biospecimens Network; the Breast Unit at Royal Brisbane and Women's Hospital; the Dana-Farber/Harvard SPORE in breast cancer (reference CA089393); A. M. Sieuwerts; and the Singhealth Tissue Repository, Singapore. We are grateful also for the support of T. B. Tean, and acknowledge the input and guidance of P. Spellman and A. Ashworth.	Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Howard B, 2006, PLOS GENET, V2, P1121, DOI 10.1371/journal.pgen.0020112; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Merrell KW, 2011, ONCOGENE, V30, P1608, DOI 10.1038/onc.2010.528; MILLER DG, 1980, CANCER, V46, P1307, DOI 10.1002/1097-0142(19800915)46:6<1307::AID-CNCR2820460602>3.0.CO;2-6; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Schinzel AC, 2008, FRONT BIOSCI-LANDMRK, V13, P71, DOI 10.2741/2661; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Spirin KS, 1996, CANCER RES, V56, P2400; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tigli Hatice, 2005, Mol Diagn, V9, P17, DOI 10.2165/00066982-200509010-00003; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Varghese JS, 2010, CURR OPIN GENET DEV, V20, P201, DOI 10.1016/j.gde.2010.03.012; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	34	1214	1251	9	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					400	+		10.1038/nature11017	http://dx.doi.org/10.1038/nature11017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722201	Green Accepted, Green Published			2022-12-28	WOS:000305466800043
J	Trivedi, BP				Trivedi, Bijal P.			GUSTATORY SYSTEM The finer points of taste	NATURE			English	Editorial Material							RECEPTORS; CELLS; SWEET; EXPRESSION; FAMILY; TRACT											Blakeslee AF, 1932, J HERED, V23, P97, DOI 10.1093/oxfordjournals.jhered.a103585; BOYD WC, 1950, SCIENCE, V112, P153, DOI 10.1126/science.112.2901.153; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Damak S, 2003, SCIENCE, V301, P850, DOI 10.1126/science.1087155; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; Fisher RA, 1939, NATURE, V144, P750, DOI 10.1038/144750a0; Fox A., 1931, SCIENCE, V73, P14; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Snyder LH, 1931, SCIENCE, V74, P151, DOI 10.1126/science.74.1910.151; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699	15	22	23	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					S2	S2		10.1038/486S2a	http://dx.doi.org/10.1038/486S2a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RB	22717400	Bronze			2022-12-28	WOS:000311781000002
J	Minichiello, T				Minichiello, Tracy			Catheter-directed thrombolysis reduced the postthrombotic syndrome in acute iliofemoral DVT	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Minichiello, T (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.							Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301	2	0	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12							JC6-6	10.7326/0003-4819-156-12-201206190-02006	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711107				2022-12-28	WOS:000307783200005
J	Streiff, MB; Carolan, HT; Hobson, DB; Kraus, PS; Holzmueller, CG; Demski, R; Lau, BD; Biscup-Horn, P; Pronovost, PJ; Haut, ER				Streiff, Michael B.; Carolan, Howard T.; Hobson, Deborah B.; Kraus, Peggy S.; Holzmueller, Christine G.; Demski, Renee; Lau, Brandyn D.; Biscup-Horn, Paula; Pronovost, Peter J.; Haut, Elliott R.			Lessons from the Johns Hopkins Multi-Disciplinary Venous Thromboembolism (VTE) Prevention Collaborative	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HOSPITALIZED-PATIENTS; PULMONARY-EMBOLISM; PROPHYLAXIS; RATES; RISK	Problem Venous thromboembolism (VTE) is a common cause of potentially preventable mortality, morbidity, and increased medical costs. Risk-appropriate prophylaxis can prevent most VTE events, but only a small fraction of patients at risk receive this treatment. Design Prospective quality improvement programme. Setting Johns Hopkins Hospital, Baltimore, Maryland, USA. Strategies for change A multidisciplinary team established a VTE Prevention Collaborative in 2005. The collaborative applied the four step TRIP (translating research into practice) model to develop and implement a mandatory clinical decision support tool for VTE risk stratification and risk-appropriate VTE prophylaxis for all hospitalised adult patients. Initially, paper based VTE order sets were implemented, which were then converted into 16 specialty-specific, mandatory, computerised, clinical decision support modules. Key measures for improvement VTE risk stratification within 24 hours of hospital admission and provision of risk-appropriate, evidence based VTE prophylaxis. Effects of change The VTE team was able to increase VTE risk assessment and ordering of risk-appropriate prophylaxis with paper based order sets to a limited extent, but achieved higher compliance with a computerised clinical decision support tool and the data feedback which it enabled. Risk-appropriate VTE prophylaxis increased from 26% to 80% for surgical patients and from 25% to 92% for medical patients in 2011. Lessons learnt A computerised clinical decision support tool can increase VTE risk stratification and risk-appropriate VTE prophylaxis among hospitalised adult patients admitted to a large urban academic medical centre. It is important to ensure the tool is part of the clinician's normal workflow, is mandatory (computerised forcing function), and offers the requisite modules needed for every clinical specialty.	[Hobson, Deborah B.; Haut, Elliott R.] Johns Hopkins Univ Hosp, Sch Med, Dept Surg, Baltimore, MD 21287 USA; [Streiff, Michael B.] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; [Streiff, Michael B.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Carolan, Howard T.; Hobson, Deborah B.; Holzmueller, Christine G.; Demski, Renee; Pronovost, Peter J.; Haut, Elliott R.] Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA; [Kraus, Peggy S.] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD 21287 USA; [Holzmueller, Christine G.; Pronovost, Peter J.; Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA USA; [Lau, Brandyn D.] Johns Hopkins Univ Hosp, Dept Med, Pittsburgh, PA USA; [Biscup-Horn, Paula] Allegheny Gen Hosp, Dept Pharm, Pittsburgh, PA 15212 USA; [Pronovost, Peter J.; Haut, Elliott R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Grad Training Program Clin Invest, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21218 USA; [Haut, Elliott R.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Allegheny General Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Haut, ER (corresponding author), Johns Hopkins Univ Hosp, Sch Med, Dept Surg, Sheikh Zayed 6107C,1800 Orleans St, Baltimore, MD 21287 USA.	ehaut1@jhmi.edu	Haut, Elliott R./J-3948-2019; Lau, Brandyn/H-4825-2018	Lau, Brandyn/0000-0003-3575-2440; Haut, Elliott/0000-0001-7075-771X	Sanofi-Aventis; BristolMyersSquibb; Agency for Healthcare Research and Quality; Lippincott Williams Wilkins; Association for Professionals in Infection Control and Epidemiology; National Institutes of Health; Robert Wood Johnson Foundation; Commonwealth Fund	Sanofi-Aventis(Sanofi-Aventis); BristolMyersSquibb(Bristol-Myers Squibb); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Lippincott Williams Wilkins; Association for Professionals in Infection Control and Epidemiology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Commonwealth Fund	MBS has received research funding from Sanofi-Aventis and BristolMyersSquibb; honoraria for CME lectures from Sanofi-Aventis and Ortho-McNeil; consulted for Sanofi-Aventis, Eisai, Daiichi-Sankyo, and Janssen HealthCare; and has given expert witness testimony in various medical malpractice cases. DBH has given expert witness testimony in various medical malpractice cases. ERH is the primary investigator of a Mentored Clinical Scientist Development Award from the Agency for Healthcare Research and Quality entitled "Does screening variability make DVT an unreliable quality measure of trauma care?"; receives royalties from Lippincott Williams & Wilkins for the book Avoiding Common ICU Errors; and has given expert witness testimony in various medical malpractice cases. PJP receives consultancy fees from the Association for Professionals in Infection Control and Epidemiology; grant or contract support from the Agency for Healthcare Research and Quality, National Institutes of Health, Robert Wood Johnson Foundation, and the Commonwealth Fund; honoraria from various hospitals and the Leigh Bureau (Somerville NJ); and royalties from his book Safe Patients Smart Hospitals. CGH has received a honorarium from MCIC Vermont to speak about organising and writing a manuscript reporting patient safety or quality improvement research.	Alikhan R, 2004, J CLIN PATHOL, V57, P1254, DOI 10.1136/jcp.2003.013581; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Ashrani AA, 2009, J THROMB THROMBOLYS, V28, P465, DOI 10.1007/s11239-009-0309-3; Beeler PE, 2011, THROMB HAEMOSTASIS, V106, P734, DOI 10.1160/TH11-04-0220; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Dentali F, 2007, ANN INTERN MED, V146, P278, DOI 10.7326/0003-4819-146-4-200702200-00007; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Goldhaber SZ, 2004, AM J CARDIOL, V93, P259, DOI 10.1016/j.amjcard.2003.09.057; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Haut ER, ARCH SURG IN PRESS; Haynes AB, 2011, BMJ QUAL SAF, V20, P102, DOI 10.1136/bmjqs.2009.040022; Lesselroth BJ, 2011, BMJ QUAL SAF, V20, P381, DOI 10.1136/bmjqs.2010.042689; National Institute for Health and Clinical Excellence, 2010, NICE CLIN GUID 92 VE; Prandoni P, 2009, BRIT J HAEMATOL, V145, P286, DOI 10.1111/j.1365-2141.2009.07601.x; Pronovost P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1714; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Qaseem A, 2011, ANN INTERN MED, V155, P625, DOI 10.7326/0003-4819-155-9-201111010-00011; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Schaden E, 2012, INTENS CARE MED, V38, P984, DOI 10.1007/s00134-012-2533-0; Spyropoulos AC, 2007, J MANAGE CARE PHARM, V13, P475, DOI 10.18553/jmcp.2007.13.6.475; Stein PD, 2010, CLIN CHEST MED, V31, P611, DOI 10.1016/j.ccm.2010.07.001; Streiff MB, 2009, JAMA-J AM MED ASSOC, V301, P1063, DOI 10.1001/jama.301.10.1063; Tooher R, 2005, ANN SURG, V241, P397, DOI 10.1097/01.sla.0000154120.96169.99; Welfare M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6452	25	92	94	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 19	2012	344								e3935	10.1136/bmj.e3935	http://dx.doi.org/10.1136/bmj.e3935			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	965CU	22718994	Green Published			2022-12-28	WOS:000305744600014
J	Ferdinand, P; Warrener, T; Mitchell, L; Zahir, R				Ferdinand, Phillip; Warrener, Timothy; Mitchell, Lauren; Zahir, Rasheed			Older Still ...	LANCET			English	Editorial Material							DISEASE		[Ferdinand, Phillip; Warrener, Timothy; Mitchell, Lauren; Zahir, Rasheed] Wolverhampton New Cross Hosp, Dept Acute Med, Wolverhampton WV10 0QP, W Midlands, England	New Cross Hospital	Ferdinand, P (corresponding author), Wolverhampton New Cross Hosp, Dept Acute Med, Wolverhampton WV10 0QP, W Midlands, England.	phillip.ferdinand@nhs.net						Catagay Y, 2009, INT J CLIN PRACT, V63, P1050; Fautrel B, 2001, J RHEUMATOL, V28, P322; Fautrel B, 2008, BEST PRACT RES CL RH, V22, P773, DOI 10.1016/j.berh.2008.08.006; MAGADURJOLY G, 1995, ANN RHEUM DIS, V54, P587, DOI 10.1136/ard.54.7.587; YAMAGUCHI M, 1992, J RHEUMATOL, V19, P424	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 16	2012	379	9833					2312	2312		10.1016/S0140-6736(12)60320-1	http://dx.doi.org/10.1016/S0140-6736(12)60320-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	962AM	22704170				2022-12-28	WOS:000305511400038
J	Jacob, Y; Martienssen, R				Jacob, Yannick; Martienssen, Rob			All Packed Up and Ready to Go	SCIENCE			English	Editorial Material							DIRECTED DNA METHYLATION; ORGANIZATION; PATHWAY; GENOME		[Jacob, Yannick; Martienssen, Rob] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Jacob, Y (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM067014] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Feng SH, 2011, CURR OPIN PLANT BIOL, V14, P179, DOI 10.1016/j.pbi.2010.12.002; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-8; Law JA, 2010, CURR BIOL, V20, P951, DOI 10.1016/j.cub.2010.03.062; Lorkovic ZJ, 2012, CURR BIOL, V22, P933, DOI 10.1016/j.cub.2012.03.061; Moissiard G, 2012, SCIENCE, V336, P1448, DOI 10.1126/science.1221472; Pontes O, 2009, MOL PLANT, V2, P700, DOI 10.1093/mp/ssp006; Qian WQ, 2012, SCIENCE, V336, P1445, DOI 10.1126/science.1219416; Rigal M, 2011, BBA-GENE REGUL MECH, V1809, P452, DOI 10.1016/j.bbagrm.2011.04.001; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Watson ML, 1998, P NATL ACAD SCI USA, V95, P14361, DOI 10.1073/pnas.95.24.14361	15	2	2	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1391	1392		10.1126/science.1224272	http://dx.doi.org/10.1126/science.1224272			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700909	Green Accepted			2022-12-28	WOS:000305211700030
J	McManus, DP; Gray, DJ; Zhang, WB; Yang, YR				McManus, Donald P.; Gray, Darren J.; Zhang, Wenbao; Yang, Yurong			Diagnosis, treatment, and management of echinococcosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CYSTIC ECHINOCOCCOSIS; ALVEOLAR ECHINOCOCCOSIS; DISEASE		[McManus, Donald P.] Queensland Inst Med Res, Natl Hlth & Med Res Council Australia, Brisbane, Qld 4006, Australia; [Gray, Darren J.] Queensland Inst Med Res, Australian Res Council, Brisbane, Qld 4006, Australia; [Gray, Darren J.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Yang, Yurong] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia; [Yang, Yurong] Ningxia Med Univ, Yinchuan, Ningxia Hui Aut, Peoples R China	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Queensland; Griffith University; Menzies Health Institute Queensland; Ningxia Medical University	McManus, DP (corresponding author), Queensland Inst Med Res, Natl Hlth & Med Res Council Australia, Brisbane, Qld 4006, Australia.	don.mcmanus@qimr.edu.au	McManus, Don/AAC-5394-2020; McManus, Donald P./G-2678-2013	McManus, Don/0000-0001-6443-1449; 	National Health and Medical Research Council of Australia; Queensland Institute of Medical Research	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Queensland Institute of Medical Research	The authors' studies on echinococcosis have received financial support from the National Health and Medical Research Council of Australia and the Queensland Institute of Medical Research.	Bresson-Hadni S, 2011, LIVER TRANSPLANT, V17, P855, DOI 10.1002/lt.22299; Brunetti E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001146; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Brunetti E, 2009, CURR OPIN INFECT DIS, V22, P497, DOI 10.1097/QCO.0b013e328330331c; Budke CM, 2006, EMERG INFECT DIS, V12, P296; Craig PS, 2007, LANCET INFECT DIS, V7, P385, DOI 10.1016/S1473-3099(07)70134-2; Eckert J, 2004, CLIN MICROBIOL REV, V17, P107, DOI 10.1128/CMR.17.1.107-135.2004; Hemphill A, 2009, J HELMINTHOL, V83, P99, DOI 10.1017/S0022149X0928936X; Horton J, 2003, FUND CLIN PHARMACOL, V17, P205; Junghanss T, 2008, AM J TROP MED HYG, V79, P301, DOI 10.4269/ajtmh.2008.79.301; Kern P, 2006, PARASITOL INT, V55, pS283, DOI 10.1016/j.parint.2005.11.041; Macpherson CNL, 2003, ACTA TROP, V85, P253, DOI 10.1016/S0001-706X(02)00213-9; McManus DP, 2010, ADV PARASIT, V72, P267, DOI 10.1016/S0065-308X(10)72010-8; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Moro P, 2009, INT J INFECT DIS, V13, P125, DOI 10.1016/j.ijid.2008.03.037; Nasseri-Moghaddam S, 2011, COCHRANE DB SYST REV, V1; Pawlowski ZS, 2001, WHO/OIE MANUAL ON ECHINOCOCCOSIS IN HUMANS AND ANIMALS: A PUBLIC HEALTH PROBLEM OF GLOBAL CONCERN, P20; Stojkovic M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000524; Thompson RCA, 2002, TRENDS PARASITOL, V18, P452, DOI 10.1016/S1471-4922(02)02358-9; Torgerson PR, 2008, J HEPATOL, V49, P72, DOI 10.1016/j.jhep.2008.03.023; Torgerson PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000722; Wen H, 2011, CHINESE MED J-PEKING, V124, P2813, DOI 10.3760/cma.j.issn.0366-6999.2011.18.003; Zhang WB, 2008, J IMMUNOL, V181, P6679, DOI 10.4049/jimmunol.181.10.6679; Zhang WB, 2006, FEMS IMMUNOL MED MIC, V47, P24, DOI 10.1111/j.1574-695X.2006.00060.x	24	157	173	1	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2012	344								e3866	10.1136/bmj.e3866	http://dx.doi.org/10.1136/bmj.e3866			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961KJ	22689886	Green Submitted			2022-12-28	WOS:000305463000002
J	Nargund, AM; Pellegrino, MW; Fiorese, CJ; Baker, BM; Haynes, CM				Nargund, Amrita M.; Pellegrino, Mark W.; Fiorese, Christopher J.; Baker, Brooke M.; Haynes, Cole M.			Mitochondrial Import Efficiency of ATFS-1 Regulates Mitochondrial UPR Activation	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; PROTEINS; STRESS; TRANSPORT	To better understand the response to mitochondrial dysfunction, we examined the mechanism by which ATFS-1 (activating transcription factor associated with stress-1) senses mitochondrial stress and communicates with the nucleus during the mitochondrial unfolded protein response (UPRmt) in Caenorhabditis elegans. We found that the key point of regulation is the mitochondrial import efficiency of ATFS-1. In addition to a nuclear localization sequence, ATFS-1 has an N-terminal mitochondrial targeting sequence that is essential for UPRmt repression. Normally, ATFS-1 is imported into mitochondria and degraded. However, during mitochondrial stress, we found that import efficiency was reduced, allowing a percentage of ATFS-1 to accumulate in the cytosol and traffic to the nucleus. Our results show that cells monitor mitochondrial import efficiency via ATFS-1 to coordinate the level of mitochondrial dysfunction with the protective transcriptional response.	[Nargund, Amrita M.; Pellegrino, Mark W.; Fiorese, Christopher J.; Baker, Brooke M.; Haynes, Cole M.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Fiorese, Christopher J.; Haynes, Cole M.] Weill Cornell Med Coll, BCMB Allied Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Haynes, CM (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA.	haynesc@mskcc.org		Fiorese, Christopher/0000-0002-7521-7103	Louis V. Gerstner Jr. Young Investigators Fund; Alfred W. Bressler Scholar Fund; Ellison Medical Foundation; NIH [R01AG040061]; NATIONAL INSTITUTE ON AGING [R01AG040061] Funding Source: NIH RePORTER	Louis V. Gerstner Jr. Young Investigators Fund; Alfred W. Bressler Scholar Fund; Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by the Louis V. Gerstner Jr. Young Investigators Fund, the Alfred W. Bressler Scholar Fund, the Ellison Medical Foundation, and NIH grant R01AG040061. We thank K. Rainbolt for lon(RNAi) advice, the National BioResource Project, and the Caenorhabditis Genetics Center and the Genomics Facility at Memorial Sloan-Kettering Cancer Center. The microarray data have been submitted in MIAME-compliant format to the Gene Expression Omnibus database (accession no. GSE38196).	ADES IZ, 1980, J BIOL CHEM, V255, P9925; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Donzeau M, 2000, CELL, V101, P401, DOI 10.1016/S0092-8674(00)80850-8; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Wright G, 2001, EXP CELL RES, V263, P107, DOI 10.1006/excr.2000.5096; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	15	582	607	7	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2012	337	6094					587	590		10.1126/science.1223560	http://dx.doi.org/10.1126/science.1223560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22700657	Green Accepted			2022-12-28	WOS:000307058700047
J	Landers, RM				Landers, Renee M.			The Denouement of the Supreme Court's ACA Drama	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Suffolk Univ, Sch Law, Boston, MA 02114 USA	Suffolk University	Landers, RM (corresponding author), Suffolk Univ, Sch Law, Boston, MA 02114 USA.								0	11	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 19	2012	367	3					198	199		10.1056/NEJMp1206847	http://dx.doi.org/10.1056/NEJMp1206847			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	975PI	22747179				2022-12-28	WOS:000306522900002
J	Churchland, MM; Cunningham, JP; Kaufman, MT; Foster, JD; Nuyujukian, P; Ryu, SI; Shenoy, KV				Churchland, Mark M.; Cunningham, John P.; Kaufman, Matthew T.; Foster, Justin D.; Nuyujukian, Paul; Ryu, Stephen I.; Shenoy, Krishna V.			Neural population dynamics during reaching	NATURE			English	Article							OPTIMAL FEEDBACK-CONTROL; MOTOR CORTEX REFLECTS; PREPARATORY ACTIVITY; OUTPUT KINEMATICS; ISOMETRIC-FORCE; ARM MOVEMENTS; PREMOTOR; MUSCLE; DIRECTION; NEURONS	Most theories of motor cortex have assumed that neural activity represents movement parameters. This view derives from what is known about primary visual cortex, where neural activity represents patterns of light. Yet it is unclear how well the analogy between motor and visual cortex holds. Single-neuron responses in motor cortex are complex, and there is marked disagreement regarding which movement parameters are represented. A better analogy might be with other motor systems, where a common principle is rhythmic neural activity. Here we find that motor cortex responses during reaching contain a brief but strong oscillatory component, something quite unexpected for a non-periodic behaviour. Oscillation amplitude and phase followed naturally from the preparatory state, suggesting a mechanistic role for preparatory neural activity. These results demonstrate an unexpected yet surprisingly simple structure in the population response. This underlying structure explains many of the confusing features of individual neural responses.	[Churchland, Mark M.] Columbia Univ, Med Ctr, David Mahoney Ctr, Dept Neurosci,Kavli Inst Brain Sci, New York, NY 10032 USA; [Churchland, Mark M.; Kaufman, Matthew T.; Foster, Justin D.; Ryu, Stephen I.; Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Churchland, Mark M.; Kaufman, Matthew T.; Shenoy, Krishna V.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Cunningham, John P.] Washington Univ St Louis, Dept Biomed Engn, St Louis, MO 63130 USA; [Cunningham, John P.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Nuyujukian, Paul; Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94705 USA; [Nuyujukian, Paul] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Ryu, Stephen I.] Palo Alto Med Fdn, Dept Neurosurg, Palo Alto, CA 94301 USA; [Shenoy, Krishna V.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Columbia University; Stanford University; Stanford University; Washington University (WUSTL); University of Cambridge; Stanford University; Stanford University; Palo Alto Medical Foundation Research Institute; Stanford University	Churchland, MM (corresponding author), Columbia Univ, Med Ctr, David Mahoney Ctr, Dept Neurosci,Kavli Inst Brain Sci, New York, NY 10032 USA.	mc3502@columbia.edu	Kaufman, Matthew T/B-6273-2014; Kaufman, Matthew/AAK-2860-2020	Kaufman, Matthew T/0000-0002-8072-023X; Kaufman, Matthew/0000-0002-8072-023X; Nuyujukian, Paul/0000-0001-7778-5473	Helen Hay Whitney postdoctoral fellowship; National Institutes of Health (NIH); Burroughs Wellcome Fund Career Awards in the Biomedical Sciences; Engineering and Physical Sciences Research Council [EP/H019472/1]; McDonnell Center; National Science Foundation; Texas Instruments Stanford Graduate Fellowship; Paul and Daisy Soros Fellowship; Stanford Medical Scientist Training Program; NIH [1DP1OD006409]; NIH NINDS EUREKA [R01-NS066311]; NIH NINDS BRP [R01-NS064318]; NIH NINDS CRCNS [R01-NS054283]; DARPA-DSO REPAIR [N66001-10-C-2010]; Stanford Center for Integrated Systems; NSF Center for Neuromorphic Systems Engineering at Caltech; Office of Naval Research; Whitaker Foundation; McKnight Foundation; Sloan Foundation; Weston Havens Foundation; EPSRC [EP/H019472/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD075623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054283, R01NS064318] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006409] Funding Source: NIH RePORTER	Helen Hay Whitney postdoctoral fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Awards in the Biomedical Sciences(Burroughs Wellcome Fund); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); McDonnell Center; National Science Foundation(National Science Foundation (NSF)); Texas Instruments Stanford Graduate Fellowship; Paul and Daisy Soros Fellowship; Stanford Medical Scientist Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NINDS EUREKA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NINDS BRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH NINDS CRCNS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DARPA-DSO REPAIR; Stanford Center for Integrated Systems; NSF Center for Neuromorphic Systems Engineering at Caltech(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Whitaker Foundation; McKnight Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Weston Havens Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are deeply grateful to K. Briggman and W. Kristan for providing data recorded from the leech. We thank M. Risch for animal care, S. Eisensee for administrative support, and D. Haven and B. Oskotsky for information technology support. We thank Z. Ghahramani and C. Rasmussen for discussion of jPCA and related methods. We thank D. Sussillo, S. Grossman and M. Sahani for analysis suggestions and commentary on the manuscript. This work was supported by a Helen Hay Whitney postdoctoral fellowship and National Institutes of Health (NIH) postdoctoral training fellowship (M.M.C.), the Burroughs Wellcome Fund Career Awards in the Biomedical Sciences (M.M.C., K.V.S.), Engineering and Physical Sciences Research Council grant EP/H019472/1 and the McDonnell Center (J.P.C.), a National Science Foundation graduate research fellowship (M.T.K.), a Texas Instruments Stanford Graduate Fellowship (J.D.F.), a Paul and Daisy Soros Fellowship (P.N.), the Stanford Medical Scientist Training Program (P.N.), and these awards to K.V.S.: NIH Director's Pioneer Award (1DP1OD006409), NIH NINDS EUREKA Award (R01-NS066311), NIH NINDS BRP (R01-NS064318), NIH NINDS CRCNS (R01-NS054283), DARPA-DSO REPAIR (N66001-10-C-2010), Stanford Center for Integrated Systems, NSF Center for Neuromorphic Systems Engineering at Caltech, Office of Naval Research, and the Whitaker Foundation, the McKnight Foundation, the Sloan Foundation and the Weston Havens Foundation.	Aflalo TN, 2007, J NEUROSCI, V27, P2760, DOI 10.1523/JNEUROSCI.3147-06.2007; Briggman KL, 2006, J NEUROSCI, V26, P10925, DOI 10.1523/JNEUROSCI.3265-06.2006; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Churchland MM, 2006, J NEUROPHYSIOL, V96, P3130, DOI 10.1152/jn.00307.2006; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cisek P, 2006, J NEUROPHYSIOL, V96, P2842, DOI 10.1152/jn.00857.2006; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; FETZ EE, 1992, BEHAV BRAIN SCI, V15, P679; Foster J. D., 2011, P 5 INT IEEE EMBS C, P613; GEORGOPOULOS AP, 1989, SCIENCE, V245, P1209, DOI 10.1126/science.2675307; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gilja V, 2010, CURR OPIN NEUROBIOL, V20, P676, DOI 10.1016/j.conb.2010.06.007; Graziano MSA, 2011, NEURON, V71, P387, DOI 10.1016/j.neuron.2011.07.014; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hatsopoulos NG, 2005, J NEUROPHYSIOL, V94, P2261, DOI 10.1152/jn.00533.2005; Herter TM, 2009, J NEUROPHYSIOL, V101, P150, DOI 10.1152/jn.90230.2008; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kalaska JF, 2009, ADV EXP MED BIOL, V629, P139, DOI 10.1007/978-0-387-77064-2_8; Kaufman MT, 2010, J NEUROPHYSIOL, V104, P799, DOI 10.1152/jn.00231.2009; KRISTAN WB, 1976, J EXP BIOL, V65, P643; Lemon RN, 2008, EXP PHYSIOL, V93, P798, DOI 10.1113/expphysiol.2007.039081; Llinas R, 2002, I VORTEX; Messier J, 2000, J NEUROPHYSIOL, V84, P152, DOI 10.1152/jn.2000.84.1.152; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Miranda H, 2010, IEEE T BIOMED CIRC S, V4, P181, DOI 10.1109/TBCAS.2010.2044573; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Morrow MM, 2009, ADV EXP MED BIOL, V629, P179, DOI 10.1007/978-0-387-77064-2_9; MUSSAIVALDI FA, 1988, NEUROSCI LETT, V91, P106, DOI 10.1016/0304-3940(88)90257-1; Rokni U, 2012, NEURAL COMPUT, V24, P289, DOI 10.1162/NECO_a_00223; SANGER TD, 1994, NEURAL COMPUT, V6, P29, DOI 10.1162/neco.1994.6.1.29; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Scott SH, 2008, J PHYSIOL-LONDON, V586, P1217, DOI 10.1113/jphysiol.2007.146068; Sergio LE, 2005, J NEUROPHYSIOL, V94, P2353, DOI 10.1152/jn.00989.2004; Shenoy K. V., 2011, PROGR BRAIN RES ENHA; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Yakovenko S, 2011, J NEUROPHYSIOL, V105, P388, DOI 10.1152/jn.00469.2010; Yuste R, 2005, NAT REV NEUROSCI, V6, P477, DOI 10.1038/nrn1686	42	680	698	8	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2012	487	7405					51	+		10.1038/nature11129	http://dx.doi.org/10.1038/nature11129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722855	Green Accepted			2022-12-28	WOS:000305982900048
J	Starck, SR; Jiang, VV; Pavon-Eternod, M; Prasad, S; McCarthy, B; Pan, T; Shastri, N				Starck, Shelley R.; Jiang, Vivian; Pavon-Eternod, Mariana; Prasad, Sharanya; McCarthy, Brian; Pan, Tao; Shastri, Nilabh			Leucine-tRNA Initiates at CUG Start Codons for Protein Synthesis and Presentation by MHC Class I	SCIENCE			English	Article							TRANSLATION INITIATION; MESSENGER-RNA; CRYPTIC EPITOPES; DENDRITIC CELLS; READING FRAME; VIRUS; LYMPHOCYTES; COMPLEXES; MOLECULES; PRESSURE	Effective immune surveillance by cytotoxic T cells requires newly synthesized polypeptides for presentation by major histocompatibility complex (MHC) class I molecules. These polypeptides are produced not only from conventional AUG-initiated, but also from cryptic non-AUG-initiated, reading frames by distinct translational mechanisms. Biochemical analysis of ribosomal initiation complexes at CUG versus AUG initiation codons revealed that cells use an elongator leucine-bound transfer RNA (Leu-tRNA) to initiate translation at cryptic CUG start codons. CUG/Leu-tRNA initiation was independent of the canonical initiator tRNA (AUG/Met-tRNA(i)(Met)) pathway but required expression of eukaryotic initiation factor 2A. Thus, a tRNA-based translation initiation mechanism allows non-AUG-initiated protein synthesis and supplies peptides for presentation by MHC class I molecules.	[Starck, Shelley R.; Jiang, Vivian; Prasad, Sharanya; Shastri, Nilabh] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA; [Pavon-Eternod, Mariana; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [McCarthy, Brian] Univ Calif Berkeley, DNA Sequencing Facil, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of Chicago; University of California System; University of California Berkeley	Shastri, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	nshastri@berkeley.edu			NIH; Cancer Research Institute; Ruth Kirschstein NRSA predoctoral fellowship; International AIDS Vaccine Initiative	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Ruth Kirschstein NRSA predoctoral fellowship; International AIDS Vaccine Initiative	We thank K. Collins, A. H. Bakker, K. Chen, N. Nagarajan, and T. Greene for helpful discussions and advice; Y. Ow for initial experiments with NSC119893; and N. Nagarajan and K. Lind for assistance with intravenous injections. The data presented in this paper are tabulated in the main paper and in the supplementary materials. S. R. S. was supported in part by an NIH training grant, a postdoctoral fellowship from the Cancer Research Institute, and a National Research Service Award (NRSA) fellowship from the NIH. M.P.-E was supported by an NIH training grant and by the Ruth Kirschstein NRSA predoctoral fellowship. This research was supported by grants from the NIH to N.S. and T. P. and the International AIDS Vaccine Initiative to N.S. The authors declare no competing financial interests.	ADAMS SL, 1975, J BIOL CHEM, V250, P9083; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bansal A, 2010, J EXP MED, V207, P51, DOI 10.1084/jem.20092060; Berger CT, 2010, J EXP MED, V207, P61, DOI 10.1084/jem.20091808; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dmitriev SE, 2010, J BIOL CHEM, V285, P26779, DOI 10.1074/jbc.M110.119693; Dolstra H, 1999, J EXP MED, V189, P301, DOI 10.1084/jem.189.2.301; Geslain R, 2010, J MOL BIOL, V396, P821, DOI 10.1016/j.jmb.2009.12.018; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jackson RJ, 2001, RNA, V7, P765, DOI 10.1017/S1355838201002539; Kim JH, 2011, EMBO J, V30, P2454, DOI 10.1038/emboj.2011.146; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Kozak M, 1998, NUCLEIC ACIDS RES, V26, P4853, DOI 10.1093/nar/26.21.4853; Lelouard H, 2007, J CELL BIOL, V179, P1427, DOI 10.1083/jcb.200707166; Malarkannan S, 1999, IMMUNITY, V10, P681, DOI 10.1016/S1074-7613(00)80067-9; Maness NJ, 2007, J EXP MED, V204, P2505, DOI 10.1084/jem.20071261; Maness NJ, 2010, J VIROL, V84, P11569, DOI 10.1128/JVI.01419-10; Mayrand SM, 1998, J IMMUNOL, V160, P39; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MERRICK WC, 1975, J BIOL CHEM, V250, P1197; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; Nemeth AL, 2007, FEBS J, V274, P1610, DOI 10.1111/j.1742-4658.2007.05708.x; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; Pestova TV, 2000, CELL MOL LIFE SCI, V57, P651, DOI 10.1007/PL00000726; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Ronsin C, 1999, J IMMUNOL, V163, P483; Schwab SR, 2004, PLOS BIOL, V2, P1774, DOI 10.1371/journal.pbio.0020366; Schwab SR, 2003, SCIENCE, V301, P1367, DOI 10.1126/science.1085650; Sisido M., 2007, CHEM BIOL SMALL MOL, V1, P271; Skabkin MA, 2010, GENE DEV, V24, P1787, DOI 10.1101/gad.1957510; Starck SR, 2011, CELL MOL LIFE SCI, V68, P1471, DOI 10.1007/s00018-011-0655-0; Weinzierl AO, 2008, CANCER RES, V68, P2447, DOI 10.1158/0008-5472.CAN-07-2540	36	146	148	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1719	1723		10.1126/science.1220270	http://dx.doi.org/10.1126/science.1220270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745432				2022-12-28	WOS:000305794500054
J	Metzger, ML; Weinstein, HJ; Hudson, MM; Billett, AL; Larsen, EC; Friedmann, A; Howard, SC; Donaldson, SS; Krasin, MJ; Kun, LE; Marcus, KJ; Yock, TI; Tarbell, N; Billups, CA; Wu, JR; Link, MP				Metzger, Monika L.; Weinstein, Howard J.; Hudson, Melissa M.; Billett, Amy L.; Larsen, Eric C.; Friedmann, Alison; Howard, Scott C.; Donaldson, Sarah S.; Krasin, Matthew J.; Kun, Larry E.; Marcus, Karen J.; Yock, Torunn I.; Tarbell, Nancy; Billups, Catherine A.; Wu, Jianrong; Link, Michael P.			Association Between Radiotherapy vs No Radiotherapy Based on Early Response to VAMP Chemotherapy and Survival Among Children With Favorable-Risk Hodgkin Lymphoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INVOLVED-FIELD RADIOTHERAPY; PEDIATRIC-ONCOLOGY-GROUP; COMBINED-MODALITY TREATMENT; PROSPECTIVE CLINICAL-TRIAL; LONG-TERM SURVIVORS; LOW-DOSE RADIATION; STAGE-I; CHILDHOOD-CANCER; DISEASE; ADOLESCENTS	Context More than 90% of children with favorable-risk Hodgkin lymphoma can achieve long-term survival, yet many will experience toxic effects from radiation therapy. Pediatric oncologists strive for maintaining excellent cure rates while minimizing toxic effects. Objective To evaluate the efficacy of 4 cycles of vinblastine, Adriamycin (doxorubicin), methotrexate, and prednisone(VAMP) in patients with favorable-risk Hodgkin lymphoma who achieve a complete response after 2 cycles and do not receive radiotherapy. Design, Setting, and Patients Multi-institutional, unblinded, nonrandomized single group phase 2 clinical trial to assess the need for radiotherapy based on early response to chemotherapy. Eighty-eight eligible patients with Hodgkin lymphoma stage I and II (<3 nodal sites, no B symptoms, mediastinal bulk, or extranodal extension) enrolled between March 3, 2000, and December 9, 2008. Follow-up data are current to March 12, 2012. Interventions The 47 patients who achieved a complete response after 2 cycles received no radiotherapy, and the 41 with less than a complete response were given 25.5 Gy-involved-field radiotherapy. Main Outcome Measures Two-year event-free survival was the primary outcome measure. A 2-year event-free survival of greater than 90% was desired, and 80% was considered to be unacceptably low. Results Two-year event-free survival was 90.8% (95% CI, 84.7% - 96.9%). For patients who did not require radiotherapy, it was 89.4% (95% CI, 80.8%-98.0%) compared with 92.5% (95% CI, 84.5%-100%) for those who did (P = .61). Most common acute adverse effects were neuropathic pain (2% of patients), nausea or vomiting (3% of patients), neutropenia (32% of cycles), and febrile neutropenia (2% of patients). Nine patients (10%) were hospitalized 11 times (3% of cycles) for febrile neutropenia or nonneutropenic infection. Long-term adverse effects after radiotherapy were asymptomatic compensated hypothyroidism in 9 patients (10%), osteonecrosis and moderate osteopenia in 2 patients each (2%), subclinical pulmonary dysfunction in 12 patients (14%), and asymptomatic left ventricular dysfunction in 4 patients (5%). No second malignant neoplasms were observed. Conclusions Among patients with favorable-risk Hodgkin lymphoma and a complete early response to chemotherapy, the use of limited radiotherapy resulted in a high rate of 2-year event-free survival.	[Metzger, Monika L.; Hudson, Melissa M.; Howard, Scott C.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Krasin, Matthew J.; Kun, Larry E.] St Jude Childrens Res Hosp, Dept Radiol Sci, Memphis, TN 38105 USA; [Billups, Catherine A.; Wu, Jianrong] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Metzger, Monika L.; Hudson, Melissa M.; Howard, Scott C.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Weinstein, Howard J.; Friedmann, Alison] Massachusetts Gen Hosp, Dept Pediat Hematol & Oncol, Boston, MA 02114 USA; [Yock, Torunn I.; Tarbell, Nancy] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Billett, Amy L.] Childrens Hosp Boston, Dept Pediat Oncol, Boston, MA USA; [Marcus, Karen J.] Childrens Hosp Boston, Dept Radiat Oncol, Boston, MA USA; [Billett, Amy L.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Marcus, Karen J.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Larsen, Eric C.] Barbara Bush Childrens Hosp, Maine Med Ctr, Portland, Dorset, England; [Donaldson, Sarah S.] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Link, Michael P.] Dept Pediat Hematol & Oncol, Stanford, CA USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Stanford University; Stanford University	Metzger, ML (corresponding author), 262 Danny Thomas Pl,MS 260, Memphis, TN 38015 USA.	monika.metzger@stjude.org	Krasin, Matthew J/D-4188-2018; Hudson, Melissa M/N-4441-2018; Howard, Scott C/K-3401-2013	Hudson, Melissa M/0000-0001-6984-2407; Howard, Scott C/0000-0003-2244-1686; Donaldson, Sarah/0000-0001-7125-3118	Seattle Genetics; Amgen; Millennium; American Society for Clinical Oncology; St Jude Children's Research Hospital; Pfizer; National Institutes of Health [CA-21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	Seattle Genetics; Amgen(Amgen); Millennium(Takeda Pharmaceutical Company Ltd); American Society for Clinical Oncology; St Jude Children's Research Hospital; Pfizer(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Metzger reported that she has received funding for an international conference unrelated to the study from Seattle Genetics, Amgen, and Millennium. Dr Kun reported that he is a board member for the National Cancer Institute Brain Malignancies steering committee. Dr Link reported that he has received funding for his institution from American Society for Clinical Oncology for his role as president, and from St Jude Children's Research Hospital for patient enrollment on this study and for his roles on the Scientific Advisory Board and Cancer Center Advisory Board. Dr Link reported that he receives support from Seattle Genetics for clinical trial participation (unrelated to this study) and Pfizer (unrelated to this study). No other financial disclosures were reported.; Study supported by grant CA-21765 from the National Institutes of Health Cancer Support Core Grant and the American Lebanese Syrian Associated Charities.	Baez F, 1997, ANN ONCOL, V8, P247, DOI 10.1023/A:1008200210674; Behrendt H, 1996, MED PEDIATR ONCOL, V26, P244, DOI 10.1002/(SICI)1096-911X(199604)26:4<244::AID-MPO4>3.0.CO;2-J; Brepoels L, 2007, LEUKEMIA LYMPHOMA, V48, P1539, DOI 10.1080/10428190701422414; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; CARBONE PP, 1971, CANCER RES, V31, P1860; Castellino SM, 2011, BLOOD, V117, P1806, DOI 10.1182/blood-2010-04-278796; COX DR, 1972, J R STAT SOC B, V34, P187; Donaldson SS, 2007, J CLIN ONCOL, V25, P332, DOI 10.1200/JCO.2006.08.4772; DONALDSON SS, 1987, J CLIN ONCOL, V5, P742, DOI 10.1200/JCO.1987.5.5.742; Donaldson SS, 2002, J CLIN ONCOL, V20, P3081, DOI 10.1200/JCO.2002.12.101; Dorffel W, 2003, KLIN PADIATR, V215, P139; Friedmann AM, 2002, J CLIN ONCOL, V20, P3088, DOI 10.1200/JCO.2002.03.051; GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.2307/2333825; Hakvoort-Cammel FGAJ, 2004, PEDIATR BLOOD CANCER, V43, P8, DOI 10.1002/pbc.20031; HUDSON MM, 1993, J CLIN ONCOL, V11, P100, DOI 10.1200/JCO.1993.11.1.100; Hudson MM, 2004, J CLIN ONCOL, V22, P4541, DOI 10.1200/JCO.2004.02.139; Hudson MM, 1998, J CLIN ONCOL, V16, P3592, DOI 10.1200/JCO.1998.16.11.3592; Hudson MM, 1997, J CLIN ONCOL, V15, P2205, DOI 10.1200/JCO.1997.15.6.2205; HUNGER SP, 1994, J CLIN ONCOL, V12, P2160, DOI 10.1200/JCO.1994.12.10.2160; JACOBS P, 1984, CANCER, V53, P210, DOI 10.1002/1097-0142(19840115)53:2<210::AID-CNCR2820530204>3.0.CO;2-Z; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karayalcin G, 1997, MED PEDIATR ONCOL, V29, P519, DOI 10.1002/(SICI)1096-911X(199712)29:6<519::AID-MPO1>3.0.CO;2-N; Kung FH, 2006, J PEDIAT HEMATOL ONC, V28, P362, DOI 10.1097/00043426-200606000-00008; Landman-Parker J, 2000, J CLIN ONCOL, V18, P1500, DOI 10.1200/JCO.2000.18.7.1500; Mauz-Korholz C, 2007, CANCER-AM CANCER SOC, V110, P179, DOI 10.1002/cncr.22762; Mauz-Korholz C, 2010, J CLIN ONCOL, V28, P3680, DOI 10.1200/JCO.2009.26.9381; Murphy SB, 2003, J PEDIAT HEMATOL ONC, V25, P684, DOI 10.1097/00043426-200309000-00003; Nachman JB, 2002, J CLIN ONCOL, V20, P3765, DOI 10.1200/JCO.2002.12.007; Nogova L, 2005, ANN ONCOL, V16, P1683, DOI 10.1093/annonc/mdi323; OLWENY CLM, 1978, CANCER-AM CANCER SOC, V42, P787, DOI 10.1002/1097-0142(197808)42:2<787::AID-CNCR2820420251>3.0.CO;2-4; Sandoval C, 2002, J PEDIAT HEMATOL ONC, V24, P269, DOI 10.1097/00043426-200205000-00010; Schwartz CL, 2010, 2010 ED BOOK, P391; Straus DJ, 2004, BLOOD, V104, P3483, DOI 10.1182/blood-2004-04-1311; Tebbi CK, 2006, PEDIATR BLOOD CANCER, V46, P198, DOI 10.1002/pbc.20546; vandenBerg H, 1997, ANN ONCOL, V8, P15, DOI 10.1023/A:1008229211885; Weiner MA, 1997, J CLIN ONCOL, V15, P2769, DOI 10.1200/JCO.1997.15.8.2769; Wirth A, 2005, CANCER-AM CANCER SOC, V104, P1221, DOI 10.1002/cncr.21303	37	68	72	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2012	307	24					2609	2616		10.1001/jama.2012.5847	http://dx.doi.org/10.1001/jama.2012.5847			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	964KF	22735430	Green Accepted, Bronze			2022-12-28	WOS:000305692600029
J	Hammar, P; Leroy, P; Mahmutovic, A; Marklund, EG; Berg, OG; Elf, J				Hammar, Petter; Leroy, Prune; Mahmutovic, Anel; Marklund, Erik G.; Berg, Otto G.; Elf, Johan			The lac Repressor Displays Facilitated Diffusion in Living Cells	SCIENCE			English	Article							ESCHERICHIA-COLI-LAC; PROTEIN TRANSLOCATION; OPERATOR INTERACTION; DRIVEN MECHANISMS; TARGET LOCATION; NUCLEIC-ACIDS; IN-VIVO; DNA; SEQUENCE; KINETICS	Transcription factors (TFs) are proteins that regulate the expression of genes by binding sequence-specific sites on the chromosome. It has been proposed that to find these sites fast and accurately, TFs combine one-dimensional (1D) sliding on DNA with 3D diffusion in the cytoplasm. This facilitated diffusion mechanism has been demonstrated in vitro, but it has not been shown experimentally to be exploited in living cells. We have developed a single-molecule assay that allows us to investigate the sliding process in living bacteria. Here we show that the lac repressor slides 45 T 10 base pairs on chromosomal DNA and that sliding can be obstructed by other DNA-bound proteins near the operator. Furthermore, the repressor frequently (>90%) slides over its natural lacO(1) operator several times before binding. This suggests a trade-off between rapid search on nonspecific sequences and fast binding at the specific sequence.	[Hammar, Petter; Leroy, Prune; Mahmutovic, Anel; Marklund, Erik G.; Berg, Otto G.; Elf, Johan] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden	Uppsala University	Elf, J (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden.	johan.elf@icm.uu.se	Marklund, Erik G/G-7480-2012	Marklund, Erik G/0000-0002-9804-5009; elf, johan/0000-0001-5522-1810	European Research Council; Swedish Foundation for Strategic Research (SSF); Swedish Research Council (VR); Goran Gustafssons Stiftelse; EMBO young investigator programme; Knut and Alice Wallenberg Foundation; Centre for Interdisciplinary Mathematics, Uppsala University	European Research Council(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Research Council (VR)(Swedish Research Council); Goran Gustafssons Stiftelse; EMBO young investigator programme(European Molecular Biology Organization (EMBO)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Centre for Interdisciplinary Mathematics, Uppsala University	We are grateful to G.-W. Li, M. Ehrenberg, X. S. Xie, and N. Grantcharova for helpful suggestions and to members of the Elf lab for comments on the manuscript. This work was supported by the European Research Council, the Swedish Foundation for Strategic Research (SSF), the Swedish Research Council (VR), Goran Gustafssons Stiftelse, EMBO young investigator programme, and the Knut and Alice Wallenberg Foundation. A. M. was funded by the Centre for Interdisciplinary Mathematics, Uppsala University.	BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bonnet I, 2008, NUCLEIC ACIDS RES, V36, P4118, DOI 10.1093/nar/gkn376; Czarniecki D, 1997, J BACTERIOL, V179, P423, DOI 10.1128/jb.179.2.423-429.1997; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; HSIEH WT, 1987, J BIOL CHEM, V262, P14583; Jeltsch A, 1996, EMBO J, V15, P5104, DOI 10.1002/j.1460-2075.1996.tb00891.x; KAOHUANG Y, 1977, P NATL ACAD SCI USA, V74, P4228, DOI 10.1073/pnas.74.10.4228; Li GW, 2009, NAT PHYS, V5, P294, DOI 10.1038/NPHYS1222; RICHEY B, 1987, J BIOL CHEM, V262, P7157; RICHTER PH, 1974, BIOPHYS CHEM, V2, P255, DOI 10.1016/0301-4622(74)80050-5; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; RIMSKY S, 1990, BIOCHEMISTRY-US, V29, P3765, DOI 10.1021/bi00467a024; RUUSALA T, 1992, P NATL ACAD SCI USA, V89, P4903, DOI 10.1073/pnas.89.11.4903; Slutsky M, 2004, BIOPHYS J, V87, P4021, DOI 10.1529/biophysj.104.050765; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030	20	284	288	1	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1595	1598		10.1126/science.1221648	http://dx.doi.org/10.1126/science.1221648			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723426				2022-12-28	WOS:000305507500062
J	Rappuoli, R; Dormitzer, PR				Rappuoli, Rino; Dormitzer, Philip R.			Influenza: Options to Improve Pandemic Preparation	SCIENCE			English	Editorial Material							SEASONAL INFLUENZA; YOUNG-CHILDREN; VACCINE; VIRUS; HEMAGGLUTININS; INFECTIONS; CELLS	Science and society have been struggling to find a way to protect humankind from recurring epidemics and pandemics of influenza. Here, we review the options available in the short term and also briefly address the solutions that research may make available in the long term.	[Rappuoli, Rino] Novartis Vaccines & Diagnost, I-53100 Siena, Italy; [Dormitzer, Philip R.] Novartis Vaccines & Diagnost, Cambridge, MA 02139 USA	Novartis; Novartis	Rappuoli, R (corresponding author), Novartis Vaccines & Diagnost, I-53100 Siena, Italy.	rino.rappuoli@novartis.com						CDC, 2009, UPD CDC EST 2009 H1N; CDC, 2012, SEAS INFL FLU VIEW 2; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Collin N, 2009, VACCINE, V27, P5184, DOI 10.1016/j.vaccine.2009.06.034; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Couch RB, 2012, CLIN INFECT DIS, V54, P311, DOI 10.1093/cid/cir809; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Kawaoka Y, 2012, NATURE, V482, P155, DOI 10.1038/nature10884; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Lorbetskie B, 2011, VACCINE, V29, P3377, DOI 10.1016/j.vaccine.2011.02.090; Mustaquim D., 2010, Morbidity and Mortality Weekly Report, V59, P901; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Osterholm MT, 2012, J INFECT DIS, V205, P1636, DOI 10.1093/infdis/jis259; Palese P, 2012, P NATL ACAD SCI USA, V109, P2211, DOI 10.1073/pnas.1121297109; Perez DR, 2012, SCIENCE, V335, P799, DOI 10.1126/science.1219066; Plans-Rubio P, 2012, PREV MED, V55, P72, DOI 10.1016/j.ypmed.2012.02.015; SCHILD GC, 1975, B WORLD HEALTH ORGAN, V52, P223; Vesikari T, 2011, NEW ENGL J MED, V365, P1406, DOI 10.1056/NEJMoa1010331; WHO, 2009, INFL SEAS; Williams TL, 2008, VACCINE, V26, P2510, DOI 10.1016/j.vaccine.2008.03.014; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	23	58	60	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1531	1533		10.1126/science.1221466	http://dx.doi.org/10.1126/science.1221466			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	961ZE	22723412				2022-12-28	WOS:000305507500046
J	Appleby, J				Appleby, John			A productivity challenge too far?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London W1G 0AN, England		Appleby, J (corresponding author), Kings Fund, London W1G 0AN, England.	j.appleby@kingsfund.org.uk						Gainsbury S, 2012, FINANCIAL TIMES 0319	1	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 19	2012	344								e2416	10.1136/bmj.e2416	http://dx.doi.org/10.1136/bmj.e2416			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965CU	22718949				2022-12-28	WOS:000305744600022
J	Miyake, F; Nagaya, K; Masuda, K; Nakamura, T				Miyake, Fusa; Nagaya, Kentaro; Masuda, Kimiaki; Nakamura, Toshio			A signature of cosmic-ray increase in AD 774-775 from tree rings in Japan	NATURE			English	Article							RADIOCARBON AGE CALIBRATION; SOLAR; EVENTS; ICE	Increases in C-14 concentrations in tree rings could be attributed to cosmic-ray events(1-7), as have increases in Be-10 and nitrate in ice cores(8,9). The record of the past 3,000 years in the IntCal09 data set(10), which is a time series at 5-year intervals describing the C-14 content of trees over a period of approximately 10,000 years, shows three periods during which C-14 increased at a rate greater than 3 parts per thousand over 10 years. Two of these periods have been measured at high time resolution, but neither showed increases on a timescale of about 1 year (refs 11 and 12). Here we report C-14 measurements in annual rings of Japanese cedar trees from AD 750 to AD 820 (the remaining period), with 1- and 2-year resolution. We find a rapid increase of about 12 parts per thousand in the C-14 content from AD 774 to 775, which is about 20 times larger than the change attributed to ordinary solar modulation. When averaged over 10 years, the data are consistent with the decadal IntCal C-14 data from North American and European trees(13). We argue that neither a solar flare nor a local supernova is likely to have been responsible.	[Miyake, Fusa; Nagaya, Kentaro; Masuda, Kimiaki] Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Nakamura, Toshio] Nagoya Univ, Ctr Chronol Res, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Miyake, F (corresponding author), Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	fmiyake@stelab.nagoya-u.ac.jp	Masuda, Kimiaki/M-4932-2014		Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [B: 22340144]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Kimura for providing our tree B sample and dating the sample tree rings by dendrochronology. We also thank Y. Itow and Y. Matsubara for commenting on our manuscript. This work was partly supported by Grants-in-Aid for Scientific Research (B: 22340144) provided by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Baker DN, 2005, LECT NOTES PHYS, V656, P3; Brakenridge GR, 2011, ICARUS, V215, P101, DOI 10.1016/j.icarus.2011.06.043; Burrows A, 2000, NATURE, V403, P727, DOI 10.1038/35001501; Cuntz M, 2000, ASTROPHYS J, V533, pL151, DOI 10.1086/312609; Damon PE, 1995, RADIOCARBON, V37, P599, DOI 10.1017/S003382220003109X; Damon PE, 2000, RADIOCARBON, V42, P137, DOI 10.1017/S0033822200053108; Horiuchi K, 2008, QUAT GEOCHRONOL, V3, P253, DOI 10.1016/j.quageo.2008.01.003; Ip WH, 2004, ASTROPHYS J, V602, pL53, DOI 10.1086/382274; Iyudin AF, 1998, NATURE, V396, P142, DOI 10.1038/24106; Katsuda S, 2009, ADV SPACE RES, V43, P895, DOI 10.1016/j.asr.2009.01.004; Konstantinov B. P., 1965, NASACR77812; Lanza AF, 2008, ASTRON ASTROPHYS, V487, P1163, DOI 10.1051/0004-6361:200809753; LaViolette PA, 2011, RADIOCARBON, V53, P303, DOI 10.1017/S0033822200056575; Masarik J, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010557; McCracken KG, 2001, J GEOPHYS RES-SPACE, V106, P21585, DOI 10.1029/2000JA000237; Menjo H, 2005, Proceedings of the 29th International Cosmic Ray Conference, Vol 2: SH3, P357; Motizuki Y, 2009, ANTARCTIC ICE CORE R; NAKAMURA T, 1987, NUCL INSTRUM METH B, V29, P355, DOI 10.1016/0168-583X(87)90264-3; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Sato T, 2008, RADIAT RES, V170, P244, DOI 10.1667/RR1094.1; Schaefer BE, 2000, ASTROPHYS J, V529, P1026, DOI 10.1086/308325; Struck C, 2004, MON NOT R ASTRON SOC, V347, P173, DOI 10.1111/j.1365-2966.2004.07189.x; Stuiver M, 1998, RADIOCARBON, V40, P1127, DOI 10.1017/S0033822200019172; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; Takahashi Y, 2007, P 30 INT COSM RAY C, V1, P673; Telezhinsky I, 2009, ASTROPART PHYS, V31, P431, DOI 10.1016/j.astropartphys.2009.04.007; Usoskin IG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026059; Willson L. A., 2001, Journal of the American Association of Variable Star Observers, V30, P23	29	267	272	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					240	242		10.1038/nature11123	http://dx.doi.org/10.1038/nature11123			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699615				2022-12-28	WOS:000305189000031
J	Won, H; Lee, HR; Gee, HY; Mah, W; Kim, JI; Lee, J; Ha, S; Chung, C; Jung, ES; Cho, YS; Park, SG; Lee, JS; Lee, K; Kim, D; Bae, YC; Kaang, BK; Lee, MG; Kim, E				Won, Hyejung; Lee, Hye-Ryeon; Gee, Heon Yung; Mah, Won; Kim, Jae-Ick; Lee, Jiseok; Ha, Seungmin; Chung, Changuk; Jung, Eun Suk; Cho, Yi Sul; Park, Sae-Geun; Lee, Jung-Soo; Lee, Kyungmin; Kim, Daesoo; Bae, Yong Chul; Kaang, Bong-Kiun; Lee, Min Goo; Kim, Eunjoon			Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function	NATURE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; POSITIVE ALLOSTERIC MODULATOR; POSTSYNAPTIC DENSITY; SYNAPTIC PLASTICITY; SPECTRUM DISORDER; SHANK3; PROTEINS; COMMUNICATION; TRAFFICKING; DYSFUNCTION	Autism spectrum disorder (ASD) is a group of conditions characterized by impaired social interaction and communication, and restricted and repetitive behaviours. ASD is a highly heritable disorder involving various genetic determinants(1). Shank2 (also known as ProSAP1) is a multi-domain scaffolding protein and signalling adaptor enriched at excitatory neuronal synapses(2-4), and mutations in the human SHANK2 gene have recently been associated with ASD and intellectual disability(5). Although ASD-associated genes are being increasingly identified and studied using various approaches, including mouse genetics(6-16), further efforts are required to delineate important causal mechanisms with the potential for therapeutic application. Here we show that Shank2-mutant (Shank2(-/-)) mice carrying a mutation identical to the ASD-associated microdeletion in the human SHANK2 gene exhibit ASD-like behaviours including reduced social interaction, reduced social communication by ultrasonic vocalizations, and repetitive jumping. These mice show a marked decrease in NMDA (N-methyl-D-aspartate) glutamate receptor (NMDAR) function. Direct stimulation of NMDARs with D-cycloserine, a partial agonist of NMDARs, normalizes NMDAR function and improves social interaction in Shank2(-/-) mice. Furthermore, treatment of Shank2(-/-) mice with a positive allosteric modulator of metabotropic glutamate receptor 5 (mGluR5), which enhances NMDAR function via mGluR5 activation(17), also normalizes NMDAR function and markedly enhances social interaction. These results suggest that reduced NMDAR function may contribute to the development of ASD-like phenotypes in Shank2(-/-) mice, and mGluR modulation of NMDARs offers a potential strategy to treat ASD.	[Lee, Hye-Ryeon; Kim, Jae-Ick; Kaang, Bong-Kiun] Seoul Natl Univ, Natl Creat Res Initiat Ctr Memory, Dept Biol Sci, Coll Nat Sci, Seoul 151747, South Korea; [Won, Hyejung; Mah, Won; Lee, Jiseok; Ha, Seungmin; Chung, Changuk; Park, Sae-Geun; Kim, Daesoo; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Won, Hyejung; Mah, Won; Lee, Jiseok; Ha, Seungmin; Chung, Changuk; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea; [Gee, Heon Yung; Jung, Eun Suk; Lee, Jung-Soo; Lee, Min Goo] Yonsei Univ, Dept Pharmacol, Brain Korea Project Med Sci 21, Severance Biomed Sci Inst,Coll Med, Seoul 120752, South Korea; [Cho, Yi Sul; Bae, Yong Chul] Kyungpook Natl Univ, Dept Oral Anat & Neurobiol, Sch Dent, Taegu 700412, South Korea; [Lee, Kyungmin] Kyungpook Natl Univ, Dept Anat, Sch Med, Brain Sci & Engn Inst, Taegu 700412, South Korea; [Kaang, Bong-Kiun] Seoul Natl Univ, Dept Brain & Cognit Sci, Seoul 151747, South Korea; [Kim, Eunjoon] World Class Univ, Grad Sch Nanosci & Technol, Korea Adv Inst Sci & Technol, Taejon 305701, South Korea; [Kim, Eunjoon] Inst for Basic Sci Korea, Ctr Synapt Brain Dysfunct, Taejon 305811, South Korea	Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University Health System; Kyungpook National University; Kyungpook National University; Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Institute for Basic Science - Korea (IBS)	Kaang, BK (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr Memory, Dept Biol Sci, Coll Nat Sci, Gwanangno 599, Seoul 151747, South Korea.	kaang@snu.ac.kr; mlee@yuhs.ac; kime@kaist.ac.kr	Lee, Kyungmin/ABC-5624-2020; Kim, Jae-Ick/AAY-6005-2020; Lee, Min Goo/D-5635-2012; Gee, Heon Yung/K-7781-2019; Kim, Eunjoon/C-1566-2011; Lee, Jiseok/I-9372-2017; Kim, Jae-Ick/R-4007-2017; Kim, Daesoo/C-1625-2011; Lee, Kyungmin/AAH-9165-2020; Lee, Min Goo/AAS-4636-2020	Lee, Kyungmin/0000-0002-5425-4212; Lee, Min Goo/0000-0001-7436-012X; Gee, Heon Yung/0000-0002-8741-6177; Lee, Jiseok/0000-0002-5966-4237; Kim, Jae-Ick/0000-0001-9705-0394; Kim, Daesoo/0000-0001-9915-1463; Lee, Min Goo/0000-0001-7436-012X; Chung, Changuk/0000-0003-3628-6090	National Creative Research Initiative Program [2007-0054846]; WCU [2007-0054846, R31-2008-000-10071-0]; Institute for Basic Science; National Research Foundation of Korea [2012-0000812, 2011-0028240]; National Leading Research Laboratory [2011-0028772]; BK21 fellowship; TJ Park Doctoral Fellowship; National Junior Research Fellowship	National Creative Research Initiative Program(Ministry of Science & Technology (MOST), Republic of Korea); WCU; Institute for Basic Science; National Research Foundation of Korea(National Research Foundation of Korea); National Leading Research Laboratory; BK21 fellowship(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); TJ Park Doctoral Fellowship; National Junior Research Fellowship	We would like to thank Macrogen for assistance in the production of mice. This work was supported by the National Creative Research Initiative Program, WCU program (R31-2008-000-10071-0), and Institute for Basic Science (to E. K.), the National Research Foundation of Korea (to M. G. L.; grant 2012-0000812), the National Creative Research Initiative Program & WCU program (to B.-K.K.; 2007-0054846), the Basic Science Research Program through the National Research Foundation of Korea (to K. L. and Y.C.B.; 2011-0028240), and the National Leading Research Laboratory Program (to D. K.; 2011-0028772). H.-R.L. and J.-I.K. are supported by the BK21 fellowship, and H. W. is supported by the TJ Park Doctoral Fellowship and National Junior Research Fellowship.	Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Ayala JE, 2009, NEUROPSYCHOPHARMACOL, V34, P2057, DOI 10.1038/npp.2009.30; Bangash MA, 2011, CELL, V145, P758, DOI 10.1016/j.cell.2011.03.052; Berkel S, 2012, HUM MOL GENET, V21, P344, DOI 10.1093/hmg/ddr470; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Darrah JM, 2008, BEHAV PHARMACOL, V19, P225, DOI 10.1097/FBP.0b013e3282feb0ac; Ehlers MD, 1999, CURR BIOL, V9, pR848, DOI 10.1016/S0960-9822(00)80043-3; Ehninger D, 2011, TRENDS MOL MED, V17, P78, DOI 10.1016/j.molmed.2010.10.002; Gregory KJ, 2011, NEUROPHARMACOLOGY, V60, P66, DOI 10.1016/j.neuropharm.2010.07.007; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Kinney GG, 2005, J PHARMACOL EXP THER, V313, P199, DOI 10.1124/jpet.104.079244; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Schmeisser M. J, 2012, NATURE          0429; Sheng M, 2000, J CELL SCI, V113, P1851; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Silverman JL, 2011, BRAIN RES, V1380, P120, DOI 10.1016/j.brainres.2010.09.026; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Uslaner JM, 2009, NEUROPHARMACOLOGY, V57, P531, DOI 10.1016/j.neuropharm.2009.07.022; Verpelli C, 2011, J BIOL CHEM, V286, P34839, DOI 10.1074/jbc.M111.258384; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	30	463	484	7	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					261	265		10.1038/nature11208	http://dx.doi.org/10.1038/nature11208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699620				2022-12-28	WOS:000305189000036
J	Zouboulis, CC; Liakou, AI				Zouboulis, Christos C.; Liakou, Aikaterini I.			Flashing, Pulsating Angioma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zouboulis, Christos C.; Liakou, Aikaterini I.] Dessau Med Ctr, Dessau, Germany	Dessau Medical Center	Zouboulis, CC (corresponding author), Dessau Med Ctr, Dessau, Germany.		Zouboulis, Christos C./I-4493-2013	Zouboulis, Christos C./0000-0003-1646-2608					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2012	366	24					E36	E36						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	957PD	22694018				2022-12-28	WOS:000305174100012
J	Meurer, WJ; Lewis, RJ; Berry, DA				Meurer, William J.; Lewis, Roger J.; Berry, Donald A.			Adaptive Clinical Trials A Partial Remedy for the Therapeutic Misconception?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Meurer, William J.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Meurer, William J.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, Los Angeles, CA USA; [Berry, Donald A.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77230 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Texas System; UTMD Anderson Cancer Center	Berry, DA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biostat 1409, POB 301402, Houston, TX 77230 USA.	dberry@mdanderson.org	Meurer, William J/A-7547-2010	Meurer, William J/0000-0002-1158-5302	NINDS NIH HHS [U01NS073476] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS073476] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berry DA, 2011, J CLIN ONCOL, V29, P606, DOI 10.1200/JCO.2010.32.2685; Cairns CB, 2010, ANN EMERG MED, V56, P538, DOI 10.1016/j.annemergmed.2010.05.029; Henderson GE, 2007, PLOS MED, V4, P1735, DOI 10.1371/journal.pmed.0040324; Hu FF, 2003, J AM STAT ASSOC, V98, P671, DOI 10.1198/016214503000000576; Kasner SE, 2011, ANN EMERG MED, V57, P346, DOI 10.1016/j.annemergmed.2010.07.009; Locock L, 2011, CLIN TRIALS, V8, P85, DOI 10.1177/1740774510392257; Robinson EJ, 2004, SOC SCI MED, V58, P811, DOI 10.1016/S0277-9536(03)00255-7; Vist GE, 2005, BMJ-BRIT MED J, V330, P1175, DOI 10.1136/bmj.330.7501.1175	8	52	53	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 13	2012	307	22					2377	2378		10.1001/jama.2012.4174	http://dx.doi.org/10.1001/jama.2012.4174			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	956UX	22692168				2022-12-28	WOS:000305115900020
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Screening for and Management of Obesity in Adults: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							LIFE-STYLE	Description: Update of the 2003 U. S. Preventive Services Task Force (USPSTF) recommendation statement on screening for obesity and overweight in adults. Methods: The USPSTF reviewed new evidence on the benefits and harms of screening and primary care-feasible or referable nonsurgical weight-loss interventions. Recommendation: The USPSTF recommends screening all adults for obesity. Clinicians should offer or refer patients with a body mass index of 30 kg/m(2) or higher to intensive, multicomponent behavioral interventions (B recommendation).	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.				USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.; Dr. Moyer: Consulting fee or honorarium: USPSTF. Support for travel to meetings for the study or other purposes: USPSTF. Disclosure forms from USPSTF members can be viewed at www. acponline.org/authors/icmje/ConflictOfInterestForms.do? msNum = M12- 1323.	American Academy of Family Physicians, 2003, OBESITY; [Anonymous], 2011, Obstet Gynecol, V117, P1008, DOI 10.1097/AOG.0b013e318219226e; [Anonymous], 2007, GUID WOM HLTH CAR RE; Berg AO, 2003, ANN INTERN MED, V139, P930, DOI 10.7326/0003-4819-139-11-200312020-00012; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lau DCW, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.061409; LeBlanc E, 2011, PUBLICATION AGENCY H; LeBlanc ES, 2011, ANN INTERN MED, V155, P434, DOI 10.7326/0003-4819-155-7-201110040-00006; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; U.S. Food and Drug Administration, 2010, FDA DRUG SAF COMM CO; U.S. Food and Drug Administration, 2010, QUEST ANSW ORL SEV L; Weir MA, 2011, ARCH INTERN MED, V171, P703, DOI 10.1001/archinternmed.2011.103	15	370	381	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2012	157	5					373	U126		10.7326/0003-4819-157-5-201209040-00475	http://dx.doi.org/10.7326/0003-4819-157-5-201209040-00475			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000BM	22733087				2022-12-28	WOS:000308361500007
J	Birchall, M; Hamilton, G				Birchall, Martin; Hamilton, George			Tissue-engineered vascular replacements for children	LANCET			English	Editorial Material							GRAFTS; INDUSTRY		[Birchall, Martin] UCL, UCL Ear Inst, London WC1X 8DA, England; [Birchall, Martin] UCL, UCL Ctr Stem Cells & Regenerat Med, London WC1X 8DA, England; [Birchall, Martin; Hamilton, George] Royal Free Hampstead NHS Fdn Trust, UCL Div Surg, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust	Birchall, M (corresponding author), UCL, UCL Ear Inst, London WC1X 8DA, England.	martinbirchall@btinternet.com	hamilton, george/K-4764-2013		MRC [G1001539] Funding Source: UKRI; Medical Research Council [G1001539] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Brindley DA, 2011, CELL STEM CELL, V9, P397, DOI 10.1016/j.stem.2011.10.010; de Mel A, 2009, BIO-MED MATER ENG, V19, P317, DOI 10.3233/BME-2009-0597; Hibino N, 2012, J THORAC CARDIOV SUR, V143, P696, DOI 10.1016/j.jtcvs.2011.06.046; Hibino N, 2011, FASEB J, V25, P2731, DOI 10.1096/fj.11-182246; Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057; Klinkert P, 2003, J VASC SURG, V37, P149, DOI 10.1067/mva.2002.86; Lowdell MW, LANCET IN PRESS; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; McManus R, ATALA SURVEYS SUCCES; Olausson M, 2012, LANCET, V380, P230, DOI 10.1016/S0140-6736(12)60633-3; Plagnol AC, 2009, REGEN MED, V4, P549, DOI 10.2217/RME.09.21	11	8	8	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 21	2012	380	9838					197	198		10.1016/S0140-6736(12)60817-4	http://dx.doi.org/10.1016/S0140-6736(12)60817-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	976TV	22704551				2022-12-28	WOS:000306609200009
J	Grant, J; Mahadevaiah, SK; Khil, P; Sangrithi, MN; Royo, H; Duckworth, J; McCarrey, JR; VandeBerg, JL; Renfree, MB; Taylor, W; Elgar, G; Camerini-Otero, RD; Gilchrist, MJ; Turner, JMA				Grant, Jennifer; Mahadevaiah, Shantha K.; Khil, Pavel; Sangrithi, Mahesh N.; Royo, Helene; Duckworth, Janine; McCarrey, John R.; VandeBerg, John L.; Renfree, Marilyn B.; Taylor, Willie; Elgar, Greg; Camerini-Otero, R. Daniel; Gilchrist, Mike J.; Turner, James M. A.			Rsx is a metatherian RNA with Xist-like properties in X-chromosome inactivation	NATURE			English	Article							PRIMORDIAL GERM-CELLS; DOSAGE COMPENSATION; MOUSE; GENE; METHYLATION; EXPRESSION; MAMMALS	In female (XX) mammals, one of the two X chromosomes is inactivated to ensure an equal dose of X-linked genes with males (XY)(1). X-chromosome inactivation in eutherian mammals is mediated by the non-coding RNA Xist(2). Xist is not found in metatherians(3) (marsupials), and how X-chromosome inactivation is initiated in these mammals has been the subject of speculation for decades(4). Using the marsupial Monodelphis domestica, here we identify Rsx (RNA-on-the-silent X), an RNA that has properties consistent with a role in X-chromosome inactivation. Rsx is a large, repeat-rich RNA that is expressed only in females and is transcribed from, and coats, the inactive X chromosome. In female germ cells, in which both X chromosomes are active, Rsx is silenced, linking Rsx expression to X-chromosome inactivation and reactivation. Integration of an Rsx transgene on an autosome in mouse embryonic stem cells leads to gene silencing in cis. Our findings permit comparative studies of X-chromosome inactivation in mammals and pose questions about the mechanisms by which X-chromosome inactivation is achieved in eutherians.	[Grant, Jennifer; Mahadevaiah, Shantha K.; Sangrithi, Mahesh N.; Royo, Helene; Taylor, Willie; Elgar, Greg; Gilchrist, Mike J.; Turner, James M. A.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Khil, Pavel; Camerini-Otero, R. Daniel] NIDDKD, NIH, Bethesda, MD 20892 USA; [Duckworth, Janine] Landcare Res Manaaki Whenua, Pest Control Technol Grp, Lincoln 7640, New Zealand; [McCarrey, John R.] Univ Texas San Antonio, San Antonio, TX 78249 USA; [VandeBerg, John L.] Texas Biomed Res Inst, San Antonio, TX 78227 USA; [Renfree, Marilyn B.] Univ Melbourne, Dept Zool, Victoria 3010, Australia	MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Landcare Research - New Zealand; University of Texas System; University of Texas at San Antonio (UTSA); Texas Biomedical Research Institute; University of Melbourne	Turner, JMA (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	jturner@nimr.mrc.ac.uk		Sangrithi, Mahesh/0000-0002-0008-4588; Elgar, Greg/0000-0001-7323-1596; Renfree, Marilyn/0000-0002-4589-0436; Khil, Pavel/0000-0002-4903-8777	Medical Research Council (MRC) [U117588498, U117597141, U117581331, U117597137]; NIH [HD60858]; Robert J. Kleberg Jr and Helen C. Kleberg Foundation; New Zealand Foundation for Research, Science and Technology, Possum Biocontrol [C10X0501]; Australian National Health and Medical Research Council [1010453]; NIDDK (NIH); MRC [MC_U117597141, MC_U117597137] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052035] Funding Source: NIH RePORTER; Medical Research Council [MC_U117597137, MC_U117597141] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert J. Kleberg Jr and Helen C. Kleberg Foundation; New Zealand Foundation for Research, Science and Technology, Possum Biocontrol(New Zealand Foundation for Research, Science and Technology); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NIDDK (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. Bell and R. Lovell-Badge for advice on the characterisation of Rsx, J. Cloutier and G. Polikiewicz for help with germ-cell preparations and quantitative PCR, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Genomics core (National Institutes of Health, NIH) for RNA sequencing, A. Toth for the HORMAD1 antibody, the Biological and Procedural Services units at the National Institute for Medical Research (NIMR) for animal husbandry and Rsx transgenesis, and J. Cocquet, L. Reynard, H. Byers and members of the Turner and P. Burgoyne laboratories for reading of the manuscript. This work was supported by the Medical Research Council (MRC) (U117588498, U117597141, U117581331, U117597137), the NIH (HD60858), the Robert J. Kleberg Jr and Helen C. Kleberg Foundation, the New Zealand Foundation for Research, Science and Technology, Possum Biocontrol (C10X0501), the Australian National Health and Medical Research Council (1010453) and the NIDDK (NIH) Intramural Research Program.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Chaumeil J, 2004, METHOD ENZYMOL, V376, P405; Chaumeil J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019040; Lopes SMCD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040030; de Napoles M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000860; Deakin JE, 2009, CHROMOSOME RES, V17, P671, DOI 10.1007/s10577-009-9058-6; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Herzing LBK, 1997, NATURE, V386, P272, DOI 10.1038/386272a0; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lyon MF, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/59746; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mahadevaiah SK, 2009, CURR BIOL, V19, P1478, DOI 10.1016/j.cub.2009.07.041; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Namekawa SH, 2010, MOL CELL BIOL, V30, P3187, DOI 10.1128/MCB.00227-10; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rens W, 2010, P NATL ACAD SCI USA, V107, P17657, DOI 10.1073/pnas.0910322107; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Royo H, 2010, CURR BIOL, V20, P2117, DOI 10.1016/j.cub.2010.11.010; SHARMAN GB, 1971, NATURE, V230, P231, DOI 10.1038/230231a0; Sharov AA, 2009, DNA RES, V16, P261, DOI 10.1093/dnares/dsp014; Straub T, 2007, NAT REV GENET, V8, P47, DOI 10.1038/nrg2013; Sugimoto M, 2007, PLOS GENET, V3, P1309, DOI 10.1371/journal.pgen.0030116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	38	103	110	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2012	487	7406					254	U1511		10.1038/nature11171	http://dx.doi.org/10.1038/nature11171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	972LP	22722828	Green Accepted			2022-12-28	WOS:000306278900044
J	Shirayama, M; Seth, M; Lee, HC; Gu, WF; Ishidate, T; Conte, D; Mello, CC				Shirayama, Masaki; Seth, Meetu; Lee, Heng-Chi; Gu, Weifeng; Ishidate, Takao; Conte, Darryl, Jr.; Mello, Craig C.			piRNAs Initiate an Epigenetic Memory of Nonself RNA in the C. elegans Germline	CELL			English	Article							DOUBLE-STRANDED-RNA; SILENCING PATHWAYS; INTERFERENCE; GENE; ARGONAUTE; PIWI; LINE; POLYMERASE; EXPRESSION; PROTEINS	Organisms employ a fascinating array of strategies to silence invasive nucleic acids such as transposons and viruses. Although evidence exists for several pathways that detect foreign sequences, including pathways that sense copy number, unpaired DNA, or aberrant RNA (e.g., dsRNA), in many cases, the mechanisms used to distinguish "self" from "nonself" nucleic acids remain mysterious. Here, we describe an RNA-induced epigenetic silencing pathway that permanently silences single-copy transgenes. We show that the Piwi Argonaute PRG-1 and its genomically encoded piRNA cofactors initiate permanent silencing, and maintenance depends on chromatin factors and the WAGO Argonaute pathway. Our findings support a model in which PRG-1 scans for foreign sequences and two other Argonaute pathways serve as epigenetic memories of "self" and "nonself" RNAs. These findings suggest how organisms can utilize RNAi-related mechanisms to detect foreign sequences not by any molecular signature, but by comparing the foreign sequence to a memory of previous gene expression.	[Shirayama, Masaki; Seth, Meetu; Lee, Heng-Chi; Gu, Weifeng; Ishidate, Takao; Conte, Darryl, Jr.; Mello, Craig C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Shirayama, Masaki; Ishidate, Takao; Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	craig.mello@umassmed.edu		Lee, Heng-Chi/0000-0001-8154-906X	Ruth L. Kirschstein National Research Service Award [GM099372]; NIH [GM058800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099372, R37GM058800, R01GM058800] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kirsten Hagstrom and Anna Zinovyeva for primer information, technical advice on ChIP experiments, and helpful discussion. We are grateful to the members of the Mello lab for input and discussion, Sandra Vergara for help with genetic studies, William Stanney III for technical help, and Elaine Youngman and Colin Conine for advice on figure presentation. Some strains used in this study were obtained from the Caenorhabditis Genetic Center. H.-C.L. is supported by a Ruth L. Kirschstein National Research Service Award (GM099372). C.C.M. is a Howard Hughes Medical Institute Investigator and is supported by NIH grant GM058800.	Alcazar RM, 2008, GENETICS, V180, P1275, DOI 10.1534/genetics.108.089433; Antonovics J, 2011, ANN NY ACAD SCI, V1230, P12, DOI 10.1111/j.1749-6632.2011.06127.x; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Aravin AA, 2008, COLD SH Q B, V73, P283, DOI 10.1101/sqb.2008.73.058; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bagijn M.P., 2012, SCIENCE; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bessler JB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000830; Birchler James A., 2003, P23; Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; BRENNER S, 1974, GENETICS, V77, P71; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Couteau F, 2002, EMBO REP, V3, P235, DOI 10.1093/embo-reports/kvf051; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; Dernburg AF, 2000, GENE DEV, V14, P1578; Erhard KF, 2011, CURR OPIN PLANT BIOL, V14, P210, DOI 10.1016/j.pbi.2011.02.005; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grentzinger T, 2012, GENOME RES; Grishok A, 2005, GENE DEV, V19, P683, DOI 10.1101/gad.1247705; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Johnson CL, 2011, SCIENCE, V333, P1311, DOI 10.1126/science.1208178; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kelly WG, 1998, DEVELOPMENT, V125, P2451; Kelly WG, 1997, GENETICS, V146, P227; Kelly WG, 2002, DEVELOPMENT, V129, P479; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lin RL, 2003, DEV BIOL, V258, P226, DOI 10.1016/S0012-1606(03)00119-2; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Murray NE, 2002, MICROBIOL-SGM, V148, P3, DOI 10.1099/00221287-148-1-3; Nakamura K, 2005, GENE DEV, V19, P1749, DOI 10.1101/gad.1323705; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Parrish S, 2001, RNA, V7, P1397; Praitis Vida, 2006, V351, P93; Rieckher Matthias, 2009, Methods Mol Biol, V561, P21, DOI 10.1007/978-1-60327-019-9_2; Robert VJP, 2004, COLD SPRING HARB SYM, V69, P397, DOI 10.1101/sqb.2004.69.397; Rulicke T, 2000, EXP PHYSIOL, V85, P589, DOI 10.1017/S0958067000020923; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	66	377	387	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 6	2012	150	1					65	77		10.1016/j.cell.2012.06.015	http://dx.doi.org/10.1016/j.cell.2012.06.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	970GB	22738726	Bronze, Green Accepted			2022-12-28	WOS:000306115000007
J	Hines, PJ; Zahn, LM				Hines, Pamela J.; Zahn, Laura M.			Green Pathways INTRODUCTION	SCIENCE			English	Editorial Material																			0	3	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1657	1657		10.1126/science.336.6089.1657	http://dx.doi.org/10.1126/science.336.6089.1657			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	965VD	22745416				2022-12-28	WOS:000305794500035
J	Greider, CW				Greider, Carol W.			Wnt Regulates TERT-Putting the Horse Before the Cart	SCIENCE			English	Editorial Material							TELOMERASE; TARGET		Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University	Greider, CW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 603 PCTB,725 N Wolfe St, Baltimore, MD 21205 USA.	cgreider@jhmi.edu						Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Bilsland AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006459; Blackburn EH, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003558; Broccoli D, 1996, MOL CELL BIOL, V16, P3765; Buseman CM, 2012, MUTAT RES-FUND MOL M, V730, P90, DOI 10.1016/j.mrfmmm.2011.07.006; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Mizumoto K, 2001, AM J GASTROENTEROL, V96, P1261; Mukherjee S, 2011, P NATL ACAD SCI USA, V108, pE1363, DOI 10.1073/pnas.1112414108; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Strong MA, 2011, MOL CELL BIOL, V31, P2369, DOI 10.1128/MCB.05312-11; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vidal-Cardenas SL, 2010, NUCLEIC ACIDS RES, V38, P60, DOI 10.1093/nar/gkp855; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769	15	27	28	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1519	1520		10.1126/science.1223785	http://dx.doi.org/10.1126/science.1223785			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723405				2022-12-28	WOS:000305507500039
J	Hashimoto, K; Cho, K; Shibauchi, T; Kasahara, S; Mizukami, Y; Katsumata, R; Tsuruhara, Y; Terashima, T; Ikeda, H; Tanatar, MA; Kitano, H; Salovich, N; Giannetta, RW; Walmsley, P; Carrington, A; Prozorov, R; Matsuda, Y				Hashimoto, K.; Cho, K.; Shibauchi, T.; Kasahara, S.; Mizukami, Y.; Katsumata, R.; Tsuruhara, Y.; Terashima, T.; Ikeda, H.; Tanatar, M. A.; Kitano, H.; Salovich, N.; Giannetta, R. W.; Walmsley, P.; Carrington, A.; Prozorov, R.; Matsuda, Y.			A Sharp Peak of the Zero-Temperature Penetration Depth at Optimal Composition in BaFe2(As1-xPx)(2)	SCIENCE			English	Article							SUPERCONDUCTIVITY; CROSSOVER; BCS	In a superconductor, the ratio of the carrier density, n, to its effective mass, m*, is a fundamental property directly reflecting the length scale of the superfluid flow, the London penetration depth, lambda(L). In two-dimensional systems, this ratio n/m* (similar to 1/lambda(2)(L)) determines the effective Fermi temperature, T-F. We report a sharp peak in the x-dependence of lambda(L) at zero temperature in clean samples of BaFe2(As1-xPx)(2) at the optimum composition x = 0.30, where the superconducting transition temperature T-c reaches a maximum of 30 kelvin. This structure may arise from quantum fluctuations associated with a quantum critical point. The ratio of T-c/T-F at x = 0.30 is enhanced, implying a possible crossover toward the Bose-Einstein condensate limit driven by quantum criticality.	[Hashimoto, K.; Shibauchi, T.; Kasahara, S.; Mizukami, Y.; Katsumata, R.; Tsuruhara, Y.; Ikeda, H.; Matsuda, Y.] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Cho, K.; Tanatar, M. A.; Prozorov, R.] Ames Lab, Ames, IA USA; [Cho, K.; Prozorov, R.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Kasahara, S.; Terashima, T.] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Kyoto 6068501, Japan; [Kitano, H.] Aoyama Gakuin Univ, Dept Math & Phys, Chuo Ku, Sagamihara, Kanagawa 2525258, Japan; [Salovich, N.; Giannetta, R. W.] Univ Illinois, Loomis Lab Phys, Urbana, IL 61801 USA; [Walmsley, P.; Carrington, A.] Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England	Kyoto University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University; Kyoto University; Aoyama Gakuin University; University of Illinois System; University of Illinois Urbana-Champaign; University of Bristol	Shibauchi, T (corresponding author), Kyoto Univ, Dept Phys, Kyoto 6068502, Japan.	shibauchi@scphys.kyoto-u.ac.jp; matsuda@scphys.kyoto-u.ac.jp	Hiroaki, Ikeda/F-2635-2018; Matsuda, Yuji/ABH-7166-2020; Hashimoto, Kenichiro/C-4925-2012; Mizukami, Yuta/AAG-9991-2019; Kasahara, Shigeru/H-3064-2014; Shibauchi, Takasada/B-9349-2008; Prozorov, Ruslan/A-2487-2008	Matsuda, Yuji/0000-0001-9947-9418; Hashimoto, Kenichiro/0000-0003-4651-4077; Mizukami, Yuta/0000-0002-3881-331X; Kasahara, Shigeru/0000-0002-6007-9617; Shibauchi, Takasada/0000-0001-5831-4924; Prozorov, Ruslan/0000-0002-8088-6096; Carrington, Antony/0000-0001-8624-6148; Ikeda, Hiroaki/0000-0002-9258-9478; Walmsley, Philip/0000-0001-8225-7990	Ministry of Education, Culture, Sports, Science and Technology of Japan; KAKENHI from Japan Society for the Promotion of Science; Engineering and Physical Sciences Research Council (UK); U.S. Department of Energy, Basic Energy Sciences, Materials Science and Engineering Division [DE-AC02-07CH11358]; Center for Emergent Superconductivity; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC0298CH1088]; EPSRC [EP/H025855/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H025855/1] Funding Source: researchfish; Grants-in-Aid for Scientific Research [23654118] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI from Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); U.S. Department of Energy, Basic Energy Sciences, Materials Science and Engineering Division(United States Department of Energy (DOE)); Center for Emergent Superconductivity; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank R. M. Fernandes, S. Kivelson, H. Kontani, Q. Si, U. Welp, and Y. Yanase for valuable discussion. Supported by Grant-in-Aid for the Global Centers of Excellence program "The Next Generation of Physics, Spun from Universality and Emergence," Grant-in-Aid for Scientific Research on Innovative Areas "Heavy Electrons" from the Ministry of Education, Culture, Sports, Science and Technology of Japan, KAKENHI from Japan Society for the Promotion of Science, and the Engineering and Physical Sciences Research Council (UK). Work at the Ames Laboratory was supported by the U.S. Department of Energy, Basic Energy Sciences, Materials Science and Engineering Division, under contract no. DE-AC02-07CH11358. Work at the University of Illinois was supported by the Center for Emergent Superconductivity, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award no. DE-AC0298CH1088.	Broun DM, 2008, NAT PHYS, V4, P170, DOI 10.1038/nphys909; Bud'ko SL, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.220516; Chaparro C., 2011, DOPING DEPENDENCE SP; Chen QJ, 2005, PHYS REP, V412, P1, DOI 10.1016/j.physrep.2005.02.005; Dai JH, 2009, P NATL ACAD SCI USA, V106, P4118, DOI 10.1073/pnas.0900886106; DEMELO CARS, 1993, PHYS REV LETT, V71, P3202, DOI 10.1103/PhysRevLett.71.3202; Fernandes RM, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.014521; Gordon RT, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.054507; Hashimoto K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.220501; Hirschfeld PJ, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124508; Kasahara S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.184519; LEGGETT AJ, 1965, PHYS REV, V140, P1869, DOI 10.1103/PhysRev.140.A1869; Luan L, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.067001; Moon EG, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.035117; Nakai Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.107003; Norman MR, 2005, ADV PHYS, V54, P715, DOI [10.1080/00018730500459906, 10.1080/00018730500489906]; Panagopoulos C, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.064501; Prozorov R, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124505; Sachdev S, 2011, PHYS TODAY, V64, P29, DOI 10.1063/1.3554314; Shishido H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.057008; Stewart GR, 2011, REV MOD PHYS, V83, P1589, DOI 10.1103/RevModPhys.83.1589; Uemura YJ, 2009, PHYSICA B, V404, P3195, DOI 10.1016/j.physb.2009.07.110; Uemura YJ, 2004, J PHYS-CONDENS MAT, V16, pS4515, DOI 10.1088/0953-8984/16/40/007; VARMA CM, 1986, PHYS REV LETT, V57, P626, DOI 10.1103/PhysRevLett.57.626; Yamashita M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.060507; Zaanen J, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.212502	29	234	235	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1554	1557		10.1126/science.1219821	http://dx.doi.org/10.1126/science.1219821			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723416	Green Submitted			2022-12-28	WOS:000305507500050
J	Herfst, S; Schrauwen, EJA; Linster, M; Chutinimitkul, S; de Wit, E; Munster, VJ; Sorrell, EM; Bestebroer, TM; Burke, DF; Smith, DJ; Rimmelzwaan, GF; Osterhaus, ADME; Fouchier, RAM				Herfst, Sander; Schrauwen, Eefje J. A.; Linster, Martin; Chutinimitkul, Salin; de Wit, Emmie; Munster, Vincent J.; Sorrell, Erin M.; Bestebroer, Theo M.; Burke, David F.; Smith, Derek J.; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.			Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets	SCIENCE			English	Article							PATHOGENIC AVIAN INFLUENZA; TO-PERSON TRANSMISSION; A VIRUS; H5N1 VIRUS; RECEPTOR SPECIFICITY; MEDIATED SELECTION; HEMAGGLUTININ; HOST; INFECTION; MODEL	Highly pathogenic avian influenza A/H5N1 virus can cause morbidity and mortality in humans but thus far has not acquired the ability to be transmitted by aerosol or respiratory droplet ("airborne transmission") between humans. To address the concern that the virus could acquire this ability under natural conditions, we genetically modified A/H5N1 virus by site-directed mutagenesis and subsequent serial passage in ferrets. The genetically modified A/H5N1 virus acquired mutations during passage in ferrets, ultimately becoming airborne transmissible in ferrets. None of the recipient ferrets died after airborne infection with the mutant A/H5N1 viruses. Four amino acid substitutions in the host receptor-binding protein hemagglutinin, and one in the polymerase complex protein basic polymerase 2, were consistently present in airborne-transmitted viruses. The transmissible viruses were sensitive to the antiviral drug oseltamivir and reacted well with antisera raised against H5 influenza vaccine strains. Thus, avian A/H5N1 influenza viruses can acquire the capacity for airborne transmission between mammals without recombination in an intermediate host and therefore constitute a risk for human pandemic influenza.	[Herfst, Sander; Schrauwen, Eefje J. A.; Linster, Martin; Chutinimitkul, Salin; de Wit, Emmie; Munster, Vincent J.; Sorrell, Erin M.; Bestebroer, Theo M.; Smith, Derek J.; Rimmelzwaan, Guus F.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Burke, David F.; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge, England; [Smith, Derek J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Erasmus University Rotterdam; Erasmus MC; University of Cambridge; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Fouchier, RAM (corresponding author), Erasmus MC, Dept Virol, Rotterdam, Netherlands.	r.fouchier@erasmusmc.nl	Linster, Martin/AAY-9088-2020; Burke, David F/C-2091-2013; Smith, Derek/Z-3075-2019; Munster, Vincent/I-7607-2018; Fouchier, Ron A/A-1911-2014; de Wit, Emmie/A-1549-2019	Burke, David F/0000-0001-8830-3951; Smith, Derek/0000-0002-2393-1890; Munster, Vincent/0000-0002-2288-3196; Fouchier, Ron A/0000-0001-8095-2869; de Wit, Emmie/0000-0002-9763-7758; Osterhaus, Albert/0000-0002-6074-1172; Herfst, Sander/0000-0001-9866-8903; Linster, Martin/0000-0003-2636-2512	NIAID-NIH [HHSN266200700010C]; NIH Director's Pioneer Award [DP1-OD000490-01]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant; European Union FP7 program EMPERIE [223498]; Human Frontier Science Program [P0050/2008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001179] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER	NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant; European Union FP7 program EMPERIE; Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. de Meulder, G. van Amerongen, and D. Akkermans for technical assistance. M. Peiris, Univ. of Hong Kong, provided A/Indonesia/5/2005 with permission from I. Kandun of the Indonesian government. This work was financed through NIAID-NIH contract HHSN266200700010C. D.J.S. and D.F.B. were supported in part by NIH Director's Pioneer Award DP1-OD000490-01. We acknowledge a Nederlandse Organisatie voor Wetenschappelijk Onderzoek VICI grant, European Union FP7 program EMPERIE (223498), and Human Frontier Science Program grant P0050/2008. D.F.B. and D.J.S. acknowledge the use of the CamGrid distributed computing resource. Sequence data generated from this study were deposited in GenBank with accession numbers CY116643 to CY116698. Special arrangements are in place with the NIH and the contractor at Mount Sinai School of Medicine, New York, for sharing the viruses (and plasmids) in the present paper; please contact R.A.M.F. A.D.M. E.O. and G.F.R. are CSO and part-time employee of ViroClinics Biosciences BV. A.D.M.E.O. has advisory affiliations on behalf of Viroclinics Biosciences BV with GlaxoSmithKline, Novartis, and Roche. A.D.M.E.O. and R.A.M.F. are holders of certificates of shares in ViroClinics Biosciences B.V. To avoid any possible conflict of interests, Erasmus MC policy dictates that the shares as such are held by the Stichting Administratiekantoor Erasmus Personeelsparticipaties. The board of this foundation is appointed by the Board of Governors of the Erasmus MC and exercises all voting rights with regard to these shares.	Alexander DJ, 2009, REV SCI TECH OIE, V28, P19, DOI 10.20506/rst.28.1.1856; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bataille A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002094; Bodewes R, 2011, J VIROL, V85, P2695, DOI 10.1128/JVI.02371-10; Bodewes R, 2011, AM J PATHOL, V179, P30, DOI 10.1016/j.ajpath.2011.03.026; Brown IH, 2009, INFLUENZA OTHER RESP, V3, P59, DOI 10.1111/j.1750-2659.2009.00078.x; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; Conenello GM, 2007, CELL HOST MICROBE, V2, P207, DOI 10.1016/j.chom.2007.09.010; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Costa T, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-28; de Wit E, 2008, VACCINE, V26, pD54, DOI 10.1016/j.vaccine.2008.07.072; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; DEOM CM, 1986, P NATL ACAD SCI USA, V83, P3771, DOI 10.1073/pnas.83.11.3771; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fouchier RAM, 2012, SCIENCE, V335, P662, DOI 10.1126/science.1218376; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Jonges M, 2011, J VIROL, V85, P10598, DOI 10.1128/JVI.05369-11; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; Kreijtz JHCM, 2009, VACCINE, V27, P4983, DOI 10.1016/j.vaccine.2009.05.079; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; MirShekari SY, 1997, J BIOL CHEM, V272, P4027, DOI 10.1074/jbc.272.7.4027; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2; Palese P., 2007, FIELDS VIROLOGY, V3, P1647; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; Rudneva IA, 2005, J GEN VIROL, V86, P2831, DOI 10.1099/vir.0.81185-0; Schrauwen EJA, 2012, J VIROL, V86, P3975, DOI 10.1128/JVI.06828-11; Smith W, 1933, LANCET, V2, P66, DOI 10.1016/S0140-6736(00)78541-2; Sorrell EM, 2011, CURR OPIN VIROL, V1, P635, DOI 10.1016/j.coviro.2011.07.003; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; WEBSTER RG, 1987, CELL, V50, P665, DOI 10.1016/0092-8674(87)90321-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wright P. F., 2007, FIELDS VIROLOGY, V3, P1691; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	56	1124	1174	17	389	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1534	1541		10.1126/science.1213362	http://dx.doi.org/10.1126/science.1213362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723413	Green Accepted			2022-12-28	WOS:000305507500047
J	Callaway, E				Callaway, Ewen			EVOLUTIONARY BIOLOGY The lost appetites	NATURE			English	Editorial Material																		Campbell MC, 2012, MOL BIOL EVOL, V29, P1141, DOI 10.1093/molbev/msr293; Fisher RA, 1939, NATURE, V144, P750, DOI 10.1038/144750a0; Imai H, 2012, BIOL LETTERS, V8, P652, DOI 10.1098/rsbl.2011.1251; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Wooding S, 2006, NATURE, V440, P930, DOI 10.1038/nature04655; Zhao HB, 2012, GENOME BIOL EVOL, V4, P73, DOI 10.1093/gbe/evr126	7	9	9	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					S16	S17		10.1038/486S16a	http://dx.doi.org/10.1038/486S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	046RB	22717398				2022-12-28	WOS:000311781000009
J	Jones, DS; Podolsky, SH; Greene, JA				Jones, David S.; Podolsky, Scott H.; Greene, Jeremy A.			200TH ANNIVERSARY ARTICLE The Burden of Disease and the Changing Task of Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AMERICA		[Jones, David S.; Podolsky, Scott H.; Greene, Jeremy A.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Podolsky, Scott H.] Brigham & Womens Hosp, Ctr History Med, Countway Lib Med, Boston, MA 02115 USA; [Greene, Jeremy A.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Jones, David S.; Greene, Jeremy A.] Harvard Univ, Dept History Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University	Jones, DS (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02115 USA.							Brandt Allan M., 1987, NO MAGIC BULLET SOCI; Kleinman A., 1980, PATIENTS HEALERS CON; Marmot M., 2004, STATUS SYNDROME, DOI 10.1111/J.1740-9713.2004.00058.X; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; ROSENBERG CE, 1986, MILBANK Q, V64, P34, DOI 10.2307/3350040; Rosenberg CE, 2002, MILBANK Q, V80, P237, DOI 10.1111/1468-0009.t01-1-00003	6	171	175	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					2333	2338		10.1056/NEJMp1113569	http://dx.doi.org/10.1056/NEJMp1113569			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961GH	22716973	Green Submitted			2022-12-28	WOS:000305451700001
J	Vannier, E; Krause, PJ				Vannier, Edouard; Krause, Peter J.			CURRENT CONCEPTS Human Babesiosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRANSFUSION-ASSOCIATED BABESIOSIS; HUMAN GRANULOCYTIC EHRLICHIOSIS; NECROSIS-FACTOR-ALPHA; NEW-YORK-STATE; NANTUCKET-ISLAND; LYME-DISEASE; MOLECULAR CHARACTERIZATION; MICROTI INFECTION; GAMMA-INTERFERON; T-CELLS		[Vannier, Edouard] Tufts Med Ctr, Dept Med, Boston, MA USA; [Vannier, Edouard] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Krause, Peter J.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Krause, Peter J.] Yale Univ, Sch Med, New Haven, CT 06520 USA	Tufts Medical Center; Tufts University; Yale University; Yale University	Krause, PJ (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol & Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.	peter.krause@yale.edu			Gordon and Llura Gund Foundation; National Institutes of Health [R01 AG019781, R21 AI088079]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019781] Funding Source: NIH RePORTER	Gordon and Llura Gund Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the Gordon and Llura Gund Foundation (to Drs. Krause and Vannier) and the National Institutes of Health (R01 AG019781, to Dr. Vannier; and R21 AI088079, to Dr. Krause).	Aguilar-Delfin I, 2003, INFECT IMMUN, V71, P2002, DOI 10.1128/IAI.71.4.2002-2008.2003; Allred DR, 2003, TRENDS PARASITOL, V19, P51, DOI 10.1016/S1471-4922(02)00065-X; [Anonymous], 2009, BIOL PROD HEM CELL T; Asad S, 2009, TRANSFUSION, V49, P2564, DOI 10.1111/j.1537-2995.2009.02380.x; Babes V, 1888, CR HEBD ACAD SCI, V107, P692; Beattie JF, 2002, NEW ENGL J MED, V347, P697, DOI 10.1056/NEJM200208293470921; Bloch EM, 2011, TRANSFUSION     1213; Bonnet S, 2007, EMERG INFECT DIS, V13, P1208, DOI 10.3201/eid1308.061560; Brown RN, 2005, TICK-BORNE DISEASES OF HUMANS, P363; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; Clawson ML, 2002, INFECT IMMUN, V70, P5304, DOI 10.1128/IAI.70.9.5304-5306.2002; Committee on Lyme Disease and Other Tick-Borne Diseases, 2011, STAT SCI CRIT NEEDS; Conrad PA, 2006, INT J PARASITOL, V36, P779, DOI 10.1016/j.ijpara.2006.03.008; Cullen G, 2010, INFLAMM BOWEL DIS, V16, P1269, DOI 10.1002/ibd.21158; Dao AH, 1996, LAB INVEST, V74, P853; DESFORGES JF, 1976, NEW ENGL J MED, V295, P103, DOI 10.1056/NEJM197607082950211; DesVignes F, 1997, J MED ENTOMOL, V34, P379, DOI 10.1093/jmedent/34.4.379; El-Bahnasawy Mamdouh M., 2011, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V41, P99; Falagas ME, 1996, CLIN INFECT DIS, V22, P809, DOI 10.1093/clinids/22.5.809; Fish D, 2009, VECTOR-BORNE ZOONOT, V9, P357, DOI 10.1089/vbz.2009.0022; Fox LAM, 2006, PEDIATR INFECT DIS J, V25, P169, DOI 10.1097/01.inf.0000195438.09628.b0; Froberg MK, 2008, ANN CLIN LAB SCI, V38, P390; Fujisawa K, 2011, JPN J INFECT DIS, V64, P403; Goethert HK, 2003, PARASITOLOGY, V127, P301, DOI 10.1017/S0031182003003822; Gorenflot A, 1998, ANN TROP MED PARASIT, V92, P489, DOI 10.1080/00034989859465; Gray J, 2010, TICKS TICK-BORNE DIS, V1, P3, DOI 10.1016/j.ttbdis.2009.11.003; Gubernot DM, 2009, TRANSFUSION, V49, P2759, DOI 10.1111/j.1537-2995.2009.02429.x; Gubernot DM, 2009, CLIN INFECT DIS, V48, P25, DOI 10.1086/595010; Haselbarth K, 2007, INT J MED MICROBIOL, V297, P197, DOI 10.1016/j.ijmm.2007.01.002; Hatcher JC, 2001, CLIN INFECT DIS, V32, P1117, DOI 10.1086/319742; Hayes EB, 2003, NEW ENGL J MED, V348, P2424, DOI 10.1056/NEJMra021397; Hemmer RM, 2000, J PARASITOL, V86, P736; Hemmer RM, 2000, PARASITOL RES, V86, P121, DOI 10.1007/s004360050021; Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362; Herwaldt BL, 2004, EMERG INFECT DIS, V10, P622, DOI 10.3201/eid1004.030377; Herwaldt BL, 2003, EMERG INFECT DIS, V9, P942; Herwaldt BL, 1996, ANN INTERN MED, V124, P643, DOI 10.7326/0003-4819-124-7-199604010-00004; Hildebrandt A, 2007, EUR J CLIN MICROBIOL, V26, P595, DOI 10.1007/s10096-007-0333-1; Hunfeld KP, 2008, INT J PARASITOL, V38, P1219, DOI 10.1016/j.ijpara.2008.03.001; IGARASHI I, 1994, J PROTOZOOL RES, V4, P164; JACOBY GA, 1980, NEW ENGL J MED, V303, P1098, DOI 10.1056/NEJM198011063031906; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Joseph JT, 2011, EMERG INFECT DIS, V17, P843, DOI 10.3201/eid1705.101334; Kim JY, 2007, J CLIN MICROBIOL, V45, P2084, DOI 10.1128/JCM.01334-06; Kjemtrup AM, 2000, INT J PARASITOL, V30, P1323, DOI 10.1016/S0020-7519(00)00137-5; Krause PJ, 2007, TRENDS PARASITOL, V23, P605, DOI 10.1016/j.pt.2007.09.005; Krause PJ, 2008, CLIN INFECT DIS, V46, P370, DOI 10.1086/525852; Krause PJ, 2003, AM J TROP MED HYG, V68, P431, DOI 10.4269/ajtmh.2003.68.431; KRAUSE PJ, 1994, J INFECT DIS, V169, P923, DOI 10.1093/infdis/169.4.923; Krause PJ, 1996, JAMA-J AM MED ASSOC, V275, P1657, DOI 10.1001/jama.275.21.1657; Krause PJ, 1996, J CLIN MICROBIOL, V34, P2014, DOI 10.1128/JCM.34.8.2014-2016.1996; Krause PJ, 1996, J CLIN MICROBIOL, V34, P2791, DOI 10.1128/JCM.34.11.2791-2794.1996; Krause PJ, 2000, NEW ENGL J MED, V343, P1454, DOI 10.1056/NEJM200011163432004; Krause PJ, 1998, NEW ENGL J MED, V339, P160, DOI 10.1056/NEJM199807163390304; Krause PJ, 2002, CLIN INFECT DIS, V34, P1184, DOI 10.1086/339813; Leiby DA, 2011, ANN INTERN MED, V155, P556, DOI 10.7326/0003-4819-155-8-201110180-00363; Leiby DA, 2011, CLIN MICROBIOL REV, V24, P14, DOI 10.1128/CMR.00022-10; LEVINE ND, 1988, J PROTOZOOL, V35, P518, DOI 10.1111/j.1550-7408.1988.tb04141.x; Lobo CA, 2012, CURR OPIN HEMATOL, V19, P170, DOI 10.1097/MOH.0b013e328352245a; Lubina AS, 2011, LEUKEMIA RES, V35, pE77, DOI 10.1016/j.leukres.2010.11.029; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; MELDRUM SC, 1992, CLIN INFECT DIS, V15, P1019, DOI 10.1093/clind/15.6.1019; Otsuka Y, 2002, J VET MED SCI, V64, P221, DOI 10.1292/jvms.64.221; Perkins HA, 2010, TRANSFUSION, V50, P2080, DOI 10.1111/j.1537-2995.2010.02851.x; PERSING DH, 1995, NEW ENGL J MED, V332, P298, DOI 10.1056/NEJM199502023320504; Ríos Leonardo, 2003, Rev. Soc. Bras. Med. Trop., V36, P493, DOI 10.1590/S0037-86822003000400010; RUDZINSKA M, 1984, PROTISTOLOGICA, V20, P649; RUEBUSH TK, 1977, ANN INTERN MED, V86, P6, DOI 10.7326/0003-4819-86-1-6; RUEBUSH TK, 1981, AM J TROP MED HYG, V30, P291, DOI 10.4269/ajtmh.1981.30.291; RUEBUSH TK, 1977, NEW ENGL J MED, V297, P825, DOI 10.1056/NEJM197710132971511; Ryan R, 2001, CLIN DIAGN LAB IMMUN, V8, P1177, DOI 10.1128/CDLI.8.6.1177-1180.2001; Senanayake SN, 2012, MED J AUSTRALIA, V196, P350, DOI 10.5694/mja11.11378; Shaio MF, 1998, AM J TROP MED HYG, V58, P335, DOI 10.4269/ajtmh.1998.58.335; Shih CM, 1997, J CLIN MICROBIOL, V35, P450, DOI 10.1128/JCM.35.2.450-454.1997; Skrabalo Z., 1957, Documenta de Medicina Geographica et Tropica, V9, P11; Smith T, 1893, BUREAU ANIMAL IND B, P177; Spaete J, 2009, J CLIN APHERESIS, V24, P97, DOI 10.1002/jca.20197; SPIELMAN A, 1976, AM J TROP MED HYG, V25, P784, DOI 10.4269/ajtmh.1976.25.784; SPIELMAN A, 1985, ANNU REV ENTOMOL, V30, P439, DOI 10.1146/annurev.en.30.010185.002255; Stafford 3rd KC, 2007, TICK MANAGEMENT HDB, P1; Stowell CP, 2007, NEW ENGL J MED, V356, P2313, DOI 10.1056/NEJMcpc079011; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Taiwo B, 2007, ARTHRIT RHEUM-ARTHR, V57, P179, DOI 10.1002/art.22479; Teal AE, 2012, J CLIN MICROBIOL, V50, P903, DOI 10.1128/JCM.05848-11; Telford SR, 2004, PARASITOLOGY, V129, pS301, DOI 10.1017/S0031182003004669; Tokarz R, 2010, VECTOR-BORNE ZOONOT, V10, P217, DOI 10.1089/vbz.2009.0036; Tonnetti L, 2009, TRANSFUSION, V49, P2557, DOI 10.1111/j.1537-2995.2009.02317.x; Vannier E, 2004, J INFECT DIS, V189, P1721, DOI 10.1086/382965; Vannier E, 2008, INFECT DIS CLIN N AM, V22, P469, DOI 10.1016/j.idc.2008.03.010; Vazquez M, 2008, EMERG INFECT DIS, V14, P210, DOI 10.3201/eid1402.070725; Wei Q, 2001, J CLIN MICROBIOL, V39, P2178, DOI 10.1128/JCM.39.6.2178-2183.2001; Weiss LM, 2001, NEW ENGL J MED, V344, P773; WESTERN KA, 1970, NEW ENGL J MED, V283, P854, DOI 10.1056/NEJM197010152831607; White DJ, 1998, ARCH INTERN MED, V158, P2149, DOI 10.1001/archinte.158.19.2149; WITTNER M, 1982, ANN INTERN MED, V96, P601, DOI 10.7326/0003-4819-96-5-601; Wormser GP, 2007, CLIN INFECT DIS, V45, P941, DOI 10.1086/522848; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2010, CLIN INFECT DIS, V50, P381, DOI 10.1086/649859; Yokoyama N, 2006, VET PARASITOL, V138, P22, DOI 10.1016/j.vetpar.2006.01.037; Young C, 2012, TRANSFUSION     0327; Young C, 2009, TRANSFUSION, V49, P2548, DOI 10.1111/j.1537-2995.2009.02494.x	101	367	400	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					2397	2407		10.1056/NEJMra1202018	http://dx.doi.org/10.1056/NEJMra1202018			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961GH	22716978				2022-12-28	WOS:000305451700009
J	Jepsen, P; Ott, P; Andersen, PK; Sorensen, HT; Vilstrup, H				Jepsen, Peter; Ott, Peter; Andersen, Per Kragh; Sorensen, Henrik Toft; Vilstrup, Hendrik			Risk for Hepatocellular Carcinoma in Patients With Alcoholic Cirrhosis A Danish Nationwide Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							LIVER-CIRRHOSIS; CLINICAL-COURSE; CANCER; POPULATION; HEPATITIS; SURVEILLANCE; SURVIVAL; QUALITY; HCV	Background: Patients with alcoholic cirrhosis are at higher risk for hepatocellular carcinoma (HCC). The role of HCC surveillance for these patients is undefined. Objective: To provide population-based estimates of HCC incidence and comparisons of HCC-related mortality and total mortality among patients with alcoholic cirrhosis as a basis for assessing the role of HCC surveillance. Design: Nationwide, registry-based, historical cohort study. Setting: Denmark. Patients: All Danish citizens with a first-time hospital diagnosis of alcoholic cirrhosis from 1993 to 2005. Measurements: Hepatocellular carcinoma incidence and mortality starting 1 year after diagnosis of alcoholic cirrhosis through 2009; ratio of HCC-related mortality to total mortality. Results: Among 8482 patients, 169 developed HCC. A total of 5734 patients died, 151 of whom had developed HCC. Five-year cumulative HCC risk was 1.0% (95% CI, 0.8% to 1.3%), and 5-year cumulative mortality was 43.7% (CI, 42.6% to 44.7%). Only 1.8% of all deaths were HCC-related. In sensitivity analyses that included all possible HCC diagnoses and a subpopulation of patients who were followed by hepatologists, the highest 5-year HCC risk was 1.9% (CI, 0.8% to 3.9%). These patients did not have higher mortality than patients in the nationwide cohort. Limitation: Cirrhosis and HCC diagnoses were made by hospital physicians without uniform clinical criteria, and use of registry data precluded detailed information on clinical care of patients, including HCC surveillance. Conclusion: Danish patients with alcoholic cirrhosis have a low risk for HCC, and HCC contributes little to their high mortality. On the basis of these data, HCC surveillance would be expected to have a minimal effect on mortality and is unlikely to be cost-effective.	[Jepsen, Peter] Aarhus Univ Hosp, Dept Hepatogastroenterol, DK-8000 Aarhus C, Denmark; Univ Copenhagen, Copenhagen, Denmark	Aarhus University; University of Copenhagen	Jepsen, P (corresponding author), Aarhus Univ Hosp, Dept Hepatogastroenterol, Norrebrogade 44, DK-8000 Aarhus C, Denmark.	pj@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Jepsen, Peter/0000-0002-6641-1430				ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Andersen TF, 1999, DAN MED BULL, V46, P263; Alvarez MA, 2011, J CLIN GASTROENTEROL, V45, P906, DOI 10.1097/MCG.0b013e3182284e13; Braillon A, 2010, HEPATOLOGY, V52, P1863, DOI 10.1002/hep.23780; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Dans LF, 2011, J CLIN EPIDEMIOL, V64, P231, DOI 10.1016/j.jclinepi.2010.09.009; del Olmo JA, 1998, J CANCER RES CLIN, V124, P560, DOI 10.1007/s004320050215; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Fleming K, 2010, HEPATOLOGY, V52, p913A; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Ioannou GN, 2007, CLIN GASTROENTEROL H, V5, P938, DOI 10.1016/j.cgh.2007.02.039; Jepsen P, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-3; Jepsen P, 2010, HEPATOLOGY, V51, P1675, DOI 10.1002/hep.23500; Kuper H, 2001, HEPATOLOGY, V34, P714, DOI 10.1053/jhep.2001.28233; N'Kontchou G, 2006, CLIN GASTROENTEROL H, V4, P1062, DOI 10.1016/j.cgh.2006.05.013; Olsen J, 1999, SCAND J PUBLIC HEALT, V27, P78, DOI 10.1177/14034948990270010601; Omland LH, 2010, J HEPATOL, V53, P36, DOI 10.1016/j.jhep.2010.01.033; POOLE C, 1987, AM J PUBLIC HEALTH, V77, P195, DOI 10.2105/AJPH.77.2.195; Poustchi H, 2011, HEPATOLOGY, V54, P1998, DOI 10.1002/hep.24581; R Development Core Team, 2009, R LANG ENV STAT COMP; Sangiovanni A, 2011, HEPATOLOGY, V54, P1898, DOI 10.1002/hep.24684; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Sherman M, 2011, CLIN LIVER DIS, V15, P323, DOI 10.1016/j.cld.2011.03.003; Sola R, 2006, LIVER INT, V26, P62, DOI 10.1111/j.1478-3231.2005.01181.x; Sorensen HT, 1998, HEPATOLOGY, V28, P921, DOI 10.1002/hep.510280404; Storm HH, 1997, DAN MED BULL, V44, P535; Torisu Y, 2007, HEPATOL RES, V37, P517, DOI 10.1111/j.1872-034X.2007.00077.x; Toshikuni N, 2009, J GASTROEN HEPATOL, V24, P1276, DOI 10.1111/j.1440-1746.2009.05851.x; Trichopoulos D, 2011, JNCI-J NATL CANCER I, V103, P1686, DOI 10.1093/jnci/djr395; Uetake S, 2003, ALCOHOL CLIN EXP RES, V27, p47S, DOI 10.1097/01.ALC.0000079449.47468.B0; Vestberg K, 1997, J Med Syst, V21, P11, DOI 10.1023/A:1022835207287; Yang JD, 2012, CLIN GASTROENTEROL H, V10, P16, DOI 10.1016/j.cgh.2011.06.004; Yang JD, 2011, CLIN GASTROENTEROL H, V9, P617, DOI 10.1016/j.cgh.2011.03.027	35	77	78	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12					841	U1		10.7326/0003-4819-156-12-201206190-00004	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711076				2022-12-28	WOS:000307783200013
J	Rodseth, R; Devereaux, PJ				Rodseth, Reitze; Devereaux, P. J.			Review: Perioperative statins reduce perioperative MI and AF in statin- naive patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							FLUVASTATIN; SURGERY		[Rodseth, Reitze; Devereaux, P. J.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Rodseth, R (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Rodseth, Reitze/B-2471-2010; Devereaux, PJ/AAY-1757-2021; Rodseth, Reitze Nils/N-5008-2013; Devereaux, PJ/AAF-2862-2019	Rodseth, Reitze/0000-0002-3779-7805; 				Committee for the Investigation of Scientific Integrity, 2012, INV POSS VIOL SCI IN; Dunkelgrun M, 2009, ANN SURG, V249, P921, DOI 10.1097/SLA.0b013e3181a77d00; Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388; Schouten O, 2009, NEW ENGL J MED, V361, P980, DOI 10.1056/NEJMoa0808207	4	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12							JC6-2	10.7326/0003-4819-156-12-201206190-02002	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711103				2022-12-28	WOS:000307783200001
J	Braunschweig, H; Dewhurst, RD; Hammond, K; Mies, J; Radacki, K; Vargas, A				Braunschweig, Holger; Dewhurst, Rian D.; Hammond, Kai; Mies, Jan; Radacki, Krzysztof; Vargas, Alfredo			Ambient-Temperature Isolation of a Compound with a Boron-Boron Triple Bond	SCIENCE			English	Article							PERTURBATION-THEORY; PI-BOND; CHEMISTRY; SYSTEMS; REDUCTION; MOLECULE; DIBORENE; ADDUCTS; ANALOG; AR	Homoatomic triple bonds between main-group elements have been restricted to alkynes, dinitrogen, and a handful of reactive compounds featuring trans-bent heavier elements of groups 13 and 14. Previous attempts to prepare a compound with a boron-boron triple bond that is stable at ambient temperature have been unsuccessful, despite numerous computational studies predicting their viability. We found that reduction of a bis(N-heterocyclic carbene)-stabilized tetrabromodiborane with either two or four equivalents of sodium naphthalenide, a one-electron reducing agent, yields isolable diborene and diboryne compounds. Crystallographic and spectroscopic characterization confirm that the latter is a halide-free linear system containing a boron-boron triple bond.	[Braunschweig, Holger; Dewhurst, Rian D.; Hammond, Kai; Mies, Jan; Radacki, Krzysztof; Vargas, Alfredo] Univ Wurzburg, Inst Anorgan Chem, D-97074 Wurzburg, Germany	University of Wurzburg	Braunschweig, H (corresponding author), Univ Wurzburg, Inst Anorgan Chem, D-97074 Wurzburg, Germany.	h.braunschweig@uni-wuerzburg.de	Vargas, Alfredo/N-6711-2015; Dewhurst, Rian D/B-7062-2009; Braunschweig, Holger/W-8600-2019	Vargas, Alfredo/0000-0001-7491-791X; Dewhurst, Rian D/0000-0001-5978-811X; Braunschweig, Holger/0000-0001-9264-1726; Radacki, Krzysztof/0000-0003-3088-6327	Deutsche Forschungsgemeinschaft [BR 1149/13-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft grant BR 1149/13-1. Crystallographic data have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication nos. 868974 (5) and 868975 (6). These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif.	Braunschweig H, 2006, ANGEW CHEM INT EDIT, V45, P162, DOI 10.1002/anie.200502825; Braunschweig H, 2010, SCIENCE, V328, P345, DOI 10.1126/science.1186028; Cheeseman JR, 1996, J CHEM PHYS, V104, P5497, DOI 10.1063/1.471789; DITCHFIELD R, 1974, MOL PHYS, V27, P789, DOI 10.1080/00268977400100711; Ducati LC, 2009, J PHYS CHEM A, V113, P11693, DOI 10.1021/jp902780t; Entwistle CD, 2002, ANGEW CHEM INT EDIT, V41, P2927, DOI 10.1002/1521-3773(20020816)41:16<2927::AID-ANIE2927>3.0.CO;2-L; Fischer RC, 2010, CHEM REV, V110, P3877, DOI 10.1021/cr100133q; Grigsby WJ, 1996, CHEM COMMUN, P2235, DOI 10.1039/cc9960002235; Grigsby WJ, 1997, CHEM-EUR J, V3, P368; Hardman NJ, 2003, J AM CHEM SOC, V125, P2667, DOI 10.1021/ja028579j; Hardman NJ, 2002, ANGEW CHEM INT EDIT, V41, P2842, DOI 10.1002/1521-3773(20020802)41:15<2842::AID-ANIE2842>3.0.CO;2-O; Holzmann N, 2011, CHEM-EUR J, V17, P13517, DOI 10.1002/chem.201101915; KELLER W, 1992, CHEM BER-RECL, V125, P2343, DOI 10.1002/cber.19921251102; KLUSIK H, 1981, ANGEW CHEM INT EDIT, V20, P870, DOI 10.1002/anie.198108701; Li SD, 2008, J AM CHEM SOC, V130, P2573, DOI 10.1021/ja0771080; London F, 1937, J PHYS-PARIS, V8, P397, DOI 10.1051/jphysrad:01937008010039700; MCWEENY R, 1962, PHYS REV, V126, P1028, DOI 10.1103/PhysRev.126.1028; Mitoraj MP, 2011, INORG CHEM, V50, P2168, DOI 10.1021/ic101576g; MOEZZI A, 1992, ANGEW CHEM INT EDIT, V31, P1082, DOI 10.1002/anie.199210821; MOEZZI A, 1992, J AM CHEM SOC, V114, P2715, DOI 10.1021/ja00033a054; NOTH H, 1981, CHEM BER-RECL, V114, P398, DOI 10.1002/cber.19811140143; PAETZOLD P, 1982, CHEM BER-RECL, V115, P2819, DOI 10.1002/cber.19821150813; PAETZOLD P, 1979, CHEM BER-RECL, V112, P3811, DOI 10.1002/cber.19791121207; Papakondylis A, 2004, J PHYS CHEM A, V108, P4335, DOI 10.1021/jp031308q; POWER PP, 1992, INORG CHIM ACTA, V198, P443, DOI 10.1016/S0020-1693(00)92388-0; Steffen A, 2010, COORDIN CHEM REV, V254, P1950, DOI 10.1016/j.ccr.2010.03.002; Wang Y, 2007, J AM CHEM SOC, V129, P12412, DOI 10.1021/ja075932i; Wang YZ, 2011, INORG CHEM, V50, P12326, DOI 10.1021/ic200675u; Wang YZ, 2009, CHEM COMMUN, P5201, DOI 10.1039/b908048a; WOLINSKI K, 1990, J AM CHEM SOC, V112, P8251, DOI 10.1021/ja00179a005; Wright RJ, 2006, ANGEW CHEM INT EDIT, V45, P5953, DOI 10.1002/anie.200601925; Zhou MF, 2002, J AM CHEM SOC, V124, P12936, DOI 10.1021/ja026257+	32	388	388	9	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1420	1422		10.1126/science.1221138	http://dx.doi.org/10.1126/science.1221138			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700924				2022-12-28	WOS:000305211700039
J	Charlesworth, JD; Warren, TL; Brainard, MS				Charlesworth, Jonathan D.; Warren, Timothy L.; Brainard, Michael S.			Covert skill learning in a cortical-basal ganglia circuit	NATURE			English	Article							FOREBRAIN CIRCUIT; BIRDSONG; MODEL; VARIABILITY; PERFORMANCE; MECHANISMS; REWARD; SIGNAL; SONG	We learn complex skills such as speech and dance through a gradual process of trial and error. Cortical-basal ganglia circuits have an important yet unresolved function in this trial-and-error skill learning(1); influential 'actor-critic' models propose that basal ganglia circuits generate a variety of behaviours during training and learn to implement the successful behaviours in their repertoire(2,3). Here we show that the anterior forebrain pathway (AFP), a cortical-basal ganglia circuit(4), contributes to skill learning even when it does not contribute to such 'exploratory' variation in behavioural performance during training. Blocking the output of the AFP while training Bengalese finches to modify their songs prevented the gradual improvement that normally occurs in this complex skill during training. However, unblocking the output of the AFP after training caused an immediate transition from naive performance to excellent performance, indicating that the AFP covertly gained the ability to implement learned skill performance without contributing to skill practice. In contrast, inactivating the output nucleus of the AFP during training completely prevented learning, indicating that learning requires activity within the AFP during training. Our results suggest a revised model of skill learning: basal ganglia circuits can monitor the consequences of behavioural variation produced by other brain regions and then direct those brain regions to implement more successful behaviours. The ability of the AFP to identify successful performances generated by other brain regions indicates that basal ganglia circuits receive a detailed efference copy of premotor activity in those regions. The capacity of the AFP to implement successful performances that were initially produced by other brain regions indicates precise functional connections between basal ganglia circuits and the motor regions that directly control performance.	[Charlesworth, Jonathan D.; Warren, Timothy L.; Brainard, Michael S.] Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA; [Charlesworth, Jonathan D.; Warren, Timothy L.; Brainard, Michael S.] Univ Calif San Francisco, Neurosci Grad Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Charlesworth, JD (corresponding author), Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA.	jcharles@phy.ucsf.edu		Brainard, Michael/0000-0002-9425-9907; Warren, Timothy/0000-0002-4429-4106	National Institutes of Health [NIDCD R01]; National Institute of Mental Health [P50]; National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank L. Frank, A. Doupe, M. Stryker and D. Mets for discussion and comments on the manuscript. This work was supported by National Institutes of Health grant NIDCD R01 and National Institute of Mental Health grant P50. J.D.C. and T. L. W. were supported by National Science Foundation graduate fellowships.	Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Atallah HE, 2007, NAT NEUROSCI, V10, P126, DOI 10.1038/nn1817; Balleine BW, 2007, ANN NY ACAD SCI, V1104, P147, DOI 10.1196/annals.1390.006; Charlesworth JD, 2011, NAT NEUROSCI, V14, P373, DOI 10.1038/nn.2748; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; Doya Kenji, 2000, P469; Fee MS, 2011, NEUROSCIENCE, V198, P152, DOI 10.1016/j.neuroscience.2011.09.069; Fiete IR, 2007, J NEUROPHYSIOL, V98, P2038, DOI 10.1152/jn.01311.2006; Frank MJ, 2011, CURR OPIN NEUROBIOL, V21, P381, DOI 10.1016/j.conb.2011.02.013; Goldberg JH, 2012, NAT NEUROSCI, V15, P620, DOI 10.1038/nn.3047; Hampton CM, 2009, J NEUROPHYSIOL, V101, P3235, DOI 10.1152/jn.91089.2008; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Houk JC, 1995, MODELS INFORMATION P, P249; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Mooney R, 2009, LEARN MEMORY, V16, P655, DOI 10.1101/lm.1065209; Olveczky BP, 2011, J NEUROPHYSIOL, V106, P386, DOI 10.1152/jn.00018.2011; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Sober SJ, 2008, J NEUROSCI, V28, P10370, DOI 10.1523/JNEUROSCI.2448-08.2008; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; Vates GE, 1997, J COMP NEUROL, V380, P275; Warren TL, 2011, J NEUROPHYSIOL, V106, P1806, DOI 10.1152/jn.00311.2011	28	73	74	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					251	+		10.1038/nature11078	http://dx.doi.org/10.1038/nature11078			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699618	Green Accepted, Green Submitted			2022-12-28	WOS:000305189000034
J	Quigley, S; Colledge, J; Patel, S; Gayed, W				Quigley, Shaun; Colledge, Jonathan; Patel, Shilpa; Gayed, Wade			Abdominal discomfort and abnormal liver function	BRITISH MEDICAL JOURNAL			English	Editorial Material							TRICUSPID REGURGITATION; CT		[Quigley, Shaun; Colledge, Jonathan; Patel, Shilpa; Gayed, Wade] St Bartholomews & Royal London, Clin Radiol, London E1 1BB, England	University of London; Queen Mary University London	Quigley, S (corresponding author), St Bartholomews & Royal London, Clin Radiol, London E1 1BB, England.	shaun.quigley@bartsandthelondon.nhs.uk						ABUYOUSEF MM, 1991, AM J ROENTGENOL, V156, P79, DOI 10.2214/ajr.156.1.1898574; COLLINS MA, 1995, BRIT J RADIOL, V68, P1058, DOI 10.1259/0007-1285-68-814-1058; Giallourakis CC, 2002, CLIN LIVER DIS, V6, P947; Giallourakis Cosmas C, 2002, Clin Liver Dis, V6, P947, DOI 10.1016/S1089-3261(02)00056-9; Goldhammer E, 1999, J AM SOC ECHOCARDIOG, V12, P988, DOI 10.1016/S0894-7317(99)70153-7; Groves AM, 2004, CLIN RADIOL, V59, P715, DOI 10.1016/j.crad.2004.02.007; Ishida Keiichi, 2010, Asian Cardiovasc Thorac Ann, V18, P229, DOI 10.1177/0218492310367684; Mancini MC, 2011, MEDSCAPE; MOULTON JS, 1988, AM J ROENTGENOL, V151, P939, DOI 10.2214/ajr.151.5.939; Rodes J, 2007, TXB HEPATOLOGY BASIC; SAGIE A, 1994, J AM COLL CARDIOL, V24, P446, DOI 10.1016/0735-1097(94)90302-6; Wittram C, 2007, AM J ROENTGENOL, V188, P1255, DOI 10.2214/AJR.06.1104; Xiushui R, 2010, MEDSCAPE	13	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 12	2012	344								e2096	10.1136/bmj.e2096	http://dx.doi.org/10.1136/bmj.e2096			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961KQ	22693048				2022-12-28	WOS:000305463700001
J	Salmon, D; Vanwalleghem, G; Morias, Y; Denoeud, J; Krumbholz, C; Lhomme, F; Bachmaier, S; Kador, M; Gossmann, J; Dias, FBS; De Muylder, G; Uzureau, P; Magez, S; Moser, M; De Baetselier, P; Van den Abbeele, J; Beschin, A; Boshart, M; Pays, E				Salmon, Didier; Vanwalleghem, Gilles; Morias, Yannick; Denoeud, Julie; Krumbholz, Carsten; Lhomme, Frederic; Bachmaier, Sabine; Kador, Markus; Gossmann, Jasmin; Dias, Fernando Braga Stehling; De Muylder, Geraldine; Uzureau, Pierrick; Magez, Stefan; Moser, Muriel; De Baetselier, Patrick; Van Den Abbeele, Jan; Beschin, Alain; Boshart, Michael; Pays, Etienne			Adenylate Cyclases of Trypanosoma brucei Inhibit the Innate Immune Response of the Host	SCIENCE			English	Article							AFRICAN TRYPANOSOMIASIS; SURFACE GLYCOPROTEIN; EXPRESSION SITE; MACROPHAGES; ACTIVATION; GENES; INFECTIONS; FAMILY; DOMAIN; ALPHA	The parasite Trypanosoma brucei possesses a large family of transmembrane receptor-like adenylate cyclases. Activation of these enzymes requires the dimerization of the catalytic domain and typically occurs under stress. Using a dominant-negative strategy, we found that reducing adenylate cyclase activity by about 50% allowed trypanosome growth but reduced the parasite's ability to control the early innate immune defense of the host. Specifically, activation of trypanosome adenylate cyclase resulting from parasite phagocytosis by liver myeloid cells inhibited the synthesis of the trypanosome-controlling cytokine tumor necrosis factor-alpha through activation of protein kinase A in these cells. Thus, adenylate cyclase activity of lyzed trypanosomes favors early host colonization by live parasites. The role of adenylate cyclases at the host-parasite interface could explain the expansion and polymorphism of this gene family.	[Salmon, Didier; Vanwalleghem, Gilles; Dias, Fernando Braga Stehling; De Muylder, Geraldine; Uzureau, Pierrick; Pays, Etienne] Univ Libre Brussels, Inst Mol Biol & Med IBMM, Mol Parasitol Lab, B-6041 Gosselies, Belgium; [Salmon, Didier; Dias, Fernando Braga Stehling] Univ Fed Rio de Janeiro, Ctr Ciencias & Saude, Inst Med Biochem, BR-21941590 Rio De Janeiro, Brazil; [Morias, Yannick; De Baetselier, Patrick; Beschin, Alain] Vrije Univ Brussel VIB, Myeloid Cell Immunol Lab, Brussels, Belgium; [Morias, Yannick; Magez, Stefan; De Baetselier, Patrick; Beschin, Alain] Vrije Univ Brussel, Cellular & Mol Immunol Unit, Brussels, Belgium; [Denoeud, Julie; Moser, Muriel] Univ Libre Brussels, IBMM, Immunobiol Lab, B-6041 Gosselies, Belgium; [Krumbholz, Carsten; Bachmaier, Sabine; Kador, Markus; Gossmann, Jasmin; Boshart, Michael] Univ Munich, Genet Sect, Biocenter, Martinsried, Germany; [Lhomme, Frederic] Ctr Microscopy & Mol Imaging, Gosselies, Belgium; [Magez, Stefan] VIB, Dept Biol Struct, Brussels, Belgium; [Van Den Abbeele, Jan] Inst Trop Med, Unit Vet Protozool, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Pays, Etienne] Walloon Excellence Life Sci & Biotechnol WELBIO, Wavre, Belgium	Universidade Federal do Rio de Janeiro; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Universite Libre de Bruxelles; University of Munich; Flanders Institute for Biotechnology (VIB); Institute of Tropical Medicine (ITM); WELBIO	Salmon, D (corresponding author), Univ Libre Brussels, Inst Mol Biol & Med IBMM, Mol Parasitol Lab, 12 Rue Prof Jeener & Brachet, B-6041 Gosselies, Belgium.	salmon@bioqmed.ufrj.br; boshart@lmu.de; epays@ulb.ac.be	Vanwalleghem, Gilles C/N-9573-2017; Boshart, Michael/A-2700-2011; Magez, Stefan/D-9497-2014; Magez, Stefan/AAC-5682-2021; Dias, Fernando Braga Stehling/A-9232-2013; De Baetselier, Patrick/D-3866-2014; Beschin, Alain/L-2154-2014; Salmon, Didier/M-5670-2013	Vanwalleghem, Gilles C/0000-0002-6188-9582; Boshart, Michael/0000-0002-5070-2663; Magez, Stefan/0000-0003-3760-7968; Magez, Stefan/0000-0003-3760-7968; Dias, Fernando Braga Stehling/0000-0001-7747-6136; Beschin, Alain/0000-0001-8478-6941; Van Den Abbeele, Jan/0000-0002-4533-4480	Belgian Fund for Scientific Research (FRSM); Wallonie-Bruxelles International/Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Jean Brachet Fund; Interuniversity Attraction Poles Programme-Belgian Science Policy; German Research Foundation (DFG) [1100/7-1]; University of Munich	Belgian Fund for Scientific Research (FRSM)(Fonds de la Recherche Scientifique - FNRS); Wallonie-Bruxelles International/Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Jean Brachet Fund; Interuniversity Attraction Poles Programme-Belgian Science Policy(Belgian Federal Science Policy Office); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Munich	We thank S. McKnight and P. Amieux (University of Washington) for the RI alpha B mice and helpful suggestions; O. Leo (IBMM, Gosselies) for excellent advice; and D. Monteyne, P. Poelvoorde, M. A. Laute, E. Omasta, and P. Tebabi for technical assistance. This work was supported by the Belgian Fund for Scientific Research (FRSM), the Wallonie-Bruxelles International/Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) bilateral cooperation agreement, the Jean Brachet Fund, the Interuniversity Attraction Poles Programme-Belgian Science Policy, German Research Foundation (DFG) grant 1100/7-1, and the University of Munich. The trypanosome DNA sequences can be retrieved from release 4.0 of the TriTrypDB (www.tritrypdb.org) and NCBI GenBank. The kinetoplastid AC sequence alignments and accession nos. have been deposited at TreeBase (http://purl.org/phylo/treebase/phylows/study/TB2:S12552). Author contributions: D.S., G.V., M.B., A.B., and E.P. conceived the work; D.S., G.V., Y.M., J.D., C.K., F.L., S.B., J.G., M.K., F.B. S.D., G.D.M., P.U., S.M., and J.V.D.A. performed experiments; D.S., M.M., P.D.B., M.B., A.B., and E.P. supervised different aspects of the experimental plan; and E.P. wrote the paper. The authors declare that they have no competing financial interests.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Alexandre S, 1996, MOL BIOCHEM PARASIT, V77, P173, DOI 10.1016/0166-6851(96)02591-1; ALEXANDRE S, 1990, MOL BIOCHEM PARASIT, V43, P279, DOI 10.1016/0166-6851(90)90152-C; Bieger B, 2001, EMBO J, V20, P433, DOI 10.1093/emboj/20.3.433; Bridges DJ, 2008, PROTEOMICS, V8, P83, DOI 10.1002/pmic.200700607; Cui J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000782; DEMPSEY WL, 1983, J IMMUNOL, V130, P405; Guilliams M, 2009, J IMMUNOL, V182, P1107, DOI 10.4049/jimmunol.182.2.1107; Lecordier L, 2005, MOL BIOCHEM PARASIT, V140, P127, DOI 10.1016/j.molbiopara.2004.12.009; Magez S, 1999, INFECT IMMUN, V67, P3128, DOI 10.1128/IAI.67.6.3128-3132.1999; Magez S, 1998, J IMMUNOL, V160, P1949; Magez S, 2002, MICROBES INFECT, V4, P999, DOI 10.1016/S1286-4579(02)01617-9; Mansfield JM, 2005, PARASITE IMMUNOL, V27, P361, DOI 10.1111/j.1365-3024.2005.00791.x; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Naula C, 2001, MOL BIOCHEM PARASIT, V112, P19, DOI 10.1016/S0166-6851(00)00338-8; PAINDAVOINE P, 1992, MOL CELL BIOL, V12, P1218, DOI 10.1128/MCB.12.3.1218; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; PAYS E, 1989, CELL, V57, P835, DOI 10.1016/0092-8674(89)90798-8; Ratier L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003524; Rolin S, 1996, J BIOL CHEM, V271, P10844, DOI 10.1074/jbc.271.18.10844; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Salmon D, 2012, MOL MICROBIOL, V84, P225, DOI 10.1111/j.1365-2958.2012.08013.x; Seebeck T, 2004, CURR MOL MED, V4, P585, DOI 10.2174/1566524043360113; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; VOORHEIS HP, 1980, EUR J BIOCHEM, V113, P223, DOI 10.1111/j.1432-1033.1980.tb06160.x; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Wei GJ, 2011, J INFECT DIS, V203, P418, DOI 10.1093/infdis/jiq051; Willis BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018772	28	85	85	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2012	337	6093					463	466		10.1126/science.1222753	http://dx.doi.org/10.1126/science.1222753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	979FS	22700656				2022-12-28	WOS:000306802300042
J	Dumont, S; Salmon, ED; Mitchison, TJ				Dumont, Sophie; Salmon, E. D.; Mitchison, Timothy J.			Deformations Within Moving Kinetochores Reveal Different Sites of Active and Passive Force Generation	SCIENCE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; DIRECTIONAL INSTABILITY; MITOTIC SPINDLE; CHROMOSOME; MICROTUBULES; ARCHITECTURE; DYNAMICS; MOTILITY; ANAPHASE; TENSION	Kinetochores mediate chromosome segregation at mitosis. They are thought to contain both active, force-producing and passive, frictional interfaces with microtubules whose relative locations have been unclear. We inferred mechanical deformation within single kinetochores during metaphase oscillations by measuring average separations between fluorescently labeled kinetochore subunits in living cells undergoing mitosis. Inter-subunit distances were shorter in kinetochores moving toward poles than in those moving away. Inter-subunit separation decreased abruptly when kinetochores switched to poleward movement and decreased further when pulling force increased, suggesting that active force generation during poleward movement compresses kinetochores. The data revealed an active force-generating interface within kinetochores and a separate passive frictional interface located at least 20 nanometers away poleward. Together, these interfaces allow persistent attachment with intermittent active force generation.	[Dumont, Sophie; Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Salmon, E. D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill	Dumont, S (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.	sophie.dumont@ucsf.edu			Charles A. King Trust; Bank of America; NIH [K99GM094335, R37GM024364, R01GM039565]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM039565, R37GM024364, K99GM094335, R01GM039565] Funding Source: NIH RePORTER	Charles A. King Trust; Bank of America; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Shah for the stable Ptk2 EYFP-Cdc20 line, C. Carroll and A. Straight for the mCherry-CenpC construct, J. DeLuca for Hec1 constructs, X. Wan for sharing SpeckleTracker, and M. Kirschner for equipment loan. We thank I. Cheeseman, P. Choi, S. Churchman, J. DeLuca, M. Ginzberg, Q. Justman, J. Shah, X. Wan, and J. Waters (HMS Nikon Imaging Center) for discussions. S. D. was supported by the Charles A. King Trust, Bank of America and by NIH K99GM094335; E. D. S. was supported by NIH R37GM024364; and T. J. M. was supported by NIH R01GM039565. Data are presented in the supplementary materials.	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Dumont S, 2009, CURR BIOL, V19, P1086, DOI 10.1016/j.cub.2009.05.056; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Joglekar AP, 2010, CURR OPIN CELL BIOL, V22, P57, DOI 10.1016/j.ceb.2009.12.010; Joglekar AP, 2009, CURR BIOL, V19, P694, DOI 10.1016/j.cub.2009.02.056; Khodjakov A, 1996, J CELL BIOL, V135, P315, DOI 10.1083/jcb.135.2.315; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; LaFountain JR, 2004, MOL BIOL CELL, V15, P5724, DOI 10.1091/mbc.E04-08-0750; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schittenhelm RB, 2007, CHROMOSOMA, V116, P385, DOI 10.1007/s00412-007-0103-y; SKIBBENS RV, 1995, J CELL SCI, V108, P2537; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Tirnauer JS, 2002, MOL BIOL CELL, V13, P4308, DOI 10.1091/mbc.e02-04-0236; Uchida KSK, 2009, J CELL BIOL, V184, P383, DOI 10.1083/jcb.200811028; Venkei Z, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110032; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035	25	70	70	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 20	2012	337	6092					355	358		10.1126/science.1221886	http://dx.doi.org/10.1126/science.1221886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22722252	Green Accepted, Green Submitted			2022-12-28	WOS:000306542600055
J	Tsai, A; Petrov, A; Marshall, RA; Korlach, J; Uemura, S; Puglisi, JD				Tsai, Albert; Petrov, Alexey; Marshall, R. Andrew; Korlach, Jonas; Uemura, Sotaro; Puglisi, Joseph D.			Heterogeneous pathways and timing of factor departure during translation initiation	NATURE			English	Article							TRANSFER-RNA; PROTEIN-SYNTHESIS; GUANOSINE TRIPHOSPHATE; COMPLEX-FORMATION; FACTOR IF2; REAL-TIME; RIBOSOME; BACTERIA; GUIDES	The initiation of translation establishes the reading frame for protein synthesis and is a key point of regulation(1). Initiation involves factor-driven assembly at a start codon of a messenger RNA of an elongation-competent 70S ribosomal particle (in bacteria) from separated 30S and 50S subunits and initiator transfer RNA. Here we establish in Escherichia coli, using direct single-molecule tracking, the timing of initiator tRNA, initiation factor 2 (IF2; encoded by infB) and 50S subunit joining during initiation. Our results show multiple pathways to initiation, with orders of arrival of tRNA and IF2 dependent on factor concentration and composition. IF2 accelerates 50S subunit joining and stabilizes the assembled 70S complex. Transition to elongation is gated by the departure of IF2 after GTP hydrolysis, allowing efficient arrival of elongator tRNAs to the second codon presented in the aminoacyl-tRNA binding site (A site). These experiments highlight the power of single-molecule approaches to delineate mechanisms in complex multicomponent systems.	[Tsai, Albert; Petrov, Alexey; Marshall, R. Andrew; Uemura, Sotaro; Puglisi, Joseph D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Tsai, Albert] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Marshall, R. Andrew] McKinsey & Co Silicon Valley, Palo Alto, CA 94304 USA; [Korlach, Jonas] Pacific Biosci, Menlo Pk, CA 94025 USA; [Uemura, Sotaro] RIKEN Yokohama Inst, Omics Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Puglisi, Joseph D.] Stanford Univ, Sch Med, Stanford Magnet Resonance Lab, Stanford, CA 94305 USA	Stanford University; Stanford University; RIKEN; Stanford University	Uemura, S (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	s-uemura@gsc.riken.jp; puglisi@stanford.edu		Tsai, Albert/0000-0002-1643-0780	National Institutes of Health [GM51266]; Japan Science and Technology Agency; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099687, R01GM051266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health grant GM51266 (J.D.P.) and the Japan Science and Technology Agency (S.U.).	Aitken CE, 2010, NAT STRUCT MOL BIOL, V17, P793, DOI 10.1038/nsmb.1828; Antoun A, 2003, EMBO J, V22, P5593, DOI 10.1093/emboj/cdg525; Antoun A, 2006, EMBO J, V25, P2539, DOI 10.1038/sj.emboj.7601140; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Caserta E, 2006, J MOL BIOL, V362, P787, DOI 10.1016/j.jmb.2006.07.043; Dorywalska M, 2005, NUCLEIC ACIDS RES, V33, P182, DOI 10.1093/nar/gki151; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; LOCKWOOD AH, 1971, P NATL ACAD SCI USA, V68, P3122, DOI 10.1073/pnas.68.12.3122; LOCKWOOD AH, 1972, P NATL ACAD SCI USA, V69, P3602, DOI 10.1073/pnas.69.12.3602; Marshall R. A., 2008, THESIS STANFORD U; Marshall RA, 2009, MOL CELL, V35, P37, DOI 10.1016/j.molcel.2009.06.008; Milon P, 2010, EMBO REP, V11, P312, DOI 10.1038/embor.2010.12; Myasnikov AG, 2005, NAT STRUCT MOL BIOL, V12, P1145, DOI 10.1038/nsmb1012; PETERSEN HU, 1979, BIOCHEM BIOPH RES CO, V91, P1068, DOI 10.1016/0006-291X(79)91989-2; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925	18	68	68	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2012	487	7407					390	394		10.1038/nature11172	http://dx.doi.org/10.1038/nature11172			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975JB	22722848	Green Accepted			2022-12-28	WOS:000306506500048
J	Gruber, N; Hauri, C; Lachkar, Z; Loher, D; Frolicher, TL; Plattner, GK				Gruber, Nicolas; Hauri, Claudine; Lachkar, Zouhair; Loher, Damian; Froelicher, Thomas L.; Plattner, Gian-Kasper			Rapid Progression of Ocean Acidification in the California Current System	SCIENCE			English	Article							BIOLOGICAL PRODUCTION; UPWELLING SYSTEMS; ATMOSPHERIC CO2; CARBON-DIOXIDE; ECOSYSTEM; CALCIFICATION; ORGANISMS; SEAWATER; MODEL; WORLD	Nearshore waters of the California Current System (California CS) already have a low carbonate saturation state, making them particularly susceptible to ocean acidification. We used eddy-resolving model simulations to study the potential development of ocean acidification in this system up to the year 2050 under the Special Report on Emissions Scenarios A2 and B1 scenarios. In both scenarios, the saturation state of aragonite Omega(arag) is projected to drop rapidly, with much of the nearshore region developing summer-long undersaturation in the top 60 meters within the next 30 years. By 2050, waters with Omega(arag) above 1.5 will have largely disappeared, and more than half of the waters will be undersaturated year-round. Habitats along the sea floor will become exposed to year-round undersaturation within the next 20 to 30 years. These projected events have potentially major implications for the rich and diverse ecosystem that characterizes the California CS.	[Gruber, Nicolas; Hauri, Claudine; Lachkar, Zouhair; Loher, Damian] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland; [Froelicher, Thomas L.] Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; [Plattner, Gian-Kasper] Univ Bern, Bern, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; University of Bern	Gruber, N (corresponding author), Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland.	nicolas.gruber@env.ethz.ch	Gruber, Nicolas/B-7013-2009; Frölicher, Thomas L/E-5137-2015; Plattner, Gian-Kasper/A-5245-2016; Froelicher, Thomas/AAG-9598-2019	Gruber, Nicolas/0000-0002-2085-2310; Frölicher, Thomas L/0000-0003-2348-7854; Plattner, Gian-Kasper/0000-0002-3765-0045; Froelicher, Thomas/0000-0003-2348-7854	ETH Zurich; European Project on Ocean Acidification; European Community's Seventh Framework Programme [211384]; Carbon Mitigation Initiative project at Princeton Univ.; BP; Ford Motor Company	ETH Zurich(ETH Zurich); European Project on Ocean Acidification; European Community's Seventh Framework Programme; Carbon Mitigation Initiative project at Princeton Univ.; BP; Ford Motor Company	This work was supported by ETH Zurich and the European Project on Ocean Acidification, which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 211384. T. L. F. was supported by the Carbon Mitigation Initiative project at Princeton Univ., sponsored by BP and Ford Motor Company. We thank J. C. McWilliams and his group at the Univ. of California Los Angeles for the long-term collaboration on the development of ROMS.	BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Barry J.P., 2011, OCEAN ACIDIFICATION, P192, DOI DOI 10.1093/OSO/9780199591091.003.0015; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Broecker W.S., 1971, IMPINGEMENT MAN OCEA, P287; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Cooley SR, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/2/024007; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Diffenbaugh NS, 2004, P NATL ACAD SCI USA, V101, P27, DOI 10.1073/pnas.0305746101; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gruber N, 2011, NAT GEOSCI, V4, P787, DOI [10.1038/NGEO1273, 10.1038/ngeo1273]; Gruber N, 2011, PHILOS T R SOC A, V369, P1980, DOI 10.1098/rsta.2011.0003; Gutierrez D, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046324; Hauri C, 2009, OCEANOGRAPHY, V22, P60, DOI 10.5670/oceanog.2009.97; Joos F., 2011, OCEAN ACIDIFICATION, P273; Juranek LW, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040778; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Lachkar Z, 2011, BIOGEOSCIENCES, V8, P2961, DOI 10.5194/bg-8-2961-2011; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Ohman MD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039901; Orr J.C., 2011, OCEAN ACIDIFICATION, V1, P41; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Stumm W., 1970, AQUATIC CHEM INTRO E; Tans P., 2012, RECENT MAUNA LOA DAT; Turley C, 2010, MAR POLLUT BULL, V60, P787, DOI 10.1016/j.marpolbul.2010.05.006	39	273	282	3	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2012	337	6091					220	223		10.1126/science.1216773	http://dx.doi.org/10.1126/science.1216773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22700658				2022-12-28	WOS:000306323500055
J	Bauer, J; Prenzel, M				Bauer, Johannes; Prenzel, Manfred			European Teacher Training Reforms	SCIENCE			English	Editorial Material							EDUCATION		[Bauer, Johannes; Prenzel, Manfred] Tech Univ Munich, TUM Sch Educ, D-80799 Munich, Germany	Technical University of Munich	Bauer, J (corresponding author), Tech Univ Munich, TUM Sch Educ, Schellingstr 33, D-80799 Munich, Germany.	jbauer@tum.de	Bauer, Johannes/I-9271-2012	Bauer, Johannes/0000-0001-6801-2540				Barnett WS, 2011, SCIENCE, V333, P975, DOI 10.1126/science.1204534; Bauer J, 2011, Z ERZIEHWISS, V14, P629, DOI 10.1007/s11618-011-0239-7; Baumert J, 2010, AM EDUC RES J, V47, P133, DOI 10.3102/0002831209345157; Blomeke S, 2012, TEACH TEACH EDUC, V28, P44, DOI 10.1016/j.tate.2011.08.006; Coates H., 2011, HIGHER ED MANAGEMENT, V23, P51; Cochran-Smith M., 2005, EDUC RESEARCHER, V34, P3; Darling-Hammond L., 2005, PREPARING TEACHERS C; Davies P, 1999, BRIT J EDUC STUD, V47, P108, DOI 10.1111/1467-8527.00106; Enders J., 2006, EXTENT IMPACT HIGHER; ETUCE, 2008, TEACH ED EUR; European Commission (EC), 2007, IMPR QUAL TEACH ED; Eurydice, 2009, KEY DAT ED EUR 2009; Gaston Paul, 2010, CHALLENGE BOLOGNA; Gonzales J., 2008, U CONTRIBUTION BOLOG, V2nd; Jorde D., 2010, S TEAM SCI TEACHER E; Niemi H., 2008, LIFELONG LEARN EUROP, V61; *OECD, 2000, ED GLANC OECD IND; OECD, 2005, DEF SEL KEY COMP; OECD Secretary-General, 2009, CREAT EFF TEACH LEAR; *ORG EC COOP DEV, 2005, TEACH MATT; Pantic N, 2010, TEACH TEACH EDUC, V26, P694, DOI 10.1016/j.tate.2009.10.005; Schmidt W. H., 2011, TEACHER ED MATTERS; Schmidt WH, 2011, SCIENCE, V332, P1266, DOI 10.1126/science.1193855; Sursock A., 2010, TRENDS 2010 DECADE C; Tatto MT, 2011, J TEACH EDUC, V62, P121, DOI 10.1177/0022487110391807; Witte J., 2009, HIGHER ED 2030, V2; Zgaga P., 2006, PROSPECTS TEACHER ED; Zuzovsky R., 2006, STUDIES ED EVALUATIO, V32, P37, DOI DOI 10.1016/J.STUEDUC.2006.01.006	28	33	33	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1642	1643		10.1126/science.1218387	http://dx.doi.org/10.1126/science.1218387			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	965VD	22745406				2022-12-28	WOS:000305794500025
J	Coombes, R				Coombes, Rebecca			NHS REFORMS How will secondary care need to shape up to survive? A roundtable discussion	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Coombes, R (corresponding author), BMJ, London WC1H 9JR, England.	rcoombes@bmj.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 27	2012	344								e4384	10.1136/bmj.e4384	http://dx.doi.org/10.1136/bmj.e4384			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	968MX	22740570				2022-12-28	WOS:000305987100026
J	Pitman, A; Krysinska, K; Osborn, D; King, M				Pitman, Alexandra; Krysinska, Karolina; Osborn, David; King, Michael			Suicide in young men	LANCET			English	Article							MARITAL-STATUS; YOUTH SUICIDE; UNDETERMINED DEATHS; ALCOHOL-CONSUMPTION; COMPLETED SUICIDES; UNITED-STATES; RISK-FACTORS; SOUTH-KOREA; LIFE LOST; HONG-KONG	Suicide is second to only accidental death as the leading cause of mortality in young men across the world. Although suicide rates for young men have fallen in some high-income and middle-income countries since the 1990s, wider mortality measures indicate that rates remain high in specific regions, ethnic groups, and socioeconomic groups within those nations where rates have fallen, and that young men account for a substantial proportion of the economic cost of suicide. High-lethality methods of suicide are preferred by young men: hanging and firearms in high-income countries, pesticide poisoning in the Indian subcontinent, and charcoal-burning in east Asia. Risk factors for young men include psychiatric illness, substance misuse, lower socioeconomic status, rural residence, and single marital status. Population-level factors include unemployment, social deprivation, and media reporting of suicide. Few interventions to reduce suicides in young men have been assessed. Efforts to change help-seeking behaviour and to restrict access to frequently used methods hold the most promise.	[Pitman, Alexandra; Osborn, David; King, Michael] Univ London Univ Coll, Mental Hlth Sci Unit, London W1W 7EJ, England; [Krysinska, Karolina] Univ Leuven, KU Leuven, Fac Psychol & Educ Sci, Louvain, Belgium	University of London; University College London; KU Leuven	Pitman, A (corresponding author), Univ London Univ Coll, Mental Hlth Sci Unit, Charles Bell House,67-73 Riding House St, London W1W 7EJ, England.	a.pitman@ucl.ac.uk	King, Michael B/D-7477-2011; Osborn PhD FRCPsych, David/B-8165-2009	King, Michael B/0000-0003-4715-7171; Pitman, Alexandra/0000-0002-9742-1359; Osborn PhD FRCPsych, David/0000-0003-2519-1539	Medical Research Council; Medical Research Council [G0802441] Funding Source: researchfish; National Institute for Health Research [ACF-2007-18-010] Funding Source: researchfish; MRC [G0802441] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Ruth Muscat, Knowledge Resources Librarian, Royal Free Hospital Medical Library (UCL Medical School) for help undertaking the database searches. AP is supported by a Medical Research Council Population Health Scientist Fellowship. The views expressed in this review are those of the authors.	Andersen K, 2010, AUST NZ J PSYCHIAT, V44, P243, DOI 10.3109/00048670903487142; [Anonymous], OXFORD TXB SUICIDOLO; Arsenault-Lapierre G, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-37; Beautrais A., 2003, New Zealand Medical Journal, V116, P461; Beautrais AL, 2000, AUST NZ J PSYCHIAT, V34, P413, DOI 10.1080/j.1440-1614.2000.00690.x; Beautrais Annette, 2003, N Z Med J, V116, pU460; Berk M, 2006, PSYCHOL MED, V36, P181, DOI 10.1017/S0033291705006665; Biddle L, 2008, BRIT MED J, V336, P539, DOI 10.1136/bmj.39475.603935.25; Boothroyd LJ, 2001, CAN MED ASSOC J, V165, P749; Bose A, 2006, TROP MED INT HEALTH, V11, P1553, DOI 10.1111/j.1365-3156.2006.01707.x; Burrows S, 2005, SUICIDE LIFE-THREAT, V35, P592, DOI 10.1521/suli.2005.35.5.592; Burrows S, 2007, SCAND J PUBLIC HEALT, V35, P133, DOI 10.1080/14034940600975773; Cantor C, 2000, AUST NZ J PSYCHIAT, V34, P370, DOI 10.1080/j.1440-1614.2000.00756.x; Carlsten A, 2001, PHARMACOEPIDEM DR S, V10, P525, DOI 10.1002/pds.618; Centers for Disease Control Prevention, SUIC FACTS GLANC; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; Chen YY, 2012, SOC PSYCH PSYCH EPID, V47, P215, DOI 10.1007/s00127-010-0331-y; Cheng ATA, 2007, INT J EPIDEMIOL, V36, P1229, DOI 10.1093/ije/dym196; Corcoran P, 2011, EUR J PUBLIC HEALTH, V21, P209, DOI 10.1093/eurpub/ckp236; De Leo D, 2004, INT SUICIDE RATES PR; Mello-Santos Carolina de, 2005, Rev. Bras. Psiquiatr., V27, P131, DOI 10.1590/S1516-44462005000200011; Desjeux G, 2004, EUR J EPIDEMIOL, V19, P823, DOI 10.1023/B:EJEP.0000040527.59987.b2; DIEKSTRA RFW, 1989, ACTA PSYCHIAT SCAND, V80, P1, DOI 10.1111/j.1600-0447.1989.tb03043.x; Dzurova D, 2008, INT J PUBLIC HEALTH, V53, P139, DOI 10.1007/s00038-008-7048-7; EchoHawk Marlene, 2006, Arch Suicide Res, V10, P169, DOI 10.1080/13811110600558224; Etzersdorfer E, 2005, WIEN KLIN WOCHENSCHR, V117, P31, DOI 10.1007/s00508-004-0263-1; Evans J, 2004, SOC PSYCH PSYCH EPID, V39, P165, DOI 10.1007/s00127-004-0733-9; Fear NT, 2009, OCCUP ENVIRON MED, V66, P438, DOI 10.1136/oem.2008.040816; Gagne M, 2010, INJURY PREV, V16, P247, DOI 10.1136/ip.2009.022491; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1044, DOI 10.1176/appi.ajp.164.7.1044; Griffiths Clare, 2008, Health Stat Q, P8; Gunnell D, 2007, INT J EPIDEMIOL, V36, P1235, DOI 10.1093/ije/dym164; Gunnell D, 2011, J AFFECT DISORDERS, V131, P104, DOI 10.1016/j.jad.2011.01.002; Gunnell D, 1999, BRIT J PSYCHIAT, V175, P263, DOI 10.1192/bjp.175.3.263; Gunnell D, 1999, LANCET, V353, P556, DOI 10.1016/S0140-6736(99)00408-0; Gunnell D, 2012, J EPIDEMIOL COMMUN H, V66, P536, DOI 10.1136/jech.2009.104000; Hawton K, 2003, BRIT J PSYCHIAT, V182, P537, DOI 10.1192/bjp.182.6.537; Hawton K, 2001, J EPIDEMIOL COMMUN H, V55, P296, DOI 10.1136/jech.55.5.296; Hempstead K, 2006, SOC SCI MED, V62, P3186, DOI 10.1016/j.socscimed.2005.11.038; Hong J. P., 2006, PSYCHIAT INVEST, V3, P7; Hu GQ, 2008, AM J PREV MED, V35, P589, DOI 10.1016/j.amepre.2008.07.005; Hunter Ernest, 2002, Emerg Med (Fremantle), V14, P14, DOI 10.1046/j.1442-2026.2002.00281.x; Im JS, 2011, COMPR PSYCHIAT, V52, P231, DOI 10.1016/j.comppsych.2010.07.005; Innamorati M, 2010, ALCOHOL, V44, P463, DOI 10.1016/j.alcohol.2010.07.007; Jacob KS, 2007, LANCET, V370, P1061, DOI 10.1016/S0140-6736(07)61241-0; Jayasinghe NRM, 2011, ARCH SUICIDE RES, V15, P223, DOI 10.1080/13811118.2011.589705; Joseph A, 2003, BRIT MED J, V326, P1121, DOI 10.1136/bmj.326.7399.1121; Kaplan MS, 2009, J TRAUMA, V67, P503, DOI 10.1097/TA.0b013e3181b36521; Kapusta ND, 2004, J MENS HLTH GENDER, V1, P197; Kapusta ND, 2008, SOC PSYCH PSYCH EPID, V43, P311, DOI 10.1007/s00127-008-0317-1; Kim CD, 2003, PSYCHOL MED, V33, P1299, DOI 10.1017/S0033291703008146; Kirmayer LJ., 2007, SUICIDE ABORIGINAL P; Klieve H, 2009, SOC PSYCH PSYCH EPID, V44, P285, DOI 10.1007/s00127-008-0435-9; Knapp M., 2011, MENTAL HLTH PROMOTIO; Krysinska K, 2009, IDENTITY VOICE PLACE; Kwon JW, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-72; Largey Maeve, 2009, Ulster Med J, V78, P16; Law CK, 2011, CRISIS, V32, P152, DOI 10.1027/0227-5910/a000070; Law Samuel, 2008, Curr Psychiatry Rep, V10, P80; Levi F, 2003, ACTA PSYCHIAT SCAND, V108, P341, DOI 10.1034/j.1600-0447.2003.00147.x; Li XY, 2008, PSYCHOL MED, V38, P397, DOI 10.1017/S0033291707001407; Li Z, 2004, SOC SCI MED, V72, P608; Liang DW, 2003, MED SCI LAW, V43, P141, DOI 10.1258/rsmmsl.43.2.141; Liu KY, 2007, J EPIDEMIOL COMMUN H, V61, P248, DOI 10.1136/jech.2006.048553; Lotrakul M, 2006, PSYCHIAT CLIN NEUROS, V60, P90, DOI 10.1111/j.1440-1819.2006.01465.x; Lubell K. M., 2007, Morbidity and Mortality Weekly Report, V56, P905; Lubin G, 2001, SOC PSYCH PSYCH EPID, V36, P123, DOI 10.1007/s001270050300; Ludwig J, 2000, JAMA-J AM MED ASSOC, V284, P585, DOI 10.1001/jama.284.5.585; Luoma JB, 2002, AM J PUBLIC HEALTH, V92, P1518, DOI 10.2105/AJPH.92.9.1518; Masocco M, 2008, PSYCHIAT QUART, V79, P275, DOI 10.1007/s11126-008-9072-4; Mathy RM, 2011, SOC PSYCH PSYCH EPID, V46, P111, DOI 10.1007/s00127-009-0177-3; Middleton N, 2003, SOC SCI MED, V57, P1183, DOI 10.1016/S0277-9536(02)00496-3; Middleton N, 2004, SOC PSYCH PSYCH EPID, V39, P45, DOI 10.1007/s00127-004-0707-y; Middleton N, 2006, J EPIDEMIOL COMMUN H, V60, P1040, DOI 10.1136/jech.2005.045302; Moller-Leimkuhler AM, 2002, J AFFECT DISORDERS, V71, P1, DOI 10.1016/S0165-0327(01)00379-2; Morii D, 2010, J OCCUP MED TOXICOL, V5, DOI 10.1186/1745-6673-5-28; Morrell S, 2007, SOC SCI MED, V64, P747, DOI 10.1016/j.socscimed.2006.09.027; Northern Ireland Statistics and Research Agency, 2010, STAT B DEATHS NO IR; Ojima T, 2004, J EPIDEMIOL, V14, P187, DOI 10.2188/jea.14.187; Page AN, 2002, AUST NZ J PSYCHIAT, V36, P81, DOI 10.1046/j.1440-1614.2002.00975.x; Page A, 2007, SOC SCI MED, V65, P442, DOI 10.1016/j.socscimed.2007.03.029; Page A, 2006, SOC PSYCH PSYCH EPID, V41, P911, DOI 10.1007/s00127-006-0112-9; Page A, 2011, BRIT J PSYCHIAT, V199, P423, DOI 10.1192/bjp.bp.111.093856; Pan YJ, 2010, J AFFECT DISORDERS, V120, P254, DOI 10.1016/j.jad.2009.04.003; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; Prasad J, 2006, INT J SOC PSYCHIATR, V52, P65, DOI 10.1177/0020764006061253; Pritchard C, 2008, CRISIS, V29, P145, DOI 10.1027/0227-5910.29.3.145; Pritchard C, 2007, PSYCHOL MED, V37, P421, DOI 10.1017/S0033291706009159; Qin P, 2005, INT J EPIDEMIOL, V34, P846, DOI 10.1093/ije/dyi085; Qin P, 2001, ACTA PSYCHIAT SCAND, V103, P117, DOI 10.1034/j.1600-0447.2001.00008.x; Rezaeian M, 2005, SOC PSYCH PSYCH EPID, V40, P785, DOI 10.1007/s00127-005-0960-x; Rockett IRH, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-35; Rodrigues NCP, 2005, SOC PSYCH PSYCH EPID, V40, P192, DOI 10.1007/s00127-005-0877-2; Sakharova O, 2007, MENTAL HLTH INDICATO; Sandilands EA, 2008, BRIT J CLIN PHARMACO, V66, P290, DOI 10.1111/j.1365-2125.2008.03206.x; Schmidtke A, 1999, ARCH SUICIDE RES, V5, P81, DOI 10.1080/13811119908258318; Shah A, 2011, SOC PSYCH PSYCH EPID, V46, P197, DOI 10.1007/s00127-010-0188-0; Sharma BR, 2003, MED SCI LAW, V43, P221, DOI 10.1258/rsmmsl.43.3.221; Shoval Gal, 2007, Arch Suicide Res, V11, P247, DOI 10.1080/13811110701402603; Silviken A, 2006, EUR J EPIDEMIOL, V21, P707, DOI 10.1007/s10654-006-9052-7; Soman C R, 2009, Indian J Psychiatry, V51, P261, DOI 10.4103/0019-5545.58290; Stark C, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-49; Stark C, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-80; Starkuviene S, 2006, PUBLIC HEALTH, V120, P769, DOI 10.1016/j.puhe.2006.04.009; Stone M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2880; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Tamosiunas A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-184; Taylor R, 2005, SOC SCI MED, V61, P1551, DOI 10.1016/j.socscimed.2005.02.009; Taylor R, 2005, SUICIDE LIFE-THREAT, V35, P277, DOI 10.1521/suli.2005.35.3.277; Varnik A, 2009, J AFFECT DISORDERS, V113, P216, DOI 10.1016/j.jad.2008.06.004; Vichi M, 2010, PSYCHIAT RES, V175, P89, DOI 10.1016/j.psychres.2008.12.008; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; Walsh B, 2011, ECON SOC REV, V42, P27; White A, 2006, J MENS HLTH GENDER, V3, P139, DOI [DOI 10.1016/J.JMHG.2006.04.002, DOI 10.1016/j.jmhg.2006.04.002]; WHO, 2002, WHO MULT INT STUD SU; Wilkinson D, 2000, AUST NZ J PSYCHIAT, V34, P822; Wyder M, 2009, J AFFECT DISORDERS, V116, P208, DOI 10.1016/j.jad.2008.11.007; Yip PSF, 2006, BRIT J PSYCHIAT, V189, P465, DOI 10.1192/bjp.bp.106.021816; Yip PSF, 2005, SOC PSYCH PSYCH EPID, V40, P792, DOI 10.1007/s00127-005-0952-8; Yip PSF, 2004, PSYCHOL REP, V94, P401; Yip PSF, 2001, SUICIDE LIFE-THREAT, V31, P62, DOI 10.1521/suli.31.1.62.21311; Yip PSF, 2000, J AFFECT DISORDERS, V57, P99, DOI 10.1016/S0165-0327(99)00058-0; Zacharakis CA, 2005, EUR PSYCHIAT, V20, P110, DOI 10.1016/j.eurpsy.2004.11.011	124	109	110	1	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2012	379	9834					2383	2392		10.1016/S0140-6736(12)60731-4	http://dx.doi.org/10.1016/S0140-6736(12)60731-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961ZV	22726519				2022-12-28	WOS:000305509600033
J	Carone, BR; Rando, OJ				Carone, Benjamin R.; Rando, Oliver J.			Rewriting the Epigenome	CELL			English	Editorial Material							CHROMATIN; METHYLATION; PLURIPOTENT; CELLS		[Carone, Benjamin R.; Rando, Oliver J.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carone, BR (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01605 USA.	benjamin.carone@umassmed.edu; oliver.rando@umassmed.edu		Rando, Oliver/0000-0003-1516-9397; Carone, Benjamin/0000-0002-9822-4218				Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Zacharioudakis L, 2007, CURR BIOL, V17, P2041, DOI 10.1016/j.cub.2007.10.044	11	6	6	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1422	1423		10.1016/j.cell.2012.06.008	http://dx.doi.org/10.1016/j.cell.2012.06.008			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726428	Bronze			2022-12-28	WOS:000305753800006
J	Ellis, MJ; Ding, L; Shen, D; Luo, JQ; Suman, VJ; Wallis, JW; Van Tine, BA; Hoog, J; Goiffon, RJ; Goldstein, TC; Ng, S; Lin, L; Crowder, R; Snider, J; Ballman, K; Weber, J; Chen, K; Koboldt, DC; Kandoth, C; Schierding, WS; McMichael, JF; Miller, CA; Lu, C; Harris, CC; McLellan, MD; Wendl, MC; DeSchryver, K; Allred, DC; Esserman, L; Unzeitig, G; Margenthaler, J; Babiera, GV; Marcom, PK; Guenther, JM; Leitch, M; Hunt, K; Olson, J; Tao, Y; Maher, CA; Fulton, LL; Fulton, RS; Harrison, M; Oberkfell, B; Du, FY; Demeter, R; Vickery, TL; Elhammali, A; Piwnica-Worms, H; McDonald, S; Watson, M; Dooling, DJ; Ota, D; Chang, LW; Bose, R; Ley, TJ; Piwnica-Worms, D; Stuart, JM; Wilson, RK; Mardis, ER				Ellis, Matthew J.; Ding, Li; Shen, Dong; Luo, Jingqin; Suman, Vera J.; Wallis, John W.; Van Tine, Brian A.; Hoog, Jeremy; Goiffon, Reece J.; Goldstein, Theodore C.; Ng, Sam; Lin, Li; Crowder, Robert; Snider, Jacqueline; Ballman, Karla; Weber, Jason; Chen, Ken; Koboldt, Daniel C.; Kandoth, Cyriac; Schierding, William S.; McMichael, Joshua F.; Miller, Christopher A.; Lu, Charles; Harris, Christopher C.; McLellan, Michael D.; Wendl, Michael C.; DeSchryver, Katherine; Allred, D. Craig; Esserman, Laura; Unzeitig, Gary; Margenthaler, Julie; Babiera, G. V.; Marcom, P. Kelly; Guenther, J. M.; Leitch, Marilyn; Hunt, Kelly; Olson, John; Tao, Yu; Maher, Christopher A.; Fulton, Lucinda L.; Fulton, Robert S.; Harrison, Michelle; Oberkfell, Ben; Du, Feiyu; Demeter, Ryan; Vickery, Tammi L.; Elhammali, Adnan; Piwnica-Worms, Helen; McDonald, Sandra; Watson, Mark; Dooling, David J.; Ota, David; Chang, Li-Wei; Bose, Ron; Ley, Timothy J.; Piwnica-Worms, David; Stuart, Joshua M.; Wilson, Richard K.; Mardis, Elaine R.			Whole-genome analysis informs breast cancer response to aromatase inhibition	NATURE			English	Article							MYELOID-LEUKEMIA GENOME; CELL LUNG-CANCER; ENDOCRINE THERAPY; SUPPRESSOR GENE; MUTATION; PATHWAY; PHOSPHORYLATION; MECHANISMS; CARCINOMA; OUTCOMES	To correlate the variable clinical features of oestrogen-receptor-positive breast cancer with somatic alterations, we studied pretreatment tumour biopsies accrued from patients in two studies of neoadjuvant aromatase inhibitor therapy by massively parallel sequencing and analysis. Eighteen significantly mutated genes were identified, including five genes (RUNX1, CBFB, MYH9, MLL3 and SF3B1) previously linked to haematopoietic disorders. Mutant MAP3K1 was associated with luminal A status, low-grade histology and low proliferation rates, whereas mutant TP53 was associated with the opposite pattern. Moreover, mutant GATA3 correlated with suppression of proliferation upon aromatase inhibitor treatment. Pathway analysis demonstrated that mutations in MAP2K4, a MAP3K1 substrate, produced similar perturbations as MAP3K1 loss. Distinct phenotypes in oestrogen-receptor-positive breast cancer are associated with specific patterns of somatic mutations that map into cellular pathways linked to tumour biology, but most recurrent mutations are relatively infrequent. Prospective clinical trials based on these findings will require comprehensive genome sequencing.	[Ellis, Matthew J.; Van Tine, Brian A.; Hoog, Jeremy; Lin, Li; Crowder, Robert; Snider, Jacqueline; Weber, Jason; DeSchryver, Katherine; Maher, Christopher A.; Ley, Timothy J.] Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Ellis, Matthew J.; Margenthaler, Julie; McDonald, Sandra; Bose, Ron; Ley, Timothy J.; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Siteman Canc Ctr, St Louis, MO 63110 USA; [Ellis, Matthew J.; Luo, Jingqin; Allred, D. Craig; Chang, Li-Wei; Bose, Ron] Washington Univ, Breast Canc Program, St Louis, MO 63110 USA; [Ding, Li; Shen, Dong; Wallis, John W.; Koboldt, Daniel C.; Kandoth, Cyriac; Schierding, William S.; McMichael, Joshua F.; Miller, Christopher A.; Lu, Charles; Harris, Christopher C.; McLellan, Michael D.; Wendl, Michael C.; Maher, Christopher A.; Fulton, Lucinda L.; Fulton, Robert S.; Harrison, Michelle; Oberkfell, Ben; Du, Feiyu; Demeter, Ryan; Vickery, Tammi L.; Dooling, David J.; Ley, Timothy J.; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Shen, Dong; Wallis, John W.; Koboldt, Daniel C.; Kandoth, Cyriac; Schierding, William S.; McMichael, Joshua F.; Miller, Christopher A.; Lu, Charles; Harris, Christopher C.; McLellan, Michael D.; Wendl, Michael C.; Fulton, Lucinda L.; Fulton, Robert S.; Harrison, Michelle; Oberkfell, Ben; Du, Feiyu; Demeter, Ryan; Vickery, Tammi L.; Dooling, David J.; Wilson, Richard K.; Mardis, Elaine R.] Washington Univ, Dept Genet, St Louis, MO 63108 USA; [Luo, Jingqin; Tao, Yu; Watson, Mark] Washington Univ, Div Biostat, St Louis, MO 63110 USA; [Suman, Vera J.; Ballman, Karla] Mayo Clin, ACOSOG Stat Ctr, Rochester, MN 55905 USA; [Goiffon, Reece J.; Weber, Jason; Elhammali, Adnan; Piwnica-Worms, Helen; Piwnica-Worms, David] Washington Univ, BRIGHT Inst, Sch Med, St Louis, MO 63110 USA; [Goiffon, Reece J.; Elhammali, Adnan; Piwnica-Worms, David] Washington Univ, Mol Imaging Ctr, St Louis, MO 63110 USA; [Goiffon, Reece J.; Elhammali, Adnan; Piwnica-Worms, David] Washington Univ, Malinckrodt Inst Radiol, St Louis, MO 63110 USA; [Goldstein, Theodore C.; Ng, Sam; Stuart, Joshua M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Weber, Jason] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Chen, Ken; Babiera, G. V.; Hunt, Kelly] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Allred, D. Craig; Watson, Mark; Chang, Li-Wei] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Esserman, Laura] Univ Calif San Francisco, Helen Diller Canc Ctr, San Francisco, CA 94143 USA; [Unzeitig, Gary] Doctors Hosp Laredo, Laredo, TX 78045 USA; [Marcom, P. Kelly; Olson, John] Duke Univ, Ctr Canc, Durham, NC 27705 USA; [Guenther, J. M.] Good Samaritan Hosp, Cincinnati, OH 45406 USA; [Leitch, Marilyn] Univ Texas SW, Simmons Canc Ctr, Dallas, TX 75390 USA; [Piwnica-Worms, Helen] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [McDonald, Sandra; Watson, Mark] Washington Univ, ACOSOG Cent Specimen Bank, St Louis, MO 63110 USA; [Ota, David] Duke Univ, ACOSOG Operat Ctr, Durham, NC 27705 USA; [Piwnica-Worms, David] Washington Univ, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Mayo Clinic; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Santa Cruz; Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center; Washington University (WUSTL); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Duke University; Good Samaritan Hospital - Cincinnati; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Washington University (WUSTL); Duke University; Washington University (WUSTL)	Ellis, MJ (corresponding author), Washington Univ, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA.		van+Tine, Brain/AAI-1919-2019; Mardis, Elaine/W-2202-2019; Marcom, Paul/AAE-4761-2020; Wendl, Michael C/A-2741-2008; Miller, Christopher A./A-1060-2009; Piwnica-Worms, Helen/C-5214-2012; Goiffon, Reece J/C-9686-2013; Chen, Ken/AAU-1432-2021; Marcom, Paul/M-4516-2019; Wilson, Richard K./AAF-4139-2019	Marcom, Paul/0000-0001-5302-6368; Miller, Christopher A./0000-0003-4266-6700; Goiffon, Reece J/0000-0003-1622-7253; Chen, Ken/0000-0003-4013-5279; Wilson, Richard K./0000-0002-1992-1358; Weber, Jason/0000-0002-1069-6983; Stuart, Joshua/0000-0002-2171-565X; MCLELLAN, MICHAEL/0000-0002-2703-8784; Kandoth, Cyriac/0000-0002-1345-3573; Schierding, William/0000-0001-5659-2701	National Human Genome Research Institute (NHGRI) [U54 HG003079]; National Cancer Institute [NCI R01 CA095614, NCI U01 CA114722]; Susan G. Komen Breast Cancer Foundation [BCTR0707808]; Fashion Footwear Charitable Foundation, Inc. [NCI U10 CA076001]; Breast Cancer Research Foundation; Novartis; Pfizer; Center grant [NCI P50 CA94056]; NCI core grant [NCI 3P50 CA68438]; NATIONAL CANCER INSTITUTE [U24CA143858, U10CA076001, P30CA016672, P30CA091842, R01CA095614, P50CA094056, U01CA114722, P50CA068438] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Fashion Footwear Charitable Foundation, Inc.; Breast Cancer Research Foundation; Novartis(Novartis); Pfizer(Pfizer); Center grant; NCI core grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This article is dedicated to the memory of Evelyn Lauder in recognition of her efforts to eradicate breast cancer. We would like to thank the participating patients and their families, clinical investigators and their support staffs, and J. A. Zujewski and the Cancer Therapy Evaluation Program at the US National Cancer Institute. We would like to acknowledge the efforts of the following people and groups at The Genome Institute for their contributions to this manuscript: the Analysis Pipeline group for developing the automated analysis pipelines that generated alignments and somatic variants; the LIMS group for developing tools to manage validation array ordering, capture and sequencing, and J. Veizer and H. Schmidt for structural variant and recurrent screening analyses. We thank the many members of the Siteman Cancer Center at Washington University in St Louis for support, and the committed members of the American College of Surgeons Oncology Group and their patients for contributing samples to the Z1031 trial. This work was funded by grants to R. K. W. from the National Human Genome Research Institute (NHGRI U54 HG003079), grants to M. J. E. from the National Cancer Institute (NCI R01 CA095614, NCI U01 CA114722), the Susan G. Komen Breast Cancer Foundation (BCTR0707808), and the Fashion Footwear Charitable Foundation, Inc., grant awards to ACOSOG included NCI U10 CA076001, the Breast Cancer Research Foundation, and clinical trial support from Novartis and Pfizer, and a Center grant (NCI P50 CA94056) to D.P.-W. We also acknowledge institutional support in the form of the Washington University Cancer Genome Initiative (R. K. W.), and a productive partnership with Illumina, Inc. The tissue procurement core was supported by an NCI core grant to the Siteman Cancer Center (NCI 3P50 CA68438). The BRIGHT Institute is supported in part by an ATT/Emerson gift to the Siteman Cancer Center.	Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chen Z, 2007, BLOOD, V110, P171, DOI 10.1182/blood-2007-02-071589; Chia YH, 2010, BRIT J CANCER, V103, P759, DOI 10.1038/sj.bjc.6605845; Dees N., GENOME RES IN PRESS; Delle H, 2012, J AM SOC NEPHROL, V23, P37, DOI 10.1681/ASN.2011010046; Ellis MJ, 2008, J NATL CANCER I, V100, P1380, DOI 10.1093/jnci/djn309; Ellis MJ, 2011, J CLIN ONCOL, V29, P2342, DOI 10.1200/JCO.2010.31.6950; Ellis MJ, 2010, BREAST CANCER RES TR, V119, P379, DOI 10.1007/s10549-009-0575-y; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lamant L, 2003, GENE CHROMOSOME CANC, V37, P427, DOI 10.1002/gcc.10232; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mao SF, 1999, MOL CELL BIOL, V19, P3635; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Olson JA, 2009, J AM COLL SURGEONS, V208, P906, DOI 10.1016/j.jamcollsurg.2009.01.035; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Prat A, 2009, NAT MED, V15, P842, DOI 10.1038/nm0809-842; PROSSER J, 1990, ONCOGENE, V5, P1573; Rajaram V, 2007, GENE CHROMOSOME CANC, V46, P508, DOI 10.1002/gcc.20437; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Spirin KS, 1996, CANCER RES, V56, P2400; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; Tararuk T, 2006, J CELL BIOL, V173, P265, DOI 10.1083/jcb.200511055; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang XX, 2011, PATHOL ONCOL RES, V17, P429, DOI 10.1007/s12253-010-9316-0; Wendl MC, 2011, BIOINFORMATICS, V27, P1595, DOI 10.1093/bioinformatics/btr193; Westerlund N, 2011, NAT NEUROSCI, V14, P305, DOI 10.1038/nn.2755; Widmann C, 1997, ONCOGENE, V15, P2439, DOI 10.1038/sj.onc.1201421; Wilund KR, 2002, HUM MOL GENET, V11, P3019, DOI 10.1093/hmg/11.24.3019; Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007	45	755	781	3	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					353	360		10.1038/nature11143	http://dx.doi.org/10.1038/nature11143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722193	Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000305466800034
J	Lounkine, E; Keiser, MJ; Whitebread, S; Mikhailov, D; Hamon, J; Jenkins, JL; Lavan, P; Weber, E; Doak, AK; Cote, S; Shoichet, BK; Urban, L				Lounkine, Eugen; Keiser, Michael J.; Whitebread, Steven; Mikhailov, Dmitri; Hamon, Jacques; Jenkins, Jeremy L.; Lavan, Paul; Weber, Eckhard; Doak, Allison K.; Cote, Serge; Shoichet, Brian K.; Urban, Laszlo			Large-scale prediction and testing of drug activity on side-effect targets	NATURE			English	Article							PHARMACOLOGY; NETWORK; DATABASE; IDENTIFICATION; INHIBITION; GENERATION; TOXICITY; HERG	Discovering the unintended 'off-targets' that predict adverse drug reactions is daunting by empirical methods alone. Drugs can act on several protein targets, some of which can be unrelated by conventional molecular metrics, and hundreds of proteins have been implicated in side effects. Here we use a computational strategy to predict the activity of 656 marketed drugs on 73 unintended 'side-effect' targets. Approximately half of the predictions were confirmed, either from proprietary databases unknown to the method or by new experimental assays. Affinities for these new off-targets ranged from 1nM to 30 mu M. To explore relevance, we developed an association metric to prioritize those new off-targets that explained side effects better than any known target of a given drug, creating a drug-target-adverse drug reaction network. Among these new associations was the prediction that the abdominal pain side effect of the synthetic oestrogen chlorotrianisene was mediated through its newly discovered inhibition of the enzyme cyclooxygenase-1. The clinical relevance of this inhibition was borne out in whole human blood platelet aggregation assays. This approach may have wide application to de-risking toxicological liabilities in drug discovery.	[Lounkine, Eugen; Whitebread, Steven; Mikhailov, Dmitri; Jenkins, Jeremy L.; Urban, Laszlo] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Keiser, Michael J.] SeaChange Pharmaceut Inc, San Francisco, CA 94158 USA; [Keiser, Michael J.; Doak, Allison K.; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Hamon, Jacques; Lavan, Paul; Weber, Eckhard; Cote, Serge] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland	Novartis; University of California System; University of California San Francisco; Novartis	Jenkins, JL (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	jeremy.jenkins@novartis.com; shoichet@cgl.ucsf.edu; laszlo.urban@novartis.com	Keiser, Michael J./F-2825-2016	Keiser, Michael J./0000-0002-1240-2192; Jenkins, Jeremy/0000-0001-9795-0771	US National Institutes of Health [GM71896, AG002132, GM93456]; QB3 Rogers Family Foundation 'Bridging-the-Gap' Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071896, R44GM093456, R43GM093456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002132] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); QB3 Rogers Family Foundation 'Bridging-the-Gap' Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	E. L. is a presidential postdoctoral fellow supported by the Education Office of the Novartis Institutes for Biomedical Research (co-mentors L. U. and B. K. S.). Supported by US National Institutes of Health grants GM71896 (to B. K. S. and J. Irwin), AG002132 (to S. Prusiner and B. K. S.), and GM93456 (to M. J. K.), and by QB3 Rogers Family Foundation 'Bridging-the-Gap' Award (to M. J. K.).	Akarasereenont P, 2006, PLATELETS, V17, P441, DOI 10.1080/09537100600745302; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antunes AMM, 2010, CHEM RES TOXICOL, V23, P1714, DOI 10.1021/tx100186t; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Azzaoui K, 2007, CHEMMEDCHEM, V2, P874, DOI 10.1002/cmdc.200700036; Bender A, 2007, CHEMMEDCHEM, V2, P861, DOI 10.1002/cmdc.200700026; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyer S, 2009, ATLA-ALTERN LAB ANIM, V37, P467, DOI 10.1177/026119290903700505; Brown EG, 1999, DRUG SAFETY, V20, P109, DOI 10.2165/00002018-199920020-00002; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cosgrove BD, 2010, MOL BIOSYST, V6, P1195, DOI 10.1039/b926287c; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Giacomini KM, 2007, NATURE, V446, P975, DOI 10.1038/446975a; Hert J, 2008, J CHEM INF MODEL, V48, P755, DOI 10.1021/ci8000259; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; James C.A., 2005, DAYLIGHT THEORY MANU; Ji ZL, 2003, DRUG SAFETY, V26, P685, DOI 10.2165/00002018-200326100-00002; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kong SX, 1998, AM J MANAG CARE, V4, P399; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Kuo CC, 2000, MOL PHARMACOL, V57, P135; Laggner C, 2012, NAT CHEM BIOL, V8, P144, DOI 10.1038/nchembio.732; Lee S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S2; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Marshall V, 2003, MOVEMENT DISORD, V18, pS22, DOI 10.1002/mds.10574; Matthews EJ, 2010, REGUL TOXICOL PHARM, V56, P247, DOI 10.1016/j.yrtph.2009.11.006; Mestres J, 2008, NAT BIOTECHNOL, V26, P983, DOI 10.1038/nbt0908-983; Mestres J, 2009, MOL BIOSYST, V5, P1051, DOI 10.1039/b905821b; Muchmore SW, 2008, J CHEM INF MODEL, V48, P941, DOI 10.1021/ci7004498; NORRIS LA, 1994, THROMB HAEMOSTASIS, V72, P926; Oprea TI, 2011, MOL INFORM, V30, P100, DOI 10.1002/minf.201100023; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Perrone MG, 2010, CURR MED CHEM, V17, P3769; Peters JU, 2009, CHEMMEDCHEM, V4, P680, DOI 10.1002/cmdc.200800411; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Rothman RB, 2000, CIRCULATION, V102, P2836; Roy ML, 1996, CIRCULATION, V94, P817, DOI 10.1161/01.CIR.94.4.817; Scheiber J, 2009, J MED CHEM, V52, P3103, DOI 10.1021/jm801546k; SCHOEN RT, 1989, AM J MED, V86, P449, DOI 10.1016/0002-9343(89)90344-6; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Stein SE, 2003, PROCEEDINGS OF THE 2003 INTERNATIONAL CHEMICAL INFORMATION CONFERENCE, P131; Tatonetti NP, 2011, CLIN PHARMACOL THER, V90, P133, DOI 10.1038/clpt.2011.83; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wong DR, 2005, CURR OPIN PHARMACOL, V5, P204, DOI 10.1016/j.coph.2005.02.001; Yang L, 2009, NUCLEIC ACIDS RES, V37, pW406, DOI 10.1093/nar/gkp312; Yang XA, 2010, J BIOMED INFORM, V43, P376, DOI 10.1016/j.jbi.2010.04.006; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhang JX, 2007, BIOINFORMATICS, V23, P1710, DOI 10.1093/bioinformatics/btm139	53	588	599	15	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					361	+		10.1038/nature11159	http://dx.doi.org/10.1038/nature11159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722194	Green Accepted, Green Submitted			2022-12-28	WOS:000305466800035
J	Turner, MS				Turner, Michael S.			Aspen physics turns 50	NATURE			English	Editorial Material									[Turner, Michael S.] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA	University of Chicago	Turner, MS (corresponding author), Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA.	mturner@kicp.uchicago.edu						ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393	1	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					315	317		10.1038/486315a	http://dx.doi.org/10.1038/486315a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722174	Bronze			2022-12-28	WOS:000305466800016
J	Hamers, RL; Kityo, C; Lange, JMA; de Wit, TFR; Mugyenyi, P				Hamers, Raph L.; Kityo, Cissy; Lange, Joep M. A.; de Wit, Tobias F. Rinke; Mugyenyi, Peter			Global threat from drug resistant HIV in sub-Saharan Africa	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIRETROVIRAL THERAPY; TIME TRENDS; CELL COUNT; INDIVIDUALS; MUTATIONS; FAILURE; PREVALENCE; MORTALITY; OUTCOMES		[Hamers, Raph L.; Lange, Joep M. A.; de Wit, Tobias F. Rinke] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Hamers, Raph L.; Lange, Joep M. A.; de Wit, Tobias F. Rinke] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Hamers, Raph L.; de Wit, Tobias F. Rinke] PharmAccess Fdn, Amsterdam, Netherlands; [Kityo, Cissy; Mugyenyi, Peter] Joint Clin Res Ctr, Kampala, Uganda	University of Amsterdam; Academic Medical Center Amsterdam; Joint Clinic Research Center - United Arab Emirates	Hamers, RL (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.hamers@aighd.org	de Wit, Tobias TF Rinke/A-1224-2013	Hamers, Raph/0000-0002-5007-7896				Aghokeng AF, 2011, AIDS, V25, P2183, DOI 10.1097/QAD.0b013e32834bbbe9; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bennett DE, 2008, ANTIVIR THER, V13, P1; Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; Cane P, 2005, BMJ-BRIT MED J, V331, P1368, DOI 10.1136/bmj.38665.534595.55; Clinton HIV AIDS initiative, ARV PRIC 2011; Cohen MS, 2011, N ENGL J MED; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hamers R, 2012, 19 C RETR OPP INF SE; Hamers RL, 2012, CLIN INFECT DIS, V54, pS261, DOI 10.1093/cid/cir995; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hosseinipour MC, 2010, HIV MED, V11, P510, DOI 10.1111/j.1468-1293.2010.00825.x; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Panel on Antiretroviral Guidelines for Adults and Adolescent, 2011, PAN ANT GUID AD AD G; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Phillips AN, 2002, AIDS, V16, P1073, DOI 10.1097/00002030-200205030-00016; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Resch S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025310; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Sigaloff KCE, 2012, J INFECT DIS, V205, P1739, DOI 10.1093/infdis/jis261; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Stevens WS, 2010, J INFECT DIS, V201, pS16, DOI 10.1086/650392; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Fernandez-Montero JV, 2009, EXPERT OPIN PHARMACO, V10, P1615, DOI 10.1517/14656560902980202; Wainberg MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMra1004180; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; WHO, 2003, SCAL ANT THER EXP UG; WHO, ANT THER HIV INF AD; Wilson D, 2009, T ROY SOC TROP MED H, V103, P601, DOI 10.1016/j.trstmh.2008.11.007; [World Health Organization Joint United Nations Programme on HIV/AIDS], 2011, GLOB HIV AIDS REP EP; World Health Organization, 2021, ANT DRUGS TREAT PREG	36	31	31	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 18	2012	344								e4159	10.1136/bmj.e4159	http://dx.doi.org/10.1136/bmj.e4159			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965BT	22709963				2022-12-28	WOS:000305741800008
J	Hellstrom, J				Hellstrom, John			Absolute Dating of Cave Art	SCIENCE			English	Editorial Material							AGE		Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia	University of Melbourne	Hellstrom, J (corresponding author), Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia.	j.hellstrom@unimelb.edu.au	Hellstrom, John C/B-1770-2008	Hellstrom, John C/0000-0001-9427-3525				Aubert M, 2012, J ARCHAEOL SCI, V39, P573, DOI 10.1016/j.jas.2011.11.009; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Drysdale RN, 2009, SCIENCE, V325, P1527, DOI 10.1126/science.1170371; Drysdale RN, 2007, GEOLOGY, V35, P77, DOI 10.1130/G23161A.1; EDWARDS RL, 1987, EARTH PLANET SC LETT, V81, P175, DOI 10.1016/0012-821X(87)90154-3; Hellstrom J, 2003, J ANAL ATOM SPECTROM, V18, P1346, DOI 10.1039/b308781f; Hoffmann DL, 2009, CHEM GEOL, V259, P253, DOI 10.1016/j.chemgeo.2008.11.015; Pettitt P, 2007, J ARCHAEOL METHOD TH, V14, P27, DOI 10.1007/s10816-007-9026-4; Pike AWG, 2012, SCIENCE, V336, P1409, DOI 10.1126/science.1219957; Pike AWG, 2005, J ARCHAEOL SCI, V32, P1649, DOI 10.1016/j.jas.2005.05.002; St Pierre E, 2012, J ARCHAEOL SCI, V39, P922, DOI 10.1016/j.jas.2011.10.027; Tacon PSC, 2012, J ARCHAEOL SCI, V39, P492, DOI 10.1016/j.jas.2011.10.004	12	7	7	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2012	336	6087					1387	1388		10.1126/science.1224185	http://dx.doi.org/10.1126/science.1224185			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	958BT	22700907				2022-12-28	WOS:000305211700027
J	Westhoff, JL; Koepsell, TD; Littell, CT				Westhoff, John L.; Koepsell, Thomas D.; Littell, Christopher T.			Effects of experience and commercialisation on survival in Himalayan mountaineering: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							NATIONAL-PARKS; MOUNT EVEREST; FATALITIES; MORTALITY; SEARCH; RESCUE; DEATH; SPORT	Objectives To determine whether previous Himalayan experience is associated with a decreased risk of climbing death, and whether mountaineers participating in commercial expeditions differ in their risk of death relative to those participating in traditional climbs. Design Retrospective cohort study. Setting Expeditions in the Nepalese Himalayan peaks, from 1 January 1970 to the spring climbing season in 2010. Participants 23 995 non-porters venturing above base camp on 39 038 climbs, 23 295 on 8000 m peaks. Outcome Death. Results After controlling for use of standard route, peak, age, season, sex, summit success, and year of expedition, increased Himalayan experience was not associated with a change in the odds of death (odds ratio 1.00, 95% confidence interval 0.96 to 1.05, P=0.904). Participation in a commercial climb was associated with a 37% lower odds of death relative to a traditional venture, although not significantly (0.63, 0.37 to 1.09, P=0.100). Choice of peak was clearly associated with altered odds of death (omnibus P<0.001); year of expedition was associated with a significant trend toward reduced odds of death (0.98, 0.96 to 0.99, P=0.011). Conclusions No net survival benefit is associated with increased Himalayan experience or participation in a traditional (versus commercial) venture. The incremental decrease in risk associated with calendar year suggests that cumulative, collective knowledge and general innovation are more important than individual experience in improving the odds of survival.	[Westhoff, John L.; Littell, Christopher T.] Madigan Healthcare Syst, Dept Prevent Med, Tacoma, WA 98431 USA; [Koepsell, Thomas D.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Westhoff, JL (corresponding author), Madigan Healthcare Syst, Dept Prevent Med, Tacoma, WA 98431 USA.	john.westhoff@us.army.mil						AVERY JG, 1990, PUBLIC HEALTH, V104, P417, DOI 10.1016/S0033-3506(05)80084-8; Boyce JR, 2010, J SPORT ECON, V11, P496, DOI 10.1177/1527002509355639; Christensen ED, 1999, AM J FOREN MED PATH, V20, P173, DOI 10.1097/00000433-199906000-00014; Firth PG, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2654; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hansen E, 2011, OUTSIDE MAGAZINE APR, P46; Heggie TW, 2008, WILD ENVIRON MED, V19, P164, DOI 10.1580/07-WEME-OR-178.1; Heggie Travis W, 2008, Travel Med Infect Dis, V6, P355, DOI 10.1016/j.tmaid.2008.07.002; Heggie TW, 2009, WILD ENVIRON MED, V20, P244, DOI 10.1580/08-WEME-OR-299R.1; Huey RB, 2007, BIOL LETTERS, V3, P498, DOI 10.1098/rsbl.2007.0317; Huey RB, 2000, JAMA-J AM MED ASSOC, V284, P181, DOI 10.1001/jama.284.2.181-a; Huey RB, 2001, J EXP BIOL, V204, P3115; Huey RB, 2003, AM ALPINE J, V2, P10; LATTIMORE C, 1993, J WILDERNESS MED, V4, P358, DOI 10.1580/0953-9859-4.4.358; Miglioretti DL, 2007, AM J EPIDEMIOL, V165, P453, DOI 10.1093/aje/kwk020; Miglioretti DL, 2004, BIOSTATISTICS, V5, P381, DOI 10.1093/biostatistics/kxg042; Monasterio M Erik, 2005, N Z Med J, V118, pU1249; O'Neil D, 2010, ROCK ICE MAGAZIN SEP, P42; Preston SH, 2006, SERVICE IRAQ JUST RI; Salisbury R., 2011, HIMALAYA NUMBERS STA; Tumbat G, 2011, J CONSUM RES, V38, P42, DOI 10.1086/658220; Viesturs E, 2006, NO SHORTCUTS TOP CLI; Weinbruch S, 2010, HIGH ALT MED BIOL, V11, P147, DOI 10.1089/ham.2009.1079; Windsor JS, 2009, POSTGRAD MED J, V85, P316, DOI 10.1136/pgmj.2009.078824	24	19	19	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 13	2012	344								e3782	10.1136/bmj.e3782	http://dx.doi.org/10.1136/bmj.e3782			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961KT	22695902	Green Published, hybrid			2022-12-28	WOS:000305464000012
J	Chanchlani, N; Neale, E; Rylance, PB				Chanchlani, Neil; Neale, Elizabeth; Rylance, Paul B.			A South African man with renal failure and pulmonary shadowing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; DIAGNOSIS; DISEASE; PNEUMONIA; ERA		[Chanchlani, Neil; Neale, Elizabeth] Univ Birmingham, Birmingham B29 7PU, W Midlands, England; [Rylance, Paul B.] Royal Wolverhampton NHS Trust, New Cross Hosp, Wolverhampton, W Midlands, England	University of Birmingham; New Cross Hospital	Chanchlani, N (corresponding author), Univ Birmingham, Birmingham B29 7PU, W Midlands, England.	nxc651@bham.ac.uk		Chanchlani, Neil/0000-0003-0207-6706				Atta MG, 2004, J ULTRAS MED, V23, P603, DOI 10.7863/jum.2004.23.5.603; Betjes MGH, 2001, NETH J MED, V59, P111, DOI 10.1016/S0300-2977(01)00141-3; BOURGOIGNIE JJ, 1988, AM J KIDNEY DIS, V12, P131, DOI 10.1016/S0272-6386(88)80008-8; Trullas JC, 2010, JAIDS-J ACQ IMM DEF, V55, P582, DOI 10.1097/QAI.0b013e3181efbe59; Carmona Eva M, 2011, Ther Adv Respir Dis, V5, P41, DOI 10.1177/1753465810380102; Cosgrove CJ, 2002, AM J MED SCI, V323, P102, DOI 10.1097/00000441-200202000-00009; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Durand-Joly I, 2005, FEMS IMMUNOL MED MIC, V45, P405, DOI 10.1016/j.femsim.2005.06.006; Fine DM, 2008, DRUGS, V68, P963, DOI 10.2165/00003495-200868070-00006; Ford N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010460; Helweg-Larsen J, 2009, J ANTIMICROB CHEMOTH, V64, P1282, DOI 10.1093/jac/dkp372; Izzedine H, 2009, NAT REV NEPHROL, V5, P564, DOI 10.1038/nrneph.2009.142; Jayne D, 2009, BEST PRACT RES CL RH, V23, P445, DOI 10.1016/j.berh.2009.03.001; Kalayjian RC, 2010, ADV CHRONIC KIDNEY D, V17, P59, DOI 10.1053/j.ackd.2009.08.013; Kichner JT, 2002, AIDS READ, V12, P110; KICHNER JT, 2002, AIDS READ, V12, P103; Lewington A, 2010, ACUTE KIDNEY INJURY; Mazuecos A, 2011, NEPHROL DIAL TRANSPL, V26, P1401, DOI 10.1093/ndt/gfq592; Monnet X, 2008, CRIT CARE, V12, DOI 10.1186/cc6806; Morris A, 2003, AIDS, V17, P73, DOI 10.1097/00002030-200301030-00010; Roling J, 2006, CLIN INFECT DIS, V42, P1488, DOI 10.1086/503566; Savige J, 2005, BEST PRACT RES CL RH, V19, P263, DOI 10.1016/j.berh.2004.10.003; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Touzot M, 2010, AM J TRANSPLANT, V10, P2263, DOI 10.1111/j.1600-6143.2010.03258.x; Wyatt CM, 2007, AM J MED, V120, P488, DOI 10.1016/j.amjmed.2007.01.025	25	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 11	2012	344								e2789	10.1136/bmj.e2789	http://dx.doi.org/10.1136/bmj.e2789			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961KJ	22689885				2022-12-28	WOS:000305463000001
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Behavioral Counseling Interventions to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							RISK	Description: Update of the 2003 and 2002 U. S. Preventive Services Task Force (USPSTF) recommendation statements on behavioral counseling to promote a healthful diet and physical activity in adults without preexisting cardiovascular disease (CVD) or its risk factors. Methods: The USPSTF reviewed new evidence on whether counseling interventions relevant to primary care for physical activity or a healthful diet modify self-reported behaviors; intermediate physiologic outcomes (for example, reduced lipid levels, blood pressure, weight, and body mass index and increased glucose tolerance); and cardiovascular morbidity and mortality in adults without known CVD, hypertension, hyperlipidemia, or diabetes. Population: General adult population without a known diagnosis of hypertension, diabetes, hyperlipidemia, or CVD. Recommendation: Although the correlation among healthful diet, physical activity, and the incidence of CVD is strong, existing evidence indicates that the health benefit of initiating behavioral counseling in the primary care setting to promote a healthful diet and physical activity is small. Clinicians may choose to selectively counsel patients rather than incorporate counseling into the care of all adults in the general population. Issues to consider include other risk factors for CVD, a patient's readiness for change, social support and community resources that support behavioral change, and other health care and preventive service priorities. Harms may include the lost opportunity to provide other services that have a greater health effect. This is a grade C recommendation.	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.				USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The U.S. Congress mandates that the Agency for Healthcare Research and Quality support the operations of the USPSTF.; Dr. Moyer: Consulting fee or honorarium: USPSTF. Support for travel to meetings for the study or other purposes: USPSTF. Disclosure forms from USPSTF members can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum = M12-1261.	American Academy of Family Physicians, 2012, SUMM REC CLIN PREV S; Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Lin JS, 2010, ANN INTERN MED, V153, P736, DOI 10.7326/0003-4819-153-11-201012070-00007; Lin JS, 2010, AHRQ PUBLICATION; U.S. Department of Health and Human Services and U.S. Department of Agriculture, 2010, AGRICULTURE; US Department of Health and Human Services, 2008, ODPHP PUBL U, VU0036; Valderrama Amy L., 2011, Morbidity and Mortality Weekly Report, V60, P1248	9	58	61	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2012	157	5					367	U119		10.7326/0003-4819-157-5-201209040-00486	http://dx.doi.org/10.7326/0003-4819-157-5-201209040-00486			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000BM	22733153				2022-12-28	WOS:000308361500006
J	Aral, S; Walker, D				Aral, Sinan; Walker, Dylan			Identifying Influential and Susceptible Members of Social Networks	SCIENCE			English	Article							CONTAGION; IDENTIFICATION; DIVERSITY; SPREAD	Identifying social influence in networks is critical to understanding how behaviors spread. We present a method that uses in vivo randomized experimentation to identify influence and susceptibility in networks while avoiding the biases inherent in traditional estimates of social contagion. Estimation in a representative sample of 1.3 million Facebook users showed that younger users are more susceptible to influence than older users, men are more influential than women, women influence men more than they influence other women, and married individuals are the least susceptible to influence in the decision to adopt the product offered. Analysis of influence and susceptibility together with network structure revealed that influential individuals are less susceptible to influence than noninfluential individuals and that they cluster in the network while susceptible individuals do not, which suggests that influential people with influential friends may be instrumental in the spread of this product in the network.	[Aral, Sinan; Walker, Dylan] NYU, Stern Sch Business, New York, NY 10012 USA	New York University	Aral, S (corresponding author), NYU, Stern Sch Business, 550 1St Ave, New York, NY 10012 USA.	sinan@stern.nyu.edu; dwalker@stern.nyu.edu		Aral, Sinan/0000-0002-2762-058X	Microsoft; NSF [0953832]	Microsoft(Microsoft); NSF(National Science Foundation (NSF))	We thank S. Aral, H. Frydman, C. Hurvich, P. Perry, J. Simonoff, and M. Sternberg for invaluable discussions. Supported by a Microsoft research faculty fellowship (S. A.) and by NSF Career Award 0953832 (S. A.). The research was approved by the NYU institutional review board. There are legal obstacles to making the data available, but code is available upon request. The requests for data and randomization of message targets we used are standard ways in which applications request and use user data on Facebook. They are covered by the Facebook privacy policy and terms of service. Opt-in permissions were granted by the user to the application developer on a per-application basis when the user installed the application, via Facebook application authentication dialogs. In the dialogs we asked for all the categories of data we used in the study, and all of these requests were in line with the Facebook terms of service. Users saw these requests and opted in to them before installing the app.	Aral S, 2011, IEEE INTELL SYST, V26, P91, DOI 10.1109/MIS.2011.89; Aral S, 2011, MANAGE SCI, V57, P1623, DOI 10.1287/mnsc.1110.1421; Aral S, 2011, AM J SOCIOL, V117, P90, DOI 10.1086/661238; Aral S, 2011, MARKET SCI, V30, P217, DOI 10.1287/mksc.1100.0596; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Bakshy E., 2012, WWW 12 P 21 INT C WO, P519, DOI DOI 10.1145/2187836.2187907; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Currarini S, 2010, P NATL ACAD SCI USA, V107, P4857, DOI 10.1073/pnas.0911793107; Dodds PS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.218701; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Godes D, 2005, MARKET LETT, V16, P415, DOI 10.1007/s11002-005-5902-4; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Hartmann WR, 2008, MARKET LETT, V19, P287, DOI 10.1007/s11002-008-9048-z; Heath C, 2001, J PERS SOC PSYCHOL, V81, P1028, DOI 10.1037//0022-3514.81.6.1028; Iyengar R, 2011, MARKET SCI, V30, P195, DOI 10.1287/mksc.1100.0566; KATZ E, 1957, PUBLIC OPIN QUART, V21, P61, DOI 10.1086/266687; Kempe D., 2003, P 9 ACM SIGKDD INT C, P137, DOI DOI 10.1145/956750.956769; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Leider S, 2009, Q J ECON, V124, P1815, DOI 10.1162/qjec.2009.124.4.1815; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Lyons Russel, 2011, STAT POLITICS POLICY, V2, P1, DOI DOI 10.2202/2151-7509.1024; MANSKI CF, 1993, SOCIOL METHODOL, V23, P1, DOI 10.2307/271005; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Sun E., 2009, P 3 INT C WEBL SOC M; Valente T, 1995, NETWORK MODELS DIFFU; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527	32	616	654	16	439	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					337	341		10.1126/science.1215842	http://dx.doi.org/10.1126/science.1215842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	975WQ	22722253				2022-12-28	WOS:000306542600050
J	Hendricks, M; Ha, H; Maffey, N; Zhang, Y				Hendricks, Michael; Ha, Heonick; Maffey, Nicolas; Zhang, Yun			Compartmentalized calcium dynamics in a C. elegans interneuron encode head movement	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GLUTAMATE-RECEPTOR; NERVOUS-SYSTEM; BEHAVIOR; CIRCUIT; DENDRITES; G(Q)ALPHA; RELEASE; NEURONS; PATHWAY	The confinement of neuronal activity to specific subcellular regions is a mechanism for expanding the computational properties of neurons. Although the circuit organization underlying compartmentalized activity has been studied in several systems(1-4), its cellular basis is still unknown. Here we characterize compartmentalized activity in Caenorhabditis elegans RIA interneurons, which have multiple reciprocal connections to head motor neurons and receive input from sensory pathways. We show that RIA spatially encodes head movement on a subcellular scale through axonal compartmentalization. This subcellular axonal activity is dependent on acetylcholine release from head motor neurons and is simultaneously present and additive with glutamate-dependent globally synchronized activity evoked by sensory inputs. Postsynaptically, the muscarinic acetylcholine receptor GAR-3 acts in RIA to compartmentalize axonal activity through the mobilization of intracellular calcium stores. The compartmentalized activity functions independently of the synchronized activity to modulate locomotory behaviour.	[Hendricks, Michael; Ha, Heonick; Maffey, Nicolas; Zhang, Yun] Harvard Univ, Ctr Brain Sci, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Zhang, Y (corresponding author), Harvard Univ, Ctr Brain Sci, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	yzhang@oeb.harvard.edu		Hendricks, Michael/0000-0002-3408-3858	Esther A. and Joseph Klingenstein Fund; March of Dimes Foundation; Alfred P. Sloan Foundation; John Merck Fund; National Institutes of Health [DC009852]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009852] Funding Source: NIH RePORTER	Esther A. and Joseph Klingenstein Fund; March of Dimes Foundation(March of Dimes); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); John Merck Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the Caenorhabditis Genetics Center and C. elegans Gene Knockout Consortium for C. elegans strains; the Wellcome Trust Sanger Institute for cosmid; C. Bargmann for the TeTx cDNA, eat-4 cDNA and Pttx-3::GCaMP strain; Y. Kohara for the gar-3 cDNA; J. Nakai for the GCaMP DNA; N. Bhatla for help with integration; L. Tian and L. Looger for the GCaMP3.3 plasmid; Y. Shen for the lad-2 promoter; and C. Bargmann, K. Blum, F. Engert, C. Fang-Yen, S. Hendricks, S. Jesuthasan, A. Samuel, J. Sanes, E. Soucy and members of the Zhang laboratory for advice and discussion. M. H. thanks S. Moser for personal support. This work was supported by funding from The Esther A. and Joseph Klingenstein Fund, the March of Dimes Foundation, the Alfred P. Sloan Foundation, the John Merck Fund and the National Institutes of Health (DC009852) to Y.Z.	Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Ha HI, 2010, NEURON, V68, P1173, DOI 10.1016/j.neuron.2010.11.025; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Liu YS, 2007, J NEUROSCI, V27, P1411, DOI 10.1523/JNEUROSCI.4320-06.2007; Lockery SR, 2011, CURR OPIN NEUROBIOL, V21, P782, DOI 10.1016/j.conb.2011.06.009; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; Park YS, 2003, BIOCHEM BIOPH RES CO, V308, P961, DOI 10.1016/S0006-291X(03)01508-0; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Rand James B., 1997, Cold Spring Harbor Monograph Series, V33, P611; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Steger KA, 2004, GENETICS, V167, P633, DOI 10.1534/genetics.103.020230; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wang XL, 2008, J CELL BIOL, V180, P233, DOI 10.1083/jcb.200704178; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhu JJ, 2001, J NEUROSCI, V21, P1148	30	94	95	4	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 5	2012	487	7405					99	+		10.1038/nature11081	http://dx.doi.org/10.1038/nature11081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968LM	22722842	Green Accepted			2022-12-28	WOS:000305982900058
J	Weng, JK; Philippe, RN; Noel, JP				Weng, Jing-Ke; Philippe, Ryan N.; Noel, Joseph P.			The Rise of Chemodiversity in Plants	SCIENCE			English	Review							LIGNIN BIOSYNTHESIS; GENE-CLUSTER; EVOLUTION; PROTEIN; IDENTIFICATION; EVOLVABILITY; ARABIDOPSIS; METABOLISM; SYNTHASES	Plants possess multifunctional and rapidly evolving specialized metabolic enzymes. Many metabolites do not appear to be immediately required for survival; nonetheless, many may contribute to maintaining population fitness in fluctuating and geographically dispersed environments. Others may serve no contemporary function but are produced inevitably as minor products by single enzymes with varying levels of catalytic promiscuity. The dominance of the terrestrial realm by plants likely mirrored expansion of specialized metabolism originating from primary metabolic pathways. Compared with their evolutionarily constrained counterparts in primary metabolism, specialized metabolic enzymes may be more tolerant to mutations normally considered destabilizing to protein structure and function. If this is true, permissiveness may partially explain the pronounced chemodiversity of terrestrial plants.	[Weng, Jing-Ke; Philippe, Ryan N.; Noel, Joseph P.] Salk Inst Biol Studies, Howard Hughes Med Inst, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute	Noel, JP (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Jack H Skirball Ctr Chem Biol & Prote, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	noel@salk.edu	Weng, Jing-Ke/E-7343-2013; Weng, Jing-Ke/V-5934-2019; Weng, Jing-Ke/A-6900-2015; Ye, Mingli/G-4909-2012; Noel, Joseph P/A-9459-2009	Weng, Jing-Ke/0000-0003-1079-3668; Weng, Jing-Ke/0000-0003-3059-0075; Weng, Jing-Ke/0000-0003-3059-0075; 	NSF; Pioneer Fund; Natural Sciences and Engineering Research Council of Canada	NSF(National Science Foundation (NSF)); Pioneer Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants from the NSF. J.-K.W. is supported by a postdoctoral fellowship from the Pioneer Fund; R.N.P. is supported by a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada; and J.P.N. is an investigator with the Howard Hughes Medical Institute.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2008, NAT CHEM BIOL, V4, P217, DOI 10.1038/nchembio0408-217; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Croteau Rodney, 2006, Phytochemistry Reviews, V5, P75, DOI 10.1007/s11101-005-3748-2; Fani R, 2009, PHYS LIFE REV, V6, P23, DOI 10.1016/j.plrev.2008.12.003; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Huang RQ, 2012, P NATL ACAD SCI USA, V109, P2966, DOI 10.1073/pnas.1019605109; Kienow L, 2008, J EXP BOT, V59, P403, DOI 10.1093/jxb/erm325; Kopycki JG, 2008, J MOL BIOL, V378, P154, DOI 10.1016/j.jmb.2008.02.019; Landmann C, 2011, PLANTA, V234, P305, DOI 10.1007/s00425-011-1400-5; Lim EK, 2001, J BIOL CHEM, V276, P4344, DOI 10.1074/jbc.M007263200; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; O'Maille PE, 2008, NAT CHEM BIOL, V4, P617, DOI 10.1038/nchembio.113; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Petersen M, 2009, PHYTOCHEMISTRY, V70, P1663, DOI 10.1016/j.phytochem.2009.05.010; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Schilmiller AL, 2012, CURR OPIN PLANT BIOL, V15, P338, DOI 10.1016/j.pbi.2011.12.005; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Weng JK, 2011, PLANT CELL, V23, P2708, DOI 10.1105/tpc.110.081547; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607	29	234	237	6	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1667	1670		10.1126/science.1217411	http://dx.doi.org/10.1126/science.1217411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745420				2022-12-28	WOS:000305794500039
J	Clark, PJ; Muir, AJ				Clark, Paul J.; Muir, Andrew J.			Overcoming Barriers to Care for Hepatitis C	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Clark, Paul J.] Duke Univ, Med Ctr, Dept Gastroenterol, Durham, NC 27708 USA; Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University	Clark, PJ (corresponding author), Duke Univ, Med Ctr, Dept Gastroenterol, Durham, NC 27708 USA.		Clark, Paul J/A-1480-2012	Clark, Paul J/0000-0002-1821-4969				Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Chung RT, 2012, NEW ENGL J MED, V366, P273, DOI 10.1056/NEJMe1113272; *I MED COMM PREV C, 2010, HEP LIV CANC NAT STR; Stepanova M, 2011, HEPATOLOGY, V53, P737, DOI 10.1002/hep.24131; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220	5	24	24	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2436	2438		10.1056/NEJMp1202608	http://dx.doi.org/10.1056/NEJMp1202608			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965DP	22738095				2022-12-28	WOS:000305747000002
J	Conley, DJ				Conley, Daniel J.			Save the Baltic Sea	NATURE			English	Editorial Material									Lund Univ, GeoBiosphere Sci Ctr, Dept Geol, S-22100 Lund, Sweden	Lund University	Conley, DJ (corresponding author), Lund Univ, GeoBiosphere Sci Ctr, Dept Geol, S-22100 Lund, Sweden.	daniel.conley@geol.lu.se		Conley, Daniel Joseph/0000-0001-9668-9284				Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3407, DOI 10.1021/es8027633; Gustafsson B. G, 2012, AMBIO; Kumblad L., 2011, FOSFORFALLNING FORBA; Meier HEM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049929; Stigebrandt A, 2007, AMBIO, V36, P280, DOI 10.1579/0044-7447(2007)36[280:IOBPWQ]2.0.CO;2	5	82	83	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					463	464		10.1038/486463a	http://dx.doi.org/10.1038/486463a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22739295				2022-12-28	WOS:000305760600016
J	Harris, TH; Banigan, EJ; Christian, DA; Konradt, C; Wojno, EDT; Norose, K; Wilson, EH; John, B; Weninger, W; Luster, AD; Liu, AJ; Hunter, CA				Harris, Tajie H.; Banigan, Edward J.; Christian, David A.; Konradt, Christoph; Wojno, Elia D. Tait; Norose, Kazumi; Wilson, Emma H.; John, Beena; Weninger, Wolfgang; Luster, Andrew D.; Liu, Andrea J.; Hunter, Christopher A.			Generalized Levy walks and the role of chemokines in migration of effector CD8(+) T cells	NATURE			English	Article							TOXOPLASMA-GONDII; RESISTANCE; MOVEMENT; MOTILITY; SUCCESS; LAWS	Chemokines have a central role in regulating processes essential to the immune function of T cells(1-3), such as their migration within lymphoid tissues and targeting of pathogens in sites of inflammation. Here we track T cells using multi-photon microscopy to demonstrate that the chemokine CXCL10 enhances the ability of CD8(+) T cells to control the pathogen Toxoplasma gondii in the brains of chronically infected mice. This chemokine boosts T-cell function in two different ways: it maintains the effector T-cell population in the brain and speeds up the average migration speed without changing the nature of the walk statistics. Notably, these statistics are not Brownian; rather, CD8(+) T-cell motility in the brain is well described by a generalized Levy walk. According to our model, this unexpected feature enables T cells to find rare targets with more than an order of magnitude more efficiency than Brownian random walkers. Thus, CD8(+) T-cell behaviour is similar to Levy strategies reported in organisms ranging from mussels to marine predators and monkeys(4-10), and CXCL10 aids T cells in shortening the average time taken to find rare targets.	[Banigan, Edward J.; Liu, Andrea J.] Univ Penn, Sch Arts & Sci, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Harris, Tajie H.; Christian, David A.; Konradt, Christoph; Wojno, Elia D. Tait; John, Beena; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Norose, Kazumi] Chiba Univ, Grad Sch Med, Dept Infect & Host Def, Chuo Ku, Chiba 2608670, Japan; [Wilson, Emma H.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Weninger, Wolfgang] Centenary Inst, Newtown, NSW 2042, Australia; [Weninger, Wolfgang] Sydney Med Sch, Discipline Dermatol, Sydney, NSW 2006, Australia; [Luster, Andrew D.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA	University of Pennsylvania; University of Pennsylvania; Chiba University; University of California System; University of California Riverside; University of Sydney; Centenary Institute; University of Sydney; Harvard University; Massachusetts General Hospital	Liu, AJ (corresponding author), Univ Penn, Sch Arts & Sci, Dept Phys & Astron, 209 S 33rd St, Philadelphia, PA 19104 USA.	ajliu@physics.upenn.edu; chunter@vet.upenn.edu	Christian, David/AAE-6425-2019; Liu, Andrea J/K-3968-2017; Liu, Andrea/GYD-4759-2022; Luster, Andrew/ABE-6504-2020; Norose, Kazumi/HGE-1796-2022	Liu, Andrea J/0000-0002-2295-2729; Liu, Andrea/0000-0002-2295-2729; Luster, Andrew/0000-0001-9679-7912; Weninger, Wolfgang/0000-0003-3133-8699; Banigan, Edward/0000-0001-5478-7425; Tait Wojno, Elia/0000-0003-2822-296X; Harris, Tajie/0000-0002-1355-2109	National Institutes of Health [AI-41158, AI-42334, EY-021314, T32-AI-055400, AI-081478, CA-069212, RNS-072298, AI-090234]; National Science Foundation [DMR-0520020, DMR-1104637]; state of Pennsylvania; Japan Society for the Promotion of Science [20592071]; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL CANCER INSTITUTE [R01CA069212] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY021314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007532, R21AI090234, F32AI098374, R01AI041158, T32AI055400, F32AI081478, R01AI042334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072298] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1104637] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); state of Pennsylvania; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by grants from the National Institutes of Health AI-41158 (C. A. H.), AI-42334 (C. A. H.), EY-021314 (C. A. H.), T32-AI-055400 (T. H. H.), AI-081478 (T. H. H.), CA-069212 (A. D. L.), RNS-072298 (E. H. W.) and AI-090234 (B.J.); the National Science Foundation DMR-0520020 (E.J.B.) and DMR-1104637 (E.J.B. and A.J.L.); the state of Pennsylvania; Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research Grant 20592071 (K.N.); and the Ministry of Education, Culture, Sports, Science and Technology of Japan (K.N.). We acknowledge L. Zhang and the Penn Vet Imaging Facility for technical assistance.	Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Budhu S, 2010, J EXP MED, V207, P223, DOI 10.1084/jem.20091279; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Denkers EY, 1997, J IMMUNOL, V159, P1903; Dzierszinski F, 2007, INFECT IMMUN, V75, P5200, DOI 10.1128/IAI.00954-07; Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Khan IA, 2000, IMMUNITY, V12, P483, DOI 10.1016/S1074-7613(00)80200-9; Li YM, 2004, J EXP MED, V200, P613, DOI 10.1084/jem.20040725; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Pepper M, 2004, INFECT IMMUN, V72, P7240, DOI 10.1128/IAI.72.12.7240-7246.2004; Potdar AA, 2009, ANN BIOMED ENG, V37, P230, DOI 10.1007/s10439-008-9592-y; Reynolds AM, 2009, J THEOR BIOL, V260, P98, DOI 10.1016/j.jtbi.2009.05.033; Reynolds AM, 2007, ECOLOGY, V88, P1955, DOI 10.1890/06-1916.1; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Strack A, 2002, GLIA, V40, P372, DOI 10.1002/glia.10104; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Wilson EH, 2009, IMMUNITY, V30, P300, DOI 10.1016/j.immuni.2008.12.013; ZUMOFEN G, 1995, PHYS REV E, V51, P1818, DOI 10.1103/PhysRevE.51.1818	33	347	352	1	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					545	U145		10.1038/nature11098	http://dx.doi.org/10.1038/nature11098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22722867	Green Submitted, Green Accepted			2022-12-28	WOS:000305760600046
J	Lagiou, P; Sandin, S; Lof, M; Trichopoulos, D; Adami, HO; Weiderpass, E				Lagiou, Pagona; Sandin, Sven; Lof, Marie; Trichopoulos, Dimitrios; Adami, Hans-Olov; Weiderpass, Elisabete			Low carbohydrate-high protein diet and incidence of cardiovascular diseases in Swedish women: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; LOW-FAT DIET; WEIGHT-LOSS; RISK; OBESITY; MEN; POPULATION; HEALTH; MORTALITY; SURVIVAL	Objective To study the long term consequences of low carbohydrate diets, generally characterised by concomitant increases in protein intake, on cardiovascular health. Design Prospective cohort study. Setting Uppsala, Sweden. Participants From a random population sample, 43 396 Swedish women, aged 30-49 years at baseline, completed an extensive dietary questionnaire and were followed-up for an average of 15.7 years. Main outcome measures Association of incident cardiovascular diseases (ascertained by linkage with nationwide registries), overall and by diagnostic category, with decreasing carbohydrate intake (in tenths), increasing protein intake (in tenths), and an additive combination of these variables (low carbohydrate-high protein score, from 2 to 20), adjusted for intake of energy, intake of saturated and unsaturated fat, and several non-dietary variables. Results A one tenth decrease in carbohydrate intake or increase in protein intake or a 2 unit increase in the low carbohydrate-high protein score were all statistically significantly associated with increasing incidence of cardiovascular disease overall (n=1270)-incidence rate ratio estimates 1.04 (95% confidence interval 1.00 to 1.08), 1.04 (1.02 to 1.06), and 1.05 (1.02 to 1.08). No heterogeneity existed in the association of any of these scores with the five studied cardiovascular outcomes: ischaemic heart disease (n=703), ischaemic stroke (n=294), haemorrhagic stroke (n=70), subarachnoid haemorrhage (n=121), and peripheral arterial disease (n=82). Conclusions Low carbohydrate-high protein diets, used on a regular basis and without consideration of the nature of carbohydrates or the source of proteins, are associated with increased risk of cardiovascular disease.	[Lagiou, Pagona] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Lagiou, Pagona; Trichopoulos, Dimitrios; Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Sandin, Sven; Lof, Marie; Adami, Hans-Olov; Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Lof, Marie] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, GR-10679 Athens, Greece; [Weiderpass, Elisabete] Canc Registry Norway, N-0310 Oslo, Norway; [Weiderpass, Elisabete] Univ Tromso, Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Samfundet Folkhalsan, Folkhalsan Res Ctr, Helsinki, Finland	Athens Medical School; National & Kapodistrian University of Athens; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Linkoping University; Academy of Athens; University of Oslo; UiT The Arctic University of Tromso; Folkhalsan Research Center; Samfundet Folkhalsan	Lagiou, P (corresponding author), Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, 75 M Asias St, GR-11527 Athens, Greece.	pdlagiou@med.uoa.gr	Weiderpass, Elisabete/M-4029-2016; Löf, Marie/AAW-3323-2020; Löf, Marie/ABB-2697-2020; Weiderpass, Elisabete/AAP-2747-2021; Sandin, Sven/ABE-2959-2021; Sandin, Sven/L-5357-2015	Weiderpass, Elisabete/0000-0003-2237-0128; Löf, Marie/0000-0002-2273-4430; Weiderpass, Elisabete/0000-0003-2237-0128; Sandin, Sven/0000-0001-6994-4884; Sandin, Sven/0000-0001-6994-4884	Swedish Cancer Society; Swedish Research Council	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported by grants from the Swedish Cancer Society and the Swedish Research Council. The study sponsors were not involved in the study design and the collection, analysis, and interpretation of data, nor the writing of the article or the decision to submit it for publication. The authors were independent from the study sponsors.	Astrup A, 2010, ANN NY ACAD SCI, V1190, P25, DOI 10.1111/j.1749-6632.2009.05272.x; Astrup A, 2004, LANCET, V364, P897, DOI 10.1016/S0140-6736(04)16986-9; Bergstrom L., 1991, Var Foda, V43, P439; Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165; Bessesen DH, 2008, J CLIN ENDOCR METAB, V93, P2027, DOI 10.1210/jc.2008-0520; Bravata DM, 2003, JAMA-J AM MED ASSOC, V289, P1837, DOI 10.1001/jama.289.14.1837; Foo SY, 2009, P NATL ACAD SCI USA, V106, P15418, DOI 10.1073/pnas.0907995106; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Fung TT, 2010, ANN INTERN MED, V153, P289, DOI 10.7326/0003-4819-153-5-201009070-00003; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Khani BR, 2004, J NUTR, V134, P1541, DOI 10.1093/jn/134.6.1541; Kleinbaum D, 1988, APPL REGRESSION ANAL; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lagiou P, 2007, J INTERN MED, V261, P366, DOI 10.1111/j.1365-2796.2007.01774.x; Larsson SC, 2011, AM J CLIN NUTR, V94, P417, DOI 10.3945/ajcn.111.015115; Li ZP, 2005, SURG CLIN N AM, V85, P681, DOI 10.1016/j.suc.2005.04.006; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Noakes M, 2005, AM J CLIN NUTR, V81, P1298; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Paddon-Jones D, 2008, AM J CLIN NUTR, V87, p1558S, DOI 10.1093/ajcn/87.5.1558S; Pawitan Y, 2001, ALL LIKELIHOOD STAT, P326; Pi-Sunyer X, 2009, POSTGRAD MED, V121, P21, DOI 10.3810/pgm.2009.11.2074; Preis SR, 2010, AM J CLIN NUTR, V92, P1265, DOI 10.3945/ajcn.2010.29626; Preis SR, 2010, AM J CLIN NUTR, V91, P39, DOI 10.3945/ajcn.2009.28060; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Sjogren P, 2010, AM J CLIN NUTR, V92, P967, DOI 10.3945/ajcn.2010.29345; Steffen LM, 2006, LANCET, V367, P880, DOI 10.1016/S0140-6736(06)68357-8; Trichopoulou A, 2007, EUR J CLIN NUTR, V61, P575, DOI 10.1038/sj.ejcn.1602557; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Veierod MB, 2003, J NATL CANCER I, V95, P1530, DOI 10.1093/jnci/djg075; Volek JS, 2002, CLEV CLIN J MED, V69, P849, DOI 10.3949/ccjm.69.11.849; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P848, DOI 10.1093/oxfordjournals.aje.a117333; Whitehead J., 1980, Applied Statistics, V29, P268, DOI 10.2307/2346901; Willett WC, 2007, J INTERN MED, V261, P363, DOI 10.1111/j.1365-2796.2007.01804.x; Willett W.C., 1998, SAUPTIKAPARVAN MAHAB, DOI [10.1093/acprof:oso/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.001.0001, DOI 10.1093/ACPROF:OSO/9780195122978.003.11]; Wolk A, 1998, ARCH INTERN MED, V158, P41, DOI 10.1001/archinte.158.1.41; Zyriax BC, 2005, EUR J CLIN NUTR, V59, P1201, DOI 10.1038/sj.ejcn.1602233	39	156	159	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2012	344								e4026	10.1136/bmj.e4026	http://dx.doi.org/10.1136/bmj.e4026			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	968MU	22735105	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000305986700002
J	Alberts, B				Alberts, Bruce			INTRODUCTION H5N1	SCIENCE			English	Editorial Material																			0	5	6	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1521	1521		10.1126/science.336.6088.1521	http://dx.doi.org/10.1126/science.336.6088.1521			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	961ZE	22723406				2022-12-28	WOS:000305507500040
J	Yen, HL; Peiris, JSM				Yen, Hui-Ling; Peiris, Joseph Sriyal Malik			VIROLOGY Bird flu in mammals	NATURE			English	Editorial Material							INFLUENZA-A VIRUS; H5N1 VIRUSES; AVIAN H5N1; RECEPTOR SPECIFICITY; TRANSMISSION; HEMAGGLUTININ; MUTATIONS; BINDING; H1N1		[Yen, Hui-Ling; Peiris, Joseph Sriyal Malik] Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China; [Yen, Hui-Ling; Peiris, Joseph Sriyal Malik] Univ Hong Kong, Influenza Res Ctr, LKS Fac Med, Pokfulam, Hong Kong, Peoples R China; [Yen, Hui-Ling; Peiris, Joseph Sriyal Malik] HKU Pasteur Res Ctr, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Yen, HL (corresponding author), Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China.	hyen@hku.hk; malik@hku.hk	Yen, Hui-Ling/C-4501-2009; Yen, Hui-Ling/GNH-5083-2022	Yen, Hui-Ling/0000-0003-2493-3609; 				Belser JA, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001705; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Cline TD, 2011, J VIROL, V85, P12262, DOI 10.1128/JVI.05582-11; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jackson S, 2009, J VIROL, V83, P8131, DOI 10.1128/JVI.00534-09; Maines TR, 2011, VIROLOGY, V413, P139, DOI 10.1016/j.virol.2011.02.015; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Nidom CA, 2010, EMERG INFECT DIS, V16, P1515, DOI 10.3201/eid1610.100508; Octaviani CP, 2010, J VIROL, V84, P10918, DOI 10.1128/JVI.01140-10; Sorrell EM, 2011, CURR OPIN VIROL, V1, P635, DOI 10.1016/j.coviro.2011.07.003; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	13	10	10	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					332	333		10.1038/nature11192	http://dx.doi.org/10.1038/nature11192			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722190				2022-12-28	WOS:000305466800030
J	Madsbad, S				Madsbad, Sten			Type 2 diabetes: which drug as add-on to metformin?	LANCET			English	Editorial Material							GLUCAGON-LIKE PEPTIDE-1; CARDIOVASCULAR SAFETY; RECEPTOR AGONISTS; CLINICAL-TRIALS; THERAPIES; MEDICATIONS; GUIDELINE; EFFICACY; MELLITUS		[Madsbad, Sten] Hvidovre Univ Hosp, Dept Endocrinol, DK-2650 Hvidovre, Denmark; [Madsbad, Sten] Univ Copenhagen, DK-2650 Hvidovre, Denmark	University of Copenhagen; University of Copenhagen	Madsbad, S (corresponding author), Hvidovre Univ Hosp, Dept Endocrinol, DK-2650 Hvidovre, Denmark.	sten.madsbad@hvh.regionh.dk		Madsbad, Sten/0000-0002-5017-1815				Bennett WL, 2012, ANN INTERN MED, V156, P27, DOI 10.7326/0003-4819-156-1-201201030-00005; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Best JH, 2011, DIABETES CARE, V34, P90, DOI 10.2337/dc10-1393; Drucker DJ, 2011, J CLIN ENDOCR METAB, V96, P2027, DOI 10.1210/jc.2011-0599; Gallwitz B, 2012, LANCET, V379, P2270, DOI 10.1016/S0140-6736(12)60479-6; Goldfine AB, 2008, NEW ENGL J MED, V359, P1092, DOI 10.1056/NEJMp0805758; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Madsbad S, 2011, DIABETES OBES METAB, V13, P394, DOI 10.1111/j.1463-1326.2011.01357.x; Madsbad S, 2008, CURR OPIN CLIN NUTR, V11, P491, DOI 10.1097/MCO.0b013e328302f414; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Ratner R, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-22; Schernthaner G, 2010, DIABETOLOGIA, V53, P1258, DOI 10.1007/s00125-010-1702-3; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405	15	2	2	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 16	2012	379	9833					2222	2223		10.1016/S0140-6736(12)60769-7	http://dx.doi.org/10.1016/S0140-6736(12)60769-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	962AM	22683136				2022-12-28	WOS:000305511400009
J	Lee, EJ; Groisman, EA				Lee, Eun-Jin; Groisman, Eduardo A.			Control of a Salmonella virulence locus by an ATP-sensing leader messenger RNA	NATURE			English	Article							PHOP-REGULATED GENES; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; INTRAMACROPHAGE SURVIVAL; SENSOR KINASE; TYPHIMURIUM; EXPRESSION; ENTERICA; MGTC; TRANSCRIPTION	The facultative intracellular pathogen Salmonella enterica resides within a membrane-bound compartment inside macrophages(1). This compartment must be acidified for Salmonella to survive within macrophages(2), possibly because acidic pH promotes expression of Salmonella virulence proteins(3,4). We reasoned that Salmonella might sense its surroundings have turned acidic not only upon protonation of the extracytoplasmic domain of a protein sensor(5) but also by an increase in cytosolic ATP levels, because conditions that enhance the proton gradient across the bacterial inner membrane stimulate ATP synthesis(6,7). Here we report that an increase in cytosolic ATP promotes transcription of the coding region for the virulence gene mgtC, which is the most highly induced horizontally acquired gene when Salmonella is inside macrophages(8). This transcript is induced both upon media acidification and by physiological conditions that increase ATP levels independently of acidification. ATP is sensed by the coupling/uncoupling of transcription of the unusually long mgtC leader messenger RNA and translation of a short open reading frame located in this region. A mutation in the mgtC leader messenger RNA that eliminates the response to ATP hinders mgtC expression inside macrophages and attenuates Salmonella virulence in mice. Our results define a singular example of an ATP-sensing leader messenger RNA. Moreover, they indicate that pathogens can interpret extracellular cues by the impact they have on cellular metabolites.	[Lee, Eun-Jin; Groisman, Eduardo A.] Yale Univ, Howard Hughes Med Inst, Sch Med, Sect Microbial Pathogenesis,Boyer Ctr Mol Med, New Haven, CT 06536 USA; [Lee, Eun-Jin; Groisman, Eduardo A.] Yale Microbial Divers Inst, West Haven, CT 06516 USA	Howard Hughes Medical Institute; Yale University	Groisman, EA (corresponding author), Yale Univ, Howard Hughes Med Inst, Sch Med, Sect Microbial Pathogenesis,Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06536 USA.	eduardo.groisman@yale.edu			National Institutes of Health [AI49561]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Turnbough for discussions, M. Wade for help with the mouse virulence assays, and R. Breaker and A. Roth for help with in-line probing experiments. This work was supported, in part, by grant AI49561 from the National Institutes of Health to E. A. G., who is an investigator of the Howard Hughes Medical Institute.	Alix E, 2007, TRENDS MICROBIOL, V15, P252, DOI 10.1016/j.tim.2007.03.007; Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; ARANDA CMA, 1992, P NATL ACAD SCI USA, V89, P10079, DOI 10.1073/pnas.89.21.10079; Bearson BL, 1998, J BACTERIOL, V180, P2409, DOI 10.1128/JB.180.9.2409-2417.1998; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Buchmeier N, 2000, MOL MICROBIOL, V35, P1375, DOI 10.1046/j.1365-2958.2000.01797.x; Chamnongpol S, 2000, J MOL BIOL, V300, P291, DOI 10.1006/jmbi.2000.3848; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Harold F. M., 1996, ESCHERICHIA COLI SAL, P283; Harvey PC, 2011, INFECT IMMUN, V79, P4105, DOI 10.1128/IAI.01390-10; Heithoff DM, 1997, P NATL ACAD SCI USA, V94, P934, DOI 10.1073/pnas.94.3.934; JENSEN KF, 1979, ANAL BIOCHEM, V98, P254, DOI 10.1016/0003-2697(79)90138-6; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lavigne JP, 2005, INFECT IMMUN, V73, P3160, DOI 10.1128/IAI.73.5.3160-3163.2005; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Lee EJ, 2010, MOL MICROBIOL, V76, P1020, DOI 10.1111/j.1365-2958.2010.07161.x; Maloney KE, 2006, INFECT IMMUN, V74, P5477, DOI 10.1128/IAI.00798-06; Merino E, 2005, TRENDS GENET, V21, P260, DOI 10.1016/j.tig.2005.03.002; Park SY, 2010, CELL, V142, P737, DOI 10.1016/j.cell.2010.07.046; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Rathman M, 1996, INFECT IMMUN, V64, P2765, DOI 10.1128/IAI.64.7.2765-2773.1996; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; Rehfuss MYM, 2011, ISME J, V5, P262, DOI 10.1038/ismej.2010.128; Retamal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005551; Rust MJ, 2011, SCIENCE, V331, P220, DOI 10.1126/science.1197243; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; Shu D, 2003, J BIOL CHEM, V278, P7119, DOI 10.1074/jbc.M209895200; SNAVELY MD, 1991, J BIOL CHEM, V266, P815; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; Spinelli SV, 2008, FEMS MICROBIOL LETT, V280, P226, DOI 10.1111/j.1574-6968.2008.01065.x; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000	39	64	64	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					271	+		10.1038/nature11090	http://dx.doi.org/10.1038/nature11090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699622	Green Accepted			2022-12-28	WOS:000305189000038
J	Jinek, M; Chylinski, K; Fonfara, I; Hauer, M; Doudna, JA; Charpentier, E				Jinek, Martin; Chylinski, Krzysztof; Fonfara, Ines; Hauer, Michael; Doudna, Jennifer A.; Charpentier, Emmanuelle			A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity	SCIENCE			English	Article							CRISPR RNA; ANTIVIRAL DEFENSE; COMPLEX; SYSTEM; INTERFERENCE; RECOGNITION; MECHANISM; ENDORIBONUCLEASE; MATURATION; RESISTANCE	Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems provide bacteria and archaea with adaptive immunity against viruses and plasmids by using CRISPR RNAs (crRNAs) to guide the silencing of invading nucleic acids. We show here that in a subset of these systems, the mature crRNA that is base-paired to trans-activating crRNA (tracrRNA) forms a two-RNA structure that directs the CRISPR-associated protein Cas9 to introduce double-stranded (ds) breaks in target DNA. At sites complementary to the crRNA-guide sequence, the Cas9 HNH nuclease domain cleaves the complementary strand, whereas the Cas9 RuvC-like domain cleaves the noncomplementary strand. The dual-tracrRNA:crRNA, when engineered as a single RNA chimera, also directs sequence-specific Cas9 dsDNA cleavage. Our study reveals a family of endonucleases that use dual-RNAs for site-specific DNA cleavage and highlights the potential to exploit the system for RNA-programmable genome editing.	[Jinek, Martin; Doudna, Jennifer A.] Univ Calif Berkeley, HHMI, Berkeley, CA 94720 USA; [Jinek, Martin; Hauer, Michael; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Chylinski, Krzysztof] Univ Vienna, MFPL, A-1030 Vienna, Austria; [Chylinski, Krzysztof; Fonfara, Ines; Charpentier, Emmanuelle] Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, Lab Mol Infect Med Sweden, S-90187 Umea, Sweden; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Umea University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, HHMI, Berkeley, CA 94720 USA.	doudna@berkeley.edu; emmanuelle.charpentier@mims.umu.se	Jinek, Martin/E-6621-2011; Fonfara, Ines/S-8369-2018; Hauer, Michael/U-4800-2019	Jinek, Martin/0000-0002-7601-210X; Fonfara, Ines/0000-0003-4075-9217; Chylinski, Krzysztof/0000-0001-7029-8090; Hauer, Michael/0000-0001-7463-3191	HHMI; Austrian Science Fund [W1207-B09]; Univ. of Vienna; Swedish Research Council [K2010-57X-21436-01-3, 621-2011-5752-LiMS]; Kempe Foundation; Umea University	HHMI(Howard Hughes Medical Institute); Austrian Science Fund(Austrian Science Fund (FWF)); Univ. of Vienna; Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundation; Umea University	We thank K. Zhou, A. M. Smith, R. Haurwitz and S. Sternberg for excellent technical assistance; members of the Doudna and Charpentier laboratories and J. Cate for comments on the manuscript; and B. Meyer and T.-W. Lo (Univ. of California, Berkeley/HHMI) for providing the GFP plasmid. This work was funded by the HHMI (M.J. and J.A.D.), the Austrian Science Fund (grant W1207-B09; K.C. and E.C.), the Univ. of Vienna (K.C.), the Swedish Research Council (grants K2010-57X-21436-01-3 and 621-2011-5752-LiMS; E.C.), the Kempe Foundation (E.C.), and Umea University (K.C. and E.C.). J.A.D. is an Investigator and M.J. is a Research Specialist of the HHMI. K.C. is a fellow of the Austrian Doctoral Program in RNA Biology and is cosupervised by R. Schroeder. We thank A. Witte, U. Blasi, and R. Schroeder for helpful discussions, financial support to K.C., and for hosting K.C. in their laboratories at MFPL. M.J., K.C., J.A.D., and E.C. have filed a related patent.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Gottesman S, 2011, NATURE, V471, P588, DOI 10.1038/471588a; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Howard JAL, 2011, BIOCHEM J, V439, P85, DOI 10.1042/BJ20110901; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Taylor GK, 2011, NUCLEIC ACIDS RES, V39, P9705, DOI 10.1093/nar/gkr669; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	38	8432	9984	994	6846	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 17	2012	337	6096					816	821		10.1126/science.1225829	http://dx.doi.org/10.1126/science.1225829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	989BQ	22745249	Green Submitted, Green Accepted			2022-12-28	WOS:000307535600036
J	Carter, JA; Agol, E; Chaplin, WJ; Basu, S; Bedding, TR; Buchhave, LA; Christensen-Dalsgaard, J; Deck, KM; Elsworth, Y; Fabrycky, DC; Ford, EB; Fortney, JJ; Hale, SJ; Handberg, R; Hekker, S; Holman, MJ; Huber, D; Karoff, C; Kawaler, SD; Kjeldsen, H; Lissauer, JJ; Lopez, ED; Lund, MN; Lundkvist, M; Metcalfe, TS; Miglio, A; Rogers, LA; Stello, D; Borucki, WJ; Bryson, S; Christiansen, JL; Cochran, WD; Geary, JC; Gilliland, RL; Haas, MR; Hall, J; Howard, AW; Jenkins, JM; Klaus, T; Koch, DG; Latham, DW; MacQueen, PJ; Sasselov, D; Steffen, JH; Twicken, JD; Winn, JN				Carter, Joshua A.; Agol, Eric; Chaplin, William J.; Basu, Sarbani; Bedding, Timothy R.; Buchhave, Lars A.; Christensen-Dalsgaard, Jorgen; Deck, Katherine M.; Elsworth, Yvonne; Fabrycky, Daniel C.; Ford, Eric B.; Fortney, Jonathan J.; Hale, Steven J.; Handberg, Rasmus; Hekker, Saskia; Holman, Matthew J.; Huber, Daniel; Karoff, Christopher; Kawaler, Steven D.; Kjeldsen, Hans; Lissauer, Jack J.; Lopez, Eric D.; Lund, Mikkel N.; Lundkvist, Mia; Metcalfe, Travis S.; Miglio, Andrea; Rogers, Leslie A.; Stello, Dennis; Borucki, William J.; Bryson, Steve; Christiansen, Jessie L.; Cochran, William D.; Geary, John C.; Gilliland, Ronald L.; Haas, Michael R.; Hall, Jennifer; Howard, Andrew W.; Jenkins, Jon M.; Klaus, Todd; Koch, David G.; Latham, David W.; MacQueen, Phillip J.; Sasselov, Dimitar; Steffen, Jason H.; Twicken, Joseph D.; Winn, Joshua N.			Kepler-36: A Pair of Planets with Neighboring Orbits and Dissimilar Densities	SCIENCE			English	Article							TRANSIT TIMING VARIATIONS; LOW-MASS; STAR; MISSION; SYSTEMS; PERFORMANCE; STABILITY; COMPANION; SCIENCE; CURVES	In the solar system, the planets' compositions vary with orbital distance, with rocky planets in close orbits and lower-density gas giants in wider orbits. The detection of close-in giant planets around other stars was the first clue that this pattern is not universal and that planets' orbits can change substantially after their formation. Here, we report another violation of the orbit-composition pattern: two planets orbiting the same star with orbital distances differing by only 10% and densities differing by a factor of 8. One planet is likely a rocky "super-Earth," whereas the other is more akin to Neptune. These planets are 20 times more closely spaced and have a larger density contrast than any adjacent pair of planets in the solar system.	[Carter, Joshua A.; Holman, Matthew J.; Geary, John C.; Latham, David W.; Sasselov, Dimitar] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Agol, Eric] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [Chaplin, William J.; Elsworth, Yvonne; Hale, Steven J.; Miglio, Andrea] Univ Birmingham, Sch Phys & Astron, Edgbaston B15 2TT, England; [Basu, Sarbani] Yale Univ, Dept Astron, New Haven, CT 06520 USA; [Bedding, Timothy R.; Stello, Dennis] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Bedding, Timothy R.; Stello, Dennis] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Buchhave, Lars A.] Univ Copenhagen, Ctr Star & Planet Format, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Christensen-Dalsgaard, Jorgen; Handberg, Rasmus; Karoff, Christopher; Kjeldsen, Hans; Lund, Mikkel N.; Lundkvist, Mia] Aarhus Univ, Stellar Astrophys Ctr, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Deck, Katherine M.; Rogers, Leslie A.; Winn, Joshua N.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Deck, Katherine M.; Rogers, Leslie A.; Winn, Joshua N.] Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Fabrycky, Daniel C.; Fortney, Jonathan J.; Lopez, Eric D.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Ford, Eric B.] Univ Florida, Dept Astron, Gainesville, FL 32611 USA; [Hekker, Saskia] Univ Amsterdam, Astron Inst Anton Pannekoek, Netherlands Sch Phys, Amsterdam, Netherlands; [Christiansen, Jessie L.; Jenkins, Jon M.; Twicken, Joseph D.] NASA, SETI Inst, Ames Res Ctr, Moffett Field, CA 94035 USA; [Kawaler, Steven D.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Metcalfe, Travis S.] White Dwarf Res Corp, Boulder, CO 80301 USA; [Cochran, William D.; MacQueen, Phillip J.] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Gilliland, Ronald L.] Penn State Univ, Ctr Exoplanets & Habitable Worlds, University Pk, PA 16802 USA; [Hall, Jennifer; Klaus, Todd] NASA, Orbital Sci Corp, Ames Res Ctr, Moffett Field, CA 94035 USA; [Howard, Andrew W.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Steffen, Jason H.] Fermilab Ctr Particle Astrophys, Batavia, IL 60510 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Washington; University of Washington Seattle; University of Birmingham; Yale University; University of Sydney; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; Aarhus University; Massachusetts Institute of Technology (MIT); University of California System; University of California Santa Cruz; State University System of Florida; University of Florida; University of Amsterdam; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Iowa State University; University of Texas System; University of Texas Austin; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Berkeley	Carter, JA (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	jacarter@cfa.harvard.edu; agol@astro.washington.edu	Steffen, Jason H./A-4320-2013; Carter, Joshua A/A-8280-2013; Hale, Steven J/HDM-7599-2022; Lund, Mikkel Nørup/AAJ-2112-2021; Miglio, Andrea/M-5789-2018; miglio, andrea/O-9594-2019; Ford, Eric B./AAB-5479-2019; Buchhave, Lars A./ABF-2000-2020; Hale, Steven J/E-3472-2015; Basu, Sarbani/B-8015-2014; Stello, Dennis/Q-9754-2019; Agol, Eric/B-8775-2013; Huber, Daniel/AAE-9440-2019; Cochran, William D/M-4421-2014; Bedding, Timothy/AAU-9400-2021; Karoff, Christoffer/L-1007-2013; Fortney, Jonathan/F-8813-2014; Metcalfe, Travis/A-9388-2008; Chaplin, William/M-9160-2018	Hale, Steven J/0000-0002-6402-8382; Lund, Mikkel Nørup/0000-0001-9214-5642; Miglio, Andrea/0000-0001-5998-8533; miglio, andrea/0000-0001-5998-8533; Ford, Eric B./0000-0001-6545-639X; Buchhave, Lars A./0000-0003-1605-5666; Hale, Steven J/0000-0002-6402-8382; Basu, Sarbani/0000-0002-6163-3472; Stello, Dennis/0000-0002-4879-3519; Agol, Eric/0000-0002-0802-9145; Huber, Daniel/0000-0001-8832-4488; Cochran, William D/0000-0001-9662-3496; Bedding, Timothy/0000-0001-5222-4661; Karoff, Christoffer/0000-0003-2009-7965; Fortney, Jonathan/0000-0002-9843-4354; Kawaler, Steven/0000-0002-6536-6367; Hekker, Saskia/0000-0002-1463-726X; Metcalfe, Travis/0000-0003-4034-0416; Handberg, Rasmus/0000-0001-8725-4502; Bedding, Timothy/0000-0001-5943-1460; Fabrycky, Daniel/0000-0003-3750-0183; Latham, David/0000-0001-9911-7388; Christiansen, Jessie/0000-0002-8035-4778; Chaplin, William/0000-0002-5714-8618; Christensen-Dalsgaard, Jorgen/0000-0001-5137-0966; Steffen, Jason/0000-0003-2202-3847; Rogers, Leslie/0000-0003-0638-3455; Lundkvist, Mia Sloth/0000-0002-8661-2571	NASA's Science Mission Directorate; NASA [HF-51267.01-A, HF-51272.01-A, NAS 5-26555]; Space Telescope Science Institute; NSF [AST-0645416]; Center for Astrophysics; UK Science and Technology Facilities Council (STFC); Danish National Research Foundation; ASTERISK project (ASTERoseismic Investigations with SONG and Kepler); European Research Council [267864]; Netherlands Organization for Scientific Research (NWO); NASA Kepler Participating Scientist program [NNX12AC76G]; STFC [ST/J001163/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J001163/1] Funding Source: researchfish	NASA's Science Mission Directorate; NASA(National Aeronautics & Space Administration (NASA)); Space Telescope Science Institute(Space Telescope Science Institute); NSF(National Science Foundation (NSF)); Center for Astrophysics(Canadian Institutes of Health Research (CIHR)); UK Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Danish National Research Foundation(Danmarks Grundforskningsfond); ASTERISK project (ASTERoseismic Investigations with SONG and Kepler); European Research Council(European Research Council (ERC)European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NASA Kepler Participating Scientist program; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	NASA's Science Mission Directorate provided funding for the Kepler Discovery mission. J.A.C. and D. C. F. acknowledge support by NASA through Hubble Fellowship grants HF-51267.01-A and HF-51272.01-A awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Incorporated, for NASA, under contract NAS 5-26555. E. A. acknowledges NSF Career grant AST-0645416 and thanks the Center for Astrophysics, where this work began. W.J.C., A. M., and Y.E. acknowledge the financial support of the UK Science and Technology Facilities Council (STFC). Funding for the Stellar Astrophysics Centre (SAC) is provided by the Danish National Research Foundation. The research is supported by the ASTERISK project (ASTERoseismic Investigations with SONG and Kepler) funded by the European Research Council (grant agreement no. 267864). S. H. acknowledges financial support from the Netherlands Organization for Scientific Research (NWO). Computational time on Kraken at the National Institute of Computational Sciences was provided through NSF TeraGrid allocation TG-AST090107. J.N.W. was supported by the NASA Kepler Participating Scientist program through grant NNX12AC76G. Refer to the supplementary materials for access information to data used in this work.	Barnes R, 2006, ASTROPHYS J, V647, pL163, DOI 10.1086/507521; Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Caldwell DA, 2010, ASTROPHYS J LETT, V713, pL92, DOI 10.1088/2041-8205/713/2/L92; Carter JA, 2011, SCIENCE, V331, P562, DOI 10.1126/science.1201274; Chaplin WJ, 2011, SCIENCE, V332, P213, DOI 10.1126/science.1201827; Charbonneau D, 2009, NATURE, V462, P891, DOI 10.1038/nature08679; Cochran WD, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/7; Gautier TN, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/15; GLADMAN B, 1993, ICARUS, V106, P247, DOI 10.1006/icar.1993.1169; Hatzes AP, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/75; Jenkins J. M., 2010, P SOC PHOTO-OPT INS, V7740, P7740; Jenkins JM, 2010, ASTROPHYS J LETT, V713, pL87, DOI 10.1088/2041-8205/713/2/L87; Kel'manov AV, 2004, IEEE T SIGNAL PROCES, V52, P645, DOI 10.1109/TSP.2003.822285; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; Lissauer JJ, 2011, NATURE, V470, P53, DOI 10.1038/nature09760; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; MARCHAL C, 1982, CELESTIAL MECH, V26, P311, DOI 10.1007/BF01230725; Marcus RA, 2009, ASTROPHYS J LETT, V700, pL118, DOI 10.1088/0004-637X/700/2/L118; Miralda-Escude J, 2002, ASTROPHYS J, V564, P1019, DOI 10.1086/324279; Steffen JH, 2012, MON NOT R ASTRON SOC, V421, P2342, DOI 10.1111/j.1365-2966.2012.20467.x; Winn JN, 2011, ASTROPHYS J LETT, V737, DOI 10.1088/2041-8205/737/1/L18	26	271	276	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2012	337	6094					556	559		10.1126/science.1223269	http://dx.doi.org/10.1126/science.1223269			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982PU	22722249	Green Accepted, Green Submitted			2022-12-28	WOS:000307058700038
J	Melles, M; Brigham-Grette, J; Minyuk, PS; Nowaczyk, NR; Wennrich, V; DeConto, RM; Anderson, PM; Andreev, AA; Coletti, A; Cook, TL; Haltia-Hovi, E; Kukkonen, M; Lozhkin, AV; Rosen, P; Tarasov, P; Vogel, H; Wagner, B				Melles, Martin; Brigham-Grette, Julie; Minyuk, Pavel S.; Nowaczyk, Norbert R.; Wennrich, Volker; DeConto, Robert M.; Anderson, Patricia M.; Andreev, Andrei A.; Coletti, Anthony; Cook, Timothy L.; Haltia-Hovi, Eeva; Kukkonen, Maaret; Lozhkin, Anatoli V.; Rosen, Peter; Tarasov, Pavel; Vogel, Hendrik; Wagner, Bernd			2.8 Million Years of Arctic Climate Change from Lake El'gygytgyn, NE Russia	SCIENCE			English	Article							ANTARCTIC ICE-SHEET; LATE PLIOCENE; PLEISTOCENE; PACIFIC; QUATERNARY; VARIABILITY; GREENLAND; RECORD; VEGETATION; RESOLUTION	The reliability of Arctic climate predictions is currently hampered by insufficient knowledge of natural climate variability in the past. A sediment core from Lake El'gygytgyn in northeastern (NE) Russia provides a continuous, high-resolution record from the Arctic, spanning the past 2.8 million years. This core reveals numerous "super interglacials" during the Quaternary; for marine benthic isotope stages (MIS) 11c and 31, maximum summer temperatures and annual precipitation values are similar to 4 degrees to 5 degrees C and similar to 300 millimeters higher than those of MIS 1 and 5e. Climate simulations show that these extreme warm conditions are difficult to explain with greenhouse gas and astronomical forcing alone, implying the importance of amplifying feedbacks and far field influences. The timing of Arctic warming relative to West Antarctic Ice Sheet retreats implies strong interhemispheric climate connectivity.	[Melles, Martin; Wennrich, Volker; Andreev, Andrei A.; Kukkonen, Maaret; Vogel, Hendrik; Wagner, Bernd] Univ Cologne, Inst Geol & Mineral, D-50674 Cologne, Germany; [Brigham-Grette, Julie; DeConto, Robert M.; Coletti, Anthony; Cook, Timothy L.] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; [Minyuk, Pavel S.; Lozhkin, Anatoli V.] Russian Acad Sci, NE Interdisciplinary Sci Res Inst, Far E Branch, Magadan 685000, Russia; [Nowaczyk, Norbert R.; Haltia-Hovi, Eeva] GFZ German Res Ctr Geosci, Helmholtz Ctr Potsdam, D-14473 Potsdam, Germany; [Anderson, Patricia M.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Rosen, Peter] Umea Univ, Climate Impacts Res Ctr, SE-98107 Abisko, Sweden; [Tarasov, Pavel] Free Univ Berlin, Inst Geol Sci, D-12249 Berlin, Germany	University of Cologne; University of Massachusetts System; University of Massachusetts Amherst; Russian Academy of Sciences; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Washington; University of Washington Seattle; Umea University; Free University of Berlin	Melles, M (corresponding author), Univ Cologne, Inst Geol & Mineral, Zuelpicher Str 49A, D-50674 Cologne, Germany.	mmelles@uni-koeln.de	Andreev, Andrei A/J-2701-2015; Melles, Martin/J-4070-2012; Vogel, Hendrik/ABG-1123-2020; Vogel, Hendrik/C-6148-2014; Wennrich, Volker/I-3435-2012; Wagner, Bernd/J-4682-2012; Tarasov, Pavel/ABG-3993-2020	Andreev, Andrei A/0000-0002-8745-9636; Melles, Martin/0000-0003-0977-9463; Vogel, Hendrik/0000-0002-9902-8120; Wennrich, Volker/0000-0003-3617-1963; Wagner, Bernd/0000-0002-1369-7893; Tarasov, Pavel/0000-0002-7219-5009; Cook, Timothy/0000-0002-4982-6415	ICDP; NSF; German Federal Ministry of Education and Research (BMBF); Alfred Wegener Institute; Helmholtz Centre Potsdam (GFZ); Russian Academy of Sciences Far East Branch; Russian Foundation for Basic Research; Austrian Federal Ministry of Science and Research; BMBF [03G0642]; German Research Foundation (Deutsche Forschungsgemeinschaft) [ME 1169/21, ME 1169/24]; NSF [0602471]; Vetenskapsradet; Swedish Research Council; Kempe Foundation; Civilian Research and Development Foundation [RUG1-2987-MA-10]	ICDP; NSF(National Science Foundation (NSF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Alfred Wegener Institute; Helmholtz Centre Potsdam (GFZ); Russian Academy of Sciences Far East Branch(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Austrian Federal Ministry of Science and Research; BMBF(Federal Ministry of Education & Research (BMBF)); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); Vetenskapsradet(Swedish Research Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundation; Civilian Research and Development Foundation	Drilling operations were funded by the ICDP, the NSF, the German Federal Ministry of Education and Research (BMBF), Alfred Wegener Institute and Helmholtz Centre Potsdam (GFZ), the Russian Academy of Sciences Far East Branch, the Russian Foundation for Basic Research, and the Austrian Federal Ministry of Science and Research. The Russian Global Lake Drilling 800 drilling system was developed and operated by DOSECC. We thank all participants of the expedition for their engagement during recovery of the ICDP 5011-1 cores. Funding of core analyses was provided by BMBF (grant 03G0642), German Research Foundation (Deutsche Forschungsgemeinschaft, grants ME 1169/21 and ME 1169/24), the NSF (grant 0602471), Vetenskapsradet, The Swedish Research Council, the Kempe Foundation, and the Civilian Research and Development Foundation (grant RUG1-2987-MA-10). We thank N. Mantke, A. Shahnazarian, and numerous students (Univ. of Cologne) for their competent help in core processing; T. Matrosova for contributing modern surface pollen data; and R. McKay for providing a modified lithological log of the ANDRILL 1B record. We also thank four anonymous reviewers for supportive and constructive comments that greatly improved the manuscript. The data reported in this paper are available in the databases of PANGAEA via www.pangaea.de (DOI:10.1594/PANGAEA.783305) and of the U. S. National Climatic Data Center via www. ncdc.noaa.gov/paleo/paleolim/paleolim_data.html.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Anderson P, 2006, QUATERNARY SCI REV, V25, P1383, DOI 10.1016/j.quascirev.2006.01.033; [Anonymous], 2005, ARCTIC CLIMATE IMPAC; BRIGHAMGRETTE J, 1992, ARCTIC, V45, P74; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Clark PU, 2006, QUATERNARY SCI REV, V25, P3150, DOI 10.1016/j.quascirev.2006.07.008; Colville EJ, 2011, SCIENCE, V333, P620, DOI 10.1126/science.1204673; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; DeConto RM, 2012, GLOBAL PLANET CHANGE, V88-89, P45, DOI 10.1016/j.gloplacha.2012.03.003; Demske D, 2002, PALAEOGEOGR PALAEOCL, V184, P107, DOI 10.1016/S0031-0182(02)00251-1; Elias SA, 2002, CAN J EARTH SCI, V39, P911, DOI 10.1139/E01-096; Fawcett PJ, 2011, NATURE, V470, P518, DOI 10.1038/nature09839; Foldvik A, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002008; Fradkina A. F., 2005, 382 GEOL SOC AM; Funder S, 2001, B GEOL SOC DENMARK, V48, P117; Galbraith ED, 2007, NATURE, V449, P890, DOI 10.1038/nature06227; Gischler E, 2010, SEDIMENTOLOGY, V57, P1049, DOI 10.1111/j.1365-3091.2009.01133.x; Goodfriend GA, 1996, QUATERNARY RES, V45, P176, DOI 10.1006/qres.1996.0018; Hall IR, 2001, NATURE, V412, P809, DOI 10.1038/35090552; Haug G. H., 1995, P ODP SCI RESULTS, V145, P293, DOI DOI 10.2973/ODP.PROC.SR.145.115.1995; Haug GH, 2005, NATURE, V433, P821, DOI 10.1038/nature03332; Helmke JP, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000794; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Jaccard SL, 2010, QUATERNARY SCI REV, V29, P206, DOI 10.1016/j.quascirev.2009.10.007; KAUFMAN DS, 1993, QUATERNARY SCI REV, V12, P21, DOI 10.1016/0277-3791(93)90046-O; Koenig SJ, 2011, CLIM DYNAM, V37, P1247, DOI 10.1007/s00382-011-1050-0; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Layer PW, 2000, METEORIT PLANET SCI, V35, P591, DOI 10.1111/j.1945-5100.2000.tb01439.x; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Maiorano P, 2009, MAR MICROPALEONTOL, V71, P166, DOI 10.1016/j.marmicro.2009.03.002; Martinez-Garcia A, 2010, SCIENCE, V328, P1550, DOI 10.1126/science.1184480; McKay R, 2012, QUATERNARY SCI REV, V34, P93, DOI 10.1016/j.quascirev.2011.12.012; Melles M, 2007, J PALEOLIMNOL, V37, P89, DOI 10.1007/s10933-006-9025-6; Melles M, 2011, SCI DRILL, V11, P29, DOI 10.2204/iodp.sd.11.03.2011; Miller GH, 2010, QUATERNARY SCI REV, V29, P1679, DOI 10.1016/j.quascirev.2010.03.001; Miller GH, 2010, QUATERNARY SCI REV, V29, P1779, DOI 10.1016/j.quascirev.2010.02.008; Milne GA, 2008, QUATERNARY SCI REV, V27, P2292, DOI 10.1016/j.quascirev.2008.08.018; Mock CJ, 1998, INT J CLIMATOL, V18, P1085, DOI 10.1002/(SICI)1097-0088(199808)18:10<1085::AID-JOC305>3.0.CO;2-K; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Nolan M., 2012, CLIM PAST DISCUSS, V8, P1443, DOI DOI 10.5194/CPD-8-1443-2012; Nolan M, 2007, J PALEOLIMNOL, V37, P17, DOI 10.1007/s10933-006-9020-y; O'Regan M, 2011, OCEANOGRAPHY, V24, P66, DOI 10.5670/oceanog.2011.57; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Polyak L, 2011, OCEANOGRAPHY, V24, P52, DOI 10.5670/oceanog.2011.55; Prokopenko AA, 2010, CLIM PAST, V6, P31, DOI 10.5194/cp-6-31-2010; Raymo ME, 2012, NATURE, V483, P453, DOI 10.1038/nature10891; Scherer RP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032254; Shuster DL, 2005, SCIENCE, V310, P1668, DOI 10.1126/science.1118519; Stein R, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001639; Tarasov PE, 2011, EARTH-SCI REV, V108, P64, DOI 10.1016/j.earscirev.2011.06.002; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Woodgate RA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041621; Yin Q. Z., 2011, CLIM DYNAM, V36, P1	55	318	328	8	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					315	320		10.1126/science.1222135	http://dx.doi.org/10.1126/science.1222135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22722254				2022-12-28	WOS:000306542600044
J	Harris, JB; LaRocque, RC; Qadri, F; Ryan, ET; Calderwood, SB				Harris, Jason B.; LaRocque, Regina C.; Qadri, Firdausi; Ryan, Edward T.; Calderwood, Stephen B.			Cholera	LANCET			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; SINGLE-DOSE CIPROFLOXACIN; LATEX AGGLUTINATION ASSAY; ORAL REHYDRATION SOLUTION; VACCINE CVD 103-HGR; VIBRIO-CHOLERAE; WHOLE-CELL; FIELD TRIAL; PROTECTIVE EFFICACY; IMMUNE-RESPONSES	Cholera is an acute, secretory diarrhoea caused by infection with Vibrio cholerae of the O1 or O139 serogroup. It is endemic in more than 50 countries and also causes large epidemics. Since 1817, seven cholera pandemics have spread from Asia to much of the world. The seventh pandemic began in 1961 and affects 3-5 million people each year, killing 120 000. Although mild cholera can be indistinguishable from other diarrhoeal illnesses, the presentation of severe cholera is distinct, with pronounced diarrhoeal purging. Management of patients with cholera involves aggressive fluid replacement; effective therapy can decrease mortality from more than 50% to less than 0.2%. Antibiotic treatment decreases volume and duration of diarrhoea by 50% and is recommended for patients with moderate to severe dehydration. Prevention of cholera depends on access to safe water and sanitation. Two oral cholera vaccines are available and the most effective use of these in integrated prevention programmes is being actively assessed.	[Harris, Jason B.; LaRocque, Regina C.; Ryan, Edward T.; Calderwood, Stephen B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA USA; [Harris, Jason B.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [LaRocque, Regina C.; Ryan, Edward T.; Calderwood, Stephen B.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Calderwood, Stephen B.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Qadri, Firdausi] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Ryan, Edward T.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; International Centre for Diarrhoeal Disease Research (ICDDR); Harvard University; Harvard T.H. Chan School of Public Health	Calderwood, SB (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA USA.	scalderwood@partners.org	Harris, Jason/ABF-2684-2020; Al, Mamun M./AAF-5850-2019; Ibrahim, Essam Hassan/G-1960-2018; Qadri, Firdausi/AAF-4583-2019	Harris, Jason/0000-0003-3642-5126; Ibrahim, Essam Hassan/0000-0003-0130-2257; 	National Institutes of Health [AI058935, U01 AI077883]; Bill & Melinda Gates Foundation; Swedish International Development Agency (Sida); Charles H Hood Foundation; Howard Hughes Medical Institute; International Centre for Diarrhoeal Research, Dhaka; International Research Scientist Development Award [K01 TW07409]; FOGARTY INTERNATIONAL CENTER [K01TW007409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI058935, U01AI077883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Swedish International Development Agency (Sida); Charles H Hood Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); International Centre for Diarrhoeal Research, Dhaka; International Research Scientist Development Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SBC, ETR, RCL, FQ, and JBH receive support from grants from the National Institutes of Health for research into immunity to cholera. FQ receives grants from the Bill & Melinda Gates Foundation and the Swedish International Development Agency (Sida) for research into vaccines and immunology in cholera. JBH receives a grant from the Charles H Hood Foundation for research into cholera immunology, and RCL receives a grant from the Howard Hughes Medical Institute for research into human genetic susceptibility to cholera. SBC, ETR, and FQ are co-inventors on institutional patents related to cholera vaccine development. SBC and ETR are editors for the infectious diseases sections of UpToDate, a medical education programme that includes topics related to cholera, and receive editorial payments from the publisher.; This work was supported by the International Centre for Diarrhoeal Research, Dhaka, and grants from the National Institutes of Health, AI058935 (SBC, ETR, FQ), U01 AI077883 (ETR, FQ) and an International Research Scientist Development Award, K01 TW07409 (JBH), a Physician-Scientist Early Career Award from the Howard Hughes Medical Institute (RCL), and a Charles H Hood Foundation Child Health Research Award (JBH).	Alam NH, 1999, LANCET, V354, P296, DOI 10.1016/S0140-6736(98)09332-5; Alam NH, 2006, JAMA-J AM MED ASSOC, V296, P567, DOI 10.1001/jama.296.5.567; ALBERT MJ, 1993, LANCET, V341, P704; Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; ALMEIDA RJ, 1990, J CLIN MICROBIOL, V28, P128, DOI 10.1128/JCM.28.1.128-130.1990; Andrews JR, 2011, LANCET, V377, P1248, DOI 10.1016/S0140-6736(11)60273-0; Anh DD, 2007, VACCINE, V25, P1149, DOI 10.1016/j.vaccine.2006.09.049; Anh Dang Duc, 2011, PLoS Negl Trop Dis, V5, pe1006, DOI 10.1371/journal.pntd.0001006; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1586; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; BARUA D, 1977, ANN HUM BIOL, V4, P489, DOI 10.1080/03014467700002481; BENENSON A. S., 1964, BULL WORLD HEALTH ORGAN, V30, P827; BENNISH ML, 1990, NEW ENGL J MED, V322, P1357, DOI 10.1056/NEJM199005103221905; BENYAJATI C, 1960, ANN INTERN MED, V52, P960, DOI 10.7326/0003-4819-52-5-960; Bhandari N, 2008, PEDIATRICS, V121, pE1279, DOI 10.1542/peds.2007-1939; Bhuiyan NA, 2003, J CLIN MICROBIOL, V41, P3939, DOI 10.1128/JCM.41.8.3939-3941.2003; BIK EM, 1995, EMBO J, V14, P209, DOI 10.1002/j.1460-2075.1995.tb06993.x; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; Chao DL, 2011, P NATL ACAD SCI USA, V108, P7081, DOI 10.1073/pnas.1102149108; CHAUDHURI A, 1978, T ROY SOC TROP MED H, V72, P664, DOI 10.1016/0035-9203(78)90031-7; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Chowdhury F, 2008, PEDIATR INFECT DIS J, V27, P986, DOI 10.1097/INF.0b013e3181783adf; Chowdhury F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000898; Chowdhury F, 2010, INFECT IMMUN, V78, P2117, DOI 10.1128/IAI.01426-09; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; CLEMENS JD, 1990, LANCET, V335, P270, DOI 10.1016/0140-6736(90)90080-O; Clemens JD, 2001, J INFECT DIS, V183, P1306, DOI 10.1086/319673; CLEMENS JD, 1988, LANCET, V1, P1375; Cohen MB, 2002, INFECT IMMUN, V70, P1965, DOI 10.1128/IAI.70.4.1965-1970.2002; COLWELL RR, 1992, FEMS MICROBIOL LETT, V97, P215, DOI 10.1016/0378-1097(92)90339-P; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; COMSTOCK LE, 1995, INFECT IMMUN, V63, P317, DOI 10.1128/IAI.63.1.317-323.1995; Deen JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000173; Dhar U, 1996, T ROY SOC TROP MED H, V90, P402, DOI 10.1016/S0035-9203(96)90522-2; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Enserink M, 2010, SCIENCE, V330, P738, DOI 10.1126/science.330.6005.738; Farmer P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001145; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Faruque SM, 2006, J INFECT DIS, V193, P1029, DOI 10.1086/500953; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P6119, DOI 10.1073/pnas.0502069102; Garcia L, 2005, INFECT IMMUN, V73, P3018, DOI 10.1128/IAI.73.5.3018-3024.2005; GILL DM, 1975, P NATL ACAD SCI USA, V72, P2064, DOI 10.1073/pnas.72.6.2064; GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050; GILL DM, 1976, BIOCHEMISTRY-US, V15, P1242, DOI 10.1021/bi00651a011; GLASS RI, 1985, AM J EPIDEMIOL, V121, P791, DOI 10.1093/oxfordjournals.aje.a114050; Greenough WB, 2004, J CLIN INVEST, V113, P334, DOI 10.1172/JCI200420982; GREENOUGH WB, 1964, LANCET, V1, P355; Guerrant RL, 2003, CLIN INFECT DIS, V37, P398, DOI 10.1086/376619; Harris JB, 2010, LANCET, V376, P1961, DOI 10.1016/S0140-6736(10)62172-1; Harris JB, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000403; Harris JB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000221; Harris JB, 2005, INFECT IMMUN, V73, P7422, DOI 10.1128/IAI.73.11.7422-7427.2005; Harris JR, 2009, TROP MED INT HEALTH, V14, P1117, DOI 10.1111/j.1365-3156.2009.02335.x; Hartley DM, 2006, PLOS MED, V3, P63, DOI 10.1371/journal.pmed.0030007; HASAN JAK, 1994, J CLIN MICROBIOL, V32, P249, DOI 10.1128/JCM.32.1.249-252.1994; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Islam MS, 2009, JAMA-J AM MED ASSOC, V302, P2321, DOI 10.1001/jama.2009.1750; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; Jensen MA, 2006, P NATL ACAD SCI USA, V103, P4652, DOI 10.1073/pnas.0600166103; Jeuland M, 2009, VALUE HEALTH, V12, P899, DOI 10.1111/j.1524-4733.2009.00562.x; Jutla AS, 2011, AM J TROP MED HYG, V85, P303, DOI 10.4269/ajtmh.2011.11-0181; Kanungo S, 2009, VACCINE, V27, P6887, DOI 10.1016/j.vaccine.2009.09.008; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Kaushik JS, 2010, INDIAN PEDIATR, V47, P309, DOI 10.1007/s13312-010-0059-5; KENNER JR, 1995, J INFECT DIS, V172, P1126, DOI 10.1093/infdis/172.4.1126; Khan AM, 2009, J TROP PEDIATRICS, V55, P122, DOI 10.1093/tropej/fmn090; Khan WA, 1996, LANCET, V348, P296, DOI 10.1016/S0140-6736(96)01180-4; Kim HB, 2010, ANTIMICROB AGENTS CH, V54, P799, DOI 10.1128/AAC.01045-09; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; KOTLOFF KL, 1992, INFECT IMMUN, V60, P4430, DOI 10.1128/IAI.60.10.4430-4432.1992; LaRocque RC, 2009, GENES IMMUN, V10, P267, DOI 10.1038/gene.2009.2; LESMANA M, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P265; LEVINE MM, 1988, LANCET, V2, P468, DOI 10.1016/S0140-6736(88)90120-1; Li STT, 2007, PLOS MED, V4, P495, DOI 10.1371/journal.pmed.0040098; Liang WL, 2003, INFECT IMMUN, V71, P5498, DOI 10.1128/IAI.71.10.5498-5504.2003; LINDENBAUM J, 1967, B WORLD HEALTH ORGAN, V37, P529; LINDENBAUM J, 1966, LANCET, V1, P1066; Longini IM, 2002, J INFECT DIS, V186, P246, DOI 10.1086/341206; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; Lukacik M, 2008, PEDIATRICS, V121, P326, DOI 10.1542/peds.2007-0921; MAHALANABIS D, 1970, PEDIATRICS, V45, P374; MAHALANABIS D, 1994, EPIDEMIOL INFECT, V112, P463, DOI 10.1017/S0950268800051165; Mahalanabis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002323; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Mayo-Wilson E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5094; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Mintz ED, 2009, NEW ENGL J MED, V360, P1060, DOI 10.1056/NEJMp0810559; MOLLA AM, 1981, J PEDIATR-US, V98, P835, DOI 10.1016/S0022-3476(81)80863-3; Morris JG, 2003, CLIN INFECT DIS, V37, P272, DOI 10.1086/375600; Murphy C, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003754.PUB2; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; NALIN DR, 1968, LANCET, V2, P370; Neilan RLM, 2010, B MATH BIOL, V72, P2004, DOI 10.1007/s11538-010-9521-8; Nelson EJ, 2007, P NATL ACAD SCI USA, V104, P19091, DOI 10.1073/pnas.0706352104; Nelson EJ, 2011, NEW ENGL J MED, V364, P5, DOI 10.1056/NEJMp1013771; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; Nelson EJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000187; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; PELTOLA H, 1991, LANCET, V338, P1285, DOI 10.1016/0140-6736(91)92590-X; Qadri F, 1997, INFECT IMMUN, V65, P3571, DOI 10.1128/IAI.65.9.3571-3576.1997; Qadri F, 2007, VACCINE, V25, P231, DOI 10.1016/j.vaccine.2006.08.031; Ramakrishna BS, 2000, NEW ENGL J MED, V342, P308, DOI 10.1056/NEJM200002033420502; RAMAMURTHY T, 1993, LANCET, V341, P703, DOI 10.1016/0140-6736(93)90480-5; Reyburn R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000952; Richie E, 2000, VACCINE, V18, P2399, DOI 10.1016/S0264-410X(00)00006-2; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Rowe-Magnus DA, 2001, P NATL ACAD SCI USA, V98, P652, DOI 10.1073/pnas.98.2.652; Roy SK, 2008, BMJ-BRIT MED J, V336, P266, DOI 10.1136/bmj.39416.646250.AE; Ryan ET, 2006, EXPERT REV VACCINES, V5, P483, DOI 10.1586/14760584.5.4.483; Ryan ET, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001003; Ryan ET, 2000, AM J TROP MED HYG, V63, P12, DOI 10.4269/ajtmh.2000.63.12; Sack DA, 1997, J INFECT DIS, V176, P201, DOI 10.1086/514025; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Saha A, 2011, VACCINE, V29, P8285, DOI 10.1016/j.vaccine.2011.08.108; Saha D, 2005, LANCET, V366, P1085, DOI 10.1016/S0140-6736(05)67290-X; Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493; SANCHEZ JL, 1994, LANCET, V344, P1273, DOI 10.1016/S0140-6736(94)90755-2; Schwartz BS, 2006, AM J TROP MED HYG, V74, P1067, DOI 10.4269/ajtmh.2006.74.1067; Shin OS, 2011, J INFECT DIS, V204, P1349, DOI 10.1093/infdis/jir544; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Tariq M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007552; Taylor DN, 2000, J INFECT DIS, V181, P1667, DOI 10.1086/315462; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Thiem VD, 2006, VACCINE, V24, P4297, DOI 10.1016/j.vaccine.2006.03.008; TOOLE MJ, 1995, LANCET, V345, P339, DOI 10.1016/S0140-6736(95)90338-0; Trach DD, 1997, LANCET, V349, P231, DOI 10.1016/S0140-6736(96)06107-7; Trucksis M, 1998, P NATL ACAD SCI USA, V95, P14464, DOI 10.1073/pnas.95.24.14464; Tuite AR, 2011, ANN INTERN MED, V154, P593, DOI 10.7326/0003-4819-154-9-201105030-00334; vanLoon FPL, 1996, VACCINE, V14, P162, DOI 10.1016/0264-410X(95)00122-H; Waldor MK, 1996, J BACTERIOL, V178, P4157, DOI 10.1128/jb.178.14.4157-4165.1996; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Walton DA, 2011, NEW ENGL J MED, V364, P3, DOI 10.1056/NEJMp1012997; WANG F, 1986, NEW ENGL J MED, V315, P1591, DOI 10.1056/NEJM198612183152506; Weil AA, 2009, CLIN INFECT DIS, V49, P1473, DOI 10.1086/644779; WHO, 2011, PREV CONTR CHOL OUTB; WHO, WAT SAN HLTH FACT FI; World Health Organization, 2005, TREATM DIARRH MAN PH; World Health Organization Global Task Force on Cholera Control, 2010, 1 STEPS MAN OUTBR AC; YAM WC, 1992, J CLIN MICROBIOL, V30, P2518, DOI 10.1128/JCM.30.9.2518-2520.1992; YAMAMOTO T, 1995, ANTIMICROB AGENTS CH, V39, P241, DOI 10.1128/AAC.39.1.241	148	374	386	8	131	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 30	2012	379	9835					2466	2476		10.1016/S0140-6736(12)60436-X	http://dx.doi.org/10.1016/S0140-6736(12)60436-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	967NV	22748592	Green Accepted			2022-12-28	WOS:000305915900032
J	Lee, G; Bratkowski, MA; Ding, F; Ke, AL; Ha, T				Lee, Gwangrog; Bratkowski, Matthew A.; Ding, Fang; Ke, Ailong; Ha, Taekjip			Elastic Coupling Between RNA Degradation and Unwinding by an Exoribonuclease	SCIENCE			English	Article							VIRUS NS3 HELICASE; YEAST EXOSOME CORE; QUALITY-CONTROL; UVRD HELICASE; BASE-PAIR; DNA; MECHANISM; TRANSCRIPTION; RECRUITMENT; DYNAMICS	Rrp44 (Dis3) is a key catalytic subunit of the yeast exosome complex and can processively digest structured RNA one nucleotide at a time in the 3' to 5' direction. Its motor function is powered by the energy released from the hydrolytic nuclease reaction instead of adenosine triphosphate hydrolysis as in conventional helicases. Single-molecule fluorescence analysis revealed that instead of unwinding RNA in single base pair steps, Rrp44 accumulates the energy released by multiple single nucleotide step hydrolysis reactions until about four base pairs are unwound in a burst. Kinetic analyses showed that RNA unwinding, not cleavage or strand release, determines the overall RNA degradation rate and that the unwinding step size is determined by the nonlinear elasticity of the Rrp44/RNA complex, but not by duplex stability.	[Lee, Gwangrog; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Lee, Gwangrog] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea; [Bratkowski, Matthew A.; Ding, Fang; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Gwangju Institute of Science & Technology (GIST); Cornell University; Howard Hughes Medical Institute	Ha, T (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	tjha@illinois.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Lee, Gwangrog/0000-0002-1720-8524	National Science Foundation [0646550, 0822613]; National Institutes of Health [GM065367, GM-086766]; Jane Coffin Childs Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086766, R01GM065367] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Park, R. Vafabakhsh, A. Jain, S. Park, R. Zhou, X. Shi, M. Comstock, and S. Syed for helpful discussions; J. Yoo, C. Maffeo, and S. Arslan for experimental help; and K. Lee for the data acquisition program. Funds were provided by grants from National Science Foundation (0646550, 0822613 to T. H.) and National Institutes of Health (GM065367 to T. H. and GM-086766 to A. K.). G. L. was supported in part by the Jane Coffin Childs Medical Institute. T. H. is an investigator with Howard Hughes Medical Institute.	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Cheng W, 2011, SCIENCE, V333, P1746, DOI 10.1126/science.1206023; DICKERSON RE, 1982, SCIENCE, V216, P475, DOI 10.1126/science.7071593; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lee G, 2011, NAT CHEM BIOL, V7, P367, DOI [10.1038/NCHEMBIO.561, 10.1038/nchembio.561]; Lee G, 2010, NANO LETT, V10, P5123, DOI 10.1021/nl103754z; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; LESNIK EA, 1995, BIOCHEMISTRY-US, V34, P10807, DOI 10.1021/bi00034a013; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; MOFFITT JR, 2009, EMBO J, V457, P446, DOI DOI 10.1038/EMBOJ.2010.121; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schwartz A, 2009, NAT STRUCT MOL BIOL, V16, P1309, DOI 10.1038/nsmb.1711; Seol Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158103; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104	29	54	55	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1726	1729		10.1126/science.1216848	http://dx.doi.org/10.1126/science.1216848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745434	Green Accepted			2022-12-28	WOS:000305794500056
J	Wu, XH; Zhang, C; Goldberg, P; Cohen, D; Pan, Y; Arpin, T; Bar-Yosef, O				Wu, Xiaohong; Zhang, Chi; Goldberg, Paul; Cohen, David; Pan, Yan; Arpin, Trina; Bar-Yosef, Ofer			Early Pottery at 20,000 Years Ago in Xianrendong Cave, China	SCIENCE			English	Article							AGRICULTURE; ORIGINS; ASIA	The invention of pottery introduced fundamental shifts in human subsistence practices and sociosymbolic behaviors. Here, we describe the dating of the early pottery from Xianrendong Cave, Jiangxi Province, China, and the micromorphology of the stratigraphic contexts of the pottery sherds and radiocarbon samples. The radiocarbon ages of the archaeological contexts of the earliest sherds are 20,000 to 19,000 calendar years before the present, 2000 to 3000 years older than other pottery found in East Asia and elsewhere. The occupations in the cave demonstrate that pottery was produced by mobile foragers who hunted and gathered during the Late Glacial Maximum. These vessels may have served as cooking devices. The early date shows that pottery was first made and used 10 millennia or more before the emergence of agriculture.	[Bar-Yosef, Ofer] Harvard Univ, Dept Anthropol, Cambridge, MA 02318 USA; [Wu, Xiaohong; Zhang, Chi; Pan, Yan] Peking Univ, Sch Archaeol & Museol, Beijing 100871, Peoples R China; [Goldberg, Paul; Cohen, David; Arpin, Trina] Boston Univ, Dept Archaeol, Boston, MA 02215 USA; [Goldberg, Paul] Univ Tubingen, D-72070 Tubingen, Germany	Harvard University; Peking University; Boston University; Eberhard Karls University of Tubingen	Bar-Yosef, O (corresponding author), Harvard Univ, Dept Anthropol, Cambridge, MA 02318 USA.	obaryos@fas.harvard.edu	Wu, Xiaohong/AAH-4348-2020; Cohen, David J/A-7526-2015	Wu, Xiaohong/0000-0002-3819-0829; Cohen, David J/0000-0002-5973-8566	Jiangxi Provincial Institute of Cultural Relics and Archaeology; NSF [0917739]	Jiangxi Provincial Institute of Cultural Relics and Archaeology; NSF(National Science Foundation (NSF))	We thank the State Administration of Cultural Heritage of China for permission to carry out this project and the Jiangxi Provincial Institute of Cultural Relics and Archaeology for their support, in particular C. Fan and G. Zhou. W. Yan (Peking University) and B. Wang (Cultural Relics Bureau, Wannian, Jiangxi) provided assistance and information concerning the earlier excavations. We also thank S. Liu (Jiangxi Provincial Institute) for assistance. Detailed descriptions of the stratigraphy and the pottery fragments are in (17). We thank K. Liu and X. Ding for the atomic mass spectrometry (AMS) radiocarbon measurements. The American School of Prehistoric Research (Peabody Museum, Harvard University) supported the fieldwork and, in part, the preparation of the samples for microscopic analysis. P.G. is grateful to the NSF (grant no. 0917739) for partial support of this project. W.X., Z.C., and O.B.-Y. contributed to conceiving the project and organizing the fieldwork. P.G. and T.A. analyzed the micromorphology of the thin sections. W.X. and P.Y. conducted the dating of the new radiocarbon samples. W.X., O.B.-Y., P.G., Z.C., and D.C. prepared the paper. The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to O.B.-Y. and X.W. (wuxh@pku.edu.cn).	Bar-Yosef O, 2011, CURR ANTHROPOL, V52, pS175, DOI 10.1086/659784; Barton L, 2007, DEV QUATER SCI, V9, P105, DOI 10.1016/S1571-0866(07)09009-4; Boaretto E, 2009, P NATL ACAD SCI USA, V106, P9595, DOI 10.1073/pnas.0900539106; BRAMMER H, 1971, GEODERMA, V6, P5, DOI 10.1016/0016-7061(71)90047-4; Carmody RN, 2011, P NATL ACAD SCI USA, V108, P19199, DOI 10.1073/pnas.1112128108; Cohen DJ, 2011, CURR ANTHROPOL, V52, pS273, DOI 10.1086/659965; Courty M.A., 1989, SOILS MICROMORPHOLOG; Goldberg P, 2006, EVOL ANTHROPOL, V15, P20, DOI 10.1002/evan.20094; Goldberg P, 2003, GEOARCHAEOLOGY, V18, P571, DOI 10.1002/gea.10079; Hayden B, 2003, WORLD ARCHAEOL, V34, P458, DOI 10.1080/0043824021000026459a; Huang EQ, 2011, QUATERNARY RES, V75, P196, DOI 10.1016/j.yqres.2010.08.014; Jiangxi Provincial Cultural Relics Administration Committee, 1963, KAO GU XUE BAO, V1, P1; Jiangxi Provincial Museum, 1976, WEN WU, V12, P23; Jordan P., 2009, CERAMICS FARMING; Keally CT, 2004, RADIOCARBON, V46, P345, DOI 10.1017/S0033822200039643; Kumin YV, 2009, J HUM EVOL, V57, P91, DOI 10.1016/j.jhevol.2009.04.003; MacNeish R. S., 1998, 2 AND FDN ARCH RES; MacNeish R. S., 1995, PUBLICATIONS ANTHR; Ni J, 2010, PALAEOGEOGR PALAEOCL, V289, P44, DOI 10.1016/j.palaeo.2010.02.008; Prendergast ME, 2009, J ARCHAEOL SCI, V36, P1027, DOI 10.1016/j.jas.2008.12.002; VANDIVER PB, 1989, SCIENCE, V246, P1002, DOI 10.1126/science.246.4933.1002; Wang L., 2010, HUMAN POTTERY MAKING; Yasuda, 2002, ORIGINS POTTERY AGR, P157; Zhao ZJ, 2011, CURR ANTHROPOL, V52, pS295, DOI 10.1086/659308; Zhao ZJ, 2010, ARCHAEOL ANTHROP SCI, V2, P99, DOI 10.1007/s12520-010-0028-x; Zhao ZJ, 1998, ANTIQUITY, V72, P885, DOI 10.1017/S0003598X00087524	26	175	185	11	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1696	1700		10.1126/science.1218643	http://dx.doi.org/10.1126/science.1218643			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	965VD	22745428				2022-12-28	WOS:000305794500048
J	Levin, I; Veidt, C; Vaughn, BH; Brailsford, G; Bromley, T; Heinz, R; Lowe, D; Miller, JB; Poss, C; White, JWC				Levin, I.; Veidt, C.; Vaughn, B. H.; Brailsford, G.; Bromley, T.; Heinz, R.; Lowe, D.; Miller, J. B.; Poss, C.; White, J. W. C.			No inter-hemispheric delta(CH4)-C-13 trend observed	NATURE			English	Letter							MIXING-RATIO; CH4		[Levin, I.; Veidt, C.; Heinz, R.; Poss, C.] Heidelberg Univ, Inst Umweltphys, D-69120 Heidelberg, Germany; [Vaughn, B. H.; White, J. W. C.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Brailsford, G.; Bromley, T.] Natl Inst Water & Atmospher Res Ltd, Wellington 6021, New Zealand; [Lowe, D.] Victoria Univ Wellington, Antarctic Res Ctr, Wellington 6140, New Zealand; [Miller, J. B.] NOAA ESRL, Boulder, CO 80305 USA; [Miller, J. B.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA	Ruprecht Karls University Heidelberg; University of Colorado System; University of Colorado Boulder; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Victoria University Wellington; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder	Levin, I (corresponding author), Heidelberg Univ, Inst Umweltphys, D-69120 Heidelberg, Germany.	Ingeborg.Levin@iup.uni-heidelberg.de	White, James W.C./A-7845-2009; Miller, John B./AAE-7714-2019; Vaughn, Bruce/AAO-8867-2020	White, James W.C./0000-0001-6041-4684; Miller, John B./0000-0001-8630-1610; VAUGHN, BRUCE/0000-0001-6503-957X				Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Dlugokencky EJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039780; Kai FM, 2011, NATURE, V476, P194, DOI 10.1038/nature10259; Lassey KR, 2010, J INTEGR ENVIRON SCI, V7, P109, DOI 10.1080/19438151003621441; Miller JB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000630; Monteil G, 2011, ATMOS CHEM PHYS, V11, P9141, DOI 10.5194/acp-11-9141-2011; Nakazawa T, 1997, ENVIRONMETRICS, V8, P197, DOI 10.1002/(SICI)1099-095X(199705)8:3<197::AID-ENV248>3.0.CO;2-C; Patra PK, 2011, ATMOS CHEM PHYS, V11, P4163, DOI [10.5194/acp-11-4163-2011, 10.5194/acp-11-12813-2011]; Quay P, 1999, GLOBAL BIOGEOCHEM CY, V13, P445, DOI 10.1029/1998GB900006	9	48	48	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					E3	E4		10.1038/nature11175	http://dx.doi.org/10.1038/nature11175			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22739319				2022-12-28	WOS:000305760600001
J	Lewiecki, EM; Miller, SA				Lewiecki, E. Michael; Miller, Sara A.			Suicide affects all of us	LANCET			English	Editorial Material									[Lewiecki, E. Michael] New Mexico Clin Res & Osteoporosis Ctr, Albuquerque, NM USA; [Miller, Sara A.] Harvard Univ, Boston, MA 02115 USA	New Mexico Clinical Research & Osteoporosis Center; Harvard University	Lewiecki, EM (corresponding author), New Mexico Clin Res & Osteoporosis Ctr, Albuquerque, NM USA.	mlewiecki@gmail.com	Lewiecki, E. Michael/B-3706-2018	Lewiecki, E. Michael/0000-0003-2026-9587				Boyce N, 2011, LANCET, V378, P1452, DOI 10.1016/S0140-6736(11)61634-6; Cheatle MD, 2011, PAIN MED, V12, pS43, DOI 10.1111/j.1526-4637.2011.01131.x; Erlangsen A, 2003, J GERONTOL B-PSYCHOL, V58, pS314, DOI 10.1093/geronb/58.5.S314; Fishbain DA, 2012, PAIN MED, V13, P552, DOI 10.1111/j.1526-4637.2012.01358.x; Florentine JB, 2010, SOC SCI MED, V70, P1626, DOI 10.1016/j.socscimed.2010.01.029; Geulayov G, 2012, PSYCHOL MED, V42, P1567, DOI 10.1017/S0033291711002753; Harvard Injury Control Research Center, CHAR VICT SUIC; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; Kuberski Samantha, S KUBERSKI 6 YEARS O; Lewiecki EM, 2011, JAMA-J AM MED ASSOC, V305, P1070, DOI 10.1001/jama.2011.258; Niederkrotenthaler T, 2012, J EPIDEMIOL COMMUN H, V66, P1037, DOI 10.1136/jech-2011-200707; Pitman A, 2012, LANCET, V379, P2383, DOI 10.1016/S0140-6736(12)60731-4; World Health Organization, PREV SUIC RES GEN PH; Yip PSF, 2012, LANCET, V379, P2393, DOI 10.1016/S0140-6736(12)60521-2	14	5	5	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2012	379	9834					2316	2318		10.1016/S0140-6736(12)60726-0	http://dx.doi.org/10.1016/S0140-6736(12)60726-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961ZV	22726502				2022-12-28	WOS:000305509600005
J	Dagdas, YF; Yoshino, K; Dagdas, G; Ryder, LS; Bielska, E; Steinberg, G; Talbot, NJ				Dagdas, Yasin F.; Yoshino, Kae; Dagdas, Gulay; Ryder, Lauren S.; Bielska, Ewa; Steinberg, Gero; Talbot, Nicholas J.			Septin-Mediated Plant Cell Invasion by the Rice Blast Fungus, Magnaporthe oryzae	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CYTOKINESIS; INFECTION; MEMBRANE; POLARITY; GRISEA; GENES; CYCLE; COMPARTMENTALIZATION	To cause rice blast disease, the fungus Magnaporthe oryzae develops a pressurized dome-shaped cell called an appressorium, which physically ruptures the leaf cuticle to gain entry to plant tissue. Here, we report that a toroidal F-actin network assembles in the appressorium by means of four septin guanosine triphosphatases, which polymerize into a dynamic, hetero-oligomeric ring. Septins scaffold F-actin, via the ezrin-radixin-moesin protein Tea1, and phosphatidylinositide interactions at the appressorium plasma membrane. The septin ring assembles in a Cdc42- and Chm1-dependent manner and forms a diffusion barrier to localize the inverse-bin-amphiphysin-RVS-domain protein Rvs167 and the Wiskott-Aldrich syndrome protein Las17 at the point of penetration. Septins thereby provide the cortical rigidity and membrane curvature necessary for protrusion of a rigid penetration peg to breach the leaf surface.	[Dagdas, Yasin F.; Yoshino, Kae; Dagdas, Gulay; Ryder, Lauren S.; Bielska, Ewa; Steinberg, Gero; Talbot, Nicholas J.] Univ Exeter, Sch Biosci, Exeter EX4 4QG, Devon, England; [Yoshino, Kae] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Sakyo Ku, Kyoto 6068502, Japan	University of Exeter; Kyoto University	Talbot, NJ (corresponding author), Univ Exeter, Sch Biosci, Geoffrey Pope Bldg, Exeter EX4 4QG, Devon, England.	n.j.talbot@exeter.ac.uk	Talbot, Nicholas J/I-9584-2014; Bielska, Ewa/B-4936-2019; Talbot, Nicholas J/I-5618-2019	Talbot, Nicholas J/0000-0001-6434-7757; Bielska, Ewa/0000-0002-3138-4719; Talbot, Nicholas J/0000-0001-6434-7757; Dagdas, Yasin/0000-0002-9502-355X	Halpin Scholarship; Biotechnology and Biological Sciences Research Council; European Research Council; Kyoto University Foundation	Halpin Scholarship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Kyoto University Foundation	We thank J. Thorner (UC Berkeley) for providing yeast septin mutants, M. Momany for critical reading of the manuscript and valuable discussions, H. Florence from Exeter Mass Spectrometry facility, and M. Schuster from the Exeter Bio-imaging Centre. This work was funded by a Halpin Scholarship for rice blast research to Y.F.D. and grants to N.J.T. from the Biotechnology and Biological Sciences Research Council and the European Research Council. K.Y. is funded by the Kyoto University Foundation. Accession numbers are provided in supplementary materials.	ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Bechinger C, 1999, SCIENCE, V285, P1896, DOI 10.1126/science.285.5435.1896; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; BOURETT TM, 1990, CAN J BOT, V68, P329, DOI 10.1139/b90-044; Casamayor A, 2003, MOL CELL BIOL, V23, P2762, DOI 10.1128/MCB.23.8.2762-2777.2003; Castillon GA, 2003, CURR BIOL, V13, P654, DOI 10.1016/S0960-9822(03)00247-1; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Douglas LM, 2005, EUKARYOT CELL, V4, P1503, DOI 10.1128/EC.4.9.1503-1512.2005; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gilden J, 2010, CYTOSKELETON, V67, P477, DOI 10.1002/cm.20461; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Iwase M, 2006, MOL BIOL CELL, V17, P1110, DOI 10.1091/mbc.E05-08-0793; Li L, 2004, MOL PLANT MICROBE IN, V17, P547, DOI 10.1094/MPMI.2004.17.5.547; Lindsey R, 2006, CURR OPIN MICROBIOL, V9, P559, DOI 10.1016/j.mib.2006.10.009; Madania A, 1999, MOL BIOL CELL, V10, P3521, DOI 10.1091/mbc.10.10.3521; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Onishi M, 2010, MOL CELL BIOL, V30, P2057, DOI 10.1128/MCB.01529-09; Park G, 2002, MOL PLANT MICROBE IN, V15, P183, DOI 10.1094/MPMI.2002.15.3.183; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Saunders DGO, 2010, PLANT CELL, V22, P2417, DOI 10.1105/tpc.110.074492; Saunders DGO, 2010, PLANT CELL, V22, P497, DOI 10.1105/tpc.109.072447; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Zhao HX, 2011, CURR OPIN CELL BIOL, V23, P14, DOI 10.1016/j.ceb.2010.10.005	32	221	242	7	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1590	1595		10.1126/science.1222934	http://dx.doi.org/10.1126/science.1222934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723425	Green Accepted			2022-12-28	WOS:000305507500061
J	Harris, NL; Brown, S; Hagen, SC; Saatchi, SS; Petrova, S; Salas, W; Hansen, MC; Potapov, PV; Lotsch, A				Harris, Nancy L.; Brown, Sandra; Hagen, Stephen C.; Saatchi, Sassan S.; Petrova, Silvia; Salas, William; Hansen, Matthew C.; Potapov, Peter V.; Lotsch, Alexander			Baseline Map of Carbon Emissions from Deforestation in Tropical Regions	SCIENCE			English	Article							ANNUAL NET FLUX; LAND-USE; ATMOSPHERE; DIOXIDE; BIOMASS; ROOT; CO2	Policies to reduce emissions from deforestation would benefit from clearly derived, spatially explicit, statistically bounded estimates of carbon emissions. Existing efforts derive carbon impacts of land-use change using broad assumptions, unreliable data, or both. We improve on this approach using satellite observations of gross forest cover loss and a map of forest carbon stocks to estimate gross carbon emissions across tropical regions between 2000 and 2005 as 0.81 petagram of carbon per year, with a 90% prediction interval of 0.57 to 1.22 petagrams of carbon per year. This estimate is 25 to 50% of recently published estimates. By systematically matching areas of forest loss with their carbon stocks before clearing, these results serve as a more accurate benchmark for monitoring global progress on reducing emissions from deforestation.	[Harris, Nancy L.; Brown, Sandra; Petrova, Silvia] Winrock Int Livestock Res & Training Ctr, Ecosyst Serv Unit, Arlington, VA 22202 USA; [Hagen, Stephen C.; Salas, William] Appl GeoSolut, Durham, NH 03824 USA; [Saatchi, Sassan S.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Saatchi, Sassan S.] Univ Calif Los Angeles, Inst Environm, Los Angeles, CA 90035 USA; [Hansen, Matthew C.; Potapov, Peter V.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Lotsch, Alexander] World Bank Grp, Washington, DC 20433 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles; University System of Maryland; University of Maryland College Park; The World Bank	Harris, NL (corresponding author), Winrock Int Livestock Res & Training Ctr, Ecosyst Serv Unit, Arlington, VA 22202 USA.	nharris@winrock.org	potapov, peter/AAE-7388-2019; Hansen, Matthew C/ABE-7226-2020; Saatchi, Sassan/AAQ-2649-2021	Potapov, Peter/0000-0003-3977-0021	Winrock International under World Bank [7150484]; National Aeronautics and Space Administration [NNG06GD95G, NNX08AP33A]	Winrock International under World Bank; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	Funding for this work was provided to Winrock International under contract 7150484 by the World Bank's World Development Report 2010: Development and Climate Change. The findings, interpretations, and conclusions expressed in this paper are entirely those of the authors. They do not necessarily represent the views of the World Bank and its affiliated organizations or those of the Executive Directors of the World Bank or the governments they represent. Support for the forest cover loss mapping work was provided by National Aeronautics and Space Administration's Land Cover and Land Use Change and MEASURES programs under grants NNG06GD95G and NNX08AP33A. The authors would like to thank K. Mokany for providing the original data used to derive relationships between above- and belowground biomass. Forest loss data are available at http://globalmonitoring.sdstate.edu/projects/gfm. Carbon stock data are available at http://carbon.jpl.nasa.gov. Emissions data are available at www.appliedgeosolutions.com/science-paper.html.	Achard F, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002142; Arino O., 2007, GEOSC REM SENS S IEE; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; FAO/IIASA/ISRIC/ISSCAC/JRC, 2009, HARM WORLD SOIL DAT; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Hooijer A, 2010, BIOGEOSCIENCES, V7, P1505, DOI 10.5194/bg-7-1505-2010; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; HOUGHTON RA, 1985, NATURE, V316, P617, DOI 10.1038/316617a0; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; HOUGHTON RA, 1983, ECOL MONOGR, V53, P235, DOI 10.2307/1942531; Houghton RA, 2001, GLOBAL CHANGE BIOL, V7, P731, DOI 10.1046/j.1365-2486.2001.00426.x; IPCC, 2006, IPCC GUIDELINES NATL, V5; Mahli Y, 2010, CURR OPIN ENV SUST, V2, P237; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peters GP, 2012, NAT CLIM CHANGE, V2, P2, DOI 10.1038/nclimate1332; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; van der Werf GR, 2008, P NATL ACAD SCI USA, V105, P20350, DOI 10.1073/pnas.0803375105	23	428	446	22	311	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2012	336	6088					1573	1576		10.1126/science.1217962	http://dx.doi.org/10.1126/science.1217962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22723420				2022-12-28	WOS:000305507500055
J	Xiao, YM; Savchenko, T; Baidoo, EEK; Chehab, WE; Hayden, DM; Tolstikov, V; Corwin, JA; Kliebenstein, DJ; Keasling, JD; Dehesh, K				Xiao, Yanmei; Savchenko, Tatyana; Baidoo, Edward E. K.; Chehab, Wassim E.; Hayden, Daniel M.; Tolstikov, Vladimir; Corwin, Jason A.; Kliebenstein, Daniel J.; Keasling, Jay D.; Dehesh, Katayoon			Retrograde Signaling by the Plastidial Metabolite MEcPP Regulates Expression of Nuclear Stress-Response Genes	CELL			English	Article							METHYLERYTHRITOL PHOSPHATE-PATHWAY; MG-PROTOPORPHYRIN IX; ISOPRENOID BIOSYNTHESIS; ARABIDOPSIS-THALIANA; CHLOROPLAST DEVELOPMENT; ANTIMALARIAL-DRUGS; OXIDATIVE STRESS; SINGLET OXYGEN; SALICYLIC-ACID; MUTANT REVEALS	Plastid-derived signals are known to coordinate expression of nuclear genes encoding plastid-localized proteins in a process termed retrograde signaling. To date, the identity of retrograde-signaling molecules has remained elusive. Here, we show that methylerythritol cyclodiphosphate (MEcPP), a precursor of isoprenoids produced by the plastidial methylerythritol phosphate (MEP) pathway, elicits the expression of selected stress-responsive nuclear-encoded plastidial proteins. Genetic and pharmacological manipulations of the individual MEP pathway metabolite levels demonstrate the high specificity of MEcPP as an inducer of these targeted stress-responsive genes. We further demonstrate that abiotic stresses elevate MEcPP levels, eliciting the expression of the aforementioned genes. We propose that the MEP pathway, in addition to producing isoprenoids, functions as a stress sensor and a coordinator of expression of targeted stress-responsive nuclear genes via modulation of the levels of MEcPP, a specific and critical retrograde-signaling metabolite.	[Xiao, Yanmei; Savchenko, Tatyana; Dehesh, Katayoon] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Tolstikov, Vladimir] Univ Calif Davis, Genome Sci Facil, Davis, CA 95616 USA; [Tolstikov, Vladimir] Univ Calif Davis, Biomed Sci Facil, Davis, CA 95616 USA; [Corwin, Jason A.; Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Baidoo, Edward E. K.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Baidoo, Edward E. K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Chehab, Wassim E.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Hayden, Daniel M.] Complete Genom, Mountain View, CA 94043 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Rice University; University of California System; University of California Berkeley	Dehesh, K (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	kdehesh@ucdavis.edu	Tolstikov, Vladimir/P-2465-2019; Keasling, Jay D/J-9162-2012; Savchenko, Tatyana/E-7091-2014	Keasling, Jay D/0000-0003-4170-6088; Savchenko, Tatyana/0000-0003-0126-4932; Kliebenstein, Daniel/0000-0001-5759-3175; Xiao, Yanmei/0000-0002-3951-5787; Tolstikov, Vladimir/0000-0002-0445-884X; Corwin, Jason/0000-0001-6455-8474	National Science Foundation [IOS-1036491]; US Department of Energy, Office of Science, Office of Biological and Environmental Research, Genomics: GTL Foundational Science [DE-AC02-05CH11231]	National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Office of Science, Office of Biological and Environmental Research, Genomics: GTL Foundational Science(United States Department of Energy (DOE))	We thank Dr. Andrew Grover for his insightful comments on the manuscript. This project is supported by the National Science Foundation grant IOS-1036491 (K. D.). This work was performed as part of ENIGMA, a Scientific Focus Area Program supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, Genomics: GTL Foundational Science through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy (E.E.K.B. and J.D.K).	Abdallah F, 2000, TRENDS PLANT SCI, V5, P141, DOI 10.1016/S1360-1385(00)01574-0; Ankele E, 2007, PLANT CELL, V19, P1964, DOI 10.1105/tpc.106.048744; Beale SI, 2011, CURR BIOL, V21, pR391, DOI 10.1016/j.cub.2011.03.072; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; BRADBEER JW, 1979, NATURE, V279, P816, DOI 10.1038/279816a0; Chehab EW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001904; Chehab EW, 2006, PLANT PHYSIOL, V141, P121, DOI 10.1104/pp.106.078592; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dynowski M, 2008, BIOCHEM J, V414, P53, DOI 10.1042/BJ20080287; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Eudes A, 2011, APPL MICROBIOL BIOT, V89, P989, DOI 10.1007/s00253-010-2939-y; Gil MJ, 2005, PLANT J, V44, P155, DOI 10.1111/j.1365-313X.2005.02517.x; Grieshaber NA, 2004, P NATL ACAD SCI USA, V101, P7451, DOI 10.1073/pnas.0400754101; Grieshaber NA, 2006, J BACTERIOL, V188, P5289, DOI 10.1128/JB.00526-06; Gutierrez-Nava MDL, 2004, PLANT PHYSIOL, V135, P471, DOI 10.1104/pp.103.036996; Heiber I, 2007, PLANT PHYSIOL, V143, P1774, DOI 10.1104/pp.106.093328; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Jung HS, 2010, PLANT PHYSIOL, V152, P453, DOI 10.1104/pp.109.149070; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Kleine T, 2009, TRENDS GENET, V25, P185, DOI 10.1016/j.tig.2009.02.004; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Laloi C, 2006, J EXP BOT, V57, P1719, DOI 10.1093/jxb/erj183; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Moulin M, 2008, P NATL ACAD SCI USA, V105, P15178, DOI 10.1073/pnas.0803054105; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; OELMULLER R, 1986, PLANTA, V168, P482, DOI 10.1007/BF00392267; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Ostrovsky D, 1998, ARCH MICROBIOL, V171, P69, DOI 10.1007/s002030050680; OSTROVSKY D, 1992, BIOFACTORS, V3, P261; Pesaresi P, 2007, CURR OPIN PLANT BIOL, V10, P600, DOI 10.1016/j.pbi.2007.07.007; Phillips MA, 2007, PLANT MOL BIOL, V65, P243, DOI 10.1007/s11103-007-9212-5; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Piippo M, 2006, PHYSIOL GENOMICS, V25, P142, DOI 10.1152/physiolgenomics.00256.2005; Pogson BJ, 2008, TRENDS PLANT SCI, V13, P602, DOI 10.1016/j.tplants.2008.08.008; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepcion Manuel, 2006, Phytochemistry Reviews, V5, P1, DOI 10.1007/s11101-005-3130-4; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Rohdich F, 2004, BIOORG CHEM, V32, P292, DOI 10.1016/j.bioorg.2004.05.012; Savchenko T, 2010, PLANT CELL, V22, P3193, DOI 10.1105/tpc.110.073858; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Sonderby IE, 2010, PLANT PHYSIOL, V153, P348, DOI 10.1104/pp.109.149286; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Wagner D, 2004, SCIENCE, V306, P1183, DOI 10.1126/science.1103178; Walley JW, 2007, PLOS GENET, V3, P1800, DOI 10.1371/journal.pgen.0030172; Walley JW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000237; Walter MH, 2002, PLANT J, V31, P243, DOI 10.1046/j.1365-313X.2002.01352.x; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Woodson JD, 2011, CURR BIOL, V21, P897, DOI 10.1016/j.cub.2011.04.004	58	286	296	7	125	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 22	2012	149	7					1525	1535		10.1016/j.cell.2012.04.038	http://dx.doi.org/10.1016/j.cell.2012.04.038			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22726439	Bronze			2022-12-28	WOS:000305753800018
J	Williams, G				Williams, Gareth			The art of medicine What goes around, comes around	LANCET			English	Editorial Material							INSULIN		Southmead Hosp, Univ Dept Med, Bristol BS10 5NB, Avon, England	Southmead Hospital	Williams, G (corresponding author), Southmead Hosp, Univ Dept Med, Bristol BS10 5NB, Avon, England.	Gareth.Williams@bristol.ac.uk						Cartwright A, 2011, DIABETES, V28, P332; KENT LA, 1994, LANCET, V344, P778, DOI 10.1016/S0140-6736(94)92340-X; PICKUP J, 1983, DIABETES CARE, V6, P279, DOI 10.2337/diacare.6.3.279; SCHADE DS, 1986, NEW ENGL J MED, V315, P147, DOI 10.1056/NEJM198607173150302; WILLIAMS G, 1987, AM J MED, V82, P1247, DOI 10.1016/0002-9343(87)90234-8	5	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 16	2012	379	9833					2235	2236		10.1016/S0140-6736(12)60969-6	http://dx.doi.org/10.1016/S0140-6736(12)60969-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	962AM	22715508				2022-12-28	WOS:000305511400017
J	Tarsy, D				Tarsy, Daniel			Treatment of Parkinson Disease A 64-Year-Old Man With Motor Complications of Advanced Parkinson Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEEP-BRAIN-STIMULATION; SUBTHALAMIC NUCLEUS STIMULATION; HIGH-FREQUENCY STIMULATION; 5-YEAR FOLLOW-UP; QUALITY-OF-LIFE; GLOBUS-PALLIDUS; THALAMIC-STIMULATION; BILATERAL STIMULATION; COST-EFFECTIVENESS; MEDICAL-TREATMENT	In early stages, Parkinson disease typically begins with asymmetric or unilateral motor symptoms due to combinations of mild bradykinesia, rigidity, and tremor. In most cases, with progression, signs of more generalized bradykinesia appear, which include facialmasking, reduced voice volume, and slowing of activities of daily living. In more advanced Parkinson disease, other disabling manifestations may follow, such as impaired balance, gait freezing, falls, speech disturbance, and cognitive impairment. Levodopa is the most effective medical treatment for Parkinson disease. However, motor complications uniquely related to levodopa treatment may emerge that may be difficult to manage. These include fluctuating levodopa responses and involuntary movements and postures known as dyskinesia and dystonia. Medication adjustments are usually effective, but in some cases surgical intervention with deep brain stimulation becomes necessary to alleviate motor complications. The case of Mr L, a man with an 11-year history of Parkinson disease, illustrates these emerging motor complications and the manner in which they may be managed both medically and surgically. JAMA. 2012;307(21):2305-2315 www.jama.com	[Tarsy, Daniel] Beth Israel Deaconess Med Ctr, Parkinson Dis & Movement Disorders Ctr, Boston, MA 02215 USA; [Tarsy, Daniel] Beth Israel Deaconess Med Ctr, Natl Parkinson Fdn Ctr Excellence, Parkinson Dis Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Tarsy, D (corresponding author), Beth Israel Deaconess Med Ctr, Parkinson Dis & Movement Disorders Ctr, 330 Brookline Ave,KS 228, Boston, MA 02215 USA.	dtarsy@bidmc.harvard.edu			Allergan; UCB; Valeant; Ipsen; Teva Neurosciences; Medtronic; Phytopharm PLC; Solvay; GlaxoSmithKline; Esai Neuroscience; Neurocrine Biosciences; Genzyme Corporation; ASim, a medical education company; National Parkinson Foundation; Michael J Fox Foundation; book royalties	Allergan(AbbVieAllergan); UCB(UCB Pharma SA); Valeant; Ipsen(Ipsen); Teva Neurosciences(Teva Pharmaceutical Industries); Medtronic(Medtronic); Phytopharm PLC; Solvay(Solvay SA); GlaxoSmithKline(GlaxoSmithKline); Esai Neuroscience; Neurocrine Biosciences; Genzyme Corporation(Sanofi-AventisGenzyme Corporation); ASim, a medical education company; National Parkinson Foundation; Michael J Fox Foundation; book royalties	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Tarsy reported receiving unrestricted education grants from Allergan for fellowship funding; patient education grants from Allergan, UCB, Valeant, Ipsen, Teva Neurosciences, Medtronic; research funding from Phytopharm PLC, Solvay, Medtronic, GlaxoSmithKline; consulting fees from Esai Neuroscience, Neurocrine Biosciences, Genzyme Corporation; support from ASim, a medical education company; research support for research from the National Parkinson Foundation, Michael J Fox Foundation, and book royalties.	Appleby BS, 2007, MOVEMENT DISORD, V22, P1722, DOI 10.1002/mds.21551; Baas H, 1997, J NEUROL NEUROSUR PS, V63, P421, DOI 10.1136/jnnp.63.4.421; Bejjani BP, 1999, NEW ENGL J MED, V340, P1476, DOI 10.1056/NEJM199905133401905; Bejjani BP, 2002, NEUROLOGY, V59, P1425, DOI 10.1212/01.WNL.0000031428.31861.23; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Bjorklund A, 2010, PROG BRAIN RES, V184, P311, DOI [10.1016/S0079-6123(16)8401-6, 10.1016/S0079-6123(10)84016-6]; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Burkhard PR, 2004, NEUROLOGY, V63, P2170, DOI 10.1212/01.WNL.0000145603.48221.B5; Charles PD, 2004, PARKINSONISM RELAT D, V10, P475, DOI 10.1016/j.parkreldis.2004.05.006; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Deniau JM, 2010, EUR J NEUROSCI, V32, P1080, DOI 10.1111/j.1460-9568.2010.07413.x; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Durif F, 2002, MOVEMENT DISORD, V17, P803, DOI 10.1002/mds.10128; Fahn S, 2008, MOVEMENT DISORD, V23, pS497, DOI 10.1002/mds.22028; Fahn S, 2010, MOVEMENT DISORD, V25, pS2, DOI 10.1002/mds.22796; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Fox SH, 2011, MOVEMENT DISORD, V26, pS2, DOI 10.1002/mds.23829; Fraix V, 2006, J NEUROL NEUROSUR PS, V77, P443, DOI 10.1136/jnnp.2005.077677; Gervais-Bernard H, 2009, J NEUROL, V256, P225, DOI 10.1007/s00415-009-0076-2; Ghika J, 1998, J NEUROSURG, V89, P713, DOI 10.3171/jns.1998.89.5.0713; Giladi N, 2008, MOVEMENT DISORD, V23, pS482, DOI 10.1002/mds.21914; Goetz CG, 2005, MOVEMENT DISORD, V20, P523, DOI 10.1002/mds.20464; GOETZ CG, 1990, NEUROLOGY, V40, P50; Goetz CG, 2002, MOV DISORD S4, V17, pS13; Haberler C, 2000, ANN NEUROL, V48, P372, DOI 10.1002/1531-8249(200009)48:3<372::AID-ANA12>3.0.CO;2-0; Hariz MI, 2008, J NEUROL NEUROSUR PS, V79, P694, DOI 10.1136/jnnp.2007.118653; Hilker R, 2005, J NEUROL NEUROSUR PS, V76, P1217, DOI 10.1136/jnnp.2004.057893; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Kieburtz K, 1997, ANN NEUROL, V42, P747; Kirsch-Darrow L, 2008, FRONT BIOSCI, V13, P5316; Kishore A, 2010, MOVEMENT DISORD, V25, P2438, DOI 10.1002/mds.23269; Klawans H L, 1986, Mov Disord, V1, P187, DOI 10.1002/mds.870010304; Koller W, 1997, ANN NEUROL, V42, P292, DOI 10.1002/ana.410420304; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Kulisevsky J, 2002, NEUROLOGY, V59, P1421, DOI 10.1212/WNL.59.9.1421; LAITINEN LV, 1992, J NEUROSURG, V76, P53, DOI 10.3171/jns.1992.76.1.0053; LANG AE, 1984, CAN J NEUROL SCI, V11, P210, DOI 10.1017/S0317167100046436; Lyons KE, 2004, NEUROLOGY, V63, P612, DOI 10.1212/01.WNL.0000134650.91974.1A; Lyons KE, 2002, STEREOT FUNCT NEUROS, V79, P214, DOI 10.1159/000070834; Meissner W, 2005, J NEUROL, V252, P218, DOI 10.1007/s00415-005-0640-3; Mikos A, 2011, NEUROIMAGE, V54, pS238, DOI 10.1016/j.neuroimage.2010.03.068; Nutt JG, 2008, MOVEMENT DISORD, V23, pS580, DOI 10.1002/mds.22037; Obeso JA, 2000, ANN NEUROL, V47, pS22; Oh MY, 2002, NEUROSURGERY, V50, P1268; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; Olanow CW, 2001, NEUROLOGY, V56, pS1, DOI 10.1212/WNL.56.suppl_5.S1; Pahwa R, 2006, J NEUROSURG, V104, P506, DOI 10.3171/jns.2006.104.4.506; Pahwa R, 2006, NEUROLOGY, V66, P983, DOI 10.1212/01.wnl.0000215250.82576.87; Parsons TD, 2006, LANCET NEUROL, V5, P578, DOI 10.1016/S1474-4422(06)70475-6; Piboolnurak P, 2007, MOVEMENT DISORD, V22, P990, DOI 10.1002/mds.21482; Rajput AH, 2009, NEUROLOGY, V73, P206, DOI 10.1212/WNL.0b013e3181ae7af1; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Romito LM, 2002, MOVEMENT DISORD, V17, P1371, DOI 10.1002/mds.10265; Romito LM, 2009, MOVEMENT DISORD, V24, P557, DOI 10.1002/mds.22390; Saint-Cyr JA, 2000, BRAIN, V123, P2091, DOI 10.1093/brain/123.10.2091; Schroeder U, 2003, ANN NEUROL, V54, P445, DOI 10.1002/ana.10683; Schupbach WMM, 2005, J NEUROL NEUROSUR PS, V76, P1640, DOI 10.1136/jnnp.2005.063206; Schuurman PR, 2008, MOVEMENT DISORD, V23, P1146, DOI 10.1002/mds.22059; Schwid SR, 2005, ARCH NEUROL-CHICAGO, V62, P241; Selikhova M, 2009, BRAIN, V132, P2947, DOI 10.1093/brain/awp234; Shih LC, 2007, MOVEMENT DISORD, V22, P2149, DOI 10.1002/mds.21648; Shulman LM, 2010, ARCH NEUROL-CHICAGO, V67, P64, DOI 10.1001/archneurol.2009.295; Siderowf A, 2006, MOVEMENT DISORD, V21, P746, DOI 10.1002/mds.20786; Simonin C, 2009, J NEUROL, V256, P1736, DOI 10.1007/s00415-009-5195-2; Smeding HMM, 2006, NEUROLOGY, V66, P1830, DOI 10.1212/01.wnl.0000234881.77830.66; Tarsy D, 2005, STEREOT FUNCT NEUROS, V83, P222, DOI 10.1159/000091953; Temel Y, 2006, PARKINSONISM RELAT D, V12, P265, DOI 10.1016/j.parkreldis.2006.01.004; Tomaszewski KJ, 2001, NEUROLOGY, V57, P663, DOI 10.1212/WNL.57.4.663; Troster AI, 2008, LANCET NEUROL, V7, P565, DOI 10.1016/S1474-4422(08)70115-7; Valldeoriola F, 2007, MOVEMENT DISORD, V22, P2183, DOI 10.1002/mds.21652; Videnovic A, 2008, MOVEMENT DISORD, V23, P343, DOI 10.1002/mds.21753; Volkmann J, 2004, ANN NEUROL, V55, P871, DOI 10.1002/ana.20091; Volkmann J, 1998, ANN NEUROL, V44, P953, DOI 10.1002/ana.410440615; Volkmann J, 2009, MOVEMENT DISORD, V24, P1154, DOI 10.1002/mds.22496; Voon V, 2006, MOVEMENT DISORD, V21, pS305, DOI 10.1002/mds.20963; Voon V, 2008, BRAIN, V131, P2720, DOI 10.1093/brain/awn214; Waters CH, 2004, MOVEMENT DISORD, V19, P426, DOI 10.1002/mds.20036; Weaver F, 2005, J NEUROSURG, V103, P956, DOI 10.3171/jns.2005.103.6.0956; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Welter ML, 2002, BRAIN, V125, P575, DOI 10.1093/brain/awf050; Wider C, 2008, PARKINSONISM RELAT D, V14, P114, DOI 10.1016/j.parkreldis.2007.06.012; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4; Witt K, 2008, LANCET NEUROL, V7, P605, DOI 10.1016/S1474-4422(08)70114-5; Wolf E, 2010, MOVEMENT DISORD, V25, P1357, DOI 10.1002/mds.23034	85	27	27	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2012	307	21					2305	2314		10.1001/jama.2012.4829	http://dx.doi.org/10.1001/jama.2012.4829			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	952OL	22706836				2022-12-28	WOS:000304801700025
J	Hauschild, A; Grob, JJ; Demidov, LV; Jouary, T; Gutzmer, R; Millward, M; Rutkowski, P; Blank, CU; Miller, WH; Kaempgen, E; Martin-Algarra, S; Karaszewska, B; Mauch, C; Chiarion-Sileni, V; Martin, AM; Swann, S; Haney, P; Mirakhur, B; Guckert, ME; Goodman, V; Chapman, PB				Hauschild, Axel; Grob, Jean-Jacques; Demidov, Lev V.; Jouary, Thomas; Gutzmer, Ralf; Millward, Michael; Rutkowski, Piotr; Blank, Christian U.; Miller, Wilson H., Jr.; Kaempgen, Eckhart; Martin-Algarra, Salvador; Karaszewska, Boguslawa; Mauch, Cornelia; Chiarion-Sileni, Vanna; Martin, Anne-Marie; Swann, Suzanne; Haney, Patricia; Mirakhur, Beloo; Guckert, Mary E.; Goodman, Vicki; Chapman, Paul B.			Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial	LANCET			English	Article							SOLID TUMORS; RESISTANCE; VEMURAFENIB; INHIBITION; SURVIVAL; CANCER	Background Dabrafenib, an inhibitor of mutated BRAF, has clinical activity with a manageable safety profile in studies of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma. We studied the efficacy of dabrafenib in patients with BRAF(V600E)-mutated metastatic melanoma. Methods We enrolled patients in this open-label phase 3 trial between Dec 23, 2010, and Sept 1, 2011. This report is based on a data cutoff date of Dec 19, 2011. Patients aged 18 years or older with previously untreated, stage IV or unresectable stage III BRAF(V600E) mutation-positive melanoma were randomly assigned (3:1) to receive dabrafenib (150 mg twice daily, orally) or dacarbazine (1000 mg/m(2) intravenously every 3 weeks). Patients were stratified according to American Joint Committee on Cancer stage (unresectable III+IVM1a+IVM1b vs IVM1c). The primary endpoint was investigator-assessed progression-free survival and was analysed by intention to treat; safety was assessed per protocol. This study is registered with ClinicalTrials.gov, number NCT01227889. Findings Of the 733 patients screened, 250 were randomly assigned to receive either dabrafenib (187 patients) or dacarbazine (63 patients). Median progression-free survival was 5.1 months for dabrafenib and 2.7 months for dacarbazine, with a hazard ratio (HR) of 0.30 (95% CI 0.18-0.51; p<0.0001). At data cutoff, 107 (57%) patients in the dabrafenib group and 14 (22%) in the dacarbazine group remained on randomised treatment. Treatment-related adverse events (grade 2 or higher) occurred in 100 (53%) of the 187 patients who received dabrafenib and in 26 (44%) of the 59 patients who received dacarbazine. The most common adverse events with dabrafenib were skin-related toxic effects, fever, fatigue, arthralgia, and headache. The most common adverse events with dacarbazine were nausea, vomiting, neutropenia, fatigue, and asthenia. Grade 3-4 adverse events were uncommon in both groups. Interpretation Dabrafenib significantly improved progression-free survival compared with dacarbazine.	[Hauschild, Axel] Univ Hosp, Dept Dermatol, D-24105 Kiel, Germany; [Grob, Jean-Jacques] Aix Marseille Univ, Hop Timone, Assistance Publ Hop Marseille, Marseille, France; [Demidov, Lev V.] NN Blokhin Russian Canc Res Ctr, Moscow, Russia; [Jouary, Thomas] Hop St Andre, Dept Dermatol, Skin Canc Unit, Bordeaux, France; [Gutzmer, Ralf] Hannover Med Sch, Skin Canc Ctr, Dept Dermatol & Allergy, Hannover, Germany; [Millward, Michael] Sir Charles Gairdner Hosp, Perth, WA, Australia; [Millward, Michael] Univ Western Australia, Perth, WA 6009, Australia; [Rutkowski, Piotr] Maria Sklodowska Curie Mem Canc Ctr, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland; [Rutkowski, Piotr] Inst Oncol, Warsaw, Poland; [Blank, Christian U.] Antoni van Leeuwenhoek Hosp NKI AVL, Netherlands Canc Inst, Div Med Oncol, Amsterdam, Netherlands; [Miller, Wilson H., Jr.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Kaempgen, Eckhart] Univ Hosp Erlangen, Skin Canc Ctr, Dept Dermatol, Erlangen, Germany; [Martin-Algarra, Salvador] Univ Navarra Clin, Dept Med Oncol, Pamplona, Spain; [Karaszewska, Boguslawa] Przychodnia Lekarska KOMED, Konin, Poland; [Mauch, Cornelia] Univ Hosp Cologne, Dept Dermatol & Venereol, Cologne, Germany; [Mauch, Cornelia] Univ Hosp Cologne, CIO KolnBonn, Cologne, Germany; [Chiarion-Sileni, Vanna] Ist Oncol Veneto, Melanoma & Skin Canc Unit, Padua, Italy; [Martin, Anne-Marie; Swann, Suzanne; Haney, Patricia; Mirakhur, Beloo; Guckert, Mary E.; Goodman, Vicki] GlaxoSmithKline, Collegeville, PA USA; [Chapman, Paul B.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	University of Kiel; Schleswig Holstein University Hospital; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; N.N. Blokhin Russian Cancer Research Center; CHU Bordeaux; Hannover Medical School; University of Western Australia; University of Western Australia; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Netherlands Cancer Institute; Lady Davis Institute; McGill University; University of Erlangen Nuremberg; University of Navarra; University of Cologne; University of Cologne; IRCCS Istituto Oncologico Veneto (IOV); GlaxoSmithKline; Memorial Sloan Kettering Cancer Center	Hauschild, A (corresponding author), Univ Hosp, Dept Dermatol, Schittenhelmstr 7, D-24105 Kiel, Germany.	ahauschild@dermatology.uni-kiel.de	Rutkowski, Piotr/B-3907-2013; sileni, vanna chiarion/B-9042-2018; Martín-Algarra, Salvador/CAF-3626-2022; Millward, Michael/H-5456-2014	Rutkowski, Piotr/0000-0002-8920-5429; sileni, vanna chiarion/0000-0001-9191-9124; Martín-Algarra, Salvador/0000-0002-3109-8026; Grob, Jean-Jacques/0000-0002-0667-153X	GlaxoSmithKline; Roche; BMS; MedImmune; MSD; Roche Pharma; Novartis; MSD/Essex; Pfizer	GlaxoSmithKline(GlaxoSmithKline); Roche(Roche Holding); BMS(Bristol-Myers Squibb); MedImmune(AstraZenecaMedimmune); MSD; Roche Pharma; Novartis(Novartis); MSD/Essex; Pfizer(Pfizer)	GlaxoSmithKline.; SM-A has participated in advisory boards for Roche, GlaxoSmithKline, and BMS. CUB has received payment from Roche for teaching, has participated in advisory boards for Roche and BMS, has participated in conferences for Roche and Novartis, and has received study or research funding from Roche, BMS, and MedImmune. VCS has received reimbursement for participation in advisory boards and for research protocols from BMS, Roche, MSD, and GlaxoSmithKline. LD has had consultancies with Merck, Roche, and GlaxoSmithKline; has received honoraria from HemOncToday Melanoma 2012; and has been involved in clinical trials with Roche, GlaxoSmithKline, Pfizer, and BMS. VLG is an employee of GlaxoSmithKline and has stock ownership. J-JG has participated in advisory boards for GlaxoSmithKline. MEG is an employee of GlaxoSmithKline. PH is an employee of GlaxoSmithKline and has stock ownership. AH has received study grants, compensation for presentations and consultancy honoraria for advisory boards from AstraZeneca, Biovex, BMS, Boehringer Ingelheim, Celgene, Eisai, GlaxoSmithKline, IGEA, Lilly, Medac, MelaSciences, MSD/Merck, Novartis, Roche Pharma, SOBI, Vical, and Janssen. A-MM is an employee of GlaxoSmithKline and holds stock as a GSK employee. RG has cooperated in clinical studies with Roche Pharma, BMS, GlaxoSmithKline, Novartis, MSD/Essex, Celgene, Lilly, Eisai, AstraZeneca, Vicla, Cytavis, Centocor, Genta, SwedishOrphan, and Philogen; has received research support from Roche Pharma, Novartis, and MSD/Essex; has received honoraria for lectures from Roche Pharma, BMS, GlaxoSmithKline, Novartis, Merck Serono, MSD/Essex, Almirall-Hermal, and Amgen; and has received support for participating in meetings from Roche Pharma, BMS, and MSD/Essex. WHM has received fees to his institution (Jewish General Hospital), has been a paid consultant to BMS, GlaxoSmithKline, Roche, Ziopharm, and Merck; has received grants from Merck; and has received travel, accommodation, or meetings expenses from BMS and Pfizer. MM has participated in advisory boards for GlaxoSmithKline. PBC has received consultancy fees from and participated in advisory boards with GlaxoSmithKline and Genentech/Roche. PR has received travel grants and honoraria for lectures from Novartis, Pfizer, BMS, MSD, and Roche; and has participated in advisory boards for Novartis, MSD, and BMS. SS is an employee of GlaxoSmithKline, including salary and stock ownership. MDJ, and EK declare that they have no conflicts of interest.	Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Ferlay J, 2010, IARC CANCERBASE, V10; GlaxoSmithKline, 2012, BRF113683 CLIN STUD; Jakob JA, 2012, CANCER-AM CANCER SOC, V118, P4014, DOI 10.1002/cncr.26724; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Straussman R, 2012, P 103 ANN M AM ASS C, P4837; Trefzer U, 2011, PIGM CELL MELANOMA R, V24, P1020	15	2189	2239	5	163	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	2012	380	9839					358	365		10.1016/S0140-6736(12)60868-X	http://dx.doi.org/10.1016/S0140-6736(12)60868-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	979TN	22735384				2022-12-28	WOS:000306842800033
J	Jagger, BW; Wise, HM; Kash, JC; Walters, KA; Wills, NM; Xiao, YL; Dunfee, RL; Schwartzman, LM; Ozinsky, A; Bell, GL; Dalton, RM; Lo, A; Efstathiou, S; Atkins, JF; Firth, AE; Taubenberger, JK; Digard, P				Jagger, B. W.; Wise, H. M.; Kash, J. C.; Walters, K-A; Wills, N. M.; Xiao, Y-L; Dunfee, R. L.; Schwartzman, L. M.; Ozinsky, A.; Bell, G. L.; Dalton, R. M.; Lo, A.; Efstathiou, S.; Atkins, J. F.; Firth, A. E.; Taubenberger, J. K.; Digard, P.			An Overlapping Protein-Coding Region in Influenza A Virus Segment 3 Modulates the Host Response	SCIENCE			English	Article							ENDONUCLEASE; DEGRADATION; SUPPRESSION; SUBUNIT; BINDING; IMMUNE	Influenza A virus (IAV) infection leads to variable and imperfectly understood pathogenicity. We report that segment 3 of the virus contains a second open reading frame ("X-ORF"), accessed via ribosomal frameshifting. The frameshift product, termed PA-X, comprises the endonuclease domain of the viral PA protein with a C-terminal domain encoded by the X-ORF and functions to repress cellular gene expression. PA-X also modulates IAV virulence in a mouse infection model, acting to decrease pathogenicity. Loss of PA-X expression leads to changes in the kinetics of the global host response, which notably includes increases in inflammatory, apoptotic, and T lymphocyte-signaling pathways. Thus, we have identified a previously unknown IAV protein that modulates the host response to infection, a finding with important implications for understanding IAV pathogenesis.	[Jagger, B. W.; Wise, H. M.; Bell, G. L.; Dalton, R. M.; Lo, A.; Efstathiou, S.; Firth, A. E.; Digard, P.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; [Jagger, B. W.; Kash, J. C.; Xiao, Y-L; Dunfee, R. L.; Schwartzman, L. M.; Taubenberger, J. K.] NIAID, Viral Pathogenesis & Evolut Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Walters, K-A; Ozinsky, A.] Inst Syst Biol, Seattle, WA 98109 USA; [Wills, N. M.; Atkins, J. F.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Atkins, J. F.] Univ Coll Cork, BioSci Inst, Cork, Ireland	University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Institute for Systems Biology (ISB); Utah System of Higher Education; University of Utah; University College Cork	Firth, AE (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	aef24@cam.ac.uk; taubenbergerj@niaid.nih.gov; paul.digard@roslin.ed.ac.uk	Digard, Paul/B-7717-2008; Kash, John/ABE-8280-2021; Taubenberger, Jeffery/AAQ-1407-2021	Digard, Paul/0000-0002-0872-9440; Firth, Andrew/0000-0002-7986-9520; Atkins, John/0000-0001-7933-0165	Wellcome Trust [088789, 073126]; U.K. Medical Research Council [G0700815]; NIH; National Institute of Allergy and Infectious Diseases (NIAID), NIH; Science Foundation Ireland [08/IN.1/B1889]; Defense Threat Reduction Agency [HDTRA-1-08-C-0023]; Luxembourg Centre for Systems Biomedicine; University of Luxembourg; U.K. Biotechnology and Biological Sciences Research Council; Cambridge Infectious Disease Consortium; NIH-Oxford-Cambridge Research Scholars program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000986] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864] Funding Source: researchfish; Medical Research Council [MR/J002232/1, G0700815, G9800943] Funding Source: researchfish; BBSRC [BBS/E/D/20241864] Funding Source: UKRI; MRC [G0700815, G9800943, MR/J002232/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Luxembourg Centre for Systems Biomedicine; University of Luxembourg; U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Infectious Disease Consortium; NIH-Oxford-Cambridge Research Scholars program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	A.E.F. is supported by the Wellcome Trust (088789). P. D. was supported by the U.K. Medical Research Council (G0700815) and Wellcome Trust (073126). This work was supported in part by the intramural funds of the NIH and the National Institute of Allergy and Infectious Diseases (NIAID), NIH. J.F.A. is supported by Science Foundation Ireland (08/IN.1/B1889). K.-A. W. and A.O. were funded by Defense Threat Reduction Agency contract HDTRA-1-08-C-0023, the Luxembourg Centre for Systems Biomedicine, and the University of Luxembourg. G. L. B. and A. L. were supported by studentships from the U.K. Biotechnology and Biological Sciences Research Council and the Cambridge Infectious Disease Consortium, respectively. We thank the Comparative Medicine Branch (NIAID, NIH) for assistance with animal studies and M. Howard (Utah) for the pDluc variant of the dual luciferase vector. We also thank a number of colleagues for helpful discussion, including J. Gog and L. Tiley (University of Cambridge), W. Barclay (Imperial College London), Y. J. Tao (Rice University), J. I. Cohen, K. Subbarao, K. C. Zoon, D. C. Wilson, M. M. Gottesman, R. Wyatt, and H. Metzger (NIH). B. W. J., P. D., and J. K. T. are also thankful for the support of the NIH-Oxford-Cambridge Research Scholars program. The Gene Expression Omnibus accession no. for microarray data is GSE38112.	Atkins JF, 2010, NUCLEIC ACIDS MOL BI, V24, P1, DOI 10.1007/978-0-387-89382-2; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Easterbrook JD, 2011, INFLUENZA OTHER RESP, V5, P198, DOI 10.1111/j.1750-2659.2010.00191.x; EISINGER J, 1971, NATURE-NEW BIOL, V231, P126, DOI 10.1038/newbio231126a0; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gog JR, 2007, NUCLEIC ACIDS RES, V35, P1897, DOI 10.1093/nar/gkm087; Grentzmann G, 1998, RNA, V4, P479; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Holmes EC, 2006, SCIENCE, V313, DOI 10.1126/science.1131729; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; SANZEZQUERRO JJ, 1995, J VIROL, V69, P2420, DOI 10.1128/JVI.69.4.2420-2426.1995; Smiley JR, 2004, J VIROL, V78, P1063, DOI 10.1128/JVI.78.3.1063-1068.2004; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Valkenburg SA, 2011, MICROBES INFECT, V13, P489, DOI 10.1016/j.micinf.2011.01.007; Vreede FT, 2010, VIROLOGY, V396, P125, DOI 10.1016/j.virol.2009.10.003; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Weber F, 2007, BIOCHIMIE, V89, P836, DOI 10.1016/j.biochi.2007.01.005; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0	26	441	465	6	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2012	337	6091					199	204		10.1126/science.1222213	http://dx.doi.org/10.1126/science.1222213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22745253	Green Accepted			2022-12-28	WOS:000306323500050
J	Glass, RI; Guttmacher, AE; Black, RE				Glass, Roger I.; Guttmacher, Alan E.; Black, Robert E.			Ending Preventable Child Death in a Generation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Glass, Roger I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Guttmacher, Alan E.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Black, Robert E.] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Glass, RI (corresponding author), NIH, Fogarty Int Ctr, 31 Ctr Dr,Bldg 31,Room B2C02, Bethesda, MD 20892 USA.	Roger.Glass@nih.gov		Black, Robert/0000-0001-9926-7984				Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Madon T, 2007, SCIENCE, V318, P1728, DOI 10.1126/science.1150009; UNICEF, 2012, STAT WORLDS CHILDR; United Nations Inter-agency and Expert Group on MDG Indicators, 2011, MILL DEV GOALS REP 2; Winfrey W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S32; You D, 2012, MODELING REQUIRED AC	7	24	24	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2012	308	2					141	142		10.1001/jama.2012.7357	http://dx.doi.org/10.1001/jama.2012.7357			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	971QS	22695930				2022-12-28	WOS:000306219500025
J	De Luca, V; Salim, V; Atsumi, SM; Yu, F				De Luca, Vincenzo; Salim, Vonny; Atsumi, Sayaka Masada; Yu, Fang			Mining the Biodiversity of Plants: A Revolution in the Making	SCIENCE			English	Review							SACCHAROMYCES-CEREVISIAE; OPIUM POPPY; BENZYLISOQUINOLINE ALKALOIDS; MICROBIAL-PRODUCTION; BIOSYNTHESIS; YEAST; METABOLISM; MORPHINE; RESVERATROL; PATHWAY	Only a small fraction of the immense diversity of plant metabolism has been explored for the production of new medicines and other products important to human well-being. The availability of inexpensive high-throughput sequencing is rapidly expanding the number of species that can be investigated for the speedy discovery of previously unknown enzymes and pathways. Exploitation of these resources is being carried out through interdisciplinary synthetic and chemical biology to engineer pathways in plant and microbial systems for improving the production of existing medicines and to create libraries of biologically active products that can be screened for new drug applications.	[De Luca, Vincenzo; Salim, Vonny; Atsumi, Sayaka Masada; Yu, Fang] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada	Brock University	De Luca, V (corresponding author), Brock Univ, Dept Biol Sci, 500 Glenridge Ave, St Catharines, ON L2S 3A1, Canada.	vdeluca@brocku.ca			Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs; Genome Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs(Canada Research ChairsCGIAR); Genome Canada(Genome Canada)	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant (V.D.L.), Canada Research Chairs (V.D.L.), and a Genome Canada Team Grant.	Allen RS, 2004, NAT BIOTECHNOL, V22, P1559, DOI 10.1038/nbt1033; Becker JVW, 2003, FEMS YEAST RES, V4, P79, DOI 10.1016/S1567-1356(03)00157-0; Chu HY, 2011, PLANT J, V66, P66, DOI 10.1111/j.1365-313X.2011.04503.x; Engels B, 2008, METAB ENG, V10, P201, DOI 10.1016/j.ymben.2008.03.001; Facchini PJ, 2012, TRENDS BIOTECHNOL, V30, P127, DOI 10.1016/j.tibtech.2011.10.001; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hansen EH, 2009, APPL ENVIRON MICROB, V75, P2765, DOI 10.1128/AEM.02681-08; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; Lange BM, 2000, P NATL ACAD SCI USA, V97, P2934, DOI 10.1073/pnas.97.6.2934; Li R, 2006, CHEM BIOL, V13, P513, DOI 10.1016/j.chembiol.2006.03.005; Lim CG, 2011, APPL ENVIRON MICROB, V77, P3451, DOI 10.1128/AEM.02186-10; Liscombe DK, 2011, PHYTOCHEMISTRY, V72, P1969, DOI 10.1016/j.phytochem.2011.07.001; Mikkelsen MD, 2012, METAB ENG, V14, P104, DOI 10.1016/j.ymben.2012.01.006; Mikkelsen MD, 2010, MOL PLANT, V3, P751, DOI 10.1093/mp/ssq020; Millgate AG, 2004, NATURE, V431, P413, DOI 10.1038/431413a; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Murata J., 2008, PLANT CELL, V38, P131; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Roepke J, 2010, P NATL ACAD SCI USA, V107, P15287, DOI 10.1073/pnas.0911451107; Runguphan W, 2010, NATURE, V468, P461, DOI 10.1038/nature09524; Schilmiller AL, 2008, PLANT J, V54, P702, DOI 10.1111/j.1365-313X.2008.03432.x; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Tarselli MA, 2011, NAT CHEM, V3, P449, DOI [10.1038/NCHEM.1050, 10.1038/nchem.1050]; Tattersall DB, 2001, SCIENCE, V293, P1826, DOI 10.1126/science.1062249; Wang Y., 2011, METAB ENG, V11, P310; Wege S, 2007, ANN BOT-LONDON, V100, P641, DOI 10.1093/aob/mcm118; Winzer T, 2012, SCIENCE, V336, P1704, DOI 10.1126/science.1220757	31	222	224	6	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1658	1661		10.1126/science.1217410	http://dx.doi.org/10.1126/science.1217410			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745417				2022-12-28	WOS:000305794500036
J	Egger, AE				Egger, Anne E.			Engaging Students in Earthquakes via Real-Time Data and Decisions	SCIENCE			English	Editorial Material									Cent Washington Univ, Ellensburg, WA 98926 USA	Central Washington University	Egger, AE (corresponding author), Cent Washington Univ, 400 E Univ Way, Ellensburg, WA 98926 USA.	annegger@geology.cwu.edu		Egger, Anne/0000-0001-5686-4375				Ainley M, 2002, J EDUC PSYCHOL, V94, P545, DOI 10.1037//0022-0663.94.3.545; [Anonymous], 2005, J GEOSCIENCE ED; Barrow L., 1996, J COLL SCI TEACH, V26, P143; King CJH, 2010, INT J SCI EDUC, V32, P565, DOI 10.1080/09500690902721681; Libarkin J. C., 2005, J GEOSCIENCE ED, V53, P394, DOI [DOI 10.5408/1089-9995-53.4.394, 10.5408/1089-9995-53.4.394]; Swenson S, 2011, GEOL SOC AM SPEC PAP, V474, P189, DOI 10.1130/2011.2474(13); Wampler J., 2002, J GEOSCIENCE ED, V50, P620; [No title captured]	8	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1654	1655		10.1126/science.1214293	http://dx.doi.org/10.1126/science.1214293			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	965VD	22745415				2022-12-28	WOS:000305794500034
J	Brogi, M; Snellen, IAG; de Kok, RJ; Albrecht, S; Birkby, J; de Mooij, EJW				Brogi, Matteo; Snellen, Ignas A. G.; de Kok, Remco J.; Albrecht, Simon; Birkby, Jayne; de Mooij, Ernst J. W.			The signature of orbital motion from the dayside of the planet tau Bootis b	NATURE			English	Article							REFLECTED STARLIGHT; HOT JUPITERS; UPPER LIMIT; EXOPLANETS; SPECTRUM; CATALOG; STARS; LIGHT	The giant planet orbiting tau Bootis (named tau Bootis b) was amongst the first extrasolar planets to be discovered(1). It is one of the brightest exoplanets and one of the nearest to us, with an orbital period of just a few days. Over the course of more than a decade, measurements of its orbital inclination have been announced(2) and refuted(3), and have hitherto remained elusive(4-8). Here we report the detection of carbon monoxide absorption in the thermal dayside spectrum of tau Bootis b. At a spectral resolution of similar to 100,000, we trace the change in the radial velocity of the planet over a large range in phase, determining an orbital inclination of 44.5 degrees +/- 1.5 degrees and a mass 5.95 +/- 0.28 times that of Jupiter, demonstrating that atmospheric characterization is possible for non-transiting planets. The strong absorption signal points to an atmosphere with a temperature that is decreasing towards higher altitudes, in contrast to the temperature inversion inferred for other highly irradiated planets(9,10). This supports the hypothesis that the absorbing compounds believed to cause such atmospheric inversions are destroyed in tau Bootis b by the ultraviolet emission from the active host star(11).	[Brogi, Matteo; Snellen, Ignas A. G.; Birkby, Jayne; de Mooij, Ernst J. W.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [de Kok, Remco J.] SRON, NL-3584 CA Utrecht, Netherlands; [Albrecht, Simon] MIT, Dept Phys, Cambridge, MA 02139 USA; [Albrecht, Simon] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [de Mooij, Ernst J. W.] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada	Leiden University; Leiden University - Excl LUMC; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Toronto	Brogi, M (corresponding author), Leiden Univ, Leiden Observ, Postbus 9513, NL-2300 RA Leiden, Netherlands.	brogi@strw.leidenuniv.nl	de Kok, Remco/U-5637-2019; Brogi, Matteo/GWM-8542-2022	de Mooij, Ernst/0000-0001-6391-9266; de Kok, Remco/0000-0001-6906-2662; Snellen, Ignas/0000-0003-1624-3667	Netherlands Organisation for Scientific Research (NWO); NSF [1108595]; Division Of Astronomical Sciences [1108595] Funding Source: National Science Foundation	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NSF(National Science Foundation (NSF)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the ESO support staff of the Paranal Observatory for their help during the observations. This work is based on observations collected at the European Southern Observatory (186.C-0289). S. A. acknowledges support by a Rubicon fellowship from the Netherlands Organisation for Scientific Research (NWO), and by NSF grant no. 1108595.	Burrows A, 2008, ASTROPHYS J, V678, P1436, DOI 10.1086/533518; Butler RP, 2006, ASTROPHYS J, V646, P505, DOI 10.1086/504701; Butler RP, 1997, ASTROPHYS J, V474, pL115, DOI 10.1086/310444; Catala C, 2007, MON NOT R ASTRON SOC, V374, pL42, DOI 10.1111/j.1745-3933.2006.00261.x; Charbonneau D, 1999, ASTROPHYS J, V522, pL145, DOI 10.1086/312234; Collier Cameron A, 1999, NATURE, V402, P751, DOI 10.1038/45451; Donati JF, 2008, MON NOT R ASTRON SOC, V385, P1179, DOI 10.1111/j.1365-2966.2008.12946.x; Fortney JJ, 2008, ASTROPHYS J, V678, P1419, DOI 10.1086/528370; Hebrard G, 2010, ASTRON ASTROPHYS, V516, DOI 10.1051/0004-6361/201014327; Johnson JA, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/24; Kaufl HU, 2004, P SOC PHOTO-OPT INS, V5492, P1218, DOI 10.1117/12.551480; Knutson HA, 2010, ASTROPHYS J, V720, P1569, DOI 10.1088/0004-637X/720/2/1569; Knutson HA, 2009, ASTROPHYS J, V691, P866, DOI 10.1088/0004-637X/691/1/866; Leigh C, 2003, MON NOT R ASTRON SOC, V344, P1271, DOI 10.1046/j.1365-8711.2003.06901.x; Lucas PW, 2009, MON NOT R ASTRON SOC, V393, P229, DOI 10.1111/j.1365-2966.2008.14182.x; Rodler F, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913627; Schneider J, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116713; Takeda G, 2007, ASTROPHYS J SUPPL S, V168, P297, DOI 10.1086/509763; Wiedemann G, 2001, ASTROPHYS J, V546, P1068, DOI 10.1086/318316; Winn JN, 2010, ASTROPHYS J LETT, V718, pL145, DOI 10.1088/2041-8205/718/2/L145; [No title captured]	22	228	230	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2012	486	7404					502	504		10.1038/nature11161	http://dx.doi.org/10.1038/nature11161			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22739313	Green Submitted			2022-12-28	WOS:000305760600036
J	Fauci, AS; Collins, FS				Fauci, Anthony S.; Collins, Francis S.			Benefits and Risks of Influenza Research: Lessons Learned	SCIENCE			English	Editorial Material								Given the yearly challenge of seasonal influenza and the potential catastrophic consequences of future pandemics, the need for intensive basic and clinical influenza research is unquestionable. Although the fruits of decades of research have enabled dramatic improvements in our ability to prevent and treat influenza, many fundamental questions remain, including those related to the complex factors associated with host switching and transmission of influenza viruses. Recent public concern over two H5N1 influenza manuscripts that studied the transmissibility of influenza viruses has triggered intense discussion on dual-use research and the way forward.	[Fauci, Anthony S.; Collins, Francis S.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Fauci, AS (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	afauci@niaid.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 2011, NIH PRESS STAT NSABB; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; NSABB, 2012, FIND REC; WHO, 2012, CUM NUMB CONF HUM CA	7	32	33	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1522	1523		10.1126/science.1224305	http://dx.doi.org/10.1126/science.1224305			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	961ZE	22723407	Green Published			2022-12-28	WOS:000305507500041
J	Hathaway, NA; Bell, O; Hodges, C; Miller, EL; Neel, DS; Crabtree, GR				Hathaway, Nathaniel A.; Bell, Oliver; Hodges, Courtney; Miller, Erik L.; Neel, Dana S.; Crabtree, Gerald R.			Dynamics and Memory of Heterochromatin in Living Cells	CELL			English	Article							NOVO DNA METHYLATION; HISTONE H3; LYSINE 9; SU(VAR) GENES; STEM-CELLS; CHROMATIN; HP1; METHYLTRANSFERASE; SETDB1; PLURIPOTENT	Posttranslational histone modifications are important for gene regulation, yet the mode of propagation and the contribution to heritable gene expression states remains controversial. To address these questions, we developed a chromatin in vivo assay (CiA) system employing chemically induced proximity to initiate and terminate chromatin modifications in living cells. We selectively recruited HP1 alpha to induce H3K9me3-dependent gene silencing and describe the kinetics and extent of chromatin modifications at the Oct4 locus in fibroblasts and pluripotent cells. H3K9me3 propagated symmetrically and continuously at average rates of similar to 0.18 nucleosomes/hr to produce domains of up to 10 kb. After removal of the HP1 alpha stimulus, heterochromatic domains were heritably transmitted, undiminished through multiple cell generations. Our data enabled quantitative modeling of reaction kinetics, which revealed that dynamic competition between histone marking and turnover, determines the boundaries and stability of H3K9me3 domains. This framework predicts the steady-state dynamics and spatial features of the majority of euchromatic H3K9me3 domains over the genome.	[Hathaway, Nathaniel A.; Bell, Oliver; Hodges, Courtney; Miller, Erik L.; Neel, Dana S.; Crabtree, Gerald R.] Stanford Univ, Sch Med, Dept Dev Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Hathaway, Nathaniel A.; Bell, Oliver; Hodges, Courtney; Miller, Erik L.; Neel, Dana S.; Crabtree, Gerald R.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Miller, Erik L.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA.	crabtree@stanford.edu		Bell, Oliver/0000-0002-7639-5948; Hodges, H. Courtney/0000-0003-4441-497X; Crabtree, Robert/0000-0002-6639-8707	EMBO fellowship; Human Frontier Science Program fellowship; Eunice Kennedy Shriver National Institute of Child Health and Human Development [F32HD072627]; NIH [HD55391, NS046789, AI060037]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055391, F32HD072627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789] Funding Source: NIH RePORTER	EMBO fellowship(European Molecular Biology Organization (EMBO)); Human Frontier Science Program fellowship(Human Frontier Science Program); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Schubeler and members of the Crabtree lab, in particular J.L. Ronan and A. S. Koh for insightful comments in the preparation of the manuscript. We gratefully acknowledge technical assistance by L. Chen, A. Kuo, and the Stanford FACS facility. We thank A. Sun, F. S. Liang, and J. Wysocka for sharing reagents. O.B. was supported by EMBO and Human Frontier Science Program fellowships. C. H. is supported by fellowship F32HD072627 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Research in the G. R. C. lab is supported by NIH grants (HD55391, NS046789, and AI060037) and the Howard Hughes Medical Institute.	Athanasiadou R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009937; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Graef IA, 1997, EMBO J, V16, P5618, DOI 10.1093/emboj/16.18.5618; GROUDINE M, 1982, CELL, V30, P131, DOI 10.1016/0092-8674(82)90019-8; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Ho SN, 1996, NATURE, V382, P822, DOI 10.1038/382822a0; KEREM BS, 1984, CELL, V38, P493, DOI 10.1016/0092-8674(84)90504-X; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Liang FS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001449; Lu Qianjin, 2004, Methods Mol Biol, V287, P77; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Muller HJ, 1930, J GENET, V22, P299, DOI 10.1007/BF02984195; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Ptashne M, 2007, CURR BIOL, V17, pR233, DOI 10.1016/j.cub.2007.02.030; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sato N, 2006, BIOCHEM BIOPH RES CO, V344, P845, DOI 10.1016/j.bbrc.2006.04.007; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Verschure PJ, 2005, MOL CELL BIOL, V25, P4552, DOI 10.1128/MCB.25.11.4552-4564.2005; WIGLER M, 1981, CELL, V24, P33, DOI 10.1016/0092-8674(81)90498-0; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zee BM, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-22	49	267	272	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1447	1460		10.1016/j.cell.2012.03.052	http://dx.doi.org/10.1016/j.cell.2012.03.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22704655	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000305753800012
J	Hinke, CB; Bohmer, M; Boutachkov, P; Faestermann, T; Geissel, H; Gerl, J; Gernhauser, R; Gorska, M; Gottardo, A; Grawe, H; Grebosz, JL; Krucken, R; Kurz, N; Liu, Z; Maier, L; Nowacki, F; Pietri, S; Podolyak, Z; Sieja, K; Steiger, K; Straub, K; Weick, H; Wollersheim, HJ; Woods, PJ; Al-Dahan, N; Alkhomashi, N; Atac, A; Blazhev, A; Braun, NF; Celikovic, IT; Davinson, T; Dillmann, I; Domingo-Pardo, C; Doornenbal, PC; de France, G; Farrelly, GF; Farinon, F; Goel, N; Habermann, TC; Hoischen, R; Janik, R; Karny, M; Kaskas, A; Kojouharov, IM; Kroll, T; Litvinov, Y; Myalski, S; Nebel, F; Nishimura, S; Nociforo, C; Nyberg, J; Parikh, AR; Prochazka, A; Regan, PH; Rigollet, C; Schaffner, H; Scheidenberger, C; Schwertel, S; Soderstrom, PA; Steer, SJ; Stolz, A; Strmen, P				Hinke, C. B.; Boehmer, M.; Boutachkov, P.; Faestermann, T.; Geissel, H.; Gerl, J.; Gernhaeuser, R.; Gorska, M.; Gottardo, A.; Grawe, H.; Grebosz, J. L.; Kruecken, R.; Kurz, N.; Liu, Z.; Maier, L.; Nowacki, F.; Pietri, S.; Podolyak, Zs; Sieja, K.; Steiger, K.; Straub, K.; Weick, H.; Wollersheim, H. -J.; Woods, P. J.; Al-Dahan, N.; Alkhomashi, N.; Atac, A.; Blazhev, A.; Braun, N. F.; Celikovic, I. T.; Davinson, T.; Dillmann, I.; Domingo-Pardo, C.; Doornenbal, P. C.; de France, G.; Farrelly, G. F.; Farinon, F.; Goel, N.; Habermann, T. C.; Hoischen, R.; Janik, R.; Karny, M.; Kaskas, A.; Kojouharov, I. M.; Kroell, Th; Litvinov, Y.; Myalski, S.; Nebel, F.; Nishimura, S.; Nociforo, C.; Nyberg, J.; Parikh, A. R.; Prochazka, A.; Regan, P. H.; Rigollet, C.; Schaffner, H.; Scheidenberger, C.; Schwertel, S.; Soederstroem, P. -A.; Steer, S. J.; Stolz, A.; Strmen, P.			Superallowed Gamow-Teller decay of the doubly magic nucleus Sn-100	NATURE			English	Article							SHELL-MODEL; BETA-DECAY; IDENTIFICATION; ISOMER	The shell structure of atomic nuclei is associated with 'magic numbers' and originates in the nearly independent motion of neutrons and protons in a mean potential generated by all nucleons. During beta(+)-decay, a proton transforms into a neutron in a previously not fully occupied orbital, emitting a positron-neutrino pair with either parallel or antiparallel spins, in a Gamow-Teller or Fermi transition, respectively. The transition probability, or strength, of a Gamow-Teller transition depends sensitively on the underlying shell structure and is usually distributed among many states in the neighbouring nucleus. Here we report measurements of the half-life and decay energy for the decay of Sn-100, the heaviest doubly magic nucleus with equal numbers of protons and neutrons. In the beta-decay of Sn-100, a large fraction of the strength is observable because of the large decay energy. We determine the largest Gamow-Teller strength so far measured in allowed nuclear beta-decay, establishing the 'superallowed' nature of this Gamow-Teller transition. The large strength and the low-energy states in the daughter nucleus, In-100, are well reproduced by modern, large-scale shell model calculations.	[Hinke, C. B.; Boehmer, M.; Faestermann, T.; Gernhaeuser, R.; Kruecken, R.; Maier, L.; Steiger, K.; Straub, K.; Nebel, F.; Schwertel, S.] Tech Univ Munich, Phys Dept E12, D-85748 Garching, Germany; [Boutachkov, P.; Geissel, H.; Gerl, J.; Gorska, M.; Grawe, H.; Kurz, N.; Pietri, S.; Weick, H.; Wollersheim, H. -J.; Dillmann, I.; Farinon, F.; Goel, N.; Habermann, T. C.; Hoischen, R.; Kojouharov, I. M.; Litvinov, Y.; Nociforo, C.; Prochazka, A.; Schaffner, H.; Scheidenberger, C.] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany; [Gottardo, A.] Ist Nazl Fis Nucl, Lab Nazl Legnaro, I-35020 Legnaro, Italy; [Grebosz, J. L.; Myalski, S.] Henryk Niewodniczanski Inst Nucl Phys IFJ PAN, PL-31342 Krakow, Poland; [Kruecken, R.] TRIUMF, Vancouver, BC V6T 2A3, Canada; [Liu, Z.; Woods, P. J.; Davinson, T.] Univ Edinburgh, Sch Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland; [Nowacki, F.; Sieja, K.] Univ Strasbourg, IPHC, F-67037 Strasbourg, France; [Podolyak, Zs; Al-Dahan, N.; Alkhomashi, N.; Farrelly, G. F.; Regan, P. H.; Steer, S. J.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England; [Atac, A.; Kaskas, A.] Ankara Univ, Dept Phys, Fac Sci, TR-06100 Ankara, Turkey; [Blazhev, A.; Braun, N. F.] Univ Cologne, Inst Nucl Phys, D-50937 Cologne, Germany; [Celikovic, I. T.] Univ Belgrade, Inst Vinca, Belgrade 11000, Serbia; [Domingo-Pardo, C.] Univ Valencia, IFIC, CSIC, E-46071 Valencia, Spain; [Doornenbal, P. C.; Nishimura, S.; Soederstroem, P. -A.] RIKEN, Nishina Ctr, Wako, Saitama 3510198, Japan; [de France, G.] CEA DSM CNRS IN2P3, Grand Accelerateur Natl Ions Lourds, F-14076 Caen, France; [Janik, R.; Strmen, P.] Comenius Univ, Bratislava 81806 16, Slovakia; [Karny, M.] Univ Warsaw, Inst Expt Phys, PL-00681 Warsaw, Poland; [Kroell, Th] Tech Univ Darmstadt, Inst Kernphys, D-64289 Darmstadt, Germany; [Nyberg, J.] Uppsala Univ, Dept Phys & Astron, SE-75120 Uppsala, Sweden; [Parikh, A. R.] Univ Politecn Catalunya EUETIB, Dept Fis & Engn Nucl, E-08036 Barcelona, Spain; [Rigollet, C.] Univ Groningen, KVI, NL-9747 AA Groningen, Netherlands; [Stolz, A.] Michigan State Univ, Natl Supercond Cyclotron Lab, E Lansing, MI 48824 USA	Technical University of Munich; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Istituto Nazionale di Fisica Nucleare (INFN); Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; University of British Columbia; University of Edinburgh; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Surrey; Ankara University; University of Cologne; University of Belgrade; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Corpuscular (IFIC); University of Valencia; RIKEN; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Comenius University Bratislava; University of Warsaw; Technical University of Darmstadt; Uppsala University; Universitat Politecnica de Catalunya; University of Groningen; Michigan State University	Faestermann, T (corresponding author), Tech Univ Munich, Phys Dept E12, D-85748 Garching, Germany.	thomas.faestermann@ph.tum.de	Litvinov, Yuri A./D-9555-2011; GOTTARDO, Andrea/ABG-5432-2020; Kroell, Thorsten/AAB-8739-2020; Kruecken, Reiner/A-1640-2013; Faestermann, Thomas/ABE-2360-2020; Nowacki, Frederic/K-5741-2012; Al-Dahan, N/L-4789-2019; Karny, M/AAY-5633-2021; de France, Gilles/AAS-5059-2021; Gernhäuser, Roman/AAE-6699-2019; Kruecken, Reiner/N-9449-2019; Karny, Marek/AAJ-2948-2020; Pardo, Cesar Domingo/W-4437-2018; Domingo-Pardo, César/AAA-5459-2019; Soderstrom, Par-Anders/E-2983-2017	Litvinov, Yuri A./0000-0002-7043-4993; GOTTARDO, Andrea/0000-0002-0390-5767; Kruecken, Reiner/0000-0002-2755-8042; Faestermann, Thomas/0000-0002-6603-8787; Al-Dahan, N/0000-0003-4892-271X; Karny, M/0000-0002-1050-6203; de France, Gilles/0000-0002-7439-1759; Kruecken, Reiner/0000-0002-2755-8042; Pardo, Cesar Domingo/0000-0002-2915-5466; Domingo-Pardo, César/0000-0002-2915-5466; Weick, Helmut/0000-0003-3672-1961; Dillmann, Iris/0000-0001-8521-3635; Celikovic, Igor/0000-0002-5642-4393; Nyberg, Johan/0000-0001-6996-7605; Doornenbal, Pieter/0000-0001-7530-4066; Soderstrom, Par-Anders/0000-0002-9504-2814; sieja, kamila/0000-0001-7736-656X	BMBF [06MT238, 06MT9156, 06KY205I, 06KY9136I]; GSI; DFG Cluster of Excellence 153 'Origin and Structure of the Universe'; EC within the FP6 through I3-EURONS [RII3-CT-2004-506065]; Swedish Research Council; Science and Technology Facilities Council [ST/J00006X/1, EP/D003628/1, ST/J000051/1] Funding Source: researchfish; STFC [ST/J00006X/1, EP/D003628/1, ST/J000051/1] Funding Source: UKRI	BMBF(Federal Ministry of Education & Research (BMBF)); GSI; DFG Cluster of Excellence 153 'Origin and Structure of the Universe'(German Research Foundation (DFG)); EC within the FP6 through I3-EURONS; Swedish Research Council(Swedish Research CouncilEuropean Commission); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the staff of the GSI ion source and accelerator for the preparation of a stable, high-intensity <SUP>124</SUP>Xe beam, and we thank the fragment separator technicians for setting up the beamline detectors. We acknowledge discussions with G. Martinez-Pinedo, K. Langanke and A. Zuker. We are also grateful to the EUROBALL Owners Committee for the use of the Euroball Cluster Detectors. This work was supported by the BMBF under contracts 06MT238, 06MT9156, 06KY205I and 06KY9136I; by the GSI; by the DFG Cluster of Excellence 153 'Origin and Structure of the Universe'; by the EC within the FP6 through I3-EURONS (contract no. RII3-CT-2004-506065); and by the Swedish Research Council.	Audi G, 2003, NUCL PHYS A, V729, P337, DOI 10.1016/j.nuclphysa.2003.11.003; Batist L, 2010, EUR PHYS J A, V46, P45, DOI 10.1140/epja/i2010-11025-x; Bazin D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.252501; Blazhev A, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.064304; Bobyk A, 2000, ACTA PHYS POL B, V31, P953; Boutachkov P, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.044311; Brown BA, 2001, PROG PART NUCL PHYS, V47, P517, DOI 10.1016/S0146-6410(01)00159-4; BROWN BA, 1994, PHYS REV C, V50, pR2270, DOI 10.1103/PhysRevC.50.R2270; Caurier E, 2005, REV MOD PHYS, V77, P427, DOI 10.1103/RevModPhys.77.427; Cederwall B, 2011, NATURE, V469, P68, DOI 10.1038/nature09644; Chartier M, 1996, PHYS REV LETT, V77, P2400, DOI 10.1103/PhysRevLett.77.2400; Coraggio L, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.034310; Dean DJ, 1996, PHYS LETT B, V367, P17, DOI 10.1016/0370-2693(95)01446-2; Faestermann T, 2002, EUR PHYS J A, V15, P185, DOI 10.1140/epja/i2001-10251-7; GEISSEL H, 1992, NUCL INSTRUM METH B, V70, P286, DOI 10.1016/0168-583X(92)95944-M; HAMAMOTO I, 1993, PHYS REV C, V48, pR960, DOI 10.1103/PhysRevC.48.R960; HARDY JC, 1977, PHYS LETT B, V71, P307, DOI 10.1016/0370-2693(77)90223-4; Ichimura M, 2006, PROG PART NUCL PHYS, V56, P446, DOI 10.1016/j.ppnp.2005.09.001; LEWITOWICZ M, 1994, PHYS LETT B, V332, P20, DOI 10.1016/0370-2693(94)90852-4; Pietri S, 2007, NUCL INSTRUM METH B, V261, P1079, DOI 10.1016/j.nimb.2007.04.219; Plettner C, 2002, PHYS REV C, V66, DOI 10.1103/PhysRevC.66.044319; Sasano M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.202501; SCHNEIDER R, 1994, Z PHYS A-HADRON NUCL, V348, P241, DOI 10.1007/BF01305875; Singh B., 1998, Nuclear Data Sheets, V84, P487, DOI 10.1006/ndsh.1998.0015; Stolz A, 2002, PHYS REV C, V65, DOI 10.1103/PhysRevC.65.064603; Summerer K, 1997, NUCL PHYS A, V616, pC341, DOI 10.1016/S0375-9474(97)00106-1	26	123	128	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2012	486	7403					341	345		10.1038/nature11116	http://dx.doi.org/10.1038/nature11116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22722192	Green Submitted			2022-12-28	WOS:000305466800032
J	Nielsen-Saines, K; Watts, H; Veloso, VG; Bryson, YJ; Joao, EC; Pilotto, JH; Gray, G; Theron, G; Santos, B; Fonseca, R; Kreitchmann, R; Pinto, J; Mussi-Pinhata, MM; Ceriotto, M; Machado, D; Bethel, J; Morgado, MG; Dickover, R; Camarca, M; Mirochnick, M; Siberry, G; Grinsztejn, B; Moreira, RI; Bastos, FI; Xu, JH; Moye, J; Mofenson, LM				Nielsen-Saines, Karin; Watts, Heather; Veloso, Valdilea G.; Bryson, Yvonne J.; Joao, Esau C.; Pilotto, Jose Henrique; Gray, Glenda; Theron, Gerhard; Santos, Breno; Fonseca, Rosana; Kreitchmann, Regis; Pinto, Jorge; Mussi-Pinhata, Marisa M.; Ceriotto, Mariana; Machado, Daisy; Bethel, James; Morgado, Marisa G.; Dickover, Ruth; Camarca, Margaret; Mirochnick, Mark; Siberry, George; Grinsztejn, Beatriz; Moreira, Ronaldo I.; Bastos, Francisco I.; Xu, Jiahong; Moye, Jack; Mofenson, Lynne M.		NICHD HPTN 040 PACTG Protocol Team	Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CHILD TRANSMISSION; MATERNAL-INFANT TRANSMISSION; PERINATAL TRANSMISSION; POSTEXPOSURE PROPHYLAXIS; ZIDOVUDINE TREATMENT; RANDOMIZED-TRIAL; VIRAL LOAD; NEVIRAPINE; RESISTANCE	BACKGROUND The safety and efficacy of adding antiretroviral drugs to standard zidovudine prophylaxis in infants of mothers with human immunodeficiency virus (HIV) infection who did not receive antenatal antiretroviral therapy (ART) because of late identification are unclear. We evaluated three ART regimens in such infants. METHODS Within 48 hours after their birth, we randomly assigned formula-fed infants born to women with a peripartum diagnosis of HIV type 1 (HIV-1) infection to one of three regimens: zidovudine for 6 weeks (zidovudine-alone group), zidovudine for 6 weeks plus three doses of nevirapine during the first 8 days of life (two-drug group), or zidovudine for 6 weeks plus nelfinavir and lamivudine for 2 weeks (three-drug group). The primary outcome was HIV-1 infection at 3 months in infants uninfected at birth. RESULTS A total of 1684 infants were enrolled in the Americas and South Africa (566 in the zidovudine-alone group, 562 in the two-drug group, and 556 in the three-drug group). The overall rate of in utero transmission of HIV-1 on the basis of Kaplan-Meier estimates was 5.7% (93 infants), with no significant differences among the groups. Intrapartum transmission occurred in 24 infants in the zidovudine-alone group (4.8%; 95% confidence interval [CI], 3.2 to 7.1), as compared with 11 infants in the two-drug group (2.2%; 95% CI, 1.2 to 3.9; P=0.046) and 12 in the three-drug group (2.4%; 95% CI, 1.4 to 4.3; P=0.046). The overall transmission rate was 8.5% (140 infants), with an increased rate in the zidovudine-alone group (P=0.03 for the comparisons with the two-and three-drug groups). On multivariate analysis, zidovudine monotherapy, a higher maternal viral load, and maternal use of illegal substances were significantly associated with transmission. The rate of neutropenia was significantly increased in the three-drug group (P < 0.001 for both comparisons with the other groups). CONCLUSIONS In neonates whose mothers did not receive ART during pregnancy, prophylaxis with a two-or three-drug ART regimen is superior to zidovudine alone for the prevention of intrapartum HIV transmission; the two-drug regimen has less toxicity than the three-drug regimen. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development [NICHD] and others; ClinicalTrials.gov number, NCT00099359.)	[Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Gray, Glenda; Moye, Jack; Mofenson, Lynne M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Bethel, James; Camarca, Margaret; Xu, Jiahong] Westat Corp, Rockville, MD USA; [Veloso, Valdilea G.; Grinsztejn, Beatriz] Fundacao Oswaldo Cruz Fiocruz, Lab Pesquisa Clin DST & AIDS, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Pilotto, Jose Henrique; Morgado, Marisa G.] Fundacao Oswaldo Cruz Fiocruz, Lab AIDS & Imunol Mol, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Moreira, Ronaldo I.; Bastos, Francisco I.] Fundacao Oswaldo Cruz Fiocruz, Lab Informacoes Saude, Inst Informacao Cient & Tecnol Saude, Rio De Janeiro, Brazil; [Joao, Esau C.] Hosp Fed Servidores Estado, Rio De Janeiro, Brazil; [Pilotto, Jose Henrique] Hosp Geral Nova Iguacu, Rio De Janeiro, Brazil; [Gray, Glenda] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Gray, Glenda] Chris Hani Baragwanath Hosp, Johannesburg, South Africa; [Theron, Gerhard] Univ Stellenbosch, Cape Town, South Africa; [Theron, Gerhard] Tygerberg Hosp, Cape Town, South Africa; [Santos, Breno] Hosp Conceicao, Porto Alegre, RS, Brazil; [Fonseca, Rosana] Hosp Femina, Porto Alegre, RS, Brazil; [Kreitchmann, Regis] Irmandade Santa Casa Misericordia Porto Alegre, Porto Alegre, RS, Brazil; [Pinto, Jorge] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Mussi-Pinhata, Marisa M.] Univ Sao Paulo, BR-14049 Ribeirao Preto, SP, Brazil; [Machado, Daisy] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Dickover, Ruth] Univ Calif Davis, Davis, CA 95616 USA; [Ceriotto, Mariana] Fdn Maternal & Infant Hlth, Buenos Aires, DF, Argentina; [Mirochnick, Mark] Boston Univ, Sch Med, Boston, MA 02118 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Westat; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of Witwatersrand; Stellenbosch University; Tygerberg Hospital; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); University of California System; University of California Davis; Boston University	Nielsen-Saines, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, MDCC 22-442 10833 LeConte Ave, Los Angeles, CA 90095 USA.	knielsen@mednet.ucla.edu	Pilotto, Jose Henrique/AAD-9773-2019; Mofenson, Lynne/P-9631-2019; Mussi-Pinhata, Marisa/G-6568-2012; Veloso, Valdilea Gonçalves/J-6189-2012; Pinto, Jorge A/D-1743-2014	Pilotto, Jose Henrique/0000-0003-0521-8597; Mofenson, Lynne/0000-0002-2818-9808; Mussi-Pinhata, Marisa/0000-0001-8985-1570; Pinto, Jorge A/0000-0003-2987-3238; Machado, Daisy/0000-0003-1993-6442; Kreitchmann, Regis/0000-0002-1146-0497; Joao, Esau/0000-0002-2412-0627; moye, john/0000-0001-9976-8586; Bastos, Francisco/0000-0001-5970-8896	NICHD [HHSN267200800001C, N01-HD-8-0001]; HIV Prevention Trials Network; National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI047986, U01 AI068632]; National Institute of Mental Health [AI068632]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068632, U01AI047986, UM1AI068632] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); HIV Prevention Trials Network; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the NICHD (HHSN267200800001C, N01-HD-8-0001) and by a grant from the HIV Prevention Trials Network, which is funded by the National Institute of Allergy and Infectious Diseases (NIAID), to the Brazilian AIDS Prevention Trials International Network at the University of California, Los Angeles (U01 AI047986). Overall support for IMPAACT, which endorsed the study, was provided by grants from the NIAID (U01 AI068632), the NICHD, and the National Institute of Mental Health (AI068632).	[Anonymous], 2010, GUID US ANT AG PED H; BrazilianMinistry of Health, 2010, REC PREV VERT TRANSM; Bulterys M, 2004, JAMA-J AM MED ASSOC, V292, P219, DOI 10.1001/jama.292.2.219; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Dickover RE, 1996, JAMA-J AM MED ASSOC, V275, P599, DOI 10.1001/jama.275.8.599; Division of AIDS (DAIDS) Regulatory Support Center, 1994, TABL GRAD SEV PED AD; El Beitune P, 2006, EUR J OBSTET GYN R B, V128, P59, DOI 10.1016/j.ejogrb.2006.01.013; Ellis RJ, 2003, J INFECT DIS, V188, P1820, DOI 10.1086/379894; Eshleman SH, 2006, J INFECT DIS, V193, P479, DOI 10.1086/499967; Fiscus SA, 1999, J INFECT DIS, V180, P99, DOI 10.1086/314840; Gray GE, 2005, AIDS, V19, P1289, DOI 10.1097/01.aids.0000180100.42770.a7; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Haile-Selassie HT, 2011, HIV MED, V12, P422, DOI 10.1111/j.1468-1293.2010.00902.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20; Krogstad P, 1999, CLIN INFECT DIS, V28, P1109, DOI 10.1086/514759; Krogstad P, 2002, CLIN INFECT DIS, V34, P991, DOI 10.1086/338814; Lambert JS, 2003, SEX TRANSM INFECT, V79, P448, DOI 10.1136/sti.79.6.448; Mandelbrot L, 2001, JAMA-J AM MED ASSOC, V285, P2083, DOI 10.1001/jama.285.16.2083; Marazzi MC, 2010, AIDS, V24, P2819, DOI 10.1097/QAD.0b013e32833ff58c; McKeegan K, 2011, AIDS PATIENT CARE ST, V25, P1, DOI 10.1089/apc.2010.0255; Mirochnick M, 2008, JAIDS-J ACQ IMM DEF, V47, P334, DOI 10.1097/QAI.0b013e31815f3c23; Mirochnick M, 2011, PEDIATR INFECT DIS J, V30, P769, DOI 10.1097/INF.0b013e3182242950; Nogueira S A, 2001, Braz J Infect Dis, V5, P78; Panel on treatment of HIV-infected pregnant women and prevention of perinatal transmission, 2011, REC US ANT DRUGS PRE; Pedroso C, 2007, JAIDS-J ACQ IMM DEF, V45, P251, DOI 10.1097/QAI.0b013e318050d8b0; Purohit V, 2010, J NEUROIMMUNE PHARM, V5, P507, DOI 10.1007/s11481-010-9242-7; Simon A, 2011, JAMA-J AM MED ASSOC, V306, P70, DOI 10.1001/jama.2011.915; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Sprinz E, 2009, AIDS RES HUM RETROV, V25, P861, DOI 10.1089/aid.2009.0012; Taha TE, 2004, JAMA-J AM MED ASSOC, V292, P202, DOI 10.1001/jama.292.2.202; Taha TE, 2003, LANCET, V362, P1171, DOI 10.1016/S0140-6736(03)14538-2; Theron GB, 2011, INT J GYNECOL OBSTET, V113, P44, DOI 10.1016/j.ijgo.2010.10.011; Veloso VG, 2010, REV SAUDE PUBL, V44, P803, DOI 10.1590/S0034-89102010005000034; Wade NA, 1998, NEW ENGL J MED, V339, P1409, DOI 10.1056/NEJM199811123392001; World Health Organization, 2010, ANT THER HIV INF INF	37	137	141	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					2368	2379		10.1056/NEJMoa1108275	http://dx.doi.org/10.1056/NEJMoa1108275			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961GH	22716975	Green Published, Green Accepted			2022-12-28	WOS:000305451700006
J	Cairns, J				Cairns, John			Review: Dabigatran increases MI and reduces mortality compared with warfarin, enoxaparin, or placebo	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Cairns, J (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.		Cairns, John/AAI-8744-2021; Uchino, Ken/ABC-1611-2021	Uchino, Ken/0000-0001-9468-4172				Connolly SJ, 2010, NEW ENGL J MED, V363, P1877; Hohnloser SH, 2012, CIRCULATION, V125, P669, DOI 10.1161/CIRCULATIONAHA.111.055970	2	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12							JC6-11	10.7326/0003-4819-156-12-201206190-02011	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711112				2022-12-28	WOS:000307783200010
J	Moist, L				Moist, Louise			Review: Aliskiren plus ACEIs or ARBs increases hyperkalemia more than aliskiren, ACEIs, or ARBs alone	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							METAANALYSIS; INHIBITORS; THERAPY		Univ Western Ontario, London, ON, Canada	Western University (University of Western Ontario)	Moist, L (corresponding author), Univ Western Ontario, London, ON, Canada.							Health Canada, RASILEZ AL RASILEZ H; Kuenzli A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009946; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	4	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12							JC6-9	10.7326/0003-4819-156-12-201206190-02009	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711110				2022-12-28	WOS:000307783200008
J	Moynihan, R				Moynihan, Ray			Has novelty in healthcare gone a little stale?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	raymoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					Jackson T., 2011, PROSPERITY GROWTH; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8360; Pearce M, 2012, LANCET          0607, DOI [10.1016/S0140-6736(12)60815-0, DOI 10.1016/S0140-6736(12)60815-0]; Raffle AE, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4596	4	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 19	2012	344								e4229	10.1136/bmj.e4229	http://dx.doi.org/10.1136/bmj.e4229			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965CU	22718966				2022-12-28	WOS:000305744600013
J	Sinha, AD; Agarwal, R				Sinha, Arjun D.; Agarwal, Rajiv			Use of >= 1 antihypertensive drug at bedtime reduced CV events more than use of all drugs in the morning in CKD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RAMIPRIL		[Sinha, Arjun D.] Indiana Univ Sch Med, Div Nephrol, Indianapolis, IN 46204 USA; Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Sinha, AD (corresponding author), Indiana Univ Sch Med, Div Nephrol, Indianapolis, IN 46204 USA.		Agarwal, Rajiv/H-3454-2019	Agarwal, Rajiv/0000-0001-8355-7100				Minutolo R, 2007, AM J KIDNEY DIS, V50, P908, DOI 10.1053/j.ajkd.2007.07.020; Svensson P, 2001, HYPERTENSION, V38, pE28, DOI 10.1161/hy1101.099502; Yusuf S, 2000, NEW ENGL J MED, V342, P145	3	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12							JC6-8	10.7326/0003-4819-156-12-201206190-02008	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711109				2022-12-28	WOS:000307783200007
J	Spence, D				Spence, Des			Does early diagnosis really save lives?	BRITISH MEDICAL JOURNAL			English	Editorial Material							PROSTATE; LUNG					destwo@yahoo.co.uk						[Anonymous], NHS CHOIC; Athey VL, 2012, THORAX, V67, P412, DOI 10.1136/thoraxjnl-2011-200714; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Djulbegovic M, 2011, BMJ-BRIT MED J, V341, pc4543, DOI DOI 10.1136/BMJ.C4543; NHS Thames Valley Cancer Network, LUNG CANC IS NO JOK	5	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 19	2012	344								e4252	10.1136/bmj.e4252	http://dx.doi.org/10.1136/bmj.e4252			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965CU	22718968				2022-12-28	WOS:000305744600017
J	Dugladze, T; Schmitz, D; Whittington, MA; Vida, I; Gloveli, T				Dugladze, Tamar; Schmitz, Dietmar; Whittington, Miles A.; Vida, Imre; Gloveli, Tengis			Segregation of Axonal and Somatic Activity During Fast Network Oscillations	SCIENCE			English	Article							ACTION-POTENTIAL INITIATION; ECTOPIC ACTION-POTENTIALS; IN-VITRO; GAMMA-OSCILLATIONS; PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; RELAY NEURONS; INTERNEURONS; CELLS; DENDRITES	In central neurons, information flows from the dendritic surface toward the axon terminals. We found that during in vitro gamma oscillations, ectopic action potentials are generated at high frequency in the distal axon of pyramidal cells (PCs) but do not invade the soma. At the same time, axo-axonic cells (AACs) discharged at a high rate and tonically inhibited the axon initial segment, which can be instrumental in preventing ectopic action potential back-propagation. We found that activation of a single AAC substantially lowered soma invasion by antidromic action potential in postsynaptic PCs. In contrast, activation of soma-inhibiting basket cells had no significant impact. These results demonstrate that AACs can separate axonal from somatic activity and maintain the functional polarization of cortical PCs during network oscillations.	[Dugladze, Tamar; Gloveli, Tengis] Charite Univ Med Berlin, Inst Neurophysiol, D-10117 Berlin, Germany; [Schmitz, Dietmar] Charite Univ Med Berlin, Neurosci Res Ctr, D-10117 Berlin, Germany; [Schmitz, Dietmar; Gloveli, Tengis] Bernstein Ctr Computat Neurosci Berlin, D-10099 Berlin, Germany; [Schmitz, Dietmar; Vida, Imre] NeuroCure, Cluster Excellence, D-10117 Berlin, Germany; [Whittington, Miles A.] Univ Newcastle, Sch Med, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Newcastle University - UK	Gloveli, T (corresponding author), Charite Univ Med Berlin, Inst Neurophysiol, Charitepl 1, D-10117 Berlin, Germany.	tengis.gloveli@charite.de	Vida, Imre/F-8275-2012	Vida, Imre/0000-0003-3214-2233; Dugladze, Tamar/0000-0002-4946-3984; Gloveli, Tengis/0000-0002-2209-375X; Whittington, Miles Adrian/0000-0002-0247-1362; Schmitz, Dietmar/0000-0003-2741-5241	Deutsche Forschungsgemeinschaft [SFB-TR 3/B5, GL 254/5-1, EXC 257]; Bundesministerium fur Bildung und Forschung [BCCN II/A3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	We thank R. Traub, M. Brecht, and J. Geiger for critically reading the manuscript; F. W. Johenning for help with two-photon imaging; A. McMurtrie for her contribution to morphological reconstruction; C. Schultz for generously sharing the I kappa Ba antibody; and H. Monyer for providing the parvalbumin-positive enhanced green fluorescent protein mice. This work was supported by the Deutsche Forschungsgemeinschaft (SFB-TR 3/B5 and GL 254/5-1 to T.G.; EXC 257 to D. S. and I.V.) and the Bundesministerium fur Bildung und Forschung (BCCN II/A3 to T.G.).	Avoli M, 1998, EUR J NEUROSCI, V10, P2714, DOI 10.1046/j.1460-9568.1998.t01-1-00275.x; Baude A, 2007, CEREB CORTEX, V17, P2094, DOI 10.1093/cercor/bhl117; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Colbert CM, 1996, J NEUROSCI, V16, P6676; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Glickfeld LL, 2009, NAT NEUROSCI, V12, P21, DOI 10.1038/nn.2230; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; GUTNICK MJ, 1972, SCIENCE, V176, P424, DOI 10.1126/science.176.4033.424; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Hemond P, 2008, HIPPOCAMPUS, V18, P411, DOI 10.1002/hipo.20404; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Luscher HR, 1998, J NEUROPHYSIOL, V80, P715, DOI 10.1152/jn.1998.80.2.715; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Perkins KL, 2006, J NEUROSCI METH, V154, P1, DOI 10.1016/j.jneumeth.2006.02.010; PINAULT D, 1989, NEUROSCIENCE, V31, P625, DOI 10.1016/0306-4522(89)90428-4; Sheffield MEJ, 2011, NAT NEUROSCI, V14, P200, DOI 10.1038/nn.2728; STASHEFF SF, 1993, J NEUROPHYSIOL, V70, P961, DOI 10.1152/jn.1993.70.3.961; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Traub RD, 2003, P NATL ACAD SCI USA, V100, P11047, DOI 10.1073/pnas.1934854100; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Tukker JJ, 2007, J NEUROSCI, V27, P8184, DOI 10.1523/JNEUROSCI.1685-07.2007; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004	26	85	86	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2012	336	6087					1458	1461		10.1126/science.1222017	http://dx.doi.org/10.1126/science.1222017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700932				2022-12-28	WOS:000305211700051
J	Qian, WQ; Miki, D; Zhang, H; Liu, YH; Zhang, X; Tang, K; Kan, YC; La, HG; Li, XJ; Li, SF; Zhu, XH; Shi, XB; Zhang, KL; Pontes, O; Chen, XM; Liu, RY; Gong, ZZ; Zhu, JK				Qian, Weiqiang; Miki, Daisuke; Zhang, Heng; Liu, Yunhua; Zhang, Xi; Tang, Kai; Kan, Yunchao; La, Honggui; Li, Xiaojie; Li, Shaofang; Zhu, Xiaohong; Shi, Xiaobing; Zhang, Kangling; Pontes, Olga; Chen, Xuemei; Liu, Renyi; Gong, Zhizhong; Zhu, Jian-Kang			A Histone Acetyltransferase Regulates Active DNA Demethylation in Arabidopsis	SCIENCE			English	Article							METHYLATION PATTERNS; GLYCOSYLASE/LYASE; TRIMETHYLATION; GENOME; PLANTS; ROS1	Active DNA demethylation is an important part of epigenetic regulation in plants and animals. How active DNA demethylation is regulated and its relationship with histone modification patterns are unclear. Here, we report the discovery of IDM1, a regulator of DNA demethylation in Arabidopsis. IDM1 is required for preventing DNA hypermethylation of highly homologous multicopy genes and other repetitive sequences that are normally targeted for active DNA demethylation by Repressor of Silencing 1 and related 5-methylcytosine DNA glycosylases. IDM1 binds methylated DNA at chromatin sites lacking histone H3K4 di- or trimethylation and acetylates H3 to create a chromatin environment permissible for 5-methylcytosine DNA glycosylases to function. Our study reveals how some genes are indicated by multiple epigenetic marks for active DNA demethylation and protection from silencing.	[Qian, Weiqiang; Miki, Daisuke; Zhang, Heng; La, Honggui; Zhu, Jian-Kang] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Beijing 100864, Peoples R China; [Qian, Weiqiang; Miki, Daisuke; Zhang, Heng; La, Honggui; Zhu, Jian-Kang] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Beijing 100864, Peoples R China; [Qian, Weiqiang; Zhang, Heng; Liu, Yunhua; Tang, Kai; La, Honggui; Zhu, Xiaohong; Zhu, Jian-Kang] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47906 USA; [Liu, Yunhua] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Liu, Yunhua] Shanghai Agrobiol Gene Ctr, Shanghai 201106, Peoples R China; [Zhang, Xi; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kan, Yunchao] Nanyang Normal Univ, China UK NYNU RRes Joint Lab Insect Biol, Henan, Peoples R China; [Li, Xiaojie; Gong, Zhizhong] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100193, Peoples R China; [Li, Shaofang; Chen, Xuemei; Liu, Renyi] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Zhang, Kangling] Loma Linda Univ, Sch Med, Dept Biochem, Loma Linda, CA 92350 USA; [Pontes, Olga] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Huazhong Agricultural University; University of Texas System; UTMD Anderson Cancer Center; Nanyang Normal College; China Agricultural University; University of California System; University of California Riverside; Loma Linda University; University of New Mexico	Zhu, JK (corresponding author), Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Beijing 100864, Peoples R China.	jkzhu@purdue.edu	Tang, Kai/G-3580-2019; Pontes, Olga MF/F-9768-2011; Liu, Renyi/AAA-6449-2020; Zhu, Jian-Kang/F-7658-2011; Liu, Renyi/H-7013-2012; Gong, Zhizhong/AAS-4796-2021; liu, yunhua/A-8334-2017	Tang, Kai/0000-0003-3913-6426; Pontes, Olga MF/0000-0003-3316-1145; Zhu, Jian-Kang/0000-0001-5134-731X; liu, yunhua/0000-0002-1979-685X; Shi, Xiaobing/0000-0001-5242-8189; Zhang, Heng/0000-0002-1541-3890; Chen, Xuemei/0000-0002-5209-1157; Miki, Daisuke/0000-0001-6066-3357; Li, shaofang/0000-0002-1903-023X	National Institutes of Health [R01GM070795, R01GM059138]; Chinese Academy of Sciences (CAS), China; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059138, R01GM070795] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences (CAS), China(Chinese Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01GM070795 and R01GM059138 to J.-K.Z. and by the Chinese Academy of Sciences (CAS), China. We thank B. Stevenson for technical assistance and X. Zhang for the gift of glutathione S-transferase H3 (amino acids 1 to 57) construct. Sequence data are available in the Gene Expression Omnibus database (GEO accession GSE33071).	Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	10	156	173	4	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1445	1448		10.1126/science.1219416	http://dx.doi.org/10.1126/science.1219416			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22700931	Green Accepted			2022-12-28	WOS:000305211700047
J	Elvis, M				Elvis, Martin			A midlife crisis for X-ray astronomy	NATURE			English	Editorial Material									Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Elvis, M (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	elvis@cfa.harvard.edu							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2012	486	7402					181	182		10.1038/486181a	http://dx.doi.org/10.1038/486181a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699593				2022-12-28	WOS:000305189000011
J	De Berardis, G; Lucisano, G; D'Ettorre, A; Pellegrini, F; Lepore, V; Tognoni, G; Nicolucci, A				De Berardis, Giorgia; Lucisano, Giuseppe; D'Ettorre, Antonio; Pellegrini, Fabio; Lepore, Vito; Tognoni, Gianni; Nicolucci, Antonio			Association of Aspirin Use With Major Bleeding in Patients With and Without Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-DOSE ASPIRIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED-TRIALS; EXPERT CONSENSUS DOCUMENT; OF-CARDIOLOGY FOUNDATION; CARDIOVASCULAR EVENTS; PRIMARY PREVENTION; RISK-FACTORS; SUBARACHNOID HEMORRHAGE	Context The benefit of aspirin for the primary prevention of cardiovascular events is relatively small for individuals with and without diabetes. This benefit could easily be offset by the risk of hemorrhage. Objective To determine the incidence of major gastrointestinal and intracranial bleeding episodes in individuals with and without diabetes taking aspirin. Design, Setting, and Participants A population-based cohort study, using administrative data from 4.1 million citizens in 12 local health authorities in Puglia, Italy. Individuals with new prescriptions for low-dose aspirin (<= 300 mg) were identified during the index period from January 1, 2003, to December 31, 2008, and were propensity-matched on a 1-to-1 basis with individuals who did not take aspirin during this period. Main Outcome Measures Hospitalizations for major gastrointestinal bleeding or cerebral hemorrhage occurring after the initiation of antiplatelet therapy. Results There were 186 425 individuals being treated with low-dose aspirin and 186 425 matched controls without aspirin use. During a median follow-up of 5.7 years, the overall incidence rate of hemorrhagic events was 5.58 (95% CI, 5.39-5.77) per 1000 person-years for aspirin users and 3.60 (95% CI, 3.48-3.72) per 1000 person-years for those without aspirin use (incidence rate ratio [IRR], 1.55; 95% CI, 1.48-1.63). The use of aspirin was associated with a greater risk of major bleeding in most of the subgroups investigated but not in individuals with diabetes (IRR, 1.09; 95% CI, 0.97-1.22). Irrespective of aspirin use, diabetes was independently associated with an increased risk of major bleeding episodes (IRR, 1.36; 95% CI, 1.28-1.44). Conclusions In a population-based cohort, aspirin use was significantly associated with an increased risk of major gastrointestinal or cerebral bleeding episodes. Patients with diabetes had a high rate of bleeding that was not independently associated with aspirin use. JAMA. 2012;307(21):2286-2294 www.jama.com	[De Berardis, Giorgia; Lucisano, Giuseppe; D'Ettorre, Antonio; Pellegrini, Fabio; Lepore, Vito; Tognoni, Gianni; Nicolucci, Antonio] Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, I-66030 Santa Maria Imbaro, Italy; [Pellegrini, Fabio] IRCCS, Biostat Unit, San Giovanni Rotondo, Italy; [Lepore, Vito] Univ Bari, Dept Neurosci, Bari, Italy	Consorzio Mario Negri Sud; IRCCS Casa Sollievo Della Sofferenza; Universita degli Studi di Bari Aldo Moro	Nicolucci, A (corresponding author), Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Via Nazl 8-A, I-66030 Santa Maria Imbaro, Italy.	nicolucci@negrisud.it	Lepore, Vito/ABG-4356-2020; D'Ettorre, Antonio/ABG-2375-2020	Lepore, Vito/0000-0002-5466-780X; D'Ettorre, Antonio/0000-0002-5880-4234	Bristol-Myers Squibb; Bayer	Bristol-Myers Squibb(Bristol-Myers Squibb); Bayer(Bayer AG)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Mr D'Ettorre reported receiving consulting fees from Bristol-Myers Squibb. Dr Tognoni reported receiving a research grant from Bayer. Dr Nicolucci reported receiving a research grant and fees for lectures including service on speakers bureaus from Bayer. Ms De Berardis, Messrs Lucisano and Pellegrini, and Dr Lepore did not report any financial disclosures.	Amarenco P, 2006, NEW ENGL J MED, V355, P549; [Anonymous], 2014, INT CLASS DIS 9 REV; Atar S, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.02.013; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Calonge N, 2009, ANN INTERN MED, V150, P396; Charlot M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2690; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; De Berardis G, 2012, NUTR METAB CARDIOVAS, V22, P605, DOI 10.1016/j.numecd.2010.10.016; DEBERARDIS G, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B4531; Earnshaw SR, 2011, ARCH INTERN MED, V171, P218, DOI 10.1001/archinternmed.2010.525; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Gulmez SE, 2009, BRIT J CLIN PHARMACO, V67, P460, DOI 10.1111/j.1365-2125.2009.03362.x; Hackam DG, 2011, CIRCULATION, V124, P2233, DOI 10.1161/CIRCULATIONAHA.111.055269; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Inagawa T, 2005, J NEUROSURG, V102, P60, DOI 10.3171/jns.2005.102.1.0060; Italian Republic, 2008, OFFICIAL GAZETT 0331; Lanas A, 2000, NEW ENGL J MED, V343, P834, DOI 10.1056/NEJM200009213431202; Lanas A, 2007, CURR MED RES OPIN, V23, P162, DOI 10.1185/030079907X162656; Lepore V, 2002, ITAL J CLIN PHARM, V16, P102; Macchia A, 2008, EUR J CLIN PHARMACOL, V64, P627, DOI 10.1007/s00228-008-0464-z; Macchia A, 2007, EUR J HEART FAIL, V9, P942, DOI 10.1016/j.ejheart.2007.06.004; Macchia A, 2012, EUR HEART J, V33, P515, DOI 10.1093/eurheartj/ehr410; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; Monte S, 2009, EUR J CLIN PHARMACOL, V65, P1131, DOI 10.1007/s00228-009-0692-x; Parsons LS, 2004, P 26 ANN SAS US GROU; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Pignone M, 2010, DIABETES CARE, V33, P1395, DOI 10.2337/dc10-0555; Pulcinelli FM, 2009, EUR HEART J, V30, P1279, DOI 10.1093/eurheartj/ehp097; Rahme E, 2007, ALIMENT PHARM THERAP, V26, P1387, DOI 10.1111/j.1365-2036.2007.03523.x; Rawlins M, 2008, LANCET, V372, P2152, DOI 10.1016/S0140-6736(08)61930-3; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Russo P, 2007, CLIN THER, V29, P751, DOI 10.1016/j.clinthera.2007.04.008; Serrano P, 2002, ALIMENT PHARM THER, V16, P1945, DOI 10.1046/j.1365-2036.2002.01355.x; Siller-Matula JM, 2010, J THROMB HAEMOST, V8, P2624, DOI 10.1111/j.1538-7836.2010.04049.x; Weil J, 2000, GUT, V46, P27, DOI 10.1136/gut.46.1.27; WHO Collaborating Centre for Drug Statistics Methodology, 2003, ATC IND DDDS; Winkler WE, 1992, COMP ANAL RECORD LIN, P829; Yanovitzky I, 2005, EVAL PROGRAM PLANN, V28, P209, DOI 10.1016/j.evalprogplan.2005.01.004	41	183	185	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2012	307	21					2286	2294		10.1001/jama.2012.5034	http://dx.doi.org/10.1001/jama.2012.5034			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	952OL	22706834	Bronze			2022-12-28	WOS:000304801700023
J	Tonelli, M; Muntner, P; Lloyd, A; Manns, BJ; Klarenbach, S; Pannu, N; James, MT; Hemmelgarn, BR				Tonelli, Marcello; Muntner, Paul; Lloyd, Anita; Manns, Braden J.; Klarenbach, Scott; Pannu, Neesh; James, Matthew T.; Hemmelgarn, Brenda R.		Alberta Kidney Dis Network	Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study	LANCET			English	Article							GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR-DISEASE; SERUM CREATININE; HEART-DISEASE; MYOCARDIAL-INFARCTION; ADMINISTRATIVE DATA; MORTALITY; EQUATION; EPIDEMIOLOGY; EQUIVALENT	Background Diabetes is regarded as a coronary heart disease risk equivalent-ie, people with the disorder have a risk of coronary events similar to those with previous myocardial infarction. We assessed whether chronic kidney disease should be regarded as a coronary heart disease risk equivalent. Methods We studied a population-based cohort with measures of estimated glomerular filtration rate (eGFR) and proteinuria from Alberta, Canada. We used validated algorithms based on hospital admission and medical-claim data to classify participants with baseline history of myocardial infarction or diabetes and to ascertain which patients were admitted to hospital for myocardial infarction during follow-up (the primary outcome). For our primary analysis, we defined baseline chronic kidney disease as eGFR 15-59.9 mL/min per 1.73 m(2) (stage 3 or 4 disease). We used Poisson regression to calculate unadjusted rates and relative rates of myocardial infarction during follow-up for five risk groups: people with previous myocardial infarction (with or without diabetes or chronic kidney disease), and (of those without previous myocardial infarction), four mutually exclusive groups defined by the presence or absence of diabetes and chronic kidney disease. Findings During a median follow-up of 48 months (IQR 25-65), 11 340 of 1 268 029 participants (1%) were admitted to hospital with myocardial infarction. The unadjusted rate of myocardial infarction was highest in people with previous myocardial infarction (18.5 per 1000 person-years, 95% CI 17.4-19.8). In people without previous myocardial infarction, the rate of myocardial infarction was lower in those with diabetes (without chronic kidney disease) than in those with chronic kidney disease (without diabetes; 5.4 per 1000 person-years, 5.2-5.7, vs 6.9 per 1000 person-years, 6.6-7.2; p<0.0001). The rate of incident myocardial infarction in people with diabetes was substantially lower than for those with chronic kidney disease when defined by eGFR of less than 45 mL/min per 1.73 m(2) and severely increased proteinuria (6.6 per 1000 person-years, 6.4-6.9 vs 12.4 per 1000 person-years, 9.7-15.9). Interpretation Our findings suggest that chronic kidney disease could be added to the list of criteria defining people at highest risk of future coronary events.	[Tonelli, Marcello; Lloyd, Anita; Klarenbach, Scott; Pannu, Neesh] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Tonelli, Marcello; Klarenbach, Scott] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada; [Muntner, Paul] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Manns, Braden J.; James, Matthew T.; Hemmelgarn, Brenda R.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Manns, Braden J.; James, Matthew T.; Hemmelgarn, Brenda R.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada	University of Alberta; University of Alberta; University of Alabama System; University of Alabama Birmingham; University of Calgary; University of Calgary	Tonelli, M (corresponding author), 7-129 Clin Sci Bldg, Edmonton, AB T6B 2G3, Canada.	mtonelli-admin@med.ualberta.ca	Manns, Braden J/I-8942-2012; Hemmelgarn, Brenda R./I-6894-2012; Tonelli, Marcello/B-3028-2009; Klarenbach, Scott/E-7731-2013	Tonelli, Marcello/0000-0002-0846-3187; Klarenbach, Scott/0000-0002-8611-1056	Alberta Heritage Foundation for Medical Research; Pfizer; Amgen; Government of Canada Research Chair; Roy and Vi Baay Chair in Kidney Research; Alberta Health and Wellness; University of Alberta; University of Calgary	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Pfizer(Pfizer); Amgen(Amgen); Government of Canada Research Chair; Roy and Vi Baay Chair in Kidney Research; Alberta Health and Wellness; University of Alberta(University of Alberta); University of Calgary	Alberta Heritage Foundation for Medical Research.; MT has received a research grant from Pfizer (2006) and served on Merck advisory boards (2010-11), with honoraria donated to charity. PM has received consulting fees and a research grant from Amgen. All the other authors declare that they have no conflicts of interests.; The study was supported by an interdisciplinary team grant from the Alberta Heritage Foundation for Medical Research (AHFMR). MT, BJM, SK, and BRH were supported by career salary awards from AHFMR. MT was also supported by a Government of Canada Research Chair in the optimum care of people with chronic kidney disease, and BRH by the Roy and Vi Baay Chair in Kidney Research. MT, BJM, SK, and BRH were supported by a joint initiative between Alberta Health and Wellness and the Universities of Alberta and Calgary. We thank Sophanny Tiv for assistance with the figures.	Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; [Anonymous], 2008, DIABETES CARE, V31, pS5, DOI 10.2337/dc08-S005; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Behar S, 1997, AM HEART J, V133, P290, DOI 10.1016/S0002-8703(97)70222-9; Bulugahapitiya U, 2009, DIABETIC MED, V26, P142, DOI 10.1111/j.1464-5491.2008.02640.x; Couchoud C, 1999, KIDNEY INT, V55, P1878, DOI 10.1046/j.1523-1755.1999.00411.x; Grundy SM, 2006, DIABETES CARE, V29, P457, DOI 10.2337/diacare.29.02.06.dc05-1904; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Hyre AD, 2007, AM J KIDNEY DIS, V49, P37, DOI 10.1053/j.ajkd.2006.09.017; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Miettinen H, 1998, DIABETES CARE, V21, P69, DOI 10.2337/diacare.21.1.69; Parikh NI, 2008, AM J CARDIOL, V102, P47, DOI 10.1016/j.amjcard.2008.02.095; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rashidi A, 2008, AM J CARDIOL, V102, P1668, DOI 10.1016/j.amjcard.2008.07.060; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rognant N, 2011, DIABETES CARE, V34, P1320, DOI 10.2337/dc11-0203; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Silveiro SP, 2011, DIABETES CARE, V34, P2353, DOI 10.2337/dc11-1282; Sin DD, 2003, CHEST, V124, P51, DOI 10.1378/chest.124.1.51; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Tonelli M, 2011, ANN INTERN MED, V154, P12, DOI 10.7326/0003-4819-154-1-201101040-00003; Wattanakit K, 2006, J AM COLL CARDIOL, V48, P1183, DOI 10.1016/j.jacc.2006.05.047; White SL, 2010, AM J KIDNEY DIS, V55, P660, DOI 10.1053/j.ajkd.2009.12.011; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	38	490	511	0	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2012	380	9844					807	814		10.1016/S0140-6736(12)60572-8	http://dx.doi.org/10.1016/S0140-6736(12)60572-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	000OP	22717317				2022-12-28	WOS:000308396300029
J	Toth, B; Mehes, L; Tasko, S; Szalai, Z; Tulassay, Z; Cypowyj, S; Casanova, JL; Puel, A; Marodi, L				Toth, Beata; Mehes, Leonora; Tasko, Szilvia; Szalai, Zsuzsanna; Tulassay, Zsolt; Cypowyj, Sophie; Casanova, Jean-Laurent; Puel, Anne; Marodi, Laszlo			Herpes in STAT1 deficiency	LANCET			English	Editorial Material							CHRONIC MUCOCUTANEOUS CANDIDIASIS; MUTATIONS; IMMUNITY		[Toth, Beata; Mehes, Leonora; Tasko, Szilvia; Marodi, Laszlo] Univ Debrecen, Dept Infect & Paediat Immunol, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary; [Szalai, Zsuzsanna] Heim Pal Childrens Hosp, Dept Dermatol, Budapest, Hungary; [Tulassay, Zsolt] Semmelweis Univ, Dept Internal Med 2, Budapest, Hungary; [Cypowyj, Sophie; Casanova, Jean-Laurent] Rockefeller Univ, Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA; [Casanova, Jean-Laurent; Puel, Anne] INSERM, U980, Necker Med Sch, Lab Human Genet Infect Dis,Necker Branch, Paris, France; [Casanova, Jean-Laurent; Puel, Anne] Univ Paris 05, Paris, France	University of Debrecen; Semmelweis University; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Marodi, L (corresponding author), Univ Debrecen, Dept Infect & Paediat Immunol, Med & Hlth Sci Ctr, Nagyerdei Krt 98, H-4032 Debrecen, Hungary.	lmarodi@dote.hu	Puel, Anne/H-7305-2017; Casanova, Jean-Laurent/I-3418-2017; Marodi, Laszlo/AAU-9915-2020	Puel, Anne/0000-0003-2603-0323; Casanova, Jean-Laurent/0000-0002-7782-4169				Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Toth B, 2010, CLIN ENDOCRINOL, V72, P641, DOI 10.1111/j.1365-2265.2009.03740.x; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102	5	51	52	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 30	2012	379	9835					2500	2500		10.1016/S0140-6736(12)60365-1	http://dx.doi.org/10.1016/S0140-6736(12)60365-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	967NV	22748593				2022-12-28	WOS:000305915900035
J	Nabel, GJ; Wolinsky, SM; Haynes, BF				Nabel, Gary J.; Wolinsky, Steven M.; Haynes, Barton F.			Norman L. Letvin (1949-2012)	SCIENCE			English	Biographical-Item									[Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Wolinsky, Steven M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Haynes, Barton F.] Duke Univ, Med Ctr, Durham, NC 27705 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Northwestern University; Feinberg School of Medicine; Duke University	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	gnabel@nih.gov	Wolinsky, Steven/B-2893-2012	Wolinsky, Steven/0000-0002-9625-6697				LETVIN NL, PUBLICATION LIST	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1653	1653		10.1126/science.1225947	http://dx.doi.org/10.1126/science.1225947			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22745414				2022-12-28	WOS:000305794500033
J	Boulton, G				Boulton, Geoffrey			Open your minds and share your results	NATURE			English	Editorial Material									Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland	University of Edinburgh	Boulton, G (corresponding author), Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland.	g.boulton@ed.ac.uk						Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357	1	12	14	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					441	441		10.1038/486441a	http://dx.doi.org/10.1038/486441a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	965IJ	22739274	Bronze			2022-12-28	WOS:000305760600006
J	Leow, D; Li, G; Mei, TS; Yu, JQ				Leow, Dasheng; Li, Gang; Mei, Tian-Sheng; Yu, Jin-Quan			Activation of remote meta-C-H bonds assisted by an end-on template	NATURE			English	Article							CARBON-HYDROGEN BONDS; ROOM-TEMPERATURE; ARYLATION; OLEFINATION; CATALYST; ARENES; FUNCTIONALIZATION; SELECTIVITY; REACTIVITY; COMPLEXES	Functionalization of unactivated carbon-hydrogen (C-H) single bonds is an efficient strategy for rapid generation of complex molecules from simpler ones. However, it is difficult to achieve selectivity when multiple inequivalent C-H bonds are present in the target molecule. The usual approach is to use sigma-chelating directing groups, which lead to ortho-selectivity through the formation of a conformationally rigid six- or seven-membered cyclic pre-transition state(1-14). Despite the broad utility of this approach, proximity-driven reactivity prevents the activation of remote C-H bonds. Here we report a class of easily removable nitrile-containing templates that direct the activation of distal meta-C-H bonds (more than ten bonds away) of a tethered arene. We attribute this new mode of C-H activation to a weak 'end-on' interaction(15) between the linear nitrile group and the metal centre. The 'end-on' coordination geometry relieves the strain of the cyclophane-like pre-transition state of the meta-C-H activation event. In addition, this template overrides the intrinsic electronic and steric biases as well as ortho-directing effects with two broadly useful classes of arene substrates (toluene derivatives and hydrocinnamic acids).	[Leow, Dasheng; Li, Gang; Mei, Tian-Sheng; Yu, Jin-Quan] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Yu, JQ (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu	mei, tiansheng/H-5293-2011; Leow, Dasheng/A-9549-2012; Li, Gang/I-2960-2012; Mei, Tian-Sheng/Y-3266-2019; Li, Gang/ABF-3486-2021	Leow, Dasheng/0000-0001-9823-0258; Li, Gang/0000-0001-5229-554X; Mei, Tian-Sheng/0000-0002-4985-1071; Li, Gang/0000-0001-5229-554X	Scripps Research Institute; NIH (NIGMS) [1 R01 GM084019-03]; Agency for Science, Technology and Research (A*STAR) in Singapore; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084019] Funding Source: NIH RePORTER	Scripps Research Institute; NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Agency for Science, Technology and Research (A*STAR) in Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank The Scripps Research Institute and the NIH (NIGMS, 1 R01 GM084019-03) for their financial support. We also thank the Agency for Science, Technology and Research (A*STAR) in Singapore for a postdoctoral fellowship (to D.L.).	Ackermann L, 2011, ORG LETT, V13, P4153, DOI 10.1021/ol201563r; Boele MDK, 2002, J AM CHEM SOC, V124, P1586, DOI 10.1021/ja0176907; BRESLOW R, 1980, ACCOUNTS CHEM RES, V13, P170, DOI 10.1021/ar50150a002; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Das S, 2006, SCIENCE, V312, P1941, DOI 10.1126/science.1127899; Daugulis O, 2009, ACCOUNTS CHEM RES, V42, P1074, DOI 10.1021/ar9000058; Duong HA, 2011, ANGEW CHEM INT EDIT, V50, P463, DOI 10.1002/anie.201004704; Engle K. M., 2011, ACC CHEM RES; Flemming JP, 2008, ORG BIOMOL CHEM, V6, P1215, DOI 10.1039/b716954j; Guimond N, 2011, J AM CHEM SOC, V133, P6449, DOI 10.1021/ja201143v; Gurtler C, 1999, CHEM-EUR J, V5, P3107, DOI 10.1002/(SICI)1521-3765(19991105)5:11<3107::AID-CHEM3107>3.0.CO;2-#; Hartung C. G., 2004, MODERN ARENE CHEM, P330, DOI DOI 10.1002/3527601767.CH10; Ishiyama T, 2002, J AM CHEM SOC, V124, P390, DOI 10.1021/ja0173019; Jun CH, 1999, SYNLETT, P1; KAKIUCHI F, 1995, B CHEM SOC JPN, V68, P62, DOI 10.1246/bcsj.68.62; Li JJ, 2008, TETRAHEDRON, V64, P6979, DOI 10.1016/j.tet.2008.03.026; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Park SH, 2011, ORG LETT, V13, P2372, DOI 10.1021/ol200600p; Phipps RJ, 2009, SCIENCE, V323, P1593, DOI 10.1126/science.1169975; Rakshit S, 2011, J AM CHEM SOC, V133, P2350, DOI 10.1021/ja109676d; RYABOV AD, 1985, SYNTHESIS-STUTTGART, P233, DOI 10.1055/s-1985-31169; Saidi O, 2011, J AM CHEM SOC, V133, P19298, DOI 10.1021/ja208286b; Satoh T, 2010, CHEM-EUR J, V16, P11212, DOI 10.1002/chem.201001363; SCHWARZ H, 1989, ACCOUNTS CHEM RES, V22, P282, DOI 10.1021/ar00164a004; Ueda K, 2010, ANGEW CHEM INT EDIT, V49, P8946, DOI 10.1002/anie.201005082; Wang DH, 2010, SCIENCE, V327, P315, DOI 10.1126/science.1182512; Wang XS, 2011, J AM CHEM SOC, V133, P13864, DOI 10.1021/ja206572w; Ye MC, 2011, J AM CHEM SOC, V133, P6964, DOI 10.1021/ja2021075; Zhang YH, 2009, J AM CHEM SOC, V131, P5072, DOI 10.1021/ja900327e	30	668	670	18	419	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2012	486	7404					518	522		10.1038/nature11158	http://dx.doi.org/10.1038/nature11158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965IJ	22739317	Green Accepted			2022-12-28	WOS:000305760600040
J	Gillis, VL; Senthinathan, A; Dzingina, M; Chamberlain, K; Banks, E; Baker, MR; Longson, D				Gillis, V. L.; Senthinathan, A.; Dzingina, M.; Chamberlain, K.; Banks, E.; Baker, M. R.; Longson, D.		Guideline Dev Grp	Management of an acute painful sickle cell episode in hospital: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE CHEST SYNDROME		[Longson, D.] Manchester Mental Hlth & Social Care Trust, Dept Psychiat, Manchester M8 5RB, Lancs, England; [Gillis, V. L.; Senthinathan, A.; Dzingina, M.; Chamberlain, K.; Banks, E.; Baker, M. R.] Natl Inst Hlth & Clin Excellence, Manchester M1 4BD, Lancs, England	Open University - UK; National Institute for Health & Care Excellence	Longson, D (corresponding author), Manchester Mental Hlth & Social Care Trust, Dept Psychiat, Manchester M8 5RB, Lancs, England.	damien.longson@manchester.ac.uk	Dzingina, Mendwas/C-4957-2014					Booker MJ, 2006, CHRONIC ILLN, V2, P39, DOI 10.1179/174592006X93860; Buchanan ID, 2005, PEDIATR BLOOD CANCER, V45, P716, DOI 10.1002/pbc.20403; Harris A, 1998, PSYCHOL HEALTH MED, V3, P171, DOI [10.1080/13548509808402233, DOI 10.1080/13548509808402233]; Joint Formulary Committee, 2017, BRIT NATL FORMULARY, V80th; National Institute for Health and Clinical Excellence (UK), 2012, SICKL CELL AC PAINF; NHS Sickle Cell & Thalassaemia Screening Programme, NHS SICKL CELL THAL; Serjeant GR, 1992, SICKLE CELL DIS, P455, DOI DOI 10.1007/S11999-007-0069-3; Styles LA, 2000, BLOOD, V96, P3276	8	11	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2012	344								e4063	10.1136/bmj.e4063	http://dx.doi.org/10.1136/bmj.e4063			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	968MX	22740566				2022-12-28	WOS:000305987100010
J	Phillips, MR; Cheng, HG				Phillips, Michael R.; Cheng, Hui G.			The changing global face of suicide	LANCET			English	Editorial Material							PSYCHOLOGICAL AUTOPSY		[Phillips, Michael R.; Cheng, Hui G.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Suicide Res & Prevent Ctr, Shanghai, Peoples R China; [Phillips, Michael R.] Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA 30322 USA; [Phillips, Michael R.] Emory Univ, Sch Med, Dept Global Hlth, Atlanta, GA 30322 USA	Shanghai Jiao Tong University; Emory University; Emory University	Phillips, MR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Suicide Res & Prevent Ctr, Shanghai, Peoples R China.	phillipschina@yahoo.com	Cheng, Hui G./I-2944-2019; Phillips, Michael Robert/AAE-7585-2021	Cheng, Hui G./0000-0001-7252-5090; Phillips, Michael Robert/0000-0002-5973-2439				[高士元 Gao Shiyuan], 2004, [中华精神科杂志, Chinese Journal of Psychiatry], V37, P232; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; Harwood D., 2000, INT HDB SUICIDE ATTE, P275; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; [李献云 Li Xianyun], 2002, [中国心理卫生杂志, Chinese Mental Health Journal], V16, P681; [李献云 Li Xianyun], 2004, [中国心理卫生杂志, Chinese Mental Health Journal], V18, P191; Patel V, 2012, LANCET, V379, P2343, DOI 10.1016/S0140-6736(12)60606-0; Phillips MR, 2010, AM J PSYCHIAT, V167, P731, DOI 10.1176/appi.ajp.2010.10040589; Phillips MR, 2002, LANCET, V359, P835, DOI 10.1016/S0140-6736(02)07954-0; WHO, 2022, GLOB BURD DIS 2004 U; World Health Organization, 2000, DISTR SUIC RAT PER 1; Yang GH, 2005, BIOMED ENVIRON SCI, V18, P379; Zhang J, 2010, AM J PSYCHIAT, V167, P773, DOI 10.1176/appi.ajp.2010.09101476	13	48	53	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 23	2012	379	9834					2318	2319		10.1016/S0140-6736(12)60913-1	http://dx.doi.org/10.1016/S0140-6736(12)60913-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961ZV	22726503				2022-12-28	WOS:000305509600006
J	Davis, SP; Finarelli, JA; Coates, MI				Davis, Samuel P.; Finarelli, John A.; Coates, Michael I.			Acanthodes and shark-like conditions in the last common ancestor of modern gnathostomes	NATURE			English	Article							BRAINCASE; CHONDRICHTHYAN	Acanthodians, an exclusively Palaeozoic group of fish, are central to a renewed debate on the origin of modern gnathostomes: jawed vertebrates comprising Chondrichthyes (sharks, rays and ratfish) and Osteichthyes (bony fishes and tetrapods)(1-6). Acanthodian internal anatomy is primarily understood from Acanthodes bronni(2,7-10) because it remains the only example preserved in substantial detail, central to which is an ostensibly osteichthyan braincase(1,2,7). For this reason, Acanthodes has become an indispensible component in early gnathostome phylogenies(1,11-17). Here we present a new description of the Acanthodes braincase, yielding new details of external and internal morphology, notably the regions surrounding and within the ear capsule and neurocranial roof. These data contribute to a new reconstruction that, unexpectedly, resembles early chondrichthyan crania. Principal coordinates analysis of a character-taxon matrix including these new data confirms this impression: Acanthodes is quantifiably closer to chondrichthyans than to osteichthyans. However, phylogenetic analysis places Acanthodes on the osteichthyan stem, as part of a well-resolved tree that also recovers acanthodians as stem chondrichthyans and stem gnathostomes. As such, perceived chondrichthyan features of the Acanthodes cranium represent shared primitive conditions for crown group gnathostomes. Moreover, this increasingly detailed picture of early gnathostome evolution highlights ongoing and profound anatomical reorganization of vertebrate crania after the origin of jaws but before the divergence of living clades.	[Coates, Michael I.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Finarelli, John A.] Univ Coll Dublin, UCD Sch Biol & Environm Sci, UCD Sci Educ & Res Ctr, Dublin 4, Ireland	University of Chicago; University College Dublin	Coates, MI (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	mcoates@uchicago.edu	Coates, Michael/AAO-3810-2020	Coates, Michael/0000-0003-2843-1075	Natural Environment Research Council (UK) [GT4/97/183ES]; National Science Foundation (USA) [DEB-0917922]; Division Of Environmental Biology [0917922] Funding Source: National Science Foundation	Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Science Foundation (USA)(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. Paton, Z. Johanson, M. Richter, J. Clack, D. Unwin and W. Simpson for specimen loans and collections access; M. Friedman, M. Brazeau, G. Hanke and J. Long for discussions on early gnathostome cranial anatomy. Financial support for this work was provided by Natural Environment Research Council (UK) studentship GT4/97/183ES, and grant DEB-0917922 from the National Science Foundation (USA) (to M.I.C.).	Anderson PSL, 2011, NATURE, V476, P206, DOI 10.1038/nature10207; Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Basden AM, 2001, J VERTEBR PALEONTOL, V21, P754, DOI 10.1671/0272-4634(2001)021[0754:APANFT]2.0.CO;2; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; Coates MI, 2001, SYST ASSOC SPEC VOL, V61, P241; Coates MI, 1998, T ROY SOC EDIN-EARTH, V89, P63, DOI 10.1017/S026359330000701X; Creanza N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008544; Davis J.C., 1986, STAT DATA ANAL GEOLO; Eriksson T, 2001, AUTODECAY V 5 0; Felsenstein J, 1985, EVOLUTION, V39, P783, DOI DOI 10.2307/2408678; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Goodrich ES., 1930, STUDIES STRUCTURE DE, DOI [DOI 10.5962/BHL.TITLE.82144, 10.5962/bhl.title.82144]; Goujet D, 1984, POISSONS PLACODERMES; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Hanke Gavin F., 2010, P159; Janvier P., 1996, EARLY VERTEBRATES; Jarvik E., 1980, BASIC STRUCTURE EVOL; Johanson Z, 2002, LETHAIA, V35, P169, DOI 10.1080/002411602320184024; Maisey JG, 2005, B AM MUS NAT HIST, P1; Maisey JG, 2001, SYST ASSOC SPEC VOL, V61, P263; Maisey J, 2009, ACTA ZOOL-STOCKHOLM, V90, P109, DOI 10.1111/j.1463-6395.2008.00330.x; Maisey JG, 2008, J MORPHOL, V269, P1022, DOI 10.1002/jmor.10642; Maisey JG, 2010, CR PALEVOL, V9, P289, DOI 10.1016/j.crpv.2010.07.021; Miles RS., 1973, B BR MUS NAT HIS G, V24, P111; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; Nelson G.J., 1969, B AM MUS NAT HIST, V141, P475; Pradel A, 2009, P NATL ACAD SCI USA, V106, P5224, DOI 10.1073/pnas.0807047106; Ruta M, 2011, SPEC PAP PALAEONTOL, V86, P1; Sokal RR, 1995, BIOMETRY; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Wills MA, 1998, BIOL J LINN SOC, V65, P455, DOI 10.1111/j.1095-8312.1998.tb01149.x; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2006, NATURE, V441, P77, DOI 10.1038/nature04563; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855; [No title captured]	37	136	139	4	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2012	486	7402					247	+		10.1038/nature11080	http://dx.doi.org/10.1038/nature11080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	957UH	22699617				2022-12-28	WOS:000305189000033
J	[Anonymous]				[Anonymous]			Post-marketing observational studies: my experience in the drug industry	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 12	2012	344								e3990	10.1136/bmj.e3990	http://dx.doi.org/10.1136/bmj.e3990			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961KQ	22692654				2022-12-28	WOS:000305463700007
J	Ramos-Casals, M; Brito-Zeron, P; Siso-Almirall, A; Bosch, X				Ramos-Casals, Manuel; Brito-Zeron, Pilar; Siso-Almirall, Antoni; Bosch, Xavier			PRACTICE POINTER Primary Sjogren syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LYMPHOMA DEVELOPMENT; CLASSIFICATION; PREDICTORS; CRITERIA; FATIGUE		[Ramos-Casals, Manuel; Brito-Zeron, Pilar] Hosp Clin Barcelona, ICMiD, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Sjogren Syndrome Res Grp AGAUR,Dept Syst Autoimmu, E-08036 Barcelona, Spain; [Siso-Almirall, Antoni] Univ Barcelona, Primary Care Ctr Les Corts, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Primary Care Res Grp,CAPSE, Barcelona, Spain; [Bosch, Xavier] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Dept Internal Med,ICMiD, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Ramos-Casals, M (corresponding author), Hosp Clin Barcelona, ICMiD, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Sjogren Syndrome Res Grp AGAUR,Dept Syst Autoimmu, Villarroel 170, E-08036 Barcelona, Spain.	mramos@clinic.ub.es	brito zeron, pilar/L-6551-2014	brito zeron, pilar/0000-0003-1016-5055; Siso Almirall, Antoni/0000-0001-9832-2689; Ramos-Casals, Manuel/0000-0001-5709-6734				Alamanos Y, 2006, RHEUMATOLOGY, V45, P187, DOI 10.1093/rheumatology/kei107; Baimpa E, 2009, MEDICINE, V88, P284, DOI 10.1097/MD.0b013e3181b76ab5; Bowman SJ, 2010, J RHEUMATOL, V37, P1010, DOI 10.3899/jrheum.090734; Brennan MT, 2002, ARTHRIT RHEUM-ARTHR, V47, P189, DOI 10.1002/art.10219; Brito-Zeron P, 2007, RHEUMATOLOGY, V46, P1359, DOI 10.1093/rheumatology/kem079; Callaghan R, 2007, RHEUMATOLOGY, V46, P105, DOI 10.1093/rheumatology/kel155; Derk CT, 2004, POSTGRAD MED, V116, P49, DOI 10.3810/pgm.2004.09.1587; Engel P, 2011, PHARMACOL REV, V63, P127, DOI 10.1124/pr.109.002006; Goransson LG, 2011, SCAND J RHEUMATOL, V40, P221, DOI 10.3109/03009742.2010.536164; Ng WF, 2010, RHEUMATOLOGY, V49, P844, DOI 10.1093/rheumatology/keq009; Ramos-Casals M., 2007, CURRENT DIAGNOSIS TR, P237; Ramos-Casals M, 2008, MEDICINE, V87, P210, DOI 10.1097/MD.0b013e318181e6af; Ramos-Casals M, 2007, SEMIN ARTHRITIS RHEU, V36, P246, DOI 10.1016/j.semarthrit.2006.08.007; Ramos-Casals M, 2009, CLINICIAN'S PEARLS AND MYTHS IN RHEUMATOLOGY, P107, DOI 10.1007/978-1-84800-934-9_12; Ramos-Casals M, 2010, JAMA-J AM MED ASSOC, V304, P452, DOI 10.1001/jama.2010.1014; Ramos-Casals M, 2010, J RHEUMATOL, V37, P585, DOI 10.3899/jrheum.090835; Segal B., 2012, SJOGRENS SYNDROME DI, P129; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Siso A, 2012, SJOGREN SYNDROME DIA, P501; Theander E, 2004, ARTHRITIS RHEUM-US, V50, P1262, DOI 10.1002/art.20176; Theander L, 2010, RHEUMATOLOGY, V49, P1177, DOI 10.1093/rheumatology/keq023; VITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Westhoff G, 2012, RHEUMATOLOGY, V51, P262, DOI 10.1093/rheumatology/ker208; Wirbelauer C, 2006, AM J MED, V119, P302, DOI 10.1016/j.amjmed.2005.07.065; Zintzaras E, 2005, ARCH INTERN MED, V165, P2337, DOI 10.1001/archinte.165.20.2337	27	184	194	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2012	344								e3821	10.1136/bmj.e3821	http://dx.doi.org/10.1136/bmj.e3821			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	961LA	23184549	Green Published			2022-12-28	WOS:000305464700007
J	Hughes, IA; Werner, R; Bunch, T; Hiort, O				Hughes, Ieuan Arwel; Werner, Ralf; Bunch, Trevor; Hiort, Olaf			Androgen Insensitivity Syndrome	SEMINARS IN REPRODUCTIVE MEDICINE			English	Article						androgen insensitivity; androgen receptor; mutations; germ cell tumors; hormone replacement; disclosure	ANTI-MULLERIAN HORMONE; RECEPTOR GENE-MUTATIONS; BONE-MINERAL DENSITY; N-TERMINAL DOMAIN; SEX DEVELOPMENT; TESTICULAR FEMINIZATION; STRUCTURAL BASIS; SOMATIC MOSAICISM; MOLECULAR-BIOLOGY; INGUINAL-HERNIA	The androgen insensitivity syndromes (AIS) fall within the generic category of 46,XY DSD (disorder of sex development) and present as phenotypes associated with complete or partial resistance to the action of androgens. Three categories are recognized: complete androgen insensitivity syndrome (CAIS), partial androgen insensitivity syndrome (PAIS), mild androgen insensitivity syndrome (MAIS). The androgen receptor (AR) is encoded by an 8 exon gene on the X chromosome long arm. More than 800 mutations in the AR gene have been reported in AIS patients (www.androgendb.mcgill.ca/). They are distributed throughout the gene with a preponderance located in the ligand binding domain. The most severe mutations are generally associated with a CAIS phenotype, but the correlation is less defined in PAIS. CAIS presents typically as primary amenorrhoea in an adolescent female and less commonly in infancy with bilateral inguinal/labial swellings due to testes. The differential diagnosis in CAIS is limited, whereas in PAIS, numerous other causes of DSD can also produce the typical phenotype of micropenis, severe hypospadias and bifid scrotum. Management issues in CAIS involve timing of gonadectomy, appropriate hormone replacement therapy and assessment of the need for vaginal dilation or rarely, vaginal surgery. The risk of gonadal germ cell tumor is low during childhood and adolescence but increases in later adulthood. Expert psychological counseling is mandatory to manage the disconnect between chromosomal, gonadal and phenotypic sex and to choreograph the evolving process of disclosure from late childhood through to maturity. It is implicit that management in AIS requires a multidisciplinary team and engagement with patient advocacy groups.	[Hughes, Ieuan Arwel; Bunch, Trevor] Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 0QQ, England; [Werner, Ralf; Hiort, Olaf] Univ Lubeck, Dept Paediat & Adolescent Med, Div Paediat Endocrinol & Diabet, Lubeck, Germany	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Lubeck	Hughes, IA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Box 116, Cambridge CB2 0QQ, England.	iah1000@cam.ac.uk		Werner, Ralf/0000-0003-3718-3595	European Community [201444]; New-life (formerly Birth Defects Foundation); UK National Institute of Health Research Cambridge Biomedical Research Centre; MRC [G1100236] Funding Source: UKRI; Medical Research Council [G1100236] Funding Source: researchfish	European Community(European Commission); New-life (formerly Birth Defects Foundation); UK National Institute of Health Research Cambridge Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Many of the studies described in this review received funding from the following sources: European Community FP7 Program (FP7/2007-13; grant number 201444), New-life (formerly Birth Defects Foundation) and the UK National Institute of Health Research Cambridge Biomedical Research Centre. Miss Louise Goode coordinated production of the manuscript.	Ahmed SF, 2010, CLIN ENDOCRINOL, V72, P814, DOI 10.1111/j.1365-2265.2009.03724.x; Ahmed SF, 2000, BJU INT, V85, P120, DOI 10.1046/j.1464-410x.2000.00354.x; Appari M, 2009, J MOL MED, V87, P623, DOI 10.1007/s00109-009-0462-3; Bay K, 2011, NAT REV UROL, V8, P187, DOI 10.1038/nrurol.2011.23; Bebermeier JH, 2006, J MOL MED, V84, P919, DOI 10.1007/s00109-006-0081-1; Bergada I, 2006, J CLIN ENDOCR METAB, V91, P4092, DOI 10.1210/jc.2006-1079; Bertelloni S, 2010, SEX DEV, V4, P270, DOI 10.1159/000315961; Bertelloni S, 2011, HORM RES PAEDIAT, V76, P428, DOI 10.1159/000334162; Boehmer ALM, 2001, J CLIN ENDOCR METAB, V86, P4151, DOI 10.1210/jc.86.9.4151; Boukari K, 2009, J CLIN ENDOCR METAB, V94, P1818, DOI 10.1210/jc.2008-1909; Bouvattier C, 2002, J CLIN ENDOCR METAB, V87, P29, DOI 10.1210/jc.87.1.29; Bouvattier C, 2006, J CLIN ENDOCR METAB, V91, P3310, DOI 10.1210/jc.2006-0218; Brain CE, 2010, BEST PRACT RES CL EN, V24, P335, DOI 10.1016/j.beem.2010.01.006; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chamberlain NL, 1996, J BIOL CHEM, V271, P26772, DOI 10.1074/jbc.271.43.26772; Chemes HE, 2008, J CLIN ENDOCR METAB, V93, P4408, DOI 10.1210/jc.2008-0915; Cohen-Kettenis PT, 2010, BEST PRACT RES CL EN, V24, P325, DOI 10.1016/j.beem.2009.11.005; Cools M, 2006, ENDOCR REV, V27, P468, DOI 10.1210/er.2006-0005; Crouch NS, 2011, BJOG-INT J OBSTET GY, V118, P84, DOI 10.1111/j.1471-0528.2010.02778.x; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; Danilovic DLS, 2007, OSTEOPOROSIS INT, V18, P369, DOI 10.1007/s00198-006-0243-6; Davis S E, 2001, Breast J, V7, P430, DOI 10.1046/j.1524-4741.2001.07610.x; De Bruyn R, 2011, METHODS MOL BIOL, V776, P81, DOI 10.1007/978-1-61779-243-4_6; Deans R, 2012, CLIN ENDOCRINOL, V76, P894, DOI 10.1111/j.1365-2265.2012.04330.x; Deeb A, 2005, BJU INT, V96, P401, DOI 10.1111/j.1464-410X.2005.05639.x; Faisal SF, 2011, CLIN ENDOCRINOL OXF; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; GOODALL J, 1991, LANCET, V337, P33, DOI 10.1016/0140-6736(91)93344-9; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Han TS, 2008, EUR J ENDOCRINOL, V159, P179, DOI 10.1530/EJE-08-0166; Hannema SE, 2006, J PATHOL, V208, P518, DOI 10.1002/path.1890; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; Hellwinkel OJC, 2001, J CLIN ENDOCR METAB, V86, P2569, DOI 10.1210/jc.86.6.2569; Helsen C, 2012, MOL CELL ENDOCRINOL, V348, P411, DOI 10.1016/j.mce.2011.07.025; Hines M, 2003, ARCH SEX BEHAV, V32, P93, DOI 10.1023/A:1022492106974; Holterhus PM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-292; Holterhus PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r37; Holterhus PM, 2001, TRENDS GENET, V17, P627, DOI 10.1016/S0168-9525(01)02485-4; Houk CP, 2012, CURR OPIN ENDOCRINOL, V19, P28, DOI 10.1097/MED.0b013e32834edacb; Hughes IA, 2007, ENDOCRIN DEV, V11, P47, DOI 10.1159/000111057; Hughes IA, 2006, ARCH DIS CHILD, V91, P554, DOI [10.1016/j.jpurol.2006.03.004, 10.1136/adc.2006.098319]; Hughes IA, 2012, LANCET IN PRESS; Hughes IA, 2006, BEST PRACT RES CL EN, V20, P577, DOI 10.1016/j.beem.2006.11.003; Huhtaniemi I, 2006, BEST PRACT RES CL EN, V20, P561, DOI 10.1016/j.beem.2006.09.003; Hurme T, 2009, SCAND J UROL NEPHROL, V43, P42, DOI 10.1080/00365590802299247; Imperato-McGinley J, 2002, ADV EXP MED BIOL, V511, P121; Ismail-Pratt IS, 2007, HUM REPROD, V22, P2020, DOI 10.1093/humrep/dem074; Jaaskelainen J, 2012, MOL CELL ENDOCRINOL, V352, P4, DOI 10.1016/j.mce.2011.08.006; Jameson LJ, 1999, HORMONE RESISTANCE S, P1; JENSTER G, 1993, BIOCHEM J, V293, P761, DOI 10.1042/bj2930761; Jorgensen PB, 2010, FERTIL STERIL, V94, P105, DOI 10.1016/j.fertnstert.2009.02.087; Kohler B, 2005, J CLIN ENDOCR METAB, V90, P106, DOI 10.1210/jc.2004-0462; Kurzrock EA, 1999, CELLS TISSUES ORGANS, V164, P125, DOI 10.1159/000016650; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lavery DN, 2008, BIOCHEMISTRY-US, V47, P3360, DOI 10.1021/bi702221e; Lee YS, 2007, CLIN ENDOCRINOL, V67, P20, DOI 10.1111/j.1365-2265.2007.02829.x; Liao LM, 2010, J PEDIATR UROL, V6, P609, DOI 10.1016/j.jpurol.2010.07.006; Liao LM, 2003, J REPROD INFANT PSYC, V21, P229, DOI 10.1080/0264683031000154971; Looijenga LHJ, 2007, BEST PRACT RES CL EN, V21, P480, DOI 10.1016/j.beem.2007.05.001; Looijenga LHJ, 2011, INT J ANDROL, V34, pE234, DOI 10.1111/j.1365-2605.2011.01157.x; Looijenga LHJ, 2010, BEST PRACT RES CL EN, V24, P291, DOI 10.1016/j.beem.2009.10.002; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Melo KFS, 2003, J CLIN ENDOCR METAB, V88, P3241, DOI 10.1210/jc.2002-021658; Meyts ERD, 2007, ANN NY ACAD SCI, V1120, P168, DOI 10.1196/annals.1411.013; Michala L, 2008, BJOG-INT J OBSTET GY, V115, P737, DOI 10.1111/j.1471-0528.2008.01703.x; Miles HL, 2010, ARCH DIS CHILD-FETAL, V95, pF435, DOI 10.1136/adc.2009.173575; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Minto CL, 2003, FERTIL STERIL, V80, P157, DOI 10.1016/S0015-0282(03)00501-6; Miyagawa S, 2011, ENDOCRINOLOGY, V152, P2894, DOI 10.1210/en.2011-0263; Miyagawa S, 2009, MOL ENDOCRINOL, V23, P871, DOI 10.1210/me.2008-0478; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; MORRIS JM, 1953, AM J OBSTET GYNECOL, V65, P1192, DOI 10.1016/0002-9378(53)90359-7; Pasterski V, 2010, ARCH DIS CHILD, V95, P618, DOI 10.1136/adc.2009.163840; Philibert P, 2011, FERTIL STERIL, V95, P2683, DOI 10.1016/j.fertnstert.2011.01.152; Pittock ST, 2005, AM J MED GENET A, V135A, P314, DOI 10.1002/ajmg.a.30721; Poujol N, 1997, MOL CELL ENDOCRINOL, V130, P43, DOI 10.1016/S0303-7207(97)00072-5; Priebe C, 2005, J PEDIATR SURG, V40, P136; Purves JT, 2008, J UROLOGY, V180, P1716, DOI 10.1016/j.juro.2008.03.110; Quigley CA, 2002, J CLIN ENDOCR METAB, V87, P24, DOI 10.1210/jc.87.1.24; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Rey RA, 1999, J CLIN ENDOCR METAB, V84, P627, DOI 10.1210/jc.84.2.627; Rosa S, 2007, J CLIN ENDOCR METAB, V92, P1000, DOI 10.1210/jc.2006-1486; RUTGERS JL, 1991, INT J GYNECOL PATHOL, V10, P126, DOI 10.1097/00004347-199104000-00002; Sarpel U, 2005, J PEDIATR SURG, V40, P133, DOI 10.1016/j.jpedsurg.2004.09.012; Schauwaers K, 2007, P NATL ACAD SCI USA, V104, P4961, DOI 10.1073/pnas.0610814104; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; SHAH R, 1992, J PEDIATR SURG, V27, P757, DOI 10.1016/S0022-3468(05)80110-1; Sinnecker GHG, 1997, EUR J PEDIATR, V156, P7; Slijper FME, 2000, HORM RES, V53, P9, DOI 10.1159/000023506; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Stewart CJR, 2008, HISTOPATHOLOGY, V52, P175, DOI 10.1111/j.1365-2559.2007.02927.x; Tadokoro R, 2009, CLIN ENDOCRINOL, V71, P253, DOI 10.1111/j.1365-2265.2008.03462.x; Wang RS, 2009, ENDOCR REV, V30, P119, DOI 10.1210/er.2008-0025; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Werner R, 2008, SEX DEV, V2, P73, DOI 10.1159/000129692; Werner R, 2006, J STEROID BIOCHEM, V101, P1, DOI 10.1016/j.jsbmb.2006.06.016; Werner R, 2006, J CLIN ENDOCR METAB, V91, P3515, DOI 10.1210/jc.2006-0372; Wilson JM, 2011, J PEDIATR UROL, V7, P416, DOI 10.1016/j.jpurol.2010.07.002; Yalinkaya A, 2007, PRENATAL DIAG, V27, P856, DOI 10.1002/pd.1747; Yamada G, 2006, DEV DYNAM, V235, P1738, DOI 10.1002/dvdy.20807; YONG EL, 1994, LANCET, V344, P826, DOI 10.1016/S0140-6736(94)92385-X; Zhou XC, 2010, J ANDROL, V31, P235, DOI 10.2164/jandrol.109.009266; Zuccarello D, 2008, CLIN ENDOCRINOL, V68, P580, DOI 10.1111/j.1365-2265.2007.03069.x	104	103	117	1	65	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	1526-8004	1526-4564		SEMIN REPROD MED	Semin. Reprod. Med.	SEP	2012	30	5					432	442		10.1055/s-0032-1324728	http://dx.doi.org/10.1055/s-0032-1324728			11	Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Reproductive Biology	009IA	23044881				2022-12-28	WOS:000309018300014
J	Johnson, JR				Johnson, James R.			Fostering High-Value, Cost-Conscious Care	ANNALS OF INTERNAL MEDICINE			English	Letter							INFECTIOUS-DISEASES-SOCIETY; GUIDELINES; DIAGNOSIS; AMERICA; ADULTS		Minneapolis Vet Affairs Med Ctr, Minneapolis, MN 55417 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Johnson, JR (corresponding author), Minneapolis Vet Affairs Med Ctr, Minneapolis, MN 55417 USA.		Berger, Zackary/I-7032-2013	Berger, Zackary/0000-0002-5871-0342				Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; Qaseem A, 2012, ANN INTERN MED, V156, P147, DOI 10.7326/0003-4819-156-2-201201170-00011	3	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2012	156	12					902	903		10.7326/0003-4819-156-12-201206190-00019	http://dx.doi.org/10.7326/0003-4819-156-12-201206190-00019			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	992NF	22711089				2022-12-28	WOS:000307783200023
